03.11.2014 Views

PDF File - Mahidol University

PDF File - Mahidol University

PDF File - Mahidol University

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Brain & Development 24 (2002) 345–649<br />

www.elsevier.com/locate/braindev<br />

KN<br />

Human genome project and its medical implications<br />

Y. Sakaki<br />

Human Genome Center, The Institute of Medical Science,<br />

The <strong>University</strong> of Tokyo, Tokyo, Japan<br />

Human genome project (HGP) started on 1990 under an<br />

international cooperation, and has made remarkable<br />

progress such as the first generation genetic linkage map<br />

of the human genome on 1994, and the draft sequence of<br />

the entire genome on 2000. These great achievements<br />

opened a new field of medicine and biology. Discovery of<br />

genetic variations, particularly large amounts of single<br />

nucleotide polymorphisms enabled us to genetically analyze<br />

not only typical Mendelian disorders but also complex<br />

diseases. Discovery of disease related genes opened a gate<br />

to the medical, clinical applications of genomics such as<br />

genetic diagnosis, gene therapy and drug discovery, and<br />

the progress of such applied genomics will eventually establish<br />

new types of medicine; that is, genome-based preventive<br />

medicine and personalized medicine. The progress of<br />

HGP, together with the development of new technologies<br />

such as DNA chip/micro array, and yeast two hybrid system,<br />

also allow us to explore the molecular mechanisms of<br />

complex biological process such as development and differentiation,<br />

immune system and neural system. I will summarize<br />

such progress of genomics and discuss its impact on<br />

medicine.<br />

PLENARY LECTURE/TOPIC UPDATE<br />

PL-1/TU-1<br />

Developmental Neuroscience<br />

PL-1<br />

Clinical disorders of brain plasticity<br />

M.V. Johnston<br />

Kennedy Krieger Institute and Johns Hopkins <strong>University</strong><br />

School of Medicine, Baltimore, MD, USA<br />

The child’s brain is far more plastic than the adult’s as<br />

judged by its greater ability to reorganize and recover after<br />

injury and its capacity for learning and memory. Several<br />

cellular and molecular events have been correlated with<br />

the enhanced plasticity of the developing brain, including<br />

the proliferation and pruning of synapses in cerebral cortex<br />

and the enhanced activity of excitatory neurotransmitter<br />

receptors in the neonatal period. The N-methyl-d-aspartate<br />

(NMDA)-type glutamate receptor is one of several cell<br />

surface receptors involved in neuronal plasticity, and its<br />

activity regulates neuronal survival. Over-stimulation of<br />

the NMDA receptor by perinatal hypoxic ischemia can trigger<br />

apoptosis or necrosis while blockade of NMDA receptors<br />

can also trigger apoptosis. Physiologic stimulation of<br />

the NMDA receptor as well as receptors linked to the Ras-<br />

MAP kinase pathway can activate transcription factors such<br />

as cAMP-response element-binding protein (CREB), stimulating<br />

expression of genes involved in learning and memory.<br />

An expanding group of pediatric neurologic disorders can<br />

be linked to disorders in these signaling pathways. In Coffin-<br />

Lowry syndrome, the degree of mental retardation can be<br />

correlated with the ability of the protein kinase C agonist<br />

PMA to stimulate CREB phosphorylation by the mutated<br />

kinase RSK2 in lymphoblasts (Harum et al., Neurology<br />

2001;56:207). Genetic disorders in similar signaling<br />

cascades have been detected in Rubinstein-Taybi syndrome,<br />

neurofibromatosis one, tuberous sclerosis two, and Huntington’s<br />

disease. Encephalopathies associated with congenital<br />

hypothyroidism, non-ketotic hyperglycinemia and lead<br />

poisoning also appear to involve abnormalities in these<br />

pathways. Clinical disorders of neuronal plasticity may be<br />

amenable to treatment as their pathogenesis is understood.<br />

TU-1A<br />

Disease gene hunting in China<br />

Y. Shen<br />

Chinese national human genome research center, national<br />

laboratory of medical molecular biology, IBMS, CAMS and<br />

PUMC, Beijing, China<br />

Public release of human genome sequence has ensured a<br />

level playing field worldwide for clinicians and researchers<br />

tracking the genes mutated in inherited diseases. Studies of<br />

samples taken from Chinese populations are yielding<br />

advances. The first success came in 1998, when a team<br />

led by Jia-hui Xia of the National Laboratory of Medical<br />

Genetics of China in Changsha, Hunan province, identified<br />

a gene for a form of neurological deafness. Last year, my<br />

group revealed the genetic basis of another disease, dentinogenesis<br />

imperfecta Shields type II, in which the teeth are<br />

discoloured and chip easily. We showed that a mutation in a<br />

gene called dentin sialophosphoprotein (DSSP) is responsible.<br />

Alongside our paper, researchers led by Xiangyin Kong<br />

of the Shanghai Research Center of Biotechnology reported<br />

that mutations in DSPP can also cause hearing loss.<br />

Researchers led by Lin He mapped the gene for brachydactyly<br />

type A-1, a disease in which joints of the figures are<br />

missing, misplaced or disfigured, to a small region of chro-<br />

0387-7604/02/$ - see front matter q 2002 Elsevier Science B.V. All rights reserved.<br />

PII: S0387-7604(02)00091-8


346<br />

Abstracts<br />

mosome 2 and found that mutations in Indian hedgehog<br />

(IHH) cause brachydactyly type A-1, beating competition<br />

from several groups around the world.<br />

TU-1B<br />

The central nerve system synaptic junction: evolution,<br />

architecture and plasticity of an adhesive device<br />

D.R. Colman<br />

The Montreal Neurological Institute, Canada<br />

The central nervous system (CNS) synaptic junction is<br />

likely to have evolved from the adherens junction of primitive<br />

epithelia. Both junctional types are held together by<br />

classic cadherins, and we have proposed that these bona<br />

fide adhesion molecules are involve in establishing specific<br />

connectivity patterns and in functioning as synaptic glue.<br />

Data supporting this notion will be presented. In other<br />

studies, we have been pursuing a biochemical dissection<br />

of CNS synaptic junction, and now report the key structural<br />

features of the presynaptic compartment may be solubilized<br />

and then reconstituted in vitro. This is a first step in generating<br />

a ‘synthetic’ synapse, using a minimum of functional<br />

elements.<br />

PL-2/TU-2<br />

Neonatal Neurology<br />

PL-2<br />

Brain injury in the premature infant – recent advances<br />

J. Volpe<br />

Harvard Medical School and Children’s Hospital, USA<br />

Brain injury in the premature infant is a problem of<br />

enormous importance. Periventricular leukomalacia<br />

(PVL) is the major neuropathological form of this brain<br />

injury and underlies most of the neurologic morbidity<br />

encountered in survivors of premature birth. Prevention<br />

of PVL now seems ultimately achievable because of recent<br />

neurobiologic insights into pathogenesis. The pathogenesis<br />

of this lesion relates to three major interacting factors. The<br />

first two of these, an incomplete state of development of<br />

the vascular supply to the cerebral white matter, and a<br />

maturation- dependent impairment in regulation of cerebral<br />

blood flow underlie a propensity for ischemic injury to<br />

cerebral white matter. The third major pathogenetic factor<br />

is the maturation-dependent vulnerability of the oligodendroglial<br />

(OL) precursor cell that represents the major cellular<br />

target in PVL. Recent neurobiologic studies show that<br />

these cells are exquisitely vulnerable to attack by free radicals,<br />

known to be generated in abundance with ischemiareperfusion.<br />

This vulnerability of OLs is maturation-dependent,<br />

with the OL precursor cell highly vulnerable and the<br />

mature OL resistant, and appears to relate to a developmental<br />

window characterized by a combination of deficient<br />

antioxidant defenses and active acquisition of iron during<br />

OL differentiation. The result is generation of deadly reactive<br />

oxygen species and apoptotic OL death. Important<br />

contributory factors in pathogenesis interact with this<br />

central theme of vulnerability to free radical attack. Thus,<br />

the increased likelihood of PVL in the presence of intraventricular<br />

hemorrhage could relate to increases in local<br />

iron concentrations derived from the hemorrhage. The<br />

important contributory role of maternal/fetal infection or<br />

inflammation and cytokines in the pathogenesis of PVL<br />

could be related to effects on the cerebral vasculature<br />

and cerebral hemodynamics, to generation of reactive<br />

oxygen species, or to direct toxic effects on vulnerable<br />

OL precursors. A key role for elevations in extracellular<br />

glutamate, caused by ischemia-reperfusion, is suggested by<br />

demonstrations that glutamate causes toxicity to OL<br />

precursors by both non-receptor- and receptor-mediated<br />

mechanisms. The former involves an exacerbation of the<br />

impairment in antioxidant defenses, and the latter, an<br />

amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid<br />

(AMPA)/kainate receptor-mediated cell death. Most<br />

importantly, these new insights into the pathogenesis of<br />

PVL suggest potential preventative interventions. The<br />

latter include avoidance of cerebral ischemia by detection<br />

of infants with impaired cerebrovascular autoregulation,<br />

e.g. through the use of in vivo near-infrared spectroscopy,<br />

the use of free radical scavengers to prevent toxicity by<br />

reactive oxygen species, the administration of AMPA/<br />

kanaite receptor antagonists to prevent glutamate-mediated<br />

injury, or the use of maternal antibiotics or anticytokine<br />

agents to prevent toxicity from maternal/fetal infection or<br />

inflammation and cytokines.<br />

TU-2A<br />

Neuropathological studies on neonatal hypoxic-ischemic<br />

brain damage in experimental animals<br />

H. Yoshioka<br />

Department of Pediatrics, Kyoto Prefectural <strong>University</strong> of<br />

Medicine, Kyoto, Japan<br />

Biochemical and physiological experiments on neonatal<br />

hypoxic-ischemic brain damage may demonstrate many<br />

biochemical or physiological derangements in the brain,<br />

but it cannot be known without pathological verification<br />

whether such a derangement may result in permanent brain<br />

damage or not. Neuropathological approach has advantage<br />

as follows. (1) It can distinguish irreversible damage from<br />

reversible ones. Therefore, we can find which therapy<br />

protects or reduces permanent brain damage. (2) It can<br />

demonstrate regional difference in the response of the<br />

brain. Here I present some results of neuropathological<br />

studies on neonatal hypoxic-ischemic brain damage<br />

obtained in our laboratory. Since our earlier studies<br />

using neonatal mice suggested that hypoxia alone does<br />

not lead to apparent brain damage, but ischemia with or


Abstracts 347<br />

without hypoxia causes unequivocal brain lesions, we<br />

produced a new model of global ischemia by 3-vesselocclusion<br />

in 10-day-old rats. Using this model, we investigated<br />

pathogenic mechanisms and effective treatments of<br />

ischemic brain damage. (1) One-hour-ischemia reduced<br />

cerebral blood flow (CBF) to about 10% of control level<br />

and caused exhaustion of brain adenosine-5 0 -triphosphate<br />

(ATP) within 20 min. (2) Although ATP was exhausted for<br />

more than 30 min, 24 h later the brains revealed that only<br />

10% of cortical neurons had ischemic changes. (3) Twohour-ischemia<br />

caused diffuse brain infarct: More than 70%<br />

of cortical neurons showed ischemic changes. (4) Most<br />

ischemic neurons were TUNEL positive and electrophoresis<br />

of the brain tissues showed ladder formation, but electron<br />

microscopic study revealed only necrotic changes and<br />

no evidence of apoptosis. (5) Post-ischemic administration<br />

of polyethylene glycol-superoide dismutase (PEG-SOD)<br />

reduced ischemic damage to about 10%. (6) Pre- and<br />

post-ischemic administration of magnesium sulfate<br />

reduced ischemic brain damage to about 20%. Intraventricular<br />

administration of synaptotagmine antisense DNA 3<br />

days before ischemic event prevented ischemic brain<br />

damage.<br />

TU-2B<br />

Neuroimaging characteristics of neonatal brain injury<br />

P.S. Hüppi<br />

Department of Pediatrics, <strong>University</strong> of Geneva, Switzerland<br />

and Department of Neurology, Harvard Medical<br />

School, Boston, USA<br />

Despite marked improvements in perinatal practice, perinatal<br />

brain injury remains one of the most common complications<br />

causing chronic handicapping conditions. Many of<br />

the cellular and vascular mechanisms of perinatal brain<br />

damage have been studied and show a correlation between<br />

the nature of the injury and the maturation of the brain. In<br />

vivo diagnostic tools are therefore needed to assess brain<br />

development, to detect and to localize early brain injury<br />

and monitor interventions aimed at minimizing or preventing<br />

irreversible brain injury. Magnetic resonance (MR)<br />

techniques have in recent years become the imaging<br />

modality of choice for a more detailed structural as well<br />

as metabolic and functional assessment of the developing<br />

brain. Conventional MR imaging (MRI) has widely proven<br />

its potential to identify normal and pathologic brain<br />

morphology giving objective information about the structure<br />

of the neonatal brain during development. The sensitivity<br />

of MR imaging to delineate gray matter from white<br />

matter, myelinated and unmyelinated, renders it suitable<br />

for the quantitative measurement of the cerebrum, with<br />

further application to the study of brain maturation in<br />

vivo. Volumetric analysis of 3D-MR imaging data sets is<br />

achieved by segmentation of the imaged volume into the<br />

different tissue types. Quantitative 3D-MRI at term in<br />

preterm infants with perinatal white matter injury shows<br />

significantly decreased cortical gray matter (GM) volume<br />

and a reduced amount of myelinated white matter (WM) as<br />

an expression of structural alteration of brain development<br />

after perinatal brain injury. Functional MR imaging such as<br />

diffusion- weighted imaging (DWI) and perfusion and<br />

blood-oxygenation-dependent BOLD imaging are new<br />

imaging methods providing insights into brain physiology.<br />

DWI in preterm and full term newborns have shown a<br />

reduction of apparent diffusion coefficient (ADC) with<br />

increasing age but also acutely reduced ADC in regions<br />

of early ischemic injury, making this technique ideal for<br />

the early assessment of hypoxic-ischemic injury. Magnetic<br />

resonance spectroscopy represents the unique modality to<br />

study brain metabolism and has become an important addition<br />

to MRI. This review will therefore focus mainly on<br />

recent advances in the application of magnetic resonance<br />

techniques in pre- and postnatal neuroimaging of perinatal<br />

brain injury.<br />

PL-3/TU-3<br />

Seizure Disorders<br />

PL-3<br />

Epilepsy and the developing brain<br />

K. Watanabe<br />

Department of Pediatrics, Nagoya <strong>University</strong> Postgraduate<br />

School of Medicine, Nagoya, Japan<br />

Age-related onset is a characteristic feature of childhood<br />

epilepsy, and different epileptic syndromes occur at different<br />

ages. Epileptic seizures and syndromes undergo evolutionary<br />

changes with development, and one epileptic<br />

syndrome may evolve into another as in age-dependent<br />

epileptic encephalopathy. These features of childhood<br />

epilepsy are related to the maturation of the brain as well<br />

as the plasticity of the developing brain. Epileptic<br />

syndromes of the newborn undergo evolutionary changes<br />

with development. A common evolution in symptomatic<br />

epilepsies of neonatal onset was partial epilepsy with transient<br />

West syndrome during infancy. In symptomatic West<br />

syndrome, focal and then multifocal discharges were<br />

followed by the appearance of hypsarrhythmia. In symptomatic<br />

generalized epilepsies, discrepancies between electroencephalogram<br />

(EEG) and seizure types are common:<br />

epileptic spasms may persist even if interictal paroxysmal<br />

discharges tend to show localized discharges with age.<br />

Localization-related epilepsies may demonstrate transient<br />

generalization of paroxysmal discharges with various<br />

degrees of clinical deterioration during a certain stage of<br />

development. Severe myoclonic epilepsy never evolves<br />

into Lennox-Gastaut syndrome.


348<br />

Abstracts<br />

TU-3A<br />

Pediatric epilepsy: clinical update<br />

O. Dulac<br />

Service de Neuropediatrie Hopital Saint-Vincent de Paul,<br />

France<br />

One of the major challenges in paediatric epilepsy is to<br />

prevent psychomotor and behavioural deterioration. It may<br />

result from long lasting or frequent seizures, or from major<br />

activation of so-called interictal paroxysmal activity. Early<br />

identification of at risk conditions and risk factors are necessary<br />

conditions to prevent such deterioration. Risk factors for<br />

hypothalamic harmatoma (HH) syndrome are Sturge-Weber<br />

disease, tuberous sclerosis and callosal agenesis that are<br />

disclosed from birth with neuroradiology. For Dravet<br />

syndrome, the identification of abnormal genetic background<br />

will permit optimising new antiepileptic drug treatment and<br />

prevent the use of worsening compounds, to prevent status<br />

epilepticus. West and Lennox-Gastaut syndromes may be<br />

precipitated by inappropriate medication administered for<br />

other types of seizures. For myoclonic-astatic epilepsy, the<br />

early diagnosis of this syndrome, presently based on the clinical/EEG<br />

features could benefit from the ongoing progress in<br />

molecular genetics, permitting early adequate treatment to<br />

prevent the occurrence of myoclonic status. Symptomatic<br />

continuous spikes and waves during slow sleep (CSWS)<br />

may complicate pre-, peri- or early postnatal ischaemic<br />

brain lesions. As for cryptogenic CSWS, some medications<br />

may precipitate the generalisation and the continuous spikewave<br />

activity.<br />

TU-3B<br />

Genetics of epilepsy<br />

I.E. Scheffer<br />

Epilepsy Research Institute, <strong>University</strong> of Melbourne, Austin<br />

and Repatriation Medical Centre, Monash Medical Centre<br />

and Royal Children’s Hospital, Melbourne, Australia<br />

Revolutionary insights have been gained from the discovery<br />

of epilepsy genes over the last 7 years. Although only ten<br />

idiopathic epilepsy genes have been identified to date, many<br />

encode subunits of ligand-gated and voltage-gated ion channels<br />

which are associated with specific epilepsy syndromes.<br />

For example, ligand-gated ion channels with mutations<br />

include neuronal nicotinic acetylcholine receptors in Autosomal<br />

dominant nocturnal frontal lobe epilepsy and gamma<br />

amino butyric acid A (GABA A ) receptors in generalized<br />

epilepsy with febrile seizures plus (GEFS 1 ) and childhood<br />

absence epilepsy. Similarly, potassium channel genes are<br />

mutated in benign familial neonatal convulsions and sodium<br />

channel genes in GEFS 1 . In vitro functional studies of<br />

sodium channel and GABA mutations show loss of function.<br />

Two recently identified epilepsy genes suggest different<br />

pathways. In autosomal dominant partial epilepsy with auditory<br />

features, a gene encoding the leucine-rich, glioma-inactivated<br />

1 gene has defects. X-linked infantile spasms are<br />

associated with mutations in Aristaless related homeobox<br />

gene (ARX), a homeobox gene involved in gene transcription.<br />

All genes identified thus far are associated with the rare<br />

group of monogenic epilepsies. These genes may not be relevant<br />

to the common idiopathic epilepsies following complex<br />

inheritance where several genes interact and environmental<br />

factors play a role. The challenge is to determine the genes<br />

involved in the common epilepsies and how they interact to<br />

produce specific epilepsy syndromes. A range of strategies<br />

such as sib pair analysis and association studies is being<br />

adopted to solve the genetics of the common epilepsies but<br />

it is unclear which will bear fruit. Unravelling the genetics of<br />

the idiopathic epilepsies holds the promise of refining diagnosis<br />

and treatment in the future.<br />

PL-4/TU-4<br />

Infectious Disease and Immunology<br />

PL-4<br />

Neurological manifestations of falciparum malaria in<br />

children<br />

C.R.J.C. Newton<br />

Neuroscience’s Unit, Institute of Child Health, London, UK<br />

Plasmodium falciparum remains one of the most common<br />

causes of central nervous system infection world-wide, with<br />

children living in sub-Saharan Africa bearing the brunt of the<br />

disease. In comparison to other forms of human malaria, P.<br />

falciparum appears to have a propensity for the brain. The<br />

manifestations of severe falciparum malaria depend upon the<br />

age of the patient, the immune status and there appear to be<br />

differences in the clinical presentation between children<br />

living in Africa and those in Asia. In African children,<br />

seizures and cerebral malaria are the most common acute<br />

manifestations. About 11% of these children with cerebral<br />

malaria develop neurological deficits, of which half appear to<br />

be transient. However other children develop neuro-cognitive<br />

deficits, particularly language impairment and epilepsy.<br />

Epilepsy is associated with complicated seizures during<br />

admission. In Asia, cerebellar ataxia and other post-malaria<br />

neurological syndromes occur, although the aetiology is<br />

unclear. The impact of parasitisation and the long-term<br />

consequences have received little attention, and may have<br />

profound influence on children growing up in endemic areas.<br />

TU-4A<br />

Bacterial meningitis<br />

V. Kalra<br />

Pediatrics, All India Institute of Medial Sciences, New<br />

Delhi, India<br />

Bacterial meningitis, is a catastrophic childhood illness


Abstracts 349<br />

despite advent of potent antibiotics. Bacterial meningitis may<br />

be acute, recurrent orchronic andmay occur sporadically orin<br />

epidemics. Acute bacterial meningitis is etiologically diverse<br />

in the neonatal period, from later years. Geographic differences<br />

in etiology, prevalence patterns, are common. Lumbar<br />

puncture remains the single most important investigation.<br />

Ideally blood sugar estimation – 20–30 min before a L.P.,<br />

staining of csf cells, counting cells within 30 min, gram’s<br />

stain of csf centrifugate and immediate plating for cultures<br />

should be performed. Newer antigen detection methods like<br />

CIE, LPA, Elisaand PCRare usefulduetohighspecificity and<br />

sensitivity (in increasing order), but are not always available.<br />

Evolution of empiric antibiotic regime from penicillin/ampicillin<br />

and chloramphenicolto ceftrixone or cefotaxime will be<br />

discussed. The status of I.V. corticosteroids, preceding initiationantibioticstherapyandourdataregardingoutcomewillbe<br />

discussed. Partially treated acute bacterial meningitis<br />

frequently poses a diagnostic dilemma making therapy decisions<br />

difficult. The algorithm followed in this situation will be<br />

presented. Chronic bacterial meningitis in children most<br />

commonly is tubercular. Fungal, parasitic, risickettsial,<br />

neoplastic or immune deficiency need to be excluded. TBM<br />

merits early diagnosis by high index of suspicion, csf, chest<br />

skiagram Mantoux, family screening, and cranial imaging.<br />

The low diagnostic yield of these tests and current status of<br />

AFB detection techniques will be reviewed. A five drug<br />

regimeincluding streptomycin is recommended. Dexamethasone<br />

probably reduces morbidity related to raised ICP, focal<br />

deficits and inflammatory consequences. Long term ATT<br />

regime is still recommended. Appearance of tuberculomas<br />

post therapy, BCG modification of the clinical profile and<br />

prevalence of TBM will be addressed.<br />

TU-4B<br />

Immune mechanisms in multiple sclerosis<br />

H. Wekerle<br />

Max-Planck-Institute of Neurobiology, Martinsried,<br />

Germany<br />

Multiple sclerosis is more than just one particular disease.<br />

It encompasses a broad spectrum of inflammatory demyelinating<br />

diseases, which are remarkably distinct in distribution<br />

and cellular composition of lesions. This diversity may be<br />

explained by an immune pathogenesis, which is by far more<br />

complex than traditionally assumed. It now turns out that<br />

individual MS lesions are generated in sequential steps involving<br />

close interaction between the auto aggressive lymphocytes<br />

and non-lymphoid target cells. In a first step,<br />

autoimmune T lymphocytes, which are components of the<br />

healthy immune repertoire, are activated, presumably by<br />

microbial factors. The activated T cells then migrate through<br />

immune organs, and undergo profound functional changes<br />

before they break through the endothelial blood–brain<br />

barrier. Within the brain parenchyme, the T cells act on<br />

local glia cells to become efficient presenters of myelin autoantigens.<br />

Glial cell activation is under the tight control of<br />

neurons, which critically determine immune responsiveness<br />

in the brain microenvironment. Active neurons suppress<br />

immune reactivity, while areas with compromised neuronal<br />

activity become preferred sites of immune reactions. Neurotrophins<br />

are involved in neuronal suppression of brain<br />

immune reactivity. Local antigen presentation leads to<br />

fresh activation of the autoimmune T cells, and thus sets<br />

the stage for the recruitment of inflammatory macrophages,<br />

and myelin specific B lymphocytes, processes which can be<br />

studied using transgenic knock-in mice. Myelin binding auto<br />

antibodies cause destruction of myelin sheaths and myelin<br />

forming oligodendrocytes. Axonal processes crossing a<br />

demyelinating inflammatory area degenerate either following<br />

removal of myelin, or after to direct cytotoxic T cell<br />

attacks. Each of the pathogenic steps qualifies as a potential<br />

target of specific immune therapies.<br />

PL-5/TU-5<br />

Autistic Spectrum Disorders<br />

PL-5<br />

Screening, diagnosis and treatment of autistic spectrum<br />

disorders<br />

P. Filipek<br />

<strong>University</strong> of California Irvine, Irvine, CA, USA<br />

The appropriate diagnosis of autism requires a two-tiered<br />

approach: (1) routine developmental surveillance by all<br />

primary care medical providers; and (2) a diagnostic evaluation<br />

specific to autism. Practice parameters for the diagnosis<br />

and evaluation of autism were formulated by the Child<br />

Neurology Society and the American Academy of Neurology<br />

in 2000, in conjunction with nine professional and four parent<br />

organizations, with liaisons from the National Institutes of<br />

Health. The National Academy of Science later developed<br />

specific recommendations for the treatment of young children<br />

with autism in 2001. This plenary lecture will focus on<br />

the specific detailed recommendations that were established<br />

for each level of diagnosis, and the appropriate intervention<br />

for young children with autism. These consensus statements<br />

are intended to improve the rate of early suspicion and diagnosis<br />

of autism, and therefore early appropriate intervention.<br />

TU-5A<br />

Neuroimaging in autism<br />

T. Hashimoto<br />

Department of Education for Disabled, Naruto <strong>University</strong> of<br />

Education Nakashima, Takashima, Naruto, Tokushima,<br />

Japan<br />

Autism is a behavioral disorder defined by specific qualitative<br />

impairment of reciprocal social interaction and<br />

communication, as well as restricted interest and stereotyped


350<br />

Abstracts<br />

patterns of behavior, interests, and activities. MRI studies in<br />

autism have found a variety of alterations including a<br />

decrease of size of various brain structures. In functional<br />

neuroimaging studies such as functional MRI (fMRI),<br />

magnetic resonance spectroscopy (MRS), positron emission<br />

spectroscopy (PET) and single photon emission computed<br />

tomography (SPECT), various abnormalities have been<br />

reported. SPECT has found a decrease of regional cerebral<br />

blood flow (rCBF) in the frontal and temporal regions and the<br />

left cerebral hemisphere, and has shown the relationship<br />

between rCBF and symptoms. PET has found metabolic<br />

abnormalities in frontal monoaminergic neuron systems,<br />

and a decrease of glucose metabolic activity in anterior<br />

cingulate gyrus. MRS has found energy metabolism abnormality<br />

in the frontal lobe using 31P-MRS, and abnormality in<br />

medial temporal and lateral frontal regions using 1 H-MRS.<br />

fMRI has found a lower activity in the amygdala during face<br />

recognition test and in the right fusiform gyrus during face<br />

discrimination test. These structural and functional imaging<br />

findings suggest that the anatomic abnormalities are multiple<br />

and not located, and are more likely to be the results of<br />

abnormal development of connections of undefined<br />

disturbed neural networks for complex information processing<br />

involving the frontal cerebral cortex, limbic system, and<br />

posterior fosse brain structures. In this presentation,<br />

previously reported findings will be discussed in relations<br />

with possible mechanism of symptom occurrence in autism.<br />

TU-5B<br />

ADHD: current concepts and neurobiology<br />

M. Denckla<br />

The Kennedy Krieger Institute, Baltimore, MD, USA<br />

Aided by advances in cognitive neuroscience and neuroimaging,<br />

the emerging current concept of ADHD is that it<br />

represents a group of deficits in self-control; affected in<br />

some combination are motor control, cognitive control, and<br />

emotional control. So frequent is the comorbidity with<br />

ADHD of Developmental Motor Coordination Disorder<br />

that this combination mirrors Gillberg’s DAMP syndrome.<br />

Neuroimaging implicates parallel underlying circuits<br />

comprised of frontal, striatal, and cerebellar regions, with<br />

consensus based on MRI measurements that somewhat smaller<br />

total brain volumes (3–5% reductions) are of multifocal<br />

(not diffuse) origin, mostly small frontal and striatal hypoplasia.<br />

This topic update on ADHD will also review diagnosis,<br />

behavioral genetics, prognosis (especially genderdiscrepant),<br />

neurotransmitters (with implications for genetics<br />

and pharmacotherapeutics) and non-pharmacological<br />

therapies. The emphasis, however, will be on the following:<br />

implications of motor localization clues; neurocognitive<br />

elucidation that attention allocation (not attention per se) is<br />

deficient; and evidence from in vivo MR neuroimaging, both<br />

anatomic MRI and fMRI, that frontal-striatal-cerebellar<br />

circuits deserve scrutiny in relation to ADHD.<br />

SYMPOSIUM<br />

SY-1<br />

Pathogenesis and Prevention of Prenatal and Perinatal<br />

Brain Damage<br />

SY-01-1<br />

Structural and functional studies on cadherins, synaptic<br />

adhesion molecules<br />

W. Shan, D.R. Colman<br />

Fishberg Research Center for Neurobiology, The Mount<br />

Sinai School of Medicine, New York, New York, USA<br />

The ability of the mammalian CNS to perform complex<br />

informative processes and highly cognitive functions is<br />

based on the precise and specifically determined connectivity<br />

of different neuronal cell types at synapses. Recently studies<br />

implicate that cadherins, calcium-dependent cell adhesion<br />

molecules, are involved in synaptic formation, specifying<br />

connections among different synapses and functional modulation<br />

during early development. The molecular mechanisms<br />

by which the classic cadherin mediate adhesion are beginning<br />

to be elucidated. We have identified certain key residues<br />

at the interface of N-cadherin molecules that participate in<br />

cell-cell adhesion formation. In addition, two different, but<br />

conserved cadherins are highly likely to form hetero-interaction<br />

at adherent junction sites, which may increase the<br />

diversity of synaptic connections. Furthermore, synaptic<br />

modulation could be activated in either physiological or<br />

pathological conditions, indicating a role for cadherins in<br />

synaptic plasticity. Taken together, our data provide insights<br />

into the mechanisms of formation of adherens junctions,<br />

synaptic targeting, and modulation of synaptic activity.<br />

SY-01-2<br />

Basic mechanisms and prevention of prenatal brain<br />

damage<br />

P. Evrard<br />

Service de Neurologie Pediatrique et des Maladies Metaboliques,<br />

Faculte de Medicine Xavier-Bichat, Hospital<br />

Robert-Debre, Paris, France<br />

Abstract not submitted<br />

SY-01-3<br />

Neurophysilogical analysis of periventricular<br />

leukomalacia in preterm infants<br />

A. Okumura, K. Watanabe, F. Hayakawa, T. Kato<br />

Department of Pediatrics, Nagoya <strong>University</strong> Graduate<br />

School of Medicine, Nagoya, Japan<br />

PVL is an important cause of cerebral palsy in preterm<br />

infants. Serial EEG recordings are not only of great prognostic<br />

value but also useful to determine the timing of brain


Abstracts 351<br />

injuries in preterm infants with PVL. Flash visual evoked<br />

potentials (FVEP) are also useful for the diagnosis of PVL<br />

and the analysis of its pathogenesis. EEG abnormalities can<br />

be divided into two categories; acute and chronic stage<br />

abnormalities. Acute stage abnormalities mainly consist of<br />

changes in continuity, frequency and voltage. Acute stage<br />

abnormalities appear immediately after acute brain insults.<br />

Chronic stage abnormalities consist of dysmature and disorganized<br />

patterns. Disorganized pattern refers to abnormal<br />

deformed background activities without findings of acute<br />

depression. They are usually recognized in infants with<br />

PVL and indicate irreversible brain damages. As to FVEP,<br />

we paid attention to the waveform of the negative peak with<br />

a mean latency of 300 ms (N300). Abnormal FVEP findings<br />

were categorized into three patterns; absent VEP, abnormal<br />

wave form, and delayed latencies. Our recent studies<br />

revealed that acute stage abnormalities were seen in 60%<br />

of infants with cystic PVL, chronic stage abnormalities in<br />

90%, and FVEP abnormalities in 80%. These abnormalities<br />

were always recognized before cystic changes appeared on<br />

ultrasonography. Evolutional EEG changes suggested that<br />

the timing of injury was antenatal or perinatal. It is remarkable<br />

that EEG abnormalities usually preceded FVEP<br />

abnormalities. This suggested that the interval of several<br />

days will exist from a brain insult to irreversible brain<br />

damages in infants with PVL.<br />

SY-01-4<br />

Pathogenesis, plasticity and prevention of perinatal<br />

brain damage<br />

A. Oka, A. Hirayama, S. Takashima<br />

Division of Child Neurology, Institute of Neurological<br />

Sciences Tottori <strong>University</strong> School of Medicine, Japan<br />

Infants born as prematures are highly susceptible to<br />

ischemic white matter damage, i.e. PVL. Currently, PVL<br />

is regarded as a main type of white matter injury, causing<br />

cerebral palsy and intellectual deficits. In the pathogenesis<br />

of PVL, the development of vasculature in deep white<br />

matter as well as the vulnerability of differentiating glial<br />

progenitor cells is an important predisposing factor, and the<br />

cerebral hypoperfusion associated with inflammatory<br />

factors is causally related to PVL. We have evaluated<br />

neuropathology of PVL. While cystic lesions in periventricular<br />

areas are characteristic, the lesions are often widelyspread,<br />

reaching to deeper white matter in extremely lowbirth-weight<br />

infants. Immunohistochemical studies have<br />

revealed the early stage of axonal injury is accompanied<br />

by accumulation of amyloid precursor protein, which is<br />

carried by axonal transport. Axons at PVL lesions also<br />

express adhesion molecules, such as L1 or HNK-1,<br />

which are up-regulated by axonal growth during fetal<br />

period, or GAP-43, a marker of axonal re-growth. Later,<br />

focal or diffuse accumulation of neurofilament in swollen<br />

axons persists, indicating axonal damage in PVL. These<br />

changes indicate early axonal damage, followed by reactive<br />

or repair mechanisms. In terms of glial cells, we found<br />

increased immunoreactivity of nestin and myelin transcription<br />

factor (MyT1) in PVL brains of later stage. Nestin is<br />

expressed by multipotential stem cells, and intense labeling<br />

is seen in early fetal white matter. Surrounding PVL<br />

lesions of chronic stage, nestin-immunoreactive astrocytes<br />

as well as axons are present, suggesting tissue repair.<br />

MyT1 is a zinc-dependent DNA-binding protein, and<br />

expressed in early progenitors of oligodendrocyte cell lineage.<br />

In the chronic stage, there is an increase in MyT1-<br />

immunoreactive cells, which are distributed around necrotic<br />

foci. The increase in immature oligodendrocytes near<br />

PVL lesions also indicates compensatory mechanism,<br />

probably leading to plasticity.<br />

SY-2<br />

Neuromuscular Disorders<br />

SY-02-1<br />

The molecular genetics of spinal muscular atrophy:<br />

recent progress and therapeutic implication<br />

C.H. Wang<br />

Department of Child Health, <strong>University</strong> of Missouri, One<br />

Hospital Drive, Columbia, MO, USA<br />

Spinal muscular atrophy (SMA) is a neuromuscular<br />

disorder characterized by degeneration of the spinal cord<br />

motor neurons. SMA is phenotypically heterogeneous and<br />

has been classified into three subtypes. The gene for the<br />

three types of autosomal recessive SMA was mapped to<br />

chromosome 5q13 in 1990. Further progress in the field has<br />

led to the identification of the survival of motor neuron<br />

(SMN) gene in 1995. The SMN gene is presented in two<br />

highly homologous copies: the telomeric copy SMN1, and<br />

the centromeric copy SMN2. Over 95% of the SMA<br />

patients harbor a homozygous deletion or mutation of the<br />

SMN1 gene but retain at least one copy of the SMN2 gene.<br />

The SMA severity is correlated with the copy number of<br />

the SMN2 gene and its ability to produce intact SMN<br />

messenger RNA (mRNA) and protein within the SMA<br />

patients. The SMN gene plays a crucial role in the cellular<br />

mRNA metabolism. A mouse model of SMA has been<br />

generated that exhibits both clinical and pathological<br />

resemblance of human SMA. The therapeutic application<br />

of these findings includes identifying ways to augment the<br />

production of intact SMN protein by SMN2 gene in order<br />

to ameliorate the clinical symptoms of SMA. Several transcription<br />

factors have been shown to induce the production<br />

of intact SMN protein by interacting with crucial<br />

sequences on the exon 7 of SMN2 gene. Large scale<br />

drug screen has been started in an attempt to identify pharmacological<br />

compounds which can stimulate in vivo<br />

production of SMN protein. Progress in this area will be<br />

reported.


352<br />

Abstracts<br />

SY-02-2<br />

Recent advances in congenital muscular dystrophies<br />

I. Nonaka, Y.K. Hayashi, H. Ishikawa, K. Sugie, F.<br />

Uematsu, I. Nishino<br />

National Center of Neurology and Psychiatry, Tokyo, Japan<br />

Congenital muscular dystrophy (CMD) has been classified<br />

into two major groups: Fukuyama type CMD (FCMD)<br />

and classical CMD (non-FCMD). FCMD is prevalent in the<br />

Japanese, comprising 1–2/100 000 population and characterized<br />

clinically by muscle hypotonia and weakness from<br />

early infancy and central nervous system abnormalities. The<br />

gene for FCMD has been mapped to 9q31 and the gene<br />

product, fukutin, consists of 461 amino acids, but its function<br />

is unknown. Since immunoreactivity to alpha-dystroglycan<br />

was deficient, the fukutin gene mutation is probably<br />

related to altered glycosylation, which may lead to disruption<br />

of the transmembranous molecular linkage. The classical<br />

form of non-FCMD has been further subdivided into<br />

several distinct forms, including merosin deficiency,<br />

muscle-eye-brain (MEB) disease and congenital atonicsclerotic<br />

muscular dystrophy (Ullrich’s disease). We have<br />

studied nine patients with Ullrich’s disease clinically and<br />

pathologically. From early infancy, all patients had proximal<br />

joint contractures, including limited neck flexion and<br />

kyphoscoliosis, and distal joint hyperlaxity. Although four<br />

patients learned to walk, the disease is slowly progressive.<br />

One patient had a complete collagen VI deficiency immunohistochemically<br />

and compound heterozygous mutation in<br />

the COL6 gene. The other eight had partial collagen VI<br />

deficiency immunohistochemically.<br />

SY-02-3<br />

Mitochondrial myopathies<br />

S. DiMauro<br />

Columbia <strong>University</strong> College of Physicians and Surgeons,<br />

New York, NY, USA<br />

The ‘molecular era’ of mitochondrial myopathies started<br />

in 1988 with the discovery of the first mutations in mitochondrial<br />

DNA (mtDNA). The small circular molecule of<br />

mtDNA turned out to be a Pandora’s box of pathogenic<br />

mutations, which have been associated with a bewildering<br />

variety of clinical syndromes. From a genetic point of<br />

view, mtDNA mutations can be divided into two groups:<br />

those affecting mitochondrial protein synthesis in toto; and<br />

those affecting specific proteins of the respiratory chain. In<br />

recent years, interest has shifted towards Mendelian genetics,<br />

a shift justified by the fact that most proteins of the<br />

respiratory chain are encoded by nuclear DNA (nDNA). In<br />

addition, proper assembly and function of respiratory chain<br />

complexes requires numerous nDNA-encoded ancillary<br />

proteins, whose mutations cause mitochondrial encephalomyopathies<br />

(‘murder by proxy’). Because mtDNA is the<br />

slave of nDNA, numerous nuclear factors are needed to<br />

insure mtDNA replication and to preserve mtDNA integrity.<br />

Mutations in these factors impair intergenomic<br />

communication and result in syndromes characterized by<br />

mtDNA multiple deletions, mtDNA depletion, or both<br />

together. Within the past year, mutations in four genes<br />

have been associated with autosomal dominant or recessive<br />

forms of progressive external ophthalmoplegia and multiple<br />

mtDNA deletions, and mutations in two genes have<br />

been associated with mtDNA depletion syndromes. Finally,<br />

new pathogenetic concepts are being introduced. For<br />

example, alterations of the respiratory chain may be due<br />

to altered composition of the inner mitochondrial<br />

membrane (IMM) lipid milieu. This is the case of Barth<br />

syndrome, an X-linked recessive mitochondrial myopathy/<br />

cardiopathy characterized by severe deficiency of cardiolipin,<br />

the major phospholipid of the IMM.<br />

SY-02-4<br />

Lipid storage myopathies<br />

I. Tein<br />

Division of Pediatric Neurology, Hospital for Sick Children,<br />

Canada<br />

Genetic defects in fatty acid oxidation (FAO) are an<br />

important group of infancy- or childhood-onset disorders<br />

because they are potentially rapidly fatal and a source of<br />

major morbidity. FAO defects encompass a spectrum of clinical<br />

disorders including progressive lipid storage myopathy,<br />

episodic myoglobinuria, neuropathy, pigmentary retinopathy,<br />

progressive cardiomyopathy and recurrent hypoglycemic,<br />

hypoketotic encephalopathy or Reye-like syndrome<br />

with secondary seizures and potential developmental delay.<br />

Recurrent myoglobinuria may be seen in carnitine palmitoyltransferase<br />

II, carnitine acylcarnitine translocase, long- and<br />

very long-chain acyl-CoA dehydrogenase, short-chain l-3-<br />

hydroxyacyl-CoA dehydrogenase and long-chain l-3-hydroxyacyl-CoA<br />

dehydrogenase or trifunctional protein deficiencies.<br />

As all of the known FAO defects are inherited as<br />

autosomal recessive diseases, there is oftentimes a family<br />

history of sudden unexpected death or sudden infant death<br />

syndrome (SIDS) in siblings. Early recognition and prompt<br />

initiation of therapy, as well as institution of appropriate<br />

preventive measures, may be lifesaving and significantly<br />

decrease long-term morbidity, particularly with respect to<br />

neurological sequelae. There are now at least 17 recognized<br />

defects in FAO, most of which have been diagnosed in the<br />

last 15 years. With significant biomedical advances and<br />

increased index of clinical suspicion, there has been a rapid<br />

increase in the number of diagnosed cases. In a recent survey<br />

from the Pennsylvania newborn screening program, the incidence<br />

of medium-chain acyl-coenzyme A dehydrogenase<br />

deficiency was found to be as high as 1 in 8930 live births.<br />

In order to provide the background for understanding these<br />

disorders, an overview will be given of the pathway of FAO


Abstracts 353<br />

and the central role of carnitine. This will be followed by a<br />

description of the hallmark clinical, biochemical and pathological<br />

features of specific genetic defects in FAO,<br />

approaches to diagnosis, and current treatment methodologies.<br />

SY-3<br />

Molecular Basis of Neurological Diseases in Children<br />

SY-03-1<br />

Identification and characterization of novel mutations of<br />

the aspartoacylase gene in non-Jewish patients with<br />

Canavan disease<br />

E.H. Kolodny a , B. Zeng a , Z.-H. Wang a , L.A. Ribeiro a ,P.<br />

Leone b , S.-J. Kim a , G.M. Pastores a , S. Raghavan a , E. Ong a<br />

a Department of Neurology, New York <strong>University</strong> School of<br />

Medicine, New York, NY;<br />

b Division of Neurosurgery,<br />

Department of Surgery, <strong>University</strong> of Medicine and Dentistry<br />

of New Jersey, Camden, NJ, USA<br />

Canavan disease (CD) is a severe progressive autosomal<br />

recessive neurodegenerative disorder, caused by mutations<br />

in the aspartoacylase (ASPA) gene. While two predominant<br />

mutations account for approximately 97% of the<br />

mutant alleles in Ashkenazi Jewish individuals with higher<br />

prevalence of CD, this disease has also been diagnosed in<br />

other diverse ethnic groups. However, mutations in the<br />

ASPA gene among non-Jewish patients are different and<br />

more diverse. In the present study, the ASPA gene was<br />

analyzed in 22 unrelated non-Jewish patients with CD, and<br />

24 different mutations were found. Of these, 14 novel<br />

mutations were identified, including five missense mutations<br />

(E24G, D68A, D249V, C152W, H244R), two<br />

nonsense mutations (Q184X, E214X), three deletions<br />

(923delT, 33del13, 244delA), one insertion mutation<br />

(698insC), two sequence variations in one allele<br />

([10T ! G; 11insG]), an elimination of the stop codon<br />

(941A ! G, TAG ! TGG, X314W), and one splice acceptor<br />

site mutation (IVS1-2A ! T). The E24G mutation<br />

resulted in substitution of an invariable amino acid residue<br />

(Glu) in the first esterase catalytic domain consensus<br />

sequence. The IVS1-2A ! T mutation caused the retention<br />

of 40 nucleotides of intron 1 upstream of exon 2. The<br />

results of transient expression of the mutant ASPA<br />

complementary DNA (cDNA) containing these mutations<br />

in COS-7 cells and assay for ASPA activity of patient<br />

fibroblasts indicated that these mutations were responsible<br />

for the enzyme deficiency. Our studies expand the spectrum<br />

of novel mutations in non-Jewish patients with CD,<br />

and are useful for the accurate diagnosis of CD in these<br />

patient populations, for prenatal diagnosis of CD in informative<br />

families, and for detection of carriers in affected<br />

families.<br />

SY-03-2<br />

Facioscapulohumeral muscular dystrophy (FSHD)<br />

N. Raksadawan<br />

Siriraj Hospital, <strong>Mahidol</strong> <strong>University</strong>, Bangkok, Thailand<br />

Facioscapulohumeral muscular dystrophy (FSHD), one<br />

of the common muscular dystrophy, is transmitted as an<br />

autosomal dominant in majority of cases while few show<br />

a de novo mutation. It has a characteristic and distinctive<br />

distribution of weakness. Symptoms usually begin in childhood<br />

with weakness, which affects predominantly facescapular<br />

stabilizer-humeral muscles and rarely in early<br />

infantile onset associated with generalized hypotonia.<br />

Retinal and cochlear diseases are occasionally associated<br />

defects. Its molecular pathogenesis is still unknown, though.<br />

FSHD locus is known on the subtelomeric region of human<br />

chromosome 4q. Mutation is the result of a deletion of<br />

multiple copies of 3.3-kb tandem repeats (D4Z4) which<br />

cause a position variegation effect on more proximal<br />

DNA. The molecular diagnosis based upon the detection<br />

of the short fragment of the tandem repeats, using p13E11<br />

probe after EcoRI, EcoRI/BlnI digestion, is possible in<br />

majorities of cases. Because of unknown underlying muscle<br />

injury mechanism, curative therapy is not yet available.<br />

However, few clinical trials of symptomatic treatments<br />

have been tried.<br />

SY-03-3<br />

Duchenne muscular dystrophy: from gene diagnosis to<br />

molecular therapy<br />

M. Matsuo<br />

Division of Molecular Medicine, Kobe <strong>University</strong> Graduate<br />

School of Medicine, Hyogo, Japan<br />

Duchenne and Becker muscular dystrophies (DMD/BMD)<br />

are X-linked muscular dystrophies. The isolation of the<br />

defective gene in DMD/BMD has led to a better understanding<br />

of the disease process and has promoted studies regarding<br />

the application of molecular therapy. Due to frame-shifting<br />

mutations in the DMD gene that cause dystrophin deficiency,<br />

DMD patients suffer from lethal muscle degeneration. In<br />

contrast, mutations in the allelic Becker muscular dystrophy<br />

(BMD) do not disrupt the translational reading frame,<br />

thereby resulting in a less severe phenotype. The purpose<br />

of this report is to present the recent progress made in this<br />

area of research, with particular reference to dystrophin<br />

Kobe, which is caused by exon skipping during splicing<br />

due to the presence of an intra-exon deletion. On the basis<br />

of results from the molecular analysis of dystrophin Kobe, we<br />

proposed a novel way of molecular therapy for DMD wherein<br />

antisense oligonucleotides transform DMD into a milder<br />

phenotype by inducing exon skipping. We explored a genetic<br />

therapy aimed at restoring the reading frame in muscle cells<br />

from a DMD patient through targeted modulation of dystro-


354<br />

Abstracts<br />

phin pre-mRNA splicing. In myotube cultures from a DMD<br />

patient carrying an exon 20 deletion, the induced skipping of<br />

exon 19 in mRNA led to the production of in-frame dystrophin<br />

mRNA and internally deleted dystrophin in myotubes.<br />

Our results provide evidence of restoration of dystrophin<br />

expression from the endogenous gene in DMD patientderived<br />

muscle cells. In addition, current proposals of other<br />

molecular therapies for DMD are discussed.<br />

SY-03-4<br />

Signal transduction defects: an emerging family of<br />

genetic encephalopathies<br />

J. Jaeken a , K. Freson b , N. Goemans a , P. De Cock a , C. Van<br />

Geet a,b<br />

a Department of Pediatrics and b Center for Molecular and<br />

Vascular Biology, <strong>University</strong> Hospital Gasthuisberg,<br />

<strong>University</strong> of Leuven, Leuven, Belgium<br />

Mutations in the alpha subunit of the Gs proteins<br />

(encoded by GNAS1 located in an imprinted region on<br />

chromosome 20q13.12–13) cause rare endocrine disorders.<br />

The GNAS1 gene also encodes XL-GNAS1, which is<br />

paternally expressed and maternally methylated. Using a<br />

modified platelet aggregation test (Freson et al., Thromb<br />

Haemost 2001;86:733–738) to evaluate Gs function we<br />

identified six patients (from four families) with an internal<br />

repeat extension of the XL-GNAS1 exon 1 on the paternal<br />

allele. These patients had mainly a neurological syndrome<br />

(psychomotor retardation, hypotonia, behaviour disturbances,<br />

movement disorders) as well as variable dysmorphy<br />

(mainly of face and hands) and, in only one, a<br />

clinically important bleeding tendency. This defect was<br />

associated with over expression of GNAS1 and increased<br />

cAMP levels in platelets and fibroblasts upon stimulation.<br />

In four patients this defect was combined with a polymorphism<br />

in G-b 3 . (Jaeken et al., J Inherit Metab Dis<br />

2000;23(Suppl. 1):205). In two other patients (sisters)<br />

with severe psychomotor retardation, axial hypotonia,<br />

hyporeflexia, overgrowth, thrombocytosis and hypercholesterolemia<br />

a maternally inherited G-b 3 null-allele associated<br />

with the same G-b 3 polymorphism on the paternal allele,<br />

was identified. One of them died at the age of 4 years.<br />

Conclusion: G protein defects can be associated with<br />

neurological syndromes. Platelet function analysis is a<br />

valuable tool in the identification of these (and other)<br />

signal transduction defects.<br />

SY-03-5<br />

Gene therapy/cell therapy for genetic neurological<br />

disorders<br />

Y. Eto, T. Ohashi<br />

Department of Pediatrics/Department of Gene Therapy,<br />

Institute of DNA Medicine, Tokyo Jikei <strong>University</strong> School<br />

of Medicine, Tokyo, Japan<br />

Among various genetic diseases, we focused to lysosomal<br />

storage diseases (LSD) which are caused by a genetic<br />

deficiency of lysosomal enzyme and accumulates various<br />

compounds in lysosomes. Recently, LSD patients can be<br />

treated by: (1) enzyme replacement therapy for Gaucher<br />

disease, Fabry disease, Hunter syndrome, Pompe disease<br />

and Hurler syndrome. The enzyme replacement therapy is<br />

limited to treat in non-neurological form of LSD. (2) Bone<br />

marrow transplantation (BMT) is also potentially important<br />

therapy to treat LSD since BMT may treat neurological<br />

involvement of LSD, if treated in early period. (3) Cell<br />

therapy/gene therapy are most promising treatment in<br />

future. We are trying to treat LSD using mucopolysaccharidoses<br />

(MPS) VII model mice and twitcher mice (model<br />

for human Krabbe disease). Using these model mice, we<br />

tried to treat these mice with adenovirus vector by intravenous<br />

administration or intraventricular administration.<br />

Visceral involvement in MPS VII mice was successfully<br />

treated by adenovirus administration at least for 1 month.<br />

In twitcher mice, intraventricular administration of adenovirus<br />

showed reduced number of globoid cells in CNS,<br />

which indicated that the CNS involvement could be treated<br />

with gene therapy. Many LSD patients show neurological<br />

disorders, since these cells can be converted into neuronal<br />

cells in a certain condition. These results suggest that<br />

mesenchymal cells can be used fro the treatment of CNS<br />

involvement in LSD.<br />

SY-4<br />

Epilepsies and Related Disorders in Infancy, Childhood<br />

and Adolescence<br />

SY-04-1<br />

Epileptogenic malformations of the cerebral cortex:<br />

classification and genetic mechanisms<br />

R. Guerinni<br />

Department of Child Neuropsychiatry, <strong>University</strong> of Pisa,<br />

Italy<br />

Abstract not submitted<br />

SY-04-2<br />

Seizure induced brain injury in immature rat: short<br />

term and long term<br />

Y.-W. Jiang, G.-J. Zhang, H.-Y. Cao, X.-R. Wu<br />

Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />

Beijing, China<br />

Objective: To study seizure induced brain injury and its<br />

mechanism in immature rats. Method: We established two<br />

seizure models: flurothyl inhalation induced seizure (Postnatal<br />

day 15) (in vivo model) and magnesium-free culture<br />

induced epileptiform discharge in cultured rats embryo<br />

cortical neurons (in vitro model). The apoptosis and cellu-


Abstracts 355<br />

lar MTT uptake were investigated as the indices of shortterm<br />

brain injury, while the mossy fiber sprouting, behavior<br />

and learning ability, and susceptibility to seizure-induced<br />

brain injury in adulthood were observed as the indices of<br />

long-term brain injury. We also investigated the neuron<br />

NMDA receptor (NR) expression and intracellular calcium<br />

after recurrent seizures, in order to find some clue of the<br />

mechanism of the seizure-induced brain injury. Results:<br />

From short time observation after seizure, we found that<br />

the expression of NR subunits-NR1, NR2A protein upregulated<br />

in hippocampus and cerebral cortex in vivo;<br />

meanwhile, the cellular MTT uptake decrease, intracellular<br />

calcium increase and were observed in cultured cortical<br />

neurons. However, we had not found the obvious neuron<br />

apoptosis increase. In long-term study, we found that the<br />

susceptibility to seizure-induced brain injury, such as apoptosis,<br />

mossy fiber sprouting, and learning and memory<br />

defect after the second seizure in adulthood, were increased<br />

in rats that had seizure experience during development,<br />

either febrile convulsion or the kainite-induced convulsion.<br />

Conclusions: The seizure induced brain seizure in developmental<br />

brain were relatively less serious and lethal, but it<br />

will influence the brain for a long time, which will made<br />

the brain more susceptible to new pathogenic stimulus in<br />

the adulthood.<br />

SY-04-3<br />

Idiopathic focal epilepsies in infancy<br />

F. Vigevano<br />

Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy<br />

The 1989 classification of epilepsies and epileptic<br />

syndromes (Commission, 1989) includes among the idiopathic<br />

localization-related epilepsies the occipital form and<br />

that with centrotemporal spikes, both with onset during<br />

childhood, and among generalized epilepsies familial and<br />

non-familial neonatal convulsions and benign myoclonic<br />

epilepsy of infancy. In recent years, numerous publications<br />

have reported localization-related epilepsy with onset<br />

during early infancy, idiopathic aetiology and favorable<br />

outcome. In 1963, Fukuyama reported cases occurring in<br />

the first 2 years of life that were characterized by partial<br />

seizures, absence of a etiologic factors and benign<br />

outcome. Later, other reports of this clinical entity studied<br />

the localization and semiology of seizures (Watanabe et al.,<br />

1987, 1990, 1993), the prognosis (Sugiura et al., 1983), and<br />

the presence or absence of familial occurrence (Vigevano<br />

et al., 1990; Vigevano et al., 1992; Vigevano et al., 1994).<br />

In particular, Watanabe and coworkers on several occasions<br />

described cases with partial seizures of a different<br />

type, proposing the term benign partial epilepsy of infancy<br />

with complex partial seizures (BPE with CPS) and benign<br />

partial epilepsy of infancy with secondarily generalized<br />

seizures (BPE with SGS). Most of these cases were not<br />

familial. Vigevano and coworkers directed attention to<br />

the presence of cases with a family history of convulsions<br />

with benign outcome during infancy, with autosomal dominant<br />

inheritance, suggesting the term benign infantile<br />

familial convulsions (BIFC). Benign infantile convulsions<br />

are divided now into familial and non-familial forms, even<br />

though the two forms can overlap. Genetic studies in familial<br />

forms led to the identification of a marker on chromosome<br />

19 (Guipponi et al., 1997). This was not confirmed by<br />

later studies, therefore genetic heterogeneity was hypothesized<br />

(Gennaro et al., 1999). Recently Malacarne (Malacarne<br />

et al., 2001) studying eight Italian families with<br />

BIFC mapped a novel locus on chromosome 2. In 1997,<br />

Szepetowski (1997) described the association between<br />

BIFC and variably expressed paroxysmal choreoathetosis.<br />

Following the identification of a specific marker on chromosome<br />

16, this entity constitutes a variant of the familial<br />

forms, called infantile convulsions and choreoathetosis.<br />

However, the chromosome 16 marker may account for<br />

more than this particular phenotype (Caraballo et al.,<br />

2001). Bureau and Maton (1998), Bureau et al. (1998)<br />

and Capovilla and Beccaria (2000) described another<br />

form of benign epilepsy with partial seizures, onset in<br />

infancy or early childhood and benign outcome. In these<br />

children, seizures did not present in clusters; rather they<br />

were quite sporadic with prevalently complex partial type<br />

semiology, and without automatisms. The EEG findings<br />

showed peculiar interictal anomalies characterized by<br />

central and vertex spikes or spikes and waves only evident<br />

during sleep.<br />

SY-04-4<br />

Benign focal epilepsies in childhood and adolescence<br />

N. Fejerman<br />

Hospital de Pediatria ‘J.P. Garrahan’, Department of<br />

Neurology, Combate de los Pozos 1881, 1245 Buenos<br />

Aires, Argentina<br />

Abstract not submitted<br />

SY-04-5<br />

Lafora’s progressive myoclonus epilepsy: clinical and<br />

genetic advances<br />

A.V. Delgado-Escueta b , S. Ganesh a , T. Suzuki a ,S.<br />

Francheschetti c , C. Riggio c , G. Avanzini c , A. Rabinowicz d ,<br />

S. Bohlega e , J. Bailey b , M.E. Alonso f , A. Rasmussen f , A.E.<br />

Thomson d , A. Ochoa f , A.J. Prado f , M.T. Medina g ,K.<br />

Yamakawa a<br />

a Laboratory for Neurogenetics, RIKEN Brain Science Institute,<br />

Wako-shi, Japan;<br />

b Epilepsy Genetics/Genomics<br />

Laboratories, Comprehensive Epilepsy Program, UCLA<br />

School of Medicine and VA GLAHS West Los Angeles Medical<br />

Center, Los Angeles, USA; c Instituto Nazionale Neurologico,<br />

Besta, Milano, Italy;<br />

d FLENI Medical Center,<br />

Buenos Aires, Argentina; e King Faisal Medical Center,


356<br />

Abstracts<br />

Riyahd, Saudi Arabia; f National Institute of Neurology and<br />

Neurosurgery, Mexico City, Mexico; g Direccion de Investigation<br />

Cientifica, Universidad National Autonoma de<br />

Honguras, Tegulcigalpa, Honduras<br />

Mutations in the EPM2A gene encoding a dual-specificity<br />

phosphatase (laforin) cause an autosomal recessive<br />

fatal disorder called Lafora’s disease (LD) classically<br />

described as an adolescent onset stimulus sensitive<br />

myoclonus, epilepsy and neurologic deterioration. We<br />

present correlation between mutations in EPM2A and<br />

phenotypes of 22 patients (14 families). In addition to<br />

classical LD associated mainly with mutations in exon 4<br />

(P ¼ 0:0007), we identified atypical LD with childhood<br />

onset dyslexia and learning disorder followed by epilepsy<br />

and neurologic deterioration associated mainly with mutations<br />

in exon 1 (P ¼ 0:0015). To understand the two<br />

subsyndromes better, we investigated the effect of five<br />

missense mutations in the carbohydrate binding domain<br />

(CBD-4; coded by exon 1) and three missense mutations<br />

in the dual phosphatase domain (DSPD; coded by exons 3<br />

and 4) on laforin’s intracellular localization in HeLa cells.<br />

Expression of three mutant proteins (T194I, G279S and<br />

Y294N) in DSPD formed ubiquitin positive cytoplasmic<br />

aggregates suggesting they were folding mutants set for<br />

degradation. In contrast, none of the three CBD-4 mutants<br />

showed cytoplasmic clumping. However, CBD-4 mutants<br />

W32G and R108C targeted both cytoplasm and nucleus<br />

suggesting that laforin had diminished its usual affinity<br />

for polysomes. Our data, thus, represents the first report<br />

of a novel childhood syndrome for LD. Our results also<br />

provide clues for distinct roles for the CBD-4 and DSP<br />

domains of laforin in the etiology of two subsyndromes<br />

of LD. To study the ontogenesis of LD pathology and<br />

laforin functions, we disrupted the Epm2a gene in mice.<br />

Supporting the concept of childhood onset or atypical<br />

human LD, homozygous null mutants developed widespread<br />

degeneration of neurons, most of which occurred<br />

in the absence of Lafora bodies, as early as 1–2 months<br />

of age. Dying neurons characteristically exhibited swelling<br />

in the endoplasmic reticulum, Golgi networks and mitochondria<br />

in the absence of apoptotic bodies or fragmentation<br />

of DNA. As Lafora bodies became more prominent at<br />

4–12 months, organelles and nuclei were disrupted. The<br />

Lafora bodies, present both in neuronal and non-neural<br />

tissues, were positive for ubiquitin and advanced glycation<br />

end products only in neurons, suggesting different pathological<br />

consequence for Lafora inclusions in neuronal<br />

tissues. Neuronal degeneration and Lafora inclusion bodies<br />

predate the onset of impaired behavioral responses, ataxia,<br />

spontaneous myoclonic seizures and EEG epileptiform<br />

activity. Our results suggest that LD is a primary neurodegenerative<br />

disorder that may utilize a non-apoptotic<br />

mechanism of cell death.<br />

SY-5<br />

Neuroimaging<br />

SY-05-1<br />

Introduction: focused on functional neuroimaging<br />

K. Iinuma<br />

Tohoku <strong>University</strong> School of Medicine, Sendai, Japan<br />

During the last two decades of the 20th century, various<br />

neuroimaging techniques have strikingly developed.<br />

Among various neuroimaging methods, functional imagings<br />

give us valuable information about the pathophysiological<br />

mechanisms and condition of neurological disorders. In this<br />

symposium, the several neuroimaging techniques and their<br />

applications will be explained. PET as relatively early<br />

developed imaging method is recently shifting to understand<br />

the receptor binding or brain metabolism. The functional<br />

MRI will give us more detailed mapping of the brain<br />

for fine functions by the development of various methods of<br />

tasks. Magnetic resonance spectroscopy can give us the<br />

information about characteristics of the tissues and/or cells<br />

of the brain, moreover is capable to give the information on,<br />

for example, GABA transmission, etc. Optical topography<br />

recently has been developed by means of near-infrared spectroscopy<br />

(NIRS). This method is multichannel NIRS that<br />

makes spacial expression, and has an advantage of excellent<br />

time resolution. This may have a possibility to analyze the<br />

various phenomena concerning of the brain function, such<br />

as epileptic seizures, motor and mental activity, etc.<br />

SY-05-2<br />

Applications of PET scanning in pediatric neurology<br />

H.T. Chugani<br />

Division of Pediatric Neurology, Positron Emission Tomography<br />

(PET) Center, Children’s Hospital of Michigan,<br />

Wayne State <strong>University</strong>, Detroit, MI, USA<br />

The clinical role of PET scanning is mainly in localization<br />

of epileptic foci for surgical treatment in refractory epilepsy.<br />

PET tracers used in epilepsy include 2-deoxy-2 ( 18 F) fluorod-glucose<br />

(FDG) and various ligands for evaluating neurotransmitter<br />

function. In temporal lobe epilepsy, interictal<br />

FDG-PET identifies areas of decreased glucose utilization<br />

that correspond to epileptogenic areas (sensitivity: 80–<br />

90%). In nonlesional extratemporal lobe epilepsy, FDG-<br />

PET provides useful lateralization and localization data to<br />

guide the placement of intracranial electrodes. Neurophysiological<br />

correlations based on coregistration of MRI, PET and<br />

subdural electrodes indicate that the seizure onset zone typically<br />

lies in the periphery or boundary of the cortical hypometabolism<br />

rather than within the hypometabolic zone. Our<br />

data also show that the size of the hypometabolic zone<br />

increases along the major propagation pathways as a function<br />

of duration of intractable epilepsy, thus supporting the


Abstracts 357<br />

concept of network growth and secondary epileptogenesis<br />

proposed by Morrell. In a number of childhood epilepsy<br />

syndromes characterized by generalized seizures, such as<br />

infantile spasms and Lennox-Gastaut syndrome, resection<br />

of focal PET abnormalities corresponding to focal ictal and<br />

interictal EEG abnormalities is associated with improved<br />

seizure and cognitive outcome. In PET studies on patients<br />

with infantile spasms, there is evidence of complex corticosubcortical<br />

interactions believed to be important in an agedependent<br />

secondary generalization of focal cortical<br />

discharges to result in the typical spasms. Only about 20%<br />

of patients with cryptogenic infantile spasms’ show a single<br />

PET focus amenable to resection. The other 80% of patients<br />

show more than one focus, and most of these will not be<br />

optimal surgical candidates. Some of these infants will benefit<br />

from the use of newer PET tracers (see below), which may<br />

reveal the primary seizure focus. The finding of bilateral<br />

symmetric hypometabolism suggests a nonlesional etiology<br />

for the spasms and is a useful indication to pursue further<br />

neurogenetic/neurometabolic evaluation rather than a surgical<br />

approach. In children with unilateral Sturge-Weber<br />

syndrome, we have shown that early and rapid loss of functional<br />

activity in the affected hemisphere is associated with a<br />

better cognitive outcome than slow progression, presumably<br />

because early demise of the affected hemisphere allows the<br />

intact hemisphere to undergo reorganizational changes early<br />

in the course of the disease. Recent studies using other PET<br />

tracers have attempted to provide a more specific and accurate<br />

assessment of seizure foci. 11 C-flumazenil labels central<br />

benzodiazepine receptors and is particularly useful in showing:<br />

decreased receptor binding in medial temporal sclerosis,<br />

dual pathology, perilesional epileptogenic zones, seizure<br />

onset zones, and potential secondary epileptic foci.<br />

11 C-<br />

alpha-methyl-l-tryptophan (AMT), an analogue of tryptophan,<br />

traces serotonin synthesis and kynurenine pathways<br />

in the brain. AMT-PET in patients with epilepsy demonstrate<br />

focally increased uptake in cortical regions of epileptogenesis<br />

interictally. In children with tuberous sclerosis and<br />

intractable epilepsy, focal increase in AMT uptake is seen<br />

in the region of epileptogenic tubers, but not in non-epileptogenic<br />

tubers. Other ligands, which label histamine, opioid<br />

and serotonin receptors have also been applied in patients<br />

with epilepsy. Ontogeny of brain glucose metabolism,<br />

GABA A receptors and serotonin synthesis has been studied<br />

in children using PET. These studies have shown characteristic<br />

developmental changes, which are disturbed in various<br />

disorders. For example, autistic children do not undergo the<br />

normal transient developmental increase of serotonin synthesis<br />

seen in normal children. Focal patterns of abnormal<br />

tryptophan uptake are also seen in autistic children. Glucose<br />

metabolism PET studies in newborns show the very early<br />

functional maturation of limbic structures believed to be<br />

involved in infant attachment. Children adopted from Romanian<br />

orphanages show disturbances of glucose metabolism in<br />

some of these same regions. The potential of PET scanning in<br />

the study of pediatric neurological disorders is enormous, but<br />

this technique remains under utilized in children for a variety<br />

of reasons.<br />

SY-05-3<br />

Functional MRI (fMRI) in children<br />

W.J. Logan<br />

Division of Neurology, Department of Pediatrics, The<br />

<strong>University</strong> of Toronto, The Hospital for Sick Children,<br />

Toronto, Canada<br />

It has been recognized for over a decade that function, in<br />

addition to structure, can be examined with MRI. The detection<br />

and localization of function with MRI depends on the<br />

hemodynamic changes that are known to accompany<br />

changes in neural activity. Most modern MR scanners<br />

have the capability for fMRI studies. The use of fMRI in<br />

children is appealing because it is non-invasive, has no<br />

radiation effects, is potentially widely available, can be<br />

repeated many times and provides high spatial resolution<br />

localization of brain function. Drawbacks such as need for<br />

patient restraint and confinement, susceptibility to movement<br />

induced artifact, need for a cooperative patient, extensive<br />

data analysis time required and poorer temporal<br />

resolution than electromagnetic techniques place some<br />

limits on the application of fMRI. With improvements in<br />

technique and greater experience, these limitations and<br />

other constraints are becoming less of a concern. fMRI activation<br />

does occur in children; in older children, this resembles<br />

that seen in adults. Children are very amenable to fMRI<br />

study. The major clinical application of fMRI in children is<br />

brain mapping of sensory, motor, language and possibly<br />

memory functions for pre-surgical planning. Other clinical<br />

applications include evaluation of the integrity of neurological<br />

pathways and cerebrovascular reactivity. Potential<br />

clinical applications include diagnosis of specific impairments<br />

such as dyslexia, predicting recovery of function<br />

after brain injury and localizing the epileptic focus. These<br />

are the subjects of current research studies. Other areas of<br />

research are determining the mechanisms of plasticity, the<br />

effect of rehabilitation and development on patterns of activation<br />

and development of new paradigms especially for<br />

younger children. There will be advances in the study of<br />

sedated patients, in combining electromagnetic and fMRI<br />

studies and in improving the techniques of investigation<br />

such as real time data analysis and improved motion control<br />

and correction. With advances in the above areas one can<br />

predict an increasing use of fMRI in children.<br />

SY-05-4<br />

Proton magnetic resonance spectroscopy in children<br />

with acute brain injury<br />

S. Ashwal<br />

Department of Pediatrics, Loma Linda <strong>University</strong> School of<br />

Medicine Loma Linda, CA, USA


358<br />

Abstracts<br />

Proton MRS is an emerging technology that allows for the<br />

quantitative non-invasive assessment of regional brain metabolic<br />

activity. MRS has been used to study a wide variety of<br />

pediatric neurometabolic disorders, tumors and demyelinating<br />

diseases. It has also been used to assess prognosis after<br />

acute brain injury (perinatal asphyxia, near drowning, etc.)<br />

and it is useful in localizing focal epilepsies. Brain metabolites<br />

assessed with MRS and often expressed as ratios<br />

include: (1) N-acetyl aspartate (NAA) found in neurons; (2)<br />

creatine and phosphocreatine (Cre) that reflect energy metabolism;<br />

(3) choline-containing compounds (Cho) released<br />

during membrane disruption; (4) presence of lactate indicating<br />

a disturbance in cerebral energy metabolism; and (5)<br />

glutamate/glutamine that is a reflection of asphyxial injury.<br />

Markedly reduced levels of NAA and increased lactate have<br />

been seen in patients who ultimately suffer severe long-term<br />

neurologic disability. Usually this can be seen 3–5 days after<br />

injury and is a diffuse phenomenon present in cerebral gray<br />

and white matter. Patients with malignant tumors are likely to<br />

have moderate to marked increases in choline and reduced<br />

NAA whereas patients with lower grade tumors may show<br />

milder abnormalities. MRS is also useful in evaluating children<br />

with traumatic brain injury (TBI) as is a new MR technique<br />

known as susceptibility weighted imaging which is<br />

more sensitive in detecting hemorrhagic lesions associated<br />

with diffuse axonal injury that also show very abnormal MRS<br />

patterns that correlate with outcome. Multivoxel MRS allows<br />

non-invasive sampling of many brain regions. It is likely that<br />

as MRS technology continues to improve, its use for the<br />

diagnosis of many nervous system disorders of children<br />

will increase.<br />

SY-05-5<br />

Diffusion tensor imaging<br />

A. Ohnuma<br />

Division of Pediatric neurology, Miyagi Prefectural Takutoh<br />

Rehabilitation Center for Children, Miyagi, Japan<br />

The recent development of diffusion tensor imaging<br />

(DTI) has made it possible to visualize anatomic details of<br />

the human brain and to provide quantitative measures of<br />

fiber tract integrity and orientation. The evidence of brain<br />

plasticity was confirmed via DTI and FMRI in the intellectually<br />

normal five subjects (aged 8–26 years) with unilateral<br />

extensive brain lesions, which developed in the prenatal<br />

(cortical dysplasia one and encephalo-clastic lesion two),<br />

perinatal (encephalo-clastic lesion 1) and neonatal (intracranial<br />

bleeding) stage. Fractional anisotropy (FA) images<br />

included whole brain axial images and coronal pyramidal<br />

tract images at the brainstem. FMRI during the motor task<br />

was performed by the affected hand grasping. DTI depicted<br />

markedly reduced FA of the pyramidal tract of the affected<br />

hemisphere in two cases, moderately reduced in two and<br />

bilateral normal in one. FMRI showed ipsilateral activations<br />

in two cases, bilateral in one and contralateral in one. The<br />

mode of the reorganization of the pyramidal tracts seemed<br />

to depend on the stage of the development of the hemispherical<br />

brain damages and the state of the residual brain tissues<br />

of the affected hemisphere. DTI was also examined in the<br />

cases with various kinds of white matter disorders, such as<br />

Pelizaeus-Merzbacher disease, X-linked adrenoleukodystrophy,<br />

metachromatic leukodystrophy, Cockayne<br />

syndrome and Fukuyama type congenital muscular dystrophy,<br />

in comparing with normal controls. Quantitative<br />

measures of diffusivity and FA were useful for evaluating<br />

the white matter status of these disorders.<br />

SY-6<br />

Channelopathies<br />

SY-06-1<br />

Mutations of sodium channels in GEFS 1 and SMEI<br />

K. Yamakawa<br />

Laboratory for Neurogenetics, RIKEN Brain Science Institute,<br />

Japan<br />

GEFS 1 , a clinical subset of febrile seizures (FS), is characterized<br />

by frequent episodes beyond 6 years of age (FS 1 )<br />

and various types of subsequent epilepsy. Recent evidences<br />

have indicated that the neuronal voltage-gated sodium channels<br />

(SCN1A, SCN2A, SCN1B) are responsible for GEFS 1 .<br />

Some of mutant channels showed slowed inactivation that<br />

may lead to the augment of sodium ion influx, cause hyperexcitability<br />

of neurons, and finally result in epileptic<br />

seizures. SCN1A has been also reported to be mutated in<br />

severe myoclonic epilepsy in infancy (SMEI). SMEI is an<br />

extremely intractable epilepsy; normal development before<br />

onset; seizures beginning during 1st year of life in the form<br />

of generalized or unilateral febrile clonic seizures; secondary<br />

appearance of myoclonic seizures, and associates with<br />

ataxia and mental decline. SCN1A mutations in SMEI were<br />

heterozygous and de novo, and most of them are frameshift<br />

or nonsense. Mutations in GEFS 1 are all missense mutations,<br />

and these suggest the distinct pathologies of GEFS 1<br />

and SMEI even if SCN1A is responsible for both diseases.<br />

In my talk, I will summarize the SCN1A mutations of<br />

GEFS 1 and SMEI and discuss the genotype-phenotype<br />

correlation as well as the predicted molecular pathology<br />

of these diseases.<br />

SY-06-2<br />

Benign familial neonatal convulsions<br />

S. Hirose, A. Mitsudome<br />

Department of Pediatrics, School of Medicine, Fukuoka<br />

<strong>University</strong>, Fukuoka, Japan<br />

Benign familial neonatal convulsions (BFNC) is monogenic<br />

epilepsy inherited via an autosomal dominant trait and<br />

characterized by clusters of generalized and partial seizures


Abstracts 359<br />

afflicting exclusively, if any, neonates, and remits spontaneously.<br />

However, the incidence of subsequent epilepsy<br />

later in life is also higher in individuals who suffer from<br />

BFNC. Mutations of two KQT-like K 1 -channel genes, the<br />

KCNQ2 and KCNQ3 genes, were identified as the underlying<br />

abnormalities of BFNC. To date, some ten mutations<br />

of KCNQ2 have been discovered while only two mutations<br />

including one found in a Japanese pedigree with BFNC have<br />

been identified in KCNQ3. All mutations were heterozygous.<br />

KCNQ2 and KCNQ3 synergistically contribute to<br />

the formation of the M-current, which controls the subthreshold<br />

electroexcitability of neurons. Dysfunction of<br />

either KCNQ2 or KCNQ3 can hence result in indistinguishable<br />

BFNC phenotype. The exact pathomechanisms of agedependency<br />

and propensity for future epilepsies in BFNC<br />

remain to be determined. We have recently shown that<br />

KCNQ K 1 -channels serve as a predominant inhibitory<br />

system in CNS during neonates, since GABAergic-transmission<br />

governs the inhibitory system afterwards. Thus,<br />

deficient KCNQ K 1 -channels cause convulsions during<br />

the neonatal period. We have recently suggested that<br />

abnormalities of KCNQ2 and KCNQ3 are not necessarily<br />

the only causes of BFNC phenotypes, but rather other<br />

genes are probably involved in the pathogenesis of the<br />

BFNC phenotype, i.e. further genetic heterogeneity underlies<br />

this familial epilepsy. Deficiency of other ion channels<br />

and their modulation may result in the BFNC phenotype as<br />

well.<br />

SY-06-3<br />

Single gene mutation, dual phenotype, and differential<br />

mechanisms in stargazer mutant<br />

X.-X. Qiao<br />

Department of Cellular Biology and Anatomy, Louisiana<br />

State <strong>University</strong> Health Sciences Center, Shreveport, LA,<br />

USA<br />

Voltage-dependent calcium channels (VDCC) play a<br />

key role in regulating a broad spectrum of cellular functions<br />

in both developing and mature central nervous<br />

system. While more neurological disorders have been<br />

linked to mutations of these genes in humans, several<br />

spontaneous mutant mouse strains have recently been<br />

found to harbor different VDCC subunit mutations. Interestingly,<br />

all of these mutants share a similar phenotype of<br />

characteristic spike-wave epilepsy and ataxia. Investigation<br />

of these mutants has furthered our understanding of<br />

the role of VDCC genes in neuronal function and provided<br />

more insights of the mechanisms underlying inherited<br />

neurological diseases. Studies from one such mutant, stargazer,<br />

which carries a defected VDCC g2 subunit, have<br />

revealed differential cellular processes involved in different<br />

brain regions. In the frontal brain, an autonomous<br />

increase in cortical network excitability in vitro has been<br />

correlated with the prolonged seizure activity in vivo.<br />

Aberrant mossy fiber sprouting and increased neuropeptide-Y<br />

expression in the hippocampus are subsequent to<br />

the epileptic discharges. In the cerebellum, the only area<br />

that is not invaded by the seizure activity, severe impairment<br />

of motor coordination and sensory-motor learning is<br />

correlated with regionally restricted molecular and cellular<br />

defects. The abnormalities include altered cerebellar granule<br />

cell migration, maturation, and synaptic transmission.<br />

The underlying molecules are linked to the selective failure<br />

of BDNF mRNA expression and AMPA receptor<br />

synaptic targeting. These results revealed significant regional<br />

specificity to the defects in stargazer brain. It provides<br />

clear evidence that calcium channelopathies initiate<br />

complex, region-specific, molecular defects in synaptic<br />

signaling during brain development.<br />

SY-06-4<br />

GABA gene mutations in human epilepsies symposium<br />

of channelopathies<br />

I.E. Scheffer<br />

Epilepsy Research Institute, <strong>University</strong> of Melbourne,<br />

Austin and Repatriation Medical Centre, Monash Medical<br />

Centre and Royal Children’s Hospital, Melbourne, Australia<br />

GABA is the major inhibitory neurotransmitter in the<br />

central nervous system. GABA receptors are heteropentameric<br />

ligand-gated chloride channels. GABA receptors in<br />

human brain most commonly comprise alpha subunits, beta<br />

subunits and a gamma subunit. The alpha and beta subunits<br />

can form a functional receptor alone. The gamma subunit<br />

contributes to the benzodiazepine binding site and is essential<br />

for benzodiazepine potentiation of action potentials.<br />

Three mutations of the gamma 2 subunit gene of the<br />

GABA A receptor (GABRG2) were identified in families<br />

with GEFS 1 , one also had childhood absence epilepsy<br />

(CAE). In vitro functional studies using two electrode<br />

voltage clamp recordings of the mutations expressed in<br />

functional GABA receptors showed marked attenuation<br />

of the GABA-mediated current with two mutations. In<br />

the third mutation, GABA current was not altered, however<br />

benzodiazepine potentiation was abolished. Recently, a<br />

family with Autosomal Dominant Juvenile Myoclonic<br />

Epilepsy with a mutation of the alpha 1 subunit gene of<br />

the GABA A receptor (GABRA1) was reported. In vitro<br />

studies also showed reduction of the GABA activated<br />

current. The range of mutations of GABA receptors in<br />

the idiopathic epilepsies still remains to be explored. It is<br />

likely that other subunit genes will be involved in the<br />

idiopathic generalized epilepsies, including GEFS 1 . Genotype-phenotype<br />

correlation will be essential to understanding<br />

the neurobiology of these disorders. Eventually the<br />

clinician may treat patients based on the rational understanding<br />

of the interaction of a number of ion channel<br />

mutations.


360<br />

Abstracts<br />

SY-06-5<br />

Epileptic channelopathies in man and mouse<br />

J. Noebels<br />

Department of Neurology, Baylor College of Medicine,<br />

Houston, TX, USA<br />

Inherited disorders of ion channels are now the single<br />

most common known cause of idiopathic generalized<br />

epilepsy. Despite this rapid progress in gene discovery,<br />

we are only beginning to understand their intriguing pathophysiology.<br />

Channelopathy phenotypes arise in both the<br />

developing and mature central nervous system, and show<br />

remarkable clinical diversity, including tonic/clonic,<br />

absence, and myoclonic epilepsy, as well as other episodic<br />

neurological disorders. The mutations target both voltageand<br />

ligand-gated channels, and produce disease by altering<br />

the biophysical properties of the pore subunit or by modifying<br />

auxiliary subunits that regulate membrane insertion,<br />

modulation, and localization of the channel complex. In<br />

almost all cases, the direct result is to prolong intrinsic<br />

membrane depolarisation or impair synaptic transmission.<br />

Recent studies in orthologous mouse models suggest that<br />

the mechanisms for age-dependent epileptogenesis in these<br />

inherited errors are more complex than initially realized.<br />

Despite widespread expression, only certain neural<br />

networks are vulnerable at various developmental stages,<br />

presumably accounting for phenotypic diversity. The selectivity<br />

is explained by the differential contributions of individual<br />

channels to the excitability and firing behavior, and<br />

by the presence of compensatory subunits. As one example,<br />

generalized spike-wave absence epilepsy is seen in a<br />

cluster of four mutant mouse models, each representing a<br />

subunit of the brain voltage-gated calcium channel. In two<br />

of these models (a1a and b4), the compensatory subunits<br />

have been identified, and their absence in thalamic neurons<br />

contributes to thalamocortical synchrony. We have recently<br />

identified further downstream cellular plasticity in thalamic<br />

low threshold calcium currents that may also directly<br />

contribute to the seizure phenotype.<br />

SY-7<br />

What Happens to a Child at Risk for Developmental<br />

Delay/Disability<br />

SY-07-1<br />

Introduction<br />

S. Harel<br />

Division of Pediatrics, The Institute For Child Development<br />

and Pediatrics Neurology, Tel Aviv, Israel<br />

Abstract not submitted<br />

SY-07-2<br />

School age outcomes of pre-school children diagnosed<br />

with either global developmental delay or specific<br />

language impairment<br />

M. Shevell, A. Majnemer, R. Platt<br />

Montreal Children’s Hospital-McGill <strong>University</strong>, Canada<br />

The objective of this study is to describe prospectively the<br />

school age (6–7 years) functional and developmental<br />

outcomes in a cohort of children diagnosed previously<br />

with either a global developmental delay or a specific<br />

language impairment. Two cohorts have been assembled:<br />

(a) global developmental delay (n ¼ 99); and (b) specific<br />

language impairment (n ¼ 72). These cohorts were initially<br />

assessed and diagnosed at a mean age of 37.6 and 43.3<br />

months, respectively. Functional, developmental and<br />

language outcomes were assessed in each cohort between<br />

the ages of 6–7 years using a variety of measures. These<br />

included the Battelle Developmental Inventory, Vineland<br />

Adaptive Behavior Scale, WeeFIM, Child Health Questionnaire,<br />

Parenting Stress Index, Child Behavior Checklist/4–<br />

18, Expressive One-Word Picture Vocabulary Test and the<br />

Peabody Picture Vocabulary Test-Revised. Outcomes on<br />

each of these measures for each cohort in this ongoing<br />

study will be described and co-related with factors identified<br />

at initial intake to establish the possibility and strength of<br />

prognostic variables.<br />

SY-07-3<br />

Cerebral visual disorders in children with brain lesions:<br />

outcome and correlation with neuroimaging<br />

G. Cioni, A. Guzzetta, F. Tinelli<br />

Division of Child Neurology and Psychiatry, Stella Maris<br />

Scientific Institute and <strong>University</strong> of Pisa, I Calambrone,<br />

Pisa, Italy<br />

Children with brain lesions of antenatal or perinatal<br />

onset are at high risk for early disturbances of their visual<br />

development, detectable since the first months of life by<br />

means of new behavioural and electrophysiological techniques.<br />

Several studies have reported that various aspects of<br />

visual function, such as visual acuity, visual fields, optokinetic<br />

nystagmus, fixation shift, and perception of movement<br />

are often impaired in these children. A strong<br />

correlation between the results of visual assessment, and<br />

cognitive and motor development also has been also<br />

reported, suggesting a crucial role for visual function in<br />

the early development. Long-term follow-up of these children<br />

have revealed subtle neuropsychological disorders.<br />

Neuroimaging techniques, and brain MRI in particular,<br />

are useful in predicting the occurrence and extent of visual<br />

impairment. However, the correlation between imaging<br />

findings and function is not always consistent. This is probably<br />

due to the involvement of the complex extra-striatal


Abstracts 361<br />

visual pathways and also to the plasticity of the developing<br />

brain. Children often show less severe visual impairments<br />

than adults with apparently similar brain lesions. Newer<br />

MR techniques, particularly fMRI, can provide other<br />

important contributions to this issue. These results are<br />

important for understanding the advantages but also the<br />

limitations, of plasticity and reorganization of the immature<br />

visual brain.<br />

SY-07-4<br />

The study investigates long-term effects of slight<br />

biological and slight socioeconomic risks on complex<br />

achievement variables using two different data sets<br />

G. Spie, C. Spiel, G. Sange, P. Wagner<br />

Department of Child Neurology/Psychiatry, and Special<br />

Education for Children and Adolescents-Hospital Klagenfurt,<br />

Klagenfurt, Australia<br />

On the one hand, observations collected in the Vienna<br />

developmental study (VDS), on the other hand, the same<br />

kind of data from the Viennese study ‘children at risk’<br />

(VCRS) were used. The sample of the VDS study consisted<br />

of 94 randomly selected children. The sample of the VCRS<br />

study consisted of 129 children who were selected for slight<br />

biological risks at birth. In addition a comparison sample<br />

without known biological risks was drawn from the general<br />

population. Needless to say that only compliant members of<br />

the study were followed in the long run. The following risk<br />

conditions were analyzed in both samples: biological risks,<br />

socio-economic status, hospitalizations, severe strains and<br />

life-events, and early occurring developmental variables. As<br />

outcome variables cognitive competence (fluid and crystallized<br />

intelligence) was collected at the age of 12 years, and<br />

school achievement from the first to the fourth grade(ages<br />

6–10) modeling the overall academic development during<br />

primary school. Multiple regression analyses were used in<br />

both studies to investigate the effects of risk conditions and<br />

earlier developmental parameters on outcome variables<br />

mentioned before.<br />

SY-07-5<br />

Neuropsychological outcome of children with<br />

intrauterine growth retardation (IUGR)<br />

Y. Leitner a , A. Fattal-Valevski a , R. Geva a , H. Bassan a ,H.<br />

Goez a , A.J. Jaffa b , S. Harel a<br />

a The Institute for Child Development and Pediatric Neurology<br />

Unit, Division of Pediatrics, b Department of Obstetrics<br />

and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky<br />

Medical Center, Sackler Faculty of Medicine, Tel Aviv<br />

<strong>University</strong>, Israel<br />

Intrauterine growth retardation (IUGR) occurs in 3–10%<br />

of all pregnancies, and is more prevalent in children with<br />

neurocognitive disabilities. Our study was conducted to<br />

characterize the neurodevelopmental and cognitive difficulties<br />

specific to IUGR children and identification of early<br />

risks and clinical predictors of these difficulties. Since<br />

1990, a group of 320 children with IUGR has been<br />

followed-up annually from pregnancy to school age, by<br />

neurodevelopmental and psychological evaluation, and<br />

data collected by socioeconomic, obstetric and neonatal<br />

risk questionnaires. The risk questionnaires and neurodevelopmental<br />

evaluations were all scored according to Prechtl’s<br />

‘optimality concept’. Psychological evaluation was<br />

performed by standard IQ tests. The data presented in this<br />

study demonstrates the changes observed in the IUGR<br />

group, versus the controls matched for gestational age and<br />

socioeconomic status at three points of the follow-up, i.e.<br />

age 3 (n ¼ 130), 6–7 years (n ¼ 110), and 9–10 years<br />

(n ¼ 56). Significant differences in growth parameters<br />

were found in all age groups. At all ages (3, 6–7 and 9–10<br />

years), the score of the IUGR children was significantly<br />

poorer (P , 0:005, P , 0:05, and P , 0:005, respectively)<br />

on the neurodevelopmental score, than the matched<br />

controls. At ages 6–7 and 9–10 years, the IUGR children<br />

had lower IQ scores (P , 0:05; P , 0:005). No differences<br />

were found in IQ scores at age 3. Statistically significant<br />

items on the 3-year neurodevelopmental test that differed<br />

IUGR children from controls were in the area of motor<br />

coordination. At age 6–7, a specific profile of difficulties<br />

in coordination, special maturation tasks and graphomotor<br />

skills is typical of the IUGR children. At 9–10 years of age,<br />

attention span, activity, coordination, timed coordination<br />

performance, visuomotor dysfunction, language verbal<br />

fluency and school achievements were typical for IUGR<br />

children. The clinical parameters that best predict neurodevelopmental<br />

outcome at 3 years were the cephalization<br />

index [CI]: (head circumference [HC]/birth weight based<br />

on the ‘brain sparing’ process expressing the severity of<br />

the IUGR process) (P , 0:005) and the HC (P , 0:005).<br />

At 6–7 years of age the best predictors were the neonatal<br />

risk score (P , 0:005) and weight (P , 0:005). At 9–10<br />

years, the best predictors were CI (P , 0:001) and weight<br />

(P , 0; 005). The best predictors for IQ at age 3 years were<br />

HC (P , 0:05) and maternal education (P , 0:005); at 6–7<br />

years neonatal risk score (P , 0:001); HC (P , 0:005), and<br />

maternal education (P , 0:001); and at 9–10 years the CI<br />

(P , 0:005); HC (P , 0:005) and maternal education<br />

(P , 0:005). At age 6–7 years neurodevelopmental<br />

outcome and IQ score were worse in IUGR children with<br />

neonatal complications than those without (P , 0:05;<br />

P , 0:005, respectively). Children with IUGR diagnosed<br />

prenatally had the same neuropsychological outcome as<br />

those diagnosed at birth, probably due to early delivery<br />

and careful perinatal and obstetric care. Preliminary conclusions<br />

of this long-term follow-up: children with IUGR lag<br />

behind in their somatic and neurocognitive development.<br />

The neuropsychological items that most clearly differentiated<br />

IUGR children from the controls were those requiring<br />

motor coordination, visuomotor skills, attention span,


362<br />

Abstracts<br />

language and school achievements, hinting at later learning<br />

disabilities. Clinical predictors of neurocognitive development:<br />

CI and the neonatal risk predict neurodevelopmental<br />

outcome. CI, neonatal risk score, HC, maternal education<br />

and paternal occupation predict cognitive ability. Neurodevelopmental<br />

outcome was worse in IUGR children with<br />

neonatal risk. IUGR children diagnosed prenatally, despite<br />

being at high risk, had the same outcome as the low-risk<br />

children diagnosed only at birth, probably reflecting careful<br />

obstetric and neonatal care. At a younger age, the biological<br />

parameters have a greater impact on neurodevelopment,<br />

while later environmental influences, such as maternal<br />

education, appear to gain importance in cognitive performance.<br />

SY-07-6<br />

The outcome of early intervention in<br />

neurodevelopmental disabilities<br />

T. Velickovic<br />

Ljubljana, Slovenia<br />

Abstract not submitted<br />

SY-8<br />

Neurometabolic Disorders Update<br />

SY-08-1<br />

Screening for neurometabolic disorders<br />

B. Wilcken<br />

The Children’s Hospital, Westmead, New South Wales,<br />

Australia<br />

Screening implies pre-symptomatic diagnosis. One classical<br />

criterion for screening in newborns is that there should be<br />

benefit to the baby from early diagnosis. Newborn screening<br />

began in the 1960s with a test for phenylketonuria, which had<br />

been found to account for 1% of institutionalized mentally<br />

retarded persons in western countries. Later, screening for<br />

primary congenital hypothyroidism detected another cause<br />

of mental retardation, and indicated iodine-deficiency areas<br />

where endemic cretinism occurred. The new newborn<br />

screening by tandem mass-spectrometry enormously<br />

increases the potential for early detection of genetic metabolic<br />

disorders, detecting amino acid, organic acid, and fatty<br />

acid disorders in a single test. Screening newborns for untreatable<br />

disorders is not favored, but as treatment becomes more<br />

available the classes of disorder, which are tested for, will<br />

expand. The more important neurometabolic disorders have<br />

been hard to screen for, as many do not have suitable<br />

biochemical markers in blood or urine, or common DNA<br />

mutations. There is promise of a newborn test for lysosomal<br />

storage disorders, and treatment by enzyme replacement<br />

therapy is currently available or developing for many of<br />

these. Some rare neurometabolic disorders that could likely<br />

be detected by screening using modifications to current technology<br />

include disorders of creatine deficiency, serine deficiency,<br />

purines and pyrimidines, cholesterol synthesis,<br />

carbohydrate deficient glycoprotein syndromes, and peroxisomal<br />

disorders. It is important that each potential screening<br />

initiative is carefully evaluated for evidence of benefit,<br />

before widespread adoption.<br />

SY-08-2<br />

Postnatal and prenatal diagnosis of lysosomal storage<br />

diseases<br />

H.-P. Shi a , W.-M. Zhang a , Y.-F. Guo a , S.-M. Zhao b , N.-H.<br />

Sun b<br />

a Institute of basic Medical Sciences, CAMS, School of Basic<br />

Medicine, PUMC, Beijing, China; b PUMC Hospital, Beijing,<br />

China<br />

Objective: LSD constitute a group of inherited metabolic<br />

diseases, in which lysosomal acid hydrolases are deficient,<br />

resulting in accumulation of the substrate of the affected<br />

hydrolase within lysosomes. Since there is no definitive<br />

treatment for LSD, except Gaucher disease, accurate prenatal<br />

diagnosis is the only way to prevent the birth of affected<br />

fetuses. Methods: Microanalysis of enzyme activity is<br />

adapted from the Department of clinical genetics, Erasmus<br />

<strong>University</strong>, Rotterdam, Netherlands. Fifteen kinds of methods<br />

for enzyme assays were set up. Results: Since 1991, 202<br />

index patients were diagnosed based on the characteristic<br />

clinical manifestation and specific enzyme assay. Prenatal<br />

diagnosis has been carried out in 43 pregnancies at risk of<br />

LSD (13 mucopolysaccharidoses, seven G M1 gangliosidosis,<br />

four G M2 gangliosidosis, seven metachromatic leukodystrophy,<br />

five Gaucher disease, four Niemann-Pick disease and<br />

three mucolipidosis) in early pregnancy, 11 affected fetuses<br />

were detected. Gaucher disease (GD) is the most prevalent<br />

LSD. We have performed gene analysis from 10 Chinese<br />

patients with GD. Mutation L444P is the most frequent and<br />

accounts for 40% of the alleles, which is associated with all<br />

types of GD. The genotype of one case is L444P/L444P. His<br />

mother had another pregnancy, the prenatal diagnosis was<br />

carried out by both enzyme assays and polymerase chain<br />

reaction (PCR)/restriction fragment length polymorphisms<br />

(RFLP). The result is that the fetus is a heterozygote of GD.<br />

Conclusion: Microanalysis of enzyme activity is a reliable<br />

method for postnatal and prenatal diagnosis of LSD.<br />

SY-08-3<br />

Biology and therapy of Niemann-Pick disease, type C<br />

M.C. Patterson<br />

Columbia <strong>University</strong>, New York, USA<br />

Niemann-Pick disease, type C (NPC), is an autosomal<br />

recessive, progressive neurodegenerative disorder resulting<br />

from mutations in NPC 1 (.95% of cases) or NPC2. The<br />

NPC1 gene product is an integral membrane protein with


Abstracts 363<br />

homology to the sterol-sensing domain of SREBP cleavage<br />

cleavage – activating protein (SCAP) and hemimegalencephaly<br />

(HMG) CoA reductase and to the Drosophila morphogen,<br />

patched, and is expressed in a late endosomal<br />

compartment. Cultured fibroblasts from NPC patients show<br />

impaired intracellular vesicular trafficking, of multiple<br />

macromolecular cargoes, leading to a net accumulation of<br />

free cholesterol and glycosphingolipids in membrane bound<br />

vesicles. The function of the NPC2 gene product (epididymal<br />

secretory protein E1 (hE1)) in the brain is under investigation.<br />

Clinical expression ranges from fetal/neonatal onset<br />

with predominant hepatic and pulmonary disease, through<br />

childhood presentations with multisystem neurologic<br />

disease, to psychiatric and cognitive adult disease. G M2 ganglioside<br />

accumulation in NPC correlates with meganeurite<br />

formation and ectopic dendritogenesis. Pharmacologic inhibition<br />

of glycosphingolipid synthesis by OGT 918 (that<br />

competitively inhibits glucosyltransferase synthase) leads<br />

to increased survival in the Balb/c murine model of NPC.<br />

A genetic model of glycosphingolipid synthesis in NPC,<br />

created by a cross between the Balb/c mutant and a GalNAc<br />

transferase knockout, shows no survival advantage over the<br />

untreated Balb/c mutant. These data suggest that lactosylceramide,<br />

glucosylceramide and ganglioside accumulation<br />

must all be reduced to produce increased survival in murine<br />

NPC. A phase I/II clinical trial of OGT 918 in human NPC is<br />

in progress.<br />

SY-08-4<br />

Neuropathic Gaucher disease: diagnosis and<br />

management<br />

G.M. Pastores<br />

Neurogenetics Unit, Department of Neurology, New York<br />

<strong>University</strong> School of Medicine, New York, NY, USA<br />

GD is a defect glycosphingolipid metabolism due to a<br />

deficiency of lysosomal glucocerebrosidase. Most patients<br />

do not have primary CNS involvement (type 1 GD); some<br />

develop acute or chronic neurodegeneration. Presence of the<br />

N370S mutation precludes CNS disease, while homozygosity<br />

for L444P is often seen with severe disease and a relatively<br />

high (but not invariable) risk of neurologic<br />

involvement. Brainstem auditory evoked response (BAER)<br />

may show abnormal peak forms and inter-peak latencies, and<br />

short-latency somatosensory evoked potential (SSEP) testing<br />

may reveal giant cortical potentials, which correlate with<br />

development of cognitive impairment. Although brain<br />

imaging and neurophysiological studies provide prognostic<br />

information, absence of abnormal findings does not exclude<br />

the possibility of CNS involvement. Enzyme therapy safely<br />

reverses the extra-neuronal manifestations. Treatment does<br />

not appear to ultimately influence the neurologic disease<br />

course in acute Neuronopathic Gaucher disease (NGD).<br />

Treatment of chronic NGD patients has been reported to<br />

stabilize supranuclear palsy and cognitive function, although<br />

there are patients who have worsened and developed progressive<br />

myoclonic encephalopathy accompanied by cranial<br />

MRI and EEG. Assessment of therapeutic response for<br />

chronic NGD is complicated by wide heterogeneity in clinical<br />

expression. Novel therapeutic strategies, including direct<br />

delivery to local sites of pathology, may be necessary to<br />

achieve optimal responses. Substrate synthesis inhibitors<br />

(SSI) have recently been shown to effect a clinical response<br />

in patients with type 1 GD. The safety and effectiveness of<br />

SSI for NGD remains to be established.<br />

SY-08-5<br />

Chemical chaperone therapy for lysosomal diseases with<br />

central nerve system pathology<br />

Y. Suzuki a , E. Nanba b , K. Ohno b , J. Matsuda c , S. Ogawa d<br />

a International <strong>University</strong> of Health and Welfare, Otawara,<br />

Japan; b Tottori <strong>University</strong>, Yonago, Japan; c National Institute<br />

of Infectious Diseases, Tokyo, Japan; d Keio <strong>University</strong>,<br />

Yokohama, Japan<br />

Some mutant enzyme proteins are labile and rapidly<br />

degraded in somatic cells from patients with Fabry disease<br />

(Fan, Ishii, Asano, Suzuki: Nature Med, 1999). If an<br />

exogenous substrate analog compound of low molecular<br />

weight is added to the cell, association of these two molecules<br />

stabilizes the mutant enzyme protein, which is then<br />

safely transported to the lysosome and expresses the catalytic<br />

activity after spontaneous dissociation with the<br />

compound (chemical chaperone) in the lysosome. We<br />

further confirmed this paradoxical phenomenon for b-galactosidase<br />

deficiency (G M1 -gangliosidosis and Morquio B<br />

disease) and b-glucosidase deficiency (Gaucher disease).<br />

After screening of newly synthesized compounds, we<br />

found two potent competitive inhibitors: GalX for b-galactosidase<br />

and GlcX for b-glucosidase (tentative nomenclature).<br />

They are enzyme inhibitors in vitro, but induced<br />

expression of the mutant enzyme activity at low concentrations<br />

in cultured fibroblasts from some patients, respectively,<br />

with these two diseases. Mutant enzyme activities<br />

were remarkably elevated after several days of culture<br />

with one of these compounds. The mutations responsive<br />

to this procedure mainly represented late onset or atypical<br />

clinical phenotypes. Furthermore we produced a few mouse<br />

lines expressing phenotype-specific mutant human b-galactosidase,<br />

by introducing cDNA as transgene into the<br />

enzyme-deficient knockout mouse. This new disease<br />

model, knockout-transgenic mouse, serves for animal<br />

experiments of our therapeutic approach to human b-galactosidase<br />

deficiency disorders. One of the model mouse lines<br />

expressing the R201C mutation was fed with GalX solution<br />

for a week. All tissues including the brain showed 5–15-fold<br />

elevation of the b-galactosidase activity. This result indicates<br />

that the compound GalX passed through the blood–<br />

brain barrier to restore enzyme activity in the brain, which is<br />

sufficient for intracellular degradation of stored substrates.


364<br />

Abstracts<br />

This is the first achievement for developing a new therapeutic<br />

approach by oral medication to the brain pathology in<br />

lysosomal storage diseases.<br />

SY-9<br />

Child and Adolescent Epilepsy in the Framework of<br />

the ILAE/IBE/WHO Global Campaign against Epilepsy<br />

SY-09-1<br />

The ILAE/IBE/WHO global campaign against epilepsy:<br />

A progress report<br />

S. Jan<br />

India<br />

Abstract not submitted<br />

SY-09-2<br />

Epilepsy in infancy and childhood: Incidence,<br />

prevalence and clinical spectrum<br />

S. Ohtahara<br />

Department of Child Neurology, Okayama <strong>University</strong> Medical<br />

School, Okayama, Japan<br />

Onset of epilepsies is mostly in childhood; about 70% of<br />

epileptic patients have their initial attack within the first 3<br />

years of life. Response to the treatment is usually favorable<br />

in childhood epilepsy in comparison with that of adult<br />

epilepsy. This may suggest the possibility of remarkable<br />

reduction of epileptic patients by the proper treatment of<br />

childhood epilepsy. The real condition of childhood<br />

epilepsy will be outlined according to the epidemiological<br />

findings, particularly two extensive neuroepidemiological<br />

investigations of childhood epilepsy in Okayama Prefecture.<br />

Relating the intractable cases, cardinal epileptic<br />

syndromes are overviewed. Characteristics of childhood<br />

epilepsy are mentioned, referring to the conceptualization<br />

of the age-dependent epileptic encephalopathy and its<br />

developmental aspects.<br />

SY-09-3<br />

Development and disruption: long-term effects epileptic<br />

interference with early cognitive development<br />

S.J. Wallace<br />

<strong>University</strong> Hospital of Wales, Cardiff, UK<br />

Of the stages of development of the brain, neuronal<br />

migration and organisation; and, the formation of synapses,<br />

with their reinforcement or apoptosis, seem to be the most<br />

relevant. The peak period of migration is passed well before<br />

fetal viability, but organisation and synaptic formation<br />

continue into the early years. When epilepsy develops<br />

very early, poor later cognitive development may merely<br />

be a reflection of severe abnormalities in prenatal brain<br />

development: these would be impossible to correct. Epilepsies<br />

with onset after the neonatal period will be the main<br />

subject for discussion, since there could be some scope for<br />

amelioration of subsequent cognitive difficulties. Four main<br />

aspects will be considered. Biochemical/metabolic reasons<br />

for neuronal damage following epileptic seizures include<br />

the actions of excito-toxic amino acids; and during status<br />

epilepticus, additionally, hypoxia and metabolic acidosis.<br />

Disruption of learning can be secondary to the presence of<br />

the epilepsy of particular syndromes, such as those of West,<br />

Dravet and Lennox-Gastaut, and in epilepsies with specific<br />

cognitive symptomatology. Possible effects of treatment of<br />

epilepsy, such as drugs, which might interfere with, or<br />

enhance, cognition and educational progress, need consideration.<br />

Secondary effects on psychosocial functioning, e.g.<br />

alterations in parental management and expectations, and,<br />

reduced educational and social opportunities can be important.<br />

The less florid, but equally important, educational<br />

problems of children with benign focal epilepsies and<br />

absences will be addressed. Epilepsy is a further additional<br />

handicap in children with cerebral palsy, when it is associated<br />

with enhanced cognitive problems.<br />

SY-09-4<br />

The impact of epilepsy. The influence of epilepsy on the<br />

lives of the child, the parents and the siblings<br />

M. Endziniene<br />

Kaunas <strong>University</strong> of Medicine, Lithuania<br />

One of the most difficult aspects of having epilepsy is not<br />

the epilepsy itself, but the problem of adjusting to it. In early<br />

years, physical impact of epilepsy on the child is most<br />

prominent (injuries caused by seizures, medication side<br />

effects, unpleasant medical procedures). In later years,<br />

emotional and behavioral consequences as well as difficulties<br />

in psychological and social adjustment come to front.<br />

The unpredictability of seizures make the patients feel not as<br />

good as other people. Poor self-esteem, depression, anxiety;<br />

fear of being isolated by peers and of being unable to meet<br />

parental expectations; learning difficulties, multiple restrictions,<br />

uncertainty in the future and continuous striving to<br />

avoid overprotection are the key problems that that the teenagers<br />

have to deal daily. On the other hand, the burden of<br />

having a chronically ill child has great influence on the<br />

family relationships and social roles. It sometimes takes<br />

months to accept the diagnosis of epilepsy, to settle realistic<br />

expectations and to learn how to help the child in coping<br />

with its problems. The feelings of guilt, anxiety, helplessness<br />

and doubts lead to overprotection and excessive restrictions<br />

towards the disabled child. Loss of parental attention<br />

and care may cause emotional problems in healthy siblings.<br />

Parental inability to cope with personal emotions and to plan<br />

family life often lead to complete disruption of family relations<br />

or professional career, and to social isolation. Providing<br />

adequate knowledge and timely counseling for the


Abstracts 365<br />

family members and for the child, teaching them to take<br />

active part in dealing with epilepsy-related problems can<br />

prevent stigmatization and improve social adjustment.<br />

Education of healthcare professionals as well as of the<br />

public also plays a major role.<br />

SY-09-5<br />

Living with epilepsy – a patient with epilepsy from India<br />

R. Sehgal<br />

India<br />

Abstract not submitted<br />

SY-10<br />

Tourette Syndrome<br />

SY-10-1<br />

Phenomenology and natural history of tic disorders<br />

J.F. Leckman<br />

Child Study Center, South Frontage Road, Yale <strong>University</strong><br />

School of Medicine, New Haven, CT, USA<br />

Tics are isolated, disinhibited fragments of normal motor<br />

or vocal behaviors. Like habits, tics often arise from a<br />

heightened and selective sensitivity to cues from within<br />

the body or from the outside world. Many patients report<br />

being besieged by premonitory somatosensory urges (bodily<br />

cues) that are often localized to discrete anatomical areas.<br />

These urges and the internal struggle to control them can be<br />

as debilitating as the tics themselves. Motor tics usually<br />

begin between the ages of 3 and 8 years. Typically vocal<br />

tics follow the onset of motor tics by several yrs. In uncomplicated<br />

cases, motor and vocal tic severity peaks early in<br />

the second decade with many patients showing a marked<br />

reduction in tic severity by the age of 20 years. However, the<br />

most severe cases occur in adulthood. Motor and phonic tics<br />

occur in bouts over the course of a day and wax and wane in<br />

severity over the course of weeks to months. Less well<br />

known is the ‘self-similarity’ of these temporal patterns<br />

across different time scales. Knowledge of the temporal<br />

patterning of tics is fundamental for the practitioner as it<br />

informs decisions about when to initiate or change anti-tic<br />

medications, and when to be patient and simply provide<br />

close monitoring and support to the family. A deeper understanding<br />

of the multiplicative processes that govern these<br />

temporal patterns may clarify both microscopic neural<br />

events occurring in millisecond time scales as well as<br />

macroscopic features of the natural history of tic disorders<br />

that occur over decades. In addition to tics, many patients<br />

suffer with symptoms of attention deficit hyperactivity<br />

disorder and/or obsessive-compulsive disorder. When<br />

present, these coexisting conditions can add greatly to the<br />

morbidity associated with tic disorders and detract from the<br />

patient’s overall quality of life.<br />

SY-10-2<br />

Neurobiology of Tourette syndrome<br />

H.S. Singer<br />

Department of Pediatrics Division, The Johns Hopkins<br />

<strong>University</strong>, USA<br />

Neuroanatomy: Significant data, derived from volumetric<br />

MRI, area measurements of the corpus callosum, imaging of<br />

glucose metabolism and blood flow, coulometer paradigms,<br />

transcranial magnetic stimulation, and functional MRI,<br />

supports the proposal that Tourette syndrome (TS) is associated<br />

with changes in frontal-subcortical circuits. Volumetric<br />

MRI studies in subjects with TS have shown:<br />

significant differences in the symmetry of the putamen<br />

and lenticular region in boys and a reduction in the size of<br />

these structures in adults; larger volumes of a region that<br />

approximated dorsal prefrontal and smaller volumes of<br />

regions that approximated premotor and orbitofrontal cortex<br />

in boys; and a larger percentage of white matter in the right<br />

frontal lobe. fMRI studies of tic activity and suppression<br />

have implicated various cortical regions, basal ganglia,<br />

and thalamus. Neurochemistry: The distribution of classical<br />

neurotransmitters (e.g. dopamine, serotonin, GABA, glutamate,<br />

acetylcholine, norepinephrine, and opioids) within the<br />

basal ganglia and frontal-subcortical circuits raises the<br />

possibility that a variety of transmitters could be involved<br />

in the pathobiology of TS. In general, current hypotheses are<br />

based on extrapolations from clinical trials evaluating the<br />

response to specific medications; from studies of cerebrospinal<br />

fluid (CSF), blood, and urine; from neurochemical<br />

assays on a limited number of postmortem brain tissues;<br />

and from SPECT and PET investigations. Microarray analysis<br />

in TS and control postmortem putamen has identified<br />

several significant differences in gene expression. PET<br />

studies have primarily focused on the dopamine and serotonin<br />

systems. A recent report has shown that TS patients, as<br />

compared to controls, have an increased release of dopamine<br />

in the putamen following a pharmacologic challenge<br />

with amphetamine. Neuroimmunology: Although TS is a<br />

genetic disorder, environmental factors, especially infections,<br />

have been hypothesized to evoke or exacerbate tics.<br />

The existence of pediatric autoimmune neuropsychiatric<br />

disorders associated with streptococcal infection<br />

(PANDAS), however, remains controversial. Confirmatory<br />

studies, which seek to identify an immune-mediated<br />

mechanism involving molecular mimicry, to date, have<br />

only been partially successful. A small number of patients<br />

with PANDAS have responded to immunomodulatory therapy<br />

with either intravenous immunoglobulin (IVIG) or plasmapheresis.<br />

Antineuronal antibodies measured against three<br />

distinct fractions (supernatant, pellet, and synaptosomes)<br />

from adult postmortem caudate, putamen, and globus pallidus,<br />

however, showed no difference between PANDAS<br />

patients and controls. Additionally, the validity of studies<br />

suggesting that the microinfusion of TS or PANDAS sera


366<br />

Abstracts<br />

into rodent striatum caused significant increases in oral<br />

stereotypic behaviors and episodic utterances have been<br />

questioned.<br />

SY-10-3<br />

Recent advances in genetics on Toulette syndrome<br />

J. Walkup<br />

Department of Pediatrics Division, The Johns Hopkins<br />

<strong>University</strong>, USA<br />

Abstract not submitted<br />

SY-10-4<br />

Tourette syndrome in Taiwan<br />

H.-S. Wang<br />

Division of Pediatric Neurology, Chang Gung Children’s<br />

Hospital, College of Medicine, Chang Gung <strong>University</strong>,<br />

Taoyuan, Chinese Taipei<br />

The prevalence of TS in a primary elementary school here<br />

is around 0.6%. It is no more a rare or degenerative disorder;<br />

it is a model of neuropsychiatric disorder in children.<br />

Although the pathogenesis of TS is still uncertain, the high<br />

incidence offamilial cases up to 30% suggests a possibility of<br />

genetic origin. Pharmacological, electrophysiological, and<br />

neuroimaging evidences all implicate the hyper-responsiveness<br />

of dopamine influencing the cortical-striatal-thalamocortical<br />

circuits of patients with TS. Facing patients with tics,<br />

first of all we must exclude the possibilities of Tourettism<br />

with secondary etiologies. Ninety percent of patients with<br />

primary tics occur transiently and spontaneously subside<br />

within 1 year. Those patients with tics persisting longer<br />

than a year will be chronic tic disorder or TS depending on<br />

how many types of motor and/or vocal tics they have ever<br />

had. Tics are mild in 73% of patients with TS. For them,<br />

understanding and acceptance from family, teachers, and<br />

friends are the most important things. When tics are so severe<br />

that medication is necessary, haloperidol is no longer the first<br />

or only choice. Clonidine or atypical neuroleptics such as<br />

risperidone or olanzapine should be used first for their<br />

minor side effects. Many other medicines such as topiramate<br />

are still in trial. Some children visiting our Tourette Clinics<br />

were found to have high serum copper concentrations that are<br />

under our further evaluation.<br />

SY-10-5<br />

Toulette syndrome in Asian countries<br />

Y. Nomura<br />

Segawa Neurological Clinic for Children, Chiyoda-ku,<br />

Tokyo, Japan<br />

Abstract not submitted<br />

SY-11<br />

Neurocutaneous Syndromes<br />

SY-11-1<br />

Advances in understanding neurological and<br />

behavioural phenotypes in tuberous sclerosis<br />

P. Curatolo<br />

Pediatric Neurology, Tor Vergata <strong>University</strong> of Rome,<br />

Rome, Italy<br />

Tuberous sclerosis (TSC) is a disorder of cells migration,<br />

proliferation, and differentiation. Cell lineage and cell<br />

migration disorders in the developing cortex of TSC children<br />

produce very different neurological phenotypes including<br />

epilepsy, cognitive impairment and autism. Cortical<br />

tubers constitute the hallmark of the disease. At the moment<br />

about 400 different mutations in both TSC genes are known.<br />

Patients with TSC1 mutation have on average milder<br />

disease in comparison with patients with TSC2 mutations.<br />

They have a lower frequency of seizures and moderatesevere<br />

mental retardation, fewer cortical tubers, less severe<br />

kidney involvement and facial angiofibromas, and no retinal<br />

hamartoma. Epilepsy is the most common neurological<br />

feature. Seizures often begin in the first months of life and<br />

are frequently intractable. Selected drug resistant patients<br />

could be considered for surgical treatment. The finding of<br />

the multiple areas of cerebral involvement should not automatically<br />

preclude epilepsy surgery in a child with intractable<br />

seizures and well-defined seizures origin. Autism<br />

appears to be more common in infants with frontal and<br />

parieto-temporal tubers and may be due to an early dysfunction<br />

in the associative areas. Autism could be also considered<br />

a secondary effect of seizures and/or mental<br />

retardation. An alternative and more intriguing explanation<br />

is that this abnormal behavior may reflect a more direct<br />

effect of the abnormal genetic program. A couple of genome<br />

scans in autism suggested that a potential susceptibility gene<br />

may be located on chromosome 16p13. The genetic analysis<br />

of the short arm of the chromosome 16 will help to localise<br />

such candidate gene and clarify its position with respect to<br />

the TSC2 locus.<br />

SY-11-2<br />

Recent progress about mutational analysis of TSC1 and<br />

TSC2 genes and functions of the hamartin protein<br />

E. Nanba<br />

Gene Research Center, Tottori <strong>University</strong>, Yonago, Japan<br />

TSC is a neurocutaneous syndrome characterized by<br />

development of unusual tumor-like growths. Involvement<br />

of the brain is associated with the most problematic clinical<br />

manifestations of TSC, including intellectual retardation,<br />

epilepsy and abnormal behaviors. Until now, over 300<br />

mutations of TSC1 and TSC2 were reported. We have


Abstracts 367<br />

surveyed the mutations of TSC1 and TSC2 from 76 Japanese<br />

patients. We analyzed the all the exons of both genes<br />

by single strand conformation polymorphism method<br />

(SSCP) followed by sequencing. Nine TSC1 mutations<br />

and 20 TSC2 mutations were found. The mutations were<br />

not clustered on a particular exons in either of the genes.<br />

All mutations were could not be found in the family<br />

members. The nonsense mutations in TSC1 and missense<br />

mutations in TSC2 were relatively popular and no splicing<br />

mutation was found. The patients with TSC2 mutations tend<br />

to exhibit relatively severe mental retardation in comparison<br />

to those with TSC1 mutations. Our mutation detection rate<br />

was only 40% and there are several possibilities including<br />

other undiscovered gene for Japanese TSC patients for the<br />

rate. To analysis of the function of hamartin that is TSC1<br />

gene product, we have tried to screen the proteins binding to<br />

TSC1 gene product by yeast two-hybrid method. We found<br />

several genes and have continued further study.<br />

SY-11-3<br />

Typical and atypical non-neoplastic brain abnormalities<br />

on MRI in children and adolescents with<br />

neurofibromatosis type 1<br />

O. Eeg-Olofsson, R. Raininko, L. Thelin<br />

<strong>University</strong> Hospital, Uppsala, Sweden<br />

The occurrence, localization and longitudinal course of<br />

non-neoplastic MRI abnormalities in children and adolescents<br />

with neurofibromatosis type 1 (NF1) were studied.<br />

Thirty-five patients who satisfied the criteria for NF1 underwent<br />

114 MRI examinations. They were 9 months to 18<br />

years old at the time of their first examination, and 23<br />

were examined more than once (2–11 times). The followup<br />

time varied from 3 months to 10 years (mean: 4 years).<br />

High signal intensity lesions on T2-weighted images were<br />

seen in the cerebellum, brain stem, and deep cerebral gray<br />

matter and, less frequently, in the cerebral white matter in<br />

89% of the subjects. Proton density-weighted and T1-<br />

weighted images showed changes in 80 and 50%, respectively.<br />

During follow-up, some new lesions developed,<br />

some disappeared and some changed in size and appearance<br />

without correlation to the patient’s age. In four patients, all<br />

boys, one or two of the lesions with a high T2 intensity were<br />

expansive. They were located in the upper medulla oblongata,<br />

in the medulla oblongata expanding into the spinal<br />

cord, in the left cerebellar hemisphere, and in the wall of<br />

the left lateral ventricle. The last-mentioned lesion showed<br />

contrast enhancement that disappeared in 2 years. All those<br />

lesions had atypical features, commonly regarded as signs<br />

of a neoplasm, but they receded without specific treatment.<br />

There were no related clinical symptoms in any patients.<br />

Obviously, the border between neoplastic and non-neoplastic<br />

lesions is indistinct. High signal lesions on T2-weighted<br />

MR images should be included as another criterion for the<br />

diagnosis of NF1.<br />

SY-11-4<br />

Vascular malformations and neurocutaneous diseases<br />

I. Pascual-Castroviejo<br />

Pediatric Neurology Service, <strong>University</strong> Hospital La Paz,<br />

Madrid, Spain<br />

Neurocutaneous diseases (an old concept is phakomatoses)<br />

are frequently associated with vascular intra or extracranial<br />

malformations. Vascular anomalies mostly occurs in<br />

classical phakomatoses such as SWS and also in other disorders<br />

described more recently. However, a great part of the<br />

neurocutaneous diseases can develop some type of vascular<br />

anomalies. Arteriography and especially magnetic resonance<br />

arteriography (MRA) show a great variety of vascular<br />

malformations. Neurifibromatosis type1 (NF1): it can be<br />

occasionally associated with internal carotid asymmetry or<br />

with moyamoya disease. SWS: The presence of leptomeningeal<br />

angiomatosis ipsolateral to the facial nevus flammeus<br />

distributed over a partial or total zone innervated by the first<br />

sensory branch of the trigeminal nerve is a necessary criterion<br />

in the diagnosis of SWS. Furthermore, angiomas in the<br />

ocular choroids and absence of various images in the cortical<br />

region of the affected hemisphere can be seen. Cutaneous<br />

hemangioma-vascular complex syndrome: This is<br />

the most frequent neurocutaneous disease, surpassing the<br />

NF1. This disease was described in 1978. It is associated<br />

with persistence of the trigeminal artery and absence of<br />

carotid and/or vertebral arteries, mostly of the same side<br />

of the cutaneous hemangioma, in a great part of the patients.<br />

Angiomatous or mega-arterial intracranial anomalies can be<br />

seen as well. Increase and decrease in parallel with the<br />

cutaneous and the intracranial arteries are usually seen.<br />

Conclusion: During the last years new neurocutaneous<br />

diseases appeared and new vascular findings were discovered;<br />

MRA is the most recommended study.<br />

SY-11-5<br />

Vascular malformations and neurocutaneous diseases<br />

I. Pascual-Castroviejo<br />

Pediatric Neurology Service, <strong>University</strong> Hospiutal La Paz,<br />

Madrid, Spain<br />

Neurocutaneous diseases (an old concept is phakomatoses)<br />

are frequently associated with vascular intra- or extracranial<br />

malformations. Vascular anomalies mostly occur in<br />

classical phakomatoses such as Sturge-Weber syndrome<br />

(SWS) and also in other disorders described more recently<br />

(1, 2). However, a great part of the neurocutaneos diseases<br />

can develop some types of vascular anomalies. Arteriography<br />

and especially magnetic resonance arteriography (MRA)<br />

show great variety of vascular malformations. NF1: It can be<br />

occasionally associated with internal carotid asymmetry or<br />

with moyamoya disease. SWS: The presence of leptomeningeal<br />

angiomatosis ipsilateral to the facial nevus flammeus


368<br />

Abstracts<br />

distributed over a partial or total zone innervated by the first<br />

sensory branch of the trigeminal nerve is a necessary criterion<br />

in the diagnosis of SWS. Furthermore, angioma in the<br />

ocular choroid and absence of venous images in the cortical<br />

region of the affected hemisphere can be seen. Cutaneos<br />

hemangioma-vascular complex syndrome: This is the most<br />

frequent neurocutaneous disease, surpassing the NF1. This<br />

disease was described in 1978 (1). It is associated with persistence<br />

of the trigeminal artery and absence of carotid and/or<br />

vertebral arteries, mostly of the same side of the cutaneous<br />

hemangioma, in a great part of the patients. Angiomatous or<br />

mega-arterial intracranial anomalies can be seen as well.<br />

Increase and decrease in parallel of the cutaneous and the<br />

intracranial arteries are usually seen. Conclusion: During<br />

the last years new neurocutaneos diseases appeared and<br />

new vascular findings were discovered. MRA is the most<br />

recommended study.<br />

SY-12<br />

Education of Child Neurologists<br />

SY-12-1<br />

Overview of peripheral neuropathy in childhood 2002<br />

R. Ouvrier<br />

The Children’s Hospital at Westmead, Australia<br />

This presentation describes the findings in a biopsy<br />

series of 260 cases of polyneuropathy in children up to<br />

16 years of age. Conditions in which we have had a particular<br />

interest will be emphasised and illustrated with<br />

videotapes. Approximately 83% of cases were genetic in<br />

origin, and about 17% were acquired. Of the acquired<br />

neuropathies, acute and chronic inflammatory polyneuropathies<br />

are the most frequent (8% of the series) and the<br />

most important, since effective treatment is available.<br />

Chronic polyneuropathies are of two main pathological<br />

types-axonal degenerative and de- (and re-) myelinating.<br />

The axonal forms constituted some 137 cases (53%). Their<br />

molecular basis is, in most cases, poorly understood.<br />

Hereditary motor and sensory neuropathy (HMSN) of<br />

neuronal type commencing in early childhood and the<br />

newly described severe infantile axonal neuropathy with<br />

respiratory failure (SIANR or SMARD) will be discussed<br />

in detail. There were 103 cases of demyelinating neuropathies,<br />

most of which were due to inherited mutations of<br />

specific myelin proteins. In this paediatric series, there<br />

were five documented point mutations of the methyl<br />

prednisolone (MPZ) and three of the PMP22 genes, all of<br />

which presented with features of the Dejerine-Sottas<br />

syndrome. X-linked Charcot-Marie-Tooth disease is<br />

usually caused by mutations of connexin 32. There were<br />

five cases in the series. Most cases of chronic demyelinating<br />

neuropathy presenting in childhood can be precisely<br />

diagnosed to enable accurate genetic counselling. Unfortunately,<br />

specific treatment is not yet available for such cases<br />

but the expansion of the understanding of these conditions<br />

gives real hope for an eventual cure.<br />

SY-12-2<br />

Education of child neurologists in China<br />

X.-R. Wu<br />

Department of Pediatrics, First Hospital, Peking <strong>University</strong>,<br />

Beijing, China<br />

In early 1960s, several child neurology groups were<br />

established spontaneously in Beijing, Shanghai, and<br />

Guonzhou cities, they were the pioneers and founders of<br />

child neurology in China. In 1985, Chinese Pediatric<br />

Neurology Society was formally established as one of the<br />

subsocieties of Chinese Pediatric Society. Since late 1970s,<br />

the OPEN policy greatly promoted the training and international<br />

professional exchange in child neurology of<br />

China. (1) The national pediatric resident postgraduate<br />

education program started in 1986 organized by Ministry<br />

of Health of China, it included total 5 years training,<br />

divided into first 3 years and later 2 years. During the 5<br />

years, there were national doctor’s license exam and final<br />

resident postgraduate education training qualified exam.<br />

For child neurologists, in addition to pass the 5 years training,<br />

should be further trained in a domestic child neurology<br />

eligible center (1 year), or passed the master or Ph.D.<br />

training programs of child neurology, or in adult neurology<br />

(6 month–1 year), or in child neurology of foreign countries.<br />

The national specialist examination systems of China<br />

are still during working. (2) Child neurology training class:<br />

Since 1980–2001, total 95 classes in 25 cities of China<br />

were held, 4290 pediatricians have been trained. Four to<br />

8 weeks for each class. In addition to general child neurology<br />

class, also special topic classes such as seizure disorders,<br />

cerebral palsy, anticonvulsants pharmacology,<br />

neonatal screening, EEG, learning and behavior problems,<br />

etc. (3) International professional exchange in child neurology:<br />

Send pediatricians to be trained in child neurology<br />

training program in foreign countries as USA, Japan,<br />

Australia, etc., also in Hong Kong area. We invited child<br />

neurology experts or neuroscientists from foreign countries<br />

to visit and give lectures, to establish collaborated research<br />

projects, etc. We encourage young doctors to attend international<br />

child neurology meetings. (4) So far, more domestic<br />

child neurology textbooks or reference books have been<br />

published, also there are more international child neurology<br />

textbooks and journals can be seen in most big cities<br />

library in China. The young generation of Chinese child<br />

neurologists already have been grown up today in China.<br />

We express our heartfelt thanks to all of the friends in the<br />

world they have been so kindly supported us during the<br />

passed 20 years.


Abstracts 369<br />

SY-12-3<br />

Electroencephalographic photosensitivity among<br />

Zimbabwean youths<br />

J.B. Familusi, B. Adamolekun<br />

Departments of Pediatrics and Medicine <strong>University</strong> of<br />

Zimbabwe, Harare, Zimbabwe<br />

To clarify the factors associated with EEG photosensitivity,<br />

the records of patients who had EEG examinations in the<br />

city of Harare, Zimbabwe between 1968 and 1996 were<br />

studied. EEG photosensitivity was confirmed in 107 of a<br />

total of 9082 youths (age 0–25 years), giving an overall<br />

photosensitivity prevalence of 1.17% in the study population.<br />

Photosensitivity occurred more frequently in females<br />

than in males, and the peak age period for its occurrence was<br />

during adolescence. A significantly higher prevalence of<br />

photosensitivity was recorded among whites and Asians<br />

than among black, while the coloured population had an<br />

intermediate prevalence. The monthly and seasonal incidence<br />

of photosensitivity in the present study showed no<br />

correlation with the prevailing mean monthly or seasonal<br />

temperatures, sunshine duration and sunlight intensity in<br />

Harare during the period covered by the study. These findings<br />

indicate that sunshine-related factors do not play a<br />

dominant role in the occurrence of photosensitivity, thereby<br />

negating previous opinions which attributed the relative<br />

rarity of photosensitivity in black Africans to high levels<br />

of exposure to sunshine in tropical Africa. Our findings<br />

therefore corroborate the view that photosensitivity depends<br />

primarily on genetic rather than environmental factors.<br />

SY-12-4<br />

Education approach to metabolic abnormalities in<br />

childhood<br />

K. Swaiman<br />

Pediatric Neurology, St. Paul, MN, USA<br />

The education of trainees directed at metabolic disease<br />

must convey a sense of systematic evaluation. This evaluation<br />

begins with the likelihood of a metabolic disease based<br />

on history and examination. In all cases, the patterns of<br />

genetic transmission must be understood. Among the<br />

amino acidopathies, the prototypic disease is phenylketonuria.<br />

As has been the case for many amino acidopathies,<br />

a number of forms of phenylketouria have been associated<br />

with various intricacles of the involved metabolic pathways.<br />

Other common amino acidopathies are maple syrup urine<br />

disease which is the result usually of abnormalities in<br />

branched-chain ketoacid decarboxylase, homocystinuria<br />

(of which there are several types), and a number of other<br />

less common conditions. Many of these conditions, involving<br />

essential amino acids, are treated with special dietary<br />

preparations. In some cases, patients will respond to cofactor<br />

administration because the abnormal protein enzyme<br />

requires greater than normal concentrations of the cofactor.<br />

Hyperammonemia is extremely toxic to nervous tissue.<br />

Although hyperammonemia may be a secondary finding in<br />

a number of conditions, significant metabolic central<br />

nervous system disruption may result. When the enzyme<br />

deficiency in Krebs-Hensleit urea cycle pathway is proximal<br />

in the urea cycle pathway, as a rule, the more severe the<br />

clinical condition. Lysosomal disease such as the sphingolipidoses,<br />

mucopolysaccharidoses, mucolipidoses, glycogen<br />

storage disease, glycoproteinoses and some other storage<br />

disease are the result of abnormal accumulation of normal<br />

substrates and their catabolic products within lysosome.<br />

Research has resulted in a much better understanding of<br />

mechanisms common to these diseases, as well as mechanisms<br />

specific to each disease. The peroxisomal disorders, a<br />

group of disease entities that share structural and/or functional<br />

abnormalities of the peroxisomes, are inherited and<br />

may have profound neurologic and systemic effects. Some<br />

of the disorders lack peroxisomes in cells, while others have<br />

single or multiple peroxisomal enzymatic deficiencies in<br />

spite of the presence of normal peroxisomes. Abnormalities<br />

of energy metabolism are frequently accompanied by lactic<br />

acidosis. Hypoglycemia and hyperammonemia may be<br />

evident. Abnormalities may be present in pyruvate metabolism<br />

which are usually due to abnormalities in pyruvate<br />

carboxlase deficiency or variations thereof, pyruvate dehydrogenase<br />

complex deficiency, citric acid cycle abnormalities,<br />

and respiratory chain abnormalities. Brain and muscle<br />

are chiefly involved. For most cell type, when the oxygen<br />

supply is adequate, energy requirements are met in mitochondria<br />

by oxidation of pyruvate, fatty acids, or ketone<br />

bodies. These substances are converted into acetyl-CoA<br />

and enter the citric acid cycle and the respiratory chain.<br />

Impairment of oxidative metabolism may occur due to<br />

disorders of substrate transport, of substrate utilization, of<br />

citric acid cycle function, or of the respiratory chain.<br />

SY-12-5<br />

Intractable pediatric epilepsy syndromes in early<br />

infancy<br />

S. Ohtahara<br />

Department of Child Neurology, Okayama <strong>University</strong> Medical<br />

School, Okayama, Japan<br />

The new classification of epilepsy adopted the epiltptic<br />

encephalopathy, among which Ohtahara syndrome, early<br />

myoclonic encephalopathy, peculiar early-onset type of<br />

symptomatic partial epilepsy, and severe myclonic epilepsy<br />

in infancy (Dravet syndrome) have their onset in early<br />

infancy. The concept of the epileptic encephalopathy and<br />

these epileptic syndromes will be mentioned with their<br />

etiology, clinicoelectrical characteristics, diagnostic<br />

criteria, differential diagnosis, treatment, prognosis and<br />

mutual relationship. Ohtahara syndrome is delineated, particularly<br />

from the developmental viewpoint.


370<br />

SY-13<br />

Pervasive Developmental Disorders<br />

SY-13-1<br />

Earliest signs of autism in infants<br />

Abstracts<br />

in sarcastic sentences. The number of landmine was also<br />

significantly high in HFPDD. Conclusion: ADHD children<br />

were balanced in this test, however HFPDD children<br />

showed specific difficulty in sarcastic sentences. This<br />

might cause their social troubles.<br />

P. Filipek<br />

<strong>University</strong> of California Irvine, Irvine, CA, USA<br />

Infant siblings of autistic children are routinely followed<br />

by the author to document the earliest signs suspicious for<br />

autism or other developmental disorders. Longitudinal<br />

videotapes will be shown for several case studies, to demonstrate<br />

the wide variability of the early warning signs, and the<br />

effects of early intervention on these babies.<br />

SY-13-2<br />

Genetics<br />

J.T. McCracken<br />

Division of Child and Adolescent Psychiatry, UCLA Neurophychiatric<br />

Institute, Los Angeles, USA<br />

Abstract not submitted<br />

SY-13-3<br />

Pragmatic difficulties of figurative and sarcastic<br />

sentences in pervasive developmental disorders<br />

T. Koeda<br />

Department of Humanity Education, Faculty of Education<br />

and Regional Sciences, Tottori <strong>University</strong>, Tottori, Japan<br />

It is well known that the children with high function<br />

pervasive developmental disorders (HFPDD) fail the theory<br />

of mind tasks. These children often have the episode of<br />

social troubles. The causes of the troubles are not only the<br />

mind blindness but also the language impairments, i.e.<br />

comprehensive difficulties of figurative and/or sarcastic<br />

situations. We made a novel test using figurative and sarcastic<br />

sentences for HFPDD to know their pragmatic skills. The<br />

test is constructed from five of figurative and five of sarcastic<br />

sentences. The normative distribution of this test was<br />

studied. Normative distribution: Two hundred normative<br />

children, second grade to sixth of primary school (age 7–<br />

12 year-old), 96 boys, were carried out the test. The results<br />

are following; the number of correct answers in figurative<br />

sentences is increasing as grade. In sarcastic sentences, there<br />

is no significant difference except for between the second<br />

and sixth grade. Most serious incorrect answer, we called<br />

‘landmine’, is not so much in normative children. HFPDD<br />

and attention deficit and hyperactivity disorder (ADHD) 15<br />

of HFPDD and nine of ADHD children were nominated ion<br />

this study. There is no significant difference between<br />

HFPDD and ADHD in figurative sentences, however<br />

HFPDD children answered more incorrectly than ADHD<br />

SY-13-4<br />

The neurrophysiological aspect of pervasive<br />

developmental disorders<br />

M. Miyao<br />

Department of Developmental Neuropsychology, National<br />

children’s medical center National center for child health<br />

and development, Japan<br />

Childhood autism is now widely viewed as being of<br />

developmental neurobiological origin that is defined behaviorally<br />

by severe deficiencies in reciprocal social interaction,<br />

verbal and nonverbal communication, and restricted<br />

interests. Yet, localized structural and functional brain<br />

correlates of autism have to be established. Structural<br />

brain-imaging studies performed in autistic patients have<br />

reported abnormalities such as increased total brain volume<br />

and cerebellar abnormalities. However, none of these<br />

abnormalities fully account for the full range of autistic<br />

symptoms. A large number of investigation techniques are<br />

used to relationships between the clinical and neurophysiological<br />

data were necessary to analysis in the field of pervasive<br />

developmental disorder. The prevalence of epilepsy in<br />

the general population is 0.5%; the published figures on<br />

epilepsy in autism range 4–7%. One of the most difficult<br />

things to understand in the field of autism is the many papers<br />

describing brainstem auditory evoked potentials, cortical<br />

evoked potentials and event related potentials. Midlatency<br />

auditory evoked responses (P1), measuring the ascending<br />

reticular activation system and their thalamic target cells,<br />

have been reported as abnormal in children with autism.<br />

Event related potential P3 waves are smaller in children<br />

with autism compared to controls. Resting EEGs from the<br />

bilateral frontal, central, and occipital regions were examined<br />

though power spectrum. The frequency of the dominant<br />

peak in the occipital EEGs reached maximum at 12–20<br />

years. And development of sleep spindles was analyzed.<br />

Two spindle types, 11–13 Hz frontal lobe spindles and<br />

12–14 Hz centro-parietal lobe spindles were recorded. The<br />

frontal lobe spindles were frequently recorded at 8 years, the<br />

centro-parietal spindles were frequently recorded at 18<br />

years. Topographical maps of the EEG coherence demonstrated<br />

that a synchronous component at the anterior-occipital<br />

areas and right and left were higher in subjects with<br />

autism compared to controls. We think that neurophysiological<br />

research into childhood autism has a particular interest<br />

in the broader field of developmental neuropsychology<br />

because it could give some explanation of casual mechanisms<br />

that underlie autistic syndrome and other developmental<br />

syndromes.


Abstracts 371<br />

SY-14<br />

Neurosurgery<br />

SY-14-1<br />

Technological advances in pediatric neurosurgery<br />

S. Constantini<br />

Department of Pediatric Neurosurgery, Dana Children’s<br />

Hospital, Israel<br />

Several technological advances that occurred in the last<br />

10 years completely altered the setup in the pediatric<br />

neurosurgical operating room. These innovations have<br />

significantly changed our approach towards children with<br />

complex brain and spinal cord problems. Technological<br />

advances are not all positive and common sense has to<br />

be preserved. Economical issues, an enormous logistic<br />

burden, and the potential for errors are all reasons to<br />

review our new reality with respect to prioritization, decision-making,<br />

and optimal usage. The lecture will try and<br />

provide an overview on our modern operating room and<br />

cover areas such as neuro-navigation-intraoperative MRIneuroendoscopy,<br />

and real-time, intraoperative evoked<br />

potential monitoring. The new ‘gadgets’ and their ability<br />

will be presented together with day-to-day dilemmas that<br />

come along.<br />

SY-14-2<br />

Surgical concepts of fetal hydrocephalus and<br />

dysraphism with its specific plasticity<br />

S. Oi<br />

Department of Neurosurgery, The Jikei <strong>University</strong>, School<br />

of Medicine, Tokyo, Japan<br />

The specific plasticity of the immature brain and spinal<br />

cord is one of the most significant factors affecting the<br />

therapeutic outcomes in hydrocephalus and some forms<br />

of dysraphic state. In fetal hydrocephalus, the time of<br />

onset of the hydrocephalic state is various initially involving<br />

different stage of the neuronal maturation process. In<br />

order to analyze and anticipate the postnatal outcome, we<br />

proposed a new classification of congenital hydrocephalus,<br />

namely, the perspective classification of congenital hydrocephalus<br />

(PCCH) Stage I–V (J. Neurosurg. 88:685–694,<br />

1998). Our data clearly indicated that the time of the<br />

onset of hydrocephalic state is the key in different stages<br />

of the neuronal maturation process in the affected brain of<br />

the fetus. It may be indicated to perform the intrauterine<br />

decompressive procedure as the fetal surgery. Although we<br />

have performed the experimental fetal surgery on the<br />

animal models, the best operative technique is still debatable.<br />

On the other hand, regarding the fetal surgery for<br />

fetal dysraphism, especially to fetal spina bifida, there have<br />

been over 200 fetuses with myeloschisis operated during<br />

the fetal period in utero in the United States of America<br />

since April, 1997. The results suggested that the early<br />

repair of myeloschisis, such as in PCCH Stage II, may<br />

decrease the occurrence of Chiari malformation and hydrocephalus<br />

after birth. In order to clarify both embryological<br />

and surgicoanatomical concept of the dysraphic state, we<br />

have proposed a new classification, namely, embryo-pathogenetic<br />

surgico-anatomical classification of dysraphism<br />

(Nervous System in Children 27:213–222, 2002). In our<br />

prospective analysis of spina bifida in the last 10 years, it<br />

has been identified to be important to classify the morphological<br />

findings of the fetus MRI for the indication and goal<br />

of the treatment in fetal surgery in spina bifida/cranium<br />

bifidum. The current state of these surgical of the fetal<br />

CNS anomalies will be further discussed from the specific<br />

plasticity of the fetus brain in the process of neuronal<br />

maturation.<br />

SY-14-3<br />

Current status of craniofacial surgery<br />

A. Hockley<br />

Neurosurgeon, The Birmingham Children’s Hospital,<br />

Birmingham Great Britain<br />

Abstract not submitted<br />

SY-14-4<br />

Neurosurgical treatment of phacomatoses<br />

C. Di Rocco<br />

Institute of Neurosurgery, Catholic <strong>University</strong> medical<br />

School, Rome, Italy<br />

Phacomatoses constitute a heterogeneous group of<br />

conditions of a particular interest to the pediatric neurosurgeon.<br />

Children with neurofibromatosis 1 are at a higher risk<br />

of malignancy, mainly optic pathways tumors, than the<br />

general population. Though the criteria for diagnosis are<br />

generally met when the patients are 8 year old, optic pathways<br />

gliomas become often symptomatic by 3 years of age.<br />

The occurrence of these tumors, the evolution of which is<br />

particularly unpredictable, arises significant problems in<br />

terms of management. In aggressive lesions the combination<br />

of ‘conservative’ surgical treatment and chemotherapy<br />

seems at the moment to represent the best option. Patients<br />

with tuberous sclerosis need surgical operation generally<br />

before puberty in cases in whom a progressive subependymal<br />

giant cell astrocytoma in the region of the foramen of<br />

Monro exerts a mass effect on the adjacent neural structures<br />

and/or causes an obstructive hydrocephalus. The<br />

direct surgical excision of the tumor may be curative and<br />

also assures the best change to avoid the insertion of a CSF<br />

shunt device. More rarely, the surgical operation is<br />

required in the very young subject to remove a cortical<br />

tuber responsible for an epilepsy refractory to the medical<br />

treatment in order to reduce the number and the severity of


372<br />

Abstracts<br />

seizures and favoring psychomotor development. Drugresistant<br />

seizures are indeed the main reason for operative<br />

treatment in infants and children with Sturge-Weber<br />

disease and linear nevus syndrome with hemimegalencephaly.<br />

In nearly all the case, the operation is required in the<br />

very young age. While only a subgroup of patients with<br />

Sturge-Weber disease actually needs of hemispheric ablative<br />

or deafferentative surgical procedures, the large majority<br />

of subjects with hemimegalencephaly and epilepsy<br />

benefit of an early operation. Several types of deafferentation<br />

of the malformed cerebral hemisphere are available.<br />

On the grounds of his experience, the author will discuss<br />

the pros and the cons of the various techniques.<br />

SY-14-5<br />

Syringomyelia in children<br />

T. Abe, A. Isoshima, S. Tani, S. Oi<br />

Department of Neurosurgery, Jikei <strong>University</strong> School of<br />

Medicine, Japan<br />

We performed a retrospective study of 23 patients with<br />

syringomyelia under the age of 15 in whom the results of<br />

MRI and clinical course had been used to indicate the characteristic<br />

feature of syringomyelia in children. On the basis<br />

of MRI and intraoperative findings, cases of syringomyelia<br />

were classified into three types according to the associated<br />

lesions: Chiari malformation types 1 and 2, and based<br />

arachnoiditis. Pediatric patients accounted for 12% of all<br />

cases of syringomyelia in our series. Syringomyelia with<br />

Chiari type 1 malformation was most common type of syringomyelia<br />

in children, accounting for 91% of cases, and<br />

highly associated with pituitary dwarfism that accounted<br />

for 22%. The most common initial symptom was scoliosis<br />

in children and dissociated sensory disturbance in adults.<br />

We found that foramen magnum decompression (FMD)<br />

was the most appropriate treatment for syringomyelia with<br />

Chiari type 1 malformation. During FMD, dural plasty using<br />

Goatex should be done to prevent the post operative<br />

arachnoid adhesion around the foramen magnum, but C2<br />

laminectomy should not be done to prevent the postoperative<br />

swan neck deformity in children. FMD with 4th ventricle-subarachnoid<br />

shunt was done for the patients with Chiari<br />

Type 1 malformation, basilar impression, small posterior<br />

fossa and flat posterior fossa base. Our surgical treatment,<br />

which had been selected on the basis of the results of MRI,<br />

successfully collapsed the syrinx without complications in<br />

most patients. However, four patients needed to have<br />

reoperation because of syrinx reexpansion. The causes of<br />

syrinx reexpansion were scar formation around the foramen<br />

magnum and new bone formation at the site of posterior<br />

fossa craniectomy.<br />

SY-14-6<br />

Microsurgical treatment for hypothalamic hamartoma<br />

in children with precocious puberty<br />

S.-Q. Luo, C.-D. Li, Z.-Y. Ma, Y.-Q. Zhang, G. Jia<br />

Department of Neurosurgery, Tiantan Hospital, Beijing,<br />

China<br />

Objective: To study the surgical treatment of hypothalamic<br />

hamartoma causing precocious puberty. Methods:<br />

Twelve children (six girls and six boys) with precocious<br />

puberty secondary to hypothalamic hamartoma were<br />

recruited for our study. The mean age of the patients was<br />

45 months old (ranged from 13 months to 9 years), and the<br />

mean age of the onset of puberty was 9 months. All patients<br />

were treated by microsurgery. Results: All patients had a<br />

high percentile of stature, body weight, bone growth and<br />

serum levels of sexual hormones. MR scan revealed an<br />

isointense mass below the tuber cinereum extending into<br />

supersellar and interpeduncular cistern, ranging from 3 to<br />

25 mm in diameter, consistent with pedunculate hamartoma.<br />

Ten hamartoma that was less than 16 mm in diameter were<br />

removed completely and the other two hamartoma that were<br />

large than 21 mm in diameter were gross partially removed<br />

via a right pterional approach. The symptoms and signs of<br />

precocious puberty resolved completely and sexual<br />

hormone levels decreased to the pre-pubertal range without<br />

any postoperative complications in all ten patients whose<br />

hamartoma were totally removed, the other two patients<br />

whose hamartoma were gross partially removed also<br />

improved the symptom. Conclusion: Microsurgery is a<br />

good choice of treatment for pedunculate hypothalamic<br />

hamartoma if the hamartoma was totally removed.<br />

SY-15<br />

Oriental Medicine<br />

SY-15-1<br />

Tongue acupuncture in brain disorders in children<br />

V. Wong a , J.G. Sun b<br />

a Department of Paediatrics, The <strong>University</strong> of Hong Kong;<br />

b The Jockey Club MRI Engineering Centre, The <strong>University</strong><br />

of Hong Kong, Hong Kong, China<br />

Introduction: Tongue acupuncture (TAC) is an innovative<br />

acupuncture technique invented by Dr Sun. We<br />

launched a collaborative project of integrating traditional<br />

Chinese medicine (TCM) into our NeuroHabilitation<br />

Program for children with cerebral palsy, developmental<br />

delay/mental retardation, autistic spectrum disorder<br />

(ASD), ataxia, cortical visual impairment (CVI), stroke,<br />

and various neurological functional disabilities such as<br />

drooling. Objective: To study the efficacy and tolerability<br />

of TAC in children with neurological disorders. Patients<br />

and methods: Inclusion criteria: Children with neurological


Abstracts 373<br />

disabilities undergoing conventional interdisciplinary<br />

Neuro-Habilitation program. More than 500 children were<br />

enrolled into the study during 1999 Feb–2002 May with<br />

parental consent. TAC was given to specific tongue<br />

acupoints daily (5 days per week) for 4–8 weeks<br />

(Total ¼ 20–40 sessions). The acupoints chosen were determined<br />

by the functional disability of the neurological disorder.<br />

Objective outcome measures were used to document<br />

efficacy (Pre-TAC and Post-TAC), depending on the<br />

problems addressed. Randomized placebo control trials,<br />

some double blind, were conducted for autistic spectrum<br />

disorder, cerebral palsy and stroke. Results: Functional<br />

improvement of various degrees occurred depending on<br />

the age and severity of the disabilities. Some improvement<br />

was noticeable within a few TAC sessions, especially for<br />

drooling, gait pattern (scissoring or tiptoeing) and hyperactivity.<br />

The intermediate effect was sustained with repeated<br />

courses. Occasional pain and minor bleeding occurred in<br />

some. Conclusion: (1) There is a need for integration of<br />

TCM and Western medicine in NeuroHabilitation program.<br />

There are limitations in both disciplines as the basic philosophy<br />

and theories are different. Both are complementary to<br />

each other (TCM with .2000 years of clinical human<br />

experience and Western medicine with 100 years of scientific<br />

research basis). (2) Currently we are investigating the<br />

underlying mechanism of TAC in neurological plasticity<br />

with functional neuroimaging modalities (fMRI, PET scan<br />

of the brain). We hope to document brain regeneration with<br />

TAC and create a Tongue Acu-Map for linking 14 meridians<br />

and ‘Zung-Fu’ or organ systems.<br />

SY-15-2<br />

Neurotransmitters and acupuncture<br />

E.-Y. Shen<br />

Department of Pediatrics, Mackay Memorial Hospital,<br />

Chinese Taipei<br />

Neurotransmitters are released from their storage vesicles<br />

by exocytosis. Previous study showed the release of endorphin<br />

from periaqueductal grey matters after electric stimulation<br />

on some specific acupoint. It is obvious that the<br />

endogenous analgesic system may play an important role<br />

in analgesia and pain treatment by acupuncture therapy.<br />

Chinese scientist (Han et al.) reported that intraventricular<br />

or intrathecal injection in rats with scrotonin precursor<br />

resulted in an increase of analytic effect by acupuncture.<br />

Zhu et al. reported that excitatory neurotransmitter, glutamic<br />

acid and inhibitory neurotransmitters, GABA, also play<br />

important role on acupuncture analgesia. Clinically,<br />

acupuncture has been proved to be effective in treating<br />

many neurological disorders in Chinese as well as other<br />

parts of the world. From the TCM point of view, the circulation<br />

of Qi in the meridian is important in diagnosis and<br />

treatment of diseases. However, it will be worthwhile for the<br />

neurologist to understand the release of neurotransmitters in<br />

the brain during acupuncture stimulation.<br />

SY-15-3<br />

Studies of mechanism of ‘Kangxian’ capsule on<br />

convulsion in experimental epilepsy rats induced with<br />

metrazol<br />

P.-P. Zuo a , F.-L. Yao b , X.-K. Li a ,R.Ma b<br />

a Institute of Basic Medical Science, Chinese Academy of<br />

Medical Science, Beijing, China; b Attached Hospital, Tianjin<br />

<strong>University</strong> of Traditional Chinese Medicine, Tianjin,<br />

China<br />

‘Kangxian’ capsule is composed of 14 traditional Chinese<br />

medicine, such as Acorus gramineus soland, Ginseng, and<br />

Gastrodia alata Blume, etc. ‘Kangxian’ capsule had been<br />

used to treat difficult and complicated cases for many<br />

years in clinic and they have been restored to health. To<br />

elucidate its action mechanism, in this study we adopted<br />

the epilepsy rats induced with metrazol. The behavioral<br />

experiments showed that it effectively improved the<br />

epilepsy symptoms, increased the convulsion threshold<br />

and extended the latent period in epilepsy rats. ‘Kangxian’<br />

capsule could inhibit the decrease of GABA and regulate the<br />

balance between Glu and GABA. We particularly observed<br />

the critical enzyme, glutamate decarboxylase (GAD), which<br />

transferred excited transmitter Glu to inhibited transmitter<br />

GABA and played an important role. ‘Kangxian’ capsule<br />

might affect the brain function through regulating this metabolizing<br />

process. Compared to control group, it also significantly<br />

down regulated the expression of c-fos in cerebral<br />

cortex and hippocampus (P , 0:01). ‘Kangxian’ capsule<br />

also improved the cognitive function, which was related<br />

with NMDA receptor and Ach system in epilepsy rats.<br />

These results suggested that ‘Kangxian’ capsule was<br />

multi-targeting, and its action was through different<br />

mechanisms that need further research.<br />

SY-15-4<br />

Antiepileptic action and its immunological mechanisms<br />

of traditional Chinese medicine<br />

L. Wang, H. Zhang<br />

Pediatric Neurology, Peking <strong>University</strong> First Hospital,<br />

Beijing, China<br />

Objective: Traditional Chinese medicine is a great<br />

thesaurus against human disease upon the theory ‘fu zheng<br />

gu ben’. To investigate the effects of antiepileptic action,<br />

learning-memory and its immunological mechanisms of<br />

CaoGuo ZhiMu Tang (CGZMT), we have done a comprehensive<br />

study from gross, cellular to molecular levels, both<br />

in clinic and animal experiments. Methods: (1) Clinic effects<br />

of CGZMT were observed in 22 children with epilepsy by


374<br />

Abstracts<br />

open label. (2) Three animal seizure models (maximal electric<br />

shock-MES, pentylentetrazol seizure threshold-PST,<br />

audiogenic seizure-AGS) were randomly divided into six<br />

groups (n ¼ 10), i.p. NS10 ml/kg, CGZMT 10 g/kg,<br />

CGZMT 20 g/kg, phenobarbital 50 mg/kg, clonazepam<br />

(CZP) 0.1 mg/kg, CZP 1 mg/kg, respectively. Antiepileptic<br />

effects were measured at CGZMT peak time and 7–14 days<br />

afterwards. Three progresses (acquisition, consolidation and<br />

retrieval) of learning-memory were measured by step down<br />

test. The immunological functions effects of CGZMT were<br />

studied by using the colorimetry, spectrophotometry (QHS),<br />

quantitative hemolysis 3 H-TdR incorporation, and optical<br />

microscope. Results: (1) Seizures-controlled rate was<br />

64.6% in children with epilepsy. There were no relationships<br />

with patient’s age, gender, duration of disease,<br />

mono/polytherapy. (2) Seizures-free rate of CGZMT was<br />

75% in MES, 80% in AGS and 100% (CGZMT 5 g/kg<br />

was added CZP 0.1 mg/kg). CGZMT could prolong the<br />

latency of PST. There was no statistical significance<br />

compared with phenobarbital (PB). CGZMT had no adverse<br />

effects and could accelerate learning speed and learningmemory<br />

score. CGZMT could enhance the activity of<br />

macrophage (MV), biological activity of interleukin-2<br />

(IL-2), proliferation of T lymphocyte stimulated by concanavalin-A<br />

(ConA), RBC-C 3 bRR and RBC-ICR, lower<br />

proliferation of B lymphocyte stimulated by lipopolysaccharide<br />

(LPS), level of antibody forming cell and hemolysin<br />

antibody. Conclusion: CGZMT had antiepileptic efficacy<br />

with accelerating cognitive function by increasing the activity<br />

of MV, cell immune function and RBC adhesion function.<br />

The improving of body immune state, i.e. ‘fu zheng gu<br />

ben’.<br />

SY-16-1<br />

HIV-1/AIDS in children<br />

SY-16<br />

Infectious Diseases<br />

A.L. Belman<br />

School of Medicine, State <strong>University</strong> of New York, Stony<br />

Brook, NY, USA<br />

Since the initial descriptions of AIDS in children two<br />

decades ago, much has been learned about the biology of<br />

human immunodeficiency virus 1 (HIV-1) and the cells it<br />

infects. Much has also been learned about maternal-infant<br />

viral transmission and the natural history of HIV-1 infection.<br />

Key studies led to strategies to interrupt maternal-infant<br />

transmission resulting in a significant decline in neonatal<br />

HIV-1 infection. More proficient diagnostic techniques<br />

made possible early diagnosis of HIV-1 infected neonates<br />

and infants during asymptomatic or mildly symptomatic<br />

disease stages. Major treatment advances led to better control<br />

of viral replication and thereby altered the course of disease<br />

progression. HIV-1/AIDS associated neurological disorders<br />

declined in parallel. A dramatic decline in the numbers of<br />

infants born HIV-1 infected has been observed in countries<br />

where currently recommended therapies are readily available.<br />

Children with HIV-1/AIDS are living longer, many<br />

already surviving into adolescence and young adulthood.<br />

Unfortunately, worldwide, this is not the case; and it is worldwide<br />

where the epidemic predominates and where the<br />

complexity of medical care required and expensive drug<br />

therapies are limited. Many issues remain. Just how HIV-1<br />

affects the developing central nervous system (CNS) is still<br />

not clearly understood and is the focus of continuing<br />

research. The long-term effects of prenatal exposure to antiretroviral<br />

agents are not yet known and continue to be<br />

studied. Just exactly how HAART therapy may affect early<br />

signs of pediatric HIV-1/AIDS associated CNS disease,<br />

should it develop, is unclear. As new antiretroviral agents<br />

are developed, and new combination drug regimens instituted,<br />

the potential for neurological complications, toxicities,<br />

and adverse drug interactions (for example with AEDS)<br />

exists and will need to be identified and monitored.<br />

SY-16-2<br />

Viral encephalitis<br />

Hj.M.I. Hussain<br />

Penang, Malaysia<br />

Traditionally discussions on viral encephalitis have<br />

focused on Herpes viruses and Japanese Encephalitis.<br />

However in recent years new viruses have been recognized<br />

to cause outbreaks of viral encephalitis with a high case<br />

fatality rate. Dengue hemorrhagic fever is often associated<br />

with neurological manifestations especially headache,<br />

altered sensorium and convulsions. These were thought<br />

initially to arise from an encephalopathy secondary to circulatory<br />

changes, cerebral hemorrhage or hepatic derangement.<br />

Now the virus has been isolated from the cerebral<br />

spinal fluid of patients with encephalopathy proving dengue<br />

to be a neurotropic virus. In recent years outbreaks of Enterovirus<br />

71 in Bulgaria, Malaysia and Taiwan have resulted in<br />

many deaths among young children. Most of the children<br />

died from fulminant pulmonary edema secondary to brainstem<br />

encephalitis, similar to deaths from poliovirus in the<br />

late fifties. Other affected children developed acute flaccid<br />

paralysis. This raises concerns that Enterovirus 71 may<br />

replace polio as a cause of acquired paralysis in children.<br />

Most recently, a newly identified virus, the Nipah virus<br />

caused an outbreak of encephalitis involving 265 adults in<br />

Malaysia. There were 105 deaths with 12 relapses among<br />

the survivors. As in Japanese encephalitis, swine are thought<br />

to act as amplifying host for the Nipah virus. Spread to<br />

humans is via direct contact with secretions and blood<br />

products. Climatic and environmental changes are believed<br />

to have precipitated the outbreak of Nipah encephalitis.<br />

Continued global warming and deforestation may result in<br />

similar outbreaks in future.


Abstracts 375<br />

SY-16-3<br />

Tuberculosis of the central nervous system in children<br />

P. Visudhiphan, A. Visudtibhan, S. Chiemchanya<br />

Department of Pediatrics, Ramathibodi Hospital, Bangkok,<br />

Thailand<br />

Tuberculosis in developing countries remains a significant<br />

public health problems. The number of cases is increasing,<br />

partly due to wide spreading of HIV infection in these<br />

regions. Tuberculous meningitis (TBM) is one of the most<br />

common extrapulmonary manifestations of tuberculosis in<br />

children. Despite effective antituberculosis drugs, morbidity<br />

and mortality rate remain high. Early death and poor clinical<br />

response are usually caused by failure to recognize the<br />

disease and begin appropriate therapy in the early stage.<br />

The duration and combination of drugs therapy of TBM in<br />

children is still a controversial issue. Early study showed<br />

that treatment with isoniazid (INH) and rifampin (RIF) for<br />

12-months was generally effective in children with drugsusceptable<br />

TBM. Due to increasing incidence of drug resistant<br />

tuberculosis, the American Academy of Pediatrics<br />

recommends a 12-month regimen of antituberculosis<br />

drugs in children with TBM. But some experts have<br />

shown that regimen between 6 and 9 months are equally<br />

effective. We conducted, non-randomized, prospective<br />

open clinical investigation in non-compromized host of all<br />

cases of TBM tuberculomas, and spinal tuberculosis who<br />

were admitted at the Department of Pediatrics, Ramathibodi<br />

Hospital from January 1991 to December 2000. The combination<br />

of antituberculosis drug treatment including daily<br />

INH, RIF, pyrazinamide (PZA) and the fourth drug was<br />

streptomycin (SM) or ethambutol (EMB) for 2 months<br />

then followed with daily INH and RIF for 7 months.<br />

There were 31 patients enrolled in this prospective study,<br />

which include cases of TBM 23, TBM with tuberculomas<br />

four, and spinal tuberculosis with spinal cord compression<br />

in four patients. Of 23 TBM and four tuberculomas patients,<br />

four, 11 and 12 patients were admitted in the first, second<br />

and third stages of the disease respectively. Twenty-four of<br />

these patients and four of spinal tuberculosis received the<br />

initial treatment with INH, RIF, PZA and SM and the other<br />

three patients received EMB instead of SM as the initial<br />

treatment. Four patients required ventriculoperitoneal<br />

shunting in the early stage to relieve their severe hydrocephalus.<br />

Two patients who had tuberculomas needed craniotomy<br />

for partial removal of the mass and confirmation of the<br />

diagnosis. All cases of spinal tuberculosis with spinal cord<br />

compression had surgical decompression of the spinal cord.<br />

The outcome of these patients revealed no death. There was<br />

no significant neurological deficit of the patients who were<br />

admitted in stages I and II and also in cases of spinal tuberculosis.<br />

But eight out of 12 patients who were admitted in<br />

the third stage had mild to severe neurological sequel. The<br />

mycobacterium were identified from the CSF in six patients,<br />

and all susceptible to antituberculosis drugs given. No<br />

recurrent of tuberculous infection observed at the last<br />

followed up examination from 1 to 9 years.<br />

SY-16-4<br />

Treatment and prophylaxis of falciparum malaria<br />

S. Looareesuwan<br />

Hospital for Tropical Diseases, Faculty of Tropical Medicine,<br />

<strong>Mahidol</strong> <strong>University</strong>, Bangkok, Thailand<br />

The treatment for uncomplicated malaria is aimed at<br />

producing a radical cure using the combination of: artesunate<br />

(4 mg/kg per day) plus mefloquine (8 mg/kg per day)<br />

for 3 days; a fixed dose of artemether and lumefantrine (20/<br />

120 mg tablet) named Coartem w (four tablets twice a day<br />

for 3 days for adults weighing more than 35 kg); quinine 10<br />

mg/kg 8-h plus tetracycline 250 mg 6-h for 7 days (or<br />

doxycycline 200 mg once a day for 7 days as an alternative<br />

to tetracycline) in patients aged 8 years and over; a combination<br />

of atovaquone and proguanil called Malarone w (in<br />

adult, four tablets given daily £ 3 days). In treating severe<br />

malaria, early diagnosis and early treatment with a potent<br />

antimalarial drug is recommended to save the patient’s life.<br />

The antimalarial drugs of choice are: intravenous quinine<br />

or a parenteral form of an artemisinin derivative (artesunate<br />

i.v./i.m. 2.4 mg/kg followed by 1.2 mg/kg injection at<br />

12 and 24 h and then daily for 5 days; artemether i.m. 3.2<br />

mg/kg injection followed by 1.6 mg/kg at 12 and 24 h and<br />

then daily for 5 days; arteether i.m. (Artemotil w ) with the<br />

same dose of artemether; artesunate suppository (5 mg/kg)<br />

given rectally 12 h for 3 days). Oral artemisinin derivatives<br />

(artesunate, artemether, dihydroartemisinin with the dose 4<br />

mg/kg per day should replace parenteral forms when<br />

patients can tolerate oral medication. Oral mefloquine (25<br />

mg/kg divided into two doses 8 h apart) should be given at<br />

the end of the artemisinin treatment course to reduce recrudescence.<br />

Early recognition of malaria’s complications and<br />

their adequate treatment also play an important role as<br />

these complications (hypoglycemia, pulmonary oedema,<br />

acute renal failure, metabolic acidosis, convulsions) often<br />

increase the mortality rate. Other symptomatic and supportive<br />

treatments include the careful monitoring of fluid input<br />

and urine output, the provision of good nursing care and<br />

the avoidance of harmful adjuvant treatment. In spite of<br />

these efforts, mortality from severe malaria is still high.<br />

There is no absolutely guaranteed chemoprophylaxis of<br />

malaria. Therefore, personal protection (sleeping beneath<br />

treated mosquito nets, avoidance of exposure to mosquito<br />

bites) is recommended. In low-transmission areas, the use<br />

of repellents and an awareness of any fever in the 6 weeks<br />

after exposure in areas endemic for malaria should be<br />

encouraged. Most visitors to low transmission areas probably<br />

require no chemoprophylaxis. However, in high transmission<br />

areas or in high-risk groups chemoprophylaxis<br />

(malarone w , doxycycline, primaquine with food) is recommended.


376<br />

Abstracts<br />

SY-16-5<br />

New concepts in the immunopathogenesis of central<br />

nervous system (CNS) infections<br />

P.K. Peterson, S. Hu, G. Gekker, W.S. Sheng, M.C.-J.<br />

Cheeran, J.R. Lokensgard<br />

Neuroimmunology Laboratory, Minneapolis Medical<br />

Research Foundation, and the <strong>University</strong> of Minnesota<br />

Medical School, Minneapolis, MN, USA<br />

Despite the emergence of new etiologies and the serious<br />

nature of encephalitis, little is known about the cellular and<br />

molecular mechanisms involved in defense and neuropathogenesis<br />

of infections within the brain. To address<br />

this void in knowledge, research in our laboratory has<br />

focused on interactions between neurotropic agents and<br />

homogeneous populations of microglia, the resident macrophages<br />

of the brain, astrocytes, the predominant brain cell<br />

type, and highly enriched neurons. We have studied a variety<br />

of intracellular pathogens including HIV-1, the etiologic<br />

agent of AIDS dementia, cytomegalovirus, an<br />

important cause of congenital brain disease and of encephalitis<br />

in immunocompromised patients, and herpes<br />

simplex virus (HSV)-1 which causes a devastating encephalitis<br />

in immunocompetent individuals. Striking differences<br />

have been found in the growth characteristics and in<br />

the induction of cytokines and chemokines by these viruses<br />

in microglia, astrocytes, and neurons. While several proinflammatory<br />

cytokines can inhibit viral replication in glial<br />

cells and neurons, the inability of brain cells to produce<br />

interferon represents a major defect in host defense of the<br />

brain. To solve this deficiency, it appears that chemokines<br />

are used to attract CD4 1 and CD8 1 lymphocytes into the<br />

infected brain. While this strategy may lead to resolution of<br />

infection, in HSV-1 encephalitis it appears that ingress of<br />

activated T-cells contributes to immune-mediated brain<br />

damage. These concepts of the brain as an ‘immunologically<br />

underprivileged site’ and of microglia and T-cells as<br />

‘double-edged swords’ may guide development of new<br />

therapeutic approaches to CNS infections.<br />

MORNING SEMINAR<br />

MS-1<br />

Nutrition and Developing Brain<br />

MS-01<br />

Nutrition and the developing brain: the role of<br />

polyunsaturated fatty acids<br />

B. Koletzko<br />

<strong>University</strong> of Munich, Germany<br />

Intrauterine and early postnatal growth is characterised<br />

by a very rapid deposition of lipids. The brain, retina and<br />

other membrane rich tissues rapidly incorporate long-chain<br />

polyunsaturated fatty acids (LCPUFA), especially docosahexaenoic<br />

acid (DHA, C22:6n-3). In utero, the foetus is<br />

supplied with preformed LCPUFA by placental transfer.<br />

After birth, breast fed infants receive appreciable amounts<br />

of preformed LCPUFA that meet intrauterine accretion<br />

rates in membrane rich tissues. Stable isotope studies<br />

show that human milk LCPUFA contents are not primarily<br />

regulated by maternal tissues and not maternal diet. In<br />

contrast, infant formulas based on vegetable oils did not<br />

contain LCPUFA. Term infants fed formulas without<br />

LCPUFA show a LCPUFA depletion in blood and tissues,<br />

including the brain. Several studies have evaluated the<br />

supplementation of infant formulas with different sources<br />

of LCPUFA, which may normalise LCPUFA status relative<br />

to reference groups fed human milk. Double blind<br />

randomised trials demonstrated that LCPUFA induce<br />

significant improvements of visual acuity and a variety<br />

of measures of cognitive development (Bayley, Fagan,<br />

Brunet-Lezine, and others). Our recent studies in children<br />

with phenylketonuria indicate that DHA modulates brain<br />

function also during school age. From the available data<br />

we conclude that LCPUFA are conditionally essential<br />

substrates in infants and children that modulate visual<br />

and cognitive function.<br />

MS-2<br />

Peripheral Neuropathy<br />

MS-02-1<br />

Progressive understanding on the pathogenesis of<br />

Guillain-Barré syndrome<br />

F.-C. Cai<br />

Department of Neurology, Children’s Hospital, Chongqing<br />

<strong>University</strong> of Medical Sciences, Chongqing, China<br />

Guillain-Barré syndrome (GBS) is an acute autoimmune<br />

polyneuropathy and currently is recognized as a heterogeneous<br />

disorder with several different subtypes including<br />

acute inflammatory demyelinating polyneuropathy<br />

(AIDP), acute motor axonal neuropathy (AMAN),acute<br />

motor-sensory axonal neuropathy (AMSAN), and Miller-<br />

Fisher syndrome, etc. Patients usually have antecedent<br />

events (an illness of respiratory or gastrointestinal tract in<br />

most), however recently there are strong evidences<br />

supporting that at least 30–40% of GBS patients are<br />

infected with Campylobacter jejuni prior to the onset of<br />

the disorder in 2 weeks. Infection by C. jejuni or other<br />

organisms may trigger an antibody response in patients<br />

with GBS but not in those uncomplicated cases. Most<br />

current studies of pathogenesis are centered on the hypothesis<br />

of molecular mimicry between LPS of C. jejuni and<br />

epitopes of host’s nerve gangliosides. Antibodies to ganglioside<br />

GM 1 are present in 14–50% of GBS patients, but<br />

more common in cases with axonal degeneration associated<br />

with any subtype. Antibodies to ganglioside GQ1b<br />

are very closely associated with Fisher syndrome. However


Abstracts 377<br />

attempts to match the subtypes of GBS to the fine specificity<br />

of antiganglioside antibodies have not yet full<br />

explained the pathogenesis. It has been indicated that<br />

special properties of the infecting organism could be act<br />

an important role, since some strains such as Penner 0.19<br />

and 0.41 are particularly associated with GBS but not with<br />

enteritis. It is also to be important for the immunogenetic<br />

background of the patient because the risk of developing<br />

GBS after infection with type 0.19 is estimated only to be 1<br />

in 158. Exotoxin of C. jejuni could enhance the immunogenic<br />

pathogenicity of antibodies to GM 1 such as destroying<br />

blood-nerve barrier, but no similarly immunogenic<br />

consequence to nerves as ganglioside GM 1 in rats. T<br />

cells are also involved in the pathogenesis of most or<br />

even all forms of GBS. Response of T cells to any myelin<br />

proteins such PO, P2, or PMP22 could induce experimental<br />

autoimmune neuritis but the specificity of activated T cells<br />

in pathogenesis of GBS still not quite clear. On the basis of<br />

increased immunological understanding of GBS over the<br />

past 15 years, both of plasmapheresis and IVIG infusion<br />

have been shown as effective therapies to the disease.<br />

MS-02-2<br />

Advances in childhood neuropathy 2002<br />

R. Ouvrier<br />

The Children’s Hospital at Westmead, Australia<br />

In a biopsy series of 260 cases of polyneuropathy in<br />

children up to 16 years of age, approximately 83% of<br />

cases were genetic in origin, and about 17% were acquired.<br />

Of the acquired neuropathies, acute and chronic inflammatory<br />

polyneuropathies were the most frequent (8% of the<br />

series) and the most important, since effective treatment is<br />

available. Chronic polyneuropathies are of two main pathological<br />

types – axonal degenerative and de- (and re-)<br />

myelinating. The axonal forms constituted some 137<br />

cases (53%). Their molecular basis is, in most cases, poorly<br />

understood. HMSN of neuronal type commencing in early<br />

childhood and the newly described severe infantile axonal<br />

neuropathy with respiratory failure (SMARD) will be<br />

discussed in detail. The latter condition has been shown<br />

to be due to a mutation of the IGHMBP2 gene and prenatal<br />

diagnosis is now possible. There were 103 cases of demyelinating<br />

neuropathies, most of which were due to inherited<br />

mutations of specific myelin proteins. In this paediatric<br />

series, there were five documented point mutations of the<br />

MPZ and three of the PMP22 genes, all of which presented<br />

with features of the Dejerine-Sottas syndrome (DSS).<br />

Other causes of DSS will be reviewed. Most cases of<br />

chronic demyelinating neuropathy presenting in childhood<br />

can be precisely diagnosed to enable accurate genetic<br />

counselling. Unfortunately, specific treatment is not yet<br />

available for such cases but the expansion of the understanding<br />

of these conditions gives real hope for an eventual<br />

cure.<br />

MS-3<br />

Case Presentations<br />

MS-03<br />

Cerebral vascular malformations: intravascular<br />

interventional therapy<br />

Xiang Cai<br />

Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />

Beijing, China<br />

Abstract not submitted<br />

MS-4<br />

Ethical Decisions in Neurology of Early Life<br />

MS-04-1<br />

The minimally conscious state in children<br />

S. Ashwal<br />

Department of Pediatrics, Loma Linda <strong>University</strong> School of<br />

Medicine, Loma Linda, CA, USA<br />

The minimally conscious state is a condition of severely<br />

altered consciousness in which minimal but definite behavioral<br />

evidence of self or environmental awareness is<br />

demonstrated. To make the diagnosis of the minimally<br />

conscious state, evidence of limited but clearly discernible<br />

self or environmental awareness must be demonstrated on a<br />

reproducible or sustained basis by one or more of the four<br />

types of behaviors: (1) simple command-following; (2)<br />

gestural or verbal ‘yes/no’ responses (regardless of accuracy);<br />

(3) intelligible verbalization; and (4) purposeful<br />

behavior including movements or affective behaviors that<br />

occur in contingent relation to relevant environmental<br />

stimuli and are not due to reflexive activity. Minimally<br />

Conscious State (MCS) differs from the vegetative state<br />

(VS) in several ways. Patients in a vegetative state have<br />

no awareness of self or the environment whereas MCS<br />

patients have definite although limited awareness of self<br />

or the environment. VS patients have no evidence of<br />

language comprehension or expression whereas MCS<br />

patients may show a limited but reproducible form of<br />

simple communication. MCS patients are also more likely<br />

to experience pain and suffering in contrast to VS patients.<br />

MCS must be distinguished from the VS because the<br />

evaluation, care, medical decision-making and prognosis<br />

differ in these two conditions. MCS can occur in children<br />

with acute brain injuries, progressive neurometabolic disorders<br />

or nervous system developmental malformations.<br />

Additional research concerning prognosis, long-term<br />

outcome and treatment effectiveness will be needed to<br />

help clarify many of the medical, ethical and legal issues<br />

surrounding the care of these patients.


378<br />

Abstracts<br />

MS-04-2<br />

Ethical decisions in neurology of early life<br />

P. Evrard<br />

Service de Neurologie Pediatrique et des Maladies Metaboliques,<br />

Faculte de Medicine Xavier-Bichat, Hospital<br />

Robert-Debre, Paris, France<br />

Abstract not submitted<br />

MS-05<br />

Medical Informatics<br />

MS-5<br />

Medical Informatics<br />

D. Stumpf<br />

Department of Neurology, Northwestern <strong>University</strong> Medical<br />

School, Evanston, Illinois, USA<br />

Abstract not submitted<br />

MS-6<br />

Environmental Medicine<br />

MS-06-1<br />

Preventing lead neurotoxicity in Shanghai, China<br />

X.-M. Shen<br />

Child Development and Rehabilitation Center, Shanghai<br />

Children’s Medical Center, Shanghai, China<br />

Abstract not submitted<br />

MS-06-2<br />

Neurotoxic effects of lead in children<br />

M. Markowitz<br />

Henry and Lucy Moses Division, Montefiore Medical<br />

Center The <strong>University</strong> Hospital for the Albert Einstein<br />

College of Medicine, Bronx, NY, USA<br />

The recognition that lead induces central and peripheral<br />

nervous system disease dates back more than 2000 years.<br />

Over the last two millennia these effects were recognized<br />

only at the clinical level; the neurologic aspects of the<br />

disease were characterized by symptoms of encephalopathy<br />

and peripheral neuropathy. In the latter half of the 20th<br />

century an appreciation of the subclinical effects grew as<br />

cross-sectional and then longitudinal studies of children<br />

with low level lead exposure demonstrated detrimental<br />

effects on cognition and behavior. Laboratory studies elucidated<br />

some of the biochemical mechanisms responsible for<br />

these lead effects. Most recent studies raise the question of<br />

whether there is any threshold below which lead is safe in<br />

humans.<br />

MS-07<br />

Headache<br />

MS-7<br />

Headache<br />

D. Rothner<br />

Department of Neurology, Cleveland Clinic S-71, Cleveland,<br />

OH, USA<br />

Abstract not submitted<br />

MD-08-1<br />

Short introduction<br />

MS-8<br />

Rett Syndrome<br />

Y. Nomura<br />

Segawa Neurological Clinic for Children, Chiyoda-ku,<br />

Tokyo, Japan<br />

Abstract not submitted<br />

MS-08-2<br />

The autonomic problem in Rett disorder<br />

A.M. Kerr<br />

Academic Centre, Department of Psychological Medicine,<br />

Gartnavel Royal Hospital, Glasgow Scotland, UK<br />

The British Isles Survey data comes from clinical examination<br />

and postal health questionnaires, providing a longitudinal<br />

account of the natural history of the condition. 1094<br />

individuals aged 2–66 years are under continuing review<br />

(1982–2002). Indices of health and severity first developed<br />

in 1996 are now matched to MECP2 test results (300 cases),<br />

contributing to national and international projects linking<br />

MECP2 mutation type and site to clinical presentation.<br />

Non-invasive out-patient monitoring of autonomic function,<br />

using the NeuroScope e (MediFit Diagnostics Ltd, London,<br />

UK) developed by Drs Peter Julu and Stig Hansen, has<br />

helped to explain the non-epileptic vacant spells which are<br />

common in Rett and which seem to contribute to sudden<br />

deaths accounting for at least 20% of all (74) UK deaths.<br />

Detailed analysis of clinical events, electroencephalogram,<br />

breathing rhythm, vagal tone and baroreflex sensitivity in 47<br />

cases has revealed inadequate brainstem regulation of<br />

central autonomic cardio-respiratory function. Episodes<br />

have been documented of brainstem shut down and of inappropriate<br />

brainstem activation. Without accurate autonomic<br />

monitoring these potentially life-threatening events may<br />

appear to the clinician as shallow, apneustic, deep or interrupted<br />

breathing associated with brief periods of altered<br />

consciousness and pallor or cyanosis, readily confused<br />

with epilepsy. That the autonomic abnormality can be


Abstracts 379<br />

measured non-invasively and objectively will permit the<br />

development and evaluation of effective intervention.<br />

MS-08-3<br />

MECP2 and beyond: phenotype-genotype correlations<br />

in Rett Syndrome and related disorders<br />

J. Christodoulou<br />

Western Sydney Genetics Program, Children’s Hospital at<br />

Westmead, Department of Paediatrics and Child Health,<br />

<strong>University</strong> of Sydney, Sydney, NSW, Australia<br />

Rett syndrome [RTT; OMIM 312750] is a severe neurodevelopmental<br />

disorder primarily affecting females. The<br />

diagnosis is based on the presence of a constellation of<br />

clinical features associated with a specific developmental<br />

profile. However, there is marked clinical variability, even<br />

amongst classical RTT patients. The recent recognition that<br />

methyl CpG-binding protein 2 (MECP2) gene mutations<br />

cause RTT, has permitted definitive diagnosis in many<br />

cases, including atypical variants. Large cohort studies<br />

suggest that clinical severity can in part be predicted by<br />

the type of mutation (missense versus truncation), the<br />

affected region of the methyl-CpG binding protein-2<br />

(MeCP2) protein (main binding domains versus non-critical<br />

critical domains), and whether there is skewing of X-inactivation.<br />

More recently it has been recognised that MECP2<br />

mutations may be associated with other clinical phenotypes,<br />

including an Angelman syndrome-like phenotype, nonspecific<br />

mental retardation, with or without spasticity, and<br />

with or without an X-linked inheritance pattern, or neonatal<br />

encephalopathy in males. Moreover, the marked clinical<br />

variability even in patients with identical mutations,<br />

suggests that other currently unknown genetic and epigenetic<br />

factors also modulate the clinical phenotype. The<br />

development of an international database, with pooling of<br />

data from multiple sources, will hopefully increase numbers<br />

sufficiently to permit a more thorough examination of these<br />

interactions. Finally the development of in vitro assays of<br />

MeCP2 function and mouse models for RTT will help clarify<br />

the effects of loss of protein function on embryonic<br />

development and later neurodevelopmental progress, and<br />

pave the way for a better understanding of the reasons for<br />

the phenotypic variability seen in humans.<br />

MS-08-4<br />

Concluding remarks<br />

S. Naidu<br />

The Kennedy Krieger Research Institute, Baltimore, MD,<br />

USA<br />

Abstract not submitted<br />

MS-9<br />

Neuro-Oncology<br />

MS-09-1<br />

Childhood brain tumors: biologic breakthroughs,<br />

therapeutic advances, and 0ngoing challenges<br />

R.J. Packer<br />

Children’s National Medical Center, Department of Neurology,<br />

Washington DC, USA<br />

Childhood brain tumors are the leading cause of morbidity<br />

and mortality in children with cancer. Progress is being made<br />

in some forms of childhood brain tumors, especially medulloblastomas<br />

(MB). Although surgery and radiation therapy<br />

remain the mainstays of treatment, chemotherapy is playing<br />

an increasing role in the management of most forms of malignant<br />

childhood brain tumors and some benign tumors. Molecular<br />

genetic studies have recently suggested that children<br />

with MB can be more discretely stratified into risk groups<br />

using molecular genetic findings. In some subgroups of children<br />

with MB, after treatment with aggressive surgery,<br />

immediate postoperative radiotherapy coupled with<br />

chemotherapy during and after radiation therapy, survival<br />

rates as high as 85–90%, 5 years after diagnosis, can be<br />

expected. In other subsets of patients, similar treatment will<br />

result in disease control in less than one-third of patients. For<br />

other malignant childhood brain tumors, such as brain stem<br />

gliomas and high-grade cortical gliomas, alterations in therapy<br />

have not resulted in improved survival. A relatively<br />

newly-recognized subtype of primitive tumor, the atypical<br />

teratoid tumor, has recently been characterized and carries<br />

an horrendous prognosis. Low-grade glial tumors comprise<br />

nearly 50% of all childhood brain tumors and surgery remains<br />

the primary option for the majority of patients with such<br />

tumors. However, for very young children who harbor tumors<br />

in eloquent areas of brain, chemotherapy has been shown to be<br />

effective in delaying, if not obviating, the need for extensive<br />

surgery or radiotherapy. With the therapeutic advances seen,<br />

thereisneedtopaygreaterattentiontothelong-termqualityof<br />

lifeofsurvivorsofchildhoodbraintumors.Thereisincreasing<br />

evidence that survivors have significant neurologic, neurocognitive<br />

and psychosocial sequelae. The approaches being<br />

utilized must attempt to reach a better balance between survival<br />

and quality of life of survivors.<br />

MS-09-2<br />

Pediatric neuooncology-brainstem and spinal cord<br />

tumors<br />

S. Constantini<br />

Division of Pediatric Neurosurgery, Dana Children’s<br />

Hospital, Tel-Aviv-Sourasky Medical Center, Tel-Aviv,<br />

Israel<br />

Abstract not submitted


380<br />

Abstracts<br />

MS-10<br />

Therapeutic Drug Monitoring<br />

MS-10-1<br />

Therapeutic drug monitoring (TDM) of anti-epileptic<br />

drugs in children<br />

P. Walson<br />

Professor of Pediatrics, <strong>University</strong> of Cincinnati Director,<br />

Division of Clinical Pharmacology and Clinical Trials<br />

Office Children’s Hospital Medical Center, USA<br />

Accurate measurement and proper interpretation of drug<br />

concentrations (TDM) can greatly improve medical diagnosis<br />

and management. However, TDM requires much more<br />

than just measurement of drug concentrations. TDM is a<br />

process by which measurement of drug concentrations is<br />

combined with knowledge of the drug’s pharmacokinetics<br />

and pharmacodynamics, as well as with patient specific<br />

analytical and clinical data. TDM is useful for all drugs in<br />

some specific clinical situations. TDM is especially useful<br />

for drugs with: (a) a well-defined relationship between<br />

concentration and effects (either therapeutic or toxic); (b)<br />

wide inter- or intra-individual differences in drug clearance;<br />

and (c) where this is no readily available method to clinically<br />

assess therapeutic or toxic effects. Antiepileptic drugs<br />

(AEDs) are examples of drugs for which properly done<br />

TDM has been shown to improve efficacy while decreasing<br />

toxicity. A number of published studies done over the past<br />

20 years in our laboratory with older AEDs will be briefly<br />

reviewed. Some important general and specific principles of<br />

pediatric TDM will be discussed including some practical<br />

and theoretical differences between children and adults.<br />

Some examples will be discussed to illustrate how proper<br />

pediatric TDM differs from ‘numbers only’ reporting of<br />

concentrations. These studies illustrate how much can be<br />

learned about pediatric AED use from a review of properly<br />

collected, analyzed and interpreted AED TDM database.<br />

These data also demonstrate the wide intra-individual differences<br />

in AED clearance and illustrate why TDM is required<br />

to effectively individualize AED dosing to treat pediatric<br />

seizure patients. Finally, data on the usefulness of TDM<br />

of newer AEDs will be discussed.<br />

MS-10-2<br />

Developmental and therapeutic pharmacology of<br />

antiepileptic drugs<br />

H. Miura<br />

Department of Pediatrics, Kitasato <strong>University</strong> School of<br />

Medicine, Sagamihara, Kanagawa, Japan<br />

We investigated the clinical effects and plasma levels of<br />

zonisamide (ZNS) in children with cryptogenic localizationrelated<br />

epilepsies. ZNS is absorbed slowly and its biological<br />

half-life is long as compared with that of other antiepilepic<br />

drugs. The peak-to-trough plasma level ratios during a day<br />

were as small as 1.28 ^ 0.15 in children taking a daily dose of<br />

8 mg/kg of ZNS once a day as a single drug. The plasma level<br />

(mg/ml) to dose (mg/kg per day) ratios estimated by the<br />

trough and peak plasma levels both increased with advancing<br />

age, but the peak-to-trough plasma level ratios were maintained<br />

almost uniformly throughout the pediatric age period.<br />

A wide range of the plasma levels was associated with<br />

complete freedom from seizures. However, the clinical<br />

effects of ZNS were in agreement with the range of generally<br />

accepted therapeutic plasma levels of 15–40 mg/ml. Any<br />

patient who receives polytherapy is at risk to develop drug<br />

interactions. Concurrent administration of carbamazepine<br />

(CBZ) decreases plasma concentrations of ZNS. However,<br />

ZNS does not alter plasma concentrations of CBZ or its<br />

primary metabolite, carbamazepine-10,11-epoxide (CBZ-<br />

E). Drug-protein binding interactions are one source of side<br />

effects. A simultaneous administration of valproic acid<br />

increases the total plasma CBZ-E levels relative to the<br />

CBZ dose associated with the raised free fractions of CBZ<br />

and CBZ-E. The free plasma concentrations of CBZ-E above<br />

1.5 mg/ml may be responsible for the side effects.<br />

WORKSHOP<br />

WS-1<br />

Cerebral Palsy<br />

WS-1-1<br />

Etiology and risk factors for cerebral palsy<br />

V. Kalra<br />

Department of Pediatrics, All India Institute of Medial<br />

Sciences, Ansari Nagar, New Delhi, India<br />

Cerebral palsy (CP) implies a group of non-progressive<br />

neuromotor impairment syndromes due to an acute insult to<br />

the developing brain. Prenatal and perinatal period provides<br />

greatest vulnerability. The casual factors are complex, often<br />

multiple and the attributable risk from an individual factor is<br />

often difficult to define in a patient. Preterm, extreme low<br />

birth weight, multiple pregnancies, perinatal hypoxia, hypoglycemia,<br />

hypothermia, sepsis and jaundice remain<br />

commonly identifiable perinatal factors in our data. In<br />

developing countries with domiciliary deliveries, perinatal<br />

hypoxia still remains an important contributory factor.<br />

Prevention of perinatal hypoxia neonatal sepsis, hypothermia<br />

hypoglycemia are important in developing countries.<br />

Congenital intrauterine infections are important identifiable<br />

factors due to therapy issues. Malformations of the brain<br />

remain an important cause to identify. Maternal infections<br />

are assuming greater importance. Maternal socioeconomic<br />

status, anemia, systemic diseases, hypertension, iodine deficiencies<br />

unattended during pregnancy are not uncommon in<br />

developing countries. Neuroinfections and acquired neurological<br />

insults in early childhood are also more frequent than<br />

in developing countries. Risk factors for CP in developing


Abstracts 381<br />

countries may be multiple. Reduction implies a multipronged<br />

strategy by improved obstetric and perinatal care.<br />

WS-1-2<br />

Evaluation of the risk factors associated with cerebral<br />

palsy in children<br />

Y.-Y. Zhong<br />

Cheng Du Children Hospital, Cheng Du, China<br />

Objective: To evaluate the risk factors associated with the<br />

pathogenesis of childhood cerebral palsy (CP). Method: A<br />

cross-sectionalsurvey on the prevalence of CP was conducted<br />

in 1–6 years old children in Leshan area, Sichuan Province.<br />

Cluster sampling and 1: 2 case control study methods were<br />

used to investigate the risk factors of CP pathogenesis. Result:<br />

A total of 148 723 children were surveyed among which 308<br />

(2.07‰) were diagnosed as CP. Low birth weight, twins and<br />

premature birth were associated with significantly increased<br />

CP prevalence. The single factor analysis showed that the<br />

pathogenesis of CP were multifactorial. The multifactorial<br />

analysis revealed the significant risk factors which included<br />

delivery at home, low 5 min Apgar score, illness within the 1st<br />

monthoflife,maternal‘cold’withfeverinearlygestation,low<br />

protein intake (meat and egg) during pregnancy and poor<br />

education of the mother. Conclusion: The prevalence and<br />

clinical features of CP in Leshan Area is comparable to the<br />

advanced countries. The relevant risk factors can be seen<br />

primarily in the gestational and perinatal periods which may<br />

involve in the mother and the child, the environment and<br />

heredity, etc. Better recognition of and improvement in gestational<br />

and perinatal health care should be a critical way to<br />

reduce the occurrence of CP in children.<br />

WS-1-3<br />

Severe forms of cerebral palsy<br />

K. Kodama<br />

National Rehabilitation Center for Disabled Children in<br />

Japan, Japan<br />

In this presentation I will explain the prevalence and medical<br />

problems of very severely handicapped children and<br />

special care systems for them in Japan. They have severe<br />

motor problems combined with profound cognitive damages,<br />

often accompanied by various kinds of medical problems.<br />

We estimate there are about 35 000 such cases in Japan<br />

now. Though their diagnoses are not same, over 70% of<br />

them are seemed to be cerebral palsy. About two third of<br />

them need drug therapy against epilepsy or extreme hypertonus.<br />

In most severe group among them, nearly 50% have<br />

upper respiratory problems, swallowing difficulties and<br />

gastro-easophageal refluxes. Also hip joint dislocation,<br />

high degree of scoliosis or multiple deformities they have.<br />

Since mid of 1960s we have been developing care systems for<br />

them. The number of special institutions with the functions of<br />

medical hospital and life care home has been increasing up to<br />

100 and about 16 000 cases are now living in such institutions.<br />

Also we combined day care community centers, home<br />

visiting nursing services and respite day or night care systems<br />

and made special community networks. Furthermore, we are<br />

paying our efforts to prevent future disabilities from early<br />

stages of their lives. This time I will report how they changed<br />

their posture and motor conditions and other disabilities<br />

through over 20 years life, how we predict their future course<br />

from young period and how we prevent their wrong course.<br />

WS-1-4<br />

Risk factors for pathological long bone fractures in nonambulatory<br />

cerebral palsy children: a case control study<br />

C.H. Ko, V.S.K. Ho, E.C.C. Wong, E.C.P. So, M.K.Y. Koo,<br />

P.W.T. Tse<br />

Developmental Disabilities Unit (DDU), Department of<br />

Paediatrics, Caritas Medical Centre, Hong Kong, China<br />

Introduction: Pathological long bone fractures is a<br />

common problem in non-ambulatory spastic or dyskinetic<br />

CP children. This is a retrospective study to identify the<br />

risk factors for this problem. Methods: From June 1992 to<br />

June 2001, all the CP children residing in the DDU who had a<br />

history of pathological fracture were reviewed. The data<br />

collected included the demographic data, nutritional status,<br />

mode of feeding, contracture status, orthopedic surgery and<br />

postoperative immobilization within 12 months prior to fracture,<br />

anti-epileptic therapy, and general health status. The<br />

comparison group composed of concomitant CP residents<br />

who did not have a history of fracture. Multivariate analysis<br />

was utilized to identify the independent risk factors for pathological<br />

fracture. Results: The patients composed of 19 children<br />

with 25 fractures, including 21 in the femur, two in the<br />

tibia or fibula, one in the radius and one in the humerus. The<br />

comparison group composed of 108 children. The body mass<br />

index (BMI) (P ¼ 0:0127, odds ratio ¼ 0.74) and presence of<br />

contracture in any extremity (P ¼ 0:0457, odds ratio ¼ 2.72)<br />

were found to be significant independent risk factors for<br />

pathological fracture. Discussion: In non-ambulatory spastic<br />

or dyskinetic CP children, a low BMI and the presence of<br />

severe extremity contracture were found to be significant risk<br />

factors leading to pathological fracture. The habilitation<br />

goals should include intensive physiotherapy and anti-spasticity<br />

therapies to prevent contractures, as well as nutritional<br />

measures to augment the BMI.<br />

WS-1-5<br />

Cerebral palsy – therapeutic possibilities<br />

G. Cole<br />

The Robert Jones and Agnes Hunt Orthopaedic Hospital,<br />

Oswestry, Shropshire, UK<br />

In recent years an increasing choice of treatment modal-


382<br />

Abstracts<br />

ities have become available for treating the mobility<br />

problems associated with cerebral palsy. Although the benefits<br />

conferred by certain treatments are clear, other management<br />

options are more controversial. In addition to<br />

conventional orthopaedic surgery and physiotherapy,<br />

multi-level surgery, intramuscular botulinum injections,<br />

selective dorsal rhizotomy, intrathecal baclofen, targeted<br />

training and sophisticated orthoses all have their advocates.<br />

Less orthodox strategies too, such as hyperbaric oxygen,<br />

cranial osteopathy and lycra suits have been in vogue. Cerebral<br />

palsy is a heterogeneous condition and it might be legitimately<br />

argued that its management should be highly<br />

individualised. For professionals in the field however there<br />

is now a bewildering choice of treatment options available in<br />

many countries, with only scant guidelines about the criteria<br />

of choice. Our lack of full understanding of some of the basic<br />

concepts of neuromuscular function such as tone and spasticity<br />

has contributed to some of this confusion and this has<br />

been made worse by the lack of universally acceptable<br />

‘outcome measures’ for comparing different treatment techniques.<br />

Gait analysis has been shown to be useful in the child<br />

with hemiplegia, diplegia and mild quadriplegia (less so with<br />

ataxic and dyskinetic cerebral palsy), not only for determining<br />

intervention, but also in its use of measuring outcomes in<br />

a range of therapeutic options. It is however a very expensive<br />

academic outcome tool and other less technical procedures<br />

have been developed in recent years for determining<br />

outcome. Tools such as gross motor function measure<br />

(GMFM), paediatric evaluation of disability inventory<br />

(PEDI), etc., have the major advantage of being performed<br />

at home by trained therapists but all such tools lack some<br />

versatility. Individual treatment options will be discussed,<br />

including the criteria currently available, which help us to<br />

make individual decisions about individual children.<br />

WS-1-6<br />

Treatment of 140 cerebral palsied children based on<br />

combination of traditional Chinese medicine and<br />

Western medicine<br />

X.-J. Zhou, N.-X. Zhuang, S.-Q. Zheng, T. Chen, Y.-F. Luo<br />

The Children’s Hospital, Zhejiang <strong>University</strong> School of<br />

Medicine, Hang Zhou, China<br />

Objective: To investigate the effective approaches and<br />

practicable plan for the rehabilitation on childhood cerebral<br />

palsy. Methods: Cerebral palsied children received multiple<br />

therapy based on age, type and status of cerebral palsy,<br />

including preparation of traditional Chinese medicine,<br />

scalp acupuncture, body acupuncture, point-injection therapy,<br />

auricular-plaster therapy, massage and pressing points,<br />

manipulation, physiotherapy, occupational therapy, etc.<br />

And they not only were handled in hospital, but also at<br />

home. Results: The majority of cerebral palsied children<br />

got progress on motor and social adaptation capacity.<br />

There were highly significant differences on motor and<br />

adaptive capacity between before and after treatment by<br />

signed rank test (P , 0:01). Conclusion: It is a pattern of<br />

rehabilitation suitable for the Chinese children with cerebral<br />

palsy that is based on combination of traditional Chinese<br />

medicine and Western medicine, rehabilitation in hospital<br />

and at home. If the pattern of treatment can be better implement<br />

and carried out, the most of cerebral palsied children<br />

will be rehabilitated effectively.<br />

WS-2<br />

Epilepsy<br />

WS-2-1<br />

The clinically efficacy of midazolam on childhood status<br />

epilepticus<br />

Q.-K. Huang, M. Zhao, J.-C. Gu<br />

Department of Pediatrics, Shanxian Central Hospital,<br />

Shandong, China<br />

The purpose of this study was to explore the safety and<br />

efficacy of midazolam in the treatment of childhood status<br />

epilepticus. Forty-three patients with status epilepticus (41<br />

with convulsive status epilepticus and two with epilepsia<br />

partialis continua) were treated from June 1997 to June<br />

2001. The underly disease was idiopathic status epilepticus<br />

in 35 patients and symptomatic status epilepticus in eight<br />

patients. They were divided randomly into the treatment<br />

group and control group. During the study, the pulse, respiration,<br />

blood pressure were monitored. The treatment group<br />

included 22 cases (12 boys and ten girls) aged 8 months–12<br />

years. The midazolam was given in a dose of 0.05–0.2 mg/kg<br />

bolus for the patients with continuous seizures, and 3–15 mg/<br />

kg per min infusion for those who had frequent seizures. The<br />

seizure ceased 10 min to 4 h after the administration of midazolam,<br />

and no comp1ication occurred. The control group<br />

included 21 cases (11 boys and ten girls) aged 10 months–<br />

12 years diazepam, phenobarbital, lidocain and thiopentone<br />

was given sequentially. The seizure ceased 15 min–42 h after<br />

the first anticonvulsant administration. In control group, the<br />

case with seizure continuous for 42 h that died of underlying<br />

disease, three patients need intubating and assisted ventilation<br />

because of respiration suppresion. The time interval<br />

from midazolam administration to seizure ceased was significantly<br />

shorter than that of control group (Rank test<br />

P , 0:05). It is concluded that midazolam is safe and effective<br />

in treating the childhood status epilepticus.<br />

WS-2-2<br />

Five children with frontal lobe epilepsy<br />

J. Li, H.-B. Zhang<br />

Jinan Children Hospital, Jinan, China<br />

We report five children (four male and one female; age is<br />

22 days, 5, 6, 8 and 8 years, respectively) with frontal lobe


Abstracts 383<br />

epilepsy. Three children were misdiagnosed as dyssomnia,<br />

hysteria and tetany. Two children were diagnosed as undetermined<br />

epilepsy. Twenty-three seizures (duration range<br />

10–45 s) of the five children were evaluated with longterm<br />

(12–15 h) video-EEG monitoring; two children had<br />

seizures during sleep, two in the wake of or during sleep,<br />

and the other when awake. The same child suffered from<br />

similar symptoms at every onset. All five children presented<br />

with atypical tic seizures; one child suffered from panic and<br />

crying in sleep, one adversive seizures, two tonic postural<br />

seizures, the other paresthesia with both lower extremities<br />

tics. All of the five children became flushed with panic.<br />

Common EEGs of five children are negative. Typical spikes<br />

coming from frontal lobe can be found on video-EEG in<br />

both seizure term and interval and noted in sleep. Our<br />

cases show that the clinical manifestation of frontal lobe<br />

epilepsy varied, being characterized by high seizure<br />

frequencies, short duration, and nocturnal preponderance,<br />

with vegetative and psychiatric symptoms. Video-EEG is<br />

of value in diagnosis because of a high positive rate, and<br />

the relation between clinical manifestation and cerebral<br />

electrical activity can be synchronized on video-EEG.<br />

There is one child who had seizures in the neonatal period,<br />

which has never been reported before.<br />

WS-2-3<br />

Reappraisal of a peculiar form of acute encephalitis/<br />

encephalopathy presenting with catastrophic status<br />

Y. Awaya a,b , K. Hayashi b , Y. Fukuyama b,c , M. Osawa b<br />

a Department of Pediatrics, Seibo International Catholic<br />

Hospital, Tokyo, Japan; b Department of Pediatrics, Tokyo<br />

Women’s Medical <strong>University</strong>, Tokyo, Japan; c Child Neurology<br />

Institute, Tokyo, Japan<br />

Background: In 1986 and 1989, the authors described ‘a<br />

peculiar type of post-encephalitic epilepsy’ as a probable<br />

new clinical entity, the characteristics of which consisted<br />

of acute onset of encephalitis/encephalopathy with catastrophic<br />

status followed by an evolution into intractable<br />

chronic partial epilepsy. Since, similar cases have been<br />

reported sporadically in Japan, but no description exists in<br />

non-Japanese literature yet, except for Baxter’s abstract in<br />

1999. Methods: Medical records of five patients prospectively<br />

observed by the authors were reviewed. In addition,<br />

a review of Japanese literatures from 1988 to 2001 identified<br />

29 compatible cases in 18 papers. Based upon 34 cases thus<br />

gathered, clinical features of the syndrome were reassessed.<br />

Results: (1) Age of onset: 7 years old in average (range 1–15<br />

years). (2) Preceding fever in all, except one. (3) Cardinal<br />

symptoms in acute stage; seizures, consciousness disturbance<br />

and fever. (4) Catastrophic status epilepticus, necessitating<br />

general anesthesia and intubation for one to a few<br />

weeks. (5) Stabilizes one to several months later and evolves<br />

to intractable CPS and mental impairment. (6) Mild CSF<br />

pleocytosis in some, virological and other exams negative.<br />

Discussion and conclusion: Differential diagnosis includes<br />

acute/subacute encephalitides, intoxication, Reye syndrome,<br />

brain anomalies, metabolic and circulatory disturbances. No<br />

clues suggestive for etiology are available. This is a unique<br />

devastating status which requires urgent seizure control as<br />

well as life-supportive measures.<br />

WS-2-4<br />

Study of genotypes and phenotypes of severe myoclonic<br />

epilepsy in infancy<br />

T. Fujiwara a , T. Sugawara b , E. Mazaki-Miyazaki b ,K.<br />

Fukushima a , Y. Takahashi a , M. Watanabe a , K. Hara a ,T.<br />

Morikawa a , K. Yagi a , K. Yamakawa b , Y. Inoue a<br />

a National Epilepsy Center, Shizuoka Medical Institute of<br />

Neurological Disorders, Shizuoka, Japan; b Laboratory for<br />

Neurogenetics, RIKEN, Brain Science Institute, Saitama,<br />

Japan<br />

Purpose: Recent studies have demonstrated that frameshift<br />

mutation and nonsense mutation of the sodium ion<br />

channel a1 subunit (SCN1A) gene are responsible for<br />

SME in infancy (Class et al., 2001). We analyzed the<br />

SCN1A genotypes and phenotypes in a relatively large<br />

number of Japanese SME patients. Subjects and methods:<br />

Mutations of the SCN1A gene were studied in one pair of<br />

monozygotic twins (details of phenotypes have been<br />

reported, Fujiwara et al., 1990) and 29 single patients<br />

(total 31 cases) with SME. The methods of analysis were<br />

according to the previous report (Sugawara et al., 2001).<br />

This study was approved by the Ethical Committee of<br />

RIKEN, Brain Science Institute and of Shizuoka Medical<br />

Institute of Neurological Disorders. Informed consent was<br />

obtained from all the patients or parents. Results: Mutation<br />

of the SCN1A gene was found in 25 of 31 cases (81%),<br />

consisting of six cases of frameshift mutation, ten cases of<br />

non-sense mutation (including the monozygotic twins), and<br />

nine cases of missense mutation. No SCN1A gene mutation<br />

was detected in the remaining six cases. Genetic analyses of<br />

the parents of seven patients gave negative results. These<br />

mutations were therefore considered to be de novo mutations.<br />

Conclusion: Mutations of the SCN1A gene were<br />

detected at a high rate (81%) in Japanese SME patients.<br />

The mutations were diverse, ranging from frame shift,<br />

nonsense to missense mutations. The relationship between<br />

genotypes and phenotypes is under investigation.<br />

WS-2-5<br />

The effects of epilepsy-surgery on the quality-of-life of<br />

children<br />

M. Boonzaaijer, R. van Empelen, A. Jennekens-Schinkel, C.<br />

Volman, C.W.M. van Veelen, P.C. van Rijen, O. van<br />

Nieuwenhuizen<br />

UMCU/WKZ, Department of Paediatric Physical Therapy,<br />

Utrecht, Netherlands


384<br />

Abstracts<br />

Quality of life (QoL) is more and more considered an<br />

important indicator of the impact of medical treatment.<br />

With respect to epilepsy surgery in childhood, success of<br />

the operation is measured not only at the level of impairments<br />

(ICIDH 2000), but the child and his parents are also<br />

asked to evaluate postoperative changes in the child’s functioning<br />

in respect of participation. Quality of life, therefore,<br />

is a multidimensional construct that can hardly be understood<br />

solely by quantitative research (van Zuuren, 1999;<br />

Wallander, 2001). Objective: To identify the effects of<br />

epilepsy-surgery on QoL of children suffering from intractable<br />

epilepsy. Design: explorative, pre-post surgery,<br />

prospective, partly qualitative and partly quantitative<br />

research. Methods: ‘HAY’ (how are you) (Bruil, 1999), a<br />

Dutch health-related QoL-questionnaire with a generic and<br />

an epilepsy-specific part, for children between the ages of 7<br />

and 13 years. CBSK (Veerman, 1997), a Dutch adaptation<br />

of the Self-Perception Profile for children between the ages<br />

of 7 and 13 years (Harter, 1985). An open interview was<br />

held with nine children and their parent(s) to obtain an<br />

unrestrained idea of QoL before and after epilepsy surgery.<br />

The qualitative data have been analysed quantitatively.<br />

Results: Both parental and children’s perceptions changed<br />

on all subscales of the HAY. Children report positive<br />

changes in physical and cognitive activities and in feelings<br />

about these activities. Parents report that the children have<br />

become more active in social, physical and cognitive fields<br />

and more proficient in physical activities. Both parents and<br />

children report that, postoperatively, the frequencies of<br />

seizures and of treatment contacts have significantly<br />

decreased. On the CBSK the amelioration on the sub-scale<br />

‘physical appearance’ is significant (P , 0:05) and the<br />

amelioration on the sub-scales Social Acceptance,<br />

Romance, Global Self-worth and Friendship tend to significance<br />

(P , 0:1). The interview data amplify the questionnaire<br />

findings: post-operatively, the child initiates contacts<br />

with peers, the seizure-related necessity of intense one-toone<br />

accompaniment has disappeared, freedom to undertake<br />

social activities has increased accordingly, and – but not<br />

least – the child’s energy has increased. Conclusion: Both<br />

parents and children report a significant improvement in<br />

frequency of social activities, the self-perceptions of the<br />

children improve, some to a statistically significant degree,<br />

and the parents report a significant energy gain.<br />

WS-2-6<br />

Memory impairment in specific childhood epilepsy<br />

syndromes<br />

A.M. Nolan, A. Redoblado, S. Lah, M. Sabaz, J.A. Lawson,<br />

A.M. Cunningham, A. Bleasel, A.M.E. Bye<br />

Department of Neurology, Sydney Children’s Hospital and<br />

The Children’s Hospital; The Universities of New South<br />

Wales and Sydney, Sydney, Australia<br />

Aim: Memory impairment in children with epilepsy can<br />

be a severe disability. Its incidence according to specific<br />

childhood epilepsy syndromes is not well studied. We evaluated<br />

verbal and visual memory in generalised idiopathic<br />

epilepsy (GIE), frontal lobe epilepsy (FLE), temporal lobe<br />

epilepsy (TLE), central epilepsy (CE) and non-localised<br />

partial epilepsy (PE). Methods: From a population of 130<br />

children with epilepsy aged 6–18 years monitored with<br />

video-EEG telemetry, 107 were identified with GIE<br />

(n ¼ 16), FLE (n ¼ 25), TLE (n ¼ 34), CE (n ¼ 12) or<br />

PE (n ¼ 20). Syndrome identification was determined by<br />

International League Against Epilepsy criteria using clinical<br />

data, seizure semiology, interictal and ictal recordings. Each<br />

child had detailed memory evaluation using age-normed<br />

instruments. Memory impairment was defined as scores<br />

more than two standard deviations below the normed<br />

mean. Results: Memory impairment was found in 5% of<br />

GIE and CE, 8% of FLE, 18% of TLE and 20% of PE<br />

children. Four verbal and one visual subtest showed statistically<br />

significant differences in performance between<br />

syndrome groups. GIE had significantly better performance<br />

than TLE in two verbal and the visual subtest (P ¼ 0:019,<br />

P ¼ 0:024, P ¼ 0:055). In one verbal and the visual subtest<br />

GIE had significantly better performance than PE<br />

(P ¼ 0:011, P ¼ 0:019). A trend for better performance in<br />

FLE than TLE approached significance on one verbal subset<br />

(P ¼ 0:052). Discussion: In childhood epilepsy, memory<br />

impairment is a quantifiable problem. Children with GIE<br />

perform best, and significantly worse memory function<br />

can be demonstrated in TLE and PE compared to GIE.<br />

This information is invaluable in planning educational and<br />

therapeutic interventions.<br />

WS-2-7<br />

Genetic abnormalities underlying severe myoclonic<br />

epilepsy in infancy in Japanese<br />

G. Fukuma, S. Hirose, T. Inoue, S. Yasumoto, M. Ohfu, A.<br />

Watanachai, A. Mitsudome, Study Group on Epilepsy<br />

Genetics in Japan<br />

School of Medicine, Fukuoka <strong>University</strong>, Fukuoka, Japan<br />

Objective: To identify genetic abnormalities underlying<br />

SMEI in Japanese. Background: Recently, mutations of the<br />

neuronal voltage-gated Na 1 channel 1 subunit gene<br />

(SCN1A) have been identified as a cause of SMEI.<br />

SCN1A and genes encoding other components of Na 1 channels<br />

in the brain such as 2, one and two subunits (SCN2A,<br />

SCN1B and SCN2B, respectively) were candidate genes for<br />

SMEI. Methods: Our study recruited 54 unrelated individuals<br />

whose clinical manifestations were consistent with<br />

SMEI and 96 healthy volunteers. Each participant or a<br />

responsible person signed an informed consent form<br />

approved by the Ethics Review Committee of Fukuoka<br />

<strong>University</strong> or similar committees of the participating institutions.<br />

Genetic abnormalities of SCN1A, SCN2A, SCN1B<br />

and SCN2B were sought in genomic DNA using a direct


Abstracts 385<br />

sequencing method with an ABI 3700 sequencer. Results:In<br />

SCN1A, eight heterozygous nonsense, 23 missense and<br />

three frame-shift mutations resulting in a premature stop<br />

were found in 44 individuals with SMEI. The mutations<br />

identified in the patients were not found in 96 healthy volunteers<br />

and hence considered to be disease-causing mutations.<br />

No mutation was found within the examined region of<br />

SCN2A, SCN1B and SCN2B. Conclusions: In the first<br />

report made by a Belgian group, mutations of SCN1A<br />

were found in all patients they studied while only 44 of<br />

54 patients bore causative mutations in SCN1A in our<br />

subjects. The relations between phenotype and genotype<br />

of SMEI should be further delineated.<br />

WS-2-8<br />

Severe myoclonic epilepsy of infancy and SCN1A:<br />

phenotypical-genotypical correlation<br />

B. Ceulemans a,b , L. Claes c , L. Lagae a,d , D. Audenaert c ,J.<br />

Del-Favero c , M. Boel a,d , C. Van Broeckhoven c ,P.De<br />

Jonghe c , P. Evrard e , S. Raskin f , S. Ala-Mello g , L. Basel-<br />

Vanagaite h , N.I. Wolf i , B. Plecko j<br />

a Epilepsy Center for Children and Youth, Pulderbos,<br />

Belgium; b Neurology, <strong>University</strong> Hospital Antwerp; c Molecular<br />

Genetics, <strong>University</strong> Antwerp;<br />

d Child Neurology,<br />

Gasthuisberg, Leuven, Belgium; e Inserm, Paris, France;<br />

f Genetika, Parana, Brazil; g Medical Genetics, Helsinki,<br />

Finland; h Medical Genetics, Petah Tikva, Israel; i Paediatric<br />

Neurology, Heidelberg, Germany; j Neuropediatrics,<br />

Graz, Austria<br />

SMEI is a rare epileptic syndrome included in the International<br />

League Against Epilepsy (ILAE) classification as<br />

an epileptic encephalopathy. Although it has been<br />

mentioned that the family-history for febrile seizures and/<br />

or epilepsy is frequently positive in children with SMEI, we<br />

described, last year, herterozygotic de novo mutations in the<br />

alfa subunit of a neuronal voltage-gated sodium channel<br />

SCN1A in seven Belgian patients. We hypothesised that<br />

loss of function or at least severe damage of this protein<br />

causes the clinical picture of SMEI. A new group of ten,<br />

all well characterised, cases of SMEI and mutations in the<br />

same gene will be presented. Four are Belgians, five are<br />

other Europeans and one is Brazilian. In a few families<br />

with GEFS 1 SMEI occur as the most severe clinical phenotype.<br />

On behalf of our own results and the published cases<br />

with known mutations a phenotypical-genotypical correlation<br />

will be presented.<br />

WS-2-9<br />

Rotatory seizures in non-lesional frontal lobe epilepsy –<br />

ictal recordings with video-EEG, SPECT and MEG<br />

O. Kanazawa, J. Tohyama<br />

Department of Pediatrics, Epilepsy Center, National Nishi-<br />

Niigata Central Hospital, Niigata, Japan<br />

Rotatory seizures, during which patients turn around their<br />

axis one or more times are also known as circling seizures or<br />

gyratory seizures. Pure stereotypical rotatory seizures seem<br />

to be a rare epileptic manifestation, the mechanism of body<br />

turning still being obscure. We report on two girls, who had<br />

had daily rotatory seizures with normal brain MRI findings.<br />

Patient 1, who was 5 years 8 months of age, began to have<br />

brief episodes of body turning to the right. Maximal seizure<br />

frequency was over 20 times per day. Her interictal EEG<br />

showed left frontopolar spikes. Ictal SPECT showed left<br />

frontal hyperperfusion. Two months later, complete seizure<br />

control was obtained by medication with carbamazepine<br />

200 mg. Patient 2, who is 10 years 6 months of age at<br />

present, began to have brief episodes of body turning to<br />

the left at age 7 years 10 months. Maximal seizure<br />

frequency was around 80 times per day. She had two 1-<br />

year remission periods, but subsequently seizures relapsed<br />

at age 10 years 1 month. Her interictal EEG showed right<br />

frontal spikes. Ictal SPECT showed right frontal hyperperfusion.<br />

Ictal magnetoencephalography revealed right frontal<br />

dipole sources. Four months later, her seizures were<br />

controlled by medication with phenytion 300 mg and primidone<br />

250 mg. Because circling constitutes the only ictal<br />

behaviour observed, patients may be misdiagnosed as<br />

having a psychogenic reaction. Ictal SPECT findings in<br />

our patients may support that basal ganglia involvement is<br />

a necessary part of the mechanism of rotational seizures, as<br />

Vercueil et al. have suggested.<br />

WS-3<br />

Specific Learning Disabilities<br />

WS-3-1<br />

Dyslexia in the Chinese language<br />

C.K. Leong<br />

Professor Emeritus, <strong>University</strong> of Saskatchewan and<br />

Adjunct Professor, The Chinese <strong>University</strong> of Hong Kong,<br />

Hong Kong, China<br />

This paper discusses the nature of reading disabilities in<br />

Chinese. Recent data from children in Beijing and Hong<br />

Kong provide suggestive evidence to show the universality<br />

and specific constraints on phonological analysis in learning<br />

to read Chinese and to prevent reading difficulties.<br />

WS-3-2<br />

FMRI and reading<br />

L.-H. Tan<br />

Joint Laboratories for Language and Cognitive<br />

Neuroscience 3A, The <strong>University</strong> of Hong Kong, Hong<br />

Kong, China<br />

Functional MRI findings of neuroanatomical mechanisms<br />

underlying Chinese and English reading will be reviewed.


386<br />

Abstracts<br />

Our studies using several cognitive tasks have indicated that<br />

peak activation in the processing of Chinese characters was<br />

located in the left middle frontal cortex (BA 9 and 46),<br />

regions that previous investigations with English and other<br />

alphabetic languages have not commonly identified. Because<br />

the left middle frontal cortex is known to subserve visualspatial<br />

processing of objects and spatial working memory, we<br />

have hypothesized that its extremely strong activation in<br />

reading Chinese is associated with the unique square configuration<br />

of characters. We further found that when Chinese-<br />

English bilinguals process English words phonologically, the<br />

left middle frontal cortex is most strongly activated. This<br />

suggests that the processing of Chinese phonology (where<br />

logographic characters are pronounced monosyllabically and<br />

do not call for phonemic parsing) carries over to second<br />

language processing. Finally, in a study with Chinese<br />

dyslexics, we found less middle frontal and temporal activations<br />

for dyslexic children, suggesting that they were facing a<br />

great difficulty in phonological processing.<br />

WS-3-3<br />

Specific learning disabilities (SLD): advocacy<br />

C.-W. Chan<br />

Working Party on SLD, The Hong Kong Society of Child<br />

Neurology and Developmental Paediatrics (HKCNDP),<br />

Hong Kong, China<br />

With advancement in our understanding of the neurobiological<br />

bases, clinical features and evidence-supported<br />

interventions for SLD, it is imperative that services for<br />

and interests of affected individuals are safeguarded accordingly.<br />

These are rights embodied under the UN Charter for<br />

Children’s Rights. In order to achieve these we need alignment<br />

of definitions among professionals, accurate identification<br />

and diagnosis through powerful screening and<br />

assessment tools and integrated multidisciplinary teams, as<br />

well as specific and accountable management plans. In line<br />

with these, there must be parents who understand their children’s<br />

condition and needs, school teachers who have<br />

appropriate preparation and ongoing in-service training,<br />

enlightened education administrators, as well as wide spread<br />

public awareness and acceptance of the disabilities. Adverse<br />

complications associated with undiagnosed or improperly<br />

managed children with SLD include school failure and<br />

drop out, eroded self esteem, juvenile delinquency,<br />

substance abuse, and a future life of unemployment and<br />

underachievement. Effective legislation and government<br />

policies, plus close partnerships between professionals,<br />

stakeholders and the public are foundations for success.<br />

Given the range of information and services that address<br />

the full scope of SLD and appropriate measures to promote<br />

their talents and potentials, every individual with SLD will<br />

have the opportunity to lead a productive and fulfilling life,<br />

from which society will ultimately benefit.<br />

WS-3-4<br />

Clinical diagnosis and management<br />

C.C.C. LAM<br />

Central Kowloon Child Assessment Centre, Kowloon, Hong<br />

Kong, China<br />

Abstract not submitted<br />

FREE PAPERS-Oral Presentation<br />

FO-1<br />

Neuroscience<br />

FO-1-1<br />

Effects of developmental lead exposure on nitric oxide<br />

synthase activity in different brain regions of rat<br />

G.-J. Dong, Z.-Y. Zhao, Z.-W. Zhu<br />

The Affiliated Children’s Hospital of Zhejiang <strong>University</strong><br />

School of Medicine, Hangzhou, China<br />

Objective: To observe the influence of lead exposure on<br />

nitric oxide synthase (NOS) in different brain regions of rat.<br />

Methods: By establishing a series of rat models exposed to<br />

different low levels lead during developing period, (drinking<br />

water containing 0.025, 0.05 and 0.075% lead acetate) we<br />

studied NOS activity in hippocampus, cerebellum, cerebral<br />

cortical and brain stem. Results: For 0.025 and 0.05% groups,<br />

NOS activity in hippocampus was obviously inhibited, had<br />

significant difference with that in cerebral cortical and brain<br />

stem (P , 0:05). For 0.075% group, NOS activity in cerebral<br />

cortical was obviously lower than those in hippocampus and<br />

brain stem (P , 0:05). On the 21st and 28th day after birth,<br />

NOS activity in cerebellum of 0.025 and 0.05% groups was<br />

lower than those in hippocampus, cerebral cortical and brain<br />

stem (P , 0:05), while NOS activity in cerebellum of<br />

0.075% group was lower than those in hippocampus and<br />

brain stem (P , 0:05). On the 21st and 28th day after birth,<br />

NOS activity in hippocampus and cerebellum of each experiment<br />

group was obviously lower than that of control group<br />

(P , 0:01). On different time points, NOS activity in Cerebral<br />

cortical of 0.075% group was obviously lower than that<br />

of control, 0.025 and 0.05% groups (P , 0:05). Lead exposure<br />

had no influence on NOS activity in brain stem<br />

(P . 0:05). Conclusions: NOS activities in hippocampus,<br />

cerebral cortical and cerebella cortical of rat were inhibited<br />

by lead exposure and the degree of the effect was related to Pb<br />

exposure time and level of Pb.<br />

FO-1-2<br />

Developing cortical neurons injury following recurrent<br />

epileptiform discharges induced by magnesium-free<br />

culture<br />

H.-Y. Cao, Y.-W. Jiang, T. Bo, X.-R. Wu<br />

Division of neurology, Department of Pediatrics, Peking<br />

<strong>University</strong> First Hospital, Beijing, China


Abstracts 387<br />

Objective: To study developing cortical neurons injury<br />

following recurrent epileptiform discharges induced by<br />

magnesium-free culture. Methods: We cultured the cortical<br />

neurons from 16 days rat fetuses. Cultures were exposed to<br />

magnesium-free media for 3 h, returned to regular media<br />

containing normal level magnesium, and maintained for 72<br />

h. During and after the treatment, we used intracellular<br />

recording techniques to detect the epileptiform discharges,<br />

trypan blue staining and flow cytometry to present neuronal<br />

viability and apoptosis, and MTT assay plus lactate dedhydrogenase<br />

(LDH) activity to determine the cell function and<br />

viability. Results: (1) Epileptiform discharges were induced<br />

in all neurons sampled in the culture during the magnesiumfree<br />

treatment, and spontaneous recurrent seizure activity<br />

lasted 72 h in 77.8% of the sampled neurons. (2) At different<br />

time (6, 12 and 72 h) after returning to regular media from<br />

Mg 21 free media, no differences were found among neurons<br />

in different cultured days (6, 12 and 17 days) on the rates of<br />

cell death and apoptosis (P . 0:05). (3) Compared with<br />

control, MTT metabolic activity decrease occurred at 6 h<br />

after Mg 21 -free treatment (P , 0:05) in neurons cultured<br />

for 6 days (85.69%), but at 24 h in neurons cultured for<br />

12 (78.19%) and 17 days (64.00%). (4) LDH activity in<br />

the supernatant of the culture medium decreased not significantly<br />

at all time points after Mg 21 -free treatment<br />

(P . 0:05). Conclusions: Our findings demonstrated that<br />

the acute injury of neurons in this seizure cell model was<br />

mainly functional, long term prognosis is during studying.<br />

(This work is supported by National Natural Science Foundation<br />

of China).<br />

FO-1-3<br />

Barrel field sizes are reduced in Down syndrome mouse<br />

model and barrel plasticity is stunted in neonatally nBM<br />

lesioned mouse<br />

A. Nishimura a,b, *, M.E. Blue a,b , T.H. Moran d , C.F.<br />

Hohmann e , G.T. Capone a,b,c , M.V. Johnston a,b,c<br />

a Neuroscience Laboratory, Kennedy Krieger Institute,<br />

b Department of Neurol,<br />

c Pediatrics, and d Psychiatry,<br />

Johns Hopkins <strong>University</strong> School of Med, Baltimore, MD,<br />

USA,<br />

e Department of Biology, Morgan State <strong>University</strong>,<br />

Baltimore, MD, USA<br />

*Present address: Department of Pediatrics, Kyoto Pref<br />

<strong>University</strong> of Medicine, Kamigyo-Ku, Kyoto, Japan.<br />

Previous studies have shown that neonatal lesion of basal<br />

forebrain cholinergic projections (nBM) in mice leads to a<br />

transient cholinergic depletion of neocortex and to permanent<br />

alterations in cortical cytoarchitecture and in cognitive<br />

performance. The present study examined whether neonatal<br />

nBM lesions modify neocortical plasticity. The present<br />

study also investigated whether Ts65Dn mouse, one of<br />

Down syndrome models has an aberrant neocortical development.<br />

Using cytochrome oxidase histochemistry, we<br />

compared cross-sectional areas of individual barrels in<br />

rows A–E and the Straddlers in the somatosensory cortex<br />

of four groups of postnatal day 8 (P8) old mice that received<br />

(1) right nBM lesions; or (2) left C row 1–4 whisker follicle<br />

ablations; or (3) combined treatment on P1 (12–24 h after<br />

birth) and in (4) untreated controls. And using young adult<br />

Ts65Dn mice and control littermates, we compared crosssectional<br />

areas of individual barrels in rows A–E. The plastic<br />

response to whisker removal was stunted in nBM<br />

lesioned animals. The present findings correspond to those<br />

from a study of rats injected with the cholinergic immunotoxin,<br />

IgG-saporin. We also found that the barrel field sizes<br />

were reduced in Ts65Dn mouse whose nBM cholinergic<br />

neurons degenerate at 6 months of age (Holtzman et al.,<br />

PNAS 93 (23): 13333–8, 1996). These results suggest that<br />

cholinergic inputs play a role in mouse barrel cortex development<br />

and plasticity.<br />

FO-1-4<br />

Dioxin alters cell proliferation of neural progenitor cells<br />

in the developing cerebral wall<br />

T. Takahashi<br />

Keio <strong>University</strong> School of Medicine, Tokyo, Japan<br />

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most<br />

potent dioxin, is an artificial environmental pollutant<br />

known to disturb hormonal homeostasis and induce maldevelopment<br />

of immune and urogenital systems in mice. In the<br />

CNS, in utero and lactational exposure to TCDD causes<br />

deficits in spatial learning and memory in rats. Several<br />

reports in vitro indicate that TCDD may directly alter cell<br />

cycle kinetics: TCDD retards G1 phase progression by inducing<br />

p27Kip1 in a hepatoma cell line and in fetal thymocytes.<br />

We have previously shown that G1 phase regulation<br />

of proliferative neural progenitor cells plays a critical role in<br />

the course of cerebral histogenesis. Thus, it is possible that<br />

in utero TCDD exposure may affect cell cycle regulation,<br />

particularly during G1 phase, of neural progenitor cells and<br />

results in abnormal histogenesis of the neocortex. We investigated<br />

effects of TCDD on cell cycle kinetics in the developing<br />

mouse brain. Pregnant mice were given a single oral<br />

dose of TCDD (20 mg/kg body weight) on embryonic day<br />

(E) 7. On E14, after a continuous exposure to 5-bromodeoxyuridine<br />

(BUdR) for 2, 8, 12 and 16 h, the BUdR labeling<br />

index (LI; BUdR positive nuclei/all nuclei) was calculated<br />

for the neural progenitor cell population of the proliferative<br />

neuroepithelium in the developing cerebral wall. BUdR LI’s<br />

of the neural progenitor cells were reduced in the TCDD<br />

exposed embryos as compared to those in the control<br />

embryos. All of the mitotic figures were BUdR positive<br />

after 2 h exposure to BUdR both in the TCDD exposed<br />

and control embryos, indicating that the combined length<br />

of G2/M phases was not affected by TCDD. BUdR LI for 16<br />

h-BUdR exposure was 1.0 for TCDD exposed embryos as in<br />

control, indicating that all of the neural progenitor cells of<br />

the proliferative neuroepithelium retained proliferative


388<br />

Abstracts<br />

activity even after TCDD exposure. These observations<br />

taken together, the reduction in the LI’s after TCDD exposure<br />

indicates that TCDD exposure caused G1 phase prolongation<br />

in the neural progenitor cells. These results suggest<br />

that in utero exposure to dioxin may affect cell cycle regulation<br />

of the neural progenitor cells and thus, alter the process<br />

of neuron production and eventually result in abnormal<br />

development of the neocortex. Supported by Grant-in-Aid<br />

from the Ministry of Health and Welfare, Pharmacia Fund<br />

for Growth and Development Research, Science and Technology<br />

Agency and CREST Tohyama Team, JST.<br />

FO-2<br />

Cerebral Palsy (1)<br />

FO-2-1<br />

Botulinum toxin type A in prevention of hip luxation of<br />

bilateral cerebral palsy. Treatment of 65 patients<br />

P.P. Si, P. Castroviejoi<br />

Service of Pediatric Neurology, Hospital Infantile ‘La Paz’,<br />

Madrid, Spain<br />

Introduction: In bilateral CP, tetraplegic or diplegic, the<br />

spasticity of flexor and adductor muscles of the hip often<br />

produce hip dysplasia and/or progressive luxation. Objective:<br />

To study the effectiveness of botulinum toxin type A<br />

(BT-A) in prevention of external femoral head migration<br />

and hip luxation in CP. Material and methods: All CP<br />

patients treated with BT-A because pelvic girdle spasticity<br />

were revised. Ages at the first injection were two–7 years.<br />

The clinical and radiological evolution prior to BT-A treatment<br />

and after it is analyzed. The drug was infiltrated in<br />

adductors, medial hamstring muscles in every patient and<br />

also in iliac psoas muscles if required. Post-treatment<br />

follow-up ranged between 1 and 4 years. Results: Sixtyfive<br />

children, 22% of 295 patients treated in our hospital<br />

with BT-A because CP, suffered hip disorder. A total of 122<br />

hips were treated. Pre-treatment evolution was bad, progressive<br />

external femoral head migration out of Perkins’ line<br />

was seen (10% of mean migration at 1 year of age, 21%<br />

at 2, 26% at 3, 31% at 4 years of age). Nineteen/122 hip<br />

were already luxated (more than 50% of migration) at the<br />

onset of treatment, in spite of correct physiotherapy and<br />

other treatments. After BT-A treatment, the progressive<br />

impairment stopped. There was not statistical difference in<br />

radiograph migration in patients group analysis, 10% of<br />

femoral heads improved it position, 8% worsened and the<br />

rest did not change during follow-up). Only one hip resulted<br />

luxated after treatment. This is a very good result according<br />

to the negative natural evolution of the disorder. Motor<br />

function improved in every case whose hip was not luxated.<br />

Conclusion: It is necessary to study clinically and radiologically<br />

the hips of every child with bilateral CP before 3<br />

years old. BT-A allows us to treat all the muscles implicated<br />

in hip spasticity and avoids the progressive functional<br />

impairment of hip mobility, so negative for the future physical<br />

independence of CP patients.<br />

FO-2-2<br />

An epidemiological study of cerebral palsy in Henan<br />

Province, China<br />

L. Gao, Y. Meng, S.-Y. Zhao, C.-J. Zhou, C.-Z. Yuan, Y.-H.<br />

Wang, M. Zhao, S.-L. Ma<br />

Department of Pediatrics, Henan Provincial People’s<br />

Hospital, Zhengzhou City, China<br />

Objective: To investigate the prevalence, distribution of<br />

different types and correlative etiologic factors and complications<br />

of CP in Henan Province, China. Methods: From<br />

January to December 2001, a random cluster sampling of<br />

children aged 0 , 6 years were investigated in ten cities and<br />

counties, including three districts – JinShui, ErQi,<br />

MangShan in Zhengzhou City; JianXi district in Luoyang<br />

City; JiYuan City and counties as YuanYang, XinYie,<br />

TangHe, TaiKang, YuCheng, among others. The etiology,<br />

clinical types, computed tomography and magnetic resonance<br />

imaging of all cases were analyzed. Results: There<br />

were 582 CP patients among 434 920 children investigated;<br />

the total prevalence rate of CP was 1.58%, Of the 582 cases<br />

of CP, spastic type was 56.87%, hypotonic type 21.13%,<br />

mixture type 7.56%, tonic type 6.70%, ataxia type 5.33%,<br />

tremor type 1.38%, and athetosis type 1.03%. The causes of<br />

CP were perinatal asphyxia or hypoxic-ischemic encephalopathy<br />

(HIE) (38.32%); premature or low birth weight<br />

(16.84%); maternal infections during early pregnancy<br />

(11.86%); hyperbilirubinemia (10.14%); intraventricular<br />

hemorrhage (IVH) (8.25%). The incidence rate of complications<br />

was 68.38%, 47.08% related to mental retardation<br />

(MR). Conclusion: This investigation demonstrated the<br />

approximate prevalence of CP in Henan Province. The spastic<br />

type is the most common type of CP. Asphyxia and HIE,<br />

premature and low birth weight, maternal infections during<br />

early pregnancy and hyperbilirubinemia, among others were<br />

high-risk factors. The main complication was MR. Most of<br />

the causes could be prevented by health care in perinatal<br />

period.<br />

FO-2-3<br />

Neonatal periventricular/intraventricular hemorrhage:<br />

incidence and some risk factor<br />

T.S. Al-Karagully<br />

Department of Pediatrics, Saddam College of Medicine,<br />

Baghdad, Iraq<br />

Background: In a prospective study extending along an 8-<br />

month period (April–November 1998), 100 newborns at the<br />

<strong>University</strong> Hospital/Saddam College of Medicine, were<br />

randomly selected and examined by cranial ultrasound (U/<br />

S) to determine the incidence of periventricular hemorrhage/


Abstracts 389<br />

intraventricular homorrhage (PVH/IVH) and some risk<br />

factors. Methods: All sonograms were performed using<br />

Real-time sector scanner with a 5-megahertz (5-MHz) Phasedarry<br />

transducer. All examinations were performed by taking<br />

the baby to the ultrasound examination room. No sedation<br />

was used. Standard sonographic techniques, including axial<br />

and occipital views, were used to obtain sections in coronal<br />

and sagittal planes. The cranial U/S examination was<br />

performed by the same doctor for all the babies included in<br />

the study. Results: The incidence of PVH/IVH was 43.8% in<br />

babies less than 1500 gm birth weight, 14.3% in babies 1500–<br />

2500 g birth weight and no hemorrhage in babies more than<br />

2500 g birth weight. Asphyxia was significantly (P ¼ 0:02)<br />

related to PVH/IVH in babies less than 1500 g birth weight. A<br />

total of 44.4% of the babies were clinically silent and the<br />

most common presenting features were lethargy 55.5%,<br />

convulsion 27.8%, bulging fontanel 22.2% and apnea<br />

16.7%. Conclusions: (1) PVH/IVH is a major problem of<br />

infants with birth weight of 1500 g; or less. (2) Asphyxia is<br />

a major risk factor for the development of PVH/IVH in babies<br />

with birth weight 1500 gm. or less. (3) A clinically silent<br />

presentation may occur in the majority of cases of PVH/<br />

IVH. (4) Lethargy, although non-specific, is the most<br />

common presentation followed by convulsion, bulging<br />

fontanel and apnea. (5) Sonography has enabled us to have<br />

a better understanding of the morbid anatomy; and pathophysiology<br />

of intracranial hemorrhage with the least invasion<br />

and disturbance to the baby.<br />

FO-2-4<br />

DC-EEG unmasks very slow activity patterns during<br />

sleep in infants<br />

S. Vanhatalo a,b , P. Tallgren a , S. Andersson 3 , K. Sainio d ,J.<br />

Voipio a , K. Kaila a<br />

a Department of Biosciences, b Department of Child Neurology,<br />

c Department of Pediatrics,<br />

d Department of Clinical<br />

Neurophysiology, <strong>University</strong> of Helsinki, Finland<br />

Abundance of slow frequencies is the most prominent<br />

feature of neonatal EEG. We used direct current electroencephalography<br />

(DC-EEG) to test the hypothesis that the<br />

immature human brain exhibits slow electrical activity<br />

which is not detected by the conventional (i.e. high pass<br />

filtered) EEG method. We performed recordings with DC-<br />

EEG during sleep on 24 infants ranging from 32 to 46 weeks<br />

of conceptional age. At all ages, DC-EEG revealed a significant<br />

amount of oscillatory and other activity patterns that<br />

are not seen with regular filter settings. Spectral analysis of<br />

DC-EEG revealed prominent peaks at 0.01–0.2 Hz. Most<br />

surprisingly, the activity pattern resembling delta-frequency<br />

bursts in conventional EEG appeared to be, in fact, gigantic<br />

negative transients. They had occipital maximum with a<br />

very large amplitude (200–700 mV) and long duration (1–<br />

5 s). They were also associated with bursts of high<br />

frequency activity with intriguing similarity to the spontaneous,<br />

synchronous neuronal activity described in recent<br />

animal experiments. Our results demonstrate that neonatal<br />

EEG contain significant amount of activity patterns that are<br />

too slow to detect with a conventional EEG method. These<br />

EEG waveforms are both quantitatively and visually very<br />

prominent. We propose that their proper visualization with<br />

DC-EEG may open a new avenue for non-invasive assessment<br />

of physiological and pathological brain functions<br />

during the neonatal period.<br />

FO-3<br />

Seizure Disorders (1)<br />

FO-3-1<br />

Higher incidence of posterior slow synchrony in EEG of<br />

children with complex febrile seizures<br />

V. Komárek, D. Pavlová, Z. Hrncir, M. Palus, T. Procházka,<br />

P. Jiruska<br />

Department of Child Neurology, Charles <strong>University</strong> Hospital<br />

Motol, Prague, Czech Republic<br />

Objective: Febrile seizures (FS) affect 3–5% of all children.<br />

About 20% of FS are familial. The seizure type,<br />

whether ‘simplex’ or ‘complex’, is important since it relates<br />

to further prognosis. The role of EEG in differential diagnosis<br />

of FS is still controversial (Maytal, 2000). The aim of our<br />

study was to evaluate characteristic patterns in EEG of children<br />

with different FS subtypes. Methods: The clinical and<br />

EEG data were collected from 587 children suffering from<br />

FS. In addition to visual evaluation we used linear spectral<br />

(right-left coherence) and on-linear EEG analysis (phase<br />

synchronization). Results: The normal EEG was found in<br />

406 children. Specific epileptiform discharges were present<br />

in six records. The excessive posterior slow (2–5 Hz)<br />

synchrony (PSS) was found in 58 children (10%). The incidence<br />

of PSS was significantly higher in children with<br />

complex febrile seizures – 42 from 141 (27 %) than in<br />

simplex febrile seizures – 16/446 (3.5%). Comments:<br />

Doose (1997) reported PSS in 64% of FS with later epilepsy<br />

and in 20% of FS with good prognosis. Our data suggest that<br />

visual and mathematical evaluation of the EEG may be<br />

important not only for electroclinical subclassification of<br />

FS but also for further genotypical studies. Supported in<br />

part by grant IGAMZCR-6258.<br />

FO-3-2<br />

A first locus for common simple febrile seizures<br />

R. Nabbout a,b,c , J.F. Prud’Homme b , A. Herman a ,J.<br />

Feingold a,e , A. Brice a,d,e , O. Dulac c , E. LeGuern a,d,e<br />

a INSERM U289, Hôpital Pitié-Salpêtrière,<br />

b Généthon,<br />

Evry, c Service de Neuro-Pédiatrie, Hôpital Saint Vincent<br />

de Paul, Paris, d Fédération de Neurologie, Hôpital Pitié-<br />

Salpêtrière, e Departement de Génétique, Cytogénétique et<br />

Embryologie, Hôpital Pitié-Salpêtrière, Paris, France


390<br />

Abstracts<br />

We report a large multigenerational French family with a<br />

homogeneous phenotype consisting of isolated simple FS.<br />

The FS trait did not show any linkage with the reported loci<br />

for FS and GEFS 1 . After a genome scan, a new locus for FS<br />

was identified. Patients and methods: This family was<br />

obtained through a national campaign for familial epilepsy.<br />

It consisted of 166 individuals in five generations. Affected<br />

members presented a history of simple FS that segregates as<br />

an autosomosal dominant trait. After exclusion of reported<br />

loci for FS and GEFS 1 , a genome-wide search was<br />

performed with 380 markers. Results: The clinical data<br />

were obtained from the parents and/or medical files. In the<br />

oldest generation, the status of all members was considered<br />

as unknown since their parents were not alive at the time of<br />

the present study. All FS occurred after 10 months of age<br />

and ceased before 5 years. Only two affected patients had a<br />

transitory anti-epileptic treatment. None presented a febrile<br />

seizure or epilepsy and all family members have a normal<br />

cognitive development. The genome wide search allowed<br />

the identification of a new candidate region (Z max ¼ 3:31 at<br />

q ¼ 0:00). Multipoint analysis and haplotypes construction<br />

confirmed the genetic linkage of this region to simple FS<br />

trait. Conclusion: Our family presents a homogeneous<br />

phenotype consisting of isolated simple FS, the commonest<br />

form of FS. A new locus is identified in this family and the<br />

sequence analysis of potential candidate genes is in<br />

progress.<br />

FO-3-3<br />

Infantile primary generalized epilepsy: benign epileptic<br />

syndrome during infancy<br />

E. Shahar a , S. Barak a , J. Andraus a , U. Kramer b<br />

a Child Neurology Unit and Epilepsy Service, Rambam<br />

Medical Center; b Haifa, Epilepsy Service, Dana Children’s<br />

Hospital, Tel-Aviv, Israel<br />

The present study delineates a benign generalized epileptic<br />

disorder during infancy and early childhood, which we<br />

termed infantile primary generalized epilepsy (IPGE), similar<br />

to PGE. It includes infants under the age of 4 years<br />

presenting with generalized clonic non-febrile seizures<br />

associated with generalized epileptic EEG discharges,<br />

favorable response to anti-epileptic drugs, and preserved<br />

cognition and speech. Twenty-five infants who fulfilled<br />

the inclusion criteria for IPGE, presenting at age 4–36<br />

months (mean: 17) with recurrent generalized short-lived<br />

clonic seizures, two also had status epilepticus. Eighteen<br />

infants (72%) had accompanying recurrent, commonly<br />

preceding, febrile seizures. Family history of seizures was<br />

detected in eight (32%). EEG showed generalized 3–4 Hz<br />

epileptiform discharges and normal background activity in<br />

21 (84%), with a photosensitive response induced in three.<br />

The larger group of 18 infants, mainly treated with valproate,<br />

promptly responded to therapy terminated after 2 years,<br />

with EEG normalization and no recurrence of seizures. A<br />

smaller group of seven patients require prolonged therapy<br />

that maintains them seizure-free, the EEG remains paroxysmal<br />

and seizure may recur if treatment is discontinued.<br />

Cognition and speech are intact in all children, but twelve<br />

are irritable with a short attention span. The data presented<br />

here delineates a unique generalized epileptic syndrome<br />

during infancy with a benign course, rapid response to therapy<br />

and preservation of cognitive skills, similar to adolescent<br />

PGE.<br />

FO-3-4<br />

Non-convulsive status epilepticus (NCSE) in children<br />

R. Koul, S. Qaboos<br />

<strong>University</strong> Hospital, BW-1, Children ward one, Alkhod,<br />

Oman<br />

Non-convulsive status epilepticus is a condition characterized<br />

by a cognitive or behavioral change, which lasts for<br />

at least 30 min, with EEG evidence of seizures. NCSE is<br />

uncommon in children and often seen after 10 years age.<br />

This form of status epilepticus (SE) is often missed and is<br />

picked up in epilepsy clinics, EEG laboratories and neurointensive<br />

care units. One must keep this condition in mind in<br />

patients with epilepsy who develop recent change in behavior,<br />

memory, unexplained ataxia, prolonged speech loss<br />

and prolonged inattention. The EEG is diagnostic. Various<br />

types of NCSE are absence SE, complex partial SE,<br />

Lennox-Gastaut SE, Landau-Kleffner SE, myoclonic astatic<br />

epilepsy of Doose status and electrical epilepticus of slow<br />

wave sleep. Eighteen patients of NCSE (26.5%) were seen<br />

over last 8 years out of total 68 patients with SE. Complex<br />

partial SE and Lennox-Gastaut SE formed six and five<br />

patients, respectively, making 61% of cases. Majority of<br />

literature supports aggressive management like convulsive<br />

SE. Twelve children were treated with iv midazolam, nine<br />

with additional phenytoin sodium while rest on oral antiepileptic<br />

drugs. Outcome was good in six, poor in six and<br />

recurrent attacks of NCSE were seen in four. Two patients<br />

were lost to follow up. NCSE should be kept in mind in<br />

children with epilepsy who develop change in behavior, loss<br />

of speech, prolonged inattention or automatisms, or confusional<br />

state. The management should be effective and<br />

adequate.<br />

FO-4<br />

Neuroscience/Genetics<br />

FO-4-1<br />

Genotype-phenotype correlation of glucose transporter-<br />

1 (Glut-1) deficiency syndrome<br />

D. Wang, J.M. Pascual, P. Kranz-Eble, H. Yang, M.G.<br />

Alvarez, R.P. Sun, D.C. De Vivo<br />

Colleen Giblin Laboratories for Pediatric Neurology<br />

Research, Columbia <strong>University</strong>, New York, NY, USA


Abstracts 391<br />

Glut-1 deficiency syndrome (Glut-1 DS) was first<br />

described in 1991. Since then, about 80 patients have been<br />

diagnosed. Glut-1 DS is characterized by infantile seizures,<br />

developmental delay, hypotonia, ataxia, acquired microcephaly,<br />

and hypoglycorrhachia (30–35 mg/dl). The clinical<br />

diagnosis can be confirmed by decreased glucose uptake<br />

into erythrocytes (46.8%), fluorescence in situ hybridization<br />

studies and molecular analysis of the GLUT-1 gene. We<br />

have screened 36 patients and identified pathogenic mutations<br />

including three cases of hemizygosity, 13 missense<br />

mutations, four nonsense mutations, three insertions, six<br />

microdeletions and three splice site mutations. The mutations<br />

tend to be private with two exceptions. A missense<br />

mutation (R333W) has been seen in three unrelated patients,<br />

and several missense mutations have been seen in three<br />

families at the R126 amino acid residue. There is a spectrum<br />

of clinical severity in this patient population. Patients are<br />

from relatively minor to severely disabled neurologically.<br />

The phenotype-genotype correlations thus far have<br />

remained elusive, although there is an emerging impression<br />

that the patients with the milder phenotypes tend to have<br />

less pathogenic missense mutations whereas the patients<br />

with the more severe phenotypes tend to have more pathogenic<br />

nonsense mutations or frame shift mutations that<br />

produce a stop codon. These preliminary observations are<br />

preliminary and subject to future modifications as more<br />

patients are investigated.<br />

FO-4-2<br />

Fukutin protein expression in developing human<br />

brainstem<br />

Yoshiaki Saito a,b , Makio Kobayashi c , Kayoko Saito a ,<br />

Masashi Mizuguchi d , Masayuki Itoh e , Sachio Takashima e ,<br />

Makiko Osawa a<br />

a Department of Pediatrics, Tokyo Women’s Medical<br />

<strong>University</strong>, Tokyo Japan; b Division of Pediatric Neurology,<br />

Yokohama Ryo-iku En; c Department of Pathology, Tokyo<br />

Women’s Medical <strong>University</strong>; d Department of Pediatrics,<br />

Jichi Medical School; e National Institute of Neuroscience,<br />

National Center of Neurology and Psychiatry, Japan<br />

FCMD results from fukutin gene defects and is characterized<br />

pathologically by polymicrogyria of the cerebral and<br />

cerebellar cortex, as well as brainstem anomalies including<br />

the aberrant pyramidal tract. In accordance with its<br />

predicted role in the regulation of corticogenesis, fukutin<br />

is expressed in neurons of the developing cerebral and cerebellar<br />

cortices. This time we examined immunohistochemically<br />

its expression in the brainstem structures, which has<br />

not been scrutinized. Antisera were raised in rabbits against<br />

synthetic peptides that correspond to amino acid residues of<br />

fukutin protein. Brainstem tissues were obtained at necropsy<br />

from 14 control subjects aged 13 gestational weeks to 1 year<br />

7 months. In the pons (n ¼ 9), fukutin was immunoreactive<br />

in neurons of the facial, trigeminal and pontine nuclei as<br />

well as the tegmentum areas including the locus ceruleus. In<br />

medulla oblongata (n ¼ 9), positive labeling was noted in<br />

the neurons of the vestibular, hypoglossal, ambiguus, arcuate<br />

and inferior olivery nuclei. During the first trimester,<br />

immunoreactivity (IR) was also noted in the subependymal<br />

germinal cell layer and the roof attachment area of fourth<br />

ventricle in the medulla oblongata. The IR in the pontine<br />

nucleus was limited in the outer areas during this period. IR<br />

was preserved in many of the above structures during early<br />

childhood. The spatial and temporal pattern of fukutin<br />

expression in the brainstem structures may suggest its role<br />

in the morphogenesis of brainstem, as well as possible<br />

abnormalities in brainstem function of FCMD patients,<br />

including sleep state maintenance, respiration and deglutition.<br />

FO-4-3<br />

Effective international collaboration in rare disease<br />

research: DNA banking in the interest of the community<br />

P.F. Terry a,b , S.F. Terry a,c , M.E. Davidson c , C.T. Driscoll d ,<br />

E.W. Johnson e<br />

a PXE International, Inc., Sharon MA, USA; b Directory of<br />

Consumer Advocacy, Genomic Health, Inc., Palo Alto, CA,<br />

USA; c Genetic Alliance, Washington, DC, USA; d Technology<br />

Transfer Office, NHGRI, NIH, Bethesda, MD, USA;<br />

e Barrow Neurological Institute, Neurogenetics, Phoenix,<br />

AZ, USA<br />

Susceptibility to genetic disease crosses national borders.<br />

International rare disorder laid advocacy groups accelerate<br />

and focus research efforts. A diverse set of international<br />

advocacy organizations, including those falling under the<br />

umbrella of larger groups such as The Genetic Alliance in<br />

the United States, have created small, niche repositories of<br />

biological materials or ‘biobanks’. These biobanks provide<br />

an invaluable asset to the research community by streamlining<br />

what is perhaps the most logistically difficult aspects of<br />

searching for a gene: local ‘red tape’, including accessing<br />

and collecting appropriate DNA samples, protecting patient<br />

confidentiality, recontacting/redrawing patients as needed,<br />

and making sure the patient community is regularly<br />

informed about progress in the field, often needing to be<br />

done in an international context. It is also an exceptional<br />

opportunity to empower these groups and the communities<br />

that support them and foster the global effort to find the<br />

causes and cures for these diseases. Pseudoxanthoma elasticum<br />

(PXE) international is a lay advocacy group that has<br />

served as a major player in advancing research into the<br />

biology and genetics of a rare genetic disorder, PXE. PXE<br />

International has been able to encourage a number of<br />

productive international collaborations in 21 countries<br />

throughout the world that have rapidly accelerated the<br />

research on PXE. The organization is also uniquely able<br />

to safeguard confidentiality by acting as both a bridge and<br />

a ‘firewall’ between researchers, participants, and govern-


392<br />

Abstracts<br />

mental organizations. Lessons learned from biobanking<br />

efforts, all born of advocacy, for different diseases, using<br />

different models, will be discussed.<br />

FO-4-4<br />

MeCP2 expression in human neocortex<br />

W.E. Kaufman, M.H. Jarrar, S.M. MacDonald<br />

Departments of Pathology, Neurology, Pediatrics, Psychiatry,<br />

and Radiology, The Johns Hopkins <strong>University</strong> School of<br />

Medicine, and the Kennedy Krieger Institute, Baltimore,<br />

MD, USA<br />

MeCP2 is a member of the methyl-CpG-binding family<br />

of proteins, which is involved in transcriptional repression.<br />

Rett syndrome is a disorder characterized by mental retardation<br />

and autistic features, which is associated in a majority<br />

of cases with mutations within the coding region of the<br />

MeCP2 gene. Considering that MeCP2 mutations are<br />

mainly associated with neurologic disorders, we examined<br />

the pattern of expression of MeCP2 in normal human frontal<br />

neocortex by immunoblotting using a battery of antibodies<br />

targeting different domains of the protein. In<br />

addition to our recent demonstration of extra-nuclear,<br />

mainly postsynaptic, MeCP2 immunoreactivity, we found<br />

that MeCP2 is expressed as two distinctive bands of ,75<br />

and ,100 kd. Both bands are better defined under higher<br />

denaturing conditions, suggesting that MeCP2 has a<br />

complex conformation in brain. The most abundant 75<br />

kd MeCP2 band is the predominant one in nuclear fractions<br />

and in bovine whole cortex, our technical control<br />

mammalian sample, with 75:100 kd ratios of 2.59 and<br />

2.23, respectively. In contrast, in human whole homogenates<br />

the 100 kd is expressed in a higher proportion with<br />

respect to the 75 kd (75:100 kd ratio: 1.80). This suggests<br />

that the 100 kd MeCP2, at this point of uncertain origin<br />

(posttranslational modification versus different isoform), is<br />

a major component of MeCP2’s extra-nuclear pool. These<br />

findings further support the concept that MeCP2 may link<br />

synaptic activity and other signaling processes with transcriptional<br />

regulation in neurons, a base for the predominant<br />

neurologic involvement shown by individuals with<br />

MeCP2 mutations.<br />

FO-5<br />

Cerebral Palsy (2)<br />

FO-5-1<br />

The normal tissue distribution of the neuroglobin gene<br />

and its expression under hypoxic-ischemic brain damage<br />

H.-Y. Wang, M.-Y. Deng, C.-G. Zhang<br />

Department of Pediatrics the General Hospital of the PLA,<br />

Beijing, China<br />

The globins are proteins famous for their oxygen-carrying<br />

capacity. Two types are known in vertebrates: hemoglobin<br />

and myoglobin. Recently neuroglobin (NGB) has<br />

been identified, mainly in the brain, which is a monomer<br />

with a high oxygen affinity. The globin has a distinct function<br />

similar to myoglobin. To investigate its function to a<br />

greater degree, we initially studied the normal distribution<br />

of the NGB gene in the brain. Using the nucleic acid in situ<br />

hybridization (ISH) and immunohistochemistry method,<br />

we found that NGB mRNA and NGB protein were abundant<br />

in the brain of the normal adult rat. A large number of<br />

NGB mRNA and NGB-immunoreactive (NGB-IR) positive<br />

cells were distributed in the neurons of the rat brain. They<br />

were both distributed in the cytoplasm of neurons. Notably,<br />

the number of NGB mRNA and NGB-IR positive cells in<br />

the cerebral cortex was much higher than in the hippocampus<br />

and cerebellum, especially in the piriform cortex.<br />

Secondly, the dynamic change of expression of NGB<br />

mRNA in cerebral tissue was studied by using an adult<br />

rat ischemic brain damage model and reverse transcription<br />

(RT)-PCR technique. We discovered that the expression of<br />

NGB gene showed a time-dependent pattern. It increased<br />

rapidly at 1 min after ischemia, kept at a high level at 5<br />

min, then returned to normal at 15 min. It then increased<br />

again, but more slowly. Finally, we studied the expression<br />

of NGB mRNA in 13 different tissues of humans. The<br />

result showed that there was high expression in fetal<br />

kidneys and normal adult livers, apart from the brain.<br />

FO-5-2<br />

Types and complications of 1192 cases with cerebral<br />

palsy<br />

Y.-K. Li a ,Q.Li b , Y.-J. Liu b , X.-S. Wen a<br />

a Qingdao Children Hospital, Qingdao City, China; b Rehabilitation<br />

Center for Cerebral Palsy, Jiamusi <strong>University</strong>,<br />

China<br />

We analyzed types and complications of 1192 cases with<br />

CP, come around China and hospitalized in Rehabilitation<br />

Center for Cerebral palsy, Jiamusi <strong>University</strong> during 1986–<br />

1997. Ages of those patients varied from 5 months to 7<br />

years 3 months, averaged 3 years 2 months. Purpose: This<br />

report provides basic data for studies of cerebral palsy in<br />

China. Results: On types of CP, spastic was 715 cases<br />

(60.0%), athetosis 287 (24.1%), mixed types 113 (9.5%),<br />

atonic 58 (4.9%), ataxia nine (0.7%), unclassified ten<br />

(0.8%), similar to the investigation of Narabayashi. In the<br />

spastic CP, quadriplegia was most, 375 cases (52.5%),<br />

diplegia 135 (18.9%), hemiplegia 83 (11.6%), double<br />

hemiplegia 77 (10.8%), triplegia 21 (7.3%), paraplegia<br />

13 (1.8%) and monoplegia 11 (1.5%). In the athetosis,<br />

quadriplegia was predominant (284 cases, 99.0%), only<br />

three cases of hemiplegia (1.0%). Complications of CP<br />

chiefly were MR, 567 cases (47.6%), principally found in<br />

spastic quadriplegia (53.6%), triplegia (57.1%), double<br />

hemiplegia (46.8%), athetosis (48.1%) and mixed type


Abstracts 393<br />

(54.0%), caused almost always by anoxia or asphyxia. But<br />

rates of MR in spastic hemiplegia, diplegia and paraplegia<br />

were lower (respectively 31.3, 25.2 and 15.4%). Other<br />

complications were dysopsia (114 cases, 9.6%), microcephalia<br />

(77, 6.5%), epilepsy (53, 4.5%), dysphasia (51,<br />

4.3%) and dysacousis (6, 0.5%). Dysopsia mainly occurred<br />

in spastic diplegia and quadriplegia, then microcephalia<br />

and epilepsy chiefly in spastic quadriplegia, and dysphasia<br />

mostly in spastic quadriplegia and athetotic quadriplegia.<br />

In the dysopsias, internal strabismus was most (73 cases,<br />

6.1%), occurring mainly in spastic quadriplegia (21) and<br />

diplegia (14). Others were external strabismus (13, 1.1%),<br />

optic atrophy (7, 0.6%), nystagmus (7, 0.6%) and dislocate<br />

of the lens (one case).<br />

FO-5-3<br />

A model of combination of pediatric clinical<br />

rehabilitation and community rehabilitation<br />

J.-N. Mai<br />

Neurological and Rehabilitating Department, Guangzhou<br />

Children’s Hospital, China<br />

In the past 15 years, many pediatric hospitals have set<br />

up rehabilitation department. A majority of children with<br />

neurological disorders, such as cerebral palsy, have been<br />

treated in the pediatric hospitals in the means of ‘comprehensive<br />

rehabilitation service program on bed’. In some<br />

hospitals, the rehabilitation service programs were carried<br />

out by rehabilitation doctors and their multi-disciplinary<br />

teams. Therefore, children with neurological damages<br />

could enjoy the rehabilitation service from acute, chronic<br />

and periods on beds and under the clinical condition, for<br />

example, prevention of CP could start in neonatal stage<br />

and the treatment of CP could be infantile period. Clinical<br />

rehabilitation on bed plays an important role in the prevention<br />

of CP and decreases the severity of disability in the<br />

children with high risk factors. Since the rehabilitation of<br />

motor dysfunction and disability must be long term or for<br />

life time, only clinical rehabilitation on bed could not meet<br />

the needs of these disabled children. Community and home<br />

site rehabilitation can be an ideal model which disabled<br />

children could benefit for life. A community rehabilitation<br />

service and home rehabilitation program can be set up with<br />

the help and long term supervision of experts from pediatric<br />

hospital which is in the place of top level. Therefore, a<br />

network which includes pediatric hospital, community<br />

rehabilitation service and home rehabilitation program<br />

can provide effective and economical service to children<br />

with neurological disorders. the children with high risk<br />

factors and abnormal function can receive early intervention<br />

program and early rehabilitation service on the hospital<br />

base, disabled children can enjoy long term or lifetime<br />

service on the site of community and home. Neurological<br />

and rehabilitation department in Guangzhou children’s<br />

hospital which is a top level hospital in the south China<br />

has played a positive role in constructing the network of<br />

neurological rehabilitation service for disabled children in<br />

the communities, home and the rural areas.<br />

FO-5-4<br />

Interrater reliability of a visual function checklist for<br />

cerebral palsy children with severe grade mental<br />

retardation<br />

C.H. Ko a , C.Y. Ko b , L. Chia b , C.C.H. Lo a , P.W.T. Tse a<br />

a Department of Paediatrics, b Department of Ophthalmology,<br />

Caritas Medical Centre, China<br />

Introduction: The visual function checklist (VFC) is an<br />

innovative behavioral tool to assess visual function in children<br />

with severe visual impairment or poor cooperation. It<br />

assesses the child’s response to light perception, abilities of<br />

visual exploration, fixation, following, distance viewing,<br />

grabbing, orientation, and the presence of optokinetic<br />

nystagmus. Methods: The subjects included 15 children<br />

with cerebral palsy and severe to profound grade mental<br />

retardation residing in the Developmental Disabilities Unit<br />

of Caritas Medical Centre. Patients with underlying<br />

syndrome disorders, poorly controlled epilepsy, respiratory<br />

diseases requiring oxygen therapy, concurrent acute<br />

ophthalmic or systemic infections were excluded from<br />

the study. Each child received repeated independent assessments<br />

by an ophthalmologist, paediatric neurologist, and<br />

optometrist with the VFC. The assessment was conducted<br />

in standardized settings. The results were converted into a<br />

visual quotient (VQ), with a range from 0 to 1. Each rater<br />

was blinded to the others’ scores. Intraclass correlation<br />

coefficients (ICC) were computed to determine the interrater<br />

reliability. Results: The mean VQs measured by the<br />

ophthalmologist, paediatric neurologist, and optometrist<br />

were 0.592 ^ 0.397, 0.597 ^ 0.390, and 0.615 ^ 0.431,<br />

respectively. The overall ICC was 0.873 (95% C.I.<br />

0.695–0.961). The ICC between the ophthalmologist and<br />

optometrist was 0.954 (0.837–0.987). The ICC between the<br />

ophthalmologist and neurologist was 0.747 (0.378–0.911),<br />

and the ICC between the neurologist and the optometrist<br />

was 0.838 (0.506–0.954). Discussion: The VFC has a high<br />

degree of interrater reliability across different disciplines of<br />

health care professions. It is particularly useful for children<br />

with multiple disabilities precluding accurate determination<br />

of visual acuity. It is also a useful tool to monitor<br />

treatment outcomes in this group of patients. (Acknowledgement:<br />

This Project is supported by a grant from S.K.<br />

Yee Medical Foundation 2000).


394<br />

Abstracts<br />

FO-6<br />

Seizure Disorders (2)<br />

FO-6-1<br />

Efficacy of ketogenic diet on intractable epilepsy in<br />

children: a report of 215 cases<br />

M. Ghofrani<br />

Mofid Children Hospital, Tehran, Iran<br />

The ketogenic diet is a high fat, low protein, low carbohydrate<br />

diet. This study is conducted to determine the<br />

effectiveness of ketogenic diet in epileptic children refractory<br />

to medication. A total of 215 children, age 2–12 years,<br />

who continued to have more than two seizure attacks<br />

weekly despite adequate therapy with at least two anticonvulsant<br />

medications, were enrolled in this study and<br />

followed for 1 month to 3 years. Ketogenic diet’s effectiveness<br />

was studied at the first, second and third follow<br />

ups (1st, 6th and 12th month, respectively). Tolerance to<br />

diet and adverse events secondary to ketogenic diet<br />

consumption were recorded. Two hundred and fifteen children<br />

with mean age of 5.1 years, averaged 235 seizures per<br />

month before the diet, despite an exposure to a mean of 6.6<br />

antiepileptic medications were enrolled. At 1 month follow<br />

up after the initiation of diet, 68.8% were seizure-free and<br />

11.7% had .50% decrease in seizure frequency. A total of<br />

98.3% of the patients had adhered to the diet regimen and<br />

reported at 1-month follow up. At 6 months, 44.5% were<br />

seizure-free and 21.7% had .50% decrease in seizure<br />

frequency. A total of 89.3% had observed the diet till the<br />

6th month and reported for follow up. At 12 months, 14.8%<br />

were seizure-free and 12.9% had .50% decrease in seizure<br />

frequency. A total of 57.2% continued with the ketogenic<br />

diet for 1 year and were observed. In conclusion, the ketogenic<br />

diet should be considered as effective treatment for<br />

epileptic children whose seizures remain refractory to treatment.<br />

It seems that ketogenic diet is more effective and<br />

cheaper than many new antiepileptic medications.<br />

FO-6-2<br />

Low-dose synthetic ACTH therapy for West syndrome:<br />

initial effects and long-term outcome<br />

M. Ito<br />

Kyoto Multi-Institutional Study Group of Pediatric Neurology,<br />

Shiga Medical Center for Children, Moriyama, Japan<br />

Background: Most Japanese pediatric neurologists<br />

attempt other treatments before using adrenocorticotropic<br />

hormone (ACTH) therapy for West syndrome (WS), and<br />

even then, they use only a low-dose synthetic ACTH to<br />

avoid serious adverse effects. In this multi-institutional<br />

study, we analyzed the initial effects, adverse effects and<br />

long-term outcome in patients treated with low-dose<br />

synthetic ACTH in Japan. Methods: We analyzed the medical<br />

records of 138 patients with WS, who were treated with<br />

low-dose synthetic ACTH therapy for the first time at our<br />

institutions between 1989 and 1998. Results: At the end of<br />

ACTH therapy, excellent effect on seizures was noted in<br />

106 out of 138 (76%) patients, good effect in 23 (17%), and<br />

poor effect in nine (7%). Initial effects on EEG were excellent<br />

in 53 out of 138 (38%) patients, good in 76 (55%) and<br />

poor in nine (7%). As for seizure prognosis at the time of<br />

follow-up, 51 out of 99 (52%) patients were seizure-free,<br />

while 48 (48%) patients had seizures. Mental outcome was<br />

normal in six out of 98 (6%) patients, mild MR in 16<br />

(16%), moderate MR in 26 (27%) and severe MR in 50<br />

(51%). The initial effects of ACTH on seizures and longterm<br />

outcome were not dose-dependent (daily dosage;<br />

0.005–0.032 mg/kg, 0.2–1.28 IU/kg, total dosage; 0.1–<br />

0.87 mg/kg, 4–34.8 IU/kg). The severity of adverse effects<br />

correlated with total dosage of ACTH and the severity of<br />

brain volume loss due to ACTH correlated well with the<br />

daily dosage and total dosage of ACTH. Conclusion: Lowdose<br />

synthetic ACTH therapy is as effective for the treatment<br />

of WS as the higher doses used in previous studies.<br />

The dosage of synthetic ACTH used in the treatment of<br />

WS can be decreased as much as possible to avoid serious<br />

adverse effects.<br />

FO-6-3<br />

Neurophysiological responses to novel stimuli in infants<br />

with infantile spasms<br />

K.G. Werner, T. Baldeweg, R.C. Scott, S. Boyd, B.G.R.<br />

Neville<br />

Neurosciences Unit, Institute of Child Health, London,<br />

United Kingdom<br />

Objectives: Infantile spasms (IS) are strongly associated<br />

with cognitive and social impairment, possibly related to<br />

abnormalities in frontal/temporal neuronal networks. In<br />

adults and older children novel environmental sounds elicit<br />

prominent event-related potentials (ERPs) in temporal and<br />

frontal cortices. The aims of this study were to determine<br />

whether similarly robust novelty ERPs can be recorded in<br />

infants and if they are abnormal in infants with IS. Methods:<br />

Twenty-four full term infants (age range 3–10 months)<br />

and 13 infants with IS (range 3–10 months) were recruited.<br />

EEG was recorded continuously from 19 electrodes (10–20<br />

system). An oddball paradigm was used with frequent<br />

tones (80%, 1 kHz), deviant tones (10%, 1.5 kHz) and<br />

brief novel environmental sounds (10%, 200 ms long),<br />

delivered binaurally (interstimulus interval 700 ms) via<br />

speakers at a distance of 30 cm. Infants were either asleep<br />

in stages I to II or awake and feeding. Three blocks were<br />

recorded, with 180 deviants and 180 novels. Results:<br />

Robust and reproducible ERPs to novels were detected in<br />

all normal infants, with peak to peak amplitudes of up to 25<br />

mV. They consisted of two components over the temporal<br />

(latency 250 ms) and fronto-central scalp (500 ms), respec-


Abstracts 395<br />

tively. In all patients with IS the novelty-ERPs showed<br />

markedly reduced amplitudes or delayed latencies in<br />

comparison with controls. Conclusions: Novelty-ERPs<br />

can be recorded reliably from 3 months of age. ERPs are<br />

different in children with infantile spasms compared with<br />

controls. The preliminary results support the hypothesis<br />

that there is altered temporal lobe processing in children<br />

with infantile spasms.<br />

FO-6-4<br />

Practice parameter: evaluating a first non-febrile<br />

seizure in children<br />

D. Hirtz, S. Ashwal, A. Berg, D. Bettis, C. Camfield, P.<br />

Camfield, P. Crumrine, R. Elterman, S. Schneider, S.<br />

Shinnar<br />

National Institute of Neurological Disorders and Stroke,<br />

Bethesda, MD, USA<br />

Objective: The Quality Standard Subcommittee of the<br />

American Academy of Neurology and the Practice Committee<br />

of the Child Neurology Society develop practice parameters<br />

as strategies for patient management based on<br />

analysis of evidence. For this practice parameter, the authors<br />

reviewed available evidence concerning the value of diagnostic<br />

testing after a first non-febrile non-provoked seizure<br />

in a child. Neonatal seizures and seizures lasting more than<br />

30 min or more were excluded. Methods: Multiple searches<br />

revealed relevant literature and each article was reviewed,<br />

abstracted, and classified. Recommendations were based on<br />

a three-tiered scheme of classification of the evidence.<br />

Results: There was sufficient evidence to provide a recommendation<br />

that an EEG be obtained routinely as part of the<br />

diagnostic evaluation. Other studies were recommended as<br />

based on specific clinical circumstances. Conclusions:<br />

Further studies are needed using large, well-characterized<br />

samples and standardized data collection instruments.<br />

Collection of data regarding appropriate timing as well as<br />

the choice of evaluations would be important.<br />

FO-7<br />

Neuroimaging (1)<br />

FO-7-1<br />

Prognostic value of combined use of general movement<br />

assessment and proton magnetic resonance spectroscopy<br />

in term infants affected by hypoxic-ischemic<br />

encephalopathy<br />

G. Rapisardi a , M. Cappellini b , M. Luce Cioni a , C. Ernst a ,C.<br />

Fonda b<br />

a NICU, Department of Pediatrics; b Pediatric Radiology<br />

Unit, A. Meyer Hospital, Florence, Italy<br />

Objective: To evaluate the neurodevelopmental (ND)<br />

prognostic value of the early combined use of Prechtl’s<br />

method of qualitative assessment of general movements<br />

(GMs) and proton magnetic resonance spectroscopy (1H<br />

MRS) in term infants affected by hypoxic-ischemic encephalopathy<br />

(HIE). Subjects and methods: 24 infants born at<br />

term transferred to our NICU for suspected HIE. All the<br />

infants had a 1 H MRS within the 1st week after admission,<br />

repeated GM assessments before discharge and then<br />

between 9 and 16 weeks post-term ( fidgety age) and the<br />

neurological outcome assessed at 12 months of age. Results:<br />

The 11 infants with a poor ND outcome (death or CP) had a<br />

significantly higher mean Lac/Cr and lower NAA/Cr at 1 H<br />

MRS than the 13 infants with a normal ND outcome<br />

(P , 0:05). All infants with normal GMs at 9–16 weeks<br />

had a normal ND outcome. Within the 15 subjects with<br />

signs of moderate to severe hypoxic-ischemic insults at 1 H<br />

MRS, the four who had a normal ND outcome had normal<br />

GMs before the discharge. Within the 18 subjects with<br />

abnormal GMs in the 1st week after admission, the seven<br />

who had a normal ND outcome had lower Lac/Cr and higher<br />

NAA/Cr in the first week of life. Conclusion: In term infants<br />

affected by HIE the combined use of GMs and 1 H MRS<br />

increases their specific separate ND prognostic value.<br />

FO-7-2<br />

Non-invasive focus localization using dipole modeling<br />

and EEG-assisted functional MRI in benign childhood<br />

epilepsy with centrotemporal spikes<br />

R. Boor, G. Vucurevic, G. Kutschke, T. Bauermann, S. Boor<br />

<strong>University</strong> Children’s Hospital, Department of Child<br />

Neurology, Mainz, Germany<br />

The localization of epileptic foci is an important issue in<br />

children with extratemporal epilepsies. However, the value<br />

of non-invasive methods such as dipole modeling of EEG<br />

spikes, and the EEG-assisted fMRI has not been sufficiently<br />

investigated in children. As a model of extratemporal<br />

epilepsies, we studied nine patients aged 4–13 (median<br />

10) years with benign rolandic epilepsy. Interictal EEGs<br />

were recorded with 23 channels and included four lower<br />

temporal electrodes. The spikes were averaged and the<br />

dipoles were modeled with the BESA 2000 program, and<br />

then imported into the anatomical 3D-MRI (T1-weighted<br />

3D-MPRAGE). Additionally, interictal spikes were<br />

recorded during the fMRI acquisition (BOLD, 1.5 Tesla,<br />

EPI T2-sequence, TR 6000 ms, TE 66 ms, matrix<br />

128 £ 128, slice thickness 6 mm, 16 transversal slices) on<br />

a MR-compatible battery-powered digital EEG system with<br />

16 channels. The fMRI sequences were correlated off-line<br />

with the EEG spikes and analyzed with the SPM 99 software.<br />

EEG source analysis demonstrated the spike onset in<br />

the central region (face or hand area) in all patients. The<br />

fMRI results were consistent with the modeled dipoles in<br />

five patients; we could not demonstrate fMRI activation<br />

despite active spiking in two patients, and two patients did<br />

not produce sufficient spikes (under sultiame treatment) for


396<br />

Abstracts<br />

fMRI analysis. In conclusion, we localized the interictal<br />

spikes in the central region in patients with rolandic epilepsy<br />

and confirmed these results by EEG-assisted fMRI. These<br />

techniques appear to improve focus localization in children<br />

with extratemporal epilepsies<br />

FO-7-3<br />

Quantitative measurement of hippocampal volume in<br />

children with epilepsy and clinical analysis<br />

L.-M. Ye<br />

Department of Neurology, Tianjin Children’s Hospital,<br />

China<br />

Objective: We aim to measure normal hippocampal<br />

volume of Chinese children with an age of 6–14 and the<br />

hippocampal volume loss of patients with epilepsy, to<br />

compare the reliability of two assessment methods, and to<br />

study patients with hippocampal volume loss. Methods:We<br />

selected 30 members for experiment group and 40 members<br />

for comparison group. We used Marconi 1.5 T.MR scanner<br />

to get hippocampal images, measured the right/left hippocampal<br />

volume, and then performed P testament after differential<br />

analysis. We analysed the relation between eight<br />

clinical data and different treatment effects. We examined<br />

the therapeutic effect of Topamax, the newly developed<br />

medicine for epilepsy. Result: Normative hippocampal<br />

volume: right: 0.5530 ^ 0.0458 cm 3 , left:<br />

0.5500 ^ 0.0495 cm 3 . Right/left differential value:<br />

0.0033 ^ 0.0250 cm 3 . The P for self-differential value and<br />

self-differential ratio: 0.000.Visual estimation for hippocampal<br />

loss: left: 0.0895 ^ 0.0243 cm 3 ; right:<br />

0.07 ^ 0.0183cm 3 . Diagnosis limit: right .0.05, left<br />

,20.05 cm 3 . Only 24.4% of traditional medicines for<br />

epilepsy are effective. Topamax presents obvious effects<br />

for controlling the attack of epilepsy and reaching normal<br />

EEG. Conclusions: Selective performance of hippocamal<br />

volume measurement is conducive to the diagnosis, treatment<br />

and prevention of epilepsy.<br />

FO-7-4<br />

The utility of neuroimaging in the evaluation of pediatric<br />

migraine and migraine-like headache<br />

V. Farkas, A. Nyquist<br />

Semmelweis <strong>University</strong>, Children’s Hospital, Budapest,<br />

Hungary<br />

The aim of this study was to collect data about the<br />

usefulness of neuroimaging in the diagnosis of pediatric<br />

patients suffering from migraine with aura as well as<br />

migraine-like headache accompanied by neurological deficient<br />

symptoms. Children and adolescents (range 6–15<br />

years) with a complaint specifically of migraine with<br />

aura (130 patients) classified according to the International<br />

Headache Society (IHS) criteria and migrainous disorder<br />

not fulfilling the IHS criteria of migraine (80 patients) were<br />

investigated. They had attacks with severe neurological<br />

deficient symptoms like sensory disturbances, dysphasia,<br />

dysarthria, unilateral short lasting hemiparesis with<br />

decreased level of consciousness. All patients underwent<br />

at the diagnosis a skull CT scan with intravenous contrast<br />

agent. During the follow-up period (3–8 years) 59 patients<br />

had a further neuroimaging by using of MRI because of<br />

progressive worsening of headache symptoms (a); longlasting<br />

unilateral slowing of the EEG background activity<br />

(b); newly developed headache symptoms (c): basilar<br />

migraine, ophtalmoplegic migraine and thunderclap headache.<br />

At the diagnosis CT scans in both group of patients<br />

revealed various non-significant pathologies of the CNS,<br />

but three otherwise healthy young children had findings<br />

thought to be clinical significant: Arnold-Chiari malformation<br />

I–II (one patient), cerebral arteriovenous malformation<br />

(two patients). By using MRI techniques during the followup<br />

period in 53 patients findings were normal or irrelevant<br />

to the headache, but in two patients with long lasting<br />

ophthalmoplegia a swollen oculomotor nerve with contrast<br />

enhancement was present and in four additional patients<br />

deep venous abnormality was detected. According to our<br />

results the greater resolution and discrimination of MRI,<br />

appeared to be of little clinical importance in the evaluation<br />

of pediatric migraineurs. Although there are some rare,<br />

unique headache types like ophthalmoplegic migraine,<br />

non-aneurysmal thunderclap headache that remain a diagnosis<br />

only by exclusion.<br />

FO-7-5<br />

Clinical and MR imaging study in term children with<br />

spastic diplegia<br />

Y. Kobayashi, S. Tanaka, A. Onuma<br />

Division of Pediatric Neurology, Takutoh Rehabilitation<br />

Center for Children, Sendai, Miyagi Japan<br />

In preterm children with spastic diplegia (preterm SD),<br />

the brain lesions on MRI have predominantly shown periventricular<br />

leukomalasia (PVL). Lesions of SD in term birth<br />

children (term SD) are, however, heterogeneous on MRI<br />

and distinct from preterm SD, although both have clinically<br />

been categorized as SD. We studied MR images of the brain<br />

in 61 terms SD (57 singletons, four twins, 36 males, 25<br />

females, mean age 14.2 ^ 5.1 years). The mean birth weight<br />

was 3027 ^ 326 g. The correlation was examined between<br />

clinical profiles and MRI findings. Our results showed: (1)<br />

MRI findings in term SD showed various lesions, PVL in<br />

seven, posthemorrhagic porencephaly in five, dysmyelination<br />

in four, brain infarction in three, brain anomalies in one,<br />

and others. No lesions on MRI were seen in 32 of 61 term<br />

SD (52.5%). (2) Perinatal complications were not so<br />

common, asphyxia in 14, respiratory distress in 5, seizures<br />

in 5 and feeding difficulty in 15. (3) Mental retardation was<br />

found in 44 children with term SD (72.1%). (4) Seizures and


Abstracts 397<br />

EEG abnormalities were more often observed in children<br />

with various lesions on MRI. MRI findings in term children<br />

with SD were more heterogeneous. The most common finding<br />

was no lesion on MRI. A different approach may<br />

provide some answers in term SD with normal MRI finding.<br />

Term SD seems to be associated with more severe disability<br />

than preterm SD. The pathogenesis of term SD remains to<br />

be studied further.<br />

FO-7-6<br />

Magnetic resonance imaging patterns of immediate<br />

brain damage and their evolution following ‘Shaken<br />

Baby Syndrome’<br />

R.A. Minns a , T.-Y.M. Lo a , M. McPhillips b , R.J. Gibson b<br />

a Department of Child Life and Health, <strong>University</strong> of Edinburgh,<br />

Edinburgh UK; b Department of Paediatric Radiology,<br />

Royal Hospital for Sick Children, Edinburgh UK<br />

The pathological consequences of acute rotation-deceleration<br />

injury that occur in ‘shaken baby syndrome’ are<br />

most comprehensively seen on MRI (Barlow et al., 1999).<br />

As part of an ongoing prospective study, a total of 72 MRI<br />

scans were obtained from a cohort of children who were<br />

scanned during the acute encephalopathic phase (20 infants)<br />

and during the follow-up period (38 children). The acute<br />

phase scan evaluation was based on the frequency of the<br />

following observations: (1) subtemporal, suboccipital and<br />

interhemispheric subdural haematoma; (2) tearing of pericerebral<br />

veins; (3) compartmentalisation and varying signal<br />

intensity of the subdural haematoma; (4) contusion and<br />

lacerations; (5) petechiae of the corpus callosum and the<br />

grey-white interface; (6) cerebral oedema; (7) intraventricular<br />

and subarachnoid haemorrhages; and (8) asphyxial<br />

injury. Seventeen of the 38 patients with long-term<br />

follow-up scans had equential MR imagings (a mean of<br />

four scans per child). Microencephaly occurred in 94% of<br />

these children on follow-up and diffuse or focal white matter<br />

atrophy was responsible for more than 50% of these cases.<br />

FO-8<br />

Infection/Immunology<br />

FO-8-1<br />

Effect of dexamethasone on nitric oxide synthase gene<br />

expression in endotoxemia in neonate rats<br />

H. Wang, X.-H. Du, Y.-B. Wu, B.-M. Wu<br />

Department of Pediatrics, The Second Clinical College,<br />

China Medical <strong>University</strong> Shenyang, China<br />

NOS played a role in endotoxemic brain injury, which<br />

has been increasingly concerned. The expression of three<br />

types of NOS mRNA in the brain and effects of dexamethasone<br />

on NOS and caspase-3 mRNA expression<br />

were investigated by RT-PCR in postnatal 7-day Wistar<br />

rats with acute endotoxemia established by intraperitoneal<br />

administration of Escherichia coli LPS. The results showed<br />

neuronal nitric oxide synthase (nNOS) and caspase-3<br />

mRNA were faintly expressed in the brain of normal<br />

control rats, while iNOS and endothelial nitric oxide<br />

synthase (eNOS) mRNA could not detected. The expressions<br />

of three types of NOS mRNA were weak at 2 h after<br />

acute endotoxemia (LPS 5 mg/mg), peaked at 6 h, thereafter<br />

reducing gradually to 24 h. The intensity of expression<br />

was nNOS . iNOS . eNOS. It was found that<br />

expression of NOS mRNA was inhibited in rats when<br />

dexamethasone was administered together with LPS (5<br />

mg/mg) with intensity of iNOS . nNOS . eNOS.<br />

Caspase-3 mRNA expression was increased at 2, 4 and 6<br />

h after acute endotoxemia, peaked at 24 h, and inhibited<br />

partially by dexamethasone administration. The results<br />

suggest that LPS-induced NO production induces apoptotic<br />

death of neurons through mechanism involving the<br />

caspase-3 activation, which may play an important role<br />

in the pathogenesis of brain injury during endotoxemia,<br />

and neuro-protective effects of dexamethasone may be<br />

partially realized through inhibiting the expression of<br />

NOS mRNA.<br />

FO-8-2<br />

Dynamic changes of brain derived neurotrophic factor<br />

(BDNF) mRNA after experimental bacterial meningitis<br />

and antibiotic treatment<br />

L. Li, Q.-X. Shui<br />

Affiliated Children’s Hospital, Zhejiang <strong>University</strong> School<br />

of Medicine, Hangzhou, China<br />

To investigate why mortality and neurologic deficits still<br />

occur following bacterial meningitis (BM) in children with<br />

newer and more potent antibiotics, we used in situ hybridization<br />

to study the mRNA expression of BDNF in the brain<br />

during the course of experimental meningitis and after antibiotic<br />

treatment in the rats (n ¼ 42). We established the<br />

animal models by inoculating Streptococcus pneumoniae<br />

(SP) intracisternally, and inoculating the same volume of<br />

normal saline suspension in uninfected control rats. BDNF<br />

protein was also evaluated by immunohistochemistry in the<br />

brain of SP inoculated rats. BDNF mRNA expression was<br />

obviously up-regulated at 24 h post-inoculation (p.i.)<br />

(0.13320 ^ 0.0275) (P , 0:01), then declined and still<br />

stronger (0.09403 ^ 0.00383) than that of control rats<br />

(0.06495 ^ 0.01241) on 5 days p.i. (P , 0:05), but downregulated<br />

and nearly undetectable in the brain of rats on 5<br />

days by antibiotic treatment for 3 days (0.03814 ^ 0.0120)<br />

(P , 0:01). Immunochemistry showed similar changes to<br />

mRNA expression, but the differences from mRNA expression<br />

was that BDNF protein had declined to normal levels<br />

on 5 days p.i. The results of the study support the hypothesis<br />

that BDNF might play a neuroprotective role in brain<br />

damage process of bacterial meningitis in rats. The expres-


398<br />

Abstracts<br />

sion of BDNF mRNA expression might be inhibited after<br />

antibiotic treatment, and this may weaken the endogenous<br />

neuroprotective ability. It might be one of the mechanisms<br />

of mortality and neurologic deficits following BM. Supplementary<br />

BDNF might be a possible therapeutic strategies to<br />

prevent brain damage.<br />

FO-8-3<br />

Spectrum of movement disorders in children with<br />

Japanese encephalitis: a clinicoradiological correlation<br />

U.K. Misra, J. Kalita<br />

Department of Neurology, Sanjay Gandhi PGIMS, Lucknow,<br />

India<br />

Background: A systematic evaluation of movement disorders<br />

in children with Japanese encephalitis (JE) is lacking.<br />

Aim: To evaluate the spectrum of movement disorders in<br />

children with JE and correlate these with MRI findings.<br />

Methods: Consecutive children with JE admitted to our<br />

institute were included. The diagnosis of JE was based on<br />

clinical, radiological and serological criteria. CT and MRI<br />

were carried out. The movement disorders were documented<br />

and their severity was graded on a 0–IV scale. Outcome<br />

was defined at 3 months on the basis of the Barthel Index<br />

score. Movement disorders were correlated with radiological<br />

findings and outcome. Results: Thirty consecutive children<br />

(eight females) with JE whose mean age was 11.2 years<br />

were included. In the acute stage mean Glasgow coma scale<br />

(GCS) score was 7.4 and 13 had seizures. CT scan was<br />

abnormal in nine out of 26 revealing thalamic lesion in<br />

nine, basal ganglia, substantia nigra and pons in one each.<br />

Cranial MRI was abnormal in 22 out of 27 patients revealing<br />

thalamic lesions in 19, basal ganglia nine, substantia nigra<br />

16 and pons two. Movement disorders were noted in 25<br />

patients after 1–4 weeks of ictus. Parkinsonian features<br />

were present in all and dystonia in 18 patients. Dystonia<br />

involved trunk and limbs mainly but three patients had<br />

mouth open dystonia. Dyskinesia was present in nine<br />

patients. There was no statistical correlation of the various<br />

movement disorders with MRI changes (P . 0:05). Patients<br />

with movement disorders had poorer outcome at 3 months<br />

compared to those without (P , 0:01) and patients with<br />

dystonia had worse outcome compared to parkinsonian<br />

features only. Conclusion: A wide variety of movement<br />

disorders are common in children with JE. Presence of<br />

dystonia is associated with poor outcome.<br />

FO-8-4<br />

Acute necrotizing encephalopathy of childhood:<br />

radiologic and pathologic features of thalamic lesions<br />

M. Mizuguchi a , M. Hayashi b , Y. Nakai c , M. Itoh c ,S.<br />

Takashima c<br />

a Department of Pediatrics, Jichi Medical School, Minamikawachi,<br />

Tochigi; b Department of Clinical Neuroscience,<br />

Tokyo Metropolitan Institute for Neuroscience, Fuchu;<br />

c Department of Mental Retardation and Birth Defect<br />

Research, National Institute of Neuroscience, Kodaira,<br />

Japan<br />

Acute necrotizing encephalopathy of childhood (ANE), a<br />

fulminant parainfectious disorder prevalent in Japan and<br />

Taiwan, is characterized by multiple, symmetrical brain<br />

lesions affecting the bilateral thalami, putamina and cerebral<br />

white matter. To elucidate the pathomechanism of ANE, we<br />

studied cranial CT and MRI findings of 14 patients, and<br />

necropsy findings of four of them. In all the cases, CT<br />

demonstrated thalamic hypodensity as soon as coma developed.<br />

After the 3rd day of illness, the center of thalamic<br />

lesions of most cases became hyperdense, producing a<br />

concentric appearance which was further evident on MRI.<br />

Neuropathologic examination revealed laminar changes of<br />

vascular and parenchymal pathology. Excessive permeability<br />

of blood vessels and resultant vasogenic edema became<br />

more prominent with increasing depth from the cerebral<br />

surface. The deep portion of the lesions showed severe perivascular<br />

hemorrhage, accounting for the central high<br />

density on CT. These results indicate that brain lesions of<br />

ANE are caused by local breakdown of the blood–brain<br />

barrier.<br />

FO-8-5<br />

The outcome of severe pediatric Guillain-Barre<br />

syndrome seen in a tertiary hospital: supportive care<br />

alone vs. intravenous immunoglobulin treatment and<br />

supportive care<br />

A.L.F. Luat<br />

Child Neuroscience Division, Philippine Children’s Medical<br />

Center, Quezon City, Philippines<br />

Objective: To compare the outcome of the pediatric<br />

patients with severe Guillain-Barre syndrome (GBS) who<br />

received supportive care alone with the outcome of those<br />

who received intravenous immunoglobulins plus supportive<br />

care. Methods: This was a 6-year retrospective, descriptive,<br />

cross-sectional study. Among the 48 patients diagnosed to<br />

have GBS during the study period, 37 were included.<br />

Twenty four received supportive care alone, while 13<br />

received intravenous immunoglobulins in addition to<br />

supportive care. The main outcome criterion was the<br />

improvement by at least one functional grade within 28<br />

days after the onset of illness. The secondary outcome<br />

criterion was the ability walk unaided within 42 days of<br />

the onset of illness. Other outcome measures were the<br />

mean length of hospitalization, mean length of intensive<br />

care unit stay and mean duration of intubation. Results: A<br />

total of 69% of the patients in the IVIG group improved by<br />

one functional grade within 28 days after the onset of illness<br />

compared to 41% of the patients who received supportive<br />

care alone. Similarly, 69% of the patients in the IVIG group


Abstracts 399<br />

were able to walk unaided within 42 days, compared to 37%<br />

of the supportive care group. The results however did not<br />

reach statistically significant difference with p values of<br />

0.0873 and 0.0652, respectively. There was also no statistically<br />

significant difference in the duration of hospitalization<br />

between the two groups (IVIG-17 days, supportive care-19<br />

days; P-value ¼ 0.5569). Similarly, although there was a<br />

trend towards shorter days of intubation and ICU stay in<br />

the IVIG group, the results did not reach statistical significance.<br />

In the supportive care group, one had hypoxic<br />

ischemic encephalopathy and one died due to sepsis.<br />

Conclusions: This restropective study showed that though<br />

there was a trend towards benefits in favor of the IVIG group<br />

in all outcome measures, the difference did not reach statistical<br />

significance.<br />

FO-8-6<br />

Neuroradiological diagnostic and prognostic features of<br />

tuberculous meningitis in childhood<br />

S. Andronikou a , B. Smith a , R. van Toorn b , H. Douis a , J.M.<br />

Wilmshurst b<br />

a Department of Pediatric Radiology, and b Department of<br />

Pediatric Neurology, Red Cross Children’s Hospital,<br />

School of Child and Adolescent Health, <strong>University</strong> of<br />

Cape Town, Cape Town, South Africa<br />

We present our clinical experience of affected patients<br />

and correlating neuroradiological features. Methods: The<br />

study composed of a retrospective review of all CT scans,<br />

clinical and laboratory findings in children presenting with a<br />

provisional diagnosis of TBM between 1998 and 2001. CT<br />

scans were assessed with regard to the presence of imaging<br />

features such as basal meningeal enhancement, hydrocephalus,<br />

infarction and tuberculomata. Patients were defined as<br />

those with definite proof of TBM (TB CSF culture positive),<br />

those with circumstantial proof of TBM (clinical presentation<br />

and consistent CSF features) and those without<br />

evidence of TBM. Correlation was made between the<br />

presence and severity of meningeal enhancement with<br />

presentation, proof of TB and outcome, initially concentrating<br />

on the CSF culture positive group and then including the<br />

probable group. Results: Seventy-two patient records were<br />

reviewed, from the group 19 patients (seven M:12 F) were<br />

CSF culture positive and 40 (24 M:16 F) were clinically<br />

consistent with a diagnosis of TBM. The youngest patient<br />

was 3.3 months and the oldest was 12 years with a median of<br />

16 months for the culture positive group. The clinical<br />

features in the two groups were summarized and statistically<br />

compared with no significant difference found. The<br />

commonest positive CT finding of the affected patients<br />

was basal meningeal enhancement, followed by hydrocephalus,<br />

cisternal high-density exudate prior to IVI contrast,<br />

infarction and TB granulomas. Conclusion: From this an<br />

inclusion criterion has been devised, including the neuroradiology,<br />

to enhance the early confirmation of TBM.<br />

Current established guidelines are lacking this.<br />

FO-9<br />

Genetics/Molecular Pathology<br />

FO-9-1<br />

Docosahexaenoic acid induced opening of voltage-gated<br />

K channels prevents repetitive firing in neurons<br />

D. Erichsen a , X.-P. Xu b , F. Elinder a<br />

a Department of Neuroscience, and The Nobel Institute for<br />

Neurophysiology, Karolinska Institute, Stockholm, Sweden;<br />

b Department of Pediatrics, the First Hospital of Harbin<br />

Medical <strong>University</strong>, Harbin, China<br />

Epilepsy is a brain disorder characterized by recurrent<br />

seizures caused by the synchronous firing of large groups<br />

of neurons. About 25–30% of epileptic children are intractable<br />

to the conventional anti-epileptic drug treatment.<br />

However, the ketogenic diet (KD) could be an effective<br />

option for them. In order to investigate the mechanism of<br />

the KD anticonvulsant action from the effect of free fatty<br />

acids (FFAs) and ketone bodies on voltage-gated K channels,<br />

we carried out the study with the two-electrode voltage<br />

clamp technique on the Shaker K channel expressed in<br />

Xenopus oocytes and measured currents through channels<br />

with the concentrations changed from those before treatment<br />

to those during treatment. The results showed docosahexaenoic<br />

acid (DHA), eicosapentaenoic acid (EPA) and<br />

linoleic acid (LA) within clinically relevant concentrations<br />

for the KD open the K channel by shifting the G (V) in<br />

negative direction. A total of 30 mV DHA shifts the G (V)<br />

curve with 22.3 ^ 0.4 mV (n ¼ 3). In experiments with<br />

200 mg/l albumin, 100 mM DHA did not shift the G (V)<br />

curve. At the concentration of 100 mM, EPA and LA,<br />

respectively, shift the G (V) curve with 25.0 ^ 2.2<br />

(n ¼ 3) and 24.0 ^ 0.4 mV (n ¼ 3). In contrast, similar<br />

experiments performed for ketone bodies (b-hydroxybutyric<br />

acid and acetoacetate) showed no effect at all. Computer<br />

simulations of a simple excitable system showed that repetitive<br />

firing is completely abolished at all stimulating<br />

currents when the voltage dependence of the K channels<br />

in shifted as little as 22 mV. The present findings open<br />

up a new mechanism for anti-epileptic treatment.<br />

FO-9-2<br />

Glucose transporter (GLUT1) deficiency without<br />

epilepsy, an unusual cause for developmental delay<br />

W.C.G. Overweg-Plandsoen a , J.E.M. Groener b , O.F.<br />

Brouwer c , H.D. Bakker d , D.C. De Vivo e<br />

a Department of Pediatric Neurology,<br />

b Department of<br />

Pediatrics, Leiden <strong>University</strong> Medical Center, LEIDEN,<br />

The Netherlands; c Groningen <strong>University</strong> Center: Department<br />

of Pediatric Neurology; d Academic Medical Center


400<br />

Abstracts<br />

Amsterdam: Department of Pediatrics; e Columbia Presbyterian<br />

Medical Center New York: Department of Neurology,<br />

USA<br />

The case of a 7.5 year old boy will be presented. His<br />

psychomotor development was delayed and especially his<br />

ability to walk remained poor due to imbalance. His<br />

parents reported fluctuations during the day. He never<br />

had epileptic seizures. The neurological and psychological<br />

examinations showed a TIQ (WIPPSI-R) of 61, a cerebellar<br />

syndrome, signs of involvement of the pyramidal tract<br />

and dystonic posturing of the arms while walking. Examinations<br />

for detecting the cause of the retardation were<br />

performed. The EEG and MRI-brain were without abnormalities.<br />

The results of the metabolic screen showed a serum<br />

lactate of 2.3 mmol/l. Lactate in CSF was low (0.85 mmol/<br />

l). The CSF/plasma ratio of glucose was low twice (0.31<br />

and 0.34, normal value .0.6) indicating a deficiency of<br />

glucose transport across the blood–brain barrier. In De<br />

Vivo’s laboratory the GLUT1 deficiency was confirmed<br />

in erythrocytes, DNA analysis is underway. Although this<br />

patient does not have epilepsy he has been treated with a<br />

ketogenic diet to provide an alternative energy source and<br />

to try influencing his neurological symptoms. There seems<br />

to be amelioration of the neurological symptoms after 3<br />

months of using the diet. An overview will be presented<br />

of the symptoms of ‘De Vivo’ disease. Epilepsy is present<br />

in all patients except in this one. The disease is autosomal<br />

dominant, the gene is located on chromosome 1. This is the<br />

first case of GLUT1 deficiency without epilepsy.<br />

FO-9-3<br />

Immunological pathogenesis of the allergic neuropathy<br />

induced by lipopolysaccharide of Campylobacter jejuni<br />

Y.-X. Gao, F.-C. Cai<br />

Department of Neurology, Chongqing Children’s Hospital,<br />

Chongqing <strong>University</strong> of Medical Science, Chongqing,<br />

China<br />

Objective: To investigate the immunological pathogenesis<br />

of neuropathy induced by Campylobacter jejuni (CJ)<br />

LPS. Methods: (1) The specific anti-CJ LPS IgG antibody<br />

was purified from the sera of immunized rats by affinity<br />

chromatography; (2) pathologic examination of sciatic<br />

nerve was performed after perineural injection by specific<br />

anti-CJ LPS IgG antibody; (3) the affinity of the specific<br />

anti-CJ LPS IgG antibody to the sciatic nerves of normal<br />

rat or human was detected by immunohistochemistry<br />

(streptavidin-biotin-peroxidase complex (SABC) and fluorescein<br />

isothiocyanate (FITC)-immunofluorescent method);<br />

(4) expression of the specific CJ LPS IgG in the pathological<br />

nerves was detected by immunohistochemistry; and<br />

(5) Expression of tumor necrosis factor alpha (TNF-a)<br />

mRNA in damaged nerves was detected by in situ hybridization<br />

histochemistry. Results: (1) Significant lesion of<br />

sciatic nerves caused by the specific antibody of CJ LPS<br />

was observed. The incidence of pathologic fibers (20.7%)<br />

was much higher than that of control group (4.8%),<br />

P , 0:01; (2) strong conjugation of the specific anti-CJ<br />

LPS antibody with the sciatic nerves of normal rat or<br />

human was confirmed by immunohistochemistry; (3) the<br />

specific IgG was strongly deposited in nerves with axonal<br />

degeneration and mixed lesion. However there was sparse<br />

IgG deposition in 60% nerves with demyelination; (4) there<br />

was high expression of TNF-a mRNA in 84% of pathological<br />

nerves after repeated immunization by CJ LPS and no<br />

expression of TNF-a mRNA in that of control group.<br />

Conclusion: CJ LPS could induce peripheral neuropathy,<br />

result in more expression of specific antibody and TNF-a<br />

on pathological fibers. This might be an important factor in<br />

the pathogenesis of patients of CJ-associated GBS.<br />

FO-9-4<br />

Platelet-derived growth factor and its receptor in<br />

muscular dystrophies<br />

Y.-J. Zhao a,b , K. Haginoya a , K. Iinuma a<br />

a Department of Pediatrics, Tohoku <strong>University</strong> School of<br />

Medicine, Sendai, Japan;<br />

b Department of Pediatrics,<br />

Second Clinical College of China Medical <strong>University</strong>,<br />

Shenyang, China<br />

We examined the immunological localization of platelet-derived<br />

growth factor (PDGF)-A, PDGF-B, and PDGF<br />

receptor PDGFR alpha and beta to clarify their role in the<br />

progression of human muscular dystrophy. Biopsied<br />

frozen muscle from patients with DMD, BMD, and<br />

CMD were analyzed immunohistochemically using antibodies<br />

raised against PDGF-A, PDGF-B, PDGFR alpha<br />

and beta. In normal control muscle, neuromuscular junctions<br />

and vessels were positively stained with antibodies<br />

against PDGF-A, PDGF-B, PDGFR alpha and beta. In<br />

dystrophic muscle, PDGF-A, PDGF-B, PDGFR alpha<br />

and PDGFR beta were strongly immunolocalized in the<br />

regenerating muscle fibers and infiltrating macrophages.<br />

PDGFR alpha was also immunolocalized at the muscle<br />

fibers sarcolemma and endomysial connective tissue. The<br />

most significant finding in this study was a remarkable<br />

over-expression of PDGFR beta in the endomysium in<br />

DMD and CMD muscles. Double immunolabeling<br />

revealed that activated interstitial fibroblasts were clearly<br />

positive for PDGFR beta. These findings indicate that<br />

PDGF and its receptors have an important role in the<br />

proliferation of fibroblasts, which leads to muscle fibrosis<br />

in DMD and CMD. They also have role in muscle fiber<br />

regeneration and signaling at neuromuscular junctions in<br />

normal and diseased muscle.


Abstracts 401<br />

FO-9-5<br />

A novel autosomal dominant hereditary motor and<br />

sensory neuropathy with intermediate conduction<br />

velocities in six children<br />

Y. Pan a , F.P. Thomas a,b , F. Gondim a , L.J. Kinsella a , M. Al-<br />

Lozi c , J.A. Antenor a , T.J. Geller a , S.S. Scherer d ,P.De<br />

Jonghe e , V. Timmerman e<br />

a Department of Neurology, Saint Louis <strong>University</strong> School of<br />

Medicine, St. Louis, MO, USA; b St. Louis Veterans Administration<br />

Hospital, Institute for Molecular Virology, Department<br />

of Molecular Microbiology and Immunology, Saint<br />

Louis <strong>University</strong>; c Department of Neurology, Washington<br />

<strong>University</strong>, St. Louis, MO, USA; d Department of Neurology,<br />

<strong>University</strong> of Pennsylvania Medical Center, Philadelphia,<br />

PA, USA; e Peripheral Neurology Group, Department of<br />

Neurology and Molecular Genetics, <strong>University</strong> of Antwerpen,<br />

Antwerpen, Belgium<br />

Charcot-Marie-Tooth disease (CMT) encompasses multiple<br />

heterogeneous hereditary neuropathies linked to numerous<br />

genetic loci and genes. We diagnosed CMT in five girls<br />

and one boy, ages 5–14, among 20 children from a fourgeneration<br />

family with a novel genotype and phenotype.<br />

Walking age was normal; disease onset was in the 1st decade.<br />

The central and autonomic nervous systems and cranial<br />

nerves were uninvolved. Heel walking was impaired in<br />

five; otherwise strength was normal. Tremor was present in<br />

four, distal atrophy in one. Hyporeflexia was present in three.<br />

Sensation was impaired in five. Romberg sign, nerve enlargement<br />

and foot deformities were absent. Neurophysiologic<br />

studies were normal in two children (ages 5 and 9). One child<br />

(age 7) had borderline sural nerve conduction velocities<br />

(NCV, m/s) of 41; a 2nd (age 8) had abnormal NCVs of 42<br />

(peroneal), 39 (tibial) and 40 (sural); a 3rd (age 10) had a<br />

borderline motor peroneal amplitude; a 4th (age 14) had<br />

NCVs of 45 (median), 32 (peroneal) and 37 (tibial), low<br />

sensory nerve action potential amplitudes and distal muscle<br />

denervation. No peripheral myelin protein 22, myelin protein<br />

zero, connexin-32, early growth response gene 2, or neurofilament<br />

light chain gene mutations were found. Linkages to<br />

the CMT1A, CMT1B, CMT1D, CMT2A, CMT2D, CMT2E,<br />

CMT2F loci and the intermediate NCV loci on chromosomes<br />

19p12–p13.2 and 10q24.1–q25.1 were excluded. A genomewide<br />

search is in progress. This study describes the clinical,<br />

electrical and genetic features of a novel, axonal and demyelinating<br />

autosomal dominant polyneuropathy with intermediate<br />

NCV; a new gene locus is likely.<br />

FO-9-6<br />

The value of serum neuron specific enolase and SPECT<br />

rCBF imaging in children with status epilepticus<br />

Y. Ouyang, Q. Peng, F.-G. Mu<br />

Sichuan Provincial Hospital, No32, first ring road in<br />

western, Chengdu, China<br />

Objective: To explore the value of serum neuron specific<br />

enolase (NSE) and SPECT rCBF imaging in the evaluation<br />

of brain injury of SE in children. Methods: Serum NSE was<br />

detected through ABC-ELISA method. Serum NSE was<br />

performed in 28 status epilepticus within 24 h after seizure<br />

attacks, and in 40 normal controls. Ten of SE cases had<br />

serum NSE detection at 1, 3 and 7 days. SPECT rCBF<br />

imaging was performed in 15 of status epilepticus. Results:<br />

The mean serum NSE in SE patients was 15.13 ^ 6.22 mg/l,<br />

which was higher than that of normal controls(mean<br />

2.635 ^ 0.765 mg/l, P , 0:001); the serum NSE returned<br />

to normal at 7th day and these children’s long-term outcome<br />

was better. The SPECT rCBF imaging abnormal rate in 15<br />

SE was 73.4%. In SE patients with acute etiological factors,<br />

rCBF abnormal region was larger than those with chronic<br />

etological factors. Conclusion: Status epilepticus in children<br />

can cause brain injury. The serum NSE is a reliable marker<br />

of brain injury. Observation of serum NSE may predict<br />

long-term neurological outcome. SPECT rCBF imaging<br />

abnormalities in childhood status epilepticus might be of<br />

help in the evaluation of brain injury. Therefore, serum<br />

NSE and SPECT rCBF imaging in children with SE may<br />

be very useful to assess the degree brain injury and longterm<br />

outcome.<br />

FO-10<br />

Neuroimaging (2)<br />

FO-10-1<br />

Variability in clinical and neuroimaging presentation in<br />

congenital bilateral perisylvian polymicrogyria (CBPP)<br />

in pediatric patients<br />

R.M. Valério, F.N. Arita, S. Rosemberg<br />

Neuropediatrics Division, Department of Pediatrics, Santa<br />

Casa de Sao Paulo Medical School, Sao Paulo, Brazil<br />

CBPP refers to a clinicopathological syndrome characterized<br />

by a particular type of neuronal migratory disorder<br />

easily detected through MRI. The most frequent clinical<br />

signs include dysarthria, abnormal tongue movements,<br />

dysphagia, pyramidal signs, epilepsy and mental retardation.<br />

We report ten patients calling attention to the variability<br />

of clinical presentation and MRI findings in CBPP.<br />

There were five males and five females. There were no<br />

familial cases. The pregnancy was uneventful in eight.<br />

Toxoplasmosis was detected and treated during the 4th<br />

month of pregnancy in one case and in the remaining, the<br />

mother was drug addicted. Age at first consultation ranged<br />

from 7 months to 14 years (mean: 5.2 years). Eight patients<br />

were referred for developmental delay, one for seizures and<br />

one for speech disturbance. Four patients were microcephalic,<br />

and macrocephaly was observed in one. Three patients,<br />

all under 2 years of age were severely handycaped. Motor<br />

examination was normal in two patients. Pyramidal and/or<br />

extra-pyramidal signs were observed in the remaining five.


402<br />

Abstracts<br />

Pseudo-bulbar sings were detected in nine patients. Six<br />

patients had epilepsy whose onset varied between ages of<br />

10 months and 12 years (mean: 3.5 years). MRI revealed<br />

relatively symmetrical bilateral perisylvian polymicrogyria<br />

in nine patients and in one the alteration predominated on<br />

the right side. In addition, bifrontal periventricular nodular<br />

heterotopia, bifrontal schizencephaly, and biparietal schizencephaly<br />

were associated in three cases. In conclusion,<br />

CBPP is not a homogeneous cortical developmental malformation.<br />

It is worth mentionning that in this series of no<br />

familial cases, the incidence of intractable epilpsy was<br />

30% and CBPP may be accompanied by other disorders<br />

of cortical development.<br />

FO-10-2<br />

Attention deficit hyperactivity disorder: subtypes and<br />

1 H-magnetic resonance spectroscopic characteristics<br />

Z. Jin a , Y.-W. Zeng a , L. Sun b , G. Liu a , Y. Wang a , Y.-F.<br />

Wang b<br />

a fMRI Center, Hospital 306, Beijing, China; b Mental Institute,<br />

Peking <strong>University</strong>, Beijing, China<br />

Background: According to DSM-IV, the patients with<br />

ADHD could be divided into three clinical subtypes, those<br />

were different in demographic characteristics, functional<br />

impairment, and comorbidity with other disorders. Thus,<br />

we hypothesized that there would be different neurochemical<br />

status among the patients. Methods: Thirty-four<br />

untreated school children suffering from ADHD (inattentive<br />

subtype ADHD-IA, n ¼ 19; hyperactive/impulsive subtype<br />

ADHD-HI, n ¼ 4; combined subtype ADHD-C, n ¼ 11)<br />

were investigated by using 1 H-MRS. Spectra were acquired<br />

bilaterally in the globus pallidus. Peaks of NAA, Cho, myoinositol,<br />

glutamate and creatine (Cr) were measured and<br />

their ratios were calculated and compared with data from<br />

matched controls. Results: All three subtypes showed significant<br />

decreased NAA/Cr ratios comparing with normal<br />

controls. Among them the ADHD-C subtype had the lowest<br />

NAA/Cr value. ADHD-IA and ADHD-C subtypes appeared<br />

mild increased Cho/Cr ratios, while the value in ADHD-HI<br />

group was decreased. Conclusion: These findings suggested<br />

that striatal neuronal death or dysfunction exits in all the<br />

three ADHD subtypes. Among them ADHD-C subtype was<br />

the most severe one. There seemed to be a mild hyperactivity<br />

of the cholinergic system in ADHD-IA and ADHD-C<br />

subtypes, but not the ADHD-HI subtype.<br />

FO-10-3<br />

Single photon emission computed tomography (SPECT)<br />

in attention deficit hyperactivity disorder (ADHD) –<br />

baseline and post intervention<br />

S. Gulati a , V. Kalra a , C.S. Bal b , H. Zamir a<br />

a Departments of Pediatrics and Nuclear Medicine; b All<br />

India Institute of Medical Sciences, New Delhi, India<br />

Background: ADHD is a common childhood neurobehavioral<br />

disorder. Objective: To study the cerebral perfusion<br />

abnormalities in children with ADHD. Materials and methods:<br />

A randomized double blind placebo controlled trial to<br />

evaluate the efficacy of a polyherbal formulation, Mentat<br />

(Bacopa monnieri, Withania somnifera, Centella asiatica,<br />

Nardostachys jatamanasi) in 60 children with ADHD<br />

(DSM IV criteria). Subjects were randomised into Mentat<br />

(30) and placebo groups (30). Cerebral perfusion was evaluated<br />

using 99mTc ethyl cystine dimer brain SPECT in a<br />

subset of 37 children whose parents gave consent. SPECT<br />

images were acquired using a dual-headed gamma camera<br />

system with fan beam – collimator (Elscint varicans).<br />

SPECT scans were performed at baseline (37) and if abnormal<br />

(26), repeat at 6 months. Consent for post intervention<br />

repeat scan was obtained in 12/26 with abnormal SPECT.<br />

Results: Thirty-seven ADHD children age range 5–14<br />

years, boys predominated (30). Abnormal cerebral perfusion<br />

was seen in 26/37 (70.2%) (P ¼ 0:006). Twenty-four/<br />

37 (64.8%) had hypoperfusion in thalamus and/or basal<br />

ganglia. Two had temporal and basifrontal hypoperfusion<br />

respectively. Among 12 follow up scans, decoding at the<br />

end of the trial revealed six from either group. In Mentat<br />

group 3/6 (50%) showed post treatment normalization of<br />

perfusion abnormality versus 1/6 (16.6%) in placebo group<br />

(P ¼ 0:11). Conclusions: A statistically significant proportion<br />

of children with ADHD had thalamic and/or basal<br />

ganglia hypoperfusion. The area identified may help to<br />

understand the anatomic substrates in this entity. SPECT<br />

abnormalities may in future be used to evaluate and monitor<br />

therapy outcomes in ADHD.<br />

FO-10-4<br />

Correlation of long-term intellectual and<br />

neuropsychological effects of closed head injury in<br />

infants and children using proton MR spectroscopy<br />

S. Ashwal, B.A. Holshouser, T. Brenner, M.C. Freier, T.<br />

Burley<br />

Radiology and Psychology, Departments of Pediatrics,<br />

Loma Linda <strong>University</strong>, Loma Linda CA, USA<br />

The ability to predict long-term neurologic and neuropsychological<br />

outcome in 22 children, ages 1 week to 14<br />

years at the time of closed head injury (CHI), were investigated<br />

using proton magnetic resonance spectroscopy<br />

(MRS) acquired post injury and compared to standardized<br />

neurologic, intellectual, and neuropsychological testing<br />

done 1–7 years later. Clinical indicators of acute injury<br />

severity including age at injury, electroencephalography,<br />

MRS variables of NAA/Cho, Cho/Cre, and lactate presence<br />

accurately classified children as functioning above or<br />

below the average range for most outcome measures.<br />

Combined clinical and MRS variables accounted for<br />

approximately 50% of the variance in cognitive and<br />

neuropsychological outcome confirming the validity of


Abstracts 403<br />

their predictive use. Of the injury severity indictors,<br />

presence of lactate is a particularly important prognostic<br />

marker of poor long-term intellectual and neuropsychological<br />

functioning. Our findings indicate the potential for<br />

providing accurate estimates of long-term intellectual and<br />

neuropsychological functioning after CHI in infants and<br />

children using proton MRS in combination with clinical<br />

variables.<br />

FO-11<br />

Morphogenesis<br />

FO-11-1<br />

Partial trisomy 16 mice model for Down syndrome: an<br />

analysis of brain morphology and physiology<br />

P. Belichenko a , A. Kleschevnikov a , E. Masliah b ,W.<br />

Mobley a<br />

a Department Neurology and Neurological Science, Stanford<br />

<strong>University</strong> Medical Center, Stanford; b School of Medicine,<br />

UCSD, La Jolla, USA<br />

Partial trisomy 16 mice (Ts65Dn) are a genetic model<br />

for Down syndrome. The medial and lateral septum, fascia<br />

dentata (FD), CA1 area of hippocampus, motor and somatosensory<br />

cortices were studied. Sections for confocal<br />

microscopy were immunostained for synaptophysin (p38),<br />

or were examined after neuronal microinjection with Lucifer<br />

yellow. Electrophysiological experiments were<br />

performed on hippocampal slices. Relative to controls,<br />

the area of p38-IR was significantly increased in cortex,<br />

hippocampus, FD and medial septum of Ts65Dn mice at 21<br />

days, 3, 6 and 16 months of age. In granule cells of FD, the<br />

number of dendritic spines was decreased in Ts65Dn mice<br />

at 21 days, 3 and 6 months of age. In Ts65Dn mice, spine<br />

head area was significantly increased while the length of<br />

spine neck was decreased. In all areas investigated in<br />

Ts65Dn mice, EM showed enlarged and tortuous neurites<br />

with abundant electrodense, laminated bodies and occasional<br />

synaptic vesicles and spines were distended with<br />

vacuolization of the endomembrane system. There was a<br />

defect in induction of long-term potentiation (LTP) of the<br />

perforant path input to the FD in Ts65Dn mice: LTP was<br />

suppressed at 45–60 min after the first tetanus. Furthermore,<br />

paired-pulse depression of the population spike<br />

observed in FD was significantly stronger in the Ts65Dn<br />

mice, suggesting enhanced efficiency of the feed-back inhibitory<br />

system. Our data show dramatic changes in both<br />

morphology and function of synapses in Ts65Dn mice.<br />

The defects are seen in both developing and mature<br />

Ts65Dn mice. Further studies are required to show whether<br />

or not these abnormalities are also present in the brain of<br />

Down syndrome patients. Supported by NIH grants<br />

AG16999 and NS38869.<br />

FO-11-2<br />

Clinical spectrum of holoprosencephaly: a clinicalneuroradiologic<br />

analysis<br />

J.S. Hahn, L.L. Plawner, M. Delgado, V. Miller, E. Levey,<br />

S.L. Kinsman, A.J. Barkovich, E. Simon, N. Clegg, V.<br />

Sweet, E. Stashinko<br />

Stanford <strong>University</strong> School of Medicine, Department of<br />

Neurology, Stanford, Texas Scottish Rite Hospital, Dallas,<br />

Kennedy Krieger Institute, Baltimore, <strong>University</strong> of California<br />

San Francisco, San Francisco, Children’s Hospital of<br />

Philadelphia, PA, USA<br />

Holoprosencephaly (HPE) is a brain malformation that<br />

results from incomplete cleavage of the prosencephalon<br />

into two hemispheres. We evaluated 68 children with HPE<br />

with history, developmental assessment, and physical examination.<br />

Neuroimaging studies were assessed for the grade of<br />

HPE (from least to most severe: lobar, semilobar, and<br />

alobar), the degree of non-separation of the deep gray nuclei,<br />

and presence of dorsal cyst or cortical malformation. In<br />

general, the severity of clinical problems and neurological<br />

dysfunctions paralleled the grade of HPE. Dystonia was<br />

correlated with the degree on non-separation of the caudate<br />

and lentiform nuclei, as well as, the grade of HPE (P , 0:05).<br />

Hypotonia was correlated with the grade of HPE (P , 0:05).<br />

Mobility, upper extremity function, and language were all<br />

significantly correlated with the degree of non-separation of<br />

the caudate, lentiform, and thalamic nuclei and grade of HPE<br />

(P , 0:01). Seizures occurred in approximately half of the<br />

children with HPE. The presence of cortical malformation<br />

was associated with seizures that were difficult to control.<br />

Endocrinologic dysfunction was noted in 72% of the patients<br />

with all having at least diabetes insipidus. The severity of<br />

endocrine abnormality correlated with the degree of<br />

hypothalamic non-separation (P ¼ 0:029). There was a<br />

correlation between the severity of the facial malformation<br />

and the grade of HPE (P ¼ 0:032), but there were many<br />

exceptions. In conclusion, this study shows that by combining<br />

the detailed neuroradiologic features of HPE with clinical<br />

assessments, we were able to develop a more accurate classification<br />

scheme for predicting outcome and clinical<br />

problems.<br />

FO-11-3<br />

Role of intrauterine infection for the pathogenesis of<br />

epilepsy in children at the early stage of life<br />

S.A. Gulyaev, A.A. Ovchnnickova, S.E. Gulyaeva, I.V.<br />

Archipenko, L.V. Viborova<br />

Vladivostok State Medical <strong>University</strong>, Vladivostok, Russia<br />

Distinctive clinical signs of epilepsy in 79 children at the<br />

age up to 5 years born from mothers infected by sexual<br />

relations and having high percentage of miscarriages, stillborn<br />

fetus, pathology in pregnancy and delivery were


404<br />

Abstracts<br />

studied. It was found that among all examined children 71%<br />

of babies were carried to full term, 57% had signs possibly<br />

due to intrauterine hypoxia, or perinatal asphyxia, 73.4%<br />

had signs of intrauterine infection, and 16.5% had slight<br />

traumatic destruction (of the nervous system). At the early<br />

neonatal period incidence of epilepsy reached 27.5%.<br />

Among all kinds of epilepsy generalized form was prevalent<br />

(63.6%). Hemangioma was found in 45.5%, and subarachnoidal<br />

hemorrhage – in 41.4%. Central nervous system<br />

symptoms were observed only in 1/3 of all patients at this<br />

stage. No further information was obtained. The pathological<br />

lesion at the early years of life was most precisely<br />

recorded by neurosonography that was useful to see changes<br />

of brain structure (77.3%). The findings were characterized<br />

as a stable increase of echodensity in parenchyma in 17.6%,<br />

and as inborn defects of brain structure development in<br />

5.8%. This research demonstrated not only early clinical<br />

signs of epilepsy in children born to mothers infected by<br />

sexual relations but also severe pathology with changes in<br />

the brain structure caused by infectious agents, influencing<br />

the nervous tissue. We conclude that prevention of brain<br />

pathology in these prenatally affected children is an urgent<br />

issue in child neurology.<br />

FO-11-4<br />

Epileptic chromosomopathies: epileptic syndromes of<br />

childhood due to chromosomal disorders<br />

P.A. Hwang, L. Chen, J. Shaw, P. Wyatt<br />

Departments of Paediatrics and Genetics, North York<br />

General Hospital, Bloorview Epilepsy Research Program,<br />

<strong>University</strong> of Toronto, Toronto, Canada<br />

A retrospective review of over 1500 patients in a community-based<br />

practice revealed about 2% of children with chromosomal<br />

disorders, detected by karyotype, fluorescent in-situ<br />

hybidization (FISH), methylation studies or specific DNA<br />

probes. In addition to the usual trisomy 21 in Down syndrome,<br />

two had balanced Robertsonian translocation, 15 had Angelman<br />

Syndrome, with and without deletions at 15q11–12 loci,<br />

ten had Rett syndrome and one each had Smith-Magenis with<br />

17p and Wolff-Hirschorn with 4p deletions respectively. The<br />

clinical features were quite characteristic although not specific:<br />

dysmorphic features, developmental delay, and multiple<br />

seizure types: partial and generalized, often refractory to antiepileptic<br />

drugs. The EEGs were variable: disorganized background<br />

activity, multifocal epileptiform discharges, and<br />

characteristic features in certain syndromes: central spikes,<br />

pseudoperiodic discharges of Rett syndrome, and stimulussensitive<br />

central-parietal spikes of Angelman syndrome.<br />

Certain chromosomal disorders have a high risk of epileptic<br />

seizures: Angelman (but not Prader-Willi), Rett and Wolff-<br />

Hirschorn, but not Prader-Willi, Smith-Magenis or Down<br />

syndrome. Only in the Angelman syndrome does the deletion<br />

at 15q11–12 involve GABA-A receptor subunit loci and may<br />

be considered to constitute an epileptic chromosomopathy.<br />

FO-12<br />

Genopathies<br />

FO-12-1<br />

The frequency of common mutations among patients<br />

with mucopolysaccharidosis types I, II and IIIA<br />

diagnosed in Austria over the last 17 years<br />

Th. Kroepfl, K. Paul, B. Plecko, E. Paschke<br />

<strong>University</strong> of Graz, Department of Pediatrics, Graz, Austria<br />

The MPS are a hereditary, clinically heterogeneous group<br />

of 11 disorders caused by the deficiency of lysosomal<br />

enzymes involved in mucopolysaccharide catabolism.<br />

Their phenotypes include growth retardation, dysostosis,<br />

enlargement of visceral organs, progredient psychomental<br />

retardation and reduced life span. In populations originating<br />

from Northern European and Anglo-American countries,<br />

three enzyme defects comprise the majority of cases,<br />

namely a-l-iduronidase, MPS I, iduronate-2-sulphatase,<br />

MPS II, and heparan N-sulphatase, MPS IIIA. Several mutations<br />

have been shown to be common among European<br />

cases and genotyping has become essential for genetic counselling<br />

and possible prediction of clinical phenotype. Therefore,<br />

we started to define the genotype of all cases diagnosed<br />

enzymatically in Austria between the years 1983–2000.We<br />

initially tested 66 cases for common mutations in MPS I, II<br />

and IIIA. Similar to other European countries the majority<br />

of cases were MPS I (23), MPS II (21) and MPS IIIA (22).<br />

Taken together, the frequency of common mutations in<br />

MPS I and IIIA among patients diagnosed in Austria was<br />

found to be slightly below the average distribution found in<br />

other European countries with a reversed ratio of the<br />

frequency of the main common mutations Q70X and<br />

W402X in MPS I. Moreover, S66W, a mutation common<br />

in Italian populations, was found to be unexpectedly<br />

frequent in MPS IIIA. The methods for the discovery of<br />

these mutations are simple and reliable. We therefore<br />

suggest that W402X and Q70X in MPS I as well as R74C,<br />

R245H and S66W in MPS IIIA should be assayed routinely<br />

after identification of the enzyme defect. This would help to<br />

avoid time-consuming cell cultivation procedures and thus<br />

be helpful in situations of late amniocentesis.<br />

FO-12-2<br />

Spectrum of mutations and phenotype/genotype<br />

correlations in muscle-eye-brain (MEB), another defect<br />

of glycosylation<br />

H. Pihko, C. Diesen, J. Dieguez-Lucena, W. Dobyns, P.<br />

Santavuori, A.-E. Lehesjoki<br />

Hospital for Children and Adolescents, HUS, Helsinki, and<br />

Department of Medical Genetics, <strong>University</strong> of Helsinki,<br />

Finland<br />

MEB disease is a recessively inherited disorder charac-


Abstracts 405<br />

terized by a severe brain malformation, ocular abnormalities<br />

and muscular dystrophy. The disease was first described in<br />

Finland 20 years ago, but after the localization of the gene to<br />

1p32, we have been able to identify MEB-patients from<br />

several countries around the world. Although the clinical<br />

severity of MEB is more variable than previously thought,<br />

we were able to exclude patients with Walker-Warburg<br />

syndrome from the MEB locus, thus showing that these<br />

two disorders are caused by different genes. The defective<br />

gene, O-mannose b-1,2-N-acetylglucosaminyl transferase<br />

(POMGnT1), places the disease into the increasing group<br />

of inherited disorders of glycosylation. We have analyzed<br />

mutations of POMGnT1 in Finnish as well as in patients<br />

from different nationalities. So far, one mutation, G to A at<br />

position 5750, has been found in 18 Finnish patients studied.<br />

The results of this mutation analysis as well as genotypephenotype<br />

correlations will be presented.<br />

FO-12-3<br />

Septo-optic dysplasia: a new phenotype associated with a<br />

heteroplasmic mutation in the mitochondrial<br />

cytochrome B gene<br />

M. Schuelke a , H. Krude b , B. Finckh c , E. Mayatepek d ,J.<br />

Smeitink e<br />

a Department of Neuropediatrics, b Department of Pediatric<br />

Endocrinology, Charité <strong>University</strong> Hospital, Berlin,<br />

Germany; c Children’s Hospital, <strong>University</strong> of Hamburg,<br />

Germany; d Division of Metabolic and Endocrine Diseases,<br />

<strong>University</strong> Children’s Hospital, Heidelberg, Germany; e Nijmegen<br />

Center for Mitochondrial Disorders at the Department<br />

of Pediatrics, <strong>University</strong> Medical Center, Nijmegen,<br />

The Netherlands<br />

Septo-optic dysplasia (de Morsier syndrome, MIM<br />

182230) is characterized by hypoplasia of the optic nerve,<br />

agenesis of the septum pellucidum, and hypothalamic<br />

dysfunction. The most frequent endocrine defect is growth<br />

hormone deficiency. Most cases occur spontaneously and<br />

their genetic basis is unknown. Recently a missense mutation<br />

in the homeobox gene HESX1 was detected in one familial<br />

case. Here we present a patient in whom a mutation in HESX1<br />

was excluded but in whom we detected an isolated respiratory<br />

complex III-deficiency due to a new heteroplasmic<br />

mutation (14849T . C) in the mitochondrially encoded<br />

cytochrome b gene. The 25-year-old patient suffered from<br />

septo-optic dysplasia, retinitis pigmentosa, lactic acidosis,<br />

exercise intolerance, hypertrophic cardiomyopathy and<br />

rhabdomyolysis. The mutation causes a replacement of the<br />

serine35 by proline at the ubiquinone (Q i ) binding site. This<br />

interrupts the electron flow from complex II to cytochrome c.<br />

Lack of ATP due to malfunction of the respiratory chain<br />

could explain the exercise intolerance and lactic acidosis<br />

but not the septo-optic dysplasia or the retinitis pigmentosa.<br />

The latter condition hints to free oxygen radicals as putative<br />

pathogenic agents. A low a-tocopherol concentration in the<br />

muscle, a reduced total radical trapping parameter of the<br />

plasma and an increased excretion of leukotriene E 4 in the<br />

urine are compatible with increased reactive oxygen species<br />

(ROS)-generation. Morphogenesis of the brain demands a<br />

fine tuning between proliferation and apoptosis. We hypothesize<br />

that in our patient a disturbance of this balance due to<br />

increased ROS-concentration and a subsequent increase in<br />

apoptosis might have resulted in deranged fetal brain development<br />

such as seen in septo-optic dysplasia.<br />

FO-12-4<br />

Identification of the genetic defect in an Asian-Indian<br />

community with megalencephalic leukoencephalopathy<br />

and cysts<br />

B.S. Singhal a , E.P. Hoffman b , F.-F. Wu b , D. Stephan b ,S.<br />

Naidu c , R. Gorospe b<br />

a Bombay Hospital, Department of Neurology, Institute of<br />

Medical Science, Medical Research Center, Bombay,<br />

India;<br />

b Children’s National Medical Center, Research<br />

Center for Genetic Medicine, Washington, DC; c Kennedy<br />

Krieger Institute/Johns Hopkins Medical Institute, Division<br />

of Neurology and Pediatrics, Baltimore, MD, USA<br />

We screened the entire coding region of the MLC1 gene in<br />

a group of 23 unrelated Asian Indian patients from one ethnic<br />

group-Agarwals-who presented with a clinical syndrome<br />

characterized by early-onset megalencephaly, leukoencephalopathy<br />

with cysts, progressive spasticity, seizures, and<br />

learning problems. The majority of the patients (22/23, 96%)<br />

were homozygous for an insertion of cytosine in exon 2<br />

between nucleotides 250 and 251, indicative of a recessive<br />

disorder with a founder effect. One patient (1/23, 4%) was<br />

homozygous for C585A; however, he was adopted and<br />

parental details were unknown. Despite the commonality<br />

of the gene defect in this ethnic group, there was significant<br />

phenotypic variability indicative of possible environmental<br />

factors or individual genetic background as contributors.<br />

These novel mutations in MLC1 gene indicate that this clinical<br />

syndrome among Asian Indian Agarwals is the same as<br />

that among Turkish and European patients. Individuals from<br />

this Indian community live in various parts of the world.<br />

When a patient from this ethnic group presents with the<br />

above-mentioned clinical and neuroimaging features, mutations<br />

in the MLC1 gene should be sought.<br />

FO-13<br />

Higher Cortical Functions<br />

FO-13-1<br />

Reactus: a new cognitive function diagnostic device<br />

B. Scott, S. Freiger, J. Rehrmann<br />

Trifolium, ideas and solutions, Kassel, Germany<br />

The ‘Reactus’ consists of integrating medical test proce-


406<br />

Abstracts<br />

dures into a comprehensive system where visual reaction,<br />

audio reaction, psycho-motor abilities, visual-motor coordination,<br />

attentiveness and concentration are examined. The<br />

doctor will be able to analyze the cognitive function of<br />

children and adults in a 5-min test procedure and the results<br />

can be printed in an easy to understand graph. The Reactus<br />

evaluates various abilities of an individual including: *starting<br />

reflex, *surprise reactions, *visual and auditory reaction,<br />

*visual and auditory differentiation, *visual and auditory<br />

reliability, *constancy of reactions, *attentiveness,<br />

*concentration, *strategy, *psycho-motor abilities,<br />

*visual-motor coordination, *short-and long-term endurance.<br />

The user-friendly software can enable the doctor to<br />

perform further analysis using SPSS data. Researches in the<br />

field of ADHD, LD, Turner, diabetes mellitus, effects of<br />

medicine and very low birth weight (VLBW) had been<br />

performed in Japan (National Children’s Hospital Tokyo,<br />

Teikyo <strong>University</strong>, Saitama Municipal General Center,<br />

Tokyo Metropolitan <strong>University</strong> of Health Sciences, Jichi<br />

Medical <strong>University</strong> and Tokyo Gakugei <strong>University</strong>); in<br />

China (Hua Shan Hospital, Shanghai); in Germany (Leipzig<br />

<strong>University</strong>). All doctors are connected via the Internet and<br />

the research activities were printed in a bi-monthly email-<br />

Newsletter. The results of Reactus display a more specific<br />

picture about the abilities of children and adults.<br />

FO-13-2<br />

Environmental mercury exposure in children with<br />

autistic spectrum disorder (ASD): A case-control study<br />

P. Ip, H.K. Ho, J. Lee, W. Wong, V. Wong<br />

Division of Neurodevelopmental Paediatrics, Department<br />

of Paediatrics, Queen Mary Hospital, The <strong>University</strong> of<br />

Hong Kong, Hong Kong SAR, China<br />

Objective: To study whether there is any increased<br />

environmental mercury exposure in children with ASD.<br />

Methods: A cross-sectional study was performed from<br />

April to September, 2000. Simultaneous hair and blood<br />

mercury levels were analysed in 2 groups of children: (i)<br />

ASD; and (ii) control. A questionnaire on sociodemographic<br />

data, dietary habits and other risk factors for environmental<br />

mercury exposure was completed. Results:<br />

Altogether 82 autistic (aged 7.2 years) and 55 normal children<br />

(aged 7.8 years) were recruited. There was no difference<br />

in the mean hair mercury level of autistic group (2.3<br />

ppm) as compared with control group (mean 2.1 ppm)<br />

(P ¼ 0:79). The mean blood mercury level of autistic<br />

group (19.5nmol/l) compared to control group (14.7<br />

nmol/l) (P ¼ 0:056). The mean hair mercury level in<br />

both groups of children (n ¼ 137) was 2.2 ppm, even<br />

higher than the levels of adults in Europe (1.2 ppm) and<br />

U.S. (1.5 ppm). Hair mercury levels correlated well with<br />

blood mercury levels in our children (r ¼ 0:88). The<br />

frequency of fish consumption was the only independent<br />

variable correlated with hair (r ¼ 0:51) and blood<br />

(r ¼ 0:54) mercury levels. For those children who<br />

consumed fish more than three times per week, their hair<br />

and blood mercury levels were twice than those who<br />

consumed fish less than three times per week and three<br />

times of those who never consumed fish. Five autistic children<br />

had toxic blood mercury levels (.45 nmol/l). Their<br />

family members were screened and half of them also had<br />

toxic mercury levels. However, some had features of<br />

mercury poisoning. The mean blood mercury level of<br />

those with mercury intoxication dropped from 70.5 to<br />

26.8 nmol/l (P ¼ 0:0001) after reducing fish consumption<br />

for 3 months. Conclusions: There was no significant difference<br />

in the hair and blood mercury levels between autistic<br />

and normal children. All our children had high hair<br />

mercury levels which correlated well with blood mercury<br />

levels. Frequency of fish consumption correlated with hair<br />

and blood mercury levels in Hong Kong children. Thus<br />

there is an overall increased risk of environmental mercury<br />

exposure.<br />

FO-13-3<br />

A study to use modern IT device in facilitating written<br />

communication of children with developmental dyslexia<br />

C.W. Chan, K.Y. Cheng, C.C. Lam, T.F. Ho, C.K. Leong<br />

Working Party on Specific Learning Disabilities (SLD), The<br />

Hong Kong Society of Child Neurology and Developmental<br />

Paediatrics (HKCNDP), China<br />

The aim of this study was to explore the feasibility and<br />

effectiveness of using Cantonese speech-to-text input technology<br />

as a tool for dictating Chinese characters into word<br />

processing applications in facilitating written communication<br />

of children with dyslexia. Fourteen Hong Kong children<br />

with dyslexia, aged 9–14, and three without dyslexia,<br />

aged 10–15, were trained. In the six training sessions, participants<br />

were familiarized with the use of the input device<br />

and guided to personalize the associated speech template,<br />

input specially designed reading texts into the computer,<br />

and complete two oral pictorial composition exercises.<br />

These sessions were conducted with the help of parents<br />

and volunteer workers. Usefulness of the technology was<br />

evaluated with regard to both the written product and to<br />

process factors. Participants’ written output was analyzed<br />

for recognition accuracy rate for different types of writing<br />

tasks. Through analysis of structured feedback from helper<br />

observations, parent questionnaires, and interviews, difficulties<br />

encountered and factors noted to contribute to<br />

success in the training and trial processes were studied.<br />

Results indicated high individual variability in the effectiveness<br />

of using this tool. Implications for the improvement<br />

of this Cantonese speech-to-text technology as well<br />

as its potential application for facilitating the learning of<br />

children with dyslexia at home and school will be<br />

discussed.


Abstracts 407<br />

FO-13-4<br />

The ‘learning brain’ and environment: Pavlovian<br />

philosophy<br />

K.B. Kulkarni<br />

Sanjivani Nursing Home, Gwalior (M.P.), India<br />

The ‘learning brain’ and environment implies unity of<br />

organism and its social and ecological environment which<br />

becomes manifest during the early phase of neuropsychic<br />

development of a growing child. This has important applications<br />

in neonatology, developmental Pediatrics, disorders<br />

of affect, even environmental Pediatrics. Interrelationships<br />

between body and environment are realised through conditioned<br />

reflexes which by perseverence and practice can be<br />

transformed into instinctive, even herd reflexes (genetic<br />

transmission). Relationship between interoceptors from<br />

viscera and exteroceptors from environment is inseparable.<br />

We must appreciate the claims put on newborn CNS by<br />

adjustment to environmental influences. The newborn<br />

cortex is under protracted protective inhibition resulting in<br />

continuous sleep. Powerful stimuli for conditioned reflexes<br />

inducing sleep are fresh air or breeze, quiet environment,<br />

certain body positions, light clothing and even mother’s<br />

sweet song or words. Even the experimental model of cat<br />

newborn for studying the ontogenesis of breast feeding<br />

related behaviour draws parallels from Pavlovian ethos<br />

which has great bearing on the human situation of breast<br />

feeding. Principal Pavlovian idea is the process of ‘imprinting’<br />

which answers ‘No’ for the question: should parents<br />

prevent children from being exposed to life’s dangers and<br />

difficulties? Pavlov’s observations lay the ground work for<br />

this by observing behaviour of animal newborns under<br />

adverse circumstances. Birdies under comfortable environment<br />

loath to build nests later. Pavlov further thought that<br />

Nature has worked out detailed programme of behaviour for<br />

each animal species including Man but has consciously left<br />

numerous gaps to be filled by ‘imprinting’ –a form of<br />

conditioned reflex activity.<br />

FO-13-5<br />

Conversion disorder: under diagnosed? Over<br />

investigated?<br />

P.M. Leary<br />

Bristol Royal Hospital for Children, Bristol, United Kingdom<br />

The term ’conversion disorder’ (DSM-IV) is applied<br />

when symptoms and deficits involving voluntary motor<br />

and sensory function suggest a neurological or other physical<br />

condition, which in fact is not present. In Britain and<br />

almost certainly elsewhere as well such cases are regularly<br />

encountered by paediatric neurologists and place significant<br />

demand on consulting time and diagnostic resources. The<br />

widely diverse manner in which organic neurological disorder<br />

may present creates a dilemma in the diagnosis and<br />

management of conversion disorders. While there is real<br />

need to exclude organic disease the thoroughness with<br />

which this is often done may strengthen patient and parental<br />

conviction that there must be a physical explanation for the<br />

symptoms. Management may be further complicated by<br />

anxiety about litigation, parental refusal to accept an<br />

emotional cause for symptoms, ’Gillick competent’ patient<br />

refusal to accept intervention and a community shortage of<br />

resources for treating children and adolescents with<br />

emotional problems. In this study illustrative cases are<br />

presented, diagnostic procedures reviewed, management<br />

strategies discussed and guidelines suggested.<br />

FO-13-6<br />

Trial of risperidone in children with conduct disorders<br />

A. Dayan-Nahmad, S. Mann-Shvili, A. Gonzalez-<br />

Astiazaran, M.-A. Collado-Corona, C. Martínez-Wbaldo<br />

Centro Nacional de Rehabilitación, Instituto de la Comunicación<br />

Humana, México City, Mexico<br />

Objective: To study the use of Risperidone in children<br />

with behavior dysfunctions. Method: An open-labelled<br />

prospective trial was conducted for the use of risperidone<br />

from July 2000 to December 2001 in 220 subjects with<br />

conduct disorder. A total of 112 were excluded as they<br />

received another drug or abandoned the treatment. Thus,<br />

108 (80 boys, 28 girls) were enrolled in the study 95 had<br />

additional language problems and 30 also had hypoacusia.<br />

The ages were 2–13.11 years. Patients were seen monthly<br />

throughout the trial. Risperidone was increased at monthly<br />

intervals with an initial dose of 0.027 mg/kg per day,<br />

depending on symptom control. Results: Risperidone was<br />

associated with clinical improvement at a dose of 0.027–<br />

0.15 mg/kg per day. Almost all patients showed minor<br />

adverse effects, (initial drowsiness and weight gain).<br />

None-developed extrapyramidal side effects. Conclusions:<br />

These data provide preliminary evidence that risperidone<br />

efficacy in the treatment of conduct disorders in children.<br />

FO-14<br />

Treatment<br />

FO-14-1<br />

Effect of topiramate on body mass index and<br />

hyperphagic behaviour of morbid obese children, after<br />

brain tumour treatment<br />

C.E. Catsman-Berrevoets a , E.L.T. Van den Akker b , F.K.<br />

Aarsen a , S.L.S. Drop b<br />

a Departments of Child Neurology and 2 Child Endocrinology,<br />

<strong>University</strong> Hospital Rotterdam/Sophia Children’s<br />

Hospital, Rotterdam, The Netherlands<br />

Reduced appetite and weight loss were found in clinical


408<br />

Abstracts<br />

trials of topiramate for epilepsy. In children treated for brain<br />

tumour and especially craniopharyngioma hyperphagia and<br />

therapy resistant morbid obesity frequently occurs. In a pilot<br />

study we explored the effectiveness and the tolerability of<br />

topiramate in children with obesity, after treatment of brain<br />

tumour. We evaluated the response after 3, 6 and 12 months<br />

of treatment with topiramate up to 7 mg/kg per day. Eating<br />

behaviour, weight, effect on hypothalamic dependent<br />

hormones and neuropsychological side effects were evaluated.<br />

Two boys and four girls (aged 8.7–17.2 years) with a<br />

BMI 2.75–4.4 SD above the age related were included. Five<br />

had been treated for craniopharyngeoma, one for primitive<br />

neuroectodermal tumor (PNET). After starting topiramate<br />

treatment, at doses ranging from 2.7 to 3.7 mg/kg per day<br />

parents of all five children reported a marked reduction of<br />

the obsessive hyperphagia. On the child behavioural checklist<br />

they all scored better on items of self-esteem. BMI at 3<br />

months ranged from 10.15 to 3.78 (mean 21.38) in<br />

comparison to BMI at the start of the study. After 6 months<br />

BMI ranged from 11.44– 2 4.47 (mean 20.94) and after<br />

12 months from 11.36 to 24.38 (mean 20.3) with BMI at<br />

the start of the study. No important changes in blood parameters<br />

were detected. Neuropsychological evaluation in<br />

comparison to that at the start of the study mainly showed<br />

a decreased performance on tests of attention and concentration,<br />

verbal short memory, verbal sequential memory and<br />

a reduced verbal fluency. These problems started to occur<br />

with a dosage exceeding 4 mg/kg per day and were reversible.<br />

Results of this small pilot study suggest that topiramate<br />

stabilizes weight in children with morbid obesity,<br />

which have been treated for a brain tumour, but does not<br />

lead to important weight loss. Doses of topiramate exceeding<br />

4 mg/kg per day mainly have adverse, but reversible<br />

effects on performance on attention, concentration, verbal<br />

memory and verbal fluency tasks. Topiramate seems to have<br />

a positive effect on the obsessive, ‘craving’ behaviour of the<br />

child in respect to food and subsequently on feelings of selfesteem.<br />

FO-14-2<br />

Curative effect in cerebral palsy with acupoint injection<br />

of drug<br />

Q.-F. Yuan, W.-C. Nan, S.-S. Yun, H.-L. Rong<br />

Woman and Child Health Center, Shenyang, China<br />

Objective: To investigate the effect of acupoint injection of<br />

drug in children with cerebral palsy. Sixty children from 40<br />

days to 3 years were divided into two groups. Both groups<br />

adopted physical treatment, massage and other therapy. In<br />

the treatment group acupoint injection of drug was added,<br />

which included cerebral and body acupoint injection, 10-<br />

day-injection is a course. Then 10 days break, three courses<br />

consecutively. Drugs include Lizhusaile injection and<br />

dansen injection and vitamin B12, B1 and ATP. Injective<br />

acupoints on head area, feeling area and equilibrium area<br />

and so on. Clinic Curative rate in the treatment group was<br />

94.95%, clinic curative rate in the control group is 78.4%<br />

(P , 0:01). So comprehensive treatment is better than single<br />

motor treatment and reduces the treatment course.<br />

FO-14-3<br />

Effect of cerebroprotein hydrolysate injection and<br />

conductive education in children with cerebral palsy<br />

D. Wu, J.-L. Tang, D.-Y. Liu, J.-X. Wu<br />

Pediatric department, the first Hospital Affiliated to Anhui<br />

Medical <strong>University</strong>, Hefei City, China<br />

To find a new way to treat children with cerebral palsy.<br />

One hundred eighty three children with cerebral palsy, aged<br />

3 months to 5 years were divided into three groups: CHI<br />

group, conductive education (CD) group, CHI plus CD<br />

group and control group. They were followed-up for 5<br />

years. CHI was intravenously injected, 5 ml/day for 1-<br />

year-old children and 10 ml/day for children older than 1-<br />

year-old. We defined 3 months as a course of treatment. We<br />

regularly give a short course of CD for the children with<br />

cerebral palsy and their parents from May 1997. Children<br />

with cerebral palsy and their parents attended the course.<br />

Some simply training methods of CD were introduced to the<br />

parents – home conductors, and then the parents began to<br />

train the cerebral palsy children at home. The results are as<br />

follows: (1) CHI plus CD was most effective in all ways. (2)<br />

Both CHI group and CD method group were more effective<br />

than control group (P , 0:01). (3) CHI group and CD group<br />

were more effective than CD group (P , 0:05).<br />

FO-14-4<br />

Quantum neurodynamics and biofeedback efficiency in<br />

treating neurological disorders<br />

J. Pop-Jordanov a , N. Pop-Jordanova b , D. Dimitrovski a ,E.<br />

Solov’ev a , N. Markovska a<br />

a Research Center of Energy, Informatics and Materials,<br />

Macedonian Academy of Science and Arts, Skopje, Macedonia;<br />

b Department of Psychophysiology, Pediatric Clinic,<br />

Faculty of Medicine, Macedonia<br />

As a technique for learning self-control by back-reported<br />

biological signals, biofeedback is ultimately based on<br />

mental-neural information flow. All standard attempts to<br />

explain the mechanism of the subtle two-way interaction<br />

between non-material mental agencies and neural events<br />

were confronted with violation of the energy-matter conservation<br />

laws of physics. One non-classical hypothesis was<br />

defined by Eccles (Nobelist for Physiology and Medicine) in<br />

his paper with a provocative title: ‘do mental events cause<br />

neural events analogously to the probability fields of quantum<br />

mechanics?’ In this paper, the consecutive steps of<br />

biofeedback signal flow are investigated, in the light of<br />

the fundamental Eccles hypotheses. An advanced quantum


Abstracts 409<br />

mechanical modeling is performed, to calculate the probabilities<br />

for quantum transitions within neural molecules in<br />

cortical electric field. The results indicated the brain-wave<br />

frequency as a physical quantity associated with perception<br />

and memory processing. In addition, limiting the probability<br />

of transitions as to maximize the information entropy, the<br />

relevant number of molecules is calculated for the<br />

frequency of electric fields the cytoplasm is exposed to.<br />

Consequently, some basic rationales for biofeedback efficiency<br />

in treating neurological disorders, like seizure, attention<br />

deficit, as well as neuromuscular computer related ones,<br />

are deduced and discussed. In particular, the effects of brainwave<br />

frequency ‘filtering’ by neurofeedback are considered.<br />

FO-14-5<br />

Randomized treatment study of inosiplex versus<br />

combined inosiplex and intraventricular alpha<br />

interferon in subacute sclerosing panencephalitis (SSPE)<br />

G.G. Gascon, B.A. Anlar, M. Fojas, V. Udani<br />

The International Consortium on SSPE, and Devol E Brown<br />

<strong>University</strong>, Providence, RI, USA: Haceteppe <strong>University</strong>,<br />

Ankara, Turkey; Makati Medical Center, Manila, Philippines;<br />

Hinduja National Hospital and Research Center,<br />

Bombay, India, King Faisal Specialist Hospital and<br />

Research Centre, Riyadh, Saudi Arabia<br />

Methods: One hundred and twenty-one patients, mainly<br />

from Ankara, Manila and Bombay, who met diagnostic<br />

criteria for SSPE were randomized into oral inosiplex<br />

alone (Group A) and combined oral inosiplex and intraventricular<br />

alpha interferon (Group B), delivered through an<br />

Ommaya reservoir. Inclusion criteria were Stage II SSPE<br />

or better. The Stage, Neurological Disability Index (NDI),<br />

and Brief Assessment Exam (BAE) were used for clinical<br />

rating of neurological status. The principal laboratory value<br />

followed was the CSF IgG Synthesis Index (Tourtellotte).<br />

Dose of inosiplex (Isoprinosine, Newport Pharmaceuticals,<br />

Dublin) was 100 mg/kg per day in divided doses, for 6<br />

months. Alpha interferon 2b (Intron A, Schering Plough,<br />

NJ, USA) started with 100 000 units per meter squared<br />

and escalated to 1 000 000 units per meter squared over 5<br />

inpatient days, then 1 000 000 units/meter squared twice a<br />

week for 6 months. Baseline and follow-up data flow sheets<br />

were filled at 3, 6, 12, 18, 24 and 30 weeks, and at longer<br />

intervals till at least 2 years. Results: After excluding 35<br />

cases whose data sheets were not received and another 18<br />

disqualified for various reasons, mainly protocol noncompliance,<br />

68 cases remained for analysis, 40 in Group<br />

A and 28 in Group B). Survival analysis, carried out so<br />

far through 30 weeks, showed five observed deaths during<br />

treatment in Group A and one in Group B, total 6. There was<br />

82% survival at 30 weeks in Group A, 90% in Group B. The<br />

Log-Rank test between Groups A and B, showed a chisquare<br />

of 1.0134, with P ¼ 0:31. Conclusion: No evidence<br />

of difference in survival at 30 weeks between treatment with<br />

inosiplex alone, versus combined inosiplex-alpha interferon.<br />

Commentary: Survival analysis will be carried out<br />

further to 2 years post-institution of treatment. Morbidity<br />

over time will be analyzed similarly for NDI, BAE and<br />

Staging. Toxicity and complications will be analysed.<br />

FO-14-6<br />

Population pharmacokinetic model of valproate in<br />

children with epilepsy and prediction of valproate serum<br />

concentrations<br />

D.-C. Jiang, L. Wang<br />

Department of pediatrics of Peking <strong>University</strong> 1st Hospital,<br />

Beijing, China<br />

Objective: Using therapeutic drug monitoring data of<br />

valproate serum concentrations to set up the population<br />

pharmacokinetic model of valproate for pediatric patients<br />

with epilepsy in China and to predict serum concentrations<br />

for new patients by Bayesian approach. Method: We<br />

collected valproate serum concentrations of 50 pediatric<br />

patients with epilepsy who were taking valproate in monotherapy<br />

regimens, and had no hepatic or renal disease. They<br />

were divided into two groups (n ¼ 25). Each patient had at<br />

least two steady state concentration points. This study used<br />

the NPEM2 software to estimate valproate population pharmacokinetic<br />

parameter values and distributions in a first<br />

group of patients. On a second group, we used these parameters<br />

to predict valproate blood concentrations with Bayesian<br />

approach by the USC*PACK PC Program. Accuracy<br />

and precision were assessed by mean prediction error (ME)<br />

and mean squared prediction error (MSE). Results: We<br />

successfully set up the population pharmacokinetic model<br />

of valproate. Estimated population parameter values<br />

(mean ^ SD) were Kel, 0.0868 ^ 0.0507 h 21 ; Ka,<br />

0.143 ^ 0.120 h 21 ; and Vs 0.0419 ^ 0.025 L/kg.<br />

ME ¼ 22.18; MSE ¼ 16.82. Using these parameters, we<br />

can accurately predict valproate blood levels in new patients<br />

with epilepsy by Bayesian approach. Conclusion: The adoption<br />

of the previously mentioned population pharmacokinetic<br />

model of valproate and Bayesian approach can<br />

accurately predict steady state concentrations. It must be<br />

essential for a better use of valproate in clinical practice.<br />

FO-15<br />

Headache/Vasculopathy<br />

FO-15-1<br />

Idiopathic intracranial hypertension in childhood<br />

D.I. Zafeiriou a , C. Basiakos b , E. Maratou a , E. Vargiami a ,G.<br />

Katzos a , N. Gombakis a , E. Kontopoulos a<br />

a 1st Department of Pediatrics, Aristotle <strong>University</strong>,<br />

‘Hippokratio’ Hospital, Thessaloniki, Greece; b Department<br />

of Ophthalmology, ‘Hippokratio’ Hospital, Thessaloniki,<br />

Greece


410<br />

Abstracts<br />

Idiopathic intracranial hypertension (IIH) is an unusual,<br />

but important cause of headache, which can result in loss of<br />

vision. In a partly retrospective partly prospective study, the<br />

etiology, the presenting symptoms and the clinical course of<br />

24 patients with IIH (ten females, 14 males; age range 4–16<br />

years) who were admitted to our Department between 1991<br />

and 2001. Predisposing factors included acute otitis media<br />

(N ¼ 7 children), upper airway infection (N ¼ 3), obesity<br />

(N ¼ 2), frontal sinusitis (N ¼ 1), previous use of corticosteroids<br />

(N ¼ 1), growth hormone use (N ¼ 1), peptic ulcer<br />

(N ¼ 1), systemic hypertension (N ¼ 1), marfanoid habitus<br />

with mitral valve prolapse (N ¼ 1) and allergy (N ¼ 1),<br />

while in five patients no association could be found. Most<br />

frequent signs at presentation included headache (91.7%),<br />

vomiting (37.5%), nausea (29.2%), vision blurring (27.5%),<br />

abducens nerve palsy (20.8%), diplopia (16.6%) and photophobia<br />

(12.5%). Nineteen patients (79.2%) presented with<br />

the classical clinical picture with headache, papilledema and<br />

raised CSF pressure. Two patients had increased CSF pressure<br />

without papilledema and three patients had papilledema<br />

without increased CSF pressure. In 15 patients, IIH<br />

resolved with the use of acetazolamide, in two patients with<br />

corticosteroids, in four patients with acetazolamide and<br />

corticosteroids and in two patients with acetazolamide and<br />

furosemide. Only one patient was treated with repeated<br />

lumbar punctures, while in four of them, IIH relapsed<br />

(range 2–4 relapses). Other ophthalmologic findings<br />

included decreased visual acuity (6/24), abnormal visual<br />

field examination (4/20) and abnormal visual evoked potential<br />

testing (3/15); however, only one patient continues to<br />

have a mild decrease of his visual acuity to date (follow-up<br />

range 6 months–4 years). In none of the patients was either a<br />

lumboperitoneal shunting or an optic nerve sheath fenestration<br />

required. From our series, we conclude that acetazolamide<br />

alone or in combination seems to be the treatment of<br />

first choice for most patients with IIH, since it is associated<br />

with a relative low risk (4.2%) for long-term visual loss.<br />

However, careful and frequent ophthalmologic follow-up,<br />

as well as prospective multicenter randomized studies, is<br />

needed in order to establish evidence-based treatment protocols<br />

associated with minimal long term residuals.<br />

FO-15-2<br />

Changes in the visual crowding effect as a function of age<br />

E. Vandenbussche a , G. Van Hamme a , T. Reinehr a ,H.<br />

Maes a , L. Lagae b<br />

a Laboratory of Neuropsychology K.U. Leuven, Campus<br />

Gasthuisberg, Leuven, Belgium; b Department of Neuropediatrics,<br />

U.Z. Gasthuisberg, Leuven, Belgium<br />

Introduction: Visual crowding is a form of contour interaction<br />

due to spatial lateral masking. Originally, Flom et al.<br />

(1963) used Landolt-C and four surrounding bars to quantify<br />

thistypeofcontourinteraction.Theyvariedtheangularsizeof<br />

a single black four-position Landolt-C in a larger white field,<br />

so that the C was monocularly recognised in less than 100% of<br />

the time. Although the literature mentions that crowding<br />

decreased by age, no data are yet available. Aim of the study:<br />

To assess the visual crowding effect in binocular vision, in<br />

children of 60–146 month of age. Method: We used the procedureofFlom<br />

withaLandolt-Cat aspecific angularsize,sothat<br />

it was recognised in 70% of the time. The Landolt-C was<br />

presented 1 sec at maximal contrast. The distance of the four<br />

surrounding bars to the Landolt-C was varied in 5 steps (0.1,<br />

0.2, 0.4, 0.8, 1.6 times the size of the Landolt-C). During the<br />

crowding assessment the refraction of both eyes was optimally<br />

corrected Results: (1) The crowding effect is maximal<br />

at a distance 0.4 times the size of the Landolt-C. In children<br />

younger than 72 months there is even a tendency to reach the<br />

maximal crowding effect at a smaller distance. (2) The crowdingeffect<br />

decreases gradually with age. (3) The distance range<br />

withinwhichthecrowdingeffectoccurred,decreasedsymmetrically<br />

around the distance with optimal crowding.<br />

FO-15-3<br />

A clinical study on spontaneous intracranial<br />

hemorrhage in children<br />

J.-L. Cai a , K.-R. Bao a , J.-M. Yu b<br />

a Department of Pediatrics, b Department of radiology, The<br />

Xinhua Hospital of Shanghai Second Medical <strong>University</strong>,<br />

China<br />

Objective: To study the causes, clinical manifestations,<br />

neuroimaging features and prognosis in children with spontaneous<br />

intracranial hemorrhage. To seek for the methods to<br />

reduce the morbidity, mortality and sequelae. Methods: A<br />

retrospective study was performed on 49 cases with spontaneous<br />

intracranial hemorrhage confirmed by clinical manifestation<br />

combined with neuroimaging features and/or<br />

cerebrospinal fluid examination. Results: Delayed vitamin<br />

Kdeficiency (36.7%) and cerebral vascular malformation<br />

(22.4%) were the common causes of spontaneous intracranial<br />

hemorrhage in children. No risk factors were found in<br />

22.4% cases. The main clinical manifestations were headache<br />

and/or vomiting, seizure and disturbance of consciousness.<br />

Hemorrhages in cerebral parenchyma were commonly<br />

seen in children with spontaneous intracranial hemorrhages<br />

and had relatively better prognosis. Conclusion: Prevention<br />

of delayed vitamin K deficiency, hemorrhage relapse and<br />

ischemic damage of cerebral vascular malformation can<br />

effectively reduce the morbidity, mortality and sequelae of<br />

spontaneous intracranial hemorrhage in children.<br />

FO-15-4<br />

Stroke: outcome, risk factors and aetiology in Pakistani<br />

children<br />

Z. Habib, S. Ibrahim, S. Mithani, B.S. Hasan<br />

Department of Pediatrics, Aga Khan <strong>University</strong> Hospital,<br />

Karachi, Pakistan


Abstracts 411<br />

Objectives: This is the first descriptive study that addresses<br />

factors for stroke outcome, clinical features and etiology in<br />

Pakistani children. Aims of the study were to (a) describe age<br />

groups, gender and selected clinical variables in ischemic (I)<br />

and hemmorhagic (H) stroke; (b) classify causes of strokes;<br />

and (c) investigate poor prognostic indicators for stroke<br />

mortality within hospital and morbidity (length of hospital<br />

stay). Methods: Data from 138 children (ages 2 days–192<br />

months; 92 (67%) males, 46 (33%) females) was gleaned<br />

from chart reviews of the past ten years from the pediatric<br />

department of the Aga Khan <strong>University</strong> Hospital. Descriptive<br />

statistics, chi-square, odds ratios, 95% confidence intervals<br />

and multiple logistic regression analyses were used.<br />

Results and conclusions: The mortality was higher in hemorrhagic<br />

(64%) versus ischemic (36%) strokes at P ¼ 0:002.<br />

Overall, the percentage of strokes (I 1 H) was higher in the<br />

infant age group (40%). The percentage of (I) strokes was<br />

higher in the neonate (83%), preschool (74%) and toddler age<br />

groups (73%). The occurrence of seizure activity was higher<br />

in (I) stroke, odds ratio 2.45, P ¼ 0:01. Anemia occurred<br />

with higher frequency in (H) strokes with odds ratios of<br />

5.3, P ¼ 0:000. Presence of seizures dictated morbidity<br />

(bivariate analysis). However, morbidity was not affected<br />

by age at onset of stroke, gender, level of consciousness,<br />

seizure or stroke type at the multivariate level of analysis.<br />

The odds of the child dying from hemmorhagic stroke was<br />

three times higher than ischemic stroke. Plausible pathophysiological<br />

mechanism in the etiology of both (I) and<br />

(H) strokes were presented.<br />

FO-15-5<br />

Visual failure without headache in paediatric ‘Benign’<br />

intracranial hypertension<br />

M.J. Lim, A. Penn, D. Calver, J.P. Lin<br />

Paediatric Neurology and Ophthalmology Department,<br />

Guy’s Hospital, London, UK<br />

Background and objective: We have recently described a<br />

small group of children (n ¼ 7) with benign intracranial<br />

hypertension (BIH) with no headaches, presenting with<br />

focal neurological signs, visual problems and an increased<br />

risk of visual failure. We have continued to recruit more<br />

patients to further assess the differences between the headache<br />

and non-headache groups in BIH. Results: (Table 1)):<br />

A significant proportion present without headaches (31%),<br />

within the paediatric BIH group, In our current bigger<br />

sample size, the atypical presentation group continues to<br />

exhibit more visual abnormalities (blurred vision, diplopia,<br />

visual field defects, larger blind spots and poor visual<br />

acuity) and focal neurological signs (6th and 7th nerve<br />

palsy) when compared to the headache group. Four children<br />

in the non-headache group have marked visual impairment<br />

at follow up. The recognised risk factors for BIH (e.g.<br />

weight) are also less commonly seen within the non-headache<br />

group. Conclusion: These children without headaches<br />

represent a subgroup that have different characteristics to<br />

the headache group and are at risk of visual failure, warranting<br />

early recognition, aggressive management and very<br />

close follow up.<br />

FO-15-6<br />

Confusional migraine: revisited<br />

D. Ghosh, E. Varley, K. Busch, A.D. Rothner<br />

Division of Pediatric Neurology and Otolaryngology and<br />

Communication Disorders, The Cleveland Clinic Foundation,<br />

Cleveland, OH, USA<br />

Confusion is defined as disorientation with or without<br />

altered sensorium. It is the cardinal symptom in acute<br />

confusional migraine (ACM). Our experience and review<br />

of the literature suggest that: (a) confusion is seen in<br />

several migraine variants; and (b) may represent either a<br />

receptive or expressive aphasia. The charts of 20 patients<br />

with ‘confusional’ migraine were reviewed. Twelve were<br />

males. Ages were 5–20 years (14.25). Six had ACM, five<br />

basilar artery migraine, three hemiplegic migraine, three<br />

trauma triggered migraine, two ‘complicated’ migraine<br />

and 1 migraine with aura. One to four episodes per patient<br />

occurred lasting 20 min to 36 h (6.5 h). All had throbbing<br />

headache. Eleven had aphasia. Two were examined during<br />

the attack. One had an expressive aphasia (dysfluent speech<br />

with preserved comprehension), the other a receptive aphasia<br />

(with reading, writing and naming difficulties). EEG in<br />

both showed focal slowing over the dominant cortex. Focal<br />

slowing was seen in six of 11 cases. Interictal CT and/or<br />

MRI were normal. In one child the MRI showed middle<br />

cerebral artery spasm and cortical T2-hyper-intensity over<br />

the dominant cortex. In no patient was an underlying etiol-<br />

Table 1<br />

Headache group (n ¼ 24) Non-headache group (n ¼ 11)<br />

Age (95% CI) 9.8 (^3.3) 7.6 (^3.4)<br />

Sex M:F 7:5 4:7<br />

Associated risk factors (%) 62 27<br />

Visual failure (acuity worse than 6/36 in either eye) (%) 8 36<br />

Blind spot affected (%) 5 (n ¼ 20) 25 (n ¼ 8)<br />

Focal neurological signs (%) 12 45


412<br />

Abstracts<br />

ogy found. In conclusion, confusion can be a prominent<br />

feature of the different migraine variants. Awareness of this<br />

may help avoid invasive investigations. Aphasia as a<br />

component of ACM is common. A detailed language<br />

evaluation during the attack may be useful. Reversible<br />

vasospasm of intracranial vessels causing ischemia contributes<br />

to the mechanism for confusion and aphasia in<br />

migraine.<br />

FREE PAPERS-Poster Presentation<br />

FP-A<br />

Developmental/Basic Neuroscience<br />

FP-A-001<br />

Significance of Pavlov’s work on the physiology of<br />

neuropsychic behaviour of man<br />

K.B. Kulkarni<br />

Sanjivani Nursing Home, Gwalior (M.P.), India<br />

Pavlov’s epoch making observations and animal experiments<br />

provide the edifice for understanding neonatology,<br />

developmental pediatrics, psychology and overall higher<br />

nervous activity. His concept of integral nature of organism,<br />

nervism, unity of organism with social and ecological environs,<br />

the complex toxicosis involving CNS excitation and<br />

inhibition, his idea of multitudinous reflexes as basic reserve<br />

of higher nervous activity, the concept of sleep and internal<br />

inhibition as part of the same process of excitation are only a<br />

few examples. The Pavlovian thought underscores not just<br />

conditioned reflexes but also the instinctive reflexes of<br />

dynamic stereotypes, conditioned switching and reflex<br />

chains. Ukhstomsky’s dominance focus or the dominant<br />

and Pavlov’s conditioned reflex is the elementary functional<br />

unit of central organisation of behaviour. In fact, many<br />

mechanisms of mental activity are a part of the second<br />

and third signalling system of conditioned reflex activity:<br />

even speech, writing and developing communication skills<br />

in the era of information technology. According to him, by<br />

forming numerous two ways connections – forward and<br />

backward – we form mental images of the world around<br />

and likewise, respond reflexively or voluntarily. His observations<br />

on young birds and mammals provide the answer<br />

whether our children should be exposed to life’s dangers and<br />

difficulties. He therefore immensely valued the process of<br />

‘imprinting’. Pavlov stressed on ‘reinforcement’ mechanism<br />

on which elaboration, existence, discontinuation and<br />

extinction of conditioned reflex depends. He took pains to<br />

differentiate between a biologically significant stimulus<br />

from useless one, both in the laboratory and in real life.<br />

Without Pavlovian theory of emotions it would not have<br />

been possible to extricate psychology so early from physiology.<br />

FP-A-002<br />

Aminophylline aggravates long-term morphological and<br />

cognitive damages in status epilepticus in immature rats<br />

L.-T. Huang a , S.N. Yang a , M.-C. Lai b , P.-L. Hung a<br />

a Department of Pediatrics, Chang Gung Memorial Hospital,<br />

Kaohsiung, Chinese Taipei; b Department of Pediatrics,<br />

Chi Mei Foundation Hospital, Chinese Taipei<br />

The aim of this work was to investigate whether aminophylline,<br />

an adenosine receptor antagonist used usually as a<br />

treatment for premature apnea, had synergistic effects on<br />

status epilepticus in the developing brain. On the postnatal<br />

day 14 (P14), four groups of rats intraperitoneally received<br />

saline, aminophylline, lithium-pilocarpine (Li-PC), and Li-<br />

PC plus aminophylline, respectively. Subsequently, Morris<br />

water maze task was performed at P80. The brains were then<br />

analyzed with cresyl violet stain for histological lesions and<br />

evaluated for mossy fiber sprouting with the Timm stain. No<br />

seizures were elicited in the saline-treated or aminophyllinetreated<br />

rats. Both the Li-PC-treated and aminophylline plus<br />

Li-PC-treated rats exhibited seizures and there was no<br />

significant difference in mortality between the two groups.<br />

More interestingly, as in adulthood (P80), aminophylline<br />

aggravated the spatial deficits and histological damages in<br />

hippocampus seen in Li-PC-treated rats. In summary, this<br />

present study suggests that the use of adenosine receptor<br />

antagonists, such as aminophylline, exacerbates seizureinduced<br />

damage in the developing brain.<br />

FP-A-003<br />

Immunohistological evaluation of the diencephalon and<br />

basal ganglia in alobar holoprosencephaly<br />

M. Hayashi a , K. Hamano b , S. Araki c , T. Kohji a ,S.<br />

Kumada b , M. Itoh a , K. Tamagawa c , J. Satoh a ,Y.<br />

Morimatsu a<br />

a Department of Clinical Neuropathology, Tokyo Metropolitan<br />

Institute for Neuroscience, Tokyo, Japan; b Tokyo<br />

Metropolitan Medical Center for SIMDS, Tokyo, Japan;<br />

c Tokyo Metropolitan Neurological Hospital, Tokyo, Japan<br />

Holoprosencephaly (HPE) is caused by the impaired cleavage<br />

of the embryonic prosencephalon and in the severest<br />

type, alobar HPE, the bilateral diencephalon and basal ganglia<br />

are usually fused and tend to intermingle with the upper<br />

brainstem. Therefore, their detailed neuropathological<br />

features have not fully been investigated, although disturbed<br />

regulation in body temperature, electrolyte balance and/or<br />

muscle tonus is frequently observed in HPE patients. We<br />

immunohistologically examined the expression of hypothalamic<br />

markers such as vasopressin and orexin A, neurotransmitters,<br />

neuropeptides and calcium binding proteins in six<br />

female autopsy cases of alobar HPE, in addition to six agematched<br />

controls, who showed preserved immunoreactivities<br />

for these markers from the neonatal period. The HPE


Abstracts 413<br />

cases consisted of two preterm babies, two infants and two<br />

cases over 1 year in age. The neurons immunoreactive for<br />

either vasopressin and/or orexin A were found on both sides<br />

of the diencephalic midline cleft in five cases, with the<br />

exception of the preterm infant case of 35 weeks of gestational<br />

age. The tyrosine hydroxylase-immunoreactive fibers<br />

and neurons were observed in the mixture of diencephalon<br />

and basal ganglia and the mesencephalic substantia nigralike<br />

structure in all the HPE cases. The parvalbumin-immunoreactive<br />

structures mimicking the red nucleus was identified<br />

in one preterm infant case and two cases over 1 year,<br />

while the immunoreactivity for methionine-enkephalin was<br />

found only in cases over 1 year in the mixture of diencephalon<br />

and basal ganglia. These data suggest that the<br />

jumbled diencephalon and basal ganglia showed some<br />

degree of functional development in alobar HPE, and<br />

incomplete or delayed expression of the markers examined<br />

here may partly reflect the diencephalic and motor disturbances<br />

in HPE.<br />

FP-A-004<br />

Developmental changes in EEG multifractal<br />

characteristics of normal and abnormal brain<br />

E.L. Wasserman a , R.I. Polonnikov b , N.K. Kartashev b<br />

a V.M. Bekhterev Psychoneurological Research Institute,<br />

Saint-Petersburg, Russia;<br />

b Institute of Informatics and<br />

Automation of RAS, Russia<br />

One hundred-ten males and females (6.5–19.5 years old)<br />

were investigated (48 healthy persons, 51 ones with hemiplegic<br />

cerebral palsy and 11 ones with similar acquired<br />

cerebral defect). Monopolar 12-channel EEG were<br />

processed and then regarded as multifractal processes.<br />

Power spectrums of 30 successive 1-s fragments of background<br />

activity in each channel were approximated by k·f b<br />

model ( f-frequency in 2–30 Hz band, k and b-model parameters).<br />

Model parameters were averaged in all 30 fragments<br />

and 12 channels and then analysed. Stable<br />

correlations (accordant to Spearman, r s , P , 0:0001) of<br />

both parameters with the age of person were discovered:<br />

k (r s ¼ 20:63) and b (r s ¼ 20:58). These dependences<br />

were approximated well by exponential functions and<br />

observed in healthy persons (r s ¼ 20:55, r s ¼ 20:56) as<br />

well as in patients (r s ¼ 20:67, r s ¼ 20:64). It was<br />

concluded: (1) parameter b (which is an informational<br />

characteristic of EEG as multifractal) and parameter k<br />

(which is a power characteristic of EEG) demonstrate regular<br />

changes with age reflecting the process of cerebral<br />

maturation; and (2) this regularity takes place not only in<br />

the cases of normal development of brain but also in the<br />

cases of its abnormal development caused by early or later<br />

injury.<br />

FP-A-005<br />

The expression of PRL, GFAP and Fos in the cerebral<br />

cortex and amygdala of acute heat stress model of<br />

seizure in weanling rats<br />

H. Ni, Q.-X. Shui<br />

Department of Neurology, Children’s Hospital, College of<br />

Medicine, Zhejiang <strong>University</strong>, Hangzhou, China<br />

Many investigations have suggested the possibility that<br />

febrile convulsions (FC) in early childhood are an etiologic<br />

factor in human temporal lobe epilepsy. In order to explore<br />

the morphological basis of pathogenesis in FC, the expression<br />

of prolactin, glial fibrillary acidic protein (PRL, GFAP)<br />

and Fos immunoreactivity in cerebral cortex and amygdala<br />

of weanling rats was examined. We studied this by using the<br />

warm-water-immersion model and immunohistochemistry<br />

method. Thirty rats were randomly divided into two groups:<br />

normal control group (n ¼ 6) and hyperthermia-treated<br />

group (n ¼ 14). The latter was further divided into FC<br />

(n ¼ 6, score reaching Grade 5, two rats were abandoned<br />

for only reaching Grade 2) and hyperthemic (non-convulsion)<br />

groups according to the reaction to hyperthemia treatment.<br />

Our results demonstrated that there was a large<br />

number of positive cells with PRL, GFAP and Fos immunoreaction<br />

in both cerebral cortex and amygdala in<br />

hyperthermia-treated group (P , 0:01). Moreover, the<br />

expression of GFAP and Fos were markedly high in FC<br />

group than in hyperthemic (non-convulsion) group, meanwhile<br />

the expression of PRL did not change significantly<br />

between the hyperthemic and FC group (P . 0:05). These<br />

results indicated that the increased prolactin immunoreactivity<br />

is involved in the progress of heat stress activity, but<br />

may have no significant relationship with seizure activity.<br />

However, GFAP and Fos are not only involved in pathogenesis<br />

of heat stress progress, but may also associate with<br />

seizure activity.<br />

FP-A-006<br />

Different expression of c-Fos and prolactin in neonatal<br />

rat with hypoxic-ischemic encephalopathy<br />

H. Ni a , Q.-X. Shui a , Y.-C. Wang b , C.-C. Shi b<br />

a Department of Neurology, Children’s Hospital, College of<br />

Medicine, Zhejiang <strong>University</strong>, Hangzhou, China; b The<br />

Peoples’ Hospital of Jinhua, Zhejiang Provence, China<br />

Recent studies have showed that prolactin is not only<br />

synthesized in the pituitary gland, but also within the central<br />

nervous system to control a variety of behaviors. The<br />

expression of c-fos like protein is regarded as a marker for<br />

neuronal activity following noxious stimulation in the rat.<br />

The present study was to investigate the relationship<br />

between c-fos and prolactin expressions in neonatal rat<br />

with HIE. Twenty 7-day-old SD rats were randomized<br />

divided into two groups: normal control group (n ¼ 8, with-


414<br />

Abstracts<br />

out hypoxic-ischemic treatment) and hypoxic-ischemic<br />

treatment group (HIE, n ¼ 12). After ligation of the left<br />

common carotid artery, the rats of HIE group were exposed<br />

to 8% oxygen-92% nitrogen at 378C for 3 h. At the end of<br />

the hypoxic period, they were removed from the container<br />

and placed in room air for 60 min before being decapitated.<br />

Immunohistochemistry was used to detect the expression of<br />

PRL and Fos. Compared with controls, the number of Fos<br />

positive neurons elevated significantly in hypothalamus,<br />

supramammillary nucleus, suprachiasmatic nucleus, thalamic<br />

pavaventricular nucleus, the thalamic midline nucleus,<br />

and amygdala (P , 0:01). On the other hand, cortical and<br />

hippocampal PRL immunoreactive cells were significantly<br />

elevated compared with the control (P , 0:01). The<br />

increased expression of Fos and PRL might closely related<br />

to hypoxic-ischemic processes. The different expression<br />

region of Fos and PRL suggest differential role of them in<br />

HIE.<br />

FP-A-007<br />

Ontogenic expression of colony stimulating factor-1<br />

receptor on neurons<br />

S.-Q. Qu, Y.-Q. Wang, L. Zuo, X.-H. Hu<br />

Navy general hospital, Beijing, China<br />

The mice with different ages, from embryonic day 14, 18<br />

(E14, E18) to newborn and postnatal 7, 14, 21, 28 (P7, P14,<br />

P21, P28) were used in our experiment. Immunochemical<br />

staining and immunoblotting were used to examine the<br />

expression of CSF-1 receptor (CSF-1R) on neurons in<br />

CNS. The results showed that the expression of CSF-1R<br />

could be detected on brain neurons of mice from fetal age<br />

14 days and increased gradually along with the growing of<br />

fetal mice and reached the peak value in newborn mice.<br />

The expression decreased gradually after birth and reached<br />

plateau 4 weeks later showed by Western blot. The<br />

numbers of CSF-1R positive neurons also showed the<br />

same pattern as western blot in immunochemical study. It<br />

was indicated that there might be a close relationship<br />

between the level of CSF-1R expression and the ontogeny<br />

and development of neurons in CNS in mice. Ya-qi<br />

Wang’s work showed that expression of CSF-1R were<br />

only observed in a few of neurons in the brainstem in<br />

normal state, but up-regulated not only at the vicinity of<br />

the lesion but also in distant areas after the ischemic lesion.<br />

It was suggested that neurons have the potency of expressing<br />

CSF-1R during the development, which might be<br />

down-regulated somehow after birth and up-regulated in<br />

the lesion’s conditions in our experiment. We supposed<br />

that CSF-1R might play an important role in the development<br />

course of neural system in mice and was one of the<br />

factors in response to the stimulation.<br />

FP-A-008<br />

Effect of nerve growth factor on neuronal injury in<br />

strychnine-nitrate induced seizure rats<br />

M.-Y. Hu, Z.-M. Ren, M. Jiang<br />

Department of pediatric Second Affiliated Hospital of<br />

Harbin Medical <strong>University</strong> Harbin, China<br />

Objective: To probe whether exogenous nerve growth<br />

factor (NGF) might have an active effect on the encephalo-neuronal<br />

apoptosis induced by acute seizures. Methods:<br />

With the model of strychnine-nitrate-induced epilepsy,<br />

the morphological changes of brain cells were observed<br />

under the photomicroscrope with hematoxylin and eosin<br />

(HE) dying as well as the amount of apoptotic neurons<br />

and the effect of NGF on that were detected by the method<br />

of immuno-histochemistry with bax and bc1-2 protein.<br />

Result: Apoptotic neurons in CA1 of the hippocampus and<br />

the cortex were seen 24 h after epilepsy was induced, which<br />

increased significantly at 48 h and reached the peak at 72 h,<br />

then decreased toward 7 days to the valley. There are far<br />

fewer apoptotic neurons in brain cells of the rats injected<br />

with NGF into their abdomen than those without injection<br />

killed at the same time expectedly (P , 0:05). Conclusions:<br />

Exogenous NGF could inhibit the encephalo-neuronal apoptosis<br />

induced by acute seizures, which means that NGF may<br />

have a neuroprotective effect against brain damage owing to<br />

epilepsy.<br />

FP-A-009<br />

Levels of CSF neurotrophic factors in patients with Rett<br />

syndrome and children with autism<br />

R.S. Riikonen, R. Vanhala, U. Turpeinen<br />

Children’s Hospital, <strong>University</strong> of Kuopio, Kuopio, Finland<br />

Autism and Rett syndrome (RS) are both developmental<br />

disorders of unknown origin. Differentiation of RS from<br />

infantile autism in the very early stages is not always<br />

easy. The aim of the present study was to determine whether<br />

CSF NGF or CSF insulin-like growth factor-I (IGF-I). (1)<br />

Distinguish patients with RS from autism; and (2) could<br />

have a role in the pathogenesis of the syndromes. Method:<br />

We measured CSF NGF levels with two-site ELISA method<br />

and CSF IGF-1 levels with radioimmunoassay (RIA).<br />

Results: Patients with RS had low to negligible levels of<br />

CSF NGF. Patients with autism had normal CSF NGF<br />

levels. CSF IGF-I of patients with RS did not differ from<br />

controls. Patients with autism had low levels of CSF IGF-I<br />

compared to controls. NGF acts specifically on cholinergic<br />

neurons of the basal forebrain. In RS the frontal cortex is<br />

more severely affected than the other cortical areas. IGF-1 is<br />

important for cerebellar development. In autism, many<br />

studies show hippocampal or cerebellar pathology. Conclusions:<br />

Our findings are in agreement with the different<br />

morphological and neurochemical findings (brain growth,


Abstracts 415<br />

affected brain areas, neurotransmitter metabolism) in the<br />

two syndromes.<br />

FP-A-010<br />

Monoamines in brain tissues of newborn rabbits with<br />

cerebral palsy<br />

X.-J. Li, Y.-Q. Li, Z.-M. Jiang, L. Li<br />

Prevention, Treatment and Rehabilitation Center for Child<br />

Cerebral Palsy in Heilongjiang Province, Jiamusi, Heilongjiang,<br />

China<br />

To study the role of monoamines (DA, 5-hydroxytryplamine,<br />

5-HT, NE) in pathogenesis of CP by measuring the<br />

levels of dopamine (DA), 5-HT, nonepinephrine (NE) in CP<br />

rabbit models. Twenty newborn rabbits (2–3 days) were<br />

randomly divided into two groups: the control group (C<br />

n ¼ 10), the model group (M n ¼ 10). Rabbits in group M<br />

were administered intraperitoneal bilirubin 100 mg/kg, total<br />

dose was 300 mg/kg. Rabbits in group C were administered<br />

saline as the same dose as those in group M. Animals were<br />

killed after being fed naturally for 45 days, hippocampus,<br />

cerebral cortex, basal ganglia and brainstem were separated<br />

respectively. Each region was divided into two parts: one<br />

part was fixed and examined with light microscope. The<br />

levels of monoamines in the other part were determined.<br />

The levels of NE, 5-HT in basal ganglia and NE in brainstem<br />

in group M were significantly lower than those in<br />

group C (P , 0:05). There was positive correlation between<br />

DA, 5-HT in basal ganglia and NE in brainstem<br />

(r ¼ 0:8979, r ¼ 0:7112, P , 0:05), and between 5-HT<br />

and DA in basal ganglia (r ¼ 0:6178, P , 0:05). The results<br />

suggest that bilirubin may be responsible for the decreased<br />

DA, 5-HT, NE in brain tissues. DA, 5-HT may participate in<br />

the damage of basal ganglia induced by bilirubin. The levels<br />

of NE may be related to the symptoms of CP.<br />

FP-A-011<br />

Pilocarpine-induced status epilepticus produces<br />

neuronal death: implications for programmed cell death<br />

mechanisms<br />

R.-Z. An, Y.-R. Yin, C.-J. Jin, G.-H. Li<br />

Department of Pediatrics, College of Medicine, YanBian,<br />

<strong>University</strong>, Yanji, China; New Era Children Hospital,<br />

Yanji, China<br />

Purpose: Prolonged and continuous epileptic seizures<br />

(SE) induced by pilocarpine activate programmed cell<br />

death mechanisms. In order to test this hypothesis, we<br />

investigated the morphology of neuronal death (necrotic<br />

and apoptotic) from pilocarpine-induced SE, and the<br />

expression of proapoptotic and antiapoptotic protein bax<br />

and bcl-2, respectively. Methods: Pilocarpine induced<br />

status epilepticus lasting 2 h was induced in Sprague-<br />

Dawley adult male rats, which were allowed to recover<br />

for 24 or 72 h before perfusion-fixation. Neuronal death<br />

was assessed by light microscopy with the haematoxylinand<br />

-eosin stain and with in situ terminal deoxynucleotidyl<br />

transferase dUTP nick-end labelling (TUNEL stain). Bax<br />

and bcl-2 protein expression were examined by immunohistochemistry.<br />

Results: Twenty-four and 72 h after 2 h<br />

pilocarpine induced SE, neuronal death in hippocampus<br />

(CA1 and CA3) was morphologically necrotic, but there<br />

were TUNEL-positive and morphologically necrotic cells<br />

in the hippocampal CA1 and CA3 regions at 72 h, but not<br />

at 24 h, after SE. Bax protein expression was also increased<br />

in the hippocampal CA1 and CA3 regions at 72 h after SE.<br />

Bcl-2 protein expression was not detected. Conclusion: Our<br />

results suggest that programmed cell death promoting<br />

mechanisms are activated by SE in neurons that become<br />

necrotic and could contribute necrotic, as well as apoptotic,<br />

neuronal death.<br />

FP-A-012<br />

Expression of GABA A receptor a 1 subunit in rat<br />

hippocampus following kainic acid-induced temporal<br />

lobe epilepsy<br />

G.-F. Lei, R.-P. Sun, Y.-L. Wang, B.-M. Li, J.-W. Wang,<br />

R.-M. Hu, S.-H. Guo<br />

Pediatric Department, Shandong <strong>University</strong> Qilu Hospital,<br />

Shandong, China<br />

Intrahippocampus injection of kainic acid (KA) in the rat<br />

represents a widely used animal model of human TLE, the<br />

etiology of which is controversial. This study evaluated by<br />

immunohistochemistry for the expression of GABA A receptor<br />

a 1 subunit (major a subunit expressed in adult brain) in<br />

the contralateral hippocampus of rats 12, 24, 72 h, 7 and 30<br />

days after injection of KA into right hippocampus. At early<br />

intervals (within 24 h after KA injection) a 1 subunit expression<br />

on hippocampus was decreased. The decrease was<br />

followed by increase of a 1 subunit expression after 7–30<br />

days. The results indicate that the decreased GABA A receptor<br />

a 1 subunit expression on hippocampus at early interval<br />

may play an important role in the induction and maintenance<br />

of epilepsy, and the decrease in GABA A receptor a 1<br />

subunit expression may be compensated partly by increased<br />

expression at late interval. Thus the compensatory mechanism<br />

is operative in epileptic hippocampus.<br />

FP-A-013<br />

Effect of radix salviae miltiorrhizae on inducible nitric<br />

oxide synthase activity in rat astrocytes<br />

F. Gao, J.-F. Lu, Q.-X. Shui, Z.-Z. Xia, B.-L. Zhou<br />

Department of Neurology, Children’s Hospital, Zhejiang<br />

<strong>University</strong> Medical College, Hangzhou, China<br />

Objective: The present study was undertaken to examine<br />

the effect of radix salviae miltiorrhizae (RSM) on the indu-


416<br />

Abstracts<br />

cible nitric oxide synthase (iNOS) activity induced by endotoxin<br />

in cultured rat astrocytes. Method: We detected iNOS<br />

activity in normal astrocytes, LPS induced astrocytes, and<br />

RSM treated LPS induced astrocytes by Griess methods.<br />

Results: (1) The effect of LPS induced iNOS activity expression<br />

in astrocytes was significant among the different LPS<br />

concentrations within the range of 0.01–50 mg/ml, the maximum<br />

stimulation for iNOS activity was obtain with 10 mg/<br />

ml LPS (40.00 ^ 2.52 mM). (2) The effect of different incubation<br />

time on iNOS activity of astrocytes: the iNOS activity<br />

of astrocytes in the control group was no significant<br />

change from 0 to 48 h of incubation time. However, when<br />

it was stimulated with 5 mg/ml LPS, the iNOS activity<br />

increased to be 6.02 ^ 0.52, 6.93 ^ 0.52, 27.65 ^ 1.47,<br />

29.20 ^ 6.09, 29.40 ^ 1.60 mM with the time of incubation<br />

at 3, 12, 24, 36 and 48 h, respectively. The induction of<br />

iNOS activity by endotoxin was not influenced by RSM<br />

incubation within 12 h, otherwise RSM exhibited strong<br />

inhibition at 24, 36 and 48 h, respectively, as compared<br />

with that of LPS group. (3) The effect of various concentrations<br />

of RSM on 5 mg/ml LPS induced iNOS activity: iNOS<br />

activity attenuated gradually, with the increase of RSM<br />

concentrations. Conclusions: It was suggested that the<br />

iNOS of astrocytes might take part in the pathology of<br />

bacterial infection in central nervous system, and its role<br />

could be decreased by RSM.<br />

FP-A-014<br />

Gene therapy for rat hypoxic-ischemic encephalopathy<br />

by neurotrophin-4-engineered marrow stromal cell<br />

Y.-J. Jia, Y.-J. Yang, X.-R. Zheng, J.-B. Liu, J.-H. Song<br />

Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />

China<br />

Objective: Marrow stromal cells, which have many characteristics<br />

of stem cells, populate various non-hematopoietic<br />

tissues including the brain. In the present study, we explored<br />

the protocol of gene therapy for hypoxic-ischemic encephalopathy<br />

by neurotrophin-4(NT-4)-engineered marrow stromal<br />

cell. Methods: The recombinant pcDNA3.1(1) NT-4<br />

plasmids were constructed and transduced into marrow stromal<br />

cells by lipofectin. The newborn rat hypoxic-ischemic<br />

model was successfully established, and NT-4-engineered<br />

marrow stromal cells were transplanted into brain. Results:<br />

The plasmids could express active NT-4 protein and mRNA<br />

in marrow stromal cells presented by immunohistology and<br />

in situ hybridization. Four weeks after transplantation, more<br />

NT-4 immuno-reaction positive cells were observed in the<br />

transplanted group compared with the control group. In addition,<br />

significant difference in motor activity and histological<br />

changes were detected between the two groups. Conclusion:<br />

These results suggested that NT-4-engineered marrow stromal<br />

cells were effective in gene therapy for hypoxicischemic<br />

encephalopathy.<br />

FP-A-015<br />

Changes of nestin expression in marrow stromal cells<br />

differentiate to neuron and islet<br />

Y.-J. Jia, Y.-J. Yang, J.-B. Liu, X.-R. Zheng, J.-H. Song<br />

Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />

China<br />

Objective: Marrow stromal cells (MSCs) exhibited multiple<br />

traits of a stem cell population. In the present study, we<br />

explored changes of nestin expression during marrow stromal<br />

cells differentiating into neurons and islets. Methods:<br />

MSCs from adult rats were induced by baicalin in serumfree<br />

medium for 6 h, and post-induced by baicalin for neuron<br />

or by kinetics gain factor (KGF) for islet. After inducement,<br />

neuron and islet were evaluated by immunocytochemistry<br />

staining. And insulin released was measured by radioimmunoassay.<br />

The expression of nestin was measured by immunocytochemistry<br />

and RT-PCR. Results: After induction,<br />

MSCs expressed neuronal special proteins, such as NSE,<br />

NF and NeuN, and islet special proteins, such as insulin<br />

and glucagons. In addition, cumulative quantities of insulin<br />

with 24 h and the stimulation index maintained at high level.<br />

The expression of nestin was appeared in 6 h of differentiating<br />

into both neuron and islets. After 24 h, the expression was<br />

not detected. Conclusions: The results showed that nestin<br />

may play a role in MSCs differentiate into neuron and islets.<br />

They suggested that there may be a common path of neuron<br />

and islets differentiation.<br />

FP-A-016<br />

Effects of phenytoin on primary cortical neuron cultures<br />

Y.-J. Jia, Y. Zhou, Y.-J. Yang<br />

Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />

China<br />

Objective: By observing the effects of phenytoin (PHT)<br />

on cortical neuron, we tried to give an explanation of the<br />

mechanism of PHT-induced neurotoxicity. Methods: After<br />

established the method of primary rat cortical neuron<br />

culture, neuron membranous fluidity, percentage of surviving,<br />

LDH releasing ratio, and morphologic changes in the<br />

various doses of PHT (2.5, 5, 12.5, 25 mg/ml and control<br />

groups) were measured. Moreover, the conformation of<br />

membrane proteins was calculated by circular dichroism<br />

spectra. Results: There were no significant differences<br />

between the control group and low-dosed groups (2 and<br />

12.5 mg/ml). On the contrary, in the high-dosed groups<br />

(25 and 50 mg/ml), there were significant decrease of<br />

membranous fluidity and the percentage of neuron surviving,<br />

and increase of LDH releasing ratio (P , 0:05). a-helix<br />

content in the membrane proteins of control group was<br />

48.3%. After treated by high-dosed PHT, the content<br />

increased to 53.7 and 55.9%, respectively. Conclusions:<br />

The results showed that the high-dosed PHT may play a<br />

role in decrease of membranous fluidity, increase of LDH


Abstracts 417<br />

efflux and a-helix content in the membrane proteins. They<br />

suggested that there is a relationship between PHT-induced<br />

neurotoxicity and changes of membranous structure.<br />

FP-A-017<br />

Isolation and cultivation of neural stem cells from<br />

newborn rats<br />

Y.-J. Jia, Y.-J. Yang, J.-H. Song, J.-B. Liu, X.-R. Zheng<br />

Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />

China<br />

Objective: To study the isolation and cultivation of<br />

neural stem cells from newborn rats. Methods: Cell culture,<br />

indirect immunofluorescence cytochemistry and gene<br />

transfection techniques were used. Results: The neural<br />

stem cells isolated from newborn rats had the potential to<br />

form clones, express neuroepithelial stem cell protein<br />

(nestin) and differentiate into mature neurons and astrocytes.<br />

Moreover, green fluorescent protein vector could<br />

be efficiently transfected into this cell line. Conclusion:<br />

The results demonstrated that our neural stem cells can<br />

only be characterized on a critical functional basis in<br />

terms of their undifferentiated features, capacity for selfrenewal,<br />

proliferation, pluripotentiality, and ability to efficiently<br />

express ex vivo gene.<br />

FP-A-018<br />

The dose-dependents and time-dependents in induced<br />

brain heat shock protein 70 (HSP70) expression with<br />

curcumin<br />

R. Huang, F. Luo, Y.-J. Yang<br />

Department of pediatrics, XiangYa Hospital, Central South<br />

<strong>University</strong>, Changsha, China<br />

Objectives: To study the dose-dependents and timedependents<br />

in induced HSP70 expression with curcumin.<br />

Methods: I The dose-dependents. SD rats were randomly<br />

divided into seven groups: (1) blank group (B); (2) DMSO<br />

group (DMSO); (3) heat shock group (HS); (4) curcumin<br />

80 mg group (C80); (5) curcumin 40 mg group (C40); (6)<br />

curcumin 20 mg group (C20); (7) curcumin 10 mg group<br />

(C10); animals were killed 24 h after HS or injection<br />

DMSO or curcumin. Brain HSP70 were tested by Western<br />

blot analysis. II The time-dependents. SD rats were all<br />

injected with curcumin 40 mg/kg into peritoneal. Then<br />

randomly divided into eight groups according the killed<br />

time, 0, 2, 4, 6, 12 and 16, 24 and 48 h. Brain HSP70<br />

expression was detected by the Western blot analysis.<br />

Results: The Brain HSP70 expression of HS, C40, C80<br />

group were increased significantly, especially in C40<br />

group (P , 0:01). HSP70 expression was increased gradually<br />

with the time going, and the top in 16H group; then,<br />

there was a plateau in 24 and 48 h group. Conclusions:<br />

Brain HSP70 expression can be induced by pretreatment<br />

with curcumin, and there are dose-dependents and timedependents.<br />

FP-A-019<br />

Effects of developmental lead exposure on N-methyl-daspartate<br />

receptor mRNA expression in rat<br />

hippocampus<br />

Z.-W. Zhu, Z.-Y. Zhao, G.-J. Dong<br />

The Affiliated Children’s Hospital of Zhejiang <strong>University</strong><br />

School of Medicine, Hangzhou, China<br />

Objective: To investigate the effect of developmental<br />

lead exposure on NMDA receptor mRNA expression in<br />

rat hippocampus. Methods: We established a series of<br />

developing rat models exposed to low level lead (drinking<br />

water containing 0.025, 0.05 or 0.075% lead acetate), and<br />

examined mRNA expression levels of the subunit NR2A<br />

and NR2B in rat hippocampus with RT-PCR method.<br />

Results: There were no differences in body weight of rat<br />

pups between any two groups at any age (P . 0:05). The<br />

blood lead level of Pb-exposed rats changed regularly: at<br />

age of 14 days, it was lower than that of 7 days, and<br />

increased to a highest level at 21 days, then returned to<br />

lower level at 28 days. There was difference between 21<br />

days and any other age groups (P , 0:05). The expression<br />

levels of NR2A mRNA of 0.05 and 0.075% groups at age<br />

of 7 and 14 days were higher than those of control group<br />

(P , 0:05), but in 0.025% group, the expression level of<br />

NR2A mRNA was higher than that of control group at 7<br />

days (P , 0:05). There were no significant differences in<br />

expression level of NR2B mRNA between any two groups<br />

at any age (P . 0:05). Conclusions: Developmental low<br />

level lead exposure of rats can raise the expression level<br />

of NR2A mRNA in hippocampus. Developmental low<br />

level lead exposure of rats does not affect the expression<br />

level of NR2B mRNA in hippocampus.<br />

FP-A-020<br />

Development of the prefrontal layer IIIc pyramidal<br />

neurons in fetuses and infants with Down’s syndrome<br />

M. Vukšić, J. Bošnjak, A. Cepika, Z. Petanjek, I. Kostović<br />

Croatian Institute for Brain Research, Salata 12, School of<br />

Medicine, <strong>University</strong> of Zagreb, Zagreb, Croatia<br />

In this study we have analysed the development of associative<br />

layer IIIc pyramidal neurons of the prefrontal cortex<br />

in children with DS during the late fetal and early postnatal<br />

period. Basal dendritic tree of rapid Golgi impregnated<br />

pyramidal neurons was quantitatively analysed (dendritic<br />

length; number and morphology of dendritic spines) in the<br />

postmortal brains from 3 subjects with DS (fetus 36 weeks<br />

of gestation, infants aged 2.5 and 4.5 months) and in 5 age<br />

matched controls. During the perinatal period there is the<br />

most intensive dendritic growth and spinogenesis. No differ-


418<br />

Abstracts<br />

ences were present between DS infants and control subjects<br />

concerning the pattern of the dendritic elongation and<br />

segment outgrowth. Increase in spine number followed in<br />

DS the normal curve up to third postnatal month. At 4<br />

months decreased spine density was observed only on the<br />

most distal terminal branches. Some morphological alterations<br />

of the dendritic spines are present in DS subjects from<br />

the beginning of their occurrence. It was proposed that the<br />

basis of cognitive dysfunction in DS lies in the disordered<br />

development of their associative cortex. These data suggest<br />

that children with DS begin their life with morphologically<br />

normal layer IIIc prefrontal pyramids, which are the key<br />

cellular elements of the corticocortical connectivity. Since<br />

the first regressive changes are not present before the fourth<br />

postnatal month, it seems reasonable to conclude that the<br />

application of some therapeutic procedures in the early<br />

period of life could mitigate a cognitive decline present<br />

later in these patients.<br />

FP-A-021<br />

Reelin and calretinin immunohistochemistry in<br />

ibotenate-induced cortical dysplasia in newborn hamster<br />

T. Takano, Y. Takeuchi<br />

Department of Pediatrics, Shiga <strong>University</strong> of Medical<br />

Science, Otsu, Japan<br />

Reelin is an extracellular matrix protein synthesized and<br />

secreted by Cajar-Retzius (CR) cells in the marginal zone,<br />

and plays a pivotal role in cortical lamination. Calretinin, a<br />

calcium-binding protein, has been postulated to have a<br />

correlation with calcium-dependent events such as synaptogenesis,<br />

neurite elongation or neuroprotective process. The<br />

present experiment reported the model of cortical dysplasia<br />

induced by intracerebral inoculation of ibotenate in<br />

newborn hamsters. In order to investigate the role of reelin<br />

and calretinin in the development of cortical dysplasia,<br />

immunohistochemical localization of these proteins was<br />

analyzed. Main types of cortical dysplasia detected were<br />

microgyria (Mg), leptomeningeal glioneuronal heterotopia<br />

(LGH) and subcortical nodular heterotopia (SNH). Reelin<br />

immunohistochemistry showed evenly spaced CR-like<br />

cells, mainly in the more superficial aspects of the marginal<br />

zone. Focal increases of reelin immunoreactive CR-like<br />

cells were observed in the lesions of Mg and LGH. In the<br />

area of SNH, reelin immunoreactivity was not detected.<br />

Calretinin immunoreactivity was mainly observed in the<br />

following areas; small number of horizontally oriented<br />

cells in the marginal zone, intensively stained cells and<br />

fibers in the subplate, and large number of neurons in the<br />

piriform cortex. Focal accumulation of calretinin positive<br />

fibers and cells was observed in the lesions of Mg and LGH.<br />

Small number of calretinin immunoreactive cells were also<br />

detected in SNH. Overexpression of reelin or calretinin in<br />

the areas of MG, LGH and SNH was thought to be related to<br />

the abnormal tangential neuronal migration.<br />

FP-A-022<br />

Study the protection role of TGF-b1 in acute ischaemia<br />

brain damage of mice<br />

B. Xue, F. Li, X.-Z. Fang<br />

Department of Pediatrics, Sheng Li Hospital of Sheng Li<br />

Petroleum Administrative Bureau, Dong Yin, China<br />

Objective: To investigate the protection role of TGF-b1in<br />

acute ischaemia brain damage. Method: One hundred and<br />

eighty mice were randomly divided into control group,<br />

model group, TGF-b1 prevention and treatment group, cytidine<br />

5 0 -diphosphocholine (CDPC) prevention and treatment<br />

group. Mice in the prevention group were injected TGF-b1<br />

25 mg/20 g or CDPC 62.5 mg/20 g into abdominal cavity an<br />

hour before acute ischaemia brain damage model was established,<br />

while mice in the treatment group were injected the<br />

same medicines as the prevention group an hour after model<br />

was established. Ten mice of each group were killed after 24<br />

and 48 h, the brain tissues were collected to observe the<br />

changes of pathology using light microscope and electric<br />

microscope. Nerve cells of hippocampus CA1 area were<br />

counted. Expression of TGF-b1 mRNA in neuron and glial<br />

cells were detected by in situ hybridization. The death condition<br />

of the rest mice was observed. Results: TGF-b1 mRNA<br />

was not expressed in control group. It was completely<br />

expressed and most III degree in model group. Although<br />

there was also expressed in TGF-b1 prevention group and<br />

treatment group, the degree was lower than those in model<br />

group. TGF-b1 mRNA was completely expressed in CDPC<br />

prevention group and treatment group. But the degree was<br />

lower than those in model group and more than those in TGFb1group.<br />

There were more hippocampus CA1 nerve cells in<br />

TGF-b1 prevention group and treatment group than in model<br />

group and CDPC group. The change of morphology was<br />

lower than in model group and CDPC prevention and treatment<br />

group. The survive time of mice was prolonged in TGFb1<br />

prevention group and treatment group. Conclusion: TGFb1<br />

can down-regulation TGF-b1 mRNA expression, lighten<br />

the extent of damage in hippocampus CA1 area, prolong the<br />

survive time of mice, play a protection role in acute ischaemia<br />

brain damage. The effect of TGF-b1 prevention is superior<br />

to the effect of treatment.<br />

FP-A-023<br />

Building a mouse model hallmarking the congenital<br />

human cytomegalovirus infection in central nervous<br />

system<br />

J.-L. Tang a , M.-L. Wang b , J.-J. Qiu a ,D.Wu a ,W.Hu b<br />

a Pediatric Department, The First Affiliated Hospital, Anhui<br />

Medical <strong>University</strong>, Hefei, China;<br />

b The Microbiology<br />

Teaching and Researching Section, Anhui Medical <strong>University</strong>,<br />

Hefei, China<br />

To investigate the mechanisms that human cytomegalo-


Abstracts 419<br />

virus (HCMV) can vertically transmit from the placenta of<br />

mice to infect their offspring in the CNS and cause congenital<br />

anomalies, in addition provide basic research for<br />

preparing HCMV vaccine, we have developed a new type<br />

of mouse model of HCMV congenital CNS infection. Pure<br />

strain mice were propagated after being infected with<br />

HCMV, then we looked for evidences that CNS of their<br />

filial generations were infected by HCMV. The experiment<br />

shows that in the infection groups the mortality of fetal mice<br />

and the fatality of neonatal mice in 1 week are higher than<br />

that of in the control groups (P , 0:01). At the same time<br />

we research the CNS of fetus’s mice whose mother were<br />

infected by HCMV, the results are as fellows: (1) the virus<br />

was successfully isolated from their cerebral cortex. (2) The<br />

signal of HCMV hybridization print was found in their<br />

nervous cell through in situ hybridization. (3) Especially<br />

human herpes virus-like particles and inclusion bodies in<br />

the cytoplasm of nerve cell were found in the tissue of<br />

their brain under the electronic microscopy. This new type<br />

of mouse model of HCMV inherent CNS infection will help<br />

us to prepare HCMV vaccine and research HCMV congenital<br />

infection in CNS.<br />

FP-A-024<br />

Cerebrolysin protects cortical neurons from<br />

extracorporal HSV-1 infection<br />

J.-L. Tang, M.-L. Wang, D. Wu, Y. Hu<br />

Pediatric department, the First hospital affiliated to Anhui<br />

medical <strong>University</strong>, Hefei City, China<br />

The effects of cerebrolysin on isolated mice cortical<br />

neurons in a herpes simplex virus HSV-1 infection model<br />

has been examined. First prepared culture solution of<br />

newborn mouse’s cerebral cortex neurons (CCNs) and<br />

cultured them, then 0.4 ml cerebrolysin for each aperture<br />

(provided by Austrian Ebewe Medicine Factory) was added<br />

to CCNs culture solution respectively on the 2nd, 4th, 6th<br />

and 10th day. At the same time one group of normal culture<br />

solution of newborn mouse’s cerebral cortex neurons was<br />

utilized as control group. On the 12th day, each aperture was<br />

received 3.0 log TCID50 suspension of HSV-1. The results<br />

are as follow: (1) the culture groups that receiving cerebrolysin<br />

on the 4th or 6th day were found to suffer lower CCNs<br />

pathological damages ratio (25–40%) after 24 h later, while<br />

other culture groups receiving cerebrolysin on the 2nd, 8th<br />

or 10th day suffered higher CCN’s pathological damage<br />

ratio (75–90%). (2) In five kinds of culture solution with<br />

different cerebrolysin concentration showed no obviously<br />

pathological damage, which indicated that cerebrolysincan<br />

protect CCNs from the harm of HSV-1. This conformed that<br />

adding cerebrolysin to CCN culture on the 4th or 6th day<br />

could intensify CCN’s HSV-1 resistance. But why the<br />

culture groups that receiving cerebrolysin on the 2nd day<br />

shows no enough protective efficacy is worthy studying in<br />

the future.<br />

FP-A-025<br />

Experimental study in the effect of platelet activating<br />

factor and its antagonist on hypoxic ischemic<br />

encephalopathy<br />

W. Wang, D. Li, S.-Y. Li, Y. Gao<br />

Children Hospital of Changchun, Changchun, China<br />

Objective: To investigate the relationship between platelet<br />

activating factor (PAF) and hypoxic ischemic encephalopathy<br />

(HIE), and new method of therapy. Methods: Serum<br />

PAF in Wistar rats and 20 patients with HIE were assessed<br />

by improved Henson’s method. The PAF antagonist<br />

(BN51021) was used to treat test rats with HIE. Results:<br />

The level of serum PAF in test Wistar rats and patients<br />

with HIE was significantly higher than that of normal<br />

control group P , 0:001). The level of serum PAF in tests<br />

Wistar rats with higher PAF was reduced by ginkgolides<br />

antagonist (BN51021). Conclusion: The PAF is related to<br />

HIE, can be considered as a marker to assess HIE severity<br />

and prognosis. The ginkgolides antagonist (BN51021) can<br />

obviously inhibit the production of PAF in test Wistar rat<br />

with HIE and decrease serum PAF (0.001). This study may<br />

help for future treatment of HIE.<br />

FP-A-026<br />

Stimulation of N-methyl-d-aspartate (NMDA) receptors<br />

inhibits neuronal migration in the embryonic cerebral<br />

cortex<br />

M. Kihara a , H. Yoshioka b , K. Hirai b , M. Murata b ,K.<br />

Hasegawa b , Z. Kizaki b , T. Sawada c<br />

a Kyoto First Red Cross Hospital; b Department of Pediatrics,<br />

Kyoto Prefectural <strong>University</strong> of Medicine, Kyoto,<br />

Japan; c Kyoto Second Red Cross Hospital, Japan<br />

The role of the NMDA receptor in neuronal migration in<br />

the cerebral cortex is still unclear. We performed a tissue<br />

culture study using embryonic rat brain to investigate the<br />

effect of excessive stimulation of NMDA receptors on the<br />

neuronal migration in the cerebral cortex. Four significant<br />

cellular zones were identified in the cultured cerebral wall:<br />

the ventricular zone, the inner intermediate zone, the outer<br />

intermediate zone, and the cortical plate. After we labeled<br />

progenitor cells in the ventricular zone of E16 cerebral<br />

cortex explants by [ 3 H] thymidine, the explants were<br />

cultured for 48 h, and distribution of labelled cells was<br />

autoradiographically evaluated. Stimulation of NMDA<br />

receptors, by adding the NMDA receptor agonist, NMDA<br />

(10 mM) or ibotenate (1 mM), to the culture medium caused<br />

a significant percent decrease of labeled cells in the intermediate<br />

zone and an increase in the ventricular zone. This<br />

suggests that stimulating NMDA receptors by agonists inhibits<br />

neuronal migration in rat cerebral cortex. It is known<br />

that blocking NMDA receptors also inhibits neuronal migration<br />

in the cerebral cortex. These results suggested that acti-


420<br />

Abstracts<br />

vation of NMDA receptors within a relatively narrow<br />

window is essential for a normal rate of neuronal migration.<br />

FP-A-027<br />

The effect of pentylenetetrazol on the activation of NFkB<br />

in cultured primary hippocampal cells<br />

K.-Y. Wang, X.-Z. Ruan, S.-Q. Zhu, W. Wang<br />

Department of Neurology, Tongji Hospital, Tongji Medical<br />

College, Huazhong; <strong>University</strong> of Science and Technology,<br />

Wuhan, China<br />

Objective: To investigate the role of pentylenetetrazol on<br />

the activation of NF-kB in cultured primary hippocampal<br />

cells. Methods: We measured the apoptosis and inhibiting<br />

rate initiated by pentylenetrazol (PTZ) in both PB-treated<br />

and PB-untreated primary cultured hippocampal cells<br />

respectively by a FACScan side scatter analysis and MTT<br />

method. The activation of NF-kB was detected by laser<br />

scanning confocal microscopy with FITC-tagged p65 antibody<br />

and PI-staining DNA. Results: NF-kB/p65 associated<br />

green fluorescence can be seen in the nuclei of PB-untreated<br />

hippocampal cells after PTZ stimulation, but were not seen<br />

in the nuclei of cells without PTZ stimulation and in the<br />

nuclei of PB-treated cells after PTZ stimulation. After PTZ<br />

stimulation, surviving rates of PB-treated hippocampal cells<br />

were not significantly higher than those of PB-untreated<br />

hippocampal cells (P . 0:01). The percentages of apoptosis<br />

in PTZ stimulated PB-untreated cells were not significantly<br />

higher than those without PTZ stimulation and PB-treated<br />

cells after PTZ stimulation (P . 0:01). Conclusion: These<br />

results demonstrated that PTZ can activate NF-kB of hippocampal<br />

cells, and not induced excitotoxicity. PB may interfere<br />

the effect of PTZ through the pathway of the activation<br />

of NF-kB.<br />

FP-A-028<br />

The mechanism and pathway of cytokine-induced<br />

apoptosis in astrocytes of rats<br />

J.-B. Liu, Y.-J. Yang<br />

Department of Pediatric, Xiangya Hospital, Changsha,<br />

Huna Province, China<br />

Objective: To explore the mechanism of LPS, interleukin<br />

1b (IL-1b), and TNF-a-induced apoptosis and the pathway<br />

of the apoptosis in astrocytes of rats. Methods: The astrocytes<br />

were cultured in vitro and treated with sole or combination<br />

of LPS, IL-1b, and TNF-a. Cell viability was<br />

demonstrated by MTT method. Apoptosis was observed<br />

by fluorescence microscope using acridine orange, EB,<br />

and anti-annexinV-cy3 monoclonal antibody and by electron<br />

microscope. Apoptosis rates of astrocytes were evaluated<br />

by flow cytometry; NO 2 2 /NO 2<br />

3 were assayed by<br />

spectrophotometer; cytochrome c in cell plasma was determinated<br />

by Western blot; caspase-3 mRNA was observed<br />

by in situ hybridization. Results: LPS 1 IL-1b 1 TNF-a<br />

can decrease the cell viability to 0.46 ^ 0.15. The amounts<br />

ranking of MTT in cells were LPS 1 IL-1b 1 TNF-a treated<br />

.LPS 1 IL-1b treated .LPS 1 TNF-a treated.<br />

Amount of NO 2 2 /NO 3 2 produced by astrocytes stimulated<br />

by LPS 1 IL-1b 1 TNF-a was the highest at 72 h. Amount<br />

of NO 2 2 /NO 3 2 and MTT of astrocytes had negative relation,<br />

l-NMMA pretreatment can attenuate NO 2 2 /NO 3 2 produced<br />

by astrocytes stimulated by LPS 1 IL-1b 1 TNF-a and<br />

relieve the cell viability. Cytochrome c in cell plasma of<br />

astrocytes stimulated by LPS 1 IL-1b 1 TNF-a and the<br />

expression of caspase-3 mRNA were higher than normal<br />

control. l-NMMA decreased the amount of cytochrome c<br />

in cell plasma of astrocytes and the expression of caspase-3<br />

mRNA. Conclusion: Cytokines decreased the viability of<br />

astrocytes because of autoendocrine of NO. Inhibition of<br />

NO by l-NMMA relieved the viability of astrocytes stimulated<br />

by LPS 1 IL-1b 1 TNF-a. NO can cause astrocytes<br />

apoptosis, this may relate to releasing the cytochrome c<br />

from mitochondria cell plasma, and activating the expression<br />

of caspase-3 mRNA.<br />

FP-A-029<br />

Treatment of Rett syndrome patients with<br />

transplantation of embryonic nervous tissue<br />

V.I. Tsymbaliuk, N.A. Pichkur, L.D Pichkur<br />

Institute of Neurosurgery Named Academician A.P. Romodanov,<br />

Academy of Medical Sciences, Ukrainian Children’s<br />

Specialized Hospital ‘OKhMATDET’, Kyiv, Ukraine<br />

RS is a neurodevelopmental disorder occurring exclusively<br />

in girls. D. Armstrong et al. (1995) found striking<br />

decrease in the dendritic trees of selected cortical areas,<br />

chiefly projection neurons of the motor, association, and<br />

limbic cortices. They suggested that the pathologic changes<br />

were based on the trophic factors deficit. Degenerating<br />

axons in the caudate nucleus were identified, which suggests<br />

dysfunction in the dopaminergic nigrostriatal system. The<br />

authors suggested applying the method of RS treatment with<br />

transplantation of embryonic nervous tissue into the motor<br />

area of cerebral cortex. Treatment and assessment of five<br />

patients with classic RS phenotype aged 3–10 years was<br />

conducted. Chromosomes and metabolic screening results<br />

of these patients were normal. The patients were observed<br />

6–12 months post-operatively. Positive dynamics in clinical<br />

status was identified in five patients: reductions in stereotypic<br />

behaviors (body rocking, hand mannerisms). Purposeful<br />

hand use improved in two patients. They re-acquired<br />

self-service feeding skills and were able to grasp objects<br />

and transferred them from hand to hand. Signs of spasticity<br />

with rigidity in lower extremities and truncal ataxia diminished<br />

and gait improved (in four patients). Bursts of hyperventilation<br />

stopped in two patients. Significant<br />

improvement was noted in the youngest patients (3 and 4<br />

years old). The changes were stable. Embryonic nervous


Abstracts 421<br />

tissue transplantation could be a potential method of RS<br />

treatment.<br />

FP-A-030<br />

Expression of adhesion and extracellular matrix<br />

molecules in the developing human brain<br />

B. Anlar, P. Atilla, A.N. Çakar, M.F. Kose, M.S. Beksaç,A.<br />

Dagdeviren, Z. Akçören<br />

Hacettepe <strong>University</strong> Department of Pediatric Neurology,<br />

Ankara, Turkey<br />

Cell adhesion molecules (CAM) and extracellular matrix<br />

molecules (ECM) have important roles in cell migration and<br />

connection. Their developmental expression has not been<br />

fully described in human brain. In this report, CAM and<br />

ECM immunohistochemistry was examined in frontal tissue<br />

samples from 14 to 28 weeks old fetuses aborted for obstetrical<br />

reasons (n ¼ 22) and four fetuses with nervous system<br />

abnormalities. Neural adhesion molecule (NCAM) and<br />

fibronectin were present at all gestational ages examined<br />

while laminin and tenascin expression started at 17 weeks.<br />

As gestational age progressed, expression of NCAM and<br />

glial fibrillary acidic protein tended to increase while N-<br />

cadherin and laminin decreased. The distribution was predominantly<br />

vascular for laminin and fibronectin, and in the<br />

neuropil for NCAM, tenascin and thrombospondin. The<br />

expression of thrombospondin and fibronectin shifted from<br />

periventricular to outer cortical layers with advancing gestational<br />

age. This time- and site-related expression supports<br />

the role of these molecules in tissue differentiation and<br />

response to injury. The descriptive data obtained in this<br />

study might constitute a basis for further studies investigating<br />

the role of CAM and ECM in developmental abnormalities<br />

of the CNS.<br />

FP-A-031<br />

Transient intrauterine hypotension causes apoptosis in<br />

fetal brain and affects learning<br />

M. Tombakoglu, M. Durakoǧlugil, G. Kale, H. Orer, B.<br />

Anlar<br />

Hacettepe <strong>University</strong> Departments of Pediatric Neurology,<br />

Pediatric Pathology and Pharmacology, Ankara, Turkey<br />

Hypotensive episodes are frequent during pregnancy, and<br />

their functional effect on fetal brain has not been studied.<br />

We produced systemic hypotension for 30 min during midgestation<br />

in pregnant rats and examined their offsprings on<br />

postnatal days 1 and 28. When compared to sham controls,<br />

the brains of the hypotensive group contained more<br />

TUNEL-positive cells in the hippocampal and periventricular<br />

regions on both time points. Spatial learning was<br />

impaired in 28 day-old pups of the hypotensive mothers,<br />

and correlated with the number of apoptotic cells. These<br />

results indicate that transient maternal hypotension induces<br />

apoptotic cell death in fetal brain and affects learning. Similar<br />

mechanisms might be involved in the pathogenesis of<br />

human learning disorders.<br />

FP-A-032<br />

Use of fluorescent proteins expressed in specific neural<br />

cell types to trace differentiation of neural progenitor<br />

cells<br />

M. Maletic-Savatic a,b , J. Mignone a , R. Malinow a ,G.<br />

Enikolopov a<br />

a Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold<br />

Spring Harbor, NY, USA;<br />

b School of Medicine, State<br />

<strong>University</strong> of New York, HSC T12-020, Stony, Brook, NY,<br />

USA<br />

Neurogenesis, a process first thought to be limited to the<br />

prenatal period, occurs throughout life in distinct brain<br />

regions, such as the subventricular zone and the dentate<br />

gyrus subgranular zone. Over the past decade, a considerable<br />

amount of data has been accumulated regarding the identification,<br />

isolation, propagation, and pluripotency of neural<br />

progenitor cells (NPC). However, little is known about the<br />

specific mechanisms that commit differentiation of neural<br />

progenitor cells toward a specific cell lineage, such as the<br />

neuronal or glial lineage. To investigate the in vivo differentiation<br />

of neural progenitor cell, we developed a unique<br />

approach, which enabled us to visualize differentiation of<br />

neural progenitor cells into different neural cell types,<br />

under a variety of experimental conditions. We generated<br />

transgenic mice that express different fluorescent proteins,<br />

specific to a neural cell type, and we observed differentiation<br />

of NPCs into these cell types using two-photon microscopy.<br />

We studied this process in organotypic slice cultures derived<br />

from the mature (.3-week-old) transgenic mice. This<br />

culture model is a very-well studied model that closely<br />

mimics in vivo conditions, with preserved hippocampal<br />

circuitry. The therapeutic potential of adult hippocampal<br />

neurogenesis may be profound. Identification of specific<br />

conditions that promote neurogenesis will increase the<br />

potential use of NPCs as agents for brain tissue reorganization<br />

and repair.<br />

FP-A-033<br />

Changes of calcium calmodulin and phasphodiesterase<br />

in the brain damage of newborn pigs of hypoxic ischemic<br />

encephalopnthy<br />

L.-P. Hu<br />

Beijing Military Medical College, Beijing, China<br />

Objective: The changes of calcium (Ca 21 ), calmodulin<br />

(CaM) and phosphodiesterase (PDE) were tested in the<br />

brain damage model of newborn pigs HIE. Methods: PDE<br />

indirect determine of improvement Thompson CaM, PDE<br />

and CaM were removed in the response solution and atom


422<br />

Abstracts<br />

spectrophotometry. Results: The brain Ca 21 content was not<br />

change at unit volume of fresh cerebral tissue, CaM content<br />

and PDE activity rose significantly at that time and 12 h of<br />

the brain damage. Conclusion: The changes of CaM content<br />

and PDE activity were related to the brain damage of HIE.<br />

FP-A-034<br />

Resistance to brain damage caused by prolonged<br />

seizures in rats with different maturational stages<br />

L. Jiang, F.C. Cai, X.P. Zhang<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: To demonstrate the special ability to resist brain<br />

damage from prolonged seizures and convulsive status<br />

epilepticus (SE) in premature animals. Methods: Megimide<br />

was injected in 80 healthy and adult rats respectively to evoke<br />

prolonged seizures and SE. The incidences of injured<br />

neurons were analyzed at the slices of hippocampus CA3,<br />

dentate gyrus and parietal cortex. Results: (1) Adults rats<br />

(ARs) only had less than 20 min prolonged seizures with<br />

the same dose of megimide. However 71.4% baby rats<br />

(BRs) experienced SE. (2) The average duration from the<br />

onset to death during the period of seizures was 44 ^ 24<br />

min in BRs, and 7 ^ 5 min in ARs. (3) Comparing the incidences<br />

of dead neurons at different cortical areas, a typical<br />

pathologically pattern of selective neuron damage was<br />

shown predominately at the hippocampus and dentate<br />

gyrus. (4) On the 4th day after the seizure in BRs, the number<br />

of necrotic neurons counted in the hippocampus and dentate<br />

gyrus was 60 ^ 21 in the group with seizures lasting #29<br />

min; 167 ^ 51 with seizures lasting 30 ^ 59 min. However<br />

there were 227 ^ 34 min of necrotic neurons in ARs although<br />

the seizures lasted only #20 min. The number of dead<br />

neurons could be equal between ARs and BRs only when<br />

the seizures of BRs was lasting .60 min. Conclusion: (1)<br />

Premature brain was more likely to have prolonged seizures<br />

or SE than adults. (2) There was a big difference of the resistance<br />

to brain damage caused by severe seizures between the<br />

premature and mature brain, the more premature the more<br />

resistant. (3) Brain damage induced by severe seizures was<br />

characteristically observed as selected neuronal loss predominantly<br />

at the hippocampus and dentate gyrus. (4)<br />

Prolonged SE, particularly more than 60 min, could also<br />

induce brain injury in BRs in spite of their much stronger<br />

resistance to the injury.<br />

FP-A-035<br />

Serial observation on the patterns of selective neuron<br />

injury after prolonged seizures in premature and<br />

mature brain<br />

L. Jiang, F.C. Cai, X.P. Zhang, X. Li<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: To explore the difference of the patterns on<br />

selective neuron injury after prolonged seizures or convulsive<br />

SE in the premature and mature brain. Methods: ARs<br />

experienced 15–20 min seizures, and BRs experienced 21–<br />

75 min seizures were sacrificed at six time points during the<br />

period of 4–168 h after the seizure stopped. The necrotic and<br />

apoptotic neurons were counted microscopically. The incidence<br />

of apoptosis was also comparatively studied by FACS,<br />

TUNEAL and electron microscopy. Results: (1) The process<br />

of neuronal death was shown even at 4 h after severe seizures.<br />

The peak of necrotic process reached at 24–48 h after<br />

seizures in ARs (180 ^ 38 cells). It was two times higher<br />

than BRs (90 ^ 5.9 cells). (2) In ARs, apoptotic neurons<br />

had been shown from the early stage after seizures, and the<br />

peak level of apoptosis (28 ^ 3.3%) was reached at 24–72 h<br />

after prolonged seizures, which was 5–8or5–6 times higher<br />

than controls, and 4–7 or 3–4 times higher than BRs<br />

measured by FACS or TUNEAL. (3) However, there was<br />

only a mild increase of apoptotic neurons in BRs at early<br />

stage, but lower than that of control in 24 h. Conclusion:<br />

(1) Selective neuronal death induced by prolonged seizures<br />

and SE resulted from necrosis and apoptosis. (2) Significant<br />

processes of necrosis and apoptosis of neurons could be well<br />

presented from the early stage, and apoptosis became dominant<br />

with time 12 h after seizures in ARs. (3) The severity of<br />

neuronal death in BRs was much lower than ARs, especially<br />

in the process of apoptosis after severe SE. It was indicated<br />

that there could be an internal response physiologically in the<br />

premature brain after SE to protect neuronal death, or even to<br />

inhibit the process of apoptosis.<br />

FP-A-036<br />

A molecular biological study on the resistance to brain<br />

damage induced by prolonged seizures in the premature<br />

brain<br />

L. Jiang, F.C. Cai, X.P. Zhang<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: In a previous study we found that the premature<br />

brain has a stronger resistance to brain damage induced<br />

by prolonged seizures or SE. In this study we tried to<br />

explore the molecular biological basis of internal protective<br />

response in the premature brain which reduces the process<br />

of apoptosis and necrosis of neurons. Methods: Megimide<br />

was injected in healthy ARs and BRs to evoke prolonged<br />

seizures and SE. ARs and BRs rats were sacrificed at 1/2, 2,<br />

8, 24, 48, and 72 h after the prolonged seizure stopped.<br />

Hippocampus, dentate gyrus and parietal cortex were<br />

taken for immunocytochemistry and Western blot studies<br />

for expression of apoptosis associated genes bcl-2 and<br />

p53. Results: (1) There was a much stronger and higher<br />

rate (90%) of p53 expression in ARs’ brain, and such a<br />

state was continually kept even at 72 h after the seizure<br />

stopped; however, bcl-2 expression was weak and low


Abstracts 423<br />

(57%), and no difference was found in bcl-2 expression at<br />

several hours as compared with normal controls. (2) In BRs’<br />

brain there were more than 85% neurons with a strongest<br />

expression of bcl-2; and the strongest bcl-2 expression was<br />

sustained 72 h after SE. However p53 expression lasted less<br />

than 24 h. Conclusion: Significant difference between the<br />

premature and mature brain was shown in genes expression<br />

associated apoptosis after seizures. Anti-apoptosis gene<br />

(bcl-2) expression was much higher and longer than apoptosis<br />

gene (p53) in BRs’ brain, and it was reversed in the<br />

ARs group. The strongest expression of bcl-2 after SE could<br />

be the important molecular biological basis for the special<br />

resistance to neuronal injury in the premature brain.<br />

FP-A-037<br />

A dynamic study of neuronal death after prolonged<br />

seizures in rats<br />

L. Jiang, F.C. Cai, X.P. Zhang<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: To explore the feature of selective neuronal<br />

injury after prolonged seizures in the mature brain, and to<br />

explore the relationship of serum neuron specific enolase<br />

(NSE) with brain damage. Method: Prolonged seizures<br />

were evoked by Megimide in 30 adult Wistar rats. All rats<br />

experienced prolonged seizures with duration of 15–20 min.<br />

Five rats were sacrificed at 4, 12, 24, 48 and 72 h and 7 days<br />

after seizures stopped. The dead neurons were observed<br />

light-microscopically (HE & Thionine staining) and electron-microscopically<br />

at the areas of hippocampus and the<br />

cortices. At the same time, the serum level of NSE was tested<br />

by ELISA. Results: (1) There was a obvious selective neuronal<br />

death after prolonged seizures. The process of neuronal<br />

death was remarkably shown even at the early stage of 4 h<br />

after severe seizures. A peak of necrotic process was counted<br />

at 24 , 48 h after seizures (180 ^ 38 cells); it was five times<br />

higher than that for controls (38 ^ 6 cells). (2) By the ELISA<br />

study, the NSE level was also increased 4 h after seizures, and<br />

reached its peak concentration at 48 h (5.13 ^ 0.77 nmol/l),<br />

much higher than that of controls (3.53 ^ 0.87 nmol/l).<br />

Conclusion: Prolonged seizures in the mature brain will<br />

lead to selective neuronal death mainly in the hippocampus,<br />

which was related with changes of serum NSE. Serum NSE<br />

could be a useful marker for detecting neuronal death.<br />

FP-A-038<br />

The role of heat shock reaction for protection of brain<br />

damage in the premature brain after prolonged seizures<br />

L. Jiang, F.C. Cai, X.P. Zhang<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: In our previous study we found that the premature<br />

brain has a stronger resistance to brain damage induced<br />

by prolonged seizure. In this study we tried, to explore the<br />

role of heat shock reaction (HSR) and its molecular mechanism<br />

for protection of brain damage in the premature brain<br />

after prolonged seizures. Method: Prolonged seizures were<br />

evoked by Megimide in 30 each of BRs and ARs, respectively.<br />

At 1/2, 2, 8, 24, 48 and 72 h after the seizures stopped,<br />

five rats were sacrificed in each group, and the hippocampus,<br />

dentate gyrus and temporal cortex of their brains were taken<br />

for the following studies: (1) expression of HSR associated<br />

protein, heat shock protein70 (HSP70) was tested by immunocytochemistry;<br />

and in thick liquid of brain tissue by<br />

Western blot; and (2) measurement of the NO level in thick<br />

liquid of brain tissue by fluorospectrometry. Results: (1)<br />

There was a big difference in expression of HSP70 between<br />

the premature and mature brain after severe seizures. Positive<br />

rate of the neurons with HSP70 expression was as high as<br />

85% in the premature brain, and 52.5%of them with strongest<br />

or stronger expression. However, in the adults’ brain, the<br />

positive rate was 65% only, particularly with weak expression<br />

in most (77.5%). (2) A similar result was obtained by<br />

Western blotting. The strongest or stronger HSP70 expression<br />

was well shown continually in the premature brain even<br />

3 days after severe seizures. In contrast, the strongest or<br />

stronger HSP70 expression in the adults’ brain was sustained<br />

less than 24 h. (3) The NO level in the brain quickly increased<br />

in both age groups after severe seizures. A peak level<br />

(9.0 ^ 1.2 nmol/l) in the baby brain was reached within 2 h<br />

after SE but decreased rapidly in 8 h and was lower than<br />

control (5.0 ^ 1.4 nmol/l) 24 h later. In contrast, there was<br />

a peak level (6.6 ^ 1.2 nmol/l) in 24 h after seizures but with<br />

the high level continually in the adult brain. Conclusion: (1)<br />

There was also a significant difference between the premature<br />

and mature brain in heat shock response after prolonged<br />

seizures. There was quick and continual HSP70 expression at<br />

a high level to protect the neurons in the premature brain, but<br />

only weak expression temporally in the adult brain. (3) The<br />

strongest expression of HSP70 after SE could be the important<br />

molecular biological basis of special resistance to neuronal<br />

injury in the premature brain. They are not only to inhibit<br />

apoptosis and protect neurons but also to reduce NO in brain.<br />

FP-A-039<br />

An experimental study on rectal administration of a<br />

mixed solution of clonazepam with acetaminophen<br />

L. Jiang, F.C. Cai, P. Qu<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: To study the efficacy of clonazeparm (CNP)<br />

after rectal administration of CNP with acetaminophen<br />

(ACE). Methods: (1) The mixed solution of CNP-ACE (1<br />

mg CNP with 100 mg ACE) and CNP were administered<br />

rectally to Wistar rats in a dose of 1.5 mg/kg, respectively.<br />

(2) The concentration of CNP was measured by HPLC in the


424<br />

Abstracts<br />

blood at different time points, and the parameters of pharmacokinetics<br />

were calculated by a computer program of<br />

3P87. (3) The pharmacology of CNP was detected by the<br />

change of EEG patterns and the efficacy of seizure control.<br />

(4) At the same time the rectal mucosa was studied pathologically.<br />

Results: (1) The pharmacokinetic study demonstrated<br />

that CNP was rapidly absorbed from rectum in both<br />

groups with a peak blood level at 15.3 ^ 6.1 and 15.8 ^ 1.6<br />

min, respectively. (2) Within 5 min after CNP or CNP-ACE<br />

administration, EEG patterns were significantly changed<br />

and the frequency of b band was increased by 7.8 and<br />

7.3%. (3) Compared with the control group, the incidence<br />

of seizures, duration of seizures, and death induced by<br />

seizures were decreased from 100 to 50, 20%; 9.8 ^ 3.2–<br />

0.7 ^ 0.6, 0.3 ^ 0.1 min; 70% to 0, respectively. (4) There<br />

were no obviously pathological changes of rectal mucosa or<br />

any side effect in both groups. Conclusion: ACE had no<br />

obvious interfering effect with CNP when such a mixed<br />

solution was administered rectally in Wistar rats. CNP-<br />

ACE may be a quick and effective way to control febrile<br />

seizures in clinical work, especially for outpatients.<br />

FP-A-040<br />

The expression of caspase-3 mRNA in the hippocampus<br />

of 7-day-old hypoxic-ischemic rats and the mechanism of<br />

neural protection by magnesium sulfate<br />

Y. Tang, F.-L. Zhao<br />

Department of Pediatrics, The Third Hospital of Beijing<br />

<strong>University</strong>, Beijing, China<br />

Objective: There was consanguineous relationship<br />

between caspase-3 and early damage after hypoxia and ischemia.<br />

Caspase-3 played a key role in the process of apoptosis<br />

in the neuron. Magnesium sulfate could protect the neuron<br />

from injury but the mechanism was not clear yet. The<br />

research was to investigate the expression of caspase-3<br />

mRNA in the hippocampus of 7-day-old hypoxic-ischemic<br />

rats and the possible mechanism of neural protection by<br />

magnesium sulfate. Methods: The model of 7-day-old<br />

hypoxia-ischemia rats was performed. The rats were divided<br />

randomly into six groups as follows: (1) normal control<br />

(n ¼ 4); (2) sham surgery control (n ¼ 4); (3) hypoxia-ischemia<br />

(n ¼ 4); (4) sodium chloride injection with hypoxiaischemia<br />

(n ¼ 4); (5) magnesium sulfate pro-injection with<br />

hypoxia-ischemia (n ¼ 4); and (6) magnesium sulfate postinjection<br />

with hypoxia-ischemia (n ¼ 4). The therapy groups<br />

received a bolus injection of 500 mg/kg magnesium sulfate<br />

intraperitoneally 0.5 h before or after hypoxia-ischemia.<br />

Semi-quantitative RT-PCR was used to measure caspase-3<br />

mRNA expression in the hippocampus 24 h after hypoxiaischemia.<br />

The differences were compared among the groups.<br />

Results: The expression of caspase-3 mRNA was significantly<br />

increased in the hippocampus of the hypoxia-ischemia<br />

pups (P , 0:01). Both magnesium sulfate pro-injection and<br />

post-injection significantly decreased the expression of<br />

caspase-3 mRNA (P , 0:05). Conclusion: Caspase-3 is activated<br />

in the hippocampus of the 7-day-old rats 24 h after<br />

hypoxia-ischemia. The suppression of the expression of<br />

caspase-3 mRNA in the hippocampus is probably related to<br />

the protective effect of magnesium sulfate to brain injury<br />

with hypoxia-ischemia.<br />

FP-B<br />

Epidemiology<br />

FP-B-001<br />

A neuroepidemiological study on severe motor and<br />

intellectual disabilities syndrome in Okayama<br />

prefecture<br />

Y. Yamatogi, M. Morooka, M. Murao<br />

Okayama Prefectural <strong>University</strong>, Kuboki Soja-City, Japan<br />

Objective:Toclarifytheinfluencesofmedicalprogressand<br />

social support systems, a neuroepidemiological study was<br />

carriedoutonseverelymentalandmotorhandicappedpersons<br />

with onset before 18 years of age, on the prevalence day of<br />

January 31, 2001, in Okayama Prefecture in Japan. Results:<br />

(1) 681 severely handicapped persons were found in a population<br />

of1 958 403; prevalence rate was 0.348/1000 population<br />

(0.414 for males and 0.287 for females). Prevalence rates in<br />

the age groups were: 0.33 (0–4 years); 0.87 (5–9 years); 0.97<br />

(10–14 years); 0.73 (15–19 years); 0.57 (20–24 years); 0.52<br />

(25–29 years); 0.55 (30–39 years); 0.32 (40–49 years); 0.04<br />

(50–69 years); and (2) cerebral palsy was most frequently<br />

observed in 57.7% of patients, followed by post-encephalitis<br />

orencephalopathicstatesin13.5%.Etiologieswerepresumed<br />

prenatal in 28.8%, perinatal in 42.6%, postnatal in 22.6%, but<br />

undetectable in 6.0%. A total of 72.8% had epilepsy, which<br />

was more prevalent in those with more severe mental retardation.<br />

(3) According to the severity of handicap, 52.3%<br />

belonged in the severest group and 38.2% in the group with<br />

some, but useless, movement and severe mental defect. The<br />

rate of those institutionalized was 43.5%; lowest in the severest<br />

group, but with a rapid increase after the age of 20 years.<br />

Conclusion: No change was observed in the prevalence rate in<br />

school-age during the last 35 years, but was etiologically<br />

different; very-low-weight births, brain malformations, chromosomal<br />

abnormalities and postnatal factors were increased<br />

and hyperbilirubinemia was markedly decreased. Extremely<br />

severe cases are increasing.<br />

FP-B-002<br />

A study on the epidemiology of childhood cerebral palsy<br />

in Zhejiang Province, China<br />

Z.-Y. Zhao, X.-J. Zhou, Q.-X. Shui<br />

The Affiliated Children’s Hospital of Zhejiang <strong>University</strong><br />

School of Medicine, China<br />

Objective: To understand the prevalence and status of CP


Abstracts 425<br />

in children, in order to provide basic data for future prevention<br />

and therapy of CP. Methods: During October and<br />

November 1998, we investigated the status of CP among<br />

children aged 1 , 6 years from 66 townships of 15 cities or<br />

counties in Zhejiang province. The investigators were given<br />

professional training before the study. Physical examinations<br />

were performed on children selected by screening<br />

standard. According to the diagnostic standard, some of<br />

these children were diagnosed with CP. Results: The register<br />

comprised 62–949 children aged 1 , 6 years, 92 of<br />

whom were diagnosed with CP (1.46‰). No statistical<br />

significance was found between sex or age (P . 0:05).<br />

Furthermore, no significant difference was found in prevalence<br />

between children in cities and rural areas. Conclusions:<br />

The prevalence of CP in Zhejiang province was<br />

lower than that of some developing countries, and also<br />

lower than that of Jiangsu province.<br />

FP-B-003<br />

Epidemiology of childhood brain tumor in Croatia – 30<br />

years analysis of a series of hospital patients<br />

I. Prpić, E. Paučić-Kirinčić, M. Smokvina, A. Sasso, Z.<br />

Modrušan-Mozetič, D. Fiket<br />

<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />

From 01.01.1971. to 31.12.2001 in the Pediatric Clinic<br />

‘Kantrida’, 87 children with primary brain tumor were<br />

analysed retrospectively and prospectively. The mean incidence<br />

of brain tumor was three children annually. There<br />

were 48 boys and 39 girls, and the average age was 6.7<br />

years (^4.1 years). In 48 children (55.1%) the tumor was<br />

located infratentorial (IT), and in 39 (44.8%) supratentorial<br />

(ST). The most common pathohistological type was astrocytoma<br />

and medulloblastoma. Before the brain tumor was<br />

confirmed, symptoms lasted an average of 55.9 days<br />

(median 30 days); the IT tumors 73.1 days, and the ST<br />

tumors 31.5 days, which is a statistically significant difference.<br />

In making a diagnosis, based on neuroimaging techniques,<br />

brain CT was used from 1978, and MR<br />

systematically since 1989. With the purpose of early detection<br />

of brain tumor in children, our data indicates the need<br />

for systematic follow-ups and broader medical attention to<br />

children who besides specific tumor symptoms, show nonspecific<br />

EEG changes. During the last 10 years (1991–2001)<br />

from a total of 36 children diagnosed with brain tumor, eight<br />

have died (22%), 16 are still living (44%), while the<br />

outcome for the other 12 children is unknown. This is in<br />

line with a general survival rate of children diagnosed with<br />

brain tumor (40–50%). Results of our research are comparable<br />

to the results of research conducted on a larger number<br />

of patients which point to the fact that analysis of a hospital<br />

series of patients provides reliable data. Moreover, such<br />

research can be used to implement a registry of children<br />

with history of brain tumor with the purpose of following<br />

the progress of the treatment. and analysing the immediate<br />

and long term effects on the children’s quality of life.<br />

FP-B-004<br />

The epidemiological data of febrile seizures in the<br />

northern coastal region of Croatia<br />

E. Paučić-Kirinčić, S. Surijan, I. Prpić, Z. Modrusan-<br />

Mozetič, A. Sasso, D. Fiket<br />

<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />

Clinical and epidemiological investigations of FS have<br />

appeared in the paediatric literature for many years but<br />

accurate data from Croatia are deficient. From 1.1.1996.<br />

till 31.12.2000. at the <strong>University</strong> Children Hospital<br />

‘Kantrida’ 399 children with FS were retrospectively and<br />

prospectively analysed. Children Hospital ‘Kantrida’ is the<br />

only referral specialist child health centre in this region of<br />

Croatia and all children are referred to the Hospital to ensure<br />

accuracy of the presented data. There were 208 boys and<br />

191 girls. The peak age incidence was between 12 and 24<br />

months and 87.9% of the children were between 7 months<br />

and 3 years of age. The FS were frequently connected with<br />

upper respiratory tract infections and most FS occurred in<br />

the month of February. A total of 271 (67.9%) children had<br />

simple FS, 37 (9.3%) children had complex FS and 91<br />

(22.8%) children had repeated FS. The mean days of hospitalization<br />

were 8.9 days, but longer for complex FS (10.8<br />

days). FS represents 18.2%, of total number of hospitalized<br />

children in the Department of Child Neurology, which is<br />

time and money-consuming for conditions with minor<br />

long term consequences. The results of our study are similar<br />

to the results of researches conducted on larger numbers of<br />

patients, which demonstrates that analyses of a hospital<br />

series gives reliable data.<br />

FP-B-005<br />

A clinical-epidemiological study of epilepsy in the first 3<br />

years of life among children who attended the<br />

Alexandria university children hospital for the period of<br />

1 year<br />

F.M. Kamel, M.I. Kamel, T. El-Omar, A.M.M. Maged<br />

Department of Pediatrics, Faculty of Medicine, Alexandria<br />

<strong>University</strong>, El-Shatby, Alexandria, Egypt<br />

There are many methodological difficulties in studying<br />

epidemiological aspects of epilepsy are developing countries.<br />

These include: incomplete and inaccurate medical<br />

records; questionnaires may miss mild, partial and inactive<br />

epilepsy; traditional views of illness; symptoms and etiology<br />

of epilepsy are different in rural areas; and lastly, epileptic<br />

seizures may be misdiagnosed. This study comprised a hospital-based<br />

cross-sectional cohort. The aim was to evaluate the<br />

pattern of epilepsy in children aged 3 years or less at the time


426<br />

Abstracts<br />

of the study, among those children who attended the epilepsy<br />

clinic at the Alexandria <strong>University</strong> Children Hospital for a<br />

period of 1 year (April 1999–April 2000). A total number of<br />

182 children with epilepsy were selected, and an equal<br />

number of age and sex-matched healthy children served as<br />

controls. Records were revised and filed in a special computer<br />

software package. The data included: demographic characteristics,<br />

medical history, family history, seizure<br />

description, neurological signs, investigations, treatments,<br />

compliance and epilepsy classification. High risk factors<br />

found were: parental illiteracy, epilepsy in the family,<br />

parents who were first cousins, lack of antenatal care, obstetric<br />

problems, congenital malformations, home delivery,<br />

admission to neonatal intensive care units, birth asphyxia,<br />

postnatal head trauma, meningitis or encephalitis, non-traumatic<br />

intra-cranial hemorrhage, status epileptics, post-DPT<br />

problems, and febrile convulsions. Partial seizures occurred<br />

in 27.4% of cases, while the generalized were found in<br />

80.2%, and neurological handicaps were found in 52.7%.<br />

Symptomatic epilepsy was diagnosed in 58.2% of cases.<br />

Recognized epileptic syndromes were found in 15.9%.<br />

Monotherapy was the rule in 86.6% of cases. In conclusion:<br />

major determinants of epilepsy in developing countries,<br />

though similar to developed countries, still constitute controversy.<br />

Epilepsy care in developing countries may be in accordance<br />

with international guidelines; however, precise<br />

delineation of the needs should be based on actual characteristics<br />

in each country.<br />

FP-B-006<br />

Clinical epidemiological analysis of seizures in children<br />

for last 5 years<br />

C.-Y. Zhang<br />

Paediatrics of Xi’an No. 1 Hospital, Xi’an, China<br />

Objective: To analyze the characteristics of clinical<br />

epidemiology of seizures in children during the last 5<br />

years. Methods: Collection of data of 169 cases of seizures<br />

in children treated in the Paediatrics Department, Xi’an No.<br />

1 Hospital from January 1997 to December 2001, and analysis<br />

of types of seizure, the illness-age at onset, seasonal and<br />

annual distribution of cases, and related factors. Results:We<br />

treated seizures in 169 children (107 males and 62 females)<br />

over the last 5 years. The annual distribution of cases was<br />

23, 18, 26, 45, 57. With the annual increasing tendency,<br />

60.3% of the cases manifested in the last 2 years. Generalized<br />

tonic clonic seizures occurred in 158 cases (93.5%).<br />

Ninety four patients (55.6%) had a seizure for the first time,<br />

75 patients (44.4%) had a history of previous seizures.<br />

Febrile convulsions occurred in 140 cases (82.8%), the<br />

body temperature was 38 , 398C in 68 cases, 39 , 408C<br />

in 59 cases, and above 408C in 13 cases. The simple type<br />

of febrile convulsion occurred in 105 cases, and the complex<br />

type in 35 cases. The patients with respiratory tract infection<br />

numbered 109 (77.9%). A FS occurred in 29 cases (17.2%),<br />

14 of these patients had a history of complex febrile seizures<br />

(more than three episodes), and 11 of these patients had<br />

partial seizures with abnormal EEG. The peak age at<br />

onset was from 8 months to 3 years; 71.6% (121/169) of<br />

patients belong to this age group. The seizures occurred<br />

most frequently in January (34 cases), December (31<br />

cases), and February (25 cases), a total of 53.3% patients<br />

had seizures in these months. Patients (28.4%) had seizures<br />

in August, September, and October. It seems that the<br />

seizures occurred more frequently in winter and autumn.<br />

Conclusions: Infant seizures are one of the most common<br />

serious and emergent illnesses in the Pediatrics Department,<br />

with an increasing incidence in recent years. There were<br />

obvious features regarding age and season. Respiratory<br />

tract infections were the most common diseases in these<br />

patients. Febrile convulsions, especially the complex febrile<br />

convulsions, are an important danger factor for future development<br />

of epilepsy.<br />

FP-B-007<br />

Incidence patterns of cerebral palsy in Shiga Prefecture,<br />

Japan, 1977–1991<br />

J. Suzuki a , M. Ito b<br />

a Department of Preschool Education, Shiga Women’s<br />

Junior College; b Department of Pediatrics, Shiga Medical<br />

Center for Children, Shiga, Japan<br />

The prevalence of CP in 6-year-old children in Shiga<br />

Prefecture, Japan, born between 1977 and 1991, was<br />

compared in three successive 5-year periods: period I<br />

(1977–1981), period II (1982–1986) and period III<br />

(1987–1991). Data on accumulated age-specific prevalence<br />

of CP was collected and calculated. During the study<br />

period, 242 293 children entered elementary school, and<br />

326 cases (194 boys, 132 girls) of CP were ascertained<br />

in Shiga Prefecture. The overall prevalence of CP per<br />

1000 6-year-old children was 1.35. The prevalence of CP<br />

for 6-year-old children increased from periods II to III,<br />

although it did not vary from periods I to II. The proportion<br />

of low birth weight (LBW) infants and pre-term infants<br />

among those with CP increased during periods I–III. The<br />

prevalence of CP for term and birth weight .2500 g<br />

infants did not vary over the study period. The prevalence<br />

of CP for pre-term and LBW infants, especially gestational<br />

age ,32 weeks and birth weight ,1500 g, increased from<br />

periods II to III, although the prevalence did not increase<br />

from periods I to II. Multiple births and use of mechanical<br />

ventilation increased from periods II to III. The changes in<br />

the prevalence of CP in Shiga Prefecture suggest that the<br />

intact survival among pre-term and LBW infants increased<br />

in period II owing to better obstetric and neonatal care, and<br />

further improvement in survival of very small babies<br />

receiving intensive care increased CP prevalence in period<br />

III.


Abstracts 427<br />

FP-B-008<br />

The prevalence of epilepsy in Turkish children aged 0–<br />

16<br />

A. Serdaroglu, S. Özkan, K. Gücüyener, K. Aydin, S.<br />

Tezcan, S. Aycan<br />

Sebahat Tezcan, Sefer Aycan, Ankara, Turkey<br />

The aim of this cross-sectional study was to determine the<br />

prevalence of epilepsy in Turkey among children aged 0–16.<br />

The study population comprised 24 773 569 children aged 0–<br />

16 living in Turkey. Since the prevalence of epilepsy in childhood<br />

was 1–0.001% in the world literature, the sample size<br />

was determined as 48 260 with 0.05 error type I; 0.10 error<br />

type 2 (power 0.90) and effect size was 2. By cluster sampling<br />

methods, children from city districts, sub-districts and<br />

villages were selected according to their weight. A total of<br />

46 813 (97 %) children were reached. In the study questionnaire,<br />

there were sections regarding personal information,<br />

questions about related factors, and questions about the diagnosis<br />

of epilepsy and physical examination. Epilepsy classification<br />

was made according to the International League<br />

Against Epilepsy (ILAE). The prevalence of epilepsy was<br />

determined as 0.8%. A total of 55.2% of the subjects with<br />

diagnosed epilepsy were grouped as general; 39% partial<br />

and 5.8% were identified. Age, place of residence, mode of<br />

delivery, place of delivery socioeconomic status had no statistically<br />

significant effect on development of epilepsy. The risk<br />

was increased by male sex, and preterm and post term deliveries.<br />

FP-B-009<br />

The prevalence status of fetal alcohol syndrome among<br />

children in the special classes of east Taiwan<br />

H.-T. Kuo a , P.-Z. Tsai b , M.-L. Lee a<br />

a Research Institute and b Faculty of Early Education and<br />

Care, Chaoyang <strong>University</strong> of Technology, Chinese Taipei<br />

Fetal alcohol syndrome (FAS) is a clinical diagnosis characterized<br />

by fetal pre- and postnatal growth delay, dysfunction<br />

of the central nervous system, and facial dysmorphism,<br />

due to maternal alcohol consumption during pregnancy. In<br />

our study, we focused on the prevalence rate of FAS and fetal<br />

alcohol effect (FAE) on wsux RION special classes in the<br />

area of east Taiwan. The results revealed that of the 847<br />

children (from over ten villages and towns), aged between<br />

6–15 years, who were examined, three were diagnosed with<br />

FAS and two with FAE. This result equals a prevalence rate<br />

of 0.35 (FAS) and 0.24% (FAE). Hualien City has the highest<br />

prevalence rate: 0.63 (FAS) and 0.21% (FAE). The prevalence<br />

rate according to sex is 0.70 (male) and 0.48% (female).<br />

All these results are almost the same, but higher than the<br />

average international rate of 0.19%. In this study, we have<br />

proved: (1) alcohol has the same teratogenicity in Taiwan as<br />

in other parts of the world; and (2) in east Taiwan, there is an<br />

even higher prevalence rate than in other parts of the world.<br />

We think this is a significant phenomenon in Taiwan, because<br />

the children will need additional help that will place a high<br />

financial burden on the government in the future. Of special<br />

importance is the fact that these conditions can be prevented,<br />

if the mother does not drink alcohol during pregnancy.<br />

FP-B-010<br />

The epidemiology of subacute sclerosing<br />

panencephalities at the Philippine General Hospital,<br />

1999–2001<br />

A.M. Salonga, M.B. Lukban, B.C. Sanchez, J.R. Pipo-<br />

Deveza, B.C. Chua<br />

Section of Pediatric Neurology, Institute of Neurosciences,<br />

<strong>University</strong> of the Philippines-Philippine General Hospital<br />

and Medical Center, Manila, Philippines<br />

The demographic characteristics and incidence of SSPE<br />

among pediatric patients at the Philippine General Hospital<br />

were determined by review of data from the hospital registry<br />

of confirmed cases of SSPE patients from January 1999 to<br />

December 2001. Sixty-three cases were identified. All<br />

patients are of Filipino descent, with 55% coming from the<br />

national capital region (Metropolitan Manila). Age at presentation<br />

ranged from 1.5 to 17 years, with a mean of 9.8 years.<br />

There was a male predominance, with a male: female ratio of<br />

1.2:0.8. Eighty-nine percent of the patients had measles<br />

infection prior to the development of SSPE. Mean age at<br />

measles infection was 1.4 years. Only 37.7% of the cases,<br />

however, had measles vaccination. Of the 89% of patients<br />

who had measles infection, 30% had previous measles vaccination.<br />

Mean average interval from measles infection to onset<br />

of SSPE was 8.6 years. The majority were in the late stage at<br />

diagnosis; 44.4% were in Stage II, and 42.9% were in Stage<br />

III (Dyken Clinical Staging). Only six patients (9.5%) were in<br />

Stage I. Our patients received the following treatment modalities:<br />

intraventricular interferon (six cases), IVIG (15 cases),<br />

isoprinosine or inosiplex alone (18 cases), interferon 1 IVIG<br />

(one case). Isoprinosine or inosiplex was given together with<br />

IVIG or interferon in 33 cases. Anticonvulsants were used as<br />

needed. Fifty-six patients (88.9 %) are alive and seven<br />

patients (11.1%) succumbed to infection. Three patients are<br />

in remission, and attending school at present.<br />

FP-B-011<br />

Multiple sclerosis in children: the data of a prospective<br />

study in Russia<br />

O.V. Bylova, A.N. Boilo, V.M. Studenikin, O.I. Maslova,<br />

E.I. Gusev<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

In Moscow since 1996, we have performed a prospective


428<br />

Abstracts<br />

study of 67 patients with multiple sclerosis (MS), with onset<br />

before 16 years of age (mean duration of observation<br />

4.91 ^ 0.58 years). Age and symptoms of MS onset, duration<br />

of the first and the second remissions, relapse frequency, time<br />

from onset to secondary progression and to permanent<br />

disability with expanded disability status scale (EDSS) ¼ 3<br />

and EDSS ¼ 6 were analyzed. Mean age at onset of MS in 67<br />

children (38 girls and 29 boys) was 11.72 ^ 0.34 years. There<br />

were more boys with MS onset before age 8, and significantly<br />

more girls with MS onset at ages 12–13. The analyses of<br />

initial symptoms of MS showed that optic neuritis was the<br />

most frequent (32.8%), the second was brainstem symptoms<br />

(25.4%), and third was sensory disturbances (20.9%).<br />

Female sex was associated with optic neuritis and sensory<br />

disorders at MS onset, while male sex was associated with<br />

brainstem lesions, both clinically and on MRI. No cases with<br />

primary progressive MS were found. Annual relapse rate was<br />

1.00 ^ 0.06 per year; 49 patients (73.1%) had two or more<br />

relapses during the first 2 years of MS. At the final observation,<br />

seven patients (11.4%) had secondary progressive MS<br />

course, 17 (25.4%) had confirmed disability with EDSS ¼ 3,<br />

and three (4.5%) EDSS ¼ 6. Annual relapse rate, relapse<br />

frequency during first 2 years of the disease, duration of the<br />

first and the second remission were significantly associated<br />

with time to EDSS ¼ 3. The high percentage of young<br />

disabled patients with active MS course, raises the question<br />

of early disease modifying treatment.<br />

FP-B-012<br />

The prevalence of headache in Swedish schoolchildren<br />

K. Laurell, B. Larsson, O. Eeg-Olofsson<br />

Departments of Neuroscience and Women’s and Children’s<br />

Health, Uppsala <strong>University</strong>, Uppsala, Sweden; Department<br />

of Child and Adolescent Psychiatry, NTNU, Trondheim,<br />

Norway<br />

Headache is one of the most common health problems, the<br />

first symptoms appearing already at school age. During the<br />

last decades the frequency of unspecific headache as well as<br />

migraine has apparently increased in children and adolescents.<br />

The aim of this study, which was performed during<br />

1997/1998, was to report the prevalence of headache in<br />

schoolchildren from the city of Uppsala, and to compare it<br />

with a similar study performed by Bille 1955. The study<br />

group consisted of 1850 schoolchildren, aged 6–17 years<br />

(median:11). In order to limit the sociodemographic differences<br />

and to get a representative population, the material was<br />

stratified with one class in each grade from different schools<br />

in Uppsala. A questionnaire including questions to receive<br />

information about different types of headache was distributed.<br />

The response rate was 74%, equivalent to 1371 children,<br />

686 girls and 685 boys. The IHS criteria were used for classification.<br />

No headache at all during the last year was<br />

reported by 16% compared to 41% in the study by Bille.<br />

Headache of primary type was found in 45%. For both girls<br />

and boys an increased incidence occurred up to 11 years,<br />

whereupon the incidence further increased in girls but not<br />

for boys. The prevalence of migraine was 15.8% and for<br />

tension type headache 13.6%. Besides comparison with<br />

other prevalence studies, the applicability of the IHS criteria<br />

for classifying headache in children will be discussed and an<br />

exclusion of the duration criterion proposed.<br />

FP-B-013<br />

Survey reports of epidemiological studies of Japanese<br />

encephalitis (JE) in Andhra Pradesh, India<br />

P. Nagabhushana Rao a , Z.-Y. Xu b , J. Jacobson c , W. Liu b<br />

a Niloufer Hospital and Department of Neurology, Osmania<br />

Medical College, Hyderabad, Andhra Pradesh, India;<br />

b International Vaccine Institute, Seoul, Korea; c Program<br />

Officer, Bill and Melinda Gates CVP, Seattle, USA<br />

Survey reports of epidemiological studies of Japanese<br />

encephalitis (JE) in Andhra Pradesh, India, from 1980 to<br />

1997 were analyzed retrospectively and cases from the referral<br />

hospital in the state capital were compared to cases from<br />

rural sites to assess the case fatality rate (CFR) and causes of<br />

death. Subsequently, these results were used to outline appropriate<br />

preventative measures for implementation. The CFR<br />

was used to assess the success of the interventions. From 1980<br />

to 1997, there were 9525 suspected cases of JE reported from<br />

rural sites in Andhra Pradesh out of which 3528 died for a<br />

cumulative CFR of 37.04 %. These results were compared<br />

with 189 morbid cases of suspected JE admitted to Niloufer<br />

Hospital (NH) where ventilator facilities were not available<br />

and patients received only symptomatic treatment. Out of<br />

them 23 cases died for a CFR of 12.17%. Causes of mortality<br />

in NH were analyzed and compared with those of rural areas.<br />

The causes of death, mostly preventable in cases treated in the<br />

rural area, significantly differed from those in NH. Case<br />

management differed between the two groups. The care<br />

given in NH could have been given in the rural setting with<br />

the available medical and nursing staff and budget. Therefore,<br />

detailed step-by-step preventive, diagnostic and clinical<br />

management guidelines were prepared and 65 000 copies<br />

were distributed freely and training was provided for implementation.<br />

A dramatic impact was found within 3 years with a<br />

fall in the cumulative case fatality rate to 12.12% in the year<br />

2001.<br />

FP-C<br />

Perinatal/Neonatal Neurology<br />

FP-C-001<br />

Assessment of damage and efficacy of rehabilitation<br />

therapy of posthypoxic encephalopathy<br />

A. Nigin, D.I. Akhmedova, B.G. Gafurov, K.Sh. Salikhova,<br />

Z.K. Mirsaeva<br />

Scientific Research Institute of Pediatrics, Proesd Talant 3,<br />

Tashkent, Uzbekistan


Abstracts 429<br />

Investigations on changes of cerebral circulation in the<br />

circle of Willis performed by transcranial Dopplerography<br />

in young children, showed that in the diagnosis of posthypoxic<br />

states and their complications, in the evaluation of the<br />

efficacy of criteria of the therapeutic effect of neurotropic<br />

drugs such as in acute periods, or stages of dynamic monitoring,<br />

compared to other functional methods, the leading<br />

role may belong to the non-invasive method of ultrasound<br />

investigation, i.e. transcranial Dopplerography. Thus, in our<br />

investigations we determined Dopplerography criteria of<br />

treatment efficacy. Taking into account that hypoxicischemic<br />

and other damages to the CNS have wave character<br />

and pathologic processes not limited by primary focus of<br />

damage, we consider that observation of children should be<br />

carried out gradually during the whole period of the first<br />

year of life, not only in the contingent of children with<br />

severe damage to the CNS, but also in children with clinically<br />

invisible delayed forms. Dynamic Dopplerography of<br />

cerebral hemodynamics enabled us to reliably determine<br />

perinatal damage to the CNS in children with light injuries<br />

of the CNS. This method allowed us to evaluate: (1) efficacy<br />

of therapy administered, and to increase this therapy if<br />

necessary; (2) compensatory capacities of cerebral autoregulatory<br />

mechanisms in selected cases; and (3) to avoid<br />

administration of pathogenically unfounded therapy.<br />

FP-C-002<br />

Neonatal EEG tracing of burst-suppression: etiological<br />

and evolutionary aspects<br />

V. López-Martín, A. Martínez-Bermejo, J. Arcas, C. Roche,<br />

A. Tendero<br />

Service of Neuropediatrics, Hospital La Paz, Madrid, Spain<br />

Introduction: The EEG tracing seen during the neonatal<br />

period which shows so-called discharges of burst-suppression,<br />

is caused by a severe disorder of cerebral electrogenesis<br />

occurring at this time. Objective: To determine the<br />

aetiology, clinical significance and evolution of a group of<br />

newborns with this type of EEG tracing. Patients and methods:<br />

We performed a retrospective study of full term babies<br />

in whom burst-suppression EEG recordings had been<br />

obtained during the neonatal period. Results: We studied<br />

34 patients. In 14 cases the tracing was associated with<br />

hypoxic-ischemic encephalopathy; four with meningitis;<br />

another four with early infantile epileptic encephalopathy<br />

(Ohtahara syndrome); four cases were attributed to drugs<br />

(four with fentanyl associated in one case with phenobarbitone<br />

and in another with midazolam); two cases were due to<br />

early myoclonic epilepsy; three to multiorganic failure; one<br />

to non-ketonic hyperglycinemia and another to leucinosis.<br />

In one patient the aetiology could not be determined. Seven<br />

patients died before the age of 6 months. Severe neurological<br />

sequelae were seen in all the others except for four cases<br />

(three treated with fentanyl and 1 case with hypoxicischemic<br />

encephalopathy). Conclusions: The presence of a<br />

burst-suppression EEG tracing in a term neonate makes it<br />

necessary to perform extensive studies to determine the<br />

aetiology. Although associated with a worse prognosis,<br />

those not treated with piperidine derivatives should be classified<br />

separately. Those treated with piperidine derivatives<br />

have a good prognosis.<br />

FP-C-003<br />

The early intervention treatment of hypoxic-ischemic<br />

brain damage<br />

L. Liu, S.-T. Fu, Z. Liao<br />

Department of pediatrics, The Second People’s Hospital of<br />

Chengdu, China<br />

Objective: For more effective treatment and reduction of<br />

permanent disability of hypoxic-ischemic brain damage<br />

(HIBD) caused of newborn asphyxia. Methods: 60 cases<br />

of mild and serious newborns with HIBD were divided<br />

into the early intervention treatment group and control<br />

group. After HIBD early treatment, for the intervention<br />

group, the training of motion, cognition, language and social<br />

intercourse were given for 2 years. The development quotient<br />

(DQ) and clinical data were used to evaluate treatment<br />

effect. Results: Compared with the score of DQ that was<br />

followed up for 3, 6, 12, 18 and 24 months, the DQ of the<br />

intervention group was obviously higher than that of the<br />

control group (P , 0:05, P , 0:01). The percentage of<br />

unfavorable prognosis of the intervention group was only<br />

5%, obviously lower than that of the control group<br />

(P , 0:05). Conclusion: The ability of compensation and<br />

plasticity of the brain is best in the early infant stage.<br />

Early intervention can promote brain development and the<br />

connective passageways of nerve cells. It is valuable for the<br />

improvement of the patient’s prognosis.<br />

FP-C-004<br />

Correlation between cerebral palsy (CP) and<br />

periventricular leukomalacia (PVL) in premature<br />

infants<br />

K.-Z. Liu, J.-H. Yao, C.-H. Wang<br />

ICU, Shanxi Children’s Hospital, Taiyuan, Shanxi, China<br />

Objective: To study the prevalence of CP in premature<br />

infants with PVL. Methods: 23 premature infants with PVL<br />

comprised the study group; they were divided into two<br />

subgroups according to cranial CT presentations of<br />

whether lesions were symmetrical, 30 full-term infants<br />

with HIE served as the control group. Results: The prevalence<br />

of CP in the PVL group was significantly higher than<br />

that of the control group (P , 0:01). The prevalence of CP<br />

in the PVL group with symmetrical lesion was remarkably<br />

higher than that with unilateral lesion (P , 0:01). Conclusion:<br />

The premature infants with PVL had a higher probability<br />

of developing CP. The severity of the lesions and


430<br />

Abstracts<br />

the symmetry of lesions in cranial CT were good predicting<br />

factors for the neurological outcomes of the patients.<br />

FP-C-005<br />

The changes and clinical significance of determination of<br />

the neuro-specific enolase in serum of neonates with<br />

hypoxic ischemic encephalopathy<br />

Y. Hong a , Y.-M. Liu b , D.-Z. Chen a<br />

Department of Pediatrics, Zhongnan Hospital of Wuhan<br />

<strong>University</strong>, Hubei Province, China; Department of Neurology,<br />

Zhongnan Hospital of Wuhan <strong>University</strong>, Hubei<br />

Province, China<br />

Objective: To observe the changes of the neuro-specific<br />

enolase (NSE) concentration in the serum of a neonate with<br />

HIE and evaluate its clinical significance. Methods: Fortyeight<br />

neonates with HIE were examined. The concentration<br />

of serum NSE was measured at 3 and 7 days of life. The<br />

cranial CT scan was examined in the 1st week of life.<br />

Results: The concentrations of serum NSE of neonates<br />

with HIE (diagnosed clinically or by CT) at 3 days of<br />

life increased, especially in moderate and heavy cases,<br />

and were identical to the clinical and CT manifestations.<br />

Conclusions: NSE is a specific parameter for early diagnosis<br />

of HIE and estimate of hypoxic-ischemic brain<br />

damage and prognosis.<br />

FP-C-006<br />

Clinical analysis on late diagnosis and late or irregular<br />

treatment of neonatal hypoxic-ischemic encephalopathy<br />

(HIE)<br />

H. Yang, L. Zhang<br />

Paediatric Department, First Teaching Hospital Medical<br />

College of ShiHeZi <strong>University</strong>, Xinjian, China<br />

Objective: To emphasize early diagnosis and treatment of<br />

neonatal HIE in order to decrease sequelae. Methods: Retrospective<br />

analysis of perinatal period factors combined with<br />

clinical manifestation and EEG, skull CT data, to sum up the<br />

clinical data and clinical treatment effect of 36 infants with<br />

late diagnosis, and treatment of HIE. Results: A study of the<br />

curative effect and prognosis demonstrated that the early HIE<br />

diagnosed and treated group of infants had better clinical and<br />

EEG results than the later diagnosed group. For infants who<br />

were diagnosed with HIE at age 6–7 months and 1-year-old,<br />

the clinical symptoms were restored more slowly, and no<br />

clear improvement was shown by EEG. In comparison,<br />

those neonates who were admitted to our pediatric department<br />

at the same time and were given the early, regular and<br />

combined treatment, achieved a quite different curative<br />

effect and prognosis. A certain degree sequel of nervous<br />

system have been left, patient’s limb had dyscinesia and<br />

hypophvenia. Conclusion: The curative effect and prognosis<br />

of late diagnosis, and late or irregular treatment given to HIE<br />

patients, are worse than that of early diagnosis and regular<br />

treatment of neonatal HIE.<br />

FP-C-007<br />

The effect of oxygen chamber in the treatment of infant<br />

hypoxic-ischemic encephalopathy (HIE)<br />

Z.-Z. Wei, W.-Q. Geng, M. He<br />

Shenyang Children’s Hospital, Shenyang, Liaoning, China<br />

Objective: To study the clinical response to the oxygen<br />

chamber of 100 infants with HIE. Methods: Control group:<br />

50 cases of infant HIE treated with cerebroprotein hydrolysate<br />

injection. Study group: 50 cases of infant HIE treated<br />

with cerebroprotein hydrolysate injection in the oxygen<br />

chamber. Infant age: 0–5 days after birth. No statistically<br />

significant difference was found between age and sex in the<br />

two groups (P . 0:05). The transparent infant oxygen<br />

chamber was manufactured by 701 Research Institute of<br />

China Boat Industry Company. Observation Index:<br />

NBNA, DQ, response to the treatment and the evaluation<br />

of prognosis. Results: In the control group: 38 cases (76%)<br />

NBNA score $35, 12 cases (24%) NBNA ,35; 36 cases<br />

(72%) DQ $80, 14 cases (28%) DQ ,80. In the treatment<br />

group: 45 cases (90%) NBNA $35, five cases (10%) NBNA<br />

,35 (10%); 46 cases (92%) DQ $80, four cases (8%) DQ<br />

,80. A statistically significant difference was found<br />

between the two groups (P , 0:05). Conclusions: (1) Treatment<br />

of HIE with the aid of an oxygen chamber is satisfactory.<br />

(2) Treatment of HIE with the aid of an oxygen<br />

chamber decreases the treatment-abandoning rate, disability<br />

rate and mortality.<br />

FP-C-008<br />

Early intervention in hyperbilirubinemia and the<br />

abnormalities of brainstem auditory evoked potential<br />

(BAEP)<br />

H.-Q. Li<br />

Woman’s and Children’s Hospital, Baoji, Shanxi Province,<br />

China<br />

Objective: To observe the hyperbilirubinemic damage to<br />

the conducting route of the hearing nerves, and to study the<br />

diagnosis and curative effect of brainstem auditory evoked<br />

potential (BAEP). Methods: Of 62 hyperbilirubinemic cases,<br />

the ratio of abnormal BAEP account for 61%, as the following<br />

increased interval period (PL) of BAEP’s I, III, V waves,<br />

extended and disappeared interval peak length (IPL). Fifty<br />

seven of the 62 cases had abnormal hearing. We divided them<br />

into three groups A–C with different treatment regimens.<br />

Group A: control group; group B: cerebrolysin 1<br />

hyperbaric; and group C: citicoline sodium injection 1<br />

taurine granules. Results: The disappearance ratios of abnormal<br />

hearings of groups A–C after treatment were 40, 70 and<br />

65%, respectively. No notable difference was found in cura-


Abstracts 431<br />

tive effects between the treated groups (t ¼ 5, P . 0:05), but<br />

the control group (group A) was notably different from the<br />

other two groups (t ¼ 15, P , 0:05). Conclusion: As the<br />

ratio of hyperbilirubinemic hearing injuries is 61%, we<br />

should pay attention to it; BAEP has diagnostic value on<br />

hearing nerve conducting route damage caused by hyperbilirubinemia.<br />

It is also a marker for judging the curative effect.<br />

FP-C-009<br />

The therapeutic effect of naloxone plus cerebrolysin in<br />

the treatment of neonatal hypoxic ischemic<br />

encephalopathy<br />

G.-H. Sun<br />

The Second People’s Hospital of Yichang City, Yichang,<br />

Hubei, China<br />

Objective: To observe the therapeutic effect of naloxone<br />

plus cerebrolysin in the treatment of neonatal HIE. Methods:<br />

Sixty one neonates with HIE were randomly divided into<br />

two groups: 31 as the treatment group who were treated by<br />

naloxone plus cerebrolysin, 30 as the control group who<br />

were treated by cerebrolysin only. Results: The clinical therapeutic<br />

effect in the treatment group was 93%, in the control<br />

group it was 83%. There are significant differences between<br />

the clinical therapeutic effects of the two groups, x 2 ¼ 4:69,<br />

P , 0:05. Conclusion: Naloxone plus cerebrolysin can raise<br />

the clinical therapeutic effect of neonatal HIE.<br />

FP-C-010<br />

High-risk infants in Shenyang: netweb screening report<br />

and methods<br />

Q.-F. Yuan, C.-N. Wang, S.-Y. Shang, Y. Jin<br />

Woman and Child Health Center, Shenyang, China<br />

Objective: To conduct overall early screening of high-risk<br />

neonates and initiate early intervention. Methods: On the<br />

basis of second degree netweb, the third degree netweb-<br />

Woman and Child Health Center determined early diagnosis<br />

and treatment according to the following methods: the Vojta<br />

posture reflection, child neurological development method,<br />

muscle tension, joint activity degree, among others and then<br />

made the assessment. Results: 1235 high-risk neonates were<br />

screened, including normal neonates (n ¼ 637), and abnormal<br />

neonates (n ¼ 598); 306 (24.8%) of the abnormal<br />

neonates suffered from breastfeeding jaundice. Among<br />

breastfed babies with jaundice, 65 (21.2%) had hyperbilirubinemia,<br />

183 (14.8%) had central in coordination, 86<br />

(6.9%) had CP, ten (0.8%) suffered from mental retardation,<br />

and 13 (1.1%) from other conditions. All 306 cases of<br />

breastfed babies with jaundice were cured after 1 year of<br />

treatment according to the study protocol. The number of<br />

central in coordination and CP is 115, among which positive<br />

rate is 98%, normalization is 50%. The perinatal period is<br />

one of the main high-risk factors. The objective of early<br />

screening is to identify various adverse factors in the perinatal<br />

period, and initiate early intervention to prevent the<br />

occurrence of CP.<br />

FP-C-011<br />

Effects of tetramethyl pyrazine (TMP), and<br />

prostaglandin E1 on newborn rats with hypoxicischemic<br />

brain damage (HIBD)<br />

Z.-Y. Jin, C.-H. Xu, H.-Z. Li, Z. Jin, C.-J. Jin<br />

Paediatric Department, Yanbian Hospital, Yanji City,<br />

China<br />

Objective: To study the effects of exogenous tetramethylpyrazine<br />

(TMP) and prostaglandin E1 (PGE1) on brain<br />

neuronal apoptosis of hypoxic-ischemic brain damage<br />

(HIBD) in neonatal rats. Methods: We selected 52, 7-dayold<br />

Wistar rats and randomly divided them into six groups:<br />

normal control group (n ¼ 8), HIBD group (n ¼ 7), normal<br />

saline (NS) group (n ¼ 7), TMP treated group (10). After<br />

established HIBD model, intraperitoneally and subcutaneous<br />

injected TMP and PGE1 then the rats were killed<br />

after hypoxia and ischemia for another 48 h alive. The<br />

number of neuronal apoptosis, the apoptotic rate and apoptotic<br />

density of rats was detected after the brain tissue was<br />

stained by HE and TUNEL. Results: The number of neuronal<br />

apoptosis, apoptotic rate and apoptotic density in the<br />

HIBD group was much higher than in the normal controls<br />

(P , 0:01); the value in the TMP, PGE1 and TMP 1 PGE1<br />

groups was much lower (P , 0:01, P , 0:01, P , 0:01,<br />

respectively), and the value in the TMP 1 PGE1 group<br />

was much lower than that in the TMP and PGE1 groups<br />

(P , 0:05). Conclusion: TMP and PGE1 can pass through<br />

the blood–brain barrier and inhibit cerebrocellular apoptosis;<br />

Moreover, a combination treatment of TMP and PGE1<br />

is more effective than if administered separately; they coordinate<br />

and complement each other, and can enhance the<br />

curative effect.<br />

FP-C-012<br />

Experimental research on the hyperbaric oxygen (HBO)<br />

treating mechanism on SD neonate rat model with<br />

hypoxic-ischemic brain damage (HIBD)<br />

L. Liu, Y.-J. Yang, Y.-J. Jia, J.-H. Song<br />

Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />

China<br />

Objective: To clarify the mechanism of hyperbaric<br />

oxygen (HBO) in the treatment of the SD neonate rat<br />

model with HIBD. Methods: Forty rats were randomly<br />

divided into four groups: normal, sham, HIBD and HBO<br />

groups. The rats in the HBO group were treated with 2.0<br />

atmosphere absolute HBO every day for 7 days. At the end<br />

of the HBO treatment, we investigated the Bcl-2 and Bax,<br />

apoptosis-regulating protein in CA1 sector of hippocampus


432<br />

Abstracts<br />

and cortex of the brain, and IkBa expression by Western<br />

blot. Results: HBO can increase the expression of Bcl-2 and<br />

reduce the expression of IkBa with no obvious change in<br />

Bax expression compared to the other three groups. Conclusion:<br />

HBO can induce NF-kB activation and the expression<br />

of Bcl-2 to protect the neuron from apoptosis.<br />

FP-C-013<br />

Research on improving the mental development of<br />

hypoxic-ischemic encephalopathy (HIE) children by<br />

early intervention<br />

J.-H. Song, R. Huang, Y.-J. Yang, J. Liu, Z. Luo<br />

Xiangya hospital, Central South <strong>University</strong>, Changsha,<br />

Hunan, China<br />

Objective: To understand the influence of early intervention<br />

on the mental development of children with HIE, and to<br />

ascertain the best time for this measure. Methods: 36 children<br />

with HIE, diagnosed by doctors at the outpatient<br />

department, who did not receive early intervention, served<br />

as the control group. Thirty two children who accepted early<br />

intervention comprised the intervention group. Mental<br />

development of the children in both groups was tested by<br />

the CDCC mental developmental test. Results: The Mental<br />

Development Index (MDI) score of one child and the<br />

Psychomotor Development Index (PDI) score of two other<br />

children were in the marginal level. The MDI and PDI<br />

scores of all the other children were all above medium.<br />

All the children in the control group suffered from mental<br />

retardation. The mental development in the two groups was<br />

significantly different (P , 0:01). Conclusion: Early intervention<br />

can improve the mental development of children<br />

with HIE.<br />

FP-C-014<br />

Study of hypoxia inducible factor 1a (HIF-1a) gene in<br />

neonatal rat models with hypoxic ischemia<br />

X.-R. Zheng, Y.-J. Yang, Y.-J. Jia<br />

Xiang Ya Hospital, Central South <strong>University</strong>, Changsha,<br />

China<br />

Objective: To explore the expression of hypoxia inducible<br />

factor 1a (HIF-1a) gene in a neonatal rat model of cerebral<br />

hypoxic ischemia (HI), and to evaluate whether the<br />

expression of the HIF-1a gene could be available as a<br />

marker of hypoxic ischemia. Methods: Using a neonatal<br />

rat model of cerebral hypoxic ischemia, the expression of<br />

HIF-1a was detected by employing a method of quantitative<br />

RT-PCR in cerebral tissue. Results: In the normoxic condition<br />

the expression of HIF-1a mRNA in cerebral tissue of<br />

the neonatal rat was at a very low level. Expression of HIF-<br />

1a mRNA occurred at once after HI in the HI group, reached<br />

its peak at 24 h, and maintained a higher level within 72 h,<br />

decreased at 7 days after HI, but was still at a mild higher<br />

level compared with the normal group. Conclusion: These<br />

results demonstrate the expression of HIF-1a increased<br />

rapidly under hypoxia-ischemia in neonatal rats. It was<br />

confirmed that expression of the HIF-1a gene could be<br />

sensitively induced by HI, and it may be available as a<br />

marker of hypoxic ischemia.<br />

FP-C-015<br />

Twenty-four hour non-invasive monitoring of anterior<br />

fontanel pressure and blood pressure in sick neonates<br />

Y.J. Yang, Q.H. Wang, L. Liu, X. Wang<br />

Division of Neonatology, Xiangya Hospital of Central South<br />

<strong>University</strong>, Changsha, China<br />

Objective: The present study was undertaken to investigate<br />

the method of anterior fontanel pressure (AFP)<br />

measurement to establish the rhythm of AFP and mean<br />

arterial pressure (MAP) over 24 h in sick neonates. Method:<br />

Sixty-seven neonates were divided into four groups: nonintracranial<br />

disease, slight asphyxia (ASP), hyperbilirubinemia<br />

and premature infant. None of the patients received<br />

dehydrated therapy. AFP (intracranial pressure monitor<br />

SP2000) and MAP were monitored continuously over 24<br />

h. Results: (1) The AFP levels in all patients ranged from<br />

1 to 10 mmHg. (2) The AFP was variable over 24 h, the<br />

highest level of AFP was at 09:00–11:00 h, whereas the<br />

lowest was at 01:00–02:00 h. (3) AFP was lower in premature<br />

infants than term infants. (4) There were no correlations<br />

among AFP and weight, size of fontanel, gestational age,<br />

head circumference and MAP. Conclusions: (1) The appreciated<br />

time was at 09:00–11:00 h in 1 day for AFP measurement.<br />

(2) AFP was lower in the premature infants than term<br />

infants. (3) The AFP has increase obviously in neonates<br />

with slight asphyxia, non-intracranial disease or hyperbilirubinema.<br />

FP-C-016<br />

Relationship between hyperbaric oxygen therapy and<br />

apoptosis, caspase-3 in neonatal hypoxic-ischemic brain<br />

damage<br />

Y.-J. Yang, L.-X. Liu, V. Tukei, Y.-J. Jia<br />

Department of pediatrics, XiangYa Hospital, Central South<br />

<strong>University</strong>, Changsha, China<br />

The objective of this experiment was to investigate the<br />

probable mechanisms of HBO therapy by assessing the<br />

expression of apoptosis and caspase-3 mRNA in a neonatal<br />

HIBD model. Healthy 7-day old SD rats were randomly<br />

divided into three groups: control group (n ¼ 8), HIBD<br />

group (n ¼ 8), and HBO group (n ¼ 8). Detection of the<br />

expression of apoptosis and caspase-3 mRNA was<br />

performed by the TUNEL and hybridization in situ techniques.<br />

Using these techniques the results showed that there<br />

was minimal or no expression of apoptosis and caspase-3


Abstracts 433<br />

mRNA in the control group, but there was massive expression<br />

of apoptosis and caspase-3 mRNA in the HIBD group.<br />

HBO therapy (HBO group) significantly decreased apoptosis<br />

in neuronal cells [(252.96 ^ 68.59) versus<br />

(342.24 ^ 74.16), P , 0:05] and weakened the expression<br />

of caspase-3 mRNA in HIBD rats. The expression of apoptosis<br />

and caspase-3 mRNA was obviously increased in the<br />

HIBD group. We conclude that HBO therapy can weaken<br />

the expression of caspase-3 mRNA and decreases apoptosis<br />

in cells, and this is the probable mechanism of neuronal<br />

protective effect of HBO therapy.<br />

FP-C-017<br />

Change of serum sodium in 78 newborn infants with<br />

hypoxic-ischemic encephalopathy<br />

B. Liu<br />

Department of Infant Medicine Jinzhou Children’s Hospital,<br />

Jinzhou, China<br />

Objective: To study the change of serum Na level in<br />

neonate HIE, and explore the relationship between serum<br />

Na level and severity of HIE. Methods: Serum Na levels<br />

were measured by MI-921 K-Na-Cl Analyzer in 78 neonates<br />

with HIE. Results: Serum Na levels of 70 cases were lower<br />

than the normal value. Serum Na levels of moderate and<br />

severe groups were much lower than that of the mild group.<br />

There were significant differences between the moderate<br />

and severe groups. Conclusion: Serum Na reduced in<br />

neonates with HIE, and the changes of serum Na levels<br />

was related to the severity of HIE.<br />

FP-C-018<br />

Changes of local fibrinolysis in premature newborns<br />

with periventricular leucomalacia<br />

K.S. Ormantaev, L. Saulebekova, D. Kachurina, E.<br />

Gromenko<br />

Scientific Center Pediatrics and Children’s Surgery,<br />

Almaty, Kazakhstan<br />

Severe cerebral ischemia is often accompanied by disturbances<br />

of hemostasis. The aim of our investigation was to<br />

study the tromboplastic and fibrinolitic properties of liquor<br />

in 36 premature newborns with PVL. The mean weight of<br />

the premature newborns was 1400–2000 g. The level of 5-<br />

nucleotidase in liquor was high 2486.0 1 35.0 n/cat, which<br />

indicated the presence of tissue and cerebral thromboplastin.<br />

Production of degradation of fibrinogen (<strong>PDF</strong>) in liquor was<br />

determined in concentrations from 3.1 to 3.75 mg.%, Severe<br />

cerebral ischemia in premature newborns is accompanied by<br />

withdrawal activators of plasminogen, high fibrinolytic<br />

activity, and appearance of <strong>PDF</strong> in CSF. This indicates<br />

the development of local fibrinolysis and more severe disorders<br />

of cerebral circulation<br />

FP-C-019<br />

The neurobiology of the normal and brain damaged<br />

infant cry: a comparison of animal, statistical and<br />

neurobiological models<br />

C. Lenti a,b , B.D. Lenti b,c , D. Galbusera a,c , F. Rocca a,c<br />

a Chair of Child Neuropsychiatry, <strong>University</strong> of Milan,<br />

Milano, Italy; b Laboratory of Bioacoustics and Comparative<br />

Analysis of Behaviour and Cognitive Functions,<br />

<strong>University</strong> of Milan, Italy;<br />

c Faculty of Paedagogical<br />

Sciences, <strong>University</strong> of Urbino, Urbino, Italy<br />

The cry of the human infant primate is a differentiated<br />

signal that can be voiceless, partially voiced and voiced<br />

with many different melodic contours. The physioacoustics<br />

of the infant cry, however, is poorly known and we must rely<br />

on animal models, or on statistical elaboration on measured<br />

parameters of recorded and measured infant cries. In this<br />

preliminary work we compare the qualitative and quantitative<br />

parameters of measured on cries produced by six asphyxic<br />

brain-damaged infants with the same parameters obtained<br />

from normal infants, and examine the differences that can<br />

help in understanding the neurobiology of the human cry.<br />

Our preliminary data show alterations of voicing and abnormal<br />

melodic contours: The frequency jump, that is a discontinuity<br />

in the melodic contour is present only in the<br />

asphyxiated subjects and the vibrato is significantly more<br />

frequent in the pathological sample. This indicates a role<br />

for the higher nervous centers in controlling the shape and<br />

continuity of the contours. A surprising fact was that even<br />

with massive lesions, many single cry units appeared similar<br />

to those emitted by normal infants: This could suggest that the<br />

programming of the cry unit’s main characteristics is<br />

controlled by lower centres, possibly related to the respiratory<br />

function, and whose lesions could not be compatible with life.<br />

Results will be compared with animal and statistical models.<br />

FP-C-020<br />

Study of the electroencephalogram in neonatal infants<br />

with fetal distress<br />

C.-J. Yan a , A.-S. Piao a , G.-H. Li b<br />

a Yanbian women-children hospital, Yanji City, Jilin, China;<br />

b New ear children hospital, Yanji city, Jilin, China<br />

Background: Fetal distress is fetal compromise caused by<br />

hypoxia. Fetal distress can cause brain damage, so early<br />

diagnosis and treatment for fetal distress is very important.<br />

The most commonly used tests for fetal distress are the nonstress<br />

test (NST), and the contraction test (CST). Although<br />

the NST and CST have low false-negative rates, both have<br />

high false-positive rates. In this study, we investigated the<br />

value of the electroencephalagraph in fetal distress. Methods:<br />

Twenty-one cases of fetal distress in newborn were<br />

included in this study and 21 normal newborns were<br />

selected for controls. In the study group, the range of gesta-


434<br />

Abstracts<br />

tional age, Apgar score and weight were. A total of 37–42<br />

weeks, 8–10 and 2500–3999 g, respectively. We used the<br />

international 10–20 electrode placement newborn system<br />

and recorded the sleeping EEG by monopolar and bipolar<br />

montage. Results: Index of EEG in fetal distress of<br />

newborns was significantly lower than that of non-fetal<br />

distress newborns (P , 0:05). The results suggested that<br />

pathophysiological changes by hypoxia in fetal distress<br />

could cause brain dysfunction and EEG could detect this<br />

type of disorder. Conclusion: EEG in the newborn is useful<br />

diagnostic method for fetal distress and it is necessary to<br />

check EEGs in newborns at risk to prevent prolonged brain<br />

damage by fetal distress.<br />

FP-C-021<br />

Intracranial hemorrhage in infants after massaging by a<br />

traditional birth attendant<br />

E.S. Herini, Sunartini, S.W. Daniel<br />

Department of Child Health, Medical School, Gadjah Mada<br />

<strong>University</strong>, Sardjito Hospital, Yogyakarta, Indonesia<br />

The overall incidences of birth injuries appear to be<br />

declining as a result of improved obstetrical practices.<br />

However, it is unknown whether or not incidences of head<br />

trauma were caused by massage of traditional birth attendants.<br />

As a culture in Indonesia especially in Yogyakarta<br />

and Central Java, the infants were massaged after delivery in<br />

order that the baby would be. Despite good intentions,<br />

massaging resulted in intracranial bleeding as if it was<br />

caused by abuse. We report four infants with intracranial<br />

hemorrhage after massaging by traditional birth attendants.<br />

All the infants referred to the Sardjito Hospital, Yogyakarta<br />

were in a bad condition and had severe anemia (hemoglobin<br />

was 6.6, 4.4, 8.6 and 3.7 mg/dl), while the clotting bleeding<br />

times were normal in three infants and the rest had<br />

prolonged clotting time. Head CT scan showed a right hemisphere<br />

cerebral infarct due to intracranial hemorrhage in<br />

case 1, epidural hemorrhage and subdural hemorrhage in<br />

case 2, intracranial hemorrhage in the right temporal parietal<br />

lobe in case 3 and the last case had a subdural hematoma in<br />

the parieto-occipital bilateral region. Three underwent<br />

craniotomy and one was under observation only.<br />

FP-C-022<br />

The effect of hyperbaric oxygen treatment on neonatal<br />

hypoxic-ischemic encephalopathy (HIE)<br />

Q.-H. Yu<br />

Department of Pediatrics, Center Hospital, Qilu Petroleum<br />

Chemical Company, Shandong, China<br />

Objective: To analyze the effect of hyperbaric oxygen<br />

treatment on neonatal hypoxic-ischemic encephalopathy.<br />

Method: The 40 patients with HIE were treated with hyperbaric<br />

oxygen combined with other regular therapy, 30<br />

patients with HIE had only regular therapy. The clinical<br />

features, NBNA scores and cranial CT findings were<br />

recorded during following 3 , 6 months. Result: The<br />

patients treated by hyperbaric oxygen combined with regular<br />

therapy had significant better prognosis than those with<br />

only regular therapy. Conclusion: The hyperbaric oxygen<br />

treatment should be applied to neonatal HIE as soon as<br />

possible for its remarkable effect on improving prognosis.<br />

FP-C-023<br />

Brain stem involvement in neonatal neurological<br />

disorders: ultrasonographic findings and clinical<br />

correlates<br />

Y.-F. Tu, C.-C. Huang<br />

Department of Pediatrics, National Cheng Kung <strong>University</strong><br />

Hospital, Tainan City, Taipei, Chinese Taipei<br />

Neurologic disorders with brain stem involvement often<br />

indicate poor prognosis. Conventional cerebral ultrasound<br />

examination through anterior fontanelle is limited in evaluating<br />

the brain stem lesion. There are few reports on other<br />

trans-cranial views that demonstrate the extent of brain stem<br />

lesions. From the year 2000 through 2002, we found 11<br />

newborns with brain stem lesions detected by ultrasound<br />

examinations obtained via squamous portion of temporal<br />

bone and foramen magnum. The etiology included metabolic<br />

encephalopathy (n ¼ 5), hypoxia-ischemia encephalopathy<br />

(n ¼ 4), birth trauma (n ¼ 1) and group B<br />

Streptococcus meningoencephalitis (n ¼ 1). All the<br />

newborns presented with consciousness disturbance, hypotonia,<br />

and respiratory insufficiency that require artificial<br />

ventilation. Trans-axial ultrasound findings showed hyperechogenic<br />

midbrain and/or pons, and the degree of hyperechogenecity<br />

correlated to disease severity. Trans-foramen<br />

magnum examination demonstrated the medulla and cervical<br />

cord lesions, and especially signs of tonsil herniation<br />

(absence of cisterna magna). All patients had a poor<br />

outcome: six died, and the other five have severe neurologic<br />

deficits, including ventilator dependency. We concluded<br />

that cerebral ultrasound examination through temporal<br />

bone and foramen magnum is valuable in defining the<br />

brain stem involvement, which has a prognostic implication<br />

in neonatal neurological disorders.<br />

FP-C-024<br />

The early application of brain-cell metabolism activator<br />

in the newborns with hypoxic-ischemic encephalopathy<br />

(HIE)<br />

B.-J. Liu, P. Zhang, Z.-H. Zhang<br />

Pediatrics department of Laiwu Iron and Steel Group Ltd.<br />

Hospital, Shandong, China<br />

Objective: To explore the effect of the brain-cell metabolism<br />

activator, by the early application of citicoline or


Abstracts 435<br />

cerebrolysin, on the prognosis of the newborns with HIE.<br />

Methods: We selected 108 newborns with HIE who had<br />

been admitted to hospital during the period 1999 , 2001.<br />

We randomly divided them into two groups: the first group<br />

included 51 cases that began to take citicoline or cerebrolysin<br />

from the 7th day after birth. The second group<br />

comprised 57 cases that began to take these drugs before<br />

24 h after birth. These brain-cell metabolism activators<br />

were combined with other routine treatments. There were<br />

no significant differences in the severity of diseases<br />

between the two groups (P . 0:05). The period of treatments<br />

were both 14 , 21 days. The NBNA evaluations and<br />

electroencephalogram examinations were carried out on<br />

the 7th day, 14th day, the 1st month, the 2nd month, the<br />

6th month and the 1st year after birth, respectively. Results:<br />

The rates of unfavorable prognosis were 19.61%, and<br />

5.26% in the first and second groups, respectively. The<br />

differences were significant between the two groups<br />

(P , 0:05). Conclusion: Early application of brain-cell<br />

metabolism activator may decrease the rate of unfavorable<br />

prognosis of newborns with HIE.<br />

FP-C-025<br />

Characteristics of immune status of newborns with<br />

hypoxemic – ischemic encephalopathia<br />

Kh.T. Mukhamedova, F.A. Nazarova<br />

Doctors Advance Training Institute, Tashkent, Uzbekistan<br />

Chronic fetal hypoxia results in thymus involution. At<br />

neonatal asphyxia there accrues blocking of ferments,<br />

responsible for thymosin synthesis, which results in reduction<br />

of activity both of cellular and humoral immunity.<br />

Studies of immune status revealed that specific weight of<br />

lymphocytes in peripheral blood of patients with perinatal<br />

brain injuries ranges within the normal limits with a rising<br />

tendency in children with severe injuries of CNS. In children<br />

with severe brain injures at birth the absolute numbers of<br />

lymphocytes have been increased as well. Conducted studies<br />

of main sub-populations of T- and B-lymphocytes in children<br />

with perinatal brain injures showed redivision of main immunity<br />

cellular factors depending on severity and duration of<br />

hypoxia. Studies of T-lymphocyte content in children who<br />

had had asphyxia revealed much lower readings (indications)<br />

at birth, irrespective of severity and duration of anoxaemia.<br />

Decrease of cellular immunity in newborns who had had<br />

asphyxia indicates an impairment of the main regulating<br />

member of immune reactions and is combined with decrease<br />

of anti-infective resistance of the organism.<br />

FP-C-026<br />

Characteristics of cellular immunity in newborns with<br />

perinatal brain injures<br />

Kh.T. Mukhamedova, F.A. Nazarova<br />

Doctors Advance Training Institute, Tashkent, Uzbekistan<br />

We conducted an immunologic examination of 40<br />

newborns who had had asphyxia and perinatal hypoxia.<br />

The newborns were been divided into two groups: The<br />

first group was composed of newborns whose condition<br />

was mild to severe, who had had chronic hypoxia due to<br />

the mother’s chronic diseases, and complicated pregnancy.<br />

The second group was composed of newborns who had had<br />

acute asphyxia with combined hypoxia. Studies of subpopulations<br />

of T-lymphocytes/T-helpers, T-suppressors/in<br />

children with perinatal brain injures revealed a decrease of<br />

relative and absolute number of T-lymphocytes, suppressors<br />

and helpers. The findings indicate that perinatal brain injury<br />

leads to substantial impairment of the newborns’ organism<br />

immunologic reaction to imbalance of the immunity cellular<br />

basis, which depends on the severity of the patient’s condition,<br />

age, duration of anoxaemia, state of health and course<br />

of mother’s pregnancy. A severe form of combined hypoxia<br />

results in more acute impairment of cellular immunity,<br />

which makes this group potentially threatening regarding<br />

sepsis and development of acute neurology symptoms.<br />

FP-C-027<br />

Hypoxia-ischemia induced upregulation of brain iron<br />

histochemistry in neonatal SD rats<br />

M.-Y. Hei, S.-J. Kuang<br />

Department of Pediatrics, the 3rd Affiliated Xiangya Hospital<br />

of Central South <strong>University</strong>, Changsha, Hunan, China<br />

The developing characters of the neonatal brain make<br />

them vulnerable to multiple types of injury, including<br />

hypoxic/ischemic injury. The over-accumulation of iron in<br />

the brain may lead to free radical-caused cell damage after<br />

HI insult. Objective: To understand the histochemical<br />

change of iron in the brain tissue in both normal and HI<br />

insulted neonatal SD rats. Method: 30 neonatal SD rats<br />

were randomly divided into normal group (n ¼ 15) (including<br />

postnatal days 7, 8, 10, 14 and 21 subgroups) and HIE<br />

group (n ¼ 15) (postnatal day 7 rats treated with right carotid<br />

artery ligation combined with 2.5 h 8% O 2 /92% N 2 exposure).<br />

After 12, 24 h, 3, 7 and 14 days of recovery, the HIinsulted<br />

animals were perfusion fixed. A total of 45 mm<br />

thick free-floating sections were stained in Perl’s solution<br />

and intensified by DAB/H 2 O 2 . Results: In normal P7–P14<br />

SD rats, there were iron-positive cell foci mainly distributed<br />

in cingulum and corpus callosum, periventricular zone,<br />

internal capsule and the tip of the external capsule. The<br />

iron positive cells were morphologically similar to oligodendrocytes<br />

and microglia. The iron staining intensity of<br />

ipsilateral hemisphere in the HI insulted brain was increased<br />

as early as 12 h after HI and progressed in a time-dependent<br />

pattern with the peak at 7 days after HI insult, especially in<br />

the damaged cortex, internal capsule and hippocampus. The<br />

iron-positive material was mainly glia. An intensified<br />

phenomenon of perivascular iron positive foci was particularly<br />

noticeable. Conclusions: Brain iron histochemistry


436<br />

Abstracts<br />

was upregulated after HI-insult and can be used to assess<br />

cerebral damage in moderate to late stages after hypoxic<br />

ischemia insult.<br />

FP-C-028<br />

Effect of early intervention on the brain and<br />

development quotient of newborns with hypoxic<br />

ischemic encephalopathy<br />

D.-Y. Zhou, M. Peng, S.-Y. Jiang<br />

Harbin Children’s Hospital, Daoli District Harbin, Harbin,<br />

China<br />

Objective: To explore the efficacy of early intervention on<br />

newborns suffering from hypoxic ischemic encephalopathy<br />

(HIE), and evaluate their prognosis. Method: One hundred<br />

newborns suffering from neonatal HIE (states of II, II–III,<br />

III) who received early intervention were followed-up for 2<br />

years. CT and DQ were performed in these cases. Results:<br />

(1) An early intervention was carried out for improving the<br />

prognosis of the newborns with HIE (II, II–III) The normal<br />

rate of their brain CT and DQ in the early intervention group<br />

was higher than that of the non-intervention group. This<br />

difference was statistically significant, P , 0:01. There<br />

were significant differences in neonatal HIE (III),<br />

P , 0:05. (2) The follow-up examination showed a high<br />

correlation between the brain CT and DQ in the early intervention<br />

group, r ¼ 0:88. The brain CT in the early intervention<br />

group was improved, accompanied by the improvement<br />

of clinical signs (DQ level). Meanwhile, the low correlation<br />

between the brain CT and DQ in the non-intervention group,<br />

r ¼ 0:55. Conclusion: Clearly early intervention can<br />

improve the prognosis of neonatal HIE. CT integrated<br />

with DQ can improve accuracy and early diagnosis.<br />

FP-C-029<br />

P-selectin expression and neuroprotective effect of<br />

fucoidin on hypoxic-ischemic brain injury in neonatal<br />

rats<br />

B.-L. Eun a , K.-B. Kim b , D.-H. Pee a , Y.-C. Tockgo a<br />

Department of Pediatrics, College of Medicine,<br />

a Korea<br />

<strong>University</strong>, b Kwandong <strong>University</strong>, Seoul, Korea<br />

Objective: Leukocyte-endothelial adhesion is a key step<br />

in the initiation of post-ischemic reperfusion injury in many<br />

organ systems. We hypothesized that P-selectin might<br />

mediate post-HI injury in the immature rat brain. Methods:<br />

To elicit focal hypoxic-ischemic brain injury, 7-day-old<br />

(P7) rats (n ¼ 160) underwent right carotid coagulation,<br />

followed by 2 h hypoxia (F i O 2 ¼ 0.08). We performed<br />

RT-PCR for mRNA (n ¼ 28) and Western blot for protein<br />

of P-selectin (n ¼ 37). To test the efficacy of a pretreatment<br />

regimen, P7 rats (n ¼ 59) received fucoidin immediately<br />

before and again after hypoxia intra-peritoneally with a 26<br />

gauge needle. Results: P-selectin mRNA expression in the<br />

ipsilateral (right) hemisphere reached a peak at 8 h after HI<br />

and then was barely detected after 24 h. P-selectin protein<br />

was detected as early as 15 and 30 min at both hemispheres<br />

in experimental rats and decreased at 1 h, and increased in<br />

the right hemisphere at 4 h post-HI, peaked at 8 h and was no<br />

longer detectable at 24 h. We found a substantial neuroprotective<br />

effect after pretreatment with fucoidin as a dose<br />

dependency. Conclusion: The temporal profiles of post-HI<br />

P-selectin mRNA and protein expression are consistent with<br />

a role in the evolution of subsequent brain injury. Potential<br />

of therapeutic application of P-selectin blockade or similar<br />

anti-adhesion strategies may reduce the brain damage after<br />

perinatal HI.<br />

FP-C-030<br />

Clinical analysis of 86 neonatal hypoxic ischemia<br />

encephalopathy<br />

A.-Q. Li<br />

The department of Pediatrics, Weihai Municipal hospital,<br />

Huancui district Weihai, Shandong, China<br />

Objective: To investigate the relationship between the<br />

clinical degree of severity of HIE with asphyxia and the<br />

cranial image changes. Method: The data of 86 neonates<br />

diagnosed with HIE were analysed retrospectively. Seventy<br />

five cases had at least once undergone cranial CT examinations<br />

between the age of 2 and 19 days. Result: Among 86<br />

subjects, including 54 male cases and 32 females, 58 cases<br />

diagnosed with mild HIE included 20 cases of mild<br />

asphyxia, and 38 cases of severe asphyxia. Among 17<br />

cases of moderate HIE, one case had mild asphyxia and<br />

16 cases were severe. In 11 cases of severe HIE all had<br />

severe asphyxia. In 75 cases with cranial CT, 58 cases<br />

showed abnormal, including 31 cases of mild pathological<br />

changes, 16 had moderate change, and 11 cases of severe<br />

changes. Among the cases with severe changes in CT scan,<br />

there were three with parenchymal hemorrhage and three<br />

with subarachnoid hemorrhage. The positive rate of CT in<br />

mild and moderate HIE were 64.7 and 84%, respectively. In<br />

severe HIE, all patients had apparently abnormal changes.<br />

The patients diagnosed as mild HIE with mild asphyxia<br />

were usually presented 36 h after birth. The clinical symptoms<br />

of patients with the brain lesion mainly in the occipital<br />

lobe were staring, lethargy, etc., usually not affecting eating.<br />

If the lesion in anterior frontal or temporal lobes, the<br />

patients presented irritability, bulge of fontanel, and many<br />

of them had convulsions. Some had apnea or stubborn<br />

hiccups. The common drugs used in HIE, included vitamin<br />

K, sodium bicarbonate, luminal, antibiotics, ATP, citicoline,<br />

and dehydrating agents. The effect of using dehydrating<br />

agents regularly was better than using them provisionally.<br />

Conclusion: This observation showed the more severe the<br />

asphyxia the more the severity of the state of the patients. It<br />

was important to start treatment before the hypoxemia and<br />

ischemia occurred, and after resuscitation of asphyxia.


Abstracts 437<br />

Additionally, the cooperation of pediatricians and obstetricians<br />

in treatment was imperative to improve the prognosis<br />

of the patients with asphyxia or HIE.<br />

FP-C-031<br />

Neonatal choroid plexus cysts (CPC) and early<br />

childhood developmental outcome<br />

K.-L. Hung, H.-T. Liao<br />

Department of Pediatrics, Cathay General Hospital, Taipei,<br />

China<br />

Choroid plexus cysts (CPCs) are incidental findings on<br />

sonograms of the neonatal head. The true incidence is not<br />

yet known. Childhood neurodevelopmental outcome associated<br />

with neonatal CPCs has been rarely reported. The aim<br />

of this study was to determine the incidence of neonatal<br />

CPCs and early childhood developmental outcome. During<br />

the period July 1997 to June 1998, 2111 normal newborns<br />

underwent brain sonographic examinations as a routine<br />

screening. All newborns detected as having CPCs underwent<br />

serial sonograms at 1, 2, 4 and 6 months of age. Developmental<br />

milestones were evaluated subsequently at followup<br />

visits. Developmental assessment was performed with<br />

the Denver II Developmental Screening Test. The results<br />

showed CPCs were identified in 186 neonates (8.8%). Of<br />

these, 14 (7.5%) were bilateral. The mean size of the cysts<br />

was 2.6 mm (range 1.1 , 8.6). Five cysts were larger than 5<br />

mm in size. Physical check-up was normal in all the 186<br />

neonates with CPCs follow-up ultrasonic studies were available<br />

for 155 children. The cysts regressed spontaneously in<br />

the majority of the infants and, by 6 months of age, residual<br />

cysts were visible in 18 infants (11.6%) only. During the<br />

clinical follow-up period from 30 to 42 months, developmental<br />

outcome was normal in all available 179 children.<br />

The existence of isolated CPCs in the newborn is neither<br />

associated with abnormal physical findings nor with any<br />

delay of early childhood development.<br />

FP-C-032<br />

Protective and therapeutic effects of valproic acid<br />

against hypoxic-ischemic brain injury in the newborn<br />

N. Kabakus, I. Ay, S. Aysun, F. Soylemezoglu, A. Ozcan, B.<br />

Celasun<br />

Pharmacology and Neuropathology, Departments of Pediatric<br />

Neurology, Hacettepe <strong>University</strong> Faculty of Medicine,<br />

Ankara, Turkey<br />

HIBD is still an important cause for morbidity and<br />

mortality in the newborn, and new approaches need to be<br />

developed for the treatment of HIBD. The present study<br />

aims to investigate neuroprotective/neurotherapeutic<br />

effects of valproic acid (VPA) which is reported to be a<br />

protective and therapeutic agent in cellular damage. VPA<br />

was administered acutely (first 24 h) and chronically (after<br />

24 h) at both low (200 mg/kg per day) and high (400 mg/kg<br />

per day) therapeutic doses. All experiments were<br />

performed on 7-day-old rat pups which is an immature<br />

rat model. The findings have shown that VPA had no<br />

significant therapeutic effect on cerebral infarcts<br />

(P . 0:05) following both acute and chronic administration.<br />

However, when administered for five consecutive<br />

days, VPA had significant protective and therapeutic<br />

effects on the area of cerebral infarct in a dose-dependent<br />

manner (control: 17.9%; low dose: 11.2%; high dose:<br />

7.9%). High doses of VPA within the first 24 h showed<br />

therapeutic effects on the patchy lesions in the thalamus,<br />

caudate nucleus and putamen (P , 0:05). VPA protected<br />

the brain from possible deterioration of patchy and cortical<br />

(cerebral and hippocampal) damages into more severe<br />

forms (grades 3–4/4). VPA also prevented progression of<br />

pronounced atrophy in the ipsilateral hemisphere (,75%).<br />

In view of the present results it is concluded that therapeutic<br />

properties of VPA in HIBD need to be elucidated in<br />

more comprehensive studies.<br />

FP-C-033<br />

The effect of intravenous immunoglobulin in hypoxicischemic<br />

brain damage in an experimental immature rat<br />

model<br />

G. Haliloglu, P. Atilla, M. Berker, B. Anlar, A.N. Cakar, S.<br />

Aysun<br />

Histology and Embryology and Neurossurgery, Departments<br />

of Pediatric Neurology, Hacettepe <strong>University</strong> Faculty<br />

of Medicine, Ankara, Turkey<br />

Immunoinflammatory system and cytokines activate a<br />

biochemical cascade of events after hypoxia-ischemia.<br />

Effects of intravenous immunoglobulin as cytokine suppression<br />

and remyelination have been reported in human tissue<br />

cultures and demyelinating diseases. The aim was to study<br />

these effects in histopathological findings in hypoxia-ischemia<br />

immature rat model. Hypoxic-ischemia was induced in<br />

7-day-old rats (right common carotid artery occlusion 18%<br />

O 2 for 2.5 h). The animals were then divided into two groups:<br />

first group received 1 g/kg IVIg intraperitoneally, and the<br />

second group received the same amount of serum physiologic<br />

within 1 h after the insult. The animals were decapitated<br />

after 24 h, and a morphologic classification was done using<br />

vacuolization, clumping of nuclear chromatin, disappearance<br />

of nuclear depression and nucleus pyknosis from both<br />

hemispheres and frontal, temporal and occipital regions<br />

separately. It was demonstrated that vacuolization and<br />

nuclear pyknosis were decreased in the inner cortex in the<br />

first group. Pyknotic changes seen in the outer cortex in both<br />

groups represented cells in the process of apoptosis,<br />

supported by TUNEL method. This study demonstrated the<br />

morphologic effects of IVIg on hypoxic-ischemic encephalopathy<br />

in an immature rat model, and forms a base for<br />

further studies.


438<br />

Abstracts<br />

FP-C-034<br />

Brainstem evoked response in term neonates<br />

L.M.F.F. Guilhoto, E.A. Abreu, E. Ornelas, V.S. Quintal,<br />

M.T.Z. da Costa<br />

Hospital Universitário da Universidade de São Paulo, São<br />

Paulo, Brazil<br />

Brainstem evoked response (BSER) in neonates may<br />

evaluate objectively the integrity of the auditory system<br />

up to the brainstem level. It seems to be a reliable test<br />

for auditory and neurological dysfunction at this age and<br />

it permits early diagnosis and rehabilitation. The purpose<br />

of this study is to demonstrate the latencies of BSER in<br />

normal term neonates in order to obtain normative data in a<br />

university hospital. BSER was performed on the 2nd day of<br />

life of 47 normal newborns (25 males, 22 females) ranging<br />

in gestational ages between 37 and 40 weeks that did not<br />

present with familial history of deafness. The examination<br />

was performed during sleep, after feedings, with 80 dBHL<br />

clicks of alternating polarity presented monaurally at a rate<br />

of 10/s. A total of 2.000 stimulus trials was averaged and<br />

duplicated for each ear. The mean latency time of waves I–<br />

V, as well as the inter-peak latencies were measured. The<br />

mean of the latencies in milliseconds was the following:<br />

wave I, 1.79 (SD 0.20); wave II, 2.88 (SD 0.28); wave III,<br />

4.54 (SD 0.31); wave IV, 5.86 (SD 0.36); wave V, 6.75<br />

(SD 0.38); IPL I–III, 2.75 (SD 0.36); IPL III–V, 2.22 (SD<br />

0.22); and finally IPL I–V, 4.97 (SD 0.43). Normative<br />

BSER studies in term neonates undertaken in university<br />

hospitals are necessary to establish reference values for<br />

evaluation of auditory and neurologic prognostic factors,<br />

as well as to early diagnose children with auditory dysfunction.<br />

FP-C-035<br />

Guidelines for intensive care in the delivery room of<br />

extremely premature newborns<br />

G. Verlato, D. Gobber, D. Drago, L. Chiandetti, P. Drigo,<br />

B.M. Amelia and the Working Group<br />

Intensive Care in the Delivery Room of the Bioethic<br />

Committee of the Department of Pediatrics; Department<br />

of Pediatrics, <strong>University</strong> of Padua, Padova, Italy<br />

Ethical problems related to neonatal intensive care of<br />

extremely preterm newborns, #25 weeks gestational age<br />

(GA) and at risk of disability are extensively debated; withholding<br />

intensive care is considered appropriate for<br />

newborns of GA ,23 weeks and of birth weight ,400 g<br />

(International Guidelines for Neonatal Resuscitation,<br />

Pediatrics 2000), but the importance of local and national<br />

guidelines is underlined. The Bioethical Committee of our<br />

Department promoted a multidisciplinary group to release<br />

guidelines to help the staff in charge of neonatal intensive<br />

care facing the medical and ethical problems related to an<br />

extremely premature birth. The group comprised nurses,<br />

physicians, ethicists and lawyers. The vitality limit, survival,<br />

outcome and the ethical and legal aspects were<br />

analysed according to the literature and the local context.<br />

As a result, a document was produced and distributed to all<br />

the health care professionals involved. Summary of guidelines:<br />

we suggest at 222 GA, defined by the anamnesis and<br />

the clinical evaluation of the neonate, to provide compassionate<br />

care only; 223 GA, in the presence of detectable<br />

vital signs, to practice immediate intubation, respiratory<br />

support and to revaluate neonatal conditions; from 24<br />

GA, to provide intubation, ventilatory support and cardiovascular<br />

resuscitation. If clinical and anamnestic GA are<br />

different, we proceed according to the best one. The importance<br />

of correct information to parents, and the role of<br />

compassionate care are outlined. An annual audit of guidelines<br />

is considered mandatory.<br />

FP-C-036<br />

Parasagittal cerebral lesions in full-term newborns<br />

F. Ciardo, E. Della Giustina, G. Cioni, M. Verdecchia, P.<br />

Curatolo<br />

Pediatric Neurology, Tor Vergata <strong>University</strong> of Rome,<br />

Rome, Italy<br />

Parasagittal cerebral injury (PCI) is a specific pathologic<br />

lesion of full-term newborns suffering from hypoxicischemic<br />

encephalopathy. PCI is characterized by necrosis<br />

of the cortex (most vulnerable in the term infant), and close<br />

subadjacent white-matter, especially in the parieto-occipital<br />

areas of the brain; neuronal elements are most severely<br />

affected. The injury is bilateral and although usually<br />

symmetrical, may be more striking in one hemisphere<br />

than the other. The spectrum of PCI is, however, wide,<br />

including frequent symmetric involvement of basal ganglia<br />

and thalami. Because of its unclear pathogenetic mechanism,<br />

we have studied the clinical and neuroradiological<br />

follow-up of four patients suffering from fetal distress, in<br />

whom MRI scans had clearly demonstrated in vivo the<br />

presence of parasagittal lesions due to perinatal hypoxicischemic<br />

insults. We noted that: (1) the pattern of injury<br />

seen on MRI seems to be related to the type and severity of<br />

the insult, and very strongly to the gestational age at which<br />

the insult occurred; (2) severe acute asphyxia is associated<br />

with lesions in the basal ganglia, thalami, brainstem, hippocampus<br />

and the corticospinal tracts around the central<br />

fissure; (3) the infants were affected by severe white<br />

matter, severe basal ganglia and thalamic injury, which<br />

may have been caused by a more severe perinatal insult<br />

occurring in combination with a chronic and repetitive<br />

insult that involves the white matter; and (4) in the absence<br />

of basal ganglia lesions, the motor outcome may be surprisingly<br />

good even with extensive white matter loss.


Abstracts 439<br />

FP-C-037<br />

Early intervention promotes intellectual development in<br />

asphyxiated newborn and premature infants<br />

X.-L. Bao, S.-Y. Sun, R.-J. Yu, J.-T. Sun, S.-Z. Wei<br />

Intervention of Asphyxiated Newborn and Premature<br />

Infants Cooperative Research Group Pediatric department,<br />

Peking Union Medical College Hospital, Chinese Academy<br />

of Medical Sciences, Beijing, China<br />

Objective: To evaluate the effect of early intervention on<br />

the intellectual development in asphyxiated newborn and<br />

premature infants. Methods: 119 cases of full term<br />

asphyxiated newborn infants (Apgar score ,6 at 5 min<br />

after birth) and 104 premature infants (gestational age ,37<br />

weeks) were randomly assigned to early intervention group<br />

and conventional care group. The normal control group<br />

consisted of same number infants. Sex, mother’s educational<br />

background; environmental condition and physical development<br />

were not significantly different in above groups. A total<br />

of 0–2 years early intervention program was compiled on<br />

basis of the national and foreign material about 1 month<br />

ahead of average development of the child. It included<br />

motor, cognitive, speech development and social behavior.<br />

Parents were instructed to carry out early intervention. At the<br />

age of 1.5 and 2 years. All infants received infant development<br />

tests (CDCC). The examiner did not know which infant<br />

had received intervention. Results: At the age of 1.5 years,<br />

average score of MDI in early intervention groups of<br />

asphyxiated and premature infants were 14.6 and 13.8 higher<br />

than that in conventional care groups respectively<br />

(P , 0:01). MDI score in early intervention group caught<br />

up with that in normal control group (P . 0:05). Conventional<br />

care group were 9.7 and 11.5 lower than normal control<br />

group, respectively (P , 0:01). There were 9 and 7.8%<br />

infants in conventional care group mentally retarded while<br />

none were mentally retarded in the early intervention group.<br />

Conclusions: The results showed that the early intervention<br />

could promote intellectual development of asphyxiated and<br />

premature infants and it may be beneficial to the prevention<br />

of mental retardation. Early and intensive intervention can<br />

produce better results. Bringing parent’s initiative into full<br />

play through deepening their understanding of the importance<br />

of early intervention is the key to success.<br />

FP-C-038<br />

Protective effect of ligustrazine on hypoxic-ischemic<br />

encephalopathy by NBNA<br />

R. Zhu, D.-D. Zhuo<br />

Zhong Lan Hospitol, WuHan <strong>University</strong>, WuHan, China<br />

Purpose: To observe the protective effect of ligustrazine<br />

on hypoxic-ischemic encephalopathy (HIE) by NBNA.<br />

Methods: Sixty cases of HIE were enrolled and divided<br />

randomly into two groups. The treatment course was 10<br />

days. The change score of NBNA 20 were observed before<br />

and after treatment. Thirty healthy cases were taken for<br />

control. Results: The score of NBNA 20 in the tested<br />

group was significantly (P , 0:01) higher than in the<br />

control group. Conclusion: Ligustrazine has protection on<br />

HIE, is a good Chinese drug for HIE in clinical practice.<br />

FP-C-039<br />

A study of the protective effect of magnesium sulfate on<br />

the brain injury of hypoxia and ischemia in newborns<br />

with birth asphyxia<br />

F.-L. Zhao, Y. Tang<br />

Department of Pediatrics, The Third Hospital of Beijing<br />

<strong>University</strong>, Beijing, China<br />

Objective: Perinatal cerebral hypoxia-ischemia remains a<br />

frequent cause of disablement and death of newborn. The<br />

aim of this study was to investigate the protective effect and<br />

security of magnesium sulfate on the brain injury of hypoxia<br />

and ischemia in newborn with birth asphyxia. Methods:<br />

Thirty-nine mature newborns with birth asphyxia were<br />

divided randomly into two groups: therapy and control.<br />

The first group received magnesium sulfate infusions<br />

comprising a loading dose of 200 mg/kg, followed by two<br />

doses of 125 mg/kg at 24 and 48 h later. The occurrence<br />

ratio of HIE, the difference of clinical index and the<br />

instances of side effect were compared between the 2 groups<br />

after the intervention. Results: (1) There was no significant<br />

difference in the occurrence ratio of hypoxic ischemic encephalopathy,<br />

EEG, CT and NBNA scores between the two<br />

groups (P . 0:05), whereas the ratio of serious encephalopathy<br />

in the therapy group was lower (P , 0:05). (2) No<br />

serious side effect was found in the therapy group. Conclusion:<br />

(1) Magnesium sulfate protected hypoxic-ischemic<br />

brain injury in the newborn with birth asphyxia to a certain<br />

extent. (2) The infusion doses were not associated with<br />

serious side effects.<br />

FP-C-040<br />

The relationship among umbilical cord serum<br />

interleukin-6, brain damage in the preterm newborn and<br />

the neurologic prognosis<br />

C.-X. Du, F.-L. Zhao<br />

Department of Pediatrics, Third Hospital of Peking <strong>University</strong>,<br />

Beijing, China<br />

Objective: Brain damage in the preterm newborn is a<br />

major risk of neonatal death and is often associated with a<br />

variety of neurologic deficits in survivors, including CP.<br />

Recently, the roles of maternal choriamnionitis and cytokine<br />

produced in response to maternal infection in the<br />

pathogenesis of preterm birth and neonatal brain damage<br />

have become a major focus of attention. The purpose of<br />

this study is to examine the relationship among neonatal


440<br />

Abstracts<br />

brain damage, maternal choriamnionitis and umbilical cord<br />

serum interleukin-6 (IL-6) concentration, to evaluate the<br />

clinical significance of examining umbilical cord serum<br />

IL-6 concentration, and to provide a new method for diagnosing<br />

of brain damage in the preterm neonate and preventing<br />

neurologic deficits. Methods: The objects of this study<br />

were 31 preterms. The procedure was: (1) the umbilical cord<br />

serum IL-6 concentration of neonates was detected by<br />

ELISA; (2) maternal choriamnionitis was determined by<br />

histologic examination; (3) brain damage was diagnosed<br />

by ultrasonography or CT in the first 3 days; and (4) following<br />

up the neurologic development of these preterms within<br />

3 years after their birth. Results: (1) Five preterms failed to<br />

be followed up, and the loss rate was 16%. The incidence of<br />

neurologic deficits was higher in preterms with brain<br />

damage than in those without brain damage; (2) the incidence<br />

of brain damage and the incidence of neurologic deficits<br />

were higher in preterms whose mothers had<br />

choriamnionitis than in those without maternal infection;<br />

(3) umbilical cord serum IL-6 concentrations of preterm<br />

newborns were higher in preterms with brain damage and<br />

those with neurologic deficits; (4) among the preterm<br />

neonates with brain damage, cord serum IL-6 levels were<br />

significantly higher in the presence of choriamnionitis than<br />

in the absence of choriamnionitis; and (5) using the results<br />

of brain imaging examination as the standard, a cord serum<br />

IL-6 level of $1.20 ng/ml was 80.0% sensitive and 75.0%<br />

specific for identification of the brain damage associated<br />

with maternal infection. Conclusions: These results show<br />

that maternal chorioamnionitis associates with an increased<br />

incidence of brain damage in preterm newborns. So it is<br />

very important to prevent and treat maternal intrauterine<br />

infection early in order to prevent the occurrence of brain<br />

damage in preterm neonates and decrease the risk of neurologic<br />

deficits like CP. IL-6 in umibilical cord serum might<br />

be the link between maternal infection and neonatal<br />

damage. These results provide a new practicable method<br />

for preventing and diagnosing of brain damage in preterm<br />

newborns and preventing of neurologic deficits. An increase<br />

in umbilical cord serum level is a good index for brain<br />

damage in preterm newborns. There is a clinical significance<br />

to examine IL-6 concentration in umbilical cord<br />

plasma of neonates.<br />

FP-C-041<br />

Long-term prognosis of convulsions in the newborn<br />

L. Wei, C.-X. Du<br />

The Third Hospital, Peking <strong>University</strong>, Beijing, China<br />

Objective: To evaluate long-term prognosis in neonates<br />

with convulsions and related factors. Methods: Fifty-six<br />

infants with convulsions were studied. All of them were<br />

subjected to systemic physical examination and intelligence<br />

test, and some of them underwent CT and EEG<br />

examinations. The relationship between prognosis, situation<br />

of perinatal stage and convulsions was analyzed.<br />

Results: CP developed in four infants, and five infants<br />

(including two infants with CP) suffered from epilepsy.<br />

Twelve infants had low IQ (three infants with CP and<br />

one infant with epilepsy). In all infants, 15 infants had<br />

nervous system sequelae. The rate of sequelae was 27%.<br />

Neonatal convulsions caused by hypoxic-ischemic encephalopathy<br />

were significantly different from those caused<br />

by other factors. Additionally, prognosis was highly correlated<br />

with convulsion styles, the number of seizure times<br />

and seizure duration. Conclusion: A high correlation exists<br />

between prognosis and etiology of neonatal convulsions.<br />

FP-D<br />

Neurodevelopmental Neurology<br />

FP-D-001<br />

Organising logopedic therapy for babies with unilateral<br />

or bilateral brain lesion in the pre-speech period<br />

V. Gec<br />

Centre for Hearing and Speech, Maribor, Slovenia<br />

Therapy was carried out in an experimental group of 30<br />

babies in the pre-speech period and suffering from perinatal<br />

unilateral or bilateral lesion at the age of 6–24 months.<br />

The control group comprised 60 babies. Therapy is made<br />

possible by early detection of factors of risk in the earliest<br />

period of the child’s life. Important are: (1) function of<br />

sucking, swallowing and later chewing in the course of<br />

the feeding therapy; and it is also important to (2) improve<br />

proprioceptive findings regarding speech musculature by<br />

means of passive-active motor exercises, to develop a<br />

correct breathing function and vocal activities. Simultaneously<br />

with the simulation of articulation, phonation,<br />

breathing in speech and phonematic hearing, attention<br />

should also be given to the stimulation of speech kinaesthetics,<br />

kinaesthetic observation and the kinaesthetic<br />

scheme of speech musculature. After intensive medical<br />

treatment, therapy is continued in the child’s home environment<br />

guided by a speech therapist, but carried out by the<br />

baby’s parents and surrounding. Based on existing knowledge<br />

and personal experience we examined the basic<br />

elements of logopedic diagnostics, therapy and stimulation,<br />

which were classified into categories and applied to individual<br />

patients, depending on their abilities. The data from<br />

the reports and responses in the logopedic dispensary were<br />

inserted into the protocol of the new-born at risk and the<br />

protocol I had formed to meet the demands of this study.<br />

Both protocols are related and include all the basic phases<br />

of logopedic diagnostics and the results of treatment to 24<br />

months of age. The protocols and the rest present a<br />

complete medical-logopedic treatment and development<br />

of the newborn at risk.


Abstracts 441<br />

FP-D-002<br />

An analysis of electroencephalographic characteristics<br />

in 68 young infants and children with cerebral palsy<br />

S.-M. Li, H.-C. Zheng, X.-G. Li<br />

HeBei Children Hospital, Shijiazhuang, China<br />

Objectives: To study the electroencephalographic characteristics<br />

in young infants and children with cerebral palsy.<br />

Methods: A total of 68 patients (45 boys, 23 girls) aged 4<br />

months–6 years (mean 1 year 5 months) with cerebral palsy<br />

was investigated. They all had clinical evaluation and routine<br />

electroencephalographic studies. Results: electroencephalographs<br />

are normal in 29 patients and abnormal in thirty-nine<br />

with an abnormality rate of 57.4%. In those with abnormal<br />

EEG findings 12 showed focal abnormality and 27 showed<br />

widespread abnormality. All focal abnormal electroencephalographsshowedfocalepileptiformdischarges.Inwidespread<br />

abnormal electroencephalographs, diffuse slow wave was<br />

noted in 12 patients (three of them associated with focal<br />

epileptiform discharges). Hypsarrhythmia was noted in ten<br />

patients (one of them associated with extreme spindles),<br />

with mental retardation in all. Depression of normal rhythms<br />

wasnotedinthreepatients,leapingoutofbackgroundrhythms<br />

and suppression burst of a rhythms was noted in two patients.<br />

The abnormality rate of electroencephalographs in patients<br />

with normal mental faculties is 29.4%. The rate of abnormal<br />

EEG in those with delayed mental function is 83.3%. Conclusions:<br />

The abnormality rate of electroencephalographs is high<br />

in patients with mental retardation. Electroencephalography<br />

might have an important role in the clinical predictions and<br />

provide more objective indexes for the evaluation of brain<br />

function in patients with cerebral palsy<br />

FP-D-003<br />

The etiologies analysis of 292 cerebral palsy children<br />

M.-L. Liu, W.-Y. Wang, J.-Y. Yan<br />

Department of Pediatrics, Affiliated Hospital of Medical<br />

College of Chinese People’s Armed Police Force; Center<br />

of Handicapped Children Recuperation, Tianjin, China<br />

We had analyzed the etiologies of 292 cases diagnosed<br />

cerebral palsy. Result: Among many pathogenic factors<br />

related to cerebral palsy, premature delivery and neonatal<br />

asphyxia was the most common. They accounted for about<br />

49.96% cases. Conclusion: To strengthen perinatal period<br />

care, prevent premature delivery and perinatal asphyxia was<br />

the key to decease occurrence of cerebral palsy.<br />

FP-D-004<br />

Cerebral palsy in 1–6 years old children in the Leshan<br />

area of Sichuan province: an epidemiological survey<br />

Y.-Q. Zhong, W. Ju, D.-Z. Peng<br />

Cheng Du Children Hospital, Cheng Du, China<br />

Objective: To describe the epidemiological features of<br />

childhood CP in Leshan area. Method: A cross-sectional<br />

survey on the prevalence of CP in 1–6 years old children<br />

was conducted using cluster sampling from eight Counties<br />

or Districts of Leshan area. Results: The survey was done<br />

among 148 723 children from the sampled locations and a<br />

CP prevalence of 2.07‰ was found. The results showed that<br />

among CP children there ware more male than female. There<br />

were also more premature and post-term infants than term<br />

infants, with the increased prevalence 22.21 and 5.4 times in<br />

the former than the later, respectively. The prevalence of CP<br />

in low birth weight infants was 16.32 times to that in normal<br />

birth weight infants. Twin infants suffered CP 4.2 times more<br />

frequently than single-born infants. Conclusion: CP prevalence<br />

in 1–6 years old children in Leshan area and the epidemiological<br />

features are comparable to those in advanced<br />

countries. Better recognition of and improvement in gestational<br />

and perinatal health care should be a critical way to<br />

reduce the occurrence of CP in children.<br />

FP-D-005<br />

The diagnosis and outcome of cerebral palsy: a clinical<br />

and neuroimaging study<br />

B.-N. Zhan<br />

Department of Pediatrics, Tongji Hospital, Tongji Medical<br />

<strong>University</strong>, Huazhong; <strong>University</strong> of Science and Technology,<br />

Wuhan, China<br />

Objective: To explore the etiology, methods of early diagnosis,<br />

and management of cerebral palsy. Method: clinical<br />

data analysis, EEG and neuroimaging study (CT, MRI).<br />

Results: Complete clinical data of 51 cases of cerebral palsy<br />

were analyzed. Among them 20 cases had birth asphyxia, 20<br />

cases were with positive history of maternal perinatal<br />

diseases, 12 cases were premature/low-birth-weight/smallfor-gestational<br />

infants. All 51 cases manifested different<br />

extent of mental retardation and neuromotor dysfunction in<br />

the follow-up, while the most common type of disability was<br />

spasticdiplegia (40cases, 78.4%).Neuroimaging study for all<br />

the cases (CT and/or MRI) revealed an 84.3% (43/51) of<br />

abnormality, with brain atrophy as the most frequent finding<br />

(34/51, 66.7%). A comprehensive management strategy was<br />

adopted in the clinic. Among the 16 cases with long-term<br />

follow-up, four (25%) had significant psychomotor improvement<br />

and 12 cases (75%) showed moderate improvement.<br />

FP-D-006<br />

Electrophysiological study of deep coma and its outcome<br />

in children<br />

Yutaka Tomita a , Sachiko Fukuda b<br />

a Department of Pathological Science and Technology,<br />

School of Health Science, Yoshihiro Maegaki; b Department<br />

of Pediatric Neurology, Faculty of Medicine, Tottori<br />

<strong>University</strong>, Yonago, Japan


442<br />

Abstracts<br />

One of the major clinical features of brain death is deep<br />

coma. Therefore, we conducted an electrophysiological<br />

study of 31 children who had suffered from deep coma in<br />

order to investigate its pathophysiological characteristics and<br />

outcome. The patient age at coma ranged from 1 month to 10<br />

years (mean 2 years 1 months). We compared results between<br />

fair and poor prognostic groups. Subsequently, lack of P14,<br />

N18 and N20, and amplitude reduction or vagueness of P13<br />

in short-latency SSEPs in these comatose children strongly<br />

suggested high risk in their future prognosis. SSEPs revealed<br />

findings for a deep coma condition more specific than ABR<br />

and blink reflex. In conclusion: SSEPs might be a very sensitive<br />

and specific examination for predicting the long-term<br />

prognosis of deep coma in children.<br />

FP-D-007<br />

Development of children born to drug-dependent<br />

mothers<br />

E. Berger a , Th. Elstner a , S. Fiala-Preinsperger a , B. Schuch b ,<br />

G. Fischer c , M. Weninger d , G. Langer e<br />

a Department for Neuropsychiatry of Children and Adolescents,<br />

Neurological Hospital Rosenhuegel, Vienna; b Clinic<br />

for Neuropsychiatry of Children and Adolescents, <strong>University</strong><br />

of Vienna; c Clinic for Psychiatry, Outpatient Dep. For<br />

Drug Abuser, <strong>University</strong> of Vienna; d Clinic for Paediatric<br />

and Adolescent Medicine, <strong>University</strong> of Vienna; e Clinic for<br />

Gynaecology and Obstetrics, <strong>University</strong> of Vienna, Austria<br />

Since 1995 we observed in a prospective longitudinal study<br />

thedevelopment of130children (between 6weeksand6years<br />

of age) of drug dependent mothers. We must take into account<br />

a combination of different risks: unspecific and drug-specific<br />

biological risk as the root of neurological risk and multiple<br />

psychosocial risks. We designed the follow-up in a biopsycho-social<br />

frame: The combination of comprehensive<br />

care with clinical evaluation – in a ‘network of helpers’<br />

(drug care, obstetric care, neonatologic care, developmental<br />

care and psychosocial care). We define the risk on different<br />

levels by the following test-battery: pre- and perinatal risk:<br />

drug levels in urine, dosis range of drug-substitute, intrauterine<br />

dystrophy, prematurity; postnatal risk: intensity(Finegan-<br />

Score) and duration of symptoms of detoxication; developmental<br />

parameters: neurological investigations (Prechtl,<br />

Beintema), general movements (Prechtl), sensorimotor and<br />

cognitive investigations (KABC-Scale), Parent Infant Global<br />

Assessment Scale (PIRGAS), Zero to three – diagnosis, child<br />

behavior problem lists (CBCL). Preliminary results: 95 children<br />

(born between march 1995 to November 1999) are<br />

included for evaluation. The biological risks (neurological<br />

development) are very low, if the drug substitution is correct;<br />

the risks are increasing by additional use of benzodiazepines<br />

and cocain. The psychosocial risks are increased: 35% of relationship<br />

disorders and 20% of psychopathological disorders<br />

in the first 3 years. Summarising we can say, that the approach<br />

of comprehensive care can minimise the developmental risks.<br />

FP-D-008<br />

Investigation on the pathogenic factors and clinical<br />

features of cerebral palsy in Shenzhen<br />

L. Chen, J.-X. Liao, B. Li, T.-S. Huang<br />

Epilepsy Center and Department of Pediatric Neurology,<br />

Shenzhen Children’s Hospital and Shenzhen Institute of<br />

Pediatrics, Shenzhen, China<br />

Objective: To explore the pathogenic factors and clinical<br />

features of CP in Shenzhen. Methods: To analyze retrospectively<br />

CP patients’ clinical data in the outpatients department<br />

of Shenzhen Children’s Hospital. Results: A total of<br />

110 cases were investigated. Thirty two had premature birth<br />

history, 44 had low birth weight (less than 3000 g) and 12<br />

had congenital brain malformations, and 15 had perinatal<br />

asphyxia history. Most patients with premature birth or low<br />

birth weight history developed spastic CP and had the cerebral<br />

periventricular leukomalacia tested by computerized<br />

scanning in neuropathology. Most patients with congenital<br />

malformations had small head circumference (range 39–<br />

44.5 cm, median 43 cm, n ¼ 9) and mental retardation.<br />

Conclusion: The common pathogenic factors of CP in<br />

Shenzhen are premature birth, low birth weight and congenital<br />

brain malformations. Asphyxia is now less important<br />

as a pathogenic factor than before. Periventricular leukomalacia<br />

is a common neuropathologic lesion.<br />

FP-D-009<br />

Pre-placement neurodevelopmental screening in<br />

international adoption: key to improved outcome<br />

G.W. Diamond a,b , Y. Senecky a , D. Inbar a,b , M. Nas c , H.J.<br />

Cohen b<br />

a Center for Child Development, Schneider Children’s Medical<br />

Center, Petah Tiqva, Israel; b CERC, Albert Einstein<br />

College of Medicine, Bronx, NY, USA; c Fundatie Prima<br />

Generatie, Bucuresti, Romania<br />

Background: Young, institutionalized children, adopted<br />

from abroad, constitute a high risk, special needs population.<br />

Those who underwent pre-adoption comprehensive<br />

medical and neurodevelopmental testing demonstrated<br />

improved adjustment to their new home environment and<br />

were treated earlier for identified medical and neurodevelopmental<br />

impairments. Objective: To determine the character<br />

and extent of medical and neurodevelopmental<br />

impairments most prevalent among a cohort of young children<br />

who were candidates for adoption in East European<br />

orphanages in order to provide improved treatment and<br />

support services for them and their adoptive families<br />

upon arrival in their new homes. Surveyed also were<br />

those disabilities militating against adoption of select children.<br />

Design: Sixty two East European children, age 3<br />

months–4.5 years (median age: 11 months) were screened<br />

by physicians while still in their original residential


Abstracts 443<br />

settings. Evaluations comprised examinations using standardized<br />

assessment tools, and laboratory analysis of<br />

blood samples, including genetic screening. Results:<br />

Eleven children (18%) were not placed in adoptive<br />

homes abroad due to significant medical illness or developmental<br />

delays. These included hepatitis B and C infection,<br />

MR, CP, and positive family psychiatric history.<br />

Parents reported greater satisfaction with the pre-adoption<br />

method of screening.<br />

FP-D-010<br />

Exploration study to find out increased risk of later<br />

developmental delay in neonates who received intensive<br />

care<br />

S. Usman, N. Somani, S. Raltani<br />

The Age Khan <strong>University</strong>, School of Nursing, Karachi, Pakistan<br />

Many of the health care institutions are equipped and<br />

staffed to provide high technical and quality care to the<br />

high-risk neonates to enhance their survival rate, but there<br />

are number of observed factors, i.e. prematurity, low birth<br />

weight, maternal related diseases and nutritional status to<br />

determine the quality of life of a neonate. The Main purpose<br />

of this study is to test the validity and reliability of the tool,<br />

Jerri and Richi (1993) in our setting, what risk of developmental<br />

delay is involved for neonates who receive intensive<br />

care in our Hospital. The data was collected retrospectively<br />

by convenient sampling. The inclusive criteria is based on<br />

neonate with weight ,1000 g, and gestational age more than<br />

34 weeks. Jerri and Richi (1993) used a screening tool to<br />

identify neonates at risk for cognitive, motor and physical<br />

development delay. The same tool was adopted in this study.<br />

The tool is comprises of seven variables. The variables are<br />

further divided to determine the degree of intensity that is<br />

assigned score. Neonates who score more than five are<br />

considered to be at a higher risk of developmental delay<br />

than others. In conclusion, the study did not show a significant<br />

result because of small sample size and selection of<br />

gestational age, i.e. .34 weeks. Based on the findings,<br />

recommendations are suggested to replicate the study on a<br />

larger sample size.<br />

FP-D-011<br />

Developmental coordination disorder in schoolchildren<br />

with extremely low birthweight<br />

H. Hara, T. Takamura<br />

The National Institute of Special Education, Kanagawa,<br />

Japan<br />

As a result of improving outcome of extremely low<br />

birthweight (ELBW; birthweight ,1000 g) infants, it<br />

becomes more important to evaluate their psychomotorbehavioral<br />

outcome up to school ages. In the cohort of<br />

100 ELBW children without severe neurological sequelae,<br />

we found out thirty-two, 25 boys and seven girls, diagnosed<br />

as having developmental coordination disorder<br />

(DCD) by age of 6. The motor development of 86 children<br />

out of the original cohort was assessed on Kobayashi-Frostig<br />

Movement Skills Test Battery (MSTB, 1989) at ages of<br />

6–7 and/or 8–9. Fine and gross motor skills of the DCD<br />

group were significantly inferior to those on the non-DCD<br />

group at both evaluation ages. Although the means of DCD<br />

group in all the MSTB scores were below the normal<br />

ranges, the improving rates between the first and second<br />

evaluations were approximated with those of non-DCD<br />

group. Interestingly, the gross motor scores of ELBW<br />

boys increased more steadily than those of ELBW girls<br />

from 6–7 to8–9 years old. Whereas MSTB scores of the<br />

ELBW girls marked higher than those of the boys, the<br />

differences became smaller at the second evaluation. A<br />

gender factor might affect gross motor development of<br />

the ELBW children during early school age.<br />

FP-D-012<br />

Psychological intervention in habilitation process with<br />

cerebral palsy preschool children<br />

E.S. Julia, M. Velichko, L. Zeldin, A. Bitova<br />

Russian Federation President’s Medical Center, Center for<br />

Curative Pedagogics, Moscow, Russia<br />

CP is the most common and severe neurological disability<br />

in children. Curative factors bordering pathogenic therapy<br />

and correction of neurological defect is still quite actual.<br />

Purpose: To check up the hypothesis of evolution of<br />

motor competence of CP patients in habilitation work<br />

process including sensory stimulation. Material and methods:<br />

We studied 12 children with different type of CP at the<br />

age of 16 months–6 years (I group) and control group of<br />

seven children with CP. Patients of 2nd group got standard<br />

treatment program and patients of 1st group got modified<br />

one. We pointed the level of motor disabilities (1–5 level of<br />

disability) and investigated not only motor disorders but<br />

also sensorial, social, cognitive, perceptual ones as well as<br />

to get more insight in the developmental evolution of the<br />

behavioural phenotype and analysed relations of ‘therapistpatient’<br />

during habilitation process. The follow-up period<br />

was 2 years. Results: As we got disappointed of the existing<br />

relations ‘patient-therapist’ where the patient with CP<br />

played predominantly passive role. The ‘model of action’<br />

was desired and it allows the patient plays the role of<br />

precosiour of motor competence improvement (I group-<br />

66%, II group-43%). Conclusion: We carry out the analysis<br />

of system of the relations ‘patient-therapist’ which shows<br />

the vertical interaction was the dominant form and patient<br />

had passive role. We suggest adding methods of sensorial<br />

stimulation into standard treatment program of CP<br />

preschool children so it is the essential and necessary part<br />

of it.


444<br />

Abstracts<br />

FP-D-013<br />

Intellectual development of premature infants and<br />

effects of early interventions<br />

L.-F. Liao, R.-Y. Huang, C.-W. Yang<br />

The First People’s Hospital of Shunde, Daliang Town,<br />

Shunde City, Guangdong, China<br />

Purposes: To compare intellectual developmental status<br />

between natural delivery and abnormal delivery premature<br />

infants. To study the effect of early interventions on promoting<br />

their intellectual development. Objectives and methods:<br />

One hundred twenty infants, including 54 natural delivery<br />

premature, 39 abnormal delivery premature (terminate gravidity<br />

artificially), 37 normal full term infants, with average<br />

gestation age of 35.3, 35.9 and 40.0 weeks, respectively, were<br />

assigned randomly into intervention or control group. The<br />

intervention group received early intellectual interventions<br />

beginning from newborn period. All parents of these infants<br />

joined regular routine children health care instruction course<br />

at outpatient clinic. Using Gasell infants diagnosis measuring<br />

scale to check intellectual DQ regularly, five observing<br />

indexes are included: gross motor, fine motor, cognitive,<br />

communication and language, social ability. Results:<br />

Among all six factors of infants’ basic situation (monthly<br />

age, body weight at born, mother’s age when giving birth,<br />

gestational complications, type of delivery, complications of<br />

new-born infants), only infants’ monthly age has influence on<br />

their intellectual development. After adjusting monthly age,<br />

premature delivery seems to influence gross motor and<br />

cognitive ability only (that means lower scores of these two<br />

factors in premature infants) but not influence other indexes.<br />

Early interventions strongly influence all five intellectual<br />

indexes. The intervention group got remarkably higher<br />

scores on all indexes than the control group. Conclusions:<br />

Early interventions promoted intellectual development of<br />

premature infants. It was plausible to promote infant’s intellectual<br />

development on their gross motor and cognitive ability<br />

effectively through training.<br />

FP-D-014<br />

A study about the effects of external hydrocephalus on<br />

neurological and psychomotor development in infants<br />

J.-N. Mai<br />

Neurological and Rehabilitating department, Guangzhou<br />

Children’s Hospital, Guangzhou, China<br />

Objective: To study the effects of external hydrocephalus<br />

(EH) on neurological and psychomotor development of<br />

infants. Methods: Four hundred and twenty-two infants<br />

with EH were assessed with head CT scan and divided into<br />

three groups based on the width of the subarachnoid space<br />

(mild, moderate and severe groups). All infants were<br />

assessed with Gesell development scale, TCD, BAEP and<br />

EEG at age of 4, 8, 18 and 24 months. Results: Two hundred<br />

and sixty-five were in mild group; 119 were in moderate<br />

group and 38 were in severe group. One hundred and<br />

twenty-six Infants (47.5%) in mild group appeared slight<br />

abnormal neuropsychological behaviors within 6 months<br />

age periods, transient motor delay within 12 months age<br />

periods; EEG and TCD were normal and enlargement of E<br />

space disappeared over 24 or 30 months age; 57 infants<br />

(21.5%) appeared 1–2 episodes of convulsion with fever<br />

during 10–24 months age and 15 infants (5.6%) were diagnosed<br />

as seizure. At age of 8 months age, 43 infants (36.1%)<br />

in moderate group had abnormal EEG and in TCD, 86<br />

(72.2%) showed abnormal blood flows in cerebral posterior<br />

or/and middle arteries; and 29 infants (76.3%) in severe<br />

group had abnormal EEG and twenty-one (55.2%) showed<br />

abnormal TCD. Among 157 infants in moderate group and in<br />

severe group, 143 infants (91.0%) had motor delay; at 2 years<br />

age 56 infants (35.6%) had motor dyscoordination with some<br />

neurological soft signs, 46 infants (29.2%) diagnosed as CP;<br />

35 infants had (22.2%) speech problems; only 15 infants<br />

(9.5%) encountered convulsion and five (0.02%) were diagnosed<br />

as seizure. Conclusion: Infant in mild group had transient<br />

effects on infants in motor and neuro-psychological<br />

behaviors. Moderate and severe groups had significant<br />

effects in motor functions and neuro-psychological behaviors<br />

which are some functions of frontal lobes. But long<br />

term effects needs further follow-up.<br />

FP-D-015<br />

1:2 case-control study of risk factors for childhood<br />

cerebral palsy<br />

X.-J. Zhou, Z.-Y. Zhao, Q.-X. Shui, K. Chen, K.-H. Zheng<br />

The Children’s Hospital, Zhejiang <strong>University</strong> School of<br />

Medicine, Hang Zhou, China<br />

Objective: To investigate the possible risk factors for CP in<br />

children. Methods: A population-based 1–2 case-control<br />

study was performed within 66 townships of 15 cities or<br />

counties in Zhejiang Province, from October to November<br />

1998. Results: Statistically significant variables associated<br />

with an increased risk for childhood CP were neonatal<br />

diseases, maternal diseases, low birth weight, maternal irregular<br />

menstruation, receiving toxic substances in pregnancy,<br />

malnutrition in pregnancy, paternal ages. It was highly<br />

significant that mothers perinatal health care was a protective<br />

factor for CP in children. Conclusions: The prevention and<br />

elimination of the possible risk factors for CP might be<br />

expected to reduce the morbidity of CP.<br />

FP-D-016<br />

Neuromental development of term non-asphyxiatd small<br />

for gestational age (SGA) children at the age of four<br />

I. Prpić, I. Vlašić-Cicvarić, E. Paučić-Kirinčić, D. Fiket<br />

<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia


Abstracts 445<br />

The aim of the study was to establish whether the intrauterine<br />

growth retardation (IUGR) has direct effect on<br />

neuromental development in children at age of 4. Term<br />

(38–42 weeks of gestation) small for gestational age children<br />

(SGA) without any detectable risk factors for IUGR<br />

were analysed at the age of four. SGA infants were defined<br />

by birth weight less than 10 percentile considering gestational<br />

age, sex and mother parity, using normative data<br />

from proper population. Control group was appropriate<br />

for gestational age infants, without any risk factors for<br />

altered neuromental development. Retrospectively<br />

collected data were compared by parent’s statement, moreover,<br />

all parents filled specially prepared questionnaire to<br />

avoid possible socio-economic influence on child’s neurodevelopment.<br />

There were 40 SGA children and 20 children<br />

in control group which exams and tests were compared<br />

using standard statistical methods. At the age of four of<br />

SGA children still had statistically significant lower height<br />

and weight than control group children, as it was at the<br />

newborn period. There were no statistically significant<br />

differences in other (sex, age, socio-economic environment)<br />

parameters. All children had normal neurological<br />

exam. Psychological tests of showed adequate neuromental<br />

development of SGA children, but statistically significantly<br />

lower than control group children. These results proved<br />

that SGA children have delayed neuromental development<br />

comparing with their mates, which is a direct consequence<br />

of IUGR. SGA infants need long term neuropsychological<br />

follow up and advising. Further researches needed to determine<br />

pathophysiological mechanism of delayed/decreased<br />

CNS maturation caused by IUGR.<br />

FP-D-017<br />

The etiologic spectrum of cerebral palsy: a<br />

contemporary perspective<br />

M.I. Shevell, A. Majnemer, I. Morin<br />

Montreal Children’s Hospital, McGill <strong>University</strong>,<br />

Montreal, Canada<br />

Objective: CP is an established symptom complex which<br />

results from heterogeneous etiologies. Our understanding<br />

of the relative contribution of etiologies to the occurrence<br />

of CP is largely derived from studies lacking systematic<br />

neurological evaluation or the application of contemporary<br />

imaging modalities. Methods: Over a 10 years inclusive<br />

period, the case records of all consecutive patients diagnosed<br />

with CP in a single pediatric neurology practice were<br />

reviewed with reference to clinical features and etiologic<br />

determination. Results: A total of 217 cases of CP were<br />

identified (129 male, 88 female) – 77 (35.5%) spastic quadriplegic<br />

(Q), 68 (31.3%) spastic hemiplegic (H), 39 (18%)<br />

spastic diplegic (D), 5 (2.7%) spastic monoplegic (M), 12<br />

(5.5%) mixed (Mx), 12 (5.5%) ataxic-hypotonic (AH), 2<br />

(0.9%) dyskinetic (Dk), 2 (0.9%) Worster-Drought<br />

syndrome (WD). Overall etiologic yield was 82.0% varying<br />

according to type of CP; 50% Dk, 59% D, 80% M,<br />

80.9% H, 90.9% Q, 91.7% AH and 100% Mx/WD. As an<br />

identified cause, the top five etiologic entities identified<br />

were: periventricular leukomalacia 24.9%, intrapartum<br />

asphyxia 21.7%, cerebral dysgenesis 17.1%, intracranial<br />

hemorrhage 12.9%, vascular 9.7%. While a single etiology<br />

was apparent in 144 (66.4%) of the cases, multiple etiologies<br />

were felt to be contributory in 34 (15.6%) of the cases.<br />

The etiologic profile varied according to such features as<br />

the type of CP, gestational age and the source (high risk<br />

neonatal population or not) of the patients. Features of the<br />

child’s CP such as microcephaly, neonatal difficulties, prior<br />

or co-existing epilepsy and high-risk source were found to<br />

be predictive of eventual etiologic yield. Conclusion: This<br />

contemporary evaluation of CP etiologic yield suggests<br />

that it is much higher than previously reported and varies<br />

depending on key clinical features suggesting strategies for<br />

prevention, identification and treatment of this symptom<br />

complex.<br />

FP-D-018<br />

Predictors of developmental disability following openheart<br />

surgery in infants with congenital heart defects<br />

A. Majnemer, C. Limperopoulos, M.I. Shevell, C. Rohlicek,<br />

B. Rosenblatt, C. Tchervenkov, H.Z. Darwish<br />

Montreal Children’s Hospital, McGill <strong>University</strong>,<br />

Montreal, Canada<br />

Objective: Neurodevelopmental disabilities are increasingly<br />

reported in infants with congenital heart defects<br />

requiring open-heart surgery. This study describes the<br />

prevalence of persistent developmental impairments 1<br />

year following surgical correction, and identifies risk<br />

factors. Methods: In this prospective study, 131 infants<br />

were recruited and assessed in a blind fashion preoperatively,<br />

following surgery before discharge, and 12–18<br />

months later using standardized developmental assessments<br />

and neurological examination. Results: At a mean<br />

age of 19.1 ^ 6.6 months, 41% had abnormal neurologic<br />

examinations. Motor delays were noted in 42%, and 23%<br />

had global developmental concerns. Using the WeeFIM<br />

measure, moderate disability in functional activities was<br />

documented in 37% but only 6% were severely disabled.<br />

Socialization and daily living skills were delayed in .40%.<br />

Factors enhancing risk for long-term developmental<br />

disabilities included: pre and postoperative neurodevelopmental<br />

status, microcephaly, type of heart lesion, length of<br />

circulatory arrest time, age at surgery, and days in the ICU<br />

(univariate and multiple regression analyses: P , 0:05).<br />

Conclusion: Although severe deficits are rare, ongoing<br />

mild to moderate developmental disabilities are common<br />

in infants undergoing open-heart surgery. Risk factors<br />

suggest that etiology is likely multifactorial and includes<br />

brain injury prior to, during and following surgical correction<br />

of the defect.


446<br />

Abstracts<br />

FP-D-019<br />

How early is it possible to predict cerebral palsy and to<br />

differentiate between the spastic and the dyskinetic<br />

forms?<br />

C. Einspieler a , G. Cioni b , A.F. Bos c , F. Ferrari d , H.F.R.<br />

Prechtl a<br />

a Department Physiology, Graz <strong>University</strong>, Graz, Austria;<br />

b Division of Child Neurology and Psychiatry, <strong>University</strong><br />

and Stella Maris Scientific Institute, Pisa, Italy; c Department<br />

of Paediatrics, Division of Neonatology, Groningen<br />

<strong>University</strong>, Groningen, The Netherlands; d Department of<br />

Obstetrical, Gynaecological and Paediatric Sciences, Division<br />

of Neonatology, Modena <strong>University</strong>, Modena, Italy<br />

The fetus and young infant are characterised by a repertoire<br />

of distinct spontaneous movement patterns. One set of<br />

these patterns is the GMs. They emerge at 10 weeks postmenstrual<br />

age and continue in a similar pattern until the end<br />

of the 2nd month post term. Around this time GMs change<br />

into the fidgety pattern. From 3 to about 5 months these<br />

fidgety movements (FMs) are present in normal awake<br />

infants. They are circular movements of small amplitude,<br />

moderate speed, and variable acceleration of neck, trunk,<br />

and limbs in all directions. A number of studies demonstrated<br />

that any impairment of the young nervous system<br />

changes the GM quality. Applying the GM assessment longitudinally<br />

in 259 infants revealed that two age-specific GM<br />

abnormalities reliably predict spastic CP: (a) crampedsynchronised<br />

GMs (all limb and trunk muscles contract<br />

and relax almost simultaneously and GMs appear to be<br />

rigid). If this pattern exists over several weeks during<br />

preterm and term age, spastic CP will develop at later age;<br />

(b) and the absence of FMs. In addition, the absence of FMs<br />

is also predictive for dyskinetic CP. In contrast to spastic<br />

cases, later dyskinetic cases have ‘arm movements in<br />

circles’, finger spreading, and a lack of limb movements<br />

towards the midline. By qualitative assessment of GMs<br />

and concurrent movements we early identified infants at<br />

high risk for spastic or dyskinetic CP, which is of significant<br />

clinical relevance because the two types of cerebral palsy<br />

ask for different management and early intervention.<br />

FP-D-020<br />

The neonatal and early developmental outcome of very<br />

low birth weight infants ventilated at a private hospital<br />

in South Africa<br />

B. Laughton, A. Crafford, R. Alexander, G.F. Kirsten, P.D.<br />

Muller, J. Smith<br />

Tygerberg Children’s Hospital, Tygerberg, Western Cape,<br />

South Africa<br />

Introduction: The only documented outcome for VLBW<br />

infants in South Africa are for those born at tertiary state<br />

hospitals. Private hospitals have better resources, and we<br />

need accurate information on the outcome of infants managed<br />

at these institutions. Objectives: To determine the<br />

morbidity, mortality and developmental outcome of<br />

VLBW infants admitted to the Panorama NICU. Patients<br />

and methods: 99 VLBW infants admitted between 1 January<br />

1999 and 31 December 2000 were followed prospectively.<br />

The infants were followed up at 4.5, 8, 12 and 18 months by<br />

a paediatrician and a physiotherapist. Development was<br />

assessed on the Molteno Scale (before 24 months corrected<br />

age) and the Griffiths Scales at 24 months corrected age.<br />

Results: (Table 2). Conclusion: The mortality rate (9%), and<br />

early motor developmental and cognitive outcome is similar<br />

to that reported for VLBW and extremely low birth weight<br />

infants managed in first world countries. The prevalence of<br />

ROP and IVH is significantly lower.<br />

FP-D-021<br />

The neurodevelopmental outcome at 6 years of infants<br />

,1250 g electively not admitted to the neonatal intensive<br />

care unit<br />

J.I. van Zyl, G.F. Kirsten<br />

Tygerberg Children’s Hospital, <strong>University</strong> of Stellenbosch,<br />

Tygerberg Hospital, Tygerberg, Western Cape, South Africa<br />

Introduction: Infants with birth weights ,1250 g are<br />

selectively admitted to intensive care because of limited<br />

resources. Objective: To compare the neurodevelopmental<br />

and cognitive outcome at 6 years of age of infants ,1250 g<br />

Table 2<br />

Birth weight and no. (%) , 1000 g (40) 1000–1499 g (59)<br />

Mean gestational age (weeks) 7.2 (r: 25–32) a 29.4 (r: 26–36)<br />

Mean birth weight (g) 814.1 (r: 480–880) 1229.0 (r: 1000–1480)<br />

IVH grades 3 and 4 (%) 3 (8) 3 (5)<br />

Survival – total (%) 33 (83) 57 (97)<br />

ROP grades 3 and 4 (%) 2 (6) b 0<br />

Patients followed up (%) 28 (84) 43 (75)<br />

Definite CP (%) 3 (11) 3 (7)<br />

DQ .80 (%) c 24 (86) 43 (100)<br />

a<br />

b<br />

c<br />

r ¼ range.<br />

None blind.<br />

DQ ¼ developmental quotient.


Abstracts 447<br />

who received neonatal intensive care during the first 48 h of<br />

life (NICU group) to those who received high care (neonatal<br />

ward, NW group). Methods: 178 infants were admitted of<br />

whom 60.4% (NW group) and 80.5% (NICU group) survived<br />

(P ¼ 0:0004). Disability was defined as CP, sensori-neural<br />

(SN) deafness and a general developmental quotient (GDQ)<br />

,80. Results: At 6 years of age 20% were disabled; [NW<br />

group 12% versus NICU group 27%, P ¼ 0:08]. The NW<br />

group had significantly less physical disability (CP and SN<br />

deafness) than the NICU group [5 versus 18% P ¼ 0:047].<br />

The mean GDQ of the Griffiths Mental Developmental<br />

Scales did not differ between the NW and NICU groups<br />

while the locomotor subscale quotient was significantly<br />

higher in the NW group [NW: 107.5 NICU: 93.9,<br />

P ¼ 0:007]. The NW group had significantly less children<br />

with a total impairment score #15%. Movement ABC Test,<br />

only physically normal children tested than the NICU group<br />

[NW: 25%, NICU 50%, P ¼ 0:021]. Conclusions: Elective<br />

refusal to the NICU resulted in a higher mortality rate, but did<br />

not impact on the cognitive outcome. NICU admission<br />

however did result in more physical disabilities and worse<br />

scores for the physically normal children on the Movement<br />

ABC Test. The reason is probably multifactorial and could<br />

include compromise on admission and postnatal complications<br />

of ventilation.<br />

FP-D-022<br />

Observation on pre- and postnatal maternal use of<br />

sertraline, causing transient floppy infant syndrome<br />

I. Sos<br />

Department of Developmental Neurology and Neurohabilitation<br />

Pediatric Institute ‘Svábhegy’, Budapest, Hungary<br />

The SSRI treatment of some psychiatric diseases spread<br />

worldwide, because of its effectiveness and few adverse<br />

effects. By former opinions there is not known side effects<br />

of the treatment of the pregnant or nursing women on the<br />

fetuses, and on the breast fed infants. Our patient’s mother<br />

had used sertraline 50 mg/day from the second trimester of<br />

her pregnancy. The pregnancy and labour was uneventful,<br />

but the neonate was floppy infant. This clinical picture<br />

persisted until the sertraline uptake stopped. Some weeks<br />

later the baby was symptom free. We shortly discuss the<br />

possible adverse effects of the early serotoninerg excess<br />

on the developing human brain.<br />

FP-D-023<br />

Elementary sensorimotor functions in clinical practice<br />

F. Katona, M. Berenyi<br />

Department of Developmental Neurology Pediatric Institute<br />

‘Svabhegy’, Budapest, Hungary<br />

Stimulation of the striopallidal system through vestibular<br />

and reticular channels triggers a series of complex automatically<br />

repeated continuous movements. These are: unsupported<br />

sitting up and sitting in the air, unsupported crawldown<br />

and semi supported crawl-up on a slide, supported<br />

rotation, assisted creep and walk, and others. Activation of<br />

these complex movements can be achieved in neonates from<br />

the 27th–30th weeks of gestation, even in seemingly hypotonic<br />

prematures, and in infants during the first two trimesters.<br />

Elementary sitting, crawling, walking imitate later<br />

human-specific movements and are most likely their ontogenetic<br />

precursors and these elementary activities depend upon<br />

the integrity of the basal ganglia. Authors present evidence<br />

by examinations of various anencephalus neonates. In an<br />

anencephalic neonate whose brain developed up to the rostral<br />

part of the pons all primitive reflexes are present, but none of<br />

the complex elementary functions are elicitable. Examination<br />

of elementary forms of sitting, crawling, walking, rotation<br />

in several weeks old infants offers the possibility to<br />

reveal differences in muscular activity, tonus and coordination<br />

during active movements. Authors illustrate the application<br />

of elementary sensorimotor poly-electromyography<br />

(EMG) activities to diagnose young infants, also applying<br />

videotape, and computerised motor analysis. Evaluation of<br />

sensibility-specificity relation is presented by statistics of<br />

2000 brain injured infants compared to normal control<br />

groups.<br />

FP-D-024<br />

Symptomatic epilepsy in brain injured young infants<br />

M. Berenyi, F. Katona, E. Gisztl, I. Sos<br />

Department of Developmental Neurology, Pediatric Institute<br />

‘Svabhegy’, Budapest, Hungary<br />

Out of 2000 brain injured infants 450 produced symptomatic<br />

epilepsy. From this 450 the number of continuous<br />

epileptic activity from birth was 60 and the other 390<br />

presented their first convulsions with positive EEG<br />

between 4 and 8 months of life. In 300 cases the foci of<br />

the convulsive activity change not only from one hemispherical<br />

lobe to another (178 cases) but from one hemisphere<br />

to the other (36 cases). In 230 cases West type<br />

epilepsy was detected, among them 170 with unspecified<br />

movements during convulsions, nevertheless with classic<br />

EEG signs. In 150 cases the development of epilepsy<br />

was followed up from the first signs of sharp waves to<br />

wave depression and finally to hypsarhythmia. All infants<br />

received in our service regular anticonvulsive therapy<br />

(carbamazepine, vigabatrin, ACTH, etc.). Summary: (1)<br />

Occurrence of symptomatic epilepsy in brain injured<br />

infants is a warning sign predicting serious outcome in<br />

sensorimotor and cognitive development despite any<br />

improvement reached by early neurotherapy. (2) In the<br />

majority of cases abnormal precognitive development<br />

preceded the onset of epilepsy and is not a consequence<br />

of epileptic fits. (3) Serial video-EEG and/or polygraphy<br />

are necessary to follow changes in the nature and location<br />

of bioelectric activity in the injured developing brain.


448<br />

Abstracts<br />

FP-D-025<br />

Effect of cerebrolysin and simple training method at<br />

home on children with cerebral palsy<br />

J.-L. Tang, D. Wu<br />

Pediatric department, The first hospital affiliated to Anhui<br />

medical university, Hefei City, China<br />

The purpose of this study was to find a better and<br />

cheaper way to cure children with cerebral palsy. There<br />

are 266 cases of children with cerebral palsy from 3<br />

months to 10 years old. They were divided into four<br />

groups: cerebrolysin group, simple training method<br />

(STM, which designed by ourselves) group, cerebrolysin<br />

plus STM group and control group which were follow-up<br />

in 5 years. Cerebrolysin was transfused through vein to the<br />

patients, 5 ml/day for no more than 1-year-old children, 10<br />

ml/day for kids older than 1-year-old children. We define 3<br />

months as period of treatment. At the same time we regularly<br />

hold short courses of STM method for the children<br />

with Cerebral palsy and their parents from October 1992.<br />

Children with cerebral palsy and their parents attended to<br />

the course. Some simply training methods of STM method<br />

were introduced to the parents-home conductors, and then<br />

the parents began to train the CP children at home. The<br />

results show that STM plus cerebrolysin is most effective<br />

in all groups (P , 0:01). Both cerebrolysin group and STM<br />

group have show more effective than control groups<br />

(P , 0:01): but the cerebrolysin group is more effective<br />

than STM groups in young children group (age ,3 years<br />

old) and they have no difference in old children group (age<br />

3 years old).<br />

FP-D-026<br />

Case-control study on 89 cases of childhood cerebral<br />

palsy<br />

Q.-X. Shui, X.-J. Zhou, Z.-Y. Zhao<br />

The Children’s Hospital, Zhejiang <strong>University</strong> School of<br />

Medicine, Hang Zhou, China<br />

Objective: To investigate the early identification of CP<br />

in children. Methods: One to two case-control study and an<br />

analysis on the symptoms and signs of 89 children with CP<br />

were done. Results: There were 69 (77.6%) cases with<br />

spasticity type, 11 (12.4%) cases with hypotonia type, 5<br />

(5.6%) cases with the mixed type, 2 (2.2%) cases with<br />

athetosis type, and 2 (2.2%) cases with ataxia type. And<br />

there were 74 (83.1%) children with mental retardation, 20<br />

(23.3%) children with psychological behavior disorders<br />

and 13 (14.8%) children with epilepsy. The high-risk<br />

factors included neonatal diseases, maternal malnutrition,<br />

low birth weight, maternal irregular menstruation, older<br />

father, absence of perinatal health-monitoring, and contacting<br />

toxic substances in pregnancy. Conclusion: The four<br />

main points for earlier identification of CP included<br />

detailed medical history, understanding the normal motor<br />

development of infants, grasping four characteristic manifestation<br />

of abnormal motor of CP, and selective accessory<br />

examinations.<br />

FP-D-027<br />

Morbus Little can be successfully treated – case report<br />

K. Boskovic a , N. Naumovic b , D. Filipovic b , S. Tomasevic a ,<br />

N. Mesanovic a<br />

a Clinical Center Novi Sad, Medical Rehabilitation Clinic;<br />

b <strong>University</strong> of Novi Sad, Medical Faculty, Department of<br />

Physiology, Novi Sad, Yugoslavia<br />

The Morbus Little (ML) or spastic infantile diplegia is<br />

very frequent form of children’s cerebral palsy. Treatment<br />

of that disease has multidisciplinary approach and rehabilitation<br />

team with many members. The aim of this article<br />

was case report of one patient with ML whose result of<br />

treatment was very successful. The patient MM, female,<br />

was born in 1974 year with 32-gestation week’s, 1300-mg<br />

weight and with signs of cerebral hemorrhage. During 1st<br />

year of life motor deterioration, without mental backwardness<br />

was noticed. The diagnosis of ML was established.<br />

Immediately the kinesitherapy for management of muscle<br />

spastics was used and also further stimulation of basic<br />

forms of sitting, standing and walking. But strong spastic<br />

changes of plantar flexor muscles of the foot and knee<br />

flexor and adductor muscles independent walk made<br />

impossible. When patient was 4 years old, the surgical<br />

lengthening of Achilles tendon and adductor tendons was<br />

made. By operation the ‘scissors’ walk was moderated. The<br />

further aim of treatment was independent walk, which is<br />

realized in the patient’s age of 6 years. The walks was<br />

spastically paraparetic, with massive mobilization of<br />

whole body and with rely on interior part of the foot.<br />

Despite to the continuous treatment, in age of 10 years,<br />

patient has second surgery with lengthening knee flexor<br />

and also adductor muscles. The rehabilitation treatment<br />

was applied further with different physical procedures<br />

(hydro-, heating-, exercise- therapy) usage. Because of<br />

very late start of standing and walking patient’s articulations<br />

development was insufficient, and arthritic changes of<br />

the hips appeared in age of 16 years. Until now patient was<br />

under rehabilitation treatment with the aim of the muscle<br />

strengthening, preservation of the articulation motion and<br />

improving of all kind of balance. The result of this long<br />

and difficult treatment is person of 27 years, graduated<br />

psychologist, completely independent in activities of<br />

daily living. So, we can conclude that ML is very difficult<br />

and complex disease which demands continuous, persistent<br />

and multidisciplinary therapy with active participation of<br />

patient, its family and wide social community, but it can be<br />

treated successfully.


Abstracts 449<br />

FP-D-028<br />

Combined conductive education and therapeutics of<br />

neurophysiology to improve and evaluate the motor<br />

function in children with cerebral palsy<br />

C.-M. Zhao, Y.-P. Zhang, W. Liao, Y.-P. Ai, M. Xi, L. Yao<br />

The Pediatrics, The Xinqiao Hospital, Third Military Medical<br />

<strong>University</strong>, Chongqing, China<br />

Objective: To observe combined conductive education<br />

and neurophysiology therapies in the improvement of the<br />

gross motor function in CP patients. Methods: Group one in<br />

23 cases of CP children treated with conductive education<br />

and therapeutics of neurophysiology and group two in 25<br />

cases of CP children treated only with Bobath and Vojta<br />

processes all of cases are 1–3 years old. Results: The results<br />

showed that the improvement of patients’ motor function<br />

can be seen in both groups (P , 0:01). The function<br />

improvement in group one after treatment is much better<br />

than group two (P , 0:05). Conclusion: The results show<br />

that the combined conductive education with therapeutics of<br />

neurophysiology in the improvement of the gross motor<br />

function in CP patients is better than Bobath and Vojta<br />

processes.<br />

FP-D-029<br />

Some new approaches to an estimation of a functional<br />

condition of a spinal cord at children with cerebral palsy<br />

syndrome<br />

T.E. Cimbal, A.G. Remnev<br />

Altai Diagnostic Center, Barnaul, Russia<br />

We observed 53 children with an age between 7 and 15<br />

years with cerebral palsy syndrome (CPS). All patients were<br />

divided into two groups: 24 patients with clinical attributes<br />

bottom spastic paraplegia (first group) and 29 patients with<br />

clinical attributes spastic hemiplegia (second group). We<br />

studied a functional condition of the pyramidal ways<br />

(PW) at magnetic stimulation (MS) of cerebrum cortex<br />

and lumbar region of spinal cord and afferent ways of spinal<br />

cord at MS of cervical and lumbar departments of spinal<br />

cord. We used Magstim-200 (Magstim, UK) and Sapphire<br />

2M (Medelec, UK). As a result of research the attributes of<br />

infringement of realization of excitation on PW at 20<br />

patients of the first group (mainly bilateral changes) and<br />

12 patients of the second group (at seven patients bilateral<br />

changes) as increase of time of the central realization till<br />

21–36 ms were registered. At research of a functional condition<br />

AWSC at 22 patients of the first group and 20 patients<br />

of the second group we have registered decrease of speed of<br />

distribution of excitation on AWSC till 34–49 m/s. Thus,<br />

through a method MS the definition of a defeat of various<br />

conducting ways of a back brain is possible. At the patients<br />

with clinical attributes spastic hemiplegia the attributes of a<br />

defeat of the ‘healthy’ party were registered. It means, that<br />

the functional changes not always correspond clinical.<br />

FP-D-030<br />

The study of Chinese children’s vocabulary development<br />

W.-L. Liang a , B. Hao a , S. Wang a , Y.-Q. Jiang a , Z.-X.<br />

Zhang a , Q.-H. Zuo a , T. Tardif b , P. Fletcher c<br />

a Peking <strong>University</strong> Fist Hospital, Beijing, China; b <strong>University</strong><br />

of Michigan, Ann Arbor, MI, USA; c <strong>University</strong> of Hong<br />

Kong, Hong Kong, China<br />

Objective: To conduct a norm study of Chinese communicative<br />

development inventory (CCDI) and to study<br />

Chinese children’s vocabulary development. Method:<br />

Using CCDI – Putonghua version), Parents of 1056 toddlers<br />

were asked to report their children’s language abilities.<br />

Results: Sixteen-month-old children can say an average of<br />

79 words appearing on the CCDI, including 38 nouns and 21<br />

verbs. By 30 months, children can say an average of 709<br />

words on the CCDI, including 334 nouns and 117 verbs. The<br />

speed with which children acquire nouns and verbs is similar.<br />

After 19 months of age, children also began to use<br />

classifiers question words and pronouns. For most types of<br />

the words, the mean production scores tended to be higher<br />

for females than for males of the same age. Conclusions:<br />

From 16 to 30 months, the development of the children’s<br />

words is rapid for content words, including both nouns and<br />

verbs. After 19 months, Chinese-speaking children also<br />

begin to use function words, including classifiers, question<br />

words and pronouns.<br />

FP-D-031<br />

Birth asphyxia: still a major risk factor for cerebral<br />

palsy in Bangladesh<br />

S. Akhter, M.-M. Rahman, K. Akhter, M.N. Islam<br />

Department of Paediatrics, Bangabandhu Sheikh Mujib<br />

Medical <strong>University</strong>, Dhaka, Bangladesh<br />

This study was done to assess some of the identifiable<br />

risk factors for CP. Four hundred and fifty children suffering<br />

from CP attending over 2 years 3 months time period in<br />

the our-patient department of Bangabandhu Sheikh Mujib<br />

Medical <strong>University</strong> in Dhaka, Bangladesh -were studied<br />

retrospectively. Information regarding antenatal, natal and<br />

postnatal period was collected by taking detailed history.<br />

Physical examinations were done to confirm the diagnosis.<br />

In some of the cases relevant laboratory investigations<br />

were done. Mean age was observed to be 2 years 6 months.<br />

Male to female ratio was 2:1. Most common type of CP<br />

was spastic (82.2%). Diskinetic, hypotonic and mixed were<br />

also found. In the spastic group, diplegia comprised the<br />

maximum number of cases (34%). Tetraplegia (27.3%)<br />

and hemiplegia (19%) were also common. Majority of<br />

the risk factors were natal. Birth asphyxia was found in<br />

43.8% of all the cases making it the most common identifiable<br />

risk factor. Other important natal factors were low<br />

birth weight (18.7%) and preterm (15.8%). Postnatal


450<br />

Abstracts<br />

factors like neonatal convulsion (14%), neonatal jaundice<br />

(9%) was responsible in 34% of cases. Prenatal factors<br />

were identified in 23% of cases. In 13% of cases there<br />

was no antenatal check up at all and in 78% of cases<br />

delivery was conducted at home. From the study it can<br />

be concluded that birth asphyxia has still remained as a<br />

major risk factor for CP in a developing country like<br />

Bangladesh. An integrated antenatal and perinatal care<br />

might reduce the rate of CP.<br />

FP-D-032<br />

Effective analysis of part radicotomy in convulsive palsy<br />

Z.-X. Wang<br />

China-Japan friendship Hospital, Beijing, China<br />

Objective: To explore the effect of part radicotomy in<br />

spastic cerebral palsy and the significance of combination<br />

with rehabilitation. Subjects and methods: 43 cases with<br />

spastic cerebral palsy aged from 2 to 14 years old were<br />

enrolled in the study. All underwent selective part radicotomy,<br />

of that 19 cases were combined with rehabilitation<br />

after operation. Effects were compared between the cases<br />

with only surgical group and the group combined surgery<br />

and rehabilitation. Results: Most of them had asphyxia<br />

history (19 cases 44.4%) and premature birth (12 cases<br />

25.96%). Part radicotomy had effect on 51.2% of 44<br />

cases. However, in contrast to the effective rate of the<br />

only operation group, the combined with rehabilitation<br />

group had much better result (P , 0:05). Conclusion: The<br />

part radicotomy was one of effective therapy for spastic<br />

cerebral palsy. Operation combined with rehabilitation<br />

was more effective than only operation.<br />

FP-D-033<br />

Developmental screening in infancy<br />

F. Soleimani<br />

<strong>University</strong> of Social Welfare and Rehabilitation Sciences,<br />

Tehran, Iran<br />

In this study we screened 6000 infants between 4 and 18<br />

months by infanib scoring. In this assessment infants<br />

divided to three groups; Normal, transient and Abnormal<br />

by 20 items that based on French angles, reflexes, tone<br />

and posture. The transient group was visited 1 month later<br />

and the abnormal group was referred to pediatric neurologist<br />

for diagnostic evaluation and to Rehabilitation Center for<br />

treatment. In the beginning the Infanib was selected because<br />

of high validity and reliability in the previous studies, and in<br />

this study we also found out that it is the same in Iran. thus<br />

the Infanib is proposed as an appropriate screening test in<br />

the developing countries because of quantified, reliable<br />

measure of body tone and posture, short time for examination<br />

and the ability of occupational, physical therapist,<br />

nurses and physician to perform it.<br />

FP-D-034<br />

The outcome of the term infants with low-Apgar score<br />

and the predictor to the cerebral palsy<br />

K.-W. Jiang, Q.-X. Shui<br />

Department of Neurology, Affiliated Children’s Hospital of<br />

Medical College, Zhejiang <strong>University</strong>, Hangzhou, China<br />

To study the factors and the predictors correlated with the<br />

long-term prognosis of the term infants with low-Apgar<br />

score. We carried out a dynamic prospective study on a<br />

cohort of 252 cases in a year. The Infant Motor Screen<br />

test and the children’s development milestones evaluation<br />

were applied at 6 months and 1-year-old, respectively. Five<br />

died, and seven lost during follow-up. Of 240 survivors, 19<br />

infants at 6 months were abnormal, and 15 infants at 1 year.<br />

Compared to the control group, the differences were significant<br />

(P ¼ 0:019 and 0.067, respectively). Four factors<br />

(low-Apgar scores #3 at 1 min and #6 at 5 min, cranial<br />

injury, intrauterine distress and cord wrapped around neck)<br />

were correlated with the long-term prognosis. The neonatal<br />

signs were predictors to the prognosis. Discriminant analyse<br />

indicated that combination of convulsion, apnea, staring,<br />

and spontaneous movements may predict 91.3% CP cases<br />

at 1 year. The special neurobehavioral abilities at 6 months,<br />

such as controlling the trunk at sitting, Moro reflex, may<br />

predict 97.9% CP cases. Duration of severe asphyxia and the<br />

encephalon trauma due to asphyxia were correlated to the<br />

long-term prognosis in term neonates with low-Apgar score.<br />

The neonatal abnormal signs had a positive predictive value<br />

to the long-term prognosis, and a serially observation<br />

showed a more precise prediction to the CP.<br />

FP-D-035<br />

The role of positioning and movement therapy for<br />

infants with gross motor delay due to hypoxic-ischemic<br />

encephalopathy<br />

B. Bayasgalantai, P. Otgonbayar<br />

Maternal and Child Health Research Center, Bayangol<br />

Duureg, Ulaanbaatar, Mongolia<br />

The incidence of infant developmental delay are numerous<br />

in our country: this fact is justifiably one of the major issues<br />

that draws the attention of pediatricians, neurologists and<br />

researchers. As some researchers believe the main cause of<br />

infants disabilities are severe hypoxic-ischemic encephalopathy/HIE/and<br />

cerebral palsy. Objectives: (1) To identify<br />

types of gross motor delay in infants due to HIE. (2) To<br />

investigate role of positioning and movement therapy as an<br />

early intervention in infants with HIE. Study design: We<br />

followed 120 neonates with HIE to identify gross motor<br />

delay, with regular neurological examination by a neonatologist<br />

until 12 months of age: at discharge and follow-ups at 3,<br />

6, 9 and 12 months of age. Then developmentally tested the<br />

children using special scales. We provided a case-controlled,


Abstracts 451<br />

quasi-experimental study. Results: Among the 120 children<br />

followed 68 were identified as having a gross motor delay.<br />

There are differences of muscle tone in 40.8–59.2% of the<br />

children; inability to hold a head, and inability to sit and walk<br />

in 24–62% of children. We have used positioning, sensory<br />

stimulation and motor developmental intervention<br />

approaches individually for each infant. Developmental<br />

outcomes after motor developmental intervention<br />

approaches were good: we have observed results after one<br />

to two courses of therapy. Conclusions: HIE is the most<br />

common disease in the neonatal period which causes developmental<br />

delay. Each infant with HIE should be followed<br />

with the Denver test during the 1st year of life. Positioning<br />

and motor developmental intervention approaches are effective<br />

for the therapy of developmental delay. We developed<br />

standards of treatment for gross motor delay due to HIE<br />

among infants.<br />

FP-D-036<br />

Cutaneomuscular reflex in the lower limbs of patients<br />

with cerebral palsy and its clinical significance<br />

Z.-M. Jiang, L.-Y. Shan, X.-H. Li<br />

Prevention, Treatment and Rehabilitation Center for Child<br />

Cerebral Palsy in Heilongjiang, Jiamusi, Heilongjiang,<br />

China<br />

To study the abnormal cutaneomuscular reflex (CMR)<br />

changes recorded in the lower limbs in children with CP,<br />

provide the index for clinical diagnosis. CMR were recoded<br />

in the lower limbs in 80 cerebral palsy children aged 3 , 5<br />

years and 30 normal children with the same age. Compared<br />

with the control group, the latency of I1 and E2 of patients<br />

with spastic cerebral palsy prolonged (P , 0:05). The<br />

amplitude ratio of E2 and E1 reduced (P , 0:05). The<br />

abnormal degree of CMR in spastic hemiplegia children<br />

accorded with degree of clinical hemiplegia. There were<br />

significant differences in the latency of E2 and the amplitude<br />

ratio of E2 and E1 between the mild and the severe sides or<br />

between side of health and hemiplegic side (P , 0:05 and<br />

P , 0:01). Compared with the control group, the amplitude<br />

rate of E2 and E1 increased in the patients with athetoid CP<br />

(P , 0:05), the amplitude of E1 increased significantly<br />

(P , 0:01). These results suggested that the main damage<br />

brain area of spastic cerebral palsy was motor cortex and<br />

pyramidal tract; the main lesion area of athetoid cerebral<br />

palsy was extrapyramidal system. CMR may be used as<br />

objective index for diagnosis of cerebral palsy.<br />

FP-D-037<br />

The evaluation of developmental age in infants in<br />

Tehran city<br />

P. Karimzadeh<br />

<strong>University</strong> of Social Welfare and Rehabilitation Sciences,<br />

Tehran, Iran<br />

The differentiation of human being in life that leads to<br />

somatic, mental, verbal and social promotion is called<br />

development. Development in childhood period (specially<br />

first and second year of life) is more rapid than the other<br />

stages of life. We decided to evaluate the developmental<br />

age in infants because there is no study in Iran. We studied<br />

the developmental age in 611 infants in respect of Grasping<br />

age, Crawling age, sitting age, walking age and social age.<br />

Before study, infants were examined by pediatrician and all<br />

of cases with genetic, congenital and acquired disorders<br />

were excluded. A descriptive-analytic study was carried<br />

out to evaluate the developmental age in infants in Tehran<br />

city. We used Munich functional Diagnostic test. The<br />

information collected using checklists. The results showed<br />

that the level of developmental age in Iranian infants in<br />

comparison of the results in other countries is upper. In our<br />

studies with increase in educational level in mothers, we<br />

had increase in medians of DQ in infants. The median of<br />

DQ was 115.51 The median of grasping age, crawling age,<br />

sitting age walking age, perception age, speech age, speech<br />

comprehension age and social age were 2, 4, 7, 12, 5, 7, 10,<br />

10 month.<br />

FP-D-038<br />

Hyperbaric oxygen therapy in Malaysian children with<br />

cerebral palsy: a pilot study<br />

M. Thambyayah a , C.T. Lee c , K. Thillainathan b ,S.T.<br />

Cheoh b , K.M. Letchumi b<br />

a Paediatrician, Hospital Selayang, Malaysia;<br />

b Occupational<br />

Therapist, Developmental Nurse/Physiotherapist,<br />

Hospital Klang, Malaysia; c Diving Medicine Physician,<br />

Armed Forces Hospital Lumut, Malaysia<br />

Hyperbaric oxygen therapy (HBOT) has been used an<br />

adjunct to treat children with cerebral palsy in several countries.<br />

Numerous anectodal reports and few randomized trials<br />

indicate that it works, despite ongoing controversies. In this<br />

open-label, non-randomized study, 20 children, aged from<br />

3.5 to 14.8 years, (mean 7.5 years) who had varying types of<br />

cerebral palsy,(spastic ¼ 13, dystonic ¼ 3, ataxic ¼ 1,<br />

mixed ¼ 1) were treated at Armed Forces Hospital Lumut<br />

since May 2000, with 1.5 ATA hyperbaric oxygen, for a<br />

total of 100 treatments (40 1 40 1 20), administered for 1<br />

our, twice daily, 5 days a week, with a 12 week break in<br />

between the three sessions. The team consisted of a child<br />

neurologist, diving medicine specialist, occupational therapist,<br />

developmental nurse and physiotherapist. The<br />

outcomes used to measure were modified Ashworth Spasticity<br />

Scale, (MAS) modified tests of gross motor and fine<br />

motor function, parental reporting/satisfaction scale and<br />

video-recording – these were employed before and after<br />

HBOT. Eighteen children completed the entire treatment,<br />

evaluations and assessments in Dec 2001. There were<br />

significant improvements in alertness, overall communication<br />

and cognition, drooling and also in fine motor more


452<br />

Abstracts<br />

than gross motor testing. Spasticity reduction was maintained<br />

for about 12 weeks. The mean pre-HBOT MA in<br />

hamstrings 1.2 and mean post HBOT MAS: 0.7 (42 %<br />

improvement) were minimal (middle ear and sinus barotrauma).<br />

HBOT is well tolerated in children with cerebral<br />

palsy and there were significant improvements in several<br />

areas of neurological functions.<br />

FP-D-039<br />

Evaluation of rehabilitation to children with cerebral<br />

palsy<br />

O. Nitta, M. Aoyama, M. Miyao, Y. Iwasaki, M. Shibata, M.<br />

Yamamoto, K. Miura<br />

Tokyo Metropolitan <strong>University</strong> of Health Sciences, Tokyo,<br />

Japan<br />

Purpose: Various rehabilitation programs have been<br />

provided to children with cerebral palsy. However, there<br />

has been no sufficient evaluation whether these programs<br />

were adequate or not. Main reasons of this insufficient<br />

evaluation may involve very long clinical course of the<br />

disease, i.e. cerebral palsy, and the absence of objective<br />

criteria to evaluate the programs. Thus, we examined the<br />

rehabilitation programs during the life cycle of disabled<br />

children from the birth to the adult. Furthermore, we<br />

inquired whether these programs were appropriate for<br />

their parents. Subjects and methods: We have made an<br />

investigation based on a questionnaires sent out to the<br />

parents of 110 handicapped children with cerebral palsy<br />

(mean age, 12.26 years; range, 6–18 years) enrolled in<br />

schools for physically handicapped or mentally retarded<br />

children in Tokyo Metropolitan area. We inquired what<br />

kind of rehabilitation programs their children received at<br />

each class of age, and on whether they thought the programs<br />

were appropriate or not. Results: In effective responses, 46%<br />

of parents answered that contents of the programs were<br />

‘inappropriate’ or ‘equivocal’. The reasons of the inappropriateness<br />

involved ‘insufficient frequency’ and ‘inconsistent<br />

programs by various therapists’.<br />

FP-D-040<br />

Do pre- and perinatal factors predict a need for special<br />

education?<br />

M. Mannerkoski, T. Autti, L. Åberg, M. Hoikkala, K.<br />

Kuismanen, H. Heiskala<br />

Departments of Child Neurology and Radiology, Helsinki<br />

<strong>University</strong>, Hospital for Children and Adolescents, Helsinki,<br />

Finland<br />

Our purpose was to see whether some pre- or perinatal<br />

factors as recorded in the school health care units could<br />

serve as predictors for a need for special education? We<br />

used a random and representative sample, altogether 900<br />

pupils, of children attending classes for special education<br />

in Uusimaa (population 1.4 million), Finland. This survey<br />

was carried out in 1997–1998 in 19 different schools. The<br />

teaching programs of these children (born between 1980 and<br />

1993, boys 64% and girls 36%) were: (1) education modified<br />

for specific neurological disabilities (23%); (2) adjusted<br />

education (46%); and (3) training education (30%). A<br />

random sample of children (N ¼ 300) in mainstream education<br />

was used as a control. In preliminary analyses the most<br />

important predictors were abnormalities detected after birth.<br />

Also birth weight, birth height and occipitofrontal circumference<br />

and Apgar score correlated with future academic<br />

problems. More thorough regression analyses will be<br />

presented and discussed.<br />

FP-D-041<br />

Treatment of spastic cerebral palsy by local injection<br />

with different doses of Botulinum Toxin-A<br />

B.-Q. Gao, W.-L. Yang, Y.-J. Wang, B.-J. Zhu, Z.-G. Zhao,<br />

X. Deng, G.-F. Wang<br />

Department of pediatrics, Beijing Tiantan Hospital Affiliate<br />

of Capital <strong>University</strong> of Medical Science, Beijing, China<br />

Objective: To evaluate the efficacy of local intramuscular<br />

injections of three different doses of botulinum-A toxin in<br />

the management of the spasm of cerebral palsy. Methods:A<br />

total of 120 children with cerebral palsy were averagely<br />

divided into three groups: group 1, group 2 and group 3.<br />

Three different doses of BTX-A (group 1 1 m/kg, group 2 2<br />

m/kg, group 3 3 m/kg) were administered. The effect of<br />

treatment was evaluated by Physician Rating Scale method.<br />

The difference among these groups was calculated by<br />

‘analysis of variance’. The tolerance to BTX-A and the<br />

side effects were also assessed. Results: Reduction on<br />

spasm of muscle became apparent after injection in all<br />

patients. Large doses of BTX-A (2 and 3 m/kg) were more<br />

effective than small doses. No markedly side effects<br />

occurred. Conclusion BTX-A may be proved as a safe and<br />

effective treatment for the cerebral palsy.<br />

FP-D-042<br />

Neurological complications in child abuse at King<br />

Chulalongkorn Memorial Hospital<br />

S. Phancharoen a , T. Desudchit a , V. Pongpanlert a ,N.<br />

Thadakul a , S. Chittinand a , N. Suwanwela b , S. Kaoropthum c<br />

a Department of Pediatrics,<br />

b Department of Radiology,<br />

c Department of Surgery, Faculty of Medicine Chulalongkorn<br />

<strong>University</strong>, Bangkok, Thailand<br />

We studied neurological complications abused children<br />

in King Chulalongkorn Memorial Hospital between Jan 1,<br />

1997 to December 31, 2001. There were 65 cases in<br />

suspected child abuse and neglected, 37 girls and 28<br />

boys. Neurological problems were seen in 16 cases<br />

(24.61%). The average age was 4.75 months (12 days–10


Abstracts 453<br />

months). There were seven girls and nine boys. The most<br />

common presentations were lethargy (five cases ¼ 31.25%)<br />

and convulsion (five cases ¼ 31.25%). The neurological<br />

examination and imaging revealed subdural hematoma<br />

(ten cases ¼ 62.5%), retinal hemorrhage (four<br />

cases ¼ 25%), and external physical injury only two<br />

cases (12.5%). One serial imaging change revealed nonaccidental<br />

head injured (Shaking Baby syndrome). Two<br />

patients died shortly after hospital admission due to severe<br />

brain edema. During a follow up 2 months–4 years (mean 2<br />

years), nine cases (56.25%) had delayed development, six<br />

cases (37.5%) had epilepsy and two cases (12.5%) had V-P<br />

shunt. Only two cases (12.5%) were normal development.<br />

High degree of clinical suspicious and early recognition of<br />

this condition and team approach may improve outcome<br />

and prevent child abused in the future.<br />

FP-D-043<br />

Differences in developmental trajectories as a function of<br />

age and weight at birth in premature infants<br />

J.M. Gardner a , B.Z. Karmel a , A. Harin b , A. Barone b , E.M.<br />

Lennon a , M.J. Flory a , H. Phan a<br />

a NYS Institute for Basic Research, Staten Island, NY; b St.<br />

Vincents Catholic Medical Centers of NY, St. Vincent’s<br />

Staten Island, Staten Island, NY, USA<br />

Major advances in pre- and postnatal care in the last<br />

decade have produced a cohort shift in the numbers and<br />

types of infants surviving, with a growing number having<br />

shorter gestations, lower birth weight (BW), and the products<br />

of multiple birth. However, long-term outcome in this population<br />

is poorly understood. This presentation will concentrate<br />

on early medical indices used for predicting<br />

developmental outcome over the first 2 years in 287 surviving<br />

infants born ,32 weeks gestational age (GA) weighing<br />

,1500 g, who were part of a follow-up study of neurofunctional<br />

outcome of at-risk infants (28% were ,27 weeks and<br />

20% were ,751 g). Infants with genetic or congenital<br />

abnormalities were excluded. Bayley Scales of Infant Development<br />

(BSID) were administered every 3 months from 4 to<br />

25 months. Multiple regression indicated no significant<br />

differences in GA or BW as a function of gender, ethnicity,<br />

maternal education, exposure to cocaine in utero, or level of<br />

prenatal care. Using hierarchical linear analyses, and modeling<br />

performance as either a constant or a linear function over<br />

age, we found that as GA or BW decreased, the Mental<br />

Development Index (MDI) decreased regardless of age at<br />

test even when corrected for inherent age trends in the<br />

BSID. However, the PDI showed an accelerated decline as<br />

infants got older, with the youngest and smallest infants at<br />

birth declining fastest. Although increased severity of CNS<br />

injury also predicted decreases in MDI and PDI across age, it<br />

did not produce an accelerated decline in PDI. Combining<br />

severity of CNS injury with degree of immaturity predicted<br />

the developmental trajectories of outcomes best.<br />

FP-D-044<br />

Predicting cognitive and motor outcome in the 2nd year:<br />

the role of early measures of attention, and elicited and<br />

spontaneous movements<br />

B.Z. Karmel, J.M. Gardner, E.M. Lennon, M.J. Flory, H.<br />

Phan, I. Miroshnichenko, R.L. Freedland<br />

NYS Institute for Basic Research, Staten Island, NY, USA<br />

Defining the consequences of CNS injury in neonates is<br />

important for predicting both short-term recovery from<br />

acute problems and long-term outcome. We report relations<br />

among three procedures: arousal-modulated attention<br />

(AMA), neurobehavioral exam (NB), and spontaneous<br />

general movements (GM), to each other and to Bayley<br />

Scales of Infant Development over the first two years.<br />

The sample consisted of 70 high-risk infants studied longitudinally<br />

(mean GA ¼ 29.6 weeks; mean BW ¼ 1284 g;<br />

CNS injury: none ¼ 12%, mild ¼ 54%, moderatesevere<br />

¼ 34%). Infants were tested at hospital discharge<br />

and at 1, 3 and 4 months. Both concurrent and predictive<br />

validity of measures were demonstrated for our AMA<br />

visual preference procedure, our neonatal NB emphasizing<br />

elicited motor behaviors, and Prechtl’s assessment of GMs.<br />

Although CNS injury was associated with each measure in<br />

neonates, relations changed over time. Thus, CNS findings<br />

alone were insufficient to predict later outcome. Early<br />

behavioral evaluations were better predictors into the 2nd<br />

year and indicated that: (1) high-risk infants who<br />

performed normally as neonates had normal development;<br />

(2) those with early transient abnormalities appeared to<br />

normalize by 4 months, but started to show deficits by<br />

13–16 months; and (3) increased degree and/or duration<br />

of abnormal early behavior predicted the worst outcome.<br />

Use of multiple measures in the neonatal period, including<br />

attention and autoregulation along with elicited and spontaneous<br />

movements, as well as multiple assessments across<br />

early infancy, provide the most useful approach for evaluating<br />

recovery from CNS injury, and for predicting later<br />

mental and motor performance.<br />

FP-D-045<br />

Transsynaptic degeneration of lateral geniculate bodies<br />

in children affected by cerebral visual impairment<br />

S.M. Bova a , E. Fazzi a , S.G. Signorini a , C. Uggetti b , P.E.<br />

Bianchi c , G. Lanzi a<br />

a Department of Child Neurology and Psychiatry – IRCCS<br />

C. Mondino, Pavia, Italy; b Paediatric Neuroradiology Unit-<br />

IRCCS C. Mondino, Pavia, Italy; c Department of Ophthalmology<br />

– IRCCS <strong>University</strong> of Pavia, Italy<br />

Cerebral visual impairment (CVI) is the leading cause of<br />

bilateral visual impairment in Western countries. It is characterised<br />

by bilateral impairment of visual functions caused<br />

by damage to the CNS. A common cause is PVL following


454<br />

Abstracts<br />

perinatal hypoxic-ischemic brain injury. Diagnosis of CVI<br />

is based mainly on clinical signs but damage to the posterior<br />

visual pathways is frequently documented on brain MR<br />

in children with PVL. Lateral geniculate body (LGB) is the<br />

thalamic relay nucleus of the geniculate visual pathway.<br />

Lesion at this level have frequently been demonstrated<br />

by pathological examinations - following transsynaptic<br />

degeneration of these nuclei secondary to pregeniculate<br />

or postgeniculate interruption of visual pathways - but<br />

seldom documented on brain MR. In this study we investigate<br />

MR alterations of visual pathways and in particular<br />

of LGB in 20 children affected by CVI and cerebral palsy.<br />

The presence of a small, symmetric area of T2 prolongation<br />

in the exact site in which the LGB are located-consistent<br />

with gliosis – was considered indicative of LGB<br />

damage. Neurophthalmological findings are compared<br />

with a control group of 20 children with similar clinical<br />

and neuroradiological picture, except for LGB damage.<br />

Comparison between the two groups shows higher incidence<br />

of optic nerve atrophy, lower visual acuity, and<br />

higher incidence of disorder of ocular motility (saccades,<br />

and smooth pursuit) in children with LGB damage. These<br />

findings suggest that MR signal alterations in the LGB,<br />

probably attributable to transynaptic degeneration, can<br />

also extend to the optic nerve and lead to poorer visual<br />

outcome.<br />

FP-D-046<br />

The correlations of motor functions with speech and<br />

psychosocial functions in the children with cerebral<br />

palsy<br />

C.-L. Chen a , I.-C. Chen b , C.-Y. Wu a , C.-Y. Chung a , C.-H.<br />

Chen a , S.-C. Chen b<br />

a Department of Physical Medicine and Rehabilitation,<br />

Chang Gung Memorial and Children Hospital, Taoyuan,<br />

Chinese Taipei; b Department of Physical Medicine and<br />

Rehabilitation, Taipei Medical <strong>University</strong> Hospital,<br />

Chinese Taipei<br />

CP is characterized by non-progressive motor impairment.<br />

The developmental functions varied in the children<br />

with spastic CP. This study was to investigate the correlations<br />

of motor functions with speech and psychosocial<br />

functions in the children with CP. We collected 179 children<br />

with CP, aged less than 6 years. We used the Chinese<br />

Child Development Inventory to assess the developmental<br />

functions with 8 domains, including GM, fine motor (FM),<br />

expressive language (EL), concept comprehension (CC),<br />

social comprehension (SC), self help (SH), personal social<br />

(PS), and general development (GD). CP children were<br />

divided into two groups: SD and spastic quadriplegia<br />

(SQ). We compared the DQ between the two groups.<br />

The correlations of different developmental functions<br />

were analyzed by Pearson’s correlation. We found eight<br />

DQs in the SD group were higher than SQ group<br />

(P , 0:01). The DQs of GM and FM in the SD group<br />

were 47 and 75%, respectively. While those in the SQ<br />

group were 23 and 38%, respectively. The DQs of the<br />

other functions in the SD group were 62–83%, while<br />

those in the SQ group were 31–57%. The speech functions<br />

(EL, CC, SC) were correlated more with FM function<br />

(r ¼ 0:6–0:8, P , 0:01) than GM function (r ¼ 0:4–0:7,<br />

P , 0:01). The other functions (SH, PS, GD) were also<br />

correlated more with FM function (r ¼ 0:8, P , 0:01)<br />

than GM function (r ¼ 0:68–0:78, P , 0:01). Our findings<br />

suggest the SD group had better motor, speech and psychosocial<br />

functions than SQ group. The fine motor function<br />

may provide us as the predictor for speech and psychosocial<br />

functions in the children with CP.<br />

FP-D-047<br />

Etiologic determination of 1088 children with<br />

developmental delay<br />

C.-L. Chen, I.-C. Chen, A.M.-K. Wong, C.-Y. Chung, S.F.-<br />

T. Tang, C.-H. Chen<br />

Department of Physical Medicine and Rehabilitation,<br />

Chang Gung Memorial and Children Hospital, Kwei-<br />

Shan, Tao-Yuan, Chinese Taipei<br />

Children with developmental delay (DD) had varieties in<br />

developmental function. The purpose of this study was to<br />

analyze the etiologic diagnosis and risk factors in children<br />

with different functional delay. We collected 1088 children,<br />

aged less than 6 years, who underwent assessments<br />

of developmental function, etiologic diagnosis, and risk<br />

factors. All children were classified into five functional<br />

delay groups: speech, motor, pervasive, global, and nonspecific<br />

DD. The etiologic diagnosis was classified into<br />

brain, neuromuscular, genetic, psychomental, and other<br />

disorders. Differences of etiologic diagnosis and risk<br />

factors of five functional delay groups were determined.<br />

Most children had global (45.3%), motor (22.3%) and<br />

speech (17.3%) delay, the other children had non-specific<br />

(10.6%) and pervasive (4.5%) delay. Approximately 61.5%<br />

of children were associated with biological factors (20.0%<br />

of neonatal insults, 19.9% of genetic defect/congenital<br />

anomaly, 13.5% of central nervous system lesions, 3.5%<br />

of prematurity/low birth body weight, and 4.8% of other<br />

factors). Most children with motor delay were brain disorders<br />

and associated with major risks of neonatal insults<br />

(P , 0:05). While most children with global delay were<br />

brain or psychomental disorders and associated with<br />

major risks of genetic defect/congenital anomaly or neonatal<br />

insults (P , 0:05). Our findings suggested there were<br />

heterogeneous risk factors and etiologic diagnosis in children<br />

with different functional delay. These data could<br />

provide us to investigate the underlying diseases for children<br />

with developmental delay.


Abstracts 455<br />

FP-D-048<br />

Glasgow scale relationships in children with traumatic<br />

brain injury<br />

C.-Y. Chung, C.-L. Chen, M.-K. Wong, L.-C. See, F.-T.<br />

Tang<br />

Department of Physical Medicine and Rehabilitation,<br />

Chang Gung Memorial and Children Hospital, Kwei-<br />

Shan, Tao-Yuan, Chinese Taipei<br />

The purpose of this study was trying to find out the<br />

proper cutting point of GCS as a determinant of outcome<br />

for children with traumatic brain injury (TBI). We<br />

followed 319 children, aged 2–10 years old, with TBI.<br />

The outcome of the children was evaluated using modified<br />

Glasgow Outcome Scale (GOS). The GCS and GOS of the<br />

children were studied in relation to clinical associated<br />

injury and computed tomography scan features. Using<br />

statistical analysis, we investigate the correlation of the<br />

GOS with GCS. We found that a cutting point of GCS at<br />

five got the best correlation of the GOS with GCS. Children<br />

with TBI and GCS equal to or below five had worse<br />

outcome while those with GCS above five had better<br />

outcome. In the associated injuries and neuroimage<br />

features, indicators like chest trauma, basal ganglion<br />

lesion, cerebellar lesion, brainstem lesions, subdural<br />

hemorrhage and other intra-cranial hemorrhage were<br />

significantly correlated with lower GCS. Children had<br />

chest trauma, abdominal trauma, frontal lesions, basal<br />

ganglion lesions, cerebellar lesions, brainstem lesions,<br />

subdural hemorrhage and other intra-cranial hemorrhage<br />

also had worse GOS. We conclude that a cutting point of<br />

GCS at five can best predict the outcome of TBI in children.<br />

The best predictors of outcome from TBI are the<br />

GCS score and other indictors of overall severity of brain<br />

injury.<br />

FP-D-049<br />

Antenatal risk factors associated with the unfavorable<br />

neurological status in newborns and at 2 years of age<br />

T. Stelmach, E. Kallas, H. Pisarev, T. Talvik<br />

Tartu <strong>University</strong> Clinics, Children’s Clinic; Department of<br />

Pediatrics, <strong>University</strong> of Tartu, Tartu, Estonia<br />

The aim of this prospective cohort study was to evaluate<br />

the influence of different antenatal and birth factors on the<br />

neurological signs at first days of life and the neurological<br />

outcome at 2 years of age. Patients and methods: the study<br />

group consisted of 390 children drawn from the cohort of<br />

828 consecutive live births between October 1st 1998 and<br />

March 31st 1999 at the Women’s Clinic, Tartu <strong>University</strong><br />

Clinics, Estonia. The data about all potential antenatal risk<br />

factors were abstracted from pregnancy and delivery<br />

records and registered in the database. The data about<br />

any birth complications and the neonatal course for all<br />

children were also collected from the hospital registry.<br />

Crude Odds ratio estimates with 95% confidence intervals<br />

were used to measure the associations between different<br />

antenatal factors and the neurological symptoms, both in<br />

newborn period and at 2 years of age. Significance level<br />

P , 0:05 was considered acceptable. At 2 years of age 49<br />

children from 390 exhibited adverse neurodevelopmental<br />

outcome (CP and other developmental disorders). The<br />

development of remaining 341 children was age-appropriate.<br />

Comparative analysis of risk factors was conducted.<br />

The strongest correlation with further development of HIE<br />

at first days of life was found in such antenatal factors as<br />

trichomoniasis during pregnancy (OR, 4.34; 95% CI, 1.32–<br />

14.23,) and acute respiratory disease (temperature . ¼ 388<br />

C) in II half of pregnancy (OR, 2.86; 95% CI, 1.08–7.58).<br />

From different antenatal factors, only bacterial vaginosis<br />

(diagnosed both clinically and microbiologically)<br />

combined with threatening abortion in 1st half of pregnancy<br />

(OR, 4.96; 95% CI 1.35–18.26) had significant association<br />

with adverse neurodevelopmental outcome at 2<br />

years of age. Arterial hypertension during pregnancy,<br />

acute respiratory disease, intrauterine growth retardation,<br />

edema, proteinuria, hypertension (EPH)-gestosis and preeclampsia<br />

were not associated with adverse outcome at 2<br />

years of age. Presence of at least one complication at delivery<br />

placed the child at risk of adverse neurological<br />

outcome (OR, 2.44; 95% CI, 1.32–4.54) at 2 years of age.<br />

FP-D-050<br />

Premature rupture of membranes and neonatal<br />

neurological outcome in a cohort of preterm births: an<br />

ongoing study<br />

C. Arpino a,b , A. Di Paolo c , C. Ticconi d , S. Brescianini e ,D.<br />

Poveromo b , E. Piccione d , P. Curatolo b<br />

a ‘E. Litta’ Rehabilitation Center for Developmental<br />

Disabilities, Grottaferrata, Rome, Italy; b Pediatric Neurology,<br />

‘Tor Vergata’ <strong>University</strong> of Rome, Italy; c Department<br />

of Pediatrics, Section of Neonatology, ‘Tor Vergata’<br />

<strong>University</strong> of Rome, Italy; d Department of Surgery, Section<br />

of Obstetrics and Gynaecology, ‘Tor Vergata’ <strong>University</strong> of<br />

Rome, Italy; e National Institute of Health, Rome, Italy<br />

Premature rupture of membranes (PROM) is associated<br />

to 30–40% of preterm deliveries and it is complicated by<br />

chorioamnionitis in up to 70% of cases. Data from medical<br />

literature suggest that the risk of adverse neonatal neurological<br />

outcome is higher in preterm births exposed to<br />

PROM compared to non exposed preterm birth. The objective<br />

of this study is to evaluate the effect of premature<br />

rupture of membranes, on neonatal neurological outcome<br />

in preterm births. To this end, we conducted a retrospective<br />

cohort of preterm births, including all consecutive<br />

preterm newborns (n ¼ 600; gestational age ,37 weeks),<br />

referred to the Pediatric Unit, Neonatal Intensive Care and<br />

Nursery, of the ‘Tor Vergata’, <strong>University</strong> of Rome, in the


456<br />

Abstracts<br />

period 1996–2001. The source of information was represented<br />

by clinical records of newborns (all clinical information<br />

relevant to outcome evaluation and control for<br />

confounding) and newborns’ mothers (history of pregnancy<br />

and delivery, in particular onset, duration and<br />

complications of PROM). Up to now, 109 newborn-andmother<br />

pairs have been enrolled into the study. Overall,<br />

32% of preterm births were exposed to PROM. Adverse<br />

neurological and respiratory outcome (adj RR: 1.5; CI:<br />

0.4–5.7; adj RR: 1.5; CI: 0.9–2.5) tended to occur more<br />

frequently in preterm births with PROM. Our preliminary<br />

results suggest that adverse neurological and respiratory<br />

outcome have a higher incidence among preterm newborns<br />

exposed to PROM.<br />

FP-D-051<br />

The early home-based intervention program on children<br />

with fetal alcohol syndrome and fetal alcohol effect in<br />

east Taiwan<br />

H.-T. Kuo<br />

Research Institute and Faculty of Early Education and<br />

Care, Chaoyang <strong>University</strong> of Technology, Chinese Taipei<br />

Fetal alcohol syndrome (FAS) is a clinical diagnosis<br />

characterized by fetal pre-and postnatal growth delay,<br />

dysfunction of central nervous system, and facial<br />

dysmorphism due to maternal alcohol consumption during<br />

pregnancy. Fetal alcohol syndrome was described by<br />

Rouquette (1957), Lemoine (1968), and Jones (1973).<br />

The fetal alcohol effect (FAE) was then proposed as a<br />

mild form of alcohol teratogenesity by Smithells and<br />

Smith (1984), Abel and Sokol (1987), and Streissguth<br />

and Ladue (1987). The study was performed in Hualien<br />

between 1997 and 1998. The subjects of the study included<br />

six children with age under 6 years old, who lived in<br />

Hualien County. There are five FAS and one FAE children<br />

in our study group. We used Bayley’s Scale of Infant<br />

Development (BSID, II), and CCDI for objective and<br />

subjective developmental assessment. For learning status<br />

we use Individualized Education Program Screening<br />

Checklist (IEPSC) as assessment instrument. The Curriculum<br />

base program including active and quiet activities was<br />

arranged. At the end, the result was compared. The result<br />

of BSID, CCDI, and IEPSC all shows no significant difference.<br />

But, the results of CCDI and IEPSC items show<br />

developmental progress in two assessment sessions. Our<br />

conclusions on this study are (1). The FAS/FAE children<br />

all shows subnormal mentality and is high-risk group for<br />

future developmental disability, so they need early intervention<br />

(2). Although the intervention effect is not statistically<br />

significant, but there is qualitative developmental<br />

progress. For the purpose of promoting developmental<br />

potential and reducing load of family and society, we<br />

would still like to suggest early intervention for all those<br />

children.<br />

FP-D-052<br />

The numerical features of syndrome of hypertension<br />

hydrocephaly and syndrome of hydrocephaly among<br />

children with perinatal lesions of nervous system<br />

B.A. Abeuov, Sh.A. Bulekbayeva, G.A. Mukhambetova,<br />

A.S. Karimova, D.R. Purev<br />

Kazakh National Medical <strong>University</strong>, Almaty, Kazakhstan<br />

Quite often many symptoms of perinatal brain lesions are<br />

barely recognizable and clinically not obvious on the early<br />

stage, although they make effect on the neuro-psychological<br />

growth of the child. In the current report we present the<br />

results of clinical observation, diagnosis and treatment of<br />

1087 patients aged from 1 month to 4 years with perinatal<br />

pathology of central nervous system. To determine the aetiology<br />

of the pathological process the anamnesis of the patients<br />

was carefully learned by inquiring parents with the help of<br />

specially developed questionnaire. The results of the<br />

research revealed that different pathogenic factors are<br />

present in perinatal period in 1045 cases, among which the<br />

intranatal hypoxia is on the first place, on the 2nd place is the<br />

combination of the hypoxia in the 2nd half of the pregnancy<br />

with the trauma during travail, on the 3rd place – birth<br />

trauma. In 3.8% of cases the cause of the nervous system’s<br />

pathology was not succeeded. It is not enough to make a<br />

visual qualitative analysis of CT-scans to determine the<br />

pathological substrate. That’s why we used the quantitative<br />

method which has revealed the following: the dilation of the<br />

ventricular system, especially of the index of anterior horns<br />

of the lateral ventricles (IAHLV) on (17.4), took place. The<br />

indices of cerebral coat at the level of anterior horns and<br />

corpuses of lateral ventricles were reduced accordingly.<br />

The reduction at the level of posterior horns was less noticeable.<br />

Also the considerable dilation of all liquor areas was<br />

determined with the high degree of certainty. The considerable<br />

dilation from the direction of subarachnoid interspace<br />

and apertures of Silvii was revealed in the group of patients<br />

with hydrocephaly. Among children with syndrome of<br />

hypertension-hydrocephaly the indices of ventricular system<br />

increased moderately, which caused the reduction of indices<br />

of the cerebral coat. IAHLV most changed – on (14.3), that is<br />

essentially less than in the group of children with syndrome<br />

of hydrocephaly. Thus, syndrome of hydrocephaly in<br />

comparison with syndrome of hypertension-hydrocephaly<br />

in cases with perinatal cerebral lesions characterizes by<br />

more considerable changes of the indices of the ventricular<br />

system, indices of cerebral coat and sizes of liquor areas.<br />

FP-D-053<br />

Congenital pathology of nervous system in children<br />

U.A. Karimov, N.A. Zakirova, D.S. Aripova, M.K.<br />

Saidakhmedov<br />

Scientific Research Institute of Pediarics, Tashkent, Uzbekistan


Abstracts 457<br />

Analysis of congenital pathology of nervous system in<br />

children under conditions of Tashkent region revealed the<br />

level of the most occurring congenital pathologies of<br />

nervous system at the time of birth. Among 346 live-birth<br />

newborns Spina bifida was noted in 6.9%, among 80 stillborns-in<br />

2.5% and among 40 newborn dead during 0 , 6<br />

day after birth-in 6.2% of cases. Microcephaly was found in<br />

3.7, 10 and 2.5% of newborns, respectively. Hydrocephalyin<br />

4.6, 10 and 1.25% of cases, respectively. The Down<br />

disease was determined in 5.8% and disease of peripheral<br />

nervous system-in 3.5% only in livebirth newborns. Thus,<br />

more early diagnosis before school age and prophylaxis of<br />

congenital pathology of nervous system with determination<br />

of risk factors are very important for reduction of abovementioned<br />

indicators of nervous system disease in children.<br />

FP-D-054<br />

Identification of congenital pathology of nervous system<br />

in children in relation to age in the family polyclinics<br />

N.A. Zakirova, U.A. Karimoy<br />

Scientific Research Institute of Pediatrics, Tashkent, Uzbekistan<br />

Long-term observation of 223 340 children aged from 1 to<br />

14 years in the family polyclinics in Tashkent (Uzbekistan)<br />

revealed congenial diseases and malformations of different<br />

organs and systems in 778 (0.35%) children. Among them the<br />

diseases of nervous system have the special place. Among the<br />

children with congenital pathology of nervous system being<br />

under long-term observation of neuropathologist, we carried<br />

out analysis of their incidence in relation to age. It was found<br />

that Down disease was diagnosed more often in children<br />

under 3 years of age, microcephaly was determined in all<br />

the age groups with equal frequency, DYN was noted more<br />

frequently among children aged from 3 to 7 years. Thus, the<br />

data obtained allow to organize rehabilitation of congenital<br />

pathology of nervous system in relation to age and dynamic<br />

observation in all the age groups for determination of congenital<br />

diseases of nervous system.<br />

FP-D-055<br />

Neuropsychological outcome of 9–10 year-old children<br />

with intrauterine growth retardation (IUGR):<br />

preliminary findings<br />

R. Geva a,b , R. Eshel a , Y. Leitner a , A. Fattal-Valevski a ,M.<br />

Varon a , Y. Vila a , O. Bitchuniski a , B. Radiano a ,K.<br />

Goldberg a , S. Harel a<br />

a Institute for Child Development and Pediatric Neurology<br />

Unit, Division of Pediatrics, Dana Children’s Hospital, Tel<br />

Aviv Sourasky Medical Center and Sackler school of Medicine,<br />

Tel-Aviv <strong>University</strong>, Tel Aviv, Israel; b Department of<br />

Psychology, Bar-Ilan <strong>University</strong>, Ramat-Gan, 52900, Israel<br />

The objective of the study was to trace the neuropsychological<br />

profile of 9–10 years-old children with IUGR<br />

(N ¼ 56) compared with children who are matched for<br />

gestational age and socio-economic factors (N ¼ 31).<br />

Fifty-six children with IUGR were followed-up prospectively<br />

to the age of 9–10 years. They underwent comprehensive<br />

neuropsychological evaluation (lasting 4.5–5 h).<br />

The preliminary results show that the cognitive competence<br />

of most children with IUGR are within normal limits,<br />

however their school achievements are significantly low,<br />

evident in general knowledge, reading decoding and<br />

comprehension and arithmetic. The neuropsychological<br />

analysis showed that these difficulties arise from lower<br />

verbal skills (Ps range ¼ 0.001–0.023), a deficit in shortterm<br />

memory span for auditory stimuli (P , 0:026),<br />

visuo-motor perceptual deficits (P , 0:01), graphomotor<br />

difficulties (P , 0:004) and deficits in executive functioning<br />

(P , 0:003). Both risk groups had difficulties in visual<br />

attention and short-term memory for visual abstract material<br />

as well as executive rigidity. Hence, three neuropsychological<br />

domains impede learning in children with IUGR:<br />

short-term memory for verbal material as proposed by<br />

Pennington (1991), deficiency in executive functioningwas<br />

suggested by Barkley (1997) and visuo-motor, primarily<br />

graphomotor deficits-indicated by Denckla.<br />

FP-D-056<br />

Cerebral palsy and twin pregnancy: zygosity, risk<br />

factors, clinical course and MRI findings<br />

D.I. Zafeiriou, E. Vargiami, A. Vardarinos, E. Pavlou, E.<br />

Kontopoulos, I. Tsikoulas<br />

1st Department of Pediatrics, Aristotle <strong>University</strong>, ‘Hippokratio’<br />

Hospital, Thessaloniki, Greece<br />

The prevalence of twinning and other multiple births is<br />

increasing all over the world, due at least in part to fertility<br />

enhancing medical therapies. Twins and multiplets are at a<br />

higher risk for intrauterine and neonatal death than singletons<br />

and are also at increased risk for neurologic morbidity,<br />

including CP. In a partly retrospective, partly prospective<br />

study during the year period 1984–2001, we identified 149<br />

patients with CP who were the product of a twin pregnancy<br />

(80 males, 69 females; age range 3–13 years). The incidence<br />

of CP due to twinning in the whole CP population taking<br />

care of during the same period (N ¼ 1128) was estimated to<br />

be 13.9%. A total of 117 CP twins (78.5%) were of the same<br />

sex as their co-twin, while only 32 (21.5%) were of the<br />

opposite sex. Eight-six patients (57.7%) had caesarean<br />

section; 68 patients (45.6%) were A twins, while the rest<br />

81 patients (54.4%) were B twins. The vast majority of<br />

patients were monozygotic twins (N ¼ 85; 57.0%)<br />

compared to dizygotic (N ¼ 64; 43.0%). Forty-two twins<br />

(28.2%) had a birth weight (BW) , 1500 g, 82 (55.0%)<br />

between 1500 and 2500 g, and only 25 (16.8%) . 2500 g.<br />

A total of 130 twins were preterm (,37 weeks) and 19 were<br />

full-term (.37 weeks). Regarding the fate of the co-twin, it


458<br />

Abstracts<br />

was normal 68 cases (30 monozygotic, 38 dizygotic;<br />

P , 0:05), the co-twin had CP in 40 cases (31 monozygotic,<br />

nine dizygotic; P , 0:05), there was intrauterine death in 18<br />

cases and death in the first 6 months of life in 23 cases.<br />

Monozygotic twins had smaller mean BW compared to<br />

dizygotic ones; the same was true for normal co-twins of<br />

dizygotic twins compared to normal co-twins of monozygotic<br />

ones (P , 0:05, respectively). Sixty-one patients had<br />

spastic diplegia, 54 had tetraplegia, 26 had hemiplegia and<br />

eight had dystonia. Additional impairments and disabilities<br />

included mental retardation (47.7%), speech impairment<br />

(69.1%), visual impairment (31.5%), hearing impairment<br />

(9.4%), epilepsy (26.2%) and orthopedic problems<br />

(81.9%). MRI of the brain demonstrated prenatal type findings<br />

in 51% of the patients (porencephaly, PVL and combination),<br />

perinatal type findings 36.2% (cystic or subcortical<br />

leucomalacia, cortical atrophy, basal ganglia involvement<br />

and combinations) and dysgenesis in 12.8% of the patients.<br />

Monozygotic twins demonstrated more frequent prenatal<br />

findings and less frequent infarcts compared to dizygotic<br />

(P , 0:05, respectively). We conclude: (1) Twins of the<br />

same sex seem to be at increased risk for CP compared to<br />

those of opposite sex; (2) birth order is not associated with<br />

CP; (3) monozygotic and SGA dizygotic twins are at<br />

increased risk for CP; and (4) intrauterine death of a monozygotic<br />

twin increases significantly the risk for CP in the<br />

surviving co-twin.<br />

FP-E<br />

Nutrition<br />

FP-E-001<br />

Dietary intake and blood folate levels in Honduran<br />

women of childbearing age<br />

K.R. Holden, J.S. Collins, J.F. Greene, S. Hinkle, J.M.<br />

Portillo, R.E. Stevenson<br />

Greenwood Genetic Center, Mt Pleasant, USA<br />

Neural tube defects (NTDs) are common birth defects<br />

whose frequency appears to be reduced by maternal supplementation<br />

and/or fortification of folic acid. Latin Americans<br />

have a high incidence of NTDs, with Honduras having an<br />

estimated NTD prevalence of 2.6 per 1000 live births. A<br />

recent Center for Disease Control study demonstrated that<br />

folic acid supplementation and/or fortification appears effective<br />

in the US Hispanics to reduce the risk of NTD recurrence.<br />

We surveyed the dietary intake of 231 Honduran women of<br />

childbearing age using a 24-h dietary recall questionnaire in<br />

inner city, town, and country areas. We also randomly<br />

checked 24 blood folates in the surveyed population to<br />

compare to the normal range for the US population. Normal<br />

US recommended dietary allowance intake of folic acid<br />

equal to 292.1 ^ 152.0 mcg was documented in Honduran<br />

women in association with a low intake of many other essential<br />

nutrients. There were also differences in nutrient intake in<br />

city, town, and country areas. Serum (6.0 ^ 3.3 ng/ml) and<br />

red blood cell (203.3 ^ 61.6 ng/ml) folate levels in all locations<br />

were in the low normal range when compared to the presupplementation/pre-fortification<br />

US population. Even when<br />

considering the multiple socio-economic hurdles presented<br />

by this developing country, our data support using an established<br />

folic acid fortification public health initiative to<br />

decrease the prevalence of NTDs in Honduras.<br />

FP-E-002<br />

Malnutrition increases dentate granule cell neurogenesis<br />

in immature rats after status epilepticus<br />

Y.-L. Wang, R.-P. Sun, G.-F. Lei, J.-W. Wang, B.-M. Li<br />

Department of Pediatrics, Shandong <strong>University</strong> Qilu Hospital,<br />

Jinan, China<br />

Several experimental seizure inductions that produce<br />

epilepsy as a consequence have been shown to be always<br />

associated with the proliferation of dentate granule cells. To<br />

investigate the effects of prolonged seizures on dentate granule<br />

cell proliferation, and to study the associations among<br />

malnutrition, granule cell proliferation and epilepsy, we<br />

examined proliferating cells using bromodeoxyuridine<br />

(BrdU) mitotic labeling combined with immunohistochemistry<br />

for markers of immature granule neurons (TuJ1) and<br />

mature granule neurons (calbindin). We maintained rat pups<br />

on a starvation regimen from P2 to P22. The status epilepticus<br />

was elicited by unilateral microinfusion of kainic acid<br />

(1 mg) into the amygdula at P15. Rat pups were given BrdU<br />

twice daily for 4 days beginning 3 days after status epilepticus<br />

to label newly born cells. At P22, the rat pups were<br />

killed and the brains were processed for dual-labeling<br />

experiments. The results indicated that early malnutrition<br />

did not modify seizure susceptibility and behavioral manifestations.<br />

Although exposure to status epilepticus augumented<br />

the expression of new cells in the dentate gyrus of<br />

the immature rats, this expression was more pronounced in<br />

the malnourished rat pups. Most BrdU-labeled cells coexpressed<br />

neuro-specific markers (TuJ1 or calbindin). The<br />

findings suggest that malnutrition followed by status epilepticus<br />

can further increase granule cell proliferation, furthermore,<br />

the vast majority of these mitotically active cells<br />

differentiated into neurons in the dentate granule cell layer.<br />

FP-E-003<br />

Effect of iron deficiency on brain monoamine<br />

neurotransmitters in rats<br />

R.-M. Hu, M.-W. Wei, R.-P. Sun<br />

Department of Pediatrics, Qilu Hospital of Shandong<br />

<strong>University</strong>, Jinan, China<br />

Objective: To identify the mechanism of iron deficiency on<br />

learning and memory ability in brain. Methods: An iron deficient<br />

diet (11.9 mg/kg) was used to make an animal model of


Abstracts 459<br />

iron deficiency. The contents of iron in brain and liver were<br />

determined by DCP-AES technique. An enzyme histochemical<br />

method was used to test monoamine oxidase (MAO)<br />

activity. Monoamine neurotransmitter and its metabolites<br />

were determined by high performance liquid chromatography<br />

with electrochemical detection (HPLC-ECD). Results:<br />

The brain iron content(11.2 ^ 5.5 versus 20.7 ^ 6.5 mg/g<br />

wet tissue, P , 0:001) and MAO activity were both<br />

decreased in iron deficient non-anemic rats. The levels of<br />

norepinephrine (NE) and 5-HT in cerebral cortex were<br />

significantly higher than those of controls (269.2 ^ 46.9<br />

versus 208.4 ^ 27.3 ng/g wet tissue, P , 0:05,<br />

1568.8 ^ 234.8 versus 1194.1 ^ 163.4 ng/g wet tissue,<br />

P , 0:01), while hydroxyindoleacetic acid (5-HIAA), a<br />

metabolite of 5-HT in the hippocampus, was lower than<br />

that of controls (2753.7 ^ 365.4 versus 3623.4 ^ 754.1 ng/<br />

g wet tissue, P , 0:05). These changes were more significant<br />

in anemic rats. Conclusion: The result suggested that the<br />

abnormal metabolism of monoamine neurotransmitters in<br />

brain may be a biochemical basis for learning and memory<br />

defect caused by iron deficiency.<br />

FP-E-004<br />

Intracranial hemorrhage infarction due to late onset<br />

Vitamin K deficiency-11 case studies<br />

S.-Z. Xu, H.-H. Zhang, X.-X. Liu<br />

Department of Pediatrics, Affiliated Hospital, Binzhou<br />

Medical College, Binzhou, China<br />

Objective: To summarize the clinical manifestations,<br />

etiology, diagnosis and prognosis of 11 cases with intracranial<br />

hemorrhage infarction which were diagnosed in our<br />

hospital in the past 5 years. All cases were breast feeding,<br />

seven cases had infantile hepatitis syndrome. These were<br />

the common causes of the late onset vitamin K deficiency.<br />

Among seven cases of infantile hepatitis syndrome, four<br />

were CMV-IgG antibody positive. Prenatal or perinatal<br />

CMV infection was an important cause of hepatitis<br />

syndrome. The onset of Vitamin K deficiency in these<br />

cases was between 31 and 70 days. The clinical manifestations<br />

included convulsions, drowsiness, anorexia, irritability,<br />

pallor, bulging of the anterior fontanelle, hypertonia and<br />

external bleeding. Laboratory examination: coagulation<br />

time .15 min. Twenty-four hours after vitamin K1 administration,<br />

it became normal in all cases. Thrombocytosis was<br />

found in eight cases (.350 £ 109/l). CT studies showed left<br />

cerebral infarction after hemorrhage in nine cases, multiple<br />

infarction after hemorrhage in two cases. Multiple intracranial<br />

heamorrhage was seen in eight cases, mild hemorrhage<br />

and quickly absorbed in three cases. Large cerebral infarctions<br />

remained. The hemorrhage or hematoma was absorbed<br />

in 2 weeks, but there were still low density areas on CT.<br />

These areas enlarged in three cases 3 months later and encephalomalacia<br />

formed. Typical clinical manifestations,<br />

coagulation time test and CT are simple and reliable diagnostic<br />

methods. The follow-up CT played an important role<br />

in prognosis evaluation. Early administration of Vitamin K1<br />

is effective in prevention this disease.<br />

FP-F<br />

Cytogenetics/Teratology<br />

FP-F-001<br />

Bilateral frontoparietal polymicrogyria<br />

L. Sztriha, M. Nork<br />

Department of Paediatrics, FMHS, UAE <strong>University</strong> and<br />

Department of Radiology, Tawam Hospital, Al Ain, United<br />

Arab Emirates<br />

Polymicrogyria is a form of non-lissencephalic cortical<br />

dysplasia with abnormal gyration characterized by narrow<br />

and crowded gyri. According to a recent classification of the<br />

malformations of cortical development, polymicrogyria is a<br />

result of abnormal cortical organization. It can be either a<br />

generalized or focal unilateral or bilateral lesion. Among the<br />

rare, bilateral symmetrical forms several syndromes, such as<br />

bilateral perisylvian polymicrogyria, bilateral parasagittal<br />

parieto-occipital polymicrogyria and bilateral frontal polymicrogyria<br />

have been recognized and characterized. Bilateral<br />

polymicrogyria in other cortical areas seems to be even<br />

more infrequent; only a few cases of large, bilateral frontoparietal<br />

polymicrogyria have previously been described.<br />

The clinical and radiological findings in three patients<br />

with bilateral frontoparietal polymicrogyria and epilepsy<br />

are presented. The patients had serious delay in mental<br />

and motor development and seizures with epileptiform electroencephalographic<br />

findings. The MRI revealed bilateral<br />

abnormalities in the frontal and parietal lobes. The cortex<br />

was thick with an irregular outer surface and multiple small<br />

gyri and sulci were recognizable. The cortical-subcortical<br />

junction showed a festoon-like appearance. The abnormal<br />

cortex extended bilaterally from the frontal pole to the<br />

parieto-occipital fissure medially and to the level of the<br />

lateral cerebral fissure (fissure of Sylvius). The volume of<br />

the underlying white matter was reduced, and the lateral<br />

ventricles were moderately dilated. Bilateral frontoparietal<br />

polymicrogyria might represent a variety of the congenital<br />

bilateral symmetrical polymicrogyria syndromes in addition<br />

to perisylvian, parasagittal parieto-occipital and frontal<br />

polymicrogyria.<br />

FP-F-002<br />

The study of telomeric microaberrations in<br />

chromosomes of children with undifferentiated forms of<br />

mental retardation<br />

S.G. Vorsanova, Y.B. Yurov, A.D. Kolotii, A.K. Beresheva,<br />

I.V. Soloviev<br />

Institute of Pediatrics and Children Surgery, Russian Ministry<br />

of Health and National Research Center of Mental


460<br />

Abstracts<br />

Health, Russian Academy of Medical Sciences, Moscow,<br />

Russia<br />

Molecular-cytogenetic studies of chromosomal microanomalies<br />

at subtelomeric chromosomal regions have been<br />

conducted by two-step fluorescence in situ hybridization<br />

(FISH) in 407 children with mental retardation and apparently<br />

normal chromosome complements. A large set of<br />

cosmid, BAC and PAC clones, containing telomeric<br />

sequences was identified by FISH studies. Availability of<br />

large-insertion PAC probes, which contain DNA sequences,<br />

common for telomeric and, partially subtelomeric regions of<br />

all human chromosomes allowed us to mark all telomeric<br />

regions in one FISH study. Therefore, first FISH study for<br />

each patient was performed with large-insertion PAC probe,<br />

specifically marking telomeric and subtelomeric regions of<br />

all human chromosomes. If some chromosome arm had<br />

absence of telomeric hybridization signals, or the intensity<br />

of hybridization signal was reduced in comparison to homologous<br />

chromosome arm, we used second DNA probe,<br />

which is strongly specific todefinite telomeric region of<br />

individual chromosome. Microdeletions of chromosomes,<br />

involving telomeric regions were detected in 20 (4.8%)<br />

cases from 420 patients with severe and mild forms of<br />

mental retardation and apparently normal karyotypes<br />

revealed by classical banding techniques. Microdeletions<br />

were detected in the following chromosomal loci: 4q35.2;<br />

5p15.33 (two cases); 9q34.3; 10q26.3 (two cases); 11q25;<br />

13q34; 16q24.3 (two cases); 18p11.32 (four cases); 18q23<br />

(two cases); 21q22.2 (two cases) and 22q13.33 (two cases).<br />

These data demonstrate that undifferentiated forms of<br />

mental retardation could be associated with non-specific<br />

telomeric micro-aberrations of different chromosomes.<br />

FISH studies using specially developed panel of telomeric<br />

DNA probes could be useful for identification of generally<br />

undetermined forms of mental retardation.<br />

FP-F-003<br />

Bilateral perisylvian atrophy – a study of 11 cases from<br />

Oman<br />

R.A. Syed, S.M. Khusaiby<br />

Department of Child Health, Royal Hospital, Muscat, Oman<br />

Recent advances in neuroimaging have helped the clinician<br />

to correlate clinical features with radiological findings<br />

in various neurological disorders. This study describes 11<br />

children with developmental delay with no known etiology<br />

who showed bilateral perisylvian abnormalities in imaging<br />

studies. Most of the patients had spastic weakness of the<br />

limbs, microcephaly, severe developmental retardation<br />

and seizures, as common symptoms. Speech and language<br />

disorders along with masticatory and swallowing problems<br />

were encountered in 85% of the patients. Three patients had<br />

generalized dystonia with choreic movements mostly seen<br />

in the facial and trunk muscles. Further studies are required<br />

to evaluate the definite etiology.<br />

FP-F-004<br />

Pontocerebellar hypoplasia type 1: new leads for an<br />

earlier diagnosis<br />

M.S. Salman, S. Blaser, J.R. Buncic, C.A. Westall, E. Heon,<br />

L. Becker<br />

<strong>University</strong> of Toronto and Hospital for Sick Children,<br />

Toronto, Canada<br />

Background: Pontocerebellar hypoplasia (PCH) type 1 is<br />

a rare disease characterized by PCH and anterior horn cell<br />

degeneration. Death results from respiratory failure. The<br />

oldest reported child died at the age of 26 months. Methods:<br />

Case study of two siblings with PCH. The diagnosis was<br />

made on autopsy after the death of the second sibling at 40<br />

months from respiratory failure and the finding of anterior<br />

horn cell degeneration on autopsy. The older sibling died at<br />

14 months from pneumonia following a clinical course similar<br />

to his sister. Results: Both siblings had significant global<br />

developmental delay with initial axial and peripheral hypotonia.<br />

Peripheral hypertonia with brisk reflexes developed<br />

later. Extensive investigations in the second sibling ruled<br />

out mitochondrial and other metabolic diseases. Genetic<br />

testing for Friedreich’s ataxia, spinal muscular atrophy,<br />

neuropathy/ataxia/retinitis pigmentosa (NARP), spinocerebellar<br />

ataxia 1–3 and 6–8 gene abnormalities were negative.<br />

Sleep study showed mixed central and obstructive sleep<br />

apneas. The electroretinogram (ERG) showed abnormal<br />

rod-cone response that was consistent with retinal dystrophy.<br />

Conclusions: Our cases call for the expansion of the<br />

phenotype for this disease. Survival may be prolonged with<br />

emergent spasticity. The presence of abnormal ERG<br />

response in infants with PCH may aid in the earlier diagnosis<br />

of this disease, and provide new insights into its pathogenesis.<br />

FP-F-005<br />

The brain complications of immunodeficiency in<br />

Nijmegen breakage syndrome<br />

J. Wendorff, E. Hibner, K. Zeman, M. Piotrowicz<br />

Research Institute, Polish Mother’s Memorial Hospital,<br />

Lodz, Poland<br />

Immunodeficiency is one of the most important symptoms<br />

of Nijmegen breakage syndrome (NBS). Since the<br />

description of the first patient approximately 70 cases<br />

have been reported, mainly in Central Europe. The diagnostic<br />

criteria are: characteristic phenotype with mental retardation,<br />

humoral and cellular immunity disorders, increased<br />

predisposition to cancer and chromosomal instability. The<br />

most frequent clinically manifested NBS complications<br />

result from predisposition to infections. The brain compli-


Abstracts 461<br />

cations of immunodeficiency have not been reported up till<br />

now. We present a 13-year-old girl with decreased levels of<br />

immunoglobulins in all classes, and B and T lymphocytes,<br />

in whom NBS was diagnosed on the basis of typical phenotypic<br />

features and genetic examination (deletion 5 nt in gene<br />

NBS 657–666 position). During 2 year follow-up three<br />

different neurological syndromes were diagnosed: chronic<br />

headache due to disturbance of CSF reabsorption, sinus<br />

cavernosus thrombophlebitis and cerebellitis. The occurrence<br />

of neurological symptoms was connected with lack<br />

of proper immunosubstitution due to non-compliance. All<br />

these neurological syndromes were clinically oligosymptomatic<br />

or asymptomatic while the brain MRI showed considerable<br />

involvement. The duration of neurological<br />

complications was short and they disappeared after treatment<br />

with immunoglobulins and steroids. Conclusion: The<br />

occurrence of neurological signs and symptoms in NBS may<br />

be related to immunodeficiency caused by lack of proper<br />

immunosubstitution.<br />

FP-F-006<br />

Observation of some cases of Klippel-Trenaunay<br />

syndrome<br />

S.S. Shomansurov, Z.B. Rafikova, G.T. Hojaeva, S.R.<br />

Rafikova<br />

Department of Pediatric Neurology, Tashkent Institute of<br />

Post-graduate Medical Education, Tashkent, Uzbekistan<br />

Klippel-Trenaunay syndrome was first described in 1900.<br />

Main clinical manifestations are asymmetric limb hypertrophies<br />

and hemangiomas due to congenital malformations of<br />

arteriovenous and lymphatic vessels. We observed 5 children<br />

from age 2 months to 14 years, who underwent clinical and<br />

neurological examination, brain ultrasonography (BUS),<br />

computed axial tomography (CAT), and symptomatic treatment.<br />

Follow-up lasted for 3 years. Clinical findings varied<br />

from minimal to strongly pronounced. In two patients there<br />

were no intracerebral hemangiomas. These patients developed<br />

satisfactorily physically and mentally. Three patients<br />

had cerebral hemangiomas and demonstrated developmental<br />

retardation and secondary hydrocephalus, and required careful<br />

management. BUS let us monitor forming and growth of<br />

hydrocephalus relevant to location of intracerebral angiomas.<br />

CAT showed enlargement of affected brain hemisphere<br />

in two patients without signs of structural anomalies or<br />

progress. The severity of the disease depended on craniocerebral<br />

angiomatosis; therefore we identified clinical<br />

variants of the syndrome with affected extremities only and<br />

with affected extremities plus brain. Follow-up observation<br />

and symptomatic management allowed us to achieve stabilization<br />

of pathologic process and improvement of neurological<br />

status in all children. So, progress of the disease of<br />

Klippel-Trenaunay syndrome is determined first of all by<br />

the severity of cerebral anomalies, and opportune symptomatic<br />

therapy improves patients’ condition and prognosis.<br />

FP-F-007<br />

Neuronal migration anomalies in children: a study of 43<br />

patients<br />

W.-H. Xie, Y.-C. Chen, A.-D. Zheng, X.-J. Hou<br />

Department of Pediatrics, First Affiliated of Fujian Medical<br />

<strong>University</strong>, Fuzhou, China<br />

The aim is to study the clinical and neuroimaging findings<br />

of children with neuronal migration anomalies<br />

(NMA). The medical records of 43 children with NMA<br />

seen in our hospital during the past 12 years were<br />

reviewed. There were 35 boys and 8 girls. Age ranged<br />

from 2 months to 12 years. The major clinical presentations<br />

of these patients were cerebral palsy (51.2%),<br />

seizures (32.5%), and mental retardation (16.3%). To<br />

study the characteristics of craniocerebral CT and MRI<br />

findings in these migration anomalies, CT images of 43<br />

patients with NMA were evaluated. Five patients were<br />

studied by MRI. Twenty had schizencephaly (46.5%), 14<br />

patients had lissencephaly and/or pachygria (32.6%). Five<br />

had polymicrogyria (11.6%), four had heterotopias of gray<br />

matter (9.3%). Twenty-six patients (60.5%) had other associated<br />

brain anomalies, including absence of the septum<br />

pellucidum in 14 cases, absence or agenesis of the corpus<br />

callosum in eight cases, cyst of the septum pellucidum in<br />

three cases, holoprosencephaly in two cases, and arachnoid<br />

cyst in two cases. MRI is a more superior method for<br />

diagnosing NMA than CT. It can clearly delineate the<br />

detailed morphologic changes of the brain caused by<br />

neuronal migration disorders as well as the other associated<br />

anomalies.<br />

FP-F-008<br />

Dubowitz syndrome<br />

B. Jocic-Jakubi, G. Jovanovic, V. Micic<br />

Clinic of Mental Health and Child Neuropsychiatry,<br />

Department of Child Neurology, <strong>University</strong> Hospital, Nis,<br />

Yugoslavia<br />

Dubowitz syndrome is an autosomal recessive disorder<br />

characterized by small stature, peculiar face, infantile<br />

eczema, microcephaly and mild mental retardation, originally<br />

described by Dubowitz (1965). We report a 7-year-old<br />

boy with postnatal growth retardation, characteristic facies,<br />

micrognathia, short palpebral fissures and asymmetric<br />

ptosis. Hypotonia, hyperextensible joints, clinodactyly of<br />

fifth finger were present. Eczema, speech delay, submucous<br />

cleft palate and delayed skeletal maturation were noted in<br />

early childhood. His mother has craniofacial anomalies too,<br />

but no intelligence abnormalities. In their family there<br />

were mentally retarded persons and one sibling died at<br />

birth with congenital malformation. The differential diagnosis<br />

is discussed with respect to this very polymorphous<br />

syndrome.


462<br />

Abstracts<br />

FP-F-009<br />

One case of Xp21 contiguous gene deletion syndrome<br />

H.-W. Ma a , J. Jing a , Z.-C. Wang a , L.-Y. Chen a , M. Matsuo b<br />

a Laboratory of Genetics, The Second Clinical College,<br />

China Medical <strong>University</strong>, Shenyang, China; b Division of<br />

Genetics, International Center for Medical Research, Kobe<br />

<strong>University</strong> School of Medicine, Kobe, Japan<br />

We describe a Chinese boy previously misdiagnosed with<br />

adrenoleukodystrophy who was subsequently diagnosed<br />

with Xp21 contiguous gene deletion syndrome, which<br />

included congenital adrenal hypoplasia (CAH), glycerol<br />

kinase deficiency (GKD) and Duchenne muscular dystrophy<br />

(DMD). His peripheral blood routine karyotyping was without<br />

visible deletions. Molecular mapping in the Xp21 region<br />

revealed that the deletion encompassed nearly the whole<br />

region from a portion of 3 0 end of the DMD gene to a site<br />

telomeric to the locus for X-linked CAH. The centromeric<br />

startpoint of the deletion was localized to the 3 0 end of the<br />

DMD gene, between exons 62 and 63, while the telomeric<br />

deletion breakpoint was not determined in the present study.<br />

However, no evidence for the deletion of the GKD gene<br />

located between the DMD and the CAH was observed,<br />

which might be fortuitously caused by its pseudogene. Interestingly,<br />

the deletion of the marker DXS992 located<br />

between the DMD and the GKD was not detected too,<br />

which could have resulted from either the presence of a<br />

separate double deletion or the mechanism of other complex<br />

deletion within this region. The exact mapping of the deletion<br />

could be confirmed by FISH and this study is underway<br />

in our patient. These findings suggest that Xp21 contiguous<br />

gene deletion syndrome should be further considered in any<br />

patient with adrenal insufficiency in spite of the normal<br />

karyotype. Analysis of molecular genetics will help in determining<br />

the extent of the deletion.<br />

FP-F-010<br />

Kabuki syndrome (Niikawa-Kuroki): study of five<br />

Spanish cases<br />

S.M. Briceño-Cuadros, J. Campos-Castelló, E. Miravet-<br />

Fuster, G. Bueno-Lozano, O. Pérez-Rodriguez<br />

Hospital Clinico San Carlos, Madrid, Spain<br />

Objectives: The Kabuki Syndrome, described by Niikawa<br />

and Kuroki (1981) has an estimated prevalence of 1:32 000<br />

live births. No biological marker is available yet. The diagnosis<br />

is exclusively based on phenotypic features: facial<br />

dysmorphism resembling the make-up used by kabuki<br />

actors, fetal flesh on finger tips, dermatoglyphic abnormalities,<br />

postnatal failure to thrive, and osseous malformations.<br />

It is associated with variable frequency of ophthalmologic,<br />

dental, cardiac, genitourinary, ENT and neurologic abnormalities.<br />

The latter include mental and language delays,<br />

epilepsy, migration defects and hydrocephalus. A hundred<br />

cases have been reported in Japanese, European and North<br />

American patients. We report five Spanish cases and a<br />

review of the literature. Results: We present five children<br />

(four males, one female) with a history of hypotonia, delay<br />

attaining developmental milestones, mild cognitive impairment<br />

and language with mostly phonologic and syntactical<br />

problems and excentric prosody. Facial dysmorphic features<br />

include arched eyebrows, eversion of external third of inferior<br />

eyelid, enlarged ears, high and depressed nasal bridge,<br />

high arched palate and fetal flesh on finger tips. Short height<br />

and skeletal abnormalities are variable in frequency. Chromosomal,<br />

hormonal, hematologic and metabolic tests were<br />

normal. Imaging studies (CT, MRI) only showed a mild<br />

atrophy in deep grey matter and cortex in two patients.<br />

Conclusion: Kabuki syndrome is relatively easy to recognise<br />

because of its dysmorphic features. It is a multiorgan<br />

disorder that involves the central nervous system whose<br />

most frequent clinical manifestations are mental and<br />

language delay.<br />

FP-F-011<br />

The FG syndrome: report of a large Italian series<br />

A. Battaglia<br />

Stella Maris Scientific Research Institute Division of Child<br />

Neurology and Psychiatry, <strong>University</strong> of Pisa, Pisa, Italy<br />

FG syndrome was first described by Opitz and Kaveggia<br />

in 1974, as a rare multiple congenital anomalies/mental<br />

retardation (MCA/MR) syndrome occurring only in boys,<br />

due to a recessive mutation on the X chromosome. Based on<br />

reports of over 50 reported cases, FG syndrome is associated<br />

with developmental delay (especially speech), hypotonia,<br />

postnatal onset relative macrocephaly, prominent forehead,<br />

frontal hair upsweep or whorls, ocular hypertelorism, thin<br />

vermilion border of the upper lip, relatively short fingers<br />

with broad thumbs and halluces, persistent fetal fingertip<br />

pads, anal anomalies, and/or constipation. Major malformations<br />

are rare, and include pyloric stenosis, anal agenesis,<br />

cryptorchidism, hypospadias, inguinal hernias, and congenital<br />

heart defects. Abnormal EEG findings and seizures<br />

have been reported in almost 70% of patients. MRI studies<br />

commonly show abnormalities of the corpus callosum associated<br />

with variable dilatation of the lateral ventricles; while<br />

less frequent are periventricular nodular heterotopias, mild<br />

cerebellar defects, and reduced amounts of periventricular<br />

white matter. Chiari I malformation seems to be a rather<br />

frequent finding. The behavior phenotype appears to be<br />

characterized by attention deficit/hyperactivity disorder,<br />

and relatively less developed language, fine motor and<br />

executive function skills, whereas visual-spatial abilities<br />

seem to be a relative strength. At present, due to an<br />

improved awareness, FG syndrome emerges as a rather<br />

common MCA/MR syndrome, occurring in boys and girls,<br />

presumed to be due to incompletely recessive mutations of<br />

genes on chromosome X. However, in a few instances


Abstracts 463<br />

inheritance from an affected father has been suspected. Two<br />

or three candidate loci on chromosome X are already at<br />

hand, making it possible the cloning of causal gene(s) in<br />

the near future. We describe twenty patients, referred to our<br />

Institute for investigation of developmental delay/mental<br />

retardation, and diagnosed as FG syndrome. In all of them<br />

diagnosis was confirmed by Dr Opitz. This is the first<br />

reported Italian series of FG syndrome cases, with particular<br />

emphasis on physical, neurological and developmental findings,<br />

and natural history. Follow-up on all patients ranged<br />

between 6 months and 7 years.<br />

FP-F-012<br />

Functional and genetic interactions between<br />

doublecortin and lissencephaly-1 (LIS1) in neuronal<br />

migration<br />

T. Tanaka a , C. Paczkowski a,b , F.F. Serneo a , S. Sasaki c , M.J.<br />

Gambello d , S. Hirotsune c , A. Wynshaw-Boris b,d , J.G.<br />

Gleeson a,b<br />

a Department of Neurosciences,<br />

b Graduate Program in<br />

Neurosciences, d Departments of Pediatrics and Medicine,<br />

<strong>University</strong> of California, San Diego, USA; c Center for<br />

Genome Medical Science, Saitama Medical School,<br />

Saitama, Japan<br />

Neurons destined for cerebral cortex must migrate<br />

hundreds of cell-body distances to reach their final destination.<br />

Neuronal migration is dependent upon doublecortin<br />

(DCX) and lissencephaly-1 (LIS1), as humans with mutations<br />

in either gene display defective migration. However,<br />

very little is known about the molecular events underlying<br />

neuronal migration and its disorders. Here we show that<br />

LIS1 and DCX function on a common pathway in neuronal<br />

migration. We adopted a cerebellar granule cell migration<br />

assay system with retroviral transduction of either wild type<br />

proteins or fluorescently-tagged proteins to study the effect<br />

of gene overexpression and to determine the subcellular<br />

localization of these proteins during cell migration in<br />

vitro. To study the effect of loss of function of LIS1, we<br />

utilized neurons from LIS1 deficient mice. LIS1 deficient<br />

neurons displayed a dose dependent decrease in migration<br />

distance. Overexpression of LIS1 or DCX in wild type (WT)<br />

neurons resulted in increased neuronal migration distance.<br />

DCX overexpression rescues the migration defect in LIS1<br />

deficient neurons. These results suggest that LIS1 and DCX<br />

have dosage-sensitive effects on neuronal migration in both<br />

deficiency and overexpression.<br />

FP-F-013<br />

Angelman syndrome: a case report<br />

M.H. Ortiz, E.C. Cutiongco, S.G.P. Perez<br />

Neurodevelopmental Section, Child Neuroscience Division,<br />

Philippine Children’s Medical Center, Quezon City, Philippines<br />

Angelman syndrome (AS) is a neurological disorder associated<br />

with severe developmental delay, speech impairment,<br />

gait ataxia and characteristic behavior of inappropriate<br />

laughing and smiling. It affects approximately 1 in<br />

12 000–20 000 individuals and is caused by the loss of<br />

maternally imprinted contribution in the 15q11–13 region<br />

which can occur by at least five different known genetic<br />

mechanisms. This is a case report of a 4.5-year-old Filipino<br />

boy seen at the Philippine Children’s Medical Center. He<br />

presented with feeding problems (2 months), developmental<br />

delays (4 months), frequent smiling (9 months), seizures<br />

(2.6 years), and sleep disturbance (4 years). Pertinent physical<br />

examination revealed microcephaly (47 cm P , 2 Nellhaus),<br />

wide mouth, wide-spaced teeth and prominent<br />

mandible. Neurological examination showed an inappropriate<br />

happy demeanor, fleeting eye contact, short attention<br />

span, hyperactivity, monosyllabic utterances, drooling,<br />

and mouthing. On gait testing, ataxia was noted with arms<br />

abducted and elbows flexed. Deep tendon reflexes were<br />

hyperactive. Diagnostic investigations revealed gastroesophageal<br />

reflux on barium swallow; generalized and multifocal<br />

epileptiform discharges and focal and generalized<br />

slowing of the background activity on EEG; and normal<br />

cranial MRI. Cytogenetic study revealed a normal karyotype<br />

on routine high resolution G banding which was then<br />

augmented with FISH technique using the probes small<br />

nuclear ribonucleoprotein and D15S10 loci. On FISH analysis,<br />

a deletion was detected on one of his chromosome 15<br />

confirming the diagnosis of Angelman Syndrome. This may<br />

represent the first reported genetically-confirmed AS in the<br />

Philippines.<br />

FP-F-014<br />

Angelman syndrome in Malaysian children<br />

M.-K. Thong<br />

Department of Paediatrics, <strong>University</strong> of Malaya Medical<br />

Centre, Kuala Lumpur, Malaysia<br />

AS is a neurodevelopmental disorder characterized by<br />

severe intellectual disability, movement or balance disorder,<br />

microcephaly, speech impairment with absent or minimal<br />

speech and seizures with characteristic electroencephalogram.<br />

Earlier reports emphasized the typical behavioral<br />

phenotype such as the ‘happy’ disposition, frequent laughter,<br />

hand-flapping movements and hyperactivity. Consensus<br />

for diagnostic criteria for AS included a normal antenatal<br />

and birth history, normal head circumference at birth with<br />

absence of major birth defects, on-going developmental<br />

delay evident by 6–12 months of age with no regression,<br />

normal laboratory investigations and absence of structural<br />

brain abnormalities. Other associated clinical features<br />

present in 20–80% of patients include flat occiput, deepset<br />

eyes, prognathism, wide mouth with widely spaced<br />

teeth, fair skin and hair, hyperreflexia and drooling. Diagnosis<br />

is based on diagnostic criteria and usually difficult in


464<br />

Abstracts<br />

the first 2–3 years of life. Other conditions with similar<br />

presentation include Rett syndrome, autism, Lennox-<br />

Gastaut syndrome and cerebral palsy. Currently, molecular<br />

diagnosis with DNA methylation study has improved the<br />

accuracy of the diagnosis. However, most reports are<br />

centred upon Caucasian children and there are very few<br />

reports of Angelman syndrome in Asian children. We report<br />

our series of Malaysian children of Malay, Chinese and<br />

Indian ethnic background with Angelman syndrome.<br />

FP-F-015<br />

A case of Niikawa-Kuroki syndrome with chromosomal<br />

abnormality 46, XY, add (22)(p11,2)<br />

M. Sakurai a , H. Satoh a , I. Ichihashi a , K. Yamaguchi a ,T.<br />

Takeuchi a , J. Furusho a , Y. Iikura a , K. Kumagai a,b<br />

a Department of Pediatrics, School of Medicine, Showa<br />

<strong>University</strong>, Tokyo; b Chisaki-Hanano-Sono, Institution for<br />

Social Welfare Corporation, Japan<br />

Niikawa-Kuroki syndrome (Kabuki make-up syndrome)<br />

is characterized by unusual face, mental retardation, skeletal<br />

anomalies, dermatoglyphic abnormalities, and postnatal<br />

growth retardation. However no certain causal factor has<br />

been identified in this syndrome. We report 1 year old boy<br />

case of Niikawa-Kuroki syndrome with chromosomal<br />

abnormality (46,XY, add (22)(p11,2)). He was the second<br />

child of healthy parents. Facial anomalies, skeletal anomalies<br />

and pulmonary artery stenosis were found at birth.<br />

Cataract, mild mental retardation, growth retardation,<br />

dermatoglyphic abnormalities, and dilatation of sylvian<br />

fissure on cranial MRI are noted now. His parents have<br />

no chromosomal abnormalities. Thirteen cases of chromosome<br />

abnormalities in associated with Niikawa-Kuroki<br />

syndrome have been reported. In summary, dominant<br />

inheritance, ring (X) chromosomes and a severe phenotype,<br />

Turner syndrome and pseudoautosomal dominant inheritance<br />

are speculated. In our case, it is very interesting<br />

that his chromatin abnormality is localized to the autosomal<br />

chromatin area (p11,2).<br />

FP-F-016<br />

Dandy-Walker malformation, hypertrophic<br />

cardiomyopathy and cranial anomalies in a newborn: a<br />

new case of 3C syndrome<br />

F. Fabbri, C. Galasso, A. Di Paolo, L. Cristina, F.<br />

Silvestrini, P. Curatolo<br />

Department of Pediatric Neurology, Tor Vergata <strong>University</strong>,<br />

Rome, Italy<br />

Ritscher-Schinzel syndrome or 3C (cranio-cerebellocardiac)<br />

syndrome, characterized by congenital heart<br />

malformation, cerebellar anomalies and cranial defects, is<br />

a rare genetic syndrome only recently delineated. Until now<br />

28 cases have been reported. Craniofacial findings include<br />

cleft palate, ocular coloboma, prominent occiput and forehead,<br />

hypertelorism, down-slanting palpebral fissures,<br />

depressed nasal bridge and micrognathia. Cerebellar<br />

anomalies including Dandy-Walker malformations<br />

(DWM) or its variant are responsible for gross motor<br />

delay associated with secondary hypotonia. Speech delays<br />

are reported in surviving patients. We describe a baby born<br />

at 37 weeks by Caesarean section, from healthy and nonconsanguineous<br />

parents. At 24th week of pregnancy a<br />

routine ultrasound scan detected DWM and cardiac defect.<br />

Birth weight was 2980 g, length 48 cm, and head circumference<br />

35 cm. The infant had no asphyxia at birth; Apgar<br />

scores were 8 and 10 at 1 and 5 min, respectively. At birth<br />

the baby was noted to have typical dysmorphic findings of<br />

3C syndrome. Hepatosplenomegaly and bilateral cryptorchidism<br />

were found. Neurological examination revealed<br />

severe generalized hypotonia with poor spontaneous movements<br />

and poor sucking reflex. Grasp reflexes, Moro and<br />

other primitive reflexes were elicitable but weak. Karyotype<br />

was normal (46,XY) and the 22q11.2 microdeletions (FISH)<br />

were excluded. Cerebral MRI showed: a posterior fossa<br />

cystic malformation with vermis hypoplasia and upward<br />

displacement of the tentorium without evidence of hydrocephalus.<br />

Echocardiogram and cardiac MRI revealed a<br />

hypertrophic cardiomyopathy with secondary valvular<br />

defects. This syndrome should be considered in the differential<br />

diagnosis whenever a newborn is found to have the<br />

DWM, or its variant phenotype, and craniofacial<br />

dysmorphic findings.<br />

FP-F-017<br />

Visual and quantitative analysis of EEG in children with<br />

a cavum of the septum pellucidum<br />

M. Kacinski, A. Kubik, M. Dolik-Michno, G. Augustyn, L.<br />

Bednarski<br />

Department of Pediatric Neurology, Collegium Medicum,<br />

Jagiellonian <strong>University</strong>, Krakow, Poland<br />

Purpose: Persistent cavum of the septum pellucidum<br />

(CSP) is an anomaly of the brain midline and is considered<br />

a marker of brain dysgenesis. The aim of the project was to<br />

determine whether the symmetry and synchrony of the<br />

bilateral bioelectric activity of the brain is different in children<br />

with and without CSP. Material: A group of 17 children<br />

with a CSP and a control group matched for age and<br />

sex were examined. The analysis included 136 pairs of<br />

EEG curves from independent leads from above both the<br />

hemispheres. Methods: A PL-EEG-24 Classic Campaign<br />

Video option apparatus was used for recording the data.<br />

Apart from visual analysis performed by a doctor, mathematical<br />

analysis was used to estimate 7-s sections of the<br />

EEG recording, Fourier transformation included. Results:<br />

The results were shown in the form of topographic description,<br />

symmetry, synchrony, character, frequency, amplitude,<br />

shape of the pattern, physiological factors and


Abstracts 465<br />

faulty elements. The results of the quantity estimation<br />

included the correlation analysis of the signal, as well as<br />

the analysis of the statistic factors and a description by<br />

means of time-frequency analysis. The strength of the<br />

signal was proved to be several times higher and the statistic<br />

factors were twice higher in CSP children in comparison<br />

to the controls; in addition the former displayed<br />

bilateral asymmetry of the activity in terms of frequency<br />

and amplitude. The differences frequently escaped the<br />

visual analysis. Conclusions: It is necessary to use the<br />

mathematical analysis of EEG in children with a cavum<br />

of the septum pellucidum. This paper was supported by a<br />

grant No 4 PO5E 124 18 of the State Committee of the<br />

Scientific Research.<br />

FP-F-018<br />

Long-term efficacy of active congenital hydrocephalus<br />

treatment in pediatric patients: results of 10-year followup<br />

L.M. Kuzenlova, O.I. Maslova, V.M. Studenikin, E.I.<br />

Stepakina<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

Background: Therapy for children with active congenital<br />

hydrocephalus remains a challenge both for pediatric<br />

neurologists and neurosurgeons. Benefits of conservative<br />

versus surgical treatment are still widely disputed. Goal:<br />

Our intention was to compare the long-term efficacy of<br />

various treatment strategies for patients with different<br />

disease types. Methods: Forty pediatric patients with various<br />

hydrocephalus types (originally aged 3 months–2 years)<br />

were followed-up for a 10-year period. Every available<br />

diagnostic procedure was incorporated. Conservative treatment<br />

was used in 20% of cases, and neurosurgery was<br />

performed in 80% of children (including ventriculo-atrial,<br />

ventriculo-peritoneal, and lumbo-peritoneal shunting).<br />

Results: Decrease of linear and planometric indices was<br />

registered in all patients (as judged from CT and MRT<br />

results). Symptomatic epilepsy (with focal sites localized<br />

by shunting regions) was evident in 85% of surgical cases,<br />

and decreased brain tissue perfusion present in the areas of<br />

surgical shunting (100%). As for biochemical hydrocephalus<br />

markers (levels of xanthine and hypoxanthine), these<br />

two indices were significantly increased in lumbar and<br />

ventricular liquor of patients with severe forms of hydrocephalus<br />

(after conservative/surgical therapy, concentrations<br />

of these two metabolites tended to decrease, but still<br />

remained elevated, suggesting that metabolic and energetic<br />

processes in brain tissue were only partially restored).<br />

Conclusion: Efficacy of surgical and non-surgical treatment<br />

protocols for hydrocephalus is still debatable and remains to<br />

be established.<br />

FP-F-019<br />

Place of hydrocephalus in cerebral dysgenesis in infants<br />

O.I. Maslova, V.M. Studenikin, S.Y. Ishkhanova, L.M.<br />

Kuzenkova, E.I. Stepakina<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

Background: Most congenital anomalies and malformations<br />

of the central nervous system are known either to be<br />

combined with or to induce formation of hydrocephalus,<br />

which fact supplements heavily to clinical course and prognosis<br />

of the disease. Goal: Aim of our study was to reveal<br />

the incidence of hydrocephalus in cerebral dysgenesis<br />

syndromes among a group of 1st year patients. Method:<br />

Case histories of 112 pediatric patients with verified cerebral<br />

dysgenesis (infants aged from 1 to 12 months, among<br />

them 78 males and 34 females), hospitalized in our clinic in<br />

1999–2001, were analyzed. Additional diagnostic methods<br />

of neurovisualization (CT, MRI, and neurosonography,<br />

SPECT) were utilized. Results: Excessive head circumference<br />

(pathological) accretion was registered in 26.8% of<br />

cases during the first 6 months of life (30 patients), considered<br />

as an active hydrocephalus form in seven cases, and as<br />

residual or passive hydrocephalus in the rest of patients (23<br />

cases). Etiology of verified hydrocephalus cases varied from<br />

various pathological conditions, such as congenital malformations<br />

and intrauterine infections, to intraventricular<br />

hemorrhages, etc. Conclusion: Our data suggest that hydrocephalic<br />

cases should be identified during infancy. Active<br />

forms of the disease require administration of acetazolamide,<br />

while drugs of such kind are not routinely indicated<br />

for patients with static hydrocephalus. No explanation can<br />

be currently offered concerning the predominance of male<br />

hydrocephalic cases over female ones, other than for genetic<br />

mechanisms involved.<br />

FP-F-020<br />

Chinese fragile X syndrome<br />

Y.-Z. Guo, J.-H. Chia, S.-P. Zhang, Y. Dan, S.-M. Zhao, S.-<br />

Z. Wang<br />

Department of Pediatrics PUMC Hospital, CAMS and<br />

PUMC, Beijing, China<br />

Objective: Fragile X syndrome is the most common<br />

inherited mental retardation (MR) with an IQ level less<br />

than 60. Studies have been done how to perform screening<br />

and diagnosis of fragile X syndrome. Study design: Nine<br />

clinical characteristics from special patient records of 190<br />

boys and 18 female pediatrics for fragile X screening testing<br />

were analyzed. The characteristics included mental<br />

retardation, family history of mental retardation, elongated<br />

face, large or prominent ears, attention deficit hyperactivity<br />

disorder, autistic-like behavior, simain crease, macroorch-


466<br />

Abstracts<br />

idism and hyperextensible joints. The disease was screened<br />

with PCR amplified to detect (CGG) n repeat sequence, and<br />

diagnosed with PCR, Southern hybridization. Results:<br />

Seven cases were diagnosed with fragile X syndrome by<br />

Southern analysis on PCR product. Six boys have been<br />

identified to carry fragile X full mutation and one mosaicism<br />

that consists of a premutation (CGG repeat<br />

size ¼ ,100) allele. Among the nine characteristics,<br />

simian crease, macroorchidism, and hyperextensible joints<br />

were eliminated, because of low frequency and statistical<br />

insignificance. Using the remaining six-item criteria for<br />

requesting fragile X testing, about more than 60% of this<br />

test in our cases could have been eliminated clinically<br />

without missing any positive cases. Thereby the proportion<br />

of case with positive result improved from 3.4 to 8.8%.<br />

Conclusion: Our simplified six-item clinical checklist<br />

obviously increased the proportion of cases with positive<br />

FRAXA. The PCR method is fast, simple and useful in<br />

screening FRAXA.<br />

FP-F-021<br />

Place of hydrocephalus in the structure of cerebral<br />

dysgenesis in infants<br />

O.I. Maslova, V.M. Studenikin, S.Yu. Ishkhanova, L.M.<br />

Kuzenkova, E.I. Stepakina<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

Background: Most congenital anomalies and malformations<br />

of the central nervous system are presently known<br />

either to be combined with or to induce formation of<br />

hydrocephalus. This fact supplements heavily clinical<br />

course and prognosis of the disease. Goal: Aim of our<br />

study was to reveal the incidence of hydrocephalus in the<br />

structure of cerebral dysgenesis syndromes among the<br />

group of 1st year patients. Methods: Case histories of<br />

112 pediatric patients with verified cerebral dysgnenesis<br />

(infants aged from 1 to 12 months; 78 males and 34<br />

females), hospitalized in our clinic in 1999–2001, were<br />

analyzed. Additional diagnostic methods of neurovisualization<br />

(CT, MRT and neurosonography, SPET, etc.) were<br />

utilized. Results: Excessive head circumference (pathological)<br />

accretion was registered in 26.8% of cases during the<br />

first 6 months of life (30 patients); active hydrocephalus in<br />

seven cases and residual or passive hydrocephalus in 23<br />

cases. The origin of hydrocephalus varied from various<br />

pathological conditions, such as congenital malformations<br />

and intrauterine infections, to intraventricular hemorrhages,<br />

etc. Conclusion: Our data suggest that hydrocephalic cases<br />

should be properly examined, as infants with active forms<br />

of the disease require administration of acetazolamide,<br />

while drugs of such kind are not routinely indicated for<br />

patients with residual hydrocephalus. No explanation can<br />

be currently offered concerning the predominance of male<br />

hydrocephalic cases over female ones, except for genetic<br />

mechanisms involved.<br />

FP-G<br />

Infection/Immunology<br />

FP-G-001<br />

Elevated cerebrospinal fluid levels of anti-CD 9<br />

antibodies in patients with subacute sclerosing<br />

panencephalitis<br />

T. Shimizu a,b,f , T. Matsuishi b , R. Iwamoto e , K. Nihei h ,H.<br />

Yoshioka c , H. Kato b , S. Ueda d , H. Hara f,g , T. Tabira f,g ,E.<br />

Mekada a,e<br />

a Institute of Life Science, b Department of Pediatrics, School<br />

of Medicine, Kurume <strong>University</strong>, Kurume; c Department of<br />

Pediatrics, Kyoto Prefectural <strong>University</strong> of Medicine,<br />

Kyoto; Departments of d Neurovirology and e Cell Biology,<br />

Research Institute for Microbial Diseases, Osaka <strong>University</strong>,<br />

Osaka; f Division of Demyelinating Disease and Aging,<br />

National Institute of Neuroscience, Kodaira;<br />

g National<br />

Institute of Longevity Sciences, Aichi, Japan; h National<br />

Children’s Hospital<br />

SSPE is a slowly progressive and highly lethal disease of<br />

the central nervous system. Although the primary cause of<br />

SSPE is persistent infection of neuronal and glial cells by<br />

measles virus, the precise mechanism of the progression of<br />

this disease has not yet been elucidated. CD9, a member of<br />

the tetraspanin family, is expressed in myelin and other<br />

nervous tissues, and this study found that significant<br />

amounts of anti-CD9 antibodies were detected in the<br />

CSF of all SSPE patients. Anti-CD9 antibodies were also<br />

detected in the CSF of some cases of other neurological<br />

disorders, but in these patients’ levels were lower than in<br />

patients with SSPE. The level of anti-CD9 antibodies was<br />

elevated and reached a peak that coincided with the<br />

appearance of brain atrophy. Our findings appear to indicate<br />

a new aspect of the etiology and progression of this<br />

disease.<br />

FP-G-002<br />

Long-term follow up of the intelligence development of<br />

Japanese encephalitis (JE) patients<br />

B. Wang, D. Ding, Z. Hong<br />

Institute of Neurology, Fu Dan <strong>University</strong>, Hua Shan Hospital,<br />

Shanghai, China<br />

Objective: To observe the impact of the JEV infection on<br />

the intelligence development of JE patients. Methods:<br />

Forty six Japanese encephalitis virus (JEV) serological<br />

test positive encephalitis patients and 33 JEV serological<br />

test negative encephalitis patients were followed up for 8–<br />

26 years. Mini-mental state examination (MMSE) and<br />

Wechsler’s Intelligence test were used for examination


Abstracts 467<br />

for them as well as 46 healthy people who were 1:1<br />

matched by 46 JE patients. Results: Seven (15.2%) JE<br />

patients were diagnosed as mental retardation (FIQ , 70).<br />

Among them, six patients’ MMSE scores were under 21.<br />

Comparing the FIQ, VIQ, PIQ, and IQ sub-tests within<br />

these three groups, all the scores of JE patients are lower<br />

than those of other two control groups. Conclusion: JEV<br />

infection during the childhood had severe impact to the<br />

intelligence development. The intelligence development<br />

of JE patients was worse than those of patients suffered<br />

other encephalitis and normal controls.<br />

FP-G-003<br />

Long-term sequelae of Japanese encephalitis<br />

D. Ding, Z. Hong, B. Zhou<br />

Institute of Neurology, Fu Dan <strong>University</strong>, Hua Shan Hospital,<br />

Shanghai, China<br />

Objective: To measure the risk of long-term post-JE<br />

illness-associated disability, and give the basis of estimating<br />

the disease burden of JE. Methods: We carried out a<br />

retrospective, controlled cohort study with participation of<br />

neurologists-experts, to follow up patients suffering from<br />

JE from 1973 to 1994. Two control groups, no-JE (JE<br />

serological test negative) patients and healthy people,<br />

were followed up as control groups. Physical and neurologic<br />

examinations, IQ measurement and MMSE were used<br />

for examination. Results: We found 29 [34%, (95% CI: 24–<br />

44%)] JE patients (including the dead) with long-term<br />

sequelae associated with JE among the 85 patients<br />

followed up, six [8%, (95% CI: 2–14%)] no-JE patients<br />

(including the dead) with long-term sequelae associated<br />

with no-JE among the 73 patients followed up, and only<br />

one [1%, (95% CI: 21–3%)] subject with IQ ¼ 82 in<br />

normal control group. The proportion of long-term sequelae<br />

of JE patients is larger than that of no-JE and normal<br />

control group with the relative risk of 4.15 (95% CI: 1.83–<br />

9.44) and 26.61 (95% CI: 3.71–190.76), respectively<br />

(P , 0:00). Conclusion: The long-term post-JE illnessassociated<br />

disability is very severe, and will give heavy<br />

burden to the society and families.<br />

FP-G-004<br />

CSF b 2 -MG value for the diagnosis of convulsive<br />

diseases<br />

J.-K. Wei, H.-Z. Liu, Y. Tian, X.-Y. Li, Y.-C. Wang, X.-M.<br />

Ma, P.-F. Wei<br />

The Affiliated Hospital of Hebei Medical College for Continuing<br />

Education, Baoding, China<br />

Objective: Mild viral meningitis with convulsions is<br />

similar to infectious toxic encephalopathy in general clinical<br />

manifestations. It is difficult to make therapy scheme<br />

and to predict prognosis. The objective of this paper is to<br />

investigate the search differential diagnosis value of CSF<br />

b 2 -microglobulin (b 2 -MG, X ^ S ng/ml) measuring. Methods:<br />

CSF b 2 -MG was detected in cases with mild viral<br />

meningitis with convulsions and in those with infectious<br />

toxic encephalopathy with CSF b 2 -MG of non-infectious<br />

non-hemorrhagic convulsions by radio-immunization using<br />

the wide-range testing box provided by China Atomic<br />

Scientific Research Institute. Each group included 38<br />

cases. Result: CSF b 2 -MG in mild viral meningitis<br />

(2484.01 ^ 357.57) was obviously higher than that in<br />

infectious toxic encephalopathy (1043.78 ^ 140.73)<br />

(P , 0:01) and the non-infectious non-hemorrhagic<br />

convulsion group (972.12 ^ 102.03), but CSF b 2 -MG in<br />

infectious toxic encephalopathy was not significantly<br />

different from that in non-infectious non-hemorrhagic<br />

convulsion group. Conclusions: CSF b 2 -MG testing is of<br />

help to differentiate mild viral meningitis from infectious<br />

toxic encephalopathy when their clinical symptoms are<br />

similar.<br />

FP-G-005<br />

Effects of early compositive treatment with<br />

immunoglobulin (IG) on serious CNS viral infection<br />

J.-K. Wei, H.-Z. Liu, X.-F. Li, Y.-H. Xu, X. Shi, X.-R. Cao<br />

The Affiliated Hospital of Hebei Medical College for Continuing<br />

Education, Baoding, China<br />

To explore the effects of compositive treatment with IG<br />

in different disease stages on serious CNS viral Infection,<br />

retrospective analysis was taken on 84 cases (1–13 years<br />

old) of serious CNS viral infection. Among them seven<br />

cases had herpes simplex, three cases EB, one case pox<br />

viral infection. The treatment included IG (1.5–2 g/kg IV<br />

divided into 3–5 days), combined with Ribavirin (R, 15<br />

mg/kg daily, 10–14 days) and/or Acyclovir (A, 10–15 mg<br />

daily, 10–14 days), Dexamethasone (0.5–1 mg/kg daily, 5–<br />

7 days), Cerebrolysin (1 ml/kg daily, 10–14 days) and<br />

other supportive therapies. Some cases were subjected to<br />

EEG and CT scan tests. To compare the effect on two<br />

groups, 50 cases of early compositive treatment group<br />

(within 3 days of disease stage) and 34 cases of late<br />

(Middle/Late, M/L) treatment group (after 3 days of<br />

disease stage), we found early treatment is more effective<br />

than later treatment, especially the group with compositive<br />

treatment with IG and R 1 A showed the best result (Table<br />

3).<br />

Table 3<br />

The effect on compositive treatment on meningitis with IG in two stages<br />

Dead Low intelligence Epilepsy Cerebral palsy Recovery<br />

Early 1 3 4 0 42<br />

M/L 5 7 7 3 12


468<br />

Abstracts<br />

FP-G-006<br />

Angiostrongyliasis cantonensis in children: 3 years<br />

follow-up of two cases<br />

X.-Y. Ye, H.-W. Hu, Z.-D. Lin, G.-Q. Li, Y.-L. Zhang<br />

Neurology department, the Yu-Ying Children Hospital<br />

affiliated to Wenzhou Medical College, Wenzhou, Zhejiang,<br />

China<br />

Objective: To confirm the prognosis and manifestations,<br />

and the differences from adults, of Angiostrongyliasis<br />

cantonensis in children. Methods: We analyzed the manifestations,<br />

diagnosis and treatment in two children (a 4-<br />

year-old boy and a 2-year-old girl) with Angiostrongyliasis<br />

cantonensis infection. The two cases had been followed up<br />

for 3 years. Results: The disease was characteristically<br />

demonstrated with eosinophilic meningitis (boy) or eosinophilic<br />

meningoradiculitis (girl). Symptoms of elevated<br />

intracranal pressure and abnormal sensation was observed<br />

in the 2nd week after the onset of the disease. Eosinophils of<br />

peripheral blood and cerebrospinal fluid had been increased<br />

for one month, 43 worms (42 larva) were collected from<br />

CSF during the 1st week of hospitalization in the girl. It<br />

was shown that the conduction was delayed in both patients<br />

at upper brain stem on BAEP, meanwhile intracranial/spinal<br />

CT scan or MRI was negative. After two courses (1 week<br />

per month as a procedure) of the treatment with mannitol,<br />

dexamethasone and Zental, the boy recovered, but the girl’s<br />

CFS returned normal 4 months later after the treatment. The<br />

boy was found without any abnormality associated with the<br />

episode. The girl showed neurological bladder, although it<br />

was gradually improved. Conclusion: In the patient with<br />

Angiostrongyliasis cantonensis, eosinophilic meningitis<br />

would result in complete recovery, but eosinophilic meningoradiculitis<br />

may be followed by some sequelae. The<br />

outcome may be associated with the loci of the disease,<br />

but not with the age of patient.<br />

FP-G-007<br />

The influence of dexamethasone on TNF-a and IL-8<br />

contents in brain tissue during edema induced by<br />

lipopolysaccharide in rats<br />

H.-L. Wang, J.-P. Lu<br />

Department of Pediatrics, The First Affiliated Hospital,<br />

Zhengzhou <strong>University</strong>, Zhengzhou, China<br />

Objective: To study the influence of dexamethasone<br />

(DXM) on TNF-a and IL-8 expression and the relation<br />

between them in brain edema induced by lipopolysaccharide<br />

(LPS) in rats. Methods: TIA and ELISA methods were<br />

used to measure the contents of TNF-a and IL-8 in brain<br />

tissue after brain edema induced by LPS in rats. Results:<br />

The water content and Evans blue (EB) were increased<br />

significantly in the brain tissue of rats in LPS group and<br />

DXM group compared with those of the rats in NS group<br />

(P , 0:05). The levels of TNF-a and IL-8 in brain tissue of<br />

the rats in LPS group were higher than those in NS group<br />

(P , 0:01). The levels of TNF-a and IL-8 in brain tissue in<br />

DXM group were higher than those in NS group in earlier<br />

time (P , 0:05). After 24 h, there was no significant difference<br />

(P . 0:05) between them. In the LPS group, the water<br />

content in brain tissue and EB content, TNF-a and water<br />

content in brain tissue, IL-8 and water content in rain<br />

tissue, IL-8 and EB content were all have positive correlation<br />

(r were 0.537, 0.423, 0.437, 0.831, respectively,<br />

P , 0:05). Conclusion: TNF-a and IL-8 could participate<br />

in the onset and development of brain edema induced by<br />

LPS. Glucocorticoid could inhibit the production of inflammatory<br />

cytokines and attenuate inflammatory response and<br />

tissue injury.<br />

FP-G-008<br />

The role of tumor necrosis factor-a and interlerlcukin-8<br />

in the pathogenesis of brain edema induced by LPS in rat<br />

J.-P. Lu, H.-L. Wang<br />

Department of Pediatrics, The First Affiliated Hospital,<br />

Zhengzhou <strong>University</strong>, Zhengzhou, China<br />

Objective: To study the role of TNF-a and IL-8 in the<br />

pathogenesis of brain edema induced by LPS in rats. Methods:<br />

RIA and ELISA methods were used to measure the<br />

contents of TNF-a and IL-8 in brain tissue after infectious<br />

brain edema was induced by LPS in rats. Results: The<br />

levels of TNF-a and IL-8 in brain tissue in the LPS<br />

group were successively increased as compared to the<br />

blank control group and NS group (P , 0:01) They continued<br />

to be high until 48 h. In the LPS group, water content<br />

in brain tissue and EB content, TNF-a and water content in<br />

brain tissue, IL-8 and water content in brain tissue, IL-8<br />

and EB content were all have positive correlation. (r was<br />

0.537, 0.423, 0.437, 0.831, respectively, P , 0:05).<br />

Conclusion: TNF-a and IL-8 could contribute to the<br />

onset and development of inflammatory brain edema<br />

induced by LPS and have closely relationship with brain<br />

injury.<br />

FP-G-009<br />

Levels of insulin-like growth factors in cerebrospinal<br />

fluid of children with meningitis<br />

X.-P. Guo, G.-C. Xue, T.-X. Shi, W.-M. Wang<br />

Department of Pediatrics, the First Affiliated Hospital of<br />

Xinxiang Medical College, Weihui, Henan, China<br />

The insulin-like growth factors, IGF-I and IGF-II, are<br />

potent mitogenic and anabolic peptides. They play prominent<br />

roles in the regulation of immunity and inflammation.<br />

We used an immunoradiometric assay kit for measuring<br />

CSF IGF-I and IGF-II in four groups of patients: bacterial<br />

meningitis (7), tuberculous meningitis (5), viral meningitis<br />

(21), and normal controls (15). Levels of CSF IGF-I in


Abstracts 469<br />

patients with bacterial meningitis and tuberculous meningitis<br />

were elevated in comparison with that in the control<br />

subjects (P , 0:001 and P , 0:001, respectively), but the<br />

levels of IGF-I in CSF of patients with viral meningitis<br />

were not elevated (P ¼ 0:199). The patients with bacterial<br />

meningitis or tuberculous meningitis had significantly<br />

higher levels of CSF IGF-I than those with the viral meningitis<br />

(P , 0:001 and P ¼ 0:001, respectively). CSF levels<br />

of IGF-II in patients with bacterial meningitis were<br />

elevated in comparison with levels in the control subjects<br />

(P , 0:001) but the levels of IGF-II in CSF of patients<br />

with tuberculous meningitis and viral meningitis were not<br />

elevated (P ¼ 0:221 and P ¼ 0:512, respectively). The<br />

patients with bacterial meningitis had significantly higher<br />

levels of CSF IGF-II than those with tuberculous meningitis<br />

and viral meningitis (P ¼ 0:050 and P ¼ 0:001, respectively).<br />

These data suggested that IGF-I and IGF-II might<br />

play an important roles in the pathophysiological process<br />

of meningitis, especially bacterial meningitis.<br />

FP-G-010<br />

Levels of insulin-like growth factor binding protein-3 in<br />

cerebrospinal fluid of children with meningitis of<br />

different etiologies<br />

G.-C. Xue, X.-P. Guo, T.-X. Shi, F.-L. Zhu, F.-Y. Wang, H.-<br />

Y. Qian<br />

Department of Pediatrics, the First Affiliated Hospital of<br />

Xinxiang Medical College, Weihui, Henan, China<br />

Objective: To observe changes of insulin-like growth<br />

factor binding protein-3 (IGFBP-3) in the CSF of children<br />

with viral meningitis, tuberculous meningitis, and partially<br />

treated bacterial meningitis, and the relations between<br />

IGFBP-3 and CSF inflammatory parameters. Methods:<br />

CSF IGFBP-3 levels of these patients with meningitis and<br />

of normal controls were tested by RIA. Results: In comparison<br />

with normal controls, IGFBP-3 levels in CSF of children<br />

with tuberculous meningitis and partially treated<br />

bacterial meningitis were elevated significantly<br />

(P , 0:001 and P , 0:001, respectively), but the levels of<br />

IGFBP-3 in CSF of children with viral meningitis were not<br />

elevated significantly (P ¼ 0:090). The levels of CSF<br />

IGFBP-3 of patients with tuberculous meningitis were<br />

higher than those of patients with partially treated bacterial<br />

meningitis (P , 0:001), and the latter were higher than<br />

those of patients with viral meningitis (P , 0:001). The<br />

CSF IGFBP-3 levels were not significantly correlated with<br />

the CSF leukocyte counts (P ¼ 0:241), CSF protein concentrations<br />

(P ¼ 0:113), and CSF glucose concentrations<br />

(P ¼ 0:320). Conclusion: These data suggested that<br />

IGFBP-3 involved in pathophysiological process of meningitis<br />

and it might be a useful index for differential diagnosis<br />

of viral meningitis, tuberculous meningitis, and partially<br />

treated bacterial meningitis.<br />

FP-G-011<br />

The clinical features and prognostic analysis of acute<br />

myelitis<br />

S.-J. Yu, W. Wang, X. Wang, X. Wu<br />

Department of neurology, Harbin Children’s Hospital,<br />

Harbin, China<br />

We have done an overall analysis of 30 children with<br />

acute myelitis and follow-up of ten cases. The results<br />

showed that clinical features are diverse, and it is easily<br />

misdiagnosed. Children under the age of 6 years were<br />

more likely featured as the transverse lesion than adults,<br />

and may get a relatively long spinal cord shock period and<br />

serious prognosis. The earlier the application of gammaglobulin<br />

and glucocorticoid hormone, the better the prognosis<br />

was observed.<br />

FP-G-012<br />

Diagnosis and treatment of 86 cases with cerebral<br />

malaria<br />

M.-L. Bao, C. Ma, Y. Chen<br />

Inner Mongolia Medical <strong>University</strong>, Hohhot, China<br />

Objective: To investigate the diagnosis and treatment of<br />

cerebral malaria (CM). Materials and methods: Eight six<br />

cerebral malaria children, male 54, female 32, aged 2<br />

months–14 years. Malaria parasites were examined in<br />

blood experimentally. Quinine and other medicine were<br />

given. Results: The rate of malaria parasites was 100%.<br />

After treatment 53 cases were obviously improved on the<br />

1st day and 25 cases on the 2nd day. eight children died.<br />

Conclusion: The early diagnosis of cerebral malaria was<br />

very important. Mortality may be reduced if the medicine<br />

was given timely. The key of the treatment was eliminating<br />

malaria parasites, lowering down intracranial pressure,<br />

controlling high fever, convulsion, and protecting comatose<br />

patients.<br />

FP-G-013<br />

The relationship of neuroimages and clinical status at<br />

different stages of tuberculous meningitis in children<br />

G.-Q. Li, H.-W. Hu, X.-Y. Ye, Z.-D. Lin, J.-W. Zhao, D.-K.<br />

He<br />

Yuying Children Hospital, Wenzhou Medical College,<br />

Wenzhou, Zhejiang, China<br />

Objective: To investigate the relationship of CT and MRI<br />

at different stages of tuberculous meningitis in children and<br />

the clinical status. Methods: Ninety one cases of tuberculous<br />

meningitis at different stages were studied by CT, MRI and<br />

the clinical status. Results: Sixty seven cases were examined<br />

by CT, and 58 cases were abnormal; the abnormality rate<br />

was 86.6%. Thirty eight cases were examined by MRI, and


470<br />

Abstracts<br />

35 cases were abnormal; the abnormality rate was 92.1%.<br />

Changes of CT were similar to those of MRI: changes of<br />

cisterns and sulci or slightly low density of parenchyma in<br />

the early stage; encephaledema and hydrocephalus in the<br />

middle stage; and low, mixed, or high density in parenchyma<br />

and oppressed, occluded, or adhered sulci in the late<br />

stage. Almost recovered patients had slight changes in CT or<br />

MRI. The patients with poor prognosis had obvious changes<br />

in CT or MRI. Conclusion: We thought that CT and MRI<br />

were useful for clinical evaluation of the degree and prognosis<br />

of TM.<br />

FP-G-014<br />

The change of immune function and serial observation<br />

on IL-2R expression of PHA-activated PBL in 20<br />

patients with viral encephalitis<br />

Y.-Y. Liang a , S.-G. Li b , Q.-H. Kong c , X.-J. Yan c<br />

a Children’s Hospital of Shanxi Province, b Department of<br />

Paediatrics, Shanxi Medical <strong>University</strong>, Taiyuan, China<br />

Objective: The aim of study is to evaluate the significance<br />

of T-lymphocyte subsets, IL-2R, NK cells in peripheral<br />

blood, serial observation on IL-2R expression of PHA-activated<br />

(0, 24, 48 and 72 h) PBL in patients with viral encephalitis<br />

in acute and convalescence stages, with a group of<br />

normal children as controls. Methods: The 20 patients with<br />

viral encephalitis and normal controls were recruited into<br />

the study using the immunofluoresent antibody test (IFAT)<br />

method. The results revealed that the percentages of the<br />

CD8, NK, IL-2R, and B cells in patients with viral encephalitis<br />

are obviously increased compared with those of the<br />

control group, but the expression of IL-2R obviously<br />

decreased in patients with viral encephalitis at different<br />

times (0, 24, 48 and 72 h). The percentages of the NK, Il-<br />

2R, CD8, B cells and CD4/CD8 in patients with viral encephalitis<br />

of the convalescence stage were clearly higher than<br />

those in the acute stage. Conclusion: The result suggested<br />

that the measurement of immune function and observation<br />

of IL-2R expression may be regarded as a valuable judge<br />

index in the evaluation of therapy and the prognosis in the<br />

patients with viral encephalitis.<br />

FP-G-015<br />

A study of nitric oxide in serum and cerebrospinal fluid<br />

in children with viral encephalitis<br />

S.-G. Li a , Y.-Y. Liang b , Q.-H. Kong c , X.-J. Yan c<br />

a Department of Paediatrics,<br />

b Shanxi Medical <strong>University</strong>,<br />

and c Children’s Hospital of Shanxi Province, Taiyuan,<br />

China<br />

Objective: The aim of study is to evaluate the significance<br />

of NO in serum and cerebrospinal fluid in children with viral<br />

encephalitis. Methods: Twenty patients with viral encephalitis<br />

and 20 normal controls were recruited into the study.<br />

The levels of NO in serum and cerebrospinal fluid were<br />

determined by spectrophotometry. Result: The result<br />

revealed the level of serum NO in patients with viral encephalitis<br />

was higher than that the normal control (P , 0:01).<br />

The NO level of the serum in patients of acute stage was<br />

clearly higher than that of convalescence stage. The level of<br />

serum NO showed positive relation with the level of cerebrospinal<br />

fluid (r ¼ 0:489, P , 0:01). Conclusion: The<br />

result suggests that the NO level is associated with the<br />

onset, progress and severity in patients with viral encephalitis.<br />

FP-G-016<br />

The change of C-type natriuretic peptide and<br />

neurotensin in rabbit brain injury induced by endotoxin<br />

Y.-C. Zhang, D.-H. Tang, Y.-M. Zhang, L. Xu, L.-Q. Chen<br />

Shanghai Children’s Hospital, Shanghai, China<br />

Objective: To study the change and significance of C-type<br />

natriuretic peptide (CNP) and neurotension (NTin brain<br />

injury induced by endotoxin in rabbits. Methods: One<br />

hundred mg/kg endotoxin was intraventricully injected in<br />

30 New Zealand white rabbits and the same volume of<br />

normal saline was injected in five rabbits as controls. CNP<br />

and NT concentrations were detected by radioimmunoassay<br />

in variable periods in the plasma, CSF and brain tissue<br />

(hippocampus area), and brain water content were measured<br />

by the dry method. Results: The plasma, CSF and brain<br />

tissue CNP concentrations after 3–6 h endotoxin injection<br />

were significantly higher than those of the control group or<br />

before injection (P , 0:05 or P , 0:01). Then, the CNP<br />

altered to decrease in the following periods and the lower<br />

levels emerged at 12–24 h after endotoxin injection. The NT<br />

content were decreased and the lower levels also emerged at<br />

12–24 h after endotoxin injection (P , 0:05 or P , 0:01).<br />

Brain water content was significantly higher (P , 0:05 or<br />

P , 0:01) and reached the peak level at 24 h after injection.<br />

Conclusions: The changes of CNP and NT were related to<br />

brain injury and brain edema induced by endotoxin. The<br />

early high CNP expression may be one of the protective<br />

mechanism.<br />

FP-G-017<br />

The clinical analysis of eight cases in children colti virus<br />

encephalitis<br />

H.-H. Zhu, C.-F. Yan<br />

Guangzhou Children’s Hospital, Guangzhou, China<br />

The study was designed to examine all double serums of 54<br />

children patients, suffering from clinically diagnosed viral<br />

encephalitis from 1999 till 2001. Their serums were checked<br />

to detect pathogens with ELISA provided by Institute of<br />

Virology of Chinese Preventing Medical Academy of<br />

Sciences. Among them, in eight cases IgM anti-colti virus


Abstracts 471<br />

antibodies were positive; males six, females two, the youngest<br />

child 7 months old, and the oldest 10 years old. The<br />

months they got the disease: one in May, one in September,<br />

and in June, July, August, each of them has two cases. All of<br />

them suffered sickness with acuteonset, and all had symptoms<br />

of upper respiratory infection for 1–7 days before they<br />

showed neurological symptoms. All eight cases had fever at<br />

38–39.58C, five of them had consciousness disturbance of<br />

various degrees. Brain CT: showed disseminating low<br />

density foci in one case, and brain atrophy in three cases.<br />

No patient died, five cases recovered; one case developed<br />

secondary epilepsy, one case mild left hemiparesis, one<br />

case disturbance of speech and intelligence. Colti virus is a<br />

new category of Reoviridae, which was denominated by<br />

International Virology Classifying Committee in Berlin in<br />

1990. This virus has been isolated in America, Germany,<br />

France, Indonesia, and also in Beijing, Hainan Province,<br />

Yunnan Province and Gansu Province. In the 54 cases for<br />

this study with double serum testing with ELISA, eight cases<br />

were found to be positive for anti-colti virus IgM antibody.<br />

Today, ELISA is the most widely used examination technique,<br />

which can be applied to checking virus antibodies. This<br />

group of eight cases got the diseases during May–September,<br />

most of them during June–August. Three cases developed<br />

sequelae although there was no fatal case. The colti virus is<br />

one of the pathogens of the summer-autumn children’s viral<br />

encephalitis in the Guangzhou area, and it has severe clinical<br />

symptoms and poor prognosis. It is important for the clinical<br />

staff to pay more attention and confirm the diagnosis.<br />

FP-G-018<br />

Observing evoked potentials of virus encephalitis in 16<br />

children<br />

Y.-L. Zhu, J. Yang, H. Cai, W.-M. Yang, G.-Z. Xu<br />

Capital Institute of Pediatrics, Beijing, China<br />

This paper is discussing whether the evoke potentials<br />

could serve as an evaluation marker of virus encephalitis<br />

causing brain damage. By assaying the evoked potentials at<br />

the acute phase, recovery phase and sequela phase of 16<br />

children the final diagnosis of virus encephalitis, we demonstrated<br />

that in clinically severe virus encephalitis abnormal<br />

evoked potentials were elicited at all clinical stages studied.<br />

We therefore concluded that evoked potential is well correlated<br />

with the prognosis of encephalitis resulting in brain<br />

damage.<br />

FP-G-019<br />

Cerebellar hypoplasia with in utero parvovirus infection<br />

D.L. MacGregor, E.L. Ford-Jones, S. MacPhee, E.N. Kelly,<br />

S. Blaser<br />

The Hospital for Sick Children, Toronto, Ont., Canada<br />

Background: In utero parvovirus infection is associated<br />

with feline cerebellar hypoplasia – kittens so affected<br />

demonstrate dysmetric head movements and abnormal<br />

behavior. In mice and rats, parvovirus has been found to<br />

be teratogenic and similarly to cause cerebellar hypoplasia<br />

with ataxia. Human fetal parvovirus (B19) infection causes<br />

non-immune hydrops and fetal anemia. Autopsy studies<br />

previously reported confirmed hydrops but no other malformations.<br />

However, there are case reports of CNS abnormalities<br />

including ventriculomegaly, periventricular<br />

calcifications, arthrogryposis and neurodevelopmental<br />

disorders. Case report: An 8 month-old girl was referred<br />

for assessment of dysconjugate eye movements and developmental<br />

delay. The pregnancy was complicated by gestational<br />

diabetes mellitus and hypertension. At 28 weeks, fetal<br />

hydrops was diagnosed requiring treatment with in utero<br />

transfusions. A positive culture for parvovirus B19 was<br />

obtained. Delivery was at 30 weeks by Cesarean section<br />

for breech presentation. Neurological examination showed<br />

poor visual responses and wandering eye movements. There<br />

was optic nerve atrophy and underdevelopment of the macular<br />

area. Motor examination demonstrated hypotonia – but<br />

no tremors or ataxia. MRI – showed extensive periventricular<br />

calcification and severe volume loss in the posterior<br />

fossa – including the pons, anterior medulla and cerebellar<br />

hemispheres without sparing of the vermis. Discussion: This<br />

case represents the first human report of cerebellar hypoplasia<br />

with parvovirus infection. P antigens (blood group P<br />

system) – the binding sites for parvovirus, are located on<br />

vascular endothelium and erythroid precursors – suggesting<br />

that vasculitic thrombosis may be a mechanism for brain<br />

injury with in utero parvovirus infection.<br />

FP-G-020<br />

Inborn syphilis – its diagnostics and problems of<br />

treatment<br />

A.A. Ovchinnikova, S.E. Goulyaeva, N.V. Michailichenko,<br />

S.A. Goulyaev<br />

Vladivostok State Medical <strong>University</strong>, Vladivostok, Russia<br />

Peculiarities of the nervous system prenatal pathology of<br />

198 children born from the mothers infected with syphilis<br />

were studied. Ninety seven children took a course of standard<br />

specific therapy and 101 did not take it. The control<br />

group represented children born from 365 mothers infected<br />

through sex relation, of non-syphilitic etiology. It was found<br />

that infant syphilis developed in children born from the<br />

mothers having a second relapse and early latent syphilis.<br />

In the early neonatal period the following triad was<br />

observed: symptoms of generalized infectious intoxication;<br />

intrauterine growth retardation; and signs of central nervous<br />

system irritation. Abnormalities of skin and mucous<br />

membrane were not specific, and they were fragmentary<br />

and transient. Skeletal system abnormalities were revealed<br />

in 15% of the cases. Blood serological tests were not informative.<br />

Among the infants without treatment at full dosage,


472<br />

Abstracts<br />

signs of the central nervous system disturbance were found<br />

in 80% by the end of the 1st month of life. Generalized brain<br />

symptoms were transformed into meningitis and meningoencephalitis.<br />

In cases of treatment according to the traditional<br />

scheme, 30% of the children got delayed meningitis<br />

and meningoencephalitis at 2 or 3 months of life. The diagnosis<br />

was confirmed by serological tests in the cerebrospinal<br />

fluid. The most precise changes were seen by NSG of the<br />

nervous tissue. This study showed that there is no guarantee<br />

for full recovery in children with syphilis by using the traditional<br />

therapy scheme of treatment. Our result points out the<br />

necessity of diagnosing children as ‘inborn syphilis’ at the<br />

very early stages of life in cases with specific clinical<br />

changes (triad) and also the necessity of early treatment in<br />

full dosage, so that the drugs will pass through the blood–<br />

brain barrier in sufficient amount.<br />

FP-G-021<br />

Intercellular adhesion molecule-1 (ICAM-1) mRNA<br />

changes and drug effects in the brain of mice with herpes<br />

simplex encephalitis<br />

L.-Y. Zhu a ,M.Yi b , B. Wei a , B.-M. Wu b<br />

a Pediatric Department, PLA, 202 Hospital, and b Pediatric<br />

Department, The Second Clinical College, China Medical<br />

<strong>University</strong>, Shenyang, China<br />

Objective: To investigate the ICAM-1 mRNA changes in<br />

the brain of mice with herpes simplex encephalitis (HSE),<br />

and in the brain after the treatment with acyclovir (ACV)<br />

or ACV 1 dexamethasone (DEX). Methods: (1) The HSE<br />

mice models were established by HSV-1 injection into the<br />

cerebral ventricle; (2) ICAM-1 mRNA expression was<br />

detected by the half quantitative RT-PCR method; and<br />

(3) The changes in the brain cells of mice were observed<br />

under transmission electron microscopy. Results: (1) In the<br />

control group, the ICAM-1 mRNA expression was very<br />

low but detectable. In the HSE group, the expression<br />

increased gradually, reached the highest point on the day<br />

4, and then decreased gradually. There was no difference in<br />

ICAM-1 mRNA expression between HSE on day 1 and the<br />

control group. ICAM-1 mRNA expression of HSE 2 day<br />

group was slightly higher than that of the control group<br />

(t ¼ 2:46, P , 0:05). (2) ICAM-1 mRNA expression was<br />

decreased significantly after ACV and ACV 1 DEX treatment.<br />

ICAM-1 mRNA expression of HSE 3 day group was<br />

significantly higher than that of ACV 3 day group<br />

(t ¼ 4:02, P , 0:01). No difference was seen in the<br />

ICAM-1 mRNA expression between ACV 3 day group<br />

and ACV 1 DEX 3 day group. (3) The edema of ACV 1<br />

DEX treated mice brain vessels were attenuated. Conclusions:<br />

ICAM-1 was involved in pathological process of<br />

HSE inflammatory reaction. Treating HSE mice with<br />

ACV or ACV 1 DEX could decrease ICAM-1 gene<br />

expression. ACV 1 DEX might be necessary in treating<br />

HSE in the early phase.<br />

FP-G-022<br />

The effect of dexamethasone therapy on the changes of<br />

nitric oxide in children with bacterial meningitis<br />

F. Gao, J.-F. Lu, Q.-X. Shui, Z.-Z. Xia, B.-L. Zhou<br />

Department of Neurology, Children’s Hospital, Zhejiang<br />

<strong>University</strong> Medical College, Hangzhou, China<br />

Objective: To investigate the effect of dexamethasone<br />

therapy on the changes of nitric oxide in children with<br />

bacterial meningitis. Methods: The concentrations of the<br />

end product of nitric oxide (nitrite) and its precursor (larginine)<br />

in CSF of 26 cases of bacterial meningitis were<br />

detected with Griess method and an amino acid analyzer,<br />

and 31 children without any neurologic diseases formed the<br />

control group. Results: (1) The CSF nitrite level of bacterial<br />

meningitis before the treatment of antibiotic drug with or<br />

without dexamethasone was significantly higher than that of<br />

the control group (P , 0:01). The concentrations of l-arginine<br />

were lower in patients than in controls (P , 0:05). (2)<br />

Among the 26 patients, 16 cases were treated with antibiotic<br />

drug only, and the other ten cases were treated with pulsed<br />

dexamethasone. Dexamethasone exerted a significant effect<br />

on the end product of nitric oxide (P , 0:05). CSF nitrite in<br />

children with bacterial meningitis declined to the normal<br />

range after the treatment of antibiotic drug with or without<br />

dexamethasone. (3) CSF levels of l-arginine were significantly<br />

lower in patients with antibiotic drug only than those<br />

with pulsed dexamethasone (P , 0:05). Conclusion: Dexamethasone<br />

therapy might decrease the neuropathologic<br />

damage of patients with bacterial meningitis caused by the<br />

overproduction of nitric oxide partly.<br />

FP-G-023<br />

The protective effect and its mechanism of pretreatment<br />

with curcumin on infectious brain edema in rats<br />

F. Luo, R. Huang, Y.-J. Yang<br />

Department of Pediatrics, XiangYa Hospital, Central South<br />

<strong>University</strong>, Changsha, China<br />

Objectives: To study the protective effect and its mechanism<br />

of pretreatment with curcumin against infectious brain<br />

edema in rats. Methods: SD rats weighing 210 ^ 27 g were<br />

randomly divided into five groups (1) Normal control group<br />

(NS); (2) Infectious brain edema (PB); (3) DMSO control<br />

group; (4) HS pretreatment group; and (5 curcumin pretreatment<br />

group (CUR). The water content (WC), Na 1 and K 1<br />

content in the brain tissue were measured. The content of<br />

MDA and SOD were assessed by chromatometry. The levels<br />

of TNF-a and IL-1b were detected by ELISA. The HSP70<br />

expression was examined by Western blot analysis. Results:<br />

The results were shown: (1) the contents of water and Na 1 ,<br />

MDA, TNF-a and IL-1b were significantly increased in PB<br />

group than in NS group (P , 0:01 or P , 0:05; compared<br />

with PB group, the WC, the content of Na 1 , MDA, TNF-a


Abstracts 473<br />

and IL-1b were significantly decreased in HS and CUR<br />

groups P , 0:01 or P , 0:05; and (2) the content of SOD<br />

was significantly decreased in PB group than in NS group<br />

(P , 0:05). Compared with PB group, the content of SOD<br />

was significantly increased in HS and CUR group<br />

(P , 0:05); (3) Western blot analysis showed that the band<br />

density areas of HS, CUR and PB groups were more<br />

increased than NS and DMSO group, especially in CUR<br />

group. Conclusion: There is a protective effect against infectious<br />

brain edema in rats of pretreatment with curcumin. The<br />

effect might be associated with antioxidant, inhibiting the<br />

activity of cytokines and inducing expression of HSP70.<br />

FP-G-24<br />

Study of enteroviral central nervous system infection by<br />

polymerase chain reaction in China<br />

Z.-B. Chen, Y.-S. Dong, X.-W. Fan<br />

Department of Pediatrics, The Qingdao Haici Hospital of<br />

Qingdao <strong>University</strong>, Qingdao, China<br />

Objective: The aim of the present study was to evaluate the<br />

diagnostic potential of previously published enterovirus<br />

(EV) PCR assay to detect EV in CSF samples from children<br />

with a diagnosis of aseptic meningitis and to investigate the<br />

patient characteristics and epidemic status in China. Methods:<br />

EV RNA was detected in 187 CSF samples and serum<br />

and/or urine samples of partial patients by PCR and developed<br />

viral culture technique. Results: PCR was positive in all<br />

62 CSF specimens with positive viral culture as well (100%).<br />

In addition 93 (74%) of 125 CSF samples with negative viral<br />

cultures had positive PCR. In 21 cases of these 93 patients,<br />

viral culture from other sites (serum and/or urine) was positive.<br />

The positive rate of CSF PCR based on clinical diagnosis<br />

in patients with meningitis of negative bacterial culture<br />

results was 83%, considerably higher than the sensitivity of<br />

CSF virus culture (33%). This PCR results are available<br />

within 4 h, whereas the viral culture of CSF requires 4.6<br />

days for a cytopathic effect to develop. Echovirus 6 and<br />

echovirus 30 in this study caused twice summer outbreak<br />

in different regions of China. The clinical characteristics of<br />

155 patients with EV meningitis are different in different age<br />

groups. Conclusion: EV infection is the most common cause<br />

of aseptic meningitis in China. The PCR assay was rapid,<br />

sensitive and specific for the diagnosis of EV meningitis<br />

and showed the potential for PCR tests to shorten hospitalization<br />

and reduce the use of antibiotics.<br />

FP-G-025<br />

Clinical characteristics and follow-up studies in 22 cases<br />

of herpes simplex encephalitis in children<br />

F. Fang<br />

Beijing Children’s Hospital, Beijing, China<br />

Objective: HSE was one of the severe forms of acute viral<br />

encephalitis in children, with high mortality and morbidity.<br />

We analyzed the clinical characteristics and the prognosis of<br />

herpes simplex encephalitis in children. Method: Twentytwo<br />

patients with HSE, 14 males and eight females, were<br />

included in our study. The ages were between 3 months<br />

and 13 years. Eighteen patients were treated with acyclovir,<br />

15 mg/kg per day for 14 days. Fifteen of 22 patients were<br />

followed up 6 months–6 years, including intellectual ability<br />

assessment, CT examination, etc. Diagnosis of HSE was<br />

based on positive anti-HSV IgM in CSF, or fourfold increase<br />

in anti-HSV IgG titres in the two different CSF samples, or<br />

ratio of serum to CSF anti-HSV antibody titers ,20 by<br />

ELISA; or using PCR to detect HSV-DNA in CSF. Results:<br />

Fever was found in 22 patients (100%), altered consciousness<br />

in 18 patients (81%, coma in 12 patients. The Glasgow Coma<br />

scale scores were ,4 in three cases, 5–7infive cases, 8–9in<br />

four cases. Seizures were found in 16 (72%), vomiting in 13<br />

(59%), headache in ten (45%), personality change in eight<br />

(36%). Cranial nerve paresis in ten (45%), hemiparesis in<br />

seven (31%). Cranial CT and/or MRI showed abnormalities<br />

in 19 of 22 patients. Temporal and frontal lobes were affected<br />

in 12 patients. Cerebral hemorrhages in seven cases. Five of<br />

15 patients recovered during follow-up, three cases were<br />

mildly disabled, five cases moderately disabled, two cases<br />

severely disabled. Conclusions: HSE was classified as mild<br />

and diffuse encephalitis. The early consciousness and<br />

personality changes are clinical characteristics of HSE. Definite<br />

diagnosis of HSE was based on virological diagnostic<br />

tests in CSF. The duration of illness prior to treatment, the<br />

Glasgow Coma scale score and lesions of the brain are important<br />

to prognosis.<br />

FP-G-026<br />

The clinical characteristics and the treatments of brain<br />

abscess in children<br />

J. Xiao<br />

Beijing Children Hospital, Beijing, China<br />

Objective: To summarize the clinical characteristics and<br />

discuss the treatments of brain abscess in children. Methods:<br />

We summarized the clinical characteristics in 37 patients<br />

with brain abscess diagnosed by CT or MRI. Twentythree<br />

of them were followed up from 3 months to 5 years.<br />

Results: The causes of brain abscess in 78% of patients were<br />

obscure. The seizures as the first symptom were presented in<br />

20 patients (54%). Twenty-four patients (65%) were without<br />

fevers, and 18 patients (49%) with headache. Thirty<br />

patients were treated with antibiotics through intravenous<br />

injections for 3–6 weeks. Eleven patients recovered completely,<br />

12 had improvement and one died, and total efficiency<br />

was 77%; seven patients received surgery, one recovered,<br />

three got better. Conclusions: Clinical symptoms of brain<br />

abscess in most children were not specific; we always<br />

needed to do the diagnostic neuroimaging examinations to<br />

make the diagnosis earlier. The conservation treatments


474<br />

Abstracts<br />

with antibiotics under the surveillance of CT or MRI were<br />

the main therapy.<br />

FP-G-027<br />

Clinical research of treatment with ganciclovir on the<br />

virus encephalitis of children<br />

R. Huang, G.-Y. Zhang, Y.-J. Yang, L. Liang, Y. Yu<br />

Department of Pediatrics, Xiangya Hospital of Center South<br />

<strong>University</strong>, Changsha, China<br />

Objective: To observe the clinical therapeutic effect of<br />

ganciclovir in the children with virus encephalitis. Method:<br />

Ninety eight patients with virus encephalitis were<br />

randomly divided into the virazole treatment group (52<br />

cases) and the ganciclovir treatment group (46 cases). Clinical<br />

performance and therapeutic effect were compared.<br />

Results: The mean time of headache, vomiting, seizures<br />

and the recovering of consciousness was shorter than the<br />

virazole treatment group. The duration of fever was<br />

shorter, but there was no statistical difference. Conclusion:<br />

Ganciclovir showed an obvious effect for the treatment of<br />

children with virus encephalitis.<br />

FP-G-028<br />

Clinical analysis in 37 cases of brain abscess in children<br />

X.-H. Yu, Y.-J. Yang, L.-Z. Cao<br />

Department of Pediatrics, Xiangya Hospital, Central South<br />

<strong>University</strong>, Changsha, China<br />

Objective: To clarify the clinical characteristics and<br />

discuss the causes of misdiagnosis and the treatments of<br />

brain abscess in children. Method: The clinical characteristics<br />

were analyzed in 32 patients with brain abscess diagnosed<br />

by CT or MRI. Results: In the 32 patients, the causes<br />

of brain abscess in ten patients (31.2%) were obscure; ten<br />

patients (31.2%) were otogenic; four patients (12.5%) were<br />

traumatic; eight patients (25%) were hematogenous. There<br />

are only ten patients with typical clinical symptoms of<br />

fever, headache and local signs of the nervous system. A<br />

total of 68.8% patients had no significant clinical manifestations,<br />

so that brain abscess was easily misdiagnosed.<br />

Conclusions: The causes of brain abscess were obscure<br />

or otogenic; most clinical symptoms of brain abscess in<br />

children were not specific. The surgical treatment is the<br />

main therapy.<br />

FP-G-029<br />

Twenty one cases of childhood vestibular neuritis<br />

C.-J. Liu, X.-T. Song, G.-F. Zhao, B.-F. Xu<br />

Yishui Central Hospital, Yishui, Shandong, China<br />

We report 21 cases of childhood vestibular neuritis (M/F<br />

13/8, age 9–13 years). Before onset, there were upper<br />

respiratory tract infection (n ¼ 16), nasosinusitis (n ¼ 1),<br />

and cases with unknown cause (n ¼ 4). Major finding:<br />

vertigo of sudden onset and remission after 7 days; five<br />

cases recovered in 10 days. The concomitant symptoms:<br />

nausea, vomiting, and horizontal nystagmus. No headache,<br />

deafness or tinitus. Cold water test: unilaterally positive in<br />

15 cases and bilaterally positive in six cases. Treatment:<br />

dexamethasone was IV dripped first, then prednisolone,<br />

antibiotics and vitamins were used. The water-electrolyte<br />

imbalance was corrected by transfusion. Completely recovery<br />

was achieved in 16 patients, and hearing loss was<br />

recovered in five patients with persistent mild dizziness.<br />

The time of hospitalization was 10–31 days. No recurrence<br />

has been reported after 2 years. This disease is idiopathic,<br />

but the virus infection theory is approved and no specific<br />

treatment is available. The dexamethasone, antibiotics, and<br />

vitamins can be used. It has the tendency of self-remission.<br />

The recovery was correlated to the age. The younger the<br />

child was, the more rapidly recovery was achieved. The<br />

patients in this group were all children who recovered<br />

rapidly with no sequelae.<br />

FP-G-030<br />

Rhythmic fast activity on EEG in a patient with Mollaret<br />

meningitis<br />

J. Arita<br />

Department of Pediatrics, The Jikei <strong>University</strong> School of<br />

Medicine, Tokyo, Japan<br />

Mollaret meningitis is a very rare disease of unknown<br />

etiology, characterized by repeated aseptic meningitis with<br />

transient neurological manifestations and quick recovery.<br />

The patient, a 16-year-old boy, developed acute encephalitis<br />

with complete recovery from age 13 to 16 every year.<br />

The symptoms at the onset were loss of consciousness,<br />

generalized tonic clonic seizure and pyramidal signs.<br />

First admission to our hospital was at age 15. EEG at the<br />

early stage showed diffuse and low voltage rhythmic fast<br />

activity. He recovered his consciousness after a week. A<br />

recent episode of the attack occurred at age 16. He was<br />

admitted to our hospital last year because of high fever of<br />

398C. Right after admission, he developed generalized<br />

tonic clonic seizure and consciousness disturbance with<br />

the alternating pattern of deep coma and delirium. Cerebrospinal<br />

fluid during the early stage revealed mild leukocytic<br />

pleocytosis, elevation of protein and high level of IL-<br />

6, although brain CT and MRI showed no positive findings.<br />

EEG showed intermittent diffuse middle voltage rhythmic<br />

fast activity. After 5 days of admission, his neurological<br />

symptoms completely disappeared, and the EEG changed<br />

into normal. This is the first report of rhythmic fast activity<br />

on EEG in Mollaret meningitis. These clinical pictures<br />

suggest that this illness could cause a brainstem dysfunction.


Abstracts 475<br />

FP-G-031<br />

Laboratory findings in children with bacterial<br />

meningitis<br />

N.-C. Chiu, H. Chi, C.-S. Ho, E.-Y. Shen<br />

Department of Pediatrics, Mackay Memorial Hospital,<br />

Taipei, Chinese Taipei<br />

Laboratory data from 239 episodes of culture-proved<br />

bacterial meningitis were collected during the period from<br />

1984 to 2000. The most common causative agent was group<br />

B streptococcus (GBS, 19.7%), followed by Streptococcus<br />

pneumoniae (15.9%), Escherichia coli (13.8%), Hemophilus<br />

influenzae (7.5%), and Enterobacter cloacae (5.4%).<br />

The major pathogens in patients less than 1-month-old<br />

were GBS and E. coli, in patients aged between 1 month<br />

and 1 year were GBS, S. pneumoniae and E. coli, and in<br />

patients older than 1 year were S. pneumoniae and H. influenzae.<br />

During the study period, cases of S. pneumoniae<br />

meningitis increased strikingly since 1991. More than<br />

1000 leukocytes/mm 3 in CSF was found in 42.4% patients.<br />

Protein level higher than 200 mg/dl in CSF was found in<br />

53.6%. Normal CSF leukocyte counts, protein levels,<br />

glucose levels or CSF to plasma glucose ratio were found<br />

in 9.6, 5.0, 15.9 and 12.2% in the cases examined. However,<br />

only one patient had all four factors within normal range.<br />

Blood cultures yielded the same bacteria as the CSF cultures<br />

were recorded in 61.2% cases. Hyponatremia (serum<br />

sodium ,130 mEq/l) was found in 19.1% patients. High<br />

mortality rates were found in patients with CSF less than<br />

five leukocytes/mm 3 (40.0%), CSF glucose less than 20 mg/<br />

dl (22.1%), CSF protein more than 250 mg/dl (30.2%), and<br />

serum sodium less than 130 mEq/l (34.8%).<br />

FP-G-032<br />

Long-term follow-up of childhood tuberculous<br />

meningitis<br />

J.F. Schoeman a , J. Wait d , M. Burger b , F. van Zyl c ,G.<br />

Fertig a , A.J. van Rensburg a , P. Springer a , P.R. Donald a<br />

Departments of a Paediatrics and Child Health, b Physiotherapy,<br />

and c Audiology, Tygerberg Children’s Hospital and<br />

Faculty of Health Sciences; and d Department of Psychology,<br />

<strong>University</strong> of Stellenbosch, Tygerberg, South Africa<br />

Introduction: The morbidity of tuberculous meningitis<br />

(TBM) remains high in spite of modern antituberculosis<br />

treatment. Methods: The long-term outcome of 76 children<br />

with TBM, who received modern antituberculosis drugs and<br />

active normalization of raised intracranial pressure, was<br />

determined. The median age on admission was 29.5 months<br />

and on follow-up 9 years. Intelligence, motor function, vision<br />

and hearing were assessed by a team of health professionals,<br />

while functionality was also assessed by means of a quality of<br />

life questionnaire. Results: Only 20% of children were functionally<br />

completely normal on follow-up. Main areas of functional<br />

deficit were cognitive impairment (80%), poor<br />

scholastic progress (43%) and emotional disturbance<br />

(40%). Twenty-five per cent of children had evidence of<br />

motor impairment, but all could walk and only five children<br />

(6% of total) were unable to run. One child was blind but no<br />

child had sensori-neural deafness. Conclusions: Older longterm<br />

follow-up studies on TBM found that 21% of survivors<br />

had moderate to severe hearing loss and 12% were deaf. The<br />

improved auditory outcome in our study is most readily<br />

explained by the exclusion of streptomycin from the treatment<br />

regimen. The multiple other handicaps documented in<br />

this study, however, have serious implications for social,<br />

academic and career prospects, especially since most children<br />

come from socially deprived backgrounds. A high index<br />

of suspicion of TBM in communities as ours where tuberculosis<br />

is highly prevalent will help to diminish the morbidity<br />

associated with this devastating disease.<br />

FP-G-033<br />

Clinical features of multiple sclerosis (MS) in children<br />

L.-L. Tian<br />

Xuanwu Hospital of the Capital <strong>University</strong> of the Medical<br />

Sciences, Beijing, China<br />

Objectives: To obtain clinical features for the early diagnosis<br />

of MS among patients with neurological diseases.<br />

Patients and methods: Clinical data of five patients with<br />

MS hospitalized at pediatrics were analyzed and collected<br />

retrospectively. Results: Age at onset of the five patients vary<br />

from 7 to 10 years (mean 9.4 years). Visual symptoms were<br />

reported in the five patients and were the first manifestation in<br />

four of them. Seizure occurred in one patient. A 10-year-old<br />

boy had developed central diabetes insipidus for 3 years<br />

before visual symptom occurred. Some other clinical<br />

features were found in these five patients, such as hypesthesia,<br />

paresthesia, limb weakness and so on. Brain MRI<br />

disclosed subcortical lesions in four of them. Conclusion:<br />

Visual acuity decrease is a clinical characteristic of MS in<br />

children. Some other symptoms and signs may be found<br />

either. They must be emphasized. Brain MRI and visual<br />

evoked potentials (VEPs) should be recorded as soon as<br />

possible in order to obtain more data for early diagnosis.<br />

FP-G-034<br />

Communication problem and neurological aspect of<br />

cytomegalovirus infection in children<br />

Sunartini<br />

Department of Pediatrics, Gadjah Mada <strong>University</strong>, School<br />

of Medicine, Yogyakarta, Indonesia<br />

Cytomegalovirus (CMV) infections or inclusion diseases<br />

in children, can affect many organs, especially the central<br />

nervous system. Clinical manifestations range from slight to<br />

severe and often fatal. Recently, the incidence of CMV


476<br />

Abstracts<br />

infections in infants and children has been increasing. This<br />

research is a case study, with an analytical descriptive<br />

approach. Subjects and methods: Children with abnormal<br />

psychomotor development, speech or communication disorder<br />

were suspected to have toxoplasmosis, other agents,<br />

rubella, cytomegalovirus, herpes simplex (TORCH) infection,<br />

and admitted to Dr Sardjito Hospital. Routine blood<br />

and serological tests were carried out at least once. USG,<br />

brain CT Scan, EEG and other supporting examinations also<br />

were done based on clinical indicators. Results: The serological<br />

tests of almost 50% of cases were positive for CMV. A<br />

majority was diagnosed as active infections of CMV. Some<br />

cases, particularly with acute infections, and latent infections<br />

suggesting the possibility of reactivation were treated<br />

with ganciclovir. Improvement of psychomotor development,<br />

communication, and clinical course of the disease<br />

varied greatly and continues to be observed, along with<br />

drug side effects. Treatment with ganciclovir remains<br />

controversial. The drug is difficult to obtain and is very<br />

expensive.<br />

FP-G-035<br />

Neurologic and neuropsychologic characteristics of<br />

early disseminated Lyme disease in children<br />

A.L. Belman, M. Milazzo, T. Preston, P.K. Coyle, R.<br />

Grimson, L. Hyman<br />

School of Medicine, State <strong>University</strong> of New York, Stony<br />

Brook, Stony Brook, NY, USA<br />

To identify neurologic and neuropsycholgic features of<br />

early disseminated Lyme disease (LD) in children, we<br />

enrolled 37 children (22 boys, eight girls, ages 6–17<br />

years) with CDC defined LD in a prospective study.<br />

Controls were 25 healthy children (14 boys, 11 girls, ages<br />

6–17 years) from the same LD endemic geographic area.<br />

None had evidence of LD or Bb exposure. Protocol: structured<br />

neurologic history, examination; laboratory studies;<br />

standardized neuropsychologic and behavioral assessments.<br />

Presenting LD syndromes: facial nerve palsy (FNP) (17),<br />

lymphocytic meningitis (LM) (9), radiculoneuritis (1),<br />

multifocal EM (MEM) (4), and arthritis (3). The most<br />

frequent self-reported symptoms were fatigue/listlessness<br />

(84%), headache (81%), neck pain (72%), mood disturbance<br />

(70%), and sleep problems (62%). Disrupted/lost school<br />

days were reported for 56% of the cases; 85% reported<br />

missed activities/sports. CSF findings: " wbc/mm 3 (76<br />

%), " protein (52%), and intrathecal anti-Bb production<br />

(37%). Of the 24 children with CSF pleocytosis, 13 had<br />

FNP, seven had LM, three had MEM, one had radiculoneuritis.<br />

Of the 17 children with FNP, 75% had " wbc/mm 3 .<br />

Behavioral problems (mood disturbances) were significantly<br />

more frequent in cases than controls. Psychometric<br />

evaluation showed no difference between the two groups.<br />

Conclusions: Headache, fatigue, and sleep problems are<br />

frequent in early disseminated LD; a high rate of morbidity<br />

results in disrupted school days and activities; CSF abnormalities<br />

are common, even in children without frank meningeal<br />

signs; FNP is often associated with an occult<br />

meningitis; disturbance of mood is common; and cognitive<br />

function is not affected. Supported in part by NINDS (NIH)<br />

P01-NS34092; NGCRC: M01-RR10710-02.<br />

FP-G-036<br />

Diagnosis of acute disseminated encephalomyelitis and<br />

multiple sclerosis in childhood and their differential<br />

diagnosis<br />

W.-C. Zhang, H.-S. Wu, T.-C. Liu<br />

Beijing Children’s Hospital, Beijing, China<br />

Objective: Acute disseminated encephalomyelitis<br />

(ADEM) and MS are both common demyelinating diseases<br />

of the CNS. This paper was to study the clinical and lab test<br />

features of ADEM and MS so as to improve clinical and<br />

differential diagnosis. Methods: The clinical features and<br />

experimental results were analyzed in 34 cases with<br />

ADEM and 17 cases with MS compatible with the established<br />

criteria. Results: ADEM cases included 19 boys and<br />

15 girls, and MS cases seven boys and ten girls. Frequency<br />

of certain clinical features (ADEM%; MS%) were helpful to<br />

differentiate between ADEM and MS, such as fever (64.7<br />

and 29.4%), headache (58.8 and 23.5%), consciousness<br />

change (64.7 and 5.9%) including coma (17.6 and 0%);<br />

and seizures (35.3 and 0%). ADEM often produced widespread<br />

CNS disturbance, but MS usually presented monosymptomatic<br />

syndrome, such as six cases of myelopathy,<br />

five hemiplegia, and 33 optic neuritis, etc, It was impossible<br />

to make a certain distinction on CSF immunological examinations.<br />

Cranial MRI revealed thalamic involvement<br />

(ADEM 32.4%; MS 0%); EMG examination showed<br />

peripheral nerve damage in ADEM whereas not any in<br />

MS. Conclusion: It is suggested that ADEM be considered<br />

in the patients presenting previous history of an infection or<br />

vaccination, widespread CNS disturbance and alteration of<br />

consciousness or seizures in particular, and multifocal white<br />

matter lesion on MRI especially with thalamic involvement,<br />

and that MS be considered with onset of monosymptomatic<br />

syndrome, at least two non-associated lesions in the white<br />

matter, and relapses and remissions.<br />

FP-G-037<br />

Long term outcome of streptococcal movement<br />

disorders<br />

K.G. Walker, J. Wilmshurst<br />

Neurology/Cardiology Units, School of Child and Adolescent<br />

Health, <strong>University</strong> of Cape Town, Red Cross Children’s<br />

Hospital, Cape Town, South Africa<br />

Post streptococcal conditions such as rheumatic carditis,<br />

Sydenhams chorea (SC), PANDAS and other movement


Abstracts 477<br />

disorders remain major public health problems in South<br />

Africa. Whilst the ideal goal is primary prevention, some<br />

measure of secondary prevention has been attained using<br />

prophylactic penicillin but too many children’s lives are<br />

ruined by long term complications and morbidity. A retrospective<br />

study of 40 cases attending the Rheumatic Fever<br />

Clinic and/or neurology clinics over the past 10 years has<br />

been undertaken in order to direct attention to possible<br />

means of preventing complications but also to emphasize<br />

the urgency of addressing primary prevention and penicillin<br />

prophylaxis. We are discharging children to the same<br />

conditions from which they come! Forty patients with<br />

movement disorders and a past infection with b-haemolytic<br />

streptococcus were identified (22 males:18 females). Average<br />

age of presentation was 8 years. Twenty-one children<br />

are severely socio-economically deprived and 19 moderately<br />

deprived. Pharmacological interventions, results and<br />

side effects have been reviewed. The natural history, long<br />

term morbidity and association with penicillin prophylaxis<br />

and compliance have been addressed. Three patients initially<br />

diagnosed with SC have now been diagnosed as<br />

having Tourette’s syndrome. This study emphasized the<br />

high morbidity of neuropsychiatric disorders in post-streptococcal<br />

movement disorders. Possible links between SC,<br />

PANDAS and Tourette’s syndrome will be discussed.<br />

FP-G-038<br />

Misdiagnosis analysis of 38 children with tuberculous<br />

meningitis<br />

Z.-C. Wang, X.-T. Cai<br />

Department of Pediatrics, Longgang Central Hospital,<br />

Shenzhen, China<br />

Object: To analyse the causes of misdiagnosis of tuberculous<br />

meningitis and to explore prevention methods. Methods:<br />

A total of 186 cases of tuberculous meningitis were<br />

treated from January 1, 1996 to December 31, 2000. We<br />

analysed 38 cases which were misdiagnosed as other<br />

diseases initially. Results: The misdiagnosis rate is 20.4%.<br />

Thirty eight cases were misdiagnosed initially as the following<br />

diseases: viral encephalitis (seven cases), purulent<br />

meningitis (six cases), bronchopneumonia (five cases),<br />

epidemic encephalitis B (four cases), acute upper respiratory<br />

infection with febrile convulsion (four cases), acute<br />

toxic encephalopathy (three cases), typhoid (two cases),<br />

septicemia (two cases), and others (five cases). The main<br />

causes of misdiagnosis included atypical early clinical<br />

manifestations, atypical changes in CSF and the appropriate<br />

using drugs, which may disturb the natural course. Conclusion:<br />

Improving the knowledge of tuberculous meningitis,<br />

serially monitoring the radiography of chest and CSF<br />

features of suspected cases and taking a necessary diagnostic<br />

therapy early can effectively decrease the occurrence of<br />

misdiagnosis.<br />

FP-G-039<br />

Recurrent cerebellar ataxia with central nervous system<br />

(CNS) demyelination: a particular multiple sclerosis<br />

(MS) form in children?<br />

C. Triki, F. Kammoun, Z. Mnif, F. Choyakh, I. Feki, M.S.<br />

Kéchaou, C. Mhiri<br />

Department of neurology, CHU H. Bourguiba, Sfax, Tunisia<br />

Demyelinating CNS diseases include MS, optic neuritis,<br />

acute transverse myelitis, acute disseminated encephalomyelitis<br />

and some rare conditions such as Schilder disease.<br />

MS is rare in children under 10 years and uncommon in<br />

adolescents. We report two patients. A 9 years old girl<br />

and a 15 years old boy presented with subacute cerebellar<br />

ataxia following non-specific infections. Clinical examination<br />

showed cerebellar ataxia, vestibular disturbances and a<br />

pyramidal syndrome in the lower limbs. Eye examination<br />

was normal. CSF was normal: pleocytosis was absent and<br />

oligoclonal banding was present only in one case. Lactic<br />

acid was normal. Evoked potential studies showed an<br />

increase in the latency of the P100 potential of the visual<br />

evoked response and increase of latency of somatosensory<br />

and auditory evoked responses in the two patients. Cerebellar<br />

MRI showed several areas of increased signal on T-2<br />

weighted sequences located in the cerebellum, brainstem,<br />

cervical spinal cord and hemispheric white matter. Basal<br />

ganglia were normal. A diagnosis of acute disseminated<br />

encephalomyelitis was made and these patients were treated<br />

by high-dose intravenous corticosteroids followed by oral<br />

therapy. The outcome was good, in fact, the cerebellar<br />

ataxia disappeared. But, when the dose of corticosteroids<br />

was under 20 mg/day, cerebellar ataxia reappeared. The<br />

diagnosis of MS was suspected, but absence of any other<br />

symptoms continues. After 4 years cerebral MRI showed the<br />

same lesions. These cases show the difficulty of MS diagnosis<br />

in children.<br />

FP-G-040<br />

Early cerebral sonographic abnormalities in a case of<br />

vertically transmitted HIV-1<br />

R.O. Jorge<br />

Hospital G Fricke-Facultad de Medicina Universidad de<br />

Valparaíso-Alvarez, Viña del Mar, Chile<br />

Previously Bode and Rudin (1995) reported echogenic<br />

stripes in the basal ganglia identified in a 4 months infant<br />

with human immunodeficiency virus. This was attributed to<br />

a calcifying arteriopathy. These authors postulated that<br />

cerebral sonography performed in early infancy might<br />

allow identification of HIV encephalopathy even before its<br />

clinical manifestation. We had a control patient whose<br />

parents are both affected with AIDS. During a short period<br />

between the second and third month of age, progressive and<br />

severe developmental abnormalities, acquired microce-


478<br />

Abstracts<br />

phaly, hypotonia and finally quadriplegia were observed. In<br />

this period CMV, toxoplasma, varicella zoster, and other<br />

bacterial, fungal and parasitic infections of CNS were<br />

ruled out. A transfontanelle sonographic examination (US)<br />

was performed in the newborn period and described as<br />

normal. At the age of 1 month a second brain US showed<br />

an increase of distance in which the pericallosal branches of<br />

the anterior cerebral artery were easy followed. Its course<br />

was evident in almost all its extension in the parasagittal<br />

views without moving the transducer. This was associated<br />

with an increase of the pulse ratio in the pericallosal and in<br />

the cortical branches of middle cerebral arteries. The hipoechogenicity<br />

surrounding these vessels was increased. A<br />

brain CT at this stage of disease was considered normal.<br />

Progressive symmetric frontal ventriculomegaly was<br />

evidenced by ultrasounds in the period between 2 and 4<br />

months. A second CT at the age of 4 months showed a<br />

severe frontal and cerebellar atrophy, white matter hypodensity<br />

and multiple calcifications. We postulate that the early<br />

vessels sonographic findings express the increase of sulks<br />

space due to initial cortex atrophy. This findings could help<br />

in the early suspicion of HIV encephalopathy, even before<br />

ultrasound calcifications and clinical regression becomes<br />

evident.<br />

FP-G-041<br />

Multiple sclerosis in children<br />

V.N. Yefimenko<br />

Medical university, Donetsk, Ukraine<br />

Twenty five children with the authentic diagnosis of MS<br />

according to C. Poser et al. (1983) are under our observation.<br />

In the study group the number of female persons predominates<br />

(16 girls and nine boys). The age of onset was 4–15<br />

years, the peak age being 12–13 years. The first symptoms<br />

in eight children (32%) appeared prior to the age of 10. The<br />

earliest onset was noted in a 4-year-old girl. A monosymptomatic<br />

onset was present in 16 children (64%), a polysymptomatic<br />

onset in 9 (36%). The initial symptoms were<br />

retrobulbar neuritis of the optic nerve, ataxia, isolated<br />

disturbance of sensation, facial nerve neuropathy, dyskinesia.<br />

A broad picture of MS developed by the age of 2<br />

months–9 years from the onset, 21 within the first 2 years<br />

(84%). At the onset of the disease a remittent course with<br />

frequent exacerbations, twice to four times a year, prevailed.<br />

Follow-up in these children was studied during 2–12 years<br />

(7.1 years the average). A remittent course persisted in 17<br />

children; in seven patients the course had a secondary<br />

progressive character. A primary progressive course was<br />

noted in one case. At the stage of the first MS manifestations,<br />

MRI abnormalities were revealed in 58.3% of cases,<br />

an increase up to 77% was seen at 5 years. Immunologic<br />

studies during exacerbation showed a decrease in the<br />

content of CD3 1 , CD4 1 , CD8 1 – cells of blood and<br />

increase in the level of circulating immune complexes. The<br />

number of CD8 1 – cells increased and the ratio of CD4/<br />

CD8 decreased when reaching the stage of remission.<br />

Immunogenetic studies of class I HLA-antigens demonstrated<br />

an increase in HLA-B12 incidence in patients in<br />

comparison with controls (P , 0:025; RR ¼ 6.29).<br />

FP-G-042<br />

Brainstem encephalitis and acute disseminated<br />

encephalomyelitis following mumps<br />

F.M. Aynaci a , A. Ayvaz a , A. Ahmetoglu b<br />

Karadeniz Technical <strong>University</strong>, Faculty of Medicine,<br />

a Department of Child Neurology and b Radiology, Trabzon,<br />

Turkey<br />

A previously healthy 4 years 3 month old female developed<br />

brainstem encephalitis with clinical manifestations<br />

including fever, decreased level of consciousness, left facial<br />

and abducens paralysis, and midriasis of the left eye 1 week<br />

after bilateral swelling of the parotis and submandibular<br />

regions. Twenty days after remission of encephalitis,<br />

marked ataxia, dysarthria and fever became apparent. MRI<br />

revealed multiple hyperintense lesions which were<br />

increased in size when compared with MRI at admission.<br />

High dose MPZ therapy was started and followed with<br />

decreased MPZ doses for 2 months. Two weeks after beginning<br />

MPZ, ataxic symptoms resolved. Within 48 days, she<br />

was able to walk with support. Today, now in her 8th month<br />

of illness she has no neurological deficit.<br />

FP-G-043<br />

Reverse Shapiro’s syndrome – an unusual cause of fever<br />

of unknown origin<br />

K.-L. Lin, H.-S. Wang<br />

Division of Pediatric Neurology, Chang-Gung Children’s<br />

Hospital, Taoyuan, Chinese Taipei<br />

Shapiro et al. first described two cases of recurrent spontaneous<br />

hypothermia associated with agenesis of the corpus<br />

callosum (Shapiro’s syndrome). Here we report a girl<br />

presenting with fever of unknown of origin who had<br />

complete agenesis of the corpus callosum. The same condition<br />

had been reported by Hirayama et al. called ‘reverse<br />

Shapiro’s syndrome’. This 9-month-old girl had had the<br />

symptom of periodic hyperthermia since the age of 7<br />

months. On examination, she had mild hypotonia with<br />

delayed developmental milestones. No other neurological<br />

or physical abnormalities were noted besides the callosal<br />

agenesis. Investigations for her prolonged fever including<br />

complete blood cell counts, peripheral blood smear, serum<br />

electrolyte levels, urinalysis, renal function, liver enzyme<br />

levels, thyroid function, immunologic work-up (C-reactive<br />

protein, rheumatoid factor), as well as radiology were<br />

normal. Thus, hidden infections, collagen vascular disease,<br />

hematologic diseases, malignancy, and thyroid dysfunction


Abstracts 479<br />

were carefully excluded as the cause of her periodic<br />

hyperthermia. Whole body Gallium-67 scan revealed no<br />

active inflammatory focus. Hormonal studies were normal.<br />

Her electroencephalogram was normal. According to the<br />

observation of previous literature, we suggest that periodic<br />

hyperthermia in this girl is caused by the dopaminergic<br />

denervation of the hypothalamic thermoregulatory center.<br />

We tried a dopamine agonist (levodopa with carbidopa) in<br />

this girl but failed to control the hyperthermia.<br />

FP-G-044<br />

Neonatal bacterial meningitis in southern Taiwan:<br />

epidemiologic trends and prognostic factors<br />

C.-J. Chang<br />

Department of Pediatric Neurology, Chang Gung Memorial<br />

Hospital (Kaohsiung), Kaohsiung Hsien, Chinese Taipei<br />

In two investigative phases over a 16-year study period<br />

(1986–2001), 60 neonatal patients (under 28 days) were<br />

studied. Normal and mildly abnormal were considered<br />

good outcome. Group B streptococci were the most<br />

common causative pathogens, accounting for about 32%<br />

of the episodes. Escherichia (E) coli, the second common<br />

pathogen, was more frequently noted in the second time<br />

period. Moreover, 73% of E. coli strains and 10% of<br />

Group B streptococci isolates were resistant to ampicillin.<br />

The overall mortality rate was 10%. However, if those with<br />

poor outcomes were considered, 38% would be considered<br />

treatment failures. Significant prognostic factors included<br />

the presence of seizures, thrombocytopenia, high CSF<br />

protein concentration, and low CSF glucose concentration.<br />

Initial empirical antibiotics with third-generation cephalosporins<br />

should be considered for the majority of meningitis<br />

cases resulting from infection with Gram-negative bacilli<br />

and streptococcal species. Despite the availability of<br />

newer and more potent antibiotics, the outcome of neonatal<br />

bacterial meningitis remains unsatisfactory. There has been<br />

increasing incidence for the emergence of resistant strains<br />

presenting a therapeutic challenge in resent years. Early<br />

diagnosis and choice of appropriate antibiotics according<br />

to in vitro antimicrobial susceptibility and epidemiologic<br />

trends are essential to maximize the potential for survival.<br />

FP-G-045<br />

The use of intravenous immunoglobulin in subacute<br />

sclerosing panencephalitis: a retrospective cohort study<br />

M.B. Lukban, B.C. Chua, A.M. Salonga, M.L. Bolanos,<br />

B.C. Sanchez<br />

Section of Pediatric Neurology, Departments of Neurosciences<br />

and Pediatrics, <strong>University</strong> of the Philippines-Philippine<br />

General Hospital, Manila, Philippines<br />

In the search for a treatment for SSPE, Gurer et al. in 1996<br />

reported the successful use of IVIg in SSPE. A retrospective<br />

cohort study was done to compare the clinical outcome of<br />

SSPE patients who received IVIg to those who did not<br />

(control group). The clinical stages before the initiation of<br />

IVIg treatment and serially after from 1 to 36 months were<br />

noted. For patients in the control group, their clinical<br />

outcome was followed from the approximate time of treatment<br />

in the IVIg group (mean ¼ 7 months of illness). Clinical<br />

outcome parameters noted were improvement in the<br />

clinical staging, stabilization of the illness, and deterioration<br />

in staging. There were 33 patients in the IVIg group with a<br />

mean age of 9.8 years. The control group had 26 patients<br />

with a mean age of 10.1 years. Among patients in stages 1<br />

and 2 of the disease, 31% (5/16) improved within 1 until 6<br />

months of the treatment as compared to 0% (0/12) in the<br />

control group. Among patients in stages 3 and 4 of the<br />

disease, 12% (2/17) in the IVIg group improved within 1<br />

month of the treatment however, this decreased to 6% (1/17)<br />

by 6 months from treatment whereas none improved in the<br />

control group. The use of IVIg in SSPE may produce a<br />

transient improvement in the clinical staging of the disease<br />

for up to 6 months among patients in the earlier stages of the<br />

disease.<br />

FP-G-046<br />

Risk factors for the development of subacute sclerosing<br />

panencephalitis among pediatric patients in the<br />

Philippine General Hospital<br />

B.C. Chua, A.M. Salonga, M.B. Lukban, B.C. Sanchez<br />

Section of Pediatric Neurology, Departments of Neurosciences<br />

and Pediatrics, <strong>University</strong> of the Philippines-Philippine<br />

General Hospital, Manila, Philippines<br />

SSPE is a late complication of measles infection the incidenceofwhichappearstobeincreasinginthePhilippines.The<br />

risk factors for the development of SSPE still remain undetermined.<br />

The medical records of the pediatric patients diagnosed<br />

with SSPE in the Philippine General Hospital from<br />

July 1998 to June 2001 were reviewed to determine the risk<br />

factors for the development of SSPE. The subjects for the<br />

control group are children without SSPE seen in the outpatient<br />

follow-up clinic unrelated to the SSPE subjects. Information<br />

on sex, race, family size, birth order, socio-economic status,<br />

residence, educational attainment of parents, medical history,<br />

nutritional status and circumstances surrounding the initial<br />

measles infection of the patients were obtained. The Chisquare<br />

test was used to analyze the relationship between<br />

these factors and the development of SSPE. Thirty-four<br />

patients were included in the SSPE group and 29 patients in<br />

the control group, with a male to female ration of 1.43:1 in the<br />

SSPE group and 1:1.6 in the control group. Among the factors<br />

analyzed, children who contracted measles at less than 24<br />

months of age have a statistically significant increased risk<br />

of developing SSPE ( £ 2 value-8.94, P ¼ 0.001). Male sex, a<br />

history of a sibling who contracted measles at the same time as<br />

the patient did, and the absence of measles immunization can


480<br />

Abstracts<br />

beconsideredasriskfactors,however,thevaluesarrivedatdid<br />

not reach statistical significance. This may be due to the small<br />

sample size.<br />

FP-G-047<br />

Levels of IL1, IL6, and IL8 in serum in viral encephalitis<br />

in children<br />

J. Zhang<br />

Department of Neurology Hunan Children’s Hospital,<br />

Hunan, China<br />

Objectives: Viral encephalitis (VE) is one of the most<br />

frequent infectious diseases of the central nervous system<br />

in children. The prognosis is closely associated with the<br />

severity of the infection. In order to identify the related pathogens<br />

of the infection, we tested the levels of cytokines IL1,<br />

IL6, and IL8 in serum of the patients with viral encephalitis.<br />

Methods: Twenty three patients admitted to the neurology<br />

department of our hospital were randomly selected, as well as<br />

30 normal healthy children. We took blood samples from all<br />

participants early in the morning before they took any food.<br />

ELISA was used to test the levels of IL2, IL6, and IL 8 in<br />

serum. Results: IL1, IL6, and IL8 in the VE patients were<br />

significantly higher than those in the normal controls<br />

(P , 0:001). Conclusion: The higher levels of IL1, IL6,<br />

and IL8 in serum from children with VE indicated that<br />

viral infection and following brain injury may activate<br />

microglial cells to produce IL1. IL1 may stimulate microglial<br />

cells or astrocytes to express IL6 and IL8. All this cytokine<br />

activation may induce secondary neural cell injury and make<br />

more severe functional defects of the central nervous system.<br />

FP-G-048<br />

Effect of heat shock response on brain tissue in rats with<br />

infectious brain edema<br />

D.-A. Mao<br />

The Second Xiang-Ya Hospital of Central South <strong>University</strong>,<br />

Changsha, China<br />

Objective: To explore the effect of heat shock response on<br />

brain tissue in rats with infectious brain edema. Methods:<br />

Sprague–Dawley (SD) rats were randomly divided into<br />

three groups: control group, normal saline treated rats (NS)<br />

and infectious brain edema (PB) group. The rats were administered<br />

pertussis bacilli (PB, 0.2 ml/kg) injected into left<br />

ICA without pretreatment. In the pretreatment with heat<br />

shock (HS 1 PB) group, the rats were pretreated with heat<br />

shock before being injected with PB into left ICA. The rats<br />

were killed at 8, 24 h after injected PB or NS, respectively.<br />

The WC, cations of Na 1 and K 1 in the brain tissue were<br />

measured and the morphological changes were studied by<br />

electron microscopy. Results: The WC and Na 1 content<br />

were significantly decreased in the HS 1 PB group<br />

compared to the PB group (P , 0:01). The K 1 content in<br />

HS 1 PB group was significantly higher than those in the<br />

PB group at all time points except for 24 h (P , 0:01). The<br />

electron microscope revealed that neurons were severely<br />

swollen and the nuclei were slight pyknotic in PB group at<br />

8 h, the processes of astroglial cells were moderately swollen,<br />

mitochondria of neurons were enlarged in HS 1 PB group at<br />

8 h. Dark cells and broken astroglial cells characterized cells<br />

of PB group at 24 h. Dark cells and light cells, processes of<br />

astroglial cells of perivascular region were severely swollen<br />

and neuronal cells widened in HS 1 PB group at 24 h.<br />

Conclusions: Heat stress response had a neuroprotective<br />

effect on the infectious brain edema in rats, the effect may<br />

be associated with the reduction of WC, Na 1 content and<br />

enhancement of K 1 content.<br />

FP-G-049<br />

Clinical evaluation of high dosage intravenous<br />

immunoglobulin on treatment of acute paralysis in<br />

children<br />

S.-H. Guo, R.-M. Hu, R.-P. Sun<br />

Department of Pediatrics, Qilu Hospital of Shandong<br />

<strong>University</strong>, Jinan, China<br />

Objective: To evaluate the clinical effects of high dosage<br />

intravenous immunoglobulin on treatment of acute paralysis<br />

in children. Methods: 72 cases of admitted acutely paralyzed<br />

children were randomly divided into two groups. There were<br />

42 cases in the experimental group, which were given high<br />

dosage intravenous immunoglobulin (400 mg/kg per day for<br />

5 days). There were 30 cases in the control group, which were<br />

given regular treatment. We compared the recovery period of<br />

muscle force and the duration of hospitalization in the two<br />

groups. Result: The recovery period of muscle force of the<br />

experimental group was shorter than the control group<br />

(3.18 ^ 1.38 versus 12.94 ^ 5.19 days P , 0:01). The average<br />

duration of hospitalization of the experimental group was<br />

shorter than that of the control group (14.45 ^ 4.18 versus<br />

21.49 ^ 5.83 days; P , 0:01). The experimental group had<br />

excellent results during an average of 3 months follow-up.<br />

The validity rate in the experimental group was higher than<br />

that of the control group (95.2 versus 86.6%). Conclusion:<br />

Application of high dosage intravenous immunoglobulin in<br />

acutely paralyzed children can increase cure rate and shorten<br />

the average duration of hospitalization. IVIG should be<br />

broadly used in acute paralyzed children.<br />

FP-G-050<br />

Clinical evaluation of the role of ancillary investigations<br />

in the diagnosis of cerebral cysticercosis in 51 patients<br />

G.-L. Li a , D.-Y. Zhou a , X. Yan b<br />

a Harbin Children’s Hospital, Harbin, and b No. 203 Hospital<br />

of P.L.A, Qiqiha’er, China<br />

Objective: To evaluate ancillary investigations in the


Abstracts 481<br />

diagnosis of patients with cerebral cysticercosis. Method:<br />

We reviewed and analyzed ancillary investigations including<br />

cysticercosis skin test (N: 38), cranial MRI (N: 13),<br />

cranial CT scan (N: 45) and strengthened cranial CT scan<br />

(N: 42) in 51 patients diagnosed with cerebral cysticercosis.<br />

Results: Thirty eight cases had the cysticercosis test and 20<br />

of them were positive, with the sensitivity rate 52.6% and<br />

specificity rate 100%. The sensitivity and specificity of<br />

cranial MRI/CT scan and strengthened cranial CT scan to<br />

the low density areas in the brain were 84.6, 44.4 and 100%,<br />

respectively. Our data showed that cranial CT scan had<br />

poorer specificity in the diagnosis of cerebral cysticercosis<br />

but strengthened cranial CT scan was much better in showing<br />

low-density areas of cerebral cysticercosis. Conclusion:<br />

Strengthened cranial CT scan may be used as a good method<br />

in the diagnosis of cerebral cysticercosis.<br />

FP-G-051<br />

Study on the damage to peripheral nerves induced by<br />

Campylobacter jejuni exotoxin<br />

L.-S. Xie, F.-C. Cai<br />

Department of Neurology, Children’s Hospital, Chongqing<br />

<strong>University</strong> of Medical Sciences, Chongqing, China<br />

To explore the pathogenesis of the damage to peripheral<br />

nerves induced by C. jejuni exotoxin (CJT), the CJT was<br />

extracted from Penner’s serotype 19 of the bacterium and<br />

injected perineurally and intravenously in Wistar rats,<br />

respectively. The animals were sacrificed and their sciatic<br />

nerves were examined for teased fibers, transverse section<br />

with toluidine blue stain and electron microscopy; sections<br />

of sciatic nerves in either normal rats or humans were preincubated<br />

with CJT and the pathological sciatic nerves<br />

induced by CJT were obtained for observation of the binding<br />

capability of CJT with peripheral nerves by streptavidinbiotin-peroxidase<br />

complex (SABC) and FITC-immunofluorescent<br />

methods, and nucleic acid hybridization techniques<br />

for detection of TNF-a mRNA expression in<br />

pathological sciatic nerves samples. The results showed:<br />

(1) pathological changes were identified in 76.8% of teased<br />

fibers after perineural injection, but only 9.6% fibers were<br />

damaged in the control group (P , 0:01). The fiber damage<br />

(19.5%) was found on the 3rd day after CJT intravenous<br />

injection, and abnormalities still in 15.5% on the 14th<br />

day. However, no abnormal changes were demonstrated in<br />

the control group, and in the groups with the injection of<br />

anti-CJT sera and the supernatants of peripheral blood<br />

mononuclear cells (PBMCs) (P . 0:05). (2) Positive<br />

combination of CJT was found predominantly in the sciatic<br />

nerves of normal rats or humans incubated with CJT and<br />

also in the pathological sciatic nerves induced by CJT.<br />

Conclusion: CJT could remarkably damage the peripheral<br />

nerves in rats, but the immunological pathogenicity of CJT<br />

could not be demonstrated in the nerves of rats after immunization<br />

with CJT.<br />

FP-G-052<br />

Levels of b-EP in serum and cerebrospinal fluid and<br />

changes in erythrocytes immunological function in<br />

children with nervous system infectious diseases<br />

Y. Chen, X.-H. Wang, Q.-Y. Meng<br />

Department of Pediatrics. The First Affiliated Hospital of<br />

Jiamusi <strong>University</strong>, Jiamusi, China<br />

Objective: To study the levels of b-EP in serum and<br />

cerebrospinal fluid and the changes in erythrocytes immunological<br />

function in children with nervous system infectious<br />

diseases. Methods: Fifty-six children with nervous<br />

system infectious diseases (observation group) and 44<br />

aged-matched children with no nervous diseases (control<br />

group) were selected. Their levels of b-EP in serum and<br />

cerebrospinal fluid, ECR1 and their nitrate reductase<br />

(NtrR) were assayed. Results: The levels of b-EP in serum<br />

in the observation group were higher than in the control<br />

group (P , 0:001). The levels of b-EP in cerebrospinal<br />

fluid in the observation group were higher than that in the<br />

control group too. Compared with the control group, the<br />

quantity of ECR1 showed no obvious changes (P . 0:05)<br />

and NTRR decreased in the observation group (P , 0:001).<br />

The more severe the disease condition was, the higher the<br />

levels of b-EP in serum and cerebrospinal fluid were, and<br />

the lower the NTRR was. Conclusion: b-EP had dual regulation<br />

of erythrocytes immunological function, and both of<br />

them related to the disease condition. Because the levels of<br />

b-EP in serum and cerebrospinal fluid rose in children with<br />

nervous system infectious diseases, their erythrocyte immunological<br />

function was suppressed.<br />

FP-G-053<br />

A case of streptococcus acidominimus meningitis<br />

Q. Zhen<br />

Department of Pediatrics, Anhui Provincial Corps Hospital,<br />

Hefei, China<br />

A 2-year-old boy had chopsticks poked into his pharynx,<br />

which left a small hole in his pharynx. Next day, he had a<br />

fever, cough and whoop with a convulsion. White blood cells<br />

were increased. Chest X-ray showed bronchopneumonia.<br />

Fever, cough and whoop disappeared after treatment by penicillin<br />

and ampicillin for 20 days. Chest X-ray was normal.<br />

However, the child became agitated and irritable. Hypertonia<br />

was found in his right limbs. He was unable to stand and hold.<br />

Five days later, fever relapsed. The patient received penicillin,<br />

ampicillin and chloromycetin intravenous infusion for 10<br />

days. Symptoms had not remitted. Therefore, he was transferred<br />

to our hospital. Temperature was 39.18C. No neck<br />

stiffness was found. Right Babinski sign was positive.<br />

Peripheral WBC was 23.5 £ 10 9 /l, with neutrophils (N)<br />

87%, lymphocytes (L) 10%, eosinophils (E) 1%, monocytes<br />

(M) 2%. CSF was turbid, with the WBC 4050 £ 10 6 /l, includ-


482<br />

Abstracts<br />

ing N 95%, L 5%. In CSF, the protein was 540 mg/l, glucose<br />

0.8 mmol/l, chloride 120 mmol/l. Streptococcus acidominimus<br />

were found in the CSF culture. The child was treated<br />

with ceftriaxone 1.0/day, dexamethasone 2.5 mg/day intravenously.<br />

He was better from 2 days after treatment. The<br />

temperature declined to 37.48C after 4 days treatment. But<br />

2 days later, the temperature was up to 398C. He was irritable<br />

again. The parents of child gave up treatment. Streptococcus<br />

acidominimus belongs to the group of Streptococcus viridans.<br />

It is a Gram 1ve coccus. It resides in respiratory tract<br />

and enteric tract of human being. Streptococcus acidominimus<br />

is a low-virulent pathogen. It is seldom that Streptococcus<br />

acidominimus causes meningitis.<br />

FP-G-054<br />

A case of cryptococcosis accompanying ascariasis of the<br />

biliary tract<br />

X.-D. Wang<br />

Department of Pediatrics, The Chinese People’s Armed<br />

Police Forces Hospital, China<br />

We treated a patient with cryptococcosis accompanying<br />

ascariasis of the biliary tract in June, 1996. A boy, 6 years<br />

old, came from the countryside of Henan province. His chief<br />

complaints were abdominal pain and jaundice for 70 days,<br />

and headache, vomiting, cough and fever for 40 days. Physical<br />

examination found a large head circumference, about 58<br />

cm, a 1 cm long skin lesion on the top of his head and a<br />

setting-sun eye sign. The left eye had strabismus. His neck<br />

was stiff. The liver was palpable at 4 cm below the costal<br />

margin. Deep tenderness was found in the right upper quadrant<br />

of the abdomen. The muscle strength of limbs was<br />

grade IV. Knee and ankle reflexes were weak, Kernig’s<br />

and Brudzinski’s sign were positive. Laboratory examination:<br />

cryptococcus was found in CSF and secretion of skin<br />

lesion. Cranial CT showed a low density lesion. Ultrasonogram<br />

showed ascariasis of the biliary tract. Treatment:<br />

amphotericin B associated with 5-flucytocin was used to<br />

treat cryptococcosis. One month later, his general condition<br />

was obviously better. The setting-sun sign disappeared. The<br />

skin lesion and cough were cured. His neck was flexible.<br />

Cryptococcus had not been found in CSF for three consecutive<br />

examinations. Cranial CT demonstrated that the low<br />

density lesion disappeared completely.<br />

FP-G-055<br />

Outbreak of Coxsackie virus B meningitis in Xuzhou<br />

district of China<br />

B.-Q. Yuan, H. Cheng, A.-H. Guo, M. Lu, T.-Y. Xie, L.<br />

Pang, S.-G. Lu<br />

Department of Pediatrics, The Affiliated Hospital of Xuzhou<br />

Medical College, Xuzhou, China<br />

An outbreak of aseptic meningitis due to Coxsackie virus<br />

B occurred in the Xuzhou district, north of Jiangsu in China,<br />

during May–August 2001, with 262 cases fitting the clinical<br />

case definition. Medical files were reviewed and a standard<br />

questionnaire administered. Viral PCR including Coxsackie<br />

virus B, echovirus, encephalitis B virus and adenoviruses<br />

were performed on cerebrospinal fluid. Meanwhile indirect<br />

immunofluorescence assays were made on serum. Coxsackie<br />

virus B was isolated in 39 of 75 (52%) cerebrospinal fluid<br />

specimens with RT-PCR and 69.8% of 254 cases in serum.<br />

The clinical presentation and laboratory findings were typical<br />

of viral meningitis. Cases were aged 28 days to 49 years;<br />

90% of patients were aged around 3 years. Headache was<br />

present in 20%, photophobia in 10%, vomiting in 40%,<br />

fever in 80%, and neck stiffness in 36.8%. A total of 10%<br />

of cases had seizures, and 84.5% of cases had abnormal EEG.<br />

One case died and other patients got well. In spite of temporal<br />

clustering, the mode of transmission in this outbreak<br />

remained speculative. Respiratory transmission was possibly<br />

responsible for this outbreak of Coxsackie virus B meningitis.<br />

FP-G-056<br />

A clinical values of NSE, NO/NOS changes in<br />

cerebrospinal fluid in patients with various nervous<br />

system diseases<br />

Z. Huang, Q. Chen, C.-F. Zai<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences Chongqing, China<br />

Objective: To determine both NSE and NO/NOS in CSF.<br />

We also investigated their regular changing pattern, their<br />

relationship, their influence on the originating, developing<br />

and recovering of various nervous system diseases. Their<br />

clinical values were illustrated. Methods: A total of 115<br />

cases with nervous system diseases including 18 GBS, 30<br />

epilepsy, 28 bacterial meningitis and 40 acute viral encephalitis<br />

were studied. Twenty age-matched children with<br />

normal neurologic development were taken as the control<br />

group. NSE and NO/NOS levels in CSF were studied by<br />

ELISA enzymo-immunoassay and Griess chemical colorimetric<br />

methods, respctively. Results: (1) NSE, NO/NOS<br />

levels in CSF were significantly higher in all disease groups<br />

(5.309 ^ 0.59 , 11.91 ^ 4.28 ng/ml, 2.45 ^ 0.58 , 6.89<br />

^ 0.89 mmol/ml, 4.44 ^ 0.89 , 12.60 ^ 2.10 mmol/ml<br />

per min, respectively) than those of the control group<br />

(4.11 ^ 0.431 ng/ml, 1.90 ^ 0.41 mmol/ml, 2.82 ^ 0.65<br />

mmol/ml per min). (2) The CSF-NSE levels were at highest<br />

level in the bacterial meningitis group (11.91 ^ 4.28 ng/ml),<br />

and NO/NOS levels in CSF were at highest level in the<br />

epilepsy group (6.89 ^ 0.89 mmol/ml, 12.6 ^ 2.10 mmol/<br />

ml per min). (3) NSE to NO, NSE to NOS and NO to<br />

NOS in CSF changes were markedly correlated<br />

(r ¼ 0:57 , 0:78, P , 0:05 , 0:01) in all groups of<br />

subject. Conclusion: (1) NSE, NO/NOS levels in CSF<br />

were elevated to varying degrees in patients with nervous


Abstracts 483<br />

system diseases. These illustrated the definite neuronal and<br />

glial cell damage in these diseases, including GBS, epilepsy,<br />

bacterial meningitis and acute viral encephalitis. (2) As the<br />

biological marker of living neurons, NSE and NO/NOS CSF<br />

changes correlated (r ¼ 0:57 , 0:78, P , 0:05 , 0:01).<br />

That indicated that they all play an important role in<br />

diseases’ originating and developing course. (3) NSE levels<br />

in bacterial meningitis and epilepsy were highest, associated<br />

with the highest levels of NO/NOS. This implied the most<br />

serious neuronal and glial cell damage, NO/NOS might<br />

make this damage more serious by their cytotoxic effects.<br />

In GBS, mainly due to immunological damage of axon and<br />

myelin of peripheral nerves, the neuronal damage was not<br />

serious, so NSE levels were elevated mildly, as were NO/<br />

NOS levels.<br />

FP-G-057<br />

A child with acute pandysautonomia: recovery after two<br />

courses of intravenous high-dose immunoglobulin<br />

therapy<br />

M. Ishitobi, K. Haginoya, T. Kitamura, M. Munakata, H.<br />

Yokoyama, K. Iinuma<br />

Department of Pediatrics, Tohoku <strong>University</strong> School of<br />

Medicine, Miyagi, Japan<br />

Acute pandysautonomia is a rare disorder, characterized<br />

by acute dysfunction of the autonomic nervous system with<br />

history of preceding infection. It is recently recognized as a<br />

neuroimmunologic disorder like Guillain-Barre syndrome,<br />

and is occasionally treated with IVIG. Here we report a<br />

previously healthy 11 year-old boy, who suffered from<br />

severe orthostatic hypotension after a febrile episode.<br />

Serial examination of the orthostatic test and coefficient<br />

of variation in the R-R intervals showed complete recovery<br />

after two courses of IVIG, which were given 3 months<br />

from the onset. One or more courses of IVIG should be<br />

considered to treat this disorder without spontaneous<br />

remission.<br />

FP-G-058<br />

Availability of cerebrospinal fluid ferritin for early<br />

diagnosis of bacterial meningitis in children<br />

Y.-O. Kim, Y.-J. Woo, M.-H. Youm, E.-Y. Kim<br />

Department of Pediatrics, Chonnam <strong>University</strong> Hospital,<br />

Kwangju, Korea<br />

Purpose: To determine the normal CSF ferritin level<br />

according to age and the cut-off value for early diagnosis<br />

of bacterial meningitis. Methods: 203 children (27 weeks<br />

gestation to 16 years old) were classified into four groups:<br />

non-meningitis (73), aseptic meningitis (76), bacterial<br />

meningitis (26), and bacterial meningitis suspected group<br />

(28). WBC, protein, glucose and ferritin in CSF were<br />

analyzed in each group. Results: CSF ferritin level in the<br />

bacterial meningitis group was significantly higher than in<br />

the non-meningitis group or the aseptic meningitis group.<br />

The CSF ferritin had positive correlation with WBC and<br />

protein in CSF, but negative with CSF glucose<br />

(P , 0:01). The CSF ferritin decreased up to 1 year old<br />

but was not related to age over 1 year in the non-meningitis<br />

group. For early diagnosis of bacterial meningitis, 15.58 ng/<br />

ml was considered as the appropriate cut-off value of CSF<br />

ferritin with a sensitivity of 96.2% and a specificity of<br />

96.6% in this study. Conclusion: The normal CSF ferritin<br />

level according to age was determined and it showed<br />

decreasing levels up to 1 year old including the premature.<br />

CSF ferritin level of 15.58 ng/ml was considered as an<br />

appropriate cut-off value for discriminating bacterial meningitis.<br />

FP-G-059<br />

Enterovirus 71 infection with severe neurological<br />

complications<br />

M.A. Nolan, M. Lahra, M. Craig, P.C. Prager, W.D.<br />

Rawlinson, G.D. Williams, P.I. Andrews<br />

Sydney Children’s Hospital, Sydney, Australia<br />

Enterovirus 71 (EV71) is a picornavirus. It is usually<br />

associated with hand, foot and mouth disease, a mild,<br />

self-limiting febrile illness. Neurologic complications are<br />

infrequent but include aseptic meningitis, acute flaccid<br />

paralysis (AFP) and brainstem encephalitis (BSE). A<br />

distinctive syndrome due to invasive EV71 infection in<br />

infants and young children has emerged. It is characterised<br />

by acute neurogenic pulmonary edema (PE), acute respiratory<br />

failure, BSE, AFP and characteristic MRI signal<br />

abnormalities in pons, medulla and spinal cord, and is<br />

almost universally fatal. We describe seven patients with<br />

this distinctive syndrome who survived the acute illness.<br />

The acute cardiopulmonary crisis was managed with<br />

mechanical ventilation, aggressive after load reduction<br />

and moderate inotrope support. Other acute therapies<br />

included pleconaril (anti-enteroviral agent, unproven activity<br />

against EV71; n ¼ 4), high-dose intravenous steroids<br />

(n ¼ 4) and IVIG (n ¼ 3). Variable neurological improvement<br />

occurred within the first 2 months. The six patients,<br />

who have survived at least 18 months, have severe, residual,<br />

motor dysfunction, including flaccid paresis of one or<br />

more limbs, cranial nerve palsies and ventilatory failure,<br />

with preserved cognition and sensation. Residual motor<br />

deficits are consistent with persistent MRI signal abnormalities<br />

in the respiratory centre and other regions of the<br />

brainstem, phrenic nerve nuclei, and anterior grey matter<br />

of the spinal cord. Clinical improvement after the first 12<br />

months has been limited, and four require ongoing ventilatory<br />

support. At least three epidemics of EV71 infection<br />

associated with this syndrome have occurred in the last 5<br />

years, and there is great need for effective immunisation<br />

and specific therapy.


484<br />

Abstracts<br />

FP-G-060<br />

Spastic paraparesis and encephalpathy associated with<br />

HTLV-1 infection in Argentinian seronegative children<br />

L. Czornyj, A. Mangano, L. Sen, N. Fejerman<br />

Hospital de Pediatria ‘J.P. Garrahan’, Buenos Aires,<br />

Argentina<br />

Human T-cell leukemia virus-1 (HTLV)-1 has been associated<br />

with T cell-leukemia and myelopathy/tropical spastic<br />

paraparesis. There have been some reports of adult patients<br />

with spastic paraparesis (SP) and asymptomatic individuals<br />

carrying detectable tax sequences in PBMC but were<br />

HTLV-1 seronegative. We studied ten children (six girls<br />

and four boys) three with SP and seven with encephalopathy<br />

(E), who were referred for diagnosis of HTLV-1 infection<br />

by serologic and molecular assays. They had an average age<br />

of 43.9 months (ranging from 3 months to 16 years). Detection<br />

of antibodies to gag and env HTLV-1/2 was accomplished<br />

by gelatine particle agglutination and Western<br />

blotting test. HTLV tax and pol sequences were investigated<br />

by nested PCR amplification from PBMC, and then<br />

subtyped by RFLP for HTLV-1 and HTLV-2.All children<br />

were HTLV-1/2 seronegative. HTLV-1 tax sequence was<br />

present in the ten patients studied while the pol fragment<br />

was absent in the seven cases checked. Although preliminary,<br />

the presence of tax sequences in the absence of pol<br />

sequences and without detectable antibodies to HTLV-1<br />

gag and env in children with neurological disorders, may<br />

suggest an HTLV-1 infection with a defective provirus.<br />

FP-G-061<br />

Multiple sclerosis in children: a case series<br />

M.A.M. Prudencio, M.H. Ortiz, E.L. Avendaño<br />

Child Neuroscience Division, Philippine Children’s Medical<br />

Center, Quezon City, Philippines<br />

MS is a chronic relapsing, remitting disease characterized<br />

by neurologic symptoms referable to lesions disseminated<br />

throughout the neuraxis with a propensity for spontaneous<br />

improvement. This disease is rare among infants and children<br />

with an incidence of 2.7%. It is even rare in children<br />

less than 10 years of age. Three boys aged 4–9 years and one<br />

girl aged 15 years were diagnosed as having MS at the<br />

Philippine Children’s Medical Center (PCMC) within a 3<br />

year period (1996–1999). All presented with multiple<br />

neurologic deficits occurring with a relapsing and remitting<br />

course. Neurodiagnostic evaluations included the following:<br />

CSF IgG was elevated in two/four cases (50%) and abnormal<br />

evoked responses (visual evoked response, somatosensory<br />

evoked response, brainstem auditory evoked response)<br />

were noted in three/four cases (75%). Cranial MRI done in<br />

all patients showed presence of nodular lesions with<br />

increased T2 signals involving different areas of the white<br />

matter. Improvements were observed with steroid administration.<br />

FP-G-062<br />

Recurrent purulent meningitis in Thai children<br />

S. Chiemchanya, A. Visudtibhan, J. Patrungsri,<br />

P. Visudhiphan<br />

Division of Neurology, Department of Pediatrics, Faculty of<br />

Medicine, Ramathibodi Hospital, <strong>Mahidol</strong> <strong>University</strong>,<br />

Bangkok, Thailand<br />

Background: Recurrent purulent meningitis in children<br />

was rare and the diagnosis for the causes remained problematic.<br />

There were few reports concerning this illness in<br />

children. Objective: To study the causes of recurrent purulent<br />

meningitis in children. Method: A retrospective study<br />

was conducted by reviewing medical records of all pediatric<br />

patients who had purulent meningitis admitted at the<br />

Department of Pediatrics, Ramathibodi Hospital between<br />

January 1, 1977 and December 31, 1997. Result: Nineteen<br />

children were included in this study. There were 13 patients<br />

who had more than two episodes of purulent meningitis<br />

before presenting for evaluation. Seventeen children had<br />

anatomical defects, which were congenital CSF fistula (11<br />

children) and acquired diseases causing leakage of CSF (six<br />

children). Those with congenital fistula comprised five children<br />

with inner ear anomaly, five children with meningoceles,<br />

and one child with cribriform plate defect. Among<br />

those with acquired diseases, five had traumatic CSF fistula<br />

and the other had chronic otitis media. There were two<br />

children who did not have either demonstrable anatomical<br />

defect or immune deficiency disease. Streptococcus pneumoniae<br />

was the most common causative microorganism.<br />

During follow up evaluation ranging from 1 to 10 years,<br />

one child with temporal bone defect had recurrent meningitis.<br />

However, after second surgical treatment, there was no<br />

recurrence. Conclusion: Anatomical defect was the most<br />

common cause of recurrent purulent meningitis observed<br />

in this study. Complete investigation to exclude any congenital<br />

defect is recommended in children with recurrent purulent<br />

meningitis.<br />

FP-G-063<br />

Herpes simplex encephalitis in pediatrics diagnosed by<br />

CSF polymerase chain reaction: a report of three cases<br />

and review of literature<br />

A.L.F. Luat<br />

Child Neuroscience Division, Philippine Children’s Medical<br />

Center, Quezon City, Philippines<br />

HSE is an acute, devastating infection of the central<br />

nervous system that causes significant morbidity and<br />

mortality. The clinical presentation of HSE includes a<br />

syndrome of acute onset characterized by fever, headache,


Abstracts 485<br />

seizures, focal neurological signs and impaired consciousness,<br />

however, cases of atypical HSE have also been<br />

reported. Early diagnosis of HSE is important because it<br />

is the only viral infection of the central nervous system for<br />

which treatment has been proven effective in rigorous clinical<br />

trials. The diagnosis, however, is difficult because of<br />

the protean clinical manifestations and the inability to<br />

isolate virus from the cerebrospinal fluid. Both the detection<br />

of intrathecal HSV antibody and HSV antigen are<br />

retrospective means of establishing the diagnosis. Brain<br />

biopsy used to be the only means of making a definitive<br />

diagnosis of HSE. The development of PCR as a diagnostic<br />

procedure may contribute to the early diagnosis of HSE<br />

and, therefore, early initiation of treatment and better therapeutic<br />

outcome. We report three cases of pediatric HSE<br />

diagnosed by CSF PCR and treated with Acyclovir. The<br />

use of PCR may uncover a wider clinical spectrum of HSE<br />

than has been previously recognized.<br />

FP-G-064<br />

Acute severe pediatric central demyelination<br />

E. Shahar<br />

Child Neurology Unit, Rambam Medical Center, Haifa,<br />

Israel<br />

The different clinical presentations, medical therapy and<br />

current outcome are reported in a series of thirteen children<br />

diagnosed with acute severe central demyelination<br />

(ASCDM), namely acute disseminated encephalomyelitis<br />

(ADEM) or spinal cord multi-focal myelopathy (SMM):<br />

seven males and six females presenting at age of 2.5–14<br />

years (mean: 6.6). Four children developed ADEM,<br />

presenting with deteriorating alertness and developing<br />

coma along with cranial nerves and brainstem involvement,<br />

brisk tendon reflexes and extensor plantar responses.<br />

Seven children developed SMM with flaccid pyramidal<br />

weakness of limbs, mainly the lower limbs, of whom<br />

seven became bed-ridden, along with bladder and bowel<br />

incontinence, without apparent change in alertness. All<br />

ADEM patients were treated with high-dose methylprednisolone<br />

(HDMP), of whom three completely recovered<br />

within 5–7 days. An additional child, with combined<br />

myelo-radiculoneuropathy (MRN), also treated with<br />

IVIG, failed both therapies and remains handicapped. Of<br />

the seven bed-ridden SMM patients, six were initially treated<br />

with HDMP of whom five completely recovered within<br />

2–9 days (range: 5.83). The seventh patient with West Nyle<br />

Fever MRN, was also given IVIG but remains handicapped.<br />

Another patient with SMM initially failed oral<br />

steroids and subsequently fully recovered with IVIG. Overall,<br />

eight of eleven children with ASCDM, given HDMP<br />

completely recovered. Therefore, HDMP or IVIG, either<br />

given separately or even combined in protracted cases,<br />

seems to be efficacious in severe debilitating pediatriconset<br />

ASCDM with negligible adverse-effects.<br />

FP-G-065<br />

Bacterial meningitis during the season of flu epidemic<br />

Z. Milenkovic, K. Karovski, N. Pop-Jordanova, V.<br />

Markovski, P. Stojovska, R. Naumovski<br />

Clinic of infectious diseases, Faculty of medicine, Skopje,<br />

Macedonia<br />

In an open, randomized, controlled study on 118 patients<br />

with purulent meningitis (PM) treated at Clinic of infectious<br />

diseases in Skopje during the season of flu epidemic (test<br />

group, tg) in the last 5-year (1997–2002) period, some<br />

biochemical, clinical and microbiological characteristics<br />

have been analysed. The results obtained were compared<br />

with the findings of 186 patients with PM treated outside<br />

that period (control group, cg). The etiology of disease was<br />

confirmed by bacterial isolation from CSF in 55.6% of<br />

cases. The most frequent etiological agent in both groups<br />

was Str. pneumoniae. Biochemical and microbiological<br />

findings: lower initial CSF WBC count (898 ^ 788<br />

(87.7%) versus 1.699 ^ 1.008 (59.3%) £ 10 6 /l) with relatively<br />

higher CSF protein level (1.86 ^ 1.36 (73.1%) versus<br />

2.06 ^ 1.46 (70.9%) g/l) and higher percentage of presence<br />

of parameters of bacteriaemia (19.5 versus 16.7%), sepsis<br />

and septic shock (37.3 versus 32.8%), in tg were found.<br />

Clinical parameters: higher frequency of initially disturbed<br />

state of consciousness (32.2 versus 30.6%) and transitory<br />

neurological deficit (11.9 versus 8.6%), in the tg were found.<br />

Contrary to our expectations based on the biochemical, clinical<br />

and microbiological findings cited, the mortality rate<br />

was lower in tg (10.2 versus 13.4%).<br />

FP-G-066<br />

Subacute sclerosing panencephalitis (SSPE): summary<br />

of the California experience<br />

M. Philippart<br />

Brain Research Institute, UCLA, Los Angeles, USA<br />

Measles vaccination almost eliminated SSPE, which still<br />

presents challenges of diagnosis, treatment and pathophysiology.<br />

The natural course has been distorted towards the<br />

most severe cases, leading to early death. SSPE was<br />

confirmed in 26/29 cases evaluated since 1979. Six cases<br />

were born in California, two of them among four born in<br />

1989 during the 400-case Riverside epidemic; two in other<br />

States; 14 in Central America; one each in Belgium, Brazil,<br />

Canada, and the Philippines. Two died within 6 months.<br />

Fourteen with onset from 1965 to 2000 are still alive. One<br />

survives 25 years after onset without treatment. One with a<br />

Rasmussen presentation seems cured after a left hemispherectomy<br />

in 1989. Five received Inosiplex only: one, in stage 4,<br />

did not benefit but survived 8 years; one lived 20 years after a<br />

recovery to stage 1, lasting 10 years; one was lost to followup<br />

(F/U); one, who recovered to stage 2 for 8 years, is still<br />

alive 15 years after onset. One with no benefit from recom-


486<br />

Abstracts<br />

binant interferon has been 15 years in stage 4. Fifteen were<br />

treated with partially purified human interferon: four (stage<br />

4) did not benefit, two of them were lost to F/U; three died<br />

within 2 years of onset; three stabilized (9–15 years); five<br />

improved: two from stage 2 (6 months, 4 years); two from<br />

stage 3 (2 and 6 years), the last, who 6 months after onset sank<br />

to stage 4, had the quickest biological response, IgG synthesis<br />

rate/day falling from 59.6 to 6.8 mg (normal ,3.3).<br />

FP-G-067<br />

Atypical form of subacute sclerosing panencephalitis<br />

related to vaccine measles virus<br />

F.N. Arita, S. Rosemberg<br />

Santa Casa of Sao Paulo School of Medicine, Department of<br />

Pediatrics, Neuropediatrics Division, Sao Paulo, Brazil<br />

SSPE is a rare progressive inflammatory disease of the<br />

CNS caused by persistent mutant measles virus infection<br />

whose onset occurs several years after the primary infection<br />

in early life. Its occurrence fell dramatically after introduction<br />

of measles vaccine. However, a few vaccinal cases have<br />

been reported. It is estimated that this occurs at a rate of 0.5–1<br />

cases per million of applied doses of vaccin. We report three<br />

patients who had been vaccinated after the measles<br />

epidemics of 1997 in Sao Paulo State and presented an<br />

unusually early onset and rapid progressive course of the<br />

disease. At onset, the ages of the patients were 2 years, 2<br />

years 2 months, and 3 years, and all had been vaccinated,<br />

respectively, at 14 months, 16 months, and 2 years 2 months<br />

prior the onset. This third patient, however, had had measles<br />

infection at age of 9 months, 1 month before immunization.<br />

In all cases, the first symptoms consisted of frequent falls and<br />

periodic myoclonic jerks occurring every 5 or 10 s. The EEG<br />

showed typical periodic complexes. CSF protein electrophoresis<br />

showed levels of g-globulins above 30 mg.% and<br />

measles virus-specific antibodies were detected. The clinical<br />

course was characterized by a dramatically rapid progressive<br />

psycho-motor deterioration. In a few weeks all patients were<br />

bedridden and unresponsive to external stimuli. One patient<br />

died at 4 years 8 months of age and the others, aged 4 years 7<br />

months and 5 years 3 months, are alive in a vegetative state.<br />

These cases demonstrate that measles vaccine virus may<br />

provoke a special clinical form of SSPE in which the incubation<br />

period is short and the clinical course acute.<br />

FP-G-068<br />

Subacute sclerosing panencephalitis presenting with<br />

hemiparesis: a case report<br />

H. Ozyurek, A. Degerliyurt, G. Turanl<br />

Hacettepe <strong>University</strong>, Department of Pediatric Neurology,<br />

Ankara, Turkey<br />

Subacute sclerosing panencephalitis (SSPE) is a slow<br />

virus infection of the central nervous system characterized<br />

by myoclonic seizures, involuntary movements, and mental<br />

deterioration. SSPE is diagnosed with strikingly elevated<br />

levels of measles antibodies in the serum and CSF in addition<br />

to the clinical picture. Epidemiologic studies revealed<br />

that the age at onset of SSPE (7.6–5 years) decreased especially<br />

after 1995 in Turkey. In childhood, SSPE rarely<br />

present with focal neurologic signs. A 14-month-old girl<br />

was admitted because of intermittent fever and lethargy of<br />

2 months duration, followed by left-sided hemiparesis. Her<br />

past medical and family histories were unremarkable. Her<br />

motor and mental development was normal. There was no<br />

history of measles. During follow-up, firstly partial than<br />

generalized seizures developed in the patient. In cranial<br />

magnetic resonance, on T2-weighted images there was<br />

hyperintensity of frontoparietal cortex bilaterally and<br />

white matter especially in the right hemisphere. Electroencephalogram<br />

showed periodic paroxysmal activity characterized<br />

by suppression burst that did not disappear with<br />

diazepam. There was delay in the latencies of visual evoked<br />

potentials. Electroretinogram was normal. Urine sample for<br />

organic acids and lysosomal screening was negative. The<br />

lactic and pyruvic acid concentrations were normal in CSF.<br />

Serology for rubella and herpes type I was negative.<br />

Elevated measles antibody titers were detected in both<br />

serum and CSF by complement fixation (1/512 and 1/16,<br />

respectively). The patient was diagnosed with SSPE on<br />

laboratory findings. In summary, symptoms of SSPE may<br />

present as early as infancy like in Sour patient. Although<br />

focal neurological signs are mostly seen in adults with<br />

SSPE, they rarely may be a component of SSPE in childhood.<br />

Thus one should also consider SSPE in infants with<br />

focal neurological signs.<br />

FP-G-069<br />

Long-term follow-up of a patient with subacute<br />

sclerosing panencephalitis successfully treated with<br />

intrathecal interferon alpha<br />

M. Miyazaki a,b , M. Nishimura a , Y. Toda a , T. Saijo a ,K.<br />

Mori a , Y. Kuroda a<br />

a Department of Pediatrics, Tokushima <strong>University</strong> School of<br />

Medicine, Tokushima; b Miyoshi Medical Clinic, Kagawa,<br />

Japan<br />

We previously reported that a patient with SSPE was<br />

successfully treated with intrathecal interferon alpha (IFNa)<br />

and his pronounced improvement was observed in a<br />

dose-dependent manner (Ann Neurol 1991). To clarify<br />

long-term effects of IFN-a in SSPE, we followed up the<br />

patient for 17 years with neuroradiological and physiological<br />

examinations. He was diagnosed with SSPE at age 8<br />

years and treated weekly or fortnightly with 1.0 to<br />

3.0 £ 106 IU IFN-a by intrathecal route. IFN-a therapy<br />

induced remission of SSPE and he maintained a higher<br />

quality of life for approximately 8 years compared with<br />

other SSPE patients. At age 16 years, he gradually devel-


Abstracts 487<br />

oped muscle rigidity, gait disturbance and difficulty in<br />

speech. Increasing the dose of IFN-a to 5 £ 106 IU and<br />

changing to IFN-a brought no remarkable benefit. Currently<br />

he is a malnourished 25-year-old male with akinetic mutism<br />

who barely responds to loud sounds and strong painful<br />

stimulation. The electroencephalogram shows diffused low<br />

voltage fast activity without a-rhythm, and brain CT scan<br />

discloses severe brain atrophy in the cerebellum and brainstem,<br />

as well as linear high density along the circle of Willis.<br />

These results may indicate that IFN-a-induced remission is<br />

most likely to be temporary, even if an SSPE patient shows<br />

an excellent initial response to the treatment. To improve<br />

the long-term prognosis of SSPE patients, more effective<br />

therapy, such as a combination of IFN-a with novel agents,<br />

still needs to be developed.<br />

FP-G-070<br />

CXCL10 production from cytomegalovirus-stimulated<br />

human microglia: regulation by interleukin-10<br />

S. Hu, M.C.-J. Cheeran, S.L. Yager, P.K. Peterson, J.R.<br />

Lokensgard<br />

Neuroimmunology Laboratory, Minneapolis Medical<br />

Research Foundation; and the <strong>University</strong> of Minnesota<br />

Medical School, Minneapolis, USA<br />

Microglial cells orchestrate multi-cellular immune<br />

responses to viral infections of the central nervous system<br />

and synchronize various immune functions through a regulated<br />

network of cytokines and chemokines. Recruitment of<br />

T lymphocytes to local sites of infection is critical for resolution<br />

of cytomegalovirus disease. In the present study, we<br />

investigated the production of an alpha-chemokine<br />

CXCL10 (interferon-gamma inducible protein-10, IP-10)<br />

in response to CMV infection of glial cells and the regulation<br />

of its production by IL-10. We found that human microglial<br />

cells, but not astrocytes, produced CXCL10 in<br />

response to CMV, reaching maximal levels at 48–72 postinfection.<br />

Expression of CXCL10 mRNA in CMV-stimulated<br />

microglia was not dependent on secondary protein<br />

synthesis but did require replication competent virus. Activation<br />

of NF-kappa B and p38 MAP kinase in microglial<br />

cells was observed in response to stimulation with CMV and<br />

inhibitors of this activation decreased viral-induced<br />

CXCL10 production. Exogenous CXCL10 itself had no<br />

effect on CMV replication in permissive astrocytes,<br />

however, supernatants from CMV stimulated microglial<br />

cells increased chemotaxis of activated T-cells, which<br />

could be partially suppressed by anti-CXCL10 antibodies.<br />

Anti-inflammatory cytokines appear to play a critical role in<br />

preventing excessive CNS inflammation including T-cell<br />

accumulation. Treatment of microglial cells with IL-10<br />

was found to inhibit CXCL10 production at the level of<br />

mRNA transcription and was associated with decreased<br />

CMV-induced NF-kappa B activation. These studies<br />

suggest that microglial cell production of CXCL10 plays a<br />

major role in recruitment of T-cells to foci of CMV infection<br />

and that IL-10 functions to prevent excess inflammation.<br />

FP-G-071<br />

Reactivation of HHV-6 infection in chronic<br />

encephalopathy<br />

C. Arpino a,c , L. Lopez a , G. Anzidei b , M.P. Camporiondo b ,<br />

D. Poveromo c , P. Curatolo c<br />

a Eugenio Litta Rehabilitation Center for Developmental<br />

Disabilities; b IRCCS Infectious Diseases L. Spallanzani;<br />

and c Pediatric Neurology Unit, Tor Vergata <strong>University</strong>,<br />

Rome, Italy<br />

We present a case of a 13 year-old girl with chronic<br />

encephalopathy, whose recrudescence of symptoms was<br />

associated with the reactivation of HHV-6 infection both<br />

at the systemic level and at the level of the CNS. Since<br />

the age of 3 years, she had suffered from frequent epileptic<br />

seizures resistant to treatment, and at the age of 8 years she<br />

began to present cognitive deterioration. At the time of our<br />

evaluation, the girl showed intermittent episodes of delirium<br />

and epileptic seizures. Her karyotype, blood and urine<br />

screening for metabolic diseases, optic fundi, motor and<br />

sensory conduction velocity studies, immunoglobulins and<br />

T lymphocyte subsets, were normal. Interictal EEG showed<br />

absence of normal background activity, and a prominent<br />

slow delta activity bilaterally in the anterior leads. MRI<br />

imaging showed mild, non-specific, diffuse cortical atrophy<br />

prevailing in the frontal regions. CSF examination for DNA<br />

sequences of several viral agents (i.e. Cytomegalovirus,<br />

HHV-6, herpes simplex 1 and 2, Epstein-Barr virus, varicella<br />

zoster virus) by nested polymerase chain reaction<br />

revealed HHV-6 sequences, which were also detected in<br />

peripheral blood mononuclear cells. HHV-6 is a neurotropic<br />

virus; up to now, demyelination and seizures or status<br />

epilepticus have been observed in primary disease (i.e.<br />

exanthema subitum) or in immunocompromized children.<br />

Our report suggests that human Herpesvirus-6 (HHV-6)<br />

reactivation, at the CNS level, may occur also in immunocompetent<br />

hosts with severe neurological disease. It remains<br />

to be defined whether, in our patient, viral reactivation was<br />

the mere consequence of illness-related stress or a factor<br />

contributing to the recrudescence of CNS disease.<br />

FP-G-072<br />

Experimental study of endotoxic brain edema in infant<br />

rats and its treatment<br />

M. Li, F.-C. Cai<br />

Department of Neurology, College of Pediatrics, Chongqing<br />

Medical <strong>University</strong>, Chongqing, China<br />

Glucocorticoids are considered as effective drugs in reducing<br />

blood–brain barrier (BBB) permeability. IVIG is


488<br />

Abstracts<br />

frequently used to cure neurological disease, but its role and<br />

potential mechanism in brain edema has not been reported.<br />

In this study, the infant rat endotoxic brain edema was<br />

produced by intraperitoneal administration of 10 mg/kg of<br />

LPS, and the brain water and EB content, intracellular free<br />

Ca 21 and CaM expression were observed. The results<br />

showed that brain water and EB content were remarkably<br />

increased in endotoxemic rats compared with controls. Electron<br />

microscopy studies revealed that brain microvesicular<br />

endothelial cells had more endocytotic vesicles, degeneration<br />

and basal membrane disrupted and the space around<br />

brain capillaries was enlarged. The increase of brain intracellular<br />

free Ca 21 and up-regulation of cellular CaM expression<br />

were coincident with increase of EB and water content<br />

caused by LPS. Administration of DEX and IVIG could<br />

markedly decrease brain water and EB content. These<br />

results suggested that LPS increases the intracellular free<br />

Ca 21 and active CaM-dependent function via the Ca 21 /<br />

CaM pathway, which might relate to the increased BBB<br />

permeability and brain edema formation. The two drugs<br />

have the ability to reduce the BBB permeability and alleviate<br />

brain edema via reducing the intracellular free Ca 21 ,<br />

inhibiting the expression of CaM, and blocking the Ca 21 /<br />

CaM signal pathway. But IVIG failed to reduce the intracellular<br />

free Ca 21 , which suggests that other factors may be<br />

involved in regulating the intracellular free Ca 21 .<br />

FP-G-073<br />

Neurological outcome of children born to<br />

antiphospholipid antibody-positive mothers<br />

B.M. Tabarki, S. Boudhir, N. Salem, T. Mahjoub, A.<br />

Trabelsi, M. Yacoub, H. Selmi, A.S. Essoussi<br />

Farhat Hached Hospital, Sousse, Tunisia<br />

Objective: To evaluate the neurological features and<br />

outcome of children born to antiphospholipid antibodypositive<br />

mothers treated with calcium heparin and/or aspirin<br />

during pregnancy. Design: Retrospective data collection<br />

and prospective pediatric review of patients seen at Farhat<br />

Hached hospital between 1997 and 2001. Results: Seventythree<br />

children, with ages ranging from 10 months to 5 years,<br />

born to mothers with antiphospholipid antibodies were<br />

reviewed. Four patients (5%) died because of prematurity<br />

and/or nosocomial infection. Sixty-one (84%) patients were<br />

normal on neurodevelopmental and physical examination at<br />

pediatric review. Eight patients (11%) showed neurological<br />

abnormalities: severe intellectual and motor dysfunctions<br />

associated with epilepsy (four patients), mild mental retardation<br />

(two patients), hemiplegia (one patient), and epilepsy<br />

(one patient). Neuroradiological findings were: diffuse cerebral<br />

ischemia (four patients), middle cerebral artery infarction<br />

(one patient), sinovenous thrombosis (one patient),<br />

CNS malformation (one patient), and normal MRI in one<br />

patient. Four of the eight patients had positive antiphospholipid<br />

antibodies. Neurologic complications were not related<br />

to prematurity, growth restriction or other diseases. Conclusion:<br />

These data indicate that children born to antiphospholipid<br />

antibody positive mothers are at increased of CNS<br />

diseases, especially cerebrovascular disorders.<br />

FP-G-074<br />

Epidemiological and clinical features of 63 cases with<br />

subacute sclerosing panencephalitis diagnosed in 4 years<br />

Ö.F. Aydin, N. Şenbil, M. Kara, Y.K.Y. Gürer<br />

Department of Pediatric Neurology, Dr. Sami Ulus Children’s<br />

Hospital, Ankara, Turkey<br />

SSPE is an inflammatory neurodegenerative disease<br />

caused by persistence of measles virus. Although its<br />

frequency is declining because of widespread measles vaccination,<br />

it is still prevalent in areas where measles is endemic.<br />

We reviewed 63 patients diagnosed with SSPE over a period<br />

of 4 years (1998–2001). The diagnosis is based on the characteristic<br />

clinical and electroencephalographic findings and<br />

demonstration of an elevated antibody titer against measles in<br />

the plasma and the cerebrospinal fluid. Fifty-one of the<br />

patients were males (81%) and 12 were females (19%);<br />

male/female ratio was 4.25. The mean age of onset of SSPE<br />

was 68.29 ^ 29.87 months and follow-up duration was<br />

9.85 ^ 7.49 months. The initial symptoms noticed by<br />

families were unsteady gait/stumbling (26.9%), head drops<br />

(20.6%), frequently falling (15.8%) and jerks (11.1%). Head<br />

trauma was the precipitating factor in 14 cases (25.9%). Fiftythree<br />

patients had had measles and 20 of 43 patients questioned,<br />

hadreceivedimmunization. Themeanage ofinfection<br />

was 15.68 ^ 11.6 months, mean latent period was<br />

51.8 ^ 28.34 months. Mean time between first symptoms<br />

and admission was 11.4 ^ 14.87 weeks. Major complaints<br />

on admission were slurred speech (41%), frequent falling<br />

(38%) and unsteady gait/stumbling (34%). Examination on<br />

admission revealed myoclonic jerks in 53% of patients and<br />

they were mostly at clinical stage 3 A (24.5%) and 3B<br />

(33.3%). Thirteen of the 49 patients (26.5%) that could be<br />

followed up died. Conclusion: it is necessary to re-evaluate<br />

the immunization programme in preventing in SSPE, which is<br />

a complication of an infection preventable by immunization.<br />

FP-G-075<br />

Evaluation of the treatment results of 63 cases with<br />

SSPE diagnosed between the years 1998–2001<br />

Ö.F. Aydin, N. Şenbil, Ö. Eǧritas¨, Y.K.Y. Gürer<br />

Department of Pediatric Neurology, Dr. Sami Ulus Children’s<br />

Hospital, Ankara, Turkey<br />

Sixty three patients diagnosed as SSPE between the<br />

years 1998–2001 were treated with oral isoprinosine (100<br />

mg/kg per day), subcutaneous a-interferon 2a (Roferon-A,<br />

Roche) 10 million U/m 2 /three times a week and oral lamivudin<br />

(10 mg/kg per day). Patients that received treatment


Abstracts 489<br />

according to this protocol for at least 6 months (19<br />

patients) have been compared with 13 patients controls<br />

that did not or could not take the treatment. On the basis<br />

of neurological deficit index, clinical stage and the average<br />

of ages, there was no statistical difference between the<br />

treatment and control groups. There was no difference<br />

between the groups on their final evaluation for neurological<br />

deficit index and clinical stages. There was no statistical<br />

difference between the exitus ratios of treatment and<br />

control groups, 3 and 6, respectively. Remission ratios<br />

between the treatment and control groups were 7/19 and<br />

0/13, respectively and were statistically significant<br />

(P ¼ 0:036). Survival time was significant in the treatment<br />

group (P ¼ 0:01). The findings that remission ratios were<br />

different in the treatment group compared with the control<br />

group and also different from the 5% spontaneous remission<br />

rate reported in previous studies, and that the survival<br />

periods were remarkably different, has made us think this<br />

treatment protocol is effective.<br />

FP-G-076<br />

Enteroviral meningitis in Northern Jordan: prevalence,<br />

association of clinical presentation, laboratory findings,<br />

and serotypes involved<br />

A. Abdallah, M. Meqdam, M. Kbaloussi<br />

Princess Rahma Teaching Hospital, Irbid, Jordan<br />

During the summer-autumn of 1999,a total of 390 CSF<br />

specimens from infants and children less than 15 years of<br />

age, suspected of having meningitis, and admitted to Princess<br />

Rahma Hospital. Northern Jordan, were studied to determine:<br />

the incidence of enteroviral meningitis, serotypes<br />

involved, clinical presentation, and laboratory data (shell<br />

vial culture assay and fluorescent assay (FA) were used).<br />

Most cases occurred in children of 1 year of age (46.9%),<br />

and males represented 71.9% of the total of diagnosed enteroviral<br />

meningitis. The dominant symptoms were fever,<br />

vomiting, and headache. Clinical presentation did not distinguish<br />

between children with and without enteroviral meningitis.<br />

Enteroviruses were isolated from 32 (8.2%) cases.<br />

Coxsackie virus B types 2, 4 and 5 were isolated from 15<br />

(46.9%) cases, and ECHO virus 9 was the most commonly<br />

identified serotype (31.3%). The analysis of bacterial and<br />

viral CSF cultures revealed 2 (6.2%) out of 32 patients<br />

with mixed viral/bacterial meningitis. The virus isolation<br />

rate was directly proportional to the number of leukocytes<br />

in CSF. However, enteroviral isolation was directly achieved<br />

in four (12.5%) out of 32 CSF specimens without pleocytosis.<br />

Leukocyte differential count revealed that 71.4% of the cases<br />

showed polymorphonuclear cell predominance. Duration of<br />

hospitalization ranged from 1 to 25 days with a mean of 7<br />

days. The majority (88.9%) of enterovirus-infected patients<br />

were treated with at least one type of antibiotic. According to<br />

these data, we conclude that enteroviruses are frequent in our<br />

area and this indicates the importance of enteroviruses as<br />

common and important pathogens. Moreover, clinical<br />

presentation and CSF cytochemical findings in patients<br />

with enteroviral meningitis, closely resemble other bacterial<br />

and viral infections, and viral culture is a leading tool,<br />

together with promising advanced molecular techniques<br />

such as the PCR, for the diagnosis of enteroviral meningitis.<br />

FP-G-077<br />

Host defenses in children with low birth weight against<br />

pertussis, diphtheria and tetanus<br />

N.G. Kim, D.I. Makhmudova, L.D. Mullaeva<br />

Scientific Research Institute of Pediatrics, Tashkent, Uzbekistan<br />

From 5 to 10% of infants with low birth weight, on the<br />

basis of adequate weight increase and achievement of body<br />

mass 2500 g, received the same vaccines at the same terms<br />

as the full-term infants. However, the degree of physiological<br />

maturation of newborn at the moment of birth is the<br />

factor influencing the adequate immune response to<br />

diphtheria and tetanus toxoids and pertussis vaccine<br />

(DTTPV). The purpose of the investigation was to determine<br />

degree of postvaccine immunity against diphtheria,<br />

pertussis and tetanus in children with low-birth-weight.<br />

Investigation was carried out on 40 healthy children and<br />

51 infants with birth weight ,/ ¼ 2500 g and receiving<br />

the scheme of PTTP vaccination. The children with lowbirth-weight<br />

were divided into three groups: (1) premature<br />

newborns with body weight correlated to age of gestation<br />

(31–34 weeks, body weight 1600–2400 g) N ¼ 18; (2)<br />

premature newborns with body mass lower than expected<br />

for gestational age (30–35 weeks, body mass 1300–1500 g)<br />

N ¼ 18. It was established that postvaccine response in<br />

premature infants against diphtheria, pertussis and tetanus<br />

was characterized by low level of immune production.<br />

Premature infants with birth weight lower than expected<br />

for gestational age failed to induce immunity against pertussis<br />

in 60% of cases. Full-term infants with hypotrophic type<br />

of intrauterine growth and development retardation failed to<br />

produce defensive titres of antibodies against tetanus and<br />

diphtheria in every 3-d case and against tetanus in 66.6% of<br />

cases. Thus, efficacy of DTTP vaccination in children with<br />

low birth weight was correlated to the degree of physiological<br />

development of infant at the moment of its birth.<br />

FP-G-078<br />

Factors influencing the formation of postvaccine<br />

immunity in children with damage of the central nervous<br />

system<br />

Z.A. Kushnaeva, D.I. Makhmudova, G.K. Salimova<br />

Scientific Research Institute of Pediatrics, Tashkent, Uzbekistan<br />

Objective: to study the effect of degree of severity and


490<br />

Abstracts<br />

type of clinical syndrome on the formation of postvaccine<br />

antibodies in children with damage to the CNS. Investigation<br />

was undertaken of 45 children with perinatal damage<br />

of the CNS. Studied children were divided into the following<br />

groups: group I with mild degree of disease (n ¼ 16);<br />

group II moderate degree (n ¼ 20) and group III severe<br />

degree (n ¼ 9); and according to clinical syndrome: ICH<br />

(n ¼ 15) and vegetative visceral dysfunction (VVDF)<br />

(n ¼ 10). Analysis of serological data in children with<br />

mild degree of lesion were found 1.9 times more frequently<br />

as compared to control group (P , 0:05). In children with<br />

moderate degree of damage, negative results were registered<br />

in 40% of cases. Frequency of low titres in children<br />

from this group was 1.9 times more frequent (P , 0:05).<br />

The frequency of moderate and high titres in children of<br />

group II was 3.5 and 2.2, respectively (P , 0:05). In the<br />

third group of children seronegative results against<br />

diphtheria were 6.7 times more frequent than in children<br />

of the control group (P , 0:05). The frequency of moderate<br />

titres was 4.7 times higher in healthy children than in<br />

children with severe degree of damage. The titres of antibodies<br />

against diphtheria in the studied groups were as<br />

follows: group I, 62.4%, group 2, 25%, group 3, 11.2%.<br />

In children with ICH seronegative results with vaccination<br />

were eight times more frequent. The frequency of moderate<br />

antibody titres in this group was four times lower than in<br />

control group (P , 0:01). In VVDF seronegative results<br />

against diphtheria were 7.5 times more frequent<br />

(P , 0:01). The frequency of moderate titres in children<br />

of the main group was higher than 5.3 times (P , 0:01).<br />

The high titres in children against diphtheria were 2.2<br />

times lower in children of the main group (P , 0:05).<br />

Host defenses against diphtheria in ICH were 13.3% and<br />

VVDF 20%. Thus, severity and type of clinical syndrome<br />

of children with damage of the CNS influence the results of<br />

immunization against diphtheria. This category of children<br />

should undergo study of the presence of protective<br />

diphtheria antibodies after vaccination. It is necessary to<br />

develop a scheme to prepare this category of children for<br />

vaccination.<br />

FP-G-079<br />

Clinical analysis of 23 children with cryptococcal<br />

meningitis<br />

L.-Z. Zhang<br />

Department of Pediatrics, Heze Municipal Hospital, Heze,<br />

China<br />

The mean age of 23 children with cryptococcal meningitis<br />

was 4.3, 16 of them were misdiagnosed. The rate of<br />

misdiagnosis was 69.6%. A total of 30.4% were diagnosed<br />

correctly initially. Symptoms included fever, headache,<br />

vomiting, visual loss, convulsions and swelling of the spleen<br />

and liver. The principal changes in CSF were as in tuberculous<br />

meningitis. The level of CSF glucose and chloride<br />

decreased. Cryptococcus neoformans can be found by ink<br />

stain technique. Low density changes were found in head<br />

CT. It is suggested that in order to prevent misdiagnosis an<br />

attempt is made to detect the pathogen. The prognosis is<br />

related to the intracranial pressure, delay in correct diagnosis<br />

and severity of inflammation.<br />

FP-G-080<br />

Clinical features of 25 cases of children with viral<br />

encephalitis<br />

B.-Z. Jia<br />

General Hospital of Yangquan Coalmine Group Yangquan,<br />

China<br />

Objective: To explore the clinical feature of pediatric<br />

viral encephalitis to enable earlier diagnosis. Methods:<br />

The complete data of 25 cases of children with viral encephalitis<br />

in the last 2 years were analyzed. Results: The rate<br />

of common symptoms is: fever (96%), convulsions (64%),<br />

vomiting (52%), disturbance of consciousness (44%), headache<br />

(36%). The rate of rarer symptoms is: thrill (16%),<br />

paralysis (12%), supranuclear paralysis (8%), dizziness<br />

(8%), salivation (4%). Before admission into the hospital,<br />

the median of common symptoms is: headache (2.25),<br />

vomiting (2.1), fever (1.96), convulsions (1.57), disturbance<br />

of consciousness (1). The rate of positive pathological signs<br />

is: Babinski’s sign (28%), stiff neck (20%), Kernig’s sign<br />

(4%). Conclusion: In clinical work, special attention should<br />

be paid to the common symptoms of viral encephalitis and<br />

high vigilance over a few symptoms. In the case of headache<br />

and vomiting, with or without fever in the sick children,<br />

viral encephalitis is possible.<br />

FP-G-081<br />

The study of nitric oxide tumor necrosis factor and<br />

interleukin-8 in serum and cerebrospinal fluid in<br />

children patients with infection of central nervous<br />

system<br />

H.-Y. Wang, Y. Yuan, B.-L. Sun<br />

Department of Pediatrics, the First Affiliated Hospital of<br />

Jiamusi <strong>University</strong>, Jiamusi, China<br />

In this study we evaluated the levels of serum and CSF<br />

NO, NOS, TNF and IL-8. The NO, NOS, TNF, IL-8 in 18<br />

cases of viral meningitis (VM), 14 cases of tuberculous<br />

meningitis (TM), 16 cases of purulent meningitis (PM)<br />

and 20 control cases (CG) were determined by colorimetric<br />

method and radioimmunoassay. Results: (1) The levels of<br />

NO, NOS, TNF in serum and CSF with VM, TM and PM<br />

were significantly higher than those in CG (P , 0:01).<br />

Moreover, the concentrations of NO, NOS, TNF with PM<br />

were significantly higher in CSF than those in patients with<br />

VM and TM (P , 0:01). (2) The levels of IL-8 in serum and<br />

CSF with TM and PM were significantly higher than those


Abstracts 491<br />

in CG. While the concentration of IL-8 with PM was significantly<br />

higher than those with TM, there was no obvious<br />

difference between VM and CG (P , 0:01). All of these<br />

suggested that: (1) NO, NOS, TNF, IL-8 all participated<br />

in the pathogenesis of central nervous system infection.<br />

(2) The determination of NO, TNF and IL-8 of serum and<br />

CSF can be a discriminating index among VM, TM and PM.<br />

FP-G-082<br />

Clinical analysis of 68 cases with mumps encephalitis<br />

W.-Y. Sun, Y.-B. Yan<br />

People’s Hospital of Liaocheng, Liaocheng, China<br />

Objective: The aim of the study was to investigate the<br />

epidemiological characteristics and clinical effects of<br />

mumps encephalitis. Methods: Sixty-eight cases of mumps<br />

encephalitis were studied It is a common complication of<br />

epidemic parotitis and has a high incidence rate. Forty-eight<br />

of the 68 cases occurred from May to September (70.6%).<br />

The patients were aged from 7 to 12 years. All patients were<br />

treated by antivirals and replacement of fluid and electrolyte<br />

losses. Mannitol and corticoid was only used in some<br />

patients who had intracranial hypertension. All patients<br />

were cured. Conclusion: Mumps encephalitis mainly<br />

occurred in non-epidemic seasons and the pediatric age<br />

group. Prognosis is good.<br />

FP-G-083<br />

One versus 2 years of antiepileptic therapy in children<br />

with single small enhancing CT lesions<br />

P.D. Singhi a , J. Dinakaran a , N. Khandelwal b , S.C. Singhi a<br />

a Departments of Pediatrics and b Radiodiagnosis, Post<br />

Graduate Institute of Medical Education and Research,<br />

Chandigarh, India<br />

Objective: The duration of antiepileptic drug (AED) therapy<br />

in children with seizures due to single small enhancing<br />

CT lesions (SSECTL) is controversial. We sought to determine<br />

whether there is any difference in the rate of seizure<br />

recurrence after 1 versus 2 years of AED therapy and to<br />

identify the factors predictive of seizure recurrence. Methods:<br />

A total of 115 consecutive children with seizures and<br />

SSECTL were randomly assigned into two groups. Group A<br />

received AED(s) for 1 year and Group B for 2 years seizure<br />

free interval. CT scan and EEG were done prior to AED<br />

withdrawal and children were followed up for seizure recurrence<br />

for at least 1 year. Association between seizure recurrence<br />

and clinical and CT characteristics was analyzed.<br />

Results: Groups A and B consisted of 55 and 51 children;<br />

(nine lost to follow up). There were 61 boys, 45 girls; mean<br />

age 9.33 years. Most (93%) had focal seizures-36%<br />

complex partial, 22% simple partial, 35% partial with<br />

secondary generalization, 21% had status epilepticus. The<br />

two groups were comparable in clinical, EEG and CT characteristics.<br />

CT scan and EEG prior to AED withdrawal were<br />

abnormal in 44 and 33%, respectively. Six children, three<br />

from each group had seizure recurrence. Significant association<br />

was found between seizure recurrence and abnormal<br />

CT (persistence/calcification of lesion) and abnormal EEG<br />

prior to AED withdrawal (P , 0:01). The relative risk of<br />

seizure recurrence in a child with abnormal CT and EEG<br />

prior to AED withdrawal was 26.2 (95% confidence interval<br />

3.3–210.2, P ¼ 0:0003). No association was found between<br />

seizure recurrence and any of the other variables. Conclusions:<br />

There was no difference in seizure recurrence after 1<br />

versus 2 years of AED therapy. Combination of persistent/<br />

calcified CT lesion and abnormal EEG prior to AED withdrawal<br />

was the best predictor of seizure recurrence.<br />

FP-G-084<br />

Bacteraemia during the purulent meningitis<br />

K. Karovski, Z. Milenkovic, N. Pop-Jordanova, A.<br />

Bogdanovska<br />

Clinic of infectious diseases, Faculty of medicine, Skopje,<br />

Macedonia<br />

In an open, randomized, controlled study of 304 patients<br />

with PM treated at Clinic of infectious diseases in Skopje,<br />

the frequency and the influence of bacteraemia on the<br />

outcome of the disease, were investigated. The etiology of<br />

the disease was confirmed by bacterial isolation from the<br />

CSF in 55.6%, with S. pneumoniae (58%), N. meningitidis<br />

(20.7%) and H. influenzae (7.7%), being the most frequent<br />

agents. Fatal outcome in 12.2% of patients, and audiological<br />

sequelae in 8.7% out of survivors occurred. In 17.8% of<br />

patients, the etiological agent was isolated from the blood,<br />

as well; namely, in 43.2% of patients with fatal outcome,<br />

and in 14.2% of survivors. Clinical and laboratory-biochemical<br />

features for sepsis and septic shock were recognized in<br />

34.5% of patients; 70.3% out of patients with fatal outcome,<br />

and in 29.6% of survivors. Out of the laboratory-biochemical<br />

parameters, the increased levels of: ESR, WBC and<br />

granulocytosis in 72.4, 57.2 and 44.7% of patients; as well<br />

as, the decreased levels of WBC and neutropenia in 16.1 and<br />

9.2%, respectively, were found. Increased levels of bilirubinaemia<br />

and enzim activity of aminotranspherases were<br />

registered in 24.3 and 20.6% of survivors, that is in 48.6<br />

and 45.9% of patients with fatal outcome. It was concluded<br />

that sepsis and septic shock lead to dramatic worseness of<br />

the outcome in patients with PM.<br />

FP-G-085<br />

Neurological and psychological aspects of<br />

encephalopathy due to tick born infections of the CNS<br />

K. Gustaw a , K. Bel⁄towska b , M.M. Studzińska c<br />

a Outpatients Neurological Department, Institute of Agricultural<br />

Medicine, Lublin, Poland; b Department of Public<br />

Health, Institute of Agricultural Medicine, Lublin, Poland;


492<br />

Abstracts<br />

c Department of Medical Sociology, Institute of Sociology,<br />

UMCS, Lublin, Poland<br />

The purpose of this study was to delineate the differences<br />

distant neurological and neuropsychological effects of tickborne<br />

encephalitis in children. The group of 11 patients<br />

(four boys and seven girls in the age from 11–15 years)<br />

was included to the study. Every patient had suffered from<br />

encephalitis due to viral infection after bit of the tick and<br />

was properly treated. Medical history, physical examination<br />

and a series of neuropsychological experimental tests based<br />

on WAIS-R, BDI, BENTON-BENDER, DUM were<br />

performed. In the clinical history 27.3% of patients<br />

complained of headaches, 18.1% of the patients of subjective<br />

memory distortion. The neurological examination<br />

showed that. 36.4% of the patients experienced weakness<br />

of the muscles and irritability. Moreover in 72% of the cases<br />

dysmethria, 45% nystagmus and in 54% positive Romberg<br />

sign were found. A total of 45.4% of the patients showed<br />

asymmetry in deep tendon reflexes (DTR’s) and in 45% of<br />

the cases slight muscular strength abnormalities. Besides, in<br />

18% of the cases disturbances in the sensory responses were<br />

noticed. In 18% abnormalities in the function of the muscles<br />

innervated by cranial nerves were examined. Psychological<br />

tests indicated that 72% of the patients had problems in<br />

thinking process and experienced memory impairment<br />

45% of patients had significant organic damage in the<br />

central nervous system. The results of this study suggested<br />

the existence of long lasting consequences of tick born encephalitis,<br />

which can significantly influence the quality of life<br />

of the young patients.<br />

FP-G-086<br />

Conservatively treated multiple brain abscess<br />

Z. Liptai, Z. Meszner, K. Kalocsai, P. Barsi<br />

Pediatric Neurology, Saint Laszlo Hospital, Budapest,<br />

Hungary<br />

Authors report the case of a 17-year-old girl in whom<br />

severe headache and fever developed 8 days after tonsillectomy.<br />

Two days later slurred speech, adynamia and somnolence<br />

occurred. Cranial CT and MRI revealed a 1.2 cm-large<br />

mass in the right parieto-occipital region, with marked ringshaped<br />

contrast-enhancement and wide perifocal edema. An<br />

enhancement of the ipsi- and contralateral ventricular wall<br />

and meninges could be visualized, too. Routine CSF findings<br />

corresponded to massive purulent meningitis. The size<br />

and localization of the abscess did not allow neurosurgical<br />

approach. According to the susceptibility of the cultured<br />

microaerophilic Streptococcus, meropenem was administered<br />

and symptomatic treatment was added. This resulted<br />

in a rapid clinical improvement. Neuroimaging studies 4<br />

weeks later, however, showed marked progression of the<br />

abscess with spreading both inside the right and toward<br />

the contralateral, left hemisphere. Radiological improvement<br />

started on oral cloramphenicol treatment, but severe<br />

adverse effects (depression, anorexia, malnutrition, dehydration,<br />

bone-marrow hypoplasia) made rehospitalization<br />

and a change in antibiotic therapy (reinstitution of meropenem)<br />

necessary, as well as the administration of antidepressant<br />

medication. The patient has become free of complaints<br />

and MR images have shown a slow but unequivocal<br />

improvement. The CSF has been near-normalized. No<br />

relapse occurred after discontinuation of the 3.5-month lasting<br />

antibiotic therapy. Authors will discuss diagnostic and<br />

therapeutic problems related to this case and run through the<br />

scarce experience on similar cases in the literature.<br />

FP-G-087<br />

Postencephalitic parkinsonism in a 7-year-old boy<br />

K.Y. Chae, J.H. Lee<br />

Department of Pediatrics, College of Medicine, Pochon<br />

CHA <strong>University</strong>, Sungnam, Korea<br />

We experienced a 7-year-old boy who developed an<br />

akinetic-rigid Parkinson syndrome following encephalitis.<br />

On admission, he had convulsive status epilepticus with<br />

prolonged postictal confusion state. EEG showed diffuse<br />

high amplitude of slow wave discharges on the background<br />

consistent with encephalopathy. The initial brain MRI<br />

revealed focal high signal intensities on right hippocampal<br />

area. Viral markers in CSF were all negative. On the fifth<br />

hospital day, he developed lead pipe rigidity in all four<br />

extremities but improved cognition. He progressed to bradykinesia,<br />

blepharospasm, slow tongue movement with dysarthria.<br />

Subsequent brain MRI showed no different findings<br />

with the previous one. Methylprednisolone pulse therapy,<br />

amantidine and levodopa were introduced, and thereafter<br />

symptoms of parkinsonism (hypokinesia, blepharospasm,<br />

dysarthria, and lead pipe rigidity) in all four extremities<br />

partially improved. We suggest that steroid and oral amantidine<br />

with dopaminergic therapy will be worthy in the<br />

management of acute stage of postencephalitic parkinsonism.<br />

FP-G-088<br />

Clinical feature of 25 children with viral encephalitis<br />

B.-Z. Jia<br />

General Hospital of Yangquan Coalmine Group Yangquan,<br />

Shanxi Province, China<br />

Objective: To explore clinical feature of pediatric viral<br />

encephalitis for earlier diagnosis. Methods: The complete<br />

data of 25 children with viral encephalitis in the last 2<br />

years were analyzed. Results: The rate of common symptoms<br />

was: fever (96%), convulsion (64%), vomiting (52%),<br />

disturbance of consciousness (44%), and headache (36%).<br />

The rate of a few symptoms was: thrill (16%), paralysis<br />

(12%), supranuclear paralysis (8%), dizziness (8%), and


Abstracts 493<br />

salivation (4%). Before admission to the hospital, the<br />

median of common symptoms was: headache (2.25), vomiting<br />

(2.1), fever (1.96), convulsion (1.57), disturbance of<br />

consciousness (1). The rate of positive pathologic sign<br />

was: Babinski’s sign (28%), tonic neck (20%), Kernig’s<br />

sign (4%). Conclusion: In clinical work, special care should<br />

be taken to common symptoms of viral encephalitis and<br />

high vigilance be made to a few symptoms. In case of headache,<br />

vomiting and/or no fever, to the sick children perhaps<br />

the viral encephalitis is possible.<br />

FP-G-089<br />

A study on nitric oxide tumor necrosis factor and<br />

interleukin-8 in serum and cerebrospinal fluid in<br />

children with infection of the central nervous system<br />

H.-Y. Wang, Y. Yuan, B.-L Sun<br />

Department of Pediatrics, the First Affiliated Hospital of<br />

Jiamusi <strong>University</strong>, Jiamusi, China<br />

In this study we evaluated the levels of serum and CSF<br />

NO, NOS, TNF and IL-8. The NO, NOS, TNF, IL-8 in 18<br />

cases of viral meningitis (VM), 14 cases of tuberculous<br />

meningitis (TM), 16 cases of purulent meningitis (PM)<br />

and 20 cases of control group (CG) were determined by<br />

colorimetric methods and redioimmunoassay. The results<br />

showed that: (1) the levels of NO, NOS, TNF in serum<br />

and CSF with VM, TM and PM were significantly higher<br />

than those in CG (P , 0:01). Moreover the concentrations<br />

of NO, NOS, TNF in patients with PM were significantly<br />

higher in CSF than those in patients with VM and TM<br />

(P , 0:01). (2) The levels of IL-8 in serum and CSF with<br />

TM and PM were significantly higher than those in CG. The<br />

concentration of IL-8 with PM was significantly higher than<br />

those with TM. There was no obvious difference between<br />

VM and CG (P , 0:01). These results suggested that: (1)<br />

NO, NOS, TNF, IL-8 all participated in the pathogenesis of<br />

the central nervous system infection. (2) Determination of<br />

NO, TNF and IL-8 in serum and CSF can be a discriminating<br />

index among VM, TM and PM.<br />

FP-G-090<br />

Clinical analysis of 23 children with cryptococcal<br />

meningitis<br />

L.-Z. Zhang<br />

Department of Pediatrics, Heze Municipal Hospital, Heze,<br />

Shandong, China<br />

The mean age of 23 children with cryptococcal meningitis<br />

was 4.3; 16 of them were misdiagnosis. The rate of misdiagnosis<br />

was 69.6%; 30.4% was diagnosed with cryptococcal<br />

meningitis at first. Symptoms included fever, headache,<br />

vomiting, visual loss, convulsion and hepatosplenomegaly.<br />

Remarkable changes in the CSF were observed in tuberculous<br />

meningitis. The levels of CSF glucose and chloride<br />

decreased. Cryptococcus neoformans can be found by an<br />

ink stain technique. Low density lesions were found by<br />

head CT. It is suggested that misdiagnosis is prevented by<br />

detecting the pathogenic agent. The prognosis is related to<br />

the intracranial pressure, stage of misdiagnosis and severity<br />

of inflammation.<br />

FP-H-001<br />

Benign infantile seizures<br />

FP-H<br />

Seizure Disorders<br />

H.-Y. Li, S.-J. Ling, Y.-L. Cui<br />

Xi’an Children’s Hospital, Xi’an, China<br />

Objective: To determine the characteristics of benign<br />

infantile seizures. Methods: A prospective study of 13<br />

cases and a retrospective study of 44 cases of benign infantile<br />

seizures were carried out in 1989–2001. Results: Among<br />

the 57 cases of benign infantile seizures that had a normal<br />

development, there were 35 males and 22 females. The age<br />

of onset was from 50 days to 2.5 years. The clinical manifestations<br />

included tonic-clonic seizure (44), motion arrest,<br />

staring with or without smile or lip cyanosis (10), and partial<br />

seizure (3). Fifty-three patients had the pretreatment<br />

seizures frequency of two to 17 times, four had .40 times<br />

and 28 had seizures occurred in clusters. A family history of<br />

epilepsy or Fc was present in three. Interictal EEGs showed<br />

general epileptiform discharge in eight, and focal epileptiform<br />

discharges in five, and the remaining were normal.<br />

Cranial CT scans performed in 44 were normal. Phenobarbital<br />

(PB), carbamazepine (CBZ) and valproate (VPA) were<br />

effective in 25, 18 and eight cases respectively. Five patients<br />

received a drug combination of PB with CBZ or VPA and<br />

one took no AEDs at all. No seizure occurred after adding<br />

AEDs in 37 and seizures recurred because of early withdrawal<br />

of AEDs or insufficient dosage in 20. All patients<br />

were controlled between the age of 8 months and 5.5 years<br />

and remained seizure-free for 8 months to 12 years (.4<br />

years in 23). AEDs were discontinued after seizure-free<br />

period of 1–5 years in 31, among them 14 were AEDsfree<br />

for 3–10 years. Conclusion: The benign infantile<br />

seizures are not uncommon and can be easily controlled<br />

with PB or CBZ or VPA with favorable prognosis.<br />

FP-H-002<br />

P 300 test of benign focal epilepsy with centrotemporal<br />

spike in children<br />

Z.-D. Lin, H.-L. Wang, X.-Y. Ye, G.-Q. Li, H.-W. Hu<br />

Department of Neuropediatrics, Yuying Children’s Hospital<br />

Affiliated to the Wenzhou Medical College, Wenzhou,<br />

Zhejiang, China<br />

Objective:P 300 test was done in benign focal epilepsy with


494<br />

Abstracts<br />

centrotemporal spike to evaluate its cognition function.<br />

Methods: 22 benign focal epileptic patients who had never<br />

been treated with anti-epileptic drugs were studied and<br />

compared with 25 healthy controls. Auditory event related<br />

potential P 300 peak latency and amplitude were regarded as<br />

the indicator. Results: No significant differences of P 300 peak<br />

latency and amplitude were found in epileptic patients from<br />

those in controls (P . 0:05), and no significant differences of<br />

P 300 peak latency and amplitude were found in the subjects of<br />

different age or gender (P . 0:05). Conclusion: It is<br />

suggested that there is no severe cognition function abnormality<br />

in benign focal epilepsy with centrotemporal spike in<br />

children, especially in those without anti-epileptic therapy.<br />

FP-H-003<br />

Diagnostic value of video-EEG in children with<br />

paroxysmal disorders<br />

Z.-D. Lin, H.-W. Hu, G.-Q. Li, X.-Y. Ye, Y.-L. Zhang<br />

The Department of Pediatric Neurology, The Yuying Children’s<br />

Hospital affiliated to the Wenzhou Medical College,<br />

Wenzhou, Zhejiang, China<br />

To evaluate the diagnostic value of video-EEG in children<br />

with non-epileptic seizure, 52 children suspected to<br />

have or weeded out the possibility of epilepsy were examined<br />

with video-EEG. Fifty-two cases were monitored to<br />

have ‘seizure’ attacks, 35 of whom were diagnosed as<br />

non-epileptic seizure including ten children with nocturnal<br />

muscle clonic, six sleeping disorders, five habitual tics, two<br />

hysteria, four non-epileptic paroxysmal tonic, four behavior<br />

abnormality, two headache or stomachache attack, one<br />

pertussoid attack and one infantile Moro reflex respectively.<br />

While 17 of them were diagnosed as epileptic seizure,<br />

consisting of four with generalized tonic-clonic seizures,<br />

four tonic seizures, three clonic seizures, two localized<br />

motor seizures and other three complex partial seizures,<br />

myoclonic seizures and infantile spasms respectively. The<br />

results indicated the video-EEG is not only the most sensitive<br />

way to differentiate the seizure characteristics and<br />

patterns but also the most effective way in differentiation<br />

of epileptic seizures from the non-epileptic seizures, and is<br />

of value in the classification of the epilepsy and epileptic<br />

syndromes. But the major disadvantage is that in the period<br />

of monitoring with the video-EEG, the children’s daily<br />

activities must be restricted in some area, and is the best<br />

choice in the children with frequent seizures.<br />

FP-H-004<br />

Hyponatremia is a predictor for recurrence of febrile<br />

seizure<br />

I. Tan<br />

<strong>University</strong> of Santo Tomas, Manila, Philippines<br />

FS even when recurrent have relatively no adverse<br />

effects. However, witnessing a FS is a very scary event.<br />

Predicting and treating FS recurrences will tremendously<br />

allay family anxiety. Risk factors for a first FS and recurrent<br />

FS in future febrile illnesses have been identified.<br />

However, there is scanty information regarding risk factors<br />

for FS recurrence in the same febrile illness. Thus, the<br />

identification of possible risk factors for FS recurrence<br />

within the same febrile illness is important. Low serum<br />

sodium following a FS was found to be a risk factor for a<br />

FS recurrence within the same febrile illness. To affirm or<br />

negate this, 77 children with febrile seizures were prospectively<br />

studied. Serum sodium determination was<br />

performed on all of them upon presentation in the emergency<br />

room. Forty-one of the children (53.25%) had low<br />

serum sodium levels (,135 mmol/l, with a mean of<br />

131.07 mmol/l). The mean serum sodium for the normonatremic<br />

children was 137.58 mmol/l. Twenty-five children<br />

(32.46%) experienced febrile seizure recurrence in<br />

the same febrile illness. Twenty of these children with<br />

FS recurrence were hyponatremic (mean serum sodium<br />

was 129.75 mmol/l) as compared to only five from the<br />

group with normal serum sodium level (P value ,0.01,<br />

chi-squared test). Relative risk for febrile seizure recurrence<br />

in the same illness was 3.5. Our study showed an<br />

increased risk for febrile seizure recurrence in the same<br />

febrile illness in children with hyponatremia, which was<br />

statistically significant.<br />

FP-H-005<br />

The relationship between benign childhood epilepsy with<br />

centrotemporal spikes and febrile convulsions<br />

L. Yin, L.-H. Cao, J.-H. Wu, B.-D. Pang, Y. Zhang<br />

Department of pediatrics, Maternity and Children Hospital,<br />

Tangshan, Hebei, China<br />

Objective: To explore the relation between benign childhood<br />

epilepsy with centrotemporal spikes (BCECT) and<br />

febrile convulsions. To study the possible etiology of<br />

BCECT. Methods: Twenty-six patients, age 1–6 years<br />

old, with typical BCECTs were investigated about the<br />

family history of epilepsy and febrile convulsions. They<br />

were examined with MRI or CT. A control group consisted<br />

of age-matched randomly selected healthy children.<br />

Results: The CT or MRI of the 26 patients was negative.<br />

No hippocampal abnormality was found in the patients.<br />

Only one patient had a history of febrile convulsions. Positive<br />

history of febrile convulsions in the study group is<br />

higher than that in the control group (0:025 , P , 0:05).<br />

There is no difference in the positive epilepsy family<br />

histories between the two groups (P . 0:05). Conclusion:<br />

BCECTs and febrile convulsions are linked closely,<br />

though BCECTs do not certainly derive from febrile<br />

convulsions. Both disorders may have a related genetic<br />

background.


Abstracts 495<br />

FP-H-006<br />

Lateralizing value of ictal version and limbs posturing in<br />

partial seizure in children<br />

L. Yin, K.-X. Luo, J.-H. Wu<br />

Department of pediatrics, Maternity and Children Hospital,<br />

Tangshan, Hebei, China<br />

Objective: To evaluate the lateralizing value of ictal<br />

dystonic posturing of limbs and version of mouth, head<br />

and eyes in partial seizure in children. Methods: By questioning<br />

the parents who have seen the seizure and review the<br />

data of Video-EEG in 48 patients. Results: In the patients<br />

with partial seizure, version of mouth and eyes occurred in<br />

45.83 and 54.17%, respectively and were generally contralateral<br />

to the ictal focus. The version of head were of no<br />

lateralizing significance, dystonic posturing of limbs were<br />

contralateral to the seizure focus (r ¼ 20:908). Conclusion:<br />

The dystonic posturing and version of mouth and eyes have<br />

lateralizing value in partial seizure.<br />

FP-H-007<br />

The value of video-EEG evaluation in clinical diagnosis<br />

L.-H. Cao, J.-H. Wu, B.-D. Pang, Y. Liu, Y. Zhang<br />

Department of pediatrics, Maternity and Children Hospital,<br />

Tangshan, Hebei, China<br />

Objectives: To evaluate the value of video-EEG in the<br />

differential diagnosis of patients with epilepsy or nonepileptic<br />

paroxysmal disorders. Methods: A total of 726<br />

consecutive cases were investigated by VEEG during the<br />

period from August, 1999 to December, 2001, the EEG<br />

patterns and clinical seizure activities were reviewed by<br />

pediatric neurologists. Results: (1) Among the 726 cases,<br />

VEEG patterns were abnormal in 542 cases (74.66%), of<br />

whom, 425 cases had epileptic discharges (78.41% of<br />

abnormal findings) and non-specific changes in 117 cases<br />

(16.12% of abnormal findings). Of these 726 cases, there<br />

were 505 cases that had had previous routine EEG evaluation,<br />

of whom 91 cases (18.02%) had non-specific abnormalities,<br />

and 42 cases (8.31%) had epileptic discharges. There<br />

were significant differences between the two methods. (2) In<br />

the 425 cases with epileptic discharges, the foci were in<br />

frontal in 12, central in 27, frontal-temporal in 50, parietal<br />

in 24, occipital in 15, centro-temporal in 150, diffused<br />

changes in 85, hypsarrhythmia in 20 cases. The epileptic<br />

discharges were only positive during sleep in 238 cases,<br />

during alert state in 52 cases and during both states in 135<br />

cases. (3) After the VEEG evaluation, the paroxysmal disorders<br />

in 187 cases were diagnosed as non-epileptic and in 493<br />

cases were epileptic. Of the latter group, 150 cases had<br />

BECTs, 143 generalized tonic-clonic seizure, 34 complexpartial<br />

seizures, 44 secondarily developed generalized<br />

seizures from partial epileptic activity, 36 myoclonic<br />

epilepsy, 23 infantile spasms, nine Lennox-Gastaut<br />

syndrome, 12 absences, and 15 atonic attacks. (4) The<br />

epileptic discharges and clinical seizures in 227 cases had<br />

been shown simultaneously in VEEG, but only in two cases<br />

during routine EEG investigation. Conclusions: The video-<br />

EEG investigation of patients with clinical paroxysmal<br />

disorders is much more conclusive than routine EEG.<br />

FP-H-008<br />

Diazepam and aspirin-dl-lysine therapy in febrile<br />

seizures: report of 108 cases<br />

W.-Y. Wang, B.-B. Wu, M.-L. Liu<br />

Department of Pediatrics, Affiliated hospital of Medical<br />

college of Chinese People’s Armed Police Forces, Tianjin,<br />

China<br />

Objective: To explore the best method of treating child<br />

with febrile seizures in a clinic work. Methods: Children<br />

with febrile seizures had their body placed properly, their<br />

respiratory tract kept unobstructed, oxygen inspiration therapy<br />

and suction, vein transfusion pathway established<br />

rapidly, and IV diazepam and IV aspirin-dl-lysine infusion.<br />

After control of seizures, we analyzed their possible etiologies<br />

again. IV diazepam and aspirin-dl-lysine can control<br />

seizures rapidly and provides the best effects.<br />

FP-H-009<br />

New progress of drug treating epilepsy<br />

J. Peng<br />

Beijing Military region Department of Pediatrics General<br />

hospital, Beijing, China<br />

Epilepsy is a common and high morbidity disease of<br />

pediatric neural system. After many years of research, functional<br />

mechanism of drugs treating epilepsy has made<br />

progress. This article expounds two problems: (1) when<br />

valproic acid is combined with carbamazepine, the blood<br />

concentration of valproic acid decreases and the dosage of<br />

the latter drug should be increased. (2) If valproic acid,<br />

phenytoin sodium, ethosuximide and clonazepam are<br />

combined with carbamazepine, their blood levels will<br />

decrease. This report also introduces how to choose new<br />

drugs treating epilepsy and how to treat refractory epilepsy.<br />

FP-H-010<br />

Change of serum prolactin levels following children<br />

seizures<br />

Q.-Y. Guo, S.-G. Ming<br />

JiangMen Central Hospital, JiangMen, GuangDong, China<br />

We studied serum prolactin levels following seizures in<br />

49 children with epilepsy; 24 with pseudoseizures; ten<br />

normal children. The epilepsy group showed significantly<br />

increased serum prolactin concentration than the normal


496<br />

Abstracts<br />

group, when the plasma sample was obtained within 60 min<br />

of an attack; but the pseudoseizures group was not significantly<br />

different from the normal group. Different type of<br />

seizures has different effect on serum prolactin; serum<br />

prolactin concentration increased significantly after generalized<br />

tonic – clonic and complex partial seizures, while<br />

simple partial seizures, myoclonic seizures and absence<br />

seizures were not associated with increased serum prolactin<br />

concentration. Our findings showed that prolactin is useful<br />

in differencing epileptic seizures from pseudoseizures.<br />

FP-H-011<br />

Ictal video-EEG and clinical characteristics of infantile<br />

spasms<br />

X. Zhao, F. Wang<br />

Department of Pediatrics, Tangdu Hospital, Fourth Military<br />

Medical <strong>University</strong>, Xi’an, China<br />

Objective: To analyze the clinical and video-EEG characteristics<br />

of infantile spasms. Methods: 18 children with<br />

infantile spasms were monitored by video-EEG. The EEG<br />

data and behavior recordings were analyzed simultaneously.<br />

Results: (1) The seizure types of infantile spasms included<br />

flexor, extensor and mixed. The spasm seizures occurred in<br />

scatter or cluster that coincided with sleep and wakefulness<br />

onset. On average, there were 16 seizures in one cluster of<br />

seizures. The seizure lasted 1–3 s and the interval of seizures<br />

was 5–20 s. (2) Infantile spasms can occur with partial and<br />

other types seizures. (3) The interictal EEG of infantile<br />

spasms had hypsarrythmia and the ictal EEG had slow<br />

spike-and-wave complexes or suppression-burst. Conclusion:<br />

Infantile spasms have unique type of seizures and<br />

can appear as partial or other type seizures. The frequency<br />

of seizures is high. It is easily found by video-EEG. The<br />

ictal and interictal EEG of infantile have unique manifestations.<br />

FP-H-012<br />

Coincidence of Rolandic and absence features: rare, but<br />

not impossible<br />

P.S. Dimova, D.S. Daskalov<br />

Clinic of Child Neurology, <strong>University</strong> Hospital of Neurology<br />

and Psychiatry ‘St. Naum’, Sofia, Bulgaria<br />

This study’s purpose is to evaluate the incidence of<br />

concomitant clinical and EEG absence and rolandic<br />

discharges. The 1997–2000 medical files and EEG records<br />

of all children with Rolandic epilepsy, childhood, and juvenile<br />

absence epilepsy were retrospectively analyzed. Out of<br />

the 66 patients with Rolandic epilepsy, six children showed<br />

during the antiepileptic treatment clinical and/or EEG<br />

features of absences. Most of them were treated initially<br />

with carbamazepine and had generalized spike-wave<br />

discharges of a secondarily generalized type. Five cases<br />

from the group of 34 children with childhood absence<br />

epilepsy and three cases from the group of 11 patients<br />

with juvenile absence epilepsy were identified with an<br />

EEG focus of rolandic type in the first or in subsequent<br />

EEGs. None of the patients with absences experienced<br />

rolandic seizures during the disease course. All atypical<br />

EEG phenomena were registered while awake, thus precluding<br />

the possibility of sleep activation. The likely relation of<br />

absence features in Rolandic epilepsy to the treatment is<br />

considered as well as the probability of their manifestation<br />

as a sign of atypical, complicated course of Rolandic<br />

epilepsy. On the other hand, the presence of a Rolandic<br />

focus in the course of typical childhood or juvenile absence<br />

epilepsy makes the coincidence of these entirely distinct<br />

phenomena, even if very rare, not exceptional, and suggests<br />

that a genetic link between partial and generalized EEG<br />

discharges could exist. Further studies are required to elucidate<br />

the mechanisms and carriers of inheritance and liability<br />

to the most childhood epilepsies.<br />

FP-H-013<br />

Optimal treatment of Rolandic epilepsy: priority of<br />

valproate over carbamazepine<br />

P.S. Dimova, D.S. Daskalov<br />

Clinic of Child Neurology, <strong>University</strong> Hospital of Neurology<br />

and Psychiatry ‘St. Naum’, Sofia 1113, Bulgaria<br />

It was the aim of this study to evaluate the treatment effects<br />

of the anticonvulsants most often used in BECTS. The medical<br />

charts and EEG records of 66 children with the diagnosis<br />

of BECTS were retrospectively analyzed. Out of these<br />

patients, 48 children were treated initially with CBZ, and<br />

17 – with VPA. In general, CBZ and VPA had similar efficacy<br />

in seizure control and reduction, but differed in terms of<br />

lacking efficacy and seizure aggravation. Main differences<br />

between these drugs were found in their effects on the EEG<br />

abnormality. The epileptic potentials disappeared or<br />

improved significantly more often under VPA, and were<br />

unchanged or activated significantly more often with CBZ.<br />

This EEG-response reflected on the better effects of VPA on<br />

the neuropsychological disturbances in some patients. These<br />

results lead us to suggest that VPA could be a drug of first<br />

choice in BECTS.<br />

FP-H-014<br />

Self-control study of depakine for the treatment of<br />

childhood epilepsy<br />

X.-H. Shao<br />

Department of Pediatrics Neurology, Xinhua Hospital<br />

Affiliated to Shanghai Second Medical <strong>University</strong>, Shanghai,<br />

China<br />

Objective: To verify the curative effect and safety of depakine<br />

for the treatment of childhood epilepsy. Methods: An


Abstracts 497<br />

open-label, add-on, self-control study was undertaken in 26<br />

children with epilepsy. The seizure frequencies in 6 months<br />

before and after therapy were compared in these epileptic<br />

patients. The patients were treated with depakine at the<br />

dose of 15–30 mg/kg per day, and the seizure-rate and<br />

side-effects were noted. Results: The seizure frequency<br />

decreased significantly ($50%) in 24/26 (92.3%) patients<br />

after therapy, depakine was effective for all type of seizures,<br />

in particular for generalized tonic-clonic convulsions.<br />

Patients could tolerate depakine well. Most adverse events<br />

including vomiting and dizziness were mild or moderate in<br />

severity, and occurred occasionally (4/26, 15.4%). Conclusion:<br />

Depakine is an effective, broad-spectrum and had a<br />

favorable safety for the treatment of childhood epilepsy.<br />

FP-H-015<br />

Diagnostic analysis of recurrent seizures in 86 children<br />

beginning with febrile convulsions<br />

J.-X. Liao, L. Chen, Y.-H. Xiao, B. Li, T.-S. Huang, Z. Wei<br />

Epilepsy Center, Shenzhen Children’ s Hospital, Shenzhen,<br />

China<br />

Background and objectives: Childhood onset of multiple<br />

febrile convulsions continued with fever beyond 6 years, or a<br />

febrile seizures occurred. It was not mentioned in the international<br />

classification of epilepsy syndromes about how<br />

these seizures are diagnosed. Based on research of a large<br />

multigenerational family, Scheffer IE and Berkovic SF advocated<br />

a new epilepsy syndrome, the GEFS 1 . The commonest<br />

phenotype is denoted as FS 1 . We analyzed the diagnosis of<br />

recurrent seizures beginning with febrile convulsions in children.<br />

Methods: We investigated children attending the pediatric<br />

neurology service of the out-patient department from<br />

1994 to 2001 in whom detailed clinical records were available.<br />

Results: There were 86 individuals that comprised<br />

about 5.0% of seizure patients of our out-patient department.<br />

Two individuals were diagnosed as having febrile seizures,<br />

64 (74.4%) FS 1 , eight FS 1 and absences, five FS 1 and<br />

myoclonic seizures, three FS 1 and myoclonic-astatic<br />

epilepsy, two FS 1 and temporal lobe epilepsy and two FS 1<br />

as suspected and temporal lobe epilepsy. Conclusions: There<br />

are a few GEFS 1 individuals among small family or sporadic<br />

patients. The recognition of GEFS 1 is helpful for the treatment<br />

of these patients.<br />

FP-H-016<br />

The clinical use of digital ambulatory<br />

electroencephalography<br />

Y.-H. Xiao, J.-X. Liao, Y. Chen, W.-Y. Chen, P. Xia<br />

Epilepsy Center and Department of Pediatric Neurology,<br />

Shenzhen Institute of Pediatrics and Shenzhen Children’s<br />

Hospital, Guangdong, Shenzhen, China<br />

Objectives: To investigate the characteristics of digital<br />

ambulatory electroencephalography (AEEG) and the efficacy<br />

of AEEG in the diagnosis and differential diagnosis<br />

of paroxysmal diseases in children. Methods: With 16-channel<br />

digital AEEG, 88 patients whose diagnosis had not yet<br />

been determined, but clinical features made them suspected<br />

of having epilepsy, although routine electroencephalograms<br />

had been tested, were examined for 24 h. The AEEG monitoring<br />

also included activating tests such as opening- closing<br />

eyes and hyperventilation, etc. The positive results meant<br />

that epileptiform discharges and/or abnormal background<br />

activity appeared. Results: Digital AEEG was very convenient<br />

with its multiple channels up to 16, enabling to change<br />

any montage as needed, and adopt wave amplitude and<br />

scanning velocity, and the quality were as high as that of<br />

routine EEG. Of 88 patients the positive rate was 67% (59/<br />

88), and 44 were diagnosed with epilepsy definitely, their<br />

epleptiform discharges was recognized and well localized,<br />

their epilepsy type was classified. Two patients had no<br />

epileptic seizures but had typical epileptiform discharges.<br />

Referred to clinical manifestations, the diagnosis of epilepsy<br />

was excluded in 19 patients. Conclusion: Digital AEEG<br />

might obtain much more information than traditional<br />

magnetic tape analog AEEG, and the focus might be determined<br />

more precisely, and it is a great progress of electroencephalography.<br />

FP-H-017<br />

Continuous intravenous infusion of midazolam for<br />

treatment of intractable seizures in children<br />

J.-M. Zhong, J.-H. Li, M.-Z. Zhou<br />

Jiangxi Children’s Hospitol, Nanchang, Jiangxi, China<br />

Objective: To determine the efficacy and safety of midazolam<br />

given as a continuous infusion in the treatment of<br />

prolonged seizures and a cluster of seizures in children.<br />

Methods: Thirty-two patients admitted to the neurological<br />

ward in our hospital met the criteria of status epilepticus or a<br />

cluster of seizures with duration of more than 30 min and the<br />

seizures were unresponsive to diazepam, clonazepam,<br />

phenobarbital, and valproic acid. They were 24 boys and<br />

eight girls. Mean age was 2.5 ^ 2.9 years (ranging 37 days–<br />

12 years), and 46.9% (15/32) of cases were under 1 years of<br />

age. The type of seizure was generalized in 25 cases, partial<br />

in seven, myoclonus in two, respectively. Etiologically, 13<br />

children had primary epilepsy, 12 central nervous system<br />

infection, one intracranial hemorrhage, one drowning, and<br />

the remaining five had toxic encephalopathy. All patients<br />

received intravenous midazolam at 0.10–0.26 mg/kg as<br />

bolus, followed by a continuous infusion at 0.10 mg/kg<br />

per h initially; the dose was increased gradually up to 0.35<br />

mg/kg per h or until the complete control of seizures was<br />

achieved. Time to control seizures, infusion rate and sideeffects<br />

were monitored. Results: Among 32 children, 21<br />

cases were brought under complete control, and there was<br />

seizure improvement (more than 50% reduction of seizures)


498<br />

Abstracts<br />

in seven. The remaining four showed no responses. Mean<br />

time to control seizures was 10.1 ^ 14.9 h (ranging 1 min–<br />

43 h) and seizures stopped with 5 min in 47.6% of cases.<br />

Mean infusion rate was 0.18 ^ 0.09 mg/kg per h (ranging<br />

0.10–0.35 mg/kg per h). Mean duration of infusion was<br />

62.0 ^ 38.3 h (ranging 14–152 h). None of the children<br />

had clinically important changes in blood pressure, heart<br />

rate, respiratory status and retention of urine attributable<br />

to the use of midazolam. Conclusions: Midazolam infusion<br />

is an effective and safe therapeutic approach to control<br />

intractable seizures.<br />

FP-H-018<br />

The use of goggles flash visual evoked potential in<br />

disorders of children’s central nervous system (CNS)<br />

S.-H. Li, Y. Chen, Z.-X. Qiao<br />

Harbin Children’s Hospital, Harbin, China<br />

Purpose: To obtain the normal value in group of children<br />

and the abnormal value in group of children having<br />

impaired consciousness in different degree by goggles flash<br />

visual evoked potential (GO-VEP). Methods: To stimulate<br />

the eyes by goggles flash using the drawing instrument<br />

(SEEG) of 16 channels colors EEG and evoked potential<br />

made by DanDe company in Denmark. And the potentials<br />

were recorded with silver plate electrode in Oz point,<br />

stimulating both eyes. Each eye must be examined twice,<br />

which will give better reappearance. Conclusion: GO-VEP<br />

can not be affected by the power and sensitivity of sight,<br />

and can be used to detect baby, infant and child with<br />

impaired consciousness who have disorders of CNS. It is<br />

a new way to find the visual nervous damage and can be<br />

repeated. At the same time, it is foundation to detect the<br />

early damage of visual nerves. It can be an assistant<br />

method for pattern reversal visual evoked potential (PR-<br />

VEP).<br />

FP-H-019<br />

Analysis of brain electrical activity mapping of 100<br />

children with generalised epilepsy<br />

S.-H. Liu, X.-Q. Wu<br />

Shenyang Medical and Health Care Center of Children and<br />

Women, Shenyang, China<br />

Epilepsy is a common emergency in clinical pediatrics;<br />

the diagnosis depends upon the seizures and electroencephalogram.<br />

Brain electrical activity mapping (BEAM) is a<br />

new electrophysiological technique that is recently widely<br />

used clinically, but its value in the diagnosis of childhood<br />

epilepsy is rarely reported. The analysis was done in the<br />

BEAM results of 100 cases of childhood epilepsy with a<br />

confirmed diagnosis of generalised epilepsy. It was found<br />

that 91 cases had abnormal BEAM (91%), and the abnormal<br />

ratio increased with the age, there was 30% local<br />

BEAM abnormality in generalised epilepsy. It was also<br />

found that the local BEAM abnormality is coincident<br />

with the part of brain CT abnormality. BEAM can not<br />

display the epileptic waves such as sharp wave, spike<br />

wave, spike and slow waves and so on, but it can show<br />

different brain electrical activity signals which depend on<br />

different frequency of power pedigrees in corresponding<br />

simulated EEG, and make the brain electrical activities<br />

more quantitative, objective, imaginable, and directive. It<br />

is helpful in making diagnosis and observing the remedy<br />

effect of epileptic children.<br />

FP-H-020<br />

Convulsive disorders in PICU: an etiological analysis of<br />

182 cases<br />

S.-H. Liu, Y. Li<br />

Shen Yang Childrens’ Hospital, Liaoning, China<br />

Objective: To summarize and analyze the commonly<br />

encountered reasons of convulsions in pediatric intensive<br />

care unit (PICU). Methods: According to the age, the 182<br />

children from 1 month to 14 years old were divided into four<br />

groups, then according to the sex subdivided into eight<br />

groups. Results: The percentages of different reasons in<br />

these groups were reported. Febrile convulsions, vitamin<br />

Ddeficient hypocalcemic seizures, epilepsies, and central<br />

nervous system infections are most commonly encountered<br />

etiological factors in this study, whereas hereditary metabolic<br />

disorders may constitute one of the relatively rare<br />

causes.<br />

FP-H-021<br />

Applying topiramate to treatment of infantile epilepsy<br />

Y.-Q. Zhang, J. Zhu, D. Li, P.-Y. Zhang, X.-L. Yu<br />

Department of Neurology, Tianjin Children Hospital, Tianjin,<br />

China<br />

Objective: To evaluate the efficacy and tolerance of topiramate<br />

as monotherapy and adjunctive therapy in infantile<br />

epilepsy. Method: Forty-five patients were included, aged<br />

15 days to 2 years, median 9 months (male 27, female 18),<br />

weighed 2.8–15 Kg (median 9.5 Kg). Age distribution: #3<br />

months 11, 26 months 13, 21 year 12, 22 years nine. The<br />

course ranged from 4 h to 21 months. Secondary epilepsy<br />

38, and cryptogenic epilepsy seven. Twenty-five of 45<br />

received monotherapy and 20 adjunctive therapies. Dosages<br />

of topiramate were adjusted to optimal clinical response.<br />

Results: The frequency of all seizures was reduced $50%<br />

from baseline in 91% of 45 patients, and the rate of seizurefreedom<br />

was 37.8%, when the mean duration of topiramate<br />

therapy was 3 months. The frequency of all seizures was<br />

reduced $50% from baseline in 91% of 34 patients, and the<br />

rate of seizure-freedom was 52.9%, when the mean duration<br />

of therapy was 3 months. The frequency of all seizures was


Abstracts 499<br />

reduced $50% from baseline 100% of 25 patients with<br />

monotherapy and 80% of 20 patients with adjunctive therapy.<br />

The incidence of adverse effects was 20%. Adverse<br />

effects of topiramate were mild. Hypohidrosis was notable.<br />

In 28 patients, blood routine/urine routine and function of<br />

liver and kidney was normal during taking drugs. Conclusion:<br />

The study shows that topiramate is an effective and<br />

well tolerated agent in monotherapy and adjunctive treatment<br />

for infants with epilepsy. Adverse effects were mild.<br />

FP-H-022<br />

Febrile convulsions in children: a clinical analysis of 108<br />

cases<br />

Y.-Z. Zhang, M. Feng<br />

Shanghai Baoshan central Hospital, Shanghai, China<br />

To investigate the characteristics and related factors of<br />

febrile convulsions, 108 cases of young children were<br />

divided into relapse group and non-relapse group to<br />

analyse the high risk recurring factor. They were also estimated<br />

in terms of their convulsion characteristics (including<br />

seizure types, duration time and temperature, etc.) and<br />

white blood cells count (including lymphocyte count and<br />

neutrocyte count), by using of logistic multiple regression.<br />

The result shows that there is a significant difference<br />

between the relapse group and the non-relapse group in<br />

the first attack age, the first occurring temperature, seizure<br />

types and family history. There is no significant correlation<br />

between white blood cells count and the characteristics of<br />

convulsions. The results suggest that white blood cells<br />

count is of no value in diagnosis of febrile convulsions in<br />

children. Febrile convulsions are susceptible to recurrence,<br />

and are closely related with the first occurring age, the first<br />

seizure types and family history. It is necessary to estimate<br />

children with high fever by means of those risk recurrence<br />

factors mentioned above in clinical experience. Take<br />

proper intervention when necessary.<br />

FP-H-023<br />

Magnetoencephalographic study of patients with<br />

continuous spikes and waves during slow sleep (CSWS)<br />

H. Hattori a , A. Yasuhara d , K. Tanaka a , T. Tsutada b ,N.<br />

Tsuyuguchi c , M. Shimogawara e , H. Ishida a , O. Matsuoka a ,<br />

T. Yamano a<br />

Departments of a Pediatrics, b Geriatrics and Neurology, and<br />

c Neurosurgery, Osaka City Univeristy Medical School,<br />

Osaka, Japan; d Department of Pediatrics, Kansai Medical<br />

College Kori Hospital, Neyagawa, Japan; e Applied Electonics<br />

Laboratory, Kanazawa Institute of Technology,<br />

Tokyo Japan<br />

Objective: We analyzed the diffuse spikes and waves in<br />

patients with CSWS using magnetoencephalography<br />

(MEG) in order to know the pathogenesis of CSWS.<br />

Patients: MEGs were measured in seven patients who<br />

were electroclinically diagnosed as CSWS. The patients<br />

were 7–11 years old (one boy and six girls). Methods:<br />

MEGs were measured in a magnetically shielded room,<br />

using the newly developed, whole-cortex MEG that has a<br />

160-channel, first-order gradiometer. Data were filtered<br />

with a band pass of 3–250 Hz and digitized to 1000 Hz.<br />

We estimated the dipoles of the spikes in the simultaneously<br />

recorded EEG. These estimated dipoles were<br />

superimposed on the magnetic resonance images. Results:<br />

We could estimate the dipoles in five patients as mapping<br />

onto the focal cortical area bilaterally, localizing almost<br />

symmetrically. Short time differences were recognized<br />

between sides. These time differences were from 14.2 to<br />

35.3 ms. The impulse will transfer through the corpus<br />

callosum and make miller focus. The dipole was localized<br />

in the Sylvius area in two patients, the parieto-oocipital<br />

area in two patients, and the frontal area in one patient.<br />

We could not estimate the dipoles in the other two patients.<br />

Conclusion: Secondary bilateral synchronization will form<br />

diffuse spikes and waves in majority of CSWS patients,<br />

and MEG can define their focus. However, some patients<br />

with CSWS have primary bilateral synchronization. Pathogenesis<br />

of CSWS was considered heterogeneous.<br />

FP-H-024<br />

The magetoencephalographic findings in infantile<br />

spasms<br />

S. Hanaoka, M. Kawatani, M. Izumi, M. Fukumizu, K.<br />

Sugai<br />

Department of Child Neurology, National Center Hospital<br />

for Mental, Nervous and Muscular Disorder, National<br />

Center of Neurology and Psychiatry, Kodaira, Japan<br />

Infantile spasms is an early onset epilepsy with characteristic<br />

clinical and EEG findings. There are already many<br />

approaches to its electrophysiological mechanism, but it is<br />

yet unclear. The MEG is one of useful instruments to detect<br />

the source of paroxysmal discharges, and there is no report<br />

to analyze them in infantile spasms. We examined the<br />

patients affected to infantile spasms by a whole brain type<br />

MEG in order to approach to its electrophysiological<br />

mechanism from the viewpoint of magnetic field. Subjects.<br />

Method: The subjects are five cases of infantile spasms form<br />

the age of 5 months to 1 year and 4 months, three males and<br />

two females. By using Neuromag 204, we analyzed MEG<br />

findings and the source of paroxysmal discharge in comparing<br />

with simultaneous EEG records. Results: All of five<br />

cases showed multifocal pattern and their dipole sources<br />

were scattered on bilateral hemispheres. By the analysis<br />

about more than 30 points of paroxysmal discharges, the<br />

dipole sources showed a tendency to accumulate in the<br />

parietal and its adjacent lesions. The dipole sources accumulated<br />

around the posterior horns in four of five cases,<br />

which seemed to correspond to watershed areas. Conclu-


500<br />

Abstracts<br />

sions: The results suggest the importance of pathophysiological<br />

changes of the watershed areas as a development of<br />

infantile spasms.<br />

FP-H-025<br />

A comparative clinicoelectrical study on the influences of<br />

influenza infection versus vaccination on the epilepsies in<br />

the severely handicapped patients<br />

Y. Yamatogi, T. Misaki, K. Kawakubo, K. Araki, A. Tsutsui<br />

Okayama Prefectural <strong>University</strong>, Soja, Okayama, Japan<br />

To clarify the influence of influenza vaccination on<br />

epilepsy is important for the clinical management of the<br />

severely handicapped patients who are vulnerable to infection.<br />

Methods: Three clinicoelectrical investigations were<br />

made on those without change in antiepileptic medication<br />

around vaccination or infection; (1) influences of the initial<br />

vaccination on clinical seizures and epileptic discharges in<br />

28 patients; (2) influences of the repeated vaccination in 24<br />

patients; and (3) influences of influenza infection in 12<br />

patients. Results: (1) The initial vaccination transiently<br />

increased epileptic discharges more than 50% in seven<br />

patients (25.0%), with recovery within about 6 months.<br />

Allergic predisposition and age at vaccination may relate<br />

the worsening. (2) By the repeated vaccination, worsening<br />

in epileptic discharges increased from eight patients<br />

(33.3%) by the first vaccination to 14 patients (58.3%)<br />

and that in clinical seizures from none to seven patients<br />

(29.2%). Fortunately, both adverse effects were reversible.<br />

(3) Influenza infection also transiently worsened epileptic<br />

discharges in six (50.0%) and clinical seizures in two<br />

(16.7%). Conclusion: Influences on epilepsy may be the<br />

same in both influenza infection and the initial vaccination,<br />

but repeated vaccination is suggested to have a risk to accelerate<br />

the worsening of EEG and clinical seizures. Influenza<br />

vaccination should be carefully evaluated to perform in<br />

those with intractable epilepsy, particularly due to severe<br />

brain damage.<br />

FP-H-026<br />

Changes of cerebral hemodynamics in children suffering<br />

from epilepsy<br />

S.A. Goulyaev, A.A. Ovchinnikova, S.E. Goulyaeva, I.V.<br />

Archipenko<br />

Vladivostok Medical State <strong>University</strong>, Vladivostok, Russia<br />

Changes of cerebral hemodynamics in 410 children<br />

suffering from epilepsy were studied. It is determined, that<br />

a vascular factor is one of the main causes of development<br />

mechanism of epilepsy. During the period of pre-natal<br />

development the lack of blood provision makes worse<br />

genetically determined imbalance of mediator exchange,<br />

then it turns out to become a regulator of degeneration<br />

process development in nerve tissue. Dynamics of clinical<br />

manifestations of epilepsy and its EEG characteristics<br />

reflect fading of epileptic manifestations of cerebral activity<br />

with age. Computer tomography of cerebrum allows to<br />

visualize morphological defects in cerebrum structures in<br />

83.7% cases of epilepsy. Abnormality of anatomic structure<br />

of cerebrum and its atrophy can be observed in equal<br />

percentage. Transcranial dopplerography capacities in diagnosing<br />

changes of cerebral hemodynamics in epilepsy can<br />

reach 86.3%. During the period between the attacks one can<br />

observe the following: changes of vascular tonus of microcirculatory<br />

mouth; different combinations of local changes<br />

of manifestation of cerebral hemodynamics. Among the<br />

local changes we can differentiate three changes reflecting<br />

abnormality of anatomic structure of cerebral vascular<br />

system: alteration turbulent and normal blood flow; combination<br />

of signs of different degree of manifestation of stenosis;<br />

unexpected alterations of findings of peripheral<br />

resistance. All of those mentioned above could be observed<br />

in the adjacent sections of one and the same vessel. In<br />

epilepsy such changes were observed in 22% of cases.<br />

During the period of epilepsy attack one can observe<br />

synchronous registration of generalization of epileptic activity<br />

on EEG and sonic sound of angiospasm reactions on<br />

Monitor-Dopplerograph that arises later 0.3–1.2 s than<br />

generalization of epileptic patterns on EEG, but it remains<br />

even after their disappearance.<br />

FP-H-027<br />

Case report: progressive neuronal degeneration (Alpers-<br />

Huttenlocher disease)-seizure free on Topamax add-on<br />

therapy<br />

V. Mejaški-Bošnjak, K. Fumić, J. Bošnjak, L. Lujic, Z.<br />

Ardašanić, B.M.-D. Marina<br />

Children’s Hospital Zagreb, <strong>University</strong> Medical School,<br />

Zagreb, Croatia<br />

Progressive cerebral poliodystrophy – Alpers-Huttenlocher<br />

disease (A-H d) is a clinico-pathological syndrome<br />

with no specific biochemical marker. A-H d is usually<br />

presented as an early-onset progressive encephalopathy<br />

with intractable seizures and liver dysfunction. Etiology is<br />

still obscure, though respiratory chain mitochondrial disorders<br />

have been postulated. Valproate treatment of the<br />

seizures may trigger hepatic failure and fatal outcome. We<br />

present the case of a 6-year-old girl who, following a period<br />

of developmental delay and failure to thrive during infancy,<br />

suffered at age of 17 months from myoclonic seizures. After<br />

valproate administration the condition of the child worsened<br />

leading to serial seizures of various type (myoclonic, generalised<br />

clonic, etc.) and mild hepatic dysfunction progressing<br />

into coma. Valproates were immediately withdrawn, and<br />

barbiturate was given intravenously along with support of<br />

vital functions. The girl survived this acute life-threatening<br />

episode, deteriorating in terms of severe mental impairment,<br />

along with autistic traits, and intractable epilepsy of predo-


Abstracts 501<br />

minately partial complex and generalised tonic fits. Paraclinical<br />

investigation: biochemical tests, neurophysiological<br />

and neuroimaging findings, liver and muscle biopsy with<br />

analysis of respiratory chain enzymes supported A-H d.<br />

Further anticonvulsive polytherapy consisted of various<br />

drugs, being modified repeatedly due to inefficiency since<br />

the girl had 10–30 fits/day. At age of 5 years she was put on<br />

Topiramate add-on therapy slowly titrated. Fits were gradually<br />

reduced in number and severity, and at the dosage 8 mg/<br />

kg she became seizure-free for 1 year. There was no adverse<br />

effect of the drug. The mechanism of beneficial effect of<br />

Topiramate in the case of A-H d is discussed.<br />

FP-H-028<br />

Lamotrigine in the treatment of epilepsy in patients with<br />

Rett syndrome<br />

V. Mejaški-Bošnjak, L. Lujić, B.M.-D. Marina, R.<br />

Duplančić, V.D⁄ uranović, T. Gojmerac<br />

Children’s Hospital Zagreb, <strong>University</strong> Medical School,<br />

Zagreb, Croatia<br />

RS is a progressive neurodevelopmental disorder, occurring<br />

almost exclusively in female patients, clinically characterized<br />

by acquired microcephalia, mental retardation,<br />

autistic behavior, ataxia, loss of purposeful use of the<br />

hands. Epilepsy and/or EEG abnormalities are common<br />

problems in patients with RS. We present ten girls (aged<br />

4–12 years), who met diagnostic criteria of typical RS,<br />

followed-up for 1.5–9 years. At last assessment 6 of them<br />

were classified as III stage and 4 as II stage of RS. Seven out<br />

of these ten RS patients have epilepsy (generalized clonic/<br />

tonic and/or myoclonic fits), while three were seizure free,<br />

showing multifocal EEG abnormalmalities. Epilepsy was in<br />

all RS patients intractable, treated with various antiepiletic<br />

drugs, most commonly using valproates. Lamotrigine was<br />

given as add-on therapy in all seven RS patients having<br />

epilepsy, and as monotherapy in three patients with abnormal<br />

EEG. Effect of Lamotrigine therapy was evaluated after<br />

1–1.5 years. One RS girl became seizure free, while six<br />

other have marked stabilization of epilepsy in terms of<br />

severity and frequency of the seizures. Remaining three<br />

seizure free patients, during period of follow up were still<br />

seizure free, with improved EEG abnormalities in two. We<br />

conclude on beneficial effect of Lamotrigine in the treatment<br />

of epilepsy in patients with RS.<br />

FP-H-029<br />

Ketogenic diet in four Chinese children<br />

W.-W. Cheng, P.W.T. Tse<br />

Caritas Medicalcentre Caritas Medical Centre, Hongkong,<br />

China<br />

The ketogenic diet is a special diet that was first used as a<br />

treatment for epilepsy in 1921 with increased popularity<br />

recently. In our Developmental Disability Unit, 118 children<br />

had epilepsy, of which 30 were refractory. In the past 2.5<br />

years, ketogenic diet was started in four of them. All of<br />

them had been tried on at least four anticonvulsants. There<br />

were two failures in terms of no improvement in seizure<br />

frequency despite attaining deep ketosis during a 4-month<br />

and a 6-month trial period respectively. In the third child,<br />

medium-chain triglyceride ketogenic diet was implemented<br />

at the age of 5 years. There was ,50% improvement in<br />

seizure frequency initially. After changing to classical ketogenic<br />

diet, .90% improvement was attained. The general<br />

well being of the patient improved. He has been on the diet<br />

for 30 months and experienced no complications such as<br />

growth failure, hypercholesterolaemia and renal stone<br />

formation. In the fourth child, ketogenic diet was started at<br />

the age of 18 months. She attained 50% improvement in<br />

seizure frequency. Prior to the diet, she suffered catastrophic<br />

seizures and status epilepticus which disappeared after the<br />

diet. At the age of twenty-three months, a renal stone of 6 mm<br />

was revealed. Balancing the risk of withdrawal from the diet,<br />

ketogenic diet was continued with close monitoring of the<br />

complications. Conclusion: Ketogenic diet is worthwhile<br />

trying especially in those children for whom epilepsy surgery<br />

will unlikely be an option to them.<br />

FP-H-030<br />

The application of Topamax w to children with epilepsy<br />

J.-F. Guo, H. Zhao, X. Wang, J.-C. Guo, Y.-L. Guo, T. Chen<br />

Panjin No. 2 People’s Hospital, Panjin City, Liaoning,<br />

China<br />

We reported the results of using Topamax w , a new antiepileptic<br />

drug, to 30 cases of children’s epilepsy in our hospital<br />

since June, 1999. Out of the 30 cases, 17 cases were male,<br />

13 cases were female, and they were at the age of 2–12,<br />

average 5.6. The courses of disease were 3 months–10<br />

years. During the period of treatment, of five cases with<br />

simple partial seizures, three cases were seizure free, one<br />

case was markedly controlled and one case partially<br />

controlled. The total effectiveness is 100%. Of eight cases<br />

with complex partial seizures, three cases were seizure free,<br />

one case was markedly controlled, two cases partially<br />

controlled, and two cases not controlled. The total effectiveness<br />

is 75%. Of six cases with tonic clonic seizures, two cases<br />

were seizure free, one case markedly controlled, two cases<br />

partially controlled and one case not controlled. The total<br />

effectiveness is 83.3%. Of six cases with myoclonic seizures,<br />

two cases markedly controlled, two cases partially controlled<br />

and two cases not controlled. The total effectiveness is<br />

66.7%. Of five cases with atypical absence seizures, two<br />

cases partially controlled, three cases not controlled. The<br />

total effectiveness is 40%. Totally eight cases with seizure<br />

freedom occupied 26.7%. five cases with markedly<br />

controlled seizures occupied 16.7%. Nine cases with<br />

partially controlled seizures occupied 30%. The seizures


502<br />

Abstracts<br />

were not controlled in eight cases. The total effectiveness was<br />

73.3%. The best results were obtained in the patients with<br />

simple partial seizures, tonic clonic seizures and complex<br />

partial seizures, in this order. It was relatively difficult to<br />

control the patients with myoclonic seizures and atypical<br />

absence seizures. Our results indicated that 50% infant<br />

patients had adverse events in 1–3 weeks after initiating<br />

medicine. This showed that these adverse events occurred<br />

during the period of dose-increasing. As the time went on,<br />

the adverse events will get improved.<br />

FP-H-031<br />

Infantile autonomic epilepsy: clinical analysis of 32 of<br />

patients<br />

J.-F. Guo, H. Zhao, X. Wang, J.-C. Guo, Y.-L. Guo, T. Chen<br />

Panjin No. 2 People’s Hospital, Panjin City, Liaoning,<br />

China<br />

The study makes an analysis of 32 children with autonomic<br />

epilepsy diagnosed in our section from 1995 to 2001. Out of<br />

the 32 cases, 19 are male, and 13 female. They are at the age of<br />

3–12.Therearefivecasesattheageof3–5,19attheageof6–8,<br />

eight at the age of 9–12. The criteria for diagnosing autonomic<br />

epilepsy are as follows: (1) no positive symptoms were<br />

checked out for nervous system in all of these cases to eliminateorganicdiseaseswhichbelongtothedepartmentofinternal<br />

medicine and those which belong to the surgical<br />

department. (2) Repeated seizures. (3) Autonomic symptoms<br />

are dominant. (4) Abnormal EEG. (5) Antiepileptic drugs are<br />

effective in patients whose EEGs are normal. All cases had<br />

EEG examinations. Abnormal results appeared in the EEG of<br />

23 cases (71.9%). Spikes or spiky slow waves appeared in the<br />

EEG of 15 cases, scattering spikes and sharp waves appeared<br />

in the EEG of eight cases, and the other nine cases had normal<br />

EEGs. As for the distribution of paroxysmal discharges, they<br />

appeared in different regions; 13 cases had notable paroxysmal<br />

discharges in the central area, six in the frontal areas, and<br />

four infrontalorone sideof thefrontalareas. Theantiepileptic<br />

drugs (carbamazepine, phenobarbital, valproic acid, etc.)<br />

were used for the therapy in all of these cases. We gave the<br />

drugs to the patients according to the routine dosage or individual<br />

difference. Notable clinical outcome has been<br />

achieved.<br />

FP-H-032<br />

Analysis of electroencephalogram in 415 children with<br />

febrile seizures<br />

Y. Chen, Y.-H. Xiao, J.-X. Liao<br />

Epilepsy Center, ShenZhen Children’s Hospital, Shenzhen,<br />

China<br />

Objective: To analysis the relationship between recording<br />

time after FS and abnormal rate of EEGs; And to imply<br />

abnormal EEG of FS can predict further seizures and the<br />

occurrence of later epilepsy. Method: EEGs were recorded<br />

2 , 3 days after FS in 415 FS children at the age 5<br />

months , 6 years old. Some of them were recorded again<br />

15 , 20 days after FS. Result: There was no relationship<br />

between the abnormal rate of EEG and the FS history of<br />

their relatives, but it was related to clinical features of FS<br />

(local seizure and FC lasting .15 min) and ages. The rate of<br />

abnormal EEGs was 80% 2 , 3 days after FS. It contained<br />

61% of slow activity and indefinite spikes and 19% of spikes<br />

or spike-slow wave. In records taken again after 15 days, the<br />

rate of spikes and spike-slow wave discharges was 17%.<br />

There was no significant relation between EEG at different<br />

times. The rate of further seizures was raised in children<br />

with abnormal EEGs, and some of them (four of them)<br />

developed epilepsy. Conclusion: There may be no relationship<br />

between the abnormal rate of EEG and FS history in<br />

relatives. It was related to clinical features of FS. EEGs<br />

recorded 2 , 3 days after FS was as important as those<br />

after 15 days. Further seizures might be related to abnormal<br />

EEGs and abnormal EEGs may lead to epilepsy.<br />

FP-H-033<br />

The clinical analysis of 158 cases of iatrogenic<br />

intractable epilepsy in children<br />

G.-B. Bian, Y.-P. Qiu<br />

Hospital Attached to Ningxia Medical College, Yinchuan,<br />

Ningxia, China<br />

In order to explore the causes of iatrogenic intractable<br />

epilepsy and its solutions, 158 cases have been classified<br />

and analysed intensively. Among these causes are: improper<br />

diagnosis and classification of epilepsy, lack of aim of drug<br />

choices, abuse of multi-drugs, improper drug dosage, lack of<br />

individuality, the drug usage are not in accordance with pharmacokinetics,<br />

improper drug variety and dosage regulation,<br />

too short courses, too early drug termination, no consideration<br />

of sick children’s general status. Here is to ask pediatrician<br />

clinical doctors to master epilepsy diagnosis and its<br />

classification skilfully and fully understand pharmacological<br />

characteristics of pharmacokinetics and pharmacodynamics<br />

on different anti-epileptic drugs. With the combination of<br />

examination measures such as EEG and serum drug concentration,<br />

doctors are able to give a regular and individual treatment<br />

to each case after the detailed analysis of the interaction<br />

among diseases, sick children’s status and drugs.<br />

FP-H-034<br />

Determination of neuropeptide Y (NPY) in the plasma<br />

and its clinical significance in children with epilepsy<br />

D. Liu a , Q.-Y. Zhang b<br />

a Department of Pediatrics, Central Hospital Affiliated to<br />

Shenyang Medical College, Shenyang, China; b Department<br />

of Pediatrics, The First Clinical College, China Medical<br />

<strong>University</strong>, Shenyang, China


Abstracts 503<br />

Objective: To observe the change of NPY in the plasma<br />

in children with epilepsy and thereby to evaluate its possible<br />

application in clinical practice. Methods: In the early<br />

morning, 2 ml venous blood was collected from all<br />

enrolled subjects, including 53 children with epilepsy<br />

(43 cases with primary epilepsy, ten cases with symptomatic<br />

epilepsy). Among the children with primary<br />

epilepsy, 34 cases had not been treated, nine cases had<br />

seizures after being treated. Twenty-one healthy children<br />

were enrolled to serve as normal controls. The levels of<br />

plasma NPY were measured by means of radioimmunoassay.<br />

Results: (1) The levels of NPY in children with<br />

epilepsy (210.57 ^ 71.28 pg/ml) were markedly higher<br />

than those of normal control subjects (159.99 ^ 65.10<br />

pg/ml), the difference was significant, P , 0:01. (2) The<br />

levels of NPY in children with primary epilepsy<br />

(210.57 ^ 71.28 pg/ml) compared with that with symptomatic<br />

epilepsy (219.25 ^ 97.14 pg/ml), the difference was<br />

not significant, P . 0:05. (3) The levels of NPY in children<br />

with primary epilepsy who had not been treated<br />

(205.57 ^ 63.89 pg/ml) compared with that with primary<br />

epilepsy who had seizures after being treated<br />

(229.44 ^ 96.61 pg/ml), the difference was not significant,<br />

P . 0:05. Conclusions: The results indicated that the<br />

levels of NPY in children with epilepsy were markedly<br />

increased and the change of NPY did not correlate to<br />

pathogenesis and treatment.<br />

FP-H-035<br />

A study on epileptic children’s intelligence quotients and<br />

affecting factors<br />

Y.-L. Hu<br />

Department of Pediatrics, First Peoples’ Hospital of<br />

Yunnan Province, Kunming, Yunnan, China<br />

Objective: To study the IQ and affecting factors of epileptic<br />

children. Methods: IQ was assessed in 28 children with<br />

epilepsy and 30 normal children. Thirteen possible affecting<br />

factors of the intellectual development were investigated.<br />

Results: IQ of epileptic children was significantly lower<br />

than normal children. With stepwise regression analysis,<br />

the main risk factors were in proper order: age, type of<br />

disease, frequency of disease, course of disease and time<br />

for controlling symptom. Conclusions: Childhood epilepsy<br />

should be diagnosed early and treated correctly, which helps<br />

to reduce the incidence of mental retardation.<br />

FP-H-036<br />

The clinical and EEG analysis of 120 cases of benign<br />

focal epilepsy of childhood with centrotemporal spikes<br />

Y.-W. Zheng a , Q. Zhang b , C.-G. Fong b<br />

a Children’s Hospital Affiliated to Chongqing Medical<br />

<strong>University</strong>, Chongqing, China; b Kunming Children’s Hospital,<br />

Kunming, China<br />

Objective: To recognize the relationship between the<br />

prognosis of benign focal epilepsy of childhood with centrotemporal<br />

spikes (BFECT) and its clinical seizures as well as<br />

its EEG features. Method: The clinical materials and EEG<br />

features of 120 BFECT cases summarized and analyzed.<br />

Result: Age 6–10 is the high incidence period (70.8%) of<br />

BFECT which has the close relations to sleep, the basic type<br />

of epileptic seizure is general tonic-clonic and partial, its<br />

EEG features are partial spikes or sharp waves, 86.6% of<br />

which are in the central part of centrotemporal region.<br />

Conclusion: The literature indicates that the BFECT occurs<br />

during a particular growing period of childhood, the clinical<br />

prognosis of BFECT and its response to treatment with<br />

antiepileptic medicines are good.<br />

FP-H-037<br />

Clinical and electrophysiologic features of patients with<br />

Cockayne syndrome<br />

H.-S. Wu<br />

Beijing Children Hospital, Beijing, China<br />

Objective: Cockayne syndrome (CS) is a rare autosomal<br />

recessive inherited disorder. We studied the clinical and electrophysiological<br />

features in sixteen patients with CS. Methods:<br />

Data of all patients with classical CS admitted in the<br />

Beijing Children’s Hospital between September 1987 and<br />

April 2001 had been reviewed. Results: There were 14<br />

boys and two girls, ranging from 18 months–13 years.<br />

Sixteen patients showed premature ageing, cachectic dwarfism,<br />

microcephaly and mental retardation; 15 patients had<br />

photosensitivity and ataxia, 13 patients had pigmentary<br />

retinal degeneration, and 13 patients had sensorineural hearing<br />

loss. Age-matched control study showed, results of electromyography<br />

and nerve conduction velocity analysis<br />

(EMG/NCV) were abnormal in ten of 14 patients. Both<br />

motor and sensory nerves conduction velocities of median<br />

nerve reduced in eight cases (26.0 , 34.3 and 26.9 , 40.0 m/<br />

s, respectively), whereas in two cases, only motor nerves<br />

conduction velocities reduced in both median and peroneal<br />

nerves (40 , 42 and 30.7 , 38.8 m/s, respectively). All<br />

patients were abnormal on cranial CT or MRI. CT scan<br />

showed calcifications of the bilateral basal ganglia in 15<br />

patients. In one case, it was normal on CT scan, but MRI<br />

showed long T1 and long T2 signal lesions in left basal ganglia.<br />

Conclusions: Our study showed that the most useful diagnostic<br />

tool in CS is cranial neuroimaging. The findings of<br />

EMG suggested the presence of primary demyelinating<br />

neuropathy in peripheral nerves.<br />

FP-H-038<br />

Topamax as a first-choice drug in the treatment of West<br />

syndrome<br />

L.-P. Zou<br />

Beijing Children Hospital, Beijing, China


504<br />

Abstracts<br />

Objective: To establish the efficacy, tolerability and<br />

related events of using topamax as a first-choice drug in<br />

children with West syndrome. Methods: Fifty-four patients<br />

with West syndrome were given Topamax as monotherapy<br />

or as add-on therapy to nitrazepam. We followed up them<br />

ranged from 6 to 21 months (mean, 13 months). Results:<br />

31cases (57.4%) were seizure-free more than 6 months. A<br />

significant reduction from baseline in seizures frequency<br />

was found in 44 cases (81.4%), poor or null response ten<br />

cases (18.6%). The average, maximal and minimal doses<br />

were 5.2, 26 and 1.56 mg/kg per day, respectively. The<br />

adverse reactions included poor appetite (three cases),<br />

absent sweating (three cases), to difficult falling asleep<br />

(three cases). Conclusion: Topamax was proved to be an<br />

effective and safe drug as a first-choice drug in the treatment<br />

of West syndrome.<br />

FP-H-039<br />

Effects of topiramate on immunological function in<br />

patients with West syndrome<br />

L.-P. Zou<br />

Beijing Children Hospital, Beijing, China<br />

Objective: To explore the effect of topiramate on immunological<br />

function in patients with West syndrome. Methods:<br />

We used flow cytometry to measure the proportion of<br />

lymphocytes subsets in peripheral blood of the patients<br />

with West syndrome, and analysis/rate nephelometry to<br />

measure immunoglobulin level in the serum of the patients<br />

before and after topiramate treatment. Twenty-five normal<br />

health infants were taken as controls. Results: After topiramate<br />

treatment, CD4 1 cells in the patients were markedly<br />

decreased (P , 0:05). Compared to control group, CD19 1<br />

cells and serum IgA levels were significant decreased either<br />

before or after topiramate treatment (P , 0:001 and<br />

P , 0:05, respectively). NK cells in the patients were markedly<br />

increased after topiramate treatment (P , 0:05). Serum<br />

IgG levels were significant increased after topiramate treatment,<br />

and nearly reached normal level. Conclusions: Treatment<br />

with topiramate could affect immunological function of<br />

the patients with West syndrome, and it may play a role on its<br />

control to seizures.<br />

FP-H-040<br />

The relationship between the electroencephalogram<br />

(EEG), head computerized tomography (CT) and the<br />

prognosis of the West Syndrome<br />

S.-X. Yu a , H.-Y. Dong a , Z.-X. Li b<br />

a Jiading distract central hospital, Shanghai, China; b Jilin<br />

city children Hospital, Jilin, China<br />

Objective: To observe the relationship between the<br />

EEG, head CT and the prognosis of the West Syndrome.<br />

Methods: All of the 47 cases had EEG and head CT, and<br />

we had a follow-up study to compare with their prognosis.<br />

Results: Nineteen (60.6%) of 31 cases with abnormal<br />

head-CT, and 14 (87.5%) of 16 cases with normal head-<br />

CT showed progress. Twenty-nine of 34 cases with high<br />

rhythm disorder of EEG demonstrated progress, whereas<br />

only four cases with other kinds of EEG disorder did.<br />

Conclusions: There was no obvious relation between the<br />

prognosis of West Syndrome and the morphology of head<br />

CT (P . 0:05). But there was an obvious correlation<br />

between the prognosis and the change of EEG. The prognosis<br />

of patients with high rhythm disorder of EEG was<br />

better than those with the other kind disorders of EEG<br />

(P , 0:01).<br />

FP-H-041<br />

TPM as adjunctive therapy in the long-term<br />

management of children epilepsy<br />

W. Zhou, H. Li, X.-Q. Liu<br />

Qingdao Municipal Hospital, Qingdao, China<br />

Purpose: A total of 35 children (mean age, 6.6 years; range<br />

6 months , 14 years) with partial and/or generalized<br />

seizures previously resistant to AED therapy (median baseline<br />

seizure rate, six seizures/month) were treated with openlabel<br />

topiramate (TPM) at dosages of 3.2 , 12.5 mg/kg per<br />

day. Methods: The mean duration of TPM treatment was<br />

447 ^ 142 days (range, 14 , 582 days) and the mean TPM<br />

dosage was 6.75 mg/kg per day (range, 3.2 , 14.0 mg/kg per<br />

day). Seizure reduction was calculated from seizure counts<br />

during the last 3 months and last 6 months of TPM therapy<br />

compared with baseline. Results: .70% of patients achieved<br />

$50% seizure reduction. A total of 38% of patients were<br />

seizure free for $33 months at the last visit; 43% of patients<br />

were seizure free for $6 months at the last visit. This robust<br />

therapeutic response was consistent for children patients<br />

receiving TPM dosages ,4, 4 , 8 and .8 mg/kg per day.<br />

The most commonly reported adverse events were related to<br />

the central nervous system. Over the 1.5-year treatment<br />

period, 26% of patients discontinued TPM therapy because<br />

of adverse events and inadequate seizure control. Conclusions:<br />

TPM as adjunctive therapy was well tolerated and<br />

safe. It is a useful AED for long-term seizure control and<br />

resulted in seizure freedom for extended periods despite failing<br />

previous AED therapy.<br />

FP-H-042<br />

Treating children with refractory epilepsy with<br />

additional topiramate<br />

X.-W. Wang, Y. Sun, W.-D. Zi<br />

Department of Pediatrics, People’s Hospital of Xingjiang,<br />

Xingjiang, China<br />

Purpose: This paper is to observe the curative effect and<br />

safety in treating childhood refractory epilepsy with the


Abstracts 505<br />

addition of topiramate. Method: Of the twenty cases we<br />

treated, there were four cases of Lennox-Gastaut; three<br />

cases of West syndrome; seven cases of complex partial<br />

seizures; and six cases of generalized tonic-clonic seizures.<br />

In addition to the primary drug treatment, topiramate was<br />

added on with dosage from 0.5 mg/(kg per day), with an<br />

increase of 0.5–1.0 mg/kg every 7–10 days, to 8.0 mg/(kg<br />

per day) at its maximum, the purpose of which is to<br />

observe the effect and side effect. Result: Of the twenty<br />

treated cases, the drug was fully effective in eleven (55%),<br />

seizures reduced by 75% in three (15%), 50% in three<br />

(15%), and it was ineffective in two (10%). One failed to<br />

return for a checkup. In terms of side effects, two cases had<br />

anorexia so that further treatment became impossible; one<br />

became obviously weak; two had symptoms of adiapneustia<br />

and low fever; and the rest showed no obvious undesirable<br />

symptoms. Conclusion: Topiramate is remarkable in<br />

its effect and safe when it is added on in treating children<br />

with refractory epilepsy. It also has low side effects.<br />

However, the side effects, adiapneustia and low fever,<br />

have not been reported up till now. Whether or not topiramate<br />

has effect on the secretion of sweat gland need<br />

further observation and research.<br />

FP-H-043<br />

K ATP channel subunit Kir6.2 and NMDA receptor<br />

subunit 1 mRNA expression in status epilepticus rat<br />

model<br />

Z.-Z. Xia, K.-W. Jiang, Q.-X. Shui<br />

Department of Neurology, Affiliated Children’s Hospital of<br />

Medical College, Zhejiang <strong>University</strong>, Hangzhou, China<br />

K ATP channels play a key role in the neurons excitability<br />

for coupling the intracellular metabolic state to electrical<br />

activity at the plasma membrane. To understand the role<br />

of the K ATP channels in status epilepticus (SE), in the present<br />

study, we determined the alterations of K ATP channels subunit<br />

Kir6.2, and NMDA receptor subunit 1 mRNA expression.<br />

SE was induced in male adult rats by single i.p.<br />

pilocarpine. The survivals (n ¼ 43) were sacrificed for<br />

mRNA assay at 1, 4, 6, 12, and 24 h after SE by in situ<br />

hybridization. One hour after the seizures Kir6.2 mRNA in<br />

CA1 and CA2 hippocampus increased, reached the highest<br />

points at 4 h, and was still higher than that of normal control<br />

group at 24 h after seizure. The up-regulation of the<br />

NMDAR1 mRNA expression was slower than that of<br />

Kir6.2 mRNA. SE evoked the expression of the Kir6.2<br />

mRNA may activate the K ATP channels of the hippocampus<br />

and the excitability modulation of the neuron itself. There<br />

was no correlation between the expression of Kir6.2 mRNA<br />

and NMDAR1 mRNA. It suggested that SE altered the<br />

excitability by activating the NMDAR1.<br />

FP-H-044<br />

Teachers and children with epilepsy<br />

I. Prpić a , Z. Korotaj a , I. Vlašić-Cicvarić a , E. Paučić-<br />

Kirinčić a , A. Valerjev b , V. Tomac c<br />

a <strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia; b Primary<br />

school ‘Kantrida’, Department of <strong>University</strong> Children<br />

Hospital School, Rijeka, Croatia;<br />

c Institute for Public<br />

Health of Primorsko-Goranska County, Rijeka, Croatia<br />

The purpose of the study was to investigate primary<br />

school teachers’ attitude towards children with epilepsy.<br />

Two hundred and sixteen teachers were investigated regarding<br />

their opinion or knowledge about children with epilepsy.<br />

The results reveal that teachers do not have an accurate<br />

conception of the capabilities of children with epilepsy<br />

and that those attitudes differ from teacher to teacher.<br />

Nearly half of the teachers believe that children with<br />

epilepsy differ from healthy children by their behaviour.<br />

The majority of teachers (60%) do not get information<br />

about child’s disease from the parents, but from other<br />

sources. One third of teachers do not feel confident in<br />

their work with children with epilepsy. Great majority<br />

(91.80%) of teachers feel necessity to get additional information<br />

and education about epilepsy. Primary school<br />

teachers who work with children with epilepsy have inconsistent<br />

approach to the capabilities, behaviour and an inadequate<br />

way of working with children. Therefore they are<br />

eager to get more information on epilepsy. Our results are<br />

concordant with similar studies performed in various countries,<br />

which prove that epilepsy as a disease has a similar<br />

social effect on the affected person with no regard of cultural<br />

or social background. It is the duty of the medical team to<br />

offer teachers the necessary information, so that the<br />

approach, work and life quality of children with epilepsy<br />

can be improved.<br />

FP-H-045<br />

Effects of febrile seizures on peripheral blood leukocyte<br />

count<br />

J. Roganović, I. Prpić, E. Paučić-Kirinčić, I. Klarić<br />

<strong>University</strong> Children Hospital “Kantrida” and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />

In children presenting with febrile seizures, peripheral<br />

leukocyte count is often determined to evaluate the source<br />

of the fever. However, some studies have shown that an<br />

increased leukocyte count, without any other obvious clinical<br />

signs indicating a bacterial infection, might be<br />

explained by the seizure duration itself rather than by the<br />

nature of the infection. We assessed data of 82 patients (38<br />

boys and 44 girls) with the history of 129 febrile seizures,<br />

aged 6 months–5 years, referred to the Department of<br />

Paediatrics, <strong>University</strong> School of Medicine, Rijeka, Croatia,


506<br />

Abstracts<br />

between January 1995 and July 2001. The characteristics<br />

included duration of the fever prior to seizure, duration of<br />

seizure, temperature at seizure and peripheral blood leukocyte<br />

count. The parameters for bacterial infection were<br />

defined as follows: obvious clinical finding, sedimentation<br />

rate .40, and positive C-reactive protein. Our results indicate<br />

that peripheral blood leukocyte count was significantly<br />

higher in children with febrile seizures accompanied by<br />

bacterial infection (16.58 ^ 0.86) compared to viral infection<br />

(10.07 ^ 0.4), due to increased neutrophile count. In<br />

children with bacterial infection no association between<br />

seizure duration and blood leukocyte count was found. In<br />

contrast, in children with febrile seizures and viral infection<br />

the leukocyte count in the peripheral blood was significantly<br />

related to the duration of seizures. We conclude that leukocyte<br />

count should be used only as an additional tool to a<br />

carefully performed patient history and physical examination.<br />

FP-H-046<br />

Mutation analysis of Na v 1.1 and GABRG2 in patients<br />

with severe myoclonic epilepsy in infancy and its<br />

borderland<br />

I. Ohmori a , Y. Ohtsuka a , M. Ouchida b , K. Shimizu b ,J.<br />

Hattori a , H. Ota a , M. Oka a , K. Abiru a , M. Inutsuka a ,F.<br />

Endo a , E. Oka a<br />

a Department of Child Neurology, b Department of Molecular<br />

Genetics, Graduate School of Medicine and Dentistry,<br />

Okayama <strong>University</strong>, Okayama, Japan<br />

Purpose: To investigate genotype-phenotype correlation,<br />

we performed mutation analysis of the voltagegated<br />

sodium channel a1-subunit (Na v 1.1) and GABA A<br />

receptor g2-subunit (GABRG2) in patients with severe<br />

myoclonic epilepsy in infancy (SME) and its borderland<br />

(SMEB) who lack myoclonic seizures. Subjects and methods:<br />

Ten patients with SME and 11 patients with SMEB<br />

were recruited. Genomic DNA was extracted from peripheral<br />

blood leukocytes. All coding exons of the Na v 1.1 and<br />

GABRG2 genes were amplified by PCR and analyzed by<br />

direct sequencing. We also investigated clinical and EEG<br />

findings on these patients. Results: Mutations of the<br />

Na v 1.1 gene were identified in 18 of the 21 patients<br />

(85.7%) with SME and SMEB. There was no difference<br />

of detection rate and mutation type between the two<br />

groups. No mutation was found in the GABRG2 gene.<br />

Eight patients with SME (80%) had photoparoxysmal<br />

response on EEG transiently during the clinical course,<br />

in contrast to none with SMEB. Conclusions: It is thought<br />

that the Na v 1.1 mutations were related to the common<br />

clinical characteristics in the both groups. Other factors<br />

may influence occurrence of myoclonic seizures and<br />

photoparoxysmal response in SME.<br />

FP-H-047<br />

The occurrence of migraine in families of children with<br />

benign rolandic epilepsy<br />

H. Bazigou, M. Savani, A. Papavasiliou<br />

Pendeli Children’s Hospital, Section of Pediatric Neurology,<br />

Athens, Greece<br />

The relationship of benign rolandic epilepsy (BRE) and<br />

migraine has not been universally accepted and this study<br />

intended to examine the occurrence of migraine in their<br />

relatives as compared to healthy controls. Methods: Fiftynine<br />

patients with BRE, 31 males, £ 4.7 years and 82<br />

healthy children, 45 males, £ 8.2 years were included.<br />

Detailed histories regarding migraine in first and second<br />

degree relatives were obtained International diagnostic<br />

criteria for migraine and ILAE classification for BRE<br />

were utilized. Results: One child with BRE had migraine<br />

VS none of the controls. This patient developed migraine at<br />

the time of resolution of the BRE (13 years).Thirty BRE<br />

patients (51%) VS 18 controls (22%) had either first or<br />

second degree relatives or both who met the diagnostic<br />

criteria for migraine. A chi-square test resulted in a<br />

P , 0:05. Eleven were first degree relatives (36.6%) of<br />

BRE patients versus 12 (66.6%) in the controls. Three<br />

members from the first group and six from the second had<br />

both first and second degree relatives with migraine. There<br />

was a maternal prevalence (20 out of 30) in the relatives of<br />

the BRE patients. Conclusions: Our results support observations<br />

of some investigators regarding the increased<br />

frequency migraine among relatives of BRE. The association<br />

of these two entities might be due to a common defect<br />

with variable expression. Further clinical and genetic<br />

studies are needed to further clarify the possible association<br />

between the two disorders.<br />

FP-H-048<br />

The effect of subconvulsant discharges on hippocampal<br />

LTP and learning memory of space changes in rats<br />

L. Gu, X.-Y. Lui<br />

Department of Pediatrics, the affiliated railway hospital of<br />

Shanghai, Tongji <strong>University</strong>, Shanghai, China<br />

In order to study the effect of SED on learning and<br />

memory, we set up a model of subconvulsant cerebral<br />

discharges (SCD) by giving subconvulsant electric stimulation<br />

(SES) on anterior frontal lobe cortex of rats. The results<br />

showed that the SES in anterior frontal lobe could cause<br />

SCD in cortex and hippocampal. The SCD interfered with<br />

obtaining and store information and obstructed the transmission<br />

from short-term memory to long-term memory. In the<br />

rats which have formed the long-term memory, SCD can<br />

inhibit extracting of information. These cognitive impairments<br />

are reversible. Study about effect of SCD on hippocampal<br />

LTP indicated that continuous discharges for 3 min


Abstracts 507<br />

could temporally suppressed LTP built in the dentate gyrus<br />

in hippocampus. The suppression phenomena disappeared<br />

after stopping stimulation for 5 min. This phenomenon<br />

revealed that LTP suppression is one the mechanisms of<br />

SCD resulting in TCI. Presumably under the effect of<br />

SES, EAA was over released, resulting in NMDA receptor<br />

channel continuously opened. This leads to intracellular<br />

excessive Ca 21 accumulation and TIC of neuronal function.<br />

This may be one of the mechanisms of SED infecting learning<br />

memory.<br />

FP-H-049<br />

Reasons for drug treatment failure in patients with<br />

juvenile myoclonic epilepsy<br />

R. Naumovski, M. Demerdziev<br />

Clinic of Neurology, Clinical Centre, Skopje, Macedonia<br />

Fourteen patients were referred to our dispensary for<br />

epilepsy due to seizure pharmacoresistance (generally due<br />

to generalized tonic-clonic seizures, GTCS) in the period of<br />

1995–2000. The group consisted of six men (42.85%) and<br />

eight women (57.14%), aged between 12 and 28 years<br />

(18.78 1 4.33) who had previously been treated in pediatric<br />

dispensary unsuccessfully. The disease onset ranged<br />

between 5 and 14 years (10.7 1 3.17); all had myoclonic<br />

seizures (previously not being diagnosed), 13 (92.85%) of<br />

these patients had GTKS, and six (42.8%) had typical<br />

absences as well. None of them previously was diagnosed<br />

to have JME being treated with phenytoin, primidone,<br />

carbamazepine, and part of them administered valproate;<br />

none of them registered the number and the type of the<br />

seizures and the therapy administered. After revision of<br />

the diagnosis, the previous therapy was gradually interrupted<br />

and valproate was administered as monotherapy in<br />

therapeutic doses. Within a year, all patients achieved<br />

complete control of myoclonic and GTS, and one patient<br />

only reported occasional occurrence of absences. Our<br />

results clearly suggested the superiority of valproate in<br />

control of the mixed seizures in JME and the need of its<br />

early diagnosis.<br />

FP-H-050<br />

Clorazepate for refractory epilepsies: excellent efficacy,<br />

tolerance and adverse effects in 200 cases of personal<br />

experience<br />

K. Sugai, S. Hanaoka, M. Fukumizu, M. Sasaki<br />

Department of Child Neurology, National Center Hospital<br />

for Mental, Nervous and Muscular Disorders, National<br />

Center of Neurology and Psychiatry, Kodaira, Japan<br />

Prolonged efficacy, effective epilepsy classifications and<br />

seizure types of clorazepate (CLZ) are controversial. Its<br />

efficacy for refractory epilepsies, tolerance and adverse<br />

effects were studied. CLZ was added on or replaced with<br />

conventional AEDs in 200 patients with refractory epilepsies<br />

unresponsive to three to ten conventional AEDs (average<br />

5.9 AEDs), and its short-term efficacy was studied after<br />

.4 weeks of CLZ administration. Long-term efficacy was<br />

examined in 110 cases administered CLZ for .6 months.<br />

CLZ was started at 0.3–1.0 mg/kg and increased by 0.2–0.5<br />

mg/kg every 1 or 2 weeks up to 2.5 mg/kg. Seizures reduced<br />

by .50% in 136 of 200 short-term subjects, including 45<br />

seizure-free cases, and in 87 of 110 long-term subjects, with<br />

25 seizure-free cases. Both short-term and long-term efficacies<br />

were more favorable in the patients with localizationrelated<br />

epilepsies or focal epileptiform discharges on EEG.<br />

Short-term efficacy was better for partial seizures. Sixtyseven<br />

episodes of adverse effects occurred in 60 patients<br />

including 42 episodes of drowsiness, and CLZ was withdrawn<br />

in 32 episodes. The frequency of adverse effects<br />

decreased by modifications of initial dosage and increase<br />

rate. Tolerance developed in 60 of 130 effective cases, by<br />

2 months in 29 cases, by 4 months in 17 cases, by 6 months<br />

in seven cases, and later than 6 months in seven cases. CLZ<br />

again became effective in 51% of such cases by maintaining<br />

or increasing the dosage. CLZ has prolonged efficacy for<br />

refractory epilepsies. Frequent tolerance and adverse effects<br />

were major but manageable problems.<br />

FP-H-051<br />

Localization-related idiopathic occipital epilepsy –<br />

difficulties in classification<br />

I.S. Ivanov<br />

Department of Pediatrics, Plovdiv Higher Medical School<br />

Hospital, Plovdiv, Bulgaria<br />

The recognition of the types of childhood epilepsy with<br />

occipital spikes (CEOS) is a widely discussed development,<br />

which should promote prognosis and treatment of the<br />

affected children. Aim: To test the clinical application of<br />

the criteria for early-onset CEOS (Panayiotopoulos type)<br />

and late-onset CEOS (Gastaut type). Methods: Retrospective<br />

analysis of the clinical, electrophysiologic, imaging and<br />

other data of the 126 epileptic children registered at the<br />

epilepsy clinic of the pediatric department in the last 2<br />

years. Results: Clinical and EEG data of occipital lobe<br />

epilepsy were revealed in 11 children: four were diagnosed<br />

as symptomatic or criptogenic, three – as late-onset type of<br />

CEOS, and one – as early-onset type of CEOS. Three other<br />

children disclosed signs of benign partial occipital epilepsy<br />

but did not strictly fit the criteria for the CEOS types: The<br />

first child had symptoms of early-onset CEOS (eye deviation,<br />

vomiting, impaired consciousness, occurrence at night,<br />

bilateral occipital discharges) but starting at the age of 9<br />

years. The second patient was an 8 years old girl with occipital<br />

sharp waves on the EEG which had only three brief<br />

episodes of amaurosis with chaotic eye movements at the<br />

earlier ages of 3, 4 and 5 years that ceased without treatment.<br />

The third patient complained of frequent photopsies


508<br />

Abstracts<br />

induced by TV, rarely followed by secondary generalized<br />

seizures, and focal occipital paroxysmal activity with photosensibility.<br />

All but four patients were easily controlled by<br />

carbamazepine or oxcarbazepine. Conclusion: The clinical<br />

practice exposes a variety of symptoms that do not fit<br />

exactly to the criteria for CEOS. Nevertheless strict adherence<br />

to them is essential for unification purposes.<br />

FP-H-052<br />

Epileptic seizures in the first 5 years after hypoxicischaemic<br />

encephalopathy – results from a prospective<br />

study<br />

I.S. Ivanov<br />

Department of Pediatrics, Plovdiv Higher Medical School<br />

Hospital, Plovdiv, Bulgaria<br />

Epilepsy is a major sequela after HIE but prospective<br />

studies on this topic are not numerous. Aim: To estimate<br />

the frequency and characteristics of epileptic seizures after<br />

HIE. Methods: A prospective study of the first 43 children<br />

from a cohort of HIE patients that were followed-up from<br />

birth though their 1st year and at 5-years age undergoing<br />

neurological, kinesiological, developmental, psychological<br />

and neurophysiological examinations. Results: Ten children<br />

(23.2%, Sp ¼ 4.6%) developed epileptic seizures before<br />

their sixth birthday. They were mostly partial (n ¼ 6),<br />

followed by infantile spasms (n ¼ 2) and complicated<br />

febrile convulsions (n ¼ 2). The age of onset was variable.<br />

Valproates were the most frequently applied treatment.<br />

Only two children continued to have seizures at 5-years of<br />

age and three others were still on continuous medication. CP<br />

was more frequent in the epileptic group (3/10) than among<br />

children without epilepsy (0/33) while the occurrence of<br />

mental retardation (MR) did not differ significantly (2/10<br />

versus 4/33). Even when CP and MR patients were excluded<br />

from analysis the results on the neurodevelopmetal Michelsson-Ylinen<br />

test were worse in the epileptic group (33.6<br />

versus 11.8, P , 0:01) and children with more than 24<br />

points (suspected minor neurological dysfunction, MND)<br />

were more common in that group (3/6 versus 1/27). The<br />

occurrence of epilepsy correlated with worse neurodevelopmental<br />

results at 1-year of age. Conclusions: 23.2%<br />

(Sp ¼ 4.6%) of children that suffered HIE developed epileptic<br />

seizures in their first 5 years. They were most often<br />

partial and frequently associated with CP and MND and<br />

abnormal neurodevelopmetal status at age 1 year.<br />

FP-H-053<br />

The alterations of K ATP subunit Kir6.2, SUR1, and<br />

NMDA receptor subunit 1 mRNA in cerebral cortex and<br />

hippocampus of rats with picrotoxin-induced seizure<br />

Q.-X. Shui, K.-W. Jiang<br />

Department of Neurology, Affiliated Children’s Hospital of<br />

Medical College, Zhejiang <strong>University</strong>, Hangzhou, China<br />

Previous reports showed that the K ATP channels play a<br />

pivotal role in neuroprotection induced by epileptic preconditioning.<br />

To study the role of K ATP channels in chronic<br />

epilepsy, we investigate the alterations of K ATP subunit<br />

Kir6.2, SUR1, and NMDA receptor subunit 1 mRNA in<br />

cerebral cortex and hippocampus of rats with picrotoxin<br />

(PTX) induced seizure. Two weeks after the last continuous<br />

PTX injection (20 times, i.p.), those achieved a completely<br />

kindling state (n ¼ 36) were divided into four groups<br />

randomly. And three groups were injected with PTX once<br />

more to kindle the seizures, which sacrificed at 1 h, 1 and 3<br />

days after the seizures, respectively. Another two groups<br />

were the interictal group and control group. K ATP subunits<br />

Kir6.2, SUR1, and NMDA receptor subunit 1 mRNA<br />

expression were detected by in situ hybridization. The<br />

results showed the levels of Kir6.2 mRNA and SUR1<br />

mRNA of the 1 h, 1 and 3 days after seizures groups were<br />

higher than those of interictal and control groups<br />

(P , 0:05). especially the 1 h group. These mRNA<br />

expressed highest in hippocampus CA1. There was no<br />

significant difference of NMDAR1 mRNA among all<br />

seizure model groups, but with a significant difference<br />

compared with the normal control group. Our results<br />

suggested that model process was also a preconditioning<br />

to activate the excitability modulation of the neuron itself,<br />

and the activation of NMDAR1 may result in kindling of the<br />

chronic epilepsy.<br />

FP-H-054<br />

Malignant migrating partial seizures in infancy<br />

V. Gross-Tsur, B. Ben-Zeev<br />

Neuropediatric Units of Shaare Zedek Medical Center and<br />

Sheba Medical Center, Jerusalem, Israel<br />

We report two cases with malignant migrating partial<br />

seizures in infancy, a disorder described in only 20 other<br />

patients. Patient 1, a 3 year old girl, was born with microcephaly<br />

of unknown origin and at age 4 months intractable,<br />

multifocal seizures appeared with bilateral deviation of the<br />

eyes and head, tonic elevation of the arm and flushing of the<br />

face. Despite vigorous AED therapy, the seizures became<br />

virtually continuous and her development arrested so that at<br />

age 3 years she just smiles and responds to voices. A second<br />

pregnancy was terminated at 32 weeks because of progressive<br />

microcephaly, head circumference three standard<br />

deviations below normal. Patient 2 had normal development<br />

until 3 months of age when multiple episodes of partial<br />

status epilepticus appeared, characterized by decreased<br />

motor activity, head deviation, eye blinking and cyanosis.<br />

Aggressive AED therapy was ineffective and at her death at<br />

18 months she had severe psychomotor delay. Interictal<br />

EEG in both cases showed diffuse slowing of background<br />

activity and multifocal spikes. During seizures, the EEG<br />

was characteristic of the disorder, showing rhythmic theta<br />

activity restricted to one region spreading to adjacent areas


Abstracts 509<br />

or the entire hemisphere. In consecutive attacks the epileptogenic<br />

activity shifted between hemispheres (ping-pong<br />

seizures). MRI showed mild atrophy. MRS (patient 2) was<br />

normal. An extensive biochemical and metabolic workup<br />

was normal; TORCH and karyotype in patient 1 and CSF<br />

neurotransmitters in patient 2 were also normal. In<br />

summary, we present two patients with malignant migrating<br />

partial seizures in infancy. The etiology of this syndrome is<br />

unknown but the familial microcephaly in patient 1 is<br />

suggestive of a genetic basis for at least a subgroup of<br />

patients. Alternatively, neurotransmitter dysfunction with<br />

abnormal excitatory activity may explain the continuous<br />

erratic epileptic activity.<br />

FP-H-055<br />

Topiramate as add-on therapy in children with<br />

refractory partial seizure<br />

J. Wu, Z.-P. Wang, K.-R. Bao, X.-P. Xu<br />

Shanghai Xin Hua Hospital, Shanghai Second Medical<br />

<strong>University</strong>, Shanghai, China<br />

Objective: To evaluate the efficacy and safety of TPM in<br />

children (age 4–14 years) as adjunctive therapy for intractable<br />

partial-onset seizures with or without secondarily<br />

generalized seizures. Methods: Patients with at least six<br />

partial-onset seizures during the 12-week baseline phase<br />

while maintained on therapeutic doses of one or two appropriate<br />

AEDs were treated with TPM. The initial TPM doses<br />

were 0.5–0.7 mg/kg per day and increased by 0.5–1.0 mg/kg<br />

per day increments at 1-week intervals. Top dose was ,8<br />

mg/kg per day. Results: Eight patients (25%) were seizure<br />

free for at least 7 months and more than 50% reduction in<br />

seizure was found in 14 patients (43.75%). Inefficacy was<br />

21.88 and 6.25% of the patients had their seizure frequency<br />

increased during treatment. Two patients (6%) had transient<br />

anorexia, dizziness and somnolent, two (6%) had dizziness,<br />

bluntness and impairment of memory, one (3%) had speech<br />

decreased, and one (3%) had abnormal behavior. The<br />

adverse event developed during increment of TPM and<br />

disappeared gradually within 2–4 weeks. Conclusion:<br />

TPM therapy was effective and well tolerated in most of<br />

the patients.<br />

FP-H-056<br />

Predictors of intractable epilepsy – a case-control study<br />

in a cohort of Chinese epileptic children<br />

L.K. Kwong, W.K. Chak, K.T. So<br />

Department of Paediatrics, Tuen Mun Hospital, Hong<br />

Kong, China<br />

Informationaboutearlypredictorsofintractableepilepsyin<br />

childhood is scarce. We performed a case-control study to<br />

identify early predictors of medically intractable epilepsy in<br />

children. Cases were patients who had an average of at least<br />

one unprovoked seizure per month during an observational<br />

period of at least 2 years. Controls were children having<br />

achieved at least 2 seizure-free years. Strong univariate association<br />

was observed between intractability and the following<br />

factors: onset of seizure in infancy, high initial seizure<br />

frequency, remote symptomatic etiology, infantile spasms<br />

and mixed seizure types, abnormal neurological status,<br />

history of status epilepticus, neonatal seizure and early breakthroughattacks<br />

after treatmentinitiation.Independentpredictors<br />

of intractability with multiple regressions were: age of<br />

seizure onset (OR 0.53, 95% CI 0.35, 0.97), abnormal neurological<br />

status (OR 18.6, 95% CI 5.19, 63.6), .3 attacks in the<br />

second half year of treatment (OR 21.86, 95% CI 7.35, 65.01)<br />

and febrile seizures (OR 25.9, 95% CI 1.41 455.7). Our study<br />

suggested that seizure intractability could be predicted early<br />

in the course of illness in children with abnormal neurological<br />

status, high initial seizure frequency, early presentation of<br />

epilepsy and lack of early response to treatment.<br />

FP-H-057<br />

Seizure recurrence in epileptic children after<br />

withdrawal of anti-epileptic drugs<br />

B. Törer, N. Şenbil, Ö.F. Aydin, Ü. Ertan, Y. Gürer<br />

Dr. Sami Ulus Children’s Hospital, Ankara, Turkey<br />

Aim and method: We investigated the rate and the predictive<br />

factors of seizure recurrence after AED discontinuation<br />

in a retrospective analysis of 76 children with epilepsy who<br />

had not had a seizure for at least 2 years, infantile spasms<br />

were excluded. Prognostic criteria analyzed in the patients<br />

were: sex, age at seizure onset, age at AED discontinuation,<br />

type of seizure, etiology, type of epilepsy, family history of<br />

epilepsy in first-degree relatives, mental retardation, delay<br />

in neuromotor development, motor deficit, EEG abnormalities,<br />

multiple medication, history of neonatal and febrile<br />

seizures, history of status epilepticus, time from first to<br />

second seizures, duration of epilepsy, duration of AED<br />

treatment, number of seizures before medication, number<br />

of seizures during first 6 months of treatment, time required<br />

for seizure control, number of seizures experienced until<br />

seizure control, seizure free interval. Results: The overall<br />

recurrence rate was 32.9%. More than half of the recurrences<br />

occurred within 1 year after discontinuation of therapy<br />

and all within 2 years. The factors indicating a higher<br />

recurrence risk were older age at AED discontinuation,<br />

longer duration of epilepsy, longer duration of treatment,<br />

longer time required for seizure control (P , 0:05, Mann–<br />

Whitney U-test). Conclusion: Although some factors<br />

provide an estimate of an individual’s likelihood of recurrence,<br />

the final decision regarding medication withdrawal<br />

must be individualized and should be made jointly by the<br />

physician and the family. The decision process must take<br />

into account the statistical risk of seizure recurrence, the<br />

potential consequences of such a recurrence, and the potential<br />

adverse effects of continued AED therapy.


510<br />

Abstracts<br />

FP-H-058<br />

Case-control study and transmission/disequilibrium test<br />

of childhood absence epilepsy in Chinese population<br />

J.-J. Lu, H. Pan, Y.-H. Zhang, X.-R. Wu<br />

Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />

Beijing, China<br />

CAE is one of the most frequently recognized syndromes<br />

of the idiopathic generalized epilepsies. The inheritance of<br />

CAE is complex. Genes responsible for susceptibility to<br />

CAE have not been identified. Pharmacological studies of<br />

animal models have implicated the GABAergic system<br />

involved in the mechanism of this disease. Our previous<br />

study suggested that the GABA A receptor subunits genes-<br />

GABRA5 and GABRB3 may be either directly involved in<br />

the etiology of CAE or in linkage disequilibrium with<br />

disease- predisposing sites. To further confirm the results<br />

we used the SNPs found in the coding regions of the<br />

GABA A receptor subunits genes GABRA5 and GABRG2<br />

as genetic markers to detect TDT in 90 Chinese nuclear<br />

families. The TDT results suggested that GABRA5 and<br />

GABRG2 may not be the susceptible genes to CAE. On<br />

the other hand, animal models suggested that the GABA B<br />

receptor plays a critical role in the epileptogenesis of<br />

absence seizures. As a result, we used the SNPs found in<br />

the GABA B receptor subunits gene GABBR2 as genetic<br />

markers to conduct a case-control study in 96 CAE patients<br />

and 96 controls from North China. The frequency of the<br />

alleles and genotypes of SNPs showed significant discrepancy<br />

between CAE patients and normal controls. The<br />

results suggested that GABBR2 may either directly<br />

involved in the etiology of CAE or in linkage disequilibrium<br />

with disease-predisposing sites.<br />

FP-H-059<br />

Therapeutic drug monitoring and the pharmacokinetics<br />

of carbamazepine in children<br />

B.-M. Li, R.-P. Sun, J.-W. Wang, G.-F. Lei, R.-M. Hu, S.-H.<br />

Guo<br />

Pediatric department, Qilu hospital, Shandong <strong>University</strong>,<br />

Jinan Shandong, China<br />

Objective: To investigate the factors affecting CBZ serum<br />

concentration in children with epilepsy. Methods: The minimum<br />

steady-state concentrations of CBZ of 68 specimens of<br />

49 children with epilepsy were measured using HPLC.<br />

Results: The minimum steady-state concentrations of CBZ<br />

increased with dose, but no statistical difference was found<br />

among the groups of the children administrated different<br />

doses (P . 0:05). It was seen that CBZ concentrations<br />

increased with weight and age of children. However, sex<br />

and the time after administrating CBZ did not affect the<br />

CBZ serum concentrations significantly. Conclusions: The<br />

factors affecting concentration of CBZ were mainly body<br />

weight, age and dosage. There was no significant correlation<br />

between the concentration of CBZ and sex or time after<br />

CBZ administration. Therefore, CBZ doses that would be<br />

suitable for pediatric patients of different ages or weights are<br />

proposed. And a small CBZ dose at the beginning is the best<br />

choice for administration to children with epilepsy.<br />

FP-H-060<br />

Clinical analysis of childhood convulsion in 508 cases<br />

S.-Y. Shao<br />

Department of Pediatrics, First Affiliated Hospital, Inner<br />

Mongolia Medical College, Huhhot China<br />

Aim: To study the pathogenesis, the season in which the<br />

disease occurred and the preventive measures of childhood<br />

convulsions. The results are that febrile convulsions are<br />

mainly induced by upper respiratory tract infections with<br />

high fever and non-febrile convulsions of infants are mainly<br />

induced by hypocalcemia and CNS infections. Childhood<br />

convulsions can be seen in four seasons of 1 year, especially<br />

in Winter and Spring. Prevention of childhood upper<br />

respiratory tract infections and CNS infections and good<br />

care of high-risk infants are significant factors in decreasing<br />

the percentages of childhood convulsion.<br />

FP-H-061<br />

Febrile seizures: factors affecting risk of recurrence in<br />

hospital in Pakistani children<br />

S. Akram, Z. Habib, S. Ibrahim, B. Hasan<br />

Department of Pediatrics and Physical Therapy, Aga Khan<br />

<strong>University</strong> Hospital, Karachi, Pakistan<br />

Objectives: This is the first descriptive study that<br />

addresses risk factors for seizure recurrence in the emergency<br />

room (ER) in Pakistani children. Aims of the study<br />

were to: (a) describe the effect of temperature rise on seizure<br />

recurrence in the ER; (b) investigate the effect of age,<br />

gender, family and developmental history, type, duration<br />

and multiple seizures, past history and number of seizures<br />

and treatment given (either late or early) on seizure recurrence<br />

in the ER; and (c) explore prognostic indicators for<br />

seizure recurrence in the ER. Methods: Data from 352 children<br />

[ages 3–84 months; 220 males (62.5%) 131 females<br />

(37.2%)] was gleaned from chart reviews for the years January<br />

1998–August 2000 inclusive, from the Pediatric department<br />

of the Aga Khan <strong>University</strong> Hospital. Descriptive<br />

statistics, chi-square, odds ratios, 95% CI and discriminant<br />

analysis were used. Results and conclusions: Of the 52<br />

(16%) cases that had seizure recurrence in the ER, majority<br />

(36.5%) occurred in .38.5 #39.58C temperature range. The<br />

percentage declined to 15% at higher temperatures. Bivariate<br />

tests showed that age, family and developmental history,<br />

type of seizure and treatment given did not affect seizure<br />

recurrence in the ER. Past history number of seizures


Abstracts 511<br />

(P ¼ 0:008, OR ¼ 2.4) and duration of seizure (.5 min)<br />

(P ¼ 0:000, OR ¼ 2.2) were the two most important factors<br />

affecting seizure recurrence in the ER at the bivariate level<br />

of analysis. Duration of seizure was also the most important<br />

prognostic indicator for FS recurrence in the ER at the<br />

multivariate level with b ¼ 0.79. Early treatment did not<br />

affect recurrence, suggesting timely anti-pyretic versus<br />

anti-epileptic medication use.<br />

FP-H-062<br />

Tuberous sclerosis and epilepsy<br />

D. Plesca, F. Buruiana, D. Dragomir<br />

Department of Pediatric Neurology, Dr. Victor Gomoiu”<br />

Children’s Hospital, Bucharest, Romania<br />

Introduction: Tuberous sclerosis is one of the most<br />

commonly occurring and recognized neurocutaneous<br />

syndromes, with a prevalence of about 1 in 6000 newborns.<br />

It is a multi-system disorder affecting predominantly the<br />

CNS and skin. Neurological manifestations associated<br />

with tuberous sclerosis include: recurrent seizures, retardation,<br />

psychological and behavioral disturbances. Epilepsy,<br />

occurring with an incidence ranging between 80 and 90% in<br />

tuberous sclerosis patients, represents the most important<br />

clinical problem. Method: Fourteen children with tuberous<br />

sclerosis associated seizures were diagnosed and evaluated<br />

between 1995 and 1999 at the Department of Pediatric<br />

Neurology. Their clinical manifestations and evolution<br />

under therapy are evaluated in this study. Results: Different<br />

types of seizures were encountered (infantile spasms, focal<br />

and generalized tonic-clonic seizures). The clinical and<br />

electrical patterns were found to be related to the age of<br />

the patient. The patients benefited from anticonvulsant therapy.<br />

The patients were reassessed at 3, 6, 12 and 24 months<br />

in the order to evaluate their response to the therapy and<br />

neurological and mental stage of their development.<br />

Conclusions: This study confirms the existence of a relationship<br />

between the early onset of seizures and the severity of<br />

mental retardation. Failure to obtain seizure control under<br />

therapy represents an unfavorable predictive factor for<br />

neurological and mental outcome of children with tuberous<br />

sclerosis.<br />

FP-H-063<br />

Difficulties of diagnosis in a case of seizures in infancy –<br />

case report<br />

D. Plesca, M. Moiceanu, F. Buruiana, D. Dragomir<br />

Department of Pediatric Neurology, ‘Dr. Victor Gomoiu’<br />

Children’s Hospital, Bucharest, Romania<br />

Background: Menkes disease is a neurodegenerative<br />

illness with an X-linked inheritance. The degenerative<br />

process affects the grey matter in the central nervous<br />

system. The diseased infant presents with particular features<br />

of the hair and facies. The genetic defect is located on the<br />

long arm of the chromosome X (Xq13.3). The authors report<br />

the case of a 2 months and 3 weeks old, male infant (S.O.)<br />

admitted on 17 September 2000 for intractable myoclonic<br />

seizures. On physical examination the patient exhibited an<br />

expressionless facies with rounded cheeks, sparse, short,<br />

rough hair, dry, pale skin, obvious generalised muscular<br />

hypotonia and absent deep tendon reflexes. There were no<br />

eye movements elicited by a moving object and no sounds<br />

produced. EEG revealed irrigative elements and slow, highvoltage<br />

waves located alternatively on the right and on the<br />

left leads. Eye funduscopy showed bilateral optic atrophy.<br />

Serum copper and ceruloplasmin were extremely low (0 and<br />

5.2 mg/dl, respectively). The presumed diagnoses of<br />

Menkes disease was confirmed by a microscopic examination<br />

of the infant’s hair that featured a twisted, fractured<br />

aspect and multiple knots which are quite typical for<br />

Menkes disease. Enzymatic assays were not feasible.<br />

Conclusions: Based on the aforementioned clinical and<br />

paraclincal data, a diagnosis of Menkes disease was established.<br />

Despite its low incidence this disease, still represents<br />

a cause of seizures in infants.<br />

FP-H-064<br />

Benign rolandic epilepsy in two pairs of identical twins<br />

with mirror image localization of spikes<br />

R. Amit<br />

Division of Neurology, Tod Children’ Hospital, Youngstown,<br />

Ohio, USA<br />

Background: BRE is an age and localization related<br />

epileptic syndrome believed to be genetically determined<br />

by autosomal dominant trait. Objective: In the absence of<br />

reported studies of BRE in identical twins, to report this<br />

epileptic syndrome in two pairs of identical twins with<br />

mirror image of the localization of the spikes. In one pair<br />

of twins a discordant handedness was present. Methods:<br />

Medical history, seizures history, physical and neurological<br />

examinations as well as imaging studies of the brain, routine<br />

and long term video-EEG were used. In one case of doubted<br />

identity a monozygocity test was used. Conclusion: BRE<br />

does exist in identical twins. The transcription of the epileptogenic<br />

area may have a mirror image pattern.<br />

FP-H-065<br />

CSF glucose concentrations in convulsive infants with<br />

and without fever and the role of acetaminophen<br />

M. Mohammadi a , M.R. Mohebbi b , F. Naderi c<br />

a Children’s Medical Centre, Tehran <strong>University</strong> of Medical<br />

Sciences (TUMS) b TUMS,<br />

c Bahrami Children Hospital,<br />

TUMS, Tehran, Iran<br />

Hyperglycaemia is common following FS. This leads to<br />

hyperglycorrhachia within 1–2 h after a convulsion. The


512<br />

Abstracts<br />

aim of the present study was to explore the relationship<br />

between the CSF glucose concentrations, and body temperature,<br />

seizure, and prior use of acetaminophen. The cases<br />

consist of 117 convulsive infants aging 3–18 months.<br />

Patients were divided in to several groups based on body<br />

temperature, duration of fever and convulsion, and prior use<br />

of acetaminophen. There was a linear correlation between<br />

CSF glucose level and body temperature in those who had<br />

not taken acetaminophen before admission (r ¼ 0:515,<br />

n ¼ 83, P , 0:001 Spearman’s correlation analysis). The<br />

CSF glucose levels were significantly higher in the febrile<br />

infants (75.33 mg/dl, n ¼ 70), compared with the nonfebriles<br />

(66.15 mg/dl, n ¼ 13, P ¼ 0:014). There was a<br />

negative correlation between the CSF glucose level and<br />

body temperature in those who had taken acetaminophen<br />

before admission (r ¼ 20:389, n ¼ 34, P ¼ 0:023).<br />

Although the mean CSF glucose concentration was higher<br />

in those who had taken acetaminophen compared to the<br />

controls, the difference was not statistically significant<br />

(P ¼ 0:076). Other factors such as age, type of FS, duration<br />

of fever and convulsion and multiplicity of convulsions<br />

were not significantly correlated with CSF glucose concentration.<br />

Our study shows that both fever and convulsion are<br />

related with increased CSF glucose concentrations. The role<br />

of acetaminophen deserves more investigation.<br />

FP-H-066<br />

Benign infantile convulsions associated with mild<br />

gastroenteritis<br />

J.-H. Wu, L. Yin, L.-H. Cao<br />

Department of Pediatrics, Maternity and Children Hospital,<br />

Tangshan, Hebei, China<br />

Objective: To delineate and study the so-called benign<br />

infantile convulsions associated with mild gastroenteritis<br />

(BICE) in our hospital which is located in northern China.<br />

Methods: A clinical study was conducted between January 1,<br />

1999 and April 30, 2001 in all the patients who were treated<br />

for gastroenteritis (GE) accompanied by seizures, to delineate<br />

the clinical characteristics, then follow up these patients<br />

to clarify the prognosis of this syndrome. Results: There were<br />

898 patients who were admitted to hospital during the study<br />

period. Of them, there were 33 patients with GE accompanied<br />

by seizures during the course of the disease: of these 16<br />

patients had mild GE accompanied by a febrile seizures.<br />

There were nine boys and seven girls, the peak age was<br />

between 1 and 2 years old (12 cases, 75%): the youngest<br />

was 4.5 months, the eldest, 2.2 years. The clinical courses<br />

were mild in all cases, accompanied by a febrile seizures of<br />

generalized tonic-clonic pattern (GTCS). The inter-ictal<br />

EEG study (12 cases) and video-EEG study (four cases)<br />

disclosed 4–5 Hzu activity with a background activity of<br />

normal sleep EEG patterns. Neither spike and wave nor<br />

sharp wave activities were seen. Other laboratory findings<br />

including serum electrolytes, blood sugar, liver enzymes<br />

were within normal limits. In three cases the CSF was also<br />

examined and all specimens were normal. In ten cases a CT<br />

scan of brain was performed, with normal results. The<br />

seizures were easy to control. During follow-up study of 14<br />

cases after discharge from hospital (mean period: 1.2 years),<br />

these children have had no further seizures and have normal<br />

development in terms of physical and mental expectations in<br />

the follow-up period. Conclusion: A febrile convulsions<br />

associated with mild gastroenteritis occur in northern<br />

China, with an occurrence rate about 1.78% in the in-patients<br />

with GE in infants. The seizure patterns were GTCS, with<br />

good out-comes. Therefore this syndrome could be called<br />

BICE.<br />

FP-H-067<br />

Does long-term use of valproate cause weight gain in<br />

prepubertal epileptic children<br />

H. Çaksen, G. Deda, M. Berberoǧlu<br />

Ankara <strong>University</strong> Medical School Departments of Pediatric<br />

Neurology and Endocrinology, Ankara, Turkey<br />

VPA is an effective anticonvulsant in many types of childhood<br />

epilepsies. Use of VPA, however, is associated with an<br />

increase in body weight. The pathophysiology of weight gain<br />

is not fully understood. One theory is that elevated levels of<br />

serum leptin cause the weight gain in patients receiving VPA.<br />

In our study we evaluated 15 prepubertal children before and<br />

after VPA treatment for weight gain by calculating their BMI<br />

and serum leptin levels. Our study included 15 patients with<br />

new diagnosed epilepsy and 16 healthy age matched controls.<br />

The patients’ ages were between 9 months and 12 years. The<br />

BMI before VPA treatment in the study group and the control<br />

group were as follows: 16.25 ^ 1.63, 16.34 ^ 2.31. The<br />

serum leptin levels before VPA treatment in the study<br />

group and the control group were respectively; 3.79 ^ 2.39<br />

and 4.28 ^ 2.43. After VPA treatment the BMI in the study<br />

and control groups were as follows; 16.20 ^ 1.75,<br />

16.62 ^ 2.37. The serum leptin levels after VPA treatment<br />

in the study and control group were, respectively;<br />

4.70 ^ 2.80 and 5.44 ^ 2.79. There was no difference<br />

between the groups for BMI and serum leptin levels. In<br />

conclusion, our findings showed that long-term use of VPA<br />

did not cause weight gain in prepubertal children receiving<br />

VPA therapy, and there was no significant difference between<br />

the serum leptin levels of the study and control group.<br />

FP-H-068<br />

Remarks on clinical efficacy of the treatment of<br />

childhood epilepsy in 2000–2001<br />

N.T. Ung, L.T. Huong<br />

Neurology Department, National Institute Pediatrics,<br />

Hanoi, Vietnam<br />

Objective: To study 464 children with epilepsy aged


Abstracts 513<br />

from 1 month to 15 years and examine the efficacy of the<br />

treatment. Methods: By retrospective methods we studied<br />

464 with childhood epilepsy in 2000–2001. Result: There<br />

are 49.8% under 1 year, 25% from 1 to 3 years, 12.3%<br />

from 3 to 6 years, 8.8% from 6 to 11 years, 4.1% from 11<br />

to 15 years. A total of 59.5% was boys, and 40.5% girls.<br />

The following seizure patterns and frequencies were<br />

observed: 21.3% simple partial, 3.7% partial with secondarily<br />

generalized, 75% generalized seizures (61.6% tonicclonic,<br />

3.7% tonic, 2.2% atonic, 2.8% absence, 4.1% West<br />

syndrome, 0.6% Lennox Gastaut syndrome. A total of<br />

72.4% were on monotherapies, 27.6% were on polytherapies<br />

(9.7% a combination of valproate and phenobarbital,<br />

6.4% valproate with carbamazepine, 2.4% valproate with<br />

vigabatrin, 3.2% valproate, with carbamazepine with<br />

phenolbarbital, 0.8% valproate with phenobarbital with<br />

vigabatrin). The treatment was ineffective in 0.7% cases.<br />

A total of 81.9% became seizure free, 12.7% had at least<br />

80% reduction of seizures, 4.7% had on 50–80% reduction,<br />

0.7% had less than 50% reduction. Side effects were<br />

observed 1% cases.<br />

FP-H-069<br />

Comparative study of epilepsy in cerebral palsy and in<br />

developmentally normal children<br />

M.M. Rahman, S. Akhter, M.N. Islam, M.A. Mannan, K.<br />

Akhter, F.A. Khan, S. Parveen<br />

Department of Paediatrics, Bangabandhu Sheikh Mujib<br />

Medical <strong>University</strong>, Dhaka, Bangladesh<br />

This is a prospective analytical hospital-based study done<br />

from September 2000 through February 2001 to observe the<br />

clinical profiles of epilepsy in CP and in developmentally<br />

normal children. Fifty children with CP and 50 developmentally<br />

normal children, aged 1–15 years, comprised the study<br />

population. In both groups male outnumbered female children.<br />

In both groups most of the cases were under 5 years<br />

old. Before the 5th year of age, onset of seizures was 46<br />

(92%) in the CP group (group A) and 39 (78%) in developmentally<br />

normal children (group B). Family histories of<br />

seizures were present in 10 (20%) cases in group A<br />

compared to 8% cases in group B. Perinatal asphyxia 53<br />

(45%), and LBW, 25 (22%), were the commonest risk<br />

factors in group A. On the other hand, in group B perinatal<br />

asphyxia was observed in 14 (26%) cases, and LBW in six<br />

(11%) cases. Spastic tetraplegia, 34 (65%), was the<br />

commonest motor defect in CP patients. Generalized<br />

tonic-clonic was the commonest type of seizure found in<br />

both group - A 23 (43%) and in group B 30 (57%). In<br />

group A 38 (76%) cases had cryptogenic and symptomatic<br />

generalized epilepsy, 12 (24%) had localization-related<br />

epilepsy. In contrast, in group B 42 (84%) cases had idiopathic<br />

generalized epilepsy and eight (16%) cases had localization<br />

related epilepsy. Response to anticonvulsants was<br />

less good in group A than in group B. The clinical profile of<br />

epilepsy in cerebral palsy patients differs from that of developmentally<br />

normal children.<br />

FP-H-070<br />

Gelastic seizures in children<br />

H.-F. Lee, C.-S. Chi, S.-C. Mak, C.-H. Chen<br />

Department of Pediatrics, Taichung Veterans General<br />

Hospital, Taichung, China<br />

Objectives: To describe the etiology, clinical evolution of<br />

epilepsy, and administration of AEDs in patients with GSs.<br />

Methods: Fourteen patients whose seizures were characterized<br />

by typical laughing attacks were observed between<br />

1990 and 2002. All patients received EEG and MRI study.<br />

Results: One patient’s disorder was related to a HH and four<br />

to abnormal MRI findings without evident hypothalamic<br />

lesions. In nine patients, MRI was negative. EEG in the<br />

HH patient showed 2–2.5 Hz SWC. In the group with abnormal<br />

MRI findings, all four patients had focal epileptic<br />

discharges. In the group with normal MRI findings, EEG<br />

in six patients revealed focal epileptic discharges and three<br />

had normal results. The epileptic syndrome in the HH case<br />

was drug-resistant, with the response rate to AEDs less than<br />

25%. The response rates of AEDs in the group with abnormal<br />

brain MRI findings were less than 25% in one, 25–50%<br />

in one, 75–90% in two cases. In the other nine cases without<br />

abnormal MRI findings, three cases became seizure free and<br />

six cases had drug resistance or partial response to treatment.<br />

Conclusions: GSs are the frequent findings in HHs,<br />

but GSs may also be observed in patients without MRI<br />

lesions and with normal neurological status. In these<br />

patients, clinical evolution and response rate to AEDs<br />

seem to be more benign.<br />

FP-H-071<br />

Study on the quality of life in families of children with<br />

epilepsy<br />

Y.-L. Huang a , X.-Y. Wu a , P. Wang a , K.-Z. Ma b , P.-J. Shen b<br />

a Department of Pediatrics, Union Hospital, b Department of<br />

Medicine, Tongji Medical College, Huazhong <strong>University</strong> of<br />

Science and Technology, Wuhan, China<br />

Objectives: During the 2–4 years needed for standard<br />

antiepileptic therapy in epileptic children, their guardians’<br />

cooperation plays an important role in the administration of<br />

the treatment. The guardians’ quality of life (QoL), attitudes<br />

to therapy, and, their compliance are of special importance,<br />

because these factors affect the success of therapy. The<br />

purpose of the study is to investigate the QoL of the parents<br />

of the epileptic children and to find out their attitudes to<br />

epilepsy and to therapy and lastly, the factors affecting<br />

QoL in the family, so that correct advice may be given to<br />

them, allowing them to retain normal psychological profiles,<br />

and achieve compliance for the standard therapy; and,


514<br />

Abstracts<br />

finally, create good environments for the lives and education<br />

of the sick children and to improve their QoL and get the<br />

best results from their physical and psycho-therapy. The<br />

guardians’ attitudes to the anti-epileptic therapy are closely<br />

related to the success of the treatment, education, psychological<br />

development and QoL of the sick children. This<br />

study is aimed at investigating the QoL of parents of epileptic<br />

children, in order to offer appropriate advice to them and<br />

to ensure the success of the standard anti-epileptic treatment.<br />

Methods: The experimental group includes 100<br />

families with epileptic histories of 4 months ,14 years.<br />

The control group consists of 100 families with children<br />

who suffered acute diseases without seizures. The degrees<br />

of anxiety and depression were assessed in both groups. The<br />

questionnaires, including the epileptic situation, family<br />

profiles, parents’ attitudes to epilepsy, the effects of epilepsy<br />

on their lives, etc were offered simultaneously. Results: (1)<br />

In the experimental group, the total score of anxiety and<br />

depression (AD) was: 20.32 ^ 4.44, the anxiety scoring<br />

(A): 10.71 ^ 2.15 and the depression scoring (D):<br />

9.72 ^ 2.68. In the control group, the total score of anxiety<br />

and depression (AD) was: 5.93 ^ 1.55, the anxiety scoring<br />

(A): 3.34 ^ 1.25, and the depression scoring (D):<br />

2.71 ^ 0.65. There was a significant difference between<br />

two groups. (2) Questionnaire: most parents (80%) were<br />

unwilling to let others know of their children’s disease,<br />

and 55% were unwilling to let their children know of the<br />

disease. A total of 81% worried about the effects of the<br />

disease on growth, education, and QoL. Conclusion: Parents<br />

were commonly in a state of anxiety and depression. The<br />

quality of life in these families was decreased. It is<br />

suggested that the mood changes of the parents will exert<br />

negative influences on epileptic therapy. It is therefore<br />

reasonable to give psychological advice to epileptic<br />

families.<br />

FP-H-072<br />

Subcortical band heterotopia – clinico-radiological<br />

analysis of eight cases<br />

A. Kelemen, P. Barsi, G. Rásonyi, J. Janszky, G. Filicki<br />

National Institute of Neurology and Psychiatry, Budapest,<br />

Hungary<br />

Subcortical band heterotopia is considered to be the mildest<br />

end of the lissencephaly – pachygyria – band heterotopia<br />

spectrum, genetically a heterogeneous group. In this work,<br />

we correlated the clinical characteristics (sex, age of the<br />

onset of epilepsy, seizure type, mental and neurological<br />

deficit) with MRI characteristics (antero-posterior gradient,<br />

distribution, asymmetry, additional findings). The first<br />

seizure appeared around puberty in most patients (6/8).<br />

All the patients had multiple seizure types. In patients<br />

with the frontal dominant form (all females) the seizure<br />

disorder begun with GTCS and these patients have lower<br />

IQ (5/5) regardless of the band width, distance and abnormality<br />

of the overlying cortex and extension of the malformation.<br />

Both the males had the posterior dominant form.<br />

Cerebellar hypoplasia (in the frontal form) and aberrant<br />

corpus callosum (mainly in the posterior dominant form)<br />

were the most frequent additional MRI findings. Subcortical<br />

band heterotopia is clinically heterogeneous, with some<br />

distinct clinicoradiological features. Should the currently<br />

ongoing genetic tests reinforce our observations, the clinical<br />

features would enable targeted genetic analysis and counselling.<br />

FP-H-073<br />

Clinical analysis of 375 cases childhood seizures<br />

W. Hou<br />

Department of Pediatrics, DaGang Oil Field Worker’s<br />

General Hospital, Tianjin, China<br />

A review the data of patients with convulsion admitted in<br />

our hospital from 1989 to 1993. There were 246 males<br />

(66%) and 129 females (34%). Thirty-seven of them<br />

(10%) were newborns, 254 (68%) below 3-year old, 62<br />

(17%) below 6-year old. For the newborns, the major<br />

cause was HIE, which occurred in 20/37 (54%), followed<br />

by hypocalcemia in 14/37 (38%). For the infants, the most<br />

frequent causes were tetany, which occurred in 119/254<br />

(47%), febrile convulsions in 99/254 (39%) and epilepsy<br />

in 13/254 (5%). For the preschoolers, the major cause was<br />

febrile convulsions, occurring in 46/62 (745), followed by<br />

epilepsy in 7/62 (11.2%), viral encephalitis in 3/62 (5%).<br />

For the school-age children, the most common reasons were<br />

viral encephalitis in 10/22 (45%) and epilepsy in 9/22<br />

(41%). Among 375 cases, the commonest causes in order<br />

of frequency were febrile convulsions in 150/375 (40%),<br />

infantile tetany in 133/375 (35.5%), epilepsy in 30/375<br />

(8%), viral encephalitis in 17/375 (4.5%) and toxic bacillary<br />

dysentery in 6/375 (1.6%).<br />

FP-H-074<br />

Evaluation of sleep-deprivation EEG in the diagnosis of<br />

childhood epilepsy<br />

L.-H. Chen, Q.-Z. Pang, L.-Q. Chen, Y.-F. Lu<br />

Shanghai Children’s Hospital, Shanghai, China<br />

Objective: To evaluate the sensitivity of sleep-deprivation<br />

EEG examination in children. Method: Sixteen children<br />

suspected of epilepsy clinically but with normal standard<br />

EEG examinations were selected at random (male 12,<br />

female four, age 3–11 years, mean 6 years). Sleep-deprivation<br />

EEG was performed individually. Periods of sleep<br />

deprivation were 18–20 h for children below 7 years and<br />

24 h for the older ones. Results: All the EEG showed slowing<br />

of background electric activity. In addition, eight cases<br />

(50%) showed spike/sharp-slow wave complexes, three<br />

cases had bursts of high voltage u activity, and five cases


Abstracts 515<br />

had normal recordings. The rate of EEG abnormality was<br />

68.75%. Conclusion: Sleep-deprivation EEG is more sensitive<br />

than standard EEG in showing abnormal electric activity,<br />

and has practical value clinically.<br />

FP-H-075<br />

The follow-up survey on the prognosis of 82 cases with<br />

febrile convulsions<br />

P.-F. Xu, Z.-S. Zhou<br />

Department of Pediatrics, China-Japan Friendship Hospital,<br />

Beijing, China<br />

Objective: To explore the relapse of patients with febrile<br />

convulsion (FC) and the relationship between FC and<br />

epilepsy (EP). Subjects and methods: One hundred eight<br />

cases with FC (66 boys and 42 girls) were admitted to our<br />

hospital from 1998 to 2001. Their ages averaged 4.2 ^ 2.4<br />

years. Questionnaires were taken to survey subsequent<br />

conditions. Results: Amongst 108 in-patient hospital cases<br />

with FC during the survey period, 82 cases (75.9%) actually<br />

took part in this survey. There were 70 cases with simple FC<br />

(85.3%) and 12 cases with complex FC. Of 70 cases with<br />

simple FC, relapses occurred in 28 cases (38.8%), of whom<br />

24 cases (85.7%) relapsed within 1 year of onset. Six cases<br />

converted into EP accounting for 7.3% of all 82 cases. None<br />

died. Conclusions: (1) FC had good prognoses, but nearly<br />

half the cases had recurrences. Most of these relapsed within<br />

1 year of onset. (2) Both the number of recurrences of FC<br />

and the interval between onset and recurrence were risk<br />

factors for secondary EP.<br />

FP-H-076<br />

Effect of immunoglobulin G and phenytoin (PHT) on<br />

NMDA receptor-1 density in the brain of<br />

pentylenetrazol (PTZ) induced convulsion rats<br />

C.-N. Zheng a , Z.-S. Zhou a , M. Ariizumi a,b , M. Jinnai b , K.-D.<br />

Wang a<br />

a Pediatric department, China-Japan Friendship Hospital,<br />

Beijing, Republic of China; b Department of Pathology,<br />

Koshigaya Hospital, Dokkyo <strong>University</strong> School of Medicine,<br />

Japan<br />

Objective: To clarify the anti-epileptic mechanism of<br />

IgG, we studied the effect of IVIG on density of N-<br />

methyl-d-aspartate receptor (NR-1) positive neural cells<br />

in the brain of rats with PTZ induced convulsion,<br />

compared with that of phenytoin (PHT). Subjects and<br />

methods: Wistar rats were divided into four groups:<br />

group A, normal control; group B, PTZ 1 saline; group<br />

C, PTZ 1 IVIG; group D, PTZ 1 PHT. PTZ 50 mg/kg<br />

was intraperitoneally injected every day. IVIG 200 mg/<br />

kg and saline were each intravenously injected twice a<br />

week, while PHT 6–10 mg/kg was given orally every<br />

day 2 h before seizure onset. The brains were removed<br />

on the 15th day and NR-1 detected by immunohistochemical<br />

staining. NR-1 positive and negative neural cells were<br />

counted in the CA1 and CA3 of hippocampus, dentate<br />

gyrus, frontal cortex and cerebellum. Results: In group<br />

B, NR-1 positive neural cells were significantly reduced<br />

in CA1 and cerebellum, and the total number of neural<br />

cells tended to decrease in CA3. Group C showed moderate<br />

reduction of NR-1 positive neural cells in CA1, but<br />

not in the other regions. Group D had only minimal<br />

NR1 neural cell reduction in the cerebellum. Conclusion:<br />

These results suggested that the anti-epileptic action of<br />

IgG is possibly related to NR-1 mRNA expression<br />

or NMDA activation through immunomodulation. IgG<br />

might also possess a protective action against neuron<br />

loss due to severe convulsions, comparable to that of<br />

PHT.<br />

FP-H-077<br />

Study on frequency – amplitude gradient in pediatric<br />

sleep EEGs<br />

Z.-C. Guo, F.-C. Cai<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, China<br />

Objective: To explore the clinical significance of the<br />

frequency-amplitude gradient (FAG) in pediatric sleep<br />

EEGs. Method: The patients and normal children were<br />

divided into corresponding five groups in accordance<br />

with age (,1, ,3, ,5, ,10 and ,14 years as groups I–<br />

V). Simultaneous EEGs and brain electric activity mapping<br />

were performed during waking and sleep states. The<br />

energy ratio of slow waves between parietal-occipital and<br />

frontal prefrontal areas was calculated as FAG. The timeamplitude<br />

of EEG was converted into frequency-energy<br />

relation. Results: Thirty-one normal children and 43<br />

patients with encephalopathy joined the study. The mean<br />

values of FAG in normal children of groups I–III were<br />

higher than 1.0 and were interpreted as normal FAG. The<br />

mean values of FAG in patients of groups I–III were lower<br />

than 1.0 and were interpreted as absence of FAG. significant<br />

differences were found between those of the normal<br />

children groups and the patient groups (Ps , 0:05 , 0:01).<br />

The mean values of FAG in group IV normal children<br />

group were not different from that in the patients’ groups<br />

(Ps . 0:05). The mean values of FAG in group V normal<br />

children were lower than 1.0. No significant difference was<br />

found between the corresponding normal children group<br />

and the patients’ group (P . 0:05). Conclusions: The<br />

EEG pattern of FAG was well-developed in normal children<br />

at 4 months of age, with a progressive decrement till<br />

10 years old and absence of FAG when approaching 14<br />

years. Neurological illness may be associated with loss of<br />

FAG. The FAG examination was a valuable parameter in<br />

distinguishing normal sleep EEG from encephalopathic<br />

illness.


516<br />

Abstracts<br />

FP-H-078<br />

Clinical and experimental study of prophylactic<br />

management for febrile seizures with topiramate<br />

Z. Huang, F.-C. Chai, X.-P. Zhang, W.-Z. Zhou<br />

Department of Neurology, Children’s Hospital, Chongqing<br />

<strong>University</strong> of Medical Sciences, China<br />

Objective: To explore the effect, values and side effects of<br />

TPM in the prevention of complex febrile convulsions<br />

(CFC) in animals and children. Methods: (1) Thirty Wister<br />

rats aged from 10 to 30 days, sensitive to FC were selected<br />

randomly, and observed for changes of liability to FC after<br />

taking TPM. (2) Ninety children diagnosed with CFC were<br />

selected randomly. There were 49 males and 41 females.<br />

The patients were 8.9–110.1 months old (average<br />

52.7 ^ 28.7 months). The durations of disease were 2.7–<br />

69.7 months (average time of 25.3 ^ 22.2 months). The<br />

dosages of TPM were 3–6 mg/kg per day (average<br />

50.7 ^ 19.6 mg per day). Observation time was 6.5–18.9<br />

months (average 50.17 ^ 19.6 months). (3) To observe the<br />

side effects on Wister rats and children after taking TPM.<br />

Results: (1) The duration of CFC seizures was significantly<br />

different (t ¼ 48:15, P , 0:01) after taking TPM (respectively<br />

251.27 ^ 246.98 and 96.43 ^ 92.41 s). The incidence<br />

of the CFC seizures declined by about 80% (24/30,<br />

P , 0:01) and the severity of seizures was noticeably<br />

reduced (x 2 ¼ 24:093, P , 0:01). (2) The seizure frequency<br />

of 90 children’s CFC was reduced from 6.5 ^ 4.8 times/<br />

year to 0.38 ^ 0.82 times/year: the difference was significant<br />

(t ¼ 7:23, P , 0:01). Eighty-two of 90 cases had no<br />

CFC seizure during the observation time (91.11%). (3) A<br />

total of 36.67% (11/30) of Wister rats and 11.1% (10/90) of<br />

CFC children had side effects such as narcolepsy, loss of<br />

appetite, and loss of weight. The difference was very significant<br />

(x 2 ¼ 6:635, P , 0:01). However, their routine blood<br />

tests and liver and kidney function had not changed. Conclusion:<br />

The results suggested that TPM had values such as<br />

high clinical effect and infrequent side effects, as confirmed<br />

by animal experiments. So, TPM had good clinical value. In<br />

one word, we thought TPM, as a single drug, had a promising<br />

future in the prevention of CFC in children.<br />

FP-H-079<br />

Effect of high temperature on electrical seizure-induced<br />

neuronal damage in explant culture of rat hippocampus<br />

S.-A. Chae a , D.-W. Kim b<br />

a Chung-Ang <strong>University</strong>, Seoul, Korea; b Inje <strong>University</strong>,<br />

Koyang, Korea<br />

The immature brain has a greater susceptibility to the<br />

development of prolonged provoked seizures in response<br />

to environmental stimuli such as fever. Therefore, the influences<br />

of high temperature (HT) on normal and epileptic<br />

brain were studied in organotypic explant cultures of rat<br />

hippocampus. Fourteen days-in-vitro cultures from 8 dayold<br />

rat pups were perfused with CSF bubbled with 95/5%<br />

O 2 /CO 2 in a microchamber. At 368C initially, after<br />

discharge (AD) was evoked. In the HT group, the cultures<br />

were subjected to 398C for a period of 8 min before the<br />

second stimulus train was applied. They were then restored<br />

to 368C for 10 min. In the control group, temperature was<br />

maintained at 368C for the second stimulus train. The<br />

cultures were returned to the incubator and observed serially<br />

for neuronal damage. The cultures on the same insert that<br />

were not stimulated served as the unstimulated groups.<br />

There was no significant difference in neuronal damage<br />

between the unstimulated groups. Neuronal damage on<br />

AD induced cultures during the febrile setting (n ¼ 16)<br />

was significantly higher than in the non-febrile setting<br />

(n ¼ 16). In CA1, percentage damage (mean ^ SEM) was<br />

6.63 ^ 2.56; 0.92 ^ 0.45 at 24 h (HT group; control group;<br />

P ¼ 0:036, Student’s t-test); 26.37 ^ 7.44; 4.99 ^ 2.23 at<br />

48 h (P ¼ 0:010); and 38.59 ^ 9.63; 6.48 ^ 2.30 at 72 h<br />

(P ¼ 0:003). In CA3, percentage damage was<br />

27.86 ^ 8.68; 7.54 ^ 3.74 at 72 h (P ¼ 0:04). The results<br />

suggest that at high temperatures, seizures in epileptic brain<br />

may be more injurious than seizures at normal temperatures.<br />

FP-H-080<br />

A genome-wide linkage analysis of febrile seizures in a<br />

Japanese affected sib-pair population<br />

J. Nakayama a,b , N. Yamamoto a , K. Hamano c , N. Iwasaki b ,<br />

S. Nakahara d , M. Ohta e , Y. Horigome b , A. Matsui b ,T.<br />

Arinami a<br />

a Department of Medical Genetics; b Department of Pediatrics,<br />

<strong>University</strong> of Tsukuba,<br />

c Kitaibaraki Municipal<br />

General Hospital,<br />

d Kensei General Hospital,<br />

e Toride<br />

Kyodo General Hospital, Ibaraki, Japan<br />

FS are the most common form of childhood seizures, and<br />

they occur in about 7% of Japanese children. Four putative<br />

FS loci, FEB1 (chromosome 8q13–q21), FEB2(chromosome<br />

19p), FEB3 (chromosome 2q23–q24) and FEB4<br />

(chromosome 5q14–q15), have been mapped. Furthermore,<br />

some mutations in the voltage-gated sodium channel b1<br />

subunit gene (SCN1B), the neuronal voltage-gated sodium<br />

channel gene (SCN1A) and the GABA A receptor b2-subunit<br />

gene (GABRG2) were identified in families with a clinical<br />

subset of seizures termed GEFS 1 . Except for FEB4, these<br />

loci are linked to some large, Caucasian families. In this<br />

study, we conducted a genome-wide linkage screening of<br />

48 Japanese nuclear families (192 members) with FS children<br />

(59 affected sib-pairs) using 400 microsatellite markers<br />

separated by an average distance of 10 cM. We used the<br />

GENEHUNTER program to perform nonparametric multipoint<br />

linkage analysis. In addition to FEB4, which we have<br />

previously reported (Hum Mol Genet 2000;9:87–91),<br />

another peak with a non-parametric linkage score (NPL)<br />

.2.0 was observed on chromosome 1 (NPL score ¼ 2.54).


Abstracts 517<br />

Taken together with the report by Baulac et al. who found<br />

evidence for linkage to the near region on chromosome 1q<br />

in a large family with both FS and temporal lobe epilepsy<br />

(Ann Neurol 2001;49:786–792), our data further support the<br />

existence of FS susceptible gene(s) on chromosome 1q.<br />

FP-H-081<br />

Convulsions in children with different types of<br />

helminthiases<br />

Sh.Sh. Shamansurov, Sh.Kh. Saidasisova<br />

Tashkent Institute of Postgraduate Medical Education,<br />

Uzbekistan<br />

Background: The problem of helminthiases and their<br />

effect on the state of nervous system remain actual and<br />

important for today. Helminths creating a stable focus of<br />

stimulation in the central nervous system may lead to the<br />

appearance of convulsions in children. We have investigated<br />

45 children, aged 1–15, with convulsive paroxysms<br />

and invasions by helminths. Lambliasis, dwarf tapeworm,<br />

broad tapeworm and ascarides were found. Mixed invasions<br />

were noted in 92% of cases. Results: In additional to anticonvulsive<br />

therapy dehelminthization was performed.<br />

Convulsions stopped immediately after dehelminthization<br />

in 39% of cases; stopped gradually during 1–3 months in<br />

43% of cases, and became more frequent and stopped with<br />

time in 11% of cases (6 months after finishing of treatment<br />

and repeated dehelminthization). They did not stop and<br />

required prolonged anticonvulsive therapy in 7%. Conclusion:<br />

Thus, during treatment with anticonvulsants, of<br />

convulsive states in children, it is necessary to take into<br />

account the possibility of invasion of helminths into the<br />

children’s bodies.<br />

FP-H-082<br />

Application of a new method of auto-antibodies<br />

detection in children with convulsive state<br />

Sh.Sh. Shamansurov, D.N Gulyaniova<br />

Tashkent Institute of Postgraduate Medical Education,<br />

Uzbekistan<br />

Aim: Application of a new ‘Epitest’ method of detection<br />

of the level of auto-antibodies to fragments of glutamate<br />

receptors, quisqualate membrane protein in blood serum<br />

of children with paroxysmal states. Methods: Forty-two<br />

children were studied, at ages from 3 months to 3 years.<br />

Fifteen of them had non-febrile fits and 17 of them had<br />

febrile fits: and, for comparison, ten of them were healthy<br />

children of the same age. They were examined with ‘Epitest’,<br />

in order to find out whether there were glutamate receptors<br />

in blood. Results: The level of auto-antibodies to<br />

glutamate receptors in healthy children was low:<br />

1.01 1 0.08 ng/ml. Children with non-febrile epilepsy had<br />

elevated levels of receptors in blood: 2.66 ^ 0.13 ng/ml.<br />

But in children with febrile fits it was 1.855 ^ 0.205 ng/<br />

ml. So, by this method the following was investigated: the<br />

increases in the levels of auto-antibodies to glutamate receptor<br />

of AMPA in children with convulsive states compared<br />

with healthy children. In studies of children with epileptic<br />

syndromes and paroxysmal states of non-epileptic origin<br />

and their outcomes, there is, undoubtedly, confirmation of<br />

a hypothesis of damage to glutamate receptors secondary to<br />

high glutamate concentrations in pathological processes and<br />

also intensive production of auto-antibody receptors which<br />

are initiators of a rise in convulsive reactions. Conclusions:<br />

A new method of detection of auto-antibodies to AMPA<br />

receptors relating to cerebral pathology was found very<br />

effective in the clinical diagnosis of convulsive syndromes<br />

in children. It could be used widely to reveal and prevent<br />

paroxysmal states in their early stages.<br />

FP-H-083<br />

The relation of epilepsy related factors to anxiety and<br />

depression scores in epileptic children<br />

A. Oguz, S. Kurul, E. Dirik<br />

Dokuz Eylül <strong>University</strong> Faculty of Medicine, Izmir, Turkey<br />

Cognitive and behavioral impairments are found more<br />

often among epileptic children than among their peers. In<br />

this study, we aimed to evaluate the anxiety and depression<br />

in epileptic children, to compare their results with that of a<br />

healthy control group and to determine the relation of anxiety<br />

and depression scores to epilepsy-related factors. The<br />

State Trait Anxiety Inventory and the Children Depression<br />

Inventory were applied to 35 epilepsy patients aged 9–18<br />

years (mean age 12.9 ^ 2.52) and to 35 healthy children<br />

served as the control group. Both study and control groups<br />

were divided into two age groups (9–11 and 12–18 years) to<br />

exclude the effect of puberty on anxiety and depression<br />

scores. Significant depression and suicidal ideas were determined<br />

in the study group. The mean trait anxiety score was<br />

significantly higher in the 9–11 age group of epileptic<br />

patients than the corresponding control group<br />

(35.90 ^ 6.90 and 29.33 ^ 2.84, P , 0:05). The mean<br />

state anxiety score (33.90 ^ 3.90 and 30.40 ^ 6.02,<br />

P , 0:05), trait anxiety score (38.20 ^ 6.84 and<br />

32.20 ^ 3.90, P , 0:05) and depression score<br />

(16.65 ^ 8.32 and 8.15 ^ 3.15, P , 0:05) were significantly<br />

higher in the 12–18 age group of epileptic children<br />

than in the control group. Among the epilepsy-related<br />

factors, epilepsy duration, seizure frequency and polytherapy<br />

were found to increase the anxiety and depression; and<br />

age of seizure onset, seizure type and EEG findings were not<br />

related to anxiety and depression. In conclusion, symptoms<br />

of anxiety and depression are common among epileptic<br />

children, especially during puberty. State Trait Anxiety<br />

Inventory (STAI) and Children Depression Inventory<br />

(CDI) may be used as tools to give information to the clinicians.


518<br />

Abstracts<br />

FP-H-084<br />

Magnetoencephalographic statistical parametric<br />

mapping of interictal spikes in epileptic patients<br />

K. Imai a , K. Yanagihara a , N. Kamio a , R. Sakakibara a ,K.<br />

Shimono a , T. Okinaga a , N. Hirabuki b , T. Yoshimine c ,K.<br />

Ozono a<br />

a Department of Pediatrics,<br />

b Radiology,<br />

c Neurosurgery,<br />

Osaka <strong>University</strong> Graduate School of Medicine, Osaka,<br />

Japan<br />

Purpose: To evaluate a new MEG imaging with spatial<br />

filtering and statistical analysis to investigate spatial distribution<br />

of interictal spikes. Method: Ten cases of localization-related<br />

epilepsy were investigated. Thirty interictal<br />

spikes with similar morphology and distribution were<br />

recorded from each subject using 64 channel whole-head<br />

MEG system (CTF; Canada). The following two methods<br />

were used for analysis: (a) single dipole model (SDM); and<br />

(b) statistical-SAM (synthetic aperture magnetometry, CTF;<br />

Canada) (stat-SAM). In stat-SAM, the region of interest was<br />

set to include the entire cerebrum with a 5 mm voxel resolution.<br />

The signal power of each voxel was estimated using<br />

spatial filter (SAM). Changes in the beta band signal power<br />

between the spike phase (200 ms) and the prespike phase<br />

(200 ms) of each voxel were statistically analyzed using<br />

Student’s t-test. The distribution of t-values obtained from<br />

each voxel was superimposed on individual MRI images.<br />

Results: Using the stat-SAM, the position and spatial distribution<br />

of interictal spikes could be superimposed on MRI<br />

images in each case. These results correlated well with<br />

SDM. In subjects with localized cerebral lesions, stat-<br />

SAM revealed the precise information of the spatial relationship<br />

between epileptic foci and brain lesions. Conclusion:<br />

While SDM is useful and reliable for the analysis of<br />

interictal spikes generally, complicated results may lead to<br />

difficulties with interpretation. Stat-SAM can easily demonstrate<br />

the 3-dimensional distribution of interictal spikes,<br />

although poor in temporal resolution. Furthermore, this<br />

new statistical method may enable us to make the automatic<br />

MEG distribution images of interictal spikes.<br />

FP-H-085<br />

The therapeutic effect of topiramate in childhood<br />

epilepsy: a hospital-based study<br />

W.-T. Lee, J.-S. Liang, T.-W. Yu, Y.-Z. Shen<br />

National Taiwan <strong>University</strong> Hospital, Taipei, Taiwan,<br />

Chinese Taipei<br />

Topiramate has been shown to be safe and effective in<br />

refractory epilepsy in adults. Pharmacokinetic studies show<br />

that the clearance of topiramate is greater in children than<br />

in adults; therefore, higher doses may be needed in children<br />

than adults. In the present study, we investigate the<br />

effect of topiramate used adjunctively in Taiwanese children<br />

with refractory partial and generalized epilepsy. A<br />

total of 51 children (F:M ¼ 29:22) with epilepsy were<br />

enrolled in the present study. The mean age was 9.5<br />

years, and the mean seizure history was 5.6 years. Of<br />

these 51 children, 68% of children took two or more anticonvulsants<br />

before topiramate was added. Our result showed<br />

that the average seizure reduction rate was 59% after<br />

adding topiramate, and the mean follow-up duration was<br />

8.2 months. Overall 22% of the children became seizurefree,<br />

and another 42% showed more than 50% of seizure<br />

reduction after adding topiramate. Of ten children with<br />

adverse effects, four of them dropped out finally secondary<br />

to adverse effects. Of five children with infantile spasms,<br />

two became seizure free and two showed seizure reductions<br />

of more than 50%. We conclude that topiramate is an<br />

effective agent for the adjunctive therapy of partial and<br />

generalised epilepsy in children. Treatment-limiting<br />

adverse events may be managed by slow titration.<br />

Although comparative studies with the other newer anticonvulsants<br />

are required, topiramate may be an important<br />

addition to the range of drugs that can be used to treat<br />

refractory epilepsy in children.<br />

FP-H-086<br />

Electroencephalographic-video monitoring in<br />

pediatrics: Philippine Children’s Medical Center<br />

experience<br />

R.G. Valeriano, M.H. Ortiz, A.S. Salonga, M.F.A. Soto<br />

Philippine Children’s Medical Center, Quezon City, Philippines<br />

EEG-video monitoring is a valuable tool in evaluation<br />

and management of children suspected of having seizures<br />

or paroxysmal disorders. The prolonged monitoring of the<br />

brain activity simultaneous with prolonged video monitoring<br />

of patients permits correlation of clinical behavior and<br />

EEG activity. Its primary purpose, especially in pediatrics,<br />

is to address fundamental problems of evaluation and<br />

management of children suspected of having seizures. At<br />

Philippine Children’s Medical Center we present our<br />

experience in video-EEG. Since 1998, we have a total of<br />

70 patients who underwent prolonged EEG monitoring.<br />

The youngest patient was 2 months and the oldest, 19<br />

years old: the average age was 4.61 years. The majority<br />

were males 44/70 (63%), with females 26/70 (37%). The<br />

commonest reason, in 59/70 (82%), for prolonged video-<br />

EEG monitoring was to determine if an abnormal movement<br />

noted in a patient had an EEG correlate. Other<br />

reasons were, to determine if there were multiple seizure<br />

types, 3/70 (4%); to localize the area from which epileptiform<br />

discharges were coming 2/70 (2.8%); to determine<br />

the seizure type 2/70 (2.8%). One out of 70 patients underwent<br />

monitoring to confirm whether the seizures were<br />

infantile spasms, to confirm whether there was frontal<br />

lobe epilepsy, to confirm the findings in routine EEGs in


Abstracts 519<br />

patients who did not have clinical seizures and to confirm<br />

whether other clinical findings such as headaches, flashes<br />

of lights, and sudden generalized weakness are actually<br />

seizures. The abnormal movements requiring confirmation<br />

were mostly myoclonic jerks, stiffening of extremities,<br />

blank stares, head turning, tremors of the hands and<br />

shoulders, cyanosis and sudden transient weakness. In<br />

our experience video-EEG monitoring confirms our diagnosis<br />

of epilepsy and helps clinicians in decisions on<br />

giving antiepileptic drugs and eliminating these drugs if<br />

they are not necessary. We have determined different<br />

seizure types, and we have localized the areas from<br />

which the discharges were coming. Prolonged EEG-video<br />

monitoring, in our experience, has helped us in the diagnosis<br />

and treatment of our patients.<br />

FP-H-087<br />

Improvement in the knowledge, attitude and practice<br />

regarding epilepsy among participants of the Epilepsy<br />

Camp conducted in Philippine Children’s Medical<br />

Center<br />

R.G. Valeriano, M.L. Bolanos, M. Sosa, M.H. Ortiz<br />

Philippine Children’s Medical Center, Quezon City, Philippines<br />

Epilepsy Camp is a yearly activity of the Philippine<br />

Children’s Medical Center which aims to improve the<br />

awareness of patients with epilepsy, their parents and caregivers.<br />

This pilot study aims to evaluate the effectiveness<br />

of the camp in attaining the objective of the annual activity.<br />

We would like also to assess the knowledge, attitude<br />

and practice of participants before the Camp and determine<br />

the areas of weakness and use these to address their needs<br />

in the future epilepsy camp. Methods: We administered<br />

pre-tests and post-tests to the participants of the year<br />

2001 Epilepsy Camp. A 60-item test questionnaire, written<br />

in vernacular language was prepared. Questions about<br />

knowledge on etiology, diagnosis, and treatment, attitude<br />

towards the disease, dealing with people with the disease<br />

and common practice regarding emergency management<br />

during active seizures, importance of clinic follow-up and<br />

compliance in giving of medications. The same set of questions<br />

was prepared for the pre-test and post-test. Results:<br />

Sixty-two respondents were able to answer both pre- and<br />

post-tests. In the pre-test, 98% of the respondents are aware<br />

that epilepsy is caused by sudden changes in brain activity.<br />

More than half still believe in the myths and misconceptions<br />

about epilepsy. Sixty percent are aware that etiology<br />

can be undetermined. Ninety percent know about electroencephalography<br />

as a diagnostic procedure. Eighty two<br />

percent believed that persons with epilepsy can live normal<br />

lives. Less than 50% are aware of the emergency measures<br />

during active seizures. Although 70% believe in the importance<br />

of follow up, the majority has doubts about giving<br />

maintenance medication. There is a statistically significant<br />

difference between the results of the pre- and post-tests<br />

with improvement in the results. Conclusion: The Epilepsy<br />

Camp is effective in improving the knowledge, attitude and<br />

practice among participants.<br />

FP-H-088<br />

Seizure recurrence after antiepileptic drug (AED)<br />

discontinuation in children – the Philippine Children’s<br />

Medical Center experience<br />

J.M.B. Ahorro, M.H. Ortiz, A.M. Salonga<br />

Philippine Children’s Medical Center, Quezon City, Philippines<br />

The last decade has seen striking changes in epilepsy<br />

management in children. Identifying seizure etiology and<br />

semiology has significantly helped in the management of<br />

these cases. In all patients with epilepsy, the estimated probability<br />

of achieving seizure remission is 65%. Reported<br />

relapse rates from foreign studies following AED discontinuation<br />

varied from 6 to 76% in general and 6–40% in<br />

children; risk factors that were shown to have significant<br />

correlation to recurrence were age at onset of seizure,<br />

seizure type, and presence of slowing on EEG. This retrospective<br />

study was conducted to determine the rate of<br />

seizure recurrence following AED discontinuation and identify<br />

risk factors predictive of outcome. A total of 30 records<br />

of patients whose anticonvulsants were discontinued were<br />

available for review. The overall relapse rate of seizures in<br />

those patients whose AEDs were discontinued after a minimum<br />

seizure-free period of 2 years, as well as the risk<br />

factors for seizure relapse in these patients, will be<br />

discussed.<br />

FP-H-089<br />

Anticardiolipin antibody and childhood epilepsy<br />

K. Haginoya, H. Yokoyama, M. Munakata, M. Ishitobi, T.<br />

Kitamura, M. Koda, N. Togashi, C. Nara, K. Iinuma<br />

Tohoku <strong>University</strong> School of Medicine, Sendai, Japan<br />

Background: Anticardiolipin antibody (aCL) is reported<br />

to be positive in patients with antiphospholipid syndrome.<br />

However, aCL has been reported in patients with various<br />

CNS disorders. We examined the frequency of aCL in<br />

patients with various kind of epilepsy in order to clarify<br />

whether aCL is involved in the pathogenesis of childhood<br />

epilepsy. Methods: Serum samples from 175 epileptic<br />

patients and 71 non-epileptic patients were obtained after<br />

informed consent. The aCL IgG was measured using an<br />

ELISA kit purchased from MBL (Nagoya, Japan). The<br />

175 epileptic patients included nine with idiopathic generalized<br />

epilepsy, 46 with symptomatic generalized epilepsy<br />

(SGE) including 21 with West syndrome, 73 with cryptogenic<br />

or symptomatic localization-related epilepsy (C/<br />

SLE), 29 with idiopathic localization-related epilepsy,


520<br />

Abstracts<br />

and 18 with unclassified epilepsy. Results: Twenty-four<br />

percent of epileptic patients and 15% of non-epileptic<br />

patients were positive for aCL. When epileptic patients<br />

were divided into aCL-positive (42 patients) and aCLnegative<br />

(133 patients) groups, there were no significant<br />

differences between the two groups in terms of sex, polypharmacy,<br />

antinuclear antibody, antiDNA antibody, and<br />

drugs used for treatment. However, SGE and age less<br />

than 1 year were significantly more frequent in the aCLpositive<br />

group (P ¼ 0:014 and ,0.0001, respectively).<br />

Patients whose seizure type was epileptic spasm including<br />

West syndrome were significantly more frequent in the<br />

aCL-positive group (P ¼ 0:0001). Conclusions: There<br />

was a significant relationship between aCL and those<br />

who had SGE and whose seizure type was epileptic<br />

spasm, suggesting that aCL was involved in the pathogenesis<br />

of epilepsy in those patients.<br />

FP-H-090<br />

Epilepsy after febrile seizures<br />

M. Kuturec, F. Duma, V. Sabolic-Avramovska, O.<br />

Lekovska<br />

<strong>University</strong> Children’s Hospital, Skopje, Macedonia<br />

Data for subsequent epilepsy after febrile seizures varies<br />

form 2 to 12%, depending on the different possible risk<br />

factors: atypical febrile seizures, positive family history of<br />

epilepsy, presence of neurodevelopmental abnormalities<br />

prior to febrile seizures, etc. During the period of 2<br />

years 706 patients were registered with febrile seizures<br />

(401 with clinical features of simple febrile seizure –<br />

group P, and 305 with clinical features of complex febrile<br />

seizures – group C). The longitudinal follow up was done<br />

during a period of 3–6 years for: 327/401 and 216/305.<br />

The follow up (every 3 months the 1st year, and then every<br />

6 months) contains data for: febrile illness, recurrent<br />

febrile convulsions, development of a febrile seizures,<br />

neurodevelopmental status, EEG, AED, etc. An epilepsy<br />

developed after simple febrile seizures in 17, 5.20%. An<br />

epilepsy developed after complex febrile seizures in 27,<br />

12.5%. In both groups the main transformation occurred<br />

within 36 months of an initial or last febrile convulsion,<br />

accounting for 10 (58.82%) of children in group P, and 14<br />

(51.85%) in group C. The causal relationship between<br />

febrile seizures and the subsequent epilepsy is still controversial,<br />

and depends on many different risk factors. In our<br />

study the connection between the febrile seizures and<br />

subsequent epilepsy was more definite and more robust<br />

for group C, with even one positive factor, such as the<br />

clinical feature of an atypical or complex febrile seizure,<br />

the mental, motor or neurological deficit prior to first<br />

febrile seizure, and the initial febrile seizure after 3rd<br />

year, being of importance.<br />

FP-H-091<br />

EEG biofeedback in the treatment of attention deficit<br />

hyperactivity disorder in children<br />

N. Pop-Jordanova a , S. Markovska b<br />

a Department of Psychophysiology, Pediatric Clinic, Faculty<br />

of Medicine, b Research Center for Energy, Informatics and<br />

Materials, Macedonian Academy of Sciences and Arts,<br />

Skopje, Macedonia<br />

In the school age population, ADHD has been diagnosed<br />

worldwide in from two to even ten percent of children.<br />

Precise evidence for Macedonia is lacking and the only<br />

treatment applied so far has been pharmacotherapy, mainly<br />

with Ritalin, which has to be purchased from abroad. The<br />

subjects consisted of 12 children aged 6–13, categorized<br />

into three types of ADHD: predominantly ADD, hyperactive-impulsive,<br />

and, combined type. The diagnosis is made<br />

clinically (ICD-10) and confirmed by psychometric instruments<br />

such as Conners Questionnaire for parents and<br />

teachers, as well as WISC-R. The children participated in<br />

a 4-month program of EEG biofeedback (neurofeedback)<br />

training, twice a week, with sessions of 50 min, using<br />

Biograph/Procomp version 2.0. The aim of neurofeedback<br />

training was beta (16–20 Hz) enhancement and theta (4–8<br />

Hz) suppression. All patients showed considerable changes<br />

in EEG activity. The mean values of theta amplitudes at the<br />

end of treatment were 20–30% lower compared to the initial<br />

states, whilst the simultaneous increase in beta amplitudes<br />

was over 30%. In the cases of two patients with extremely<br />

low concentrations, where neurofeedback was combined<br />

with Ritalin, the increase of beta amplitudes was the highest,<br />

reaching 100%. However, such a synergetic effect was not<br />

observed in theta amplitudes. The comparison of IQ performances<br />

(by WISC-R) before and after the neurofeedback<br />

training program has indicated higher intelligence test<br />

scores. Also, enhanced behavior and learning, improvement<br />

in school grades and increased self-esteem have been<br />

achieved.<br />

FP-H-092<br />

Staring episodes in generalized and focal epilepsies<br />

P.S. Baxter a , A.K. Chattopadhyay b , R.H Kandler b<br />

a Children’s Hospital, Neurophysiology Department, b Royal<br />

Hallamshire Hospital, Sheffield, UK<br />

Staring or ‘blank’ episodes can be due to epileptic<br />

seizures, attentional difficulties, daydreaming, tiredness or<br />

other causes. This can cause diagnostic confusion. We<br />

examined the clinical features of epileptic staring episodes,<br />

by reviewing videos of children having seizures during EEG<br />

recordings. A total of 185 staring episodes were studied in<br />

74 children aged 7 months–15 years (median 7 years). Eighteen<br />

(10%) were isolated stares. A total of 154 episodes had<br />

additional features such as gaze deviation, eyelid flutter,


Abstracts 521<br />

and/or automatisms. During seven the eyes remained closed<br />

without additional features. Six could not be assessed.<br />

Isolated stares occurred significantly more often in children<br />

whose eyes were open rather than closed at seizure onset<br />

(P , 0:001). The 18 isolated stares were seen in 12 children,<br />

ten of whom had other ictal episodes with additional<br />

features during the same recording and two of whom only<br />

had a single seizure recorded. Seizure types were primary<br />

generalised with 3 Hz spike and wave (37), other primary<br />

generalised (89), 3 Hz spike and wave with a focal onset<br />

(13), other generalised with a focal onset (27), focal (7), and<br />

unclassified (12). Isolated stares were as common in those<br />

with focal or generalized onsets. In conclusion, staring<br />

episodes without additional features are not typical of<br />

epileptic seizures. The likelihood of recording an isolated<br />

stare of the habitual type is improved by performing the<br />

video-EEG with eyes open.<br />

FP-H-093<br />

Correlation of hemiplegic or hemiparetic CP and later<br />

development of partial epilepsy<br />

M. Carignani<br />

Neurology Institute, Universidad Nacional de Rosario,<br />

Rosario, Argentina<br />

The CP, a static, residual, pathology secondary, generally,<br />

to hypoxic-ischemic events, seen most commonly as an<br />

expression of variable patency, previously or more recently,<br />

of the basal branches of the cerebral arteries (anterolaterals<br />

or fluted branches) or of the terminal veins, of the internal<br />

cerebrum and the choroid plexus, with subsequent infarction<br />

of the subependymal germinal matrix, is one of the pathologies<br />

formerly studied in pediatric neurology and defined<br />

according to location, affected vessels, lesional sequence<br />

during its development, etiology, and, more recently by<br />

the presence of dysplasias of the cortical mantle due to<br />

genetic factors and/or disturbances of neuronal migration.<br />

It is the intention of the author to consider the hemiparetic<br />

and hemiplegic forms, and their risks for development of<br />

partial epilepsy, the latter’s evolution and factors that can<br />

indicate refractoriness and consequent indications for<br />

surgery. The study is prospective and includes 11 patients<br />

between 8 months and 14 years of age with static unilateral<br />

neurological deficits, all without previous treatment, who<br />

were taken care of between 1 and 14 days after the first<br />

seizure. The group was divided in an arbitrary way,<br />

randomly. The majority were not treated with AED and<br />

the subsequent risk for recurrence was greater than in the<br />

group treated immediately after the first seizure. The cumulative<br />

risk according to delay in the start of treatment was:<br />

60% had repetition of seizures within 36 months. The treated<br />

population was statistically significantly different for the<br />

recurrence risk, after setting down parameters such as 1 and<br />

2 months free of seizures. Of the patients who received<br />

immediate treatment, 85% had a year free of attacks and<br />

67% had repeated seizures 2 years later. Of the group with<br />

delayed treatment, (percentage in which seizures are<br />

increased based on the duration from 18 to the beginning<br />

of therapy) those 46% free of attacks are divided equally<br />

between the 1st year, and 33% both 1os. years. Only 25% of<br />

the first group of patients had almost complete or complete<br />

remission of the attacks. That number rose to 56% in the<br />

patients treated initially. The rest had little or no response to<br />

drugs, with increases, additions or changes of these, and<br />

continued to have partial seizures, thus presenting themselves<br />

as candidates for the surgery. In hemiparetic or hemiplegic<br />

C.P., therapy with anticonvulsant drugs is<br />

recommended prior to the appearance of seizures.<br />

FP-H-094<br />

Lamotrigine vs levetiracetam in treatment of JME,<br />

newly diagnoses epilepsy<br />

M. Carignani<br />

Neurology Institute, Universidad Nacional de Rosario,<br />

Rosario, Argentina<br />

We tried 19 patients with lamotrigine (200–400 mg/day),<br />

who had a diagnosis of JME, versus another group of 16<br />

patients with same pathology on levetiracetam monotherapy<br />

(1000–2000 mg/day). It is well known that levetiracetam’s<br />

mechanism of action is still unclear, apart from the anticonvulsant<br />

effect on rats treated with PTZ or electroshock<br />

seizures. Adverse effects were most frequently dizziness,<br />

often headaches, asthenia and somnolence; also renal and<br />

hepatic functions must be carefully checked. Some cases<br />

had increases in, or developed myoclonus, with eventual<br />

aggravation of seizures. Lamotrigine is a relatively new<br />

AED, with a structure and a pharmacological profile similar<br />

to that phenytoin and carbamazepine. As a triazine derivative,<br />

it is effective in partial and generalized seizures. The<br />

best-studied mechanism of action of lamotrigine is its inhibitory<br />

effects on voltage-sensitive sodium and calcium<br />

channels, which occur in use and time dependent manners.<br />

The most dangerous effect of the drug is a skin reaction<br />

which can be of variable severity, sometimes with associated<br />

multiorgan failure and death; it can be avoided with<br />

very slow titration, reduction of drug dosage when the rash<br />

appears, followed by further slower increases, or withdrawal.<br />

The groups were between 12 and 19 years old. Both<br />

had normal MRI studies, typical clinical profiles of JME,<br />

and normal evaluated results with interictal HMPAO-<br />

SPECT, interictal EEG and factor analysis of creatine or<br />

creatinine ratios. We also checked the statistical analysis<br />

with the Epilepsy Outcome Scale (EOS). We analyzed<br />

thalamic volume, finding reduced concentration of NAA<br />

in the prefrontal cortex, and low values in the hypothalamus.<br />

We found better results in clinical trials with LTG in terms<br />

of reduced myoclonus in the mornings, abolished GCT<br />

seizure rates, less sleep and psychiatric disorders and better<br />

cognitive, and behavioral performances. We also found


522<br />

Abstracts<br />

better mental condition with this drug. Also migraine,<br />

frequently co-morbid with JME, improved in patients treated<br />

with LTG. Pregnant patients had safe outcomes with<br />

both AEDs. Assays with spectroscopy images and neuropsychological<br />

tests showed improvement: the tests after treatment<br />

started were slightly better with lamotrigine.<br />

Monitoring of drug therapeutic and toxicokinetic effects<br />

on larger number of patients is needed to establish more<br />

reliable conclusions. Meanwhile, there is a lack of wider<br />

statistical data.<br />

FP-H-095<br />

Pyridoxal phosphate should replace pyridoxine for<br />

intractable childhood epilepsy<br />

H.-S. Wang a , S.-C. Huang a , M.-F. Kuo b<br />

a Division of Pediatric Neurology, Chang Gung Children’s<br />

Hospital, and Medical College of Chang Gung <strong>University</strong>,<br />

Taoyuan; b Division of (Pediatric) Neurosurgey, Department<br />

of Surgery, National Taiwan <strong>University</strong> Hospital,<br />

Taipei, Chinese Taipei<br />

We have reported a child whose intractable seizures were<br />

controlled with pyridoxal phosphate (PLP), the active form<br />

of pyridoxine, instead of pyridoxine per se. This study is to<br />

compare the efficacy of PLP with pyridoxine in the treatment<br />

of children with intractable epilepsy. Ninety-four children,<br />

aged from 2 months to 15 years, with idiopathic<br />

intractable epilepsy for more than 6 months were enrolled<br />

in the study. Under EEG monitoring, in addition to the<br />

previous antiepileptic medicine, intravenous PLP of 10<br />

mg/Kg was infused first, then 40 mg/Kg of PLP was<br />

added if there was no significant improvement. For those<br />

patients whose seizures could be controlled by PLP infusion,<br />

PLP was then replaced by oral pyridoxine at the same<br />

dose. If a seizure recurred, parenteral PLP was infused again<br />

to stop it and subsequently oral PLP 50 mg/kg per day was<br />

used. If no seizure recurred in a week, the previous antiepileptic<br />

regimen was gradually tapered. Eleven of the 94<br />

(12%) pediatric patients with idiopathic intractable epilepsy<br />

responded to PLP dramatically. Five of the 11 patients were<br />

free of their previous antiepileptic medicine within 6<br />

months of the treatment and were followed for an average<br />

period of 11 months. Three of them were controlled with<br />

PLP and the remaining two were treated with pyridoxine.<br />

The other six patients responsive to PLP therapy still need<br />

one to three kinds of antiepileptics to control their seizures.<br />

Three of them were treated with PLP and the other three<br />

with pyridoxine. In these 11 patients responsive to the initial<br />

PLP therapy, six of them failed to be treated with pyridoxine<br />

and needed PLP for seizure control. The results show that<br />

PLP is effective in 12% of patients with idiopathic intractable<br />

epilepsy. PLP can replace pyridoxine satisfactorily, but<br />

not vice versa. The value of vitamin B 6 in the treatment of<br />

epilepsy is well known. In this study, it is demonstrated that<br />

the responsive rate to PLP is higher than pyridoxine (12<br />

versus 5%). It seemed that infantile spasms were more<br />

affected by vitamin B 6 than other epilepsy types. The<br />

authors suggest that intravenous infusion of PLP, instead<br />

of pyridoxine, should be tried first when patients with<br />

intractable seizures, especially children with seizure onset<br />

under the age of 15 months, come for treatment. For the<br />

patients who fail to respond to pyridoxine treatment, PLP<br />

should not be abandoned.<br />

FP-H-096<br />

Febrile seizures in a referral hospital<br />

A. Charuvanij, N. Hoonsawad<br />

Department of Pediatrics, Bhumibol Adulyadej Hospital,<br />

Bangkok, Thailand<br />

A prospective study of 149 first episode febrile seizure<br />

patients admitted to the pediatric wards of Bhumibol<br />

Adulyadej hospital between March 1997 and February<br />

1998 was performed to determine the epidemiology and<br />

seizure recurrences. The male to female ratio was 1.22:1.<br />

The mean age was 17.15 months. The average body<br />

temperature when first seen was 39.158C. The mean duration<br />

of fever before arrival at the hospital was 20.45 h. The<br />

cause of fever was mostly upper respiratory tract infection<br />

(71.8%). Fourteen percent and 0.7% of the patients had<br />

histories of febrile seizures and epilepsy, respectively, in<br />

first-degree relatives. Ninety one percent had simple febrile<br />

seizures. The average income of the parents was 8004.61<br />

bath per month. Eighty five percent of the patients were<br />

followed up periodically up to at least 6 months. Seizures<br />

recurred in 15 patients (11.81%) and most (14/15) had the<br />

episodes within 6 months after the first attack. A positive<br />

family history of febrile seizures was the only risk factor<br />

which gave significant differences (P ¼ 0:006).<br />

FP-H-097<br />

Electrical status epilepticus during sleep (ESES): clinical<br />

follow-up and EEG changes during the course of<br />

treatment in 14 cases<br />

M. Topcu, D. Yalnizoglu, G. Turanli, A. Degerliyurt, D.<br />

Genc-Acikgoz, E. Erdogan<br />

Hacettepe <strong>University</strong> Children’s Hospital, Ankara, Turkey<br />

ESES consists of sleep-induced paroxysmal EEG activity,<br />

lasting for months or years, which may appear continuously<br />

or discontinuously during sleep and is usually diffused<br />

bilaterally. The epilepsy is relatively easily controlled.<br />

However the prognosis is complicated by cognitive and<br />

behavioral issues. Fourteen patients, aged between 7 and<br />

18 years of age, were studied. The male/female ratio was<br />

10/4. Age of onset of epilepsy ranged between 11 months<br />

and 14 years. Age of onset of ESES ranged between 3 and<br />

15 years; duration of ESES ranged between 2 months and 7<br />

years. MRI was abnormal in six of 14 patients. All patients


Abstracts 523<br />

showed attention and behaviour problems, one had autistic<br />

features. Three patients had mental retardation, two reported<br />

low school performance. Conventional AEDs including<br />

CBZ, valproate, ethosuximide, clonazepam, phenytoin,<br />

phenobarbital, primidone were tried in different combinations.<br />

Pridoxine was tried in two patients and ACTH in one.<br />

New generation AEDs vigabatrin, lamotrigine, oxcarbazepine,<br />

clobazam and topiramate, were used as add-on medications<br />

in nine patients. EEG showed focal discharges<br />

which were concentrated over the frontal, occipital or<br />

centrotemporal regions in 8/14 patients; 6/8 were on topiramate<br />

or clobazam or both. Behavioral and cognitive<br />

problems improved along with the improvement of the<br />

EEG. New generation AEDs could be promising options<br />

in the treatment of ESES, sparing the patients from the<br />

side effects of steroids. Focal features in EEG might be<br />

transitory findings during the normalization of the EEG.<br />

Topiramate and clobazam may help decrease the duration<br />

of ESES. Therefore further studies are required to determine<br />

the effects of new AEDs in ESES.<br />

FP-H-098<br />

Routine neuroimaging studies in children with complex<br />

febrile seizures<br />

S. Aysun, G. Haliloglu, D. Yalnizoglu<br />

Hacettepe Children’s Hospital, Department of Pediatric<br />

Neurology, Ankara, Turkey<br />

The relations between intractable temporal lobe epilepsy,<br />

a prolonged febrile seizure in childhood and mesial<br />

temporal sclerosis are well known, but do not necessitate<br />

a causal relationship. High-resolution magnetic resonance<br />

imaging provides opportunities to define underlying pathology.<br />

The aim of this study is to demonstrate neuroimaging<br />

findings in children with complex febrile seizures who are<br />

subgrouped according to age of seizure onset and frequency.<br />

Of the 65 children with routine cerebral imaging, we identified<br />

abnormal findings either related or unrelated to<br />

seizures in 40% (26/65), mesial temporal sclerosis being<br />

the most common underlying pathology 42.3% (11/26).<br />

The likelihood of demonstrating an abnormal finding even<br />

with routine neuroimaging studies is 33.3% in patients with<br />

an onset of febrile seizures at more than 6 years of age. We<br />

conclude that children with a febrile seizure onset and recurrence<br />

of seizures after 6 years of age, either as febrile or a<br />

febrile seizures, should be evaluated with magnetic resonance<br />

imaging, even by the care-giving pediatrician.<br />

FP-H-099<br />

Favorable seizure outcome in Kabuki make-up<br />

syndrome associated with epilepsy<br />

A. Ogawa a , S. Yasumoto a , Y. Tomoda a , M. Ohfu a ,A.<br />

Mitsudome a , Y. Kuroki b<br />

a Department of Pediatrics, School of Medicine, Fukuoka<br />

<strong>University</strong>, Fukuoka; b Division of Medical Genetics, Kanagawa<br />

Children’s Medical Center, Yokohama, Kanagawa,<br />

Japan<br />

Purpose: Kabuki make-up syndrome (KS), was first<br />

described in the same year independently by Niikawa et<br />

al. and Kuroki et al. In large previously reported series of<br />

patients with KS, the incidence of seizures was about 10–<br />

40%. However, the appearance of seizures has not been<br />

adequately reported or thoroughly evaluated for this<br />

syndrome. In this study, we analyzed seizure characteristics<br />

and differences in nine patients with KS. Methods: Nine<br />

patients with KS associated with epilepsy were identified<br />

among the patients followed at Fukuoka <strong>University</strong> Hospital<br />

and Kanagawa Children’s Medical Center. The diagnosis of<br />

KS was based on the presence of characteristic findings.<br />

Results: Of the nine patients, five were male and four<br />

were female. Patient ages at the time seizures started ranged<br />

from 7 months to 12 years with a mean of 6 years. Four<br />

patients have generalized seizures and two patients have<br />

complex partial, with secondary generalization. West<br />

syndrome, complex partial seizures and atonic seizures<br />

were seen in one case each, respectively. Electroencephalogram<br />

showed focal spikes in seven cases, frontal dominant<br />

diffuse spike and wave bursts in one and hypsarrhythmia in<br />

one. Seizures were well controlled in eight cases, and<br />

incompletely controlled in only one case. Conclusions: KS<br />

is a mental retardation-malformation syndrome affecting<br />

multiple organ systems, with a broad spectrum of neuromuscular<br />

dysfunction and mental ability. Epilepsy, together<br />

with mental retardation, may be a primary feature of KS.<br />

KS associated with epilepsy is a mainly localization-related<br />

epilepsy with a favorable seizure outcome.<br />

FP-H-100<br />

Severe myoclonic epilepsy of infancy: A drug regimen<br />

for ‘optimal’ treatment?<br />

B. Ceulemans a,b , M. Boel a,b,c , L. Dom d , H. Willekens e ,P.<br />

Thiry f , L. Lagae a,b,c<br />

a Epilepsy Center for Children and Youth, Pulderbos;<br />

b Department of Neurology, <strong>University</strong> Hospital Antwerp,<br />

Edegem;<br />

c Department of Child Neurology, <strong>University</strong><br />

Hospital Gasthuisberg, Leuven; d K. Paola Childrens Hospital,<br />

Antwerp; e A.Z. St.-Lucas, Gent; f St.-Oda Institute, Overpelt,<br />

Belgium<br />

It is well accepted that SMEI or Dravet-syndrome (International<br />

League Against Epilepsy 2001) is a very therapyresistant<br />

epileptic encephalopathy. It is only recently that<br />

the etiological genetic defect, a severe damage of the alfasubunit<br />

of the sodium channel SCN1 of the brain, has been<br />

defined. This gives a new view in the treatment of these<br />

patients. In eleven Belgian patients with SMEI, where the<br />

genetic mutations are known, a strategy for treatment is<br />

proposed. It is clear that anti-epileptic drugs working mainly


524<br />

Abstracts<br />

by blocking sodium channels are not effective in SMEI.<br />

They may even worsen attacks which are mainly myoclonic.<br />

This is certainly the case for carbamazepine, phenylhydantoin<br />

and probably also lamotrigine. Broad-spectrum antiepileptic<br />

drugs such as sodium valproate and topiramate<br />

are more effective. Benzodiazepines are the drugs of choice<br />

for acute seizure treatment. Stiripentol, an inhibitor of cytochrome<br />

P450, is not available in Belgium. An anti-epileptic<br />

drug regimen, mainly based on a combination of broad<br />

spectrum AED’s, and a fairly aggressive seizure-treatment<br />

will be presented. We believe that this regimen is preferable<br />

to a complicated multiple AED regime.<br />

FP-H-101<br />

Interleukin-1 beta and interleukine-1 receptor<br />

antagonist gene polymorphisms in patients with febrile<br />

seizure<br />

Ş. Haspolat, Y. Baysal, M. Coşkun, O. Yeǧin<br />

Akdeniz <strong>University</strong> Medical School, Department of Pediatric<br />

Neurology, Antalya, Turkey<br />

Febrile seizures are the most common type of seizure in<br />

children. There is a strong genetic heterogeneity for febrile<br />

seizures. IL-1b is a major pro-inflammatory cytokine that<br />

plays role in inflammatory responses and fever. The interleukine-1<br />

receptor antagonist (IL-1Ra) is a naturally occurring<br />

anti-inflammatory cytokine which competitively binds<br />

to interleukine-1 receptors, thus modulating the potentially<br />

injurious effects of IL-1. We studied the biallelic polymorphisms<br />

at position 2511 and 13953 of the IL-1b<br />

gene and pentaallelic polymorphism of IL-1Ra genes in<br />

73 patients with febrile seizure (36 simple, 37 complex<br />

febrile seizures) and in 154 controls. The distribution of<br />

the biallelic polymorphism at position 2511 of the IL-1b<br />

gene was significantly different in patients with febrile<br />

seizures (P , 0:05). Allele frequencies for IL-1b 13953<br />

polymorphism were not different in patients and the control<br />

group. IL-1Ra polymorphisms were found to be significantly<br />

different when the patient group was evaluated<br />

together (73 patients). But when the groups were classified<br />

as simple and complex febrile seizure groups no significant<br />

difference was present for IL-1Ra polymorphisms. We also<br />

looked for a relation between family history of febrile<br />

seizures, family history of epilepsy or gender and the polymorphisms.<br />

No relationship could be found. Our data<br />

suggest that, the biallelic polymorphism at position 2511<br />

of the IL-1b gene may play a role in the pathogenesis of<br />

febrile seizures.<br />

FP-H-102<br />

Favourable outcome of epileptic blindness in children<br />

E. Shahar, S. Barak, D. Savitzki, J. Andraus<br />

Child Neurology Unit and Epilepsy Service, Rambam Medical<br />

Center, Rappaport School of Medicine, Haifa, Israel<br />

Blindness is a rare phenomenon of epileptic seizures.<br />

We report on thirteen children with epileptic amaurosis,<br />

investigating the ictal manifestations, EEG findings,<br />

analyzing the response to therapy and elucidating the<br />

outcome in relation to termination of blindness and<br />

seizures. Most experienced single or recurrent episodes<br />

of acute visual obscuration, lasting for 1–30 min, mainly<br />

manifesting in the ictal phase and only a few in the preictal<br />

phase. Seven patients had accompanying generalized<br />

seizures, which could be induced by photic stimulation in<br />

three children. CT of brain performed in five children was<br />

unremarkable. All children in this group, treated with<br />

valproic acid, regained full constant vision and became<br />

seizure free within a period of up to 5 years. Three children<br />

who had the constellation of ictal amaurosis, occipital<br />

EEG paroxysms and migrainous headaches, compatible<br />

with the syndrome of occipital lobe epilepsy, also became<br />

asymptomatic on therapy: two on valproate and one on<br />

carbamazepine. Three children with epileptic blindness<br />

also had either focal motor seizures and/or unilateral<br />

EEG epileptic discharges, with a normal CT. On carbamazepine<br />

therapy they regained full vision and the seizures<br />

abated. Our data suggest a relatively benign course and a<br />

favorable outcome for children with epileptic blindness<br />

and associated seizures. They regain full constant vision<br />

in association with control of seizures and preservation of<br />

cognition.<br />

FP-H-103<br />

Cortical developmental malformations and epilepsy:<br />

review of 62 pediatric patients<br />

R.M. Valério, F.N. Arita, S. Rosemberg<br />

Santa Casa of São Paulo Medical School, São Paulo, Brazil<br />

We studied a series of 62 children with cortical developmental<br />

malformations (CDM) in order to determine the<br />

incidence of the different types, the clinical presentation<br />

and the occurrence of epilepsy in each group. The 62<br />

patients (32 males, 30 females) were divided into different<br />

groups according to the MRI results: 34 (18 males, one<br />

females) had polymicrogyria and/or schizencephaly<br />

(PMG/SCH) (ten bilateral opercular PMG; nine focal<br />

PMG; nine bilateral and six unilateral SCH); ten (seven<br />

males, three females) lissencephaly/pachygyria complex<br />

(LIS); one (female) type II lissencephaly; one (female)<br />

double-cortex; four focal cortical dysplasia of Taylor<br />

(FCDT) (one males, three females); two HMG (2m);<br />

seven nodular heterotopia (NH) (two males, five females)<br />

and three, complex unclassified CDM. Twenty-four<br />

patients (38.7%) did not report epilepsy on the first consultation<br />

or during the follow-up (14 PMG/SCH), six LIS, two<br />

NH and two, complex unclassified CDM). Among the<br />

remaining 38 epileptic patients, the seizures were<br />

controlled with AEDs in 15 (39.4%). All patients with<br />

abnormal cortical proliferation and differentiation disorders


Abstracts 525<br />

(FCDT and HMG), 9 with PMG/SCH (26.5%), five with<br />

LIS/type II LIS (45.4%) and two with NH (28.6%) had<br />

intractable epilepsy. Almost all patients had been referred<br />

for psycho-motor developmental delay or abnormal motor<br />

signs. We conclude from our unselected CDM series that<br />

the occurrence of epilepsy is far from being mandatory and<br />

when present it may be clinically controlled. These data<br />

differ from most reported series of CDM in which the<br />

incidence and severity of epilepsy are more prominent<br />

probably because in these series the patients are referred<br />

to pre-surgical evaluation for intractable epilepsy.<br />

FP-H-104<br />

The study of toleration to achieving the target dose<br />

rapidly in infants with epilepsy treated by Topamax<br />

X.-L. Xie, Y.-Q. Zhong, J. Wu, M. Wu, W.-G. Hu<br />

Chengdu Children Hospital, Chengdu, China<br />

Objective: To explore an appropriate dosage and a speed<br />

of increasing dosage of Topamax through observation of<br />

tolerability in infants, and to increase therapeutic effects<br />

and decrease side effects. Methods: We studied 23 infants<br />

with epilepsy from our hospital in 2001. We increased the<br />

Topamax to the target dosage rapidly at 2 or 3 weeks<br />

intervals, by increasing 0.5 mg/kg per day once every 3<br />

days. The average target dosage was 6.2 mg/kg per day.<br />

Therapeutic evaluation was: excellent, if seizure-free;<br />

better, if the frequencies decreased $75%; good, if<br />

$50%; and, bad or ineffective if ,50%. Results: Therapeutic<br />

effects were excellent in 11 of 23 cases (47.8%);<br />

better in seven (30.4%); and, good in five (21.7%). No case<br />

was defined as ineffective or deteriorated. Conclusion: The<br />

therapeutic effects and side effects of Topamax had individual<br />

differences, so methods of giving the drug are important.<br />

Side effects occurred less frequently in infants than<br />

that in other children over 1 year old. It was reasonable to<br />

reach the target dosage of Topamax rapidly in infants with<br />

epilepsy.<br />

FP-H-105<br />

Comparison of partial and generalised childhood<br />

epilepsies using principal and independent component<br />

analysis<br />

C.P. Unsworth a , J.J. Spowart b , G. Lawson b , J.K. Brown b ,B.<br />

Mulgrew a , R.A. Minns b , M. Clark b<br />

a Department of Electronics and Electrical Engineering;<br />

b Department of Child Life and Health, <strong>University</strong> of Edinburgh,<br />

Edinburgh, Scotland, UK<br />

A typical EEG consists of roughly 20 electrical recordings<br />

which are received from electrodes located at different<br />

regions of the scalp. Each recording represents a<br />

mixture of signals from a variety of brain activities.<br />

Depending upon a patient’s activity such signals can<br />

become very complicated to interpret. This is true in the<br />

case of epilepsy. Independent component analysis (ICA) is<br />

a signal-processing tool that can take data from a multichannel<br />

system, as in the EEG, and statistically de-mix the<br />

real signals from their mixtures. As long as the number of<br />

electrodes is larger than the number of real signals that<br />

exist, ICA is valid. Recently ICA has claimed to be able to<br />

de-mix the real epileptic signal components from the<br />

mixtures of an EEG. This seems quite promising as the<br />

EEG has a large number of channels and the signals<br />

detected during an epileptic attack appear relatively simple<br />

and to have few generating sources. In this paper we<br />

examine a variety of partial and generalised epilepsies,<br />

some of which are evoked and others un-evoked, which<br />

occur in children. By examining the correlation between<br />

the principal components of the epilepsies presented here,<br />

it is possible to compare and contrast the different forms of<br />

epilepsy, thus, gaining an insight into nature of the epilepsies<br />

and their connection to each other. In addition, from<br />

this analysis is possible to draw conclusions on the applicability<br />

of ICA to the EEG for the different forms of<br />

epilepsy.<br />

FP-H-106<br />

A study of supporting school life of children with<br />

epilepsy<br />

H. Nagao a , Y. Suzuki b , T. Morimoto b<br />

a Department of Pathophysiology, Faculty of Education,<br />

b Department of Pediatrics, Faculty of Medicine, Ehime<br />

<strong>University</strong>, Ehime, Japan<br />

In order that children with epilepsy can lead safe and<br />

active lives, and also be encouraged to pursue full school<br />

activities, an activity-based school safety map was made.<br />

Subjects were 27 students who had experienced seizures<br />

within the past 2 years, selected from 51 children with the<br />

diagnosis of epilepsy, in a school for mental disabilities<br />

(with a total population of 236). This activity based school<br />

safety map was planned by the school teachers and the<br />

author. The results showed that the students were divided,<br />

according to the guidance of daily life in children with<br />

epilepsy proposed by author, group A: four, group B:<br />

seven, group C: 11, and group D: five. The degree of aid<br />

required in daily activities was categorized into: (1) hand in<br />

hand; (2) within reach of hand; (3) within reach of<br />

eyesight; and (4) no supervision necessary. The school<br />

environment was categorized into five groups according<br />

to the risk and supervision necessary, as follows: (a) swimming<br />

pool; (b) stairs and edge of stage; (c) corridors; (d)<br />

training classroom; and (e) ordinary classroom. This study<br />

proved that making an activity based school safety map for<br />

individuals with epilepsy according to individual needs,<br />

enabled the children to pursue full school activities as<br />

much as possible.


526<br />

Abstracts<br />

FP-H-107<br />

Language disorders and epilepsy<br />

A. Al-Qudah<br />

Division of Pediatric Neurology, Jordan <strong>University</strong> Hospital,<br />

Amman Jordan<br />

Background: A number of language disorders have been<br />

associated with epilepsy or EEG epileptiform abnormalities.<br />

These include Landau-Kleffner syndrome (LKS), electrical<br />

status epilepticus of sleep, developmental dysphasia and<br />

possibly autism. LKS patients have been treated with antiepileptic<br />

drugs and steroids without apparent success. LKS<br />

aphasic patients have been recently treated with immunoglobulins<br />

with good results. This study reports relatively<br />

successful results after treatment of LKS patients with immunoglobulins.<br />

Patients and methods: Four patients with LKS<br />

have been included in the study since November 1999. They<br />

were all males with age range of 5.5–14 years (Mean ¼ 9.5).<br />

Patients were scheduled to receive five consecutive doses of<br />

immunoglobulins over 5 days and one dose every month for 6<br />

months. MRI was done on all patients. Results: Age of onset<br />

of seizures was 3.5, 5.3, 7.5, and 1.5 years and of aphasia was<br />

3.5, 5.9, 8, and 2 years, respectively. Duration of aphasia was<br />

7, 1, 0.8 and 4 years and follow-up was 2 years, 2 months, 5<br />

months and 1 month, respectively. Onset of response to<br />

immunoglobulins was at day 7, 5, 9 and 7, respectively, for<br />

the four patients. Patients 2 and 3 had complete recovery of<br />

their language. Conclusion: This study has added further<br />

support to the little literature on the beneficial value of immunoglobulins<br />

in aphasic LKS patients.<br />

FP-H-108<br />

Diagnosis, types, management of convulsion disease of<br />

the children<br />

R. Sutar<br />

Bhubaneswar Municpal Corporation Hospital, Bhubaneswar,<br />

India<br />

Convulsive disease of children is the most difficult,<br />

complicated disease because of its causes, different types,<br />

diagnosis and treatment which are not yet clear and definite<br />

like all types of diseases seen in the world. Convulsive<br />

disease is the result of deranged brain cells due to direct<br />

disease of the brain cells or effects of other diseases of the<br />

body affecting the brain cells. As in other diseases of people,<br />

advanced modern miracle treatment, such as treatment by<br />

new exchange of organs etc., an alternative process, can<br />

give better life in chronic disease, as seen in other diseases.<br />

But such a clear cut, easy and definite modern facility for cure<br />

of convulsive disease of children is not yet given, by any<br />

modern medical scientist of the world, as a scientific topic<br />

in publication. The parents are still in a dilemma as to<br />

whether they will get hope of a positive permanent cure of<br />

convulsions, as seen with other diseases of people. These<br />

problems are seen more in developing and poor countries<br />

which have no advanced facility for this disease, and, as a<br />

result, people are forced to believe in the old unscientific<br />

processes of treatment. So a universal, reasonably acceptable,<br />

amicable process of diagnosis, facilities, treatment and<br />

education for the people in relation to the diseases should be<br />

given to all concerned in the world, irrespective of city or<br />

remote, inaccessible area, considering the standard living of<br />

the people and facilities available therein. The modern good<br />

effect of the treatment as seen in other diseases of the world,<br />

will be shown to the people in cases of convulsive disease for<br />

their belief and acceptance; and, guidelines of education will<br />

be given to the people for the prevention of the so called<br />

incurable convulsive disease of children. This topic has<br />

been presented in television for discussion and newspaper<br />

for popular science.<br />

FP-H-109<br />

Clinical and EEG study of seven patients with chronic<br />

progressive epilepsia partialis continua of childhood<br />

A. Muto, H. Oguni, K. Imai, Y. Maeda, M. Funatsuka, M.<br />

Osawa<br />

Department of Pediatrics, Tokyo Women’s Medical <strong>University</strong>,<br />

Tokyo, Japan<br />

Chronic progressive epilepsia partialis continua (EPC) of<br />

childhood is characterized by intractable partial epilepsy<br />

and slowly progressive neurological deficits affecting one<br />

side of the body. Most of the patients with this syndrome<br />

have been regarded as Rasmussen syndrome (RS), because<br />

chronic localized encephalitis has been shown to be<br />

responsible for this epilepsy. We studied the clinical,<br />

neuroimaging and EEG findings of patients with chronic<br />

progressive EPC to reveal it’s long-term evolution.<br />

Subjects: The subjects fulfilling the clinico-electrical<br />

features of chronic progressive EPC were seven patients<br />

including two with pathologically confirmed RS. Methods:<br />

We retrospectively studied their medical records, EEG files<br />

and neuroimaging findings. Results: Two patients had uveitis<br />

and one had impetigo before epilepsy onset. The median<br />

age at onset of epilepsy was 6 years and 3 months. The<br />

period between the onset of epilepsy and that of daily<br />

seizures ranged from 1 month to 9 years. Four children<br />

ran a rapidly progressive clinical course and eventually<br />

developed hemiplegia, while the remaining three had a<br />

slower clinical course and two eventually developed mild<br />

hemiparesis. MRI showed progressive atrophy of one<br />

hemisphere in all cases. As for treatment, five patients<br />

received steroid pulse therapy without significant benefits.<br />

Three cases underwent epilepsy surgery. One child died of<br />

pneumonia. Conclusion: This study suggested the presence<br />

of two subtypes in patients with chronic progressive EPC<br />

or RS, one of which has an early epilepsy onset and rapidly<br />

progressive clinical course, while the other has a later<br />

epilepsy onset and more slowly progressive course.


Abstracts 527<br />

FP-H-110<br />

Lamotrigine pharmacokinetics in children<br />

M.I. Arranz a , M. Manero a , M. Aparicio b , Lorenzo b ,E.<br />

Saenz c , B. Tirapu a , R.J. Del a , J. Mercader a , E. Ripoll a<br />

a Bioquímica, b Pediatría, c Hospital Ramón y Cajal, Neurología,<br />

Hospital Gregorio Marañó, Madrid, Spain<br />

Lamotrigine (LTG) is a new AED approved as adjunctive<br />

therapy or monotherapy. LTG is effective against seizures:<br />

partial, primarily generalized tonic-clonic, absences, and<br />

drop attacks associated with the Lennox-Gastaut syndrome.<br />

Its metabolism is affected by co-medicated AEDs. TDM in<br />

children is useful because of age-related differences in<br />

metabolism. We present LTG pharmacokinetic behavior<br />

in children. Methods: We reviewed LTG data from May<br />

2000 to February 2002. Concentrations were determined<br />

by HPLC. Results: From 137 LTG levels, 58 in patients<br />

on monotherapy; and, in association with: VPA (n ¼ 15);<br />

clobazam (CLB) (n ¼ 15), carbamazepine (CBZ) (n ¼ 10),<br />

ethosuximide (ETX) (n ¼ 4), phenobarbital (PB) (n ¼ 1)<br />

and topiramate (TOP) (n ¼ 1); with: VPA 1 CLB (n ¼ 8),<br />

VPA 1 ETX (n ¼ 6), VPA 1 CBZ (n ¼ 3), VPA 1 TOP<br />

(n ¼ 3), ETX 1 CLB (n ¼ 4), PB 1 primidone (PRIM)<br />

(n ¼ 2), CBZ 1 CLB and CBZ 1 TOP (n ¼ 1); to: PB 1<br />

ETX 1 PRIM (n ¼ 2) and VPA 1 CBZ 1 TOP (n ¼ 1),<br />

and with: VPA 1 PB 1 CLB 1 PRIM (n ¼ 1). Mean LTG<br />

levels (mg/l) were lower on monotherapy (2.5 1 1) than<br />

with VPA alone (3.2 1 1.8), or, plus other AEDs<br />

(3.7 1 1.3) except CBZ, and lower when AEDs other than<br />

VPA were added (1.9 1 0.8). Highest LTG values were<br />

found with: VPA 1 TOP (4.9 1 0.8), VPA 1 CLB<br />

(3.9 1 1.4), VPA (3.2 1 1.8), and VPA 1 ETX<br />

(2.8 1 1.3). Lamotrigine mean doses ranged from 130 to<br />

275 mg/24 h. Conclusions: Lamotrigine efficiency increases<br />

with VPA alone or with others, except CBZ; and is underused<br />

with AEDs other than VPA.<br />

FP-H-111<br />

Topiramate as monotherapy in childhood and<br />

adolescent epilepsy<br />

M. Verdecchia, P. Parisi, M. Montanaro, C. Arpino, P.<br />

Curatolo<br />

Department of Pediatric Neurology, Tor Vergata <strong>University</strong><br />

of Rome, Rome, Italy<br />

TPM has proved to be effective as add-on therapy in children<br />

with partial onset seizures. This study was carried out to<br />

evaluate the effectiveness of TPM as monotherapy in epileptic<br />

children and adolescents with no or limited exposure to<br />

other antiepileptic drugs. Twelve patients aged 3–17 years<br />

with partial or generalised epilepsies were treated with topiramate<br />

for a median period of 10 months (range 6–20 months).<br />

Of the 12 patients enrolled, six were children with newly<br />

diagnosed epilepsy. Five patients had idiopathic tonic-clonic<br />

generalised epilepsies, three had benign rolandic epilepsies<br />

and four had symptomatic partial epilepsies. The starting<br />

dose was 0.5–1.0 mg/Kg per day. TPM was increased slowly<br />

at a mean rate of 25 mg/week up to clinical response or to a<br />

maximum of 2–4 mg/Kg per day. The concomitant AED, if<br />

present, was discontinued as TPM was titrated to target<br />

dosages. Eight patients were seizure-free and two had 50%<br />

or greater reduction in seizure frequency; two patients with<br />

rolandic benign epilepsies discontinued because of inadequate<br />

seizure control. Efficacy was seen against simple and<br />

complex partial seizures and generalised tonic-clonic<br />

seizures. The most common adverse effects were anorexia<br />

and weight loss recorded in three cases; only one patient<br />

experienced paresthesiae. Side effects were mild and transitory,<br />

usually occurring during the first 3 weeks of treatment.<br />

Our experience suggests that TPM is safe and efficacious as<br />

monotherapy in a wide spectrum of childhood epilepsies.<br />

The incidence of adverse events was lower than reported<br />

with TPM polytherapy, suggesting that some side effects<br />

observed with TPM as add-on therapy may result from pharmacodynamic<br />

interactions with other AEDs.<br />

FP-H-112<br />

Liposteroid therapy for refractory seizures in West<br />

syndrome<br />

S. Tanaka, A. Araki, Y. Kobayashi<br />

Department of Pediatrics, Kansai Medical <strong>University</strong>,<br />

Osaka Japan<br />

It was reported recently that liposteroid (LS) was effective<br />

for the treatment of West syndrome (WS), with fewer<br />

side effects than those of ACTH. We report a patient with<br />

WS who was successfully treated with LS after ACTH therapy<br />

was ineffective. A female infant was born at term after<br />

an uneventful pregnancy and delivery. Tonic spasms developed<br />

at 2 months of age. An EEG showed hypsarrythmia,<br />

and she was diagnosed as having WS. Magnetic resonance<br />

imaging of the brain disclosed no abnormality. Vitamin B6<br />

and zonisamide were started without any effect. ACTH therapy<br />

was commenced at 3 months of age (0.01 mg/kg for 2<br />

weeks). The number of seizures decreased, but tonic spasms<br />

were not controlled completely. Intravenous administrations<br />

of gamma-globulin were also not effective. Liposteroid therapy<br />

was begun at 4 months of age. In line with the original<br />

method reported by Yamamoto et al., LS (0.25 mg/kg) was<br />

given intravenously once a week for the first 4 weeks, once<br />

every 2 weeks for the next month, and once a month for the<br />

3rd month. Three weeks after the initiation of LS therapy,<br />

the seizure frequency remarkably decreased. A follow-up<br />

EEG showed the disappearance of hypsarrythmia, but<br />

diffuse polyspikes remained. She had no adverse effects.<br />

The patient is now 1 year old and free from convulsions.<br />

Our experience of this case suggests that LS therapy might<br />

be a new option for the treatment of refractory seizures in<br />

WS.


528<br />

Abstracts<br />

FP-H-113<br />

A clinico-electroencephalographic study of children<br />

suffering from febrile seizures plus<br />

K. Kobayashi a , Y. Ohtsuka a , Y. Nishio b , M. Fujiwara b ,I.<br />

Ohmori a , T. Akiyama a , T. Ogino a , H. Yoshinaga a ,N.<br />

Murakami a , K. Nakano a , Y. Watanabe a , T. Nakahori a ,E.<br />

Oka a<br />

a Department of Child Neurology, Okayama <strong>University</strong><br />

Medical School, Okayama; b Department of Pediatrics, JA<br />

Fuchu General Hospital, Hiroshima, Japan<br />

Purpose: FS 1 are attracting attention because of their<br />

related genetic abnormalities, and are defined as FS continuing<br />

beyond 6 years of age or those associated with afebrile<br />

seizures earlier than 7 years. However, general clinical<br />

pictures of children suffering from FS 1 have not yet been<br />

thoroughly clarified. We tried to elucidate their clinical and<br />

electroencephalographic characteristics as compared with<br />

those of children with only FS. Subjects and methods: By<br />

reviewing the clinical records of the pediatric neurology<br />

clinic in the JA Fuchu General Hospital, we found 27<br />

patients with FS 1 (Group FS 1 ) and 51 with only FS<br />

(Group FS), and studied their family history, clinical<br />

pictures and EEG findings. Results: Family histories of<br />

seizures were noted in ten patients (37.0%) of Group FS 1<br />

and in 23 (45.1%) of Group FS. In Group FS 1 , 14 patients<br />

(51.9%) had FS occurring beyond 6 years of age, 12 (44.4%)<br />

had afebrile seizures, and the remaining one (3.7%) had<br />

both types of seizures. Two also had seizures induced by<br />

TV/video-games, and another suffered from absences. The<br />

observed epileptic EEG abnormalities were diffuse and/or<br />

focal, and were noted in 11 patients (40.7%) of Group FS 1<br />

and 12 (23.5%) of Group FS. There were no statistically<br />

significant differences regarding the above findings within<br />

Group FS 1 or between the two groups. Conclusions: The<br />

clinico-electroencephalographic characteristics of the children<br />

with FS 1 were diverse, and their rate of positive family<br />

history was no higher than that of children with only FS.<br />

FP-H-114<br />

A case of a 15-year-old patient with intractable epilepsy<br />

who frequently showed gelasma after the introduction of<br />

clobazam<br />

T. Iwasaki, H. Miura, W. Sunaoshi, N. Hosoda, K. Takei, F.<br />

Katayama<br />

Department of Pediatrics, Kitasato <strong>University</strong> School of<br />

Medicine, Kanagawa, Japan<br />

This is a case of a 15-year-old boy patient who has severe<br />

mental retardation and spastic paraplegia due to fetal<br />

distress and hypoxic brain damage at the time of birth.<br />

The patient developed West syndrome at the age of 7<br />

months. He was diagnosed with undetermined epilepsy<br />

more recently. His intractable epilepsy had not been<br />

controlled well with the administration of nitrazepam and<br />

zonisamide for 5 years. We added clobazam (CLB) to this<br />

combination therapy. CLB was marketed 2 years ago in our<br />

country for the first time. After the introduction of CLB, his<br />

intractable tonic spasms disappeared. But so-called gelastic<br />

seizures appeared frequently before falling asleep. Sleep<br />

disturbance became troublesome subsequently. The gelastic<br />

seizures manifested as laughing with a stiff face and a wry<br />

mouth. As side effects of CLB, gelastic seizures have not<br />

been reported previously, although irritability or sleep<br />

disturbance have been recognized.<br />

FP-H-115<br />

The electro-clinical features of Landau-Kleffner<br />

syndrome<br />

K.Yu. Mukhin, A.S. Petrukhin, A.A. Kholin, L.Yu.<br />

Glukhova, N.V. Mikhalitchenko<br />

Paediatric Neurology Clinic of Russian State Medical<br />

<strong>University</strong>, Moscow, Russia<br />

Purpose: To summarise the seizure semiology, clinical<br />

and EEG findings in LKS. Methods: Clinical examination,<br />

EEG, sleep EEG, video-EEG monitoring, neuroimaging<br />

were recorded in the investigation of five patients with<br />

LKS. Results: We investigated four boys and one girl<br />

aged 6–10 years (medium – 7.8 years) affected by LKS.<br />

The epileptic seizures, presented in three children, began<br />

between 2.5 and 6 years of age (medium – 4 years) with<br />

atypical absences (two cases) and simple partial pharyngooral<br />

seizures (one case). Two of five patients had no<br />

seizures. We have observed the following types of seizures:<br />

atypical absences (all three patients with seizures) accompanied<br />

by atonic drop attacks – in one patient, simple partial<br />

with secondary generalization before awakening (two<br />

patients). All the children developed sensory and motor<br />

aphasia, and cognitive dysfunction with hyperactivity.<br />

Two presented autistic disorder with aggressive behaviour.<br />

The EEG investigation revealed fronto-temporal (three<br />

patients) or centro-temporal (two) sharp-slow wave and<br />

‘rolandic-like’ spike focuses right (one), left (one) unilateral<br />

and right (two), left (one) unilateral with diffuse sharp-slow<br />

wave patterns. Both regional and diffuse sharp-slow wave<br />

patterns increased in non-REM sleep. Secondary bilateral<br />

synchrony mechanism were evident in all cases: continuous<br />

diffuse spikes and waves during slow sleep but less than in<br />

ESES – two patients and ESES in three patients. MRI was<br />

normal in four cases. Antiepileptic drugs used in our group<br />

were valproic acid (Depakin), carbamazepine (Finlepsin),<br />

suxilep, lamotrigine, clobazam, and sulthiame. The seizures<br />

have a favourable outcome, but the aphasia is usually resistant<br />

to therapy. Conclusion: We think that the LKS is a form<br />

of partial epilepsy of cryptogenic origin with a large spectrum<br />

of clinical features. EEG findings often show secondary<br />

bilateral synchrony and continuous spikes and waves<br />

during slow sleep progressing to ESES.


Abstracts 529<br />

FP-H-116<br />

Health-related quality of life in children with epilepsy:<br />

development and validation of a self-report- and a<br />

parent proxy respondent measure<br />

G.M. Ronen, D.L. Steiner, P. Rosenbaum<br />

Canadian Pediatric Epilepsy Network, McMaster <strong>University</strong>,<br />

Hamilton, Ontario, Canada<br />

Health-related quality of life (HRQL) includes the<br />

patient’s own experiences, preferences, values, and their<br />

perceptions of their symptoms and functioning. HRQL<br />

broadens the range of outcomes that are measured and<br />

expands the professional’s awareness of issues that concern<br />

patients. We used qualitative and quantitative research<br />

methodologies sequentially to develop a self-report- and a<br />

parent proxy HRQL measure for pre-adolescent children<br />

with epilepsy. Modified focus groups, run separately with<br />

children with epilepsy and their parents, facilitated exploration<br />

of HRQL issues. Textual analysis helped us understand<br />

the HRQL components and identify 31 domains clustered<br />

into five major themes. Items for the scale were extracted<br />

from the raw data. We created a scale formatted with alternative<br />

paired options of forced responses and used factor<br />

analysis to reduce the number of items. Internal consistency<br />

was measured with Cronbach’s alpha; test-retest reliability<br />

with the Pearson Correlation, and construct validity with<br />

seven hypotheses. A total of 381 children with active<br />

epilepsy, ages 6–15, and their parent(s) completed separately<br />

a 67-item questionnaire. We chose five subscales<br />

from the factor analysis with five items per subscale. Children<br />

and parents could discern differences and report differentially<br />

between the various aspects of their HRQL. Testretest<br />

was only satisfactory for parents and children 8 years<br />

and older. Internal consistency, construct and discriminative<br />

validity were acceptable for all subscales. Our data provide<br />

solid psychometric properties for user-friendly HRQL<br />

measures for parents and children 8 years and older. The<br />

measures subscales encompass HRQL dimensions identified<br />

and judged most important by children with epilepsy<br />

and their parents.<br />

FP-H-117<br />

Evaluation of 76 patients with infantile spasms:<br />

epidemiologic and clinical data<br />

Ş. Uçar a ,Ö.F. Aydin b ,N.Şenbil b ,Ü. Ertan a , Y.K.Y. Gürer 2<br />

Dr. Sami Ulus Children’s Hospital, a Department of Pediatrics<br />

and b Pediatric Neurology, Ankara-Turkey<br />

Infantile spasms (IS) is an epileptic syndrome of early<br />

infancy with poor prognosis which is not controlled by standard<br />

antiepileptic drugs. Medical records of 76 patients<br />

diagnosed with IS between 1995 and 2001 were reviewed.<br />

Forty-two of them were males (55.3%) and 34 were females<br />

(44.7%). The mean onset of infantile spasms was<br />

5.88 ^ 0.53 months. The mean admission age was<br />

8.79 ^ 0.54 months. Spasms were seen mostly at 4–6<br />

months (50%) and 80.3% started before the aged of 1.<br />

Seventy of 76 cases were symptomatic (92.1%) and six<br />

were cryptogenic (7.9%). In the symptomatic group prenatal,<br />

perinatal and postnatal causes were 42.9, 34.3 and<br />

17.1%, respectively. No etiological cause was found in<br />

5.7%. Hypoxic ischemic encephalopathy was the most<br />

common of the prenatal and perinatal causes (48.58%).<br />

Flexor spasms were seen most frequently (59.2%), mixed<br />

spasms were less frequent (31.6%) and extensor spasms<br />

were the least frequently seen (9.2%). A total of 35.5% of<br />

the cases had other kinds of seizures before IS. Spasms<br />

disappeared before the age of 2 in 63.2% of the cases.<br />

EEG findings improved with ACTH treatment. Early treated<br />

patients showed better responses to the treatment. No significant<br />

difference was found in neurodevelopmental and<br />

mental improvement between the pre and posttreatment<br />

states. The patients who were on ACTH or ACTH 1<br />

pyridoxine treatment showed more complete response<br />

compared to the patients on the other alternative treatments.<br />

Patients with tuberous sclerosis showed better response to<br />

vigabatrin. A total of 34% of the 57.9% patients with remission<br />

showed relapse. Relapses were less in the early treated<br />

group. Relapses responded to treatment poorly. Mortality<br />

rate was 2.6%, 25% of the patients developed other kinds<br />

of epilepsies after IS, which were mostly LGS.<br />

FP-H-118<br />

Teaching paediatric and adolescent epilepsy at advanced<br />

level in Slovenia – example of a small country<br />

I.M Ravnik a , P. Wolf b<br />

a Ljubljana, Slovenia, b European Epilepsy Academy, Slovenia<br />

Rationale: In Slovenia (2 million inh), the practice of<br />

child neurology started by studying and treating seizure<br />

disorders (Jeras, 1954), evolving into full-scope child<br />

neurology. General paediatricians have been offered update<br />

courses, and special courses including paediatric and<br />

adolescent epilepsy (PAE) have been organized for paediatricians<br />

interested in neurology. Advanced epilepsy<br />

courses, due to few trained specialists and small audiences,<br />

could not be similarly established. The small team, still<br />

developing, mostly educated abroad, participates with<br />

interested adult neurologists and organizes advanced<br />

courses/workshops for child neurologists, neurophysiologists<br />

and neurologists, with foreign and local experts to<br />

compensate for the lack of formal training in epileptology.<br />

What would be the best way to go in future? Method: (1)<br />

Analysis of post-graduate teaching on epilepsy via<br />

programmes organised by the Slovenian ILAE Chapter,<br />

Slovenian Medical Society’s Epileptology Section, and<br />

local Epi-club in collaboration with European Epilepsy<br />

Academy (Eurepa), and established bilateral (e.g. Slove-


530<br />

Abstracts<br />

nian – French) co-operation. (2) Analysis of questionnaires<br />

on gaps in knowledge in PAE care in Central Eastern<br />

European countries (CEEC). Results: Different answers<br />

could be obtained from students depending on their<br />

previous knowledge. All university post-graduate courses<br />

(paediatrics, child neurology, neurophysiology, child<br />

psychiatry) do offer basic knowledge of PAE. Advanced<br />

students claim more knowledge in neuroradiology, paediatric<br />

EEG and electro-clinical characterisation of PAE<br />

syndromes. Clinical workshops (on classification of epileptic<br />

syndromes, drug treatment, assessment of drug trials,<br />

epilepsy management, EEG, neuropsychology of epilepsy,<br />

severe epilepsies, comprehensive epilepsy care, epilepsy<br />

and handicap) in collaboration with foreign centres and<br />

Eurepa’s trainers have been well attended. Assessment:<br />

clinical work with case-studies and real-life ‘know-how’<br />

added to theoretical work is favoured by the students.<br />

The CEEC questionnaire (Ravnik et al., Epilepsia 1999)<br />

on comprehensive PAE care disclosed domains in which<br />

‘knowledge and expertise were felt to be missing’: presurgical<br />

assessment, surgery (6/7 countries); social work,<br />

functional imaging (5/7); remedial teaching (4/7); neuroradiology,<br />

neuropsychology, child and adolescent psychiatry,<br />

clinical psychology (3/7); while only 2/7 listed EEG<br />

and 1/7 neuropharmacolgy. Quite a few of the above do not<br />

belong to the domain of child neurology in a narrow sense.<br />

The same study showed that in many CEEC, child neurologist<br />

was in charge of the whole bulk of problems encountered<br />

in comprehensive epilepsy care. The perceived ‘lack<br />

of knowledge’ may indeed correspond to lack of paramedical<br />

staff and/or lack of knowledge enabling effective<br />

communication between child neurologist and other<br />

professionals. This may have to be considered in planning<br />

education of child neurologists on PAE care. Conclusions:<br />

Experience gathered in post-graduate teaching of PAE<br />

through years by the local team networking with international<br />

centres of excellence, and including audience from<br />

the neighbouring countries, has proved very useful. Plans<br />

are underway to formalize some of the already tested<br />

educational projects into a curriculum adapted to the<br />

demands of European Epilepsy Academy offering future<br />

child neurologists in the region high level training opportunities<br />

in spite of non-existing formal epileptological<br />

training in their countries.<br />

FP-H-119<br />

Main side-effects of valproic acid drug treatment for<br />

pediatric patients with epilepsy<br />

V.M. Studenikin, O.I. Maslova, V.I. Shelkovsky, S.V.<br />

Balkanskaya, M.Z. Karkashadze<br />

Division of Psychoneurology, Scientific Center of Child<br />

Health (Russian Academy of Medical Sciences), Moscow,<br />

Russia<br />

Background: Valproic acid (VA) drugs are currently used<br />

world-wide as the most popular medicines for seizure<br />

control in the management of partial and generalized<br />

seizures in pediatric and adult patients, but unfortunately<br />

valproates are also known to induce some undesirable<br />

side-effects. Goal: Therefore, the aim of our study was to<br />

find out the incidence of various undesirable effects in<br />

pediatric patients with epilepsy, undergoing therapy with<br />

VA. Method: For this purpose we have analyzed case<br />

histories of 383 epileptic infants and children (aged 2<br />

months–15 years) hospitalized in the neurological clinic in<br />

1995–1999, and receiving VA as mono-or polytherapy.<br />

Results: Most side-effects observed can be divided into<br />

two main categories: hepatotoxic in 26.9% of cases (varying<br />

from raised hepatic enzymes to biliary dyskinesia, mild<br />

reactive pancreatitis, etc.) and hematological changes<br />

(leukopenia with accompanying platelet decrease) 6% of<br />

patients. The latter led to bleeding diathesis in three pts.<br />

Such various side-effects as excessive weight-gain, alopecia,<br />

decreased calcium in serum, and cognitive deficit were<br />

registered, as well, but less frequently. Only rarely VA sideeffects<br />

could be clearly categorized as dose-related, resulting<br />

from idiosyncratic or hypersensitivity reactions.<br />

Conclusion: Our data support the hypothesis that, aside<br />

from common gastrointestinal tract (GIT) side-effects,<br />

administration of VA drugs may lead to thrombocytopenia<br />

of heteroimmune origin, and another possibility is that liver<br />

dysfunction or medicinal hepatic damage develops with<br />

resulting platelets depression. These immunological considerations<br />

remain to be debated.<br />

FP-H-120<br />

Neurovisualisation techniques in diagnostics of central<br />

nervous system dysgenesis with symptomatic epilepsy in<br />

pediatric patients<br />

O.I. Maslova, L.M. Kuzenkova, V.M. Studenikin, S.Y.<br />

Ishkhanova, E.I. Stepakina<br />

Division of Psychoneurology, Scientific Center of Child<br />

Health (Russian Academy of Medical Sciences), Moscow,<br />

Russia<br />

Background: Progress in modern radiology substantially<br />

improves the arsenal of diagnostic methods in neurology.<br />

Seemingly, the diagnoses of CNS dysgenesis and seizure<br />

disorders benefit from the new investigational techniques<br />

most of all. Goal: Combined utilization of neurovisualisation<br />

methods in the determination of brain dysgenesis,<br />

extent and specificity, in children, was the aim of our<br />

study. Method: CT, MRT and SPET scans were used in a<br />

group of 35 patients, hospitalized with cerebral dysgenesis<br />

originally postulated on the basis of typical EEG-verified<br />

epileptic activity (all children aged 1–15 years). Results:<br />

The described group of patients showed the following most<br />

important findings: (1) hypoplasia of cerebral hemispheres<br />

(42.8%); (2) intracranial hemorrhages (37.1%); (3) destruction<br />

of cortical lamina (31.4%); and (4) false porencephalic


Abstracts 531<br />

cysts in white matter of the brain (28.5%). Pathological<br />

vascularisation of brain structures (varying from mild to<br />

profound) was only evident with SPET scans (in 68.5%<br />

of cases observed). Conclusion: CT and MRT scans<br />

allow the demonstration of structural and morphological<br />

cerebral problems, but establishment of adequate clinical<br />

long-term prognoses can only be expected, when the<br />

above-mentioned diagnostic routines are combined with<br />

SPET. The latter method not only objectively (quantitatively)<br />

verifies topographic vascularisation of cerebral<br />

structures, which is of critical interest in pediatric patients<br />

with congenital brain anomalies, but its prognostic value<br />

seems to be second to none, when investigating the cases<br />

of cerebral dysgenesis in pediatric patients.<br />

FP-H-121<br />

Experience in management of Rasmussen syndrome in<br />

pediatric patients<br />

V.I. Shelkovsky, V.M. Studenikin, O.I. Maslova, O.V.<br />

Globa<br />

Division of Psychoneurology, Scientific Center of Child<br />

Health (Russian Academy of Medical Sciences), Moscow,<br />

Russia<br />

Background: Rasmussen syndrome (chronic progressive<br />

focal encephalitis) is a rare neurological form of epilepsy,<br />

described over 40 years ago, with only about 50 verified<br />

pediatric cases reported worldwide. Goal: Our aim is to<br />

describe and to share our own experience in therapeutic<br />

approach and management of Rasmussen syndrome in<br />

pediatric patients. Method: We have analyzed case<br />

histories of four pediatric patients, hospitalized and receiving<br />

treatment in our clinic since 1996. Results: The ages of<br />

patients with Rasmussen syndrome (three females and one<br />

male) varied from 18 months to 14 years and 9 months.<br />

The earliest onset of the described condition was registered<br />

at the age of 9 months, and the latest took place at<br />

the age of 11 years and 8 months. In two cases (both of<br />

them young children) myoclonic paroxysms were evident<br />

with secondary generalization (tonic propulsive paroxysms<br />

with absences), while in two other cases classic partial<br />

paroxysms were seen with myoclonic seizures development<br />

after the period of 2–3 months. Anticonvulsant<br />

drugs such as valproic acid, carbamazepine and phenobarbital<br />

were used, but Rasmussen syndrome proved to be<br />

refractory (the number of paroxysms varied from 5 to 30<br />

daily). In one case complete remission (presently 3 years)<br />

was achieved in a 25-months old female patient after<br />

acyclovir intravenous administration (for herpes type I<br />

generalized infection). Conclusion: Our hypothesis is that<br />

Rasmussen syndrome results from an autoimmune pathological<br />

pathway, which can possibly be altered by using<br />

immunosuppressive drugs, but we lack evidence for this<br />

concept.<br />

FP-H-122<br />

Dynamics of EEG data in pediatric patients with various<br />

epilepsy types under valproic acid treatment and<br />

monitoring in blood<br />

A.V. Anikin, N.Y. Semenova, V.I. Shelkovsky, O.I.<br />

Maslova, V.I. Shelkovsky, S.V. Balkanskaya<br />

Scientific Center of China Health, Russian Academy of<br />

Medical Sciences, Moscow, Russia<br />

Background: Monitoring of VA blood concentration is<br />

currently viewed as disputable, compared with EEG<br />

dynamics in patients with epilepsy under treatment with<br />

this anticonvulsant class. Goal: The aim of our study was<br />

to register correlations between EEG patterns and VA blood<br />

concentrations in children with epilepsy under valproate<br />

treatment for optimization of the therapy. Methods: Ninety<br />

patients (aged 2 months–16 years) with various types of<br />

epilepsy were observed. Digital EEG (‘DG Examiner’,<br />

‘10–20’ system, standard technique) and VA blood monitoring<br />

(until 80–120 mcg concentration achievement) were<br />

incorporated. Positive clinical effect was judged by<br />

complete seizure control or decrease in attacks, with EEG<br />

evidence of reduction or abatement of epileptiform signs.<br />

Results: Typical epileptic seizures and spikes, spike-andslow<br />

wave EEG patterns were evident in 83% of cases,<br />

generalized paroxysms in 32% and focal abnormalities in<br />

42% of cases (in 9% of the latter secondary generalization<br />

was present). Patients with idiopathic epilepsy had better<br />

clinical results and EEG patterns as compared with cases<br />

of symptomatic epilepsy. Correlation was registered<br />

between the VA concentration in blood and EEG specific<br />

activity. In addition, repetitive studies revealed increases in<br />

voltage and discharges in 19% of patients with localized<br />

epileptic activity. Conclusion: Our data seemingly show<br />

that the use of valproic acid blood concentration monitoring<br />

in combination with adequate EEG control is considerably<br />

more reliable in pediatric patients with generalized epileptic<br />

activity, than in cases of epileptic partial seizures. Treatment<br />

effectiveness was considerably higher when increased<br />

VA blood concentrations were seen.<br />

FP-H-123<br />

The clinical characteristics of febrile seizures and<br />

outcomes in children<br />

T. Galia<br />

Almaty ‘480063, Aksai-4’ –101, app. 18, Kazakhstan<br />

The purpose of this research was the study of clinical signs<br />

and outcomes of febrile seizures in children. We observed<br />

179 (75.8%) children with simple and 57 (24.5%) with<br />

complex febrile seizures. Simple febrile seizures were characterized<br />

as generalized tonic-clonic in 43.6% (78), clonic in<br />

25.7% (46), atonic in 19% (34), tonic in 11.7% (21) of children.<br />

Relapses offebrile seizures in this group, were observed


532<br />

Abstracts<br />

in 46.4 (83) children. Simple febrile seizures remitted favorably<br />

in 78.2% of cases. In 21.8% the development of epilepsy<br />

was observed: absence (15), grand mal (19), Lennox-Gastaut<br />

syndrome (four), infantile spasms (one). The spasms of<br />

complex febrile seizures began with a turn of the head and<br />

eyes to the side in 10.5% (six); with nystagmus followed by a<br />

turn of the head and eyes to the side in 7% (four); with focal<br />

motor paroxysms, in 36.8% of children, followed by generalization.<br />

Other seizures observed were myoclonic-12.3%<br />

(seven), tonic-clonic 59.6% (34), tonic 10.3% (23). In 3.5%<br />

(two) children a visual and epigastric aura was observed<br />

before the beginning of an attack. In 64.9% (37) cases there<br />

was evolution to epilepsy: symptomatic partial 22.8% (13),<br />

grand mal 21.1% (12), temporal lobe 7% (four), myoclonic<br />

epilepsy-5.3% (three), infantile spasm-8.8% (five). In 35.1%<br />

(20) cases remission of disease was observed. Therefore the<br />

features of the clinical signs of the febrile seizures were<br />

reflected in the outcomes of the disease.<br />

FP-H-124<br />

Recurrent febrile seizures induced brain damage in<br />

developing rats<br />

Z.-X. Yang a , J.-M. Wang b , G.-P. Zhou a , X.-Z. Chang a ,J.<br />

Qin a<br />

a Department of Pediatrics, Beijing <strong>University</strong> First Hospital,<br />

Beijing, China; b Department of Pediatrics, Shangqiu<br />

First People’s Hospital, Shangqiu, Henan, China<br />

The present study is to establish a FS model and to<br />

explore the FS induced brain damage in developing rats.<br />

FS in Wistar rats was induced ten times, once every 2<br />

days, through a warm (44.58C) water bath. The rats were<br />

randomly divided into two groups: 37.08C water bath group<br />

(n ¼ 10), and 44.58C water bath group (n ¼ 40), The latter<br />

was subdivided into non-FS (FS ¼ 0, n ¼ 10) and FS (FS<br />

$6, n ¼ 22) groups. On HE stain, the disarrangement of<br />

hippocampal CA1 and CA2 neurons in FS group was<br />

observed. The cellular polarity was not clear, and vacuolization<br />

appeared. No obvious loss of hippocampal neurons in<br />

FS group was observed on thionine stain. Whereas neuronal<br />

numerical density (Nv, counted by means of a stereological<br />

method, the dissector system) in hippocampal CA1 in FS<br />

group was significantly decreased (P , 0:01) compared<br />

with that in normal and non-FS groups. The ultrastructural<br />

abnormalities of the hippocampal neurons were observed<br />

under the electron microscope. In FS rats, the mitochondrial<br />

volume was markedly decreased, the matrix condensed, the<br />

ridge obscured or disappeared, and vacuoles formed in some<br />

mitochondrias. Mild to moderate dilation of Golgi apparatus<br />

was also demonstrated. The results indicated that there were<br />

many similarities between warm water-induced FS in developing<br />

rats and febrile seizures in children. This model is<br />

suitable for the research on the pathogenetic mechanisms<br />

and brain damage in FS. Recurrent FS may cause damage<br />

and loss of hippocampal neurons in the developing rats.<br />

(This work was partly supported by a key clinical project,<br />

2001-03, from the Ministry of Public Health of China).<br />

FP-H-125<br />

The syndrome of facial hemangioma – cerebral cortical<br />

and vascular dysplasia: a rare neurocutaneous<br />

syndrome associated with epilepsy<br />

H.B. Szliwowski, A. Aeby, P. David, G. Rodesch, P. Van<br />

Bogaert<br />

ULB-Hôpital Erasme, Brussels, Belgium<br />

Patients with extensive facial hemangioma may present<br />

abnormalities of the cerebral arteries ranging from minor<br />

vascular dysplasia to agenesis of major arteries. Some of<br />

them present associated brain malformations which affect<br />

mainly the cerebellum (Dandy-Walker malformation, cerebellar<br />

hypoplasia or atrophy). We report a patient in whom<br />

facial hemangioma was associated with vascular cerebral<br />

dysplasia and frontal polymicrogyria. This 13-year-old girl<br />

had a history of congenital facial hemangioma which<br />

progressively extended over her nose and forehead during<br />

the first year of life, and then spontaneously regressed.<br />

Neurological examination showed mild mental retardation<br />

and a discrete congenital left hemiplegia predominating in<br />

the upper limb. Seizures were present from the age of 11<br />

years and were refractory to valproate and carbamazepine.<br />

EEG showed interictal right rolandic spikes and generalized<br />

seizures (atypical absences and tonic seizures). Cerebral<br />

MRI showed polymicrogyric-like changes affecting the<br />

right frontal lateral cortex and the parasagittal frontal<br />

cortices, and hypoplasia of the corpus callosum. At cerebral<br />

angiography, the pericallosal arteries appeared tortuous and<br />

presented focal dilatations. This is, to our knowledge, the<br />

second reported case of supra-tentorial cortical dysplasia<br />

associated with facial hemangioma and vascular cerebral<br />

malformation. The fact that the polymicrogyria extended<br />

beyond the vascular territories supplied by the dysplasic<br />

arteries suggests that polymicrogyria and vascular dysplasia<br />

are expressions of the same pathogenic process at different<br />

stages of gestation. This case illustrates that the neurocutaneous<br />

syndrome of hemangioma-cerebral dysplasia must be<br />

suspected in children presenting with epilepsy and facial<br />

hemangioma.<br />

FP-H-126<br />

Benign infantile familial convulsions and paroxysmal<br />

choreoathetosis: report of first cast with homozygous<br />

linkage to chromosome 16p12–q12<br />

V. Humbertclaude, A. Poubertie, F. Rivier, J. Rochette, P.<br />

Szepetowski, B. Echenne<br />

Service de Neuropediatrie, Chu Saint Eloi, Montpellier,<br />

France<br />

We report the first case of homozygous linkage to chro-


Abstracts 533<br />

mosome 16p12–q12 associated with benign infantile familial<br />

convulsions and paroxysmal choreoathetosis. A boy<br />

presented two clusters of seizures at 3 and 4 months of<br />

age. Seizure was characterized by left or right head and<br />

eye deviation, hypertonia of one upper limb and tonicclonic<br />

generalization. Ictal EEG showed right temporoparietal<br />

rhythmic spikes followed by generalization. Cerebral<br />

MRI was normal. Six isolated seizures recurred<br />

between 6 and 9 months. At 25 months of age. Paroxysmal<br />

choreoathetosis (PC) appeared, characterized by unilateral<br />

choreic movements, followed by generalized athetosis.<br />

Attacks occurred spontaneously or after repeated movements.<br />

Ictal and inter-ictal video-EEG were normal. Ictal<br />

ECD SPECT showed bilateral basal ganglia and mild left<br />

temporal hyper perfusion. Daily attacks of PC persisted<br />

despite multiple therapy. The grand-aunt of the boy and<br />

her daughter had presented benign infantile convulsions.<br />

No other case of PC was noted. The parents of the boy<br />

were consanguineous. Genetic analysis showed homozygous<br />

linkage to the chromosome 16p12–q12. This homozygous<br />

status may explain the unusual phenotype, with<br />

repeated seizure and severe early-onset PC.<br />

FP-H-127<br />

Quality of life in children with epilepsy – Indian scenario<br />

S. Aneja, N. Prakash, V.R. Nigam<br />

Department of Pediatrics, Lady Hardinge Medical College,<br />

New Delhi, India<br />

Objective: To study the QoL profile in children with<br />

epilepsy. Methods: A prospective (nested control) study<br />

was done among children (age 6–15 years) attending<br />

epilepsy clinic who were on AED for minimum of 6 months.<br />

Children with associated motor/cognitive deficits were<br />

excluded. Evaluation was done by interviewing parents<br />

with part open ended and part structured pretested questionnaire.<br />

It included responses to measure effect of epilepsy on<br />

physical, psychological, social and school domains. Each<br />

item was rated on a five point likert scale. Results: Ninety<br />

five children (males 56; females 39) were studied. Complex<br />

partial seizures (37%) were the commonest type followed by<br />

generalized seizures (25%). Sixty one percent had infrequent<br />

seizures. The structured questionnaire showed good testretest<br />

reliability (r ¼ 0:9), internal consistency (a ¼ 0.9)<br />

and interparental agreement (r ¼ 0:9) QoL was most<br />

affected in the school domain with 71.5% parents perceiving<br />

problems in school. Behavioural and psychological problems<br />

were felt to be affected by 65.2% of parents. Social limitations<br />

were perceived by fewer parents (40%) and physical<br />

domain was least affected (10%). The effect of Seizure severity<br />

and seizure frequency on QoL was studied after adjusting<br />

for age, sex, socioeconomic status and IQ. It was seen that<br />

patients with frequent seizures and severe seizures had lower<br />

scores on QoL. Conclusion: Epilepsy had significant effect<br />

on schooling and behaviour of children with epilepsy.<br />

Management protocol of epilepsy should include complete<br />

assessment of behaviour and psychological functions.<br />

FP-H-128<br />

The risk factors and outcome of children with<br />

intractable status epilepticus<br />

P.A.M. Kunju<br />

Division of Pediatric Neurology, Medical College Trivandrum,<br />

Kerala, India<br />

Objectives: (1) To identify the risk factors; (2) the<br />

immediate outcome; and (3) to assess the neurological<br />

and mental outcome at the end of 1 year in children<br />

with intractable SE. Setting: Paediatric Intensive Care<br />

Unit, medical college. Design: Prospective Study. Methodology:<br />

160 children with intractable generalized SE<br />

during 1998–2001 were studied. The subjects were classified<br />

into 1. those with previous history of epilepsy and 2.<br />

those with no prior history of epilepsy. Children who<br />

recovered were followed up at 6 monthly intervals had<br />

cognitive assessment by a clinical psychologist and were<br />

grouped under two categories: (1) those with neurological<br />

impairment, (i.e. IQ , 80) and or having neurological<br />

sequelae; and (2) those who were normal. A total of 160<br />

cases (56 were infants, 40 between age 1–6 years and 64<br />

belonged to 6–12 years, 86 males and 74 females) were<br />

studied. Sixty-two (38.75%) belonged to the first group<br />

and 98 (61.25%) to the second group. The causes of<br />

previous epilepsy in the 62 were cerebral palsy, meningitic<br />

sequelae, cerebral malformations, metabolic and idiopathic.<br />

Twenty-eight (45.16%) fell in the idiopathic<br />

group and 21 were having non-progressive encephalopathy<br />

(33.87%). Two had heterotopias, one lissencephaly, one<br />

agenesis of corpus callosum, one tuberous sclerosis, one<br />

Sturge-Weber syndrome and one metabolic disorder,<br />

(1.61%), Gauchers disease. Among the patients with<br />

previous epilepsy, problems with anti-epileptic drugs<br />

were the most prevalent, i.e. 36 out of 62 patients<br />

(58.06%). Twelve out of 62 were precipitated by systemic<br />

infections. In the remaining 14, no precipitating factor<br />

(22.58%) was noticed. There were 98 SE with no previous<br />

epilepsy. Of these 65 were having intracranial infections<br />

(66.32%). Twenty-two had prolonged febrile seizures<br />

(22.44%) two had metabolic problems (2.04%) One was<br />

subdural hematoma in a hemophiliac patient (1.02%).<br />

Immediate outcome of SE: Out of the 160 SE 18 died<br />

(11.4%), 14 out of 18 deaths (77.77%) were due to infections<br />

of the CNS. Two (11.11%) were due to metabolic<br />

causes, one was a case of intractable hypoglycemia, and<br />

the other a case of Gaucher’s disease. The remaining two<br />

were children with previous history of epilepsy. They had<br />

more than two episodes of SE. There was history of abrupt<br />

withdrawal of antiepileptic drugs. Sixteen out of the 18<br />

had seizures lasting for .2 h (88% of cases), five had<br />

raised intracranial tension (27%), three had hypotension,


534<br />

Abstracts<br />

(16.6), two had respiratory insufficiency (11.1%), one had<br />

hypoglycemia and one, uraemia (5.5%). Outcome at the<br />

end of 1 year: Out of the 60 children with previous<br />

epilepsy, 56 had neurological impairment (93.6%).<br />

Among the 82 with no history of prior epilepsy, six developed<br />

neurological impairment (6.25%) and 76 (93.75%)<br />

were normal. Relative risk 14.75%. Conclusions: (1)<br />

Most common cause of SE were acute symptomatic<br />

cases with the previous epilepsy. (2) Important contributing<br />

factors for mortality in SE were seizure duration .2 h<br />

and underlying cause. (3) High association was noted<br />

between children with previous epilepsy and mental retardation.<br />

FP-H-129<br />

Clinical analysis of antiepileptic therapy with<br />

individuated-dose valproate in children<br />

J. Wu, Y.-Q. Zhong, X.-L. Xie, W.-G. Hu, M. Wu<br />

Children’s Hospital of Chengdu, Chengdu, Sichuan, China<br />

Objective: The valproate is a kind of wide AEDs, which is<br />

used widely. To evaluate the efficacy of individual dose<br />

VPA in treatment of 61 epilepsy children, 29 were boys,<br />

as well as 32 girls. Method: Nine months ,14 years of age<br />

children with epilepsy in outpatient treated by single-drug<br />

VPA from August 1999 to October 2001 were retrospectively<br />

analysed. Results: The children with general seizure<br />

or partial were 42 and 19, respectively. Their therapeutic<br />

dosage was from 11.25 , 48.49 mg/kg per day, and average<br />

dosage was 22.92 ^ 7.83 mg/kg day. After 5 , 9 days<br />

taking VPA, the valley blood-drug-concentration of VPA<br />

were from 24.5 , 163 mg/l, Its average blood-drug-concentration<br />

was 69.75 ^ 20.75 mg/l. Conclusion: VPA has good<br />

therapeutic effect on epilepsy, which does better for general<br />

seizure than partial seizure. The target dosage in different<br />

children change greatly, and there are a lot of individual<br />

variations. Meanwhile we should select anti epileptic<br />

drugs according to the epilepsy type. In treatment epilepsy,<br />

it is necessary to monitor the constant concentration of VPA<br />

after five half eliminate time.<br />

FP-H-130<br />

Effects of recurrent audiogenic seizures on hippocampal<br />

structure and seizure behavior of P77PMC rats<br />

S.-G. Zhao, X.-R. Wu<br />

Pediatric Neurology, Department of Pediatrics, Peking<br />

<strong>University</strong>, First Hospital, Beijing, China<br />

To investigate the functional role of hippocampal mossy<br />

fiber (MF) sprouting in the pathophysiological mechanisms<br />

of initiation and propagation of epilepsy, we examined<br />

hippocampal MF synaptic reorganization and changes in<br />

the hippocampal neurons of AGS-prone P77PMC rats at<br />

various stages in the course of recurrent seizures using<br />

Timm’s method of sulfide silver staining and Nissl staining.<br />

Also, we observed the effects of recurrent audiogenic<br />

seizures (AGSs) on the changes of seizure behavior of<br />

P77PMC rats. Our results showed that frequent recurrent<br />

AGSs not only can cause neuronal loss in the CA1 region<br />

of the hippocampus and hippocampal MF sprouting into<br />

the inner molecular layer of dentate gyrus in P77PMC rats,<br />

but can also decrease the latency of IV/V grade AGSs, and<br />

increase the duration of AGSs. Our findings suggest that<br />

hippocampal MF sprouting and neuronal loss are not only<br />

present in limbic seizure, but are also seen in AGS, which<br />

are initiated in brainstem and rapidly generalize. In AGSprone<br />

rats, recurrent AGSs can cause MF synaptic reorganization<br />

and neuronal loss in the hippocampus, and<br />

enhance seizure susceptibility of P77PMC rats. During<br />

the course of recurrent AGSs, enhanced seizure susceptibility<br />

was observed before hippocampal MF sprouting.<br />

This finding may indicate that anatomical changes may<br />

be preceded by functional changes characterized by<br />

elevated excitability in the epileptic brain.<br />

FP-H-131<br />

Clinical and neuro-psychological analysis of epilepsy<br />

patients caused by Japanese encephalitis<br />

D. Ding, Z. Hong, B. Zhou<br />

Institute of Neurology, Fu Dan <strong>University</strong>, Hua Shan Hospital,<br />

Shanghai, China<br />

Objective: To investigate the morbidity, clinical symptoms,<br />

and brain functions of epilepsy patients caused by<br />

Japanese encephalitis. Methods: Eighty-five patients who<br />

suffered from Japanese encephalitis during 1973–1994<br />

were followed and evaluated using neurological examination,<br />

MMSE, intelligence and memory measurements, and<br />

activity of daily life (ADL). Results: Ten patients were<br />

found to have epilepsy with diverse types, including nine<br />

cases of GTCS and one case of absence petit mal seizures.<br />

Another two cases died of GTCS before evaluation. Totally<br />

12 cases (14.4%) were evaluated as epilepsy, among which<br />

nine cases had seizures beyond 1 year and within 17 years.<br />

Therefore the morbidity of lately occurring epilepsy is<br />

10.6%. The cumulative morbidity of epilepsy occurring<br />

within 17 years after discharge was 16.1% calculated by<br />

survival analysis. Among ten epilepsy patients evaluated,<br />

two cases, six cases and eight cases were confirmed as<br />

MMSE abnormal, mental retardation, and memory defect,<br />

respectively. Four cases were considered as disability<br />

because of the abnormal ADL scores. Conclusion: Epilepsy<br />

with higher morbidity and worse prognosis is one of the<br />

sequelae caused by JE virus infectious during the childhood.<br />

The prevention and control of JE should have certain impact<br />

to decrease the morbidity of epilepsy.


Abstracts 535<br />

FP-H-132<br />

The clinical and EEG characteristics of infancy epilepsy<br />

from temporal lobe origin<br />

J.-P. Liang, F.-C. Cai<br />

Department of Neurology, Children’s Hospital, Chongqing,<br />

China<br />

Introduction: The clinico-pathological data indicated<br />

Temporal lobe epilepsy may manifest differently in infants<br />

and older children. The concept of complex partial<br />

seizures, which may be useful in older children, is difficult<br />

to apply to infants, since it is often not possible to assess<br />

impairment of consciousness in this age group. The aim of<br />

study was to analyze the clinical manifestations, EEG, CT<br />

scan and MRI in a cohort of 32 infancy epilepsy from<br />

temporal lobe origin (IETLO). Materials and methods:<br />

Thirty-two cases with IETLO including 19 males and 13<br />

females were subjected to the study. The onset of IETLO<br />

was between 2 and 34 months with an average of 20<br />

months, and 25 cases were followed up for 1–6 years<br />

with the examinations of EEG, Videotapes, CT and MRI.<br />

Results: IETLO was an age-related epileptic syndrome<br />

characterized by the clinico-electrical features in infants<br />

aged less than 2 years different from those in elder children.<br />

The seizure semiology shown atypical presentations<br />

including initial motionless stare, behavioral arrest or<br />

reduction with possible impairment of consciousness in<br />

27 cases, presenting not react to visual threat or loud<br />

noise during seizures, and that all spontaneous purposeful<br />

activities were interrupted; autonomic features and oroalimentary<br />

or simple manual automatisms in 16 cases;<br />

tonic, versive or myoclonic seizures were observed in 13<br />

cases, which may not indicated a localized origin of the<br />

seizures. Most of seizures lasted for more than 1 min. The<br />

interictal EEG indicated that the epileptogenic discharges<br />

found in infants were less often than in elder children with<br />

single or multiple foci. The ictal EEG discharges were less<br />

focal and variable, even falsely lateralized, and the patterns<br />

were not very distinct, including focal attenuation of beta<br />

activity or sleep spindles, focal slowing and unilateral electrodecremental<br />

events, etc. Video-EEG monitoring was<br />

important in identifying the seizure patterns and impairment<br />

of consciousness. CT scans shown structural cerebral<br />

lesions in 5/6 cases and MRI gave more information of<br />

brain lesions in 11/14 cases, which were more valuable<br />

in localization of lesions than EEG. Conclusion: IETLO<br />

is an age-related epileptic syndrome characterized by the<br />

clinico-electrical features as follows: motionless stare,<br />

behavioral arrest or reduction with possible impairment<br />

of consciousness, autonomic features and oro-alimentary<br />

automatisms; convulsive seizures were prominent; duration<br />

of seizures was more than 1 min. The intericatal discharges<br />

were less found while ictal discharges were less focal and<br />

distinct. Video-EEG monitoring was critical to identify the<br />

seizure patterns and impairment of consciousness. Neuroimagings<br />

are more important in finding the structural cerebral<br />

lesions.<br />

FP-H-134<br />

Efficacy and safety of topiramate for pediatric epilepsy<br />

in clinical practice: data from a postmarketing<br />

surveillance study<br />

Y. Roh a , Y.S. Hwang b<br />

a Department of Pediatrics, Chosun <strong>University</strong> Hospital,<br />

KwangJu, Seoul; b Department of Pediatrics, Seoul National<br />

<strong>University</strong> Hospital, Seoul, Korea<br />

Objectives: To evaluate the efficacy and safety of topiramate<br />

in pediatric patients with epilepsy. Methods: TPM<br />

was treated in 561 patients who were taking one or more<br />

antiepileptic drugs or no medication. Topiramate dose was<br />

increased gradually from 0.5 to 1 mg/kg per day weekly or<br />

biweekly. After 16 weeks since the patients started having<br />

TPM, the antiepileptic efficacy was measured. All adverse<br />

events reported during this study period were gathered.<br />

Results: Their mean age was 8 years old (range 3 , 13<br />

years old). A total of 62% of the patients were boys. The<br />

median number of monthly seizures at baseline was 4.5<br />

(mean ¼ 41). The mean duration of epilepsy was 5 years<br />

(^4). Fifty-seven percent of patients were diagnosed idiopathic<br />

or cryptogenic epilepsy and 43% symptomatic<br />

epilepsy. Forty-seven percent of patients had other neurological<br />

disorders like as mental retardation or hemiparesis.<br />

Carbamazepine (52%), vigabatrin (52%), and valproate<br />

(50%) were the most common concomitant drugs. The overall<br />

seizure free rate in 16 weeks from topiramate treatment<br />

was 35%. The .50% seizure reduction rate was 70%.<br />

Seizure free rate in Lennox-Gastaut syndrome (LGS) or<br />

infantile spasm was 18%. Seizure free rate in patients<br />

with topiramate monotherapy was 67%, which was much<br />

higher in patients with combination therapy. Seizure free<br />

rate by monthly baseline seizure frequency was 58% in<br />

less than two times, 27% in three to nine times, 14% in<br />

10–30 times, and 17% in more than 31 times. Seizure free<br />

rate by duration of epilepsy was higher in shorter duration;<br />

70% in less than 1 year and 20% in 11–13 years. A total of<br />

69% of parents with the pediatric patients rated the efficacy<br />

of topiramate good or very good. Seventy percent of medical<br />

doctors rated the efficacy of topiramate good or very<br />

good, 20% fair and 10% poor. The adverse events of TPM<br />

were somnolence (6.0%), weight loss (5.0%), anorexia<br />

(3.7%), and lethargy (3.0%). Conclusions: Topiramate had<br />

high .50% seizure reduction rate (70%) and seizure free<br />

rate (35%) in various seizure types and showed remarkable<br />

seizure free rate (18%) in LGS and Infantile Spasm. The<br />

shorter history of seizure duration was, the higher seizure<br />

free rate of topiramate showed. Drop out due to adverse<br />

effects was 2.8%. This study suggests that topiramate is<br />

the first rank antiepileptic drug in its efficacy and is very<br />

effective for pediatric epilepsy regardless of seizure types.


536<br />

Abstracts<br />

FP-H-135<br />

Efficacy of topiramate monotherapy in pediatric patients<br />

with newly diagnosed epilepsy<br />

K.S. Lee<br />

Department of Pediatrics, ChungNam National <strong>University</strong><br />

Hospital, DaeJun, Korea<br />

Objectives: To investigate efficacy and safety of topiramate<br />

as initial therapy in pediatric patients with newly diagnosed<br />

epilepsy. Methods: Among pediatric patients were<br />

brought to the hospital emergency room due to seizure, 36<br />

patients with newly diagnosed epilepsy were recruited for<br />

this study. Topiramate was given to them for 16 weeks and<br />

CBZ and/or VPA was added if seizure was not controlled<br />

with topiramate within 6–8 weeks. Seizure reduction rate<br />

was evaluated as well as adverse events at end point of<br />

16th week. Results: Among 36 patients there were 19 patients<br />

with secondarily generalized seizure (GS), nine with<br />

complex partial seizure (CPS), six with generalized tonic<br />

clonic seizure (GTCS), one with myoclonic seizure, and<br />

one with tonic seizure. Mean age of the patients was 4.6<br />

years and mean duration of epilepsy was 0.7 year (8.4<br />

months). Mean seizure frequency was 35 times per month<br />

and mean weight was 18 kg. Eight patients had other neurological<br />

conditions such as CP or developmental delay. Five<br />

out of 36 patients were added on CBZ and/or VPA in 6–8<br />

weeks since topiramate treatment. Twenty-six patients<br />

(72%) were seizure free and all of them were on topiramate<br />

monotherapy and no seizure free patients were in CBZ and/or<br />

VPA added group. Seizure free rate by seizure type was<br />

100% in GTCS, 78% in CPS, and 63% in secondarily GS.<br />

Three out of 36 patients withdrew due to adverse events or<br />

lost follow-up. Conclusion: Topiramate was highly effective<br />

in controlling seizures of pediatric patients with newly diagnosed<br />

epilepsy, showing 72% of seizure free rate. Topiramate<br />

was effective in various seizure types and considered<br />

‘good or very good’ by more than 80% of parents and investigator.<br />

There were few serious adverse events and basically<br />

all adverse events were mild.<br />

FP-H-136<br />

Efficacy of topiramate for pediatric patients as<br />

replacement therapy of vigabatrin<br />

S.J. Chung<br />

Department of Pediatrics, KyungHee <strong>University</strong> Hospital,<br />

Seoul, Korea<br />

Objectives: Although many clinical studies of topiramate<br />

(TPM) have been reported, its effect on Asian children was<br />

not evaluated yet. Clinical efficacy of TPM was assessed on<br />

Korean epileptic children whose seizures were not controlled<br />

with more than two kinds of AEDs even at maximum doses.<br />

Methods: A total of 104 patients received add-on therapy of<br />

TPM and 96 patients completed the study. Eight patients<br />

were dropped out at 4th week due to adverse reactions of<br />

TPM. The trial consisted of 8 week baseline phase, 10–16<br />

weeks of titration phase, and 8 week stabilization phase.<br />

Seizure history, adverse events, and drug compliance were<br />

observed at patients visit every 2 weeks. TPM dose was<br />

increased by 1 mg/kg every 2 weeks up to 6 mg/kg, or in<br />

some cases, up to 9 mg/kg. Mean age of the patients was 11<br />

years old (range 2–16 years old) and male patients were 62<br />

(64.5%). A total of 61 (64.0%) patients were on vigabatrin<br />

(VGB) and 65 (68.0%) on carbamazepine. Concomitant<br />

AEDs including VGB were reduced gradually after stabilization<br />

period. Clinical efficacy was evaluated by change in<br />

seizure frequency, i.e. disappearance of seizure (seizure<br />

free), significant improvement (more than 75% of reduction<br />

of seizure), improvement (more than 50% of reduction of<br />

seizure) and no improvement (less than 50% of reduction<br />

of seizure). Results: Out of 96 patients, 65 patients (67.7%)<br />

became seizure free, 22 patients (22.9%) showed more than<br />

50% seizure reduction, nine patients (9.4%) showed less than<br />

50% seizure reduction. When the efficacy was evaluated by<br />

seizure type; 15 (83.3%) showed seizure free and one (5.6%)<br />

showed significant improvement out of 18 patients with<br />

generalized seizure. Three (25.0%) showed seizure free<br />

and 5(41.7%) showed significant improvement or improvement,<br />

while four (33.3%) showed no improvement out of 12<br />

patients with LGS. Forty-seven (71.2%) showed seizure free<br />

and 16 (24.2%) showed significant improvement or improvement<br />

out of 66 patients with partial seizure. TPM showed<br />

higher seizure free rate in less number of concomitant<br />

AEDs: 85.7% (12/14) in one AED, 70.8% (17/24) in two<br />

AEDs, 65.5% (19/29) in three AEDs, 57.1% (13/21) in four<br />

AEDs, and 50.0% (4/8) in five AEDs. Seizure free rate by<br />

duration of epilepsy was 81.8% (9/11) in less than a year,<br />

80.0% (28/35) in 2–4 years, 65.4% (17/26) in 5–7 years, and<br />

45.8% (11/24) in more than 8 years. In the efficacy by baseline<br />

monthly seizure frequency, TPM showed higher seizure<br />

free rate in lower seizure frequency: 41 (93.2%) out of 44<br />

patients whose frequency of seizure was less than once a<br />

month. Fourteen (58.3%) out of 24 patients with one to<br />

three seizures/month, four (50.0%) out of eight patients<br />

with four to five seizures/month, and six (30.0%) out of 20<br />

patients with more than six seizures/month. Seizure free rate<br />

by seizure type was highest in generalized seizure and lowest<br />

in LGS. Global assessment was excellent from 66 (69%) of<br />

patients or physicians, good from 15 (16%), fair from eight<br />

(8%), and poor from seven (7%). Conclusion: It is concluded<br />

that TPM can replace VGB and/or other AEDs without<br />

seizure aggravation or serious side effects.<br />

FP-H-137<br />

Topiramate in pediatric subjects with inadequately<br />

controlled epilepsy: multicenter trial<br />

Y.J. Woo, M.H. Lee<br />

Department of Pediatrics, ChonNam <strong>University</strong> Hospital,<br />

KwangJu, Korea


Abstracts 537<br />

In order to evaluate the efficacy and safety of topiramate<br />

as adjunctive therapy for uncontrolled pediatric seizures,<br />

multicenter add-on topiramate trial was conducted in<br />

Korea. Methods: Twenty study sites in Korea enrolled<br />

patients. Pediatric epilepsy patients, aged 2–16 years old,<br />

with uncontrolled seizures with conventional antiepileptic<br />

medications were included in this study. After receiving<br />

written informed consent, patients were enrolled in a 4-<br />

week baseline phase, followed by a 24 week trial phase<br />

which consisted of a 12 week titration and a 12 week<br />

stabilization period. Topiramate was added to each<br />

patient’s background antiepileptic drugs at an initial dosage<br />

of 1 mg/kg and titrated to target dosage of 9 mg/kg per day.<br />

Study visits were scheduled at 4-week interval. Results:<br />

Data consisted of 184 patients showed that 152 of 184<br />

patients completed this study. Among 184 patients there<br />

were 24 patients with simple partial seizure, 71 with<br />

complex partial seizure, 53 with secondarily generalized<br />

seizure, and 36 with LGS. During the entire period, the<br />

proportion of patients with 50% or higher reductions in<br />

seizure frequency was 59.2%. Among them 12 patients<br />

(6.5%) were seizure free. During the 12-week stabilization<br />

period alone, the proportion of patients with 50% or higher<br />

reductions in seizure frequency increased to 60.9% and 30<br />

of those patients were seizure free, indicating an increase<br />

of seizure free proportion (16.3%) during the stabilization<br />

period. The median percent seizure reduction was 62.2%<br />

during the entire period and 67.1% during the stabilization<br />

period. There were no significant differences in median<br />

percent seizure reduction among patients with different<br />

epilepsy duration, seizure type, and number of concomitant<br />

antiepileptic drugs. Eighteen patients withdrew from the<br />

study due to lack of efficacy, loss of follow-up, poor cooperation<br />

of parents, and adverse reactions. The most<br />

common reported adverse events were anorexia, somnolence,<br />

mental slowing, gastrointestinal disturbances, and<br />

difficulty with concentration or attention. Most reported<br />

adverse events were mild or moderate in severity. In fact,<br />

there were only eight patients who withdrew from this<br />

study due to adverse reactions. Conclusions: TPM was<br />

safe and effective as adjunctive therapy in the treatment<br />

of uncontrolled pediatric epilepsy patients with simple or<br />

complex partial seizures with or without secondary generalization<br />

and LGS.<br />

FP-H-138<br />

Clinical review of severe myoclonic epilepsy in infancy<br />

H.C. Kang, O. Dambajamts, H.D. Kim<br />

Department of Pediatrics, Inje <strong>University</strong>, Sang-gye Paik<br />

Hospital, Seoul, Korea<br />

Rationle: Severe myoclonic epilepsy in infancy (SMEI)<br />

seems to be probably more common than realized, because<br />

it is often overlooked. In addition, the etiology is unknown<br />

and the prognosis is very grave despite of newly developed<br />

anticonvulsants. This study is intended to give a help to<br />

suspect and management with reviewing our experiences<br />

about SMEI. Methods: From April 1995 to April 2002,<br />

subjects were selected by as following criteria; frequent<br />

generalized or focal febrile clonic seizures before the 1st<br />

year of life, subsequent or previous afebrile seizures of<br />

various types including myoclonic seizures, progressive<br />

delayed development from a certain period. We reviewed<br />

retrospectively clinical features such as etiology, change of<br />

seizure types, treatment, prognosis, electrophysiologic<br />

features and MRI findings. Results: Among eighteen<br />

patients enrolled to this study, ten patients were male and<br />

eight were female. The mean age of seizure onset and<br />

duration of seizure were respectively 5.1 months (SD ^ ,<br />

2.8) old and 69.9 months (SD ^ , 32.6). Five patients<br />

(27.8%) had familial tendency of seizure and four<br />

(22.2%) had photosensitivity. With related disease, mitochondrial<br />

cytochrome complex IV deficiency was<br />

confirmed in one patient. In seven patients (38.9%), seizure<br />

had been started with febrile illness and the others with<br />

afebrile seizure. Onset of febrile seizure was from 2 to<br />

11 months old (mean ^ SD, 7.8 ^ 3.0). Those features of<br />

beginning seizures were focal clonic in nine patients<br />

(50.0%), generalized clonic in five (27.8%) and focal<br />

with generalized clonic in four (22.2%), as well subsequent<br />

seizures were atonic in one (1.9%), atypical absence in<br />

6(33.3%), complex partial in 16 (88.9%), partial with<br />

secondary generalization in six (33.3%), generalized clonic<br />

in one (5.6%), generalized tonic clonic in ten (55.6%) and<br />

myoclonic in 18 (100.0%). Myoclonic seizure had been<br />

started from 7 to 48 months old (mean ^ SD,<br />

26.5 ^ 12.1) and persisted in 14 (77.8%) patients. There<br />

were afebrile or febrile status epilepticuses in nine patients<br />

(50.0%). Initial neuroimaging studies were normal in all<br />

patients but subsequently diffuse atrophy and encephalomalatic<br />

change could be seen each in one patient. EEG<br />

features of 14 patients who could have been serially<br />

followed, were initially normal, but diverse abnormal findings<br />

including background abnormalities and epileptiform<br />

discharges have been founded with followed. Duration of<br />

follow up to appearance of EEG abnormalities was from 6<br />

to 86 months (mean ^ SD, 28.2 ^ 21.0). All patients were<br />

intractable to anticonvulsants. Ketogenic diet was introduced<br />

in 13 patients, one patient has been seizure-free<br />

for 7 months, one patient has been reduced seizure<br />

frequency about more than 90%, and six patients about<br />

more than 50%. Among seventeen patients who could be<br />

observed for more over 12 months, 15 (88.2%) had<br />

progressive delayed development, mildly in four (22.2%)<br />

patients, moderately in seven (38.8%), and severely in four<br />

(22.2%). Conclusion: SMEI has progressive and diverse<br />

clinical appearances with grave prognosis. Mitochondrial<br />

cytopathy has to be considered with mechanism of SMEI<br />

and ketogenic diet could be effective to SMEI intractable<br />

to antiepileptic drugs.


538<br />

Abstracts<br />

FP-H-139<br />

Behavioral and psychological problems in pediatric<br />

epilepsy: HOPE study<br />

I.J. Seol a , H.D. Kim b<br />

a Department of Pediatrics, HanYang <strong>University</strong> College of<br />

Medicine; b Department of Pediatrics, InJe <strong>University</strong> Sanggye<br />

Paik Hospital, Seoul, Korea<br />

Purposes: Health outcome of pediatric epilepsy (HOPE)<br />

study aimed to reveal the incidence of various behavioral<br />

and psycho-social disturbances in pediatric epilepsy patients<br />

and to identify the factors related to various behavioral and<br />

psycho-social disturbances. Method: A total of 827 patients<br />

were enrolled from 37 centers during the 6-month study<br />

period. Five questionnaires were given to patients and<br />

their parents who visited epilepsy clinic during the study<br />

period; Korean version of child behavior check list (K-<br />

CBCL), Yale children’s inventory (YCI), family environmental<br />

scale (FES), children’s depression inventory (CDI),<br />

and Piers-Harris children’s self-concept scale. A set of five<br />

questionnaires was filled out by each patient or its parent.<br />

Parents checked out K-CBCL, YCI, and FES and patients<br />

checked YCI and Piers-Harris scale. In case which patients<br />

were too young to understand the questions, YCI and Piers-<br />

Harris scale were excluded but other three scales were<br />

checked by their parents. All scales were analyzed based<br />

on etiology, duration of epilepsy, seizure frequency, number<br />

of AEDs, and presence of complications. Results: Male<br />

patients was 56% and the enrolled patients were 18 years<br />

old and under. Children aged between 6 and 12 years old<br />

was the most with 59%. Based on etiology idiopathic<br />

epilepsy was 78%, crytogenic was 8% and symptomatic<br />

was 14%. Ratio of partial and generalized epilepsy was<br />

65% versus 35%. In terms of number of antiepileptic<br />

drugs (AEDs) 2% of patients did not take any AEDs and<br />

66% of patients had been taking one AED. A total of 32% of<br />

patients had been taking two AEDs and more. Duration,<br />

seizure frequency and number of AEDs were related to<br />

poor results in K-CBCL and YCI. FES showed no significant<br />

difference in all categories. The longer the duration was<br />

the higher CDI score was. In comparison with normal children,<br />

Piers-Harris scale was lower in children with epilepsy.<br />

Conclusions: Various kinds of psycho-social and behavioral<br />

problems are frequently associated with pediatric epilepsy<br />

especially in cases of older age, more frequent seizures,<br />

prolonged duration of treatment and/or using multiple<br />

AEDs.<br />

FP-H-140<br />

Comparative analysis of handedness and footedness in<br />

children with epilepsy<br />

S.R. Ahn, S.O. Nam<br />

Department of Pediatrics, College of Medicine, Pusan<br />

National <strong>University</strong>, Busan, Korea<br />

Purpose: Study for handedness and footedness of patient<br />

with epilepsy is rare. A few studies suggest that left handedness<br />

is more in children with epilepsy. We analyzed correlation<br />

of handedness and footedness of children with epilepsy<br />

according to the cause of epilepsy and site of brain lesion.<br />

Methods: Subjects were 130 epileptic patients who visited<br />

pediatric ambulatory clinic of Pusan National <strong>University</strong><br />

Hospital from June 2001 to August 2001. Controls were<br />

130 children with no history of convulsion or neurologic<br />

problem. We let check them by carrying out and inquiring<br />

ten items about use of hand and foot. We defined as left or<br />

right handedness and footedness by carrying out more than<br />

five items dominantly. We analyzed age, type of seizure,<br />

cause of epilepsy and site of brain lesion in symptomatic<br />

group. Results: In 130 epileptic patients, left handedness<br />

and left footedness were 20.0 and 15.7% which are significantly<br />

higher than 4.0 and 5.6% in control group (P , 0:05).<br />

But there was no significant difference between idiopathic<br />

epilepsy group and control group as 8.9 and 9.3%. However<br />

left handedness in symptomatic epilepsy group was 45.0%<br />

and left footedness was 31.4%, which were significantly<br />

higher than those of control group (P , 0:05). According<br />

to the site of brain lesion in symptomatic group, all patients<br />

with abnormality in left hemisphere showed left handedness,<br />

but only 57% of the patients showed left footedness. In the<br />

patients who have abnormality in both hemisphere or diffuse<br />

brain lesion, left handedness was 25.9% and left footedness<br />

was 36.8%. Concordance rate of left handedness and left<br />

footedness was 80.0% in control group, 87.5% in idiopathic<br />

epilepsy group and 76.9% in symptomatic epilepsy group.<br />

Conclusion: Left handedness and footedness are more<br />

common in epileptic patients than normal control group.<br />

This is mainly due to high proportion of left handedness<br />

and left footedness in symptomatic epileptic patients.<br />

FP-I<br />

Neuromuscular Disorders<br />

FP-I-001<br />

Assessment of the respiratory function in Duchenne<br />

muscular dystrophy patients<br />

A. Lissoni<br />

Valduce Hospital, Como, Italy<br />

Objective: The study is aimed at defining the diagnostic<br />

value and the prognostic reliability of several methods of<br />

respiratory assessment in relation with the progression of the<br />

ventilatory failure in DMD patients. The timely diagnosis and<br />

definition of respiratory insufficiency level arethe basic stepto<br />

start the non-invasive ventilatory support treatment. Methods:<br />

The results of respiratory functional tests carried out on more<br />

than200DMDpatientsina16yearsperiodhavebeenanalysed<br />

and grouped on the basis of the subjects’ age, in a continuum<br />

between the ages of 11 and 31. Mean values and standard<br />

deviations of VC, VC%, MVV, MVV%, Pimax, Pemax,


Abstracts 539<br />

PaO 2 and PaCO 2 were calculated for each age group and<br />

graphs were plotted to show the respective trends. Results:<br />

The diagnostic- prognostic significance of the different tests<br />

changes at different ages: the most appropriate tests as well as<br />

those less significant are identifiable on the basis of the disease<br />

progression. Conclusions: The respiratory assessmentof these<br />

patients is particularly justified from age of 11–12 years on;<br />

between 11 and 20 years VC, VC% and Pimax values are<br />

useful to determine the residual possibilities of the ventilatory<br />

pump. The blood gas analysis, already known to be useful<br />

after the age of 17–18, becomes a guiding criterion in respiratory<br />

function testing after the age of 20. The study of sleep<br />

patterns by oxymetry and transcutaneous capnometry is advisable<br />

after the age of 13 and compulsory after the age of 15.<br />

FP-I-002<br />

Follow up of children with corticospinal tract<br />

involvement in Guillain-Barre syndrome (GBS)<br />

N. Barisic, L. Brcic, R. Likic<br />

Department of Pediatrics, Zagreb Medical School, Clinical<br />

Medical Center Zagreb, Zagreb, Croatia<br />

GBS is characterized by areflexia.Hyperreflexia is<br />

reported in AMAN. We present 13 children with GBS at<br />

the age 14 months–12 years with hyperreflexia or positive<br />

Babinski sign in initial (5/13) or in early recovery period (10/<br />

13) and 2/13 in both periods. The children were examined<br />

clinically and electromyoneurographically 2–5 times successively<br />

during 1–7 years of follow up. Cerebrospinal fluid<br />

protein content was increased initially in seven patients without<br />

pleocytosis. Meningitic syndrome was present in 7/13<br />

children. Compound muscle action potentials (CMAP) in<br />

range 0.1–1 mV (mean 0.39 mV) and motor conduction<br />

(CMNV) ranging 15–33.6 m/s (mean 26.07 m/s) were<br />

decreased in nine children in the initial phase. Neural potentials<br />

and F waves were absent initially in 11 patients. Distal<br />

latency was prolonged in nine patients. On follow up<br />

improvement of CMAP occurred in six children. Improvement<br />

of CMNV was registered in four children. Outcome was<br />

excellent in 7/13 in the period 1 month–7 years. In 1/13<br />

remained spastic monoparesis, while five patients manifested<br />

slight peroneal gait. Hyperreflexia appeared usually in the<br />

recovery period suggesting involvement of upper motor<br />

neurons or spinal interneurons occurring both in GBS of<br />

demyelinating and axonal type in children.<br />

FP-I-003<br />

Motor neuron disease (MND) in a girl associated with<br />

neuropathy, mitochondrial abnormalities and<br />

centromeric deletion of survival motor neuron (SMN)<br />

gene on chromosome 5q13<br />

N. Barisic, J. Sertic, L. Pazanin<br />

Department of Pediatrics, Zagreb Medical School, Clinical<br />

Medical Center Zagreb, Zagreb, Croatia<br />

Childhood SMA is the most common MND. Homozygous<br />

centromeric survival motor neuron (SMNc) gene deletions<br />

are rarely described in SMA but are present in 36% of<br />

lower MND cases. We present a 12-year-old girl of normal<br />

psychomotor development. At the age of 8, she developed<br />

progressive walking difficulties. On examination, peroneal<br />

gait, left leg hypotrophy, radicular pain, absent triceps sure<br />

jerks and bilateral Babinski sign were registered associated<br />

with extensive right leg angiokeratoma. Brain CT and MRI<br />

spinal scan were normal. Clinical and electromyographical<br />

progression of neurogenic lesion and decreasing of motor<br />

nerve conduction occurred during 4 years, followed by<br />

involvement of left upper extremity and development of<br />

cavus foot on the right. Cerebrospinal fluid, immunologic<br />

tests and alpha-galactosidases activity (Fabry disease) were<br />

normal. Increased vascular resistance without stenotic<br />

abnormalities was recorded on both legs by Doppler ultrasonography.<br />

DNA analysis revealed SMNc deletion. Muscle<br />

biopsy showed neurogenic atrophy and accumulation of<br />

abnormal mitochondria. Sural nerve biopsy showed<br />

decreased number of myelinated axons with scarce onion<br />

bulbs. SMNc deletion probably acts as factor of increased<br />

susceptibility for MND. Although SMN gene deletion<br />

detection is useful in atypical SMA it might be coincidental<br />

finding in MND associated with clinical features of other<br />

pathogenetic origin.<br />

FP-I-004<br />

Early onset progressive chronic inflammatory<br />

demyelinating polyneuropathy (CIDP) associated with<br />

CNS demyelination and inflammatory myopathy<br />

N. Barisic, L. Pazanin, Z. Hutinec, L. Sojat-Cvitanovic, M.<br />

Trbojevic-Cepe<br />

Department of Pediatrics, Zagreb Medical School, Clinical<br />

Medical Center Zagreb, Zagreb, Croatia<br />

Chronic inflammatory demyelinating polyneuropathy<br />

(CIDP) is a chronic disorder, which manifests usually<br />

with monophasic or relapsing course. We present a boy,<br />

now at the age of 6, with progressive generalized muscle<br />

weakness since the age of 2, developing after viral infection.<br />

On examination, generalized hypotonia and hypotrophy of<br />

small muscles, peroneal gait, positive Gowers’ sign,<br />

areflexia, and right abducens palsy were registered. Electromyoneurography<br />

showed severe neurogenic lesion, low<br />

compound muscle action potentials, slowed motor nerve<br />

conduction and myopathic pattern in proximal muscles.<br />

Increased protein content was obtained in the cerebrospinal<br />

fluid. Muscle biopsy showed neurogenic atrophy. Sural<br />

nerve biopsy revealed demyelination and onion bulbs.<br />

Inflammatory perivascular CD 3 positive infiltrates were<br />

present in both biopsies. Brain MRI showed cortical atrophy<br />

with hyper intensities of the white matter and gray matter<br />

hypo intensities. Increased serum anti-G M1 (IgM) and anti<br />

G D1b (IgG) antibodies were registered. Very long chain fatty


540<br />

Abstracts<br />

acids, B 12 , folic acid, lactate, and immunologic test were<br />

normal. He rapidly improved on IVIG and methylprednisolone<br />

treatment, while upon tapering off the steroids<br />

complete deterioration occurred. Demyelination might<br />

develop in the central and peripheral nervous system associated<br />

with inflammatory myopathy in patients with<br />

progressive course of CIDP.<br />

FP-I-005<br />

Acute inflammatory polyradiculoneuropathy in<br />

childhood: clinical features, electrophysiological studies<br />

and treatment<br />

S.B. Yahmed, I. Turki, N. Gouider-Khouja, N. Miladi, F.<br />

Hentati<br />

National Institute of Neurology, Tunis, Tunisia<br />

Acute inflammatory polyradiculoneuropathy (AIP) is the<br />

most common form of acute polyneuropathy in Tunisia<br />

since 1992 when acute anterior poliomyelitis was eradicated.<br />

Thirty-six children with acute inflammatory polyradiculoneuropathy<br />

were analysed from 1974 to 2001. The<br />

mean age of onset was 6 years. There was a predominance<br />

of male 2:1. One half had a prodromal illness within a 4-<br />

week period before the onset of AIP. The illness affected the<br />

upper respiratory tract in 27% of patients and gastro-enteritic<br />

infection in 3% of them. Immunization was implicated in<br />

10% of patients. Weakness, particularly of the lower limbs,<br />

was the initial complaint in 89% of patients. In three patients<br />

paresthesias were present without detectable weakness. A<br />

rise in the level of cerebrospinal fluid protein in the absence<br />

of a pleiocytosis was found in 98% of patients. Electrophysiological<br />

studies showed marked slowing of motor conduction<br />

velocities along with prolonged distal latencies<br />

consistent with demyelination in 54% of patients. Axonal<br />

involvement was identified in 17% of patients. Supportive,<br />

symptomatic treatment was the mainstay of therapy until<br />

1995. The last 6 years, a high-dose gammaglobulin (0.4 g/<br />

kg per day for 5 days) was given for the first days of the<br />

disease and has been shown to reduce the duration of the<br />

hospitalization, to avoid respiratory insufficiency and to<br />

limit the extension of the paralysis<br />

FP-I-006<br />

Genetic diagnosis in childhood Duchenne muscular<br />

dystrophy<br />

H. Cai, L.-W. Wang, G.-Z. Xu, J.-X. Wu, Y.-Y. Li, Y.-L.<br />

Zhu<br />

Capital Institute of pediatrics, Beijing, China<br />

Objectives: DMD is the most common hereditary neuromuscular<br />

disease in children. Its incidence is 1:3000 live<br />

born boys whose abnormal gene is on the X chromosome<br />

at the Xq21 locus and is one of the largest gene identified.<br />

Because the genealogical research of childhood DMD have<br />

not been widely reported in our country, our study aimed at<br />

exploring the genealogical gene of the disease as well as the<br />

relationship between the gene deletion and the level of lysosomal<br />

enzymes, establishing the pediatric gene laboratory in<br />

the north area. Methods: By using the method of the PCR,<br />

blood samples from 30 DMD patients and their parents were<br />

screened for the genes deleted. Serum lysosomal enzymes<br />

were detected with biochemical auto analyzer. Results:<br />

There were significant differences in the levels of lysosomal<br />

enzymes between DMD and normal children (P , 0:01).<br />

The positive rate of the gene deletion was 56.7% (17),<br />

among which the positivity rate of No. 55 was 64.7%<br />

(11), the No. 48 was 52.9% (nine), No. 45 was 35.2%<br />

(six), No. 44 was 17.6 (30), No. 12 was 11.8% (two), and<br />

each of Nos. 8, 17, 19 was 5.9% (one). The positivity rate of<br />

monogenic deletion was 47% (eight), multigenic deletion<br />

was 52.9% (nine), and the genes deleted in parents was 0.<br />

Conclusion: (1) Levels of lysosomal enzymes in DMD are<br />

obviously higher than that in healthy children, and<br />

decreased with the severity of DMD. (2) PCR assay was a<br />

convenient and sensitive method for detecting the genes<br />

deleted in DMD. Our result corresponds to the literature<br />

that the rate of multigenic deletion among these patients<br />

are 47%. (3) The result of our research is important for<br />

studying antenatal diagnosis further.<br />

FP-I-007<br />

Mutations in the skeletal muscle a-actin gene in patients<br />

with nemaline myopathy<br />

Y.-J. Jong a , C.-Y. Yuo b , B.S.-C. Mak c , M.-Y. Chung d , S.-P.<br />

Lin e , C.-C. Huang f<br />

a Department of Pediatrics and Clinical Laboratory,<br />

b Department of Biology, Kaohsiung Medical <strong>University</strong>,<br />

Kaohsiung; c Department of Pediatrics, Taichung Veterans<br />

General Hospital, Taichung; d Department of Pediatrics,<br />

Chang Gung Memorial Hospital, Kaohsiung; e Department<br />

of Pediatrics, Mackay Memorial Hospital, Taipei; f Department<br />

of Pediatrics, National Cheng Kung <strong>University</strong> Hospital,<br />

Tainan, Chinese Taipei<br />

Namaline myopathy (NM) is a clinically heterogeneous<br />

condition characterized by the presence of abnormal rodlike<br />

structures in the muscle and ranging in severity from<br />

neonatal onset with early death to adult onset with slow<br />

progression. Recently mutations in the skeletal muscle a-<br />

actin (ACTA1) gene have been found in up to 30% of the<br />

patients with NM. In order to compare the frequency and<br />

position of mutations in the ACTA1 gene in Taiwanese<br />

patients with NM with those in Western countries, we<br />

analyzed the ACTA1 gene for mutations in the six Taiwanese<br />

patients with NM by sequencing PCR products of<br />

genomic DNA containing the coding exons 2–7. We identified<br />

two different heterozygous missense mutations in two<br />

out of the six patients. Both mutations, Tyr69Asn and<br />

Gly197Ser, have not been reported before in patients with


Abstracts 541<br />

NM. In addition, these two mutations gave rise to restriction<br />

digestion variants that were not found in DNA from all<br />

controlled individuals analyzed. We also demonstrated by<br />

DNA sequencing or restriction endonuclease digestion that<br />

the two ACTA1 mutations identified in the patients were de<br />

novo mutations. In conclusion, our results show that the<br />

frequency of the ACTA1 mutation in Taiwanese patients<br />

with NM is similar to that in patients of Western countries.<br />

The identification of two novel mutations in the ACTA1<br />

gene also reflects the genetically heterogeneous nature of<br />

NM.<br />

FP-I-008<br />

Long-term corticoid treatment in Duchenne muscular<br />

dystrophy<br />

B.F. Reitter a , R. Korinthenberg b , M. Stötter c , U. Schara d ,R.<br />

Lindemuth e<br />

Departments of Pediatrics, Universities of Mainz a , Freiburg<br />

b ,Tübingen c , Bochum d , and Homburg/Saar e , Germany<br />

A total of 125 boys with Duchenne muscular dystrophy<br />

have been treated openly and daily with Deflazacort, 0.75<br />

mg/kg resp. Prednisone, 0.9 mg/kg (N ¼ 5). Checks at 3<br />

months intervals: internal and neurological status, timed<br />

motor function tests, blood: cell count, CRP, ALAT,<br />

ASAT, CK, Gluc, Ca, P, bAP, triglycerides, electrolytes;<br />

additionally after 6 months: osteocalcin in urine, ophthalmolog.<br />

control; add. after 12 months: manual muscle test<br />

(twice), joint mobility, bone densitometry, X-ray hand,<br />

ultrasound abdomen, muscles, heart, ECG, spirometry.<br />

Treatment started above age 5 years, has lasted 2 months<br />

to 8:3 years, and was stopped at loss of ambulation (la)<br />

(N ¼ 22, age 7–14 years). Seven boys older than 14 years<br />

are still walking, some still able to hop on one foot. There<br />

was no obvious relation between age at start, duration of<br />

med and la. Effects and side effects varied considerably. In<br />

more than 75% of patients the decline of motor abilities<br />

diminished. Apart from la, medication was stopped only<br />

due to unaccepted weight gain (N ¼ 14), progressing cataract<br />

(N ¼ 1, cataracts total, N ¼ 27), bone fractures (N ¼ 3,<br />

total, N ¼ 7) due to osteopenia. Those who gained weight<br />

above two SD, did so in the 1st year and remained at<br />

approximately the same percentile (PC). Growth fell<br />

below the 3rd PC in all. No increased frequency or severity<br />

of infections were noted. In no case dilative cardiomyopathy<br />

developed. Summarizing, the positive effects outweigh<br />

negative ones in part of the patients; a strict protocol<br />

allows judging the individual balance within 1 year of<br />

treatment.<br />

FP-I-009<br />

Study of the pathgenesis of 31 GBS cases<br />

B. Li, Y.-P. Yang<br />

Shen Zhen Shi Children’s Hospital, Shen Zhen, China<br />

Objective: We measured the serum antibodies IgG and<br />

IgM to ganglioside G M1 in 31 patients with Guillain-Barre<br />

syndrome, in order to study the pathogenesis of GBS. Methods:<br />

We measured the serum antibodies IgG and IgM to<br />

ganglioside G M1 by enzyme-linked immunosorbent assay,<br />

in 31 acute-phase and recovery patients with Guillain-<br />

Barre syndrome (AIDP 23, AMAN eight), with two control<br />

groups (non-GBS neurological diseases and normal<br />

subjects). Results: The results revealed that the serum levels<br />

of anti-G M1 IgG and IgM with GBS were much higher than<br />

those of the other control groups (P , 0:05). Their cerebrospinal<br />

fluid levels also were higher than those of normal<br />

groups (P , 0:05). Conclusion: The finding indicates the<br />

immunological damage caused by gangliosides is an important<br />

factor in GBS, especially in AMAN.<br />

FP-I-010<br />

Genetic heterogeneity of the axonal form of autosomal<br />

recessive Charcot-Marie-Tooth disease (ARCMT2)<br />

Group 1: M.A.M. Salih a , M. Kabiraj b , M. Al-Rayess c ,T.<br />

Maisonobe d , M.H.S. Al-Turaiki e , F.J. Al-Shammary f , J.A.<br />

Urtizberea g , D. Grid h . Group 2: H. Azzedine, A. Brice, E.<br />

LeGuern<br />

Group 1: a Division of Pediatric Neurology, Department of<br />

Pediatrics; b Clinical Neurophysiology Unit; c Department of<br />

Pathology, College of Medicine, Department of Clinical<br />

Laboratory Sciences, College of Applied Medical Sciences,<br />

King Saud <strong>University</strong>, Riyadh; e The JCRPO, Riyadh, Saudi<br />

Arabia, d Service de Neuropathologie, Hopital de La Salpetriere,<br />

Paris; g AFM, Evry and Genethon, Evry, France.<br />

Group 2: INSERM U289, Federation de Neurologie, Hopital<br />

de La Salpetriere, Paris, France<br />

The axonal autosomal recessive phenotype of Charcot-<br />

Marie-Tooth disease (ARCMT2) is relatively frequent in<br />

the Arabian Peninsula and North Africa because of the<br />

high rate of consanguinity. The first locus for ARCMT2<br />

was recently mapped to chromosome Iq21–q21.3 in a<br />

Moroccan family and a mutation in Lamin A/C gene was<br />

reported in Two Algerian families, whereas another locus<br />

was mapped to chromosome 8q21.3 in a Tunisian family<br />

who had an associated pyramidal tract involvement. The<br />

corresponding gene, GDAP1 was identified in three<br />

families from Spain. We describe three consanguineous<br />

families who have eight children (four males and four<br />

females; aged 16 months–13 years) affected with<br />

ARCMT2. Onset was at birth (with foot deformities) in<br />

the first two families (six males and two females) and 6–<br />

7 months in the third family (two females). All patients had<br />

delayed motor development. Cognitive development was<br />

normal in six children belonging to the first two families<br />

who had distal muscle weakness associated with scoliosis<br />

in three of them. The two girls in the third family were<br />

mentally retarded, had epilepsy, showed distal and proximal<br />

muscle weakness and were bed-ridden. In seven exam-


542<br />

Abstracts<br />

ined children, the peroneal motor nerve conduction velocity<br />

ranged between 40.4 and 59.5 m/s and muscle<br />

compound action potential (CAP) was reduced (0.35–<br />

0.56 mV) in five of them. The peroneal CMAPs could<br />

not be recorded in another two patients. The sural sensory<br />

CAP was absent in five cases and abnormal in another two.<br />

The two already known loci for axonal ARCMT were<br />

tested in these three families. These loci were excluded<br />

except the 8q13 locus for the first family. The sequencing<br />

of the coding region of GDAP1 is in progress for this<br />

family. These data further demonstrate the genetic and<br />

phenotypic heterogeneity of the ARCMT2.<br />

FP-I-011<br />

Infantile neuroaxonal dystrophy (INAD). Clinical<br />

spectrum of eleven Brazilian cases, diagnosed through<br />

conjunctival biopsy<br />

S. Rosemberg, D. Fujiwara<br />

Santa Casa of São Paulo Medical School, Department of<br />

Pediatrics, Neuropediatrics Division, São Paulo, Brazil<br />

INAD is a rare neurodegenerative disease whose metabolic<br />

defect is unknown. A recent review disclosed only 44<br />

reported cases between years 1990 and 2000. The diagnosis<br />

is based on the finding of spheroid bodies of peripheral<br />

axons on ultrastructural level. We studied 11 patients diagnosed<br />

through conjunctival biopsies. There were six females<br />

and five males. All came from unrelated families. Consanguinity<br />

was present in six cases. The age of onset varied<br />

between 6 and 24 months (mean: 15 m). The ages at the time<br />

of the diagnosis varied between 20 months and 6.5 years.<br />

The time elapsed between onset and diagnosis varied from 4<br />

months and 6.5 years (mean: 2 years 8 months). The disease<br />

started insidiously, with initial arrest followed by loss of the<br />

psychomotor development. Only one patient achieved independent<br />

walk. At admission, all patients were profoundly<br />

demented. Only a few had some visual contact. The major<br />

neurological sign concerned a severe global hypotonia particularly<br />

prominent in the inferior limbs. In five cases, the<br />

patients presented a ‘frog position’ being almost paraplegic.<br />

Tendon reflexes were hypoactive or absent in seven cases<br />

and brisk in four. Babinski sign was found in all patients. All<br />

patients but one presented brisk, rapid, irregular movements<br />

of the eyeballs. Head circumference was normal even in<br />

older patients. CSF was always normal. Funduscopic<br />

exam disclosed optic atrophy in ten patients. EMG<br />

(n ¼ 6) showed denervation in five. Cranial TC or MRI<br />

revealed cerebellar atrophy in all cases. Two patients died<br />

at ages 6 and 8 years. In summary, a child presenting with<br />

slowing of psycho-motor development beginning under 2<br />

years, severe hypotonia mainly of the lower limbs, abnormal<br />

ocular movements, optic atrophy, denervation and cerebellar<br />

atrophy is highly suspected of having INAD and an<br />

ultrastructural exam of the nerve terminals should be<br />

performed.<br />

FP-I-012<br />

Peripheral neurophysiological and neuropathological<br />

studies in Charcot-Marie-Tooth atrophy disease in<br />

children<br />

J.-L. Lu<br />

Department of Neurology, Beijing Children Hospital, Beijing,<br />

China<br />

Objective: Charcot-Marie-Tooth atrophy disease (CMT)<br />

is one of the most common hereditary neuropathies in children.<br />

The diagnosis will be difficult because of lacking the<br />

available and specific genetic tests. In this study, the authors<br />

characterized the clinical features of CMT in children and<br />

analyzed the value of the neurophysiology test and the sural<br />

nerve biopsy in the diagnosis and classification of different<br />

subtypes of CMT. Methods: Fifteen patients with CMT were<br />

investigated during the years 1991–1999. Their clinical and<br />

experimental data, including nerve conduction studies,<br />

somatosensory and brainstem auditory evoked potentials<br />

and nerve pathology study were analyzed. Results: All 15<br />

patients (eight males and seven females) were characterized<br />

by progressive weakness of four or two extremities, the<br />

course of the disease varying from 1 to 11 years; three of<br />

15 patients had a family history of CMT. The patients were<br />

classified into CMT type I (hypertrophic type) and CMT<br />

type II (neuronal type) according to the neurophysiological<br />

and pathological criteria. The following features were found<br />

in CMT type I patients: the average age of onset at 2.2 years<br />

of age, all extremities involvement in seven, pes cavus in<br />

eight, the appearance of stork leg in five, sensory abnormalities<br />

in three. Five patients showed a decreased nerve<br />

conduction velocity (12–38 m/s); six patients showed<br />

demyelination in their sural nerves (moderate changes in<br />

five and severe in one), onion bulb formations were found<br />

in two patients. CMT type II was found in seven patients<br />

with the following features; average age of onset at 7 years,<br />

all extremities involvement and reduced amplitudes of<br />

compound muscle active potential without conduction slowing.<br />

The sural nerve biopsy in three patients demonstrated a<br />

chronic axonal neuropathy. Conclusion CMT can be classified<br />

into two subtypes. The peripheral neurophysiology test<br />

is a reliable method to diagnose and classify CMT, while the<br />

sural nerve biopsy may further support the diagnosis and<br />

confirm the subtype classification.<br />

FP-I-013<br />

Clinical and genetic profile of spinal muscular atrophy in<br />

Oman<br />

R. Koul<br />

<strong>University</strong> Hospital, BW-1, Children ward one, Alkhod,<br />

Oman<br />

Oman is one of the Gulf countries with a population of<br />

about 1.5 million. In last 10 years about 60 patients of spinal


Abstracts 543<br />

muscular atrophy in children were seen, majority being<br />

Werdnig-Hoffmann disease. There was positive family<br />

history in large number of cases. The genetic work up was<br />

started in last few years. A detailed clinical and genetic<br />

work up will be presented.<br />

FP-I-014<br />

Outcome of Guillain-Barre syndrome in children: Pre<br />

and post intravenous immunoglobulins (IVIG) era<br />

R. Koul<br />

<strong>University</strong> Hospital, BW-1, Children ward one, Alkhod,<br />

Oman<br />

Oman is one of the Gulf countries with a population of<br />

about 1.5 million. Forty-one children were prospectively<br />

followed from 1992 till December 2001. All received<br />

IVIG 400 mg per kg per day for 5 days. Eight children<br />

before 1992 did not receive IVIG and were picked up retrospectively<br />

from medical records. There was not much difference<br />

in age group, sex distribution and onset of weakness in<br />

both the groups. There was a significant difference in other<br />

parameters. The hospital stay was prolonged in preIVIG<br />

group (mean of 45.4 days) as compared to post IVIG<br />

group (20.4 days). Three out of eight (37.5%) required<br />

ventilation in preIVIG group while 19.5% in post IVIG.<br />

Residual neurologic deficit was 43 % in preIVIG as<br />

compared to 5% in post IVIG group. One child died in<br />

preIVIG group (12.5%) and there was no mortality in the<br />

post IVIG group though the number of patients was five<br />

times larger. IVIG has definitely improved the outcome in<br />

Guillain-Barre syndrome.<br />

FP-I-015<br />

Juvenile onset dentatorubral pallidoluysian atrophy:<br />

follow-up MPI findings<br />

T. Nakayama, H. Oguni, M. Funatsuka, M. Osawa<br />

Department of Pediatrics, Tokyo Women’s Medical <strong>University</strong>,<br />

Tokyo, Japan<br />

Purpose: Dentatorubral pallidoluysian atrophy (DRPLA)<br />

is a rare autosomal dominant neurodegenerative disorder<br />

that is mostly prevalent in Japan. Although the clinical,<br />

neouropathological and neuroradiologic findings of adult<br />

onset DRPLA have been well described, they are poorly<br />

understood in childhood onset DRPLA. In this study, we<br />

analyzed the MRI findings, including sequential MRI<br />

changes with age, to reveal the relationship between clinical<br />

symptoms and neuroradiologic findings in childhood onset<br />

DRPLA. Subjects: The subjects were four patients with<br />

childhood onset DRPLA diagnosed by molecular biological<br />

method. The expansion number of CAG repeats ranged<br />

from 68 to 71. The age of onset of clinical symptoms ranged<br />

from 6 to 11 years, with intellectual deterioration in two and<br />

seizures in two. The follow-up period was from 22 to 24<br />

months with a mean of 18.5 months. Method: MRI scan was<br />

performed with T1, T2, FLARE method with 7-mm slices.<br />

The axial, coronal and sagittal planed were recorded.<br />

Results: A total of 16 MRI imaging studies were performed,<br />

ranging from 3 to 9 in each patient. Progressive atrophy of<br />

the cerebrum and cerebellum, and enlargement of the<br />

lateral, third, and fourth ventricles were observed, which<br />

correlated with the progression of dementia and ataxia.<br />

Restoration of the red nucleus was not observed. Conclusion:<br />

The degree of progressive cortical atrophy and enlargement<br />

of the ventricles roughly corresponded to the degree<br />

of dementia and ataxia. None of our patients showed involvement<br />

of the basal ganglia, which may be related to the<br />

lack of involuntary movement in our cases.<br />

FP-I-016<br />

Myasthenia gravis in Chinese children: Hong Kong<br />

perspective<br />

C.-W. Fung, B.H.-Y. Chung, V.C-N. Wong<br />

Department of Paediatrics, The <strong>University</strong> of Hong Kong,<br />

Queen Mary Hospital, Hong Kong, China<br />

This study aims to analyze the clinical features, investigations,<br />

treatment strategies and outcome of Chinese children<br />

with myasthenia gravis (MG) in Hong Kong. A<br />

comparison was made between Chinese and Caucasians.<br />

Fifty-seven children with MG were identified in our unit<br />

from 1992 to 2002. The records were reviewed. Out of the<br />

57 children, the female to male ratio was 6 to 4. Fifty<br />

patients (88%) had ocular MG while the remaining ones<br />

had generalized MG. The mean age of onset of the disease<br />

was 4.1 years old. Only four patients (7%) had identifiable<br />

precipitating factors such as respiratory tract infections.<br />

Majority of the patients presented with unilateral or bilateral<br />

ptosis. Anti-acetylcholine receptor antibodies were positive<br />

in 29 patients (52%). All the 57 children received anticholinesterase<br />

initially. Only 13 of them (23%) required addition<br />

of steroid therapy. Four patients (7%) required<br />

intravenous immunoglobulin therapy and thymectomy was<br />

performed in six patients (10%). Thirty-one children<br />

(54.4%) entered into remission. Among this group, nine<br />

(29%) had relapse. In conclusion, considerable differences<br />

were observed among Chinese and Caucasians in the clinical<br />

presentations and outcome of this disease.<br />

FP-I-017<br />

Nerve conduction studies in Guillain-Barre syndrome of<br />

children<br />

Q. Zhang, L. Wang<br />

Children’s Hospital, Chonqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: To investigate the nerve conduction changes in<br />

GBS patients, the nerve conduction records of 162 children


544<br />

Abstracts<br />

with GBS from 1994 to 2001 were retrospectively studied.<br />

All patients came from rural area or suburbs of southwest<br />

China, including 110 males and 52 females. The onset of<br />

disease was from 9 months to 16 years (43 cases were less<br />

than 3 years; 119 cases were older than 3 years). Results:<br />

The nerve conduction studies suggested that 44 patients<br />

(27.1%, group A) were categorized as acute inflammatory<br />

demyelinating polyneuropathy (AIDP); 77 patients (47.6%,<br />

group B) were recognized as acute motor axonal neuropathy<br />

(AMAN); 41 patients (25.3%, group C) were classified as<br />

AMSAN. The electrophysiologic abnormalities were<br />

detected within the 1st week in 88 of 162 cases (54.3%).<br />

Among them, 22 cases (25%) were less than 3 years, 66<br />

cases (75%) were older than 3 years. Three nerve conduction<br />

patterns detected in two different age groups were similar.<br />

Thirty-four patients were followed up for a period from<br />

1 month to 2 years. Five of 34 (14.7%) still had the nerve<br />

electrophysiologic abnormalities, among them four cases<br />

(11.8%) were in group A, 17 cases (50%) in group B, and<br />

eight cases (23.5%) in group C. Conclusions: This study<br />

suggested that AMAN was the most common type in children<br />

with GBS, it is also not easy to recover; nerve conduction<br />

detection was valuable for GBS early diagnosis, even to<br />

infant and child patients.<br />

FP-I-018<br />

Secondary merosin deficiency CMD linked to<br />

chromosome 19 in two Tunisian families<br />

C. Triki, N. Louhichi, S. Rouissi, M. Méziou, C. Mhiri, H.<br />

Ayadi, F. Fakhfakh<br />

Department of Neurology and Laboratory of Human Biological<br />

Molecular, Sfax, Tunisia<br />

Congenital muscular dystrophy (CMD) is a heterogeneous<br />

group of muscular disorder characterized by autosomal<br />

recessive mode of inheritance. The CMD have been classified<br />

according to the involvement of the brain and the eyes. It<br />

is apparent that defects in different genes are responsible for<br />

each type. We have studied two cases affected with CMD and<br />

belonging to two Tunisian families. These patients have<br />

benefited from complete clinical investigation. Immunohistochemical<br />

and Western blot analyses on muscles biopsies<br />

was performed using antibodies against human merosin 80<br />

and 300 fragments. Linkage analysis was undertaken for<br />

members of two consanguineous families using microsatellite<br />

markers spanning LAMA2 (6q22), FCMD (9q31), MEB<br />

(1p32), CMD 1B (1q42) and FKRP (19q13.3) loci. Clinical<br />

investigation of the two patients showed severe motor delay,<br />

mental retardation and calf hypertrophy. Cranial MRI<br />

showed white matter abnormalities in two patients associated<br />

with cerebellar cysts and vermis hypoplasia in one case.<br />

Immunohistochemical and Western blot analyses revealed<br />

a partial deficiency of merosin in the two cases. DNA analysis<br />

excludes linkage to chromosomes 6, 9 and 1 and showed a<br />

linkage to chromosome 19q13.3.<br />

FP-I-019<br />

Genetic and immunohistochemical studies of congenital<br />

muscular dystrophy<br />

M. Yoshioka a , T. Toda b , I. Nishino c<br />

a Section of Pediatric Neurology, Kobe City Pediatric and<br />

General Rehabilitation Center for the Challenged, Kobe;<br />

b Division of Functional Genomics, Osaka <strong>University</strong> Graduate<br />

School of Medicine, Osaka; and c National Institute of<br />

Neuroscience, National Center of Neurology and Psychiatry,<br />

Tokyo, Japan<br />

The CMD are a heterogeneous group of autosomal<br />

recessive disorders presenting in infancy with muscle<br />

weakness, contractures, and dystrophic changes on skeletal-muscle<br />

biopsy. Recently, a selective deficiency of<br />

highly glycosylated alpha-dystroglycan (a-DG) became<br />

apparent in several forms of CMD, including FCMD,<br />

muscle-eye-brain disease, CMD with mutations in the<br />

fukutin-related protein gene and myd mouse. A-DG is a<br />

peripheral membrane protein linking the extracellular<br />

basal lamina to the cytoskeletal proteins. In Japan, most<br />

CMD patients have FCMD, characterized by severe CMD<br />

associated with brain and eye malformations. Here, we<br />

analyzed three Japanese patients from two families with<br />

FCMD-phenotype. Full mutational analysis of the fukutin<br />

gene, however, revealed neither 3 kb insertion (Japanese<br />

founder mutation) nor point mutation. RT-PCR analysis of<br />

RNA isolated from lymphoblasts of a patient revealed a<br />

normal expression of the FCMD transcript. As classification<br />

of CMD should be based on the genetic background,<br />

our present cases might be a new variant of CMD. Immunohistochemical<br />

analysis of dystrophic muscle in one<br />

patient revealed a selective deficiency of a-DG, but not<br />

beta-DG, merosin, sarcoglycan or dystrophin. These findings<br />

raise the possibility that the abnormality of a-DG is<br />

integral to the pathology in this variant of CMD.<br />

FP-I-020<br />

Benign acute childhood myositis<br />

F.M. Aynacı, M.Çakır, Ş. Yayla<br />

Karadeniz Technical <strong>University</strong>, Faculty of Medicine, Dept<br />

of Child Neurology, Trabzon, Turkey<br />

Six children, one girl and five boys, aged 3–9 years,<br />

were admitted with benign acute childhood myositis during<br />

January–February 2002. They presented with an acute<br />

onset of symmetrical calf muscle pain and tenderness,<br />

weakness and inability to walk a few days after upper<br />

respiratory tract infection. Serum creatine kinase and<br />

aspartate aminotransferase were increased all cases. Viral<br />

studies included throat swab for nasopharyngeal aspirate<br />

was done in one case and found to be negative for influenza<br />

A and B. Full clinical recovery was achieved within<br />

12 h–3 days.


Abstracts 545<br />

FP-I-021<br />

Persistent toe-walking, pain and stiffness as leading<br />

symptoms of hereditary neuropathy with liability to<br />

pressure palsies (HNPP)<br />

T. Lönnqvist, H. Pihko<br />

Hospital for Children and Adolescents, <strong>University</strong> of<br />

Helsinki, Finland<br />

Although molecular determination of the chromosome<br />

17p11.2 deletion in conjunction with electrophysiology are<br />

powerful tools in the diagnosis of hereditary neuropathy with<br />

liability to pressure palsies (HNPP), this neuropathy is underdiagnosed,<br />

especially in children. Most patients present with<br />

mononeuropathies related to mild pressure trauma, but some<br />

present with chronic generalized neuropathy. Clinically<br />

atypical forms of HNPP have been described including<br />

CMT-like polyneuropathy, chronic recurrent inflammatory<br />

demyelinating polyneuropathy, and respiratory failure with<br />

proximal muscle weakness. We present an atypical HNPP<br />

case with very persistent, asymmetric secondary toe-walking<br />

together with pain and stiffness especially in the legs. Our<br />

patient is a previously healthy boy, the only child of healthy<br />

parents, who came to our hospital because of secondary toewalking<br />

at the age of 3.5 years. He had walked normally<br />

without support since 12 months of age, but after an episode<br />

of limping of his left leg for a week at the age of 3 years, he<br />

started to walk on his toes. The clinical examination revealed<br />

an alert boy, whose psychomotor development was normal,<br />

but who persisted to walk on toes. His calves were thick, the<br />

ankles were rigid, and the deep tendon reflexes were exaggerated<br />

in the lower extremities with positive Babinski sign<br />

in the left. A central nervous system process was excluded by<br />

normal brain and spinal MR image, peripheral neuropathy<br />

with normal EMG and muscle dystrophy with EMG and<br />

normal serum concentrations of creatine kinase and transaminases.<br />

Physiotherapy was started with plaster cast treatment<br />

in both legs. In spite of the treatment, and especially<br />

when physiotherapy was discontinued, our patient preferred<br />

toe-walking and suffered from muscle pain and stiffness in<br />

the mornings. Hard exercise in the previous day worsened the<br />

pain. During the follow-up the symptoms and findings were<br />

asymmetric being more severe in the left. At the age of 7<br />

years, when the boy started to go to school, a new symptom<br />

appeared: his hands became weak, when he exercised writing.<br />

At the same time his father complained of numbness in<br />

his hands after hard work. He also told that his sister had had a<br />

brachial plexus nerve entrapment, which was cured without<br />

any treatment in a couple of months. This information after 5<br />

years follow-up made us to perform DNA tests, which<br />

revealed 17p11.2 deletion in the patient, his father and his<br />

paternal aunt and grandmother. To conclude it is important to<br />

remember possibility of HNPP in young patients with persistent,<br />

asymmetric toe-walking added with muscle pain and<br />

stiffness.<br />

FP-I-022<br />

Study of radial nerve conduction in children recording<br />

with surface electrode<br />

L. Wang, F.-C. Cai<br />

Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />

Sciences, Chongqing, China<br />

Objective: To explore the reliability recording radial<br />

nerve conduction with surface electrode in children and to<br />

investigate the norms and the maturation course of radial<br />

conduction in children. Methods: (1) A comparative study in<br />

40 children with different ages at same radial nerve for the<br />

reliability to record radial motor nerve conduction with<br />

surface and also needle electrodes; and (2) maturation<br />

course and norms of motor and sensory conduction of radial<br />

nerve recorded by surface electrode on the basis of data of<br />

128 children aged 0–14 years old. Results: (1) A clear<br />

pattern of complex motor active potential (CMAP) was<br />

recorded by surface electrodes as by the needle electrodes<br />

in all of the tested children regardless their age. The value of<br />

motor conduction velocity (MCVs) and latencies were<br />

highly consistent by both methods. (2) With surface recording,<br />

CMAPs were well presented in all age groups including<br />

neonate. F waves could be obtained also in all subjects if<br />

moving recording electrode to the proximity of upper extremity.<br />

However it was hard to record a sensory nerve potential<br />

(SNP) of radial nerve in infants younger than 6 months<br />

of age, but the incidence of SNPs were increased to 50%<br />

with age before 3 years old and still less than 90% in older<br />

children; (3) a series of norms of radial nerve conduction<br />

tested with surface electrode in children, including MCV,<br />

SCV, distal latencies, amplitudes and duration of CMAPs<br />

and SNAPs were obtained. A two-thirds level of MCV as<br />

the young adult had been reached at birth, there were no<br />

significant difference between the levels of MCV in 3 years<br />

old group and in the older age groups. As MCVs, a similar<br />

maturational course for SCV was demonstrated. Conclusion:<br />

Motor nerve conduction of radial nerve could be satisfyingly<br />

recorded with surface electrodes, instead of needle<br />

electrodes, in children at any age. It could be the most<br />

advantage to promote its clinical use in pediatric population<br />

due to their non-injury operation.<br />

FP-I-023<br />

Physiological and pathological studies in Charcot-<br />

Marie-Tooth disease in children<br />

J.-L. Lu, H.-S. Wu, Z.-Q. Lang<br />

Department of Neurology, Beijing Children’s Hospital,<br />

Beijing, China<br />

Objective: Charcot-Marie-Tooth disease is one of the<br />

most common hereditary neuropathies in children. The<br />

diagnosis can be difficult due to the lack of availability of<br />

specific genetic tests. In this study, we characterized the


546<br />

Abstracts<br />

clinical features of this illness in children and analyzed the<br />

value of neurophysiology and sural nerve biopsy in the<br />

diagnosis and classification of different subtypes. Method:<br />

Fifteen patients with CMT were investigated between 1991<br />

and 1999. Their clinical and experimental data, including<br />

nerve conduction studies, somatosensory and brainstem<br />

auditory evoked potentials and nerve pathology study<br />

were analyzed. Results: All 15 patients (eight male, seven<br />

female) were characterized by progressive weakness of four<br />

or two extremities, the course of disease varying from 1<br />

through 11 years; three of the patients had a family history<br />

of CMT. The patients were classified into CMT type I<br />

(hypertrophic type) and CMT type II (neuronal type)<br />

according to neurophysiological and pathological criteria.<br />

The following features were found in CMT type I patients:<br />

average age of onset at 2.2 years of age, all extremities<br />

involved in 7, pes cavus in eight, the appearance of stork<br />

leg in five, sensory abnormalities in three. Five patients<br />

showed a decreased nerve conduction velocity (12–38 m/<br />

s); six patients showed demyelination in their sural nerves<br />

(moderate changes in five and severe in one), onion bulb<br />

formations were found in two patients. CMT type II was<br />

found in seven patients with the following features: average<br />

age of onset at 7 years, involvement of all extremities in<br />

three, pes cavus in five and stork leg in three patients; all<br />

patients showed reduced amplitudes of compound muscle<br />

active potentials without conduction slowing. Sural nerve<br />

biopsy in three patients demonstrated a chronic axonal<br />

neuropathy. Conclusion: CMT is characterized by chronic<br />

progressive weakness and atrophy in all or lower extremities<br />

and it can be classified into two subtypes. The neurophysiological<br />

and pathological features were corresponded with<br />

chronic demyelinating neuropathy in type I and axonal<br />

neuropathy in type II. Electrophysiological test is a reliable<br />

method for diagnosing and classifying different subtypes.<br />

Sural nerve biopsy provides objective evidence in making<br />

adefinitive diagnosis.<br />

FP-I-024<br />

The study of the value of SEP for diagnosis in pediatric<br />

paralysis<br />

N. Xiao, X.-H. Lan, C.-G. Feng, L. Wang<br />

Department Neurology, Children’s Hospital, <strong>University</strong> of<br />

Medical Sciences, Chongqing, China<br />

Objective: To explore the diagnostic value of somatosensory<br />

evoked potentials (SEP) for children with paralysis.<br />

Method: Comparing the normal data of SEP along median<br />

and posterior tibial nerves in 180 healthy children aged 0–14<br />

years old, the SEP of 335 patients aged from 2 months to 14<br />

years old with extremity paralysis were analyzed and<br />

compared. Results: Among the 266 subjects with spastic<br />

paralysis, abnormal SEP was present in 230/266 cases<br />

(86.5%). The latent period records of spinal and/or scalp<br />

SEP peak were showed delay or complete absence, but<br />

their peripheral potentials were still within normal range.<br />

The SEP abnormalities were higher in 92.6% (25/27) of<br />

spinal diseases cases and 86.3% (139/161) of cerebral<br />

palsy cases. Both were more than those in other CNS<br />

diseases. In the cases with intracranial lesions, the abnormal<br />

SEP in supratentorial lesions were more common than that in<br />

postfovea lesion. In the 69 children with flaccid paralysis,<br />

20.3% (14/69 patients) presented abnormal peripheral potentials<br />

of SEP. Comparing the abnormalities rate of SEP, there<br />

was no significant difference between the two age groups,<br />

older and younger than 3 years old. Conclusion: The results<br />

of the study indicate that SEP was very important to determine<br />

the possible site of lesions pathologically particularly<br />

for spinal and cortical lesions. It was suggested that SEP was<br />

also a valuable diagnostic test for the paralysis in infants.<br />

FP-I-025<br />

Evaluation of the reasons of delayed diagnosis in<br />

Duchenne muscular dystrophy patients<br />

S. Kurul, E. Dirik<br />

Dokuz Eylül <strong>University</strong> Faculty of Medicine, Department of<br />

Pediatric Neurology, Izmir, Turkey<br />

Duchenne muscular dystrophy is a severe X-linked recessive<br />

neuromuscular disease that causes death in the second or<br />

third decade. The clinical manifestations are not recognized<br />

until 3–4 years of age. The early diagnosis of this incurable<br />

disease allows potential benefits including the avoidance of<br />

distressing diagnostic delays, enabling the family to plan for<br />

future pregnancies and prenatal diagnosis, and the offer of<br />

physiotherapy at an early stage. This study has shown that the<br />

diagnosis continues to be delayed. The failure to recognize<br />

the walking problems by families and doctors in affected<br />

boys has been found to contribute to the late diagnosis of<br />

this disorder. We conclude that all clinicians involved in<br />

the assessment of children including general practitioners,<br />

orthopedists and pediatricians should recognize the common<br />

patterns of presentation of children with Duchenne muscular<br />

dystrophy and either refer to a paediatric neuromuscular<br />

diseases center or measure creatine kinase level.<br />

FP-I-026<br />

A clinical description of cases of acute flaccid paralysis<br />

reported in Malaysia over a 5 year period of surveillance<br />

from 1997 to 2001<br />

T.G.S. Thomas c , M.T. Arif a , H. Ihmi b , S. Ali b , T.B. Khoo c ,<br />

D. Kurup b , M. Sinniah b<br />

a Chairman and b Members, Poliomyelitis eradication expert<br />

review committee, Ministry of Health, Malaysia; c Paediatric<br />

Neurology Clinic, Paediatric Department, Penang<br />

Hospital, Penang, Malaysia<br />

Objective: The nation-wide surveillance for acute flaccid<br />

paralysis (AFP) was implemented in Malaysia in 1995 and


Abstracts 547<br />

further intensified in 1996 as part of the World Health<br />

Organisation (WHO) certification process for polio eradication<br />

in the Western Pacific region. Clinical data on AFP<br />

cases during a 5-year surveillance period from 1997 to<br />

2001 were collected and analysed. Results: 517 cases of<br />

AFP were reported during the surveillance period; the<br />

overall rate of AFP was 1.38 per 100 000 children below<br />

15 years old. The major clinical diagnoses associated with<br />

AFP were Guillain-Barre syndrome (29.4%), central<br />

nervous system infection (16.2%), transverse myelitis<br />

(10.6%), non-polio enterovirus infection (6.2%), and hypokalaemic<br />

paralysis (5.2%). There was an excess of CNS<br />

infections and non-polio enterovirus infection due to enterovirus<br />

71 infections occurring in 1997 and in the year<br />

2000. There were no cases of poliomyelitis due to wild<br />

poliovirus, based on the WHO virological classification.<br />

Three cases were ‘polio compatible’ and 61 cases<br />

(11.8%) remained unclassifiable as ‘non-polio AFP’.<br />

There were no cases attributed to vaccine-associated<br />

paralytic polio. Conclusion: These data suggest the absence<br />

of circulation of wild poliovirus in Malaysia from 1997 to<br />

2001. The Malaysian AFP surveillance mechanism has<br />

improved over the years though there was still a need to<br />

improve on the adequacy of stool specimens collected and<br />

post-paralytic clinical follow-up.<br />

FP-I-027<br />

A case of opsoclonus-myoclonus syndrome: a molecular<br />

observation on pre-and-post treatment of high dose<br />

steroid therapy<br />

K. Oishi a , H.J. Okano b , T. Tokoro a , M. Kurauchi c ,H.Ota a,c<br />

a Department of Pediatrics, Jikei <strong>University</strong> School of Medicine,<br />

Tokyo; b Department of Physiology, Keio <strong>University</strong><br />

School of Medicine, Tokyo; c Department of Pediatrics,<br />

Kanagawa Prefectural Atsugi Hospital, Atsugi, Japan<br />

Introduction: Opsoclonus-myoclonus syndrome (OMS)<br />

is a rare disorder with abnormal eye movement, cerebellar<br />

ataxia and myoclonus. The onset is acute and the outcome<br />

is variable depending on the severity of the disease and the<br />

response to therapies. The pathogenesis is still unknown.<br />

However, the clinical response to immunotherapy and the<br />

expression of autoantibodies suggest that dysregulation of<br />

the immune system is involved. Objective: To investigate<br />

the pathogenesis and the efficiency of the treatment, we<br />

analyzed the expression level of autoantibodies in our<br />

patient. Methods: A 2 year-old female of OMS was treated<br />

with high dose steroid (30 mg/kg of intravenous methylprednisolone)<br />

for 3 days. Sera were obtained before and<br />

after the therapy, and were used for Western analysis.<br />

Mouse tissue lysates were used for this assay. Results:<br />

The treatment was successful, and all of the symptoms<br />

disappeared in 2 months. She has been well with several<br />

episodes of minor recurrence on a low dose of steroid.<br />

Autoantibodies were detected in serum from the patient<br />

before therapy. Their targets were 75 and 85 kD proteins<br />

in the cortex, cerebellum, and midbrain. The expression<br />

level was dramatically decreased by the therapy. Conclusion:<br />

Autoantibody was detected in our patient and their<br />

expression levels were decreased with high dose steroid<br />

therapy. This coincided with an improvement in clinical<br />

symptoms. This suggested that high dose steroid therapy<br />

was effective in reducing the expression of autoantibodies<br />

and monitoring<br />

FP-I-028<br />

Focal critical illness neuropathy in children<br />

M.J. Tan, R.H. Kandler, P.S. Baxter<br />

Sheffield Children’s Hospital, Western Bank, Sheffield,<br />

United Kingdom<br />

We describe a hitherto unrecognised association of focal<br />

neuropathy with critical illness. Four children requiring<br />

intensive care for critical illness developed clinical and electrophysiological<br />

features of focal neuropathy. Signs have<br />

persisted with some partial recovery in three. Two had a<br />

generalised polyneuropathy as well, which recovered.<br />

None had deletions in the CMT1a region on chromosome<br />

17. Patient 1 (girl 2 years) had right peroneal nerve palsy<br />

diagnosed 6 months after culture positive meningococcal<br />

septicaemia which required ventilation for 10 days, complicated<br />

by focal skin necrosis, encephalopathy, a generalised<br />

movement disorder and a right hemiparesis. She had a deep<br />

necrotic lesion over the head of the right fibula. Patient 2<br />

(boy 6 years) had right peroneal nerve palsy diagnosed 5<br />

months after type C meningococcal septicaemia, requiring<br />

ventilation for 15 days and complicated by DIC, renal failure,<br />

focal skin necrosis, and central motor signs. Patient 3<br />

(girl 14 years) had right peroneal nerve palsy diagnosed<br />

after resolution of right calf compartment syndrome requiring<br />

fasciotomy, complicating type C meningococcal septicaemia.<br />

She also developed adult respiratory distress<br />

syndrome and polyneuropathy, requiring ventilation for 2<br />

months. Patient 4 (girl 13 years) had left peroneal and tibial<br />

nerve palsies following acute focal myositis associated with<br />

influenza A infection, which also caused severe asthma<br />

requiring ventilation for 5 days. She had electrophysiological<br />

evidence of a generalised axonal polyneuropathy which<br />

recovered. We suggest that peripheral nerves already at risk<br />

from critical illness neuropathy are more susceptible to<br />

damage from local pressure.<br />

FP-I-029<br />

Spinal muscular atrophy type I, hypertension and<br />

neuropathy: a case report<br />

M. Sahin, D. Dayangac, G. Haliloglu, H. Erdem, H.<br />

Topaloglu<br />

Hacettepe Children’s Hospital, Department of Pediatric<br />

Neurology, Ankara, Turkey


548<br />

Abstracts<br />

Spinal muscular atrophy (SMA) is an autosomal recessive<br />

disorder characterized by progressive loss of motor neurons<br />

of the spinal cord. There are three types defined according to<br />

age of onset of symptoms, clinical course and different clinical<br />

severity. Homozygous mutations or deletions in telomeric<br />

copy of survival motor neuron gene located on<br />

chromosome 5q are found in more than 90% of the patients<br />

in the classical form. SMA type I begins in the first few<br />

months of life, muscle weaakness is predominantly proximal<br />

and the facial muscles are spared. The criteria for differentiating<br />

SMA type I from non-5q-linked diseases include<br />

involvement of extraocular muscles and diaphragm and<br />

pronounced facial weakness. A 2-month-old male infant<br />

was admitted to our hospital with respiratory insufficiency<br />

and hypotonia. There was first degree consanguinity. He had<br />

signs of congestive heart failure, bilateral metacarpophalangeal<br />

contractures, tongue fasciculations, abdominal breathing,<br />

hypotonic posture, and absent deep tendon reflexes. His<br />

blood pressure was 160/85 mmHg. Congenital hypomyelinating<br />

neuropathy, hereditary sensorymotor/autonomic<br />

neuropathies were included in the differential diagnosis<br />

besides SMA type I. Molecular analysis revealed that SMA<br />

gene deletion was positive and EMG showed severe and<br />

diffuse motor demyelinating neuropathy with secondary<br />

axon loss, mild sensory polyneuropathic involvement and<br />

active neurogenic process. SMA gene deletion, axonal<br />

neuropathy and hypertension were reported in two families<br />

before. In our patient, presence of severe demyelinating<br />

neuropathy, SMA, contractures and hypertension can be a<br />

different clinical entity.<br />

FP-I-030<br />

Merosin-positive congenital muscular dystrophy:<br />

characteristics of 59 patients. Hacettepe experience<br />

G. Haliloglu, B. Talim, E. Demir, M. Yetuk, G. Kale, H.<br />

Topaloglu<br />

Hacettepe Children’s Hospital, Department of Pediatric<br />

Neurology, Ankara, Turkey<br />

CMD are a heterogenous group of autosomal recessive<br />

disorders characterized by early-onset muscle weaakness,<br />

hypotonia, joint contractures and a myopathic and/or a<br />

dystrophic pattern at musscle biopsy. We present a total<br />

of 59 patients (29 girls, 30 boys) diagnosed with merosinpositive<br />

CMD with an age range of 7 months–21 years.<br />

These patients are subgrouped in four according to clinical<br />

course; severe (n ¼ 18) and mild (n ¼ 14) and presence of<br />

distal laxity (n ¼ 15) and rigid spine syndrome (n ¼ 12).<br />

Clinical presentation, physical examination findings, creatine<br />

kinase (CK) levels, muscle ultrasonography (US), electrophysiologic,<br />

muscle biopsy, cardiac evaluation and<br />

neuroimaging findings are all documented taaking defined<br />

subgroups into consideration. Clinical findings included<br />

decreased intrauterine movements (10/59), neonatal hypotonia<br />

(21/59), consanguinity (40/59), delay in motor milestones<br />

(49/59), contractures (26/59), mental retardation (6/<br />

59), and increased CK levels (17/59). Muscle US showed<br />

grades 3–4 echogenicity in 90–95% of the patients. EMG<br />

was performed in about 50% of the patients and only two<br />

were neuropathic. Cardiac evaluation showed diastolic<br />

dysfunction in some of the patients. However, none of<br />

these patients were symptomatic. Neuroimaging findings<br />

were normal in 21/23 and showed cortical atrophy in 2/23.<br />

CMD represents clinically and genetically heterogeneous<br />

group of disorders. Defining subgroups based on clinical<br />

presentation and physical examination findings will help<br />

further to classify and define molecular aspects of the<br />

disease.<br />

FP-I-031<br />

A novel variant of spinal muscular atrophy with<br />

progressive myoclonic epilepsy<br />

G. Haliloglu, H. Erdem, Z. Akcören, Y. Renda, H.<br />

Topaloglu<br />

Hacettepe Children’s Hospital, Department of Pediatric<br />

Neurology, Ankara, Turkey<br />

SMA is a clinically and genetically heterogeneous<br />

disease characterized by loss of motor function and muscle<br />

atrophy due to anterior horn cell degeneration. The most<br />

common variant is chromosome 5 linked proximal SMA,<br />

ranging in severity from congenital onset and infantile death<br />

to onset in adult life. Genetically separate variants with<br />

different distribution of weakness and/or additional features<br />

such as central nervous system involvement have been<br />

described. A rare variant with associated myoclonic<br />

epilepsy and lower motor neuron disease has been<br />

previously described in three families. We report four<br />

patients from two additional families affected by a<br />

syndrome characterized by severe and progressive myoclonic<br />

epilepsy and proximal weakness, tremor and lower<br />

motor neuron disease proven by electrophysiologic and<br />

muscle biopsy findings. Extensive metabolic investigations<br />

including tests for neuronal ceroid lipofuscinosis, lysosomal<br />

storage diseases and mitochondrial disorders were negative.<br />

Genetic analysis excluded the SMN gene. This study<br />

presents two families who differ from the patients defined<br />

in the literature before and confirms that the association of<br />

myoclonic epilepsy and motor neuron disease represents an<br />

entity genetically separate from chromosome 5 linked SMA.<br />

Metabolic and genetic defect remains unknown.<br />

FP-I-032<br />

Respiratory capacity course in patients with infantile<br />

spinal muscular atrophy<br />

C. Ioos, B. Estournet-Mathiaud, A. Barois, S. Mrad, D.<br />

Leclerc-Richard<br />

Department of Pediatric Neurology, Hôpital Raymond<br />

Poincaré, Garches, France


Abstracts 549<br />

We present the retrospective study of respiratory course<br />

in patients with infantile SMA. We report 36 patients with<br />

SMA type I for onset of symptoms before age 3 months (I<br />

pure form); 43 patients with SMA type I for onset of symptoms<br />

between 3 and 6 months (I bis form); 135 patients with<br />

SMA type II for onset of symptoms between 6 and 18<br />

months; 12 patients with SMA type III for onset of symptoms<br />

after age 18 months. In patients with SMA type I pure,<br />

75% of patients are dead. One third of patients had tracheotomy,<br />

42% of them are dead. Death is due to ventilatory<br />

insufficiency and bulbar symptoms. In patients with SMA<br />

type I bis, 52% of patients needed nasal nocturnal ventilation<br />

(NNV). Fifty-nine % of patients had tracheotomy.<br />

Twenty-three % of patients are dead. In patients with<br />

SMA type II, 39% of patients needed NNV, 16% of patients<br />

needed tracheotomy. Four % of patients are dead. In patients<br />

with SMA type II, we compared three groups: patients born<br />

before 1975, between 1975 and 1985, between 1985 and<br />

1995. This shows that earlier respiratory management<br />

allows to protect the lung function for more a long time,<br />

and reduces the need for tracheotomy. In patients SMA type<br />

III, respiratory impairment is moderate, and begins during<br />

second decade of life.<br />

FP-I-033<br />

Congenital myasthenic syndromes: a clinical study of 23<br />

children<br />

C. Ioos, L. Viollet, A. Barois, B. Estournet-Mathiaud<br />

Department of Pediatric Neurology, Hôpital Raymond<br />

Poincaré, Garches, France<br />

Congenital myasthenic syndromes (CMS) constitute a<br />

heterogeneous group of disorders in which the safety margin<br />

of neuromuscular transmission is compromised. CMS are<br />

classified as presynaptic, synaptic or post-synaptic according<br />

to the site of the primary defect. We report the clinical<br />

findings of 23 children with CMS. Age of onset vary from<br />

1st day of life to the age of 9. The first clinical features are<br />

more frequently swallowing difficulties (48% of cases) and<br />

respiratory distress (44% of cases), then ptosis (26% of<br />

cases) and fatigability of limb muscles (22% of cases).<br />

Ptosis is a frequent clinical symptom (83% of cases), as<br />

well as swallowing difficulties (61% of cases). Ophthalmoparesis<br />

is present in 52% of cases, and occurs during the<br />

course of the pathology. The muscle weakness predominates<br />

on cervical muscles and limb-girdle muscles in 78%<br />

of patients. In 55% of them, pelvic-girdle muscles are more<br />

severely affected than scapular-girdle muscles. There is an<br />

improvement of weakness and fatigability during childhood<br />

in 74% of patients, stability in 17% of them, and worsening<br />

in 9% of patients. There is a restrictive respiratory insufficiency<br />

in 87% of patients, with stability or improvement in<br />

90% of them. Twenty-two patients are treated. Seventyseven<br />

% of them respond favorably to cholinesterase inhibitors.<br />

This response to treatment is incomplete and needs<br />

high doses reaching 4 mg/kg per dose £ 4/day for pyridostigmine,<br />

and 2 mg/kg per day in four or five divided doses<br />

for ambenomium. Morphologic studies in routine histochemical<br />

studies show no abnormality or type 1 fiber<br />

preponderance isolated or combined type 2 fibers atrophy.<br />

FP-I-034<br />

Merosin-deficient congenital muscular dystrophy: lack<br />

of specificity of proton magnetic resonance spectroscopy<br />

associated to MRI in eight patients<br />

C.C. Leite a , M.T.C. Lacerda a , M.O.R. Costa a , M.G.<br />

Otaduya a , L.G. Ferreira b , M.B.D. Resende b , M.S.<br />

Carvalho b , S.K.N. Marie b , U.C. Reed b<br />

Departments of<br />

a Radiology and b Neurology, School of<br />

Medicine, São Paulo <strong>University</strong>, São Paulo, Brazil<br />

To evaluate the extensive brain white matter changes in<br />

merosin-deficient CMD we performed proton magnetic resonance<br />

spectroscopy (1h-MRS) associated to MRI in eight<br />

patients (seven with total and one with partial merosin deficiency).<br />

MRI included axial T1, T2, Flair and diffusion<br />

weighted images (DWI). Enhanced T1-weighted images<br />

were obtained in axial, coronal and sagittal planes. The 1 H-<br />

MRS consisted of STEAM (stimulated echo acquisition<br />

mode) sequence in frontal and parieto-occipital white matter<br />

and parieto-occipital gray matter. Metabolite ratios (N-acetylaspartate,<br />

choline and myo-inositol) were studied relatively<br />

to creatine and water. The apparent diffusion<br />

coefficient (ADC) was measured for the same regions.<br />

ADC and 1 H-MRS results were compared to a control. All<br />

patients presented involvement of supratentorial white<br />

matter that predominated in frontal lobes; one patient had<br />

diffuse involvement, and the external capsules were involved<br />

in all, while internal capsules, corpus callosum, optic radiation,<br />

cerebellum and brain stem were not affected. Lesions<br />

were hypointense on T1, hyperintense on T2 and Flair and<br />

did not enhance after gadolinium. No characteristic pattern in<br />

the metabolite ratios relatively to creatine was seen, but by<br />

measuring metabolite ratios relatively to water, important<br />

dilution of metabolites was observed for the white matter,<br />

compared to normal. ADC was increased only in the white<br />

matter. It was a non specific finding consistent with the metabolite<br />

dilution observed by 1 H-MRS, and correlated with the<br />

demyelination observed on MRI.<br />

FP-I-035<br />

Congenital muscular dystrophy: report of two atypical<br />

cases<br />

H.V. Linden Jr., M.B.D. Resende, L.G. Ferreira, M.S.<br />

Carvalho, S.K.N. Marie, U.C. Reed<br />

Department of Neurology, School of Medicine, São Paulo<br />

<strong>University</strong>, São Paulo, Brazil<br />

We report two atypical cases of CMD. Case 1, a 9-month-


550<br />

Abstracts<br />

old boy, presented from 7 months of age a progressive flaccid<br />

paralysis and loss of head control. The child acquired<br />

head control and was able to sit unsupported at respectively<br />

2 and 6 months of age. A 5-fold increased creatine kinase<br />

serum level and abnormal myogenic pattern on electromyography<br />

were detected. Muscle biopsy revealed marked<br />

dystrophic pattern with no signs of inflammatory changes.<br />

Merosin, sarcoglycan and dystrophin immunostaining were<br />

normal. After 12 months any improvement was observed.<br />

Case 2, a 4 year-old girl, manifested from birth severe<br />

muscle hypotonia, muscular weakness and elongated face.<br />

Her maximal motor ability was walking with support from 3<br />

years of age. MRI revealed diffuse leucodystrophic pattern<br />

and creatine kinase level was 2.5-fold increased. Muscle<br />

biopsy showed marked dystrophic pattern and total absence<br />

of merosin immunostaining. The girl became able to walk<br />

independently at 5 years and 9 months. At 6 years and 5<br />

months she gradually developed worsening of muscle weakness<br />

and of walking again needing support. Deflazacort 0.75<br />

mg/kg per day was started and strong improvement with<br />

return to the anterior walking ability was noted. After 9<br />

months walking persists stable and no side effects developed<br />

except mild weight gain. Subacutely severe course as in<br />

merosin-positive Case 1 and benign course plus additional<br />

improvement under steroid therapy in totally merosin-deficient<br />

Case 2 represent unusual clinical phenotypes to our<br />

knowledge not yet described for the correspondent subtypes<br />

of CMD.<br />

FP-I-036<br />

Juvenile myasthenia: clinical findings, treatment and<br />

prognosis<br />

B. Anlar, A. Deǧerliyurt, S. Aysun, H. Topaloglu, M.<br />

Topçu, G. Turanlı, D. Yalnizoǧlu, E. Özdirim<br />

Hacettepe <strong>University</strong>, Department of Pediatric Neurology,<br />

Ankara, Turkey<br />

Clinical and laboratory data of 27 patients being followedup<br />

with juvenile (autoimmune) myasthenia are presented.<br />

Mean age of onset is 10.1 (1.5–15) years. The F:M ratio is<br />

7:1 in disease starting after age 9, and 2.7:1 before age 8.<br />

Ocular weakness is the most common initial complaint: it<br />

was present in 85.2% of patients, and as the only symptom<br />

in 62.9%. Among the 17 patients who presented with ocular<br />

weakness only, 3 developed systemic or bulbar weakness in 4<br />

months–2 years, but 14 remained restricted to ocular muscles<br />

in average 6.5 years’ follow-up. Myasthenic crisis was seen<br />

only in six female patients with pubertal onset. In general,<br />

33% of patients had mild, 44%, moderate, and 22%, severe<br />

disease. Acetylcholine receptor antibodies were present in<br />

82% of all cases, and in 71% of those with ocular symptoms<br />

only. The rate of seropositivity did not differ between patients<br />

in remission or those with moderate to severe symptoms.<br />

Treatment was done with acetylcholineterase inhibitors in<br />

all patients. In addition, 18 patients received glucocorticoids.<br />

Those who experienced myasthenic crisis were treated with<br />

intravenous immunoglobulin or plasmapheresis. Thynectomy<br />

was performed in ten patients: five of them have been<br />

in remission for 3–11 years, and four had severe symptoms<br />

and myasthenic crisis within 4 months–8 years after surgery.<br />

These results illustrate the clinical profile of juvenile<br />

myasthenia with predominantly ocular disorder and good<br />

response to treatment in the majority of cases.<br />

FP-I-037<br />

Immunoreactivities of GDNF and its receptors in<br />

various neuromuscular disorders<br />

N. Murakami a , R. Sakuta a , T. Murai a , T. Nagai a , I. Nonaka b<br />

a Dokkyo <strong>University</strong> School of Medicine, Koshigaya Hospital,<br />

Koshigaya;<br />

b National Center of Neurology and<br />

Psychiatry, Kodaira, Japan<br />

Objective: Glial cell-line derived neurotrophic factor<br />

(GDNF) belongs to multifunctional cytokines and is a<br />

member of motor neuron survival factors. It has been<br />

reported that it is expressed in diseased muscles including<br />

amyotrophic lateral sclerosis (ALS) and DMD. However, its<br />

function in muscle remains unknown. To clarify how GDNF<br />

functions in muscle, we investigated immunoreactivities of<br />

GDNF and its receptors, GDNF receptor alfa-1 (GFR alfa-1)<br />

and receptor re-arranged during transfection (Ret) in various<br />

neuromuscular disorders. Methods: We examined muscle<br />

biopsies from ten patients with, five with Werdnig-Hoffmann<br />

disease (WHD), five with ALS, five with myotonic dystrophy,<br />

five with myotubular myopathy (MM) and five normal<br />

controls. We stained these frozen sections with anti-GDNF,<br />

GFR alfa-1 and Ret antibodies. Results: GDNF-positive<br />

immunoreactivity was observed on subsarcolemma or sarcolemma<br />

of atrophic fibers in WHD and ALS. On the other<br />

hand, GDNF-positive reactivity was found in cytoplasm of<br />

regenerating fibers in DMD. GFR alfa-1 and Ret-positive<br />

immunoreactivities were observed in regenerating fibers<br />

but not in atrophic ones. Conclusion: (1) GDNF may be<br />

expressed in atrophic fibers as a target-derived trophic factor,<br />

resulting in inducing reinnervation in motor neuron diseases.<br />

(2) GDNF could be related with the process of muscle regeneration<br />

because GDNF-Ret system is described to be<br />

concerned with cell signaling of cell proliferation.<br />

FP-I-038<br />

Autonomic function in spinal muscular atrophy<br />

H. Arai a , Y. Tanabe b , Y. Kohno c<br />

a Department of Pediatrics, National Chiba Hospital;<br />

b Department of Neurology, Chiba Children’s Hospital;<br />

and c Department of Pediatrics, Graduate School of Medicine,<br />

Chiba <strong>University</strong>, Chiba, Japan<br />

Purpose: SMA is a degeneration disease of the anterior<br />

horn cells of the spinal cord, classified into three types based


Abstracts 551<br />

on the age of onset. Scoliosis, joint contracture, pneumonia<br />

and metabolic acidosis have been known as complications<br />

of the disease. However, to our knowledge, there is no<br />

extensive study regarding autonomic function in SMA.<br />

The purpose of this study is to investigate autonomic function<br />

for improving care in SMA. Patients and methods: Six<br />

patients (three males and three females) with SMA aged 2–<br />

24 years old (three in type 1, two in type 2, one in type 3)<br />

and nine healthy age-matched controls were studied by<br />

sympathetic skin response (SSR), hunting reaction, heart<br />

rate variability (RRIV) and oral glucose tolerance test<br />

(OGTT). SSR was performed by electrical and auditory<br />

stimulation, and recorded from the both palm. Hunting reaction<br />

was performed that right index finger into iced water<br />

examined skin temperature. RRIV at rest was examined.<br />

OGTT was checked blood pressure and pulse rate for 2 h<br />

after oral glucose intake. Results: In two patients the difference<br />

of SSR amplitude between right and left palm was<br />

higher than in controls. RRIV in a patient was higher than<br />

in controls. One/6 case had hypotension after glucose intake<br />

with OGTT. Three/6 cases were abnormal in hunting reaction.<br />

Conclusion: It was suggested that there was autonomic<br />

dysfunction in some patients. Careful repeated evaluation of<br />

the autonomic function should be required in SMA.<br />

FP-I-039<br />

Schwartz-Jampel syndrome: clinical documentation of<br />

six families<br />

H. Özyürek a , S. Nicole b , E. Demir a , B. Fontaine b ,H.<br />

Topaloǧlu a<br />

a Hacettepe <strong>University</strong> Faculty of Medicine, Department of<br />

Pediatric Neurology, Ankara, Turkey; b INSERM U546,<br />

Faculte de Medecine, Pitie-Salpetriere, France<br />

Schwartz-Jampel syndrome (SJS; chondrodystrophic<br />

myotonia) is a rare autosomal recessive disorder characterized<br />

by atypical facies with blepharospasm, dwarfism, bone<br />

and joint abnormalities, and myotonia with an EMG<br />

pattern of continuous muscle fibre activity. According to<br />

the age of onset, two different types are distinguished.<br />

Type 1 (SJS1) is the most frequent form, and usually<br />

accompanied with moderate bone dysplasia. Type 2<br />

(SJS2) is more severe, and manifested by severe skeletal<br />

abnormalities and feeding difficulties. Several other<br />

features, such as mental retardation or immunodeficiency,<br />

have been sporadically associated with SJS. A positional<br />

cloning approach allowed identifying the gene responsible<br />

for SJS1. The SJS1 locus was localized on chromosome<br />

1p34–p36.1 and was found to be genetically homogeneous.<br />

Thereafter, some of us demonstrated that loss of function<br />

mutations in the gene encoding perlecan were responsible<br />

for SJS1. Perlecan is the major heparan sulfate proteoglycan<br />

of basement membrane. Recent data suggest that perlecan<br />

is necessary for the clustering of acetylcholinesterase<br />

at neuromuscular junction, suggesting that the SJS1 myotonia<br />

results from a deficiency in acetylcholinesterase. By<br />

contrast, there is no linkage between SJS2 and the SJS1<br />

locus, and the genetic basis of SJS2 is still unknown. We<br />

present seven patients diagnosed with SJS1 from six unrelated<br />

families. Our follow-up period is 5–15 years. Consanguinity<br />

was present in all. First complaints were noticed<br />

between 1 and 2 years of age in all of our cases. The main<br />

clinical findings in our series included characteristic<br />

appearance of facies; blepharospasm, ptosis, and orospasm,<br />

shortness in stature, contactures of joints, and severe<br />

myotonia. The mental status of the children was normal.<br />

EMGs consistently revealed continuous myotonic activity<br />

without any cessation in sleep. There were bone changes in<br />

the plain films (especially acetabular dysplasia). In one<br />

case coxa valga and in the other coxa vara deformity had<br />

been corrected by surgery. We used carbamazepine as an<br />

antimyotonic agent, and a mild relief was observed in the<br />

myotonic component. Genetic linkage analysis showed that<br />

all our patients were linked to the original SJS1 locus.<br />

Subsequently, mutations were detected in two of the<br />

families. The results of the others are pending. In conclusion,<br />

we analysed the natural history, clinical, radiological<br />

and genetic aspects in seven children with SJS. As far as<br />

we know this is one of the largest series reported.<br />

FP-I-040<br />

Critical illness myopathy associated with prolonged<br />

neuromuscular blockade in a 22-month-old female<br />

P. Drigo a , L. Rigon a , A.M. Laverda a , E. Pegoraro b<br />

b Department of Paediatrics and a Department of Neurological<br />

and Psychiatric Sciences, <strong>University</strong> of Padua, Padua,<br />

Italy<br />

Clinical conditions characterized by quadriplegia developing<br />

after prolonged stays in the Intensive Care Unit (ICU)<br />

are reported with increasing frequency in pediatric age as<br />

well as in adults. Their etiology may be neurogenic,<br />

myogenic or correlated with neuromuscular transmission<br />

blockade; forms with a combination of these factors have<br />

also been described. We report on a 22-month-old girl<br />

hospitalized at the ICU for sepsis and respiratory deficiency,<br />

with no prior neuromuscular pathologies, intubated for 14<br />

days and treated with high-dose methylprednisolone,<br />

pancuronium for 48 h and vecuronium for 8 days. On<br />

suspending the curarization, the child revealed quadriplegia<br />

with positive deep tendon reflexes. Serum creatine kinase<br />

levels were normal; the electromyogram showed signs of<br />

myogenic damage. Testing with neostigmine showed a valid<br />

return to spontaneous mobility of the four limbs. Muscle<br />

biopsy 18 days after extubation revealed modest, non-specific<br />

signs of myopathy, with a prevalence of type I fibers and<br />

no alteration of the myofibrillary structure or selective loss<br />

of the thick myosin filaments. A progressive improvement<br />

was observed, with complete resolution of the weakness<br />

within 7 weeks of extubation. We conclude that the patient’s


552<br />

Abstracts<br />

quadriplegia was due to a myopathic component (critical<br />

illness myopathy) overlapping the pharmacologicallyinduced<br />

neuromuscular transmission blockade, exacerbated<br />

by the use of corticosteroids and the concomitant renal deficiency<br />

and plasma acidosis. This blockade lasted longer,<br />

however, than is usually reported in the literature.<br />

FP-I-041<br />

Role of genetic analysis in definition of nosological<br />

diagnosis in pathology of peripheral motoneuron in<br />

pediatric patients<br />

L.G. Khachatrian, V.M. Studenikin<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

Background: Clinical features of spinal cord anterior horn<br />

cell lesions Include palsy, hypotonia, reduced or absent<br />

reflexes, muscular weakness and delay in motor milestones.<br />

Aim: To determine the role of molecular genetic analyses in<br />

nosological diagnostics of neuron pathology. Methods: Case<br />

histories of 28 pediatric patients (aged 3–18 months) with<br />

clinical Signs of spinal cord anterior horn lesions were<br />

analysed. Diagnostic algorithm included electroneuromyography<br />

(ENMG), CT and MRT scan of brain, molecular<br />

genetic analysis. Results: All patients were divided into<br />

two groups. There were 19 patients with SMA: 13 cases<br />

with type 1 SMA (Werdnig-Hoffman disease), six cases<br />

with intermediate type 2 (Fried-Emery disease). Group 2<br />

consisted of nine patients with myelodysplasia. All patients<br />

had the same clinical features and similar ENMG pattern, as<br />

well (poor interference pattern, fibrillation potentials, F-<br />

wave fall-out, and reduced M-reply amplitude). Twentyfour<br />

percent of Group 2 patients had ventriculomegaly<br />

according to MRT scan results. Typical deletion in chromosome<br />

5 (locus 11.2–13.3 in survival motor neuron) were<br />

revealed by molecular genetic method. Besides, in six most<br />

acute cases with type 1 SMA defect of neuronal apoptosis<br />

inhibitory protein was detected. Conclusion: Molecular<br />

genetic analysis is indicated as necessary investigational<br />

method in pathology of motoneuron. This technique allows<br />

to establish the diagnosis reliably and also to determine the<br />

prognosis and the extent of required treatment.<br />

FP-J<br />

Neuro-Oncology<br />

FP-J-001<br />

A rare case of primary diffuse leptomeningeal<br />

gliomatosis in a child: presentation, imaging, and results<br />

of temozolomide therapy<br />

L. Dom a , E. Duval b , D. De Surgeloose c , I. Neetens d ,E.<br />

Michiels b , P.P. De Deyn a<br />

Departments of a Neurology and Child Neurology, b Paediatrics,<br />

c Neuroradiology and d Pathology, Algemeen Ziekenhuis<br />

Middelheim and Koningin Paola Kinderziekenhuis,<br />

Antwerp, Belgium<br />

We report the case of a 12-year old girl with diffuse leptomeningeal<br />

gliomatosis. One year prior to admission she was<br />

diagnosed elsewhere with communicating hydrocephalus<br />

treated by ventriculo-peritoneal shunting. In the course of<br />

the next year school results deteriorated and she presented<br />

multiple episodes of headache, confusion and infantile behaviour<br />

once associated with convulsions. She was admitted to<br />

our hospital due to another of these episodes. Except for her<br />

behaviour her neurological examination was normal. Urgent<br />

CT scan of the brain showed stabilised hydrocephalus.<br />

Cranial MRI showed multiple nodular hyper intensities on<br />

the cerebellar and cerebral surface with minimal meningeal<br />

contrast enhancement. Spinal MRI disclosed leptomeningeal<br />

thickening and gadolinium enhancement from C1 to the<br />

cauda. In addition there was a non-enhancing hypointense<br />

lesion at C7. Analysis of CSF disclosed mononuclear pleocytosis<br />

(13/mm 3 ), raised protein value (447 mg/dl), normal<br />

glucose concentration and no oligoclonal bands. Cultures<br />

and serological tests were negative. Biopsy of the cerebellar<br />

arachnoidea and surface showed a grade 2 mixed astrocytic<br />

and oligodendrocytic leptomeningeal gliomatosis compatible<br />

with a diagnosis of diffuse leptomeningeal gliomatosis.<br />

Diffuse leptomeningeal gliomatosis (DLG) is a rare condition<br />

characterized by diffuse infiltration of the leptomeninges<br />

by glioma. In primary DLG, there is no parenchymal tumour<br />

of the brain or spinal cord. It is considered to arise from<br />

heterotopic glial cells. About 25 cases have been reported<br />

so far. It has to be differentiated from diffuse leptomeningeal<br />

seeding from a parenchymal tumour. This may require postmortem<br />

examination. In our case we considered the possibility<br />

of a primary intraparenchymal spinal tumour at C7.<br />

However the lesion is non-enhancing on spinal MRI which<br />

is a strong argument against an intramedullary neoplasm.<br />

Neuroimaging features in this case are furthermore remarkable<br />

for the absence of intracranial gadolinium enhancement<br />

and the nodular lesions on the cerebellar surface. These characteristics<br />

have only been described once by S. Kastenbauer<br />

et al. Therapy was initiated with vincristine and carboplatin.<br />

Despite this, her condition deteriorated and repeat cranial and<br />

spinal MRI disclosed progression of the disease. Her therapy<br />

was switched to temozolomide in November 2001. Results of<br />

this therapeutic follow-up will be presented. To my knowledge<br />

it is the first case of primary diffuse leptomeningeal<br />

gliomatosis in childhood treated with temozolomide.<br />

FP-J-002<br />

EEG in diagnosing childhood brain tumor – do we still<br />

need it?<br />

I. Prpić, E. Paučić-Kirinčić, A. Sasso<br />

<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia


Abstracts 553<br />

EEG as a technique is simple, painless and can be easily<br />

repeated, but it is not conclusive in diagnosing brain tumor.<br />

With brain CT and/or MR, there is no doubt; the diagnosis<br />

of brain tumor is conclusive. But, these relatively advanced<br />

neuroimaging techniques are still not widely accessible for<br />

every patient. In order to estimate role of EEG in diagnosing<br />

childhood brain tumor we retrospectively analyzed<br />

EEG findings of 39 children with brain tumor, treated at<br />

the Department of Pediatrics ‘Kantrida’ of <strong>University</strong><br />

Hospital Center Rijeka. Group consisted of 18 boys and<br />

21 girls; medium age was 6.8 years. Brain tumor was<br />

confirmed by CT or MR. In 22 children tumor was located<br />

infratentorial and in 17 children supratentorial. The average<br />

days from the first symptoms to final diagnosis were 73<br />

for infratentorial tumors and 32 days for supratentorial<br />

tumors. EEG, performed immediately after admission,<br />

was pathological (delta focus/spikes/spike-wave) in 18<br />

children (46.1%), non-specific (diffusely dysrhythmic) in<br />

15 children (38.6%), and normal in six children (15.3%).<br />

Normal EEG was found only in children with infratentorial<br />

located tumor. Pathological EEG was found in all children<br />

with supratentorial tumor location except two. Almost all<br />

children (13 from 15) with non-specific EEG had infratentorial<br />

tumor. Our results lead to a conclusion that EEG is<br />

suitable for the assessment of ‘tumor suspects’. If there is a<br />

doubt in the mind of the clinician, and CT or MR are not<br />

quite accessible, follow-ups EEGs on regular monthly<br />

intervals can assist in timing appropriate further neuroimaging<br />

procedures. The EEG usually might show an increasing<br />

abnormality as the pathological process advances and<br />

still has a role in diagnosing childhood brain tumor.<br />

FP-J-003<br />

A case of spinocerebellar degeneration as a late<br />

manifestation after Langerhans cell histiocytosis<br />

Y. Nakamura a , M. Ito a , M. Miyao a , K. Nihei a ,Y.<br />

Tsunematu b<br />

Departments of<br />

a Neurology and b Hematology/Oncology,<br />

National Center for Child Health and Development, Japan<br />

Central nervous system complications associated with<br />

neoplasm are well known; paraneoplastic syndrome with<br />

cerebellar degeneration and encephalomyeloneuritis caused<br />

by autoantibodies to neural tissue, as have been described in<br />

neuroblastoma and other malignancies. Langerhans cell<br />

histiocytosis (LCH) is the cryptogenic disease characterized<br />

by proliferation of the monoclonal histiocyte which is the<br />

same as the Langerhans cell in the epidermis. Diabetes insipidus<br />

and anterior pituitary dysfunction are familiar CNS<br />

complications because of proliferation and invasion of<br />

LCH into the CNS. We report a case of spinocerebellar<br />

degeneration as a late manifestation after LCH. In this<br />

case, there was no family history of spinocerebellar degeneration.<br />

Routine laboratory tests and cerebrospinal fluid were<br />

normal. Neuroimaging studies included brain CT, MRI and<br />

SPECT. Brain CT and MRI showed a global cerebellar atrophy<br />

but no evidence of direct invasion into the CNS. He<br />

received treatment with thyrotropin-releasing hormone<br />

(TRH) (2 mg/day, 14 days), g-globulin (400 mg/kg per<br />

day, 5 days) and high dose corticosteroid. Treatment with<br />

TRH was effective but g-globulin and corticosteroid were<br />

not effective. Recently, there are some reports of spinocerebellar<br />

degeneration affected with LCH and we attempt to<br />

hypothesize about the occurrence mechanisms and the treatment.<br />

FP-J-004<br />

Intracranial tumours in infants<br />

H.K. Young, H.M. Johnston<br />

Department of Neurology, Sydney Children’s Hospital,<br />

Randwick, Sydney, Australia<br />

Prognosis in infants with brain tumours has historically<br />

been very poor. This study reviews 16 infants under the<br />

age of 12 months with brain tumours, presenting to our<br />

institution between 1988 and 1999. The aim was to<br />

describe the clinical presentation, diagnosis and management<br />

of these patients, and to establish if newer diagnostic<br />

and treatment modalities have improved prognosis in terms<br />

of survival and neurocognitive outcome. Methods: Charts<br />

were reviewed retrospectively for age at diagnosis, time to<br />

diagnosis, presenting features, location, histology, surgical<br />

and adjuvant treatment, survival and neurocognitive<br />

outcome. Results: Survival has improved. Three quarters<br />

of the patients remain alive. Five year survival is 81%.<br />

Five year progression free survival was 51% with a median<br />

follow up time of 70 months. Five year survival for benign<br />

tumours was 100%. None of those with malignant tumours<br />

survived. Morbidity remains high. Eight/13 of survivors<br />

had focal neurological deficits, 7/13 had epilepsy. Seven/<br />

12 had significant cognitive disability. Conclusions: Future<br />

treatment protocols should include formal analysis of<br />

neurocognitive morbidity, functional outcome and quality<br />

of life measures to provide accurate prognostic information<br />

and to prepare families for early interventional programs.<br />

FP-J-005<br />

A clinical study on intracranial relapsing germinomas<br />

by combined chemotherapy<br />

G. Jia, S.-Q. Luo<br />

Department of Neurosurgery, Beijing Tiantan Hospital,<br />

Beijing, China<br />

Objective: To study the clinical effects of intracranial<br />

relapsing germinomas by combined chemotherapy. Methods:<br />

From August 1993 to December 2000, we conducted<br />

combined chemotherapy to ten patients with intracranial<br />

relapsing germinomas. Pathological examination of the<br />

specimens resected during operation was made in seven


554<br />

Abstracts<br />

out of ten patients. The diagnosis of the others was<br />

confirmed by the result of radiotherapy and examination<br />

of HCG in blood. Metastasis of intracranial relapsing germinomas<br />

was found in seven patients. The drugs we used are<br />

vincristine (VCR), methotrexate (MTX), Pinyangmycin and<br />

pervasive developmental disorder (PDD). Four days are<br />

considered as one course of treatment. A repeat course<br />

was taken after 4 weeks. CT and/or MRI are repeated 1<br />

month after the second course. Local radiotherapy (2500–<br />

3500 Gy) was taken with low or middle dosage 1–2 month<br />

after chemotherapy. Results: All patient were followed up<br />

for 1.5–7 years. They have resumed normal life or back to<br />

school. Conclusion: The authors suggest that combined<br />

chemotherapy should be conducted first once the diagnosis<br />

of intracranial relapsing germinomas has been confirmed.<br />

Local radiotherapy with low or middle dosage was<br />

followed. Thus, it could eliminate the tumors and avoid<br />

affecting the development of the children caused by large<br />

dosage of whole brain and spinal axis irradiation<br />

FP-J-006<br />

Clinical significance of cerebrospinal fluid b2-<br />

microglobulin in central nervous system leukaemia<br />

R.-X. Zhang<br />

Department of Pediatrics, Central Hospital of Yichang, Hu<br />

Bei, China<br />

Objective: To investigate the clinical significance of CSF<br />

b2-microglobulin in the patients with central nervous<br />

system leukemia (CNSL). Methods: We investigated 45<br />

leukemia patients, including 31 patients without CNSL, 14<br />

patients with CNSL. Thirty-one patients without CNS<br />

disease and leukemia were taken as the controls. CSF b2-<br />

microglobulin was detected with RIA. Results: b2-Microglobulin<br />

levels in patients with CNSL (2.63 ^ 0.38 mg/l)<br />

were significantly higher than either those without CNSL<br />

leukemia (1.32 ^ 0.47 mg/l) or controls (1.32 ^ 0.13 mg/l)<br />

(P , 0:01). There was no difference between CSF b2-<br />

microglobulin levels in the patients without CNSL and<br />

those in controls. Conclusion: b2-microglobulin can be<br />

considered as an important index for diagnosis of CNSL.<br />

FP-J-007<br />

Primary non-Hodgkin lymphoma of the vertebral body<br />

with spinal epidural invasion – case report<br />

D. Plesca a , D. Dragomir a , D. Teleanu b , G. Iacob b<br />

Department of Pediatric Neurology, ‘Dr. Victor Gomoiu’<br />

Children’s Hospital; and b Department of Neurosurgery,<br />

<strong>University</strong> Hospital, Bucharest, Romania<br />

A rare case of primary non-Hodgkin lymphoma of the T6<br />

vertebral body with spinal epidural invasion is reported.<br />

Primary non-Hodgkin lymphoma is a rare malignant hematological<br />

tumor. The tumor produced predominantly osteolytic<br />

lesions, usually in the femur and pelvic bones, and very<br />

occasionally presents with vertebral and spinal epidural<br />

involvement. The case now reported was a 12-year-old<br />

boy with primary non-Hodgkin lymphoma involving the<br />

T6 vertebral body and with epidural invasion, who underwent<br />

surgical treatment (laminectomy T6, T7 resection of<br />

the epidural mass), radiotherapy and chemotherapy. The<br />

patient was in complete remission at the follow-up (1 year<br />

after diagnosis). Surgical treatment is only palliative, but<br />

has several goals, e.g. obtaining a biopsy or improving the<br />

neurological symptoms through decompression. Because of<br />

its aggressive behavior, this type of lymphoma should be<br />

treated by combined modality approach (surgery,<br />

chemotherapy and radiotherapy).<br />

FP-J-008<br />

Analysis of clinical and histological characters of 33<br />

cases brain tumours in children<br />

T.N. Minh, N.T. Ung<br />

Neurology Department, National Institute Pediatrics,<br />

Hanoi, VietNam<br />

Objective: Study of 33 children with brain tumours from<br />

January 1998 to December 2001 at National Institute Pediatrics.<br />

Methods: Diagnoses were based on clinical findings of<br />

focal neurological signs and computer tomography. Results:<br />

There were 52% boys, 48% girls. Patients (39%) aged from<br />

3 to 5 years, 27% from 6 to 10 years, 34% from 11 to 15<br />

years. The clinical findings were headache in 70% patients,<br />

vomiting 36%, ataxia 18%, hemiplegia 9%; 24/28 patients<br />

had papilloedema, 4/28 normal optic disk. Histological findings:<br />

astrocytomas comprised 15%, medulloblastomas 48%,<br />

choroid plexus papillomas 6%, oligodendrogliomas 6%,<br />

teratomas 3%, and primitive neuroectodermal tumours<br />

12%. Craniotomy was performed in 33 patients with radical<br />

resection. The results of treatment showed high mortality<br />

and morbidity rates.<br />

FP-J-009<br />

The changes of sICAM-1 and soluble L-selectin in blood<br />

of children with acute lymphoblastic leukemia (ALL)<br />

during high-dose methotrexate (HD-MTX)<br />

chemotherapy<br />

W.-Q. Geng, F.-H. Guan, Y. Hu, K. Tan<br />

Shenya ng Women and Children’s Medical Health Care<br />

Center, Shenyang, China<br />

Objective: To study the mechanism that high-dose methotrexate<br />

(HD-MTX) therapy prevents and treats CNSL.<br />

Method: The serum intercellular adhesion molecule-1<br />

(sICAM-1) and soluble L-selectin (sL-selectin) levels<br />

were measured 1 h before and 24, 28, 32, 44, and 68 h<br />

after the HD-MTX therapy by dual-antibody sandwich<br />

ELISA in 30 children with ALL. The blood MTX levels


Abstracts 555<br />

were monitored 24, 28, 32, 44, and 68 h after HDMTX<br />

therapy in 12 of these cases. Results: There was no difference<br />

between the serum sICAM-1 and sL-selectin levels at<br />

24 h after HDMTX chemotherapy and those before the<br />

HDMTX treatment (P . 0:05). After chemotherapy, the<br />

serum sICAM-1 and sL-selectin levels decreased gradually.<br />

The levels at 28 and 32 h after chemotherapy were significantly<br />

decreased compared with that before chemotherapy<br />

(P , 0:05), so did the levels at 44 and 68 h after chemotherapy<br />

(P , 0:01). Conclusion: The decrease of the serum<br />

sICAM-1 and sL-selectin levels could be another major<br />

mechanism that HDMTX prevented and treated CNSL.<br />

FP-J-010<br />

High level of soluble L-selectin and prealbumin in the<br />

cerebrospinal fluid of children with central nervous<br />

system leukemia (CNSL)<br />

W.-Q. Geng, F.-H. Guan, Z.-Y. Li<br />

Shenyang Women and Children’s Medical Health Care<br />

Center, Shenyang, China<br />

Objective: To observe the changes of the levels of sLselectin<br />

and prealbumin (PA) in CSF of children with<br />

CNSL. Method: The levels of sL-selectin and PA were<br />

determined in the CSF samples of 28 ALL children with<br />

CNSL. CSF samples were obtained from 24 patients at 4–12<br />

weeks before the diagnosis of CNSL, and from 20 of these<br />

patients after treatment of CNSL. In addition, the levels of<br />

sL-selectin and PA were also assayed in 18 ALL children<br />

with complete remission at least a year. There were 12<br />

children without malignant or meningeal disorders selected<br />

as controls. Results: There was no significant difference in<br />

CSF sL-selectin levels between the children with ALL without<br />

evidence of CNSL and the controls. However, the CSF<br />

levels of sL-selectin and PA in patients with CNSL were<br />

significantly higher than those in controls at the time CNSL<br />

diagnosed and 4–12 weeks before the diagnosis of CNSL.<br />

After treatment and disappearance of the lymphoblasts in<br />

CSF, the levels of sL-selectin and PA were decreased in the<br />

majority of children who had CNSL. The levels of sL-selectin<br />

in CSF remained high in six patients after the disappearance<br />

of lymphoblasts in CSF, four of them recurred CNSL<br />

within 12 weeks. Conclusions: Detection of sL-selectin and<br />

PA in CSF may be helpful for the diagnosis of CNSL. The<br />

levels of sL-selectin in CSF may be used as a predictor of<br />

CNSL in children with acute leukemia.<br />

FP-J-011<br />

The clinical profile of pediatric leukemic patients with<br />

neurologic complications in a tertiary hospital: a 5-year<br />

retrospective study<br />

D.M. Dionson-Gigataras<br />

Philippine Children’s Medical Center, Quezon City, Philippines<br />

The leukemias are the most common form of childhood<br />

cancer. Due to advances in treatment and prolonged survival,<br />

an increased incidence of leukemic neurologic complications<br />

has been observed. Objectives: This study was<br />

undertaken to document the spectrum of problems that<br />

prompt neurologic referral in leukemic patients, to determine<br />

the diagnosis associated with the common presenting<br />

neurological symptoms, and to describe the population of<br />

leukemic children who developed such problems. Methodology:<br />

This paper reviewed the clinical profile of 48 leukemic<br />

patients referred to the Neurology service of a pediatric<br />

tertiary hospital from June 1996 to June 2001. Results: The<br />

population was composed of 26 males and 22 females. Forty<br />

percent of the study population belonged to the 4–6 year old<br />

age group. Majority (91.7%) had ALL. The average time<br />

interval from diagnosis of leukemia to the time of developing<br />

neurologic symptoms was 24 months. The most<br />

common symptoms that prompted referral to the neurology<br />

service were headache (39.6%), altered mental status,<br />

seizures and lower extremity weakness. Of the 19 patients<br />

who presented with headache, 14 were diagnosed to have<br />

CNS leukemia while three patients had intracranial hemorrhage.<br />

For those with altered mental status 42.8% had intracranial<br />

hemorrhage, 28.57% had infarction and 28.57% had<br />

CNS leukemia. Among those with seizures, 46.15% had<br />

intracranial hemorrhage, and 10% had CNS leukemia. Of<br />

the 13 patients with lower extremity weakness, 53.84% had<br />

radiculitis and 15.4% had GBS. Mortality in this study<br />

population was 26.22%, majority of which was secondary<br />

to intracerebral hemorrhage (16.4%).<br />

FP-J-012<br />

Epilepsia partialis continua associated with widespread<br />

gliomatosis cerebri<br />

E. Shahar a , U. Kramer b , D. Nass c , D. Savitzki a<br />

a Child Neurology Unit and Epilepsy Service, Rambam<br />

Medical Center, Haifa, b Epilepsy Service, Dana Children<br />

Hospital, Tel-Aviv, c Department of Pathology, Sheba Medical<br />

Center, Tel-Hashomer, Israel<br />

We present herein an uncommon association of intractable<br />

epilepsia partialis continua which was the main presentation<br />

of widespread gliomatosis cerebri in two girls. Both<br />

children had a preceding prolonged secondary generalized<br />

seizure 2–4 months prior to the evolution of epilepsia partialis<br />

continua (EPC). Patient 1 had a 6 month period of up to<br />

80–100 daily clusters of left-sided twitching but remained<br />

fully alert, accompanied with increasing left-sided pyramidal<br />

weakness and sensory impairment. Surface and video-<br />

EEG demonstrated prolonged right fronto-central epileptic<br />

spike/wave discharges, corroborating with the left focal<br />

myoclonic jerks. MRI demonstrated a wide demarcated<br />

area of increasing signals over the right fronto-central<br />

regions, with diffuse cortical-subcortical infiltration,<br />

impinging on the left hemisphere. Patient 2 had recurrent


556<br />

Abstracts<br />

focal sensory seizures followed by focal motor events, along<br />

with progressive hemiparesis, but remained alert, along with<br />

focal epileptic activity. A streotactic brain biopsy in both<br />

revealed gliomatosis cerebri (GC): diffuse widespread infiltration<br />

of glioma cells with no constitution of a circumscribed<br />

tumor mass. The first child is surviving after 2<br />

years on combined treatment, the second perished.<br />

Although very rare, GC should be taken into account in<br />

the differential diagnosis of EPC, of which Rassmussen’s<br />

encephalitis and focal cortical dysplasia are more common<br />

etiologies in children, in order to facilitate a rapid diagnosis<br />

and prompt current combined effective therapy for GC.<br />

FP-J-013<br />

Giant cell tumor in a child: Unusual location, rare<br />

presentation but favorable outcome<br />

H. Bibas-Bonet, R. Fauze, G. Lavado, R. Páez, J. Nieman<br />

Hospital del Niño Jesús, San Miguel de Tucumán, Argentina<br />

An 8-year-old female presented with a 3-month gradually<br />

worsening right (R) otalgia, tinnitus, hearing loss, R facial<br />

numbness, and diplopia. She was admitted with a 2-week<br />

swallowing difficulties, voice change, and R shoulder pain.<br />

Neurological examination revealed R abducens paralysis, R<br />

facial palsy, R sensorineural deafness, R trigeminal hyperesthesia,<br />

R shoulder weakness, right-sided tongue fasciculation,<br />

and normal motor-sensory functions of limbs. Skull X-<br />

ray revealed lytic lesions in R temporal petrous portion. CT<br />

scan showed a destructive mass involving R greater wing of<br />

sphenoid bone and temporal petrous apex. MRI demonstrated<br />

a tumor arising from temporosphenoidal region,<br />

infiltrating neither the brain nor the brainstem. No hydrocephalus<br />

was seen. Biopsy revealed giant cell tumor osteoclastoma.<br />

Posterior treatment consisted of radiotherapy.<br />

Clinical improvement was noticed by second week. After<br />

8-year follow-up, patient is well but with functional sequelae.<br />

There was no MRI evidence of tumor growing. Giant<br />

cell tumor is a primary bone tumor affecting rarely the skull<br />

base. It is considered benign, but could show local aggressiveness.<br />

Progressive involvement of cranial nerves culminating<br />

in paralysis of all unilaterally, without sensory or<br />

motor long tract disturbance, no intracranial hypertension,<br />

and osteoclastic lesion in skull base on X-ray is described as<br />

Garcin syndrome. It is usually resulting from malignant<br />

tumor, sarcoma or nasopharynx fibrosarcoma invading<br />

skull base. To our knowledge, a giant cell tumor presenting<br />

as Garcin syndrome has not yet been reported.<br />

FP-J-014<br />

Gelastic seizures and hypothalamic hamartoma: do not<br />

forget the Pallister-Hall syndrome<br />

C. Arpino a,b , C. Galasso b , M. Marzio b , M. Verdecchia b ,P.<br />

Curatolo b<br />

a ‘E. Litta’ Rehabilitation Center for Developmental<br />

Disabilities; b Pediatric Neurology, Tor Vergata <strong>University</strong><br />

of Rome, Rome, Italy<br />

Gelastic seizures are often associated with hypothalamic<br />

hamartoma. A detailed evaluation, through MRI, in patients<br />

presenting gelastic seizures is recommended. In order to<br />

exclude an autosomal dominant disorder known as Pallister-Hall<br />

Syndrome (PHS), a thorough physical examination<br />

in the presence of gelastic seizures and hypothalamic hamartoma<br />

should be also recommended. We observed a 3-yearold<br />

boy and a 21-year-old girl presenting with mental retardation,<br />

behavioral disorders, and symptomatic localization<br />

related epilepsy characterized by gelastic, partial motor,<br />

autonomic seizures accompanied by staring and impaired<br />

responsiveness, and drop attacks. Interictal EEG showed<br />

bilateral and asynchronous sequences of slow spike and<br />

wave complex (2.5–3 Hz) on fronto-temporal regions with<br />

a secondary bilateral synchrony. MRI showed a non-enhancing,<br />

midline hypothalamic mass with a diameter of 2 cm.<br />

The girl had undergone surgery for central polysyndactyly<br />

and a callosotomy to control seizures. The clinical picture<br />

presented by these patients was suggestive of PHS, for which<br />

the described phenotypic features include hypothalamic<br />

hamartoma, central polydactyly, pituitary dysfunction and<br />

visceral malformations. Seizures are occasionally reported<br />

in PHS and are not currently included in the clinical spectrum<br />

of the syndrome. Whether gelastic seizures in PHS are underdiagnosed<br />

or their occasional occurrence is dependent on the<br />

topographic localization of the hypothalamic hamartoma, as<br />

suggested by a previous study, remains an open question. The<br />

association between gelastic seizures, hypothalamic hamartoma<br />

and malformations suggestive of PHS needs to be carefully<br />

investigated in order to better define the clinical<br />

spectrum of PHS and to plan genetic counseling in apparently<br />

unaffected relatives.<br />

FP-J-015<br />

Spontaneous recovery of medulloblastoma in a girl with<br />

Gorlin-Goltz syndrome<br />

C.-W. Su a , K.-L. Lin a , J.-W. Hou b , S.-M. Jung c , E.-C. Zen d<br />

a Division of Pediatric Neurology; b Division of Pediatric<br />

Genetics; Department of Pediatrics, Chang Gung Children’s<br />

Hospital; c Department of Pathology; d Division of<br />

Oral Surgery, Department of Dentistry, Chang Gung<br />

Memorial Hospital, Taoyuan, Chinese Taipei<br />

The Gorlin-Goltz syndrome is characterized by nevoid<br />

basal cell carcinomas, odontogenic keratocysts of jaws,<br />

palmar and plantar pits, falx calcifications, and various<br />

cancer susceptibilities attributed to a mutation in a tumor<br />

suppressor gene. We presented an 11-year-old female with<br />

Gorlin-Goltz syndrome. Medulloblastoma was diagnosed<br />

when she was 4 years old. She received total excision of<br />

the tumor and adjuvant therapy of chemotherapy and radiotherapy.<br />

One year later, the tumor relapsed with CSF seeding.


Abstracts 557<br />

She recovered spontaneously without any treatment, and she<br />

did not develop basal cell carcinoma within 6 years followup.<br />

It suggests that patients with Gorlin-Goltz syndrome tend<br />

to have a better prognosis with regard to medulloblastoma,<br />

and to diagnose the syndrome as early as possible will make<br />

the management optimal.<br />

FP-K<br />

Genetics/Degenerative Diseases<br />

FP-K-001<br />

Cerebral dysgenesis associated with L1CAM mutations<br />

L. Sztriha, R.M.W. Hofstra, Y.J. Vos, J. Johansen<br />

Departments of Paediatrics and Radiology, FMHS, UAE<br />

<strong>University</strong>, United Arab Emirates; and Department of<br />

Medical Genetics, Faculty of Medical Sciences, <strong>University</strong><br />

of Groningen, The Netherlands<br />

L1 neuronal cell adhesion molecule belongs to the immunoglobulin<br />

superfamily. It plays a key role in axon outgrowth,<br />

guidance and pathfinding during development of the nervous<br />

system. The encoding gene, L1CAM is located near the telomereofthelongarmoftheXchromosome,intheXq28region.<br />

Mutations in the L1CAM gene are responsible for an X-linked<br />

recessive disorder with features of corpus callosum hypoplasia<br />

or agenesis, mental retardation, adducted thumbs, spastic<br />

paraplegia and hydrocephalus (CRASH syndrome). The clinical,<br />

MRI and molecular genetic findings of two boys with<br />

missense mutation in the L1CAM gene are presented. Patient<br />

1 had delayed development, mental retardation, adducted<br />

thumbs and spastic diplegia. Brain MRI revealed simplified<br />

pattern of gyri with reduced volume of gray and white matter,<br />

agenesis of the corpus callosum, dilated lateral ventricles and<br />

hypoplasia of the cerebellar vermis. Transition of a G<br />

(guanine) to T (thymine) was found at position 604<br />

(604G ! T) in the L1CAM gene. This mutation results in<br />

conversion of aspartic acid to tyrosine at position 202<br />

(D202Y) of the L1 protein. Patient 2 presented with congenital<br />

hydrocephalus. Three of his brothers with congenital<br />

hydrocephalus died after birth. The proband showed delayed<br />

development and mental retardation after shunt implantation.<br />

Adducted thumbs and severe spastic diplegia were observed.<br />

MRI revealed parietal-occipital hypoplasia with multiple<br />

small gyri (polymicrogyria), agenesis of the corpus callosum<br />

and fused thalami. Transition of a G (guanine) to C (cytosine)<br />

at position 1243 (1243G ! C) was found in the L1CAM gene,<br />

which led to conversion of alanine to proline at position 415<br />

(A415P) in the L1 protein.<br />

FP-K-002<br />

The Fahr disease in a family<br />

Q.-K. Huang, F.-J. Yang, J.-R. Wang<br />

Department of Pediatrics, Shanxian Central Hospital,<br />

Shanxian County, Shandong, China<br />

Fahr disease is a hereditary disease that rarely occurs in<br />

childhood characterized by calcium deposition in basal<br />

ganglia. It has been considered an autosomal dominant/<br />

recessive inheritance or chromosome disorder. We present<br />

the clinical features and the inheritance pattern of six cases<br />

of Fahr disease in a family. The proband was a 12 yeas old<br />

Chinese girl, normally delivered from unrelated parents.<br />

The initial onset of seizures occurred when she was 2<br />

months old. The head CT showed small local calcification<br />

in bilateral basal ganglia when she was 2 years old. Now she<br />

is 12 years old and still has recurrent seizures, learning<br />

disability and irritability, and CT scan shows diffuse<br />

calcium deposition in bilateral basal ganglia, chromosome<br />

analysis shows normal pattern. Proband’s sister developed<br />

seizures when she was 2 months old. The head CT have<br />

shown small local calcification in her bilateral basal ganglia<br />

when she was 10 months old. Now she is 10 years and 10<br />

months old and still have recurrent seizures, mental retardation,<br />

and CT scan showed diffuse calcium deposition in<br />

bilateral basal ganglia and hemicerebrum. Head CT scan<br />

of the prodand’s father, uncle, aunt and grandfather all<br />

have shown small local calcification in bilateral basal ganglia<br />

10 years ago, but no significant change now. They have<br />

no any clinical symptom and sign. Conclusion: (1) the mode<br />

of transmission of the Fahr disease in this family is autosomal<br />

dominant inheritance; (2) this pedigree shows a<br />

hereditary disease of early onset, and the earlier the onset,<br />

the faster the progression; and (3) the clinical features are<br />

heterogeneous and head CT is an important examination in<br />

the clinical diagnosis of Fahr disease.<br />

FP-K-003<br />

Angelman’s syndrome: Evaluation of clinical features,<br />

EEG and therapeutic approach<br />

J. Arcas, M. Cabrera, A. Martínez-Bermejo, D. López-<br />

Pajares, V. López-Martín<br />

Paediatric Neurology and Genetics, ‘La Paz’ <strong>University</strong><br />

Hospital, Madrid, Spain<br />

Angelman’s syndrome (AS) is a severe neurobehavioural<br />

disorder with a heterogeneous genetic aetiology. Epilepsy<br />

develops in 90% and it is intractable in about 50% in children.<br />

The aim of this study was to evaluate the early clinical<br />

and EEG finding in a group of patients with AS to determine<br />

whether there are any clinical or EEG features sufficiently<br />

distinctive to be of value in early diagnosis, as well as the<br />

best therapeutic approach. The charts of 13 patients with<br />

clinical/genetic diagnosis of AS were reviewed. All patients<br />

had been clinically, neurophysiologically (EEG data) and<br />

genetically investigated. There were five males and eight<br />

females, aged 13 month–19 years. Range age at diagnosis<br />

13 months–15 years. All patients had severe speech impairment<br />

and motor development was delayed in all patients but<br />

one. Seizures were reported in 11 out of 13 cases. The onset<br />

seizures age ranged 12 months–5 years. The most frequent


558<br />

Abstracts<br />

ictal patterns were atypical absences and myoclonic<br />

seizures. EEG studies showed characteristic AS EEG<br />

patterns in 12 out of 13 cases. The most effective antiepileptic<br />

drugs were Benzodiazepines and VPA regardless of<br />

seizure type. We conclude that motor and mental development<br />

delay with severe speech impairment, associated to<br />

characteristic EEG patterns, should help to identify patients<br />

with AS at an early age. Moreover, the effects of GABAergic<br />

drugs for epilepsy in AS may suggest that defective<br />

genes of the g-aminobutyrate-A receptor subunit, are implicated<br />

in the mechanism of epilepsy in this syndrome.<br />

FP-K-004<br />

A case report of mitochondrial myopathy<br />

S.-P. Ying, S.-J. Wang<br />

Department of Pediatrics, No. 3 Affiliated Hospital of<br />

Baotou Medical College, Qingshan District, Baotou, Inner<br />

Mongolia, China<br />

Mitochondrial myopathies are rare hereditary diseases in<br />

children. The prognosis in most cases is very poor. We<br />

report one case of carnitine deficiency syndrome, which is<br />

one type of mitochondrial myopathies. The patient was a 12<br />

year-old girl. The main clinical features were chronic<br />

progressive generalized weakness without muscle atrophy.<br />

The weakness got worse after exercise such as chewing and<br />

walking and improves following rest. The nervous system<br />

examination is normal, without muscle pain or symptoms of<br />

encephalopathy. The case had no positive family history.<br />

Laboratory investigations showed lactate level increased<br />

after exercise. EMG demonstrated a myopathy-type<br />

abnormality. Muscle biopsy showed that fat drops could<br />

be seen in many muscle fibers. After diagnosis, the case<br />

was treated with carnitine 0.5 g three times daily. The<br />

short-term curative effect is very good. After 2 weeks of<br />

treatment, the muscle strength returned to normal. Up to<br />

now, the case had been treated for one and a half years.<br />

The weakness did not appear again.<br />

FP-K-005<br />

Cytogenetic and molecular-cytogenetic studies of Rett<br />

syndrome (RTT): the investigation of 81 girls and four<br />

boys<br />

S.G. Vorsanova, Y.B. Yurov, V.Y. Ulas, I.A. Demidova,<br />

V.O. Sharonin, A.D. Kolotii, A.K. Beresheva, V.S. Kravets,<br />

I.V. Soloviev<br />

Institute of Pediatrics and Children Surgery, Russian Ministry<br />

of Health and National Research Center of Mental<br />

Health, Russian Academy of Medical Sciences, Moscow,<br />

Russia<br />

Rett syndrome (RTT) is a severe neurodevelopmental<br />

disorder with the incidence of 2.5% in mentally retarded<br />

girls in Russia. We have performed cytogenetic studies of<br />

85 patients (81 girls and four boys) with clinical picture of<br />

RTT. Collections of DNA samples and fixed cell suspensions<br />

of RTT patients and their parents were established for<br />

extended molecular studies. MeCP2 testing in randomly<br />

selected group of 30 RTT girls show that 84% of them<br />

have different mutations in the MeCP2 gene. Among 85<br />

patients: 81 girls with clinical picture of RTT had normal<br />

female karyotype, two boys had normal male karyotype in<br />

cells of blood (46, XY) and two boys had mosaic form of<br />

Klinefelter syndrome (47, XXY/46, XY) in blood and<br />

muscle cells. Eighty-one mothers and parents of RTT<br />

girls had normal karyotype, three mothers of RTT patients<br />

– with mosaic forms of Turner syndrome (45, X/46, XX)<br />

and of trisomy X (47, XXX/46, XX), one mother – mosaic<br />

karyotype (47, XX, 1mar/48, XXX, 1mar). We analyzed<br />

chromosome X staining after incorporation of BrdU in<br />

lymphocytes of 81 affected girls with clinical picture of<br />

RTT. Specific types of inactive chromosome X with<br />

unusual conformation of chromatin in long arm of the<br />

chromosome X were found in 93% of RTT girls. This<br />

cytogenetic technique was used for presymptomatic diagnosis<br />

of RTT in five girls in affected families. We believe<br />

that the phenomenon of altered chromatin conformation in<br />

the inactive chromosome X could be used as laboratory test<br />

for diagnosis of RTT. Supported by INTAS and COPER-<br />

NICUS grants.<br />

FP-K-006<br />

FISH analysis of DNA replication of chromosome X loci<br />

in Rett syndrome using interphase fluorescence in situ<br />

hybridization<br />

Y.B. Yurov, S.G. Vorsanova, A.D. Kolotii, I.Y. Iourov, P.<br />

Sheinson, V.V. Monachov<br />

Institute of Pediatrics and Children Surgery, Russian Ministry<br />

of Health and National Research Center of Mental<br />

Health, Russian Academy of Medical Sciences, Moscow,<br />

Russia<br />

RTT is a developmental disorder, affecting girls. It was<br />

shown recently that RTT is caused by mutations in the<br />

MeCP2 gene on chromosome Xq28, whose function is to<br />

silence other genes. In RTT patients the defective MECP2<br />

might fail to keep other genes ‘silent’. The targeting genes<br />

directly involved in the pathogenesis of RTT are still<br />

unknown. To identify the potential regions and loci with<br />

altered transcription and replication status in active and<br />

inactive chromosomes X at RTT we used molecular cytogenetic<br />

approaches. We used interphase FISH with DNA<br />

probes to determine the loci with altered replication pattern<br />

in X-chromosomes at RTT. Large-insertion PAC clones for<br />

Xptel and Xqtel, pseudoautosomal locus at Xq28 and<br />

centromeric alphoid DNA were used. PAC clones 671D9<br />

(MeCP2 gene) and 24.23.0 at telomeric region of the q-arm<br />

(Xq28) escape inactivation in inactive chromosome X only<br />

in some of the RTT patients. Therefore, this region could


Abstracts 559<br />

contain the gene(s), abnormally transcriptionally active in<br />

both chromosomes X. Our results indicate that interphase<br />

FISH analysis of DNA replication patterns allows detecting<br />

the targeting loci with altered order of replication and transcription<br />

in RTT patients. These results support the hypothesis<br />

that the disturbances in dosage compensation effect due<br />

to aberrant activation of genes in inactive chromosome X at<br />

RTT genes (bi-allelic expression instead of mono-allelic).<br />

Our results indicate that MeCP2 itself could escape X-inactivation<br />

and reduce the pathogenic effect of mutated allele at<br />

RTT. Supported in parts by INTAS and COPERNICUS<br />

grants.<br />

FP-K-007<br />

Differences in clinical picture of tuberous sclerosis<br />

complex in patients with TSC1 and TSC2 mutations<br />

S. Jóźwiak a , D. Domańska-Pakiel⁄a a , J. Kasprzyk-Obara a ,<br />

D.J. Kwiatkowski b , S. Dabora b<br />

a Department of Child Neurology, The Children’s Memorial<br />

Health Institute, Warsaw, Poland; b Division of Experimental<br />

Medicine and Medical Oncology, Brigham and Women’s<br />

Hospital, Boston MA, USA<br />

Tuberous sclerosis (TSC) is a relatively common neurocutaneous<br />

syndrome caused by mutations in either of two<br />

genes TSC1 and TSC2. We carried out a comprehensive<br />

mutational analysis in large group of patients treated in The<br />

Children’s Memorial Health Institute in Warsaw and correlated<br />

mutation findings with clinical features. Eighty-six<br />

patients were identified with mutations: 18 within TSC1<br />

gene and 68 within TSC2 gene. Age of patients ranged<br />

from 4 months to 51 years. Epilepsy was reported at an<br />

earlier age (median age 0.5 versus 1.83 years) and occurred<br />

more frequently (86.8 versus 55.6%) in TSC2 group. Incidence<br />

of infantile spasms was much higher in TSC2<br />

patients (64.4 versus 20%). In contrast, mental status of<br />

patients with TSC1 mutations was normal in 64.8% of<br />

those examined and only in 27.7% of patients with TSC2<br />

mutations. Despite of younger age of examined in TSC2<br />

group, skin lesions were more frequently reported in these<br />

patients. Only periungal fibromas were more common in<br />

TSC1 subjects. The incidence of calcified periventricular<br />

calcifications on brain CT was similar in both groups.<br />

There was a slight preponderance of TSC2 patients<br />

among those with subependymal giant cell astrocytoma<br />

(1/16 versus 7/64). Renal and liver angiomyolipomas and<br />

cardiac rhabdomyomas were more frequent in TSC2<br />

patients. None of examined TSC1 patients had retinal<br />

hamartomas or pulmonary lymphangiomatosis. The more<br />

severe clinical presentation of tuberous sclerosis in the<br />

TSC2 group demonstrates the need for more frequent<br />

inner organ screening in these patients than in those with<br />

TSC1 mutations.<br />

FP-K-008<br />

Initial manifestations and follow-up studies of optic<br />

pathway gliomas in children with neurofibromatosis<br />

type 1 (NF-1) and without NF-1<br />

S. Jóźzwiak a , E. Czyzyk b , J. Kasprzyk-Obara a<br />

a Department of Child Neurology, The Children’s Memorial<br />

Health Institute, Warsaw, Poland; b Provincial Hospital No.<br />

2, Rzeszów, Poland<br />

Optic pathway gliomas (OPGs) are frequent central<br />

nervous tumors in patients with neurofibromatosis type 1<br />

(NF-1). The main aim of our study was to compare initial<br />

clinical manifestations and natural history of OPGs associated<br />

with NF-1 from isolated OPGs. There have been 83<br />

children with OPGs identified retrospectively by a review<br />

of medical records: 51 children with N-1 and 32 children<br />

with isolated gliomas. There was a slight preponderance of<br />

female patients in NF-1 group (32/51 versus 19/51,<br />

P ¼ 0:013), while isolated OPGs occurred equally in<br />

boys and girls (16/32 versus 16/32). The median age of<br />

children was 4.6 years for OPGs with NF-1 and 4.8 years<br />

for isolated OPGs. OPGs commonly occurred at an early<br />

age in children with NF-1, but there were no significant<br />

differences. Decreased visual acuity at the time of diagnosis<br />

was more common in children without than with NF-1<br />

(18/19 versus 29/42, respectively, P , 0; 05), similar to<br />

ophthalmoscopic abnormalities (optic atrophy and oedema)<br />

(25/27 versus 30/49, respectively, P , 0:01). Children<br />

without NF-1 had more often proptosis and nystagmus<br />

(11/32 versus 10/51 and 7/32 versus 4/51, respectively).<br />

Multicentric location was more common in NF-1 (34/51,<br />

P ¼ 0:0001), whereas isolated chiasmal involvement<br />

occurred more often in those without NF-1 (15/32). Radiological<br />

signs of progression and deterioration of visual<br />

function at later follow-up were more commonly noted in<br />

children with isolated OPGs than with NF-1. The clinical<br />

presentation of OPGs at the time of diagnosis and during<br />

follow-up was more severe in children without than with<br />

NF-1.<br />

FP-K-009<br />

Three novel SURF1 mutations in Japanese patients with<br />

Leigh syndrome associated with cytochrome c oxidase<br />

deficiency<br />

E. Naito, Y. Ogawa, M. Ito, l. Yokota, T. Saijo, J. Matsuda,<br />

S. Kitamura, Y. Kuroda<br />

Department of Pediatrics, School of Medicine, <strong>University</strong> of<br />

Tokushima, Tokushima, Japan<br />

Leigh syndrome, a severe neurodegenerative disorder,<br />

commonly is associated with cytochrome c oxidase deficiency.<br />

Recent studies in Caucasian patients indicate that<br />

SURF1 gene mutations can cause Leigh syndrome associated<br />

with cytochrome c oxidase deficiency. When we


560<br />

Abstracts<br />

measured cytochrome c oxidase activity in cultured<br />

lymphoblastoid cells from Japanese patients with typical<br />

Leigh syndrome, six proved to have cytochrome c oxidase<br />

deficiency. Three novel mutations of the SURF1 gene were<br />

identified in three of these six patients with cytochrome c<br />

oxidase deficiency. We found one homozygous mutation in<br />

exon 5 of patient 1 (367AG del), and one heterozygous<br />

mutation in each of exon 7 (C640T) and exon 8 (802del<br />

26 bp insGG) of patient 2. We performed subcloning<br />

analysis of exons 7–8 in patient 2 and determined that<br />

each mutation was confined to one allele. Patient 3 showed<br />

the same mutation as patient 1 (367AG del). Parents of<br />

patients 1 and 3 are not consanguineous. Therefore, the<br />

367AG del mutation might have a high incidence in<br />

SURF1 mutations of Japanese patients with Leigh<br />

syndrome. All mutations predicted loss of function of the<br />

SURF1 protein: cytochrome c oxidase activity was<br />

decreased to less than 20% of the control mean in all of<br />

the patients. These results indicate that cultured lymphoblastoid<br />

cells are useful for elucidating the etiology of<br />

Leigh syndrome, and that loss of function of the SURF1<br />

gene product can be responsible for Leigh syndrome associated<br />

with severe cytochrome c oxidase deficiency in<br />

Japanese patients.<br />

FP-K-010<br />

Mutation analysis of phenylalanine hydroxylase gene in<br />

Northern Chinese<br />

F. Song, L.-X. Liu, Y.-L. Yang, Y.-W. Jin, H. Wang<br />

Capital Institute of Pediatrics, Beijing, China<br />

Objective: To detect the mutation of phenylalanine<br />

hydroxylase (PAH) gene in Northern Chinese. Methods:<br />

By using PCR/SSCP and DNA sequencing, we studied the<br />

mutation in exons 3, 5, 7, 10, 11 and 12 of PAH gene. A total<br />

of 108 unrelated children with phenylketonuria from the<br />

northern region of China were included in the analysis.<br />

Result: Twenty-two mutations were identified in the above<br />

exons. Eight mutations were detected in exon 7 and four in<br />

exon 5. Among them there were twelve missense, two<br />

nonsense, three splice and three silent, one insertion and<br />

one deletion mutation. The mutations: I65T, G239D,<br />

722delG, L255s, G346R, 1089-1099insC, IVS 1 2t . c,<br />

Q160Q, L385L have not been previously described in the<br />

China population. Conclusion: Because there are more<br />

mutations in exons 7 and 5 than others, it is suggested that<br />

the exons 7 and 5 is a mutant hot spot of PAH gene in<br />

Chinese. The results obtained confirm the high heterogeneity<br />

of the PAH gene and provide information about the<br />

distribution of PKU mutations in the Northern Chinese<br />

population.<br />

FP-K-011<br />

Polymorphism analysis of ATP7B related microsatellite<br />

DNA haplotype in Wilson disease<br />

X.Q. Liu, Y.F. Zhang, L. Wang, X.F. Gu, K.R. Bao<br />

Department of Pediatrics, Xin Hua Hospital, Shanghai<br />

Second Medical <strong>University</strong> and Shanghai Institute for<br />

Pediatric Research, Shanghai, China<br />

Objective: To explore the distribution and significance of<br />

haplotype of microsatellite DNA (D13S314, D13S301 and<br />

D13S316) closely related to ATP7B in normal population,<br />

WD patients and heterozygotes. Methods: Using three well<br />

characterized short tandem repeat markers of fluorescence<br />

labeling (D13S301–D13S314–D13S316), localization and<br />

sequence were analyzed with Genotype e software in 71<br />

WD patients and 123 parents. Results: Based on the analysis<br />

of haplotypes of D13 S314, D13S301 and D13S316, 19,<br />

20, and 15 alleles were obtained in 71 patients with WD,<br />

123 carriers and 54 normal persons respectively, size of<br />

segments was 134–157, 128–156 and 136–154 bp. Heterozygosity<br />

was 0.79, 0.82, and 0.23. There was a significant<br />

difference in the distribution of alleles of D13S314,<br />

D13S301 and D13S316 markers between WD patients<br />

and normal subjects (P , 0:01); four alleles in D13 S314<br />

marker, six alleles in D13 S316 marker. There were 81<br />

haplotypes. 12-6-5, 15-10-5, 6-10-5 and 6-15-5; the<br />

commonest haplotypes accounted for 5.22, 4.48, 4.48 and<br />

3.37%, respectively, 12-8-5, 12-7-5 and 6-16-5 separately<br />

accounted for 2.99%, 13-10-8,6-13-5,6-14-13, and 6-9-5<br />

separately accounted for 2.24%. Conclusion: The complexity<br />

of haplotype may be related to the complexity of mutation<br />

spectrum of ATP7B. The haplotype analysis of<br />

D13S314-D13S301-D13S316 may be an effective and<br />

feasible method with important clinical significance for<br />

the presymptomatic and prenatal diagnosis of Wilson<br />

disease.<br />

FP-K-012<br />

Gas chromatography-mass spectrometry (GC/MS)<br />

screening for inborn error of metabolism (IEM) in<br />

patients with mental retardation of unknown cause<br />

K.-M. Xu a , L.-W. Wang a , H. Cai a , T. Zhang a , C.-H. Zhang b ,<br />

I. Matsumoto b<br />

a Capital Institute of pediatrics Beijing of China; b MILS:<br />

Matsumoto Institute of Life Science of Japan<br />

Objective: To conduct screening of IEM by GC/MS in<br />

950 infants with mental-motor retardation of unknown<br />

cause. Method: All of the 950 patients’ urines were<br />

collected on filter paper and sent to MILS in Japan<br />

where the urinary compounds were analyzed using GC/<br />

MS, and the chemical diagnosis for IEM was determined.<br />

Results: Among 950 patients analyzed, 85 cases (9.0%) had<br />

abnormal urinary profiles. There were 18 cases of phenylk-


Abstracts 561<br />

etonuria (PKU), 16 cases of methylmalonic acidemia, 13<br />

cases of galactosemia, four cases of lysinuria, two cases<br />

each of glutaric aciduria, homoserinuria, and fructose-1,6-<br />

diphosphatase deficiency, one case each of pyro-glutaminuria,<br />

neuroblastoma, long-chain fatty acetyl CoA dehydrogenase<br />

deficiency, multiple carboxylase deficiency,<br />

maple syrup urine disease, propionic acidemia, ornithine<br />

transcarbamylase deficiency and Lesch-Nyhan syndrome,<br />

six cases of Fanconi syndrome and 14 cases of ketonuria.<br />

Good outcomes were obtained in most of the abovementioned<br />

patients after treatment with appropriate therapy.<br />

Conclusion: (1) Screening for IEM should be<br />

performed in infants with mental retardation of unknown<br />

cause. (2) The GC/MS analysis method is an accurate,<br />

sensitive and specific method. It is very important to<br />

extend the range and type of screening of IEM.<br />

FP-K-013<br />

The clinical analysis of PKU: report of five cases with<br />

atypical manifestations<br />

G.-Z. Xu a , C. Hong a , L.-W. Wang a , Y.-L. Zhu a , C.-H.<br />

Zhang b , I. Matsumoto b<br />

a Capital Institute of pediatrics Beijing of China; b MILS:<br />

Matsumoto Institute of Life Science of Japan<br />

Objective: Classic PKU is caused by the complete or<br />

near-complete deficiency of phenylalanine hydroxylase.<br />

The excess phenylalanine and subsequent metabolites<br />

disrupt normal metabolism and cause brain damage. Sometimes<br />

the mental retardation is misdiagnosed as an atypical<br />

syndrome and neglected by pediatricians, so that older<br />

untreated children become hyperactive with purposeless<br />

movements, rhythmic rocking and athetosis. This study<br />

aimed to explore the clinical characteristics and prognosis<br />

of the disease and diagnostic values of the urinary gas chromatography-mass<br />

spectrometric (GC/MS) analysis. Methods:<br />

All of the five patients’ clinical manifestations were<br />

non-specific. Samples of urine were collected and sent to<br />

MILS in Japan where the chemical compounds was<br />

analyzed using GC/MS. Results: Among five cases, two<br />

are diagnosed as autism, one spinal muscular atrophy, one<br />

dwarfism, and one language barrier with albinism before<br />

urinary analysis. The levels of phenylalanine, phenyllactate<br />

and phenylpyruvate in urine were obviously elevated. The<br />

diet and medical therapy was followed in four cases. One<br />

case have had a relatively satisfactory outcome, one case<br />

refused treatment, another 3 cases were recently diagnosed<br />

and still on the follow-up. Conclusion: Much attention<br />

should be paid to PKU with atypical signs such as autism,<br />

cerebral palsy especially weakness of muscle strength,<br />

dwarfism, language barrier with albinism. Early diagnosis<br />

and immediately treatment contribute to the improvement of<br />

the prognosis of PKU.<br />

FP-K-014<br />

Diagnoses and treatment of methylmalonic aciduria<br />

(MMA)<br />

L.-W. Wang a , K.-M. Xu a ,H.Cai a , C. Qian a , J.-X. Wu a , C.-<br />

H. Zhang b , I. Matsumoto b<br />

a Capital Institute of pediatrics Beijing of China; b MILS:<br />

Matsumoto Institute of Life Science of Japan<br />

Objective: Chemical diagnosis of inherited metabolic<br />

diseases in patients with mental-motor retardation, poor<br />

feeding, hypotonia, lethargy, convulsion and so on. Method:<br />

All of the 950 patients’ clinical manifestations were nonspecific.<br />

Urines were collected and sent to MILS in Japan<br />

where the chemical compounds in the urine were analyzed<br />

using GC/MS. Results: Among 950 patients analyzed, 85<br />

cases (9.0%) with abnormal urinary profiles were found.<br />

In these patients, 16 cases of MMA and one case of propionic<br />

acidemia were found. They accounted for 22.4% of all<br />

patients with abnormal urinary profiles (16/85). Good<br />

effects were obtained in eight cases after treating with suitable<br />

therapy, five did not improve, three died of late onset<br />

lethal complications (one died of intracranial hemorrhage<br />

owing to disorder of the platelet, and two died with coma<br />

and convulsion associated with ketoacidosis, and hyperammomemia).<br />

Conclusion: (1) Some patients with MMA could<br />

be treated by medication and low-protein diet. (2) Clinical<br />

manifestations of patients with MMA are non-specific, and<br />

the diagnoses cannot be achieved by clinical findings only.<br />

The GC/MS analysis method is accurate, sensitive and<br />

specific. It is important to extend the range and type of<br />

IEM screening.<br />

FP-K-015<br />

244insL, a novel mutation in methylmalonic aciduria in<br />

Chinese patients<br />

J.-X. Wu, H.-B. Chang, Z.-W. Liu, Y.-Y. Li, L.-W. Wang,<br />

H. Cai, K.-M. Xu<br />

Capital of Paediatrics Institute, Yabao Road 2, Beijing,<br />

China<br />

MMA is an autosomal-recessive disorder that results<br />

from inadequate function of methylmalonyl-coA mutase<br />

(MCM E.C. 5,4,99,2) nuclear-encoded, mitochondrial<br />

enzyme that uses the vitamin B12 derivative, adenosylcobalamin<br />

as a cofactor. It can be associated with fulminant<br />

metabolic acidosis, widespread secondary aberrations in<br />

systemic metabolic homeostasis, mental retardation, or<br />

even neonatal death. To date, 49 different mutations have<br />

been identified at the methylmalonyl-coAmutase (MUT)<br />

locus on the short arm of chromosome 6, but there have<br />

been no reports on MCM mutations in the Chinese population.<br />

Genomic DNA was extracted from leukocytes of<br />

MMA patients and normal children. DNA was amplified<br />

by PCR for exons III, XII of the MCM gene using oligonu-


562<br />

Abstracts<br />

cleotide primers recognizing flanking intronic sequences<br />

and cloned into pGEMT-easy vector. By sequencing the<br />

PCR product and cloning, we demonstrated that a two<br />

base pair insert in exon of the MCM patient in cDNA805<br />

resulted in a frame shift mutation. 244insL(c805insTT) is a<br />

novel mutation found in a compound homozygote. We also<br />

detected several SNP sites in MCM exons III and XII of the<br />

patient and controls. The positions in relation to different<br />

MCM domains allow for an interpretation of the identified<br />

mutations. This new mutation is the first reported in the<br />

Chinese population.<br />

FP-K-016<br />

Proteomics: a new strategy to identify mitochondrial<br />

diseases<br />

J. Xie a , S, Techritz a , J. Klose b , M. Schuelke a<br />

a Department of Neuropediatrics,<br />

b Institute of Human<br />

Genetics, Charité, Humboldt-<strong>University</strong> Berlin, Berlin,<br />

Germany<br />

Mitochondrial diseases can be caused by any defects in<br />

the metabolic pathways located in the mitochondria.<br />

However, there are several obstacles to the molecular diagnosis<br />

in this disease group. These are: (1) the variety of<br />

inheritance patterns (maternal, autosomal recessive, X-<br />

recessive); (2) the large number of genes involved in mitochondrial<br />

biogenesis; and (3) the similarity of the clinical<br />

features. Based on current diagnostic methods, less than<br />

20% suspected cases can be diagnosed at the molecular<br />

level. We have therefore presently developed a new screening<br />

method by which we hope to increase the identification<br />

rate. We studied the mitochondrial proteins in healthy individuals<br />

and in patients with mitochondrial diseases by twodimensional<br />

protein-electrophoresis (2DE). Differences in<br />

protein patterns between healthy and diseased individuals<br />

direct the attention to disease-specific proteins and genes.<br />

Mitochondria were purified from Epstein Barr Virus-transformed<br />

lymphocytes by density gradient centrifugation. We<br />

obtained a satisfactory yield of mitochondria from a small<br />

cell volume of ca. 10 8 lymphocytes. In order to establish a<br />

reference map of mitochondrial proteins we identified ca.<br />

100 proteins by matrix-assisted laser desorption/ionisationtime<br />

of flight (MALDI-TOF) mass spectrometry. The ensuing<br />

reference map was compared to mitochondrial 2DE<br />

maps of patients with mitochondrial diseases. Three of the<br />

patients had mutations in their mitochondrial DNA<br />

(7472inC; 3243A . G ¼ mitochondrial encephalopathy,<br />

lactic acid stroke (MELAS)-syndrome; 8344A . G ¼<br />

myoclonic epilepsy and red ragged muscle fibers<br />

(MERRF)-syndrome) three others had biochemically<br />

proven deficiencies of complex I, III and IV. We have identified<br />

numerous deviating protein spots, which can provide<br />

novel insights into the pathophysiology of mitochondrial<br />

diseases.<br />

FP-K-017<br />

A family case of spongiform leukoencephalopathy<br />

S. Yamashita, H. Iwamoto<br />

Division of Child Neurology, Kanagawa Children’s Medical<br />

Center, Yokohama Japan<br />

Three members including an 11-year-old girl, 6-year-old<br />

girl and 2-year-old boy among four siblings suffered from a<br />

similar disorder. Their parents were cousins. Their clinical<br />

courses included uneventful neonatal history, psychomotor<br />

retardation and developmental arrest. The neurological<br />

examination revealed that the elder two patients had muscle<br />

hypotonia caused by peripheral neuropathy, and the younger<br />

brother had the increased tendon reflexes and positive<br />

Babinski sign. All had cerebellar ataxia, nystagmus and<br />

slurred speech. Biochemical studies showed no evidence<br />

of mitochondrial encephalopathy, leukodytrophy, amino<br />

acid, or organic acid disorders. MRI showed similar<br />

abnormalities in both the T1 and T2 sequences in the<br />

white matter. The lesions involved cerebral white matter<br />

sparing subcortical U-fibers, corpus callosum, internal<br />

capsule, cerebellar white matter and brain stem longitudinal<br />

fibers. Two patients were autopsied and the neuropathological<br />

findings were similar. Vacuolar changes in the white<br />

matter started immediately below the cortex. The deeper,<br />

the white matter showed the more spongy alterations and the<br />

larger number of vacuoles and astrocytes. The matrix tissue<br />

was sparse and destroyed in the deep white matter with<br />

infiltration by many macrophages. The electron microscopic<br />

examination showed intralamellar splitting in the central<br />

myelin sheaths. The cerebral cortical layers showed normal<br />

structures without abnormal storage materials in the neuronal<br />

cells. A genetic disorder is suspected. We discuss this<br />

disorder in the relation to encephalopathy with vanishing<br />

white matter.<br />

FP-K-018<br />

The neurochemical peculiarity in children with<br />

neurocutaneous syndromes<br />

O.V. Globa, E.G. Sorokina, O.I. Maslova, V.M. Studenikin,<br />

V.I. Shelkovsky, V.G. Pinelis<br />

Divisions of Psychoneurology and Membranology,<br />

Research Institute of Pediatrics Scientific Center of Child<br />

Health Russian Academy of Medical Sciences, Moscow,<br />

Russia<br />

The investigations in neurochemical processes – the<br />

determination on autoantibodies (aAB) to glutamate<br />

AMPA GluR1 receptors, cyclic GMP (cGMP) (ELISA)<br />

and sialic acid (SA) (spectrophotometry) in blood serum<br />

were performed in children with different neurological<br />

diseases. To evaluate the changes in content of aAB the<br />

ELISA, elaborated by Institute of the Human Brain, RAS,<br />

was used. We examined 151 patients from 2 months to 16


Abstracts 563<br />

years of ages: 101 with epilepsy (Epi), 15 with neurocutaneous<br />

syndromes (NCS) (seven – tuberous sclerosis, five –<br />

neurofibromatosis type 1, 2-Sturge-Weber syndrome, 1-<br />

Bloch-Sulzberger syndrome) and 35 healthy children. The<br />

content of aAB was significantly increased by 1.5 times in<br />

patients with Epi in comparison with control group (CG) in<br />

all age groups (P , 0; 05). In patients with NCS the aAB<br />

level was by 2–2.5 times higher versus CG. A tendency for<br />

the increased level of SA in children with Epi was revealed.<br />

In patients with NCS the level of SA was significantly<br />

increased to 1.2 times versus CG. These data indicated the<br />

damage of neurons induced by glutamate receptors overstimulation<br />

in children with seizures. In all age groups the<br />

cGMP concentration, an indirect index of NO, was 5–7<br />

times higher than in CG (P , 0:001). In patients with<br />

NCS the cGMP level was higher by not more than three<br />

times versus CG. The results show more expressed injury<br />

of brain neuronal membranes in children with NCS than in<br />

patients with Epi and damage of the cGMP synthesis in<br />

patients with NCS compared to children suffering by Epi.<br />

FP-K-019<br />

Newly described multiple congenital anomalies in<br />

methylenetetrahydrofolate reductase deficiency in an<br />

Arab child<br />

A.A. Al Tawari, N.A. Al Torki, L.C. Heberle, M.A. Al<br />

Ajmi, J.E. Abdullah, N.A. Al Othman, M.M. Al Ajmi<br />

Child Neurology Unit, Children Department, AL Sabah<br />

Hospital, Kuwait<br />

Methylenetetrahydrofolate reductase deficiency<br />

(MTHFR) is a rare metabolic autosomal recessive inherited<br />

disorder. The principal clinical features are neurologic<br />

rather than metabolic such as hypotonia, developmental<br />

delay, seizures, microcephaly, apnea and coma. There are<br />

reports of association of MTHFR with neural tube birth<br />

defects or with congenital cardiac malformations. We report<br />

on an Arab child who is now 1 year old, presenting with two<br />

different disorders caused by two different gene mutations.<br />

Homocystinuria type III caused by methylenetetrahydrofolate<br />

reductase deficiency and spondylocostal dystosis as<br />

well as urogenital anomalies. The child showed improvement<br />

after he was commenced on betaine therapy.<br />

FP-K-020<br />

Canavan disease in Kuwait<br />

A.A. Al Tawari, Y. Habib, L.C. Heberele, M.A. Al Ajmi,<br />

J.K. Abdullah, M. Boloshi, A. Moosa<br />

AL Sabah Hospital, Children Department, Child Neurology<br />

Unit, State of Kuwait<br />

Canavan disease is a neurodegenerative autosomal recessive<br />

disease associated with disorders in the synthesis or<br />

catabolism of myelin due to deficiency of aspartoacyclase<br />

caused by mutations in the gene for this enzyme. The gene<br />

has been mapped to the short arm of chromosome 17. It is a<br />

panethnic disease more prominent among Ashkanazi Jews.<br />

We report nine children with Canavan disease from eight<br />

families. The diagnosis was confirmed by the elevated N-<br />

acetylaspartic acid in urine and brain imaging abnormalities.<br />

The eldest one is 8 years and the youngest is 6 months,<br />

one died at 3 years. We describe the clinical features, diagnostic<br />

procedures and note the need to elucidate the gene<br />

mutation among Arab Ethnic group.<br />

FP-K-021<br />

A family of episodic ataxia type 2: no evidence of genetic<br />

linkage to the CACNA1A gene on chromosome 19p13<br />

H. Hirose a , T. Arayama b , J. Takita a , T. Igarashi a ,Y.<br />

Hayashi a , Y. Nagao a,c<br />

a Department of Pediatrics, The <strong>University</strong> of Tokyo Tokyo,<br />

Japan; b Kikkoman General Hospital and c Social Health<br />

Insurance Medical Center, Japan<br />

Episodic ataxia type 2 (EA2) is an uncommon autosomaldominant<br />

disorder, which is characterized by bouts of vestibulo-cerebellar<br />

ataxia, lasting from 15 min to days, and<br />

interictal gaze-evoked nystagmus. EA2 has been reported<br />

to be caused by mutations in the CACNA1A gene, located<br />

on chromosome 19p13, which codes the pore-forming<br />

Ca v 2.1 (formerly known as a1A) subunit of a P/Q-type<br />

voltage-dependent calcium channel. In this report we<br />

describe a family with episodic ataxia, clinically indistinguishable<br />

from EA2, which was not caused by CACNA1A<br />

gene mutation. The proband is a 10 year-old boy, who has<br />

had six cerebellar ataxic attacks since 8 years. His attacks<br />

occurred almost monthly, lasting for 2–3 days. He was treated<br />

successfully with acetazolamide. His maternal grandmother,<br />

mother and identical twin had similar attacks<br />

manifesting at 50, 34 and 10 years, respectively. The symptoms<br />

in his grandmother improved gradually without medication.<br />

His mother and identical twin took acetazolamide<br />

with a good response. We examined the CACNA1A gene on<br />

this family but did not detect any mutations. Furthermore,<br />

linkage analysis, using the SNP in exon 46 and the variable<br />

number of tandem repeats of GT repeats in intron 40,<br />

showed that there was no evidence of genetic linkage<br />

between the CACNA1A gene and the symptomatic patients<br />

in this family. This suggests that the cause of EA2 can be<br />

heterogeneous, that is, defects of genes other than<br />

CACNA1A might be the cause of EA2.<br />

FP-K-022<br />

Clinical research of X-linked adrenoleukodystrophy<br />

H. Xiong, Y.-H. Zhang, J. Qin, J.-X. Xiao, C.-Y. Shi, S.-M.<br />

Zhou, X.-R. Wu<br />

Department of Pediatrics, First Hospital, Peking <strong>University</strong>,<br />

Beijing, China


564<br />

Abstracts<br />

Objective: The clinical manifestations, biochemical<br />

changes and genetic counseling aspects of X-linked adrenoleukodystrophy<br />

(ALD) were analyzed. Methods: Clinical<br />

features of 29 cases with ALD were summarized and<br />

analyzed. Results: Among these 29 cases, the clinical<br />

phenotypes include childhood cerebral type (22 cases),<br />

adolescent cerebral type (four cases), adrenomyeloneuropathy<br />

type (one case), Addison disease only (one case), and<br />

asymptomatic or presymptomatic (one case). Nine had positive<br />

family history. Pedigree investigation was consistence<br />

with typical sex-linked recessive inheritance. There were 45<br />

ALD patients in these 29 pedigrees. The neurological manifestations<br />

varied among members of the same family. Nine<br />

cases died during follow-up. The causes of death were<br />

central respiratory failure or other complications associated<br />

with ALD. Laboratory tests demonstrated abnormally high<br />

plasma levels of very long chain fatty acids (VLCFA) in<br />

ALD patients; MRI demonstrated symmetric butterfly-like<br />

T1 low T2 high signals in the parieto-occipital white matter.<br />

The involvement in the splenium of corpus callosum led to<br />

the convergence of bilateral lesions. It can progress forward<br />

and involves the posterior limb of internal capsule bilaterally<br />

and the temporal lobe, and the brainstem inferiorly.<br />

Conclusions: Atypical initial symptoms of ALD were<br />

seizures. The MRI showed abnormal signal in the cerebellar<br />

white matter. The disease can impair the normal development<br />

of children; this was more pronounced in the childhood<br />

cerebral ALD type. It tended to progress rapidly with<br />

dementia, vegetative state or death. We can now do antenatal<br />

examinations. Emphasis should be placed on antenatal<br />

examination, in order to achieve early diagnosis and to abort<br />

pregnancy if indicated.<br />

FP-K-023<br />

Detection of mutations in ALD protein (ALDP) gene by<br />

PCR-DNA sequence analysis in Chinese<br />

adrenoleukodystrophy patients<br />

H. Xiong, H. Pan, Y.-H. Zhang, X.-R. Wu<br />

Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />

Beijing, China<br />

Objective: X-linked ALD is a peroxisomal disorder characterized<br />

by impaired peroxisomal beta-oxidation of<br />

VLCFAs. The ALD gene is localized on Xq28, has ten<br />

exons and encodes a protein of 745 amino acids. The mutations<br />

in ALD gene encoding adrenoleukodystrophy protein<br />

in Chinese ALD patients were identified. Methods: Genomic<br />

DNA from 14 unrelated patients (and two patients’<br />

parent) with X-linked ALD was extracted using standard<br />

procedures from the peripheral blood leukocytes. So far,<br />

exon 6 at the 3 0 end portion of ALDP gene were amplified<br />

with the primers synthesized according to the published<br />

flanking intronic sequences. The PCR products were further<br />

analyzed by agarose gel electrophoresis and directly<br />

sequenced. Results: By DNA sequencing analyses, four<br />

PCR products were identified. One was deleted with one<br />

C nucleotide in the intronic sequences before the exon 6,<br />

maybe induce cut disorder. The missense-type mutations:<br />

T1559A was found in one patient and his mother. One other<br />

had a silent mutation: G1548A. Conclusion: Mutations in<br />

ALDP gene were identified in Chinese ALD patients in the<br />

mainland of China for the first time. No major gene deletion<br />

or rearrangement was detected. Despite many mutations<br />

having been identified in patients with these clinical phenotypes,<br />

the genotype-phenotype correlations have not been<br />

clarified. Furthermore, there were no phenotypic expression<br />

changes caused by the subtle amino acid changes. These<br />

data indicated that no obvious correlations exist between<br />

the phenotypes of ALD patients and their genotypes,<br />

suggesting that other genetic or environmental factors may<br />

also be involved in determining phenotypic expression in<br />

ALD.<br />

FP-K-024<br />

Clinical, biochemical and genetic diagnosis in a family<br />

with atypical Fabry disease<br />

Th. Kroepfl a ,K.Paul a , B. Plecko a , P. Kotanko b , E. Paschke a<br />

a <strong>University</strong> of Graz, Department of Pediatrics, Graz,<br />

Austria; b Krankenhaus der Barmherzigen Brueder Graz,<br />

Department of Internal Medicine, Graz, Austria<br />

Fabry disease (McKusick 301500) is an x-linked deficiency<br />

of lysosomal a-galactosidase A (EC 3.2.1.22) leading<br />

to the accumulation of glycosphingolipids in the<br />

lysosomes. As it mainly affects the skin, eyes, kidneys,<br />

heart and the nervous system, the patients usually suffer<br />

from severe pain attacks in childhood, later followed by<br />

angiokeratoma, renal dysfunction and severe cardiomyopathy.<br />

In a 42 year-old male mild proteinuria was noticed at<br />

the age of 29, leading to end stage renal disease and kidney<br />

transplantation within few years. At the age of 40 a marked<br />

non-obstructive cardiomyopathy became obvious.<br />

Although the majority of typical symptoms like paresthesia,<br />

hypohydrosis or lesions of the skin and the cornea were<br />

lacking, Fabry disease was histologically suspected due to<br />

the result of a kidney biopsy and was biochemical<br />

confirmed when leucocyte a-galactosidase was shown to<br />

be reduced to 1.5% of controls. A novel insertion of 6<br />

bases in exon 7 of the a-galactosidase gene on chromosome<br />

Xq22.11 was found in the DNA of the patient but not<br />

in 40 DNA controls. The mutation was also present in a<br />

sister with cardiomyopathy and her asymptomatic daughter<br />

but not in a second sister without symptoms. Surprisingly<br />

the enzyme level was normal in all relatives examined.<br />

These results illustrate importance of a complete genotype-specific<br />

diagnosis in suspected Fabry patients in<br />

order to provide the benefit of novel therapies to all male<br />

and female patients of this probably highly underdiagnosed<br />

condition. Thus, our patient will be the first to undergo<br />

ERT in Austria.


Abstracts 565<br />

FP-K-025<br />

Eighteen years follow-up of a boy with congenital<br />

disorders of glycosylation (CDG) type IIa syndrome:<br />

clinical aspects<br />

P. De Cock, J. Jaeken<br />

Department of Paediatrics, <strong>University</strong> Hospital Gasthuisberg,<br />

Leuven, Belgium<br />

Because of a cardiac murmur (VSD) and dysmorphic<br />

features J. was transferred soon after birth to our department.<br />

In the following years several diagnoses have been<br />

put forward to explain his congenital anomalies and severe<br />

psychomotor retardation. They all proved wrong when at<br />

the age of 9 years a striking pattern of haemostatic abnormalities<br />

led to the discovery of a new type of congenital<br />

disorders of glycosylation (CDG), namely CDG type IIa,<br />

due to a deficiency in Golgi localised N-acetyl-glucosaminyltransferase<br />

II (ref.). Surprisingly brain imaging showed<br />

no cerebral or cerebellar anomalies. At 18 years J. is a very<br />

dystrophic adolescent with short stature, profoundly<br />

retarded, suffering from a refractory epilepsy, progressive<br />

kyphoscoliosis and muscle wasting in more than one aspect<br />

resembling a progressive myopathy (elevated GOT, normal<br />

GPT). He learned to put a few steps unsupported but now he<br />

is no more able to do so. Communication always remained<br />

very limited. Moreover he has GE-reflux disease with recurrent<br />

GI haemorrhages, gingival hypertrophy, sleep apnea<br />

and an impressive osteoporosis. The coagulopathy almost<br />

impedes any surgical intervention and furthermore several<br />

drugs had to be discontinued because of side effects. His<br />

clinical course will be presented and illustrated and therapeutic<br />

dilemmas will be discussed.<br />

FP-K-026<br />

Familial moyamoya disease in two European children<br />

H. Bazigou a , J. Tolmie b , K. Muir c , C. Fotopoulou d ,A.<br />

Papavasiliou a<br />

a Pendeli Children Hospital, Section of Pediatric Neurology,<br />

Athens, Greece; b Medical Genetics Department, Yorkhill<br />

Hospitals, Glasgow, UK;<br />

c Institute of Neurological<br />

Sciences, Southern General Hospital, Glasgow, UK; d Humboldt<br />

<strong>University</strong>, Berlin, Germany<br />

MMD is characterized by a cerebral angiographic picture<br />

of stenosis or occlusion of the main cerebral arteries.<br />

Although the etiology is still unknown, we present two<br />

cases of familial MMD in order to stress the importance<br />

of familial factors in the pathogenesis of the disease. The<br />

first case refers to a 14-month old Greek girl with a right<br />

hemiparesis after two brief right focal motor seizures. MRI<br />

of the brain showed diffuse infarcts at the left tempo-parietal<br />

and the right temporo-occipital regions. A digital cerebral<br />

arteriography showed stenosis of the supraclinoid right and<br />

left internal carotid artery and hypertrophy of the lenticulostriate<br />

arteries. Her mother, suffering also from MMD, is<br />

heterozygous for FV Leiden, for mutant FII (20210A) and<br />

MTHFR factors, done by PCR and the patient is positive for<br />

two of these factors. A revascularization procedure had been<br />

performed in the mother at nine years of age and in the<br />

patient recently. The second patient is a 5-year old boy,<br />

coming from Scotland with a three-generation history of<br />

MMD (maternal grandmother and sister and a sibling of<br />

the patient), who during his summer holidays in Greece<br />

developed fever, headache and left-sided motor seizures,<br />

followed by left hemiplegia. MRI and bilateral carotid arteriography<br />

confirmed the diagnosis of MMD (subtotal stenosis<br />

of the initial sections of the right mainly and the left<br />

middle cerebral arteries). Coagulation factors were normal.<br />

Further studies are required to determine etiological factors<br />

in familial MMD and to elucidate the role of hemostatic<br />

abnormalities in its pathogenesis.<br />

FP-K-027<br />

CLN2 – Classic late infantile neuronal ceroid<br />

lipofuscinosis (LINCL). Report on 13 Brazilian cases<br />

S. Rosemberg, D. Fujiwara<br />

Santa Casa of São Paulo Medical School, Department of<br />

Pediatrics, Neuropediatrics Division, São Paulo, Brazil<br />

LINCL is by far the most frequent neuronal ceroid lipofuscinosis<br />

(NCL) encountered in Brazil and, perhaps in<br />

Latin America comprising all but one NCL cases diagnosed<br />

in our Service. We studied 13 unrelated patients (nine<br />

males, four females). Consanguinity was present in eight<br />

cases. Clinical phenotype was very uniform. The onset of<br />

symptoms occurred between 2 years 7 months and 4 years 6<br />

months (mean: 3 years 4 months). In three cases there was a<br />

previous delay of speech and psychomotor development<br />

was somewhat slow. Generalized tonic-clonic or astaticakinetic<br />

seizures were the first symptoms which were<br />

concomitant with or followed in a short period by arrest<br />

and decline of the psychomotor skills. Global ataxia, pyramidal<br />

signs and polymyoclonus were prominent and most<br />

patients could not walk within 18 months after the onset.<br />

Visual decline was difficult to assess due to the mental<br />

regression. Funduscopy disclosed isolated optic atrophy in<br />

three patients and macular degeneration associated with<br />

optic atrophy in six. Three patients died at age 10 years,<br />

five patients aged between 6 and 11 years are alive and<br />

five were not followed up. EEG was abnormal in all<br />

cases. Occipital photosensitive response was found whenever<br />

searched (n ¼ 4). ERG performed in four patients was<br />

extinguished. Cranial CT showed diffuse atrophy in all<br />

patients whose severity increased with the patients’ age.<br />

Vacuolated lymphocytes were never encountered. The<br />

final diagnosis was done through the ultrastructural exam<br />

of conjunctival biopsies performed in all patients, which<br />

showed pure curvilinear storage bodies in fibroblasts,<br />

endothelial or perithelial cells. Brazilian LINCL patients


566<br />

Abstracts<br />

form a very uniform clinicopathological population. Future<br />

genetic studies will show whether there is a corresponding<br />

genetic background.<br />

FP-K-028<br />

Renal lesions in tuberous sclerosis<br />

T. Yamano, K. Tanaka, H. Hattori, T. Seto, O. Matsuoka<br />

Department of Pediatrics, Osaka City <strong>University</strong> Graduate<br />

School of Medicine, Osaka, Japan<br />

In tuberous sclerosis (TS), the major causes of death<br />

include status epilepticus, renal disease, brain tumors and<br />

lymphangiomyomatosis of the lung. Child neurologists pay<br />

special attention to treatment of intractable epilepsy, but<br />

rarely to for renal involvement. This study was undertaken<br />

to elucidate renal lesions in 14 patients with tuberous sclerosis.<br />

They included six males and eight females between 3<br />

and 37 years of age (mean: 14 years of age) who were<br />

treated in our hospital. They were repeatedly examined by<br />

abdominal echography, CT and/or MRI. Abnormalities<br />

were found in ten patients. Multiple cysts were detected in<br />

one kidney of a patient and in both kidneys of two, one of<br />

whom developed renal failure at 13 years of age and then<br />

received CAPD therapy. Other three female patients had<br />

angiomyolipoma in both kidneys, which increased gradually<br />

in volume year by year. In the remaining four patients,<br />

kidneys revealed rugged surface and heterogeneous echodensity.<br />

Our study indicated that prominent renal lesions<br />

such as multiple cysts and angiomyolipoma occurred in<br />

six of 16 patients (43%) with TS. Furthermore, these lesions<br />

were progressive, occasionally resulting in renal failure.<br />

Periodical evaluations of kidney structure and function are<br />

required in TS patients.<br />

FP-K-029<br />

Infantile dentatorubral pallidoluysian atrophy: distinct<br />

phenotype from juvenile form<br />

T. Fujii a , M. Ito a , K. Ishikawa b , H. Mizusawa b ,T.<br />

Miyajima a , Toshiyuki Kito a , T. Okuno a<br />

a Department of Pediatrics, Shiga Medical Center for Children,<br />

Moriyama, Japan; b Department of Neurology, Tokyo<br />

Medical and Dental <strong>University</strong>, Tokyo, Japan<br />

Dentatorubral pallidoluysian atrophy (DRPLA) is an<br />

autosomal dominant neurodegenerative disorder associated<br />

with the expansion of an unstable (CAG)n repeat in the<br />

DRPLA gene. There are two clinical forms of DRPLA:<br />

juvenile-onset DRPLA is characterized by progressive<br />

myoclonic epilepsy and dementia; and adult-onset patients<br />

commonly have choreoathetosis, cerebellar ataxia and<br />

dementia. Shimojo et al. reported two infants with<br />

DRPLA. Both had rapid regression and severe involuntary<br />

movements without myoclonus, and an extremely<br />

expanded CAG repeat ($90 repeats). We report an<br />

infant-girl with regression, severe choreoathetosis followed<br />

by dystonia, and the extreme expansion of the CAG repeat<br />

(18/87); similar to two reported patients. Patient: A 5-yearold<br />

girl had psychomotor developmental delay with the<br />

maximum motor ability achieved being sitting and creeping.<br />

The regression started at the age of 3, and she became<br />

unable to sit or creep in 6 months. At age 4, she developed<br />

severe choreoathetosis and oral dyskinesia. CT scan<br />

showed cerebral and cerebellar atrophy. A few months<br />

later, the choreoathetosis diminished, but dystonia became<br />

apparent. Currently, she has severe dystonia and bulbar<br />

symptoms. Discussion: The phenotype of our patient is<br />

similar to that of Shimojo et al.’s two patients. All showed<br />

the infantile-onset regression, involuntary movements<br />

without myoclonus, cerebral and cerebellar atrophy, and<br />

the very long CAG repeats (87 , 93 repeats). Thus, our<br />

patient confirms the existence of another clinical form;<br />

infantile DRPLA.<br />

FP-K-030<br />

Mutation of dystrophin gene of muscular dystrophy in<br />

Javanese children in Yogyakarta Indonesia<br />

Sunartini a , E.S. Herini a , P. Soeryantoro a , Harsono b<br />

a Department of Pediatrics;<br />

b Department of Neurology,<br />

School of Medicine, Gadjah Mada <strong>University</strong>, Indonesia<br />

Both Duchenne and Becker muscular dystrophies are<br />

caused by dystrophin gene mutations. Due to the large<br />

size of the dystrophin gene, the gene mutation occurs<br />

frequently. This mutation was also found in Javanese Children<br />

in Yogyakarta, Indonesia. Materials and methods: All<br />

patients with DMD/BMD admitted to Dr. Sardjito Hospital<br />

were included in this study. The diagnosis was confirmed by<br />

clinical, laboratory and histopathological examination.<br />

Multiplex PCR for DNA analysis was used to detect the<br />

mutation of dystrophy gene. Results: Sixteen DMD/BMD<br />

patients were included in this study. The mutations were<br />

detected in eight cases (50%). Deletions occurred on the<br />

hot spot exon of 6, 7–21, 12–19, 18–49, 45, 46 and 51. In<br />

the other eight cases the mutations have not yet been<br />

detected. Search for the mutation continues in the other<br />

siblings and family members and will include carriers and<br />

cases with normal clinical appearance.<br />

FP-K-031<br />

The clinical and experimental studies of metachromatic<br />

leukodystrophy<br />

W.-C. Zhang, H.-S. Wu, T.-C. Liu<br />

Department of Neurology, Beijing Children Hospital, Beijing,<br />

China<br />

Objectives: To evaluate the clinical features of metachromatic<br />

leukodystrophy (MLD) and diagnostic value of<br />

measuring ASA activity in peripheral leukocytes. Methods:<br />

The analysis was done in 6 patients with MLD according to


Abstracts 567<br />

the clinical and experimental data. Results: There were five<br />

cases of the late infantile form with onset of symptoms<br />

ranging from 1 to 2.5 years of age and one case of the<br />

juvenile form at 6 years. All had a gait disorder at onset<br />

with a progressive course that resulted in spastic paraplegia<br />

or tetraplegia in both legs or limbs. Speech disturbance<br />

occurred in three cases and mental regression in three.<br />

Cranial CT scan revealed symmetric low density area in<br />

the cerebral hemisphere in three cases. Cranial MRI<br />

showed bilateral symmetric T2-high signal intensity<br />

white matter lesions on bilateral white matter in five<br />

cases. Six cases had low or deficient ASA activity. Conclusion:<br />

The clinical features of MLD are progressive motor<br />

deterioration, speech disturbance and mental regression.<br />

The white matter abnormalities on cranial CT and MRI<br />

are useful for the diagnosis of MLD. The diagnosis is<br />

based on the deficiency of ASA activity in peripheral<br />

leukocytes.<br />

FP-K-032<br />

Leigh syndrome with mitochondrial DNA mutation at<br />

14597 T-C<br />

G.T Riordan a , P.M. Leary b , E.P. Owen a<br />

a Department of Neurology and b Chemical Pathology, Red<br />

Cross Children’s Hospital, <strong>University</strong> of Cape Town, Cape<br />

Town, South Africa<br />

A 16 month-old female presented with dystonia of<br />

gradual onset over a month. Prior development was<br />

normal. MRI of her brain aged 3 years demonstrated<br />

symmetrical T1-WI hypointense abnormalities in bilateral<br />

basal ganglia. At 10 years clinical deterioration accelerated.<br />

Dystonia prevented ambulation and reflexes were<br />

increased with extensor plantars. Virtually complete external<br />

ophthalmoplegia was present. Irregular respiratory<br />

pattern and severe hypertension suggested autonomic<br />

disturbances. Repeat MRI showed symmetrical extension<br />

of brainstem lesions. Pyruvate dehydrogenase activity was<br />

normal. No mitochondrial (mt) mutations were found at<br />

base pairs 3271, 3243, 8344, 8993 or sites associated<br />

with Leber’s optic atrophy. A point mutation was encountered<br />

at nt T14597C altering amino acid 26, isoleucine, to<br />

threonine. Degree of heteroplasmy in fibroblasts was over<br />

95% with no normal sequence being seen. The mutation<br />

occurred in a highly conserved region of the ND6 gene and<br />

changed a non-polar to a polar amino acid. Normal<br />

sequence was present in her mother. This amino acid<br />

change could potentially cause an unstable subunit of<br />

complex 1. A mutation at ntT14596A changing isoleucine<br />

to methionine was described in a Dutch family with hereditary<br />

spastic dystonia and optic atrophy. (Am J Hum Genet<br />

1996;58:703–711). It is likely that a T14597 C mutation in<br />

mtDNA was responsible for causing Leigh Syndrome in<br />

this patient.<br />

FP-K-033<br />

Evaluation of the floppy infant: contribution of genetic<br />

and neurological disorders<br />

A.N. Prasad a , K. Birdi a , C. Prasad b , M. Cheang c ,B.<br />

Chodirker b , A.E. Chudley b<br />

Sections of<br />

a Pediatric Neuroscience, and b Genetics and<br />

Metabolism; Department of Pediatrics and Child Health,<br />

Biostatistical Consulting Unit; c Department of Community<br />

Medicine, <strong>University</strong> of Manitoba, Winnipeg, Canada<br />

This study examines in particular the impact of advances<br />

in DNA based diagnostic testing, and neuroimaging on the<br />

laboratory work up in the floppy infant. We present a retrospective<br />

analysis of 89 infants referred for evaluation to the<br />

genetics and neurology services over 11 years (1990–2000).<br />

Cases were ascertained through a systematic search of<br />

genetics/neurology clinic databases, and EMG records.<br />

There were 47 males, 42 females. The majority (83.7%)<br />

presented below the age of 1 mo. The aboriginal population<br />

is over represented in this patient group (37.5 versus 15%),<br />

in comparison to the expected proportion of the aboriginal<br />

population. Operative delivery was necessary in 26.4%<br />

(16.2–36.6, 95% CI), persistently low Apgar scores (,3 at<br />

5 min) were noted in 6% (0.3–11.6, 95% CI). The majority<br />

(56.5%) of infants were delivered at term (45.9–75.1, 95%<br />

CI), and with birth weights between 2500 and 3000 g 61%<br />

(46–75.9, 95% CI). These infants were followed up for a<br />

mean duration of 29 months (24.4–33.5, 95% CI). Genetic<br />

disorders 29% (17.7–40.3, 95% CI), structural brain malformations<br />

35.5% (23.6–47.4, 95% CI) and disorders of the<br />

motor unit 17.7% (8.2–27.3 95%CI) were most frequently<br />

encountered. DNA based diagnostic tests and neuroimaging<br />

studies (CT) were more likely to lead to the final diagnosis<br />

than other tests (P , 0:05). There is significant mortality<br />

(11.6%), and considerable morbidity; 60% showing global<br />

developmental delay, nearly half (56.6%) remaining non<br />

ambulatory, and a small proportion (2.6%) requiring home<br />

ventilation. A diagnostic algorithm for appropriate utilization<br />

of laboratory services based on the findings of the study<br />

is presented.<br />

FP-K-034<br />

Clinical survey of 138 patients with organic aciduria<br />

Y.-L. Yang, Y.-H. Zhang, Y.-W. Jiang, X.-H. Bao, Y. Qi, J.<br />

Qin, X.-R. Wu, S. Yamaguchi, X. Fu, M. Kimura T. Yasiko,<br />

H. Jun, F. Minoru<br />

Department of Pediatrics, The First Hospital of Peking<br />

<strong>University</strong>, China; Department of Pediatrics, Shimane<br />

Medical <strong>University</strong>, Japan, and Sapporo Health Institute,<br />

Japan<br />

Objective: To investigate the incidences, clinical features<br />

of organic aciduria in children with mental retardation and<br />

other neurological defects. Subjects and methods: In the past


568<br />

Abstracts<br />

4 years, 1372 patients with mental retardation, seizures,<br />

motor deficit, vomiting, growth disorders, and metabolic<br />

acidosis or lethargy were screened by urine organic acid<br />

analysis (gas chromatography/mass spectrometry). Results:<br />

Seventy-one (5.14%) patients aged from 5 days to 18 years<br />

with typical organic aciduria were confirmed. Among them,<br />

32 were methylmalonic aciduria, 13 were propionic aciduria,<br />

six were multiple carboxylase deficiency, five were<br />

glutaric aciduria, four were hyperoxalic aciduria, three<br />

were oxoprolinemia, two were methylcrotonyl CoA carboxylase<br />

deficiency, one patient with maple syrup urine disease,<br />

one ketothiolase deficiency, one isovaleric aciduria, one<br />

alcaptonuria, one carnitine palmitoyl transferase deficiency<br />

type II, one glyceric aciduria, respectively. In addition, 67<br />

cases (4.88%) of atypical organic aciduria (such as dicarboxylic<br />

aciduria) were detected. Among the above 138<br />

patients, mental retardation, seizures, metabolic acidosis,<br />

vomiting, and SIDS like strike were in 115 (83.3%), 92<br />

(66.7%), 68 (49.3%), 83 (60.1%) and 14 (10.1%) patients,<br />

respectively. A total of 105 (76.1%) patients were treated.<br />

Nineteen (13.8%) died. Clinical improvement was observed<br />

in 94 (68.1%) patients. Twenty-six (18.8%) showed normal<br />

mental development. Conclusion: Most of organic aciduria<br />

involved nervous system intensively. Early diagnosis and<br />

adequate treatment contributed to the improvement of the<br />

mental prognosis of the patients, and screening is critical.<br />

GC/MS was a very important method to the diagnosis for<br />

organic aciduria.<br />

FP-K-035<br />

Autosomal recessive centronuclear myopathy and<br />

cataract: report of a large pedigree<br />

N. Şenbil, Z. Akçören, G. Tuncer, A. Özön, H. Topaloǧlu<br />

Hacettepe Children’s Hospital, Ankara, Turkey<br />

There are three basic inheritance patterns of centronuclear<br />

myopathy (CM). The gene of the X-linked form maps<br />

to Xq28 and codes for a protein called myotubularin. The<br />

autosomal recessive and dominant forms are rare, and their<br />

genetic loci are unknown. Here, we present a large family<br />

in which three out of seven siblings were affected with<br />

autosomal recessive CM. Interestingly, cataracts were<br />

also segregating within the members. All patients showed<br />

hypotonia from infancy, delay in motor milestones and<br />

weakness. There was generalized muscle weakness, facial<br />

involvement, waddling gait, lordotic posture, and absent<br />

deep tendon reflexes. Serum CK was normal. There were<br />

myopathic alterations in the EMG. The evolution was relatively<br />

non-progressive. The eldest affected sib is an 18<br />

year-old boy with bilateral cataracts (removed), ptosis,<br />

ophthalmoplegia, and long and thin face. The second one<br />

was a 15 year-old girl. She had all the findings of the<br />

brother except the cataracts. A 4 year-old-girl was the<br />

third affected sib and her complaints have just begun.<br />

There was also a 22 year-old girl only with cataracts. We<br />

have no detailed information for the nature of the cataracts<br />

as they were removed many years before our evaluation of<br />

the family. There was no known consanguinity, but both<br />

parents were from the same village. Muscle biopsy was<br />

obtained from two of the affected patients. The pathological<br />

studies revealed a prominent variety in fiber size,<br />

centrally placed nuclei in most of the fibers and adiposis<br />

with ATPase type I fiber predominance and with succinic<br />

dehydrogenase myofibrillar disruption and many motheaten<br />

fibers were present. These findings were compatible<br />

with CM. This family may be a candidate for further<br />

genetic analysis to help to search a genetic locus of autosomal<br />

recessive CM.<br />

FP-K-036<br />

Profile of clinical and biochemical characteristics of 41<br />

pediatric patients with cerebral lipidosis<br />

A. Nalini, R. Christopher, D.K. Subbakrishna<br />

Department of Neurology, Neurochemistry and Biostatistics;<br />

National Institute of Mental Health and Neuro<br />

Sciences, (NIMHANS), Bangalore, Karnataka, India<br />

A retrospective study of 41 patients seen between 1993<br />

and 2001 was done. The clinical features and biochemical<br />

parameters were studied. Results: There were 20 cases of<br />

metachromatic leukodystrophy (MLD) (infantile-14, juvenile-6);<br />

Tay-Sachs disease (TSD)-12 (infantile-9, lateG M2 -<br />

3); Sandoff disease (SD)-8; and one of multiple sulfatase<br />

deficiency. 2 0 consanguinity seen in nine of MLD, six of<br />

TSD, three of SD, 3 0 in one from each group. The M:F ratio<br />

was: MLD (13:7); TSD (4:8); SD (6:2). There were 38<br />

Hindus and three Muslims. The mean age at onset was<br />

39.5 ^ 44.2 months in MLD; 10.0 ^ 8.9 months in TSD;<br />

7.7 ^ 5.5 months in SD. Delayed milestones seen in 80% of<br />

MLD; 75% of TSD and 88% of SD. Macrocephaly seen in<br />

one of SD and one of MLD. Seizures seen in 45% of MLD;<br />

50% of TSD; and 75% of SD. Startle myoclonus was seen in<br />

100% of TSD, 75% of SD, 10% of MLD. Visual loss was<br />

present in 42% of TSD, 50% of SD, 10% of MLD. Cherry<br />

red spot was seen in 75% of TSD and 86% of SD. Optic<br />

atrophy in 30% of MLD, 42% of TSD and 25% of SD.<br />

Deafness in one case of TSD and SD. Spasticity with<br />

brisk DTRs in 32 and absent DTRs in eight. Babinski positive<br />

in 33, cerebellar ataxia in three of MLD and two of<br />

TSD, dystonia of limbs in three of MLD. Family history<br />

of similar illness in eight of MLD, one of SD and TSD.<br />

The mean serum arylsulfatase-A level in 20 of MLD was<br />

20.7 ^ 7.1 (10–36) nmol/h. The mean serum b hexosaminidase-A<br />

level in 12 of TSD was 7 ^ 6.9 (3–23) nmol/ml<br />

per h. The mean total serum b hexosaminidase level in eight<br />

cases of SD was 37.3 ^ 32.8 (0–62) nmol/ml per h. The<br />

MSD case had low level of arylsulfatases A and B in<br />

serum and in leucocytes. NCV showed motor sensory<br />

demyelination in eight of MLD. Sural nerve biopsy was<br />

positive for metachromatic material in six of MLD. Conclu-


Abstracts 569<br />

sion: This is the largest series of biochemically confirmed<br />

cases from India.<br />

FP-K-037<br />

MECP2 gene mutation analysis in patients with Rett<br />

syndrome in China<br />

H. Pan a , Y.-P. Wang b , X.-H. Bao a , H.-D. Meng a , Y. Shen b ,<br />

X.-R. Wu a<br />

a Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />

Beijing, China; b Chinese National Human Genome<br />

Center, Beijing, China<br />

RTT is a progressive neurodevelopmental disorder that<br />

almost exclusively affects girls. Mutations in the X-linked<br />

methyl-CpG-binding protein 2 (MeCP2) gene have been<br />

found to be a cause of RTT. Methylation of CpG in the<br />

mammalian genome is important for transcriptional silence.<br />

Decreased MeCP2’s activity will lead to derepression of<br />

transcription at multiple central nervous system loci and<br />

overexpression of some genes that may be detrimental<br />

during brain development. The developing brain may be<br />

more dependent on MeCP2 than any other tissues. A lot<br />

of mutations have been reported in different races recently.<br />

In order to study the spectrum of mutations in China, we<br />

employed PCR and direct sequencing to analyze the<br />

MECP2 coding region in 31 classical sporadic RTT Chinese<br />

cases. Twelve different mutations in exon three were identified<br />

in 17 of these 31 patients, including four missense<br />

mutations (R133C, T158M, P225R, R306C), three nonsense<br />

mutations (R168X, R255X, R294X), five frameshift<br />

mutations (806delG, 875insA, 1158–1167/1171–<br />

1186del24, 1164del44, and 1152del44 bp). And there was<br />

1 bp variant at the intron (G21830A). All of missense and<br />

nonsense mutations except R168X were located either in the<br />

methyl-CpG binding domain or in the transcriptional repression<br />

domain. The three large deletion mutations were<br />

located in a hot spot for deletion that has been reported. A<br />

missense variant (P381G) was detected in a patient and her<br />

father. Mutations in MECP2 gene were considered to be a<br />

cause for Rett syndrome, and can be found in about 55%<br />

cases in our study.<br />

FP-K-038<br />

Citrullinuria: report of one case<br />

Q. Chen, K.-M. Xu, L.-W. Wang<br />

Capital Institute of Pediatrics, Beijing, China<br />

Citrullinuria is a genetic disease caused by deficiency of<br />

argininosuccinate synthetase (ASS). ASS is a urea cycle<br />

enzyme that catalyzes the synthesization of argininosuccinate<br />

from citrulline and aspartate. The deficiency of ASS<br />

results in hyperammonemia and increased citrulline in urine<br />

as well as a variety of symptoms. A 5-year-old girl was<br />

admitted to our department because of sleeplessness at<br />

night. She was born after a full-term pregnancy by normal<br />

natural delivery and was breast-fed. Her mother was in good<br />

health and had no illness during her pregnancy. Physical<br />

examination revealed normal vital signs, length, body<br />

weight and head circumference. The patient had a massively<br />

enlarged liver, 4 cm below the costal margins. She had no<br />

splenomegaly. There was no lymphadenopathy or skin rash.<br />

She had mild mental retardation (IQ ¼ 65). Her laboratory<br />

findings were mild hyperammonemia (142 mg/dl, normal<br />

,100 mg/dl). Citrulline in her urine determined by GC-<br />

MS was high (14882.3 nmol/mg, normal ,80 nmol/mg).<br />

Complete blood counts were normal; electrolytes and<br />

blood biochemistry test and blood gas analysis were within<br />

normal limit. She was started on a low protein diet after<br />

diagnosis.<br />

FP-K-039<br />

Analysis of clinical manifestations and follow-up in 130<br />

patients with Wilson’s disease<br />

J.-F. Lu, Q.-X. Shui<br />

Department of Neurology, Children’s Hospital, College of<br />

Medicine, Zhejiang <strong>University</strong>, Hangzhou, China<br />

Objective: To investigate the clinical and laboratory<br />

manifestations, and to improve diagnosis accuracy and the<br />

quality of patient’s life. Methods: A total of 130 cases with<br />

Wilson’s disease during 1974–2001 were analyzed and 53<br />

of them were followed up for 1.5–16 years. Results: Seventy<br />

patients presented with liver manifestations (about 53.8%),<br />

45 cases were found neurological damage (36.3%). Fiftyone<br />

cases were CT scanned, with 33 to be found abnormal.<br />

A total of 105 of 130 patients (80.8%) were misdiagnosed at<br />

the beginning. Fifty-three patients were followed up, and 12<br />

of them died from this disease. It was found that early diagnosis<br />

and treatment could lead to good outcome. Conclusion:<br />

Patients with Wilson’s disease are usually<br />

misdiagnosed, therefore it was essential to do laboratory<br />

examination and CT scan to the patients with unknown<br />

liver damage and neurological symptoms. Early diagnosis<br />

and long-term supervised treatment are very important for<br />

good outcome.<br />

FP-K-040<br />

Neurological assessments of phenylketonuria (PKU)<br />

patients<br />

Z.-S. Zhou, W.-M. Yu, C.-N. Zheng, P.-F. Xu<br />

Pediatric department, China-Japan Friendship Hospital,<br />

Beijing, China<br />

Objective: To explore the influence of PKU on neurological<br />

system (NS), 563 PKU patients were assessed for<br />

neurology in this study. Subjects and method: A total of<br />

563 PKU patients (aged 2 days–7 years old) were divided<br />

into two groups. One hundred nine early-treated cases (,3


570<br />

Abstracts<br />

months old) including 82 screened neonates, and 454 latetreated<br />

cases (.3 months old). All underwent clinic neurological<br />

assessments. DQ and IQ were used to evaluate<br />

mental retardation. Morphological changes of brain were<br />

evaluated with Staudt’s staging system about brain myelination<br />

and MRI grading method proposed by Thompson et<br />

al. Results: Among the early-treated group, there was no<br />

NS abnormality in 82 screened cases and mild neurological<br />

abnormality in 27 cases. Among the late-treated cases, a<br />

few patients displayed mental retardation, epilepsy, disturbance<br />

of speech, behavior disorders, affective disorder and<br />

motor retardation. Fine motor defect was prominent among<br />

the movement dysfunction. The later treatments started, the<br />

severe damage of NS occurred. Abnormal EEG records<br />

were found in 68% of 360 cases. MRI scans in 73 cases<br />

before treatment revealed abnormal high T 2 -signal intensity<br />

in the deep white matter and delayed myelination.<br />

Follow-up of 210 cases showed that after specific dietary<br />

and anti-epileptic treatments, except mental retardation,<br />

most NS symptoms had different degrees of recovery.<br />

The neuroimage abnormalities were also improved partly.<br />

Conclusion: Late-treated PKU cases had obvious NS<br />

damage, and the mental retardation was more prominent<br />

than motor retardation. The later treatment started, the<br />

severer damage of NS occurred. It is very important to<br />

carry out nationwide early neonatal screening program of<br />

PKU.<br />

FP-K-041<br />

MECP2 mutations in Swedish Rett syndrome clusters<br />

F.-Q. Xiang, Y. Stenbom, M. Anvret<br />

Department of Clinical Neuroscience, Karolinska Institute<br />

CMM-L8-02, Karonlinska Hospital Stockholm, Sweden<br />

Previous genealogic studies on Swedish females with<br />

RTT documented an increased rate of common ancestry,<br />

with a high percentage originating generations back in the<br />

same small area, ‘Rett area’ (homested). These data indicate<br />

that the disease transmission starting with a premutation<br />

that over generations can result in a full mutation<br />

giving rise to RTT, such as trinucleotide repeat expansion<br />

disease. The discovery of the RTT gene, MECP2 made it<br />

interesting to investigate the MECP2 gene in the RTT<br />

clusters to clarify the hypothesis of genetic transmission.<br />

In this study, RTT patients from three so-called RTT clusters<br />

were investigated for MECP2 mutation. Our data indicate<br />

that not all patients belonging to the same cluster had<br />

mutations and those who were positive harbored different<br />

mutations. This suggests that the Swedish RTT girls<br />

belonging to the same clusters may not be genetically<br />

related to each other and theMECP2 is not the only explanation<br />

to RTT.<br />

FP-K-042<br />

Pathogenetic significance of the CLN2 protein in lateinfantile<br />

neuronal ceroid lipofuscinosis<br />

Y.K. Hanafusa b,c , A. Oka d , M. Itoh b , M. Mizuguchi e ,M.<br />

Hayashi f , Y.-I. Goto b , S. Takashima a<br />

a National Institute of Neuroscience, National Center of<br />

Neurology and Psychiatry (NCNP); b Department of Mental<br />

Retardation and Birth Defect Research, National Institute of<br />

Neuroscience, NCNP; c Department of Pediatrics, Faculty<br />

of Medicine, <strong>University</strong> of Tokyo;<br />

d Division of Child<br />

Neurology, Institute of Neurological Sciences, Faculty of<br />

Medicine, Tottori <strong>University</strong>; e Department of Pediatrics,<br />

Jichi Medical School; f Department of Child Neuropathology,<br />

Tokyo Metropolitan Institute of Neuroscience,<br />

Kodaira, Tokyo 187-8502, Japan<br />

NCLs are hereditary progressive neurodegenerative<br />

diseases during childhood. The LINCL is caused by a mutation<br />

of the CLN2 gene, which encodes a lysosomal protein<br />

of 46–49 kDa. We previously raised polyclonal antibodies<br />

against the CLN2 gene product, and confirmed that they<br />

recognize the CLN2 protein on Western blots. To clarify<br />

when and where the CLN2 protein is expressed in human<br />

organs, we examined tissue specimens (brain and visceral<br />

organs) and cultured cells (fibroblasts) of both NCL patients<br />

and normal controls, by immunohistochemistry and<br />

Western blotting. Immunostaining of control tissues showed<br />

that the CLN2 immunoreactivity was ubiquitous in extracerebral<br />

organs as well as in the central nervous system.<br />

Intense immunoreactivity was seen in cells with phagocytic<br />

function, such as the Kupffer cells and pericytes. In pericytes,<br />

immunoreactivity was seen from the neonatal period.<br />

In the brainstem, CLN2 expression was already seen in the<br />

perinatal period. In the cerebral cortex and brainstem,<br />

neurons express the CLN2 protein, which increased with<br />

development, and reached the adult level at the age of<br />

around 2–3 years. In tissues and cells of LINCL patients,<br />

CLN2 expression was absent. The developmental profile of<br />

CLN2 expression in cortical neurons may be related to the<br />

clinical onset of LINCL.<br />

FP-K-043<br />

A novel mitochondrial mutation T3386C presenting with<br />

mental retardation, hypoparathyroidism, distal renal<br />

tubular acidosis and lactic acidosis<br />

S.K.H. Tay, K.S. Poh, K.Y. Loke<br />

Department of paediatrics, National university of Singapore,<br />

Singapore<br />

We report a novel mitochondrial mutation in a child with<br />

an unusual presentation of mitochondrial disorder. The child<br />

was 16 years old and was the fourth child of non-consanguineous<br />

parents, with a significant family history of two<br />

maternal aunts with recurrent pathological fractures and


Abstracts 571<br />

acidosis. He presented with mental retardation, recurrent<br />

bone fractures and short stature. He had distal renal tubular<br />

acidosis and hypoparathyroidism and was found to have<br />

mild lactic acidosis once only despite repeated testing. He<br />

was found on direct PCR sequencing of the ND1 gene to<br />

have a novel point mutation of the ND1 gene T3386C. This<br />

was a missense mutation that coded for a change in amino<br />

acid isoleucine to threonine at codon 27. This case illustrates<br />

the diversity of presentation of mitochondrial disorders<br />

and the need to consider mitochondrial disease as a<br />

diagnosis in a patient with multi-organ pathology even in<br />

the absence of persistent lactic acidosis.<br />

FP-K-044<br />

Rett syndrome brain neuromorphology: peculiar<br />

adaptive and protective properties of neurons in<br />

entorhinal cortex and thalamic motor nuclei<br />

L.A. Bereshnaya a , J.K. Mukhina a , P.V. Belichenko b<br />

a Brain Research Institute RAMS, Moscow, Russia; b Department<br />

of Neurology and Neurological Sciences, Stanford<br />

<strong>University</strong>, Stanford, USA<br />

RS is a neurodevelopmental disorder affecting young girls<br />

with most cases of this disease associated with mutation in<br />

the X-linked MeCP2 gene. RS patients have severe motor<br />

and cognitive dysfunction. Detailed morphological analysis<br />

demonstrated cell loss, increase in neuronal and glial density,<br />

reduced white matter volume and changes in the dendritic<br />

geometry of neurons. It is practically important to study<br />

morphological changes in single neurons related to both<br />

degenerative and compensatory events. The aim of the<br />

present work was to study the peculiarities of adaptation<br />

reactions in neurons of thalamic nuclei (ventral anterior<br />

and ventral lateralis) and in entorhinal cortex, the areas<br />

which were most affected in RS. Six cases of RS brains (8–<br />

12 years old) were studied by classical Nissl and Kluver-<br />

Barrera methods. Destructive changes included swelling of<br />

neuronal soma and dendrites, diffuse or peripheral chromatolysis<br />

of neurons, neuronal hyperchromia, vacuolization<br />

and presence of ‘ghost’ cells. Also, compensatory adaptation<br />

in neurons could be seen on the RS brains: juxtaposition of<br />

two neurons with joint cytoplasm and/or with common<br />

surface contact, formation of neuronal clusters from similar<br />

cells. These adaptive changes could be directed to maintain<br />

survival functions for these modified neurons.<br />

FP-K-045<br />

Leber’s congenital amaurosis: neurological and systemic<br />

findings<br />

E. Fazzi a , S.M. Bova a , S.G. Signorini a , J. Lanners b ,G.<br />

Lanzi a<br />

a Department of Child Neurology and Psychiatry - IRCCS C.<br />

Mondino, Pavia, Italy; b R. Holmann Foundation, Cannero<br />

Riviera (VB), Italy<br />

Leber’s congenital amaurosis (LCA) is the earliest and<br />

most severe form of inherited retinal dystrophies. It is an<br />

autosomal recessive disease, which accounts for 10–18% of<br />

congenital blindness. Its incidence is 2–3 per 100 000<br />

births. Currently accepted diagnostic criteria refer to ocular<br />

findings, but neurodevelopmental delay, mental retardation,<br />

and systemic anomalies have been frequently reported. We<br />

studied a sample of 35 children affected by LCA (mean age<br />

at first observation: 19 months, range: 6–50 months) in order<br />

to clarify the clinical aspects of this disorder, and to contribute<br />

to a new classification, correlating genotype with<br />

phenotype. All subjects underwent neurological and<br />

neurophthalmological examination, neurophysiological<br />

examinations (ERG, VEPs), EEG, BAEP, brain MRI,<br />

screening for metabolic disease (mitochondrial and peroxisomal<br />

disorders) and systemic involvement (abdomenpelvis<br />

US, hand X-ray). A developmental assessment<br />

using specific Scales for visually impaired children, and<br />

videotape (for stereotypic behaviours-SB) were also<br />

performed. Neurological examination was normal except<br />

for mild muscular hypotonia, mental retardation was documented<br />

in 20%, SB were very frequent (18–93% depending<br />

on the kind of SB), EEG showed floating alpha (21%) or<br />

slow activity (21%), pathological findings on brain MRI<br />

were detected in the 53% (ventricular enlargement, mild<br />

cerebral atrophy, white matter abnormalities, median line<br />

cysts). Systemic abnormalities were detected in a small<br />

but significant percentage of subjects. Our data confirm<br />

that LCA is a heterogeneous entity which can present itself<br />

as an isolate ocular pattern, or associated to neurological<br />

and systemic abnormalities, and support the need for a<br />

multidisciplinary approach and for genotypic-phenotypic<br />

studies.<br />

FP-K-046<br />

Rett syndrome cases at the Philippine Children’s<br />

Medical Center (1989–2001)<br />

M.H. Ortiz, L.V. Lee, E.L. Avendaño<br />

Child Neuroscience Division Philippine Children’s Medical<br />

Center Quezon Avenue, Quezon City Philippines<br />

Rett syndrome is an X-linked neurodevelopmental disorder<br />

affecting mainly females characterized by an apparently<br />

normal psychomotor development for the first 6<br />

months of life. After this age, developmental progress<br />

slows. Eighteen cases of Filipino girls with Rett syndrome<br />

diagnosed over a 12-year period will be presented. Their<br />

clinical manifestations as well as temporal profile will be<br />

described in detail. Age at onset ranged from 6 to 24<br />

months and age at initial consult was 1.1–5.10 years. Thirteen/18<br />

had an initial diagnosis of Rett syndrome, three<br />

were initially diagnosed to have autism and two were diagnosed<br />

to have psychomotor retardation of unknown etiology.<br />

All had a history of an apparently normal prenatal and<br />

perinatal period with 15/18 presenting with regression of


572<br />

Abstracts<br />

previously learned skills. Of the 11 patients with head<br />

circumference measurements noted at birth, ten (90%)<br />

had normal head circumference while one (10%) had a<br />

head circumference below the 2nd percentile. Hand<br />

apraxia, repetitive stereotypic hand movements, impaired<br />

receptive and expressive language with psychomotor retardation<br />

as well as truncal and gait ataxia was seen in all<br />

patients. Nine/18 children had breathing dysfunction.<br />

Seventeen presented with an abnormal EEG and 13 were<br />

diagnosed to have seizure disorder.<br />

FP-K-047<br />

Mutation analysis of methyl-CpG binding protein gene<br />

family in autistic patients<br />

H. Li, T. Yamagata, M. Mori, M.Y. Momoi<br />

Department of Pediatrics, Jichi Medical School, Minamikawachi,<br />

Tochigi, Japan<br />

Autism is a complex neurodevelopmental disorder with<br />

multigenic etiology. Methyl-CpG binding protein 2 gene<br />

(MeCP2) mutation was reported to be the cause of Rett<br />

syndrome, and was also involved in X-linked mental retardation<br />

and autistic disorder. Methyl-CpG binding protein<br />

family consists of MeCP2, MBD1, MBD2, MBD3 and<br />

MBD4, sharing the common methyl-CpG binding domain<br />

(MBD). All MBDs except for MBD4 form complexes with<br />

histone deacetylases and are involved in recruiting histone<br />

deacetylases to methyl-CpG enriched regions in the genome<br />

to repress transcription. Gene silencing is suspected to be<br />

involved in etiology of autism. Thus, we screened these<br />

genes as candidate genes for disease-causative mutations<br />

in autism patients using denaturing high-performance liquid<br />

chromatography (DHPLC) followed by sequencing. We<br />

detected several polymorphisms and found some interesting<br />

base changes. In MBD1, one novel missense mutation,<br />

R269C, in the exon 9 was detected in one patient. It was<br />

also detected in his father, who also has some autism-like<br />

symptom and his normal sister, but not in 100 normal<br />

controls. This mutation may relate to the genesis of autism<br />

although normal sister had same mutation, relating to sex<br />

bias or some other gene’s combination. In MBD2, two<br />

repeat variants (GGC and GGGGCC) in exon1 were<br />

detected in five patients. Although these were also detected<br />

in normal control, it looks interesting to screen more<br />

patients because more expansion out of the range of PCR<br />

may exist and relate to the disease. Autism is thought to be<br />

polygenic disease and methyl-CpG binding proteins family<br />

genes’ high-polymorphic nucleotide changes may have<br />

some effect on the etiology of autism. Further analysis on<br />

more samples is required to clarify their contribution to<br />

autism.<br />

FP-K-048<br />

Down syndrome: a link between development and aging<br />

I.T. Lott, E. Head, L. Nelson, K. Osann, E. Doran<br />

<strong>University</strong> of California, Irvine Departments of Pediatrics<br />

and Neurology; Institute on Brain Aging and Dementia UCI<br />

Medical Center, Orange, CA, USA<br />

The brains from individuals with Down syndrome (DS)<br />

show the changes of Alzheimer’s disease (AD) by age 40<br />

years. We have shown that b amyloid (Ab) is deposited in<br />

DS beginning in childhood (Exp Neurol 2000;163:111) and<br />

is associated with inflammatory and oxidative changes in<br />

the course of brain maturation (Neurbiol Dis 2001;8:792).<br />

The topography of cell loss secondary to AD in DS involves<br />

cholinergic neurons and recent reviews have suggested that<br />

a pathological cascade may involve both Ab and cholinergic<br />

dysfunction in the disorder. Based upon these observations,<br />

we undertook a pilot investigation of an<br />

acetycholinesterase inhibitor (donepezil) in 15 patients<br />

with trisomy 21 for a 5-month period. Treated (n ¼ 9) and<br />

control subjects (n ¼ 6) were comparable with respect to<br />

initial level of dementia, length of follow-up, and age.<br />

Utilizing the Down Syndrome Dementia Scale (Gedye,<br />

1995), the subjects treated with donepezil showed an<br />

improvement in test scores (mean ¼ 24.3, SEM ¼ 4.0)<br />

after 5 months compared to the control group<br />

(mean ¼ 30.7, SEM ¼ 3.0) with the results statistically<br />

significant at P ¼ 0:03. No serious side effects of the drug<br />

were encountered. The results of this pilot study suggest that<br />

further placebo-controlled trials of acetycholinesterase inhibitors<br />

are indicated for treatment of dementia in DS<br />

(supported in part by AG 05142).<br />

FP-K-049<br />

Describing the phenotype in Rett syndrome<br />

H. Leonard a , L. Colvin a , S. Fyfe b , J. Christodoulou c,d ,L.<br />

Raffaele c,d , S. Leonard a , T. Schiavello a , C. Ellaway c,d ,M.<br />

Davis e , N. De Klerk a<br />

a TVW Telethon Institute for Child Health Research, Western<br />

Australia; b Curtin <strong>University</strong> of Technology, Perth, Western<br />

Australia; c Children’s Hospital at Westmead, Sydney New<br />

South Wales; d Department of Paediatrics and Child Health,<br />

<strong>University</strong> of Sydney, Sydney, New South Wales; e Royal<br />

Perth Hospital, Perth, Western Australia<br />

The Australian Rett syndrome epidemiological research<br />

program is internationally unique with ongoing case ascertainment<br />

on a population basis since 1993. By July 2000,<br />

199 verified cases had been reported to the database and<br />

comprehensive phenotype data were collected on 152 of<br />

these. By end of 2001 there were 227 verified cases, fourteen<br />

of whom had died. Molecular testing has now been<br />

undertaken on 77% (174/227) cases and X inactivation<br />

status is complete on one third of the cohort. Of the 152


Abstracts 573<br />

cases surveyed in the 2000 follow up 84 (55.2%) were categorised<br />

as classical, 40 (26.3%) as early onset atypical and<br />

28 (18.5%) as mild atypical. Using the scoring system<br />

suggested by Kerr et al. (2001) we were able to show<br />

considerable variation in clinical severity with a mean of<br />

22.9, and a range from 9.3 to 32.0. Similar variation was<br />

seen using the scale adapted by Percy from Amir et al.<br />

(2000) and the scale designed by Monros et al. (2001) and<br />

modified by Pineda. Age-related changes were seen with the<br />

Kerr (20.5–24.2) and Percy scores (34.4–39.4) but not with<br />

the Pineda score. By including a questionnaire version of the<br />

WeeFIM (the Functional Independence Measure for Children)<br />

(Msall et al., 1994) we were also able to calculate a<br />

WeeFIM score. The mean WeeFIM score was 29 (range 18–<br />

75). Mutations have been identified in 73% (68/93) of classical<br />

and 65% (53/81) of atypical cases. The mean phenotype<br />

scores for the three scales and the mean WeeFIM score<br />

were calculated for each of nine common mutations. The<br />

R133C mutation had a significantly lower Pineda score<br />

(11.8) and a higher WeeFIM score (36) than the others<br />

indicating better functioning. This was followed by the<br />

R294 X with scores of 12.9 and 34.9. The poorest functioning<br />

was for the R270 X and P152R mutations with Pineda<br />

scores of 19.2 and 19.8 respectively. Overall the mean<br />

WeeFIM score was higher in those cases with skewed<br />

(31.9) than in those with random (25.6) X inactivation<br />

(P ¼ 0:03). In the 27 atypical cases in which X inactivation<br />

studies were complete, 10 of the 13 mild atypical cases had<br />

skewing compared with four of 14 with early onset atypical<br />

(P ¼ 0:01). In Australia ongoing case ascertainment<br />

combined with active follow up of existing cases provides<br />

a unique longitudinal profile of a genetically characterised<br />

Rett syndrome cohort over a period of 10 years.<br />

FP-K-050<br />

Neurobehavioral findings in early and late treated<br />

children with phenylketonuria<br />

K. Yalaz, L. Vanlı, I. Ozalp, T. Coşkun, A. Tokatlı, M.<br />

Özgüç<br />

Hacettepe <strong>University</strong> Departments of Pediatric Neurology,<br />

Metabolism, and Medical Biology, Ankara, Turkey<br />

We evaluated 47 children with PKU treated before they<br />

were 45 days old and 99 children treated after this age.<br />

Neurological and neurobehavioral findings including head<br />

circumference, motor performance, behavioral pattern,<br />

intellectual capacity as well as phenylalanine level and<br />

molecular analysis for phenotype-genotype correlation<br />

were examined. Microcephaly, depressed or absent deep<br />

tendon reflexes, tremor of the hands, mental retardation,<br />

hyperactivity were present in both groups but were less<br />

severe in early-treated children. Autistic signs were present<br />

only in late-treated patients. Children whose clinical<br />

response to diet restriction was unsatisfactory or less than<br />

expected had additional medical problems: maternal PKU in<br />

addition to the child’s encephalopathic episode, or other<br />

metabolic disorder. The degree of impairment could differ<br />

between siblings with the same genotype; in addition, earlytreated<br />

siblings could have lower function than later-treated<br />

ones. Further studies are needed to confirm the effect of<br />

other genes modulating the phenotype in PKU.<br />

FP-K-051<br />

Preserved speech variants of classic Rett syndrome:<br />

beneficial effects of long term l-carnitine therapy<br />

M. Topcu, C. Akyerli, R.S. Kocoglu, A. Sayi, G. Haliloglu,<br />

D. Yalnizoglu, T. Ozcelik<br />

Hacettepe <strong>University</strong> Faculty of Medicine Department of<br />

Pediatric Neurology, Bilkent <strong>University</strong> Department of<br />

Molecular Biology and Genetics, Ankara, Turkey<br />

RTT is a neurodevelopmental disorder of early childhood<br />

that is primarily seen in girls. The gene responsible for this<br />

disorder has been identified as MECP2. Although the type of<br />

mutations in MECP2 have been found to be correlated with<br />

the phenotypic manifestations of RTT to some degree, the<br />

pattern of X inactivation appears to be the major determinant<br />

in different studies including our own series. The disease is<br />

incurable as yet, and treatment strategies are essentially<br />

symptomatic and supportive including l-carnitine for<br />

improvement in patient well-being and hand function. We<br />

performed a detailed phenotype-genotype correlation in our<br />

MECP2 mutation positive RTT patients (n ¼ 20) including<br />

three girls who can be classified as preserved speech variants<br />

of the disorder. Two of these girls, an 11-year-old who carries<br />

the T158M mutation and a 4-year-old who carries the P152R<br />

mutation, associated with the classic form of the disease. The<br />

well established androgen receptor assay revealed that X-<br />

inactivation patterns are random. Both of these girls have<br />

been on 500 mg/day l-carnitine treatment since 18 months<br />

of age. The third preserved speech variant carries a 44 bp<br />

deletion at the 3 0 -end of the MECP2 gene, and mild phenotype<br />

associated with these mutations has been reported in the<br />

literature. These results may suggest that beneficial effects of<br />

l-carnitine may go beyond an improvement in patient wellbeing<br />

and hand function when administered at the early<br />

stages of the disorder.<br />

FP-K-052<br />

Rett syndrome in Hungary: clinical and mutation<br />

analysis of the Hungarian Rett syndrome girls<br />

K. Hollódy a ,J.Kárteszi b , J. Bene b , M. Czakó b , B. Melegh b ,<br />

G. Kosztolányi b<br />

a Department of Pediatrics, b Department of Medical Genetics<br />

and Child Development, <strong>University</strong> of Pécs, Pécs,<br />

Hungary<br />

Rett syndrome is a neurodevelopmental disorder. In a<br />

high proportion of sporadic patients it is caused by muta-


574<br />

Abstracts<br />

tions in the X-linked MECP2 gene. Aim: To characterize the<br />

spectrum of the clinical forms and the mutations in Hungarian<br />

girls with Rett syndrome and to relate the genetic results<br />

to the clinical features of the disease. Methods: So far we<br />

have examined 22 patients registered in the Hungarian Rett<br />

Syndrome Association. Two girls were twin with classical<br />

features. Twenty patients had no relationships at all. Fifteen<br />

suffer in the classical, seven girls in the atypical form of the<br />

syndrome. One patient has preserved speech, another one<br />

has tuberous sclerosis. A very thorough history was taken<br />

from the parents of the girls and a detailed clinical examination<br />

was performed by a pediatric neurologist, a clinical<br />

geneticist, an orthopedist, a radiologist, a gastroenterologist<br />

and a psychologist. Mutation analysis of MECP2 coding<br />

region was done by direct sequencing. Results: Mutations<br />

in the MeCP2 gene were found in 12/22 patients (54%).<br />

Among them, all but four have the clinical signs of the<br />

classical form, four have the atypical form. Eight already<br />

described mutations were detected in ten patients (R294X in<br />

three patients, R106W in two patients, in one each patient<br />

R133C, R168X, R270X, P152R, T158M). Among the three<br />

patients with the R294X mutation two have the classical and<br />

one the preserved speech variant form of Rett syndrome. In<br />

our oldest, atypical Rett syndrome patient (22 years of age)<br />

a novel single base insertion in exon 3 (276insG) was<br />

detected. A large deletion in exon 4 was found in a patient<br />

with classical form. Similarly to the published Swedish data<br />

no mutations of MECP2 gene were identified in the twin<br />

Rett syndrome patients. According to the prevalence of the<br />

disease there must be ca. 40–45 girls with Rett syndrome<br />

aged 0–18 years in Hungary. Thirty different mutations<br />

were found in 97 patients with RS. In 81% of the patients<br />

we detected nonsense and missense mutations in the coding<br />

parts of MECP2. Twelve different mutations and one polymorphism<br />

were found. MECP2 may be involved in a<br />

broader phenotype than classical RT including preserved<br />

speech variants. Mutations were identified in 72% of<br />

patients with classical RS.<br />

FP-K-053<br />

Pyruvate dehydrogenase deficiency: Clinical and<br />

molecular analysis<br />

A.M. Garcia, D. Wang, P. Kranz-Eble, D.C. De Vivo<br />

Colleen Giblin Laboratories for Pediatric Neurology<br />

Research, Columbia <strong>University</strong>, New York, USA<br />

Defects in the pyruvate dehydrogenase complex are an<br />

important cause of primary lactic acidosis, a frequent manifestation<br />

of metabolic disease in young children. Clinical<br />

manifestations are heterogeneous ranging from episodic<br />

ataxia and weakness to chronic encephalopathy and congenital<br />

lactic acidosis. The great majority of cases result from<br />

mutations in the E1a subunit gene, located on the X chromosome<br />

(Xp22.1). We present 19 patients (12 males) with pyruvate<br />

dehydrogenase deficiency caused by mutations in the<br />

E1a gene. Eleven patients (two females) showed early onset<br />

with severe lactic acidosis, six of them associated with abnormal<br />

neuroimages. Six patients (one male) developed a<br />

chronic encephalopathy with diverse CNS malformations<br />

in the five females. Two boys had a benign syndrome characterized<br />

by recurrent limb weakness, muscular cramps and<br />

exercise intolerance. Eight patients had genomic rearrangements;<br />

all located in exons 10 and 11. Six patients had a<br />

tandem repeat insertion (S370ins, Q382fs, S388ins,<br />

G365ins, K387fs, N326ins) and two had a microdeletion<br />

(S312fs, R310del). Four missense mutations were located<br />

in the upstream region of the gene involving exons 4–6,<br />

respectively. A number of previously recognized gender<br />

specific hot spots for mutations were detected. Those associated<br />

with females (S312fs, R302C, Q382fs) suggest that<br />

these mutations are severe and probably lethal in male<br />

fetuses, whereas those associated with males (K387fs,<br />

R263Q, N164S, R127W, R310del) are presumably female<br />

asymptomatic.<br />

FP-K-054<br />

Gene transfer to CNS by intrauterine administration of<br />

adenovirus.<br />

J.-S. Shen a , X.-L. Meng a , T. Ohashi a,b , Y. Eto a,b<br />

a Department of Gene Therapy, Institute of DNA Medicine;<br />

b Department of Pediatrics, The Jikei <strong>University</strong> School of<br />

Medicine, Tokyo, Japan<br />

Early and severe CNS involvement occurs in some lysosomal<br />

storage disorders such as Tay-Sachs disease, type II<br />

Gaucher disease and infantile form of Krabbe disease. In<br />

these diseases, lysosomal storage and considerable neuropathology<br />

was observed even prior to birth. Postnatal therapies,<br />

including bone marrow transplantation, enzyme<br />

replacement therapy and gene therapy are often insufficient<br />

in the treatment of these diseases. Therefore prenatal gene<br />

therapy to the CNS may be necessary. In order to investigate<br />

gene transfer to the CNS prenatally, we administered<br />

recombinant adenovirus encoding E. coli -galactosidase (-<br />

Gal) to the lateral ventricles of the brain of mouse embryos<br />

at mid-gestational period, and studied expression pattern of<br />

the transgene at various time points. Results showed that<br />

most of -Gal positive cells are distributed in the cerebral<br />

cortex and some in the brainstem and cerebellar cortex.<br />

Immunohistochemical observations using cell type specific<br />

antibodies indicated that the most of them are neurons and<br />

some are astrocytes. Histochemical and biochemical analysis<br />

showed the expression of -Gal started as early as 2 days<br />

after administration and persisted at least 2 months after<br />

birth without significant decrement of expression level.<br />

The results indicate that intrauterine administration of<br />

adenoviral vector may be useful as a gene therapy strategy<br />

for some lysosomal storage diseases with early CNS involvements.


Abstracts 575<br />

FP-K-055<br />

Frequency of major mutations in Ukrainian patients<br />

with metachromatic leucodystrophy<br />

N.V. Olkhovich, N.A. Pichkur, A.N. Nedoboy<br />

Ukrainian Specialized Children’s Hospital ‘OKhMATDET’,<br />

Kyiv, Ukraine<br />

Nine patients with MLD from eight families were examined<br />

using clinical, biochemical and molecular-genetic<br />

methods. Three patients were diagnosed with late-infantile<br />

form and the illness debut at the age of 12–24 months. Four<br />

patients were diagnosed with juvenile form, the illness<br />

began at the age of 3–7 years. Two patients were the siblings<br />

and had adult MLD form. Arylsulfatase A (ASA) activity<br />

was determined by the standard method of Baum A. et al.<br />

All the examined patients had decreased ASA activity.<br />

Mutations causing MLD were detected in the ASA gene<br />

by polymerase chain reaction amplification of fragments<br />

of the ASA gene and digestion by the appropriate endonuclease.<br />

All patients were screened for ASA-pd mutation.<br />

One homozygote for the splice mutation in intron 2<br />

(459 1 1G ! A) and one compound heterozygosity with<br />

splice mutation 459 1 1G ! A and missence mutation P<br />

426L were detected. Compound heterozygosity with<br />

P426L mutation and unknown mutation were detected in<br />

two patients. The overall frequency of the 459 1 1G ! A<br />

change was three of all 18 MLD alleles and of the P426<br />

change was three of all 18 MLD alleles. Thus, these two<br />

common alleles together accounted for 33% of all MLD<br />

alleles.<br />

FP-K-056<br />

Disease progression in X-linked adrenoleukodystrophy<br />

based on magnetic resonance imaging<br />

D.J. Loes, A. Fatemi, E.R. Melhem, N. Gupte, L. Bezman,<br />

H.W. Moser, G.V. Raymond<br />

Suburban Radiology Consultant Ltd., Minneapolis, MN;<br />

Department of Radiology, <strong>University</strong> of Pennsylvania,<br />

Philadelphia, PA and the Kennedy Krieger Institute and<br />

School of Public Health, Johns Hopkins Medical Institutions,<br />

Baltimore, MD, USA<br />

Introduction: X-linked adrenoleukodystrophy (X-ALD)<br />

has many variants with outcomes that range from no deficits<br />

to death. The purpose of this study was to evaluate the<br />

degree to which MRI findings can predict MRI disease<br />

progression in male X-ALD patients. Methods: Follow-up<br />

MR Imaging studies were performed in 140 X-ALD patients<br />

with cerebral involvement (median age: 12.3, range 1.7–<br />

73.8). Data after bone marrow transplant was excluded.<br />

Gadolinium enhanced axial T1W imaging was performed<br />

in 40 of these patients. Depending on the anatomical location<br />

of the primary involved area three patterns were defined<br />

(pattern 1: parieto-occipital; pattern 2: frontal lobe; and<br />

pattern 3: frontal-pontine/cortical-spinal projection fibers).<br />

Regression analyses were performed to determine the<br />

effects of multiple MRI factors on disease progression.<br />

Results: Average follow-up time was 3.51 years (59 days–<br />

11.1 years). The mean progression of the MRI score per year<br />

was 2.2 ^ 0.55 for pattern 1 and 2.3 ^ 0.75 for pattern 2,<br />

but was much lower, 0.4 ^ 0.16, in patients with pattern 3<br />

(P ¼ 0:001). In patients with pattern 1, age (P ¼ 0:006) and<br />

MRI severity score (P , 0:0001) at initial exam and<br />

presence or absence of perilesional contrast enhancement<br />

(P , 0:0001) accounted for 96% of the variability of MRI<br />

progression after 1 year, while in patients with pattern 2 age<br />

(P ¼ 0:05) and the initial MRI severity score (P , 0:0001)<br />

accounted for 79% of the variability. Conclusions: Our<br />

results demonstrate that differences in anatomical patterns<br />

and perilesional contrast enhancement play a significant role<br />

in prediction of disease progression and can serve as additional<br />

disease markers in the evaluation and management of<br />

X-ALD patients.<br />

FP-K-057<br />

Brain magnetic resonance imaging abnormalities in<br />

females heterozygous for X-linked<br />

adrenoleukodystrophy and association with X<br />

inactivation in fibroblasts<br />

A. Fatemi, P.A. Watkins, A.B. Moser, P.B. Barker, G.V.<br />

Raymond, H.W. Moser, S. Naidu<br />

The Kennedy Krieger Institute, Johns Hopkins Medical<br />

Institutions, Baltimore, MD, USA<br />

Objective: Although the degree of cerebral involvement<br />

has been investigated extensively in affected males with X-<br />

ALD, there is limited data for heterozygote females. The<br />

purpose of this study was to determine the degree of brain<br />

involvement in this group and to investigate the possible<br />

association between MRI abnormalities and the degree of<br />

X inactivation in fibroblasts. Methods: Conventional MRI<br />

studies were performed in 75 X-ALD heterozygotes (mean<br />

age: 42.2, median: 41.3, range: 13–75). Indirect immunofluorescence<br />

analysis of cultured skin fibroblasts using an<br />

antibody raised against the C-terminal 18 amino acids of the<br />

human peroxisomal ALDP revealed a punctate, peroxisomal<br />

immunostaining pattern and average percentages of<br />

immunopositive cells were calculated. Results: Prominent<br />

bilateral white matter T2 signal hyperintensities were<br />

observed in two girls (13, and 14 years old) and a 42<br />

years old women heterozygous for X-ALD. While in heterozygotes<br />

with normal MRI a mixed population of normal and<br />

abnormal cells was demonstrated, typically ranging from 20<br />

to 80% normal ALDP positive cells, the three patients with<br />

MRI abnormalities had 0, 1 and 7% (in the 14, 13 and 43<br />

year old, respectively) immunopositive cells suggesting<br />

skewed X inactivation. Conclusion: MRI changes similar<br />

to cerebral childhood X-ALD in males were detected in<br />

heterozygote females who showed an absence or a very


576<br />

Abstracts<br />

low ALDP expression in fibroblasts. These results suggest<br />

that assessment of X inactivation in fibroblasts correlates<br />

with the degree of brain involvement.<br />

FP-K-058<br />

Contiguous deletion of the X-linked<br />

adrenoleukodystrophy gene and DXS1357E cause a<br />

neonatal phenotype similar to peroxisomal biogenesis<br />

disorders<br />

S.J. Steinberg a,b , K. Johnson a , G.R. Cutting a,c ,P.A.<br />

Watkins a,b , A.B. Moser a,b , H.W. Moser a,b<br />

a The Kennedy Krieger Institute and b Department of Neurology,<br />

c Institute of Genetic Medicine, Johns Hopkins <strong>University</strong><br />

School of Medicine, Baltimore, MD, USA<br />

Plasma VLCFA analysis is a reliable screening tool for<br />

the identification of patients with a perturbation of peroxisomal<br />

fatty acid metabolism, including the disorders X-<br />

ALD, peroxisomal biogenesis disorders (PBD) and other<br />

single enzyme deficiencies (SED) such as D-bifunctional<br />

protein deficiency. The spectrum of X-ALD clinical phenotypes<br />

is readily distinguishable from PBD and SED.<br />

Whereas PBD and SED patients have congenital malformations<br />

and are ill from birth, patients with mutations in the X-<br />

ALD gene, ABCD1, thrive postnatally. We recently identified<br />

three male neonates presenting with severe hypotonia,<br />

cholestatic liver disease and a failure to thrive. All three<br />

died at less than 1 year of age and had increased plasma<br />

VLCFA. Other peroxisomal pathways were normal and<br />

ruled out a PBD. Immunocytochemistry indicated that<br />

their cells lacked ALD protein, but otherwise had normal<br />

peroxisomal structure. Mutation analysis showed that all<br />

three patients had large deletions of ABCD1 that extended<br />

beyond the promoter region and into the neighboring gene<br />

DXS1357. We recommend naming this new disorder<br />

‘Contiguous ABCD1 DXS1357E Deletion Syndrome,’ or<br />

CADDS. Failure to identify X-linked CADDS may lead to<br />

misdiagnosis as autosomal recessive PBD or SED and cause<br />

serious errors in genetic counseling.<br />

FP-K-059<br />

Leukoencefalopathy with vanishing white matter: report<br />

of five Brazilian cases<br />

M.S.T. Souza a ,F.Kok a , C.C. Leite b , M.T.C. Lacerda b ,<br />

M.O.R. Costa b , M.G. Otaduy b , A. Diament a , U.C. Reed a<br />

a Departments of Neurology,<br />

b Radiology of the School of<br />

Medicine of São Paulo <strong>University</strong>, São Paulo, Brazil<br />

In 1993 Hanefeld et al. reported an autosomal recessive<br />

brain white matter abnormality clinically characterized by<br />

early and slowly progressive developmental regression with<br />

episodes of acute deterioration, cerebellar and pyramidal<br />

signs but no remarkable mental deterioration. Brain MRI<br />

showed a widespread leukodystrophy with subcortical cyst<br />

formation. In the last 3 years, we evaluated five patients<br />

from four families who developed such clinical and imaging<br />

changes. All had widespread symmetrical cerebral white<br />

matter involvement, characterized by MRI signal intensity<br />

similar to CSF on all sequences, particularly on T2-<br />

weighted intense signal. No gadolinium enhancement was<br />

detected. In two patients, it was noted a partial preservation<br />

of subcortical U-fibers, and in four individuals, the central<br />

pontine tegmental tract and cerebellar white matter were<br />

also involved. All patients had cavum septi pellucidi and<br />

marked vermis cerebellar abnormality. Spectroscopic analysis<br />

of frontal and parietal white matter revealed decrease but<br />

not complete disappearance of N-acetyl aspartate signal and<br />

height, and marked? slight? increase of choline and myoinositol<br />

peaks. Lactate and glucose spectroscopic peaks<br />

were normal in all patients. Very long chain fatty acids<br />

level, arylsulfatase A and beta galactocerebrosidase activity<br />

were in the normal range. Electroneuromyography was<br />

normal in all patients. We conclude that leukoencefalopathy<br />

with vanishing white matter can be a relatively common<br />

condition in Brazilian children and that this diagnosis<br />

should be considered in the presence of striking MRI<br />

brain white matter changes associated with a chronic clinical<br />

course with acute episodes of motor deterioration and<br />

relatively preserved mental function.<br />

FP-K-060<br />

The participation of microglia in experimentally<br />

induced phenylketonuria<br />

G.G. Skibo a , J.A. McKanna b , O.V. Girnyk a<br />

a Department of Cytology, Bogomoletz Institute of Physiology,<br />

Kiev, Ukraine; b Department of Cell Biology, Vanderbilt<br />

<strong>University</strong>, Nashville, TN, USA<br />

PKU, the neurogenetic disease, is an inherited deficiency<br />

of the enzyme phenylalanine hydroxylase which lead to<br />

increase serum and brain phenylalanine and, as a consequence,<br />

to mental retardation. The primary pathologic findings<br />

during PKU are the loss of number of neurons,<br />

hypomyelination and astrocytosis of central nervous system.<br />

But participation of microglia in this pathological condition<br />

remains unknown. The aim of the present investigation was<br />

to follow the state of microglia in the rat brain with experimentally<br />

produced PKU. The model of PKU was the next:<br />

the rat pups were injected with l-phenylalanine and dl-?-<br />

methylphenylalanine during 3–14th postnatal days. The<br />

tissue of cerebellum and hippocampus was studied at<br />

the14th postnatal day. Lipocortin 1 immunoreactivity<br />

(LC1-ir) was used as a marker for microglia. The area and<br />

the shape factor of microglial cells and density of microglia<br />

in PKU brain were compared with control by computer<br />

system BioQuant OS/2. The area of microglial somata<br />

was larger and processes of microglial cells were shorter<br />

and thicker in cerebellum and hippocampus of treated rats.<br />

The density of LC1-ir microglia was higher in all layer of


Abstracts 577<br />

hippocampus and cerebellum of the PKU brain as compared<br />

with control pups, but the greatest increase in the number<br />

was noted within white matter of cerebellum and in stratum<br />

orients, stratum radiatum and stratum moleculare of hippocampus.<br />

The revealed reaction may suggest the mysterious<br />

functional role of micriglia in the current of PKU: or microglia<br />

may play definite role in repairing of abnormal brain or<br />

its reaction is the response to pathological condition.<br />

FP-K-061<br />

Increase of disaturated phosphatidylcholine in brains of<br />

Pex5 knockout mice, a mouse model of Zellweger<br />

syndrome<br />

M. Nagura a , M. Baes b , M. Saito a , I. Kimura a , H. Hirose a ,M.<br />

Kubota a , Y. Sakakihara a<br />

a Department of Pediatrics, Faculty of Medicine, the <strong>University</strong><br />

of Tokyo, Tokyo, Japan; b Laboratory of Clinical Chemistry,<br />

Katholieke Universiteit Leuven, Belgium<br />

Zellweger syndrome is a familial lethal disease presenting<br />

neuronal migration arrest in cerebral cortex and<br />

dysmorphism in liver and kidney. Its cause was proved to<br />

be the failure of peroxisome biogenesis, but the relation<br />

between disturbance of neural differentiation and peroxisomal<br />

dysfunction still remains unknown. Previously we<br />

reported that fibroblasts of patients with mutation of Pex2<br />

gene, one of the responsible genes for peroxysomal<br />

biosynthesis, contain significantly higher level of glycolipids.<br />

In this report, we aim to demonstrate changes in lipid<br />

compositions such as the increase of glycolipids in brains of<br />

Pex5 knockout mice. The result showed that the amount of<br />

disaturated phosphatidylcholine (disat-PC) was five-times<br />

higher in the brains of knockout mice than those in the<br />

control. The amount of glycosphingolipid was scarce both<br />

in the brains of knockout and control mice. The amounts of<br />

other types of lipids such as cholesterol, sphingomyelin and<br />

total glycerophospholipids did not differ between knockout<br />

and control mice. Disat-PC is involved in pulmonary surfactant<br />

and contributes to the surface tension of alveolus. The<br />

role of disat-PC in the CNS has not been reported, but<br />

increase of disat-PC may be related to peroxisome function<br />

and derangement of neuronal development.<br />

FP-K-062<br />

MECP2 mutation analysis in Rett syndrome<br />

M. Li a , V. Wong b<br />

a Department of pediatrics, First hospital, Peking <strong>University</strong>,<br />

b Department of pediatrics, The <strong>University</strong> of Hong<br />

Kong, China<br />

MECP2 gene, encoding methyl-CpG binding protein 2<br />

(MECP2), is the responsible gene for Rett syndrome. As<br />

RTT is a clinical syndrome without any diagnostic biologic<br />

markers, mutation analysis of MECP2 gene is the only diagnostic<br />

golden standard. It has been obvious that the phenotypes<br />

of Rett syndrome have shown a wide range of<br />

variability. The aims of this project is to identify the<br />

MECP2 mutation in RTT patients using direct sequencing<br />

so as to explore the spectrum of phenotypes resulting from<br />

MECP2 mutations. We identified three mutations of<br />

MECP2 gene among the six RTT patients. The mutations<br />

of P322A and R106W were found in two patients classified<br />

as fruste type. A patient with R306C mutation had the classic<br />

type of Rett syndrome. The patient with P322A mutation<br />

had no deceleration of head growth. Our report is the first<br />

that confirms the normal head growth can occur in RTT with<br />

MECP2 mutation. We think that the head growth deceleration<br />

should not be a necessary criterion for RTT, especially<br />

in the milder form of RTT.<br />

FP-K-063<br />

Progressive cerebello-cerebral atrophy - a new<br />

syndrome with microcephaly, mental retardation and<br />

spastic quadriplegia<br />

B. Ben-Zeev a , C. Hoffman b , D. Lev c , N. Watemberg c ,N.<br />

Brand a , T. Lerman-Sagie c<br />

a Pediatric Neurology Unit,<br />

b Neuroradiology Unit, Sheba<br />

Medical Center, Ramat-Gan, Metabolic-Neurogenetic<br />

Clinic; c Pediatric Neurology Unit, Wolfson Medical Center<br />

Holon, Sackler School of Medicine, Tel-Aviv <strong>University</strong>,<br />

Israel<br />

Progressive cerebellar atrophy in infancy can be seen in<br />

several genetic and metabolic diseases. Occasionally, it is<br />

accompanied by cerebral atrophy. Mental retardation is<br />

commonly seen. Hypotonia is more common than spasticity<br />

in these cases. We describe seven (five females, two males)<br />

children from six families with similar clinical and radiological<br />

features. Clinically, all suffer from profound mental<br />

retardation, and progressive spastic quadriplegia with joint<br />

contractures. Other common characteristics include: generalized<br />

seizures (5) and irritability (5). The children are nondysmorphic.<br />

Head circumference is normal at birth with<br />

progressive microcephaly evident from the 1st year of life.<br />

Radiologically, early magnetic resonance imaging can be<br />

normal but repeat studies show progressive cerebellar atrophy<br />

followed by cerebral atrophy involving both white and<br />

gray matter. All families are non-consanguineous Sepharadi<br />

Jews from Moroccan or Iraqi origin. An extensive metabolic<br />

evaluation was normal, including: blood amino acids,<br />

lactate, very long chain fatty acids, carnitine, lysosomal<br />

enzymes, isoelectric focusing of transferrin, urine organic<br />

acids and purines, CSF lactate, amino acids and biogenic<br />

amines, and muscle skin and nerve biopsies. The clinical<br />

and radiological presentation of this group of patients bears<br />

the closest resemblance to pontocerebellar atrophy type 2.<br />

However, this disorder can be ruled out because in our<br />

group of patients the cerebellar changes are progressive<br />

and are not recognized at birth, there is no pontine involve-


578<br />

Abstracts<br />

ment and clinically the patients develop severe spasticity<br />

but no chorea. We suggest that this is a new syndrome<br />

with profound mental retardation, spasticity and microcephaly.<br />

FP-K-064<br />

Abnormal movements in Leigh syndrome with<br />

cytochrome c oxidase deficiency due to SURF 1<br />

mutations<br />

B. Echenne a , A. Roubertie a , F. Rivier a , V. Humbertclaude a ,<br />

A. Dubot b , M.T. Zabot c , C. Godinot b<br />

a Neuropédiatric Department C.H.U. Montpellier. France;<br />

b U.M.R. 5534 C.N.R.S. Lyon. France; c Debrouse Hospital<br />

Lyon, France<br />

Two unrelated children with an up to now normal<br />

psychomotor development presented abnormal movements<br />

when they were respectively 14 and 16 months old. The<br />

first patient had tremor on hands and arms, occurring in<br />

clusters, lasting a few minutes, without triggering factor,<br />

many times a day. The second patient also had hands and<br />

arms tremor on awakening, occurring in clusters on brief<br />

duration, associated with myoclonic jerks of high amplitude,<br />

affecting arms and legs, triggered by noises,<br />

emotions, or voluntary movements. These abnormal movements<br />

lasted 6–8 months, and were during this period the<br />

main clinical abnormal sign, associated with deafness and a<br />

slight ataxia. Then, the neurological status of both children<br />

worsened, with progressive mental deficiency, pyramidal<br />

signs and motor regression. Death occurred at 7 years 10<br />

months and 3 years of age, respectively. In both cases, a<br />

marked complex IV deficiency was found on muscle<br />

samples, with a SURF 1 gene mutation. These observations<br />

are interesting for two reasons: (1) the early onset and long<br />

lasting abnormal movements, which were during several<br />

months the most striking clinical abnormalities; and (2)<br />

biological aspects, concerning the physiopathology of<br />

mitochondrial diseases.<br />

FP-K-065<br />

Van der Knaap syndrome<br />

K.S. Rana<br />

Army Command Hospital (Central Command), Lucknow –<br />

2, India<br />

Progressive neurological diseases of white matter origin<br />

may be due to failure of myelination or progressive demyelination.<br />

Clinical features of leucodystrophy are spastisity,<br />

gait abnormalities, special sensory deficits. Leucodystrophies<br />

with macrocephaly progress rapidly with early<br />

death. Van der Knaap et al. reported such leucodystrophy<br />

with slow progression. We present eight such children.<br />

Material and method: Case records of patients diagnosed<br />

as leucodystrophy over 10 years time. Patients compatible<br />

with Van der Knaap descriptions were included in the study.<br />

The comprehensive workup included history, neurological<br />

examination, metabolic workup included; arterial blood gas,<br />

aminoacidogram, Cerebrospinal fluid and serum lactate<br />

pyruvate, assays for mucopolysaccharidosis/glycogen<br />

storage diseases, arylsulfatase A. Electroencephalogram,<br />

visual and auditory evoked responses, nerve conduction<br />

studies and Magnetic Resonance imaging in all patients.<br />

Results: Of the eight, four were females and four males,<br />

aged between 2 and 20 years. Onset was within 1st year<br />

of life. Head circumference ranged from 54 to 60 cm.<br />

Motor symptoms progressed up to 5–6 years of age in all.<br />

All children had seizures and were well under control. Six<br />

children were attending normal school. All had increased<br />

tone in all limbs, brisk reflexes. Neuroimaging revealed<br />

diffused involvement of white matter with cysts mainly in<br />

temporal region. Other investigations were non-contributory.<br />

Discussions: Combination of megalencephaly with<br />

leucodystrophy is seen in Canavan’s and Alexander’s<br />

disease. Both have rapidly progressive course. Slow course,<br />

macrocephaly, striking neuroimaging abnormalities is quite<br />

unique in Van der Knaap syndrome into which our eight<br />

patients qualify.<br />

FP-K-066<br />

Effectiveness of creatine monohydrate in mitochondrial<br />

encephalomyopathies<br />

K. Komura a , E. Hobbiebrunken b , E. Wilichowski b ,F.<br />

Hanefeld b<br />

a Department of Pediatrics, Tokyo Women’s Medical<br />

<strong>University</strong>, Tokyo, Japan;<br />

b Abteilung Kinderheilkunde,<br />

Schwerpunkt Neuropädiatrie Georg-August-Universität,<br />

Göttingen, Germany<br />

The mitochondrial encephalomyopathies are chronic<br />

progressive disorders affecting predominantly the neuromuscular<br />

system. Symptoms are induced by insufficient<br />

energy supply resulting from a deficiency of oxidative phosphorylation.<br />

We studied one male and four females with<br />

genetically proven mitochondrial encephalomyopathies.<br />

Their ages ranged from 7 to 19 years (two Kearns–Sayre<br />

syndrome (KSS); one neuropathy, ataxia, and retinitis<br />

pigmentosa, NARP; two MELAS), using retrospective<br />

study method. We studied the effect of creatine supplementation<br />

(0.08 g–0.35 mg/kg body weight/day; 9 months–4<br />

years and 10 months) and measured skeletal muscle power<br />

analysis (bicycle ergometer). After creatine supplementation<br />

all patients showed an increase in their maximum<br />

performance (W) (14– 1 30%; mean: 112.1%).These<br />

results indicate an improved aerobic oxidative function of<br />

mitochondria following creatine administration in the<br />

patient with mitochondrial encephalomyopathies. Continuous<br />

physical exercise was improved to a greater extent than<br />

instantaneous activity.


Abstracts 579<br />

FP-K-067<br />

Early onset spastic paraplegia in purine nucleoside<br />

phosphorylase deficiency<br />

B.M. Tabarki, M. Yacoub, H. Selmi, A. Trabelsi, M. Dogui,<br />

A.S. Essoussi<br />

Pediatric department, Farhat Hached Hospital, Sousse,<br />

Tunisia<br />

Deficiency of purine nucleoside phosphorylase causes<br />

recurrent infections, usually beginning in the 1st year of<br />

life, and neurologic abnormalities. Neurologic findings<br />

range from spasticity to developmental delay, to mental<br />

retardation. We report two siblings with progressive spastic<br />

paraplegia noted from the first few months of life. MRI of<br />

the brain and spine were normal. EMG showed peripheral<br />

neuropathy. Three years later, they developed T cell immunodeficency.<br />

Enzyme study showed complete deficiency of<br />

purine nucleoside phosphorylase. Spastic paraplegia at early<br />

onset can be a prominent clinical feature of purine nucleoside<br />

phosphorylase deficiency. Proposed mechanisms for<br />

neurologic dysfunction in this disease are discussed.<br />

FP-K-068<br />

Mitochondrial encephalomyopathies: cases presentation<br />

L.A. Selim<br />

Street 86 Maadi, Cairo Egypt, Egypt<br />

Mitochondrial disorders, once thought to be relatively<br />

rare, are now thought to be the most prevalent metabolic<br />

disease. They form a heterogeneous group of disease with<br />

multi system presentation that affect mitochondrial ATP<br />

production. The most severely affected organs in mitochondrial<br />

disorders are those Depending on high rate of<br />

aerobic metabolism, such as the brain, the skeletal muscles<br />

and cardiac muscles, the sensory organs, and the kidneys.<br />

Defects in mitochondrial metabolism result in a wide variety<br />

of human disorders, which can present at any time from<br />

infancy to late adulthood and involve any tissue either<br />

alone or in combination. Neurologic presentations of mitochondrial<br />

disorders are protean, they may be highly<br />

suggestive of a specific syndrome such as: MELAS,<br />

NARP, MERRF, Lebers hereditary optic neuropathy, and<br />

more commonly may be non specific as intractable<br />

seizures, global developmental delay and severe hypotonia.<br />

The clinical presentation of five cases diagnosed as mitochondrial<br />

myopathy and encephalomyopathy will be<br />

discussed.<br />

FP-K-069<br />

Electromyographic, clinical and genetic features of<br />

Prader-Willi syndrome in infants and children<br />

L.G. Khachatrian, O.I. Masva, V.M. Studenikin<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of China Health (Russian Academy<br />

of Medical Sciences), Moscow, Russia<br />

Background: Prader-Willi syndrome is usually presented<br />

by such features as muscular hypomentia, hypogonadism<br />

and obesity. Electroneuromyographic (ENMG) investigation<br />

is an essential method in differential diagnostics<br />

between this pathological condition and various diseases<br />

accompanied with hypotonia. Aim: Complex diagnostics<br />

of pediatric patients with Prader-Willi syndrome and<br />

evaluation of ENMG in establishment of this diagnosis.<br />

Method: Case histories of 14 infants and children (aged 6<br />

months–5 years) with Prader-Willi syndrome were<br />

analyzed, ENMG, CT, and MRT can of brain and genetic<br />

analysis were incorporated. Results: Muscular hypotonia<br />

was presented in all cases, motor milestones were delayed<br />

(walking achieved after 26 months of age). In 79% of<br />

patients combination of micropenia, cryptorchidism and<br />

hypoplastic labia. Gross obesity developed after children<br />

learned to walk. Mental retardation was evident (IQ<br />

between 40 and 80). CY and MRT scans were performed,<br />

revealing ventriculomegaly (64% of patients), frontal and<br />

temporal lobes atrophy (14% of cases). Chromosome 15<br />

anomalies have been registered in 71% of pediatric patients:<br />

chromosome 15/15 transformation (57%), deletion in chromosome<br />

15 (14%). In 29% of cases the karyotype was<br />

normal. ENMG disorders were discovered in all patients,<br />

and included increased M-reply amplitude, H-reflex, F-<br />

wave (30%) and raised motor-neural conduction (40%).<br />

Conclusion: In spite of clinical symptoms characterizing<br />

Prader-Willi syndrome, ENMG plays an important role in<br />

verification of this diagnosis, especially when dealing with<br />

chromosome-negative versions of Prader-Willi syndrome.<br />

FP-K-070<br />

Tuberous sclerosis in children: a clinical and<br />

neuropathological study<br />

J. Qin a , J.-M. Wang b , M. Itoh c , X.-H. Bao a , Y.-H. Zhang a ,S.<br />

Takashima c<br />

a Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />

Beijing, China; b Department of Pediatrics, Shangqiu<br />

First People’s Hospital, Shangqiu, Henan, China; c Department<br />

of Mental Retardation and Birth Defect Research,<br />

National Institute of Neuroscience, NCNP, Kodaira,<br />

Tokyo, Japan<br />

Tuberous sclerosis complex (TSC) is a rare hereditary<br />

multiorgan disease. The present study is to summarize the<br />

clinical and neuropathological features of TSC. The clinical<br />

data from 25 children, aged 6 months–13 years, and the<br />

postmortem brain samples from four cases with TSC were<br />

investigated retrospectively. The main clinical findings in<br />

25 TSC children included seizures (23), mental retardation<br />

(16), skin lesions (25, with hypomelanotic macules in 23<br />

cases, angiofibromas in 15, shagreen patch in five, and fore-


580<br />

Abstracts<br />

head plaque in two), cardiac rhabodamyoma (three) or<br />

rhabodamyosarcoma (one), and multiple renal cysts (four).<br />

In two cases positive familial history of TSC was demonstrated.<br />

The mother of one case had severe seizures and<br />

mental retardation with typical dermatological TSC<br />

features, whereas the father of another case manifested<br />

only as typical dermatological TSC features and intracranial<br />

calcifications with no neurological symptoms. Cranial CT/<br />

MRI scan showed calcifications (22) in subependymal or<br />

other area, and cortical or subcortical tubers (nine). Neuropathological<br />

findings in all the four cases were cortical or<br />

subcortical tubers, subependymal giant cell astrocytomas,<br />

and heterotopic nodules in cerebrum or in cerebellum.<br />

Histologically, these hamartomas contain abnormal giant<br />

cells that show evidence of abnormal differentiation of<br />

immature neural cells. (*This work was partly supported<br />

by a key clinical project, 2001-03, from the Ministry of<br />

Public Health of China).<br />

FP-K-071<br />

Myopathy with Allgrove syndrome<br />

S.H. Ibrahim a , J. Vajsar b , V. Jay b<br />

a Aga Khan <strong>University</strong>, Karachi, Pakistan; b The Hospital for<br />

Sick Children, Toronto, Canada<br />

‘3A’ Syndrome or Allgrove syndrome was first described<br />

by Allgrove et al. in 1978. This syndrome typically consists<br />

of adrenal insufficiency, achalasia and alachrima. Since its<br />

first description more than 100 cases have been described.<br />

We report a 9 years old boy with the typical manifestations<br />

of achalasia, adrenal insufficiency, alachrima, and neurological<br />

manifestations of generalized muscle weakness, developmental<br />

and cognitive delay, who underwent muscle<br />

biopsy, which showed evidence of myopathy. Although<br />

various neurological manifestations including neuropathy,<br />

ataxia, impaired intelligence have been described, as yet no<br />

report has been made of myopathy in children with Allgrove<br />

syndrome. This is the first report of association of Allgrove<br />

syndrome with myopathy.<br />

FP-K-072<br />

Megalencepahlic leukodystrohy in children in a distinct<br />

aslan ethnic group – the agarwlas in India<br />

U.P. Bhat<br />

Department Of Neurosciences, Apollo Hospital Chennal,<br />

India<br />

We are presenting six cases of megalencephalic leukodystrophy<br />

who presented with a very large head in early<br />

infancy from a distinct ethnic community of Agrawals –<br />

head circumference was above the 95th centile in all with<br />

almost normal range of functioning. History of seizures<br />

was present in two cases and minimal neurological deficit<br />

in the form of pyramidal and cerebellar signs was documented<br />

in one case. Neuromaging studies revealed<br />

evidence of severe bilateral white matter changes in the<br />

cerebrum, with characteristic cystic changes in the<br />

temporal lobes. Screening for known metabolic and degenerative<br />

disorders was negative. The striking feature in these<br />

was the extensive white matter changes in the brain as<br />

contrasted with almost near normal intellectual functioning<br />

and minimal neurological deficit.<br />

FP-K-073<br />

Novel TSC2 mutations in Japanese patients with<br />

tuberous sclerosis complex<br />

J.-H. Feng, T. Yamamoto, E. Nanba, H. Ninomiya<br />

Gene Research Center, Tottori <strong>University</strong>, Yonago, Japan<br />

TSC is an autosomal dominant disorder characterized by<br />

hamartomas in many organs. Here we report mutation<br />

analysis of TSC2 in ten unrelated patients, using singlestrand<br />

conformational polymorphism analysis of all coding<br />

exons. We detected six novel mutations in addition to three<br />

mutations that had been previously reported, including two<br />

frameshifts, one in-frame deletion, two nonsense point<br />

mutations, three missense mutations and one splice site<br />

mutation. We also found five new polymorphisms. Mutations<br />

found in this study were distributed on various exons<br />

and there was no clustering of the mutations. In accordance<br />

with the previous findings, there was no obvious relationship<br />

between the location of the mutation and the clinical<br />

symptoms.<br />

FP-K-074<br />

Brain MRI findings in PKU patients<br />

E.S. Suh a , Y.H. Kim a , D.W. Lee a , H.S. Hong b<br />

a Department of Pediatrics, b Radiology, College of Medicine,<br />

Soon Chun Hyang <strong>University</strong>, Seoul, Korea<br />

Purpose: Abnormalities of MRI of the brain occur in<br />

some patients with phenylketonuria (PKU). The purpose<br />

of this study was to evaluate relation between MR findings,<br />

age and serum phenylalanine level. Methods: We investigated<br />

16 patients with biochemically documented PKU<br />

who also underwent MRI. Typical classic form was in 13<br />

patients, atypical in other two patients and malignant<br />

hyperphenylalaninemia in the other two patients. We evaluated<br />

signal intensity, the distribution of abnormal signal<br />

intensity, and the extent of the brain atrophy in MRI, and<br />

possible clinical correlation between age and serum phenylalanine<br />

level and abnormal signal intensity. Results: MRI<br />

scans revealed areas of abnormally increased signal intensity<br />

on T2-weighted images in ten (62%) patients, preferably<br />

involving the parieto-occipital lobes. In one advanced<br />

case, the high signal intensity of both the parietal and<br />

frontal lobes was seen on T2-weighted images, and brain<br />

atrophy and gyriform enhancement on contrast enhanced


Abstracts 581<br />

T1-weighted images. In six (38%) patients, the findings<br />

were normal. No abnormalities were found in the basal<br />

ganglia, brain stem and cerebellum. Nine patients were<br />

under age of 5 years old. There were no remarkable difference<br />

in the average serum phenylalanine levels for the<br />

various groups having different degree of MRI abnormalities<br />

(normal, mild, moderate, and severe – 26.4, 27.6, 28.2<br />

and 20.8 mg/dl, respectively). Conclusion: Although MR<br />

findings were not specific, PKU patients showed symmetrical<br />

high signal intensity, predominantly in the peritrigonal<br />

region. In the advanced case, on T2-weighted images,<br />

high signal intensity extended to the periventricular and<br />

subcortical white matter. There was no correlation between<br />

age, serum phenylalanine level and severity of high signal<br />

intensity.<br />

FP-K-075<br />

Influence of MECP2 gene mutation type and X<br />

chromosome inactivation on the phenotype of Rett<br />

syndrome<br />

J. Chae, H. Hwang, K.-J. Kim, Y.-S. Hwang<br />

Department of Pediatrics, Seoul National <strong>University</strong> Children’s<br />

Hospital, 28 Yongondong, Jongnogu, Seoul 110-744,<br />

Korea<br />

Rett syndrome is a progressive neurodevelopmental<br />

disorder occurring predominantly in females. Recently,<br />

Amir et al. identified mutations in the MECP2 gene on<br />

Xq28, which encodes methyl-CpG binding protein 2, as<br />

responsible for some cases of Rett syndrome. In this<br />

study, we analyzed the entire coding sequence of the<br />

MECP2 gene and their X chromosome inactivation pattern<br />

in 42 sporadic cases of Rett syndrome. Of the 42 patients, 30<br />

(71.4%) had pathogenic mutations, which included 14<br />

different mutations. Altogether, there were nine missense<br />

mutations (D97Y, L100V, R133C, S134P, P152R,<br />

T158M, A279V, R306C, P322L), four nonsense mutations<br />

(R168X, R255X, R270X, R294X), and one frameshift<br />

mutation (a 41-bp deletion at 1157–1197). Three of these<br />

were novel mutations (D97Y, L100V, S134P). Most of the<br />

nucleotide substitutions involved C to T transitions at CpG<br />

hotspots. There was a tendency for patients having nonsense<br />

mutations in TRD region to show earlier onset of regression<br />

and severer language retardation than patients having mutations<br />

in MBD region. However, the clinical severities were<br />

variable among patients with same type of mutation,<br />

depending on the pattern of X chromosome inactivation.<br />

This study suggests that the X chromosome inactivation<br />

pattern can modify the phenotype of Rett syndrome that is<br />

initially determined by type and site of MECP2 gene mutation.<br />

FP-K-076<br />

Preliminary study on linkage mapping of a Chinese<br />

benign familial infantile convulsions pedigree<br />

B. Xiao, X.-S. Yang, J.-C. Ning, Z.-G. Wu, G. Xiong<br />

Department of Neurology, Xiangya Hospital, Central South<br />

<strong>University</strong>, Changsha, 410078, China<br />

Objective: Genetic linkage analysis were performed to<br />

map the disease gene locus of a Chinese benign familial<br />

infantile convulsions pedigree on chromosome 19q12–<br />

13.1 or 2q24. Methods: Seven polymorphic microsatellite<br />

DNA markers (five markers on 19q, and two on 2q) have<br />

been typed, and parametric linkage analysis has been<br />

performed to analyze the segregation of the gene locus<br />

within our BFIC family. Results: There was not a differential<br />

haplotype that co-segregated with BFIC in this family.<br />

When the recombinant rate u was zero, the linkage between<br />

the investigated family and the mapped genes of BFIC was<br />

excluded because the two-point LOD scores were less than<br />

22. When the LOD scores were in the range of 22 and 0,<br />

there was no evidence of linkage as well. So the analysis<br />

showed no evidence of linkage between chromosome<br />

19q12–13.1 or 2q24 and the BFIC phenotype. Conclusions:<br />

There was no evidence that the BFIC gene of the investigated<br />

family was mapped on chromosome 19q12–13.1 or<br />

2q24. We suggest that BFIC shows genetic heterogeneity<br />

and maybe another gene locus is responsible for the Chinese<br />

BFIC family.<br />

FP-L<br />

Metabolism<br />

FP-L-001<br />

A possible new disorder of catecholamine metabolism; a<br />

patient with recurrent serotonin syndrome like-episode<br />

T. Ohtsuka, A. Kobayashi, M. Ito, H. Kakinuma<br />

Department of Pediatrics, Kanazawa Medical <strong>University</strong>,<br />

Uchinada, Japan<br />

Serotonin syndrome is characterized by various combinations<br />

of myoclonus, rigidity, hyperreflexia, confusion<br />

and diaphoresis, caused by the use of serotomimetic agents.<br />

Rhabdomyolysis and death are rare effects. We describe a<br />

7-year-old girl with a 5-year history of recurring serotonin<br />

syndrome-like episodes. Her elder brother died of renal<br />

failure caused by rhabdomyolysis, which was due to overwhelming<br />

involuntary movement persisting several days at<br />

age 5 years and were similar to those in the patient<br />

presented here. No relatives in the family showed any<br />

movement abnormalities. This suggests an autosomal<br />

recessive hereditary disease. She was born after an<br />

uneventful pregnancy and delivery with an Apgar score<br />

of 9. At age 2 years and half she presented with trunk<br />

hypotonia and involuntary dystonic movements. After a


582<br />

Abstracts<br />

Table 4<br />

Changes in ALT/AST during antiepileptic treatment a<br />

Pretreatment<br />

During treatment 2.6 ^ 1 year<br />

AST ALT AST ALT<br />

VPA (N:124) 25.06 ^ 3.12 16.36 ^ 7.06* 30.01 ^ 2.22 4.2 ^ 2.6* / **<br />

CB2 (N:101) 26.08 ^ 6.5 16.28 ^ 8.12 28.01 ^ 7.1 18.32 ^ 6.88**<br />

VGB (N:5) 28.07 ^ 9.3 17.16 ^ 7.45 29.11 ^ 6.4 3.0 ^ 1.31<br />

VPA 1 CB2 (N:31) 31.04 ^ 2.0 18.13 ^ 5.56 33.61 ^ 3.1 16.26 ^ 3.26<br />

VPA 1 LTG (N:24) 29.9 ^ 1.43 12.86 ^ 7.43 32.18 ^ 3.4 17.01 ^ 4.0<br />

VPA 1 VGB (N:4) 33.18 ^ 6.1 18.20 ^ 6.2 34.25 ^ 7.1 3.8 ^ 1.76<br />

Total 289<br />

a<br />

*P , 0.05; and **P , 0.05 (the difference between VPA and CBZ).<br />

viral illness, her movement worsened rapidly and eventually<br />

she became unable to control herself. She also<br />

showed agitation, restlessness, and diaphoresis. This attack<br />

persisted over a month and repeated itself every 2 or 3<br />

months. Normal laboratory findings included plasma<br />

amino acids, organic acids, serum lactic, uric acids, copper<br />

and ceruloplasmin. Five-hydroxyindole acetic acid, homovanillic<br />

acid, neopterin, teterahydroxybiopterin, and 5-<br />

methyltetrahydroforate in the cerebrospinal fluid were<br />

normal. Brain MRI showed mildly enlarged ventricles.<br />

She has slowly developed motor skills, sitting at age 2<br />

years, crawling at 4 years, and standing with support at 5<br />

years. At present her language comprehension is at the 3–4<br />

year-old level. She was treated with antiepleptic drugs and<br />

muscle relaxants, but frequency of the attacks did not show<br />

any change. We propose that this patient has a defect in the<br />

CNS catecholamine metabolism.<br />

FP-L-002<br />

Alanine aminotransferase levels during chronic use of<br />

anticonvulsant drugs<br />

D. Içaǧasioǧlu, Ö. Ünal, G. Deda<br />

Department of Pediatric Neurology, Ankara <strong>University</strong><br />

Medical School, Ankara, Turkey<br />

We aimed to determine the effect of antieplectic drugs on<br />

the serum alanine amino transferase levels in 289 epileptic<br />

children. This study, before and after 2.6 ^ 1.06 years,<br />

compared ALT and gamma-glutamly transferase activities<br />

in sera of children who were under either VPA (42.9%),<br />

CBZ (34.9%) or vigabatrin (VGB) (1.7%) monotherapy,<br />

or VPA 1 CBZ (10.7%), VPA 1 LTG (8.3%), and VPA 1<br />

VGB (%1,41) combined therapy (Table 4). Previous studies<br />

have reported reductions in plasma ALT activity due to<br />

VGB and it is not known whether this can mask early elevations<br />

in transaminases in patients with hepatocellular<br />

damage. Our data indicate that in 28% of patients serum<br />

ALT levels reduced during VPA medication and careful<br />

monitoring of hepatic function is mandatory in patients<br />

under VPA therapy.<br />

FP-L-003<br />

The effect of valproic acid on bone mineral metabolism<br />

and bone density<br />

D. Içaǧasioǧlu, G. Deda, Ö. Ünal, M. Berberoǧlu<br />

Departments of Pediatric Neurology and Endocrinology,<br />

Ankara <strong>University</strong> Medical School, Ankara, Turkey<br />

Many reports of altered calcium, vitamin D and bone<br />

metabolism associated with anticonvulsant therapy have<br />

been published. The purpose of this study was to determine<br />

whether bone mineral density is decreased by VPA treatment<br />

in epileptic children. We studied 18 children with new<br />

onset of epilepsy. Their ages ranged between 9 and 12 years.<br />

Children who had mental and motor retardation, had used<br />

medication known to alter bone metabolism, or had had<br />

neurologic deficit and abnormal cerebral imaging findings<br />

were excluded from the study. Before and after 11 ^ 2.1<br />

months of VPA therapy we measured biochemical parameters<br />

of bone mineral metabolism and dual energy X-ray<br />

absorptiometry was used to assess lumbar spine (L2–4)<br />

bone mineral density (BMD). Comparison of the mean<br />

biochemical parameters and BMD values of the before<br />

and after VPA treatment are shown in Table 5. Our data<br />

indicate that VPA therapy in epileptic children does not<br />

Table 5<br />

Laboratory parameters of patients a Before therapy<br />

After therapy<br />

Male/female 11/7 11/7<br />

Height 30.8 ^ 0.7 31.9 ^ 2.3<br />

Serum drug level (mg/ml) – 60.1 ^ 1.3<br />

Ca (mg/dl) 9.32 ^ 0.1 8.27 ^ 0.5<br />

P (mg/dl) 5.8 ^ 0.7 5.0 ^ 0.2<br />

Alkalin phosphatase (IU/l) 189 ^ 85.40* 237 ^ 97.86*<br />

PTH (pg/ml) 21.48 ^ 19.18 27.31 ^ 16.02<br />

Calcitonin 11.16 ^ 8.91 10.2 ^ 9.18<br />

Osteocalcin 12.66 ^ 7.44 14.12 ^ 6.98<br />

BMD 0.558 ^ 0.084 0.506 ^ 0.046<br />

a *P , 0.05.


Abstracts 583<br />

seem to have an adverse effect on bone mineral metabolism<br />

and BMD.<br />

FP-L-004<br />

Neonatal hypoglycemic brain injury – a specific clinical<br />

and imaging syndrome in 51 children<br />

V. Udani, M. Bawdekar, S. Karia, S. Mandasar<br />

P.D. Hinduja National Hospital and Medical Research<br />

Centre, Mumbai, India<br />

Brain injury attributed to neonatal hypoglycemia<br />

remains a significant problem in developing countries<br />

and is responsible for multiple disabilities. We describe<br />

51 children seen at a mean age of 39 months with a spectrum<br />

of disabilities and characteristic imaging findings.<br />

Forty-five/51 were males. Twenty-two were ,2.5 kg<br />

(LBW) and 22 were FT-AGA though only eight were #<br />

kg and above. A total of 79% had a neonatal encephalopathy<br />

on D2-3; 84% had microcrania; 59% were visually<br />

impaired; 57% had oromotor apraxia; and 75% had<br />

delayed language. Cerebral palsy was uncommon and<br />

was seen in only 10%. Apraxia of hand use was seen in<br />

57%. Epilepsy was seen in 88% and was partial (55%) or<br />

spasms (45%) or both. Spasms were refractory in 55% and<br />

partial seizures in 35%. Outcome in 35 children .5 years<br />

age revealed normal school performance in three, LD in<br />

seven, mild MR in six, severe MR in 11 and frank autism<br />

in eight. Cerebral palsy was noted in only five. Statistically<br />

significant association was noted between presence of<br />

epileptic spasms and autism, apraxia of hand use and<br />

oromotor apraxia. Generalised seizures were more<br />

common following spasms. Imaging revealed mostly bilateral<br />

occipital lesions in 84%, parietal lesions in 35% while<br />

only 7% had temporal lesions. No frontal lesions were<br />

noted. Conclusions: Neonatal hypoglycemic brain injury<br />

damages posterior regions with resultant visual deficits,<br />

apraxia of hand use and oromotor skills, cognitive impairment<br />

and autism, microcephaly, and often refractory<br />

epilepsy. Tone alterations are relatively less common.<br />

This preventable perinatal insult needs top priority in<br />

developing countries.<br />

FP-L-005<br />

Acute intermittent porphyria: case presentation<br />

L.A. Selim<br />

street 86 Maadi, Cairo, Egypt<br />

Acute intermittent porphyria is an autosomal dominant<br />

disorder of heme biosynthesis. The basic biochemical<br />

defect is reduced activity of the enzyme porphobilinogen<br />

deaminase caused by a genetic defect the deaminase gene<br />

located on the 11chromosome. Due to this defect only 50%<br />

of the normal enzyme quantity is produced. The disease<br />

becomes manifested only in the case of increased demands<br />

on a given metabolic pathway resulting in porphobilinogen<br />

accumulation and storage in the organs. Clinical evolution<br />

is characterized by acute attacks of abdominal pain, neurologic<br />

and psychiatric symptomatology, induced by drug<br />

intake, infection, alcohol intake or unknown factors.<br />

Laboratory diagnosis is based on the detection of deltaaminolevulinic<br />

acid, porphobilinogen, uroporphyrin and<br />

coproporphyrin in the urine. The therapy is based on infusions<br />

of 20% glucose solution and hydromineral imbalance<br />

correction. When neurologic symptoms occur it is necessary<br />

to administer hem-arginate intravenously. We report a<br />

case of a female child suffering from the disease with<br />

discussion of the treatment.<br />

FP-M<br />

Neuroimaging<br />

FP-M-001<br />

MRI study on brain in patients with tetrahydrobiopterin<br />

(BH 4 )deficiency<br />

Z.-X. Zhang, W.-M. Yu, Z.-S. Zhou, X.-Z. Zhang<br />

Department of Pediatrics, China-Japan Friendship Hospital,<br />

Beijing, China<br />

Objective: To observe the brain abnormalities of the<br />

white matter in BH 4 deficiency children in order to investigate<br />

the effect on the brain myelination. Methods: Eight<br />

patients with BH 4 deficiency were observed. In six cases,<br />

the level of blood Phe was between 480 and 1500 mmol/l<br />

on newborn screening. A low-Phe-diet was given early<br />

within 1 month after birth. Although the blood Phe had<br />

been controlled in an ideal range (120–240 mmol/l),<br />

there were the progressive myodystonia, the abynamia,<br />

and difficulty in raising their head in these patients.<br />

Among them, four patients had convulsion and the other<br />

two also had the oligophrenia accompanied by high blood<br />

Phe (.1200 mmol/l). All eight patients were diagnosed as<br />

BH 4 deficiency by using the analysis of the urine pterin,<br />

BH 4 loading test and the analysis of dihydropteridine<br />

reductase in RBC. The eight cases were subjected to<br />

0.5T superconductive MRI examination before the treatment<br />

with BH 4 and pro-neurotransmitter. Results: Delayed<br />

myelination was detected in all cases, mainly in the frontal<br />

lobe (eight cases, 100%), in the occipidfol lobe (five cases,<br />

62.5%), and in the temporal lobe (four cases 50%). There<br />

existed abnormal hyperintense foci in white matter shown<br />

by T 2 WI in all cases. Conclusions: (1) Children with BH 4<br />

deficiency have a high occurrence of brain abnormalities in<br />

the white matter. (2) These abnormalities may be related<br />

not only to HPA, but also to the decreased synthesis of<br />

neurotransmitters, such as 5-HT and DA, which could<br />

affect the development of the white matter.


584<br />

Abstracts<br />

FP-M-002<br />

3-D MRI volume of frontal lobe in autistic children<br />

Y. Toda, K. Mori, K. Tao, K. Inoue, M. Miyazaki, T. Saijo,<br />

T. Hashimoto, Y. Kuroda<br />

Department of Pediatrics, School of Medicine, <strong>University</strong> of<br />

Tokushima, Tokushima, Japan<br />

Purpose: We measured volume of the whole brain and<br />

frontal lobe using 3-D MR image and coherence with laterality<br />

and DQ examined volume of frontal lobe. Object/<br />

method: Object is totaled 35 examples of 19 autistic children<br />

(3–5 years old, DQ 50–100) and 16 healthy contrasts (3–5<br />

years old) visiting our hospital. We got informed consent<br />

from family with both group about MRI examination and<br />

measured horizontal image with 3-D SPGR method. We did<br />

reconstitution using image analysis software ‘Scion Image’<br />

and got the volume of the whole brain and frontal lobe and<br />

surveyed volume of right and left each about frontal lobe.<br />

We used Enjyoujishiki developmental test about DQ.<br />

Result: We did not recognize significant difference between<br />

autism group and healthy control group about the volume of<br />

the whole brain and frontal lobe. We compared even rate for<br />

volume of the whole brain (%) about frontal lobe, but did<br />

not still recognize significant difference. The right side was<br />

big in significance compared with the left with autism group<br />

in comparison of right and left frontal lobe volume. We did<br />

not recognize correlation during brain and frontal lobe<br />

volume about DQ. Conclusion: In volume of frontal lobe,<br />

the right side is big in significance compared with the left<br />

with autism group and coherence with frontal lobe dysfunction<br />

was suggested.<br />

FP-M-003<br />

Clinical and magnetic resonance image analysis of 36<br />

cases of periventricular leukomalacia in children<br />

X.-D. Yuan<br />

First People’s Hospital of Shangqiu City, Shangqiu, Henan,<br />

China<br />

Objective: To investigate the clinical and MRI characteristics<br />

of PVL in children. Method: To analysis the clinical<br />

data of PVL in 36 children. Result: (1) Gestational age:<br />

between 30 , 37 weeks in 22 cases, 38 , 42 weeks in 14<br />

cases. (2) Clinical manifestation: (a) paralysis in 36 cases;<br />

(b) cortical blindness in two cases; (c) mental retardation in<br />

nine cases; and (d) epilepsy in ten cases. (3) MRI manifestation:<br />

(a) foci form: patchy areas in 16 cases, punctate areas<br />

in 13 cases, streaks in seven cases; (b) section: symmetric<br />

signal abnormalities were observed in the periventricular<br />

and the subcortical white matter; (c) the signal of the<br />

focus: hyperintense/intense on T1 weighted and hyperintense<br />

on T2 weighted; and (d) other: bilateral ventricular<br />

bodies dilatation in eight cases. Trigon dilatation in five<br />

cases. Conclusion: PVL is a main cause of cerebral palsy,<br />

especially of spastic paralysis, MRI is a main way to diagnose<br />

PVL in early infants.<br />

FP-M-004<br />

Automated histogram-based brain segmentation and<br />

volume measurement in T1-weighted 3-D MR head<br />

images<br />

J.Z. Liu, Z.Y. Shan, G.H. Yue<br />

Department of Biomedical Engineering, Cleveland Clinic<br />

Foundation, Cleveland, OH, USA<br />

Information on human brain volume changes may help<br />

better understand structural and functional development and<br />

adaptations of the brain. Current semi-/automated MRbased<br />

brain segmentation and volume measurement methods<br />

are complex and not sufficiently accurate. We have<br />

developed a simpler, more accurate automated algorithm<br />

for whole-brain segmentation and volume measurement in<br />

T 1 -weighted 3-D MR images. This histogram-based brain<br />

segmentation (HBRS) algorithm is based on histogram<br />

analysis and simple morphological operations. It includes<br />

three major steps: (1) foreground/background thresholding;<br />

(2) disconnection of brain from skull and other head tissues;<br />

and (3) removal of residual fragments (cerebrospinal fluid,<br />

sinus, dura and marrow). Brain volume was measured by<br />

counting the number of brain voxels. Accuracy was determined<br />

by comparing brain volume rendered by applying the<br />

algorithm to computer-simulated MR data with the volume<br />

on which the simulation was based; average error was<br />

1.48%. Reproducibility of brain volume measurements<br />

was assessed by comparing data from two sessions (two<br />

trials in each session) with human volunteers. Intra-session<br />

variability of brain volumes for sessions 1 and 2 was<br />

0.55 ^ 0.56 and 0.74 ^ 0.56%, respectively; mean difference<br />

between the two sessions was 0.60 ^ 0.46%. These<br />

results show that the HBRS algorithm is a simple, fast,<br />

and accurate method for human brain volume assessment<br />

with high reproducibility. This algorithm may find various<br />

applications in research and clinical investigations regarding<br />

cortical development and child neurology.<br />

FP-M-005<br />

Diffusion weighted MRI for early diagnosis of acute<br />

neurological disease in the neonate<br />

W. Brussel, I.M. van Beynum, M.C. Molenschot, V.A. Bok<br />

Rijnstate Hospital, TA Arnhem, Netherlands<br />

Diffusion weighted-MRI (DW-MRI) uses water movement<br />

and transport of water in biological tissues as a source<br />

of contrast. Therefore DW-MRI can be used to obtain information<br />

about molecular displacement over distances<br />

comparable to cell’s dimensions and, consequently, about<br />

geometry and spatial organization of tissue compartments.<br />

Functional insight concerning exchanges between these<br />

compartments in various disease states can be gathered. In<br />

the presence of magnetic field gradients, protons carried by<br />

free moving water molecules, undergo a phase shift of their


Abstracts 585<br />

transverse magnetization. As diffusion is characterized by<br />

the random Brownian displacements of molecules, these<br />

phase shifts are widely dispersed. Interfering with each<br />

other finally results in attenuation of the MRI signal. The<br />

attenuation depends on the amplitude of molecular displacement<br />

and intensity of the magnetic field gradient. In<br />

conventional MRI diffusion effects are extremely small<br />

and invisible. By using strong magnetic field, gradient diffusion<br />

becomes visible and measurable. Especially in intracellular<br />

cytotoxic edema diffusion is strongly limited and<br />

the involved areas will show with high signal on the images.<br />

DW-MRI can detect pathological changes within minutes of<br />

the onset of injury, which is well before conventional MRI<br />

shows changes. Although recent publications reveal the<br />

importance of DW-MRI for early diagnosis of hypoxic<br />

ischemic injury and focal infarction in the neonatal brain,<br />

the information on clinical diagnostic significance in other<br />

neonatal neurological disease is sparse. From examples of<br />

several acute neurological diseases in the neonate, such as<br />

bacterial and viral meningoencephalitis, hypoglycemia and<br />

cerebrovascular accident, the diagnostic value of DW-MRI<br />

in an early stage of these diseases is shown.<br />

FP-M-006<br />

Predictive value of neonatal MRI with respect to late<br />

MRI findings and clinical outcome-a study in infants<br />

with periventricular densities on neonatal ultrasound<br />

L.T.L. Sie, M.S. van der Knaap, A.A.M Hart, J. van Hof, L.<br />

de Groot, W. Lems, H.N. Lafeber, J. Valk<br />

Vrije Universiteit Medical Center, Amsterdam, The Netherlands<br />

Objectives: To correlate hypoxic-ischemic white matter<br />

damage on neonatal MRI with late MRI and neurologic<br />

outcome at 1.5 years. Methods: MR images of 46 infants<br />

(mean gestational age of 31 weeks) with periventricular<br />

densities on ultrasound were obtained at a mean age of 20<br />

days after birth and at 1.5 years. To establish agreement<br />

between the neonatal and follow-up MRI (general, motor<br />

and visual scores), the weighted Cohen’s kappa was used.<br />

Predictive values of neonatal MRI with respect to the neurologic<br />

indices at 1.5 years were calculated. Results: There<br />

was a moderately good to good agreement between the<br />

general, motor and visual neonatal and follow-up MRI<br />

scores: weighted kappa ¼ 0.59 (95% CI: 0.44–0.74), 0.82<br />

(95% CI: 0.72–0.93), and 0.70 (95% CI: 0.56–0.84), respectively.<br />

Neonatal MRI scores provided a good prediction of<br />

the three neurologic outcome measures (developmental<br />

delay, cerebral palsy and cerebral visual impairment): sensitivity,<br />

specificity and predictive values were high, with little<br />

difference between the three MRI scores. The 32 patients<br />

with (nearly) normal neonatal MRI scores were neurologically<br />

(nearly) normal at 1.5 years on all three outcome<br />

measures, whereas eight patients with seriously abnormal<br />

neonatal MRI scores were neurologically abnormal at 1.5<br />

years on all three outcomes measures. Conclusions: Neonatal<br />

MRI is able to predict the precise localization and size of<br />

perinatal leukomalacia on follow-up MRI and provides a<br />

good prediction of neurologic outcome at 1.5 years.<br />

FP-M-007<br />

Ultrasonographic assessment of the fetal frontal lobe<br />

Y.-L. Zhang, Y. Wu, Z.-R. Zhang<br />

Department of Pediatrics, Daqing Medical College,<br />

Daqing, China<br />

Objective: To study the characters of normal growth of<br />

the fetal frontal lobe, and to obtain a nomogram of frontal<br />

lobe measurements in fetuses with different gestational<br />

weeks. Methods: A prospective ultrasound evaluation was<br />

conducted in 338 normal pregnant women with gestational<br />

ages ranging from 15 , 40 weeks. Several biometric<br />

measurements were obtained throughout pregnancy, including<br />

the frontal lobe distance (FLD), the thalamic frontal lobe<br />

distance (TFLD), the biparietal diameter (BPD). A nomogram<br />

of frontal lobe measurements from different gestational<br />

age (GA) and BPD were generated and included the<br />

x ^ s. The linear analysis and the parabolical curve fitting<br />

analysis were made between FLD, TFLD and the GA, the<br />

BPD. Results: The analysis of these data revealed a high<br />

degree of linear correlations between FLD, TFLD and the<br />

GA, the BPD (R. between 0.9562 , 0.9708 P , 0:0001).<br />

The second order polynomes for these two measurements<br />

versus GA and BPD were produced with the parabolical<br />

curve fitting analysis (P , 0:0001), and the growth curves<br />

were plotted by computer. FLD was almost linearly<br />

increased with the gestational age. TFLD was increased<br />

curvely with the gestational age. Conclusion: The results<br />

of this study demonstrated the pattern of normal growth of<br />

the frontal lobe. They offer a method by which early prenatal<br />

diagnosis of developmental anomalies of the fetal brain<br />

(especially microcephaly) can be made.<br />

FP-M-008<br />

Evaluation of 3D-TOF MRA in children ischemic<br />

strokes<br />

X.-L. Yu, Y.-Q. Zhang, L.-M. Ye<br />

Department of Neurology, Tianjin Children Hospital, Tianjin,<br />

China<br />

Objective: To evaluate the applying of 3D-TOF Magnetic<br />

resonance angiography (MRA) in children ischemic strokes.<br />

Methods: Between December 1999 and June 2001, 15<br />

patients (eight males, seven females) were studied. Their<br />

ages ranged from 11 month to 12 years old (mean 3<br />

years). With diagnosis of MRI, ECLIPSE 1.5-T of Marconi<br />

Company, all patients do the examination within 1 week.<br />

All ischemic foci were found on one side (nine left, six<br />

right). Frontal lobe one case, parietal lobe one case, multi-


586<br />

Abstracts<br />

focus eight cases, basal ganglia lacuna infarction five cases.<br />

Result: MRA (2) four cases, single/accompany implicated<br />

cerebral media artery (MCA) eight cases, single implicated<br />

cerebral anterior artery one case and basilar artery two<br />

cases. The initial position of artery and the first branch<br />

stricture/infarction four cases, periphery artery tenuous/<br />

branch decreasing five cases, basilar artery tortuous two<br />

cases. Through therapy, the beginning time of recovery of<br />

muscle strength are 4 , 7 days to MRA (2) and artery<br />

stricture/infarction patients, 7 , 18 days to periphery artery<br />

tenuous/branch decreasing patients, 3 , 10 days to basilar<br />

artery tortuous patients. Conclusion: Most of the ischemic<br />

strokes patients have the corresponding artery changes in<br />

MRA, the majority changed position is MCA system, the<br />

variability was related with prognosis. The patients with<br />

polyartery implicated need followed up for a long time, in<br />

order to exclude moyamoya, polyarteritis, etc.<br />

FP-M-009<br />

Potential epileptogenecity of calcified neurocysticercosis<br />

V. Kalra a , K.S. Rana a , S. Gulati a , B. Ekka a , A.K. Gupta b ,<br />

R.M. Pandey c<br />

a Departments of Pediatrics, b Radiodiagnosis, c Biostatistics,<br />

All India Institute of Medical Sciences, New Delhi, India<br />

Background: Epileptogenecity of calcified neurocysticercosis<br />

being unknown, the AED duration remains a dilemma.<br />

Objectives: To study calcification in neurocysticercosis as a<br />

risk factor for epilepsy. Materials and methods: Retrospective<br />

analysis of 296 patients with CT imaging compatible<br />

with neurocysticercosis- single/multiple parenchymal or<br />

calcified lesions after exclusion of tuberculosis. Follow up<br />

period was 3–6 years for seizure recurrences: breakthroughseizures<br />

recurring on adequate AED and relapse-recurrence<br />

of $2 seizures 3 months after AED discontinuation.<br />

Results: A total of 296 children, mean age 7.9 ^ 2.8 years<br />

of either sex. The initial CT showed calcification in 18.5%.<br />

AED were administered for 1.9 ^ 1.4 years. Albendazole<br />

was given to 33/296 and follow up scans in albendazole<br />

treated group revealed calcification in 52%. On follow up<br />

CT scans (170), 6/31 with normal scans had breakthrough<br />

seizures and similar figure for persisting lesions was 8/50<br />

and calcified 33/89 (P-0:04). Similar figures for relapse<br />

were 1/31 with normal CT scan, 3/50 persisting lesions<br />

and 12/89 calcified (P-0:39). The follow up duration after<br />

AED discontinuation was 2.2 ^ 1.8 years. A total of 130<br />

children had calcification in the initial and/or follow-up CT<br />

scans. Breakthrough seizures were seen in 50/130 (38.4%)<br />

children with calcified lesions versus 32/166 (19.2%) in the<br />

rest (P , 0:001). Similar figures for relapse were 16/130<br />

(12.3%) and 10/166 (6.0%), respectively (P ¼ 0:09).<br />

Conclusions: Calcification in neurocysticercosis, though<br />

an inactive healed lesion, is associated with increased risk<br />

of seizures as compared to persisting lesions or normal scan<br />

on long term follow-up.<br />

FP-M-010<br />

Face perception of Asperger syndrome child<br />

I. Kimura, M. Kubota, H. Hirose, M. Yumoto, Y.<br />

Sakakihara<br />

Department of Pediatrics, Department of Laboratory Medicine,<br />

The <strong>University</strong> of Tokyo, Tokyo Japan<br />

Asperger syndrome (AS) is one group of the pervasive<br />

developmental disorders and accepted as autistic spectrum<br />

entity. Although they have almost normal or superior intelligence,<br />

no significant speech delay, AS adults and children<br />

have problem in social communication skills and are<br />

supposed to have specific deficit in understanding others’<br />

mind. Considerable number of studies has shown that AS<br />

or high-function autism adults are inferior to IQ-matched<br />

controls in understanding emotions from others’ facial<br />

expression, or even if they could detect rightly, some<br />

studies revealed that they might use different pathway in<br />

the brain. As it has not been clearly understood the way AS<br />

child percepts face, we examined an 8-year-old AS girl by<br />

magnetoencephalography (MEG) with the task of selecting<br />

‘laughing faces’ among a series of projected face photographs.<br />

The task was also done with inverted faces. It is<br />

known that basal occipitotemporal cortex is mainly participated<br />

in face processing, especially at early stage, within<br />

latency of about 200 , 300 ms, and all of the controls<br />

except one showed such pattern of MEG activity waveforms<br />

and dipole locations. But the AS girl showed distinct<br />

pattern from this, with larger activation of bilateral parietal<br />

than occipitotemporal cortex. This distinct pattern was not<br />

observed when the faces were inverted. It was suggested<br />

that AS child might use special dorsal way of parietal<br />

cortex in face processing.<br />

FP-M-011<br />

Diagnostic value of magnetic resonance imaging in West<br />

syndrome<br />

F. Fang<br />

Beijing Children Hospital Beijing, China<br />

Objective: To study the value of MRI in West syndrome<br />

(WS) diagnosis. Methods: MRI results of thirty-one patients<br />

with WS were reviewed retrospectively. Results: Twentyfive<br />

patients were diagnosed symptomatic WS, three<br />

patients were cryptogenic and three patients were primary.<br />

Thirty-one patients were classified into four groups on the<br />

basis of their MRI findings: Periventricular leukomalacia,<br />

myelination delay, the other groups and normal. Conclusion:<br />

MRI was helpful in finding etiology and assessing<br />

prognosis in WS.


Abstracts 587<br />

FP-M-012<br />

Using MRI analysis the relationship between the<br />

disorder in basal ganglia in children and the reason and<br />

symptom of it<br />

T.-L. Han<br />

Beijing Children Hospital Beijing, China<br />

Objective: To study the relationship between the causes,<br />

symptoms and the disorders of basal ganglia by MRI in<br />

children. Method: Forty-one patients were studied by MRI,<br />

using CSF, EEG, lactic acid, etc., as the combined diagnostic<br />

method. Results: Forty-one cases all had disorders<br />

on basal ganglia. The number of cerebrovascular disease<br />

was 12 (29.3%), and it was the leading cause, it included<br />

eight cases of idiopathic cerebral vasculitis, and four cases<br />

of moyamoya disease. The number of the immunologic<br />

disorders on nervous system (NS) was eight (19.5%), it<br />

included four cases of acute disseminated encephalomyelitis<br />

(ADEM), two cases of Acute hemorrhagenic leukencephalitis,<br />

a case of multiple selerosis (MS) and a case of<br />

systemic lupus erythematosis (SLE). The number of metabolic<br />

diseases and heredodegenerative diseases of the NS<br />

was 10 (24.4%). The number of other causes or causes of<br />

unknown was 11. Conclusion: (1) Acquired disease was the<br />

leading cause of the disorders of basal ganglia in childhood.<br />

(2) Clinical manifestation of disorders of basal ganglia<br />

was widespread, and was not limited to dystonia and<br />

involuntary movements, and also was not limited to the<br />

nervous system.<br />

FP-M-013<br />

CT analysis of mental retardation children caused by<br />

perinatal cerebral lesion<br />

Z.-H. Song<br />

Woman and Infant Healthcare Hospital, Yangquan City,<br />

Shanxi, China Purpose: Research of the pathological<br />

changes of mental retardation children resulting from perinatal<br />

cerebral lesion and exploration of the early remedial<br />

ways. Way: Selecting 144 patient pupils equal to or under 7<br />

years old without ablepsia and deafness, who have the<br />

history of perinatal cerebral lesion without inherited metabolic<br />

diseases and mental test IQ/DQ is under 69 with head<br />

CT scan. Result: CT abnormal rate is 71.52% and with<br />

significant difference between severe and moderate mental<br />

retardation children. CT showed mainly the atrophy and<br />

hypogenesis, mostly in the frontal lobe. Conclusion: (1)<br />

Perinatal brain injury may be one of the factors to cause<br />

future mental retardation (MR). (2) Head CT scan of the<br />

children with MR showed mainly atrophy and hypogenesis,<br />

mostly in the frontal lobe.<br />

FP-M-014<br />

Abnormal cerebral glucose metabolism in patients with<br />

alternating hemiplegia of childhood<br />

M. Sasaki a , A. Fukushima a , H. Sakuma a , N. Shiroma a , K.-I.<br />

Yamada a , T. Ohnishi b , H. Matsuda b , N. Sakuragawa c<br />

a Department of Child Neurology,<br />

b Radiology, National<br />

Center Hospital for Mental, Nervous and Muscular Disorders,<br />

National Center of Neurology and Psychiatry (NCNP),<br />

c Department of Inherited Metabolic Disease, National Institute<br />

of Neuroscience, NCNP, Kodaira, Japan<br />

Alternating hemiplegia of childhood (AHC) is a rare and<br />

intractable disorder, the cause of which remains unknown.<br />

To determine the extent and degree of neuronal damage, the<br />

brain glucose metabolism in three children and two adult<br />

patients with AHC was studied by PET using 2-deoxy-[18F]<br />

FDG. FDG-PET was performed between hemiplegia attacks<br />

in all patients. All the patients met the criteria of Aicardi.<br />

Hemiplegic attacks occur 2–8 times a month in all patients.<br />

The child patients consisted of 1–3-year-old boys. They all<br />

showed psychomotor retardation and hypotonia. The adult<br />

patients consisted of 22 and 30-year-old women, whose<br />

brain MRI revealed mild cerebellar atrophy. Interictal<br />

FDG-PET revealed abnormal cerebral glucose metabolism<br />

in all patients. Low glucose metabolism in the frontal lobes<br />

with some laterality was demonstrated in all patients, and<br />

low glucose metabolism in the ipsilateral putamen was seen<br />

in three patients. The brainstem and cerebellum were<br />

normal as to glucose metabolism except for an adult patient.<br />

Areas of low glucose metabolism indicate local or regional<br />

neuronal damage, and could be related to neurological<br />

symptoms, for example, hypotonia, mental retardation,<br />

involuntary movement, etc. The unknown cause of AHC<br />

might induce focal abnormal glucose metabolism progressively<br />

or permanently in the brain.<br />

FP-M-015<br />

Neuroimaging methods for diagnosis of behavior<br />

deviations in the early life<br />

A. Jaxybayeva<br />

Institute of Medical Doctor’s improvement, Child Neurology<br />

Department, Almaty, Kazakhstan<br />

The purpose of our study was to investigate MRI-changes<br />

of the brains structure. We analyzed 50 MRI-scans of children<br />

with attention deficit hyperactivity disorder, aged 4–5<br />

years. On the MRI-scans at all of that children were detected<br />

a structure abnormalities as insignificant atrophy of the frontal<br />

lobe, insignificant dilatation of the third ventricle of the<br />

brain, decreased volume of the left caudate nucleus and<br />

increase of the right caudate nucleus. Therefore a neurobehavioral<br />

deviation as ADHD has been associated with thin<br />

brain structure abnormalities as insignificant atrophy of the<br />

frontal lobe, insignificant dilatation of the third ventricle of


588<br />

Abstracts<br />

the brain, asymmetry of basal ganglia (decrease volume of<br />

the left nucleus caudate and increase of the right nucleus<br />

caudate).<br />

FP-M-016<br />

Neuroradiological changes in infants with cysta cisterna<br />

ambiens<br />

K.S. Ormantaev, D.R. Kachurina, L.O. Saulebekova<br />

Scientific Center of Pediarics and Children’s Surgery,<br />

Almaty, Kazakhstan<br />

The purpose is study the character of changes in infants<br />

with some kinds of arachnoid cysts. During the period from<br />

1999 till 2001 years 1000 infants, aged from 0 to 3 months<br />

were examined at ultrasound diagnostic system ‘Aloka-<br />

2000’ (the transducer with frequency 7.5 MHz) was used.<br />

In seven children (0.7%) a small anechoic zone situated on<br />

the midline behind and below the dorsal end of the choroid<br />

plexus of the third ventricle, and above the vermis of the<br />

cerebellum was found. Its diameter was 7–10 mm. These<br />

changes were confirmed by computer tomography. Doppler<br />

investigations of cerebral arteries have not found any<br />

changes in cerebral blood flow. A total of 42.8% infants<br />

had convulsions, and 57.2% infants had not got severe<br />

neurological disturbances, their development was according<br />

their age. Cysta cisterna ambiens is very rare pathology. It<br />

has not specific neurological symptoms. It was found occasionally<br />

only during neurosonography and computer tomography.<br />

FP-M-017<br />

The features of image examination in children with acute<br />

hemiplegia<br />

Y.-F. Lu, L.-Q. Chen, Y.-C. Zhang, Q. Lu<br />

Shanghai children’s hospital, Shangha, China<br />

Objective: To observe the image features of acute central<br />

hemiplegia in children. Methods: Thirty-one cases with<br />

acute hemiplegia were hospitalized in neurological department<br />

of Shanghai children’s hospital from 1992 to 2001.<br />

We analyze the image features of cranial CT, MRI or<br />

MRA. Results: Thirty-one children were aged from 4<br />

months to 11 years (median 3.6 years), with the course<br />

from 6 h to 20 days. All cases were abruptly, 16 cases<br />

with preceding viral upper respiratory infection, two<br />

cases with similar history, two cases with convulsion,<br />

and two cases with fever and coma. Nineteen cases were<br />

abnormal in 23 cases by CT, and nine cases were abnormal<br />

in 11 cases by MRI. Three cases were abnormal by MRI in<br />

CT negative, and two cases were diagnosed with moyamoya<br />

disease by MRA but MRI negative. Twelve cases<br />

were shown with lateral basal ganglia embolus (38.71%);<br />

three cases were represent with bilateral basal ganglia<br />

embolus (9.68%); two cases were revealed with by nucleus<br />

lentiformis embolus; three cases were found with lateral<br />

temporo-parital lobes embolus. Two with lateral parietooccipital<br />

lobes embolus, two with lateral cerebral peduncles<br />

embolus, two with lateral internal capsula embolus,<br />

two with subdural hemorrhage, and two with moyamoya<br />

diseases. Conclusion: CT and MRI are the important diagnostic<br />

methods in acute hemiplegia, and MRI is superior to<br />

CT. It is necessary to do MRA when CT or MRI finding is<br />

negative.<br />

FP-M-018<br />

Attention deficit hyperactivity disorder (ADHD): frontal<br />

aMRI and motor inhibitory deficits<br />

M.B. Denckla<br />

Kennedy Krieger Institute, Baltimore, MD, USA<br />

On volumetric MRI, children with ADHD showed<br />

decreased volume in multiple frontal lobe regions.<br />

Comparing 12 boys with ADHD with 12 age-matched<br />

male controls using semi-automated Talairach-based<br />

parcellation methods (Kaplan, 1997; Kates, 1999), total<br />

cerebral volume was significantly smaller (8.3%) with<br />

ADHD. Frontal lobe volumes both gray and white matter<br />

accounted for most of this decrease; total non-frontal and<br />

other lobar volumes were not significantly smaller. The<br />

ratio of frontal lobe to non-frontal tissue volume in the<br />

ADHD group was smaller than that of the control group<br />

but only as a trend. Frontal lobes were subparcellated into<br />

motor, premotor (includes supplementary motor area<br />

(SMA), ventral premotor cortex (PMv), frontal eye field<br />

(FEF), and supplementary eye field (SEF)), prefrontal<br />

(includes dorsolateral-prefrontal (DLPF) and OF cortices,<br />

amongst other regions), and anterior cingulate, and deep<br />

white matter; reductions were observed in both prefrontal<br />

and premotor functional modules (as well as deep white<br />

matter). Forty-two children with ADHD were impaired on<br />

tests of skeletomotor response inhibition compared with 30<br />

age and gender-matched controls; most significant was the<br />

conflicting motor response test. Physical and neurological<br />

examination of soft signs (PANESS) in a slightly smaller<br />

subsample of children (37 ADHD, 27 controls) revealed<br />

significantly more overflow (including mirror movements)<br />

in children with ADHD. Conflicting motor response test<br />

scores significantly predicted overflow movements for all<br />

children, both ADHD and controls implicating shared inhibitory<br />

function. Oculomotor response inhibition was implicated<br />

in ADHD; unmedicated children with ADHD made<br />

significantly excessive directional errors on an antisaccade<br />

task and anticipatory errors (premature eye movements) on<br />

a memory-guided saccade task.


Abstracts 589<br />

FP-M-019<br />

The clinical significance of evaluation of glucose<br />

metabolism of brain with FDG-PET brain image during<br />

the phase and interphase of refractory epilepsy in<br />

children<br />

Q.-X. Zhai, X.-Y. Lin, X.-H. Zhou, Z.-X. Qiao, Y.-X.<br />

Zhang, H.-X. Qiao<br />

Department of Pediatrics, Guangdong Provincial People’s<br />

Hospital, Guangzhou, China<br />

Objective: To assess the diagnostic value of 18F-FDG<br />

imaging for interictal and ictal epileptic foci. Methods:<br />

Twenty-three patients with refractory epilepsy were examined<br />

in the interictal and ictal periods by 18F-FDG PET, the<br />

results of examination have been compared with MRI and<br />

EEG. The patients are ten cases in male, 13 cases in female.<br />

The youngest is a 1 year old, the oldest is 14 years old.<br />

Result: There are some abnormal metabolism focuses on<br />

PET imaging in 21 (91.3%) patients with epilepsy. Lower<br />

metabolism focus is in 19 cases, higher metabolism focus is<br />

in two cases; and two cases is in normal. One case of two<br />

with higher metabolism focus had seizures during the examination.<br />

Before examination in 3 h there is an epileptic<br />

attack in other one case. The epileptic focus had been<br />

moved by operation in another two cases. It has been<br />

found that the location of focus is the same with the abnormal<br />

metabolism focus from PET. Younger children with<br />

epilepsy, their abnormal metabolism focus is much more<br />

than elder children. MRI is abnormal in 69%, EEG is abnormal<br />

in 86%. Conclusions: The diagnostic value of 18F-FDG<br />

PET imaging foci was higher than that of MRI and EEG in<br />

sensitivity. The specificity and accuracy of 18F-FDG PET<br />

imaging for the diagnosis of epilepsy during epilepsy ictal<br />

period will be the best.<br />

FP-M-020<br />

Diagnostic value of MRA on acute hemiplegia syndrome<br />

in childhood<br />

W.-C. Zhang, H.-H. Wu, T.-C. Liou<br />

Department of Neurology, Beijing Children Hospital, Beijing,<br />

China<br />

Objective: To study the diagnostic value of MRA on<br />

acute hemiplegia syndrome. Methods: Thirty-four AHS<br />

children were studied by 3D TOF MRA, using MRI as the<br />

combined diagnostic method. Results: Twenty-four patients<br />

had cerebrovascular abnormalities including nine stenoses<br />

and 15 severe narrowing or occlusions, which were respectively<br />

located in ICA of 11 patients, MCA of 24 patients,<br />

and ACA of six patients. MRA showed vascular compensation<br />

of 20 patients. Conclusion: The results indicate that<br />

MRA showed good ability of deterting intracranial vascular<br />

disorders in AHS study as a non-invasive, quick and efficient<br />

tool with no need of radiographic agent. MRA will<br />

probably become an important and commonly used diagnostic<br />

technique for CVD in children.<br />

FP-M-021<br />

Functional MRI study in school children with attention<br />

deficit hyperactivity disorder<br />

Z. Jin a , L. Zhang a , Y.-F. Zang b , Y.-W. Zeng a , Y. Wang a , Y.-<br />

F. Wang b<br />

a fMRI Center, Hospital 306, Beijing, China; b Mental Institute,<br />

Peking <strong>University</strong>, Beijing, China<br />

Background: ADHD is a major developmental disorder<br />

affecting 3–7% of school children, which is associated with<br />

a low educational outcome and increased risk for antisocial<br />

disorders and/or drug abuse in adulthood. The pathogenic<br />

mechanisms of ADHD remain unknown. Method: Brain<br />

activation maps had been observed pre and post one dose<br />

of Ritalin (10 mg) in nine schoolboys with ADHD (aged 10–<br />

14 years) and nine matched healthy controls using blood<br />

oxygenation level dependent (BOLD) functional MRI technique.<br />

Event-related Simon tasks contained neutral and<br />

interference tasks were served as the stimuli. Results:<br />

Comparing with healthy controls, ADHD children showed<br />

significantly reduced activity in the prefrontal lobe, anterior<br />

cingulate cortex, basal ganglia, cerebellum, and inferior<br />

parietal lobulus during interference (difficult) task. During<br />

neutral (easy) task, reduced activities in ADHD children<br />

were mainly found in the prefrontal lobe, whereas more<br />

activation was found in basal ganglia, cerebellum, and inferior<br />

parietal lobules in patients compared with those in<br />

healthy controls. After one dose of Retalin, reduced brain<br />

activation were recovered in ADHD group. Conclusion: In<br />

ADHD children, there seems to be some dysfunctional brain<br />

areas, including prefrontal lobe, basal ganglia, cerebellum,<br />

and inferior parietal lobulus. Retalin may help to reverse the<br />

dysfunction partially.<br />

FP-M-022<br />

Early detection of hypoxic injury of the fetal human<br />

brain by using MRI and 1 H MRS<br />

V.A. Rogozhyn a , Z.Z. Rozhkova a , L.G. Kirillova b , E.M.<br />

Lukjanova b , A.P. Perfilov b<br />

a Radiological Center, Academy of Medical Sciences of<br />

Ukraine, Kyiv, Ukraine; b Institute for Pediatrics, Obstetrics<br />

and Gynecology, Academy of Medical Sciences of Ukraine,<br />

Kyiv, Ukraine<br />

Our goal is evaluating the brain anomalies in human<br />

fetus by MRI, for measurement of fetal brain structures,<br />

and 1 H MRS, for determination of cerebral metabolite<br />

concentrations. Two groups of 17 women with (G1) and<br />

15 women without (G2) complicated pregnancies are<br />

studied by 1.5 T Magnetom Vision System (SIEMENS).<br />

MR-images of fetal brain in utero (from 25 to 39 weeks of


590<br />

Abstracts<br />

gestational age) were obtained with HASTE sequence (TR/<br />

TE ¼ 80/8, 16, 24, 32 ms; FA ¼ 30; FOV ¼ 360, slice<br />

thickness ¼ 4 mm, matrix ¼ 256 £ 256) in sagittal, axial,<br />

and coronal planes. Fetal brain structures including lateral<br />

ventricles, corpus collosum, and cerebellar vermis are<br />

measured.<br />

1 H spectra are recorded with the STEAM<br />

sequence (TR/TE ¼ 1365/135, 20; 1500/270 ms) combined<br />

with PRESS sequence (TR/TE ¼ 1500/10 ms) for more<br />

effective suppression of water signal, VOI ¼ 15 £ 15 £ 15<br />

mm, NS ¼ 128. Integral intensity of signals of NAA, Cr,<br />

Cho, Lac, and Glu-Gln complex are determined. The metabolite<br />

ratios NAA/Cr, Cho/Cr, NAA/Cho and NAA/<br />

(Cho 1 Cr) are calculated from spectra. From MR-images<br />

of fetal brain in G2 it is found that the ratio ventricle/brain<br />

decreases, and the length of corpus collosum, and also the<br />

length, height, and area of cerebellar vermis increase with<br />

gestational age. The growth and development of the fetal<br />

brain in G1 are different from ones in G2. The normal brain<br />

demonstrate rapid changes during the fetal period, and in<br />

the case of hypoxic ischemic injury the growth retardation<br />

of fetal brain is observed. The ratios NAA/(Cho 1 Cr),<br />

NAA/Cr and NAA/Cho for G1 and G2 are not significantly<br />

distinguishable. The ratio Cho/Cr decreases significantly in<br />

G1 compared to G2. Lac signal present in nine cases in G1<br />

and in two cases in G2. In seven cases in G1 the decrease<br />

of the intensities of Glu-Gln signals in comparison with G2<br />

is observed. This occurs together with reducing the ratio<br />

Cho/Cr and appearing Lac. MRI and 1 H MRS are very<br />

sensitive and effective methods for early detection of<br />

fetal hypoxic ischemic injury. Both the methods can be<br />

applied in obstetric diagnostics for assessment and understanding<br />

of intrauterine growth retardation.<br />

FP-M-023<br />

Using digital subtracted angiography to detect children<br />

intracranial vascular malformation<br />

Z.-P. Wang, J.-M. Yu, W.-X. Zhong<br />

Shanghai Children’s Medical Center, Shanghai Xin Hua<br />

Hospital, Shanghai Second Medical <strong>University</strong>, China<br />

Objective: To report various types of intracranial vascular<br />

malformations in children; and to determine the clinical<br />

value and safety of angiography. Methods: Review of the<br />

data of 42 patients who had been suspected to have vascular<br />

diseases by CT scan or MRI examination. Digital subtracted<br />

angiographies (DSA) were conducted through the femoral<br />

artery by inserting the catheter into the brachiocephalic<br />

artery. Results: Thirty patients were found to have anomalous<br />

vessels in their brains. Among them, 15 had arteriovenous<br />

malformations, three had intracranial aneurysms, six<br />

had arteriovenous fistulas, five had moyamoya syndrome,<br />

and one had Yasuda syndrome. There were no abnormal<br />

findings in the remaining 12 patients. MRI showed two<br />

patients with cryptic intracranial vascular anomalies.<br />

Conclusion: DSA played an important role in diagnosis<br />

and treatment of vascular diseases, indicating a promising<br />

future for its use in child neurology diseases.<br />

FP-M-024<br />

Bilateral hypodensity of the basal ganglia. Clinicoevolutionary<br />

correlation in children<br />

A. Martínez-Bermejo, J. Arcas, V. López-Martín, A.<br />

Tendero, C. Roche<br />

Service of Neuropediatrics, Hospital La Paz, Madrid, Spain<br />

Introduction: The presence in neuroimaging of areas of<br />

symmetrical bilateral hypodensity in the basal ganglia<br />

(SBHBG) is a striking and unusual finding. Objective: To<br />

determine the aetiology, clinical significance and evolution<br />

of a group of paediatric patients with SBHBG. Patients and<br />

methods: We made a study of 21 patients with neuroimaging<br />

studies (CT or MR) showing SBHBG. The affected area was<br />

related to the aetiology, clinical features and evolution.<br />

Results: The ages varied between 4 months and 16 years.<br />

In seven cases Leigh’s disease was diagnosed, five had had<br />

acute hypoxia, four glutaric aciduria type I, and one case<br />

each of methylmalonic aciduria, Ia glycogenosis, CO intoxication,<br />

acute striatal necrosis and bacterial meningitis. The<br />

putamen was affected in six cases, globus pallidus in four<br />

cases and the lenticular nucleus was damaged in the rest.<br />

Three cases also had lesions in the caudate nucleus. MR was<br />

better than CT for localization of the precise area involved.<br />

Clinically, 13 cases had extrapyramidal signs. We found no<br />

relation between the size, localization of the lesion and the<br />

prognosis, which was more dependent on the aetiology, only<br />

one patient (CO intoxication) recovered and eight died<br />

(Leigh’s disease and one case of hypoxia). Conclusions:<br />

The presence of SBHBG in a patient makes extensive<br />

study necessary to find the aetiology. It is a non-specific<br />

finding, usually of metabolic origin and with little correlation<br />

with the clinical condition. Its presence implies a poor<br />

prognosis and raises suspicion of the presence of certain<br />

neurological disorders.<br />

FP-M-025<br />

Cranial ultrasonograpic characteristics and clinical<br />

correlates in young infants with Sturge-Weber<br />

syndrome (SWS)<br />

Y.-C. Chang a , C.-C. Huang b , L.-T. Huang a<br />

a Department of Pediatrics, Chang Gung Children’s Hospital,<br />

Kaohsiung, Chinese Taipei; b National Chung Kung<br />

<strong>University</strong> Hospital, Tainan, Chinese Taipei<br />

SWS is a rare congenital disorder that is marked by angiomatosis<br />

involving face, eyes, and leptomeninges. Early identification<br />

of the extent of pial angioma, cortical atrophy and<br />

calcification is critical in determining the prognosis. Ultrasonographic<br />

(US) studies are scarce in infants with SWS. In<br />

this study, cerebral US findings of SWS were characterized in


Abstracts 591<br />

four infants, including two infants presented with hemiparesis<br />

or seizures, and two newborns without neurological<br />

signs. Increased echogenicity of the pia-arachnoid was seen<br />

in all four patients, with extensive temporo- parieto- occipital<br />

involvement in three, and temporo-parietal in one. A thin<br />

ribbon of hyperechogenicity subjacent to the affected cerebral<br />

cortex was found in all four patients. Subcortical white<br />

matter hyperechogenicity was shown in three and two evolving<br />

to cortical calcification during follow-up. Contrastenhanced<br />

MR imagines performed in three patients revealed<br />

enlarged choroid plexus in three, white matter abnormalities<br />

in two and cerebral atrophy in one. One newborn developed<br />

intractable epilepsy at age 6 months, along with rapidly<br />

progressive cortical and subcortical hyperechogenicity and<br />

cortical atrophy demonstrated by US. The other newborn<br />

with stable subcortical white matter hyperechogenicity<br />

remained seizure-free, and had mild hemiparesis and normal<br />

cognitive development at age 1 year. Our study demonstrated<br />

that US is useful in early detecting the pial and parechymal<br />

involvement of SWS in newborn infants who have facial<br />

nevus flammeus, and is also of prognostic values. Moreover,<br />

it can detect more extensive cerebral abnormalities associated<br />

with SWS than contrast-enhanced MR images in<br />

young infants.<br />

FP-M-026<br />

SPET imaging of striatal dopamine transporters and D 2<br />

receptors in patients with autosomal recessive l-DOPA<br />

responsive infantile Parkinsonism due to tyrosine<br />

hydroxylase deficiency<br />

J.F. de Rijk-van Andel a , J. Booij b , P.J. van Noorden c , R.A.<br />

Wevers d , E.A. van Royen b<br />

a Department of Neurology, Amphia Hospital Breda, The<br />

Netherlands; b Graduate School of Neurosciences Amsterdam,<br />

Department of Nuclear Medicine, <strong>University</strong> of<br />

Amsterdam, Academic Medical Centre, The Netherlands;<br />

c Department of Nuclear Medicine, Amphia Hospital<br />

Breda, The Netherlands; d Laboratories of Pediatrics and<br />

Neurology, <strong>University</strong> of Nijmegen, The Netherlands<br />

The enzyme tyrosine hydroxylase (TH) catalyzes the<br />

conversion of l-tyrosine to l-dihydroxyphenylalanine (l-<br />

DOPA), the rate-limiting step in the biosynthesis of dopamine.<br />

TH deficiency (THD) has recently been found in the<br />

recessive form of dopa-responsive dystonia (DRD), which is<br />

characterized by extrapyramidal symptoms in infancy and a<br />

good clinical response on low-dose l-DOPA. In the present<br />

study, striatal dopamine transporters and D 2 receptors were<br />

studied by means of single photon emission tomography in<br />

two drug-naive children with THD. Striatal dopamine transporters<br />

were also studied in a third child with THD, already<br />

treated with a low dose of l-DOPA on the moment of<br />

imaging. The results of the study suggest normal integrity<br />

of striatal dopaminergic nerve terminals and striatal D 2<br />

receptors in recessive DRD with THD. These findings<br />

give hope for a sustained response to low-dose l-DOPA,<br />

without the development of unfavourable side-effects, in<br />

patients with THD.<br />

FP-M-027<br />

Congenital mirror movement: investigation of<br />

functional magnetic resonance imaging and transcranial<br />

magnetic stimulation<br />

Y. Maegaki a , T. Koeda b , A. Seki a , I. Suzaki a , S. Sugihara c ,<br />

T. Ogawa c , T. Amisaki d , C. Fukuda e<br />

a Division of Child Neurology, Institute of Neurological<br />

Sciences, Faculty of Medicine; b Department of Humanity<br />

Education, Faculty of Education and Regional Sciences;<br />

c Department of Radiology, Faculty of Medicine; d Department<br />

of Biological Regulation, School of Health Science,<br />

Faculty of Medicine; e Department of Pathological Science<br />

and Technology, School of Health Science, Faculty of Medicine,<br />

Tottori <strong>University</strong>, Japan<br />

Two patients with congenital mirror movement, one a<br />

child and the other an adult, were studied using fMRI and<br />

TMS. Bilateral primary sensorimotor cortices were activated<br />

during unilateral hand gripping on fMRI. Bilateral<br />

motor evoked potentials were induced from the hand and<br />

forearm muscles after TMS of each hemisphere. Bilateral<br />

motor responses were also induced from the arm muscles in<br />

the adult patient. The contralateral motor responses to TMS<br />

were smaller than the ipsilateral ones in the hand muscles,<br />

while the former were larger than the latter in the arm<br />

muscles. The contralateral motor responses reduced in<br />

amplitude or disappeared in the hand muscles and increased<br />

in the forearm muscles with increasing age while his mirror<br />

movements decreased gradually. Our results suggest that an<br />

unusual cortical motor organization develops in patients<br />

with congenital mirror movement. Bilateral activation of<br />

the primary sensorimotor cortices during intended unilateral<br />

hand movement and ipsilateral motor evoked potentials are<br />

responsible, at least in part, for the pathophysiology of<br />

congenital mirror movement. Reduction of the contralateral<br />

hand motor responses and increase of the contralateral forearm<br />

motor responses may be related to the decrease in<br />

mirror movements during development.<br />

FP-M-028<br />

Correlation of apparent diffusion coefficient of water<br />

changes with expression of a water channel protein,<br />

aquaporin 4, in developing rat brain following hypoxiaischemia<br />

S. Meng a,b , M. Qiao a , P. Latta a , M.R. Del Bigio, B.<br />

Tomanek a , U.I. Tuor a<br />

a Institute for Biodiagnostics (West), National Research<br />

Council; b Department of Pediatrics, The Second Clinical<br />

College, China Medical <strong>University</strong>, NW, Calgary, Alta,<br />

Canada


592<br />

Abstracts<br />

Introduction: Decreases in the ADC of water measured<br />

using magnetic resonance imaging techniques have been<br />

well documented to occur in cerebral ischemia. Cellular<br />

edema is considered an underlying cause of these changes.<br />

Recent studies have demonstrated a key role of water channel<br />

protein, aquaporin 4 (AQP4) in the development of brain<br />

edema, however, few studies have examined whether<br />

ischemic ADC changes in developing brain are related to<br />

changes in the expression of AQP4. Methods: One or 4<br />

weeks old rats were subjected to an episode of cerebral<br />

hypoxia-ischemia (HI) (unilateral carotid artery occlusion<br />

plus exposure to 8% oxygen 1 h). ADC images were<br />

acquired before, during, and 1 or 24 h after HI. AQP4<br />

expression was assessed immnuohistochemically in<br />

subgroups of animals at each time point. The correspondence<br />

between hypoxic-ischemic changes in AQP4 expression<br />

and ADC changes were assessed. Results: In the brain<br />

of sham control rats, there were no left-right differences in<br />

ADC values or AQP4 staining although ADC values were<br />

greater in 1-week than 4-week old animals. In both age<br />

groups, ADC values in the ipsilateral hemisphere decreased<br />

during HI, partially recovered at 1 h after HI and decreased<br />

again at 24 h after HI. The areas of ADC decreases were<br />

distributed throughout much of the ipsilateral hemisphere<br />

during HI, with some recovery at 1 h after HI, and further<br />

recovery at 24 h after HI. AQP4 expression was decreased<br />

during, and at 1 and 24 h after HI in both age groups, with<br />

the changes corresponding well to the distribution and<br />

values of altered ADC at the different times. Conclusion:<br />

The diffusibility of water in brain as detected with magnetic<br />

resonance Imaging is dependent on the stage of postnatal<br />

development. The correspondence between AQP4 and ADC<br />

changes during or following hypoxia-ischemia suggests an<br />

important role for this water channel protein in the cell<br />

swelling, however, other tissue changes should also be<br />

considered to account for the hypoxic-ischemic changes in<br />

the ADC of water.<br />

FP-M-029<br />

A quantitative MRI study of the corpus callosum in<br />

autistic children<br />

K. Tao, K. Mori, T. Hashimoto, K. Inoue, Y. Toda, M.<br />

Miyazaki, T. Saijyo, Y. Kuroda<br />

Department of Pediatrics, School of Medicine, <strong>University</strong> of<br />

Tokushima, Tokushima, Japan<br />

The corpus callosum (CC) is the main interhemispheric<br />

commisure of the brain and connects homologous cortical<br />

areas. We measured the total midsagittal area and seven<br />

subregions of the CC, which denote cortical regions according<br />

to Witelson, on MRI scans from 30 autistic and 17<br />

normal young children (age, 3–5 years). Area of the anterior<br />

subregions (Region 1: the rostrum 1 Region 2: the genu)<br />

was smaller in the autistic group (autistic group;<br />

118.5 ^ 14.6 mm 2 versus control group; 134.6 ^ 21.3<br />

mm 2 , P ¼ 0:048). There were no significant differences<br />

between groups in the total midsagittal area and the other<br />

areas. This observation suggests decreased functional<br />

connections between cerebral cortex and delayed maturation<br />

in the frontal lobe of autistic children.<br />

FP-M-030<br />

Magnetic resonance imaging (MRI) changes in<br />

childhood Wilson’s disease after treatment<br />

J.-M. Zhang, M.-X. Wang, K.-R. Bao<br />

Xinhua Hospital, Shanghai Second Medical <strong>University</strong>,<br />

Shanghai, China<br />

Objectives: To observe the changes of MRI during the<br />

course of treatment in Wilson’s disease and evaluate its<br />

clinical significance. Methods: Fifty-seven patients with<br />

Wilson’s disease received routine SE sequence MRI of<br />

brain and liver. Nineteen patients with abnormal MRI (ten<br />

pretreated or newly-treated and nine follow-up patients) and<br />

each of them had 2 , 4 times of serial MRI examinations at<br />

interval of 1 , 1.5 years. Clinical data with MRI were<br />

analysed. Results: In nineteen patients with abnormal MRI<br />

findings, nine patients had lesions in both brain and liver<br />

(46.37%), seven patients in brain (36.84%), three patients in<br />

liver (15.79%). Most of the patients with abnormal MRI<br />

showed a pattern of bilateral, symmetrical T2W high signal<br />

or/and T1W low signal. Abnormal MRI of the liver showed<br />

multiple rounded T1W high signal lesion and T2W low<br />

signal lesion. The major lesions disappeared or decreased<br />

after rational treatments. The rates of improvement in<br />

patients with adequate treatment were markedly higher<br />

than patients with inadequate treatment (x 2 ¼ 19.36,<br />

P , 0:01). Conclusions: Hepatic and brain lesion as<br />

shown in MRI may disappear after adequate treatment.<br />

There were only mild or no change in MRI abnormalities<br />

in patients with inadequate treatments comparable with poor<br />

clinical improvement. MRI was helpful in understanding<br />

therapeutic effect and prognosis of Wilson’s disease.<br />

FP-M-031<br />

Brain SPECT and MR imaging in postinfectious acute<br />

cerebellar ataxia: A case report<br />

T. Isagai, Y. Yamashita, S. Yatsuga, R. Fukui, A. Kusaga,<br />

C. Fujimoto, T. Matsuishi<br />

Department of Pediatrics and Child Health, Kurume<br />

<strong>University</strong> School of Medicine, Fukuoka, Japan<br />

Purpose: There have been few reports on SPECT findings<br />

in patients with acute cerebellar ataxia in children. We have<br />

previously reported on five patients with postinfectious<br />

acute cerebellar ataxia with decreased cerebellar blood<br />

flow using 123 I-IMP SPECT (J Neurol Neurosurg Psychiatry<br />

1999;67:109–112). No abnormal MRI findings were found<br />

in these five patients and they all recovered in 2 weeks. We


Abstracts 593<br />

here report a patient with acute cerebellitis who showed<br />

prolonged symptoms and abnormal MRI/SPECT findings.<br />

Case report: A 7-year-old girl was admitted to Kurume<br />

<strong>University</strong> Hospital with headache, ataxia and slurred<br />

speech, 2 days after upper respiratory infection. Neurological<br />

examination was unremarkable except cerebellar signs.<br />

Laboratory data showed elevated WBC of 13600 and CRP.<br />

Cerebrospinal fluid studies demonstrated 91 lymphocytes/<br />

mm 3 , total protein content of 135 mg/dl. The myelin basic<br />

protein was normal. Epstein-Barr and varicella-zoster viral<br />

titers in serum were negative. Mild consciousness disturbance<br />

and dysphagia were observed for a few weeks, but<br />

she gradually recovered in 2 months. Her initial MRI<br />

demonstrated diffuse cerebellar edema in T1-weighted<br />

image and increased cerebellar intensity in T2-weighted<br />

image, however SPECT image was normal. One month<br />

later her SPECT showed decreased cerebellar and pontiine<br />

blood flow with normal MRI images. Conclusion: The<br />

combined use of MRI and SPECT was useful in evaluating<br />

pathophysiology of patients with acute cerebellar ataxia and<br />

cerebellitis<br />

FP-M-032<br />

Quantitative ultrasonic tissue characterization of the<br />

neonatal brain<br />

C. Fujimoto a , Y. Yamashita a , H. Kanda a,b , E. Harada a,b ,Y.<br />

Maeno a,b , T. Hori b , T. Matsuishi a<br />

a Department of Pediatrics and Child Health; b Maternal and<br />

Perinatal Medical Center, Kurume <strong>University</strong> School of<br />

Medicine, Fukuoka, Japan<br />

Purpose: Increased echogenecity of periventricular white<br />

matter in the acute phase and later development of cysts is<br />

the classic sonographic picture of cystic PVL, however<br />

evaluation of periventricular echodensities (PVE) is rather<br />

subjective and normal periventricular ehogenic halo may<br />

mimic PVL in some patients. To clarify the significance<br />

of ultrasonic integrated backscatter (IBS) as a quantitative<br />

method of evaluating PVE, we investigated sequential<br />

change of IBS levels in neonatal brain by birthweight.<br />

Patients and method: Cranial sonography were routinely<br />

performed by neonatologists using SONOS 5500 (Philips)<br />

with a 12.5 MHz probe in 43 newborn neonates admitted to<br />

Maternal and Perinatal Medical Center, Kurume <strong>University</strong><br />

Hospital. The neonates were divided into four groups: group<br />

A, nine extremely low birthweight infants; group B, 14 very<br />

low birthweight infants; group C, 15 infants with birthweight<br />

1500–2499; and group D, 15 infants with birthweight<br />

more than 2500 g. The first scan was performed<br />

within 24 h after birth, then weekly follow-up scans until<br />

1 month were performed. The IBS levels were measured at<br />

five region of interests (ROIs) bilaterally; periventricular<br />

white matter (WM), choroid plexus (CP), TH, lateral ventricle<br />

(LV), and occipital skull bone (SB). Results: The IBS<br />

levels varied by individuals, however there were no differences<br />

in IBS values of five ROIs between right and left<br />

parasagittal view in each patient. The IBS levels were<br />

higher in the order of SB . CP . WM . TH . LV in all<br />

groups. The IBS levels were sequentially decreased in perivenrtricular<br />

WM in all groups. Conclusion: A real-time IBS<br />

imaging system may be useful in characterizing brain tissue<br />

in the neonate.<br />

FP-M-033<br />

Juvenile neuronal ceroid lipofuscinosis: progressive<br />

brain atrophy on serial MRI<br />

R. Fauze, H.B. Bonet, M.C. Boente, M. Winik<br />

Neurology, Dermatology, Pathology, Children Hospital,<br />

Tucumán, Argentina<br />

A 13-year-old girl, daughter of unrelated healthy parents.<br />

Pregnancy and delivery were normal. Psychomotor development<br />

was normal until 7 years when her teacher noticed a<br />

progressive decrease in her attention level in addition to<br />

communication dysfunction and social withdrawal. A<br />

psychiatric condition was suggested. At the age of 8 she<br />

developed myoclonic jerks. Neurological examination<br />

revealed an inattentive girl with poor fine motor skills. CT<br />

scan showed mild atrophy. EEG showed pseudoperiodic<br />

burst of high amplitude slow waves with posterior spikes<br />

to low frequency photic stimulation. Valproic acid was<br />

prescribed. Two months later, however, myoclonic epilepsies<br />

became more frequent and clonazepam was added to<br />

the regimen. At that time, she was completely mute. By the<br />

age of 11, fell due to ataxia. MRI showed moderate atrophy.<br />

ERG and VEP were decreased. Vacuolated lymphocytes<br />

were present. Skin ultrastructural examination showed<br />

predominance of fingerprint profiles. Ophthalmological<br />

examination not revealed macular degeneration. By the<br />

age of 13 she had myoclonias and a motor disturbance<br />

with ataxia. Myoclonic epilepsies, mental deterioration,<br />

ataxia and progressive brain atrophy suggests NCL,<br />

however a definitive diagnosis is based on skin or conjunctival<br />

biopsy that reveal storage of specific lipopigments.<br />

NCL are a group of progressive, autosomal-recessive and<br />

finally fatal neurodegenerative diseases in children marked<br />

by lysosomal accumulation of disease-specific lipopigments<br />

in cerebral and extra-cerebral tissues and neuronal loss in<br />

brain and retina.<br />

FP-M-034<br />

Magic angle spinning 1 H MR spectroscopy of autopsy<br />

samples from patients with neuronal ceroid<br />

lipofuscinoses reveals decreased neuronal metabolites<br />

T.H. Autti a , A.-M. Häkkinen b , B. Sitter c , J. Tyynelä d ,T.<br />

Bathen c , U. Sonnewald c , I.S. Gribbestad c<br />

Departments of<br />

a Radiology and b Oncology, Helsinki<br />

<strong>University</strong> Central Hospital, Finland, Helsinki, Finland,<br />

c MR Center, SINTEF Unimed and Department of Clinical


594<br />

Abstracts<br />

Fig. 1. HR MAS spin-echo spectra of autopsy samples from a control (top)<br />

and an INCL patient (bottom).<br />

Neurosciences NTNU, Trondheim, Norway; d Department of<br />

Biochemistry, Helsinki <strong>University</strong>, Finland<br />

NCLs are among the most common progressive childhood<br />

encephalopathies. We have applied MAS 1 H MRS to<br />

brain autopsy samples of infantile and juvenile NCL<br />

patients, along with samples of controls without neurological<br />

deficits. Material and methods: The autopsy samples<br />

of frontal cortices from patients with INCL (n ¼ 10), JNCL<br />

(n ¼ 6) and controls (n ¼ 9) were kept at 2808C until MR<br />

analysis. HR proton MAS spectra were recorded using a<br />

BRUKER AVANCE DRX600 spectrometer equipped with<br />

a 1 H/ 13 C MAS probe with gradient. Principal component<br />

analysis (PCA) of mean normalised spectra was performed<br />

on the spectral region 4.6–0.6 ppm. The lactate doublet<br />

was excluded from PCA due to high intensity compared<br />

to other metabolites. Score and loading plots were examined<br />

in detail. Results: Fig. 1.<br />

FP-M-035<br />

Acute disseminated encephalomyelitis and multiple<br />

sclerosis: is there any association?<br />

W.-T. Lee, T.-W. Yu, J.-S. Liang, Y.-Z. Shen<br />

Department of Pediatrics, National Taiwan <strong>University</strong><br />

Hospital, Taipei, Chinese Taipei<br />

Both MS and ADEM are rare inflammatory demyelinating<br />

diseases of the CNS in children. Compared with<br />

western countries, the incidence of MS is much lower in<br />

Taiwan. In the past 7 years, only 12 patients below 18<br />

years of age were diagnosed to have ADEM in our hospital.<br />

Of these, two (17%) turned out to have MS 6 and 2<br />

years later, respectively. The first was an 18-year-old girl.<br />

She was diagnosed to have ADEM at 12 years old, with<br />

initial manifestations of acute onset of psychiatric symptoms<br />

followed by focal neurological signs. The MRI<br />

showed multiple lesions over gray and white matters and<br />

spinal cord, compatible with ADEM. She developed<br />

sudden onset of bilateral optic neuritis followed by right<br />

hand weakness 6 years later, when MS was diagnosed. She<br />

experienced another relapse one month later. Another<br />

patient was an 8-year-old boy, who was diagnosed to<br />

have ADEM at 6 years old, when he had preceding infection<br />

followed by limb weakness. However, one episode of<br />

optic neuritis, followed by another episode of optic neuritis<br />

and limb weakness occurred 2 years later. MRI showed<br />

multiple lesions compatible with MS. Judging from the<br />

low incidence of MS and ADEM in Taiwan, we conclude<br />

that there may be some correlations between the pathogenesis<br />

of MS and ADEM. Longer follow-up of the children<br />

with ADEM may be helpful to clarify the relationship of<br />

MS and ADEM.<br />

FP-M-036<br />

Lactate quantification by means of proton magnetic<br />

resonance spectroscopy in patients with congenital lactic<br />

acidosis<br />

N. Iwasaki a , R. Tanaka a , T. Isobe b , A. Matsumura b ,I.<br />

Anno c , T. Ohto a , A. Matsui a<br />

a Department of Pediatrics, b Neurosurgery and c Radiology,<br />

Institute of Clinical Medicine, <strong>University</strong> of Tsukuba, Ibaraki,<br />

Japan<br />

Proton MRS provides a useful approach for monitoring<br />

children with disorders of lactate metabolism. However,<br />

most studies have evaluated lactate only by its existence<br />

or by relative ratio. In the present study, we have a developed<br />

method for lactate quantification and applied it to three<br />

clinical cases with congenital lactic acidosis. Two of them<br />

had pyruvate dehydrogenase complex deficiency and one<br />

had Leigh syndrome. All patients were examined on a clinical<br />

1.5 T super-conducting MR whole body system; two of<br />

them twice. Data were acquired by using point resolved<br />

spectroscopy (PRESS) sequence. We used a coupling<br />

constant of J ¼ 7.35 Hz (2/J ¼ 272 ms). T2 relaxation<br />

correction was performed for water and lactate in each<br />

case. For lactate, in-phase signals were used to calculate<br />

the T2 relaxation time. The volume of interest was placed<br />

in the ventricular space. The tissue water signal was used as<br />

an internal standard using a water concentration of 100%<br />

(55 mmol/l). The calculated lactate concentration from<br />

proton MRS was compared to the CSF lactate level. The<br />

calculated lactate concentration and CSF level were<br />

3.21 ^ 1.73 and 3.53 ^ 1.52 mmol/kg, respectively. The<br />

correlation coefficient was 0.91. To our knowledge, this is<br />

the first study to estimate the reliability of lactate quantification<br />

using proton MRS in vivo and has allowed us to<br />

examine the precise lactate metabolism of the brain noninvasively.


Abstracts 595<br />

FP-M-037<br />

Use of transcranial ultrasound in the diagnosis of<br />

intracranial bleed in critically-ill children 2 months–2<br />

years old. A pediatric intensive case unit experience<br />

J.A. Comuelo, J.A. Robles, M. Sancho, H. Cifra, L.<br />

Tolentino<br />

Child Neuroscience Division Philippine Children’s Medical<br />

Center Quezon Avenue, Quezon City, Philippines<br />

A retrospective cross-sectional validation study was<br />

conducted to determine the accuracy of transcranial ultrasound<br />

(CUTZ) in the immediate detection of intracranial<br />

(IC) bleed in critically-ill children at a pediatric ICU of a<br />

tertiary hospital over a 30-month period. Inclusion criteria:<br />

2 months–2 years, patent anterior fontanelle, suspected<br />

intracranial bleed, with initial CUTZ and confirmatory CT<br />

scan. Exclusion criteria: clinical deterioration in-between<br />

procedures, .24 H-interval between procedures. Age, sex,<br />

and initial impression were recorded, and CUTZ findings<br />

were compared with CT scan results as to presence of IC<br />

bleed, location, and associated findings. From 239 cases<br />

enrolled, 41% had IC bleed. Male comprised 61%, with<br />

70% less than 1 year old. Significant correlation was<br />

noted with 19–24 months old group-82% had IC bleed<br />

(0.131). Non-traumatic causes (61%), with 70% less than<br />

1 year old. Significant correlation was noted with 19–24<br />

months old group-82% had IC bleed (0.131). Non-traumatic<br />

causes (61%) include seizure disorders, CNS infections,<br />

sepsis, and APCD. Only sepsis showed a significant correlation<br />

(0.175)-73% had IC bleed. IC bleeds were detected at<br />

the ff. areas: intraparenchymal (47.5%) intraventicular<br />

(28%), subdural (13%), subarachnoid (9%), and cerebellar<br />

(3%). Associated findings were cerebral edema (20%),<br />

meningitis (5%), and hydrocephalus (1%), CUTZ had a<br />

sensitivity of 94% and specificity of 99%; 1PV-98.9%;<br />

PV ¼ 95.8%; accuracy ¼ 95%. Using correlation and<br />

regression analysis, CUTZ had a very high correlation<br />

(0.895; sig value ¼ 0.126) with CT scan with no significant<br />

difference. Conclusion: Transcranial ultrasound can be used<br />

as an accurate diagnosis tool for the immediate detection of<br />

intracranial bleed in critically-ill children 2 months–2 years<br />

old.<br />

FP-M-038<br />

Occipital MRI abnormalities following neonatal<br />

hypoglycemia<br />

D. Yalnizoglu, M. Topcu, G. Turanli, A. Cila<br />

Hacettepe <strong>University</strong> Department of Pediatric Neurology<br />

and Department of Radiology, Ankara, Turkey<br />

Imaging features of infants who suffered brain damage as<br />

a result of neonatal hypoglycemia were shown to have similar<br />

patterns, and to affect the parietal and occipital lobes<br />

most severely. A variety of disorders may underlie similar<br />

neuroimaging features in childhood. We report ten patients<br />

with predominately occipital lesions on MRI, and attempt to<br />

relate the neuroimaging findings with underlying neonatal<br />

and early infantile insults. The medical records of ten<br />

patients with predominately occipital lesions on MRI were<br />

reviewed retrospectively. CT was available in three patients.<br />

Imaging studies were obtained between 40 days and 11<br />

years of age. The ages at final follow up ranged between<br />

5.5 months and 11 years; age at admission ranged between 2<br />

days and 11 years. Four/10 patients had well documented<br />

hypoglycemia. Seven patients had sepsis and/or hyperbilirubinemia,<br />

associated with hypoglycemia in two. Seven<br />

patients had perinatal hypoxia. All patients have suffered<br />

mild to moderate global developmental delays. Nine<br />

patients had refractory epilepsy, and two had cortical blindness.<br />

MRI showed severe parietooccipital/occipital volume<br />

loss with some asymmetries in all patients. CT showed<br />

occipital calcification compatible with laminar cortical<br />

necrosis in one patient. Our patients who suffered merely<br />

from neonatal hypoglycemia showed occipital predominance<br />

of MRI abnormalities similar to the previous reports<br />

on neonatal hypoglycemia. Early insults such as hypoxiaischemia,<br />

neonatal sepsis may result with similar lesions.<br />

Prompt recognition and treatment of symptomatic neonatal<br />

hypoglycemia is essential to minimize future neurological<br />

sequelae such as cortical blindness, mental retardation and<br />

refractory seizure disorder.<br />

FP-M-039<br />

PET in Landau-Kleffner syndrome<br />

I. György, I. Velkey, B. Gulyás, L. Trón<br />

Pediatric Department of <strong>University</strong> of Debrecen, Country<br />

Hospital of Miskolc, Karolinska Institute, Stockholm, PET<br />

Center of <strong>University</strong> of Debrecen Pediatric Department of<br />

<strong>University</strong> Debrecen, Debrecen, Hungary<br />

LKS is a rare disorder with a variable course characterized<br />

by gradual or rapid onset of aphasia in a previously<br />

normal child. Children with LKS syndrome have abnormal<br />

EEG: focal spikes or spikes and waves in the temporal or<br />

central area of the brain and electrical status epilepticus in<br />

slow sleep. Epileptic seizures are not frequently in this<br />

syndrome and they are easy to treat. We observed three<br />

children with LKS. Two of them suffered from difficulty<br />

of comprehension of the speech and the other one from<br />

expressive aphasia. All three children had only few epileptic<br />

seizures, but their EEG showed massive paroxysmal signs:<br />

focal spikes awake and electrical status epilepticus in slow<br />

sleep. MRI was negative in all three cases. The cause of<br />

disorder remained unknown. All three children were righthanded.<br />

FDG PET was made in our patients. We found<br />

decrease in glucose utilization in all patients in the left<br />

auditory speech cortex. PET of the boy with difficulty of<br />

expressive speech showed decrease in the glucose utilisation<br />

in the left Broca area, too. All patients were treated with


596<br />

Abstracts<br />

antiepileptic drugs. Prednisolone was done plus to the two<br />

girls with disturbance of receptive speech and intravenous<br />

gammaglobulin to the boy with expressive aphasia. One girl<br />

treated with prednisolone cured. In the other, aphasia<br />

remained and a severe regression of mental function was<br />

observed. The boy with expressive aphasia cured, too. The<br />

PET investigation after healing showed marked improvement<br />

but not normalisation in glucose utilization of the<br />

speech-areas of the brain.<br />

FP-M-040<br />

The spectrum of MRI findings in subacute sclerosing<br />

panencephalitis<br />

Ö.F. Aydin, N. Şenbil, Y.K.Y. Gürer<br />

Departments of Pediatric Neurology, Dr. Sami Ulus Children’s<br />

Hospital, Ankara, Turkey<br />

Purpose: Evaluation of patients diagnosed as SSPE with<br />

MRI and investigation of the relation between MRI findings<br />

and the stage of the disease. Material and methods: Fortytwo<br />

patients with SSPE were evaluated by MRI on T1, T2,<br />

FLAIR and PD series, and the findings were compared with<br />

the stages of the disease. Results: Pathological findings were<br />

found in 33 patients and nine patients had normal findings.<br />

Inflammatory demyelinating lesions were seen mostly with<br />

hypointense appearance on T1 series and with hyperintense<br />

appearance on T2, FLAIR and PD series. Lesions were<br />

asymmetrically located, patchy and multifocal. Pial and<br />

parenchymal contrast enhancement, or local mass effect of<br />

parenchymal lesions was not found. Lesions tended to be<br />

more common in the subcortical white matter (87.8%).<br />

Cerebral atrophy was found in four patients, but this was<br />

not found to be related with the age of the disease. There<br />

was deep gray matter involvement in six patients and brainstem<br />

involvement in three patients, and cortical involvement<br />

was found in two patients. One of the two patients<br />

with cerebellar involvement, showed evident cerebellar<br />

folia and the other one showed hyperintense lesions on<br />

middle cerebellar pedincules. Conclusions: Brainstem,<br />

deep gray matter and cortical involvements observed on<br />

MRI were found at further stages of the disease. Cerebellar<br />

atrophy and cerebellar involvement were not related with<br />

the clinical stages of the disease.<br />

FP-M-041<br />

Clinical and MRI findings in children with transverse<br />

myelitis<br />

Y.-H. Huang<br />

Shantou Central Hospital, Shantou, China<br />

Objective: To explore the clinical and MRI features in<br />

children with transverse myelitis. Methods: Provide spinal<br />

cord MRI examination with the machine of SMT-100XX<br />

from Japan Daojing to four patients, who have been onset of<br />

illness within 3 months. Results: (1) The T2WI in all four<br />

patients shows high intensity, with focal border showing<br />

unclear, little patch, dot shape or reinforcement on the<br />

border. In these four patients, two cases did not have any<br />

change on the T1WI, two did not have augmentation on<br />

spinal cord and I have little augmentation on it. (2) On<br />

neck lesion patients, MRI shows obviously on clinical<br />

dysarthria, not obviously on malfunction of respiratory<br />

muscle and sphincter, slight sensory disturbance and quick<br />

recovery. Conclusion: In children with transverse myelitis,<br />

MRI shows the T2WI is the most sensitive one and the focus<br />

shows little local reinforcement. It seems that children<br />

patients have different features comparing to adults. For<br />

children patients, they have slight sensory disturbance and<br />

most of them have dysarthria, not obviously on malfunction<br />

of respiratory muscle and sphincter. Not all patients show<br />

augmentation on spinal cord.<br />

FP-N<br />

Autism/Learning/Behavior<br />

FP-N-001<br />

Usefulness and limitation of ‘draw-a person’ test to<br />

determine intellectual level<br />

C. Zix<br />

Hospitalor rue Ambroise Pare Saint-Avold Lorraine,<br />

France<br />

The draw-a-man (or draw-a-person) test has been<br />

proposed since 1926 by Goodenough for the rapid evaluation<br />

of intellectual efficiency. We made a prospective study,<br />

comparing the draw-a-man test to conventional IQ studies,<br />

in order to assess the usefulness of this method. Methods:<br />

We studied 81 children (22 girls, 59 boys) who had been<br />

refused to a specialised paediatrician for learning disorders.<br />

All children performed the draw-a-person test, which was<br />

evaluated according to the Goodenough/Harris rating<br />

system. IQ was evaluated with WISC or WPPSI, depending<br />

on age. Six children were tested twice. A total of 87 cases of<br />

combined draw-a-person/IQ tests were analysed. For each<br />

child, we established a ‘main’ diagnosis, after through<br />

analysis of the learning difficulties, including a neurological,<br />

psychological and orthophonic examination. Patients<br />

were assigned to the following categories: MR, instrumental<br />

disorders (dyslexia, dysphasia, dyspraxia: ID), hyperactivity<br />

with attention disorder (ADD), neurotic problems, epilepsy,<br />

and others (psychosis, prematurity). Correlation between<br />

the draw-a-person test and IQ was calculated with correlation<br />

coefficient and regression line. Results: Twenty-two<br />

girls and 59 boys have been examined. The average age<br />

was 9.47 ^ 2.57 years. Diagnosis distribution was as<br />

follows: 21 MR, 19 ID, nine ADD, ten neuroses, 15<br />

epilepsy, seven others. There was a low correlation<br />

(r ¼ 0:42) between the draw-a-person test and global IQ.<br />

Results were most divergent between children with instru-


Abstracts 597<br />

mental disorders and ADD children. When ID and ADD<br />

children were excluded, the correlation coefficient between<br />

draw-a-person tests and IQ tests improved to 0.67. Discussion:<br />

Literature shows an overall good correlation between<br />

draw-a-person tests and global IQ tests. Our study showed<br />

that draw-a-person test must be interpreted with caution,<br />

taking into account instrumental as well as attention disorders,<br />

which may lower the results. The draw-a-person test is<br />

still valid for a rapid initial diagnosis.<br />

FP-N-002<br />

Analysis of topography of spike wave in children with<br />

autism<br />

A. Yasuhara, Y. Yoshida, A. Hori<br />

Department of Pediatrics, Kansai Medical <strong>University</strong> Kohri<br />

Hospital, Neyagawa, Osaka, Japan<br />

We analyzed the EEG spike in order to clarify the critical<br />

age and expression site of the seizure wave in children with<br />

autism. Fifty autistic children with spike detected and<br />

followed up for over 2 years in our Hospital were included.<br />

Informed consent was obtained from a family member.<br />

Recorded spike was analyzed by the topography and the<br />

dipole analysis (GE Marquette: SynaPoint). Of 50 subjects,<br />

39 showed a spike in the frontal region, 29 in the central, 13<br />

in the parietal, and four in the occipital. The average age of<br />

onset was 3.6 ^ 1.3 in the frontal, 3.5 ^ 0.9 in the central,<br />

4.7 ^ 1.4 in the parietal, and 3.0 ^ 0.17 in the occipital<br />

region. In older patients, the spike appears in the parietal<br />

region further than the front-central region (P , 0:05).<br />

Analysis of patients (n ¼ 8) with the spike in the frontal<br />

region showed a map with the highest potential existing in<br />

Fz. Dipole analysis revealed a focus in the position which<br />

agreed with the deep direction of the frontal region, especially<br />

the cingulate gyrus, the Cz and Pz division showed the<br />

highest potential respectively in the EEG potential map with<br />

the spike in the central and the parietal area. The dipole<br />

accumulated on the spike in the frontal region, especially<br />

in the cingulate gyrus. Dysfunction of the cingulate gyrus<br />

appears to be related to the pathophysiology of autism.<br />

FP-N-003<br />

Clinical study on intelligence and behavioral<br />

characteristics in epileptic children with sub-clinical<br />

seizures<br />

Y.-C. Chen, S.-S. Ren, H.-T. Huang<br />

Department of Pediatrics, Daqing Oilfield General Hospital,<br />

Daqing City, Heilongjiang Province, China<br />

To study the intellectual level and behavior in children of<br />

sub-clinical attack of epilepsy. Methods: Forty-eight cases<br />

of epilepsy with sub-clinical outbreak were studied by<br />

WISC, Eysenck personality questionnaire (EPQ) and<br />

CBCL. Results: There were no significant differences in<br />

VIQ, PIQ and FIQ in the two groups but the code and<br />

number of WISC in the epilepsy group were obviously<br />

lower than those in the control group (P , 0:05). The<br />

total marks on CBCL were significantly higher in the<br />

epilepsy group than the control group, including depression,<br />

restlessness, attack and association. Conclusion: Behavioral<br />

characteristic of children with epilepsy should also be paid<br />

attention though no clinic attacks are observed. Overall<br />

comprehensive treatment should be given to control<br />

outbreak, clear up psychology hindrance and increase quality<br />

of life in children with epilepsy.<br />

FP-N-004<br />

The effect of secretin multidose treatment on the<br />

behaviour of autistic children<br />

W. Brussel, S. van Daalen, M.E. de Richemont<br />

Rijnstate Hospital, Arnhem, Netherlands<br />

In 1998 Horvath et al. reported three children with autistic<br />

spectrum disorders who underwent upper gastrointestinal<br />

endoscopy and intravenous administration of secretin to<br />

stimulate pancreaticobiliary secretion. Not only amelioration<br />

of the diarrhoea and increased pancreaticobiliary secretion<br />

were observed, but also a dramatic improvement in the<br />

behaviour, manifested by improved eye contact, alertness<br />

and expansion of expressive language. After this publication<br />

several anecdotal reports of behavioural improvement were<br />

done by parents on internet. Until now, four randomized,<br />

placebo controlled studies are published, which showed no<br />

effect on the behavioural status after one or two doses secretin.<br />

Secretin is a polypeptide hormone secreted by the<br />

pancreas; secretin has a function in the gastrointestinal<br />

tract, but animal experiments have shown effects on the<br />

central nervous system and behaviour in rat. We want to<br />

know whether secretin multidose treatment should give any<br />

effect on the behaviour of autistic children. Pilot prospective<br />

study was done on four autistic children (age 4–6 years/<br />

DSM-IV criteria); during half a year monthly intravenous<br />

administration of secretin (2 IU/kg bodyweight) was given.<br />

Behavioural status was reviewed by weekly parent rating<br />

scales and Childhood Autism Rating Scale (CARS) tests<br />

before the first dose and 4 weeks after the last (sixth) dose<br />

of secretin. CARS test was done by a blinded child psychologist.<br />

Results showed significant improvement in two of the<br />

four children. Conclusion: One or two doses of secretin have<br />

no effect on the behavioural status in autistic children, but<br />

multidose treatment may be effective.<br />

FP-N-005<br />

Study of behavioral problems of children in Fujian<br />

Coastal area<br />

R.-N. Ren, X.-M. Chen, M.-Y. Ling, L.-Y. Ye, H.-Q. Cao<br />

Pediatric Centre of PLA, Department of Pediatrics, Fuzhou<br />

Dongfong Hospital, Fuzhou, China


598<br />

Abstracts<br />

Objective: To explore behavioral problems of children in<br />

coastal area of Fujian. Methods: Achenbach Child Behavior<br />

Checklist was applied to investigate behavioral problems of<br />

children in Fujian coastal area. Children who live in the city<br />

were compared with those in the country. Results: The<br />

prevalence of childhood behavioral problem is 13.5% in<br />

the city group and 12.4% in the non-city group. There is<br />

no significant difference between the groups. Factors affecting<br />

childhood behavioral problems in the city included<br />

physical disease, relationship between parents and children,<br />

correct nursery method, administration attitude, schooling,<br />

achievement; whereas the country included low birth<br />

weight, physical disease, relationship between parents and<br />

children, correct nursery method, administration attitude.<br />

Conclusion: Physical attribute and family relationship<br />

were the main factors affecting behavioural problems.<br />

Medical care and familial education should be introduced<br />

to treat behavioral problems.<br />

FP-N-006<br />

Reactus in patients with diabetes mellitus and Turner<br />

syndrome<br />

N. Nakamoto, S. Kaneko, F. Inouchi, Y. Fujii, Y. Fujita, H.<br />

Kodama, Y. Yanagawa, M. Miyao<br />

Department of Pediatrics, Teikyo <strong>University</strong> School of<br />

Medicine, Tokyo, Japan<br />

Aim: Cognitive function is disturbed in adults with<br />

diabetes mellitus (DM) and Turner syndrome (TS).<br />

WISC-R (or WAIS) and event related potential (ERP)<br />

can be used for evaluating cognitive function. Recently,<br />

‘Reactus’ was developed as a test for evaluating cognitive<br />

function. We examined cognitive function in young<br />

patients with DM and TS using ERP, WISC-R and Reactus.<br />

Patient and methods: Eight patients with DM aged 13–<br />

24 years old, and six with Turner syndrome aged 7–19<br />

years were tested. Four patients had IDDM, and four<br />

patients had non-insulin-dependent diabetes (NIDDM),<br />

including two patients with mutation in mitochondria<br />

gene and two patients with maturity onset diabetes of<br />

youth-Dorland (MODY). A patient with IDDM suffered<br />

from hypoglycemic attack, and cognitive function was<br />

examined before and after the attack. Results and discussion:<br />

Visual motor performance was disturbed two patients<br />

with NIDDM and mutation in mitochondria gene. In the<br />

DM patient with hypoglycemia, visual motor performance<br />

was disturbed after the attack. This disturbance continued<br />

for 1 month. In the two patients with TS, visual reaction,<br />

acoustic reaction and visual motor performance were<br />

markedly disturbed. These results suggest that cognitive<br />

function is disturbed in some DM and TS patients.<br />

FP-N-007<br />

The investigation of related causes of abnormal behavior<br />

and emotion in school age children<br />

L.-Q. Chen, Y.-F. Lu, Y.-C. Zhang, Q. Lu<br />

Shanghai Children’s Hospital, Shanghai, China<br />

Objective: To investigate the causation of abnormal behavior<br />

and emotion in school age children. Methods: Thirtyfive<br />

cases (male 17 and female 18) were analysed on school<br />

age children with problem of behavior and emotion in<br />

Shanghai Children’s Hospital. Results: The first age range<br />

of abnormal behavior and emotion was 7–13 years (mean<br />

age was 9.1). The possible causes were related with family<br />

condition, educational model, social living environment and<br />

heredity. Conclusions: Mental problem were susceptible to<br />

outside environment. The morbidity may be increasing in<br />

school children. The behavior and emotional disorders<br />

could lead to organic dysfunction. In order to reduce incidence<br />

of psychiatric problem in childhood, the health educational<br />

model should be put to practice.<br />

FP-N-008<br />

A controlled study of behavioral problems in children<br />

with tension headache<br />

B. Wei, L.-Y. Zhu, M.-L. Liu, Y.-M. Teng<br />

Pediatric Department, PLA 202 Hospital, Shenyang, China<br />

To investigate the characters of behavioral problems in<br />

children with tension headache, 38 patients and 38 healthy<br />

children were assessed using the Achenbach Child Behavior<br />

Checklist. Behavior problems were showed in 17 patients<br />

(44.74%) and in six healthy children (15.79%). There were<br />

significant differences between two groups (x 2 ¼ 6.12,<br />

P , 0:05). Behavior problems in boys were more than in<br />

girls. The major behavior problems in boys with tension<br />

headache were depression, interpersonal difficult, obsession,<br />

social recession, aggressive behavior and violating<br />

discipline, while girls had higher scores on depression,<br />

social recession, physical complains and schizoid-obsession.<br />

We suggest that the children with tension headache<br />

had more behavior problems than healthy children, especially<br />

being in depression and social intercourse. Behavior<br />

problems of the patients should be considered in the treatment,<br />

to get rid of the source of tension headache.<br />

FP-N-009<br />

Selected neuropsychological data in children with a<br />

cavum of the septum pellucidum<br />

A. Kubik, B. Prajsner, M. Kacinski, A. Gergont, S. Kroczka<br />

Department of Pediatric Neurology, Collegium Medicum,<br />

Jagiellonian <strong>University</strong>, Krakow, Poland<br />

Purpose: This paper presents the effect of a cavum of the


Abstracts 599<br />

septum pellucidum (CSP) on cognitive functions and<br />

emotional-social functioning in children at various stages<br />

of development. Material: We examined 27 children with<br />

CSP (13 boys, 14 girls), aged 4 months–14 years, divided in<br />

three groups (,2, 2–6, .6 years), and 27 as the control<br />

group. Results: IQ of 17 of children with CSP (63%) was<br />

normal, including four patients with IQ above the average.<br />

Four children had IQ below the normal range and six had<br />

overt mental retardation. The intellectual development of<br />

17/27 children was dysharmonic. In the younger group<br />

(five children) poorer results were obtained mostly in active<br />

speech, manual skills and visual perception. In all nine children<br />

from Group 2 visuo-motor coordination development<br />

was delayed. Eight children from this group showed delayed<br />

development of active speech, in three of them passive<br />

speech development was also retarded. Of 13 children in<br />

Group 3, ten achieved higher IQ scores in the verbal than<br />

in nonverbal scale. All children from this group had linguistic<br />

function and logical thinking in the normal range.<br />

Decreased scores were most often observed in the rate of<br />

visuo-motor education, immediate memory and hand motor<br />

functioning. Four children with mental retardation (Groups<br />

2–3) had attention deficits, psychomotor hyperactivity and<br />

lower level of emotional and social maturity. Four children<br />

from Group 3 presented neurotic disturbances. Conclusions:<br />

Development of intellectual functions in more than half<br />

children with CSP was disharmonic.<br />

FP-N-010<br />

Clinical localization in children with attention deficit<br />

hyperactivity disorder (ADHD)<br />

R.J. Konkol, P.F. Carey<br />

Kaiser Permanente NW, Portland, OR, USA; Oregon<br />

Health Science <strong>University</strong>, Portland, OR, USA<br />

The neurological examination in children diagnosed with<br />

ADHD is usually to rule-out treatable conditions including<br />

epilepsy and tumors. However, functional imaging studies<br />

suggest right frontal abnormalities in ADHD. Our goal was<br />

to determine if there is a relationship between a motor<br />

examination and cognitive impairment in 74 unselected<br />

ADHD children, diagnosed by DSM IV criteria and<br />

completing a neuropsychological exam. The neurological<br />

exam sought lateralized upper motor neuron signs. The<br />

ADHD group consisted of 51 boys and 23 girls (mean<br />

age: 11.7 ^ 3.7 SD). A control group contained 61 consecutive<br />

migraine patients with 19 boys and 42 girls (mean<br />

age: 12.9 years ^ 3.9 SD). Age differences were non-significant<br />

(P , 0:05). Lateralized upper motor pattern of weakness<br />

was found in 41/74 (55%). Only three children had<br />

right-sided weakness with a language-based learning<br />

disability, while 54% (37/74) had left sided weakness. Of<br />

those with left weakness, 46% (17/37) also had verbal learning<br />

difficulty. No weakness plus verbal learning disability<br />

occurred in 36% (13/35). In contrast, only 3% (2/61) of<br />

migraine subjects had left weakness and ADHD. Half of<br />

the children with ADHD had a weakness pattern implicating<br />

the right hemisphere. The few with left hemisphere weakness<br />

had a language problem. Verbal learning problems<br />

were common in those with right hemisphere motor localization<br />

(54%), compared to those with no localization (36%).<br />

These results point to dysfunction in several regional brain<br />

networks, with a significant component in the right hemisphere,<br />

as supported by the neurological examination and<br />

emerging imaging studies.<br />

FP-N-011<br />

Early diagnosis of autism at child development centers in<br />

Israel<br />

Y. Senecky a , G.W. Diamond a , D. Inbar a , A. Apter b ,R.<br />

Weitz c<br />

a Center for Child Development, b Child Psychiatry Department,<br />

c Child Neurology Department, Schneider Children’s<br />

Medical Center, Sackler Tel Aviv <strong>University</strong> School of<br />

Medicine, Petah-Tiqva, Israel<br />

Background: Children with a variety of cognitive, physical<br />

language related handicaps are being diagnosed at a<br />

younger age. Earlier diagnosis of neurologically based<br />

debilitating conditions, such as Autistic spectrum disorders,<br />

including PDD, provide more effective intervention strategies<br />

aimed at rehabilitation during the critical developmental<br />

period of a child’s language and social skills. Objective:<br />

To determine the median age of diagnosis of a cohort of<br />

subjects with autistic spectrum disorder, and to compare<br />

the age at diagnosis by three groups of physicians involved<br />

in the diagnostic process: (1) pediatricians and neurologists<br />

at child development centers; (2) neurologists working<br />

solo; and (3) psychiatrists. Design: The charts from the<br />

National Social Security office between 1982 and 1997<br />

on 1159 children with a diagnosis of autistic spectrum<br />

disorders were subjected to a retrospective survey. Of the<br />

total, 1127 were Jews, and 32 Arabs. A total of 652 charts<br />

yielded information pertaining to age at diagnosis and<br />

identified the professional making the diagnosis. Data<br />

was subjected to chi square analysis for significance.<br />

Results: The regional distribution of diagnosed cases of<br />

autistic spectrum disorders varied widely, with statistics<br />

from the central metropolitan area reflecting incidence<br />

figures common in other countries, i.e. 2:1000. Peripheral<br />

areas and the Arab sector were significantly underrepresented.<br />

The median age at diagnosis was 35 months<br />

(^12 months), reflecting a relatively young age as<br />

compared to the literature. Developmentally based physicians<br />

diagnosed autism at 33.4 months, Independent<br />

neurologists at 37.9 months, and psychiatrists at 42.5<br />

months. Conclusions: Early diagnosis of neurological<br />

disabilities by professionals at child developmental centers<br />

will enable more efficient management and better intervention<br />

services.


600<br />

Abstracts<br />

FP-N-012<br />

Cognitive processing in paediatric epilepsy: a study of<br />

long latency auditory evoked potentials<br />

M. Zgorzalewicz, B. Zgorzalewicz<br />

Chair and Department of Developmental Neurology<br />

<strong>University</strong> of Medical Sciences, Poznań, Poland<br />

ERP reflect cognitive process such as memory, attention<br />

or speech processing. The most useful ERP for clinical<br />

evaluation of mental processing is P300 complex. The<br />

purpose of this study is to estimate treatment of epilepsy<br />

in children and adolescents. We assessed ERP in newly<br />

diagnosed patients aged 8 to 18 years before antiepileptic<br />

therapy and in those with CBZ or VPA administered as<br />

monotherapy. They were diagnosed as having generalized<br />

tonic-clonic seizures and partial seizures (simple or<br />

complex), both with and without secondary generalization.<br />

Neuropediatric status and neuroimaging were unremarkable.<br />

All had normal mentality measured by battery of<br />

psychological tests. According to the IFCN recommendation<br />

standards, the ERP was elicited with auditory discrimination<br />

paradigm by presenting a series of binaural 1000<br />

Hz frequent (standard) versus 2000 Hz rare (target) tones.<br />

Statistical analysis showed differences in P300 latencies in<br />

Fz and Cz derivations did not change in amplitudes before<br />

and after CBZ therapy. Based on ERP results, impairment<br />

of cognitive processes in these epileptic children was<br />

detected. ERP recordings after VPA treatment did not<br />

indicate any influence on cognitive function.<br />

FP-N-013<br />

Non-linear dynamic analyses of inter-words time<br />

intervals in children’s speech as a measure of<br />

developmental stage<br />

S. Avissar, D. Todder, G. Schreiber<br />

Faculty of Health Sciences, Ben Gurion <strong>University</strong> of the<br />

Negev, Beer Sheva, Israel<br />

Speech analyses are usually focused on words as signifiers<br />

ignoring inter-words time intervals (ITIs), which are<br />

related to the ‘form’ of speech, rather to its ‘content’.<br />

Speech of healthy children aged 5–15 was recorded, and it<br />

was analyzed by non linear dynamical-mathematical methods<br />

of correlation dimension, symbolic dynamics and bispectral<br />

analysis. The results of all three methods have<br />

shown age dependency. A significant correlation was<br />

detected between the combined ranks of findings based on<br />

these methods and children’s age (Spearman’s r ¼ 0:850;<br />

P , 0:0001). The results of both symbolic dynamics<br />

entropy calculations, correlation dimension analysis (i.e.<br />

presence or absence of saturation) and the bi-spectral analysis<br />

indicated that there was a transition from one type of<br />

thought processes (primary process, psychotic-like thinking)<br />

to normative adult-type thought processes (secondary<br />

process) at approximately the age of 78. The transition age<br />

obtained by ITIs is thus in agreement with the age generally<br />

accepted for transition, between Piaget’s pre-operational to<br />

concrete operational periods, in the field of developmental<br />

psychology. The analytical techniques of the present study<br />

may therefore become highly suitable for use in the assessment<br />

of child development and the detection of learning and<br />

developmental problems in children at the early years of<br />

school.<br />

FP-N-014<br />

Cognitive sequelae of closed brain injury in children:<br />

efficacy of nootropics<br />

N.N. Zavadenko a , A.I. Kemalov b , A.S. Petrukhin a<br />

a Child Neurology Department, Russian State Medical<br />

<strong>University</strong>, Moscow, Russia; b MEDEX Medical Center,<br />

Almaty, Kazakhstan<br />

Many children suffered closed brain injury (CBI) have<br />

persistent neurobehavioural sequelae due to the combination<br />

of cortical damage and diffuse involvement of axial<br />

and subcortical structures. A total of 110 children (aged 7–<br />

12 years) with cognitive problems suffered moderate or<br />

severe CBI (contusion) in the period from 6 months–4<br />

years prior to this study. They were divided into four<br />

groups to enter open-label controlled study of efficacy of<br />

Nootropics. The length of treatment was 20 days. Examination<br />

procedure before and after the treatment included<br />

structured questionnaire, scored physical and neurological<br />

examination of subtle signs, testing of working memory<br />

(ten words retention) and sustained attention, EEG. In addition<br />

to symptomatic therapy 1st group (n ¼ 30) was administered<br />

Cerebrolysin (EBEWE, Austria), containing<br />

biologically active neuropeptides (2 ml i.m. daily), 2nd<br />

(n ¼ 20) – Instenon (1 ml i.m. daily, containing etamivan<br />

25 mg, hexobendine 5 mg, ethophylline 50 mg) and 3rd<br />

(n ¼ 30) – Semax, synthetic analogous of ACTH fragment,<br />

devoid of hormonal activity (12.5 mg/kg nasally daily).<br />

Control group (n ¼ 30) received symptomatic therapy<br />

(acetazolamide, vitamines). A total of 80% of patients in<br />

the 1st group (Cerebrolysin), 70% in the 2nd (Instenon)<br />

and 67% in the 3rd (Semax) responded to the treatment<br />

in contrast to 10% of controls. Relief of complaints for<br />

headaches, tiredness, emotional instability, restlessness,<br />

poor concentration and memory, sleep disturbances was<br />

evident after the treatment with Noortopics. Significant<br />

improvement of attention and memory measures was<br />

revealed in the 1st, 2nd and 3rd groups: decrease of executive<br />

time and omissions in attention testing, improvement<br />

of acoustic-verbal memory. These changes corresponded to<br />

positive dynamics on the EEG in responders. Nootropics<br />

are effective for the treatment of cognitive sequelae in CBI<br />

children.


Abstracts 601<br />

FP-N-015<br />

Association of single nucleotide polymorphisms in<br />

serotonin and dopamine receptor genes in autism<br />

Y.-H. Ma a , E. Nanba b , K. Takeshita b<br />

a Institute of Child and Adolescent Health, Peking <strong>University</strong>,<br />

China; b Division of Child Neurology, Institute of<br />

Neurological Science, Faculty of Medicine, Tottori <strong>University</strong>,<br />

Yonago, Japan<br />

Family and adoption studies indicate that genetic factors<br />

play a role in the development of many psychiatric disorders<br />

including autistic disorder, a severe neuro-developmental<br />

disorder that affects approximately 2–10/10 000 individuals.<br />

Although many studies have been attempted to elucidate<br />

the genetic background of autism, the genetic factors<br />

associated with its pathogenesis are still not well understood.<br />

In order to evaluate the role of SNPs in serotonin<br />

and dopamine receptor genes in autism, we performed association<br />

studies using 57 autism and 100 normal controls for<br />

SNPs with PCR-SSCP. The results showed that among 20<br />

SNPs in serotonin gene tested, 18 revealed no positive association<br />

with autism, but two SNPs in HTR1A showed significant<br />

association (P , 0:05); among ten SNPs in dopamine<br />

gene tested, seven revealed no positive association with<br />

autism but three SNPs in DRD2 showed significant association<br />

(P , 0:00001). The results indicated that difference in<br />

allele and genotype frequency of HTR1A and DRD2 may<br />

play an important role in the pathogenesis of autism.<br />

FP-N-016<br />

Phencyclidine treatment in newborn rats: behavioral<br />

and neurochemical effects<br />

X.-M. Gao, A. White, C.A. Tamminga<br />

Maryland Psychiatric Research Center, <strong>University</strong> of Maryland<br />

school of Medicine, Baltimore, MD, USA<br />

Perinatal accidents contribute to the risk for schizophrenia.<br />

Moreover, the illness may involve some abnormality of<br />

the glutamatergic system, especially of NMDA-sensitive<br />

receptor, possibly of neurodevelopmental origins. Whereas,<br />

low doses of phencyclidine (PCP) can mimic the symptoms<br />

of schizophrenia in normal humans and exacerbate symptoms<br />

in those with the illness, high doses can cause cell<br />

death, possibly due to failure of downstream GABAergic<br />

inhibition. We hypothesized that perinatal treatment with a<br />

lesioning agent, especially one directed toward the NMDAsensitive<br />

glutamate system, might result in long lasting<br />

changes in cerebral systems and abnormalities in behavior<br />

in an experimental animal and produce an informative<br />

animal preparation for schizophrenia. We treated newborn<br />

rat pups with high doses of PCP (10 mg/kg) and evaluated<br />

behavioral and neurochemical measures of CNS response in<br />

the grown rat. The rat pups were treated with a single dose<br />

of the PCP or saline on days, PN7, PN9 and PN11 (three<br />

treatments). All subjects were raised to PN42 without<br />

further treatment, sacrificed at that time, and their brains<br />

harvested for study. We used in situ hybridization to quantify<br />

gene expression for zif268, arc, GAD67, and glutamate<br />

receptor subunits (NR1, NR2A and NR2B) in this tissue.<br />

Half of the animals were assessed on PN42 their locomotor<br />

response to PCP (3 mg/kg) and for PCP disruption of<br />

prepulse inhibition.<br />

FP-N-017<br />

Sleep-disordered-breathing and child behavior<br />

J. Kohyama, W. Furushima, J.S. Ohinata, T. Hasegawa<br />

Department of Pediatrics, Faculty of Medicine, Tokyo<br />

Medical and Dental <strong>University</strong>, Tokyo, Japan<br />

Aim: To assess behavioral problems in children with sleep<br />

disordered breathing (SDB). Methods: Twenty-four children<br />

with suspected SDB (M/F 19/5, age: 4–9 years<br />

(mean, 5.5)) were studied. Their care-takers filled the Japanese<br />

version of the child behavior check-list/4–18 (CBCL<br />

(by Achenbach TM)). One-night polysomnography was<br />

done for each child. The correlation coefficients (r) between<br />

the three items on SDB (1. incidence of obstructive apnea of<br />

more than 10 s per hour of total sleep time; obstructive<br />

apnea index (OAI), 2. percentage of time with<br />

SaO 2 , 90% against the total sleep time, 3. SaO 2 nadir)<br />

and scores of ten scales on CBCL were calculated. CBCL<br />

has 113 questions that were classified into eight categories<br />

(I. Withdrawn, II. Somatic complaints, III. Anxious/<br />

depressed, IV. Social problems, V. Thought problems, VI.<br />

Attention problems, VII. Delinquent behavior, VIII.<br />

Aggressive behavior), and caretakers selected one of the<br />

three answers (0 ¼ not true, 1 ¼ somewhat or sometimes<br />

true, 2 ¼ very true or often true). Internalizing<br />

(I 1 II 1 III) and externalizing (VII 1 VIII) scales were<br />

also scored. Results: Among thirty pairs of correlations<br />

examined, five pairs showed a high r; OAI and I<br />

(r ¼ 20:39, 0:05 , P , 0:1), VIII (r ¼ 0:36,<br />

0:05 , P , 0:1), and externalizing (r ¼ 0:35,<br />

0:05 , P , 0:1), and SaO 2 nadir and I (r ¼ 0:46,<br />

P , 0:05), and internalizing (r ¼ 0:35, 0:05 , P , 0:1)).<br />

Conclusion: The severity of SDB (elevation of OAI and<br />

decrease of SaO 2 nadir) tend to correlate with decrease of<br />

internalization and the increase of externalization in children<br />

with SDB.<br />

FP-N-018<br />

Survey on the prevalence of autism in Japan<br />

H. Shimoizumi, N. Iizuka, S.I. Saitou, M.Y. Momoi<br />

International <strong>University</strong> of Health and Welfare, Otawara,<br />

Japan<br />

Objective: According to recent Japanese reports, including<br />

one study documenting the prevalence of autism in


602<br />

Abstracts<br />

Yokohama at 21.1 per 10 000, the prevalence of autism in<br />

Japan has increased. A survey was conducted to ascertain if<br />

similar results would be obtained from a rural area of Japan.<br />

The Nasu area is a region dependent on agriculture and<br />

forestry, with a population of 214 323. Methods: Subjects<br />

were 6–7-year-old children in the Nasu of Tochigi Prefecture.<br />

Autism was diagnosed based on ICD-10 diagnostic<br />

criteria. Results: A total of 4533 6- and 7-year-old children<br />

(2287 boys, 2246 girls) were identified in the Nasu area in<br />

1998. This population included ten autistic 6-year-old children<br />

(six boys, four girls) and seven autistic 7-year-old children<br />

(seven boys). The prevalence of autism was thus 37.5<br />

per 10 000 (boys, 25.8; girls 17.8). Conclusions: Like the<br />

recent Japanese reports, the results of the present survey of a<br />

rural area demonstrated a high prevalence of autism. The<br />

reasons could be two-fold: (1) The current diagnostic<br />

criteria differ substantially from those used in the past;<br />

and (2) As is the case of Nasu area, the number of falsenegative<br />

cases is decreased in areas where early detection<br />

and intervention systems are available for autism. The<br />

prevalence of autism in Japan is higher than previously<br />

reported, and improvement in prognosis for autistic children<br />

through early detection and intervention are imperative.<br />

FP-N-019<br />

Relationship of social function and motor and speech<br />

functions in children with autism<br />

H.-C. Hsu, C.-L. Chen, C.-Y. Wu, C.-Y. Chung, M.-K.<br />

Wong<br />

Department of Physical Medicine and Rehabilitation,<br />

Chang Gung Memorial and Children Hospital, Kweishan,<br />

Taoyuan, Chinese Taipei<br />

Autism is a pervasive developmental disorder of early<br />

childhood characterized by severe impairment in reciprocal<br />

social interaction, communication, and restricted repertoire<br />

of activities and interests. This study investigated the relationship<br />

of social function with motor and speech function<br />

in children with autism. We collected 32 children with PDD<br />

with the mean age 3.7 years. We used the Chinese Child<br />

Development Inventory to assess the developmental functions<br />

in 8 domains, including gross motor (GM), fine motor<br />

(FM), expressive language (EL), concept comprehension<br />

(CC), social comprehension (SC), self help (SH), personal<br />

social (PS), and general development (GD). Children with<br />

PDD were divided into 2 groups: group A (DQ of PS<br />

.50%), and group B (DQ of PS ,50%) according to the<br />

DQ of PS function. We compared the DQ between the two<br />

groups. The correlations of different developmental functions<br />

were analyzed by Pearson’s correlation. The PS function<br />

was correlated with all the other seven functional<br />

domains (r ¼ 0:6–0:9, P , 0:05), with the SC function<br />

most highly correlated. While the PS function was not correlated<br />

with the age, sex, and educational and economic status<br />

of parents. Children in the group A had better developmental<br />

functions than those in group B in all the eight domains.<br />

Our findings suggest that autism is a multifacted developmental<br />

disorder with impaired motor, speech and psychosocial<br />

function. Therefore, a more comprehensive assessment<br />

and transdisciplinary therapy are more appropriate in the<br />

approach of children with pervasive developmental disorder.<br />

FP-N-020<br />

Evaluation of maturity in drawing in childhood in<br />

neuropediatric consultation. A new test graphomotor<br />

S.I. Pascual-Pascual<br />

Service of Pediatric Neurology, Hospital infantile ‘LA<br />

PAZ’, Madrid, Spain<br />

Introduction: Tests used for measuring the ability of a<br />

child to copy a drawing take more than 15 min and require<br />

direct attention to the patient. This makes them almost<br />

impossible to use in the neurological or pediatric consultation.<br />

Objective: To present a new test of drawing copy, the<br />

graphomotor test (GT). It consists of eight easy figures:<br />

diamond, stair, cross, flower, clock, house, cube and<br />

bicycle. The scoring method is simple. The maturation of<br />

drawing in childhood and the reliability and validity of the<br />

test are studied. Patients and methods: (A) Two studies<br />

were done in order to assess the validity and reliability<br />

of this test in normal childhood population of different<br />

social (n ¼ 210) and economic (n ¼ 133) levels from 5<br />

to 12 years of age, without selection. Drawings were<br />

scored blindly by a neurologist and a clinical psychologist.<br />

(B) A prospective study was made in children with varied<br />

neurologic, mental and/or psychiatric diseases. All patients<br />

of a neurology and psychiatric department completed the<br />

test (n ¼ 349, aged 5–40), and repeated after 15–30 min. A<br />

total of 276 were also studied with Wechsler test (WPPSI-<br />

R, WISC-R or WAIS-R) and in other 53 cases the mental<br />

level was known. The tests were scored blindly by a neuropediatrician<br />

and a clinical psychologist. Results: (A)<br />

Normal school children: The score system proposed is<br />

easy to do and takes less than 1 min. The perfect test get<br />

a score of 0, and the worst possible score is 20; Results<br />

showed high reliability: interobserver Pearson’s correlation<br />

coefficient r . 0:92, and reliability Cronbach alpha<br />

coefficient ¼ 0.97; test-retest reliability r . 0:91 and<br />

alpha ¼ 0.95.It is a valid tool to measure visuomotor<br />

maturation in childhood. Average scores are different at<br />

every age until 11 years. There is no difference in scores<br />

between children of the two socioeconomic levels studied.<br />

Results depend on mental or drawing level, not on the<br />

socioeconomic status. (B) In children with neurologic,<br />

mental or psychiatric diseases. The GT is a reliable tool<br />

for measuring the visuomotor level of children with mental<br />

levels above IQ 50: Cronbach’s alpha ¼ 0.98 (test-retest)<br />

and alpha ¼ 0.98 (between different observers), and Pearson’s<br />

‘r’ correlations .0.92 (P , 0:001). The repetition of


Abstracts 603<br />

the test does not change the score. The GT is a valid tool<br />

for measuring drawing maturation and the non-verbal intelligence<br />

in childhood. Pearson’s correlations with verbal,<br />

performance and total Wechsler test IQ (VIQ, PIQ and<br />

TIQ) were significant (P , 0:01), the best of them were<br />

with the PIQ and with the spatial capability factor of<br />

Wechsler test (r ¼ 20:58 to 20.72, P , 0:001). GT is a<br />

very sensitive screening test of the cognitive non-verbal<br />

level of patients, with a high negative predictive value<br />

(0.97). This allows selection of cases for further study<br />

with neuropsychological tests. Conclusions: Graphomotor<br />

test is a very useful tool to assess the drawing and performance<br />

level of school children. It is simple, fast reliable<br />

and valid in normal children and those with neuropsychiatric<br />

pathology. It can be assessed in the same neurological<br />

or pediatric consultation, while talking with the parents.<br />

The results are related to the mental level and with age.<br />

FP-N-021<br />

Early identification of children with developmental<br />

delay: an appraisal of 24 years’ experience in Hong<br />

Kong<br />

C.-W. Chan<br />

Department of Paediatrics, The <strong>University</strong> of Hong Kong,<br />

Hong Kong, China<br />

Universal Developmental Screening of children below 5<br />

years of age was first introduced in Hong Kong in April,<br />

1978 as part of the White Paper on Comprehensive Observation<br />

Scheme adopting the ‘Hong Kong Developmental<br />

Screening System’ designed by the Department of Paediatrics,<br />

The <strong>University</strong> of Hong Kong with data derived from<br />

a cohort study on Growth and Development of 782 normal<br />

Chinese children follow-up from birth to 8 years. Screening<br />

Tests are provided free of charge at all Maternal and<br />

Child Centres in Hong Kong to all preschool children and<br />

to children at-risk, and at private paediatricians’ clinics.<br />

Before 1987, tests were given at five key-ages from birth<br />

to 5 years old but tests were re-scheduled to three stages: at<br />

10 weeks, 9 and 36 months since 1987 for better compliance<br />

and for more effective utilization of local resources.<br />

At each key-age, each child is tested in major fields of<br />

development: namely, gross motor, coordination, social<br />

skills and language as well as hearing, vision, anthropometric<br />

studies and physical examination. The average<br />

coverage rate for local children is 84% per annum while<br />

detection rate is about 10%. Children with abnormalities<br />

identified were referred to paediatricians, relevant specialists<br />

or to child assessment centres for confirmation of<br />

abnormalities. All children with abnormalities were<br />

comprehensively assessed and provided with appropriate<br />

management and placement as arranged by the multidisciplinary<br />

and interdisciplinary teams at Comprehensive<br />

Child Assessment Centres.<br />

FP-N-022<br />

Evaluation of the crawling of disorders in brainstem<br />

aminergic dysfunction; infantile autism, Rett syndrome,<br />

and Down syndrome<br />

K. Hoshino, J. Uchino, K. Hachimori, Y. Nomura, M.<br />

Segawa<br />

Segawa Neurological Clinic for Children, Tokyo, Japan<br />

The brainstem aminergic neurons are known to have<br />

important roles in functional development of the brain.<br />

Ability and pattern of crawling reflect the development of<br />

locomotion system modulated by the specific brainstem<br />

aminergic neurons. To assess these neurons in infancy we<br />

evaluated locomotion in correlating with the sleep wake<br />

cycle (SWC), another biological phenomenon modulated<br />

by these neurons in disorders of the aminergic neurons.<br />

Method: Thirty-eight patients of infantile autism (IA), 42<br />

RTT, ten Down syndrome (DS) were analyzed for crawling<br />

and the development of SWC cycle in infancy and DQ/IQ<br />

levels in childhood. Result: Crawling with normal pattern<br />

was observed in 34.2% in IA, 17.5% in RTT, and none in<br />

DS, and crawling with abnormal pattern (creeping, shuffling,<br />

backward, etc.) were observed in 55.2, 30 and 70%,<br />

respectively. A total of 10.5% of IA, 52.5% of RTT, 30% of<br />

DS never crawled by the age of 12 months. IA showed delay<br />

in development of circadian SWC in early infancy, whereas<br />

RTT and DS showed delay in physiological decrease of day<br />

time sleep after late infancy. The DQ/IQ were low (moderate<br />

to severe delay) in most cases. Psychobehavioral disorders<br />

were predominant in IA. Discussion: We previously<br />

showed that locomotion during developmental period correlates<br />

with the development of functional specialization of<br />

the cerebral cortex and IQ level. The present study<br />

confirmed the results and suggested that aminergic neurons<br />

involved in locomotion are not those modulating circadian<br />

SWC but are involved in reduction of day time sleep after<br />

late infancy.<br />

FP-N-023<br />

Preschool screening and school performance: how<br />

predictive is Denver II test?<br />

B. Anlar, B.U. Bayoglu, F. Elibol, K. Yalaz<br />

Hacettepe <strong>University</strong> Department of Pediatric Neurology,<br />

Ankara, Turkey<br />

The relationship between preschool developmental<br />

screening and academic performance in the first school<br />

year was assessed in a prospective design. Six year-old children<br />

from two socioeconomically different areas of Ankara<br />

were screened in the beginning of first grade with Denver II<br />

developmental test standardized for Turkey. The results were<br />

compared with school performance in the first grade. All<br />

children with normal or questionable Denver II had satisfactory<br />

school performance while 27% of those with abnormal


604<br />

Abstracts<br />

Denver II had low scores. Denver II results improved after 1<br />

year at school, especially in children from low socioecenomical<br />

status. Denver II appeared to have a good predictive<br />

value in detecting potential school problems. These results<br />

support screening children with disadvantaged backgrounds<br />

at the beginning primary education, and providing supportive<br />

programs in the 1st year at school.<br />

FP-N-024<br />

Using mismatch negativity (MMN) to assess auditory<br />

discrimination and sensory memory in children with<br />

dyslexia<br />

R. Bombardieri, M. Terribili, L. Lopez, P. Curatolo<br />

Department of Pediatric Neurology, Tor Vergata <strong>University</strong><br />

of Rome, Rome, Italy<br />

Developmental dyslexia is a specific learning disorder,<br />

characterized by a difficulty of decoding single letters,<br />

generally due to insufficient phonological ability. Deficits<br />

in phonological skills seem to be present in children with<br />

reading disability but a topographic localization along the<br />

auditory pathways is not yet identified. Using MMN, which<br />

is an auditory event-related evoked potential, we want to<br />

test the hypothesis that children with dyslexia have impairment<br />

in auditory frequency discrimination. Twelve dyslexic<br />

children (nine males, three female) and ten normal subjects,<br />

matched for age and sex, were recruited. Mean age was 13.4<br />

and 10.4 years, respectively. Children were submitted to<br />

neurophysiological evaluation using EEG, BAEP, PEV<br />

and ERPs (MMN). MMN responses were elicited using<br />

two different tones (standard and deviant) and two different<br />

conditions (‘ignore’ and ‘count’). EEG traces and evoked<br />

potentials were normal in both groups. Data found an overlap<br />

in 200 ms latency between the two traces (one obtained<br />

using standard tones and the other using deviant tones) in<br />

children with dyslexia. This could be due to attention is<br />

activated in dyslexic children, even during ‘ignore condition’,<br />

from both tones, as if standard tones were considered<br />

‘new’ and worthy of attention. This result could be related to<br />

an excessive discrimination of auditory stimuli, in dyslexic<br />

children, and could be connected with an alteration in an<br />

early station of the auditory pathway. Thus, MMN can be<br />

used as a marker for the phonologic and mnemonic alteration<br />

and can be a valuable tool for early diagnosis.<br />

FP-N-025<br />

A profile of pervasive developmental disorders in<br />

Filipino children seen at the Philippine Children’s<br />

Medical Center<br />

E.L. Avendaño, M.A.G. Berroya, M.H. Ortiz, L.V. Lee<br />

Child Neuroscience Division, Philippine Children’s Medical<br />

Center, Quezon City Philippines<br />

A total of 187 patients evaluated at the Neurodevelopmental<br />

Section of the PCMC with a diagnosis of pervasive<br />

developmental disorder using the diagnostics and statistical<br />

manual (DSM III R and IV) criteria over a 10 year period<br />

were included in the study. All but five were diagnosed to<br />

have autistic disorder. There were more males than females<br />

with as ratio of 5:1. Majority of the children were between 3<br />

and 4 years old with a mean age of recognition at 1.86 years.<br />

Mean interval between onset of symptoms and age of referral<br />

was 2.67 years. Language delay was the most common<br />

initial manifestation and reason for referral. In majority of<br />

the patients, no definite underlying medical nor neurological<br />

disorder was established. Autistic children displayed significant<br />

impairment in the use of nonverbal behaviors, delay in<br />

or lack of development in verbal language and preoccupation<br />

with stereotyped and restricted patterns of interest.<br />

Neurodevelopmental evaluation revealed marked delays in<br />

expressive and receptive language as well as social adaptive<br />

skills. Work-ups included EEG, BAER, cranial CT scan,<br />

cranial MRI and urine metabolic screen which had low<br />

positive results. Interventions included enrollment in a<br />

special education (SPED) program, speech therapy, occupational<br />

therapy and family counseling. The profile of Filipino<br />

children with PDD in this study is comparable to that of<br />

foreign data.<br />

FP-N-026<br />

Evaluation of cognitive functions in school-age children<br />

with attention deficient with hyperactivity syndrome<br />

M.B. Guryeva, O.I. Maslova, S.V. Balkanskaya, V.M.<br />

Studenikin, M.A. Kirdyashkina<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

Background: Attention deficit with hyperactivity<br />

syndrome (ADHS) is nowadays one the main concerns in<br />

pediatric neurology and psychiatry, since this condition had<br />

been recognized to affect cognitive functions in children by<br />

the time of school education. Aim: Our goal was to evaluate<br />

the basic parameters of cognitive sphere in ADHS patients<br />

of school-age. Method: Objective quantitative evaluation of<br />

cognitive functions was performed in 45 patients (aged 6–10<br />

year) with ADHS, utilizing the testing computer systems<br />

(TCS ‘Ritmotest’, ‘Mnemotest’, and ‘Binatest’ of Russian<br />

Manufacture). Forty-three normal children of identical age<br />

were evaluated, as well, using the same diagnostic protocols.<br />

Results: Evaluation of cognitive parameters in ADHS<br />

patients mainly showed significantly compromised or<br />

impaired functions in children under our observation in<br />

comparison with their healthy compeers. The distribution<br />

of deficient parameters was following: (1) attention<br />

(86.6%); (2) short-term and/or long-term memory<br />

(73.3%); (3) psychomotor activities (82.2%); and (4) analytic/synthetic<br />

processes (80%). The results were expressed as<br />

percentage for normal indices. The important finding is that


Abstracts 605<br />

cognitive functions’ deficiency was more pronounced in<br />

cases with hereditary (genetic) predisposition (ADHS in<br />

families). Conclusion: The obtained results imply that<br />

medicinal correction should be applied for cognitive deficit<br />

correction in management of this condition. Hereditary<br />

predisposition to ADHS seems to be as important as perinatal<br />

damage, even though the precise genetic mechanisms<br />

involved still are not completely understood.<br />

FP-O<br />

Psychology/Psychiatry<br />

FP-O-001<br />

Clinical characteristics of psychogenic diseases in<br />

childhood<br />

Z.-Y. Pei<br />

The Yuncheng Central Hospital, China<br />

Objective: To discuss the clinical characteristics and<br />

diagnosis of psychogenic disease in childhood. Methods:<br />

The clinical features of psychogenic diseases in 86 children<br />

were analyzed. CT, MRI, EEG, ECG, CSF, CPK were<br />

carried out. Results: Total 86 cases, 44 males, 42 females.<br />

Among them, 62 cases lived in the cities, 24 cases lived in<br />

the countryside. The onset of the disease was between 4.7<br />

and 14 years old, and 81 cases (94.2%) were at the age of 7–<br />

12 years old. Fifty-nine cases (68.7%) had known factors<br />

which induced the diseases. Among them, 24 cases (27.9%)<br />

were due to the heavy load of school work, 18 cases (20.8%)<br />

due to the physical disease and six cases (7%) due to the bad<br />

relation between their parents. The patients manifested as<br />

paralysis in 23 cases (26.7%), convulsion in 13 cases, and<br />

headache, syncope, sense disturbance, dizziness, visual<br />

hallucination, etc., in the other cases. All the examinations<br />

were negative, which-helped us to exclude other organic<br />

diseases. Conclusion: The psychogenic diseases in childhood<br />

were not rare. The heavy load of schoolwork is the<br />

most important inducing factors, then the physical diseases<br />

and the bad family relations. The clinical manifestation was<br />

various, and it was likely misdiagnosed. So the pediatricians<br />

should pay more attention to the psychogenic diseases in<br />

children.<br />

FP-O-002<br />

Evaluation of visual perception and adaptive behavior in<br />

children with Tourette’s syndrome<br />

Z.-S. Liu, L.-Z. Yang, F.-L. Wang, J. Lin<br />

Department of Child Neurology, Wuhan Children’s Hospital,<br />

Wuhan, China<br />

Objective: To explore the visual perception and adaptive<br />

behavior of children with TS. Methods: The visual perception<br />

and adaptive behavior of 38 children aged 8–12 years<br />

(M 27, F 11) with TS were measured by means of Benton<br />

Visual Retention Test (VRT) and Scale of Adaptive Behavior<br />

for Children (SAB). Thirty healthy children were<br />

selected as the control group. Results: All correct and erroneous<br />

scores of VRT in the TS group showed no significant<br />

difference compared to the control group (P . 0:05). Adaptive<br />

behavior quotient and T score of cognitive function<br />

factor of SAB in the TS group also showed no significant<br />

difference compared to the control group (P . 0:05). T<br />

scores of independent function factor and social/self-direction<br />

factor of SAB in the TS group were significantly lower<br />

than those in the control group (P , 0:01). Conclusion:<br />

Children with TS had no visual perception deficit, and<br />

possessed lower social adaptive ability.<br />

FP-O-003<br />

A diagnostic study and classification of attention-deficit/<br />

hyperactivity disorder in children<br />

H.-J. Zhu, X.-X. Wang, Q. Zhang<br />

Department of Pediatrics, Zhejiang Provincial People’s<br />

Hospital, Hangzhou, China<br />

Objective: To evaluate the usage of the Children’s Attention<br />

Tester and scales of ADHD in the diagnosis and classification<br />

of ADHD in children. Methods: The authors tested<br />

the attention of 380 ADHD cases aged 6.5 , 11 years with<br />

NJ22 Children’s Attention Tester, and compared positive<br />

rates of attention deficit test with the Children’s Attention<br />

Tester and the DSM-IV criteria scales. The sensitivity and<br />

the specificity of the instrument were analyzed. Results: The<br />

ratios of the different types indicated that the predominately<br />

attention deficit type was 57.1%, the predominately hyperactive-impulsive<br />

type was 7.1%, and the combined type was<br />

35.8%. The general positive rates of attention deficit in these<br />

cases using Children’s Attention Tester was 78.4%. The<br />

sensitivity and specificity of this instrument was 78.4 and<br />

88.3%. The positive rates were not significantly different in<br />

the children of different clinical types x 2 ¼ 0.78, P . 0:05,<br />

but were significantly different in the children in whom<br />

severity degrees was different x 2 ¼ 22.37, P , 0:01.<br />

Conclusions: Conner’s questionnaire is a good screening<br />

tool. The scale of ADHD by DSM-IV criteria is useful for<br />

the diagnosis of the clinical type. The Children’s Attention<br />

Tester can be the index for diagnosis of ADHD, and cannot<br />

substitute of the scales.<br />

FP-O-004<br />

Anxiety of asthmatic children and salivary SIgA assay<br />

L.-H. Wang, R.-P. Sun, H.-J. Zhang, M.-H. Zhang<br />

Pediatric Department of the Second Hospital, Shangdong<br />

<strong>University</strong>, Jinan, China<br />

Objective: Assessment of anxiety in asthmatic children<br />

and observation of the relationship between anxiety and<br />

level of salivary serum immunoglobin A (SIgA), research-


606<br />

Abstracts<br />

ing the new method of improving asthmatic children’s<br />

immune condition and relieving asthmatic attacks. Method:<br />

Forty asthmatic children (asthmatic group) were tested with<br />

Hamilton Anxiety scale (HAMA), and were tested by<br />

measurement of skin resistance, salivary SIgA immunoradiometry<br />

assay, and compared with 26 healthy children<br />

(control group). Result: HAMA score was 12.03 ^ 6.01 in<br />

the asthma group and 4.96 ^ 3.89 in the control group, the<br />

asthmatic children had HAMA scores that were higher than<br />

those of the normal controls (P , 0:01); Salivary SIgA level<br />

in the asthma group was lower than that of in control group<br />

(P , 0:01); skin resistance in the asthma group was higher<br />

than that of the controls (P , 0:01). Salivary SIgA was<br />

121.37 ^ 63.10 mg/ml in the asthma group with anxiety<br />

and 208.23 ^ 166.33 mg/ml in the asthma group with no<br />

anxiety, a significant difference being found (P , 0:05).<br />

Skin resistance in the asthma group with anxiety was higher<br />

than that of the asthma group with no anxiety (P , 0:05).<br />

HAMA score in attack groups was much higher than in the<br />

remission group (P , 0:01). Salivary SIgA and skin resistance<br />

in the two groups were not significantly different<br />

(P . 0:05). Conclusion: Compared with healthy children,<br />

the asthmatics had more obvious anxiety disorders,<br />

decreased humoral immune function, and increased function<br />

of the parasympathetic nervous system. Humoral<br />

immune function was lower in anxious asthmatic children.<br />

Parasympathetic nervous excitement in asthmatic children<br />

with anxiety was higher than in asthmatic children with no<br />

anxiety. Anxiety in asthmatic children during an attack was<br />

greater than that of asthmatic children in remission.<br />

FP-O-005<br />

Emotional disorders and related factors in in-patient<br />

pediatrics<br />

L.-H. Wang, R.-Q. Zhang<br />

Pediatric Department of the Second Hospital, Shangdong<br />

<strong>University</strong>, Jinan, China<br />

Objective: To investigate the state of mental health of<br />

pediatric inpatients. Methods: Thirty-four pediatric inpatients<br />

were assessed with HAMA and Depression Status<br />

Inventory (DSI), compared to 28 healthy children. Results:<br />

HAMA scores were 14.91 ^ 6.10 in the inpatient group and<br />

5.50 ^ 4.06 in the control group. The inpatients had a<br />

HAMA score that was higher than that of the controls<br />

(P , 0:01). The percent of the pediatric inpatients with<br />

anxiety was 52.9%, higher than that of the controls<br />

(P , 0:01). DSI scores were 53.01 ^ 6.75 in the inpatient<br />

group and 47.14 ^ 6.07 in the control group. The DSI score<br />

in the inpatient group was higher than the score of the<br />

controls (P , 0:01). The percent of children with depression<br />

in the two groups was not significantly different<br />

(P . 0:05). HAMA score in female inpatients was higher<br />

(P , 0:05); HAMA score in rural inpatients was higher than<br />

that of urban inpatients (P , 0:05); HAMA score in inpatients<br />

with a longer course was higher than in those with the<br />

shorter course (P , 0:01). No significant difference was<br />

found in the scores of depression in the pediatric inpatients<br />

of different sexes, residence and courses (P . 0:05).<br />

Conclusions: More obvious emotional disorders existed in<br />

hospitalized patients than in the healthy children. The<br />

degrees of anxiety were different in pediatric inpatients of<br />

different sexes, residence and courses.<br />

FP-O-006<br />

Effects of INF on immune function in children with tic<br />

disorder<br />

Y.-H. Chen, W.-X. Chen, S. Chen, Y. Wang<br />

Department of Pediatrics, Union Hospital of Fujian Medical<br />

<strong>University</strong>, Fuzhou, China<br />

Objective: To explore the efficacy and change in cell<br />

immune function with complementary treating tic disorder<br />

(TD) with IFN. Methods: An open-controlled study was<br />

carried out. Forty children with TD were involved in the<br />

study. Twenty of the total number of patients were treated<br />

with routine medication (Haloperidol, Tiapiride, and clonazepam)<br />

(routine group), the others were treated with Haloperidol<br />

and IFN (1 £ 10 6 U/dose, i.m., qod) (IFN group).<br />

The course of treatment was 8 weeks. There were 20 healthy<br />

children (control group). The cell immune function was<br />

measured by flow cytometry. Results: The cell immunological<br />

function in children with TD was significantly<br />

depressed, compared to that in healthy controls. At the<br />

end of the research, the levels of lymphocytic subsets,<br />

NKC in peripheral blood were improved in the IFN group.<br />

The efficacy of the IFN group was 90%, which was significantly<br />

better than the routine group (60%, x 2 ¼ 4.8,<br />

P , 0:01). Conclusions: The present study demonstrates<br />

that children with TD were at low cell immune functional<br />

state, which may underlie the disease. IFN may be a new<br />

effective and safe method for complementary treatment of<br />

tic disorder.<br />

FP-O-007<br />

Consultation of parents of new cases with childhood<br />

epilepsy<br />

K.R. Bao, Z.P. Wang<br />

Department of pediatric Neurology, Xin-Hua Hospital,<br />

Shanghai, China<br />

Objective: To find and resolve the psychological<br />

problems in parents of childhood epilepsy who were<br />

newly diagnosed. Methods: Eighty-two children (aged<br />

from 6 months to 13 years) with a recent diagnosis of<br />

epilepsy (within the previous 18 months) in our clinic<br />

were followed up from January 1999 to December<br />

2000.Their parents had consulted a child neurologist about<br />

diagnosis, medical condition and prognosis for their


Abstracts 607<br />

families. The ways of consulting a doctor were by appointment<br />

interview, communication by letter, telephone and<br />

giving parents a lecture. Results: (1) Parents’ attitude to<br />

diagnosis: acceptant 75 cases, suspicious five cases, refused<br />

two cases. (2) Parents’ attitude towards starting treatment:<br />

acceptant 79 cases, postponed three cases. (3) Seizure<br />

control after 1 year , 72 cases; 13 , 18 months six cases;<br />

.18 months four cases. A significant relationship was found<br />

between effective therapies and complying with doctor’s<br />

orders. (4) The main psychological problems of parents<br />

were fear of use of antiepileptic drugs and seizures which<br />

would influence intelligence and other organ functions for<br />

children. Conclusion: This investigation demonstrated that<br />

psychological problems of parents of new cases with childhood<br />

epilepsy were closely related to being submissive to<br />

medical advice. Resolving these problems would help to<br />

obtain efficacy of treatment. We took various steps to<br />

cover many aspects for children with epilepsy. For example,<br />

nutrition, movement, hobby out of class, nursing, learning<br />

disability, etc. The purpose of our work was to open a road<br />

to keep in touch on a regular basis with the parents of<br />

children with epilepsy.<br />

FP-O-008<br />

Effects of dolphin assisted therapy (DAT) on children<br />

who have some problems of communication<br />

M. Ito a , M. Miyao a , K. Nihei a , K. Shirakawa b , Y. Sato b ,Y.<br />

Sakai b , K. Fukusima c , S. Tomita c , S. Deguchi c , K. Kobari c<br />

a Department of Neurology, National Center for Child<br />

Health and Development, Tokyo, Japan; b Department of<br />

Neuropsychology, National Children Hospital;<br />

c Ocean<br />

Wellness Foundation<br />

Dolphin assisted therapy (DAT) is classed as one of the<br />

animal assisted therapies. The treatment is for people who<br />

have physical or mental problems which can be improved<br />

by interaction with dolphins due to their charm and intelligence.<br />

DAT is reported effective in improving patients<br />

affected by depression, PTSD, Down syndrome (Bs<br />

syndrome, and autism. We applied DAT to three children<br />

(3–12 years old) who have some problems of their communication<br />

at the Dolphin lagoon and in the playroom of the<br />

Okinawa Marine Research Center in Okinawa Pref in Japan.<br />

One boy, 12 years old, had physical and mental handicaps<br />

due to sequelae of encephalitis. One boy, 8 years old, could<br />

not take communications well with the schoolmate because<br />

of ADHD. The other boy, 4 years old, had been treated<br />

cruelly by the mother. Their families also participated. We<br />

prepared clinically based DAT programs in conjunction<br />

with the Department of Neurology of National Children<br />

(Bs Hospital, and made comparative studies of the medical<br />

and psychological condition of each case before and after<br />

DAT. Consequently, DAT is effective in the improvement<br />

of their communication through the interaction with<br />

dolphins. Additionally the climate and natural environment<br />

are important factors for reducing their stress.<br />

FP-O-009<br />

A contrasting model for deficit symptoms of<br />

schizophrenia in leadership, with ‘sex-hormonal<br />

dysgenesis’ in its pathogenesis?<br />

A.G. Alias<br />

Chester Mental Health Center, Chester, IL, USA<br />

Associational loosening, impaired information processing,<br />

poor gating of irrelevant stimuli, poor ability to shift<br />

attention, poor working memory, passivity, ambivalence,<br />

anhedonia, as well as impaired motor coordination are cardinal<br />

features of schizophrenia but, unlike delusions and hallucinations,<br />

they are related more to deficit symptoms. The<br />

results of hundreds of studies during the past decades point<br />

to a striking contrast between leadership and, say, schizotypy,<br />

with the average human in between. Example: As<br />

summarized by Bass (… Handbook of Leadership, NY,<br />

Free Press, 1990), leadership correlated with ‘speed and<br />

accuracy of thought’, ‘finality of decision’, ‘ambition, initiative<br />

and persistence’, ‘mood control, and sense of humor’,<br />

etc. A relationship between cognitive processes and cerebellar<br />

and basal ganglia functions, and a role of neocerebellum<br />

in rapidly shifting attention, have been demonstrated. The<br />

cognitive styles, including a proficiency to quickly shift<br />

attention, of history’s famous leaders can be telling examples:<br />

Julius Caesar and Napoleon could dictate to up to six<br />

secretaries simultaneously, using their exceptional working<br />

memories, and proficiency in smoothly shifting attention<br />

while flawlessly gating irrelevant external and internal<br />

stimuli. I would suggest that specific brain imaging and a<br />

variety of neuropsychological studies of accomplished,<br />

younger, political and business leaders could illustrate this<br />

contrast. Neurosteroids have profound effects on brain development<br />

and functions. Though not scientifically rigorous, I<br />

had noted positive correlations (P ¼ 0:0162) between the<br />

self-rated ratings of voice depth (promoted by testosterone)<br />

and of leadership, but none between those of body hair (dihydrotestosterone<br />

dependent) and leader-ship in 47 male US<br />

National Academy of Sciences members (Alias AG. Med<br />

Hypotheses 2000;54:537–552), which was similar to what<br />

Gray et al. (Psychosom Med 1991;53:375–385) found in<br />

1709 older men.<br />

FP-O-010<br />

Clinical analysis and long-term follow-up survey for<br />

Tourette syndrome<br />

Q.-Y. Zhang<br />

Department of Pediatrics, The 1stClinical College, China<br />

Medical <strong>University</strong>, Nanjing Shenyang, China<br />

Objective: To study the treatment and prognosis of Tour-


608<br />

Abstracts<br />

ette syndrome. Methods: Forty-three cases of Tourette<br />

syndrome were followed up for 12–15 years. Results and<br />

conclusions: (1) The symptoms were self limited and<br />

abated or remitted greatly for most cases in late stage of<br />

adolescence, and their study period and social adaptability<br />

were normal. (2) The younger the patients, the more<br />

serious the symptoms and prognosis. (3) Introverted<br />

personality and relatively higher level of psychological<br />

defense are the main characteristics of their personality.<br />

(4) Mentality of most cases was normal. The intelligence<br />

quotient for some cases was low. (5) The cases with<br />

distractibility, hyperactivity, emotional disorders, obsessive-compulsive<br />

neurosis, anxiety disorder, self-injury<br />

behavior, mental confusion and abnormality of EEG had<br />

a poor prognosis. (6) Severe cases should be treated by<br />

drugs such as dopaminergic receptor blocking agent, the<br />

mild cases or cases in remission stage can be treated by<br />

main therapy with relaxation.<br />

FP-O-011<br />

The study of characteristics of sensitive children<br />

W. Yu<br />

Guangzhou Railway Central Hospital, Guangdong, China<br />

Objective: To study the personality characteristics of both<br />

inpatients and outpatients who were sensitive to infection.<br />

Methods: Both the study group (120 cases) and the normal<br />

control group (100 cases) were assessed with Jacson personality<br />

questionnaire scale. Results: The E score was lower in<br />

the study group than that in the control group (P , 0:01),<br />

but the N score was higher in the study group (P , 0:05).<br />

There were no significant differences in P and L scores in<br />

both groups (P , 0:05). Sensitive patients showed introverted<br />

and unstable characteristics of personality. Conclusion:<br />

Frequently going to hospital would strongly influence<br />

a sensitive child psychologically. It is necessary to carry out<br />

early psychological intervention in sensitive children.<br />

FP-O-012<br />

RC Schumacher and society<br />

N.C. Schumacher<br />

Epilepsy Foundation, New Haven, CT, USA<br />

Many of the problems faced by us are not understood.<br />

Something as simple as why our dog may die, or as complex<br />

as why our family is genetically inclined towards epilepsy<br />

may be shrouded in mystery. One method of removing this<br />

cloud is through education. This cannot be fully accomplished<br />

until we tap the resources of those who suffer<br />

from epilepsy and truly listen to what they themselves<br />

have to tell us. As a society, we need to understand the<br />

emotional problems they face by non-acceptance. Unless<br />

society as a whole accepts the fact that being different is<br />

not wrong, but an individual trait that we are blessed with,<br />

they will fail to accept persons who have epilepsy as the<br />

unique individuals that they are.<br />

FP-O-013<br />

Methylphenidate in children with attention deficit<br />

hyperactivity disorder: evidence from a Sri Lankan<br />

tertiary children’s hospital<br />

S.H. Kariyawasam, H. Perera, A. Koralagama, P.<br />

Jayawardane<br />

<strong>University</strong> of Colombo/Lady Ridgeway Hospital, Sri Lanka<br />

The response to methylphenidate (MPD) was assessed in<br />

children diagnosed as having ADHD during the year 2000,<br />

at the Lady Ridgeway Tertiary Hospital for Children in Sri<br />

Lanka. They were managed in outpatient child psychiatry<br />

clinics. ADHD was diagnosed according to DSM-IV<br />

criteria and severity of the symptoms was determined<br />

with a validated Sinhala assessment form based on the<br />

DSM-IV criteria. The data on problems experienced by<br />

the diagnosed children and their families was obtained<br />

using an interviewer-administered questionnaire. The<br />

severity of the symptoms, problems experienced by the<br />

children and their families were reassessed at 6 weeks<br />

and 6 months of MPD therapy. Thirty-seven new subjects<br />

were diagnosed as having ADHD in year the 2000 and 36<br />

of these were treated with MPD. Severity of symptoms and<br />

the number of subjects receiving frequent complaints from<br />

school was significantly lower 6 weeks after MPD treatment,<br />

while frequency of other social problems was not<br />

significantly reduced. At 6 months of treatment severity<br />

of symptoms was not significantly reduced when compared<br />

with the severity assessed initially and 6 weeks after. There<br />

was no improvement in social problems at the end of 6<br />

months of therapy. MPD did help with school-related<br />

problems short-term, but the long-term effects of MPD<br />

was not convincing in this group of subjects and showed<br />

poor long-term compliance, probably due to inadequate<br />

improvement seen in symptoms.<br />

FP-O-014<br />

Reassessing the efficacy of Adderall w after prolonged<br />

treatment for attention-deficit/hyperactivity disorder<br />

(ADHD)<br />

P.A. Ahmann, L.R. Campbell, F.W. Theye, R.L. Berg, A.J.<br />

Linquist<br />

Marshfield Medical Research Foundation, Marshfield, WI,<br />

USA<br />

Objectives: (1) Assess response to Adderall w over time<br />

in children 5–18 newly diagnosed for ADHD. (2) Describe<br />

long-term behavioral efficacy of Adderall w by measuring<br />

psychodynamic behavior in subjects in medicated and<br />

unmedicated conditions. (3) Assess long-term safety of<br />

Adderall w , especially growth effects. Method: Reassess


Abstracts 609<br />

Adderall w responders after a median of 24 months of treatment.<br />

Assess Adderall w response with Connors’ Parent and<br />

Teacher Rating Scales; ADD-H Comprehensive Teacher’s<br />

Rating Scale; plus parent, teacher, and child narratives.<br />

Evaluate behavioral efficacy with Strengths and Weakness<br />

of ADHD-symptoms and Normal-behaviors (SWAN) scale<br />

completed on and off Adderall w . Assess height, weight at<br />

routine visits. Results: Of 314 children completing initial<br />

assessment, 271 (86%) showed positive response to Adderall<br />

w . Of these, 133 enrolled in the reassessment study.<br />

Seventy-three have currently completed reassessment,<br />

with 47 (64%) demonstrating continuing response to<br />

Adderall w . Thirty-six of 44 (82%) SWAN scores indicate<br />

ADHD behaviors that worsened off medication<br />

(P , 0:001). After a median follow-up of 2 years, the<br />

first 44 children enrolled demonstrated highly significant<br />

(P , 0:001) declines in growth relative to national percentiles:<br />

Median height decreased 1.4 cm/year from the 65th<br />

to 42nd percentile, median weight declined from 81st to<br />

49th percentile, and median body mass index declined<br />

from 77th to 59th percentile. Highly significant negative<br />

correlation appeared between total dose/kg and rate of<br />

change in height. No significant growth trend appeared<br />

prior to therapy. Impact on growth was not significantly<br />

related to dosing schedule. Conclusion: Adderall w response<br />

and behavioral efficacy continue after prolonged treatment.<br />

Clinicians should monitor growth carefully.<br />

FP-O-015<br />

Psychostimulants, amphetamine and<br />

methamphetamine, are toxic to rat cortical neurons and<br />

induce both apoptosis and necrosis<br />

W.-T. Lee, Y.-Z. Shen<br />

Department of Pediatrics, National Taiwan <strong>University</strong><br />

Hospital, Chinese Taipei<br />

Psychostimulants, amphetamine and methamphetamine,<br />

are both popular recreational drugs of abuse in many countries,<br />

including Taiwan. Studies of amphetamine and<br />

methamphetamine neurotoxicity showed the decreased<br />

neurotransmitter levels and neurite degeneration, rather<br />

than neuronal death. However, other studies also showed<br />

that methamphetamine can lead to neuronal apoptosis.<br />

Therefore, in the present study, we investigated the pathogenic<br />

mechanisms of amphetamine and methamphetamine<br />

neurotoxicity using primary rat cortical neuronal culture.<br />

We found that both amphetamine and methamphetamine<br />

induced dose- and time-dependent neuronal necrosis and<br />

apoptosis. There was also time-dependent increase of free<br />

radical production and decrease of ATP content in<br />

neurons. Compared with amphetamine, methamphetamine<br />

led to higher free radical production and ATP depletion,<br />

and induced more necrosis and apoptosis in neurons. There<br />

was also gradual increase of caspase-3 activity and<br />

decrease of Bcl-2 expression following the application of<br />

both amphetamine and methamphetamine. We conclude<br />

that both amphetamine and methamphetamine can lead<br />

to neuronal apoptosis and necrosis by a mechanism related<br />

to mitochondrial dysfunction and free radical overproduction.<br />

FP-O-016<br />

Increased urine phenylethylamine after<br />

methylphenidate treatment in children with attention<br />

deficit hyperactivity disorder<br />

Y. Yamashita a , A. Kusaga a , M. Keneko a , T. Koeda b ,M.<br />

Hiratani1 c , S. Yamada d , T. Matsuishi a<br />

a Department of Pediatrics and Child Health, Kurume<br />

<strong>University</strong> School of Medicine, Fukuoka, Japan; b Faculty<br />

of Education and Regional Sciences, Tottori <strong>University</strong>;<br />

Tottori, Japan; c Hiratani Clinic for Developmental Disorders<br />

of Children, Fukui, Japan; d Department of Psychiatry,<br />

Saga Medical College, Saga, Japan<br />

Objective: We measured urinary monoamines to clarify<br />

the neurochemical metabolism, the pharmacological<br />

mechanism of methylphenidate (MPH), and the correlation<br />

between monoamine levels and clinical symptoms in children<br />

with ADHD. Methods: After informed consent had<br />

been obtained from the children with and without ADHD<br />

and their parents, urine samples were collected over a 24 h<br />

period. The urine levels of b-phenylethylamine (PEA),<br />

MHPG, HVA, and 5-HIAA were measured; PEA by<br />

GCMS and the others by HPLC. We investigated the correlation<br />

between severity and the concentration of monoamines,<br />

their difference between responders and nonresponders<br />

of MPH, and their changes before and after<br />

MPH treatment. Results: The urinary levels of monoamines<br />

in 37 children with ADHD, 21 age-matched controls, 12<br />

children with high function autistic disorder were<br />

measured. The 22 children with ADHD were treated with<br />

MPH, then divided into responders (n ¼ 18) and nonresponders<br />

(n ¼ 4). The mean urinary levels of MHPG,<br />

HVA, and 5-HIAA in children with ADHD were not<br />

significantly different from those of controls. The PEA<br />

levels were significantly lower in children with ADHD<br />

(n ¼ 37, 21.7 ^ 20.5 mg/g creatinine) than in the agematched<br />

controls (n ¼ 21, 46.6 ^ 46.6 mg/g creatinine).<br />

No difference in urinary monoamines was found between<br />

autistic disorder and controls or children with ADHD. PEA<br />

levels in the responders to MPH significantly increased<br />

after MPH therapy, however PEA levels in the 4 nonresponders<br />

did not increase. No changes were found in<br />

other monoamines after MPH therapy. No correlation<br />

between the levels of PEA and ADHD severity was<br />

observed.


610<br />

Abstracts<br />

FP-O-017<br />

Clinical profile of attention/deficit hyperactivity<br />

disorder among Filipino children in a tertiary referral<br />

center 1987–2000<br />

C.L.M. Cruz-Conducto, E.L. Avendano, A.L. Reyes, M.H.<br />

Ortiz, A.L. Tanega, L.K. Ledesma<br />

Neurodevelopmental Section, Child Neuroscience Division,<br />

Philippine Children’s Medical Center, Quezon City, Philippines<br />

Attention-deficit/hyperactivity disorder (AD/HD) is a<br />

developmental disorder characterized by developmentally<br />

inappropriate degrees of inattention, hyperactivity, and<br />

impulsivity affecting 3–5% of school-age children. Charts<br />

of 1355 patients seen over a 13-year period were reviewed.<br />

Of these, 64 were diagnosed as having primary AD/HD. The<br />

majority were in the early childhood age group with more<br />

males affected (6:1). Language delay with heightened activity<br />

level was the most frequent symptom in the combined<br />

type while short attention span with language delay was o<br />

the Inattentive type. AD/HD of the combined type was the<br />

most common subtype (90%) across all age groups, while<br />

AD/HD of the inattentive type was more frequent in adolescents.<br />

The least common across all age groups was the<br />

hyperactive-impulsive type. Diagnostic work-ups (EEG,<br />

neuroimaging, thyroid function test, BAER) were normal.<br />

Apart from the mental status examination, there were no<br />

significant physical and neurological examination findings.<br />

On neurodevelopmental examination, significant delay in<br />

language domains (70%), fine motor (23%), and self-help<br />

skills (7%) were noted. Neuropsycholoical evaluation<br />

revealed cognitive functioning in the average range, delays<br />

in the achievement test were noted in 44%. Co-morbidities<br />

noted were developmental language disorder (95%), oppositional<br />

defiant disorder (33%) and learning disability<br />

(20%).<br />

FP-O-018<br />

A comparative study of the psychological characteristic<br />

of epileptic and normal children<br />

A. Aghaei<br />

Islamic Azad <strong>University</strong> Khorasgan Branch, Iran<br />

Objective: The purpose of this study was to compare the<br />

psychological characteristics of epileptic and normal children.<br />

Method: Fifty elementary school children (34 boys<br />

and 16 girls) were diagnosed as epileptic on the basis of<br />

neurological experimentation. These children constituted<br />

the experimental group and were matched for sex, age,<br />

and grade with 50 normal children (control group). A<br />

demographic questionnaire, Child Symptom Inventory<br />

(CSI-4), and Raven’s matrices were administered to both<br />

groups. Both groups and their mothers were also interviewed<br />

and all the necessary information was obtained.<br />

Results: The results of multivariate of variance using<br />

SPSS showed that a difference between the two groups<br />

exists in the following characteristics: the history of family<br />

epilepsy, gestation illness, type of birth (difficulty of delivery),<br />

cyanosis, late talking, late urine control, enuresis,<br />

fever and convulsion, attention weakness, hypomnesis,<br />

sleep depth, social relations with peers, relation with<br />

teacher, school interest, neglect of appearance, neglect of<br />

personal affairs, jealousy, school GPA, school failure,<br />

hallucination, ADHD, oppositional defiant disorder,<br />

conduct disorder, generalized anxiety, voice tic, PTSD,<br />

depression, autism and Asperger symptoms, nail-biting,<br />

self-abuse and withdrawal at home.<br />

FP-O-019<br />

Psychological distress of families with children having<br />

tics – 3 years experience of a community hospital<br />

K.-W. Tsui, W.-C. Wong, M. Tse, K.-W. Li, K.-C. Chan<br />

Department of Paediatrics, North District Hospital, Hong<br />

Kong, China<br />

Introduction: Tics are not uncommon and can be distressing.<br />

Method: We retrospectively reviewed all patients<br />

referred for tics from 1 July 1998 to 28 February 2002.<br />

Data was retrieved from records, supplemented by telephone<br />

interviews of parents with emphasis on psychological<br />

distress at presentation and at the time of interview.<br />

Results: Thirty patients (25 males, five females) with<br />

median age at presentation ¼ 8 years (range: 4.5–14.5<br />

years) and median follow up ¼ 20 months (range: 3–42<br />

months) were recruited. Twenty-nine were successfully<br />

interviewed. Median symptom duration was 3 months<br />

(range: 1 month–8 years). Eleven (37.9%) had sought<br />

two or more doctors’ advice before the first interview.<br />

Nine patients (30%) had chronic motor tics and four<br />

patients (13.3%) presented with vocal tics, one of which<br />

had TS. Commonly affected muscle groups were eye blinking<br />

(43.3%), head jerk/movement (40%), facial grimace<br />

(23.3%) and shoulder shrug (20%). At presentation,<br />

96.6% of parents were distressed (86.2% worried about<br />

underlying physical illness, 31% felt embarrassed and<br />

31% used negative comments towards children). After<br />

consultations, their distress was alleviated (P , 0:01).<br />

The patients with an urge to control tics also decreased<br />

from 46.4 to 7.1% (P , 0:01). On follow up, parents<br />

perceived a decrease in tic frequency, children being<br />

happier and more confident in 86.2, 41.4 and 17.2% of<br />

cases, respectively. Conclusion: Psychological distress<br />

was not uncommon in these families. Reassurance and<br />

counseling could reduce their distress and the potential<br />

tension build-up between the parents and child.


Abstracts 611<br />

FP-O-020<br />

Clinical study of administration of fluvoxamine for<br />

epilepsy patients with obsessive symptoms<br />

J. Furusho a ,H.Sato a , K. Yamaguchi a , H. Ozawa b ,M.<br />

Fukumizu c , T. Miyajima d , J. Kohyama e , Y. Iikura a<br />

a School of Medicine, Showa <strong>University</strong> (at the present;<br />

College of Literature, Department of Education Aoyamagakuin<br />

<strong>University</strong>); b Tokyo Metropolitan Hachioji Children’s<br />

Hospital, c Division of Child Neurology, National Center of<br />

Neurology and Psychiatry; d Tokyo Medical <strong>University</strong>;<br />

e Tokyo medical and Dental <strong>University</strong>, Japan<br />

We performed a clinical study of administration of<br />

fluvoxamine for epilepsy patients with obsessive symptoms.<br />

Recently, the effectiveness of a selective serotonin reuptake<br />

inhibitor (SSRI) has been reported in patients with<br />

obsessive symptoms. Fluvoxamine is one of the SSRIs.<br />

However, it has no indication for use in children under 20<br />

years of age and patients with epilepsy in Japan because<br />

there has been no report about their usefulness in children<br />

and epilepsy. Therefore, we have established our own ethical<br />

standards by referring to overseas reports, and we have<br />

also performed a clinical study of administration of fluvoxamine<br />

for epilepsy patients with obsessive symptoms at six<br />

different institutions. We selected six patients in accordance<br />

with our criteria: (1) more than two seizures per month; (2)<br />

treated with antiepileptic drugs for at least 2 years; and (3)<br />

having obsessive symptoms. A daily dosage of 25–100 mg<br />

of fluvoxamine was administrated for at least 4 weeks under<br />

their informed consent. Usefulness of fluvoxamine for<br />

obsessive symptoms was defined using CBCL at 4 and 16<br />

weeks after administration. Alleviation of psychiatry symptoms<br />

was observed in two cases and clinical seizures were<br />

decreased in two cases. No adverse effects (including<br />

increase of seizure frequency) were observed. In view of<br />

these results, fluvoxamine may be useful for psychiatric<br />

symptoms even in pediatric patients with epilepsy.<br />

FP-O-021<br />

The importance of psychological testing in differential<br />

diagnosis of childhood headache<br />

I. Franula, I. Prpi, I. Vlaši-Cicvari, Z. Korotaj, E. Paui-<br />

Kirini<br />

<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />

The aim of the study was to establish whether neuropsychological<br />

tests may be helpful in the differential diagnosis<br />

of childhood headache. The retrospective results of<br />

neuro-psychological testing of 54 school age children with<br />

headache were analyzed. There were 18 boys and 36 girls<br />

with a mean age 11.4 years (SD ¼ 2.6). No statistical difference<br />

between the boys and the girls regarding age and social<br />

background were detected. All tests were performed as soon<br />

as a child was able to cooperate – on average 2 days following<br />

the headache (minimum 0 days and maximum 9 days).<br />

General IQ was average in 28 children, higher in 24 children<br />

and lower in two children. The Bender-Gestalt visual-motor<br />

perception test (Bender test) was normal in 28 children,<br />

pathological (cerebral organic dysfunction) in 14 and inconclusive<br />

in seven children. When applying IHS criteria for<br />

headache differentiation we found that the majority of children<br />

with migraine had a higher IQ (higher IQ in 15; average<br />

in nine children) while children with other types of<br />

headache were in the majority with an average general intelligence<br />

(average IQ 19; higher IQ nine children). These<br />

results were statistically significant (Hi2 ¼ 4.89,<br />

P ¼ 0:02). Bender test was pathological in 14 children<br />

with migraine and in one child with other types of headache.<br />

Normal Bender test was found in four children with<br />

migraine and 24 children with different types of headache.<br />

These differences were statistically significant (Hi2 ¼ 21.9,<br />

P , 0:01). Only children with migraine (six) had an inconclusive<br />

Bender test. The results clearly show the importance<br />

and reliability of neuro-psychological tests in differential<br />

diagnoses of migraine and ’ordinary’ headache. In any<br />

child with a characteristic headache attack who has a high<br />

IQ and cerebral dysfunction on the visual-motor perception<br />

test, migraine should immediately be suspected.<br />

FP-O-022<br />

Role of perinatal pathology in formation of attention<br />

deficit with hyperactivity syndrome in children of<br />

school-age<br />

M.B. Guryeva, O.I. Maslova, V.M. Studenikin<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific Center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Russia<br />

Background: Brain damage during prenatal and perinatal<br />

periods of human development is believed to be one of the<br />

principal factors in the formation of attention deficit with<br />

hyperactivity syndrome (ADHS), as well as some genetic<br />

mechanisms. Objective: The goal of our study was to determine<br />

the role of pre-/perinatal pathology as a risk factor for<br />

ADHS formation in school-age children. Method: Case<br />

histories of 45 ADHS patients aged 6–10 years were thoroughly<br />

analyzed (the cohort consisted of three groups in<br />

accordance with DSM-IV classification: (1) ADHS<br />

combined form; (2) ADHS with prevailing attention deficit;<br />

and (3) ADHS with prevailing hyperactivity and impulsivity).<br />

Results: Disturbances of physiological gestation course<br />

took place in 32 cases (17.1%): severe toxemia, threatened<br />

miscarriage, acute somatic conditions, potentially toxic<br />

substances in the domestic environment etc. Pathology of<br />

intranatal period was evident in 34 cases (75.5%): early<br />

rupture of membranes (17.7%), inadequate labour activities<br />

(20%), precipitated deliveries (24.4%). Seventeen neonates<br />

(37.7%) were delivered preterm (gestational age ,36


612<br />

Abstracts<br />

weeks), and four babies post-term (GA .42 weeks). Among<br />

term infants’ morpho-functional immaturity was present in<br />

four cases, with intrauterine hypotrophy in 6.6% of patients,<br />

and severe intranatal asphyxia in 12 pts (26.6%). Conclusion:<br />

Our data provides evidence of high risk for ADHS<br />

formation in children who experienced the influence of<br />

pre- and perinatal pathology. The establishment of social<br />

prognosis for pediatric patients with ADHS requires taking<br />

into account the peculiarities of individual perinatal history.<br />

FP-O-023<br />

Nootropic drugs in therapy of the attention deficit<br />

hyperactivity disorder (ADHD)<br />

M.M. Lepessova, A.Kh. Jaxybayeva<br />

Municipal hospital 7, Almaty, Kazakhstan<br />

The purpose of our study was comparative analysis of<br />

therapeutic effects from therapy by Instenon, a combination<br />

of Instenon and Actovegin and routine form of therapy of<br />

ADHD by Piracetam and Cavinton. During our investigation<br />

we observed three groups of children with behavioural<br />

problems such as ADHD. One group (20 children) had therapy<br />

by Instenon, the second group had therapy by combination<br />

Instenon and Actovegin, and the third group had<br />

therapy by piracetam and cavinton. For assessment of effectiveness<br />

of therapy we used neuropsyhological tests and<br />

electroencephalography. During our investigation in all<br />

the children we detected behavioural deviations such as<br />

attention deficit, hyperactivity, impassivity, different speech<br />

and motors delays. On electroencephalography we detected<br />

slow posterior rhythm. After therapy by nootropic drugs we<br />

obtained positive dynamics such as improvement in neuropsyhological<br />

tests (cognitive and speech skills, visio-kinesthetic<br />

perception, motor activity). In the first group we<br />

observed positive dynamics in 12 (60%) children, in the<br />

second group 15 (75%), and in ten of the third group<br />

(50%). Therefore, for treatment of behavioral deviation<br />

we recommended nootropic drugs, such as Instenon, or<br />

Actovegin. However, treatment by combination of Instenon<br />

and Actovegin is more effective.<br />

FP-O-024<br />

The investigation of social action characteristics in<br />

hyperkinetic syndrome of childhood<br />

D.-M. Wang, S.-M. Jia, S.-Y. Liu<br />

No. 4 Hospital of Baotou, Baotou, Inner Mongolia, China<br />

During the period 1998–1999, in order to understand the<br />

characteristic of social adaptability of hyperkinetic<br />

syndrome of childhood, we investigated the differences<br />

between 46 children diagnosed as having hyperkinetic<br />

syndrome of childhood and 50 normal children. Everyone<br />

examines EEG which expresses normal EEG and critical<br />

EEG. Their examinations of nerval system are normal.<br />

Adopting ‘Wei’s measuring chart of child intelligence’<br />

revised by Yao-Xian Gong and ‘The measuring chart of<br />

child adaptable action’ compiled by Shu-Qiao Yao, two<br />

groups of children were estimated by the intelligence quotient<br />

(FIQ) and adaptation quotient (ADQ). Result: (1) There<br />

is no significant difference in FIQ between the two groups<br />

(100; 102, P . 0:05). (2) There is no significant difference<br />

in ADQ between the two groups (105.4; 105.8, P . 0:05).<br />

But the social/self control factor of the normal children is far<br />

higher than one of sick children (57.6; 40.3, P , 0:05). The<br />

independent factor and cognition factor of the normal children<br />

is far lower than ones of the sick children (that is 52.4;<br />

60.5, P , 0:05:49:3; 57.8, P , 0:05). Analysis: the sick<br />

children is normal in FIQ and ADQ although independent<br />

and cognition Factors maintain certain levels, they are low<br />

value in social/self control Factor, which lead to pay no<br />

attention to what you are doing. Likely, their studies and<br />

lives are irregular. Their social action is unusual.<br />

FP-O-025<br />

A study on the effects of EEG biofeedback on the<br />

cognitive function of ADHD children<br />

R.-H. Jiang, Y.-F. Wang<br />

Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective: To study the effect of different sessions of<br />

EEG biofeedback training on the cognitive function, especially<br />

executive function of ADHD children. Methods:<br />

Thirty-eight cases diagnosed as ADHD according to the<br />

criteria of DSM-IV, aged 7–16 years, and 38 normal<br />

controls well matched by gender and age with ADHD children<br />

were involved in the study. Conner’s behavior rating<br />

scale-parent questionnaire, Chinese-Wechsler intelligence<br />

scale for children (C-WISC), Wechsler memory scale,<br />

number cancellation test, Stroop test, CPT and Raven’s<br />

standard progressive Matrices were administered pre and<br />

post-EEG biofeedback treatment (20 and 40 sessions) and<br />

after 6 months of treatment. No other interventions were<br />

used to the ADHD children during the treatment. Results:<br />

(1) Before treatment, ADHD children performed worse than<br />

normal controls on all psychometric tests except picture<br />

recollection, association memory in Wechsler memory<br />

scale (WMS) and Stroop color-word test. (2) After 20<br />

sessions of treatment, the scores of hyperactivity factor<br />

and index of Conner’s behavior rating scale decreased<br />

significantly. Number cancellation test, rate of omission<br />

errors in CPT, visual reproduction, tactile memory, logical<br />

memory, short-term memory in WMS improved significantly,<br />

and were similar to normal children. Memory quotient,<br />

digit span and Stroop word interference effect improved<br />

significantly, but were not as well as normal children. (3)<br />

After 40 sessions treatment, the scores of behavior and<br />

learning factors and hyperactivity index of Conner’s behavior<br />

rating scale decreased significantly. Memory quotient,


Abstracts 613<br />

number cancellation test, Stroop word-interference effect<br />

improved significantly, and was similar to normal children.<br />

Instantaneous-memory and Stroop word test improved<br />

significantly but was not as well as normal children. Performance<br />

IQ, total IQ and B factor improved significantly.<br />

There is no improvement on the Raven’s standard progressive<br />

matrices. (4) Compared the ADHD children who<br />

finished 20 sessions treatment only (20 session group)<br />

with whom finished 40 sessions of treatment (40 session<br />

group), 20 session group was better on clinical symptoms<br />

before treatment, and improved more significantly than 40<br />

session group. Before treatment, 20 session group<br />

performed better than 40 session group on number cancellation<br />

test, CPT. After 20 sessions treatment, 20 session group<br />

performed still better on number cancellation test, CPT, and<br />

worse on association memory. (5) On follow-up, reaction<br />

time of CPT improved continuously, the others were similar<br />

with post-treatment. Discussion: (1) Vigilance and sustained<br />

attention, response inhibition, working memory, EF and<br />

psychomotor speed of ADHD children started to improve<br />

after 20 sessions of EEG biofeedback treatment. Vigilance<br />

and sustained attention, response inhibition, non-verbal<br />

working memory were as well as normal children. (2) All<br />

of the cognitive functions improved continuously after 40<br />

sessions treatment and were similar with normal children<br />

except verbal working memory, planning and psychomotor<br />

speed. (3) The effect was maintained when the treatment<br />

stopped. Conclusion: (1) The EEG biofeedback was effective<br />

both on clinical symptoms and cognitive function of<br />

ADHD. (2) Cognitive functions began to improve after 20<br />

sessions EEG biofeedback treatment, and improved<br />

continuously after 40 sessions, but there is still some difference<br />

on cognitive function between ADHD children and<br />

normal controls, especially on executive function. The<br />

effect was maintained and psychomotor speed improved<br />

continuously when the treatment was stopped.<br />

FP-O-026<br />

Association of 5-HT 2A receptor T102C polymorphism<br />

and attention deficit hyperactivity disorder in children<br />

J. Li, Y.-F. Wang, Q.-J. Qian, B. Wang<br />

Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective: To detect the genetic association between<br />

attention deficit hyperactivity disorder and a T-C polymorphism<br />

at nucleotide 102 of the serotonin receptor<br />

2A(5-HT 2A ) gene. Methods: A case-control study which is<br />

based on 182 normal control and 323 children diagnosed<br />

with ADHD according to DSM-IV criteria, along with a<br />

transmit/disequilibrium test (TDT) which is based on 195<br />

nuclear families is used to analyze the association of 5-HT 2A<br />

receptor T102C polymorphism with the whole and all kinds<br />

of phenotypes of ADHD in children. Results: As for the<br />

patients of ADHD combined subtype, the genotype of<br />

T102T is sparse (22.3 versus 33.5%, odds ratio,<br />

OR ¼ 0.569, P ¼ 0:028, 95% CI 0.344 , 0.943) and the<br />

genotype of T102C is excessive (64.0 versus 47.3%,<br />

OR ¼ 1.987, P ¼ 0:003, 95% CI 1.264 , 3.124), when<br />

compared with normal control, moreover, for the patients<br />

of girl ADHD combined subtype, there is biased transmission<br />

of the alleles of T102C polymorphism gene locus to the<br />

probands. Conclusion: To ADHD combined subtype, the<br />

genotype of T102T is a protective factor and the genotype<br />

of T102C is a risk factor, besides, to the girl ADHD<br />

combined subtype, the allele C102 is the disease-predisposing<br />

gene.<br />

FP-O-027<br />

Study on developmental and circumstantial<br />

characteristics of ADHD children with and without ODD<br />

J. Liu, Y.-F. Wang<br />

Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective: To compare developmental and circumstantial<br />

characteristics among ADHD children, ADHD/ODD children<br />

and normal controls. Method: Based on DSM-IV<br />

criteria, matched by age, sex and ADHD subtypes, we<br />

sampled 34 pure ADHD cases, 34 ADHD with comorbid<br />

ODD cases and 34 normal controls, and collected information<br />

about their developmental and circumstantial features.<br />

Results: (1) General information: compared with normal<br />

controls, two case groups had significantly higher rate of<br />

self-medical expense, but lower percentages of partial<br />

state reimbursement, father with graduate education, father<br />

being professional, mother with Han nationality and mother<br />

being official. (2) Perinatal stage: two case groups had fewer<br />

mothers with satisfactory mood during pregnancy, the new<br />

born babies cried shorter immediately after their birth, but<br />

more mothers got pregnant complications, mental stress in<br />

late stage of pregnancy and work frustration than control<br />

group; more mothers in ADHD group got too much weight<br />

(more than 15 kg) than normal group; more pregnant<br />

mothers in ADHD/ODD group got medication, drank and<br />

had mental stress in early stage of pregnancy than control<br />

group; ADHD/ODD group had more neonates with intracranial<br />

bleeding than other two groups. (3) Development in<br />

infancy and early childhood: two case groups had lower<br />

rates of good physical development, and higher rates of<br />

hyperactivity after 1 year of age; more children in ADHD<br />

group had poor physical development than normal children.<br />

(4) School life: two case groups had fewer children with<br />

intimate peer relationship, or could maintain friendship for<br />

more than 1 year, or could get helps from peers when having<br />

difficulty, but more children had just a so-so peer relationship<br />

or could last friendship for less than half a year. (5)<br />

Relative factor for current behavior: the teachers or parents<br />

had less efficacy for children’s behavior by way of oral<br />

criticism in two case groups; additionally, they adopted


614<br />

Abstracts<br />

more measures of physical punishment, privilege abolishment,<br />

ignorance, connivance or avoidance. (6) Health<br />

history: more ADHD/ODD children had awkward in bold<br />

movement than normal controls. (7) Living circumstances:<br />

two case groups had worse parental relationship, and more<br />

children were afraid of their fathers; there was higher rate of<br />

harmonious parent-child relationship in normal group than<br />

ADHD group, and that of the latter group was higher than<br />

ADHD/ODD group; when meeting difficulty, families in<br />

ADHD/ODD group had worse social support than the<br />

other two groups. (8) Family history: the rate of positive<br />

family history of mental disorder was higher in ADHD/<br />

ODD group than ADHD and normal group. Conclusion:<br />

Children with ADHD had disadvantaged developmental<br />

and circumstantial features than normal children, particularly<br />

ADHD children with comorbid ODD had many even<br />

worse situations than pure ADHD children.<br />

FP-O-028<br />

A study on the cognitive function of attention deficit<br />

hyperactivity disorder<br />

Y.-X. Liu, Y.-F. Wang<br />

Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective: Our goal was to explore cognitive impairments<br />

of ADHD children. Methods: Participants were children<br />

referred for symptoms of over activity, inattention, and<br />

impulsivity, and 94 children as normal control. Using<br />

DSM-IV diagnostic criteria, we classified the 317 ADHD<br />

children into three subtypes, and assessed comorbidities. All<br />

participants received a series of neuropsychological tests<br />

which consisted of C-WISC, WMS, the number cancellation<br />

test, the Stroop test and the Raven’s standard progressive<br />

matrices. Results: (1) Although children with ADHD have<br />

normal intelligence, their C-WISC, WMS, the reverse digit<br />

span scores were all less than their counterparts. In the<br />

number cancellation test and the Raven’s standard progressive<br />

matrices, ADHD children displayed worse than the<br />

control. ADHD children spent more time on each part of<br />

the Stroop test and made more effort to eliminate the interference<br />

of word meaning; at the same time, they made more<br />

errors on C part (P all ,0.05). ADHD girls had lower scores<br />

on information subtest of C-WISC than ADHD boys<br />

(P , 0:05). However, ADHD girls displayed a tendency<br />

to be superior to that of their counterparts in the Stroop<br />

test (P all ,0.1). There were no significant differences<br />

between each subtype of ADHD children in neuropsychological<br />

tests, though they were well matched by age and sex.<br />

ADHD children combined with learning disability<br />

(ADHD 1 LD) were significantly older than children<br />

suffered from ADHD only (ADHD group). ADHD 1 LD<br />

were significantly more impaired on the Freedom From<br />

Distractibility factor (C factor) and comprehension subtest<br />

of the C-WISC, the comprehension and reverse digit span<br />

subtest of WMS, the number cancellation test (P all ,0.05).<br />

(2) Logistic regression analysis showed that age and<br />

decreased C factor were risk factors for combining with<br />

LD. Gender, subtype and executive functions had little<br />

effect on the onset of LD among ADHD children. C factor<br />

significantly related to WMS, the number cancellation test,<br />

the Stroop test and the Raven’s standard progressive<br />

matrices. The highest relationships were found between C<br />

factor and short term memory and memory quotient. The<br />

middle relationship was found between C factor and the<br />

number cancellation test. We did not find the discrepancy<br />

of C factor with other factors in C-WISC. (3) The Stroop test<br />

had little relationship with the C-WISC<br />

(r ¼ 20:107 , 0:200). It suggested that the traditional<br />

intelligence test did not assess the selective inhibition of<br />

irrelevant stimulus or the control of impulse which were<br />

assessed by the Stroop test appropriately. Full scale intelligence<br />

quotient had little effect on variables standing for<br />

executive functions. Conclusion: ADHD children have<br />

impairments in tests of intelligence, memory, attention<br />

and executive functions such as selective inhibition, working<br />

memory and plan. Compared with ADHD boys, girls<br />

with ADHD displayed a tendency of greater intellectual<br />

impairment; however, their selective inhibition probably<br />

maintained better than that documented in boys with<br />

ADHD. Three subtypes of ADHD have the similar cognitive<br />

model. When ADHD children grow up, maybe they would<br />

combine with LD more easily. ADHD 1 LD children have<br />

poorer C factor, working memory and attention level.<br />

FP-O-029<br />

A study of dopamine candidate genes and attention<br />

deficit hyperactivity disorder<br />

Q.-J. Qian, Y.-F. Wang, R.-L. Zhou<br />

Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective: To investigate the relationships between<br />

ADHD and some candidate genes of dopamine system,<br />

such as dopamine D4 receptor (DRD4) gene, dopamine<br />

transporter (DAT) gene and catechol-O-methyltransferase<br />

(COMT) gene in Han Chinese population. The distribution<br />

of gene polymorphisms in ADHD phenotypes and different<br />

genders, and potential gene-gene interactions were also<br />

analyzed. Methods: The samples were comprised of 340<br />

ADHD children, 224 unrelated controls and 202 integrated<br />

ADHD trios (included proband and biological parents). The<br />

diagnoses and subtypes were ascertained according to<br />

American clinical diagnostic interviewing scales (CDIS), a<br />

structured, interviewer-administered interview based on<br />

DSM-IV criteria. The polymorphisms consisted of 48 bp<br />

VNTR in exon 3 of DRD4 gene, 40 bp VNTR in the 3 0<br />

untranslated region of DAT gene, the restriction fragment<br />

length polymorphisms of Val158Met of COMT gene. Associations<br />

of polymorphisms with ADHD and its subtypes


Abstracts 615<br />

were examined by: (i) comparing cases and controls; and (ii)<br />

using family-based association study in an extension of<br />

TDT and haplotype-based haplotype relative risk (HHRR).<br />

Results: (1) For the association analysis of 48 bp VNTR of<br />

DRD4 gene with ADHD, the frequencies of alleles and<br />

genotypes of long repeat tandem (4 , 6 repeats) in ADHD<br />

boys were significantly higher than in the male controls. The<br />

similar results were also obtained in ADHD-C subtype and<br />

ADHD fulfilling ICD-10 criteria. But the frequency of long<br />

repeat alleles was significantly lower in ADHD girls than in<br />

female controls. The repeat numbers of 48 bp are 2 , 6, we<br />

found no 7 or more repeat alleles among our samples. TDT<br />

and HHRR revealed no preferential transmission of either<br />

allele to ADHD probands. (2) For the 40 bp VNTR of DAT<br />

gene, TDT analysis revealed preferential transmission of 11<br />

repeat allele to ADHD-C probands and nine-repeat to<br />

ADHD-I children. The frequencies of alleles and genotypes<br />

of long repeat (11 , 12 repeats) in ADHD probands were<br />

significantly higher than in the controls. The similar results<br />

were also obtained in ADHD-C, pure ADHD subtype, and<br />

ADHD fulfilling ICD-10 criteria. (3) In the family-based<br />

association of COMT gene in ADHD, TDT and HHRR<br />

suggested the association of COMT gene and ADHD<br />

boys. The low enzyme activity Met158 allele preferentially<br />

transmitted to ADHD boys. This association was particularly<br />

marked among pure ADHD boys, especially the<br />

ADHD-I subtype. The case-control study revealed that<br />

high enzyme activity Val158 allele were more frequently<br />

in ADHD girls fulfilling ICD-10 and DSM-IV criteria than<br />

in the female controls. (4) Binary logistic regression analysis<br />

with the sample of refined phenotype showed that long<br />

repeat genotypes of DRD4 gene, DAT gene, and male<br />

gender were risk factors to ADHD. There was gene-gene<br />

interactions between DAT and DRD4 genes. In the sample<br />

of pure ADHD, there was gene-gene interaction between<br />

COMT and DAT genes. Conclusions: (1) The molecular<br />

genetic mechanisms of ADHD display gender difference.<br />

(2) The length polymorphisms of genes influence ADHD<br />

liability. (3) There are gene-gene interactions which are<br />

associated vulnerability to ADHD.<br />

FP-O-030<br />

The difference of attention-deficit disorder with or<br />

without hyperactivity: a 1 H-magnetic resonance<br />

spectroscopy study<br />

L. Sun a , Z. Jin b , Y.-F. Zang a , Y.-W. Zeng b , G. Liu b , Y.-F.<br />

Wang a<br />

a Institute of Mental Health, Peking <strong>University</strong>, China;<br />

b Center of fMRI, Hospital 306, Beijng, China<br />

Objective: Using proton magnetic resonance spectroscopy<br />

( 1 H-MRS) to investigate the possible neurometabolic<br />

difference among the predominantly inattentive subtype<br />

(ADHD-I subtype), the hyperactivity-impulsive subtype<br />

(ADHD-C subtype) and normal controls. Method: Proton<br />

spectra were acquired bilaterally on the globus pallidus in<br />

20 schoolboys having ADHD and ten matched controls. The<br />

boys having ADHD were divided into ADHD-C subtype<br />

group (n ¼ 10) and ADHD-I subtype group (n ¼ 10)<br />

according to DSM-IV criteria. The peaks of N-acetylaspartate<br />

(NAA), choline moieties, myo-inositol, creatine (Cr)<br />

and a-Glx were measured and their ratios to Cr were calculated<br />

and compared. Results: (1) Though the NAA/Cr ratios<br />

in both ADHD groups were lower than the value in normal<br />

controls, however only the ADHD-C subtype group showed<br />

a significant difference, not the ADHD-I subtype group. (2)<br />

In the right globus pallidus, the NAA/Cr ratios in the<br />

ADHD-C group was significantly lower than the ADHD-I<br />

group. In the left globus pallidus, the NAA/Cr ratios in the<br />

ADHD-C group also showed a decreased tendency<br />

compared to the ADHD-I group. Conclusion: Since NAA<br />

is a useful marker of neuronal function, these findings<br />

suggest that the basal ganglia neuronal dysfunction exist<br />

in ADHD children, the neuronal dysfunction of the<br />

ADHD-C group was more severe than that of the ADHD-I<br />

group.<br />

FP-O-031<br />

Response inhibition in two subtypes of children with<br />

ADHD in a stop signal task<br />

Y.-H. Wang a , X.-L. Zhou a , Y.-F. Wang b , Y.-X. Zhang a<br />

a Department of Psychology, Peking <strong>University</strong>, Beijing,<br />

China; b Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective and method: A stop signal task was used to<br />

investigate two kinds of response inhibition, response<br />

conflict and response stopping. Subjects were two subtypes<br />

of children with ADHD (predominantly inattentive and<br />

combined) and normal controls. Results: The results<br />

showed that ADHD children were deficient in both kinds<br />

of response inhibition compared with normal controls. In<br />

response stopping, it was more difficult for ADHD children<br />

to withhold response when responding with left hand,<br />

which means that they have significant deficit in the right<br />

hemisphere. No significant differences were observed<br />

between the combined and inattentive ADHD group. In<br />

response conflict, normal children did not show significant<br />

conflict effect, suggesting that their strong conflict control<br />

ability can overcome the mild conflict manipulation. The<br />

inattentive ADHD group showed a significant conflict<br />

effect when responding with left hand, suggesting the<br />

impairment in control functions of the right hemisphere<br />

and the anterior cingulated. The combined ADHD group<br />

were more impaired than the inattentive ADHD children,<br />

showing a larger conflict effect when responding by either<br />

left or right hands. Conclusion: This suggested that the two<br />

types of ADHD children were impaired to the different<br />

extent in neurocognitive functions.


616<br />

Abstracts<br />

FP-O-032<br />

Effects of distractors on sustained attention in children<br />

with attention-deficit hyperactive disorder (ADHD)<br />

Y. Xu a , X.-L. Zhou a , Y.-F. Wang b<br />

a Department of Psychology, Peking <strong>University</strong>, Beijing,<br />

China; b Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />

China<br />

Objective and method: Using an experimental design<br />

combining the sustained attention task (CPT, SART) and<br />

the flanker task, we investigated: (1) whether children<br />

with ADHD have deficits in their sustained attention; (2)<br />

whether distractors have different effects on the response to<br />

targets at different sustained attention levels; and (3)<br />

whether different subtypes of ADHD children show different<br />

patterns in sustained attention. Results: The results<br />

support the view that ADHD children have deficits in<br />

their sustained attention, reflecting the deficits in brain<br />

development. More importantly, this study found that the<br />

effects of distractors in sustained attention can be dissociated<br />

according to the level of demand on sustained attention:<br />

distractors interfered with responses to targets when<br />

the demand on sustained attention was low while they facilitated<br />

responses to targets when the demand on sustained<br />

attention was high. There were no significant differences<br />

between ADHD-inattentive type and ADHD-combined<br />

type in their deficits in sustained attention. Conclusion:<br />

ADHD children have deficits in their sustained attention,<br />

reflecting the deficits in brain development.<br />

FP-O-033<br />

Investigation of ADHD comorbidities in a Chinese<br />

clinical sample<br />

L. Yang, Y.-F. Wang<br />

Institute of Mental Health, Peking <strong>University</strong>, China<br />

Objective: To investigate the comorbid rate between<br />

ADHD and other childhood psychiatric disorders and<br />

analyze the influence of gender and age in a Chinese clinical<br />

sample. Method: The study included 423 ADHD children<br />

consecutively diagnosed by specialists at the Institute of<br />

Mental Health, Peking <strong>University</strong>. All subjects were<br />

assessed by structured diagnostic interviews with parents<br />

for comorbidities based on DSM-IV. Results: The comorbidity<br />

of recruited ADHD children with disruptive behavior<br />

disorder is 35.1% (ODD 28.2%, CD 6.9%), with multiple<br />

anxiety disorder 8.3%, mood disorder 10.1%, Tics disorder<br />

(including Tourette syndrome, TS) 14.4%, and learning<br />

disorder 37.9%. Girls with ADHD were more likely than<br />

boys to have the anxiety disorders (P , 0:001), especially<br />

the special phobia (P , 0:05) and the general anxiety disorder<br />

(P , 0:01). In addition, adolescents with ADHD (12–16<br />

years) were more likely than children (6–11 years) to meet<br />

the criteria for mania (P , 0:05), and less likely to have<br />

chronic tics disorder (P , 0:05) and learning disorder<br />

(P , 0:001). Conclusions: The high likelihood for ADHD<br />

children to comorbid other psychiatric disorder makes it a<br />

clinical problem that should not be neglected. It is necessary<br />

to routinely evaluate, diagnose and manage the comorbidities<br />

in clinical work. The sex and age differences of comorbidity<br />

implicated different pathogenisis.<br />

FP-O-34<br />

The investigation of social action characteristics about<br />

hyperkinetic syndrome of childhood<br />

D.-M. Wang, S.-M. Jia, S.-Y. Liu<br />

No. 4 Hospital of Baotou, Aogan Str., Qingshan District,<br />

Baotou 014030, Inner Mongolia, China<br />

To understand the characteristic of social adaptability of<br />

hyperkinetic syndrome of childhood, we had carried out the<br />

investigation between diagnosed hyperkinetic syndrome of<br />

childhood 46 and normal child 50 in 1998–1999. Everyone<br />

examines EEG which expresses normal EEG and critical<br />

EEG. Their examinations of nerval system are normal.<br />

Adopting (Wei’s measuring chart of child intelligence)<br />

revised by Yao-Xian Gong and (The measuring chart of<br />

child adaptable action) compiled by Shu-Qiao Yao. Two<br />

groups of children were estimated intelligence quotient<br />

(FIQ) and adaptation quotient (ADQ). Result: (1) There is<br />

no significant difference in FIQ between the two groups<br />

(100; 102, P . 0:05). (2) There is no significant difference<br />

in ADQ between the two groups (105.4; 105.8, P . 0:05).<br />

But the social/self control Factor of the normal children is<br />

far higher than one of sick children (57.6; 40.3, P , 0:05).<br />

The independent factor and cognition factor of the normal<br />

children is far lower than ones of the sick children (that is<br />

52.4; 60.5, P , 0:05:49:3; 57.8, P , 0:05). Analysis: the<br />

sick children is normal in FIQ and ADQ although independent<br />

and cognition Factors maintain certain levels, they are<br />

low value in social/self control Factor, which lead to pay no<br />

attention to what you are doing. Likely, their studies and<br />

lives are irregular. Their social action is unusual.<br />

FP-O-035<br />

Multidisciplinary Tourette syndrome clinic<br />

V. Gross-Tsur, A. Zohar, M. Sadeh, F. Benarrouche<br />

Neuropediatric Unit, Shaare Zedek Medical Center, POB<br />

3235, Jerusalem 91031 Israel<br />

Tourette’s syndrome (TS) is a multifaceted disorder characterized<br />

by waxing and waning tics, both motor and vocal.<br />

ADHD, learning disabilities, OCD and other psychiatric<br />

phenomena are strongly associated with the syndrome. In<br />

order to address the multiple handicaps of children with TS,<br />

our patients are treated by a multidisciplinary team of pediatric<br />

neurologists, psychiatrists, clinical and experimental<br />

psychologists and a social worker. In this presentation we


Abstracts 617<br />

report the clinical characteristics and presenting signs in 60<br />

children (49 boys and 11 girls, ages 9.5 ^ 3.0 (mean ^ SD).<br />

Age of presentation was 5.3 ^ 1.5 years, the full syndrome<br />

(vocal and motor tics for 1 year) became apparent at the age<br />

8.7 ^ 2.3 while the diagnosis was made about 1 year later.<br />

Tics were the presenting sign in 57% of children: 30% had<br />

motor tics, 10% vocal tics and a combination of motor and<br />

vocal tics were seen in the rest. ADHD was the presenting<br />

problems in 30% while OCD was rarer, the presenting sign<br />

in only 3% of children. The first motor tics were eye blinking<br />

(38%) or other facial tics (37%) and the first vocal tics<br />

were throat clearing (53%). During their illness, complicated<br />

motor tics were found in 53% and copralalia in 5%.<br />

Although learning disabilities, interpersonal problems and<br />

behavioral disorders were not presenting symptoms in TS,<br />

they were very prevalent appearing in 65 and 58% respectively.<br />

OCD and ADHD were also very common, occurring<br />

in three quarters of the children. Therapy was multimodal,<br />

58% of TS children received medication and 72% psychological<br />

therapy sometime during their illness. The familialgenetic<br />

element was evident in that family history of TS was<br />

found in 10%, tics in 20% and OCD 6.6%. In conclusion, we<br />

found that the data of our TS patients as a group is very<br />

similar to that of TS worldwide despite the differences in<br />

cultural background and the known heterogeneity in the<br />

characteristics of individuals with TS.<br />

FP-O-036<br />

Clinical features in adult attention-deficit/hyperactivity<br />

disorder among substance abusers<br />

Y. Ding, Y.-F. Wang<br />

Institute of Mental Health, Peking <strong>University</strong>, China<br />

Objective: The present study is conducted to explore the<br />

clinical presentations, psychiatric comorbidities and<br />

psychosocial functioning in adults with ADHD among<br />

non-alcohol substance use disorder population. The authors<br />

reason that if the adult diagnosis of the disorder is a valid<br />

clinical entity, it should be similar to the childhood ADHD<br />

with regard to patterns of psychiatric findings. Methods:<br />

Thirty adults with ADHD and thirty non-ADHD controls<br />

were selected from Beijing Compulsory Detoxification<br />

Center, matched with sex, age, and education. Data collection<br />

included the following: (1) self-report measures of<br />

developmental history, employment history, social history<br />

and ADHD clinical symptoms. (2) Psychiatric interview<br />

using structured assessments included the CDIS for DSM-<br />

IV. (3) C-WAIS for adult used to evaluate the cognitive<br />

function. Results: (1) The mean age of ADHD group was<br />

28.97 (SD ¼ 5.90), and the mean age of control group was<br />

29.33 (SD ¼ 6.18). There was no significant difference in<br />

age (P ¼ 0:815). (2) The clinical core symptoms (such as<br />

attention deficit, restlessness, and impulsive symptoms)<br />

among adulthood ADHD were similar the childhood<br />

ADHD except for some hyperactivity symptoms. (3) The<br />

ADHD subjects were more likely to be with current or past<br />

(childhood) DSM-IV symptoms of ADHD (attention deficit,<br />

restlessness, and impulsiveness) than control subjects<br />

(P , 0.05). (4) ADHD subjects were more likely to diagnosed<br />

with comorbid ODD (60 versus 20%, P ¼ 0:008), CD<br />

(76.7 versus 23.3%, P , 0:001) and APD (60.0 versus<br />

3.3%, P , 0:001) than that in non-ADHD controls. There<br />

was no excess risk for anxiety and affective disorder in<br />

ADHD subjects than control. Furthermore, adult ADHD<br />

group was more likely to having an early onset of age of<br />

non-alcohol substance use disorder (23.53 versus 25.48,<br />

P ¼ 0:069). (5) There was no differences of marital status<br />

and occupation between the two groups. There was no<br />

significant differences in speeding violation, licenses<br />

suspended, crashes between the ADHD group and the<br />

control group. The frequency of drunk driving in ADHD<br />

subjects was significantly higher than that in the control.<br />

Conclusions: (1) The similarities and persistence of<br />

ADHD symptoms from childhood to adulthood collaborate<br />

the validity of the ADHD diagnosis for adults. (2) Adult<br />

ADHD prefer to have more antisocial behaviors including<br />

ODD, CD, and ASPD. (3) It is difficult to distinguish the<br />

psychosocial functioning impairment between ADHD and<br />

substance use disorder.<br />

FP-P<br />

Medical Informatics<br />

FP-P-001<br />

Neurologic: a web-based tutorial for teaching an<br />

anatomical approach to the neurological examination<br />

P.D. Larsen a , S.S. Stensaas b<br />

a <strong>University</strong> of Nebraska School of Medicine, Nebraska<br />

Medical Center, Omaha, Nebraska, USA; b <strong>University</strong> of<br />

Utah School of Medicine, Salt Lake City, UT, USA<br />

The first principle of neurological diagnosis is regional or<br />

anatomical localization. A physician must learn the<br />

elements of the neurological examination and how to logically<br />

and systematically interpret the findings in order to<br />

localize the site of neurological disease. In order to teach<br />

these skills we have developed a web-based tutorial that is<br />

available on the Internet for medical schools and neurology<br />

training programs. The tutorial has seven modules: an introductory<br />

module and six modules based on the components<br />

of the exam (mental status, cranial nerves, coordination,<br />

sensory, motor, and gait). Each module is divided into<br />

four sections. (1) Review of anatomical pathway(s) and<br />

structures being examined; (2) video demonstration of that<br />

portion of the exam; (3) Videos of patients showing corresponding<br />

abnormalities of that portion of the exam; and (4)<br />

self-evaluation: At the end of the tutorial there are unknown<br />

cases for the student to practice on. The tutorial is designed<br />

for use on a fast (T1) Internet connection, not a modem. It is<br />

highly interactive and uses progressively downloaded


618<br />

Abstracts<br />

QuickTime movies. Written text is kept to a minimum and<br />

ease of navigation within the site is a priority. Movies come<br />

with a £ 2 option so that they can be projected in the classroom.<br />

The site lends itself to being adapted to the teaching<br />

needs of classroom instruction as well as self-study. The<br />

tutorial will be demonstrated and discussed at the meeting.<br />

FP-P-002<br />

Can a distance learning programme provide effective<br />

training in paediatric neurodisability?<br />

V.A. Harpin, C.R. Pullen, H.A. Davies, S.M. Gentle, D.M.<br />

Hall<br />

Sheffield Childrens Hospital, Sheffield, UK<br />

Training in paediatric neurodisability in the UK was felt<br />

to be patchy and difficult to obtain for many trainees. This is<br />

incompatible with an increasing clinical need. In Sheffield<br />

we have developed a 2 year distance learning programme to<br />

provide core training in a co-ordinated way. Twenty<br />

Students began the Course in September 2000, supported<br />

by 14 tutors. The Course consists of 12 written modules (one<br />

every 2 months) and four residential courses with local<br />

practical visits. Trainees are evaluated by a written assessment<br />

per module and three further assessments. Trainees<br />

evaluated each module for usefulness and level of teaching<br />

(1–6) and each residential session for relevance and enjoyment<br />

(1–5 scale). Tutors are also providing feedback. Overall<br />

feedback has been very positive. The course is felt to be<br />

demanding and thorough. Most students consistently feel<br />

material is at the right level and useful/very useful. Individual<br />

students find different modules most useful/hardest<br />

depending on experience and their own needs. Residential<br />

sessions scored consistently highly. Teaching content<br />

scored very good to excellent throughout and the chance<br />

to meet other trainees and tutors was highly valued. Eighteen<br />

of 20 students remain on the course. One is retraining in<br />

child psychiatry. One has deferred to the next group because<br />

of personal reasons. We will present details of course development<br />

and evaluation. A distance learning course can<br />

provide a good core training in neurodisability and we<br />

feel this kind of format could be used by other specialties<br />

and in other countries.<br />

FP-Q<br />

Oriental Medicine<br />

FP-Q-001<br />

Acupuncture and facilitation technique in the treatment<br />

of cerebral palsy in children<br />

J.-G. Cao, X.-Z. Guo, H.-Y. Lu<br />

Faculty of Pediatrics, Shanxi Medical <strong>University</strong>, Taiyuan,<br />

China<br />

Objective: To explore the effect and influential factors of<br />

acupuncture and facilitation technique in CP children.<br />

Methods: A total of 246 CP were treated by acupuncture<br />

and facilitation technique. Movement function was evaluated<br />

before and after treatment. Results: Ninety-five cases<br />

had significant effect, and 127 cases had effect. Among<br />

them, 34 cases were normalized. The effective rate was<br />

90.2%. Curative effect is related to the age of starting treatment,<br />

sustained course, type, severity of diseases, and<br />

complications. Conclusion: Combined acupuncture with<br />

facilitation technique can promote rehabilitation in CP.<br />

The earlier and the longer the treatment, the better will be<br />

the effect.<br />

FP-Q-002<br />

Successful prevention of relapse in a child with multiple<br />

sclerosis using oriented herbal medicine (Sairei-to)<br />

S. Yamazaki, H. Yoshikawa, T. Abe<br />

Department of Pediatrics, Niigata City General Hospital,<br />

Niigata Japan<br />

Since the age of 3, a 9-year-old Japanese girl developed<br />

recurrent aseptic meningitis, optic neuritis, brainstem<br />

dysfunction and convulsions. At the age of 4, she suffered<br />

from aseptic meningitis and optic neuritis, and brain MRI<br />

revealed high intensity lesions in the white matter on T-2<br />

weighted images. The titers of anticardiolipin antibody was<br />

also elevated. She was diagnosed as having MS associated<br />

with positive anticardiolipin antibodies. In each episode of<br />

MS relapse, the administration of corticosteroids was effective<br />

in stopping the symptoms. However, corticosteroids<br />

had no preventive effects for MS relapse. At age 6, with<br />

the informed consent of her parent, we tried using the oriental<br />

medicine, Sairei-to to prevent MS relapse. Following<br />

this, over a period of two years she experienced no relapse<br />

of MS. Some oriental herbal medicines have been reported<br />

as being effective for MS therapy. Seirei-to has anti-inflammatory,<br />

immunoregulatory, anti-allergic, diuretic, and steroid-like<br />

effects, it has also been reported that Sairei-to is<br />

also effective against antiphospholipid antibody syndrome.<br />

These pharmacological properties could work in the prevention<br />

of MS relapse of this patient, who had a positive anticardiolipin<br />

antibody. Sairei-to is considered to be a<br />

worthwhile trial in the prevention of MS relapse.<br />

FP-Q-003<br />

Study on antiepileptic action and immunological<br />

mechanisms of CaoGuo ZhiMu Tang<br />

H. Zhang, L. Wang<br />

Department of Neurology, Baotou Central Hospital,<br />

Baotou, China<br />

Objective: On the basis of ‘fu zheng gu ben’ of Chinese<br />

traditional medicine, the related immunological mechanisms<br />

of the antiepileptic effect of CaoGuo ZhiMu Tang


Abstracts 619<br />

(CGZMT) were studied from gross, cellular and molecular<br />

levels with audiogenic seizure (AGS) rat model. Method:<br />

First, ten Wister rats and 30 AGS rats were randomly<br />

divided into four groups and were peritoneally injected<br />

NS10 ml/kg, CGZMT 10 g/kg, phenobarbital (PB) 50 mg/<br />

kg, respectively. Rats were treated continually for 7–14<br />

days. We measured the antiepileptic effect. Second, the<br />

immunological mechanisms of the rats were studied by<br />

the colorimetry, QHS, 3H-TdR incorporation, MTT analysis<br />

colorimetry. Results: Comparing with model control,<br />

CGZMT could enhance activity of macrophage (MF)<br />

(P , 0:05); accelerate biological activity of IL-2<br />

(P , 0:05). It could enhance proliferation of T lymphocyte<br />

stimulated by concanavalin-A (ConA) (P , 0:05), but its<br />

proliferation of T lymphocyte to ConA was lower than<br />

that for normal control rats (P , 0:05). It could increase<br />

RBC-C3bRR and RBC-ICR and lower proliferation of B<br />

lymphocyte stimulated by LPS. It could also decrease the<br />

levels of antibody forming cell and hemolysin antibody.<br />

Conclusion: CGZMT had antiepileptic effect. It could accelerate<br />

the activity of MF, cell immune function and RBC<br />

adhesion function. This suggested that one of its antiepileptic<br />

mechanisms is improving immune state of the body, i.e.<br />

‘fu zheng gu ben’.<br />

FP-Q-004<br />

Clinical study on efficacy of traditional Chinese medicine<br />

bushen combined with special training program on<br />

mental retardation (MR)<br />

F.-Z. Du, Y.-J. Dou, J.-F. Ding<br />

Rehabilitation Center, Gansu Traditional Chinese Medical<br />

College, Lanzhou, Gansu Province, China<br />

Objective: To observe the effect of traditional Chinese<br />

medicine (Bushen) combined with special training program<br />

on MR. Method: Patients of MR were divided into two<br />

groups (A and B) according to age. Group A (N ¼ 105)<br />

received special education in the assistant study school.<br />

Group B (N ¼ 42) were treated with western medicine,<br />

such as Vitamin B1 and lysine. Group A was randomly<br />

divided into two subgroups (A1 and A2). The 55 cases of<br />

group A1 were treated with Bushen medicine-Xingnaoyizhi<br />

granule (XNYZG) 10 g per dose, which consisting of herbs<br />

including lujiaoshuang, roucongrong, and tianzhuhuang,<br />

etc. This drug was taken orally three and two times a day<br />

in patients above and below 12 years, respectively for 3<br />

months. The 25 cases of group B1 were treated with<br />

XNYZG 5 g per dose, three times a day for 3 months.<br />

Groups A2 and B2 were control groups. IQ and clinical<br />

data were collected before and 3 months after treatment.<br />

Results: The rate of improvement was 21.8% in group A1<br />

and 12.0% in group B1.The rate of improvement was 87.3%<br />

in group A1 and 60.0% in group B1. Both were significantly<br />

higher than in the groups A2 and B2 (P , 0:01). The rate of<br />

improvement in group A1 was significantly higher than that<br />

in the group B1 (P , 0:01). Conclusion: Although there is<br />

no effective method to treat MR, traditional Chinese medicine<br />

Bushen combined with special training program may<br />

be regarded as an acceptable method for treating MR.<br />

FP-Q-005<br />

Effect of ‘Xi Feng Jing Ning Decoction’ on blood<br />

dopamine and immunological function in Gilles de la<br />

Tourette syndrome<br />

Z.-Y. Yu, J. Wang<br />

Department of Pediatrics, China-Japan Friendship Hospital,<br />

Beijing, China<br />

Objective: To study the mechanism of ‘Xi Feng Jing Ning<br />

Decoction’, a traditional Chinese medicine decoction<br />

consisting of 12 kinds of herbs, in treating Gilles de la TS.<br />

Methods: Forty TS were divided into two groups, Xi Feng<br />

Jing Ning Decoction treatment group (XF group, 30<br />

patients) and control group (C group, ten patients). A clinical<br />

observation table was set up to compare the changes<br />

before and after 60 days of treatment. A comparison was<br />

made in the change of blood DA level and IgA, IgG before<br />

and after 60 days of treatment. Results: The response rate in<br />

the XF group was 93.3%. There was no significant difference<br />

between the two groups (P , 0:01). The blood DA<br />

content in both groups was lower after treatment<br />

(P , 0:01). IgG and IgA of the XF group were increased<br />

(P , 0:01) after treatment, but those of the C group had no<br />

increase (P . 0:05). Conclusion: Xi Feng Jing Ning Decoction<br />

can relieve the symptoms and adjust the DA systems<br />

and immunological status of patients with TS. The Decoction<br />

can also decrease attacks of upper respiratory tract<br />

infection and reduce the possibility of TS relapse. This<br />

showed that the traditional Chinese medicine had a promising<br />

future in treating TS.<br />

FP-R<br />

Neurosurgery<br />

FP-R-001<br />

A case report about melanotic neuroectodermal tumor<br />

of infancy in skull<br />

N. Wang<br />

The children’s hospital of Zhejiang, Hangzhou Zhejiang,<br />

China<br />

This article reports a rare tumor named ‘melanotic<br />

neuroectodermal tumor of infancy (MNTI)’. MNTI is<br />

found more than 200 cases in the world from 1918. Our<br />

case is a male 4 months child. There is a growing mass on<br />

his left temple. After CT and MRI examining, it is diagnosed<br />

‘meningioma’. But it is MNTI in pathology. We<br />

check this tumor with immunohistology, and review it in<br />

literature. This case is the fifth in China, and is the first


620<br />

Abstracts<br />

occurred in frontal bone. Generally, MNTI is low grade<br />

malignity. Our case has not recurred about 13 months<br />

after operation. Our conclusion is that thorough operation<br />

is the most important thing in MNTI’s therapy.<br />

FP-R-002<br />

Children’s tuberous sclerosis associated with brain<br />

tumor<br />

H.-M. Jin, L.-P. Sun, N. Bao, J.-M. Zhu<br />

Department of Pediatric Surgery, Xin Hua Hospital, Shanghai<br />

Second Medical <strong>University</strong>, Shanghai, China<br />

Objectives: To explore the diagnosis and treatment of<br />

TSC associated with brain tumor in children. Clinical materials:<br />

Six tuberous sclerosis complexes, four male, two<br />

female, 4–12 years old, have been confronted during last<br />

10 years. CT and MRI scans showed brain tumors located in<br />

lateral ventricle near foramen of Monro. Four were in left<br />

and two in right. Tumors were excised completely in three<br />

cases, partially in two patients. The pathologic findings were<br />

subependymal giant cell astrocytoma. One child who had<br />

concomitant renal tumor accepted gamma radiotherapy.<br />

Results: All cases were followed 1–7 years. Three children<br />

are disease-free after complete tumor removes. One of two<br />

patients with partial resection died of recurrence, and<br />

other’s residual tumor size does not increase. One tumor<br />

has not changed after gamma radiation. Conclusions: TSC<br />

associated with brain tumor can be well diagnosed by CT<br />

and MRI. Craniotomy is the only effective treatment. The<br />

patients with TSC should be followed in order to detect and<br />

intervene brain tumor earlier.<br />

FP-R-003<br />

Microsurgical treatment for hypothalamic hamartoma<br />

causing epilepsy in children<br />

C.-D. Li, S.-Q. Luo, Z.-Y. Ma, Y.-Q. Zhang, Q. Bai<br />

Department of Neurosurgery, Tiantan Hospital, Beijing,<br />

China<br />

Object: To discuss the surgical treatment for hypothalamic<br />

hamartoma causing epilepsy in children. Methods: Six<br />

boys and five girls with epilepsy and hypothalamic hamartoma,<br />

age ranged from 2 to 15-years-old, were reported. The<br />

onset ages were 2 months–14 years. Ten patients presented<br />

with gelastic seizure, six of them also with generalized<br />

tonic-clonic seizures and three with drop attacks. All<br />

patients were treated by microsurgery via a pterional<br />

approach except one via a laminaterminalis approach and<br />

four patients underwent depth electrode encephalography<br />

with electrodes implanted into the hypothalamic hamartoma.<br />

Result: Two hamartomas were totally removed without<br />

any complications, eight hamartomas were gross<br />

partially removed and one was partially removed. All<br />

patients were followed by 16–87 months after operation,<br />

two were completely seizure-free, nine were significantly<br />

reduced the frequency of seizures. Conclusion: With<br />

removement of hamartoma we can effectively treat epilepsy<br />

caused by hypothalamic hamartoma in children.<br />

FP-R-004<br />

Pediatric craniopharyngiomas: surgical treatment and<br />

protection of the hypothalamus<br />

Y.-Q. Zang, C.-C. Wang, Z.-Y. Ma, S.-Q. Luo<br />

Department of Neurosurgery, Beijing Tiantan Hospital,<br />

Beijing, China<br />

Object: With the protection of the hypothalamus,<br />

craniopharyngiomas can be in children safely removed,<br />

total or subtotal. Methods: A total of 142 pediatric cases<br />

were operated with the transcallosal-interseptal-interforniceal<br />

approach, the transfrontal-longitudinal fissure<br />

approach, and other approaches. The methods of protection<br />

and treatment of hypothalamic functions were used<br />

before and after the operations. Results: A total of 133 out<br />

of 142 tumors (93.7%) were removed totally and subtotally.<br />

The complications were diabetes insipidus 129<br />

(90.8%), hypernatremia or hyponatremia 127 (89.4%),<br />

and seizures 4 (2.8%). However, the seizures were fatal<br />

complication. One patient (0.7%) died postoperatively due<br />

to seizures. Conclusion: For total or subtotal removal of<br />

the pediatric craniopharyngiomas, it is important to protect<br />

the hypothalamic functions before, during and after the<br />

operations. The tumors should be operated directly under<br />

a microscope.<br />

FP-R-005<br />

Evaluation of mild closed traumatic brain injury in<br />

children with CT scan: prospective international study<br />

A. Murgio a , D. Fong b , E.J. Herrera a , G. Hotz c , F. Romeo d ,<br />

D. Rocco d , S. Mutluer e , A.F. de Andrade f<br />

a Quintana 1256 – Mar del Plata (7600), Argentina; b China;<br />

c United States; d Italy, e Turkey, f Brazil<br />

Introduction: Traumatic brain injury (TBI) is the leading<br />

cause of death and disability in pediatric trauma. Although<br />

the incidence and mechanism for TBI in children 0–15<br />

years of age varies through the developmental levels,<br />

early diagnosis and treatment may ameliorate the morbidity<br />

and mortality associated with significant intracranial<br />

injury. Objectives: The principal idea was to evaluate,<br />

using an international and multicenter population, the relationships<br />

between severity of injury, risk factor and<br />

imaging findings by attending physicians. Methods: The<br />

present study was a multicenter prospective, randomized,<br />

study of children who serially presented to emergency<br />

departments with head injury. The organizing group and<br />

administrator study is the International Study of Head<br />

Injury Project, which was created in 1996. A total of


Abstracts 621<br />

9460 children were seen between 1996 and 2000, and it<br />

sample was divided in two groups: Phase I (1996–1998)<br />

with 4690 patients and Phase II (1999–2000) with 4770<br />

patients. Each child was seen by medical staff and evaluated<br />

during acute care. A standardized data base sheet was<br />

completed to include general demographics, medical<br />

status, Glasgow Coma Scale score and Pediatrics Score,<br />

neuroradiologic study. Indicators consisted in frequency<br />

counts and tabulations. On follow-up each subject was<br />

given a Glasgow Outcome Score and asked set standardized<br />

questions considered detect functional level and<br />

quality of life. The baseline information and subsequent<br />

outcome score were compared and evaluated. Results: A<br />

total 9460 children, we observed not statistical difference<br />

between two phases, by number and sex. Boys made up<br />

60% (Phase I) and 61.8% (Phase II) of the sample. The<br />

distribution by age was: birth to 2 years (77.1%: first phase<br />

and 40.8% at the second phase); 3–9 years (18.7 and 46%,<br />

respectively) and 10–15 years (4.1 and 13.2%). Use of the<br />

GCS-PGCS score to rate severity of the injuries indicated<br />

that 79.1% were milds TBI (Phase I) and 96.4% (Phase II).<br />

P ¼ ns. The most frequent mechanism of injury was a fall,<br />

which reported in approximately 70% in a two Phases, road<br />

accidents accounted for 20% (Phase I) and 16.8% (Phase<br />

II), the mechanisms in the remaining 10% hit by object,<br />

crush injury, and others. By comparison, head X-rays were<br />

performed in 89 and 88.6% of the children, 89% of the first<br />

group giving normal and 85.1% with 453 (10% ¼ Phase I)<br />

and 629 (14.9% ¼ Phase II) pathologic results. With<br />

respect the CT scan that was ordered, we found difference<br />

between the two groups: 14.3% in Phase I and 53% Phase<br />

II, were 65% of which were normal with 35% labeled<br />

‘abnormal’ and the second phase 71.4% were normal and<br />

the remaining 28.5% labeled ‘abnormal’. Seven children<br />

died (0.15%) at the first phase and three (0.06%) of the<br />

second phase, and 81 underwent some neurosurgical intervention<br />

(1.7% Phase I) and 130 (2.7% Phase II). Most of<br />

the children 91% of the Phase I and 99.8% (Phase II) were<br />

re-evaluated at the follow-up after 3 months. The vast<br />

majority 99 and 99.7% had scores of 5, i.e. good recovery.<br />

Each center participating demonstrated the same tendency<br />

for the vast majority of children to get good recovery<br />

ratings at the local follow-up assessment. Conclusion:<br />

The advantage of the multicenter study is that allows us<br />

a glimpse of practice in varied settings and makes it possible<br />

to compare these experiences with our own. The<br />

present study seems to suggest that some of the beliefs<br />

that govern us in decision-making need review, for example:<br />

the use of ‘older and familiar’ technologies (X-rays) to<br />

determine the need for a more complex evaluation, including<br />

CT. Until more definitive information is available, clinicians<br />

should be liberal in their use of CT so that early<br />

identification of significant intracranial pathology can be<br />

obtained and appropriate management of the injuries<br />

initiated.<br />

FP-R-006<br />

Is a separate cerebrospinal fluid access device useful in<br />

the management of childhood hydrocephalus?<br />

T.-Y.M. Lo, L.M. Myles, R.A. Minns<br />

Department of Child Life and Health, <strong>University</strong> of Edinburgh,<br />

Edinburgh, UK<br />

A retrospective study was undertaken to determine the<br />

long-term risks and benefits of a separate CSF access device<br />

in the management of 52 patients with shunted childhood<br />

hydrocephalus. We compared the usage and complication<br />

after separate reservoir insertion with a pre-reservoir period.<br />

The risks were assessed in terms of the frequency of: (1)<br />

ventriculoperitoneal (VP) shunt infection and ventriculitis;<br />

(2) shunt blockage; (3) access device failure; and (4) other<br />

potential complications such as porencephaly, epilepsy,<br />

hemiplegia, visual and cognitive deficits. The benefits of a<br />

separate CSF reservoir were gauged from the attendances<br />

where the reservoir was accessed to diagnose, treat or<br />

exclude, raised intracranial pressure (ICP) or shunt infections<br />

and ventriculitis. There was no mortality from raised<br />

ICP or CNS infection over a median follow-up period of<br />

19.05 years. Significantly fewer episodes of ventriculitis<br />

(P ¼ 0:0091) and shunt blockage (P , 0:0001) were<br />

found in the post-reservoir study period. There was no hemiplegia,<br />

epilepsy, visual or cognitive loss from the additional<br />

cortical puncture. The reservoir was used for access in 344<br />

attendances for diagnosis or treatment of raised pressure or<br />

CNS infection. We conclude that a separate CSF access<br />

device is very useful in the long-term management of<br />

patients with shunted hydrocephalus and is without mortality<br />

or significant morbidity.<br />

FP-S<br />

Diagnosis/Treatment<br />

FP-S-001<br />

Different dosage regime of penicillamine and urine<br />

copper for hepatolenticular degeneration<br />

Z.-C. Wen, R.-M. Wang, W.-X. Sun, X.-Y. Wang<br />

Shandong Provincial Hospital, Jing Wu Road 324, Jinan,<br />

China<br />

Objective: To determine the dosage of penicillamine in<br />

treating patients of hepatolenticular degeneration. Methods:<br />

Penicillamine with different dosages are administrated to<br />

patients with hepatolenticular degeneration, group 1<br />

(N ¼ 17) small dose (5 , 10 mg/kg per day); group 2<br />

(N ¼ 17) using moderate dose (11 , 16 mg/kg per day).<br />

The followings are monitored: extrapyramidal symptoms,<br />

liver function, hypersplenism, average amount of daily<br />

urine copper of 8 weeks; and observe side effects (including<br />

fever, white blood cell, skin rash, nausea). Results: (1)<br />

Copper excretion in the moderate dose group was better


622<br />

Abstracts<br />

than the small dose during the first 6 weeks of treatment<br />

(P , 0:01). (2) After 6 weeks, the copper excretion effects<br />

of the two groups were the same (P . 0:05). (3) The side<br />

effects of the two groups were not different. (4) The clinical<br />

symptoms were identical with above three conclusions.<br />

Conclusions: We recommend using moderate dose of penicillamine<br />

in treating patients with hepatolenticular degeneration<br />

in the acute stage (the first 6 weeks) and small dose<br />

after acute stage (after 6 weeks).<br />

FP-S-002<br />

Comparison of topamax with valpronic acid,<br />

carbamazepine and phenobarbital in the treatment of<br />

childhood epilepsy<br />

Y.-Q. Zhong, J. Wu, M. Wu, X.-L. Xie, W.-G. Hu, W.-Z.<br />

Zhou<br />

Chengdu Children’s Hospital, Sichang, China<br />

Objective: To compare the efficacy of adverse reactions<br />

of TPM, VPA, CBZ and PB in children. Method: Single<br />

drug regimens were used to treat 194 newly diagnosed<br />

cases of epilepsy in a prospectively designed non-randomized<br />

parallel control trial (TPM 63, VPA 61,CBZ 34 and<br />

PB 36 cases). The dosage of TPM was 0.5 , 1 mg/kg per<br />

day initially, increased gradually to 2 , 8.5 mg/kg per day<br />

later. The median follow-up duration was 12.2 months.<br />

Therapeutic efficacy and adverse reactions of the drugs<br />

were closely observed during follow-up period. Result:<br />

Complete control of epileptic attack was observed in 58.7,<br />

57.4, 50 and 52.8% of cases in TPM, VPA, CBZ and PB<br />

groups, while unfavorable results were seen in 6.3, 4.9, 2.9<br />

and 8.3%, respectively. The original regimens had to be<br />

discontinued in 19.1% cases owing to unsatisfied efficacy,<br />

untoward reaction or economic reason. The untoward drug<br />

reaction incidence of TPM was similar to CBZ and PB, but<br />

slightly higher than VPA, whereas the severity of which<br />

seemed to be the least among the four drugs. Conclusion:<br />

The use of TPM alone in the treatment of childhood<br />

epilepsy showed similar efficacy to other commonly used<br />

drugs, while its untoward reaction was relatively mild.<br />

FP-S-003<br />

Family rehabilitation on 15 children with cerebral palsy<br />

Chun-Xiang Li, Xue-Mei Liu, Ning-Bo Tang, Qing Chu, Li-<br />

Xia Li<br />

Department of pediatrics, Yantai Yuhuangding Hospital,<br />

Sandong Province, Yantai China<br />

Objective: To study the effect of family rehabilitation on<br />

children with cerebral palsy. Methods: The destination and<br />

scheme of rehabilitation were drawn up after 15 children<br />

with cerebral palsy had been evaluated systematically.<br />

Rehabilitation education and operation training were carried<br />

on to family trainers. Training contents included proper<br />

posture of holding in the arms and lying and training of<br />

exercise and speech. The patients were followed up once<br />

a month, whereas for those outside this city were followed<br />

up once every 2 months. When the patients were seen again<br />

they were evaluated again, their treatment effects were<br />

observed and the training scheme corrected if necessary.<br />

All cases were followed-up 1 year. Results: Three cases<br />

were nearly normal, ten cases were effective and two<br />

cases ineffective. Conclusions: Family rehabilitation is an<br />

effective, economic, and easy method for children with<br />

cerebral palsy.<br />

FP-S-004<br />

An open trial of flunarizine on therapy in children with<br />

migraine<br />

C.-Y. Zeng<br />

First Hospital, Guangzhou Medical College, Guangzhou,<br />

China<br />

Objective: To assess the efficacy and safety of flunarizine<br />

(sibelium) in children with migraine. Methods: Flunarizine<br />

was administered to 30 children with migraine, 5 mg every<br />

night for 2 months–1 year. Results: The effectiveness was<br />

20% after 1 week, 50% after 4 weeks, 80% after 12 weeks,<br />

TCD abnormalities were improved in 18 cases after 3<br />

months of therapy. Conclusion: Flunarizine is an effective<br />

therapeutic drug in children with migraine.<br />

FP-S-005<br />

Efficacy of topiramate (TPM) in refractory childhood<br />

epilepsies<br />

L. Cvitanovic-Sojat a , B. Mucic-Pucic a , S. Miskov b ,Z.<br />

Sabol c , T.F. Hajnžić a , M. Mataija a , T. Sojat a<br />

a Departments of Pediatrics and b Neurology, UH ‘Sestre<br />

milosrdnice’, c Outpatient Clinic ‘Dr. Sabol’, Zagreb, Croatia<br />

Objective: To analyse the efficacy and tolerability of<br />

TPM in children with refractory epilepsies. All patients<br />

treated with TPM had first failed trials of conventional antiepileptic<br />

drugs, some of them were treated with LTG, VGB,<br />

GPB, corticosteroids and IV globulins. Subjects and methods:<br />

We performed a retrospective study of 35 PTS patients<br />

(14 girls and 21 boys). The age range was 3, 5–17 years in<br />

32/35 and 8–10 months in 3/35. In 22 patients, epilepsy was<br />

complex partial, in two myoclonic, five had Lennox-Gastaut<br />

syndrome, multiple seizure types in three children and three<br />

had infantile spasms (IS). Epilepsy was symptomatic in 17/<br />

35 and idiopathic/cryptogenic in 18/35. TPM was administrated<br />

as add-on therapy, it was titrated to target dose of 6–<br />

9 mg/kg per day. The duration of follow-up was 6 months–3<br />

years. During the titration and maintenance phase we evaluated<br />

the seizure frequency, side effects and EEG in all<br />

patients, and visual evoked potentials in 20/35. Results:


Abstracts 623<br />

Seventeen/35 patients became seizure-free, among them<br />

one had IS. A seizure reduction .75% was observed in 6/<br />

35 patients, between 50 and 75% in 4/35, less than 50% in 4/<br />

35. Two/35 patients had seizures only during febrile illness<br />

and two patients with IS had their seizures unchanged.<br />

Twelve/35 patients were switched to monotherapy from<br />

add/on therapy. Side effects noted were transient change<br />

in appetite in 2/35, hyperactivity in 1/35, and hypochidrosis<br />

in 2/35. Conclusion: This report indicates that TPM was<br />

well tolerated, no serious side effects were noted. TPM<br />

was effective as add-on and monotherapy in refractory<br />

childhood epilepsies.<br />

FP-S-006<br />

Treatment of self-induced photosensitive epilepsy with<br />

dopamine agonist<br />

M. Horikawa a , R. Iwanaga b , E. Ohtaki c , T. Yamada a ,K.<br />

Tominaga a<br />

a National Higashi-Saga Hospital, Saga, Japan;<br />

b Asou<br />

Iizuka Hospital, Iizuka, Japan; c Koguma Gakuen, Ogouri,<br />

Japan<br />

We report a 9-year-old girl with self-induced photosensitive<br />

epilepsy in which bilaterally synchronous 3–4 Hz<br />

spike and wave discharges (SWDs) were induced by twirling<br />

of her hands in front of her face while facing the sun.<br />

She drooled in an absent-minded manner after turning her<br />

hands round and round, and on a few occasions she showed<br />

a transition to generalized tonic-clonic spasms. Selfinduced<br />

photosensitive epilepsy is notoriously resistant to<br />

therapy. We used dopamine agonist. A total of 5 mg<br />

bromocriptine mesilate, three times/day, was added to the<br />

previous medication (valproate 1 carbamazepine). After<br />

that, she lost consciousness less frequently and became<br />

unable to develop generalized convulsions although the<br />

hand movements persisted. However, the SWDs induced<br />

by the hand movements were still observed on EEG. It has<br />

been reported that high-frequency photic stimulation in<br />

cats significantly reduces the cortical release of dopamine<br />

and that this is not a phenomenon restricted to the visual<br />

cortex. It is thought that decrease in cortical release of<br />

dopamine during photic stimulation, as observed in cats,<br />

is probably a crucial physiopathological step in epileptic<br />

photosensitivity in man.<br />

FP-S-007<br />

Topiramate add-on or monotherapy in infantile spasms<br />

D.-C. Jiang<br />

Children’s Hospital, Dalian, China<br />

Objective: To study the effect, dosage, and adverse<br />

events of TPM in treating infantile spasms, either used as<br />

monotherapy or an add-on therapy. Methods: Eleven<br />

patients with infantile spasms were treated with TPM to<br />

a course of 4–13 months. Seven cases were used TPM as<br />

monotherapy. The patients were started at a dose of 12.5<br />

mg per day, which was increased by 12.5 mg every 3 days.<br />

Four cases used TPM as add-on therapy, but they were<br />

substituted by VPA and clonazepam for undesirable<br />

control. The clonazepam was used at a dose of 0.66 mg/<br />

day and increased gradually. Results: (1) Three gave up<br />

treatment due to the side effect and unknown reason. (2)<br />

There were a 50% or greater reduction from baseline in<br />

seizure frequency shown in 91% cases, and seven cases<br />

showed no free seizure including four cases using TPM<br />

and clonazepam. (3) Adverse reactions: one patient had<br />

impairment of verbal language, and another failed to<br />

sweat in hot days. Conclusion: TPM is an effective and<br />

safe drug used as monotherapy or with clonazepam in<br />

infantile spasms.<br />

FP-S-008<br />

Immunoregulation and therapeutic effect of biological<br />

agent in intractable childhood epilepsy<br />

Z. Xu, X. Tian, J.-Y. Lan, D.-F. Sun<br />

Department of pediatrics, the second clinical college of Jilin<br />

<strong>University</strong>, Changchun, China<br />

Objective: We treated intractable childhood epilepsy<br />

(ICE) with biological agents, IL-2 and IV IG, and investigated<br />

their immunoregulatory and therapeutic effects.<br />

Methods: 28 children with ICE were treated with IL-2<br />

and IV IG. Before and after treatment, serum IgA, IgG,<br />

SIL-2R, IL-6, T-cell subsets and anti-brain anti-body<br />

(ABAB) were examined, respectively. According to<br />

frequency of seizures, changes of EEG and improvement<br />

of immunological parameters, the immunoregulatory effect<br />

and therapeutic effect of IL-2 and IV IG were evaluated.<br />

Results: (1) The immune state: the serum IgA levels in<br />

epilepsy group were significantly lower than those in<br />

controls (P , 0:01). SIL-2R and Serum Il-6 levels in<br />

epilepsy group were significantly higher than those in<br />

controls (P , 0:01). The CD 4 /CD 8 ratio in epilepsy group<br />

was significantly lower than those in controls (P , 0:01).<br />

The positive rate of ABAB in epilepsy group was 35.7%<br />

(10/28). The parameters after treatment were statistically<br />

significant difference compared to pretreatment (P , 0:01<br />

or P , 0:05). (2) Therapeutic effect: the patients had been<br />

followed up for 0.5–2 years. The improved rate of EEG<br />

was 82.2%. To assess the parameters together, the markedly<br />

effective rate was 53.5%, effective rate 35.5% and<br />

total effective rate 89.2%. Conclusion: (1) The patients<br />

with ICE may present with disturbance of immune function.<br />

(2) IL-2 and IV IG have immunoregulatory effects on<br />

the immune abnormalities in patients with ICE. (3) Biological<br />

products, IL-2 and IV IG, have therapeutic effect for<br />

ICE.


624<br />

Abstracts<br />

FP-S-009<br />

Study on the diagnosis of childhood paroxysmal<br />

headache<br />

G.-Q. Li, H.-W. Hu, X.-Y. Ye, Z.-D. Lin, J.-W. Zhao, D.-K.<br />

He<br />

Yuying children Hospital, Wenzhou Medical College, Wenzhou,<br />

Zhejiang, China<br />

Objective: To investigate the differential diagnosis of<br />

childhood paroxysmal headache. Methods: Clinical data of<br />

122 patients with paroxysmal headache in our hospital<br />

outpatient service were analyzed. The case history, physical<br />

examination, EEG video electroencephalography (V-EEG),<br />

and transcranial Doppler (TCD) were analyzed. The patients<br />

were followed up. Results: Migraine was found in 85 of the<br />

122 patients, tension headache in 35, headache epilepsy in<br />

one, and intracranial tumor in one. Most EEG and V-EEG<br />

was normal. There was increase of diffuse slow wave, and<br />

only one of above abnormal EEG showing scattered epileptic<br />

waves. In 74 patients, TCD showed significant increase<br />

of cerebral blood flow velocity. Conclusion: Migraine and<br />

tension headache were frequent cause of childhood paroxysmal<br />

headache. The diagnosis should depend on the clinical<br />

manifestation, EEG and TCD findings. Headache<br />

epilepsy is rare. We need to differentiate headache epilepsy<br />

from paroxysmal headache only.<br />

FP-S-010<br />

Choice of anti-epileptic drugs for epilepsy caused by<br />

hypoxic-ischemic encephalopathy<br />

S.-W. Yang, H.-L. Yu<br />

Department of Pediatrics, Xianning Central Hospital, Xianning,<br />

China<br />

Objective: To improve the quality of life in patients with<br />

epileptic caused by HIE, to select suitable AED and to<br />

improve control the epileptic attacks. Methods: Retrospective<br />

analysis was performed on 46 cases to detect the different<br />

effect of different anti-epileptic drugs (AED). Results:<br />

Among 19 cases of partial seizure treated with CBZ,<br />

seizures were completely controlled in two cases, in six<br />

other cases the seizures decreased more than 75%. Of the<br />

27 cases of generalized seizure, only three out of 21 who<br />

were treated with PB alone were completely controlled, and<br />

two cases had decreased seizure frequency more than 75%.<br />

In six cases of infantile spasm, five were treated with CZP,<br />

resulting in none being completely controlled or decreased<br />

his seizure more than 75%. One case was treated with Topamax<br />

had its seizure frequency decreased more than 75%. Six<br />

out of 8 cases of partly seizure treated with the addition of<br />

Topamax were completely controlled and two other cases<br />

were decreased their seizure more than 75%. Similar results<br />

were achieved by adding Topamax in both generalized<br />

seizure and infantile spasm. Conclusion: Topamax is an<br />

ideal anti-epileptic medicine to treat secondary epilepsy<br />

caused by HIE.<br />

FP-S-011<br />

Long-term response to zonisamide monotherapy in West<br />

syndrome<br />

Y. Suzuki a,b , H. Ueda a,b , Y. Toribe a,b ,K.Imai a ,T.<br />

Matsuoka a , T. Mano a , T. Nagai a<br />

a Collaborate Clinical Research Group for Pediatric<br />

Neurology, Osaka <strong>University</strong> Medical School; b Division of<br />

Pediatric Neurology, Osaka Medical Center and Research<br />

Institute for Maternal and Child Health, Izumi City, Osaka,<br />

Japan<br />

Aim: To determine the long-term efficacy and safety of<br />

zonisamide (ZNS) monotherapy in patients with West<br />

syndrome. Methods: In our previous study, ZNS (3–12<br />

mg/kg per day) was administered to 54 newly diagnosed<br />

patients with West syndrome (symptomatic 40). Overall,<br />

11 of 54 infants (20%) had cessation of seizures and disappearance<br />

of hypsarrhythmia. These 11 ZNS responsive<br />

patients (symptomatic seven) were the subjects of this<br />

study and eligible to enter a long-term follow-up period.<br />

Results: During the follow-up period (24–79 months,<br />

mean 53 months), this response was maintained in seven<br />

patients (symptomatic three, relapse rate 36%). Seizures<br />

recurred in the remaining four symptomatic patients; three<br />

patients (patients 8—10) had relapses of spasms within 4–<br />

10 weeks after cessation of seizures, and one developed<br />

complex partial seizure 4 years after the initial suppression.<br />

The seven sustained responders had favorable prognosis;<br />

ZNS was discontinued without relapse in two, and five<br />

had normal psychomotor development or only mild impairment<br />

(DQ .70). No serious adverse reactions were noted.<br />

Conclusion: ZNS may be effective and well tolerated for<br />

patients with West syndrome.<br />

FP-S-012<br />

Clinical diagnosis of tuberous sclerosis in children<br />

J.-X. Liao, L. Chen, B. Li, T.-S. Huang<br />

Epilepsy Center and Department of Pediatric Neurology,<br />

Shenzhen Children’s Hospital and Shenzhen Institute of<br />

Pediatrics, Shenzhen, China<br />

Objective: To guide the practical use and to evaluate the<br />

diagnostic criteria for tuberous sclerosis syndrome made by<br />

the National Tuberous Sclerosis Association, the United<br />

States. Methods: The clinical data of 31 children with<br />

TSC features were studied. Results: The age ranged from<br />

2 months to 12 years (median age 2 years 1 month). The<br />

main clinical features of children with TSC were epilepsy,<br />

psychomotor delay, dermatologic lesions (hypomelanotic<br />

macules and facial angiofibromas), subependymal nodule,<br />

cortical tuber, cardiac rhabdomyoma and renal angiomyoli-


Abstracts 625<br />

poma. Of 31 cases 26 had definite TSC, three had probable<br />

TSC and 2 had possible TSC. Conclusion: The commonly<br />

encountered clinical features related to the diagnostic<br />

criteria are dermatologic lesions (hypomelanotic macules<br />

and facial angiofibromas), subependymal nodule, cortical<br />

tuber, cardiac rhabdomyoma and renal angiomyolipoma.<br />

FP-S-013<br />

Topiramate monotherapy in epilepsy of children<br />

W. Wang, J.-M. Li, Y. Chen<br />

Harbin Children’s Hospital, Harbin, Heilongjiang<br />

Province, China<br />

Objective: To observe the effect, dose and side-effects of<br />

topiramate (TPM) monotherapy in children with epilepsy.<br />

Methods: The study was an open-labeled research in 62<br />

children with epilepsy. TPM was administered as monotherapy.<br />

Result: Sixty-two cases were treated with TPM to an<br />

average course of more than 6 months. A total of 88.7% had<br />

50% reduction in seizure attacks and 50% with no attack<br />

occurred. The curative effect of primary epilepsy was<br />

obviously better than secondary epilepsy. TPM monotherapy<br />

may have satisfactory effects. The adverse reaction was<br />

slight and it decreased the titration of dose. Conclusion:<br />

TPM proves to be effective and safe monotherapy with<br />

few side-effects for all types of seizure in children with<br />

epilepsy.<br />

FP-S-014<br />

An open-labeled trial with topiramate in 46 children<br />

with epilepsy<br />

X.-H. Cheng, C. Zhu, C.-Z. Liu<br />

Department of pediatrics, Xiaogan central hospital, HuBei<br />

province, China<br />

Objective: To investigate the efficacy and side-effect of<br />

topiramate as monotherapy and concomitant therapy in children<br />

with different kinds of epilepsy. Methods: An openlabeled<br />

and self-controlled study was conducted in 46 cases<br />

of pediatric epilepsy treated by topiramate. Monodrug therapy<br />

was used in initiative patients and concomitant therapy<br />

was adopted in refractory epilepsy. Results: (1) The effective<br />

rate was 84.8% of all patients with the treatment of<br />

topiramate, seizure attacks decreased 50–74% in two<br />

cases, 13 cases reduced 75–99% and 24 cases were completely<br />

controlled. (2) Seven cases did not have any effect. In<br />

that seven cases, five cases lost contact, one case quitted<br />

because of aggravating of epilepsy. (3) Thirty-seven cases<br />

were treated by monotherapy of topiramate, 33 cases<br />

(89.1%) had satisfied effect; nine cases were under the treatment<br />

of concomitant therapy, four cases (44.4%) had<br />

evident effect. (4) Adverse reaction: dyspepsia and nausea<br />

occurred in 22 cases (47.8%), summer fever-like syndrome<br />

in 22 cases (47.8%), apathy and hypomnesia in 15 cases<br />

(32.6%), lethargy in 11 cases (23.9%), dizziness and gait<br />

imbalance in four cases (8.7%), weight reduction in four<br />

cases (8.7%), polyuria in two cases (4.4%) and rash in<br />

1case (2.2%). Conclusion: Topiramate is a safe and efficient<br />

new anticonvulsant drug. It produced a good curative effect<br />

to different kinds of pediatric epilepsy, and it can be used as<br />

a first-line anticonvulsant drug in children.<br />

FP-S-015<br />

Pallister-Killian phenotype. Diagnostic difficulties<br />

A. López-Lafuente, J. Campos-Castelló, M.-J. López-<br />

Rodríguez, E. Miravet-Fuster, N. Clusellas-Casals, J.<br />

Antich-Femenías, M.-L. Martínez-Frías<br />

Hospital Clinico San Carlos, Calle Martin Lagos S/N,<br />

Madrid, Spain<br />

Introduction: Pallister-Killian syndrome is a sporadic<br />

disorder with multiple congenital anomalies and a wide<br />

clinical spectrum. These anomalies include coarse face,<br />

hypertelorism, epicanthic folds, wide nasal bridge, prominent<br />

upper lip, dysplastic ears, temporal balding, hypotonia<br />

at birth, pigmentary skin anomalies, epilepsy and severe<br />

mental delay. Lymphocytes show a normal karyotype but<br />

a tissue-specific mosaic distribution of an additional<br />

isochromosome 12p often confined to fibroblast is found.<br />

Objective: We report four cases (three males, two of which<br />

were brothers, one female) with Pallister-Killian phenotype.<br />

Karyotype of lymphocytes was normal in all. Chromosomal<br />

analysis in fibroblasts showed tetrasomy 12p in 84.4% of<br />

them in first case, only in 2% in the second case and was<br />

normal in the other two cases. FISH showed three spots in<br />

75% of nuclei in first case, in 2% of nuclei in second and<br />

third cases and was unremarkable in the fourth. These data<br />

confirmed the diagnosis only in the first case but were not<br />

significant enough in the second and third cases. The fourth<br />

case only had a compatible phenotype. We review the clinical<br />

and cytogenetic characteristics of 50 cases reported in<br />

the literature. Discussion: The high percentage of cytogenetic<br />

abnormalities required to make the diagnosis could<br />

seem too strict. The possibility to decrease the diagnostic<br />

criteria should be considered when a compatible phenotype<br />

coexists.<br />

FP-S-016<br />

Diagnosis of attention deficit hyperactivity disorder with<br />

visual evoked potential<br />

L.-Y. Cai, M.-Z. Zhou, J.-H. Li, L.-L. Huang, S.-Z. Hu<br />

Department of Neurology, Jiangxi Children’s Hospital,<br />

Nanchang, China<br />

Objective: To investigate the clinical value of red flash<br />

visual evoked potential (FVEP) used as an index in diagnosing<br />

ADHD. Methods: In 15 cases of ADHD diagnosed by<br />

clinic (CCMD-3-R), red FVEP was tested. Trigger rate was


626<br />

Abstracts<br />

1.2 Hz. Amplitude was weighted 100 times by computer<br />

automatically. Results: According to FVEP P100 amplitudes,<br />

we divided the 15 cases of ADHD into four grades.<br />

Grades I and II (normal) (N ¼ 2 cases); grade III (mild<br />

disorder) (N ¼ 7 cases) and grade IV (N ¼ 6 cases). Diagnoses<br />

by both Red FVEP and CCMD-3-R can be confirmed<br />

in 86.67% of the cases. Conclusions: Red FVEP is a relatively<br />

objective index in diagnosing ADHD.<br />

FP-S-017<br />

Evaluation of medical treatment of late onset vitamin K<br />

deficiency with intracranial hemorrhage<br />

Y.-K. Zhu, Z.-Y. Ren, Y.-H. Liu, L.-J. Dong, Y. Liu, Q.-Z.<br />

Xu, F.-R. Lu<br />

Hospital of Chinese People’s Armed Police Forces, Harbin,<br />

China<br />

Objective: To summarize the prognosis and factors in<br />

medical treatment to late onset vitamin K deficiency with<br />

intracranial hemorrhage, and explore new treatment methods<br />

to change the prognosis. Methods: We studied 124 patients<br />

who suffered late onset vitamin K deficiency with intracranial<br />

hemorrhage in our hospital from 1996 to 2001. Thirty<br />

patients were followed up. Results: Seventy-two cases<br />

(59.5%) were given up for being worse in 1 of 2 days, 12<br />

(9.6%) cases died. Forty cases (32.2%) recovered. Among<br />

patients recovered, thirty were followed up, ten cases DQ<br />

$70 (33.3%), the rest were with low DQ or with cerebral<br />

paralysis, the prognosis was correlated with the severity of<br />

the lesions found by cranial CT. Conclusion: Patients with<br />

late onset vitamin K deficiency with intracranial hemorrhage<br />

had bad prognosis. The doctors in the primary hospitals were<br />

lack in experience of this disease, it was difficult for them to<br />

diagnose and treat this disease at an earlier stage. Medical<br />

treatment cannot get rid of the factors which were closely<br />

related to the prognosis, such as severe intracranial hypertension,<br />

cerebral hernia, and cerebral embolism. Therefore,<br />

early surgical invention may be more important than medical<br />

treatment for improving the affected infants’ living quality.<br />

FP-S-018<br />

The diagnosis and treatment of childhood moyamoya<br />

disease in 19 cases<br />

J. Hong<br />

Beijing Children Hospital, Beijing, China<br />

Objective: To explore the clinical characteristics and prognosis<br />

of childhood moyamoya disease (MMD) and the diagnostic<br />

value of neuroradiological findings. Methods: We<br />

analyzed the clinical data of 19 inpatients with MMD<br />

admitted to our hospital between December 1989 and January<br />

2000. Patients in this study consisted of 13 males and six<br />

females, aged from 2 years to 13 years and 2 months, of<br />

whom 12 cases were beyond 5 years old (63%). We followed<br />

up them for 9 months to 5 years and 4 months (mean 3 years<br />

and 3 months) in 13 cases in terms of residual neurological<br />

symptoms and activities of daily living, etc. Results: The<br />

main clinical symptoms were motor weakness of extremities<br />

or hemiplegia (17 cases), motor-aphasia (11 cases), and<br />

headache (ten cases). Stenosis or occlusion at the terminus<br />

of the siphon portions of internal carotid arteries (ICA) and<br />

proximal portions of anterior or middle cerebral arteries<br />

(ACA or MCA), and abnormal vascular networks in the<br />

brain were noted by the digital subtraction angiography<br />

(DSA) or magnetic resonance angiography (MRA). The<br />

medical treatments were also given in 18 cases. One case<br />

underwent a surgical treatment. We followed up 12 cases<br />

with medical treatments. Neurological impairment was<br />

found in ten cases, motor impairment in six, transient<br />

ischemic attack (TIA) or headaches in two, epilepsy in two,<br />

motor-aphasia in one and intellectual deterioration in five.<br />

The other two cases had a relatively favorable outcome without<br />

neurological sequelae. Of the 12 cases, nine could live on<br />

themselves. The patients with surgery remained absent of<br />

any neurological sequelae or intellectual impairment during<br />

a 2-year and 5-month follow-up period. Conclusions: Motor<br />

weakness of extremities or hemiplegia, motor-aphasia and<br />

headache were the predominant clinical features of MMD.<br />

The findings of MRA or DSA were crucial to the early diagnosis<br />

of the disease. And early diagnosis and timely treatment<br />

contributed to the improvement of the prognosis of MMD.<br />

FP-S-019<br />

Successful treatment of osteopenia with bisphosphonate<br />

in Duchenne muscular dystrophy. Case report.<br />

S. Christerson<br />

Department of Pediatrics, Örebro <strong>University</strong> Hospital,<br />

Sweden<br />

Introduction: Children with DMD often develop osteopenia<br />

from inactivity which is accentuated with loss of ambulation<br />

and the treatment with cortisone make this effect<br />

stronger. Fractures are reported in several studies. Case<br />

report: A 14 year-old boy with DMD was treated with cortisone<br />

0.35 mg per kilo from age 5:5 years until 10:8 years. At<br />

10 years he stopped walking and at 11:1 years he had a<br />

fracture of his right arm. He fell 5 months later and got a<br />

femur fracture. Dual energy X-ray absorbometry (DXA) at<br />

11:6 and 12:6 years showed a BMD 21.9 SD for age at<br />

lumbar spine. He was treated with dinatrium pamidronate<br />

15 mg i.v. once a month for a year. DXA 1 year later showed<br />

an improvement in BMD at lumbar spine with 40%. Side<br />

effects were, at first dose 30 mg, fever, stomach pain and<br />

diarrhea for 2 days. With half that dose there were no side<br />

effects. Discussion: Larson and Hendersson (2000) found<br />

significant decreased bone density in 41 boys with DMD<br />

with loss of ambulation. A total of 44% of the boys had<br />

sustained a fracture and four of nine boys stopped walking<br />

after fracture. Long-term effects of biphosphonates show


Abstracts 627<br />

normal linear growth and lamellar structure of bone. Side<br />

effects exist but are transient. Conclusion: Osteopenia in<br />

DMD can be treated with bisphosphonates, which might<br />

lessen the risk for fractures.<br />

FP-S-020<br />

Idebenone reduces protoporphyrin IX and improves<br />

cardiac function in Friedreich’s ataxia<br />

G.M. Buyse, I. Matthijs, L. Mertens, B. Eyskens, F.<br />

Weidemann, G. Di Salvo, J.L.K. Van Hove<br />

Department of Paediatrics (Neurology, Cardiology, Metabolic<br />

Diseases), <strong>University</strong> Hospital Gasthuisberg, Leuven,<br />

Belgium<br />

Background: In Friedreich’s ataxia (FRDA) no treatment<br />

is currently available despite causative gene and protein<br />

identification. The pathophysiology includes iron-induced<br />

increase in oxidative stress, with secondary deficiency of<br />

mitochondrial Fe-S cluster-containing enzymes such as<br />

ferrochelatase. A recent pilot study in three patients showed<br />

a reduction of hypertrophic cardiomyopathy with idebenone,<br />

a coenzyme Q10 analogue and a free-radical scavenger.<br />

Methods: We conducted a 1 year prospective<br />

therapeutic study with idebenone (5 mg/kg per day) in<br />

seven FRDA patients (age 8.5–27 years). The purpose was<br />

twofold: first, to investigate whether erythrocyte protoporphyrin<br />

IX (normally metabolized by ferrochelatase) is a<br />

therapeutic marker in FRDA, second, to study prospectively<br />

idebenone treatment in FRDA. Neurological function was<br />

assessed using the Cooperative Ataxia Group Rating Scale,<br />

and cardiac function by standard echocardiography and, for<br />

the first time, strain rate and strain imaging, a new method to<br />

quantify regional myocardial function. Results: Baseline<br />

levels of erythrocyte protoporphyrin IX were elevated in<br />

six out of seven patients, and levels decreased significantly<br />

during treatment in all. Idebenone did not improve neurological<br />

function. Long-term idebenone improved left ventricular<br />

mass index, cardiac ejection fraction, and some<br />

regional myocardial function. Changes in protoporphyrin<br />

IX levels did not correlate with changes in cardiac parameters.<br />

Conclusions: Thisisthefirst report showing that<br />

erythrocyte protoporphyrin IX is a potential therapeutic<br />

marker in FRDA. Our results indicate that long-term idebenone<br />

can improve cardiac function in FRDA. Cardiac strain<br />

rate and strain imaging is a sensitive method for therapeutic<br />

assessment in FRDA.<br />

FP-S-021<br />

Selective serotonin reuptake inhibitor (fluvoxamine)<br />

treatment for post-encephalitic Kuver-Bucy syndrome<br />

T. Usuugi, Y. Saito, S. Yanagaki, O. Mayu, E. Yazaki, H.<br />

Mithizu, H. Katumori, K. Hayashij, M. Osawa<br />

Department of Pediatrics, Tokyo Women’s Medical <strong>University</strong><br />

Tokyo, Japan<br />

Kluver-Bucy syndrome (KBS) is a rare amalgamation of<br />

cognitive, emotional and behavioral symptoms seen<br />

following insult to the bilateral temporal lobes. To date,<br />

effective treatment for KBS has not been established in<br />

children or in adults. We encountered a 3-year-old-girl<br />

suffering from KBS following acute encephalopathy with<br />

prolonged status epilepticus. She demonstrated most<br />

features of KBS, including hyperorality (i.e. a strong<br />

urge to put non-food items into her mouth), visual agnosia,<br />

language disorder with aphasia, placidity and memory<br />

dysfunction. MRI revealed marked bilateral frontotemporal<br />

atrophy. TRH (1 mg/day) injection therapy for<br />

2 weeks or daily carbamazepine (maximum 20 mg/kg per<br />

day) therapy failed to improve these behaviors. We treated<br />

her with a selective serotonin reuptake inhibitor, fluvoxamine,<br />

for the KBS-associated symptoms. After treatment<br />

with fluvoxamine (maximum 2 mg/kg per day) plus carbamazepine,<br />

the hyperoral behavior markedly decreased<br />

within 1 month, and fluvoxamine could be stopped after<br />

3 months without relapse. Although the precise pathophysiological<br />

mechanisms of KBS symptoms have not been<br />

elucidated, it is hypothesized that these neurobehavioral<br />

symptoms result from disturbance of specific temporolimbic<br />

networks, including the medial and lateral limbic<br />

circuits. The temporo-limbic networks interface with multiple<br />

cortical and subcortical circuits that care modulate<br />

emotional and behavioral symptoms. The serotonergic<br />

systems of these networks might play a role in the KBSassociated<br />

neurobehavioral symptoms, particularly in<br />

hyperorality in children.<br />

FP-S-022<br />

The clinical features and treatment of cerebral<br />

cavernous angiomas in children<br />

J. Xie, Z.-Y. Ma, S.-Q. Luo<br />

Department of Neurosurgery, Beijing Tiantan Hospital,<br />

Beijing China<br />

Objective: To discuss the clinical features, diagnosis<br />

and treatment of paediatric cerebral cavernomas. Methods:<br />

Over the past 11 years, 30 children with cerebral cavernous<br />

angiomas were reviewed. Twenty-seven were operated.<br />

Results: There were 25 boys and five girls. The<br />

average age was 9.4 years. Epilepsy and focal neurological<br />

deficits due to repeated hemorrhage of lesion were the<br />

most common symptoms. CT scan did not show the<br />

special characters. MRI appearances were mainly high<br />

or complex abnormal signal, with ‘ring sign’ of low signal<br />

on T1, especially T2 around the lesion. DSA did not<br />

reveal the feeding and drawing vessels. The results of<br />

operation were satisfactory. Conclusions: MRI examination<br />

is the best method for diagnosis and follow-up of<br />

cerebral cavernomas. Operation is the first choice for<br />

paediatric lesions.


628<br />

Abstracts<br />

FP-S-023<br />

Paroxysmal dyskinesias: clinical features and etiologic<br />

studies<br />

X.-H. Bao, Z.-Y. Pei, J. Qin, X.-R. Wu<br />

Department of Pediatrics, First Hospital of Peking <strong>University</strong>,<br />

Beijing, China<br />

In order to disclose the clinical feature and the potential<br />

etiology of each kind of paroxysmal dyskinesias, we<br />

reviewed cases with diagnosis of paroxysmal dyskinesias<br />

in the recent 5 years with respect to characteristics of attack,<br />

etiology and treatment response. We evaluated 12 patients’<br />

clinical manifestation, inducing factors, remission, frequencies,<br />

treatment response, etc. Etiologic studies include<br />

video-EEG monitoring, brain MRI/CT, serum ceruloplasmin<br />

level etc. Six belong to paroxysmal kinesigenic choreoathetosis<br />

(PKC), six paroxysmal dystonic choreoathetosis<br />

(PDC). There are family history in one PKC and one PDC.<br />

All patients with PKC were induced by sudden movement,<br />

had shorter duration and higher frequency than that with<br />

PDC. Video-EEG test found epileptic discharge in three<br />

with PKC, no abnormalities were found in patients with<br />

PDC. Antiepileptic drugs were very effective to PKC, and<br />

not useful in PDC. Brain MRI/CT and serum ceruloplasmin<br />

level were normal in all. In conclusion, PKC is different<br />

from PDC in respect of inducing factors, frequency, remission<br />

and the treatment. For PKC, epileptic discharges and<br />

the dramatic response to antiepileptic drugs indicated it<br />

might probably be associated with epilepsy.<br />

FP-S-024<br />

Allopurinol neurocardiac protection trial in infants<br />

undergoing heart surgery using deep hypothermic<br />

circulatory arrest<br />

R.R. Clancy, S.A. McGaurn, J.E. Goin, D.G. Hirtz, W.I.<br />

Norwood, J.W. Gaynor, M.L. Jacobs, G. Wernovsky, W.T.<br />

Mahle, J.D. Murphy, S.C. Nicolson, J.M. Steven, T.L. Spray<br />

National Institute of Neurological Disorder and Stroke<br />

Bethesda, MD, USA<br />

Objective: We conducted a single center, randomized,<br />

placebo controlled trial of allopurinol, an inhibitor of<br />

oxygen free radical production, in infants who underwent<br />

heart surgery using deep hypothermic circulatory arrest<br />

(DHCA). Methods: Allopurinol was administered before,<br />

during and after surgery. Adverse events, including<br />

seizures, cardiac events and coma were monitored. Results:<br />

A total of 318 infants, of whom 131 had hypoplastic left<br />

heart syndrome (HLHS) and 187 had other cardiac disease<br />

(non-HLHS) underwent heart surgery using DHCA. There<br />

was a non-significant treatment effect for death, seizures,<br />

and coma. When cardiac events were added to the primary<br />

endpoint, the allopurinol treatment group experiencing<br />

fewer events (38 versus 60%) in the HLHS stratum,<br />

compared with the non-HLHS stratum (30 versus 27%). In<br />

HLHS surgical survivors, 40 of 47 (85%) allopurinol-treated<br />

infants did not experience seizures, coma or cardiac<br />

events compared with 27 of 49 (55%) controls. Allopurinol<br />

did not reduce endpoint events in non-HLHS infants.<br />

Conclusions: Allopurinol provided neuro-cardiac protection<br />

in higher-risk HLHS infants who underwent cardiac surgery<br />

using DHCA. No benefits were demonstrated in lower risk,<br />

non-HLHS infants. No significant adverse events were associated<br />

with allopurinol treatment.<br />

FP-S-025<br />

Relationship between effect and serum concentration of<br />

loading dosage of phenobarbital in status epilepticus<br />

R.-F. Shi, J. Tian, K.-L. Wang, S.-Z. Sun<br />

Children’s Hospital of Hebei Shijiazhuang, China<br />

Objective: Tofind out the relationship between curative<br />

effect and serum concentration of PB with loading dosage<br />

PB in status epilepticus. Methods: We treated status epilepticus<br />

with intravenous loading dosage of PB at 15 mg/kg<br />

(total dosage #200 mg). We examined serum concentrations<br />

after 10, 15, 25, 30, 60 and 120 min. Results: Sixtyfour<br />

cases were treated, 51 were seizure free in 30 min.<br />

Among them, seizures stopped within 10 min in three;<br />

within 10–15 min in seven; within 15–20 min in 23; within<br />

25–30 min in 18. In 18 cases, seizure frequencies decreased<br />

in 60 min. Six cases showed no responses. In our study, we<br />

examined 180 blood samples. After treatment, serum PB<br />

concentration reached the therapeutic blood level in 15<br />

min. Seizures were controlled after the serum concentration<br />

was above this level. Conclusion: Loading dosage of iv was<br />

highly effective in treating status epilepticus. After 15 min<br />

serum PB concentrations reached the therapeutic blood<br />

level.<br />

FP-S-026<br />

Effects of computerized ultrasonic wave and medium<br />

frequency therapeutic in peripheral facial neuritis in<br />

children<br />

P. Zhang<br />

Department of neurology, Children’s Hospital, Chongqing<br />

<strong>University</strong> of Medical Sciences, Chongqing, China<br />

To explore a new physical treatment which would be safe<br />

and effective for peripheral facial neuritis in Children. Methods:<br />

Forty-one patients with peripheral facial paralysis were<br />

randomly divided into two groups: 25 patients as experimental<br />

groups, received computerized ultrasonic wave and<br />

medium frequency therapeutic apparatus, and 16 as<br />

controls, received electrical acupuncture treatment. The<br />

course of diseases ranged from 1 to 8 weeks. The cure<br />

rate, general effective rate and side effects were recorded.<br />

We considered 20 times treatment as a treatment course and


Abstracts 629<br />

evaluated three times totally for each patient. Facial nerve<br />

function was evaluated according to revised House Brackmann<br />

(H-B) criteria. Results: (1) The general effective rate<br />

in the control group was 62.5% and among them the cure<br />

rate was 37.5%; whereas in the experimental group, these<br />

were 84 and 76%, respectively. Comparison of cure rate<br />

between the two groups showed the difference was significant<br />

(x 2 ¼ 3.8567 , 11.91, P , 0:05 , 0:01). (2) All<br />

patients in the control groups suffered from pain and the<br />

obedience was poor, while nobody in the experimental<br />

groups were upset and the patients expressed good obedience,<br />

as well as their parents. (3) During the treatment, no<br />

infection occurred in two groups. Conclusion: Computerized<br />

ultrasonic wave and medium frequency therapeutics<br />

was better than electrical acupuncture in peripheral facial<br />

neuritis in children. The patients with the apparatus avoid<br />

secondary infection and the danger of pin breaking. There<br />

was nearly no pain. It is a safety and effective physical<br />

treatment for peripheral facial neuritis in children.<br />

FP-S-027<br />

Management of cerebral palsy in Egyptian children with<br />

botulinum toxin type A (BTX-A)<br />

A. Raouf, R.A. Hakim<br />

Police General Hospital, Agooza, Cairo, Egypt<br />

Background: Cerebral palsy is the commonest cause of<br />

physical handicap in children in Egypt, occurring in 3–4 of<br />

every 1000 live births. The most common form of cerebral<br />

palsy is spastic type (88%). Objective: The safety and dosage<br />

of botulinum toxin type A (BTX-A) in children under 2 years<br />

of age were examined in a 18 month period at Police General<br />

Hospital, Cairo, Egypt. Methods: Twenty-two children with<br />

diplegia, aged between 11 and 24 months, were studied. The<br />

average dose was 4–6 u/kg body weight and the interval<br />

between injections was 3–6 months. Results: Significant<br />

improvement in both Ashworth score (P , 0:001) and<br />

ROM (P , 0:01) was achieved and the safety record for<br />

these treatments was excellent. The most commonly reported<br />

adverse effect, apart from local hematoma, was muscle weakness.<br />

Conclusion: Children who respond to BTX-A treatment<br />

have improved physical functioning and gait, and are able to<br />

sustain these results long term.<br />

FP-S-028<br />

Influence of anticonvulsants on carbamazepine diurnal<br />

fluctuation and plasma protein binding in epileptic<br />

children<br />

B. Steinborn<br />

Chair and Department of Developmental Neurology K.<br />

Marcinkowski <strong>University</strong> of Medical Sciences, Poznań,<br />

Poland<br />

CBZ is one of the most commonly used AED. It is<br />

frequently prescribed in combination with other AEDs,<br />

leading to drug interactions. Aim of study was to estimate<br />

pharmacokinetic parameters of CBZ plasma protein binding;<br />

assess diurnal fluctuations in total and unbound CBZ of<br />

epileptic children treated with VPA, LTG, VGB or TPM.<br />

Eighty children, aged 3–18 years were included to the study.<br />

The doses of CBZ did not differ statistically. Blood samples<br />

were taken in steady state before the morning dose and<br />

subsequently every 3 for 24 h. Diurnal fluctuations of<br />

serum concentrations of total and free CBZ during CBZ 1<br />

VPA, CBZ 1 LTG, CBZ 1 TPM and CBZ 1 VGB were<br />

synchronous and in therapeutic range. The fluctuation<br />

index (FI) of total CBZ for polytherapy CBZ 1 VPA and<br />

CBZ 1 LTG were higher than for combination of CBZ 1<br />

TPM or CBZ 1 VGB. Diurnal fluctuations of total CBZ<br />

were prominent than fluctuations of unbound CBZ in comedication<br />

with VPA, LTG or VGB. FI for free and total CBZ<br />

in bitherapy with TPM did not differ statistically. Mean<br />

CBZ free fraction in bitherapy with LTG was 16.4%, with<br />

VGB 15.9% with VPA was 18.2% and with TPM – 21.5%.<br />

The FI for CBZ was the highest in LTG. The increase of free<br />

CBZ in patients treated with VPA or TPM may be a result of<br />

pharmacokinetic interactions between these AEDs.<br />

FP-S-029<br />

Gene therapy to murine MPS VII by human neural stem<br />

cells transplantation<br />

X.L. Meng a , J.S. Shen a , T. Ohashi a,b , S.U. Kim c , Y. Eto a,b<br />

a Department of Gene Therapy, Institute of DNA Medicine,<br />

The Jikei <strong>University</strong> School of Medicine, Tokyo, Japan;<br />

b Department of Pediatrics, The Jikei <strong>University</strong> School of<br />

Medicine; c Division of Neurology, Department of Medicine,<br />

<strong>University</strong> of British Columbia, Canada<br />

Cell therapy to murine MPS VII, authentic model of<br />

human Sly syndrome, caused by the deficiency of the lysosomal<br />

enzyme, b-glucuronidase, was studied. Immortalized<br />

human neural stem cell line, HB2F3, was labeled with EGFP<br />

and transplanted into the lateral ventricles of newborn normal<br />

mouse brain. At 2 weeks after transplantation, EGFP positive<br />

cells were observed to be lining the surfaces of the ventricles.<br />

At 4–6 weeks, some cells migrated to the olfactory bulb, the<br />

striatum and cortex, differentiated into neurons, astrocytes<br />

and oligodentrocytes in vivo. Further, we studied if the<br />

human neural stem cell transplantation is effective for the<br />

treatment of CNS pathology of MPS VII. Human neural<br />

stem cells over-expressing 80 times more b-glucuronidase<br />

activity in vitro were generated by retroviral transduction<br />

which encoding a human b-glucuronidase cDNA under the<br />

CMV promoter. After neonatal intraventricular transplantation,<br />

transplanted cells expressed biological active b-glucuronidase<br />

in the MPS VII mouse brain, which was elevated to<br />

5% that in the wild type mouse in whole brain homogenize at<br />

3 weeks after transplantation. The distribution pattern of the<br />

transplanted cells was similar to that of EGFP expressing


630<br />

Abstracts<br />

cells. Pathological improvement is currently under investigation.<br />

FP-S-030<br />

Topiramate monotherapy in childhood epilepsy<br />

M. Mazurkiewicz-Bel⁄dzińska a , A. Matheisel a , J. Wendorff b ,<br />

G. Ircha b , R. Chmielewski c<br />

a Department of Developmental Neurology Medical <strong>University</strong><br />

of Gdańsk, Gdańsk, Poland; b Department of Child<br />

Neurology, Institute of Polish Mother Health Centre,<br />

L⁄ ódź, Poland;<br />

c Johnson and Johnson Pharmaceutical,<br />

Warszawa, Poland<br />

Introduction: Topiramate is a new antiepileptic agent<br />

with multiple mechanisms of action. It is a broad spectrum<br />

of antiepileptic effect. It can be used for therapy of partial,<br />

generalized seizures and epileptic syndromes. The efficacy<br />

of TPM on monotherapy was evaluated in several clinical<br />

studies, but there are still limited data according to use of<br />

topiramate in monotherapy in children. Materials and methods:<br />

In order to evaluate the efficacy and tolerability of TPM<br />

monotherapy of childhood epilepsy, we analyzed prospectively<br />

two patients on TPM therapy as a first line antiepileptic,<br />

and 16 in whom previous AED was switched to TPM<br />

monotherapy. There were 12 children with symptomatic and<br />

six with cryptogenic epilepsy. Majority of the patients had<br />

partial evolving to secondarily generalized seizures. We<br />

administered TPM according to the slow-titration schema:<br />

initial dose was 0.5–1 mg/kg per day, the dose increased<br />

0.5–1 mg/kg every 10–14 days. The dosage of TPM at the<br />

steady state was 7–11 mg/kg. The mean time on TPM<br />

monotherapy was 10 months. Results: The mean frequency<br />

of seizures before TPM therapy was 1 per month to 2–3 per<br />

day. Seizure reduction was observed in 17 patients, nine of<br />

them were seizure free during the observation. Observed<br />

adverse events were mostly mild and transient. In one this<br />

led to discontinuation of treatment. Conclusions: The use of<br />

TPM as a first-line monotherapy in children with epilepsy<br />

seemed to be valuable and promising.<br />

FP-S-031<br />

Response to topiramate in children with catastrophic<br />

epilepsy syndromes<br />

R. Chmielewski a , M. Mazurkiewicz-Bel⁄dzińska b ,A.<br />

Matheisel b , B. Mańkowska b<br />

a Johnson and Johnson Pharmaceutical, Warszawa, Poland;<br />

b Department of Developmental Neurology Medical <strong>University</strong><br />

of Gdańsk, Gdańsk, Poland<br />

Aim of the study: Several epileptic syndromes in children<br />

are characterized by treatment resistant seizures, progressive<br />

loss of higher intellectual functions and characteristic electroencephalographic<br />

abnormalities. It is well known that<br />

control of seizure results in better intellectual outcome.<br />

The long-term efficacy and tolerability of medication are<br />

important especially in epilepsy. Materials and methods: In<br />

order to estimate the long-term effectiveness of TPM therapy<br />

in children with drug-resistant epilepsy syndromes, medical<br />

records of children with West syndrome (3), Lennox-Gastaut<br />

syndrome (38), myoclonic-astatic epilepsy (3) and severe<br />

myoclonic epilepsy (Dravet syndrome) (3) treated with<br />

TPM were analyzed. Mean age of the patients was 6.8<br />

years (range 7 months–16 years). TPM was administered as<br />

add on therapy with doses ranging 6–10 mg/kg per day. The<br />

mean age of treatment was 12 months and follow up was 18<br />

months. In order to estimate retention rates and factors<br />

predicting successful treatment with TPM we used<br />

Kapplan–Meyer analysis and Gehan tests. Results: A total<br />

of 50% remained in TPM therapy after 12 months of treatment.<br />

The factors which influenced long-term retention rates<br />

were younger age presence of tonic or absence seizures.<br />

Forty-one percent remained in TPM therapy after 18 months<br />

of treatment and seven (37%) of them were seizure free.<br />

Conclusions: Our results showed valuable and long-term<br />

efficacy of TPM in treating drug resistant epileptic seizures<br />

in childhood.<br />

FP-S-032<br />

New antiepileptic drugs in childhood epilepsy – long<br />

term efficacy, tolerability and quality of life<br />

M. Mazurkiewicz-Beldzińska a , A. Matheisel a , B. Mankowska<br />

a , J. Biclicka-Cymerman b<br />

a Department of Developmental Neurology, Medical <strong>University</strong><br />

of Gdansk, Gdans, Poland; b Department of Neurology,<br />

Children’s Hospital, Warszawa, Poland<br />

The long-term efficacy and tolerability of medication are<br />

important in epilepsy. Since 75% of first epileptic seizures<br />

occur before 18 years of age, it is important to have an idea<br />

which drug might have the greatest chance of success in children.<br />

There are a few methods of assessing quality of life in<br />

children with epilepsy. Considering the available methods of<br />

assessing quality of life in epilepsy, we have constructed and<br />

validated a questionnaire for parents children with epilepsy to<br />

estimate the influence of epilepsy on the main aspects of life in<br />

their children, and subsequently, to assess family dynamism.<br />

A retrospective chart review was conducted for epilepsy<br />

patients from our departments who were on lamotrigine<br />

(LTG) (157), vigabatrin (VGB) (79) and topiramate (TPM)<br />

(101). We calculated the retention rates for each antiepileptic<br />

usingKapplan–Meyeranalysis.Thecorrelationbetweentherapeutic<br />

effect and type of epilepsy, age of onset, etiology and<br />

concomitantantiepileptictreatmentwasanalysed.Thetimeof<br />

follow-up was 21 months. After 1 year 69% stayed on TPM,<br />

68% on LTG and 48% on VGB. After 2 years, the retention<br />

rates were 57, 61 and 30%, respectively. The seizure free rates<br />

after 1st year of treatment were 31% for TPM, 28% for LTG<br />

and22%forVGB.Therewasstrongcorrelation between good<br />

LTG effect and absence of CBZ in concomitant therapy, and


Abstracts 631<br />

the presence of generalized seizures. For VGB, correlation<br />

was good between the presence of psychomotor retardation<br />

and better seizure outcome. For TPM, we noticed better<br />

outcome in patients with symptomatic or cryptogenic epilepsies.<br />

The greatest improvement in quality of life in patients<br />

was when their seizures were controlled. Interestingly, it did<br />

not reduce the fear of the parents about child’s general health.<br />

Improvement in the quality of life was reached earliest with<br />

TPM therapy but it lasted longer on LTG therapy. Our results<br />

showed that new antiepileptic drugs can serve as a good treatment<br />

strategy for many childhood epilepsies. They can<br />

provide seizure remission or significant seizure reduction.<br />

They could be considered (in many cases) as the first-line<br />

antiepileptic medications.<br />

FP-S-033<br />

Use of trihexiphenydyl (THP) in dystonic cerebral palsy<br />

– a study of 14 patients<br />

V. Udani, M. Khadye<br />

P.D. Hinduja National Hospital and Medical Research<br />

Centre V.S. Marg, Mahim, Mumbai, India<br />

Dystonic cerebral palsy is a significant problem. High dose<br />

trihexiphenydyl has been used successfully in dystonia due to<br />

other causes. This study was undertaken to assess the effect of<br />

this drug in dystonic cerebral palsy (DCP). Methods: DCP<br />

were identified from our OPD. Those with progressive<br />

diseases were excluded. Our therapist assessed the dystonia<br />

as being functionally handicapping before inclusion. Video<br />

recording was performed using a predetermined plan and<br />

THP started at a minimum dose which was increased if<br />

needed. After 3 months a repeat video recording was<br />

performed. Both video were undated and reviewed by a<br />

blinded observer using the Barry-Albright scale. Results:<br />

Fifteen children (M:F 8:7), median age 8 months were<br />

recruited. Etiology was prenatal in two, perinatal in nine<br />

and postnatal in three. One child was excluded when follow<br />

up revealed a progressive disorder. THP was started at a<br />

median age of 12 m (range 5–144 m). Mean daily dosage<br />

was 9.9 mg/day (range 3–30 mg). Significant improvement<br />

was noted in scores in 13 children though one stopped treatment<br />

due to fever. One child worsened. The main improvement<br />

was in upper limb and neck dystonia. Functional<br />

improvements were noted in all 12 patients who continued<br />

the drug. Conclusion: High dose THP seemed to be effective<br />

for dystonic CP. It seemed to improve functional status and<br />

was well tolerated.<br />

FP-S-034<br />

Infantile spasms in Down syndrome: good response to<br />

short course of vigabatrin therapy<br />

R. Nabbout a,b , I. Melki a , B. Gerbaka a , O. Dulac b ,C.<br />

Akatcherian a<br />

a Department of Pediatrics, Hôpital Hôtel Dieu de France,<br />

Université St Joseph, Beirut, Lebanon,<br />

2 Department of<br />

Neuropediatrics, Hôpital St Vincent de Paul, Paris, France<br />

Purpose: To evaluate the efficacy of VGB in treating<br />

infantile spasms associated with DS and to assess the feasibility<br />

of early withdrawal in order to reduce the possibility<br />

of retinal toxicity. Patients and methods: Five DS children<br />

presenting with IS were treated with vigabatrin as first line<br />

monotherapy in an open prospective study. The mean age of<br />

VGB treatment was 9.9 months (range ¼ 7–14.6 months).<br />

The short term response was evaluated based on clinical<br />

response of disappearance of spasms and of paroxysmal<br />

interictal activity on EEG. VGB was continued in responders.<br />

The treatment was tapered gradually over 1 month<br />

after 6 months in those who were still spasms free. Results:<br />

Four children became spasms free on VGB (75–100 mg/kg<br />

per day) and three responded within 1 week. This response<br />

was maintained during the 6 months in VGB treatment.<br />

After VGB withdrawal with follow-up ranging from 2 to 4<br />

years, none of the responders experienced spasms recurrence<br />

or other types of seizures. Conclusion: Our study<br />

confirmed the efficacy of VGB in Infantile Spasms associated<br />

with Down Syndrome. Moreover, the duration of<br />

VGB treatment can be reduced to 6 months without relapse<br />

of IS. This short treatment might reduce the risk of developing<br />

visual field constriction.<br />

FP-S-035<br />

Analysis on myelin basic protein level in serum and CSF<br />

of infant with intracranial hemorrhage<br />

Y.-Y. Yang, X. He, S.-D. Yang<br />

Neurological and Rehabilitating Department, Guangzhou<br />

Children’s Hospital, Guangzhou, China<br />

Objective: To investigate myelin basic protein (MBP) in<br />

CSF and serum in intracranial hemorrhage (ICH) infant,<br />

study the relation between ICH and quantitative MBP.<br />

Methods: Thirty-eight cases were studied with easy MBP-<br />

ELISA method; study group I (n ¼ 16) were substantial (or<br />

combined with ventricular) hemorrhage, while group II<br />

(n ¼ 22) were non-substantial. There were ten cases in<br />

control group their quantitative MBP in CSF and serum<br />

were tested, then repeated and compared after treatment<br />

for 4–5 weeks. Results: Quantitative values MBP in CSF<br />

and serum in both study groups were significantly higher<br />

than control group (P , 0:01), while values in substantial<br />

group were also significantly higher than non-substantial<br />

one (P , 0:01). MBP levels did not decrease after treatment<br />

for 4–5 weeks. Conclusion: Quantitative test for MBP in<br />

CSF and serum can be used as a biochemical guideline for<br />

the diagnosis to this disease, and helpful in predicting prognosis.


632<br />

Abstracts<br />

FP-S-036<br />

Significance of serum S-100B and NSE of children with<br />

head injury<br />

L.-L. Jin<br />

The pediatric of Tian tan Hospital, Beijing, China<br />

Objectives: To study the significance of measurement for<br />

S-100B and NSE in serum of children with head injury.<br />

Methods: Blood samples were taken shortly after the trauma<br />

(12–24 h) 18 with severe head injury patients (GCS ,8) and<br />

18 minor head injury (GCS .12). Blood was allowed to clot<br />

and after centrifugation for 30 min (3000 g, 4 min) serum<br />

was stored at 2308C for later analysis. Serum protein S-<br />

100B and NSE were analyzed by use of immunoluminometric<br />

assays. In 16 healthy children these markers were<br />

also measured. S-100B and NSE concentrations in serum<br />

of patients and controls were compared. Results: The differences<br />

of serum S-100B and NSE in each group (group 1,<br />

group 2, and controls) are significant. The values of mean<br />

serum S-100B and NSE are as follows: group 1 S-100B:<br />

1.05 ^ 0.52 mg/l, NSE; 69.13 ^ 37.86 mg/l group 2 S-<br />

100B: 0.47 ^ 0.21 mg/l, NSE: 26.14 ^ 13.46 mg/l, controls,<br />

S-100B: 0.19 ^ 0.09 mg/l, NSE: 14.43 ^ 7.70 mg/l.<br />

Compared between groups 1 and 2 S-100B (t ¼ 4:57,<br />

P , 0:01), NSE (t ¼ 4:54, P , 0:01); group 2 and control<br />

S-100B (P ¼ 4:724, P , 0:01); NSE (P ¼ 3:059,<br />

P , 0:01), group 1 and control S-100B (t ¼ 6:569,<br />

P ¼ 0:00); NSE (t ¼ 5:665, P ¼ 0:00). Conclusion: S-<br />

100B concentration was higher in severe head injury than<br />

minor head injury. Median NSE concentration was higher in<br />

patients than controls and severe head injury higher in<br />

patients than that of minor head injury patients. S-100B<br />

and NSE is a useful marker for brain damage and neuron<br />

damage in severe and minor head injury.<br />

FP-S-037<br />

Evaluation of visual-motor Bender-Gestalt perception<br />

test (Bender test) in diagnosis of childhood migraine<br />

I. Frančula, I. Prpić, I. Vlašić-Cicvarić, Z. Korotaj, E.<br />

Paučić-Kirinčić<br />

<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />

Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />

According to IHS 3–5 attacks of headache is required to<br />

fulfil criteria for migraine, which sometimes means a period<br />

of year or more. In order to speed up the diagnosing of<br />

migraine we have analyzed the results of Bender test. Retrospectively<br />

results of the Bender test were analyzed in 24<br />

children with definite migraine diagnosis (according IHS<br />

criteria). There were nine boys (mean ¼ 9.8 age) and 15<br />

girls (mean ¼ 11.8 age). Boys were statistically significantly<br />

younger than girls. No difference between boys and<br />

girls regarding their general intelligence and social background.<br />

The children performed Bender test at an early<br />

phase of the headache (mean ¼ 2 days, SD 1.5 day) and<br />

repeated in a period without headache (mean ¼ 6 days,<br />

SD 2.5). At an early stage after the headache, suspected or<br />

definite organic cerebral dysfunction was found at 20 children<br />

while four had normal results. Bender test performed in<br />

phase without headache revealed only three children with<br />

organic cerebral dysfunction, and the rest of the children had<br />

normal results. There was statistically significant difference<br />

between the results of first and second Bender test measurement<br />

(Fisher test: 0.00015). Our results revealed that visualmotor<br />

capacity is disturbed at children with migraine in an<br />

early phase of headache and it took at least 6 days to normalize.<br />

These findings demonstrated that Bender test may be<br />

used as a rapid and useful diagnostic tool in migraine diagnosis.<br />

One can make safe conclusion of migraine accompanied<br />

by disturbed visual-motor perception. Furthermore, it<br />

was shown that children with migrainous attack need 4–8<br />

days to regain their visual-motor ability which is important<br />

information considering child’s daily school obligations,<br />

particularly reading and writing skills.<br />

FP-S-038<br />

Pontine/extrapontine myelinolysis due to dysequilibrium<br />

syndrome<br />

Ö. Faruk Aydın a ,Ç.Üner b ,N.Şenbil a ,K.Bek c ,Ö. Erdoǧan c<br />

a Departments of Pediatric Neurology and c Pediatric<br />

Nephrology; b Division of Radiology, Dr. Sami Ulus Children’s<br />

Hospital, Ankara, Turkey<br />

Neurological disorders may be seen in end-stage renal<br />

disease patients due to complications of haemodialysis or<br />

peritoneal dialysis. A dysequilibrium syndrome may be<br />

seen, usually soon after or towards the end of dialysis. We<br />

report a patient with pontine/extrapontine myelinolysis due<br />

to dysequilibrium syndrome. The patient had depressed<br />

consciousness, agitation and tremor towards the end of the<br />

second peritoneal dialysis with stupor and hyperactive deep<br />

tendon reflexes. Brain CT scan showed hypodense lesions in<br />

pontine and extrapontine locations without radiocontrast<br />

medium enhancement. After 2 days, the patient had only<br />

memorial deficits. A follow-up Brain CT scan 1 week<br />

later showed a decrease of the lesions in pontine and extrapontine<br />

locations. Central pontine/extrapontine myelinolysis<br />

should be suspected and investigated in the acute<br />

neurological disorders of dialysis patients.<br />

FP-S-039<br />

Complex metabolic therapy at newborns affected by<br />

central nervous system damage<br />

T.A. Djumabekov, B.D. Zhurkabayeva, C.V. Malinina<br />

Children’s Hospital No. 1, Almaty, Republic of Kazakhstan<br />

Objectives: Determining efficiency of a complex hyperbaric<br />

oxygenation and neurometabolic therapy at newborns


Abstracts 633<br />

with hypoxic and ischemic damage of CNS Methods: Eighty<br />

newborns with clinic damage of CNS and with manifestation<br />

of consciousness disturbance of CNS, spoor-35 children,<br />

coma-25 children. Blood circulation and breathing<br />

disturbance, edema of brain symptoms have been identified<br />

by the most of children. The hyperbaric oxygenation had<br />

been prescribed to the main group of children (50 patients)<br />

during 30 min in combination with neurometabolic medicines:<br />

Instenon 1 ml in 5% of glucose solution together with<br />

Actovegin 1000 mg in 24 h. The therapy has been effecting<br />

about 5–10 days. The control group children had only<br />

hyperbaric oxygenation. Results: During complex hyperbaric<br />

oxygenation and neurometabolic therapy had been determined<br />

improvement of rehabilitation processes: the positive<br />

dynamic in neuroreflection sphere, recovery of consciousness,<br />

stabilization of hymodynamic indexes and spontaneous<br />

breathing. The critical condition recovery of<br />

newborns reduced by 2–3 days, lethality was lowered<br />

(comparing with control group) Conclusion: Carrying out<br />

hyperbaric oxygenation and neurometabolic therapy in<br />

combination with Instenon and Actovegin at newborns<br />

with hypoxic and ischemic damage advanced the date of<br />

rehabilitation and also critical Condition recovery. In the<br />

result of this lethality was lowered, staying patients in clinic<br />

was reduced by 3 days. That approves that this method is<br />

advisable for widely using.<br />

FP-S-040<br />

Treatment of movement disorders introducing<br />

homeopathic medicine of original method<br />

T. Osipenko, O. Osipenko<br />

Scientific medical Center on treatment and prophylaxis of<br />

neurologic disability in children, Moscow, Russia<br />

Six courses of treatment have been done in a half year’s<br />

time during 3 years 20 children with movement disorders<br />

from city Pavlodar in country Kasahstan. There were children’s<br />

cerebral paralyses spastic and spastic-hyperkinetic<br />

forms. Complete course of treatment includes: (1) microinjections<br />

biologically active medicaments – homeopathics<br />

medicines by cerebrum compositum, Traumell, coenzyme<br />

compositum (Heel, Baden-Baden) in the perineural, periganglonal,<br />

miomeres and scleromeres points in the spinal<br />

card segmentes, which permits to correlate differentially the<br />

pathological posotonic and motor functions. (2) Scleromere-point<br />

pharmacomassage by Traumel pointment.<br />

After first injection course the changes were fast. Spastic<br />

syndrome and hyperkinesis are significantly decreased. At 3<br />

years children are independently walking and talking.<br />

FP-S-041<br />

Diagnostic criteria for Rett syndrome in children<br />

N.V. Andreyenko, O.I. Maslova, V.M. Studenikin<br />

Division of Psychoneurology, Research Institute of Pediatrics,<br />

Scientific center of Child Health (Russian Academy of<br />

Medical Sciences), Moscow, Lomonosovsky, Russia<br />

Background: A hereditary disease, known as Rett<br />

syndrome, that affects exclusively girls, remains a point of<br />

interest both for neurologists and psychiatrists since it has<br />

been described in 1966 by A. Rett. Goal: The goal was to<br />

determine clinical and diagnostic criteria for Rett syndrome<br />

in pediatric patients. Method: For that purpose we have<br />

observed 22 female patients (aged 1–7 years), using conventional<br />

neurological diagnostic methods, including EEG, CT<br />

and MRT, ultrasonics, etc. Results: Eighteen patients were<br />

diagnosed as having Rett syndrome in our clinic (81.8%).<br />

The main clinical findings in Rett patients were the following:<br />

(1) motor development delay (100%); (2) mental retardation<br />

(100%); (3) manual stereotypy (100%); (4) mild<br />

respiratory distress: episodes of hyperventilation and/or<br />

apnea (86.4%); (5) muscular hypotonicity (86.45); (6)<br />

seizures (72.7%); (7) microcephaly (72.7%); (8) ataxia<br />

(68.2%); (9) induced screams and/or laughter (68.2%);<br />

(10) hypersalivation (68.2%); (11) autism (autistic features)<br />

(54.5%); and (12) bruxism (50.0%), and autoagression<br />

(18.2%). Other (additional) symptoms were not so frequent<br />

or evident. MRI and CT scans revealed cortical atrophy in<br />

frontal-temporal areas of 12 patients (54.5% of cases). Characteristic<br />

EEG findings in Rett patients included quick<br />

complexes ‘peak-slow wave’ configurations with predominant<br />

localization in central areas of the brain. Conclusion:<br />

Our data allow us to conclude, that combination of manual<br />

strereotypy, respiratory paroxysms (apneic spells) and<br />

seizures against the background of developing microcephaly<br />

and progressing disturbances of psycho-motor sphere<br />

should be considered as pathognomonic diagnostic criteria<br />

for establishing the diagnosis of Rett syndrome in children.<br />

FP-S-042<br />

Thallium-201 SPECT in pediatric brain tumors<br />

V. Humbertclaude, J. Chevalier-Tessier, N. Leboucq, A.<br />

Roubertie, B. Echenne, P. Coubes<br />

Department of Pediatric Neurology and Neruosurgery,<br />

CHU Saint Eloi-Gui de Chauliac, Montpellier, France<br />

We retrospectively studied 59 children (4 months–16<br />

years of age). To determine whether Thallium 201 (T1)<br />

SPECT could detect malignant brain tumors and provide<br />

relevant information during follow-up that could not be<br />

derived from MRI imaging. A total of 209 T1 SPECT<br />

were performed. Histological diagnosis was obtained in<br />

each case. Results of T1 SPECT were compared to clinical,<br />

histological and MRI Results. Thallium uptake was considered<br />

significant when the ratio to a homologous region of<br />

interest was equal or superior to two. Twenty-five patients<br />

were studied at the moment of initial diagnosis. Thallium<br />

uptake was present in 16 cases with high grade malignant<br />

tumor. Nine cases with low grade tumor were Thallium


634<br />

Abstracts<br />

negative. A total of 184 T1 SEPCT were realized postoperatively<br />

and/or during medical therapy. SPECT scans<br />

(147) realized in children with absence of tumor recurrence<br />

or evolution on MRI showed absence of Thallium uptake<br />

(true-negative results). In one of these cases, T1 SPECT<br />

permitted the diagnosis of radionecrosis. Thirty true-positive<br />

results were obtained. Thallium uptake was present in<br />

29 SPECT scans realized in children with MRI in favor of<br />

tumoral activity. In one supplementary case. T1 uptake<br />

revealed tumor recurrence 1 month before MRI. False negative<br />

results were observed in two cases, and false positive<br />

results in five cases. Thallium 201 SPECT provided useful<br />

information for the diagnosis and the follow-up of pediatric<br />

malignant brain tumors, even in posterior fossa location,<br />

technically more difficult to study by SPECT.<br />

FP-S-043<br />

Clinical study of treating cerebral palsy with Chinese<br />

and Western medicine<br />

Z.-H. Liu, P.-G. Pan, M. Ma<br />

Pediatric Neurology, Department of Recovery Hospital for<br />

Women and Children, Nanhai, Guang Dong, China<br />

Objective: To investigate the better effective CP rehabilitation<br />

mode and suit the condition of our country. Methods:<br />

To implement modern rehabilitation (western<br />

medicine 1 physic therapist) 1 tradition rehabilitation<br />

(acupuncture, traditional Chinese medicine) 1<br />

rehabilitation mode of home rehabilitation. A total of 300<br />

CP patients of 1–7 years old were randomly divided into two<br />

grouts for clinical study. Results: In the recent period of<br />

treatment group (3 months) there were obvious effects.<br />

Value of big motion, fine action DQ, MQ, GMFM ascended<br />

more than before treatment (P , 0:01). Cranial CT cerebral<br />

atrophy, cerebromalacia recovery normal tare was 26.5%.<br />

There was significant difference (P , 0:01). Conclusion:<br />

Chinese and western rehabilitation mode is better effect<br />

and suit the condition of our country CP rehabilitation<br />

mode.<br />

FP-S-044<br />

Role of botulinum toxin in cerebral palsy<br />

P.A.M. Kunju<br />

Department of Pediatric Neurology, Medical College<br />

Trivandrum, Kerala, India<br />

We have tried botulinum toxin A (BT) for spasticity<br />

(diplegic, hemiplegic or choreoathetosis) management in<br />

15 children with cerebral palsy. Ten of them had severe<br />

spastic diplegia, three had hemiplegia and two had athetosis.<br />

All children were undergoing physiotherapy with monitoring<br />

of their baseline status for 6–24 months before BT injection.<br />

Six of them were walking with varying disability and<br />

nine were either sitting and standing with support only.<br />

Twelve had calf muscle spasticity leading to equinus deformity,<br />

ten had scissoring due to adductor spasm and nine had<br />

flexed knee posture due to hamstring spasm. Two of them<br />

were having very limited range of movement at ankle and<br />

knee. Target muscles identified by functional spasticity<br />

assessment or by EMG guidance. The mean follow-up<br />

time was 25 months. Post injection, intensive physiotherapy;<br />

splinting orthoses and other appliances were done<br />

either by the advice of physiatrist or by the author himself.<br />

Response parameters included changes in muscle tone<br />

assessed by the modified Tardieu scale, periodic observation<br />

of longitudinal gait parameters as well as parental assessments<br />

of improvement. Gait recording was done on videotape<br />

for eight patients. The effect was evident as early as 3–5<br />

days. The peak effect was noticed by 1–2 weeks in the<br />

majority; the effect lasted for 3–10 months. In five of<br />

these patients a repeat injection was done during a varying<br />

period of 4–9 months by the suggestion of relatives, as they<br />

wanted to consolidate the positive response in spite of the<br />

high cost of the treatment. All children except two with<br />

fixed contractures experienced decreased spasticity scores,<br />

scissoring, equinus deformity and improved mobility. Three<br />

non-ambulatory children became ambulatory with assistance<br />

and five with assisted ambulation became more independently<br />

mobile. Video analysis revealed comparative<br />

improvement. Ability to rise from sitting to standing also<br />

demonstrated improvement. No positive response to choreoathetosis<br />

noticed. Remote effect like improvement in<br />

drooling and swallowing also noticed. None of the children<br />

had any untoward side effects. Botulinum toxin is useful in<br />

treating spasticity of CP. Pretreatment patient observation<br />

and assessment is very important, Post treatment physio and<br />

appliances helps in consolidating the results.<br />

FP-S-045<br />

The efficacy of a newly-developed of a newly-developed<br />

package for the promotion of motor patterns<br />

M.T. Joghataei, G.R.H.P. Nezhad<br />

<strong>University</strong> of Social Welfare and Rehabilitation Sciences,<br />

Tehran, Iran<br />

How to deal with spasticity and flaccidity in the upper and<br />

lower limbs of the cerebral palsy child has always been a<br />

very unquenchably controversial issue in the field of rehabilitation<br />

of the cerebral palsy client. A demanding research<br />

area has been the comparison of various inhibitory and<br />

facilitatory techniques in dealing with tone disorders. The<br />

commonly practiced methodologies such as the Bobath<br />

method are well known to the profession. More recent<br />

attempts have, however, turned toward the promotion of<br />

more active functioning on the part of the child, whose<br />

main premise is that sound rehabilitation depends less on<br />

passive or assistive measures and more on independence<br />

through the implementation of client-controlled selfinitiated<br />

goals. The advent of sensory rooms has been a


Abstracts 635<br />

great revolution in the field. In such rooms, the child is<br />

presented with a multitude of sensory stimuli and feedbacks<br />

in order to receive compact sensory stimuli and provide<br />

proper responses to those various stimuli. However, a<br />

demerit of sensory rooms is that they demand general movement<br />

patterns (combinations of motions in different joints of<br />

the upper limb, for instance), which are not necessarily<br />

remedial to the pathological patterns and movements<br />

made by the child, but detrimental in many cases as the<br />

main goal of the use of sensory rooms is mere mobility<br />

and there is no strict control of the abnormal patterns,<br />

where the child tries to, for instance, touch a certain pad<br />

to have a specific sound heard, and may over try and make<br />

the involved muscles more spastic than they actually are.<br />

The present article is the report of the results of a 2-year<br />

research project conducted at the <strong>University</strong> of Social<br />

Welfare and Rehabilitation Sciences in Iran to develop an<br />

electronic package which aimed to have the merits of a<br />

typical sensory room and dispose of its demerits. As regards<br />

the description of the package, it consists of an attachment<br />

kit, which is a combination of pads and straps attached to the<br />

neighboring levers of the given joint (for example, forearm<br />

and arm in the case of the elbow). The pads contain certain<br />

sensors which will record the initial posture of the joint and<br />

signal the flexion/extension attempts of the client after the<br />

‘game’ starts. The ‘brain of the package’ consists of a<br />

keyboard which gets the orders from the therapist. Orders<br />

might include the assignment of the type of feedback to be<br />

presented when a certain motor attempt was reported. These<br />

include beeps, bells ringing, songs, and recorded messages<br />

such as ‘well-done’ as auditory reinforcers and lights of<br />

different color to be displayed on the light-boards of the<br />

package mounted onto the wall in the child visual field as<br />

visual feedbacks (other accessory parts provide the child<br />

with tactile feedbacks such as a breeze blown out of a<br />

small fan). The keyboard also gets orders as to what movement<br />

patterns to reinforce (flexion or extension). Packs of<br />

different sizes have made the kit versatile for all the joints of<br />

the extremities. Utilizing the above package as the instrument,<br />

a true experimental study was carried out to investigate<br />

the performance of this package compared with that of:<br />

(1) traditional facilitatory/inhibitory techniques; and (2) a<br />

typical sensory room. The study was designed for the<br />

following purposes: (1) to find out the possible challenges<br />

to the use of the package. (2) To compare the efficacy of the<br />

package with that of other measures in diminishing spasticity.<br />

(3) To compare the efficacy of the package with that of<br />

other measures in increasing mobility. (4) To cross-compare<br />

the effect of only auditory/only visual/and auditory and<br />

visual feedbacks combined. Ninety-six spastic CP children<br />

of both sexes aged between three and nine from twelve<br />

clinics located in southern and northern parts of the city<br />

were selected and assigned to the experimental group and<br />

the two control groups. The experimental group received a<br />

treatment of a 3-month period of rehabilitation with the<br />

above package, while one control group received rehabilitation<br />

in a sensory room and the other by facilitatory and<br />

inhibitory techniques. The three groups were matched on<br />

mobility, spasticity/flaccidity, and normal patterns as the<br />

dependent variables of the study. At the end of the treatment<br />

period, different scales of the above variables were then<br />

plotted, cross-compared, and interpreted. A variety of statistical<br />

techniques were employed to tackle the questions of<br />

the study. These ranged from simple correlations and<br />

ANOVAs through factor and regression analyses to structural<br />

equation modeling and path analysis. Results: Showed<br />

that the mentioned package specifically significantly<br />

reduces spasticity, increases mobility, and enhances motor<br />

pattern normality differently from the two other measures of<br />

the study. Also, it was found that a combination of auditory<br />

and visual feedbacks proved more effective than the other<br />

two choices. Implications and applications are expounded.<br />

FP-S-046<br />

Selective tibial neurotomy for relief of spasticity<br />

focalized to the ankle in children with cerebral palsy<br />

Y.-B. Yu, L. Zhang, Z.-S. Zhou<br />

Department of Neurosurgery, China-Japan<br />

Hospital, Beijing, China<br />

Friendship<br />

Objective: To study the effectiveness of selective tibial<br />

neurotomy for relief of spasticity focalized to the ankle in<br />

children with cerebral palsy. Methods: Fifty-three feet of 37<br />

cases of ankle spasticity in children with cerebral palsy were<br />

treated by microsurgical selective tibial neurotomy from<br />

February 2000 to June 2001. Results: At follow up evaluation<br />

(mean duration: 8.6 months), this study showed that<br />

100% cases experienced disappearance or notable regression<br />

of the spasticity right after operation, and the percentage<br />

in follow-up duration was 94.34%. The improved<br />

motor capacities right after operation were found in 100%<br />

cases, while 94.34% in follow-up duration. One hundred<br />

percent cases had better quality of life by follow-up studying.<br />

Postoperative complications were few, including<br />

dysaesthesias of foot in two cases. Muscle weakness was<br />

not found in all the cases. Conclusions: Selective tibial<br />

neurotomy is an effective and safe microsurgical method<br />

for the treatment of ankle spasticity in children with cerebral<br />

palsy.<br />

FP-S-047<br />

Early curative effect for neurophysiological treatment of<br />

cerebral palsy<br />

Y.-X. Ma, X. Wu, J.-J. Zhang<br />

Harbin Children’s Hospital, Harbin, Heilongjiang Province,<br />

China<br />

Objective: To investigate early curative effect for neurophysiological<br />

treatment of cerebral palsy. Methods: Diagnose<br />

and type classification of cerebral palsy depend on the


636<br />

Abstracts<br />

standard of the first national meeting of cerebral palsy.<br />

There are Spastic type 27 cases, athetosis type five cases,<br />

dystonic type 1 case. We use Vojta method to bring out the<br />

rolling reflex and bow crawl, and use Bobath method to<br />

promote establishing normal posture and reflex. We pay<br />

more attention on motor function, operative ability, and<br />

speech functional training. We evaluate the effect of treatment<br />

according to the GMFM every half a month. Comparing<br />

the results of two evaluation, it is obvious effect if the<br />

score increase more than 20 points; effective if the score<br />

increase 10 , 20 points; no effect if the score increase<br />

,10 points. Results: Obvious effects were observed in 3<br />

cases (all ,1 year old, spastic type), effective in 27 cases<br />

(23 cases ,2 years old, including spastic type 23 cases,<br />

athetosis type four cases). No effect were observed in<br />

three cases (all .3 year old, spastic type 1 case, athetosis<br />

type 1 case, dystonic type 1 case). Conclusions: Early curative<br />

effect for neurophysiological treatment of cerebral<br />

palsy is relative good, especially for the spastic type. The<br />

older children with good speech and intelligence have better<br />

effect.<br />

FP-S-048<br />

Efficacy of GPi stimulation on pantothenate kinase<br />

associated neurodegeneration (PKAN) related dystonia<br />

P. Castelnau a , A. Gannau b , L. Cif b , S. Hemm b , P. Evrard c ,P.<br />

Coubes b<br />

a Pediatric Neurology Service and INSERM 316, Clocheville<br />

<strong>University</strong> Hospital, Tours, 37044 France; b Department of<br />

Pediatric Neurosurgery (Research Group on Movement<br />

Disorders in Children), Gui de Chauliac <strong>University</strong> Hospital,<br />

Montpellier, 34295 France;<br />

c Pediatric Neurology<br />

Service and INSERM E-9935, Robert Debre <strong>University</strong><br />

Hospital, Paris, 75019 France<br />

We evaluated the efficacy of GPi stimulation on the<br />

dystonia of three patients presenting pantothenate kinase<br />

associated neurodegeneration (PKAN) (formerly Hallervorden-Spatz<br />

syndrome). PKAN related dystonia usually<br />

worsens dramatically and becomes life-threatening. Pharmaceutical<br />

therapies are poorly efficient. Our group has<br />

shown long-lasting efficacy of GPi stimulation in DYT1<br />

patients. All three patients (two boys and one girl – mean<br />

age 16 years old) had a typical PKAN clinical history with a<br />

characteristic eye-of-the tiger sign in both pallidum on cerebral<br />

MRI and a progressive generalized dystonia. Pallidal<br />

electrodes were implanted using a Leksell stereotactic frame<br />

with MRI guidance and were activated as previously<br />

reported. Functional improvement of the patients was<br />

assessed using the Burke-Marsden-Fahn dystonia rating<br />

scale (BMFDRS). Patient 1, a boy, was implanted at the<br />

age of 20. Pre and postoperative BMFDRS scores were<br />

respectively 55/120 and 27.5/120 after 9 months followup.<br />

Patient 2, a girl, was implanted at the age of 17. Pre<br />

and postoperative BMFDRS scores were respectively 52/<br />

120 and 21.5/120 after 11 months follow-up. Patient 3, a<br />

boy, was implanted at the age of 10. Pre and postoperative<br />

BMFDRS scores were respectively 86/120 and 55.5/120<br />

after 31 months follow-up. No adverse events were<br />

reported. GPi stimulation provides a long lasting efficient<br />

treatment to limit the progression of PKAN related dystonia.<br />

This procedure is reversible (unlike pallidotomy), it<br />

preserves cognition and remains compatible with other<br />

treatments. Thus, GPi stimulation should be early considered<br />

in such drug-resistant progressive dystonia. The identification<br />

of a pantothenate kinase-based pathogenesis might<br />

provide additional therapies.<br />

FP-S-049<br />

A infantile case of completely treated multiple<br />

intracranial tuberculoma<br />

E.Y. La, C.W. Lee, H. Bang<br />

Department of Pediatrics, WonKwang <strong>University</strong> College of<br />

Medicine, Iksan, Korea<br />

Although the incidence of intracranial tuberculosis in<br />

children have decreased with development of antituberculous<br />

therapy, mortality rate is high as formerly, if not early<br />

diagnosed and treated. Authors report a case of a 5 months<br />

old male with multiple intracranial tuberculoma who have<br />

been accompanied generalized miliary tuberculosis and<br />

tuberculous meningitis. He was hospitalized at the pediatric<br />

department of Wonkwang <strong>University</strong> Hospital with mild<br />

fever and persistent cough. The brain MRI was performed<br />

and showed multiple intracranial micronodular densities,<br />

perinodular edema and diffuse leptomeningeal enhancement<br />

which were disappeared completely after antituberculosis<br />

chemotherapy for 12 months and he had completely recovered<br />

without sequale.<br />

FP-T<br />

Others<br />

FP-T-001<br />

Physiological basis and significance of yawning in<br />

clinical practice<br />

K.B. Kulkarni<br />

Sanjivani Nursing Home, Gwalior (M.P), India<br />

Yawning is an index of dopaminergic function. Dopamine,<br />

a precursor of norepinephrine, is converted to norepinephrine.<br />

The hypothalamus, brain stem, reticular<br />

formation are rich with norepinephrine while dopamine is<br />

abundant in nerve terminals of corpus striatum which derive<br />

from cell bodies in the substantia nigra. Corpus striatum is<br />

involved in complex unconditioned reflexes with somatic<br />

and vegetative components; the latter through direct<br />

connections between subcortical nuclei, reticular formation<br />

and hypothalamus. The corpus striatum contains neurons


Abstracts 637<br />

influencing both sympathetic and parasympathetic nuclei of<br />

hypothalamus. Hence, yawning in diverse and opposite<br />

situations like sleepiness and over excitation, hunger and<br />

empty stomach. My decade long observations on yawning<br />

in children from newborn to 12 year age convalescent from<br />

serious illness – shock of any origin, dehydration, convulsive<br />

disorders, meningoencephalopathy and comatose<br />

states, head injury and hyperpyrexia – indicate that yawning<br />

is a favourable sign meaning the worst is over. Yawning is<br />

non-repetitive, once twice maximally thrice, and mother<br />

rarely notices it hence pediatrician’s careful observation is<br />

vital. Tone of their eyeball muscles improves after yawning<br />

and they remain awake taking interest in surroundings.<br />

Those who sleep do so comfortably like normal children.<br />

Yawning should be considered on different lines in normal<br />

healthy children and those convalescent from serious<br />

illness. Is it a conditioned reflex out of internal environment<br />

like temperature and pH changes, changed osmolality and<br />

osmolarity, effect of prostaglandins and hormones? All this<br />

appears to be grey area in the pathophysiology of yawning.<br />

The role of glomus cells of carotid sinus and Herring’s nerve<br />

also is discussed.<br />

FP-T-002<br />

Neurocutaneous melanosis (a case report and literature<br />

review)<br />

Y. Sun, W.-H. Du<br />

Department of Pediaetrics, The People’s Hospital in<br />

Xinjiang, Urumqi, China<br />

Introduction: Neurocutaneous melanosis is an infrequent<br />

condition characterised by the presence of numerous gigantic<br />

cutaneous naevi and melanocytic infiltration of the CNS<br />

and/or the leptomeningeal layers. Different clinical features<br />

may be seen: intracranial hypertension due to hydrocephalus,<br />

cranial nerve paralysis, myelopathy, seizures, etc. The<br />

prognosis is considered to be malignant. Case report: A7-<br />

year-old boy with widespread pigmented nevi, with benign<br />

self-limiting epilepsy in early childhood and ataxia. He was<br />

followed up for 6 years. Cerebral CT and MR scans were<br />

abnormal. Serial magnetic resonance imaging scans demonstrate<br />

T1 shortening and T2 shortening signals in the hippocampus<br />

and pons, with atrophy of pons and cerebellum.<br />

Conclusions: The clinical course of this boy was relatively<br />

benign. MRI should be done periodically.<br />

FP-T-003<br />

Transient parkinsonism following the ingestion of tea in<br />

a child with familial idiopathic cerebral calcification<br />

H. Yoshikawa, S. Yamazaki, T. Abe<br />

Department of Pediatrics, Niigata City General Hospital,<br />

Niigata, Japan<br />

We report here a normally developed 12-year-old girl with<br />

familial idiopathic cerebral calcification (FICC), who exhibited<br />

transient parkinsonism (TP) over a period of 20 days<br />

following the ingestion of tea. The patient drank a cup of<br />

tea during her elementary school graduation party, this was<br />

her first experience of drinking tea. The next morning, symptoms<br />

which suggested the condition known as parkinsonism<br />

developed, these included progressing rigidity, akinesia, a<br />

mask-like face and dysphagia. These symptoms gradually<br />

worsened. Although routine laboratory examination<br />

revealed no abnormal findings, brain CT revealed multiple<br />

calcification. No other specific etiology was proven, but a<br />

brain CT of her older sister with no symptoms revealed similar<br />

multiple calcification. Therefore, she was diagnosed as<br />

having FICC. After the 6th day following the onset of her<br />

symptoms, her extrapyramidal symptoms gradually faded<br />

and by the 20th day they had disappeared completely.<br />

Patients with FICC have been reported as displaying various<br />

movement disorders, such as parkinsonism or paroxysmal<br />

dystonic choreoathetosis (PDC). Although caffeine is<br />

known to have a possible protective effect against parkinson’s<br />

disease, the TP which developed in this patient could<br />

conceivably have been caused by the ingestion of caffeine,<br />

which was compounded by emotional excitement and fatigue.<br />

On the contrary, caffeine induced PDC, which is different<br />

condition to the one reported on here. There have been no<br />

reports of TP induced by caffeine in FICC, and the mechanism<br />

which caused TP in this patient remains unclear.<br />

FP-T-004<br />

The influences of methylprednisolone pulse therapy on<br />

eurological tatus in children with nephrotic syndrome<br />

C.-Y. Chen, D.-K. Chen<br />

Capital Institute of pediatrics, Beijing, China<br />

Objection: To evaluate the impact of pulse methylprednisolone<br />

treatment (PMT) on the mental and neurological<br />

status in the children suffering from NS. Method: Twentytwo<br />

administrated NS patients needed PMT. We recorded<br />

the change of their stiffness, Babinski sign, Kernig sign,<br />

Brudzinski sign, knee jerk, communication and sleepingtime<br />

before and after PMT. The methylprednisolone dose<br />

was 15–20 mg/kg per day and was given through intravenous<br />

infusion within 1.5–2 h daily for 3 days. Results: No<br />

patients had any changes except one complain mild headache.<br />

Conclusion: PMT is safe for NS children if the dose of<br />

methylprednisolone and the duration of PMT are proper.<br />

FP-T-005<br />

The analysis of detecting in children vascular headache<br />

by transcranial Doppler ultrasound (TCD)<br />

Y. Chen, J.-J. Zhang, S.-H. Li<br />

Harbin Children’s Hospital, Harbin, China<br />

Purpose: To explore the clinical significance of TCD in


638<br />

Abstracts<br />

detecting children vascular headache. Methods: TCD,<br />

TC2020 made in EME Company of Germany was carried<br />

out in 132 patients of children with vascular headache.<br />

Recording the Vm of their MCAACAPCAVA BA and<br />

their PI. Results: In 132 patients detected with TCD128 is<br />

abnormal. The abnormal rate is 96%. The mean blood flow<br />

velocity (Vm) of the basal cerebral arteries is abnormal 104<br />

is high (81%) 24 is low (19%). A total of 936 blood vessels<br />

of 104 children whose Vm is high was detected in total.<br />

MCA is abnormal in 176 of them ACA is abnormal in<br />

141 PCA is abnormal in 73 of them VA is abnormal in 60<br />

of them BA is abnormal in 43 of them. The abnormal rate is<br />

MCA (19%) . ACA (15%) . PCA (8%) . VA<br />

(6%) . BA (4.5%)in turn. A total of 1152 blood vessels<br />

of 132 patients was detected by TCD in total. PI is abnormal<br />

in 34 of them including 14 of them is lower and 20 of them<br />

is higher and the changes of them is not regular. Conclusion:<br />

TCD as a method to detect children vascular headache without<br />

damage simple and reliable. It has the great clinical<br />

value for the diagnose classification and observing the effect<br />

of treatment.<br />

FP-T-006<br />

Diagnosis and follow-up of acute high level cervical<br />

myelopathy in children<br />

B.-M. Wu, H. Wang, W. Zhang<br />

Department of Pediatrics, The Second Clinical College,<br />

China Medical <strong>University</strong> Shenyang, China<br />

High level cervical myelopathy is uncommon, which<br />

may be clinically manifested as dyspnea and high fever<br />

in addition to symptoms as caused by lesions of spinal<br />

cord. In present paper, 30 cases diagnosed as high cervical<br />

myelopathy by laboratory tests of CSF and spine MRI and<br />

intervened in our department from April, 1989 to February<br />

were reviewed. Eighteen were male and 12 female with<br />

age ranging from 11 months to 14 years old. Of the<br />

patients, 21 patients were diagnosed as acute myelitis,<br />

five as anterior spinal artery syndrome, two as hemorrhage<br />

of the spinal cord, two as extramedullary arachnoid cyst.<br />

All the patients showed abrupt onset with tetraparesis,<br />

sensory disturbances, bowel and bladder incontinences.<br />

Eighteen patients had dyspnea, and 14 had fever at the<br />

early stage of the conditions, among whom five cases<br />

manifested as persisted high fever with flush countenance<br />

and dry skin. In 24 patients experienced spine MRI, 14<br />

patients exhibited swelling of cervical spinal cord, two<br />

hemorrhage of the spinal cord, and two extramedullary<br />

arachnoid cyst. Six revealed normal images. In 18 patients<br />

received 1-year follow-up spine MRI scan, six retained<br />

normal, 12 showed slight spinal atrophy. Physical examination<br />

in clinical follow-up showed that 16 patients had<br />

muscle atrophy, upper limb dyskinesia of different degrees,<br />

and normal lower limb.<br />

FP-T-007<br />

Long term follow up after acute stroke in childhood, a<br />

retrospective study<br />

M. Steinlin, K. Roellin, G. Schroth<br />

<strong>University</strong> Hospital Inselspital, Bern, Switzerland<br />

There are only few studies concerning long term neurological<br />

and neuropsychological outcome of children after<br />

acute stroke, but revealing significant problems. Methods:<br />

Retrospective chart review followed by a questionnaire and<br />

clinical examination, concerning initial presentation,<br />

aetiology and long term outcome of children suffering a<br />

stroke between 1985 and 1999, retrieved by a computer<br />

search at the <strong>University</strong> Children’s Hospital of Bern.<br />

Results: Twenty-three children (15 boys) suffered 20<br />

acute arterial ischaemic events, two sinuous venous thrombosis<br />

and one combination. Aetiology was detected in 15,<br />

suspected in six and unknown in two. Follow up after 1–15<br />

years (median 7 years) was possible for 18 children, three<br />

had died and two were lost to follow. Only four were<br />

completely healthy, five suffered mild, six moderate and<br />

three severe handicap, 11 children presented combined<br />

neurological and neuropsychological problems. Neurological<br />

problems were mild to moderate hemisyndrome in 11,<br />

dysphasia, epilepsy and others in six each. Mild to severe<br />

neuropsychological problems were detected in 14 children,<br />

school problems in nine, attention deficits in ten and behaviour<br />

problems in seven. Headache and increased fatigue in<br />

six each. Recurrence was observed in three, all due to<br />

progressive underlying disease. Outcome was most<br />

affected by combined cortical/subcortical and best with<br />

only subcortical infarction. Size of infarction showed a<br />

tendency to influence prognosis. Epilepsy affected neuropsychological<br />

outcome. Conclusion: Neurological and especially<br />

neuropsychological problems influence the life of<br />

children after acute stroke significantly. Careful long<br />

term follow up is mandatory and more prospective and<br />

exact data on outcome are necessary.<br />

FP-T-008<br />

Sea blue histiocytosis with progressive neurologic<br />

damnification in three cases<br />

C.-H. Ding<br />

Beijing Children Hospital, Beijing, China<br />

Objectives: The cardinal clinical findings of sea blue<br />

histiocytosis (SBH) patients were hepatosplenomegaly,<br />

anemia and thrombocytopenia. The diagnosis and differential<br />

diagnosis of SBH with chronic progressive neurologic<br />

damnification were discussed. Methods: Clinical and<br />

laboratory examinations were performed in three cases<br />

with chronic progressive neurologic damnification. Results:<br />

The clinical findings of three patients were mental deterioration,<br />

paresis of vertical gaze, speaking slowly and not


Abstracts 639<br />

clear, and unsteady walking. The second and third one had<br />

difficulty in swallowing and torsion dystonia. The second<br />

and third one were sisters. Physical examination for three<br />

patients revealed dysarthria, ataxia, paresis of vertical gaze,<br />

pyramidal and cerebella signs were positive. The second<br />

and third one had mild splenomegaly. The serum ceruloplasmin<br />

level was normal. The antibodies of measles virus<br />

and rubella virus were negative in cerebrospinal fluid.<br />

Examination of bone marrow revealed sea blue histiocytes,<br />

no others specific findings. Liver function studies of the<br />

first patient were slightly abnormal. The serum lactic<br />

acid and pyruvate levels were abnormal in the first one.<br />

Conclusions: The features of SBH with neurologic damage<br />

were progressive psychomotor deterioration with vertical<br />

gaze paresis, liver function abnormal, and splenomegaly.<br />

SBH with neurologic damnification should be distinguished<br />

from Wilson’s disease, demyelinating disease,<br />

mitochondrial encephalomyopathy, and slow virus infection<br />

of central nervous system.<br />

FP-T-009<br />

Magnetic stimulation and new method of study of a blink<br />

reflex arch functional condition at children<br />

A.G. Remnev<br />

Altai Diagnostic Center, Barnaul, Russia<br />

The purpose of research: to estimate a functional condition<br />

of a trigeminal-facial complex (TFC) – blink reflex<br />

arch at children. Research of a functional condition of a<br />

blink reflex arch carried out by electrical stimulation (ES)<br />

of a supraorbital nerve and transcranial magnetic stimulation<br />

(TMS) of a cerebral cortex. The caused answers<br />

registered at a level of the eye circular muscles. At realization<br />

of researches used a complex of the equipment:<br />

Magstim-200 (Magstim, UK), Sapphire 2M (Medelec,<br />

UK). We investigated 45 healthy children with an age<br />

between 5 and 15 years: 16 children with an age between<br />

5 and 9 years (1st group), 29 children with an age between<br />

10 and 15 years (2nd group). The received results testify<br />

that TMS was characterized by steady registration of<br />

components of a blink reflex – early (R1) and late (R2).<br />

Latency of the R2 was similar at ES and TMS; latency of<br />

the R1 at ES and TMS had difference. The latency of the<br />

R1 at TMS was more, than at ES (13 % on the average).<br />

The distinction in latency of the R1 can be explained by<br />

distinction of the reflex channels, on which there is a<br />

realization of excitation at TMS and ES. Thus, the noninvasive<br />

technique of the TMS can be useful at an estimation<br />

of a functional condition of various sites of a TFC<br />

(facial nerve, trigeminal nerve and cerebronuclear tracts of<br />

a facial nerve).<br />

FP-T-010<br />

Auditory early and long latency evoked potentials in<br />

children and adolescents with headache<br />

M. Zgorzalewicz, B. Zgorzalewicz, R. Nowak<br />

Chair and Department of Developmental Neurology,<br />

<strong>University</strong> of Medical Sciences, Poznań, Poland<br />

Auditory evoked potentials were studied in 60 children<br />

and adolescents in 8–18 years old with different types of<br />

headache. The examination was carried out in interictal<br />

phase of the disease. Diagnoses of disease were performed<br />

according to the categorization of IHS. The aim of the study<br />

was to investigate the changes in BAEP and auditory ERP in<br />

migraine and non-migraine headache. The obtained results<br />

were compared with healthy controls at the matched age.<br />

The evoked potentials were recorded by Multiliner (Toennies-<br />

Germany) according to the IFCN standards. For BAEP<br />

latencies of waves I–V and inter-peak I–III, III–V, I–V were<br />

measured. The ERP was recorded with the oddball paradigms.<br />

The following parameters of ERP were measured.<br />

The N1, P2 latencies were evaluated from the responses to<br />

the non-target stimuli. The latencies of N2 and P300 parameters<br />

were estimated to target tasks. The inter-peak amplitudes<br />

were measured too. In majority of migrainous subjects<br />

prolongation of ERP latencies was found. No modifications<br />

of the P300 components were found in the tension-type<br />

headache subjects. There were also no differences in<br />

BAEP parameters between children with headache and the<br />

control group. The results were correlated with the clinical<br />

picture of the disease in the examined patients. An impairment<br />

of memory and attention processes in migrainous<br />

patients based on neurophysiological results was found.<br />

The ERP is a non-invasive diagnosis tool in young patients<br />

with headache when signs or symptoms may not be characteristic.<br />

FP-T-011<br />

Encephalopathy with intracranial calcification,<br />

dwarfism, leucodystrophy and neuropathy: a new<br />

clinical entity?<br />

F.M. Aynacı a , F. Celep b , A. Ahmetoglu c<br />

Karadeniz Technical <strong>University</strong>, Faculty of Medicine,<br />

a Department of Child Neurology, b Genetics and c Radiology,<br />

Trabzon, Turkey<br />

Microcephaly, motor and mental retardation, cataract<br />

(two cases) dwarfism and intracranial calcification occurred<br />

in five cases in large consanguineous families between 3 and<br />

6 months of age. The patients died between 4.5 and 8 years<br />

of age variably. Detailed investigation was done for two<br />

cases. Neither pleocytosis in CSF nor parathormon deficiency<br />

was determined. Peripheral neuropathy was determined<br />

in both. Muscle biopsy was performed in one case<br />

and any mutation for MELAS, MERRF, Leigh diseases was


640<br />

Abstracts<br />

not determined. Photosensitivity and pigmental retinopathy<br />

were not described in all cases. We think that these patients<br />

most resemble the first group of Fahr syndrome. But,<br />

compared with progressive intracranial calcification cases<br />

in the literature, we found in our cases autosomal recessive<br />

inheritance, early onset, severe pectus carinatus and dwarfism<br />

without growth hormone deficiency, cataract, peripheral<br />

neuropathy and progressive calcification without CSF pleocytosis.<br />

FP-T-012<br />

Neurologic complications of cyanotic congenital heart<br />

disease<br />

O.M. Luz<br />

<strong>University</strong> of Santo Tomas Hospital, Quezon City, Philippines<br />

Objective: This paper aims to identify the neurologic<br />

complications associated with cyanotic congenital heart<br />

disease and characterize the lesions in relation to different<br />

variables. Methodolegy: Retrospective study of patients 18<br />

years and younger with cyanotic congenital heart disease<br />

who presented with neurologic complications. Conclusion:<br />

Most patients presented with cerebral abscess and cerebral<br />

infarct (45% each). Infarcts tend to be multiple and<br />

abscesses tend to be solitary with predilection for the parietal<br />

area. Alteration of consciousness and seizures carries a<br />

grim prognosis.<br />

FP-T-013<br />

Selected risk factors in ischaemic strokes on migraine in<br />

children<br />

E. Pilarska a , A. Bakowska b , A. Kubik c , S. Kroczka c<br />

a Department of Developmental Neurology Medical <strong>University</strong><br />

of Gdańsk; b Department of Immunopathology Medical<br />

<strong>University</strong> of Gdańsk; c Department of Pediatric Neurology<br />

Faculty of Medicine, Jagiellonian <strong>University</strong> of Kraków,<br />

Poland<br />

Aim: The investigations were made to pronounce the<br />

value of examination of antiphospholipid antibodies and<br />

thrombomodulin in explanation of the pathogenesis of<br />

ischaemic strokes and migraine. Material and method:<br />

We investigated 30 children, who suffered ischaemic<br />

stroke at the age range between 2 and 15 years and 30<br />

children with migraine aged 8–15 years, 19 had migraine<br />

with aura and 11-without aura. The control group consisted<br />

of 30 healthy children at the some age. Anticardiolipin<br />

antibodies aCl -IgG, IgM, IgA and b2 glycoprotein and<br />

thrombomodulin were evaluated. Results: Both in ischaemic<br />

strokes and migraine there were increased concentrations<br />

of thrombomodulin and antiphospholipid antibodies<br />

compared to control group. The highest values were<br />

observed in children with ischaemic strokes. In none case<br />

there were increased b2-glykoprotein levels. Conclusion:<br />

Anticardiolipin antibodies and thrombomodulin, especially<br />

aCl- IgG, IgM maybe the important causative agents in<br />

childhood strokes and migraine. This paper was supported<br />

by a grant No 4PO5E 150 18 of the State Committee of the<br />

Scientific Research.<br />

FP-T-014<br />

Event-related potential N270 and its distribution in<br />

adults and school-age children<br />

L.-P. Li, Y.-P. Wang, H.-J. Wang, L.-L. Cui, S.-J. Tian<br />

Department of Neurology, Xuanwu Hospital, Capital<br />

<strong>University</strong> of Medical Sciences, Beijing, China<br />

To compare event-related potential N270 and its scalp<br />

potential distribution in adults and in school-age children,<br />

and to explore the development of conflict processing<br />

system in human brain, pairs of colored numbers were<br />

sequentially present on screen to subjects tested. They<br />

were instructed to discriminate whether the color or magnitude<br />

of the pairs of number was identical, and ERPs were<br />

recorded at the same time. In adults, a negative potential<br />

peaking at 270 ms (N270) was elicited when the second<br />

stimulus (S2) conflicted with the first stimulus (S1) of task<br />

relevant and irrelevant attributes. N270 was widely distributed<br />

on the entire scalp in adults. In children, N270 was<br />

only elicited by conflict in task-related attribute, the distribution<br />

of N270 in color conflict was on bilateral sides of<br />

the scalp and N270 elicited by magnitude conflict was on<br />

the left central-frontal site. Conclusion: In school-age children,<br />

event-related potential N270 was elicited under the<br />

control of attention. Its distribution in scalp depends on the<br />

attributes of stimulus pairs.<br />

FP-T-015<br />

Questionnaire study: what is the role of child<br />

neurologists who advise caregivers of disabled students<br />

at special schools?<br />

M. Aoyama a , M. Shibata a , M. Yamamoto a , O. Nitta a ,K.<br />

Miura c , M. Miyao d , Y. Iwasaki e<br />

a School of Nursing, b School of Physical Therapy, c School of<br />

Occupational Therapy Tokyo Metropolitan <strong>University</strong> of<br />

Health Sciences;<br />

d Division of Develop. Psychology,<br />

National Children’s Medical Care Center; e Division of<br />

Child Neurology, Tokyo Metropolitan Yotsugi Rehabilitation<br />

Center, Japan<br />

In 2000, we administered a questionnaire study to<br />

parents of neurologically disabled students. The questionnaire<br />

addressed such issues as medical, co-medical and<br />

social problems, all pertaining to neurologically disabled<br />

students. We found that some caregivers, mainly mothers,<br />

complained about poor explanations from doctors on the<br />

future outcomes of their children. They were also


Abstracts 641<br />

concerned about how to properly raise their children under<br />

the given circumstances. We were interested in what the<br />

doctors thought about these issues in 2001, so we conveyed<br />

a questionnaire study again. We collected 137 responses<br />

out of 202 child neurologists, who are all councilors with<br />

the ‘Japanese Society of Child Neurology’. A total of 81%<br />

of doctors ranged from the ages of 41 , 60 and 78% had<br />

over 20 years experience. Fifty-nine percent were clinical<br />

doctors, 64% of them examined the children between 10<br />

and 20 min (per child) and 82% of the doctors worked over<br />

twice a week at the outpatient clinic. Twenty-five percent<br />

of doctors indicated that their explanations were insufficient<br />

to please the caregivers, and 20% of doctors worried<br />

about the inadequate satisfaction of the parents. A total of<br />

83% of them hoped to ask other staff, chiefly clinical<br />

psychologists, to help them with children’s care.<br />

FP-T-016<br />

Electroencephalogram as a follow-up indicator in<br />

pediatric moyamoya diseases<br />

D.-S. Kim a , T.-S. Ko a , Y.-S. Ra b , C.-G. Choi c<br />

a Department of Pediatrics, b Neurosurgery and c Radiology,<br />

Asan Medical Center, <strong>University</strong> of Ulsan, College of Medicine,<br />

Seoul, Korea<br />

Moyamoya disease is one of the most common cerebrovascular<br />

diseases in childhood. The EEG is known to<br />

show the characteristic ‘rebuild-up phenomenon’. In<br />

order to evaluate the usefulness of EEG as a follow-up<br />

test, we performed the statistical analysis between clinical<br />

improvements and EEGs after indirect anastomosis. Total<br />

31 patients below 15 years old, undergone the surgery<br />

from March 1995 to March 2001, were included. The<br />

ratio of male to female was 1.58:1 (19:12) and the median<br />

age was 6 years. The clinical manifestations were TIA<br />

(n ¼ 27), seizure (n ¼ 8), hemiplegia (n ¼ 4), and headache<br />

(n ¼ 4). The analysis for the total patients did not<br />

show statistical significance between clinical and EEG<br />

improvements (P ¼ 0:142). However, the analysis only<br />

for cases with the initial abnormal EEG (n ¼ 23) did<br />

show significance (P ¼ 0:04). In addition, we performed<br />

the correlation analysis. We divided clinical and EEG data<br />

into three groups: (a) no; (b) mild; and (c) marked<br />

improvements, respectively. For the cases with abnormal<br />

initial EEG findings (n ¼ 23), we found the statistical<br />

significance between the clinical and EEG improvements<br />

(r ¼ 0:466, P ¼ 0:025). Our results suggest the EEG can<br />

be used as a non-invasive follow-up test after the bypass<br />

surgery in Moyamoya disease, when the initial EEG was<br />

abnormal.<br />

FP-T-017<br />

Ischemic stroke in a pediatric population risk factors<br />

and clinical aspects<br />

A. Schteinschnaider, C. Romero, F. Meli, R. Lagos, S.<br />

Ameriso, S. Intruvini, J. Pociecha, M. Szlago, M.G.<br />

Alvarez, M. Segalovich, G. Garate, M. Massaro<br />

Raúl Carrea Institute of Neurological Research, FLENI,<br />

Buenos Aires, Argentina<br />

Objective: Ischemic stroke are relatively uncommon in<br />

children and their etiology may differ from the adult population.<br />

We report the characteristics of all pediatric strokes<br />

seen at our institution in a 6-year period. Background:<br />

Ischemic stroke are being more frequently diagnosed in<br />

childhood in part due to greater physicians awareness and<br />

also due to the development of non-invasive diagnostic<br />

procedures such as magnetic resonance angiography, transcranial<br />

Doppler or molecular genetic techniques. Higher<br />

survival rates of patients with cardiological or oncologic<br />

diseases allows for increased time for exposure to specific<br />

risk factors. Design/methods: This was an observational,<br />

retrospective study of institutional chart reviews of every<br />

patients with a discharge diagnosis of ischemic stroke<br />

between January 1995 and December 2000. Results: During<br />

the time period studied there were 21 patients with a diagnosis<br />

of ischemic stroke. There were four girls and 17 boys<br />

aged 6.5 years (1 month–16 years). Acute hemiparesis (16)<br />

was the most frequent clinical presentation followed by<br />

altered consciousness (6), headache (3), and ataxia and/or<br />

gait disturbances (3). Sixteen patients (76%) had a predisposing<br />

risk factor: congenital heart disease (4), prothrombotic<br />

state (4), vascular abnormalities (3), and traumatic<br />

carotid dissection (3). Four patients had a positive family<br />

history of stroke. There were no stroke related deaths and<br />

only two patients suffered recurrent stroke. Twelve patients<br />

had secuelar neurological deficit. Conclusions: Ischemic<br />

stroke continues to be uncommon in the pediatric population.<br />

Nevertheless the cryptogenetic group has certainly<br />

diminished based on a complete and detailed work-up.<br />

Most patients have at least one predisposing factor. A thorough<br />

investigation of potentially treatable causes of the<br />

stroke is warranted and may have been responsible for the<br />

low recurrence rates observed.<br />

FP-T-018<br />

Auditory induced somatosensory cortex activations<br />

identified by magnetoencephalography (MEG) in<br />

patients with cortical lesion<br />

M. Kubota, Y. Sakakihara, H. Hirose, I. Kimura<br />

Department of Pediatrics, <strong>University</strong> of Tokyo, Tokyo,<br />

Japan<br />

A single kind of stimulus usually activates a single specific<br />

sensory cortex such as the auditory cortex activation by tone


642<br />

Abstracts<br />

stimulation, but it rarely activates multiple sensory cortices<br />

in various conditions. Anatomically, reciprocal connections<br />

between different cortices is known to be involved in various<br />

information processing. We here investigated the pathophysiological<br />

significance of auditory induced somatosensory<br />

cortex (SI) activation in patients with cortical lesions or<br />

dysfunction. Subjects were two patients with regional encephalitis,<br />

one with juvenile myoclonic epilepsy (JME) and<br />

four with focal epilepsy. Using MEG, we analyzed SI activation<br />

in auditory evoked magnetic fields which was induced<br />

by 1 kHz/90 dB pure tone stimuli. At first, all patients showed<br />

bilateral responses of the primary auditory cortex (AI) ,100<br />

ms after the stimuli (N100m). In addition, the SI activation<br />

was found in both hemisphere in patients with regional encephalitis<br />

and JME, and in the same hemisphere as interictal<br />

paroxysm in patients with focal epilepsy. Our findings<br />

suggest that unmasking of normally-inhibited inputs from<br />

AI to SI occurred after encephalitis or epileptogenic dysfunction<br />

(intercortical reorganization). This is the first report of<br />

auditory induced SI activation in human, although the precise<br />

mechanism of the multimodal sensory activations is not<br />

known.<br />

FP-T-019<br />

Regional variations in bone mineral density in children<br />

with cerebral palsy using dual energy X-ray<br />

absorptiometry<br />

J. Shiragaki a , N. Iwasaki b , J. Nakayama b , K. Fujita c ,T.<br />

Ohto b , A. Matsui b<br />

a Kyushu <strong>University</strong> of Health and Welfare, Nobeoka, Miyazaki<br />

Japan; b Department of Pediatrics and c Institute of<br />

Disability Science, <strong>University</strong> of Tsukuba<br />

BMD was studied in 34 children with spastic cerebral<br />

palsy (CP group), 40 children undergoing anticonvulsant<br />

therapy (epilepsy group), and 29 normal children (control<br />

group). The CP group was divided into four groups according<br />

to gross motor function. Dual energy X-ray absorptiometry<br />

was performed to evaluate BMD of the whole body, of the<br />

head, upper limbs, ribs, spine, pelvis, and lower limbs separate<br />

from the whole body scan images, and of the lumber<br />

spine separate from the lumber vertebrae images. In the<br />

control group, BMDs increased with age. There was no<br />

significant difference between the control group and epilepsy<br />

group (P . 0:05). The CP group had BMD lower than the<br />

control group for the whole body, upper limbs, ribs, spine,<br />

pelvis, lower limbs, and lumber spine but not for the head<br />

(P , 0:001). In the CP group, BMD Z scores for the pelvis,<br />

lower limbs and lumber spine were remarkably lower than<br />

for the head, upper limbs, ribs and spine. BMD of the upper<br />

limbs and spine were particularly lower in the bed-ridden<br />

group compared with the standing/walking group, whereas<br />

BMD of the lower limbs were lower in the bed-ridden, rolling,<br />

and crawling groups compared with the standing/walking<br />

group. These results suggest that the high incidence of<br />

femur fractures in CP is related not only to mechanical stress<br />

overload on the lower legs but to the strongly diminished<br />

BMD of the lower limbs and pelvis as well. And that BMD<br />

of the lower limbs and pelvis are also associated with standing<br />

posture and walking.<br />

FP-T-020<br />

The importance of rectal biopsy in the diagnosis of<br />

neuronal intranuclear hyaline inclusion disease (NIHID)<br />

R. Kulikova-Schupak a , K.G. Knupp a , J.M. Pascual a , S.S.<br />

Chin a , R. Kairam b , M.C. Patterson a<br />

a Division of Pediatric Neurology, Columbia <strong>University</strong>,<br />

New York, NY, USA; b Bronx-Lebanon Hospital Center,<br />

Bronx, NY, USA<br />

NIHID is a rare neurodegenerative disorder of childhood<br />

onset characterized by the presence of eosinophilic intranuclear<br />

inclusions and neuronal loss throughout the nervous<br />

system. Familial occurrence has been described. We identified<br />

two patients, an 11-year old boy (P1) with new onset<br />

bulbar weakness and Parkinsonism, and a 15-year old boy<br />

(P2) with severe cognitive and motor deterioration of uncertain<br />

etiology. P1 presented at 10 years of age with progressive<br />

dysarthria, drooling, hand tremor and psychomotor slowing.<br />

Key physical findings included saccadic pursuit, impaired<br />

convergence, dysarthria, hypophonia, atrophy of tongue and<br />

small hand muscles, increased tone, brisk reflexes, and electrophysiologic<br />

evidence of chronic denervation. P2 was initiallyevaluated<br />

at4yearsofage foragaitdisturbance andmotor<br />

slowing. Examination revealed drooling, sparse speech,<br />

dynamic equinus, titubation, hypertonia with hyperreflexia<br />

and extensor plantar responses. Cognitive decline, loss of<br />

head control, development of spasticity and myoclonic jerks<br />

followed. At 15, the patient was unresponsive to voice, visual<br />

or painful stimuli. He had absent gag and corneal reflexes,<br />

diffusemuscleatrophyandspasticquadriplegia.Bothpatients<br />

had a history of behavioral problems marked by frequent<br />

temper tantrums. Both had non-diagnostic MRI imaging of<br />

the head and metabolic panels. Rectal biopsy demonstrating<br />

characteristic findings in the neurons of the myenteric plexus<br />

was diagnostic 1 (P1) and 11 years (P2) after the initial evaluation.<br />

Rectal biopsies should be considered in children with<br />

otherwise unexplained multisystem degeneration, particularly<br />

in the presence of both upper and lower motor neuron<br />

signs accompanied by behavioral problems.<br />

FP-T-021<br />

Correlation between visual function and acuity in<br />

children with severe mental retardation: a double blind<br />

randomized cross-over controlled trial utilizing a visual<br />

function checklist<br />

K.K.T. Leung a , C.H. Ko b , C.Y. Ko c , L. Chia c , C.C.H. Lo b ,<br />

P.W.T. Tse b<br />

Tuen Mun Child Assessment Centre, a Department of Health,


Abstracts 643<br />

Hong Kong; b Developmental Disabilities Unit and c Department<br />

of Ophthalmology, Caritas Medical Centre, Hong<br />

Kong, China<br />

Introduction: Refractive errors is one of the major ocular<br />

defects in children with severe mental retardation. While<br />

their visual acuity may improve significantly after prescription<br />

of corrective lenses, it is not clear whether this is associated<br />

with prompt functional and behavioral improvement.<br />

The latter may be assessed by the visual function checklist<br />

(VFC), which is an innovative behavioral tool to assess the<br />

child’s response to light perception, abilities of visual<br />

exploration, fixation, following, distance viewing, grabbing,<br />

orientation, and the presence of optokinetic nystagmus.<br />

Methods: The subjects included ten children with severe<br />

grade mental retardation and significant refractive errors.<br />

They were randomly allocated to wear corrective and<br />

plano lenses. They were then assessed by a developmental<br />

paediatrician with the VFC. Subsequently, children from the<br />

plano lens group crossed over to wear corrective lenses,<br />

while those originally in the corrective lens group changed<br />

onto plano lenses. The assessor, who was blinded to the<br />

treatment allocation, would perform a second evaluation<br />

with the VFC. The assessment was conducted in standardized<br />

settings. The results were converted into a VQ, with a<br />

range from 0 to 1. The mean VQ from both groups were<br />

compared by paired samples t-test. As it was assumed the<br />

visual function might improve or remain the same after<br />

corrective lenses, the significance level was set at a one<br />

tailed probability of ,0.05. Results: The mean VQ for the<br />

corrective lens group and plano lens group were<br />

0.829 ^ 0.304 and 0.789 ^ 0.313, respectively. There was<br />

significant prompt improvement in the visual function of the<br />

subjects after improvement in visual acuity (one tailed<br />

P ¼ 0:045). Discussion: The correction of ocular defects<br />

in children with severe mental retardation may be associated<br />

with functional improvement. The VFC is complementary<br />

to conventional acuity tests in monitoring the functional<br />

improvement.<br />

FP-T-22<br />

Analysis and evaluation of visual-motor integrated<br />

coordinating motion in children -a preliminary result<br />

C. Chen a , S.-C. Chen a , C.-H. Yu a , J.-H. Yeh a , J.-H. Lai a , C.-<br />

L. Chen b<br />

a Department of Physical Medicine and Rehabilitation,<br />

Taipei Medical <strong>University</strong> Hospital, Taipei, Chinese Taipei;<br />

b Department of Physical Medicine and Rehabilitation,<br />

Chang Gung Memorial and Children Hospital, Taoyuan,<br />

Chinese Taipei<br />

The pathophysiology of clumsy hand function in children<br />

is strongly related with the development of visual-motor<br />

integration. In 1967, Berry developed the Beery-Buktenica<br />

developmental test of visual-motor integration (VMI) as an<br />

assessment tool to evaluate the integration ability of visual<br />

perception and motor coordination. Our study is designed to<br />

analyze the motion of selected functional task during daily<br />

life, e.g. spoon manipulation, which demands desirable eyehand<br />

coordination for the children based on VMI test<br />

results. Meanwhile, the comparison with normal children<br />

will be carried out. We collected three children from 3 to<br />

6 years old. They are examined with VMI test following two<br />

additional tests (visual perception and motor coordination).<br />

Furthermore, they are instructed to perform a selected functional<br />

task in activity of daily living (ADL) by using a spoon<br />

to transport objects in four directions (horizontal, vertical,<br />

right downward oblique and left downward oblique). We<br />

recorded the kinematic values including movement velocity,<br />

trajectory and the displacement corresponding to the<br />

straight line between target and initial positions. We found<br />

the child with poor visual-motor integration made more<br />

errors and the one who had pure motor coordination<br />

performed the task with more slow velocity compared<br />

with the normal child. However their movement trajectory<br />

made no significant differences. This preliminary result<br />

offered the clinical physician and therapists a guideline for<br />

further training program in children with problems of visual<br />

motor integration or motor coordination. Further recruitment<br />

of subjects for more convinced conclusion was<br />

required.<br />

FP-T-023<br />

How are fathers first informed about the disabilities of<br />

their children and how do they accept the facts?<br />

K. Miura a , M. Aoyama b , M. Shibata b , M. Yamamoto b ,O.<br />

Nitta c , M. Miyao d , Y. Iwasaki e<br />

a School of Occupational Therapy,<br />

b School of Nursing,<br />

c School of Physical Therapy Tokyo Metropolitan <strong>University</strong><br />

of Health Sciences;<br />

d Division of Develop. Psychology<br />

National Children’s Medical Care Center,<br />

e Division of<br />

Child Neurology, Tokyo Metropolitan Yotsugi Rehabilitation<br />

Center, Japan<br />

Purpose: This research was to investigate how fathers are<br />

first informed about the disabilities of their children, and<br />

how accept the facts. Subjects: Fifty-four fathers ranging<br />

from 31 to 65 years (mean age: 45.6 years) whose children<br />

have physical disabilities (CP, PMD, etc.) and are from 6 to<br />

18 years old (mean age: 12.6 years) at a special school.<br />

Method: Fathers answered a questionnaire developed from<br />

a research project team at Tokyo Metropolitan <strong>University</strong> of<br />

Health Sciences. Results: Most of the fathers were informed<br />

of the disabilities of their children before the children were 1<br />

year old, and the fathers were in the company of their wives<br />

and doctors. Most of them responded like this: ‘I have no<br />

actual feelings’, ‘it is a great shock’ and ‘I am greatly disappointed’.<br />

One father felt that the ‘doctor did not think about<br />

the parents well-being’. The period of acceptance ranged<br />

from 10 months–11 years (mean period: 15 months). Half


644<br />

Abstracts<br />

of the fathers could accept the facts in a year, and for a<br />

quarter of them, it took over 2 years. Conclusions: According<br />

to another survey made by our project team for mothers<br />

having children with physical disabilities, we found a similar<br />

result concerning the period of acceptance. More social<br />

support systems should be implemented for fathers and<br />

mothers.<br />

FP-T-024<br />

The modified paediatric coma scale as prognostic<br />

indicator for immediate outcome in acute non-traumatic<br />

encephalopathy<br />

C.P. Wong a , J.A. Eyre b<br />

a Department of Paediatrics, UMMC, <strong>University</strong> of Malaya,<br />

Kuala Lumpur, Malaysia b Paediatric Neuroscience Group,<br />

Sir James Spence Institute of Child Health, <strong>University</strong> of<br />

Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom<br />

The study examined the prognostic significance of the<br />

James’ modification of Glasgow Coma Scale in children<br />

with acute non-traumatic encephalopathy. Children aged<br />

below 5 years who were admitted into the non-traumatic<br />

coma study in the North of England were recruited for this<br />

study. The coma score on admission, the minimum coma<br />

score and the duration of significant encephalopathy were<br />

assessed for association with the outcome at 6 weeks after<br />

the illness. Minimum coma score and duration of encephalopathy<br />

correlated well with the outcome. Coma score on<br />

admission was not found to be a significant prognostic<br />

indicator. A low coma score on admission is however<br />

specific but not sensitive in predicting death.<br />

FP-T-025<br />

Ischemic stroke in Thai children<br />

A. Visudtibhan, S. Chiemchanya, D. Kitiviriyakul, A.<br />

Chuansumrit, P. Visudhiphan<br />

Division of Neurology, Department of Pediatrics, Faculty of<br />

Medicine, Ramathibodi Hospital, <strong>Mahidol</strong> <strong>University</strong>,<br />

Bangkok, Thailand<br />

Background: The diagnosis for etiologies of ischemic<br />

stroke in children has been improved with the development<br />

of newer imaging and metabolic screening techniques.<br />

Objective: To evaluate the etiologies, clinical courses and<br />

outcomes of ischemic stroke in children. Method: A retrospective<br />

study was conducted at Ramathibodi hospital.<br />

Medical records of children aged below 15 years with<br />

ischemic stroke during January 1st, 1992–December 31st,<br />

2000 were reviewed. Children with trauma or central<br />

nervous system infection were excluded. Results: Fortyone<br />

children (19 girls, 22 boys) were included. Mean age<br />

was 5.08 years (range 2 months–14 years). The most<br />

common sites of stenosis or occlusion were the middle<br />

cerebral artery or internal capsule area (73%). Stroke<br />

subtypes were as follows: ten with Moyamoya disease,<br />

five with heart disease with embolic phenomenon, 12<br />

with undetermined causes. There were 14 children categorized<br />

into inconclusive group who had abnormal coagulogram<br />

or coagulating factors such as protein C, protein S,<br />

antithrombin III. Among these children, five also had<br />

cardiac anomaly. Owing to the lack of repeated blood<br />

tests and none in this group had recurrent stroke, specific<br />

diagnosis of hypercoagulation as the cause of stroke was<br />

not possible. There were recurrences in three children (two<br />

with Moyamoya disease, one without definite cause).<br />

Conclusion: Ischemic stroke in Thai children was not<br />

different from other studies. Abnormal coagulation might<br />

be one of contributing factors of ischemic stroke in children.<br />

Complete laboratory investigations in those without<br />

definite cause of stroke should be performed to exclude<br />

treatable cause of stroke in children.<br />

FP-T-026<br />

A rare cause of cerebral arterial stroke in childhood:<br />

non-compaction of myocardium<br />

S. Hascelik, D. Yalnizoglu, G. Kafali, A. Celiker, M. Topcu<br />

Hacettepe <strong>University</strong> Children’s Hospital Departments of<br />

Pediatric Neurology and Cardiology, Ankara, Turkey<br />

Non-compaction is a developmental disorder of cardiogenesis<br />

in fetal life characterized by prominent trabeculations<br />

and recesses between them. Patients mostly present<br />

with heart failure, arrythmias or thromboembolic events.<br />

We report an 18 month-old girl with non-compaction of<br />

the left ventricle presenting with thromboembolic stroke.<br />

Her past medical history was remarkable for mild motor<br />

delay and easy fatigue. Her parents were relatives, family<br />

history was non-contributory. She was admitted to our<br />

intensive care unit with right sided motor seizures, right<br />

hemiparesis and altered mental status. CT scans and MR<br />

imaging showed infarction in the territory of the left middle<br />

cerebral artery (MCA). MR angiography showed occlusion<br />

in the distal part of the left MCA. She was worked up<br />

thorougly for the etiology of stroke. Two dimentional echocardiography<br />

revealed trabeculations and deep recesses in<br />

the left ventricle; a large thrombus was swabbing the whole<br />

left atrium. Follow up cranial CT was obtained at 1 week<br />

which showed stable radiologic findings and no hemorrhage.<br />

The patient was then started on anticoagulant therapy,<br />

and she died on the fourth day of treatment. No further<br />

imaging studies were performed. We conclude that noncompaction<br />

of myocardium is a rare disorder yet may<br />

have severe and fatal complications. Echocardiography is<br />

mandatory in all infants and children for evaluation of<br />

stroke. Early initiation of anti-aggregant therapy may be<br />

considered in children with non-compaction to prevent<br />

future cardioembolic stroke.


Abstracts 645<br />

FP-T-027<br />

Simple reaction time in children with migraine<br />

R. Matijevic, D. Filipovic, J. Mihaljev-Martinov, K.<br />

Boskovic, V. Ivetic, I. Tanackov, S. Bogdanovic<br />

Medicinski fakultet – Novi Sad, Katedra za fiziologiju, Novi<br />

Sad, Yugaoslavia<br />

In this study we assessed simple reaction time data in<br />

children. Sample consisted of 90 children, 30 of whom<br />

had migraine with aura, 30 with migraine without aura<br />

and 30 healthy children aged 10–18 years. All children<br />

were right handed. In the first group of children there<br />

were 19 (63%) girls and 11 (37%) boys. In the second<br />

group there were 23 girls (77%) and seven boys (23%). In<br />

control group there were 16 girls (57%) and 14 boys (43%).<br />

We tested reaction times with right and left hand on audio<br />

and visual stimulus. In all three groups responses with right<br />

and left hand where shorter on audio stimulus than on visual<br />

stimulus and reaction of right hand is shorter than reaction<br />

with left hand on same stimulus. Control group had significantly<br />

shorter all four reaction times (visual stimulus – right<br />

hand, visual stimulus – left hand, audio stimulus – right<br />

hand, audio stimulus – left hand) than both groups with<br />

migraine. Differentiation on base of average values of RT<br />

between groups with migraine was possible only with some<br />

of RT.<br />

FP-T-028<br />

Brain tumors in children. A review of 84 Brazilian cases<br />

A.A. Espíndola, H. Matushita, A. Diament, U.C. Reed<br />

Department of Neurology of the School of Medicine of São<br />

Paulo <strong>University</strong>, São Paulo, Brazil<br />

From 1970 the incidence of primary brain tumors among<br />

children has increased and environmental factors as well as<br />

an earlier diagnosis by improvement of detection methods<br />

have been considered for explaining it. Along this period,<br />

continuous therapeutic advances have optimized treatment<br />

planning. For evaluating outcome data, we reviewed histological,<br />

clinical and therapeutic aspects in 84 consecutive<br />

children (0–16 years) with primary central nervous system<br />

tumors, attended and followed-up from January/1997 to<br />

May/2001. Tumor was supratentorial in 63.0%, infratentorial<br />

in 30.9%, spinal intramedullary in 3.5% and spinal extradural<br />

in 2.3%. Astrocytic tumors occurred in 34.5%,<br />

followed by medulloblastoma (11.9%), craniopharygioma<br />

(10.7%) and ependymoma (10.7%). The duration of the<br />

symptoms before diagnosis ranged between 1 day and 8<br />

years (mean 9.3 months). Clinically, increased intracranial<br />

pressure manifested in 41.6%, seizures in 17.8%, focal deficits<br />

in 22.6%, visual abnormalities in 20.2%, ataxia in<br />

13.0% and endocrinological changes in 3.5%. Total removal<br />

was achieved in 54.2%, and partial removal in 39.7%. In<br />

respectively 27.3, 38.0 and 20.2%, chemotherapy, radiotherapy<br />

or both were used. Follow-up ranged between 1<br />

month and 4 years and 4 months (mean: 1 year and 6<br />

months). Tumor recurred in 18 patients. At follow-up,<br />

4.7% have died, 50.0% have no tumor and normal neurological<br />

examination; 8.3% have no tumor but neurological<br />

changes; 23.8% have residual tumor but normal neurological<br />

examination and 13.0% have residual tumor and neurological<br />

changes. We concluded that overall outcome has<br />

improved in several childhood brain tumors and the extent<br />

of removal has demonstrated to influence prognosis.<br />

FP-T-029<br />

Asymptomatic cerebrovascular lesions in children with<br />

sickle cell disease<br />

F.N. Arita, S. Rosemberg<br />

Santa Casa School of Medicine, Department of Pediatrics,<br />

Neuropediatrics Division., São Paulo, Brazil<br />

Symptomatic ischemic cerebrovascular disorder is a<br />

severe complication in children with sickle cell disease<br />

(SCD), affecting 6 to 8% of patients within the first 20<br />

years of life. In order to detect clinically silent ischemic<br />

lesions and to determine their prognostic value, we<br />

submitted 28 children with SCD between 5 and 15 years<br />

of age with normal development and without neurological<br />

disease to a unique transaxial T2-weighted MRI. Ischemic<br />

lesions were found in 14 (50%) of the asymptomatic<br />

patients. These were characterized by hyperintense, isolated<br />

or multiple, uni or bilateral punctate or small plaques<br />

images. Five patients presented isolated punctate lesions,<br />

four presented unilateral multiple punctate or small plaques<br />

and five had multiple bilateral lesions. The topographic<br />

distribution of these lesions corresponded to the deep<br />

watershed vascular territories in cerebral white matter.<br />

Two patients with bilateral extensive lesions presented<br />

strokes in the following few years, which recurred in one<br />

of them despite hypertransfusion therapy. A third patient<br />

with extensive lesions presented migraine-like episodes 3<br />

years after the exam. Albeit the control MRI was similar, the<br />

angio-MRI disclosed arterial stenosis and a ’moyamoya’<br />

pattern, and transcranial doppler detected high velocities.<br />

The remaining two patients with bilateral extensive lesions<br />

and the nine patients with less extensive lesions as well as<br />

the 14 patients without lesions remained well after 6 years<br />

of follow-up. We conclude that bilateral and extensive<br />

lesions seem to be an important predictive risk factor for<br />

the development of ulterior cerebrovascular accident in children<br />

with SCD.<br />

FP-T-030<br />

The retrospective study of early diagnosis and EEG<br />

analysis in 31 migraine children<br />

H. Li, X.-Q. Liu, W. Zhou<br />

Qingdao Municipal Hospital, Qingdao Shandong, China


646<br />

Abstracts<br />

Objective: To study the clinical characteristics and<br />

analyse the EEG in children with migraine. Methods: We<br />

reviewed the clinical manifestations and auxiliary examinations<br />

of 31 cases diagnosed as children migraine and<br />

analyzed the EEG abnormality of them. Results: Thirtyone<br />

children were studied, 19 males, 12 females. Headache<br />

occurred bilaterally in 18 cases, and in one side in five cases.<br />

Three cases had auras (10%). Duration of headache varied<br />

from half an hour to 5 h. Headache accompanied with<br />

nausea in eight cases, vomiting in 11 cases, and abdominal<br />

pain in six cases (totally occurred in 80.6% cases). The EEG<br />

abnormalities during attacks and interictal period mostly<br />

were focal and diffuse slow waves or paroxysmal high<br />

amplitude slow waves. Conclusions: There are many<br />

features in children migraine attacks. Clinical manifestations<br />

were the most important aspects in diagnose of children<br />

migraine. Abnormalities of EEG can only be<br />

considered as reference.<br />

FP-T-031<br />

Alternating hemiplegia in childhood: a study of ten<br />

patients<br />

Y.-H. Zhang, W.-X. Sun, Y.-W. Jiang, J. Qin, X.-R. Wu<br />

Department of Pediatric Neurology, Peking <strong>University</strong> First<br />

Hospital, Beijing, China<br />

Alternating hemiplegia in childhood (AHC) is a rare<br />

disorder of unknown cause. We described the clinical<br />

features of ten patients (nine males and one female). The<br />

age of onset was from 2 days to 55 months (average: 13.2<br />

months). The initial symptoms were abnormal eye movements<br />

or dystonic posturing in eight cases, hemiplegia in<br />

two cases. All patients had recurrent alternating hemiplegic<br />

episodes. The hemiplegia attacks lasted from a few minutes<br />

to 10 days. The occurrence of the attacks ranged from 8<br />

times daily to one time every 2 months. Five patients also<br />

had the episodes of quadriplegia that could be isolated manifestation<br />

or occurred when hemiplegia was shifting from<br />

one side to the other. In eight patients the abnormal eye<br />

movements or dystonia posturing recurred intermittently<br />

during the hemiplegia attack. Sleep could relieve both<br />

weakness and associated paroxysmal symptoms. Mental<br />

retardation was present in seven cases, seizures in two<br />

cases, and dysarthria in three cases. Ataxia and choreoathetosis<br />

presented in one case, respectively. EEG was abnormal<br />

in two patients; other laboratory investigations (such as<br />

brain MRI, cerebral angiography, plasma lactate and pyruvate<br />

levels, et al.) were normal in all patients. Nine patients<br />

received flunarizine therapy. Flunarizine reduced the severity,<br />

duration, or frequency of hemiplegic attacks in six<br />

patients. Our results suggested that AHC was characterized<br />

by frequent episodes of alternating hemiplegia with extrapyramidal<br />

symptoms and mental retardation; flunarizine<br />

was effective in treating some AHC patients.<br />

FP-T-032<br />

The risk of stroke recurrence in childhood<br />

V. Brankvic-Sreckovic, V. Milic-Rasic, N. Jovic, S.<br />

Todorovic<br />

Clinic for Child Neurology and Psychiatry, Belgrade, Yugoslavia<br />

Background: Stroke in children, as an important cause<br />

of morbidity, is challenging for further research. Although<br />

the different aspects of childhood stroke are under investigation,<br />

the recurrence rate is still unknown precisely. It<br />

seems to be lower than previously reported, but highly<br />

correlated with certain etiologies and underlying mechanisms.<br />

Patient and methods: Thirty-five children (21 boys,<br />

16 girls) with diagnosed ischemic infarction, all fulfilling<br />

both clinical and radiographic criteria, were investigated.<br />

Patients with neonatal stroke and SVT were excluded. The<br />

mean follow-up period was 59 months and median age of<br />

stroke onset was 8.4 ^ 4.4 years (1–16 years). Diagnostic<br />

studies were proceeded on a case-by-case analysis to determine<br />

the risk factors associated with stroke. The patients<br />

were analysed according to the etiologic contribution to<br />

initial and recurrent stroke event. Results: Cardioembolic<br />

(12 children-34.3%) and arteriopathic processes (12–<br />

34.3%) were identified as the most probable mechanisms<br />

of arterial ischemic stroke. Prothrombotic abnormalities<br />

were found in four (11.4%) children. Underlying pathology<br />

remained unknown in seven (20%). Cardiac abnormality<br />

prior to first stroke was detected in one child.<br />

Progressive arteriopathies were determined in 3 (8.6%)<br />

and transient cerebral arteriophaty of unknown origin<br />

was found in five (14.3%) children. In four (11.4%) children<br />

recurrent stroke was observed in a period of 4 days–<br />

18 months after the first stroke manifestation. In three of<br />

them (75%), recurrence was due to cardiac or transcardiac<br />

embolism. In the remaining case, the diagnosis of Moyamoya<br />

disease was established (repeated stroke in the same<br />

arterial territory). In one patient (migraine-related stoke)<br />

TIA was noticed before the stroke episode. Clinically<br />

silent cerebral infarcts (multiple lacunar infarcts limited<br />

to one hemisphere) disclosed by MRI preceded the overt<br />

stroke episode in two patients. Antiplatelet agent (aspirin)<br />

has been given in three patients, but no valuable data of<br />

effectiveness could be obtained. Conclusion: The risk<br />

factors of stroke in children appear to be multiple and<br />

overlapping, disabling the precise etiologic diagnosis in<br />

certain circumstances. However, congenital and acquired<br />

heart diseases were the most common cause of repeated<br />

stroke in our study. Better recognition of the underlying<br />

mechanisms and aetiology of childhood stroke is crucial<br />

for both effective therapeutic approach and prevention of<br />

recurrences.


Abstracts 647<br />

FP-T-033<br />

Socioeconomic background of the families with children<br />

in special education<br />

L.E. Åberg a , T. Autti b , M. Mannerkoski a , M. Hoikkala a ,K.<br />

Kuismanen a , H. Heiskala a<br />

a Departments of Child Neurology and b Radiology, Helsinki<br />

<strong>University</strong> Central Hospital, Helsinki, Finland<br />

Our aim was to determine the socioeconomic background<br />

of the families with children in special education. This<br />

epidemiological study was carried out during the years<br />

1997–1998 in southern Finland. The information was gathered<br />

from randomly chosen 19 school health care units,<br />

representing evenly different districts. The study group<br />

included 900 pupils, 64% boys and 36% girls, born in<br />

years 1980–1993. Out of these 900 pupils, 23% participated<br />

in education modified for specific neurological disabilities,<br />

46% in adjusted education and 30% in training education.<br />

Multinomial logistic regression was used to compare the<br />

size of the families, position of the pupil in the sibling series,<br />

the parental age and socioeconomic status in these different<br />

teaching groups. Our preliminary results show that neither<br />

the family size nor the position in the sibling series differed<br />

in the three teaching groups. As regards the age of the<br />

parents, the fathers of children in the training education<br />

were older as compared to the fathers of children in the<br />

other teaching groups. Also the socioeconomic status of<br />

parents differed, the parental socioeconomic status in the<br />

training education being higher and in the adjusted education<br />

lower than expected. These results indicate that aged<br />

fathers and highly educated parents may be in risk of having<br />

children in the training education, whereas parents with low<br />

socioeconomic status may be in risk of having children in<br />

adjusted education. The present information will also be<br />

compared to the socioeconomic background of the families<br />

with children in normal education.<br />

FP-T-034<br />

Characteric of the neurological signs at the children with<br />

obesity<br />

R.A. Abedimova<br />

Institute of Postgraduate Study, Almaty, Kazakstan<br />

The aim of study was an investigation of neurological<br />

signs at the children with obesity. We observed 197 children<br />

with obesity (97 of them with exogenicconstitutional<br />

obesity (ECO), 100 of them with hypothalamic obesity<br />

(HO)). We used different methods: neurological assessment,<br />

electrophysiological and neuroradiological. Results: We<br />

found some neurological symptoms such us motor delay<br />

which were determined of 86% of children with ECO and<br />

90% of children with HO). There were neuroradiological<br />

changes such us dilatation of subarachnoidal spaces, devastation<br />

of ventriculis of the brain and sub atrophy of frontal<br />

lobe (41% children with ECO; 54% with HO). Electrophysiological<br />

sings (bilateral synchronized wares, hyper<br />

synchronization) were observed at 51% of children with<br />

ECO, and 63% of children with HO. Moreover, after clinical<br />

and tools investigation we were detected neurological<br />

syndromes such as: astenoneurotical syndrome (58%<br />

ECO; 69% HO); hypertension-hydrocephalic syndrome<br />

(43% ECO; 51% HO); syndrome with vegetodystonia<br />

(49% ECO; 55% HO). Conclusion: Therefore, despite on<br />

the clinical forms of obesity, all children had neurological<br />

sings which characterized of diffuse affection of the brain<br />

during perinatal period.<br />

FP-T-035<br />

Instenon administration in children with burn disease<br />

encephalopathy<br />

T.A. Djumabekov, B.K. Nurmagambetova, B.D.<br />

Gurkabaeva, A.V. Zikeeva, S.R. Aitmagambetova<br />

Children’s Hospital, No.1 Almaty, Kazakhstan<br />

Burn trauma in children is an important medical and<br />

social problem. It is the most frequent pediatric trauma<br />

and leads to high level of mortality or handicap. Serous<br />

water and electrolytes dysbalance leads to disturbances of<br />

central nervous system functions, encephalopathy of<br />

hypoxic and toxic genesis. Instenon, is a product of<br />

Nicomed, and there are several active parts in it, which<br />

activate reticular formation, preserves the functional abilities<br />

of neuron complexes of cortex and subcorical structures.<br />

There is Improvement in oxygenation and<br />

phosphorilisation in nerve cells, stabilisation of central<br />

and peripheral haemodynamics, stimulate the vessel moving<br />

center, the center of vegetative regulation and active metabolism<br />

of myocard. This drug was used as part of a complex<br />

therapy of 34 children aged from 6 months to 14 years of age<br />

with burn trauma, complicated by shock and encephalopathy.<br />

All children had had trauma by boiling water and were<br />

hospitalized in 2 h from the trauma moment. The burn area<br />

varied from 10 to 62%. The I degree of burn shock was<br />

diagnosed in 16 children, the II degree in 12 ones, III in<br />

six ones. Antishock therapy was induced immediately.<br />

Central vein catheterization and surgical dress of wound<br />

were held. Infusional therapy was calculated according to<br />

area and daily physiological solutional need by Brooke<br />

formula. All patients underwent treatment using special<br />

aerofluid bed with temperature regulation. Signs of encephalopathy<br />

were: somnolence and consciousness disturbances<br />

in 26 children, coma of I–II degrees in four. All<br />

children had wide and narrow range tremor in all extremitiles<br />

and in chicken. Because of increasing cardiovascular<br />

and respiratory insufficiency and brain hypoxia, four children<br />

were put on artificial lunges ventilation. Instenon was<br />

administrated in children younger then 1 year of age 1 ml in<br />

glucosa solution 5% intravenously one time daily. For the<br />

older patients Instenon was administrated in dose 2 ml in


648<br />

Abstracts<br />

glucose solution 5% intravenously. Treatment course varied<br />

from 5 to 7 days. Outcomes showed positive dynamics of<br />

clinical indexes. A day after treatment started there were<br />

rapid restore of central nervous system functions, then<br />

tendency to consciousness restore appeared, even going<br />

out of coma in 2–3 days. Artificial lungs ventilation restore<br />

breathe and blood circulating. These factors supported water<br />

and electrolytes metabolism, biochemical indexes restore<br />

and transporting blood functions improvement, what manifests<br />

in positive changes of acid – alkaline blood status.<br />

Conclusion: Instenon administration in children with burn<br />

shock, complicated by toxemia, leads to rapid restoration of<br />

consciousness, improves gases transport, prevents brain<br />

hypoxia and hypoxia of other organs and tissues. Administration<br />

of this drug promotes the outcome of patients from<br />

critical status and decreased the time of hospital treatment<br />

for 3 days.<br />

FP-T-036<br />

Ischemic stroke in child with hypoplasia of right<br />

common and internal carotid artery<br />

J.K. Abdulla, M.O. Al Ajmi, S. Slakovic<br />

Paediatric Neurology Unit, Paediatric Department, Al<br />

Sabah Hospital, Al Safat, Kuwait<br />

Although cerebrovascular disorders occur less often in<br />

children than in adults, recognition of stroke in children<br />

has increased because of the widespread application of<br />

non-invasive neuroimaging studies such as CT, MRI and<br />

MRA. The recognized causes of cerebrovascular disorders<br />

in children are numerous and the probability of identifying<br />

the cause depends on the thoroughness of evaluation. We<br />

are reporting a case with Hypoplasia of rt. common and<br />

internal cartoid artery which is recognized as a rare cause<br />

of stroke in childhood. A 3 years old female child admitted<br />

with acute left sided weakness. On examination she had left<br />

sided hemiparesis, left facial palsy, other systemic examination<br />

was normal. Urgent CT head showed hypodense lesion<br />

in the right caudate and right lentiform nucleus suggestive<br />

of brain infarction. Investigations were done excluded<br />

congenital and acquired heart disease, haematological disorders<br />

and coagulopathy, inflammatory, autoimmune and<br />

other systemic disorders. MRI of brain and neck showed<br />

ischemic partially haemorrhagic infarction in rt. paraventricular<br />

mostly basal ganglia due to occluded or undeveloped<br />

rt. middle cerebral artery, rt. ant. cerebral artery. MRA<br />

showed hypoplastic rt. common car. artery, in particular<br />

int. car. artery with occlusion of middle and anterior cerebral<br />

arteries. Accentuated both posterior cerebral arteries<br />

with marked collaterals supplying territory of rt. middle<br />

cerebral artery. During hospitalization, she remained<br />

conscious and she started to show slow gradual improvement<br />

with physiotherapy. Currently, she is having mild left<br />

sided spastic hemiparesis with shortening of the left tendon<br />

Achillis and shortening of left leg.<br />

FP-T-037<br />

Therapeutic effect of parenan and cyproheptadine on<br />

childhood migraine<br />

B.-X. Tang<br />

Pediatrics Department of Central Hospital, Jinshan Shanghai,<br />

China<br />

Objective: To evaluate the effect and safety of Perenan in<br />

treating childhood migraine. Methods: Perenan and Cyproheptadine<br />

were given orally in the period of 1–3 months.<br />

Results: There were 25 children in Perenan treatment group<br />

and 27 in Cyproheptidine treatment group. The effective<br />

rate were 92 and 70.3% in Perenan and Cyproheptidine<br />

treatment, respectively. The difference between the two<br />

groups was statistically significant (P , 0:05). The therapeutic<br />

effect of Perenan was better than that of Cyproheptadine,<br />

and no side effect was observed during the treatment.<br />

Conclusion: Perenan was an effective and safe drug in dealing<br />

with childhood migraine.<br />

FP-T-038<br />

Synthesis and properties of chitosan-metal complexes<br />

S.Sh. Rashidova, N.L. Voropaeva, S. Pulatova, I.N. Ruban<br />

Institute of Polymer Chemistry and Physics Uzbekistan<br />

Academy of Sciences, Tashkent, Republic Uzbekistan<br />

Introduction: Investigation of chitosans interaction with<br />

ions of transition metals and obtaining of water-soluble<br />

polymermetal complexes with the controlled content of<br />

metal ions is an actual task. Its deciding will allow to<br />

propose a new preparations for medicine, agriculture etc.<br />

Results and discussion: Chitosan complex formation with<br />

metal ions of a transitional series (Co, Ni, Cu, Mn) have<br />

been investigated. Estimation of changes in the spectra of<br />

chitosan and its metal-complexes testify that all main<br />

changes take place in a region of stretching and deformation<br />

vibrations of amide bond (Amide-I, -II and -III). It is<br />

accounted well, because chitosan metal-complexes synthesis<br />

was carried out in an acid media and chitosan aminogroup<br />

is protonized. Therefore the most preferable interaction<br />

is an amide bond of samples chitin residue. In this case<br />

a sharp change of Amide-I and -II intensity is observed,<br />

depending on metal ions content, that can be used in a future<br />

for metal content estimation in the samples. Potentiometric<br />

estimation of chitosan interaction with metal ions evidences<br />

of significant complex-formation in a region of neutral pH,<br />

when an initial polymer precipitates. It is likely, that at a<br />

transition to neutral and weak-alkaline media (pH < 8) chitosane<br />

amino groups also take part in the process of interaction<br />

with metal ions. It is necessary a more detailed<br />

investigation of this phenomenal. Some experiments on<br />

chitosane carboxymethylation by monochloracetic acid<br />

were carried out. The conditions of chitosane-metalcomplex<br />

synthesis which allow to get a homogeneous


Abstracts 649<br />

complexes with metal ions content from 0.8 to 8.4 were<br />

selected. It was shown, that in the samples synthesized,<br />

metal ions are distributed rather uniformly along a polymeric<br />

chains. The composition, structure of the complexes<br />

formed and the conditions of incliding in a coordination<br />

process of polymer different functional groups, as well as<br />

a dynamic of macromolecular tangle behaviour in the<br />

process of metal ions binding are determined. It eventually<br />

allows to predict the system chitosan metal-ion system<br />

behavior in a real conditions when use. Laboratory and<br />

field testing of regulating and fungicidal properties of chitosan<br />

and its metal-complexes on rice and cotton seeds was<br />

carried out. The data obtained show a high activity of<br />

preparations tested. The conditions for rice and cotton<br />

seeds treatment as a growth stimulator on the base of chitin,<br />

chitosane and their derivatives are selected.<br />

FP-T-039<br />

Daytime sleepiness in children and adolescents as<br />

assessed by the Epworth sleepiness scale<br />

C.V. Harden, G.A. Fenton, C. Vemulapalli, J. Puetz, P.<br />

Codden, T.J. Geller<br />

St Louis <strong>University</strong> Medical Center, USA<br />

Objective: To evaluate the incidence of sleep abnormalities,<br />

including excessive daytime sleepiness and restless leg<br />

symptoms in post chemo/radiation therapy survivors of<br />

leukemia, comparing them to healthy sibling controls.<br />

Method: Patients with a previous diagnosis of Leukemia,<br />

who are disease-free following therapy, and non-affected<br />

siblings were consented, and questioned using the Epworth<br />

Sleepiness Scale (ESS). This questionnaire provides a<br />

measurement of the subject’s general daytime drowsiness.<br />

A target population of 80 subjects has not yet been reached.<br />

Nonetheless, a high incidence of ESS scores .10 has been<br />

noted, (a level which in adult studies has been associated<br />

with moderate daytime sleepiness). Results: Mean age of<br />

evaluated leukemia survivors is 13.7 years, SD 4.5: mean<br />

age of sibling controls is 12.9 years, SD of 5.5. Total group<br />

mean age is 13.4 years; SD of 4.75. Total group mean ESS<br />

score (42 subjects) is 7.42, SD of 3.66, with a 30.9% incidence<br />

of ESS scores .10. Conclusions: Our research<br />

suggests that ESS scores are higher in pediatric and adolescent<br />

populations compared to adult studies. In reviewing the<br />

literature regarding measures of chronic sleepiness, a single<br />

reliable tool has not been established for this age group.<br />

Among adolescent drivers in New Zealand, the distribution<br />

of ESS scores was lower than in older drivers, but our data<br />

may suggest a higher incidence of moderate daytime sleepiness<br />

in an US pediatric and adolescent population. Our<br />

enrollment does not yet permit a comparison between leukemic<br />

survivors and control siblings, regarding the incidence<br />

of excessive daytime sleepiness.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!